ENSG00000167323,STIM1,calcium influx regulation,oncogenic process,increased proliferation,metastasis promotion,therapeutic target,protein-protein interaction
ENSG00000144935,TRPC1,calcium signaling pathway,cell proliferation,epithelial-to-mesenchymal transition (emt),nf-κb activation,tumor progression,therapeutic target
ENSG00000089250,NOS1,angiogenesis,promoter of tumor progression,enhancer of cell migration,regulator of nitric oxide signaling,prognostic biomarker potential,cellular interaction and regulation
ENSG00000058668,ATP2B4,cellular calcium regulation,ca2+ pump activity,apoptosis evasion,protein kinase activation,signaling pathway modulation,tumor progression promotion
ENSG00000069431,ABCC9,atp-sensitive potassium channels,cellular ion balance,tumor progression,cancer resistance,apoptosis inhibition,genetic mutations
ENSG00000187486,KCNJ11,cellular proliferation,channel dysfunction,insulin signaling pathway,oncogenic driver,potassium homeostasis regulation,tumor growth promotion
ENSG00000084754,HADHA,mitochondrial dysfunction,fatty acid metabolism disorder,energetic alterations,cellular proliferation,metabolic reprogramming,oncogenic transformation
ENSG00000138029,HADHB,mitochondrial function,dysregulated fatty acid oxidation,metabolic reprogramming,oxidative stress,tumor suppressor potential,energetic homeostasis
ENSG00000197265,GTF2E2,transcriptional regulation,overexpression,tumor progression,cell proliferation,gene expression,oncogenic activity
ENSG00000153767,GTF2E1,tfiie transcriptional regulation,cell proliferation,dna repair,metastasis promotion,tumor aggressiveness enhancement,chemotherapy resistance
ENSG00000140307,GTF2A2,transcriptional regulation,cellular proliferation,dna repair mechanisms,oncogenesis,transcription factor assembly,gene expression dysregulation
ENSG00000165417,GTF2A1,transcriptional regulation,cell proliferation,oncogenic pathway activation,chromatin remodeling,histone modification,tumor progression
ENSG00000162738,VANGL2,wnt signaling pathway,maintenance of tissue polarity,regulation of epithelial-to-mesenchymal transition (emt),cell migration and invasion,tissue architecture regulation,cytoskeletal component interaction
ENSG00000274287,SCRIB,tumor suppression,epithelial polarity regulation,cell growth inhibition,pi3k/akt pathway modulation,apoptosis induction,cell adhesion maintenance
ENSG00000004975,DVL2,wnt/beta-catenin pathway,constitutive activation,increased cell proliferation,cell migration enhancement,oncogenic driver,molecular target
ENSG00000102981,PARD6A,par-1 interaction,ampk signaling dysregulation,abl1/egfr interaction,oncogenic protein binding,cell proliferation enhancement,prognostic marker
ENSG00000177885,GRB2,ras/raf/mapk signaling,gain of function mutations,oncogenic pathway,cell proliferation,tumor progression,signaling transduction
ENSG00000109458,GAB1,cell growth regulation,pi3k/akt pathway activation,oncogenic potential,cell proliferation enhancement,mapk/erk signaling modulation,tyrosine kinase interaction
ENSG00000146648,EGFR,overexpression,tumor progression,cell proliferation,therapeutic target,signaling pathway interaction,apoptosis resistance
ENSG00000138798,EGF,emt induction,pi3k/akt signaling,tumor progression,cell proliferation,angiogenesis,therapeutic target
ENSG00000121879,PIK3CA,constitutive activation,gain of function mutations,pi3k/akt pathway,therapeutic target,genomic instability,tumor progression
ENSG00000145675,PIK3R1,pi3k/akt pathway,oncogenic driver,regulatory subunit mutation,cell proliferation enhancement,tumor progression facilitation,genomic instability contributor
ENSG00000197122,SRC,gain of function mutations,non-receptor tyrosine kinase activity,tumor progression,cell proliferation enhancement,metastasis promotion,therapeutic target
ENSG00000089159,PXN,focal adhesion regulation,cell migration and invasion,protein-protein interaction,tumor progression and metastasis,angiogenesis promotion,signaling pathway modulation
ENSG00000137392,CLPS,androgen-regulated expression,cell growth regulation,poor prognosis marker,protein overexpression,tumor progression association,upregulated in tumor tissues
ENSG00000175535,PNLIP,lipid metabolism,cell proliferation,tumor progression,metabolic reprogramming,inflammatory regulation,glycolytic activation
ENSG00000078369,GNB1,cellular processes regulation,oncogenic signaling pathway,cell proliferation modulation,survival and migration enhancement,tumor growth promotion,chemotherapy resistance development
ENSG00000127928,GNGT1,gain of function mutations,signaling pathway activation,cell proliferation regulation,tumor progression association,g-protein regulation,prognostic marker
ENSG00000198515,CNGA1,calcium influx regulation,constitutive activation,oncogenic signaling,tumor progression,ion channel function,cell proliferation
ENSG00000070729,CNGB1,cellular proliferation,apoptosis regulation,ion channel function,signal transduction,tumorigenesis promotion,cell survival enhancement
ENSG00000257365,FNTB,fatty acid synthesis regulation,cellular energy homeostasis,tumor suppressor function,lipid metabolism modulation,apoptosis regulation,cell growth inhibition
ENSG00000168522,FNTA,fatty acid elongation,cell survival,sphingolipid biosynthesis,tumor progression,lipid metabolism,cancer cell proliferation
ENSG00000113522,RAD50,homologous recombination,genomic instability,dna damage response,aberrant signaling,tumor progression,somatic mutation
ENSG00000020922,MRE11,genomic instability,tumor suppressor loss,dna repair complex,homologous recombination,mutagenesis driving oncogenesis,cell cycle checkpoint regulation
ENSG00000182481,KPNA2,karyopherin function,cell cycle regulation,protein-protein interaction,tumor aggressiveness,chemotherapy resistance,poor prognosis outcome
ENSG00000104320,NBN,dna repair defect,genomic instability,loss-of-function mutation,homologous recombination repair disruption,tumor suppressor function loss,cancer driver mutation
ENSG00000172977,KAT5,dna repair mechanisms,tumor suppressor inhibition,histone acetylation,cell proliferation regulation,oncogenic signaling pathway,protein-protein interactions
ENSG00000149311,ATM,genomic instability,dna repair mechanism,cell cycle checkpoint control,tumor progression,therapeutic target,prognostic marker
ENSG00000009954,BAZ1B,chromatin remodeling,genome stability,cellular proliferation,gene expression regulation,protein-protein interactions,tumor progression
ENSG00000153147,SMARCA5,genomic instability,chromatin remodeling,homologous recombination,dna repair mechanisms,cellular proliferation,metabolic regulation
ENSG00000103275,UBE2I,ubiquitination pathway,protein turnover regulation,cell proliferation enhancement,nf-kb signaling interaction,oncogenic process contribution,tumor suppressor role modulation
ENSG00000116030,SUMO1,protein modification,transcriptional regulation,tumor progression,apoptosis inhibition,dna damage response,cell cycle modulation
ENSG00000169139,UBE2V2,ubiquitin-conjugating enzyme,oncogene interaction,dna repair regulation,cell cycle modulation,protein homeostasis modification,cancer-promoting function
ENSG00000177889,UBE2N,cell cycle regulation,anti-apoptotic signaling,protein ubiquitination,genomic instability,tumor progression modulation,brca1 interaction
ENSG00000138376,BARD1,genomic stability maintenance,dna repair regulation,tumor suppressor function,brca1 interaction,telomere length maintenance,cell cycle regulation
ENSG00000012048,BRCA1,genomic instability,dna repair dysfunction,tumor suppression failure,oncogene activation,chromosomal instability,cancer driver mutation
ENSG00000188612,SUMO2,sumoylation,cell cycle regulation,dna damage response,apoptosis inhibition,tumor progression,oncoprotein modification
ENSG00000225589,MDC1,dna damage response,genomic instability,non-homologous end joining repair,genome maintenance,tumor suppressor function,oncogenic potential
ENSG00000128731,HERC2,pi3k/akt pathway modulation,egfr pathway interaction,ubiquitination regulation,tumor suppressor activity loss,protein degradation dysregulation,cell proliferation enhancement
ENSG00000164053,ATRIP,genomic instability,dna damage response,cell cycle regulation,tumor suppressor function,checkpoint activation,apoptosis induction
ENSG00000175054,ATR,dna damage response,checkpoints regulation,replication stress sensing,genomic stability maintenance,tumor progression,cell cycle regulation
ENSG00000111602,TIMELESS,mitotic checkpoint control,genomic instability,dna repair regulation,cell cycle regulation,aneuploidy promotion,tumor progression
ENSG00000075131,TIPIN,dna replication regulation,genomic instability promotion,tumor progression association,cell cycle modulation,dna damage response interaction,oncogenic process contribution
ENSG00000163605,PPP4R2,pp4 regulation,cell cycle regulation,histone modification,genomic stability,protein interaction,oncogenic transformation
ENSG00000149923,PPP4C,genomic instability,tumor suppressor function,dephosphorylation activity,cell cycle regulation,apoptosis inhibition,dna repair dysfunction
ENSG00000108384,RAD51C,genomic instability,cell cycle regulation,genetic mutation,dna damage response,homologous recombination,protein-protein interaction
ENSG00000126215,XRCC3,genomic instability,dna double-strand break repair,homologous recombination,genetic alterations,tumor progression,biomarker potential
ENSG00000197774,EME2,chromatin remodeling,nucleosome unwinding,genomic stability,epigenetic regulation,oncogenic potential,helicase activity
ENSG00000172732,MUS81,genomic instability,homologous recombination repair,double-strand break repair,holliday junction resolution,non-homologous end joining,alternative end joining
ENSG00000154920,EME1,genomic instability,dna double-strand breaks,homologous recombination,chromosomal instability,tumor progression,cancer cell proliferation
ENSG00000139618,BRCA2,telomere maintenance,genomic instability,homologous recombination repair,epithelial-to-mesenchymal transition (emt),chromosomal instability,oncogene inactivation
ENSG00000051180,RAD51,homologous recombination repair,genomic instability,tumor initiation,synthetic lethality target,brca1/2 interaction,dna helicase function
ENSG00000175595,ERCC4,dna damage repair,genomic instability,impaired nucleotide excision repair,nucleotide excision repair pathway,oncogenic drivers,tumor progression
ENSG00000012061,ERCC1,dna repair pathway,genomic stability,platinum-based chemotherapy resistance,nucleotide excision repair,apoptosis modulation,genetic instability
ENSG00000073050,XRCC1,genomic instability,dna repair pathway,base excision repair (ber),oncogenesis,scaffolding protein,genome maintenance
ENSG00000005156,LIG3,base excision repair,dna damage response,genome instability,oncogenesis,tumor progression,prognostic marker
ENSG00000196419,XRCC6,dna repair,genetic instability,tumor progression,oncogenesis,genomic stability,nhej pathway
ENSG00000079246,XRCC5,genomic instability,dna repair mechanism,nhej pathway activation,tumor progression,therapeutic resistance,cancer cell survival
ENSG00000152422,XRCC4,genomic instability,non-homologous end joining (nhej),dna damage response,biomarker potential,promoter hypomethylation,tumor progression
ENSG00000174405,LIG4,genomic instability,telomere maintenance,dna repair mechanisms,nhej pathway,oncogenic mutations,chromosomal alterations
ENSG00000049860,HEXB,glycosphingolipid metabolism,tumor progression,oncogenic activity,cell proliferation,genetic instability,therapeutic target
ENSG00000213614,HEXA,lysosomal function,sphingolipid metabolism,cellular stress response,autophagy regulation,apoptosis modulation,lipid intermediate accumulation
ENSG00000151348,EXT2,genomic instability,loss-of-function mutations,dna repair mechanism,chromosomal abnormalities,tumor suppressor function,epigenetic regulation
ENSG00000182197,EXT1,dna repair and processing,mutation hotspot,tumor suppressor function,genomic instability,dna replication regulation,3'-5' exonuclease activity
ENSG00000115904,SOS1,ras pathway activation,oncogenic driver,guanine nucleotide exchange factor,cell proliferation,survival signaling,tumor metastasis
ENSG00000170312,CDK1,cell cycle regulation,proliferation enhancer,tumor suppressor loss,dna damage response,cyclin-dependent kinase,cell division regulator
ENSG00000134057,CCNB1,cell cycle progression,constitutive overexpression,chromosomal instability,genomic alterations,oncogenic driver,aggressive tumor behavior
ENSG00000165494,PCF11,cell cycle regulation,chromatin remodeling,dna repair,oncogene activation,tumor progression,biomarker
ENSG00000172409,CLP1,genomic instability,cell cycle regulation,chromosomal segregation,aneuploidy driver,dna repair mechanism,centromere function
ENSG00000187079,TEAD1,hippo signaling pathway,constitutive activation,cell proliferation regulation,transcriptional regulation,epithelial-to-mesenchymal transition,tumor suppressor dysfunction
ENSG00000137693,YAP1,hippo pathway regulation,transcriptional co-activation,cellular growth promotion,apoptosis evasion,overexpression and mutation,constitutive activation
ENSG00000074219,TEAD2,hippo-yap signaling,oncogene activity,tumor progression,epithelial-to-mesenchymal transition (emt),transcription factor regulation,genomic mutations
ENSG00000007866,TEAD3,hippo pathway,oncogenic driver,transcriptional regulation,cell proliferation,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000197905,TEAD4,hippo signaling pathway,tumor progression,transcriptional regulation,cell growth regulation,prognostic biomarker,tissue homeostasis
ENSG00000132964,CDK8,transcriptional regulation,oncogenic driver,cell cycle progression,gene expression modulation,protein kinase activation,therapeutic target
ENSG00000112237,CCNC,cell cycle regulation,oncogene activation,chromatin remodeling,transcriptional elongation,cancer progression,protein-protein interactions
ENSG00000101665,SMAD7,loss of function mutations,tgf-?-signaling pathway disruption,epithelial-to-mesenchymal transition (emt) promotion,cell invasion and metastasis facilitation,tumor suppressor activity,cancer progression
ENSG00000157450,RNF111,ubiquitination regulation,tumor suppressor degradation,oncogene activation,cell proliferation enhancement,cancer progression driver,therapeutic target candidate
ENSG00000284792,PTEN,pi3k/akt pathway regulation,gene loss or mutation,tumor suppressor function,cell proliferation regulation,dna repair interaction,genomic instability prevention
ENSG00000141510,TP53,genomic instability,tumor suppressor function loss,cell cycle arrest disruption,apoptosis inhibition,pi3k/akt/mtor pathway activation,dna repair impairment
ENSG00000165699,TSC1,mtor pathway activation,cell proliferation,tumor suppression,genomic instability,apoptosis inhibition,protein-protein interaction
ENSG00000103197,TSC2,mtor pathway inhibition failure,constitutive activation,loss-of-function mutations,tumor suppressor function,cell proliferation enhancement,oncogenic signaling
ENSG00000284194,SCO2,mitochondrial function,metabolic reprogramming,cell proliferation,energy metabolism regulation,apoptosis resistance,tumor aggressiveness enhancement
ENSG00000048392,RRM2B,cell proliferation,genomic instability,dna replication,ribonucleotide reductase regulation,tumorigenesis driver,oncogenic transcriptional regulation
ENSG00000135423,GLS2,glutaminase activity,redox regulation,metabolic reprogramming,tumor growth promotion,therapeutic target,genetic amplification
ENSG00000146674,IGFBP3,igf regulation,tumor suppression,apoptosis induction,cell proliferation inhibition,p53 interaction,dna damage response
ENSG00000141682,PMAIP1,pro-apoptotic function,tumor suppressor role,apoptosis regulation,cell death pathway regulation,mitochondrial permeability regulation,bcl2 family interaction
ENSG00000015475,BID,apoptosis regulation,tumor progression association,pro-apoptotic function,cell death modulation,cancer prognosis influence,mitochondrial membrane permeabilization
ENSG00000120471,TP53AIP1,**

protein degradation,p53 pathway disruption,ubiquitination,genomic instability,oncogenesis promotion,tumor suppressor inhibition
ENSG00000197050,ZNF420,oncogene,transcriptional regulator,apoptosis evasion,cell proliferation,tumor suppressor interaction,prognostic biomarker
ENSG00000115107,STEAP3,oncogenic signaling,iron regulation,plasma membrane localization,cell growth promotion,nf-κb activation,tumor progression
ENSG00000104765,BNIP3L,mitochondrial regulation,apoptosis inhibition,pi3k/akt signaling modulation,tumor progression facilitation,cell survival promotion,therapeutic target
ENSG00000170855,TRIAP1,transcription regulation,apoptosis regulation,cell cycle progression,tumor suppressor interaction,dna repair modulation,protein-protein interaction
ENSG00000042286,AIFM2,dna repair,genomic instability,tumor progression,epithelial-to-mesenchymal transition,oncogenic processes,therapeutic target
ENSG00000164938,TP53INP1,genomic stability regulation,tumor suppressor function,p53 interaction,dna damage response,g2/m checkpoint control,cell cycle regulation
ENSG00000120868,APAF1,apoptosis dysregulation,genomic instability,tumor progression,resistance to chemotherapy,cell proliferation enhancement,protein-protein interaction
ENSG00000177595,PIDD1,apoptosis regulation,cell cycle control,tumor suppressor function,programmed cell death,dna damage response,genetic instability
ENSG00000169372,CRADD,apoptosis regulation,caspase-2 activation,tumor suppressor function,dna damage response,death receptor interaction,p53 modulation
ENSG00000091106,NLRC4,inflammasome activation,tumor microenvironment modulation,immune cell infiltration induction,il-1β and il-18 maturation,bacterial pathogen recognition,protein-protein interaction
ENSG00000138794,CASP6,apoptosis inhibition,tumor progression,oncogenesis,cell death regulation,caspase activation,proteolytic activity
ENSG00000003400,CASP10,cellular apoptosis,proteolytic activation,apoptosis regulation,tumor suppression,genetic alterations,cancer prognosis
ENSG00000104419,NDRG1,tumor suppression,cell proliferation,cell migration,metastasis regulation,protein-protein interaction,growth arrest
ENSG00000281449,BCL2L14,apoptosis inhibition,anti-apoptotic function,tumor progression,chemoresistance,prognostic marker,cell survival modulation
ENSG00000089685,BIRC5,apoptosis inhibition,genomic instability,cell survival promotion,tumor progression,chemosensitivity reduction,protein-protein interactions
ENSG00000113916,BCL6,apoptosis regulation,cell proliferation,transcriptional repressor,oncogene activation,gene expression regulation,protein interaction network
ENSG00000161642,ZNF385A,tumor suppressor function,dna repair mechanisms,cell growth regulation,apoptosis induction,transcriptional regulation,prognostic marker potential
ENSG00000116017,ARID3A,**

chromatin remodeling,cell proliferation,transcriptional dysregulation,oncogenesis,metastasis,biomarker 
**
ENSG00000165891,E2F7,tumor suppression,apoptosis induction,cell cycle regulation,transcriptional repression,dna damage response,histone modification
ENSG00000129173,E2F8,tumor suppressor function,cell cycle regulation,transcriptional repression,genomic instability,oncogene silencing,therapeutic target
ENSG00000116717,GADD45A,tumor suppressor function,cell cycle regulation,apoptosis induction,dna damage repair,oncogenic signaling modulation,prognostic marker potential
ENSG00000087586,AURKA,cell cycle regulation,centrosome separation,chromosomal instability,aneuploidy promotion,protein phosphorylation,apoptosis resistance
ENSG00000132646,PCNA,genomic instability,tumor progression,dna replication,cell cycle regulation,oncogene potential,transcriptional regulation
ENSG00000087088,BAX,apoptosis regulation,tumor suppressor function,bcl2 family interaction,mitochondrial release,cell survival enhancement,therapeutic target
ENSG00000175793,SFN,genetic instability,cell cycle regulation,tumor suppressor function,dna repair mechanism,apoptosis regulation,proteasome interaction
ENSG00000145632,PLK2,apoptosis evasion,cell cycle regulation,cytokinesis phosphorylation,enhanced proliferation,mitotic checkpoint disruption,tumor progression
ENSG00000173846,PLK3,cell cycle regulation,genomic instability,oncogenic processes,tumor progression,centrosome maturation,spindle checkpoint dysfunction
ENSG00000102760,RGCC,hypoxia response,oncogenic signaling,cell proliferation,angiogenesis,tumor suppression,genomic instability
ENSG00000118495,PLAGL1,tumor suppressor function,cellular proliferation regulation,apoptosis promotion,cancer biomarker,cell cycle progression repression,transcriptional regulation interaction
ENSG00000115966,ATF2,cell proliferation,tumor progression,transcriptional regulation,apoptosis inhibition,pro-survival signaling,cancer driver gene
ENSG00000177606,JUN,oncogenic transcription factor,cell proliferation enhancement,apoptosis suppression,tumor progression driver,transcriptional regulation,growth factor signaling
ENSG00000170345,FOS,ap-1 transcription factor,cell cycle progression,tumor growth promotion,immune evasion,metastasis promotion,inflammation regulation
ENSG00000122512,PMS2,dna mismatch repair deficiency,genomic instability,chromosomal alteration,epigenetic modification,cancer progression,tumor suppressor activity
ENSG00000076242,MLH1,genomic instability,dna mismatch repair,tumor suppressor function,microsatellite instability-high (msi-h) tumors,poor prognosis,resistance to therapy
ENSG00000158169,FANCC,genomic instability,impaired dna repair,tumor suppressor dysfunction,cell cycle dysregulation,oncogene activation,genetic mutations
ENSG00000134574,DDB2,dna damage recognition,nucleotide excision repair pathway,genomic instability,tumor suppressor function,impaired dna repair,cancer driver mutations
ENSG00000057657,PRDM1,genetic instability,epigenetic regulation,gene expression modulation,cell cycle dysregulation,apoptosis suppression,immune evasion mechanism
ENSG00000135679,MDM2,p53 degradation,oncogene regulation,tumor suppression inhibition,genomic instability,cell proliferation promotion,therapeutic target
ENSG00000198625,MDM4,**

mdm2/p53 complex formation,tumor suppressor function disruption,p53 inhibition,cell cycle progression promotion,apoptosis suppression,overexpression association 

**
ENSG00000113328,CCNG1,genomic instability,oncogene/tumor suppressor function,cell cycle regulation,dna repair mechanism,genotoxic stress response,apoptosis resistance
ENSG00000064393,HIPK2,**
apoptosis suppression,tumor suppressor function,p53 pathway regulation,cell survival enhancement,dna repair impairment,hippo signaling pathway involvement
**
ENSG00000127445,PIN1,cell signaling regulation,protein modification,genomic stability,tumor growth promotion,dna damage response,oncogenic driver
ENSG00000163349,HIPK1,tumor suppressor function,loss of function mutations,apoptosis regulation,cell cycle progression,genome instability,prognostic marker
ENSG00000149136,SSRP1,dna damage response,genomic instability,oncogene function,homologous recombination,chromatin remodeling,genome maintenance
ENSG00000092201,SUPT16H,genomic instability,histone modification,oncogenic complex assembly,chromatin remodeling,apoptosis evasion,cell cycle progression
ENSG00000101266,CSNK2A1,**
cell cycle regulation,dna repair dysregulation,protein phosphorylation,tumor aggressiveness,apoptosis evasion,oncogenic signaling
ENSG00000070770,CSNK2A2,cell proliferation,genomic instability,oncogenesis,protein kinase activation,tumor growth,wnt/β-catenin pathway
ENSG00000088325,TPX2,constitutive activation,gain of function mutations,oncogene,therapeutic target,microtubule dynamics,pi3k/akt pathway interaction
ENSG00000188976,NOC2L,nuclear transport regulation,cell cycle progression,mitotic regulation,centrosome dynamics,genomic stability maintenance,tumor suppressor function
ENSG00000176749,CDK5R1,cell cycle regulation,constitutive activation,cancer driver gene,signaling pathway modulation,apoptosis resistance,tumor progression
ENSG00000164885,CDK5,cell cycle regulation,genomic instability,oncogenic transformation,tumor progression,apoptosis inhibition,protein kinase activation
ENSG00000152192,POU4F1,transcription factor regulation,oncogenic function,cell proliferation,tumor aggressiveness,poor prognosis,epigenetic regulation
ENSG00000151615,POU4F2,transcription factor regulation,oncogene activation,tumor progression,epithelial-to-mesenchymal transition,cell proliferation,metastasis promoter
ENSG00000172530,BANP,cell cycle regulation,apoptosis suppression,transcriptional modulation,tumor aggressiveness marker,protein-dna interaction,genomic instability
ENSG00000025293,PHF20,chromatin remodeling,oncogene function,transcriptional regulation,cell proliferation enhancement,tumor progression promotion,therapeutic target
ENSG00000185513,L3MBTL1,histone modification regulation,chromatin remodeling,genome stability maintenance,tumor suppressor function,cell cycle control disruption,dna damage response impairment
ENSG00000238134,EHMT2,epigenetic regulation,tumor suppressor silencing,oncogene activation,genomic instability,cell proliferation enhancement,histone methylation
ENSG00000181090,EHMT1,histone methylation,epigenetic regulation,oncogenic potential,cell cycle progression,chromatin compaction,transcriptional repression
ENSG00000137203,TFAP2A,epithelial differentiation,pi3k/akt pathway regulation,oncogene function,transcriptional activation,emt promotion,cell proliferation enhancement
ENSG00000124795,DEK,chromatin regulation,cell cycle progression,gene expression modulation,dna repair capacity,oncogenic driver,tumor aggressiveness
ENSG00000087510,TFAP2C,transcriptional regulator,oncogenic mutations,tumor progression,cell proliferation,downstream signaling pathway activation,gene expression dysregulation
ENSG00000186153,WWOX,tumor suppressor function,pi3k/akt pathway regulation,cell cycle regulation,protein degradation regulation,biomarker for prognosis,oncogenic process inhibition
ENSG00000008196,TFAP2B,transcriptional regulation,epithelial-mesenchymal transition,cell migration and invasion,co-regulatory interactions,poor prognosis,tumor stage advancement
ENSG00000127337,YEATS4,histone modification,chromatin regulation,gene expression regulation,oncogene potential,epigenetic reprogramming,therapeutic target
ENSG00000091831,ESR1,estrogen receptor activation,hormone-regulated transcription,tumor progression,cell proliferation,metastasis promotion,genomic instability
ENSG00000156802,ATAD2,chromatin remodeling,transcriptional regulation,cell cycle progression,genomic instability,oncogenic potential,histone modification
ENSG00000112715,VEGFA,angiogenesis promotion,pi3k/akt signaling interaction,tumor aggressiveness marker,poor prognosis indicator,vegfr1/2 receptor binding,hypoxia adaptation
ENSG00000163235,TGFA,tumor progression,cell proliferation,signaling pathway,epidermal growth factor receptor (egfr) ligand,overexpression,mapk/erk pathway activation
ENSG00000124762,CDKN1A,cyclin-dependent kinase inhibition,cell cycle progression regulation,genomic instability induction,tumor suppressor function loss,uncontrolled cell proliferation,cell cycle checkpoint bypass
ENSG00000159216,RUNX1,genomic instability,transcriptional dysregulation,tumor progression,oncogenic potential,chromatin remodeling,cell cycle control
ENSG00000078900,TP73,tumor suppressor,oncogenic properties,cell cycle regulation,apoptosis regulation,dna damage response,genomic instability
ENSG00000179588,ZFPM1,tumor suppressor gene regulation,cell cycle progression,transcriptional modulation,oncogenic process promotion,aggressive tumor behavior,therapeutic target
ENSG00000102145,GATA1,transcriptional regulation,cell differentiation,hematopoiesis,globin production,gene expression modulation,oncogenesis
ENSG00000143387,CTSK,tumor progression,metastasis,cellular signaling regulation,biomarker,extracellular matrix degradation,lysosomal function
ENSG00000197641,SERPINB13,proteolytic regulation,cell migration inhibition,tumor invasion suppression,biomarker downregulation,histone modification,proteasome interaction
ENSG00000110092,CCND1,cell cycle dysregulation,oncogenic driver,proliferation promotion,tumor progression,therapeutic target,genomic amplification
ENSG00000135446,CDK4,cell cycle progression,oncogene activation,growth factor signaling,cancer cell proliferation,protein kinase activity,cell cycle regulation
ENSG00000173153,ESRRA,oncogenic function,cell proliferation regulation,transcriptional regulation,pathway interaction,genomic mutations,biomarker potential
ENSG00000109819,PPARGC1A,metabolic reprogramming,glycolytic shift,tumor growth,warburg effect,aerobic glycolysis,prognostic marker
ENSG00000122691,TWIST1,emt induction,wnt/β-catenin pathway activation,notch signaling modulation,apoptosis suppression,angiogenesis promotion,cancer stem cell maintenance
ENSG00000124813,RUNX2,transcription factor activity,overexpression,dysregulation of cell differentiation,oncogenic transformation,metastasis suppression,co-regulatory interactions
ENSG00000109705,NKX3-2,tumor suppressor function,loss-of-function mutations,transcriptional regulation,cell cycle progression,apoptosis modulation,oncogenic pathway disruption
ENSG00000120149,MSX2,epithelial-to-mesenchymal transition,tumor progression,transcription factor activity,cellular differentiation regulation,metastasis promotion,proliferation enhancement
ENSG00000141646,SMAD4,loss of function mutations,tumor suppressor,tgf-β signaling disruption,cell cycle regulation,dna repair defect,poor prognosis
ENSG00000170365,SMAD1,disrupted tgf-β signaling,oncogenic activation,tumor progression,epithelial-to-mesenchymal transition,transcriptional regulation,metastasis driver
ENSG00000020633,RUNX3,transcriptional regulator,tumor suppressor gene,cell cycle regulation,apoptosis induction,epithelial differentiation,metastatic suppression
ENSG00000166949,SMAD3,tumor suppressor function,tgf-β pathway disruption,oncogenic mutations,cell cycle regulation,apoptosis inhibition,epithelial-to-mesenchymal transition (emt) modulation
ENSG00000198176,TFDP1,cell proliferation,tumor progression,oncogenic potential,genomic instability,transcription factor regulation,cell cycle regulation
ENSG00000169016,E2F6,cell cycle regulation,tumor suppression,transcriptional repression,oncogene inhibition,apoptosis induction,cell differentiation
ENSG00000114126,TFDP2,cell cycle regulation,transcriptional regulation,oncogene activation,tumor progression,dna replication,cell proliferation
ENSG00000174197,MGA,cell cycle progression,oncogenesis,transcriptional regulator,overexpression,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000125952,MAX,tumor progression,cell proliferation,transcriptional regulation,protein-protein interaction,genetic amplification,apoptosis evasion
ENSG00000213246,SUPT4H1,transcriptional regulation,chromatin remodeling,cellular proliferation,apoptosis regulation,gene expression modulation,dna damage response
ENSG00000196235,SUPT5H,transcription regulation,cellular proliferation,gene expression modulation,therapeutic target,tumor aggressiveness,cancer progression
ENSG00000103363,ELOB,protein synthesis regulation,cell growth promotion,tumor progression association,overexpression linked to poor prognosis,80s ribosome complex assembly,unfolded protein response modulation
ENSG00000154582,ELOC,genomic instability,cell proliferation,transcriptional elongation,rna polymerase ii regulation,tumor survival,ablation of function mutations
ENSG00000125651,GTF2F1,cellular proliferation,transcriptional regulation,genomic instability,tumor progression,overexpression,protein-protein interactions
ENSG00000188342,GTF2F2,pi3k/akt pathway,transcriptional regulation,overexpression,cellular proliferation,tumorigenesis,genomic instability
ENSG00000114503,NCBP2,mrna degradation,microrna regulation,tumor progression,therapeutic target,chromatin modification,epigenetic regulation
ENSG00000136937,NCBP1,mrna processing,pi3k/akt signaling,cell proliferation,oncogenesis,dna damage response,therapeutic target
ENSG00000224748,TAP1,cellular transport mechanism,antigen processing regulation,immune evasion mechanisms,protein expression modulation,cancer-associated interactions,tumor progression influence
ENSG00000223481,TAP2,antigen processing,immune evasion,abc transporter function,peptide transport,major histocompatibility complex class i association,tumor immunogenicity
ENSG00000166126,AMN,cell surface regulation,oncogenic processes,tumor progression,pi3k/akt signaling,cell adhesion and migration,metalloprotease activity
ENSG00000107611,CUBN,protein reabsorption,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,metastasis,biomarker
ENSG00000146085,MMUT,genomic instability,microsatellite mutations,tumor progression,biomarker potential,prognostic marker,immunotherapy resistance
ENSG00000151611,MMAA,mitochondrial function,oxidative stress regulation,genomic instability,dna damage,cancer progression,biomarker potential
ENSG00000117560,FASLG,fas signaling,apoptosis evasion,tumor progression,aggressive disease,poor prognosis,immune surveillance
ENSG00000026103,FAS,tumor suppressor function,apoptosis regulation,nf-κb signaling pathway activation,cell survival promotion,genomic alterations,immune evasion mechanism
ENSG00000156735,BAG4,apoptosis regulation,cell survival enhancement,mitochondrial interaction,tumor progression promotion,protein-protein interaction,cellular proliferation increase
ENSG00000067182,TNFRSF1A,tumor microenvironment regulation,apoptosis regulation,cell survival pathway activation,angiogenesis promotion,prognostic biomarker,immunomodulatory function
ENSG00000230108,TNF,tumor growth promotion,inflammation regulation,apoptosis induction,angiogenesis stimulation,cancer cell survival,microenvironment modulation
ENSG00000106052,TAX1BP1,tumor suppressor function,genomic instability,cell growth regulation,apoptosis modulation,transcriptional regulation,dna repair mechanism
ENSG00000118503,TNFAIP3,nf-κb pathway inhibition,immune response modulation,apoptosis suppression,tumor progression association,therapeutic target identification,genetic alteration impact
ENSG00000104689,TNFRSF10A,tumor suppressor,apoptosis regulation,pro-apoptotic function,dysregulation or downregulation,cancer progression and metastasis,potential therapeutic target
ENSG00000173530,TNFRSF10D,apoptosis regulation,tumor suppression,pi3k/akt signaling modulation,caspase-8 activation,death receptor function,immune response regulation
ENSG00000120889,TNFRSF10B,apoptosis regulation,tumor suppression,extrinsic signaling pathway,cell death induction,cancer immunotherapy,protein-ligand interaction
ENSG00000134259,NGF,tumor growth promotion,pro-inflammatory cytokine production,therapeutic target,pi3k/akt pathway activation,cell survival and migration enhancement,angiogenesis induction
ENSG00000064300,NGFR,signaling pathway activation,cell proliferation,oncogene overexpression,tumor progression,metastasis facilitation,poor prognosis marker
ENSG00000184216,IRAK1,immune evasion,nf-κb signaling pathway,tumor cell proliferation,apoptosis inhibition,angiogenesis facilitation,metastasis promotion
ENSG00000172936,MYD88,nf-κb transcription factor,inflammatory response,oncogenic mutation,cell proliferation,tumor progression,aberrant signaling pathway
ENSG00000109320,NFKB1,nf-κb pathway,constitutive activation,oncogenic signaling,immune evasion,angiogenesis,metastasis
ENSG00000173039,RELA,nf-κb activation,constitutive transcription,oncogene cooperation,tumor progression,therapeutic target,genomic instability
ENSG00000119048,UBE2B,dna repair pathway,genomic instability,cell proliferation,ubiquitination process,tumor suppressor degradation,protein interaction
ENSG00000070950,RAD18,homologous recombination,genomic instability,dna repair protein,ubiquitin ligase activity,pcna interaction,cell cycle regulation
ENSG00000114742,WDR48,cellular processes,protein-protein interactions,wd40 protein family,ubiquitin ligase regulation,signal transduction,cell cycle progression
ENSG00000162607,USP1,genomic instability,impaired dna repair,cell cycle regulation,tumor progression,therapeutic target,protein-protein interaction
ENSG00000009413,REV3L,error-prone dna repair,genomic instability,dna damage response,mutagenesis,translesion synthesis,replication stress
ENSG00000116670,MAD2L2,spindle checkpoint regulation,genomic instability,aneuploidy promotion,chromosome missegregation,cell cycle progression regulation,mitotic checkpoint control
ENSG00000163743,RCHY1,nuclear receptor regulation,transcriptional modulation,cell proliferation,apoptosis inhibition,therapeutic resistance,genetic amplification
ENSG00000170734,POLH,nucleotide excision repair,dna damage tolerance,oncogenic mutations,genomic instability,chemosensitivity loss,cancer progression
ENSG00000121060,TRIM25,p53 pathway modification,e3 ubiquitin ligase activity,cell cycle regulation,antiviral defense mechanism,oncogenic potential,genetic instability
ENSG00000156587,UBE2L6,**
homologous recombination,cell cycle regulation,protein degradation pathway,genome stability maintenance,tumor suppressor activity,cancer driver mutation 
**
ENSG00000182179,UBA7,deubiquitinating enzyme,genomic stability,dna damage response,chromosomal integrity,mutation hotspot,tumor suppressor
ENSG00000187608,ISG15,protein degradation regulation,tumor progression,cell cycle regulation,oncoprotein stability modification,ubiquitination pathway modulation,immune response regulation
ENSG00000184900,SUMO3,sumoylation,cellular regulation,protein-protein interactions,tumor promotion,signaling pathway modulation,poor prognosis marker
ENSG00000131944,FAAP24,genomic instability,dna damage repair,fa pathway component,protein complex formation,tumor suppressor role,cancer predisposition
ENSG00000187790,FANCM,genomic instability,oncogene,dna repair,tumor progression,cancer driver gene,cell proliferation
ENSG00000169689,CENPX,chromosomal instability,constitutive centromere-associated network complex,cell cycle regulation,oncogenic driver,overexpression,centriole duplication
ENSG00000175279,CENPS,chromosomal instability,aneuploidy,genome stability maintenance,mitotic spindle assembly,protein-protein interaction,poor prognosis marker
ENSG00000140525,FANCI,genomic instability,tumor progression,dna repair mechanism,fanconi anemia pathway,breast cancer predisposition,cell cycle regulation
ENSG00000144554,FANCD2,genomic instability,dna repair mechanism,oncogene promoter,loss of function mutations,tumor suppressor,brca1/brca2 interaction
ENSG00000175198,PCCA,metabolic reprogramming,tumor microenvironment modulation,cellular metabolism alteration,prognostic biomarker,genetic mutations,hif-1α regulation
ENSG00000114054,PCCB,altered metabolic fluxes,dysregulated energy metabolism,beta-oxidation pathway,propionyl-coa carboxylation,metabolic regulation,heterodimerization with alpha subunit
ENSG00000275300,MCCC2,bcaa degradation pathway,cell proliferation,metabolic reprogramming,leucine metabolism,cancer cell adaptation,tumor aggressiveness
ENSG00000078070,MCCC1,impaired mitochondrial function,altered energy metabolism,increased oxidative stress,tumor growth promotion,therapeutic target,cellular respiration regulation
ENSG00000175505,CLCF1,angiogenesis,cell proliferation,dysregulated expression,oncogenic pathway,poor prognosis marker,signaling molecule interaction
ENSG00000006016,CRLF1,cytokine signaling,overexpression,cell proliferation,immune suppression,jak/stat activation,tumorigenesis
ENSG00000130175,PRKCSH,transcriptional regulation,apoptosis evasion,cell growth regulation,protein phosphorylation,metastasis promotion,therapeutic target
ENSG00000089597,GANAB,tumor progression,impaired glycosylation,oncogenic potential,disrupted cellular processes,glycosylation pathway alteration,prognostic biomarker
ENSG00000179218,CALR,gain of function mutations,immunogenic protein,tumor progression,cell survival regulation,molecular chaperone function,signaling pathway interaction
ENSG00000283777,CANX,er quality control,calcium homeostasis regulation,cell surface protein expression modulation,apoptosis evasion,prognostic marker,chaperone-assisted autophagy pathway
ENSG00000182185,RAD51B,genomic instability,dna repair defects,tumor progression,chromosomal instability,genetic heterogeneity,double-strand break repair
ENSG00000243678,NME2,pi3k/akt pathway regulation,tumor suppressor activity,cell growth regulation,apoptosis induction,dna repair and metabolism,protein-protein interaction regulation
ENSG00000239672,NME1,nucleotide phosphorylation,cell cycle regulation,apoptosis modulation,dna repair mechanism,protein kinase activation,tumor aggressiveness
ENSG00000157500,APPL1,insulin/igf-1 pathway dysregulation,cellular adaptation,apoptosis resistance,genomic instability,tumor growth promotion,oncogenic signaling
ENSG00000187323,DCC,tumor suppressor function,cell adhesion disruption,apoptosis regulation,dna repair mechanism,protein interaction alteration,genomic instability promotion
ENSG00000179222,MAGED1,pi3k/akt signaling,oncogenic driver,epithelial-to-mesenchymal transition (emt),cell proliferation,apoptosis inhibition,stemness
ENSG00000113763,UNC5A,cellular invasion,tumor suppressor function loss,epithelial-to-mesenchymal transition,proliferation and survival enhancement,apoptosis resistance,netrin-1 receptor signaling
ENSG00000221823,PPP3R1,nfat transcription factor activation,cell proliferation regulation,oncogenesis promotion,angiogenesis enhancement,metastasis facilitation,tumor aggressiveness association
ENSG00000120910,PPP3CC,pp2b regulation,calcium/calmodulin interaction,tumor aggressiveness,cell proliferation promotion,mutations implicated,poor prognosis associated
ENSG00000171791,BCL2,anti-apoptotic function,cell death regulation,therapeutic target,prognostic marker,cell survival pathway,metabolic adaptation
ENSG00000002330,BAD,apoptosis suppression,tumor progression,chemotherapy resistance,cell survival regulation,bcl-2 family interactions,pro-apoptotic function
ENSG00000030110,BAK1,bak1-mediated apoptosis,dna damage response regulation,oncogenic survival promotion,chemoresistance modulation,mitochondrial outer membrane permeabilization,genomic instability maintenance
ENSG00000172115,CYCS,apoptosis suppression,metabolic reprogramming,tumor progression,pro-survival function,enhanced cell proliferation,mitochondrial localization
ENSG00000101966,XIAP,apoptosis regulation,anti-apoptotic protein,cell survival enhancement,therapeutic target,dna damage response modulation,cell cycle progression regulation
ENSG00000164305,CASP3,apoptosis impairment,biomarker potential,cancer cell accumulation,executioner caspase function,oncogenic contribution,programmed cell death regulation
ENSG00000165806,CASP7,apoptosis regulation,cell death execution,tumor progression,proteolytic activity,signal transduction pathway,programmed cell death
ENSG00000132906,CASP9,apoptosis regulation,cell death promotion,dna damage response,mitochondrial dysfunction,tumor suppressor function,therapeutic target potential
ENSG00000184047,DIABLO,apoptosis regulation,tumorigenesis promotion,caspase activation inhibition,necroptosis modulation,cellular proliferation enhancement,iaps inhibition
ENSG00000169598,DFFB,apoptosis,dna degradation,cell survival,tumor progression,genomic instability,histone modification
ENSG00000160049,DFFA,apoptosis evasion,genomic instability,endog cleavage,cell survival,programmed cell death,therapeutic target
ENSG00000114030,KPNA1,nuclear transport,cell cycle progression,transcription factor regulation,dna repair pathway,constitutive activation,oncogenic driver
ENSG00000108424,KPNB1,nuclear transport,tumor suppressor function loss,cell cycle regulation disruption,transcriptional regulation aberration,cancer cell proliferation promotion,therapeutic target identification
ENSG00000180370,PAK2,p21-activated kinase 2,constitutive activation,cell migration,apoptosis regulation,oncogenic signaling,kinase activity
ENSG00000071205,ARHGAP10,rhogtpase regulation,cell migration,cytoplasmic localization,tumor suppressor function,oncogenic pathway modulation,signal transduction
ENSG00000137275,RIPK1,necroptosis activation,nf-κb signaling,tumor growth promotion,apoptosis inhibition,immunosuppressive microenvironment modulation,cell death regulation
ENSG00000129465,RIPK3,necroptosis regulation,apoptosis resistance,metabolic reprogramming,tumor progression,inflammatory response,protein-protein interaction
ENSG00000131979,GCH1,bh4 biosynthesis,dysregulated immune response,nitric oxide production,tumor microenvironment modulation,cancer association,cell proliferation regulation
ENSG00000137880,GCHFR,dna damage response,cellular proliferation,oncogenic mutations,mitochondrial function,glycolysis regulation,apoptosis modulation
ENSG00000244687,UBE2V1,ubiquitination process,tumor suppression evasion,oncogenic pathway activation,dna repair regulation,cell cycle dysregulation,apoptosis inhibition
ENSG00000175104,TRAF6,nf-κb signaling pathway,oncogenic processes,cell proliferation,tumor progression,pro-inflammatory cytokine production,genetic overexpression
ENSG00000134070,IRAK2,inflammation,immune evasion,tlr signaling pathway,gain of function mutations,cell proliferation,metastasis
ENSG00000113070,HBEGF,heparin-binding growth factor,cell proliferation enhancement,overexpression in tumors,tumor progression acceleration,angiogenesis promotion,mapk/erk pathway modulation
ENSG00000198898,CAPZA2,actin filament assembly,overexpression,cell proliferation,cancer cell invasion,oncogenic process,tumor progression
ENSG00000077549,CAPZB,actin filament regulation,cell migration,cell invasion,tumor progression,loss-of-function mutation,cytoskeleton dynamics
ENSG00000177938,CAPZA3,cytoplasmic localization,cell migration regulation,oncogenic potential,prognostic significance,cytoskeletal dynamics modulation,cell invasion enhancement
ENSG00000116489,CAPZA1,actin filament regulation,cytoskeleton remodeling,cellular morphology modulation,tumor aggressiveness influence,genomic instability induction,protein expression alterations
ENSG00000114745,GORASP1,cell cycle regulation,golgi apparatus integrity,microtubule interaction,chromosomal stability,tumor progression,mitotic checkpoint control
ENSG00000167110,GOLGA2,nuclear transport regulation,cell cycle progression disruption,chromatin remodeling involvement,genomic instability promotion,tumor suppressor dysfunction,nuclear pore complex component
ENSG00000106799,TGFBR1,tgf-β signaling,oncogene function,loss of tumor suppressive functions,aberrant activation,emt and invasion,therapeutic target for cancer therapy
ENSG00000088832,FKBP1A,cell survival,apoptosis inhibition,tumor growth promotion,p53 interaction,transcriptional regulation modification,protein folding modulation
ENSG00000113319,RASGRF2,ras activation,gene amplification,tumor aggressiveness,signaling pathway activation,cell proliferation enhancement,poor prognosis marker
ENSG00000058335,RASGRF1,ras activation,tumor progression,gef activity,cell proliferation,kras/hras signaling,therapeutic target
ENSG00000120251,GRIA2,ampar signaling,cell proliferation,oncogenic driver,neuronal excitability,signaling pathway modulation,cancer aggressiveness
ENSG00000155511,GRIA1,ampa receptor function,cell proliferation regulation,glia-neuron interaction,neurotransmission modulation,oncogenic upregulation,signaling pathway activation
ENSG00000105397,TYK2,jak/stat pathway activation,tyrosine kinase activity,cell proliferation enhancement,tumor progression facilitation,stat3 phosphorylation,immune evasion mechanism
ENSG00000142166,IFNAR1,tumor immunosuppression,viral evasion mechanism,type i interferon signaling,poor prognosis marker,tumor progression driver,immune checkpoint regulation
ENSG00000162851,TFB2M,transcriptional regulator,oncogene,cell cycle progression promoter,eptithelial-to-mesenchymal transition regulator,cancer stem cell maintenance factor,genetic instability driver
ENSG00000099821,POLRMT,mitochondrial transcription,mitochondrial gene regulation,cell proliferation enhancement,oncogenic process promotion,tumor progression facilitation,genomic instability contribution
ENSG00000128191,DGCR8,microrna biogenesis,tumor suppressor function,genomic stability regulation,cell cycle control,dna repair and replication regulation,mirna-mediated regulatory network disruption
ENSG00000113360,DROSHA,mirna biogenesis,tumor suppressor regulation,cell proliferation,apoptosis inhibition,oncogene function,biomarker potential
ENSG00000116918,TSNAX,oncogenic protein interaction,tpr domain function,cell proliferation promotion,tumor progression marker,signaling pathway modulation,genomic amplification
ENSG00000211460,TSN,cellular proliferation,tumor progression,protein interaction,signal transduction,apoptosis regulation,genomic alteration
ENSG00000076108,BAZ2A,brd4 interaction,chromatin remodeling,epigenetic regulation,transcriptional activation,oncogene overexpression,cell proliferation
ENSG00000119772,DNMT3A,epigenetic regulation,oncogenic function,cell cycle progression,dna methylation patterns,tumor formation,proliferation
ENSG00000142182,DNMT3L,epigenetic regulation,methylation modification,gene expression modulation,tumor suppressor interaction,wnt/β-catenin pathway activation,prognostic biomarker significance
ENSG00000088305,DNMT3B,tumor suppressor function,dna methylation regulation,epigenetic alterations,genome integrity maintenance,cell proliferation regulation,oncogenic process modulation
ENSG00000055130,CUL1,p53 pathway modulation,e3 ubiquitin ligase complex,cell cycle regulation,ubiquitination,apoptosis resistance,tumor progression
ENSG00000111530,CAND1,cell cycle regulation,protein degradation pathway,cullin-ring ligase regulation,ubiquitination process,tumor suppressor function,genomic stability maintenance
ENSG00000072274,TFRC,iron-dependent glycolysis,overexpression associated,promotion of invasion,metabolic regulation impact,oncogenic pathway interaction,therapeutic target candidate
ENSG00000010704,HFE,iron regulation,tumor microenvironment modulation,immune response influence,cellular iron levels regulation,cancer cell growth promotion,tumor progression facilitation
ENSG00000091513,TF,chromatin remodeling,cell proliferation,oncogene activation,transcriptional regulation,genomic instability,cancer stem cell maintenance
ENSG00000225312,HSD17B8,oxidative stress modulation,genomic instability promotion,tumor progression facilitation,redox balance regulation,dna damage response modulation,ros generation
ENSG00000145439,CBR4,altered expression,cellular respiration,ion homeostasis regulation,protein interaction,cell growth modulation,tumor progression
ENSG00000157456,CCNB2,cell cycle regulation,mitotic progression,uncontrolled proliferation,anti-apoptotic properties,tumor suppressor interaction,genomic instability
ENSG00000100241,SBF1,genomic instability,histone modification regulation,cell cycle progression regulation,dna repair mechanism disruption,transcriptional dysregulation,genome stability maintenance
ENSG00000087053,MTMR2,phosphatase activity,dephosphorylation of phosphoinositides,cell proliferation enhancement,akt pathway activation,mitochondrial regulation,oncogenic signaling
ENSG00000003987,MTMR7,genomic instability,tumor suppressor function,pi3k/akt pathway inhibition,cell proliferation regulation,dna damage response,protein dephosphorylation
ENSG00000104643,MTMR9,pi3k/akt signaling inhibition,tumor suppressor function,cell cycle regulation,apoptosis induction,protein tyrosine dephosphorylation,phosphoinositide dephosphorylation
ENSG00000051382,PIK3CB,pi3k/akt/mtor signaling pathway,growth factor regulation,cell survival enhancement,genetic alteration rareness,protein complex formation,metabolic dysregulation
ENSG00000105647,PIK3R2,tumor suppressor function,regulatory subunit of pi3k,cell survival regulation,immune modulation,tumor microenvironment influence,apoptosis resistance promotion
ENSG00000171608,PIK3CD,pi3k/akt/mtor signaling,constitutive activation,gain of function mutations,tumor progression,regulatory subunit interaction,metabolic regulation
ENSG00000117461,PIK3R3,pi3k/akt pathway,constitutive activation,dysregulation,oncogenic processes,cell survival,apoptosis inhibition
ENSG00000141506,PIK3R5,pi3k/akt pathway,constitutive activation,regulatory subunit,cell proliferation,akt/mtor signaling,oncogenesis
ENSG00000105851,PIK3CG,pi3k/akt/mtor signaling pathway,constitutive activation of pi3k pathway,tumor progression through cell survival enhancement,genomic instability,apoptosis evasion,cancer proliferation
ENSG00000169499,PLEKHA2,pi3k/akt signaling,constitutive activation,cell survival promotion,mitogenic signaling,tumor progression,promoter overexpression
ENSG00000163629,PTPN13,altered expression levels,cell proliferation regulation,tumor progression modulation,cell migration involvement,signal transduction modification,phosphatase activity dysregulation
ENSG00000107679,PLEKHA1,**

overexpression,cell adhesion disruption,pkc activation,membrane trafficking regulation,oncogenic function,tumor progression
ENSG00000139505,MTMR6,pi3k/akt pathway regulation,tumor suppressor function,phosphatase activity,cell proliferation regulation,cancer associated mutations,genomic instability
ENSG00000133812,SBF2,microtubule dynamics disruption,cilia instability,protein kinase activation,cell proliferation enhancement,microtubule stabilization,aggressive tumor behavior
ENSG00000171100,MTM1,actin cytoskeleton regulation,oncogene activation,cell migration promotion,pi3k/akt pathway modulation,cell proliferation enhancement,prognostic marker
ENSG00000150712,MTMR12,tumor suppressor function,pi3k/akt pathway regulation,cell survival modulation,apoptosis and autophagy regulation,genomic instability contributor,therapeutic target
ENSG00000033327,GAB2,aberrant expression,cell survival,epithelial-to-mesenchymal transition,oncogenic transformation,receptor tyrosine kinase signaling,tumor progression
ENSG00000150995,ITPR1,calcium signaling,intracellular calcium release,cell proliferation,tumor progression,oncogene overexpression,therapeutic target
,MRVI1,microtubule regulation,tumor progression,cell proliferation,microtubule stability,apoptosis inhibition,signaling pathway modulation
ENSG00000111679,PTPN6,tumor immunosurveillance,immune modulation,cell signaling regulation,pi3k/akt pathway,cancer driver gene,sh2 domain interaction
ENSG00000261371,PECAM1,cell-cell adhesion,immune response modulation,tumor progression,metastasis,leukocyte migration regulation,biomarker for tumor aggressiveness
ENSG00000179295,PTPN11,constitutive activation,enhanced cell proliferation,gene expression alteration,increased tumor migration,oncogenic pathway activation,therapeutic target
ENSG00000160712,IL6R,il6/stat3 signaling pathway,gain of function mutations,inflammation regulation,oncogenic transformation,tumor microenvironment modulation,immune evasion mechanism
ENSG00000136244,IL6,il-6 signaling pathway,constitutive overexpression,tumor growth promotion,jak/stat3 activation,epithelial-to-mesenchymal transition (emt),chemoresistance enhancement
ENSG00000115415,STAT1,tumor suppressor function,immune regulation,oncogenic signaling inhibition,cell proliferation inhibition,downregulation in cancer,jak/stat pathway interaction
ENSG00000168610,STAT3,constitutive activation,transcription factor activity,oncogenic programming,epithelial-to-mesenchymal transition (emt),cell proliferation promotion,apoptosis evasion
ENSG00000128052,KDR,vegfr2 signaling pathway,gain of function mutations,tumor angiogenesis,therapeutic target,genomic amplification,cell proliferation
ENSG00000113905,HRG,tumor progression,pi3k/akt pathway activation,cell survival enhancement,angiogenesis promotion,integrin signaling modulation,immune microenvironment regulation
ENSG00000122194,PLG,plasminogen overexpression,tumor cell migration,extracellular matrix degradation,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,proteolytic activity enhancement
ENSG00000182718,ANXA2,cell membrane interaction,pi3k/akt signaling enhancement,calcium ion regulation,proliferation and survival,metastasis promotion,tumor progression
ENSG00000197747,S100A10,angiogenesis,cellular invasiveness,gene expression regulation,interacts with annexin a2,pi3k/akt pathway activation,prognostic biomarker
ENSG00000276838,SERPINF2,anti-plasmin activity,cell proliferation inhibition,tumor suppressor gene suppression,oncogenic process promotion,insulin-like growth factor-binding protein 1 interaction,cell migration and invasion pathway involvement
ENSG00000122861,PLAU,extracellular matrix degradation,cell migration,tumor progression,cell invasion,prognostic marker,therapeutic target
ENSG00000011422,PLAUR,cell surface receptor,tumor progression,proteolysis regulation,angiogenesis stimulation,epithelial-to-mesenchymal transition (emt) facilitation,therapeutic target
ENSG00000165240,ATP7A,copper transport dysregulation,tumor cell survival enhancement,pi3k/akt pathway interaction,cellular homeostasis disruption,hypoxia adaptation promotion,genomic instability induction
ENSG00000120509,PDZD11,disrupted cell adhesion,protein-protein interaction,chromosomal location 20q13.33,tumor progression,epithelial integrity maintenance,potential oncogene alterations
ENSG00000103249,CLCN7,ion transport regulation,cell adhesion modulation,epithelial cell differentiation,protein-protein interaction,tumorigenesis contribution,chloride channel function
ENSG00000081087,OSTM1,lysosomal trafficking,dna damage response,genomic instability,tumor aggressiveness,protein-protein interaction,cellular homeostasis
ENSG00000136810,TXN,oxidative stress modulation,redox regulation,cellular survival pathway,tumor progression,protein-protein interaction,thiol antioxidant function
ENSG00000265972,TXNIP,tumor suppression,cell survival,apoptosis repression,oxidative stress regulation,metabolic adaptation,protein homeostasis modulation
ENSG00000162711,NLRP3,inflammasome activation,oncogenic function,pro-inflammatory cytokine secretion,dna damage response,metastasis promotion,therapeutic target
ENSG00000103313,MEFV,nf-κb pathway activation,inflammation regulation,apoptosis modulation,tumor progression promotion,pro-inflammatory cytokine production,autosomal recessive disorder mutation
ENSG00000140368,PSTPIP1,tumor suppression,gain of function mutations,protein-protein interactions,immune modulation,cell signaling,oncogenic processes
ENSG00000103490,PYCARD,pro-inflammatory response,caspase activation,immune modulation,apoptosis regulation,tumor cell survival,cytokine secretion
ENSG00000135346,CGA,increased cell proliferation,overexpression,cell-cell adhesion regulation,epithelial-to-mesenchymal transition,b-cell interaction,cancer progression biomarker
ENSG00000104826,LHB,tumor growth promotion,gonadotropin signaling,fertility regulation,hormone production stimulation,cell proliferation enhancement,steroid hormone interaction
ENSG00000126895,AVPR2,g-protein coupled receptor,tumor progression,cell migration invasion,angiogenesis promotion,therapeutic target,regulation of cell proliferation
ENSG00000101200,AVP,oncogenic mechanism,constitutive activation,tumor progression,cell survival enhancement,genetic alteration,biomarker potential
ENSG00000115263,GCG,glucose metabolism,energy regulation,tumor growth inhibition,anti-tumor peptide signaling,glycogenolysis modulation,gluconeogenesis influence
ENSG00000215644,GCGR,aberrant signaling,cell proliferation,g protein activation,glucose metabolism regulation,mutations leading to oncogenesis,tumor progression
ENSG00000122679,RAMP3,gpcr signaling,tumor progression,cell growth regulation,pro-inflammatory cytokines production,angiogenesis promotion,metastasis facilitation
ENSG00000004948,CALCR,cell proliferation,g-protein coupled receptor function,calcium homeostasis disruption,oncogenic mutations and amplifications,tumorigenesis promotion,none
ENSG00000132329,RAMP1,cgrp receptor regulation,tumor progression,cell proliferation,apoptosis inhibition,gpcr signaling pathway modification,angiogenesis promotion
ENSG00000134200,TSHB,cellular differentiation,endocrine signaling pathway,hormone secretion regulation,thyroid hormone regulation,tumor suppressor gene regulation,genomic stability maintenance
ENSG00000179600,GPHB5,glycoprotein complex,urothelial integrity,cellular proliferation,apoptosis regulation,oncogenic role,tumorigenesis
ENSG00000149735,GPHA2,pi3k/akt pathway regulation,glycoprotein hormone regulation,cell proliferation promotion,tumor aggressiveness association,biomarker potential,signaling pathway modulation
ENSG00000064989,CALCRL,tumor progression,signaling pathway regulation,cell migration,receptor function,prognostic marker,potential therapeutic target
ENSG00000131477,RAMP2,calcium sensing receptor regulation,g-protein coupled receptor signaling,mitogenic pathway activation,tumor growth promotion,cell proliferation enhancement,oncogene expression
ENSG00000065325,GLP2R,cell proliferation,tumor progression,oncogene function,apoptosis resistance,g protein-coupled receptor activity,pi3k/akt pathway activation
ENSG00000131808,FSHB,tumor progression,cell proliferation,apoptosis regulation,metastasis promotion,therapeutic target,prognostic marker
ENSG00000138448,ITGAV,integrin alpha-v function,cell adhesion regulation,angiogenesis promotion,cell migration facilitation,oncogenic role,genomic instability maintenance
ENSG00000082781,ITGB5,cell migration,oncogene function,actin cytoskeleton regulation,integrin signaling pathway,focal adhesion dynamics,cell survival promotion
ENSG00000103496,STX4,regulation of membrane trafficking,altered gene expression,cell proliferation and survival,oncogenic processes,dysregulation of upr,protein-protein interactions
ENSG00000265808,SEC22B,cell cycle regulation,pi3k/akt pathway interaction,tumor aggressiveness,poor prognosis biomarker,endocytic pathway involvement,cancer cell proliferation
ENSG00000106571,GLI3,hedgehog signaling,transcription factor function,oncogene activity,chromatin regulation,cell proliferation,gene expression dysregulation
ENSG00000185920,PTCH1,shh signaling pathway,constitutive activation,loss-of-function mutations,tumor suppressor function,cell proliferation regulation,genomic instability
ENSG00000111087,GLI1,hedgehog signaling pathway,transcriptional regulator,gain of function mutations,cell proliferation,tumor progression,therapeutic target
ENSG00000074047,GLI2,gli2 activation,hedgehog pathway activation,tumor suppressor gene suppression,epithelial-to-mesenchymal transition,angiogenesis promotion,transcription factor regulation
ENSG00000107882,SUFU,hedgehog pathway activation,cell proliferation,cancer stem cell maintenance,chemoresistance,oncogenic driver,genetic loss
ENSG00000133961,NUMB,notch signaling inhibition,epithelial-to-mesenchymal transition suppression,tumor suppressor activity,cell proliferation regulation,apoptosis promotion,oncogenic pathway modulation
ENSG00000078747,ITCH,nf-kappa b activation,epithelial-to-mesenchymal transition,tumor metastasis,apoptosis inhibition,transcription factor regulation,hypothetical protein interaction
ENSG00000011198,ABHD5,lipid metabolism disruption,tumor suppression,energy production alteration,biomarker potential,glycolysis regulation,cellular proliferation enhancement
ENSG00000166819,PLIN1,lipid droplet formation,oncogenic lipid metabolism,tumor metastasis,poor prognosis marker,lipid storage regulation,metabolic reprogramming
ENSG00000079435,LIPE,enhanced lipolysis,pparγ interaction,lipid metabolism deregulation,tumor cell proliferation,fatty acid production,poor prognosis indicator
ENSG00000170323,FABP4,cellular lipid metabolism,fatty acid uptake and storage,tumor growth promotion,prognostic marker,inflammatory response modulation,metastasis regulation
ENSG00000153822,KCNJ16,potassium channel regulation,constitutive activation,gain of function mutations,tumor progression,oncogene,therapeutic target
ENSG00000157551,KCNJ15,potassium channel regulation,cell proliferation,signaling pathway modulation,ion homeostasis dysregulation,tumor progression modulation,cancer driver gene
ENSG00000177807,KCNJ10,ion channel regulation,tumor suppressor pathway modulation,cell proliferation enhancement,prognostic marker,chemotherapy resistance,electrical homeostasis disruption
ENSG00000161921,CXCL16,tumor microenvironment,prognostic biomarker,cell survival,immune evasion,angiogenesis promotion,cancer progression
ENSG00000172215,CXCR6,tumor-promoting inflammation,immune evasion strategies,chemokine signaling pathways,cell migration regulation,immune suppressive mechanisms,prognostic biomarker
ENSG00000197405,C5AR1,complement component 5a signaling,g protein-coupled receptor function,oncogene activation,angiogenesis promotion,mapk/erk pathway modulation,nf-κb transcriptional regulation
ENSG00000106804,C5,tumor progression,reactive oxygen species generation,metastasis promotion,prognostic marker,therapeutic target,oxidative stress modulation
ENSG00000006210,CX3CL1,tumor microenvironment,angiogenesis,immune evasion,cell adhesion,protein-protein interaction,signaling pathway regulation
ENSG00000168329,CX3CR1,tumor microenvironment modulation,immune cell trafficking regulation,inflammation promotion,metastasis facilitation,cancer-associated fibroblast development,immune suppressive cell infiltration
ENSG00000179002,TAS1R2,tumor progression,signaling pathway regulation,cell proliferation,oncogene,dysregulation,therapeutic target
ENSG00000169962,TAS1R3,aberrant signaling,angiogenesis promotion,cell proliferation modulation,dysregulated expression,oncogenic potential,sugar metabolism regulation
ENSG00000173662,TAS1R1,metabolic regulation,cell proliferation,tumor progression,energy status modulation,oncogenesis,nutrient availability detection
ENSG00000136928,GABBR2,gaba b receptor signaling pathway,cellular inhibition dysregulation,tumor progression driver,gene expression alterations,cancer-related cellular proliferation,neurotransmission modulation
ENSG00000204681,GABBR1,gaba_b receptor,adenylate cyclase inhibition,cell proliferation regulation,tumor progression marker,therapeutic target,metabotropic signaling
ENSG00000243646,IL10RB,immune modulation,cancer progression,oncogene overexpression,tumor metastasis,inflammation suppression,downstream signaling activation
ENSG00000104064,GABPB1,transcriptional regulation,cell cycle progression,tumor progression,oncogenic pathways,biomarker potential,transcription factor activity
ENSG00000154727,GABPA,cell cycle regulation,transcriptional activation,oncogenic signaling pathways,apoptosis suppression,metastasis promotion,chromatin remodeling
ENSG00000083312,TNPO1,nuclear transport,transcriptional regulation,gene expression modulation,dna repair facilitation,tumor aggressiveness association,nuclear import regulation
ENSG00000117245,KIF17,genomic instability,cell division regulation,motor protein activity,mitotic checkpoint disruption,protein interaction modulation,cancer cell proliferation enhancement
ENSG00000243955,GSTA1,oncogenic properties,detoxification process alteration,cell cycle regulation disruption,apoptosis inhibition,tumor progression marker,biomarker for prognosis
ENSG00000244067,GSTA2,tumor suppressor,detoxification process,loss-of-function mutations,reduced enzyme activity,carcinogen-induced dna damage,oxidative stress protection
ENSG00000001084,GCLC,glutathione synthesis,oxidative stress regulation,tumor progression,antioxidant defense mechanism,prognostic biomarker,therapeutic target
ENSG00000023909,GCLM,glutathione synthesis,antioxidant defense,cell cycle regulation,apoptosis suppression,prognostic marker,poor clinical outcome
ENSG00000254647,INS,insulin pathway,akt/mtor activation,cell proliferation,survival signal,glycolysis enhancement,tumor aggressiveness
ENSG00000171105,INSR,igf-1 signaling pathway,insulin/igf-1 receptor activation,metabolic reprogramming,cell survival promotion,tumor progression,therapeutic target
ENSG00000173208,ABCD2,multidrug resistance,overexpression,poor prognosis,cellular efflux,chemotherapy evasion,tumor progression
ENSG00000101986,ABCD1,lipid metabolism disruption,peroxisomal dysfunction,fatty acid accumulation,x-linked disorder association,cellular energy imbalance,tumor progression regulator
ENSG00000117528,ABCD3,drug efflux pump,multidrug resistance,cellular transport regulation,chemotherapy resistance,tumor aggressiveness,oncogenic metabolism
ENSG00000138075,ABCG5,lipid transport,cellular metabolism,oncogenic processes,cellular proliferation,tumor progression,lipid accumulation
ENSG00000143921,ABCG8,cholesterol efflux,abc transporter activity,cellular proliferation,tumor progression,chemotherapy resistance,genomic amplification
ENSG00000160716,CHRNB2,cell proliferation,apoptosis resistance,angiogenesis promotion,oncogenic signaling,overexpression,ligand-gated ion channel
ENSG00000101204,CHRNA4,oncogenic potential,nicotinic receptor activation,cell proliferation,apoptosis inhibition,therapeutic target,signaling pathway modulation
ENSG00000080644,CHRNA3,nicotinic receptor regulation,gene amplification,cell proliferation enhancement,oncogenic driver,tumor progression modulation,cancer cell resistance formation
ENSG00000117971,CHRNB4,nicotinic acetylcholine receptors,tumor progression,cell migration,oncogenesis,ion channel function,neuronal signaling
ENSG00000111206,FOXM1,transcription factor activation,cell cycle progression,dna replication regulation,epithelial-to-mesenchymal transition,tumor aggressiveness,therapeutic target
ENSG00000166851,PLK1,mitotic progression,kinase activation,chromosomal instability,cell cycle regulation,cancer cell proliferation,therapeutic target
ENSG00000117724,CENPF,cell cycle regulation,mitotic spindle assembly,oncogene function,dna damage response,microtubule stabilization,genomic instability
ENSG00000115353,TACR1,cell proliferation,receptor activation,g protein-coupled receptor,angiogenesis promotion,tumor progression,signaling pathway modulation
ENSG00000006128,TAC1,neuropeptide signaling,promotes proliferation,invasion and metastasis,nk1r interaction,tumor progression,poor prognosis marker
ENSG00000075073,TACR2,neurotensin activation,pi3k/akt signaling,g protein-coupled receptor,tumor growth promotion,cell invasion enhancement,oncogenic pathway engagement
ENSG00000180914,OXTR,epigenetic regulation,overexpression,pro-oncogenic effects,tumor progression,metastasis promotion,g-protein coupled receptor function
ENSG00000101405,OXT,oxytocin overexpression,cell proliferation promotion,cancer stem cell regulation,biomarker potential,pi3k/akt pathway interaction,tumor progression enhancement
ENSG00000147571,CRH,tumor progression,immunosuppression microenvironment,hpa axis regulation,cell survival promotion,angiogenesis enhancement,cell growth stimulation
ENSG00000145708,CRHBP,crh regulation,tumor suppressor function,cell proliferation inhibition,stress response modulation,oncogenic process contribution,biomarker potential
ENSG00000123146,ADGRE5,tumor progression,cell-to-cell communication disruption,oncogene role,epithelial-to-mesenchymal transition,signaling pathway interaction,metastasis promotion
ENSG00000196352,CD55,complement system modulation,tumor progression,immune evasion,apoptosis inhibition,cell adhesion regulation,surface protein expression
ENSG00000100211,CBY1,cellular proliferation,nuclear receptor coactivator function,androgen receptor interaction,oncogene overexpression,apoptosis evasion,tumor growth promotion
ENSG00000168036,CTNNB1,wnt/beta-catenin activation,cell proliferation regulation,transcriptional dysregulation,oncogenic transcription factor interaction,immune response modulation,tumor microenvironment regulation
ENSG00000178585,CTNNBIP1,wnt signaling,beta-catenin stabilization,oncogenesis,cell proliferation,tumor progression,genomic instability
ENSG00000100888,CHD8,wnt/?-catenin pathway,chromatin remodeling complex,oncogene overexpression,cell proliferation driver,gene expression regulator,mutations associated cancer
ENSG00000180398,MCFD2,iron metabolism regulation,ubiquitin-proteasome pathway interaction,cellular iron availability,tumor growth promotion,metastasis enhancement,angiogenesis support
ENSG00000074695,LMAN1,tumor progression,aberrant glycosylation,cellular proliferation,inflammation promotion,angiogenesis facilitation,tumor microenvironment modulation
ENSG00000170348,TMED10,endoplasmic reticulum homeostasis,protein transport regulation,oncogenic pathway activation,cellular proliferation enhancement,metabolic regulation dysregulation,tumor suppressor function loss
ENSG00000086598,TMED2,overexpression,protein homeostasis regulation,cell proliferation promotion,survival pathway activation,co-translational folding facilitation,march6 interaction
ENSG00000010610,CD4,t-cell receptor complex,immune cell communication,transmembrane glycoprotein,cellular adhesion molecule,antigen-presenting cells interaction,immunological function preservation
ENSG00000182866,LCK,t-cell signaling pathway,oncogenic processes,cell growth promotion,apoptosis resistance,immune evasion,therapeutic target
ENSG00000115839,RAB3GAP1,rab3 gtpase regulation,endosomal pathway modulation,tumor suppressor function,cellular growth regulation,prognostic biomarker,oncogenic process promotion
ENSG00000118873,RAB3GAP2,tumor suppressor function,loss of function mutations,mapk/erk signaling pathway,cell cycle regulation,apoptosis modulation,gtpase activity regulation
ENSG00000148053,NTRK2,oncogenic signaling,tumor progression,receptor tyrosine kinase activation,cell survival enhancement,therapeutic target,genomic amplification
ENSG00000176697,BDNF,cell growth promotion,angiogenesis stimulation,immune evasion facilitation,trkb receptor interaction,tumor progression enhancement,poor prognosis correlation
ENSG00000225950,NTF4,notch signaling antagonist,cell growth inhibition,transcription regulation,apoptosis modulation,tumor suppressor activity,protein-protein interaction
ENSG00000100385,IL2RB,il-2 signaling pathway,t-cell activation,receptor dysfunction mutations,immune evasion mechanisms,tumor progression factors,immunosuppressive effects
ENSG00000162434,JAK1,gain of function mutations,constitutive activation,non-receptor tyrosine kinase activity,oncogenic transformation,cell proliferation,tumor progression
ENSG00000105639,JAK3,tumor progression,constitutive activation,dysregulated signaling pathways,cell proliferation enhancement,oncogene overexpression,targeted therapy
ENSG00000147168,IL2RG,il-2 receptor assembly,t cell development,aberrant expression,cancer immunotherapy,tumor progression,immune dysfunction
ENSG00000120899,PTK2B,cell migration,focal adhesion kinase,overexpression,pi3k/akt signaling,protein tyrosine phosphorylation,tumor invasion
ENSG00000105246,EBI3,il-27/il-12 axis,overexpression,immune suppression,antiangiogenic effects,emt regulation,tumor growth promotion
ENSG00000197272,IL27,tumor suppressor function,immune regulation,pro-inflammatory cytokine production,cancer immunotherapy target,immune cell activation,antitumor properties
ENSG00000110400,NECTIN1,cell-cell adhesion,tumor progression,oncogenic process,apoptosis resistance,proliferation promotion,metastasis facilitation
ENSG00000177707,NECTIN3,nectin family member,oncogene activation,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,protein-protein interaction,tumor progression enhancement
ENSG00000143217,NECTIN4,cell-cell adhesion disruption,enhanced cell migration,overexpression associated with poor prognosis,tumor invasion promotion,metastasis facilitation,therapeutic target identification
ENSG00000130202,NECTIN2,cell adhesion regulation,oncogenic protein interaction,tumor progression,pi3k/akt pathway activation,poor prognosis marker,metastasis facilitation
ENSG00000073008,PVR,tumor progression,metastatic potential,cell migration regulation,integrin signaling modulation,proteolytic activity enhancement,cell adhesion influence
ENSG00000113302,IL12B,t cell activation,immune suppression,interferon-gamma induction,cytokine signaling,immunogenicity enhancement,tumor progression
ENSG00000168811,IL12A,immunomodulation,apoptosis induction,tumor suppression,cell growth regulation,angiogenesis inhibition,immune evasion
ENSG00000096996,IL12RB1,il-12/stat3 pathway,immunosuppression,tumor progression,apoptosis evasion,cell cycle dysregulation,epigenetic silencing
ENSG00000081985,IL12RB2,tumor immunomodulation,immunotherapy target,ifn-γ production,proliferation of t cells,nk cell activation,cytokine regulation
ENSG00000096968,JAK2,constitutive activation,gain of function mutations,oncogenic signaling,aberrant cell proliferation,stat3 activation,therapeutic target
ENSG00000137462,TLR2,inflammation,tumor progression,oncogenesis,immune evasion,cell survival,angiogenesis
ENSG00000174125,TLR1,immune regulation,innate immunity activation,cell proliferation promotion,tumor microenvironment modulation,signaling pathway interaction,cancer progression facilitation
ENSG00000174130,TLR6,tumor microenvironment modulation,innate immune response activation,immune-related signaling pathway,cellular inflammatory responses regulation,potential oncogenic driver,genomic instability regulation
ENSG00000168214,RBPJ,notch signaling pathway,constitutive activation,cell proliferation,transcription factor activity,oncogenic driver,tumor progression
ENSG00000100603,SNW1,transcriptional co-activator,chromatin regulation,oncogenic process,cell proliferation,metastasis promotion,emt induction
ENSG00000148400,NOTCH1,notch signaling pathway,aberrant activation,cell proliferation,tumor growth promotion,apoptosis suppression,genetic mutation
ENSG00000100644,HIF1A,hypoxia response,transcriptional regulation,tumor progression,angiogenesis promotion,energy metabolism regulation,cell survival enhancement
ENSG00000101384,JAG1,notch signaling,constitutive activation,cell proliferation,tumor progression,therapeutic target,genomic instability
ENSG00000184916,JAG2,notch signaling pathway,overexpression,cell proliferation,tumor suppressor or oncogene,apoptosis regulation,transmembrane protein
ENSG00000110395,CBL,tyrosine kinase regulation,cell proliferation,oncogenic processes,tumor progression,signaling pathway modulation,adaptor protein function
ENSG00000149294,NCAM1,adhesion molecule interaction,cell migration enhancement,emt promotion,tumor progression facilitation,molecular interaction with pi3k/akt pathway,cancer cell stemness induction
ENSG00000130287,NCAN,calcium signaling,cell adhesion regulation,tumor progression facilitation,metastasis promotion,biomarker potential,therapeutic target
ENSG00000134871,COL4A2,aberrant basement membrane formation,cell migration promotion,collagen iv degradation,gain of function mutations,overexpression in tumors,tumor progression facilitation
ENSG00000187498,COL4A1,basement membrane disruption,abnormal type iv collagen chains,tumor cell invasion,disrupted gene expression,aggressive cancer phenotypes,tissue structure and function
ENSG00000206435,HLA-C,tumor immunosurveillance,immune evasion,hla class i molecule,peptide presentation,prognostic marker,immunogenic epitopes
ENSG00000273686,B2M,antigen presentation,cancer immunotherapy target,dysregulated expression,immune evasion mechanism,major histocompatibility complex component,tumor immune microenvironment
ENSG00000274739,KIR2DS5,cellular proliferation,ion channel regulation,oncogenic processes,cell survival,potassium ion balance,cancer progression
ENSG00000011600,TYROBP,immune modulation,oncogenic signaling,tumor growth promotion,apoptosis resistance,therapeutic target,immunosuppressive microenvironment
ENSG00000258227,CLEC5A,immune modulation,tumor progression,cell surface interaction,cancer metastasis,adhesion molecule function,receptor binding
ENSG00000096264,NCR2,tumor immunosurveillance,immune evasion,cell surface receptor,protein activation,cytolytic granule component,innate immunity regulator
ENSG00000101307,SIRPB1,immunosuppression,oncogene,tumor microenvironment modulation,angiogenesis promotion,poor prognosis association,immune cell interaction
ENSG00000124731,TREM1,tumor progression,immune evasion,angiogenesis promotion,pro-tumorigenic effect,cellular activation,receptor interaction
ENSG00000095970,TREM2,immune system regulation,microglia activation,tumor microenvironment modulation,disease association,poor prognosis indicator,aggressive tumor behavior
ENSG00000186407,CD300E,immunoregulation,tumor suppressor,cell adhesion,molecular interaction,immune evasion,downregulation
ENSG00000178789,CD300LB,immunomodulatory function,immune evasion,tumor microenvironment modulation,cell signaling regulation,immune suppression,somatic mutations
ENSG00000100351,GRAP2,**

phosphoprotein binding,signaling pathway modulation,cell survival regulation,cell proliferation control,oncogene activation,tumor suppressor function
ENSG00000043462,LCP2,oncogene activation,transcriptional regulation,cell survival enhancement,apoptosis resistance,tumor progression facilitation,genomic amplification
ENSG00000136158,SPRY2,tumor suppressor,cell proliferation inhibition,fgf/egfr signaling pathway regulation,biomarker potential,therapeutic target,genomic instability modulation
ENSG00000153071,DAB2,cell adhesion disruption,tumor suppressor role,reduced expression,oncogenic processes promotion,cell proliferation enhancement,metastatic potential increase
ENSG00000081479,LRP2,cellular internalization,multiprotein interactions,tumor progression,cell migration regulation,wnt/β-catenin pathway activation,pi3k/akt signaling
ENSG00000124333,VAMP7,cell membrane trafficking,multinucleated giant cells,epithelial-to-mesenchymal transition (emt),cancer cell motility,signaling pathway modulation,protein-protein interaction
ENSG00000173744,AGFG1,**

genomic instability,cell cycle regulation,protein sorting dysfunction,tumor progression,metastasis driver,apoptosis evasion 
**
ENSG00000078053,AMPH,cellular trafficking pathways,dysregulated endocytosis,altered vesicle dynamics,tumor cell growth,invasive behavior,neurodegenerative disease connection
ENSG00000136717,BIN1,genomic instability,tumor suppressor function,cell membrane dynamics,chromatin remodeling,apoptosis regulation,gene transcription regulation
ENSG00000161011,SQSTM1,autophagy regulation,pi3k/akt pathway interaction,therapeutic target,ubiquitination regulation,protein degradation modulation,epigenetic regulation
ENSG00000198909,MAP3K3,mapk/erk pathway activation,oncogenic signaling,tumor progression promotion,therapeutic target potential,cell growth regulation,protein interaction
ENSG00000187840,EIF4EBP1,mtor pathway,constitutive activation,tumor suppressor function,loss-of-function mutations,gain-of-function mutations,protein synthesis regulation
ENSG00000151247,EIF4E,oncogenic driver,cell proliferation,mrna translation,tumor progression,therapeutic target,cancer-specific protein
ENSG00000134250,NOTCH2,constitutive activation,gain of function mutations,tumor progression,cell proliferation,apoptosis regulation,notch signaling pathway
ENSG00000137496,IL18BP,il-18 regulation,inflammation suppression,tumor microenvironment modification,immune response modulation,cancer progression impact,pro-inflammatory cytokine inhibition
ENSG00000150782,IL18,il18 overexpression,pro-tumor immunity,angiogenesis promotion,vascular endothelial growth factor induction,tumor progression correlation,poor prognosis association
ENSG00000115604,IL18R1,tumor progression,cell surface receptor,immune response regulation,inflammation mediation,cell signaling activation,cancer-associated gene expression changes
ENSG00000164136,IL15,il-15 mediated immune response,angiogenesis promotion,oncogenic function,tumor microenvironment modulation,immune cell activation,pro-inflammatory signaling
ENSG00000134470,IL15RA,jak-stat pathway,tumor progression,immune evasion,cancer therapy target,t-cell activation,receptor-ligand interaction
ENSG00000126456,IRF3,immune evasion,transcriptional regulation,oncogenic activation,tumor progression,inflammation regulation,pro-inflammatory signaling
ENSG00000185507,IRF7,immune evasion,tumor microenvironment modulation,pro-inflammatory cytokine induction,angiogenesis promotion,metastasis enhancement,chemotherapy resistance
ENSG00000005339,CREBBP,chromatin remodeling,epigenetic regulation,loss of tumor suppressor function,wnt/β-catenin pathway,pi3k/akt pathway activation,transcriptional coactivator role
ENSG00000074181,NOTCH3,notch signaling cascade,aberrant activation,cell survival enhancement,tumor progression,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000163435,ELF3,chromatin remodeling,enhanced cell survival,tumor suppressor gene suppression,constitutive activation,cell proliferation regulation,transcriptional modulation
ENSG00000018236,CNTN1,pi3k/akt pathway,cell-cell adhesion disruption,tumor progression,protein-protein interaction,oncogenic driver,epithelial-to-mesenchymal transition (emt)
ENSG00000110492,MDK,tumor progression,therapeutic target,biomarker for prognosis,angiogenesis,metastasis,cell survival
ENSG00000198719,DLL1,notch pathway,oncogenic function,tumor progression,cell-cell interactions,signaling molecule,overexpression
ENSG00000065978,YBX1,dna binding,transcriptional regulation,oncogene activation,genomic instability,tumor progression,cell proliferation
ENSG00000164683,HEY1,oncogenic activity,transcription factor function,epithelial-to-mesenchymal transition (emt),cell cycle progression regulation,apoptosis suppression,prognostic biomarker
ENSG00000160973,FOXH1,disrupted wnt/β-catenin signaling,tumor suppressor function,aberrant cell proliferation,tgf-β pathway disruption,co-factor for smad proteins,gene expression regulation
ENSG00000175550,DRAP1,dna repair,cell cycle regulation,tumor suppressor function,genome stability,apoptosis regulation,prognostic marker
ENSG00000064309,CDON,notch signaling pathway,dysregulation,cellular differentiation,oncogenic process,tumor progression,biomarker
ENSG00000144857,BOC,bet complex interaction,chromatin remodeling,genomic instability prevention,histone modification regulation,protein-protein interactions,transcriptional regulation
ENSG00000110944,IL23A,immune evasion,inflammation promotion,tumor growth promotion,metastasis enhancement,jak/stat pathway activation,pro-inflammatory cytokine production
ENSG00000162594,IL23R,il23r signaling pathway,tumor microenvironment modulation,immune evasion promotion,inflammation regulation,poor prognosis marker,wnt/β-catenin pathway interaction
ENSG00000138378,STAT4,stat/jak pathway interaction,gene amplification,dysregulated transcriptional activity,tumor microenvironment modulation,oncogenic signaling pathway,immune evasion mechanism
ENSG00000113889,KNG1,angiogenesis promotion,poor prognosis indicator,signaling pathway modulation,tumor progression enhancement,vasodilatory activity,inflammation regulation
ENSG00000108561,C1QBP,cellular adhesion,cell migration,oncogenesis,tumor growth,protein-protein interactions,apoptosis regulation
ENSG00000185010,F8,coagulation pathway,pro-coagulant protein,bleeding disorder,hemophilia a,factor viii complex,microvascular angiogenesis
ENSG00000110799,VWF,angiogenesis promotion,cell migration enhancement,platelet adhesion facilitation,oncogenic signaling modulation,tumor progression association,metastasis promotion
ENSG00000101981,F9,angiogenesis promotion,coagulation cascade overexpression,dna methylation epigenetic alterations,epithelial-to-mesenchymal transition (emt) involvement,metastasis facilitation,pro-tumorigenic microenvironment creation
ENSG00000143278,F13B,coagulation factor activation,metastasis promotion,angiogenesis induction,tumor progression,prognostic marker,genetic overexpression
ENSG00000124491,F13A1,tumor progression,cellular adhesion modulation,angiogenesis promotion,therapeutic target,metastasis facilitation,coagulation cascade involvement
ENSG00000115718,PROC,collagen biosynthesis,extracellular matrix regulation,tissue structural integrity,cancer progression enhancement,protein modification activity,fibrillogenesis
ENSG00000101000,PROCR,cell surface receptor,coagulation regulation,immune evasion mechanism,tumor progression facilitation,growth factor signaling modification,anticoagulant activity modulation
ENSG00000154589,LY96,tumor suppressor function,tlr signaling regulation,dysregulated nf-κb pathway,inflammation mediator,cell proliferation promotion,prognostic biomarker
ENSG00000136869,TLR4,innate immune activation,chronic inflammation,oncogenic signaling,tumor microenvironment,nf-κb pathway regulation,immune receptor overexpression
ENSG00000163220,S100A9,tumor-promoting factor,nf-κb pathway activation,cell proliferation enhancement,inflammation modulation,receptor-ligand interaction,immune suppression induction
ENSG00000143546,S100A8,pro-inflammatory effects,tumor growth,calcium homeostasis regulation,angiogenesis promotion,oncogene activation,apoptosis resistance
ENSG00000130522,JUND,transcriptional regulation,cell cycle control,apoptosis evasion,inflammatory microenvironment,tumor aggressiveness,oncogenic function
ENSG00000125740,FOSB,mapk/erk pathway,constitutive activation,gain of function mutations,oncogenic transformation,cell proliferation,epigenetic regulation
ENSG00000242335,CFB,tumor promotion,cell adhesion,prognostic marker,complement system activation,inflammation modulation,genomic instability
ENSG00000125730,C3,complement activation,tumor progression,immune evasion,genomic instability,angiogenesis,pro-inflammatory signaling
ENSG00000104879,CKM,energy metabolism,apoptosis regulation,cell growth promotion,biomarker potential,pi3k/akt pathway interaction,cellular energy homeostasis
ENSG00000166165,CKB,cell proliferation,metabolic regulation,anabolic processes,oncogenesis,tumor growth,energy metabolism
ENSG00000117592,PRDX6,hypoxia response,cell survival,antioxidant activity,redox regulation,therapeutic resistance,tumor progression
ENSG00000084207,GSTP1,dna repair,epigenetic regulation,genotoxic stress response,protein-protein interaction,cell proliferation regulation,therapeutic target
ENSG00000185122,HSF1,transcription factor regulation,oncogene activation,epithelial-to-mesenchymal transition (emt),tumor progression,therapeutic resistance,prognostic marker
ENSG00000230989,HSBP1,protein degradation,chaperone function,oncogenesis,cell proliferation,tumor suppression,tumor aggressiveness
ENSG00000108953,YWHAE,oncogenic driver,amplification and overexpression,cell proliferation,tumor growth promotion,prognostic biomarker,signaling pathway modulation
ENSG00000158941,CCAR2,chromatin remodeling,oncogenic coactivator,cell proliferation enhancer,tumor suppressor inhibitor,cancer-specific transcription factor,promoter binding protein
ENSG00000096717,SIRT1,dna repair regulation,apoptosis inhibition,metabolic reprogramming,oncogenic signaling,prognostic marker,histone deacetylation
ENSG00000125968,ID1,oncogene,cell proliferation,transcriptional regulation,apoptosis evasion,cell cycle modulation,therapeutic target
ENSG00000157557,ETS2,oncogenic transcription factor,transcriptional activation,cell proliferation,apoptosis regulation,tumor progression,prognostic marker
ENSG00000105722,ERF,oncogenic driver,receptor dimerization,pi3k/akt pathway activation,ligand-independent activation,amplification and overexpression,monoclonal antibody target
ENSG00000197442,MAP3K5,apoptosis evasion,cell signaling pathway,cell proliferation,genomic instability,oncogenic process,protein kinase activation
ENSG00000147883,CDKN2B,cell cycle regulation,dna damage response,chromosomal deletion,loss of function mutations,proliferation inhibition,apoptosis evasion
ENSG00000172216,CEBPB,cell growth regulation,dual function role,cell survival pathway,transcriptional regulation,metastasis suppression,tumor suppressor activity
ENSG00000198178,CLEC4C,tumor progression,immune regulation,oncogenesis,carbohydrate ligand binding,cell surface interaction,pi3k/akt pathway activation
ENSG00000158869,FCER1G,immunoglobulin binding,cell proliferation,tumor growth,metastasis promotion,biomarker potential,oncogenic processes
ENSG00000166523,CLEC4E,immune modulation,tumor-infiltrating immune cells,inflammatory microenvironment,myeloid-derived suppressor cells recruitment,cell adhesion and migration regulation,tumor progression promotion
ENSG00000006062,MAP3K14,constitutive activation,mapk pathway modulation,nf-κb pathway activation,oncogene,tumor progression,dna damage response
ENSG00000213341,CHUK,nf-κb pathway,constitutive activation,cell survival,oncogenic potential,tumor progression,immune evasion
ENSG00000077150,NFKB2,nf-kappa b signaling pathway,transcriptional regulation,oncogenic role,tumor progression,cell survival enhancement,genomic instability
ENSG00000104856,RELB,enhanced tumor aggressiveness,cell migration facilitation,oncogene activation,prognostic marker overexpression,therapeutic target potential,angiogenesis promotion
ENSG00000172175,MALT1,nf-kappa b signaling,tumor growth,cell survival,oncogenic mutation,carma1-bcl10-malt complex formation,apoptosis resistance
ENSG00000064012,CASP8,loss of function mutations,apoptosis suppression,tumor progression,cell death regulation,caspase activation,proteolytic cleavage
ENSG00000090659,CD209,tumor evasion,immune suppression,metastasis promotion,cancer progression,poor prognosis association,tumor microenvironment modulation
ENSG00000108622,ICAM2,cell-cell interaction,immune evasion,tumor microenvironment,cell adhesion regulation,tumor invasion,poor prognosis
ENSG00000075218,GTSE1,cell cycle regulation,apoptosis suppression,microtubule interaction,protein-protein interaction,cell proliferation enhancement,tumor progression association
ENSG00000117399,CDC20,anaphase-promoting complex,genomic instability,constitutive activation,mitotic checkpoint dysregulation,cell division cycle regulation,tumor progression
ENSG00000164109,MAD2L1,genomic instability,mitotic checkpoint dysfunction,spindle assembly regulation,tumor suppressor function,aneuploidy induction,cell cycle progression disruption
ENSG00000136997,MYC,oncogene,cell cycle regulation,transcriptional regulation,tumor progression,apoptosis resistance,therapeutic target
ENSG00000123374,CDK2,cell cycle regulation,oncogenic driver,tumor progression,therapeutic target,cell proliferation,poor prognosis
ENSG00000105173,CCNE1,overexpression,cell cycle dysregulation,oncogene activation,tumor progression,poor prognosis,genetic amplification
ENSG00000112312,GMNN,mitotic regulator,cell cycle progression,microtubule dynamics,spindle assembly,protein kinase activation,genomic instability
ENSG00000167513,CDT1,dna replication regulation,genomic instability,cell cycle progression,chromatin licensing,oncogenic protein,tumor suppressor dysfunction
ENSG00000006634,DBF4,transcription regulation,cell cycle progression,genomic instability,proliferation promotion,kinase activation,dna replication machinery
ENSG00000097046,CDC7,cell cycle regulation,dna replication initiation,gain of function mutations,oncogene activation,protein kinase activation,tumor progression
ENSG00000133101,CCNA1,cell cycle progression,overexpression,oncogenic pathway activation,epithelial-to-mesenchymal transition (emt),cyclin-dependent kinase interaction,dna replication and repair regulation
ENSG00000145386,CCNA2,genomic instability,cell cycle regulation,oncogene activation,cell proliferation,prognostic marker,therapeutic target
ENSG00000139289,PHLDA1,telomerase regulation,chromosomal instability,tumor suppressor function,cell cycle regulation,g1/s checkpoint modulation,genomic stability maintenance
ENSG00000288307,CTDNEP1,dna replication regulation,gene amplification,cell cycle regulator,genomic instability,tumor suppressor protein interaction,therapeutic target
ENSG00000205423,CNEP1R1,cell cycle regulation,oncogenic overexpression,aberrant cell division,tumorigenesis driver,cell proliferation enhancement,apoptosis inhibition
ENSG00000135476,ESPL1,chromosomal instability,aneuploidy,cell cycle regulation,sister chromatid separation,mitotic checkpoint control,tumor progression
ENSG00000164611,PTTG1,**
tumor suppressor dysfunction,cell cycle regulation,oncogene overexpression,genomic instability,pi3k/akt pathway activation,therapeutic target 
**
ENSG00000129933,MAU2,genomic instability,dna repair regulation,tumor suppressor interaction,oncogenic function,cell survival enhancement,brca1/bard1 pathway
ENSG00000164190,NIPBL,genomic instability,cohesin complex disruption,chromothripsis,genome integrity loss,sister chromatid cohesion impairment,tumor progression facilitation
ENSG00000112029,FBXO5,tumor suppressor function,regulation of cell cycle progression,protein degradation pathway,e3 ubiquitin ligase activity,apoptosis regulation,cell proliferation modulation
ENSG00000073712,FERMT2,oncogene,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,cell migration enhancement,wnt/β-catenin pathway interaction,biomarker for diagnosis
ENSG00000162458,FBLIM1,fblim1 expression,epithelial-to-mesenchymal transition,tumor progression,actin cytoskeleton regulation,cancer cell migration,protein-protein interaction
ENSG00000150093,ITGB1,integrin adhesion,cell migration,tumor invasion,metastasis regulation,cell proliferation,signal transduction modulation
ENSG00000166333,ILK,integrin-linked kinase signaling pathway,constitutive activation,gain-of-function mutations,tumor progression,cell adhesion disruption,akt activation
ENSG00000197702,PARVA,genomic instability,mitotic spindle regulation,dna damage response,cell cycle regulation,kinetochores interaction,aurora a kinase activity
ENSG00000129675,ARHGEF6,oncogenic driver,cell proliferation,rhoa activation,proliferative signaling,cellular adhesion disruption,gef activity
ENSG00000188677,PARVB,protein folding regulation,cell cycle dysregulation,apoptosis inhibition,genome instability,chromatin remodeling,tumor progression
ENSG00000148484,RSU1,altered splicing patterns,constitutive overexpression,cellular proliferation,tumor progression,rna-binding protein activity,genomic instability
ENSG00000169756,LIMS1,altered cell adhesion,cell migration,aberrant protein interaction,cytoskeleton disruption,tumor initiation,genomic instability
ENSG00000072110,ACTN1,cellular motility,oncogene activation,cytoplasmic protein localization,focal adhesion formation,actin filament regulation,tumor invasiveness
ENSG00000091409,ITGA6,cell adhesion disruption,laminin-binding integrins,increased cell motility,tumor progression,oncogenic potential,signaling pathway modulation
ENSG00000132470,ITGB4,cell adhesion disruption,overexpression,promotes metastasis,angiogenesis regulation,pi3k/akt pathway activation,integrin signaling
ENSG00000196776,CD47,tumor immune evasion,macrophage inhibition,phagocytosis blockade,therapeutic target,cancer stem cell maintenance,glycoprotein regulation
ENSG00000198053,SIRPA,tumor progression,tumor cell survival,immunosuppressive microenvironment,cell migration and invasion,natural killer cell suppression,immune checkpoint modulation
ENSG00000089012,SIRPG,tumor progression,immune evasion,metastasis promotion,epithelial-to-mesenchymal transition regulation,biomarker potential,prognostic significance
ENSG00000161270,NPHS1,cell-cell interactions,tissue integrity,cell adhesion regulation,podocyte development,slit diaphragm complex formation,glomerular filtration barrier maintenance
ENSG00000183853,KIRREL1,cell-cell adhesion disruption,pi3k/akt pathway activation,tumor progression facilitation,epithelial cell migration enhancement,e-cadherin complex interaction,oncogenic signaling modulation
ENSG00000118898,PPL,polyamine regulation,cell proliferation,tumor progression,oncogene activation,protein interaction,genomic amplification
ENSG00000167880,EVPL,epithelial cell regulation,cell membrane stability,protein-protein interaction,cell migration modulation,cell proliferation enhancement,genomic amplification
ENSG00000189337,KAZN,epigenetic regulation,chromatin remodeling,transcriptional regulation,cell proliferation,tumor progression,oncogene function
ENSG00000167754,KLK5,proteolytic activation,extracellular matrix degradation,tumor invasion,pi3k/akt pathway activation,cell proliferation enhancement,upregulated expression
ENSG00000133710,SPINK5,serine protease inhibition,cell proliferation,tumor microenvironment disruption,poorer prognosis,therapeutic target,overexpression
ENSG00000186474,KLK12,tumor progression,extracellular matrix degradation,proteolytic activity,cell migration,biomarker potential,tissue remodeling
ENSG00000178172,SPINK6,pi3k/akt regulation,serine protease inhibition,tumor progression,oncogenic signaling,metastasis promotion,cell proliferation enhancement
ENSG00000167759,KLK13,oncoprotein activation,tumor progression,cell invasion,metastasis facilitation,chemotherapy resistance,biomarker potential
ENSG00000129437,KLK14,cell surface receptor processing,oncogenic potential,tumor microenvironment regulation,epithelial-to-mesenchymal transition,serine protease activity,prognostic biomarker
ENSG00000204909,SPINK9,wnt/β-catenin pathway interaction,oncogenic potential,cell survival promotion,tumor progression driver,chemotherapy resistance,serine protease regulation
ENSG00000077782,FGFR1,cell proliferation,signal transduction pathway activation,oncogene overexpression,angiogenesis promotion,metastasis facilitation,apoptosis evasion
ENSG00000011201,ANOS1,anti-müllerian hormone type 2 receptor,epithelial-to-mesenchymal transition,tumor aggressiveness,cell adhesion inhibition,cancer progression,metastasis
ENSG00000165029,ABCA1,genomic instability,tumor suppression,lipid metabolism modulation,oxidative stress response,cholesterol efflux regulation,cancer driver gene
ENSG00000118137,APOA1,inflammation suppression,oxidative stress reduction,tumor growth inhibition,lipid metabolism regulation,multifunctional protein,poor prognosis biomarker
ENSG00000132855,ANGPTL3,wnt/β-catenin signaling,constitutive activation,overexpression,poor prognosis,lipid metabolism regulation,adipocyte differentiation inhibition
ENSG00000130173,ANGPTL8,angiogenesis promotion,lipid metabolism regulation,apoptosis suppression,cell proliferation enhancement,tumor growth facilitation,vascular network formation
ENSG00000126261,UBA2,dna repair mechanisms,genomic instability,oncogenic transformation,tumor suppressor regulation,poor prognosis marker,signaling pathway modulation
ENSG00000142230,SAE1,sumoylation pathway,oncogenic driver,tumor progression,cell growth regulation,protein folding regulation,genomic instability
ENSG00000112576,CCND3,cell cycle regulation,cyclin d3 overexpression,constitutive activation,growth factor independence,proliferation marker,therapeutic target
ENSG00000069956,MAPK6,constitutive activation,gain of function mutations,phosphorylation activity,cell growth promotion,tumor aggressiveness,therapeutic target
ENSG00000005884,ITGA3,cell adhesion defects,promotion of metastasis,tumor progression,interaction with stroma,prognostic marker,signaling pathway modulation
ENSG00000135424,ITGA7,adhesion,angiogenesis,cell signaling,extracellular matrix interaction,migration,metastasis
ENSG00000164171,ITGA2,cell adhesion,cell migration,metastasis progression,oncogene function,signaling pathway modulation,phosphorylation regulation
ENSG00000213949,ITGA1,tumor progression,cell adhesion regulation,metastasis promotion,epithelial-to-mesenchymal transition,signaling pathway interaction,genetic alteration correlation
ENSG00000182220,ATP6AP2,**
calcium signaling pathway,mitochondrial function regulation,oncogene activation,cellular transformation,protein-protein interactions,epigenetic regulation 
**
ENSG00000143839,REN,ren overexpression,cell proliferation,protein interaction,tumor progression,signaling pathway modulation,electrolyte imbalance regulation
ENSG00000117481,NSUN4,mitochondrial biogenesis,tumor progression,oncogene function,telomere stability,genomic instability,protein synthesis regulation
ENSG00000122085,MTERF4,mitochondrial regulation,cell growth promotion,energy metabolism modulation,oxidative stress response,tumor progression,therapeutic target
ENSG00000259207,ITGB3,integrin signaling pathway,cell adhesion molecule,cancer progression,focal adhesion kinase activation,cell migration enhancement,tumor metastasis facilitation
ENSG00000005961,ITGA2B,tumor progression,cell adhesion regulation,extracellular matrix interaction,pi3k/akt pathway activation,metastasis promotion,poor prognosis biomarker
ENSG00000130164,LDLR,hedgehog signaling pathway,cholesterol uptake,integrin beta-1 interaction,tumor growth promotion,metastasis facilitation,poor prognosis marker
ENSG00000169174,PCSK9,tumor progression,overexpression,cell proliferation,wnt/β-catenin pathway,regulatory function,metabolic regulation
,TMEM173,interferon signaling pathway,tumorigenesis,tumor immunosuppression,immune evasion,sting complex activation,cancer driver gene mutations
ENSG00000183735,TBK1,nf-κb signaling,protein kinase activation,tumor progression,cell proliferation,mutation hotspot,immune response regulation
ENSG00000139193,CD27,cell proliferation,immune regulation,nf-κb signaling,pro-survival gene expression,tumor growth,therapeutic target
ENSG00000125726,CD70,tumor progression,immune evasion,costimulatory signals,t-cell activation,cancer cell interactions,tumor microenvironment modulation
ENSG00000135960,EDAR,edar overexpression,epithelial tissue development,tnf superfamily member,cell proliferation regulation,cancer progression driver,therapeutic target interaction
ENSG00000158813,EDA,overexpression,egfr pathway activation,cell proliferation,epithelial-to-mesenchymal transition (emt),prognostic marker,oncogenic driver
ENSG00000131080,EDA2R,epithelial cell regulation,signaling pathway dysregulation,tumorigenesis promotion,cell survival enhancement,proliferation and migration regulation,apoptosis resistance
ENSG00000120337,TNFSF18,tnf superfamily member,immune regulation,tumor progression,nf-κb signaling,cell proliferation,metastasis promotion
ENSG00000186891,TNFRSF18,apoptosis induction,tumor suppressor function,pro-apoptotic signaling,immune modulation,oncogenic pathway suppression,cell death regulation
ENSG00000186827,TNFRSF4,tumor-specific immune response,immunomodulatory function,nf-κb activation,mapk signaling pathway,cell survival regulation,apoptosis evasion
ENSG00000117586,TNFSF4,tumor progression,immunomodulation,cell proliferation,t-cell activation,tumor microenvironment alteration,therapeutic target
ENSG00000215788,TNFRSF25,tnf signaling pathway,dysregulated apoptosis,genetic alterations,oncogenic properties,immune evasion,tumor cell survival
ENSG00000181634,TNFSF15,nf-κb signaling,constitutive activation,cell survival and proliferation,tumor progression,therapeutic target,cytokine activity
ENSG00000106952,TNFSF8,immunomodulation,cell survival enhancement,tumor progression promotion,immune evasion facilitation,pi3k/akt pathway interaction,therapeutic target for bladder cancer
ENSG00000120949,TNFRSF8,apoptosis regulation,cell survival promotion,immune system modulation,tumor suppressor function,nf-κb pathway interaction,epigenetic regulation
ENSG00000125657,TNFSF9,apoptosis resistance,angiogenesis promotion,cytokine function,tumor progression driver,immune evasion,oncogenic signature
ENSG00000049249,TNFRSF9,tumor immune evasion,therapeutic target,immune cell modulation,co-stimulatory signaling,cancer prognosis marker,pi3k/akt pathway regulation
ENSG00000101213,PTK6,oncogenic function,receptor tyrosine kinase activity,therapeutic target,cell proliferation,signal transduction pathway,apoptosis regulation
ENSG00000121774,KHDRBS1,alternative splicing modulation,apoptosis evasion,cell cycle progression,gene expression regulation,metastasis promotion,oncogenic protein interaction
ENSG00000186635,ARAP1,rac activation,cell migration,epithelial-to-mesenchymal transition,constitutive activation,pi3k/akt pathway interaction,guanine nucleotide exchange factor
ENSG00000142208,AKT1,pi3k/akt/mtor signaling pathway,constitutive activation,gain of function mutations,cell survival promotion,therapeutic resistance,prognostic significance
ENSG00000115325,DOK1,oncogene,tumor progression,cell signaling regulation,immune synapse modulation,protein-protein interactions,sh3 domain involvement
ENSG00000196396,PTPN1,cellular signaling pathway regulation,tumor progression,protein tyrosine phosphatase activity,dephosphorylation,oncogenesis,apoptosis inhibition
ENSG00000178078,STAP2,immune evasion,gain of function mutations,tumor progression,pi3k/akt pathway activation,cell growth regulation,antitumor immunity suppression
ENSG00000184557,SOCS3,loss of regulatory function,oncogene activation,stat protein upregulation,cell proliferation enhancement,metastasis facilitation,therapeutic resistance promotion
ENSG00000143127,ITGA10,angiogenesis promotion,cell adhesion regulation,integrin signaling pathway,metastatic progression,pro-tumorigenic microenvironment,tumor aggressiveness
ENSG00000275931,GP6,pi3k/akt activation,cell proliferation,tumor invasion,aggressive behavior,poor prognosis,metastasis facilitation
ENSG00000132155,RAF1,mapk/erk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,gene amplification
ENSG00000164924,YWHAZ,tumor progression,oncogenic processes,cell survival enhancement,pi3k/akt pathway modulation,apoptosis regulation,cancer biomarker
ENSG00000162493,PDPN,oncogene activity,cell adhesion molecule,migration and invasion factor,prognostic marker,angiogenesis promoter,signaling pathway regulator
ENSG00000165682,CLEC1B,immune response modulation,tumor progression,cell migration facilitation,protease regulation,cancer immunotherapy target,cell surface receptor function
ENSG00000197461,PDGFA,tumor progression,cell proliferation,oncogenic signaling,angiogenesis promotion,growth factor activation,receptor interaction
ENSG00000100311,PDGFB,pi3k/akt/mtor pathway,oncogene,angiogenesis,cell proliferation,metastasis,therapeutic target
ENSG00000169896,ITGAM,immune evasion,epithelial-to-mesenchymal transition,cell adhesion molecule,protein-protein interaction,cell migration,inflammation regulation
ENSG00000160255,ITGB2,cell adhesion disruption,metastasis promoter,tumor progression driver,signaling pathway modulation,epigenetic regulation alteration,growth factor interaction
ENSG00000154721,JAM2,cell migration,immune regulation,tumor progression,adhesion molecule,metastasis,prognostic marker
ENSG00000166086,JAM3,angiogenesis enhancement,cell adhesion regulation,metastasis promotion,tumor progression facilitation,poor prognosis association,cancer aggressiveness marker
ENSG00000115232,ITGA4,tumor progression,cell migration,immune evasion,angiogenesis promotion,metastasis facilitation,prognostic biomarker
ENSG00000005844,ITGAL,cell adhesion,metastasis promotion,tumor progression,therapeutic target,immune evasion,cell migration
ENSG00000140678,ITGAX,angiogenesis promotion,immune evasion facilitation,cell migration regulation,tumor growth promotion,metastasis facilitation,cell adhesion modulation
ENSG00000117091,CD48,tumor immune evasion,immune checkpoint regulation,oncogene activation,cell adhesion modulation,protein interaction,therapeutic target
ENSG00000122223,CD244,nk cell activation,immune evasion,enhanced cytolytic activity,tumor immunotherapy,cancer immunoediting,mhc-independent recognition
ENSG00000116815,CD58,adhesion molecule,cell-cell interaction,immune modulation,immune suppression,tumor progression,oncovin
ENSG00000116824,CD2,cell surface receptor,t-cell activation,antigen recognition,tumor growth promotion,metastasis facilitation,biomarker expression
ENSG00000161638,ITGA5,cell adhesion,epithelial-to-mesenchymal transition (emt),integrin signaling,mapk/erk pathway activation,tumor invasion,pi3k/akt pathway interaction
ENSG00000160593,JAML,cell adhesion disruption,oncogene activity,metastasis facilitation,tumor microenvironment modulation,signaling pathway interaction,transcriptional regulation alteration
ENSG00000154639,CXADR,cell-cell adhesion,tight junction regulation,apoptosis modulation,proliferation suppression,metastasis promotion,tumor microenvironment disruption
ENSG00000240972,MIF,nf-κb pathway modulation,pro-inflammatory cytokine function,oncogenic role in tumor progression,immune evasion promotion,tumor microenvironment modification,angiogenesis enhancement
ENSG00000019582,CD74,antigen presentation,cell proliferation,immune modulation,nf-kappab activation,pi3k/akt pathway regulation,tumor progression
ENSG00000120156,TEK,angiogenic signaling,vascular density,receptor tyrosine kinase,tumor microenvironment,cell growth regulation,blood vessel formation
ENSG00000154188,ANGPT1,angiogenesis promotion,tumor progression,vegf regulation,epithelial-to-mesenchymal transition (emt),poor prognosis biomarker,therapeutic target
ENSG00000091879,ANGPT2,angiogenesis,oncogene,vascular remodeling,cell migration,metastasis,tumor progression
ENSG00000101280,ANGPT4,vegfr signaling pathway,angiogenesis promotion,apoptosis suppression,tumor progression facilitation,biomarker potential,vascular development regulation
ENSG00000168918,INPP5D,pi3k/akt/mtor pathway regulation,tumor progression,dephosphorylation of pi(3)p,cell signaling inhibition,metabolic regulation,cell proliferation
ENSG00000124181,PLCG1,activation of downstream signaling pathways,oncogenic mutations or amplifications,cell proliferation and migration,tumor progression and invasion,receptor tyrosine kinase interaction,signal transduction regulation
ENSG00000172270,BSG,epithelial-to-mesenchymal transition,overexpression,cell migration,immunotherapy target,tumor progression,metastasis
ENSG00000100023,PPIL2,apoptosis regulation,caspase inhibition,cell proliferation,genomic instability,oncogene function,signaling pathway modulation
ENSG00000105974,CAV1,tumor suppressor,cell signaling regulation,pi3k/akt pathway modulation,oncogenic pathway activation,cell migration enhancement,protein-protein interaction regulation
ENSG00000196262,PPIA,immunomodulation,tumor progression,protein stability regulation,cell growth enhancement,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000155465,SLC7A7,lysine transport,large neutral amino acids,tumor growth,cell proliferation,protein interaction,apoptosis regulation
ENSG00000168003,SLC3A2,tumor progression,cellular metabolism regulation,cell proliferation,protein interaction,amino acid transporter function,cancer-associated mutations
ENSG00000092068,SLC7A8,glutamine metabolism,tumor aggressiveness,nutrient uptake regulation,cellular proliferation enhancement,therapeutic target,aberrant expression
ENSG00000021488,SLC7A9,cationic amino acid transport,arginine metabolism,tumor progression,protein synthesis regulation,immune response modulation,oncogenic pathway activation
ENSG00000151012,SLC7A11,glutamine dependence,cell membrane transport,oncogenic metabolism,poor prognosis indicator,therapeutic target,amino acid transporter function
ENSG00000103257,SLC7A5,glutamine metabolism,oncogenic process,cell proliferation,therapeutic target,tumor progression,prognostic marker
ENSG00000130876,SLC7A10,cellular proliferation,amino acid transport,metabolic regulation,tumor progression,genomic overexpression,biological function alteration
ENSG00000103064,SLC7A6,glutamine transport,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular adaptation
ENSG00000136750,GAD2,gaba signaling pathway,overexpression,epithelial-to-mesenchymal transition (emt),cell proliferation,tumor progression,molecular alteration
ENSG00000128683,GAD1,neurotransmitter regulation,glutamate metabolism,cellular proliferation,inhibitory signaling pathway,mutation alteration,tumor suppressor gene expression
ENSG00000186090,HTR3D,oncogene activation,neurotransmission regulation,cell proliferation enhancement,metastasis promotion,therapeutic target discovery,genomic overexpression
ENSG00000166736,HTR3A,serotonin receptor activation,cell proliferation enhancement,downstream signaling pathways,overexpression correlation,poor prognosis association,cancer progression link
ENSG00000186038,HTR3E,constitutive activation,cell proliferation,tumor progression,co-expression signature,serotonin receptor function,prognostic marker
ENSG00000149305,HTR3B,serotonin regulation,cell proliferation regulation,oncogenic process,apoptosis resistance,tumor growth promotion,therapeutic target
ENSG00000178084,HTR3C,cellular response modulation,oncogenic processes,tumor progression,serotonin receptor activation,protein interaction,metabolic regulation
ENSG00000175387,SMAD2,tgf-β signaling pathway,constitutive activation,gain of function mutations,transcriptional repressor activity,oncogenic effects,tumor progression
ENSG00000177628,GBA,autophagy induction,cell survival enhancement,hif1a interaction,pi3k/akt signaling activation,protein degradation regulation,upregulated expression
ENSG00000197746,PSAP,altered lipid metabolism,oncogenic role,regulation of protein modification,cell proliferation,sphingolipid biosynthesis,cell differentiation
ENSG00000112799,LY86,cell cycle regulation,genomic integrity maintenance,immune modulation,tumor suppressor,apoptosis induction,cell adhesion disruption
ENSG00000134061,CD180,chronic inflammation,immune response regulation,cytokine production,angiogenesis promotion,tumor growth facilitation,metastasis enhancement
ENSG00000118004,COLEC11,tumor progression,cell adhesion regulation,innate immune response,cancer-associated fibroblast regulation,protein overexpression,tissue microenvironment interaction
ENSG00000127241,MASP1,tumor progression,immune modulation,promoter activity,cell migration,serine protease activation,complement pathway regulation
ENSG00000169562,GJB1,cell-to-cell communication,oncogene function,tumor progression,metastasis enhancement,cell proliferation,gap junction regulation
ENSG00000165474,GJB2,cell-cell communication disruption,gap junctions,tumor progression,potential tumor suppressor,cancer cell proliferation,metastasis promotion
ENSG00000152661,GJA1,cell-to-cell communication,gap junctions,tumor progression,oncogene potential,biomarker for disease severity,signaling pathway modulation
ENSG00000277401,TJP1,tumor suppressor function,wnt/β-catenin pathway regulation,cell adhesion and migration regulation,apoptosis modulation,cell proliferation enhancement,genomic instability promotion
ENSG00000069869,NEDD4,e3 ligase activity,cell migration regulation,tumor suppression function,protein ubiquitination regulation,cell cycle modulation,ubiquitin-protein interaction
ENSG00000138032,PPM1B,cell cycle regulation,apoptosis inhibition,tumor progression,cell proliferation,oncogenic interaction,dna damage response
ENSG00000136068,FLNB,actin cytoskeleton disruption,cell proliferation enhancement,tumor progression promotion,gene amplification mutation,protein overexpression oncogenic,cell migration modulation
ENSG00000137033,IL33,immunomodulation,inflammation induction,tumor microenvironment modulation,immune suppressive cell recruitment,cancer progression promotion,poor prognosis indicator
ENSG00000115602,IL1RL1,immune evasion,tumor microenvironment modulation,cytokine regulation,angiogenesis promotion,cell survival enhancement,metastasis facilitation
ENSG00000125571,IL37,pro-inflammatory response,anti-tumor immunity,tumor suppressor function,cancer cell proliferation,oncogene properties,cell migration promotion
ENSG00000100368,CSF2RB,cell signaling,gm-csf pathway,oncogenic processes,tumor progression,gene expression regulation,epigenetic modifications
ENSG00000198223,CSF2RA,tumor progression,cell proliferation,oncogenic driver,immunotherapy target,cytokine receptor subunit,prognostic marker
ENSG00000164400,CSF2,oncogenic processes,cellular proliferation,tumor microenvironment regulation,signaling pathway activation,constitutive expression,cytokine-mediated responses
ENSG00000091181,IL5RA,aberrant expression,cell proliferation,stat3 activation,tumor progression,immune evasion,growth factor signaling
ENSG00000113525,IL5,inflammation,immune evasion,tumor promotion,eosinophil recruitment,mast cell regulation,t-cell differentiation
,TEC,tumor progression,cell migration,protein tyrosine kinase activity,oncogenic signaling,t-cell activation,adhesion molecule regulation
ENSG00000141968,VAV1,rho gtpase activation,gef function,cell migration regulation,tumor invasion,protein interaction modulation,signaling pathway activation
ENSG00000095585,BLNK,blnk overexpression,enhanced cell proliferation,cell migration and invasion,pi3k/akt pathway activation,pro-tumorigenic microenvironment,cytokine signal dysregulation
ENSG00000077238,IL4R,tumor progression,cell surface receptor interaction,jak/stat pathway activation,immune evasion,inflammation regulation,prognostic marker
ENSG00000131724,IL13RA1,aberrant signaling pathway,cell proliferation,immune evasion,inflammation regulation,oncogenic driver mutation,tumor growth enhancement
ENSG00000169194,IL13,stat6 activation,constitutive expression,oncogenic signaling,angiogenesis promotion,poor prognosis association,therapeutic target
ENSG00000123496,IL13RA2,cellular proliferation regulation,signaling pathway modulation,tumor progression facilitation,interleukin-13 receptor interaction,immune-related signaling activation,oncogenic potential enhancement
ENSG00000168685,IL7R,il-7/il-7r axis,t cell development,gain of function mutations,oncogenic signaling,tumor aggressiveness,therapeutic target
ENSG00000127616,SMARCA4,histone modification disruption,genomic instability induction,tumor suppressor function loss,epithelial-to-mesenchymal transition promotion,chromatin remodeling dysfunction,cell cycle regulation disruption
ENSG00000185658,BRWD1,chromatin remodeling,cell cycle progression,genomic instability,transcriptional regulation,protein-protein interactions,oncogenesis
ENSG00000164485,IL22RA2,il-22/stat3 signaling pathway,tumor progression,epithelial barrier disruption,immune evasion mechanisms,oncogene activation,genomic instability
ENSG00000127318,IL22,tumor-promoting,immune regulation,cytokine signaling,cellular proliferation,angiogenesis enhancement,anti-tumor effects
ENSG00000185436,IFNLR1,immune evasion,type iii interferon signaling,interferon lambda receptor 1 function,tumor progression modulation,immunotherapy resistance,genomic instability
ENSG00000172349,IL16,epithelial-to-mesenchymal transition,cell proliferation,tumor progression,immune evasion,signaling pathway activation,prognostic marker
ENSG00000008517,IL32,inflammation,tumor microenvironment modulation,oncogene role,pro-inflammatory cytokine,immune response regulation,nf-κb/mapk pathway interaction
ENSG00000196415,PRTN3,cellular proliferation,serine protease activity,protein-protein interactions,tumor progression,apoptosis regulation,cancer metastasis
ENSG00000122025,FLT3,flt3 overexpression,pi3k/akt signaling activation,tumor growth promotion,constitutive activation,therapeutic target,leukemogenesis
ENSG00000090554,FLT3LG,cell proliferation enhancement,stat5/akt pathway activation,metastasis promotion,angiogenesis facilitation,tumor progression driver,immunomodulation disruption
ENSG00000108342,CSF3,g-csfr activation,cell proliferation,neutrophil development,immune modulation,tumor microenvironment modification,prognostic marker
ENSG00000119535,CSF3R,constitutive activation,gain of function mutations,tumor progression,increased cell proliferation,apoptosis inhibition,signaling pathway dysregulation
ENSG00000084652,TXLNA,emt regulation,tumor progression,metastasis promotion,cell adhesion modulation,cancer association,therapeutic target
ENSG00000106089,STX1A,cancer cell proliferation,cell cycle progression inhibition,poor prognosis marker,therapeutic target,tumor progression driver,membrane fusion regulation
ENSG00000112964,GHR,growth factor regulation,jak/stat signaling pathway activation,constitutive receptor activation,tumor progression promotion,cell proliferation enhancement,apoptosis evasion
ENSG00000113494,PRLR,cell signaling pathway,oncogenic driver,immune evasion,tumor progression,protein-protein interaction,growth factor regulation
ENSG00000131323,TRAF3,nf-κb pathway inhibition,tumor suppressor function,loss-of-function mutations,apoptosis regulation,immune evasion,poor prognosis
ENSG00000028137,TNFRSF1B,nf-κb signaling pathway,altered expression,immune response modulation,tumor progression regulation,cell adhesion disruption,potential therapeutic target
ENSG00000102245,CD40LG,tumor immune evasion,t-cell modulation,cancer progression,antigen presentation,dysregulation of immune responses,enhanced metastasis potential
ENSG00000101017,CD40,tnfr superfamily member,tumor progression,inflammation mediator,cancer cell interaction,cell proliferation regulator,antigen presentation enhancement
ENSG00000159958,TNFRSF13C,oncogenic signaling,cell proliferation,immune evasion,tumor progression,apoptosis suppression,proteolytic processing
ENSG00000102524,TNFSF13B,tl1a expression,promotes tumorigenesis,activates cell proliferation,enhances survival pathways,angiogenesis facilitation,suppressed apoptosis
ENSG00000076641,PAG1,glycoprotein maturation,er-golgi transport,cell signaling pathways,tumor progression,metastasis,prognostic marker
ENSG00000103653,CSK,tumor progression,cell migration regulation,growth factor activation,pi3k/akt signaling pathway,tyrosine kinase activity,molecular interaction
ENSG00000134242,PTPN22,immune modulation,signaling pathway regulation,tumor microenvironment modulation,gene expression alteration,oncogenic process involvement,genomic instability association
ENSG00000213658,LAT,pi3k/akt pathway activation,constitutive activation,tumor progression,therapeutic target,lymphocyte activation,protein tyrosine phosphatase activity
ENSG00000082074,FYB1,scaffold protein function,stat3 interaction,cell proliferation regulation,oncogene potential,tumor progression correlation,biomarker significance
ENSG00000158092,NCK1,cell adhesion disruption,oncogenic potential,cell migration promotion,tumor progression,metastasis facilitation,pi3k/akt pathway interaction
ENSG00000135341,MAP3K7,tumor microenvironment modulation,cancer cell survival enhancement,inflammation regulation,mapk signaling pathway activation,nf-κb pathway activation,tumor progression facilitation
ENSG00000055208,TAB2,apoptosis regulation,immune response modulation,nf-κb pathway activation,cell survival enhancement,oncogenic transformation,therapeutic target
ENSG00000163600,ICOS,immune evasion,tumor progression,cell survival,therapeutic target,pi3k/akt signaling pathway,t cell activation
ENSG00000160223,ICOSLG,overexpression,immune evasion,tumor progression,cell proliferation,survival pathway activation,prognostic marker
ENSG00000157873,TNFRSF14,immunomodulation,inflammation,tumor microenvironment modulation,cell proliferation enhancement,cancer metastasis promotion,prognostic marker
ENSG00000186265,BTLA,tumor immune evasion,immunosuppression,cell proliferation inhibition,t cell activation regulation,tumor progression facilitation,immune tolerance induction
ENSG00000121594,CD80,immune regulation,t-cell activation,antigen presentation,immune evasion,cancer immunotherapy,tumor progression
ENSG00000178562,CD28,immune evasion,modulation of tumor microenvironment,t-cell activation and proliferation,aberrant signaling,tumor growth and survival,pro-immune response
ENSG00000114013,CD86,immune suppression,t cell activation,pd-1/pd-l1 checkpoint,co-stimulatory molecule,t cell proliferation,immune evasion
ENSG00000100906,NFKBIA,constitutive activation,tumor suppressor function,nf-kappa b pathway inhibition,cancer progression,apoptosis regulation,proliferation suppression
ENSG00000141367,CLTC,microtubule regulation,oncogene interaction,tumor aggressiveness,cell proliferation,membrane trafficking,prognostic marker
ENSG00000122705,CLTA,cell-cell adhesion disruption,cell migration enhancement,extracellular matrix remodeling,gene overexpression,invasion and metastasis promotion,tumor progression facilitation
ENSG00000242574,HLA-DMB,antigen presentation pathway,immune evasion mechanism,immunotherapy target,mhc class ii complex,peptide exchange facilitation,t-cell activation
ENSG00000204257,HLA-DMA,impaired antigen presentation,tumor progression,downregulation of expression,poor prognosis,genetic alterations,apoptosis regulation
ENSG00000153283,CD96,epithelial integrity regulation,tumor progression facilitation,cell adhesion modulation,nectin-like molecule interaction,pi3k/akt pathway modulation,metastasis enhancement
ENSG00000139626,ITGB7,integrin signaling pathway,metastatic potential,cell adhesion modulation,tumor progression,poor prognosis marker,adhesion molecule upregulation
ENSG00000206493,HLA-E,immune evasion,tumor immune microenvironment,mhc class i expression,immune checkpoint modulation,nk cell inhibition,prognostic marker
ENSG00000039068,CDH1,adhesion molecule disruption,loss of function mutations,decreased cell-cell adhesion,increased cellular migration,enhanced invasiveness,signaling pathway alteration
ENSG00000139187,KLRG1,immunoregulation,tumor suppressor,immune evasion,cancer immunity,t cell activation,nk cell function
ENSG00000150637,CD226,t-cell activation,promotes cell adhesion,mutations leading to overexpression,immune evasion,tumor metastasis,immunotherapeutic target
ENSG00000091972,CD200,immunosuppression,immune evasion,tumor progression,anti-tumor immune response,myeloid cell regulation,ig-like domain structure
ENSG00000163606,CD200R1,immune modulation,tumor progression,immune evasion,cancer immunity,myeloid cell regulation,molecular interactions
ENSG00000235346,HLA-G,immune evasion,tumor progression,immune modulation,angiogenesis regulation,cell adhesion molecule expression,epigenetic regulation
ENSG00000275583,KIR2DS2,potassium channel regulation,cellular proliferation,apoptosis regulation,oncogene expression,electrical property modulation,cell survival pathway interaction
ENSG00000069493,CLEC2D,cellular regulation,microenvironment modulation,immune cell interaction,inflammation regulation,tumor progression,antigen presentation
ENSG00000111796,KLRB1,immune evasion,signaling pathway modulation,cell survival promotion,tumor progression facilitation,immune regulatory function,cancer immunotherapy target
ENSG00000158125,XDH,purine metabolism regulation,reactive oxygen species modulation,tumor microenvironment modification,angiogenesis promotion,cell proliferation enhancement,prognostic marker potential
ENSG00000124557,BTN1A1,immune suppression,cell adhesion modulation,oncogenic overexpression,poor prognosis marker,tumor metastasis promotion,signaling pathway modulation
ENSG00000115221,ITGB6,integrin signaling,tumor progression,cell migration,angiogenesis,signaling pathway modulation,biomarker status
ENSG00000105329,TGFB1,tumor suppression,epithelial-to-mesenchymal transition (emt),growth factor regulation,metastasis promotion,pathway dysregulation,tissue remodeling
ENSG00000090006,LTBP4,transforming growth factor-beta pathway,epithelial-to-mesenchymal transition,cellular differentiation,tumor progression,extracellular matrix regulation,cancer metastasis
ENSG00000077943,ITGA8,integrin signaling pathway,cell adhesion regulation,invasive phenotype,prognostic marker,tumor metastasis,epithelial-mesenchymal transition
ENSG00000105855,ITGB8,cell adhesion,tumor progression,cell migration,extracellular matrix interaction,metastasis,poor prognosis
ENSG00000064692,SNCAIP,pi3k/akt pathway,constitutive activation,regulation of cell growth,protein-protein interaction modulation,tumor progression,oncogenic process
ENSG00000185345,PRKN,mitochondrial quality control,tumor suppressor function,autophagy regulation,oxidative stress resistance,cell death modulation,genomic stability maintenance
ENSG00000145335,SNCA,cellular aggregation,cytoplasmic aggregates formation,oncogenic transformation,cell survival regulation,protein degradation modulation,ubiquitin-proteasome pathway disruption
ENSG00000124486,USP9X,cell proliferation,tumor progression,oncogene activation,signaling pathway regulation,deubiquitinating enzyme,cancer development
ENSG00000137642,SORL1,cell cycle regulation,akt signaling pathway,transmembrane protein function,protein processing and trafficking,cancer cell proliferation,survival pathways overexpression
ENSG00000142192,APP,cell adhesion modulation,tumor progression,increased cell proliferation,amyloid-beta regulation,alternative splicing variants,neurotrophic signaling
ENSG00000145782,ATG12,autophagy regulation,cellular homeostasis maintenance,tumor progression association,protein ubiquitination activation,apoptosis resistance promotion,oncogenic cell survival mechanism support
ENSG00000197548,ATG7,autophagy regulation,tumor progression,cell survival modulation,apoptosis regulation,protein degradation,genomic instability
ENSG00000152348,ATG10,autophagosome formation,tumor suppressor function loss,oncogenic mutations,lysosomal degradation regulation,cell survival promotion,cancer cell proliferation enhancement
ENSG00000057663,ATG5,autophagy modulation,oncogenic potential,tumor progression,cell survival enhancement,mtor pathway regulation,protein-protein interactions
ENSG00000176194,CIDEA,mitochondrial regulation,apoptosis modulation,tumor progression,therapeutic target,cell survival,dysregulation oncogenesis
ENSG00000187288,CIDEC,apoptosis regulation,tumor progression,cell cycle modulation,dna repair interactions,protein-protein interactions,cancer cell survival
ENSG00000113721,PDGFRB,angiogenesis,constitutive activation,driver gene,gain of function mutations,metastasis,tumor progression
ENSG00000134853,PDGFRA,oncogene activation,receptor tyrosine kinase activity,cell proliferation signaling,akt pathway activation,mapk pathway regulation,genomic amplification
ENSG00000163513,TGFBR2,tumor suppressor,constitutive activation,cell invasion,tgf-β signaling pathway,metastasis promotion,dysregulated expression
ENSG00000166913,YWHAB,**

akt pathway modulation,cell signaling scaffold,oncogenesis promotion,proliferation regulation,survival enhancement,metabolic regulation
ENSG00000126934,MAP2K2,mapk/erk signaling pathway,dual specificity kinase,oncogenic transformation,cell proliferation regulation,apoptosis inhibition,therapeutic target
ENSG00000169032,MAP2K1,erk/mapk pathway activation,constitutive signaling,gain of function mutations,cell proliferation regulation,tumor progression,therapeutic target
ENSG00000141068,KSR1,mapk/erk signaling,constitutive activation,oncogenic transformation,cell proliferation,overexpression,tumor progression
ENSG00000075413,MARK3,microtubule regulation,genomic instability,cell division checkpoint,oncogenic potential,therapeutic target,protein-protein interaction
ENSG00000136807,CDK9,pol ii phosphorylation,oncogenic activation,enhanced mrna synthesis,cell proliferation driver,transcription factor regulation,cancer cell survival
ENSG00000129315,CCNT1,genomic instability,centriole duplication,aneuploidy induction,cancer cell proliferation,cell cycle checkpoint disruption,mitotic spindle assembly
ENSG00000165898,ISCA2,metabolic reprogramming,gain of function mutations,mitochondrial enzyme regulation,cellular energy homeostasis,biomarker potential,therapeutic target
ENSG00000135070,ISCA1,isoprenoid biosynthesis,protein prenylation,oncogenesis,cell proliferation,ras activation,therapeutic target
ENSG00000160703,NLRX1,apoptosis regulation,mitochondrial homeostasis disruption,oncogene regulation,cellular survival enhancement,tumor progression facilitation,genomic instability induction
ENSG00000088888,MAVS,type i ifn signaling,adaptor molecule function,cytosolic sensor activity,apoptosis regulation,tumor microenvironment modulation,innate immune activation
ENSG00000169855,ROBO1,tumor suppressor function,reduced expression,cell migration inhibition,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition regulation,metastasis suppression
ENSG00000145147,SLIT2,tumor suppressor,epithelial-to-mesenchymal transition,cell adhesion inhibition,cell migration regulation,angiogenesis suppression,loss-of-function mutations
ENSG00000185652,NTF3,neurotrophin signaling,cell proliferation,growth factor interaction,trkb receptor activation,pi3k/akt pathway,cell survival
ENSG00000179841,AKAP5,cellular signaling pathway regulation,oncogenic process promotion,cell proliferation enhancement,tumor aggressiveness association,biomarker potential,therapeutic target identification
ENSG00000154134,ROBO3,tumor suppressor,robo-slit signaling pathway inhibition,cancer cell migration inhibition,axon guidance regulation,tissue integrity maintenance,ciliogenesis pathway regulation
ENSG00000000971,CFH,complement regulation,tumor suppression,inflammation regulation,prognostic biomarker,genetic alterations,immune evasion
ENSG00000177455,CD19,b cell activation,transmembrane glycoprotein,tumor microenvironment modulation,immune response influence,prognostic marker,therapeutic target candidate
ENSG00000110651,CD81,cell adhesion,epithelial-to-mesenchymal transition,immune evasion,tumor progression,stem cell maintenance,signaling regulation
ENSG00000149131,SERPING1,regulation of coagulation,angiogenesis,tumor growth,metastasis,cell signaling,protein-protein interactions
ENSG00000182326,C1S,tumor growth promotion,proteolytic activity,immune evasion,metastasis facilitation,cell invasion enhancement,antigen processing regulation
ENSG00000288512,C1R,complement activation,oncogenic function,cell proliferation,immune modulation,tumor invasion,metastatic potential
ENSG00000178772,CPN2,cell proliferation,renin-angiotensin system regulation,tumor progression,ras signaling dysregulation,heterodimeric enzyme function,protein processing
ENSG00000120054,CPN1,peptide hydrolysis,c-terminal cleavage,regulatory interaction,transcriptional modulation,protein stability modification,cellular proliferation
ENSG00000198910,L1CAM,cell adhesion disruption,epithelial-to-mesenchymal transition,metastasis promotion,cell migration enhancement,poor prognosis association,cancer cell invasion facilitation
ENSG00000099250,NRP1,angiogenic factor regulation,co-receptor function,cell migration facilitation,tumor growth promotion,therapeutic target,prognostic marker
ENSG00000144668,ITGA9,tumor progression,metastasis,angiogenesis,cell adhesion,extracellular matrix regulation,therapeutic target
ENSG00000102882,MAPK3,constitutive activation,gain of function mutations,mapk/erk pathway,oncogenic properties,cell proliferation,phosphorylation and activation
ENSG00000100030,MAPK1,mapk/erk pathway activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000039537,C6,type vi collagen alteration,tumor progression facilitation,cell adhesion modulation,prognostic biomarker candidate,integrin interaction,extracellular matrix component
ENSG00000179115,FARSA,protein prenylation,farnesylation process,cell proliferation,biomarker potential,tumorigenesis association,oncogenic signaling pathway
ENSG00000116120,FARSB,metabolic reprogramming,tumor aggressiveness,hifα activation,therapeutic target,cell growth regulation,energy metabolism alteration
ENSG00000244734,HBB,cellular interaction,mutation effect,metabolic regulation,transcriptional regulation,chromatin remodeling,tumor progression
ENSG00000206172,HBA1,hypoxia-induced signaling,oncogenic potential,tumor progression,cell proliferation,apoptosis inhibition,angiogenesis promotion
ENSG00000188536,HBA2,hemoglobin tetramer,cellular metabolism regulation,tumor progression,poor prognosis indicator,advanced disease stage marker,oncogene overexpression
ENSG00000108854,SMURF2,ubiquitin ligase activity,protein degradation regulation,tumor suppressor inhibition,oncogene overexpression,poor prognosis indicator,therapeutic target potential
ENSG00000284126,SMURF1,hippo/yap signaling pathway,cell proliferation regulation,tumor suppressor role,loss-of-function mutations,ubiquitination and degradation,transcription factor regulation
ENSG00000049759,NEDD4L,negative regulation of oncogenes,ubiquitin ligase activity,cell proliferation suppression,regulation of pi3k/akt pathway,protein turnover modulation,tumor suppressor function
ENSG00000103266,STUB1,protein degradation,apoptosis regulation,cell survival modulation,p53 interaction,tumor suppression,genomic instability
ENSG00000130725,UBE2M,protein homeostasis regulation,ubiquitination pathway modulation,tumor progression promotion,apoptosis inhibition,cell cycle regulation,dna damage response interaction
ENSG00000285246,NEDD8,apoptosis suppression,protein modification,cell cycle regulation,tumor progression,ubiquitination,genetic alterations
ENSG00000155827,RNF20,chromatin regulation,oncogene activation,tumor suppressor repression,cell cycle dysregulation,epigenetic modification,cancer progression
ENSG00000103549,RNF40,cell cycle regulation,ubiquitination and degradation,apoptosis suppression,tumor suppressor function,pi3k/akt pathway modulation,genetic regulation
ENSG00000111816,FRK,cellular adhesion,metastasis promotion,oncogenic signaling,pi3k/akt pathway activation,protein-protein interaction,tyrosine kinase activation
ENSG00000233948,TRIM27,pi3k/akt signaling,oncogene function,e3 ubiquitin ligase activity,tumor progression,metastasis regulation,immune evasion mechanisms
ENSG00000137809,ITGA11,cell adhesion dysregulation,epithelial-to-mesenchymal transition (emt),genomic instability,growth factor signaling,integrin activation,malignant progression
ENSG00000156886,ITGAD,integrin signaling pathway,cell adhesion modulation,tumor progression enhancement,cancer cell migration facilitation,metastasis promotion,overexpression in blca
ENSG00000083457,ITGAE,tumor progression,cell migration,metastasis promotion,microenvironment modulation,immune evasion,angiogenesis facilitation
ENSG00000142798,HSPG2,overexpression,tumor progression,cell proliferation,angiogenesis regulation,epithelial-to-mesenchymal transition,emt process modulation
ENSG00000288299,LDHA,metabolic reprogramming,glycolytic shift,warburg effect,tumor aggressiveness,epithelial-to-mesenchymal transition (emt),genomic instability
ENSG00000111716,LDHB,aerobic glycolysis,cellular metabolism,redox regulation,glycolytic pathway,cancer cell proliferation,detoxification function
ENSG00000163541,SUCLG1,energy metabolism,cellular proliferation,succinate dehydrogenase activity,aerobic glycolysis,tumor growth,promoter of tumor progression
ENSG00000172340,SUCLG2,altered energy metabolism,glycolytic shift,increased lactate production,oncogene interaction,metabolic reprogramming,tumor aggressiveness
ENSG00000136143,SUCLA2,increased protein succination,loss-of-function mutation,mitochondrial dysfunction,oncogene activation,tumor suppression disruption,none
ENSG00000102265,TIMP1,tumor suppression,proteolytic regulation,mmp inhibition,angiogenesis modulation,oncogene/ tumor suppressor paradox,metastasis regulation
ENSG00000100985,MMP9,tumor progression,extracellular matrix degradation,proteolytic activity,cell signaling pathways,oncogene function,cancer prognosis
ENSG00000157227,MMP14,tumor progression,cell migration,metastasis,extracellular matrix degradation,angiogenesis,immune evasion
ENSG00000035862,TIMP2,mmp regulation,tumor suppressor,ecm remodeling,cell invasion,tissue homeostasis,downregulated expression
ENSG00000102054,RBBP7,chromatin remodeling,tumor suppressor function,dna damage repair,genomic stability maintenance,cellular growth regulation,apoptosis modulation
ENSG00000128708,HAT1,genome stability maintenance,transcriptional regulation,cell cycle progression,dna repair complex formation,oncogenic mutation susceptibility,tumor suppressor activity
ENSG00000135903,PAX3,transcriptional regulation,tumor progression,cell proliferation,oncogenic processes,apoptosis regulation,angiogenesis
ENSG00000084676,NCOA1,chromatin remodeling,coactivator function,transcriptional regulation,cell proliferation,apoptosis suppression,epigenetic regulation
ENSG00000163930,BAP1,brca1 pathway interaction,bap1 tumor suppressor function,dna repair regulation,loss-of-function mutations,urothelial carcinoma association,poorer prognosis biomarker
ENSG00000172534,HCFC1,chromatin remodeling,histone modification,tumor suppressor regulation,oncogene activation,transcriptional control,p53 interaction
ENSG00000100324,TAB1,pro-inflammatory cytokine regulation,cell survival and proliferation,immune response modulation,tumor progression facilitation,nf-κb activation,pi3k/akt pathway interaction
ENSG00000145604,SKP2,oncogenic activity,cell cycle regulation,cyclin-dependent kinase degradation,apoptosis inhibition,protein ubiquitination,tumor progression
ENSG00000070010,UFD1,ubiquitin-proteasome pathway,protein quality control,genetic instability,cell cycle regulation,protein degradation,oncogene potential
ENSG00000165280,VCP,erad pathway,cell cycle regulation,mitotic spindle assembly,tumor progression,cancer-associated mutations,cytoskeletal remodeling
ENSG00000180667,YOD1,oncogene interaction,dna damage response,protein-protein interactions,cell cycle regulation,tumor suppressor inhibition,apoptosis evasion
ENSG00000019995,ZRANB1,histone modification regulation,chromatin remodeling,oncogenic gene expression,tumor progression,genomic instability,cancer-specific protein interactions
ENSG00000134982,APC,wnt/β-catenin pathway disruption,tumor suppressor function loss,cell proliferation enhancement,genomic instability promotion,apoptosis evasion,dna repair mechanism impairment
ENSG00000066427,ATXN3,atm/atr pathway disruption,genomic instability,tumor suppressor function,cell cycle regulation,dna repair mechanism disruption,polyubiquitination regulation
ENSG00000124356,STAMBP,ubiquitin-proteasome pathway modulation,oncogene activation,cell cycle progression,apoptosis inhibition,protein stabilization,dna damage response
ENSG00000136738,STAM,stam/ hgs interaction,endocytosis regulation,cancer cell migration,adaptor protein function,cell survival modulation,metastasis promotion
ENSG00000140538,NTRK3,tumor progression,constitutive activation,kinase activity,receptor tyrosine kinase signaling,metastatic potential,therapeutic target
ENSG00000105426,PTPRS,pi3k/akt pathway activation,constitutive expression,gain of function mutations,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt)
ENSG00000106366,SERPINE1,tumor progression,cell migration,proteolytic activity inhibition,metastasis promotion,extracellular matrix degradation suppression,angiogenesis modulation
ENSG00000109072,VTN,cell adhesion regulation,tumor cell migration,metastasis promotion,integrin interaction,prognostic marker,therapeutic target
ENSG00000173402,DAG1,tumorigenesis,cell membrane trafficking,phospholipid metabolism,oncogenic signaling,amplification event,cell growth regulation
ENSG00000188157,AGRN,amplification,overexpression,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,oncogenic driver
ENSG00000142867,BCL10,nf-κb pathway activation,constitutive apoptosis inhibition,immune response dysregulation,oncogenic transcriptional regulation,myc/pik3ca interaction,tumor inflammation
ENSG00000187122,SLIT1,cell migration inhibition,tumor suppressor function,epithelial-to-mesenchymal transition regulation,apoptosis promotion,cell adhesion modulation,signaling pathway dysregulation
ENSG00000188559,RALGAPA2,downregulation,oncogenic signaling,tumor progression,cell proliferation,gtpase regulation,gap activity
ENSG00000170471,RALGAPB,oncogenic pathway regulation,g-protein coupled receptor signaling,cell proliferation regulation,cellular differentiation control,tumor progression modulation,therapeutic target potential
ENSG00000173230,GOLGB1,**
golgi apparatus formation,cell proliferation regulation,oncogenesis promotion,apoptosis inhibition,signaling pathway interaction,protein modification and transport
ENSG00000182827,ACBD3,lipid metabolism regulator,adapter molecule,fatty acid synthesis regulation,oncogene,tumor suppressor dysfunction,cell proliferation enhancement
ENSG00000100099,HPS4,transcription factor activity,tumor promotion,cell proliferation enhancement,wnt/β-catenin pathway interaction,oncogenic transformation,poor prognosis marker
ENSG00000107521,HPS1,cellular dysfunction,genomic instability,proliferation regulation,lysosome-related organelles formation,loss-of-function mutations,tumor progression
ENSG00000163083,INHBB,tumor microenvironment,oncogenesis,cell proliferation,biomarker identification,pi3k/akt/mtor interaction,overexpression
ENSG00000122641,INHBA,tumor progression,cell proliferation,signaling pathway activation,metastasis promotion,biomarker overexpression,therapeutic target
ENSG00000108950,FAM20A,chromatin remodeling,histone modification,apoptosis resistance,metastasis promotion,gene transcription regulation,tumorigenesis driver
ENSG00000177706,FAM20C,hippo pathway activation,cell growth regulation,tumor suppressor function loss,genomic instability induction,protein kinase activity,cell cycle progression
ENSG00000143799,PARP1,dna repair mechanism,genomic instability,apoptosis regulation,tumor suppressor function,cell cycle progression,chemoresistance association
ENSG00000002016,RAD52,genomic instability,homologous recombination repair,dna double-strand break repair,tumor growth promotion,chemotherapy resistance,oncogenic process facilitation
ENSG00000163961,RNF168,dna damage response,e3 ubiquitin ligase activity,genomic instability,cell cycle regulation,apoptosis,ubiquitination pathway
ENSG00000067066,SP100,dna damage response,tumor suppressor function,pml nuclear body regulation,nuclear protein interaction,chromatin remodeling,genomic instability
ENSG00000139372,TDG,dna repair mechanism,genomic instability,tumor progression,transcriptional regulation,cell proliferation,therapeutic target
ENSG00000165392,WRN,genomic instability,non-homologous end joining,cell cycle regulation,helicase activity,dna repair mechanisms,tumor progression
ENSG00000154767,XPC,genomic instability,tumor progression,dna repair deficiency,oncogenic signaling,cell proliferation,genetic mutations
ENSG00000187098,MITF,transcriptional regulation,oncogenesis,cell growth regulation,tumor progression,therapeutic target,gene expression regulation
ENSG00000172845,SP3,promotes tumor progression,upregulates cell proliferation,cell survival and growth,transcriptional regulator,dna binding protein,oncogenic function
ENSG00000067369,TP53BP1,genomic instability,mutation/deletion leading,impaired dna damage response,homologous recombination,non-homologous end joining,tumor progression
ENSG00000147889,CDKN2A,cell cycle regulation,loss of function mutations,cyclin-dependent kinase inhibition,oncogenic driver,promotes uncontrolled growth,dna repair deficiency
ENSG00000177374,HIC1,epigenetic silencing,tumor suppressor,gene regulation,cellular proliferation,apoptosis inhibition,angiogenesis promotion
ENSG00000183770,FOXL2,tumor suppressor function,cell proliferation regulation,transcriptional modulation,poor prognosis association,dual role in tumorigenesis,gene expression regulation
ENSG00000100201,DDX17,oncogene activation,tumor progression,therapeutic target,cell signaling regulation,rna helicase activity,gene expression modulation
ENSG00000182568,SATB1,transcription factor,chromatin organization,oncogene function,cell proliferation,immune response modulation,genome stability regulation
ENSG00000178691,SUZ12,epigenetic regulation,tumor suppressor silencing,oncogene activation,histone modification,transcriptional repression,tumor progression
ENSG00000068024,HDAC4,chromatin remodeling,oncosuppression,dysregulation of p53/e2f1,apoptosis regulation,epithelial-to-mesenchymal transition,tumor progression suppression
ENSG00000116478,HDAC1,histone deacetylation,transcriptional repression,cell proliferation,apoptosis suppression,metastasis facilitation,tumor suppressor activity
ENSG00000196591,HDAC2,histone deacetylase activity,chromatin remodeling,tumor suppressor gene silencing,oncogenic protein interaction,cell proliferation regulation,metastasis facilitation
ENSG00000170004,CHD3,chromatin remodeling,transcriptional regulation,oncogene activation,cell proliferation,tumor suppressor regulation,nurd complex interaction
ENSG00000092199,HNRNPC,aberrant splicing,overexpression,rna processing regulation,tumor progression,oncogene activation,chromatin remodeling interaction
ENSG00000055044,NOP58,ribosome biogenesis,pre-rrna processing,oncogenic function,tumor aggressiveness,protein synthesis regulation,growth promotion
ENSG00000198900,TOP1,dna topoisomerization,genomic stability maintenance,chemosensitivity reduction,tumor progression promotion,therapeutic target,oncogene overexpression
ENSG00000131747,TOP2A,dna replication regulation,genomic instability,chromatin remodeling,gene expression modulation,oncogene upregulation,therapeutic target
ENSG00000077097,TOP2B,genomic instability,cell proliferation,oncogenic potential,dna damage repair,therapeutic target,protein-protein interaction
ENSG00000143379,SETDB1,chromatin remodeling,epigenetic silencing,histone modification,oncogene activation,tumor suppressor gene repression,therapeutic target
ENSG00000171681,ATF7IP,pi3k/akt pathway activation,transcriptional co-activator function,oncogenic signaling modulation,cell proliferation enhancement,tumor progression facilitation,genomic aberrance association
ENSG00000100462,PRMT5,arginine methylation,chromatin regulation,oncogenic transcription factors,cell proliferation,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000116455,WDR77,cell cycle regulation,dna damage repair,homologous recombination,nuclear localization,tumor suppressor function,transcriptional control
ENSG00000158828,PINK1,cellular metabolism alteration,mitochondrial dynamics regulation,oncogenic signaling pathway activation,protein kinase activity,tumor progression promotion,apoptosis inhibition
ENSG00000178568,ERBB4,constitutive activation,amplifications,tumor progression,prognostic marker,cell proliferation,signaling pathway
ENSG00000189056,RELN,metastasis driver,cell migration regulator,tumor suppressor dysfunction,pi3k/akt pathway modulation,oncogenic signaling,adhesion molecule interaction
ENSG00000147852,VLDLR,endocytic regulation,lipid metabolism disruption,tumor aggressiveness association,cell signaling alteration,overexpression involvement,poor prognosis correlation
ENSG00000141505,ASGR1,cellular regulation,tumor progression,proliferation,apoptosis inhibition,signaling pathway interaction,gene expression regulation
ENSG00000161944,ASGR2,tumor progression,metastasis,epithelial-to-mesenchymal transition (emt),therapeutic target,signal transduction,protein-protein interaction
ENSG00000120738,EGR1,transcriptional regulation,pro-proliferative gene induction,apoptosis evasion,cell cycle progression,poor prognosis indicator,oncogenic transcription factor
ENSG00000101115,SALL4,tumor progression,cell proliferation,transcriptional regulation,pluripotency maintenance,poor prognosis marker,oncogenic factor
ENSG00000179632,MAF1,genomic instability,dna damage response,rna polymerase iii transcription,tumor suppression,apoptosis regulation,cell cycle progression
ENSG00000160007,ARHGAP35,cell migration,rho gtpase regulation,cytoskeletal organization,protein degradation,genomic instability,tumor invasion
ENSG00000145715,RASA1,ras-rap1 signaling,tumor suppressor function,growth inhibition,apoptosis promotion,cell proliferation regulation,oncogenic driver
ENSG00000285460,BCAR1,oncogenic driver,constitutive activation,therapeutic resistance,tumor progression,cell proliferation,signaling pathway regulation
ENSG00000143171,RXRG,wnt/β-catenin signaling pathway,apoptosis regulation,tumor suppressor function,cancer progression,cell growth regulation,retinoic acid signaling pathway
ENSG00000172819,RARG,tumor suppressor,dna methylation,apoptosis regulation,epithelial integrity maintenance,cell differentiation regulation,retinoic acid signaling pathway
ENSG00000186350,RXRA,transcriptional regulation,cell differentiation,tumorigenesis,oncogenic pathways,apoptosis modulation,retinoic acid response elements
ENSG00000131759,RARA,transcriptional regulation,constitutive activation,gene amplification,cell proliferation,apoptosis disruption,therapeutic target
ENSG00000231321,RXRB,retinoid x receptor beta,cell proliferation regulation,transcriptional regulation,dna binding activity,nuclear receptor interaction,tumor suppressive function
ENSG00000077092,RARB,tumor suppressor function,loss of expression,transcriptional regulation,cell cycle control,apoptosis induction,epigenetic modification
ENSG00000112033,PPARD,tumor suppressor function,regulation of cell cycle,apoptosis induction,dna repair regulation,oxidative stress modulation,inflammation response regulation
ENSG00000118257,NRP2,angiogenesis,cell migration,vascular endothelial growth factor signaling,epithelial-to-mesenchymal transition,cancer stem cell maintenance,lymphangiogenesis
ENSG00000102755,FLT1,angiogenesis,endothelial cell migration,tumor vasculature formation,receptor tyrosine kinase activation,genomic amplification,cell proliferation
ENSG00000049130,KITLG,oncogenic role,tumor growth promotion,cell proliferation enhancement,aggressive tumor behavior,poor prognosis association,signaling pathway activation
ENSG00000157404,KIT,pi3k/akt pathway interaction,gain of function mutations,constitutive activation,receptor tyrosine kinase signaling,tumor cell survival enhancement,tyrosine kinase phosphorylation
ENSG00000154229,PRKCA,pkcα activation,aberrant signaling,cell proliferation regulation,oncogenic potential,protein phosphorylation,tumor progression promotion
ENSG00000060656,PTPRU,loss of function mutations,tumor suppression,pi3k/akt pathway activation,cell adhesion disruption,cell migration promotion,oncogenic signaling enhancement
ENSG00000141027,NCOR1,transcriptional regulation,oncogene activity,tumor suppressor gene repression,cell proliferation enhancement,metastasis promotion,therapeutic target
ENSG00000131746,TNS4,cell adhesion disruption,oncogene function,growth factor regulation,protein-protein interaction,tumor cell invasion,cancer cell proliferation
ENSG00000105976,MET,amplification,constitutive activation,growth factor signaling,hgf receptor activity,metastasis promotion,tumor progression
ENSG00000144749,LRIG1,tumor suppression,rtk modulation,cell proliferation inhibition,downstream pathway disruption,therapeutic target,transmembrane protein
ENSG00000135473,PAN2,mrna stability,poly(a) tail addition,tumor progression,oncogenesis,poor prognosis,regulatory node
ENSG00000152520,PAN3,receptor signaling scaffolding,cell surface receptor interaction,tumor suppressor function,immune response regulation,signal transduction modulation,genomic instability
ENSG00000009830,POMT2,altered glycosylation patterns,cell-cell interactions disruption,cancer progression,tumor growth promotion,gene expression profile alterations,protein modification role
ENSG00000130714,POMT1,gpi-anchored protein biosynthesis,aberrant glycosylation,loss of function mutations,tumor suppressor role,cell adhesion impairment,maintenance of genome stability
ENSG00000171155,C1GALT1C1,core 1 beta-1,2-galactosyltransferase,aberrant glycosylation,overexpressed in blca,cancer-related protein modification,tumor progression marker
ENSG00000106392,C1GALT1,aberrant expression,cell surface glycosylation,dysregulated glycan structures,immune evasion mechanisms,oncogenic potential,therapeutic target
ENSG00000165688,PMPCA,atm/chk2 pathway modulation,tumor progression regulation,genomic stability maintenance,protein-protein interaction,oncogene regulation,cellular cycle control
ENSG00000105819,PMPCB,nf-κb signaling pathway,proteasome activation,cell proliferation regulation,signal transduction modulation,transcriptional regulation influence,tumor progression association
ENSG00000118217,ATF6,er stress response,transcriptional regulation,oncogenic transformation,cell survival pathways,apoptosis evasion,protein folding homeostasis
ENSG00000044574,HSPA5,er stress response,chronic activation,cellular survival,apoptosis inhibition,proliferation enhancement,tumorigenesis facilitation
ENSG00000172071,EIF2AK3,integrated stress response (isr),dna damage repair,genomic stability maintenance,selective translation regulation,protein kinase activation,therapeutic target
ENSG00000178607,ERN1,er stress response,cell survival,tumor cell migration,therapeutic resistance,upr activation,genomic instability
ENSG00000196455,PIK3R4,pi3k/akt pathway activation,constitutive activation,regulatory subunit interaction,tumor progression driver,therapeutic target candidate,mutation-driven oncogenesis
ENSG00000078142,PIK3C3,pi3k/akt pathway,regulatory subunit mutations,tumor growth promotion,cell survival enhancement,cancer prognostic marker,genomic instability
ENSG00000149476,TKFC,dna replication,genomic stability,tumor suppressor function,dna damage response,brca1 interaction,blm helicase regulation
ENSG00000115267,IFIH1,tumor suppressor,cell cycle regulation,apoptosis modulation,autophagy regulation,immune response activation,dysregulated expression
ENSG00000172757,CFL1,actin cytoskeleton regulation,cell migration promotion,epithelial-to-mesenchymal transition,cancer cell invasiveness,chemotherapy resistance,tumor progression facilitation
ENSG00000106683,LIMK1,cell migration,oncogenic processes,cell survival,cytoskeletal regulation,phosphorylation,tumor progression
ENSG00000163218,PGLYRP4,innate immune regulation,cell proliferation suppression,tumor microenvironment modulation,pro-inflammatory cytokine production,apoptosis regulation,epithelial-to-mesenchymal transition
ENSG00000159527,PGLYRP3,complement activation inhibition,tumor suppressor function,cell proliferation regulation,apoptosis promotion,immune response modulation,genomic stability maintenance
ENSG00000132170,PPARG,metabolic dysregulation,apoptosis suppression,cell proliferation enhancement,tumor progression promotion,gene expression alteration,therapeutic target interaction
ENSG00000138079,SLC3A1,glutamine metabolism,anabolic metabolism,tumor progression,oncoprotein expression,cell proliferation,metabolic reprogramming
ENSG00000165617,DACT1,tumor suppressor,downregulated expression,wnt/β-catenin signaling pathway,cell proliferation regulation,transcriptional repressor function,poor prognosis association
ENSG00000103126,AXIN1,wnt/β-catenin pathway regulation,tumor suppressor function,constitutive activation mutations,cell proliferation regulation,protein interaction with ck1α/gsk3β,biomarker significance for cancer prognosis
ENSG00000082701,GSK3B,phosphorylation regulation,cell survival,tumor progression,wnt/β-catenin pathway,oncogenic signaling,metastasis promotion
ENSG00000067057,PFKP,glycolysis,oncogenic function,warburg effect,hexokinase 2 interaction,lactate dehydrogenase a interaction,cell proliferation
ENSG00000141959,PFKL,glycolysis regulation,metabolic reprogramming,tumor growth promotion,glucose metabolism increase,therapeutic target,oncogenesis facilitation
ENSG00000152556,PFKM,glycolytic pathway,metabolic adaptation,oncogenic process,tumor growth,cell proliferation,therapeutic target
ENSG00000084734,GCKR,glycolytic regulation,oncogene function,tumor progression,cell survival modulation,metabolic reprogramming,pi3k/akt pathway interaction
ENSG00000106633,GCK,enhanced glycolysis,insulin resistance,cancer metabolism,glucose uptake,oncogenic process,therapeutic target
ENSG00000029534,ANK1,cellular motility,ankyrin-based protein interaction,tumor progression,metastasis,cell signaling regulation,cancer cell invasion
ENSG00000091129,NRCAM,cell surface interaction,enhanced migration,metastatic potential,therapeutic target,tumor progression,adhesion molecule function
ENSG00000184144,CNTN2,cell-cell adhesion,prognostic biomarker,oncogene overexpression,epithelial-to-mesenchymal transition,chemoresistance,transcriptional regulation
ENSG00000134121,CHL1,tumor progression,cell adhesion,epithelial-to-mesenchymal transition,signaling pathway modulation,biomarker potential,tissue invasion
ENSG00000163531,NFASC,neurofascin overexpression,tumor progression,cell migration,invasion,metastasis,therapeutic target
ENSG00000077279,DCX,microtubule dynamics regulation,tumor aggressiveness marker,apoptosis resistance,angiogenesis enhancement,cell migration facilitation,protein interaction modulation
ENSG00000137575,SDCBP,transcriptional coactivator,cell growth regulation,cellular proliferation,apoptosis resistance,genomic instability,tumor suppressor interaction
ENSG00000164050,PLXNB1,cell adhesion disruption,enhanced proliferation,migration and invasion,oncogenic signaling pathway,phosphorylation activation,tumor progression
ENSG00000141736,ERBB2,oncogenic driver,tumor progression,therapeutic target,constitutive activation,protein kinase activation,cell proliferation
ENSG00000137076,TLN1,cancer driver gene,integrin signaling pathway,epithelial-to-mesenchymal transition (emt),angiogenesis,metastasis,cell adhesion
ENSG00000186111,PIP5K1C,pi4p synthesis,aberrant golgi function,cell proliferation,metastasis promotion,oncogenic process,golgi apparatus disruption
ENSG00000004399,PLXND1,angiogenesis regulation,tumor progression,cell migration regulation,epithelial-to-mesenchymal transition,metastasis promotion,gene amplification
ENSG00000170381,SEMA3E,tumor suppressor,loss of function mutations,angiogenesis inhibition,cell migration regulation,protein-protein interaction,cancer metastasis
ENSG00000196189,SEMA4A,pi3k/akt pathway inhibition,tumor suppression,angiogenesis regulation,cell migration inhibition,proliferation modulation,protein interaction with pdgfra and vegfa
ENSG00000262418,PTPRC,tumor suppressor function,cell signaling pathway disruption,growth regulation,immune cell modulation,epithelial cell expression,oncogenic process contribution
ENSG00000187764,SEMA4D,tumor progression,immune evasion,metastasis promotion,cancer metastasis,plexin receptor activation,tumor suppressor function
ENSG00000137101,CD72,oncogene,overexpression,cell surface receptor,immune system modulation,signaling pathway interaction,cell proliferation enhancement
ENSG00000136040,PLXNC1,plexin signaling pathway,cell adhesion regulation,cell migration facilitation,tumor progression association,therapeutic target,pi3k/akt/mtor pathway interaction
ENSG00000138623,SEMA7A,**

metastasis induction,immune evasion,tumor stroma interaction,angiogenesis promotion,cell adhesion modulation,cell migration regulation
ENSG00000010810,FYN,oncogenic driver,cell proliferation enhancement,aberrant activation,signaling pathway modulation,protein kinase activity,tumor progression facilitation
ENSG00000185008,ROBO2,pi3k/akt pathway interactions,tumor progression,cell migration inhibition,tumor suppressor function,biomarker potential,oncogene association
ENSG00000151748,SAV1,hippo pathway dysregulation,loss of function mutations,tumor suppressor activity,cell cycle regulation,apoptosis modulation,kinase regulation
ENSG00000104375,STK3,wnt/β-catenin signaling,apoptosis regulation,gsk3 inhibition,cell cycle progression,oncogenic activation,therapeutic target
ENSG00000101109,STK4,stk4-mediated apoptosis,apoptosis regulation,cell cycle control,dna damage response pathway activation,genomic instability,tumor suppressor function
ENSG00000119139,TJP2,disrupted cell-cell adhesion,tumor suppressor role,paracellular transport regulation,epithelial polarity loss,prognostic biomarker,cell invasion enhancement
ENSG00000018408,WWTR1,transcriptional coactivator function,amplification leading to overexpression,cell cycle checkpoint regulation,transcription factor interaction,tumor progression facilitation,g2/m phase transition regulation
ENSG00000075340,ADD2,cellular adhesion,cytoskeletal regulation,genomic amplification,increased expression,migration and invasion,oncogenic driver
ENSG00000087274,ADD1,muscle contraction,cell migration,cytoskeletal dynamics,epithelial-to-mesenchymal transition (emt),metastasis promotion,cancer aggressiveness
ENSG00000148700,ADD3,actin cytoskeleton regulation,cell migration,protein interaction,oncogene,cellular signaling pathway modulation,constitutive activation
ENSG00000160862,AZGP1,iron regulation,dysregulation of growth factors,angiogenesis,immune evasion,tumor progression,cell adhesion modulation
ENSG00000159763,PIP,constitutive activation,gain of function mutations,cell proliferation,cell survival,phosphoinositide metabolism,oncogenic transformation
ENSG00000136802,LRRC8A,mtor pathway regulation,overexpression driven oncogenesis,cellular proliferation enhancement,protein-protein interaction modulation,tumor growth promotion,genomic amplification
ENSG00000197147,LRRC8B,ion channel regulation,mechanotransduction modulation,tumor progression driver,metastasis promoter,cell surface receptor interaction,aggressive disease phenotype
ENSG00000171017,LRRC8E,mtor pathway,tumor progression,cellular metabolism,ion channel function,mechanotransduction,oncogenic transformation
ENSG00000171492,LRRC8D,ltb4 signaling pathway,constitutive activation,gain of function mutations,tumor aggressiveness,inflammation regulation,prognostic biomarker
ENSG00000171488,LRRC8C,vrac function,cell volume regulation,apoptosis evasion,ion transport modulation,tumor progression driver,therapeutic target
ENSG00000158402,CDC25C,cell cycle regulation,tumor progression,constitutive activation,cdk activation,dna damage response,oncogenic driver
ENSG00000144867,SRPRB,**
cholesterol transport,cell survival,immune evasion,tumor microenvironment,lipid metabolism modification,mitochondrial dysfunction
**
ENSG00000182934,SRPRA,protein targeting,cotranslational targeting,misfolding protein,cell survival,therapeutic target,resistance to therapy
ENSG00000009950,MLXIPL,glycolysis enhancement,oncogene function,cell growth promotion,transcriptional regulation,glucose metabolism regulation,tumor progression facilitation
ENSG00000108788,MLX,transcriptional regulation,tumor progression,cell proliferation,apoptosis resistance,dna repair regulation,pi3k/akt pathway interaction
ENSG00000141526,SLC16A3,glycolytic metabolism,anti-apoptotic function,chemosensitization,cell proliferation,tumor aggressiveness,proliferation advantage
ENSG00000281917,SLC16A1,metabolic reprogramming,glycolytic activity,energy metabolism regulation,tumor aggressiveness,therapeutic target,cellular glucose uptake
ENSG00000149269,PAK1,oncogenic activation,mapk/erk pathway,rho gtpase interaction,cell migration regulation,epithelial-to-mesenchymal transition (emt),serine/threonine kinase activity
ENSG00000186575,NF2,hippo signaling pathway,dysregulation of protein degradation,genomic instability,tumor suppression,cell adhesion regulation,tissue homeostasis maintenance
ENSG00000196924,FLNA,pi3k/akt pathway interaction,tumor progression mediator,cell migration and invasion facilitator,cytoskeleton organization regulator,oncogenic driver,genomic instability promoter
ENSG00000123143,PKN1,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation,apoptosis regulation
ENSG00000122966,CIT,metabolic reprogramming,glycolysis,glutaminolysis,energy production,oncogenic,metabolic adaptation
ENSG00000111276,CDKN1B,cell cycle regulation,cyclin-dependent kinase inhibition,tumor suppressor function,post-translational modification regulation,protein-protein interaction,cell proliferation regulation
ENSG00000001626,CFTR,ion transport regulation,cell proliferation enhancement,oncogenic signaling activation,apoptosis resistance,gene expression modulation,tumor progression facilitation
ENSG00000047932,GOPC,oncogenic protein regulation,tumor progression,proliferation promotion,cell signaling modulation,membrane trafficking regulation,protein quality control interaction
ENSG00000159593,NAE1,genomic instability,dna synthesis regulation,cell proliferation enhancement,oncogene function,metabolic reprogramming,protein-rnr interaction
ENSG00000144744,UBA3,nedd8 conjugation,pi3k/akt signaling,oncoprotein activation,cell cycle regulation,ubiquitin-like modification,protein stabilization
ENSG00000184182,UBE2F,protein degradation regulation,nf-κb pathway activation,genomic instability,oncogene regulation,tumor progression driver,cell survival promotion
ENSG00000158290,CUL4B,cell cycle regulation,chromatin remodeling,e3 ubiquitin ligase activity,protein degradation pathway,transcriptional regulation,tumor progression
ENSG00000139842,CUL4A,cell cycle progression,dna repair regulation,genomic instability,oncogenic driver,proteasomal degradation,tumor suppressor interaction
ENSG00000100387,RBX1,scf complex,ubiquitin ligase activity,cancer progression,tumor suppressor degradation,cell cycle regulation,dna repair
ENSG00000112659,CUL9,ubiquitination regulation,cancer driver gene,tumor suppressor degradation,oncogenic protein stabilization,cell cycle progression,apoptosis inhibition
ENSG00000116678,LEPR,lepr overexpression,constitutive activation of pi3k/akt and mapk/erk pathways,tumor progression and metastasis,cell proliferation and angiogenesis enhancement,prognostic marker for cancer patients,potential therapeutic target
ENSG00000099800,TIMM13,mitochondrial biogenesis,cellular metabolism,glycolysis regulation,oncogenic function,hypoxia adaptation,prognostic biomarker
ENSG00000150779,TIMM8B,mitochondrial dysfunction,disrupted energy metabolism,cellular respiration alteration,oncogenic mutations,apoptosis inhibition,tumor suppressor function
ENSG00000126953,TIMM8A,mitochondrial dysfunction,iron-sulfur cluster biogenesis,cell survival pathways,hypoxia adaptation,therapeutic target,regulatory mechanisms
ENSG00000134809,TIMM10,mitochondrial complex i assembly,tumor suppressor function,cellular metabolism regulation,energy production modulation,decreased expression,oxidative phosphorylation
ENSG00000100575,TIMM9,mitochondrial dysfunction,energy metabolism regulation,oxidative stress induction,genomic instability promotion,apoptosis resistance,autophagy regulation
ENSG00000111880,RNGTT,angiogenesis,cell cycle regulation,metastasis promoter,multifunctional protein,oncogenic driver,tumor progression regulator
ENSG00000101654,RNMT,ribosome biogenesis,methylation of rrna,cell proliferation,epigenetic alterations,oncogenic potential,protein synthesis enhancement
ENSG00000133226,SRRM1,cancer driver,rna splicing regulation,cell proliferation enhancement,gene expression modulation,tumor aggressiveness association,therapeutic target potential
ENSG00000167978,SRRM2,alternative splicing,oncogenic processes,rna processing regulation,prognostic marker,tumor progression,pi3k/akt pathway interaction
,EPRS,oncogenesis,enhanced protein synthesis,cell growth promotion,transcriptional regulation,trna modification,dna damage response
ENSG00000167264,DUS2,mapk pathway regulation,constitutive activation,tumor progression,prognostic marker,loss of function mutations,proliferation enhancement
ENSG00000160193,WDR4,protein degradation,ubiquitin-protein conjugates,tumorigenesis,cellular homeostasis,aberrant protein accumulation,proteasome regulation
ENSG00000037897,METTL1,mrna translation regulation,epigenetic regulator,m6a modification,tumor progression promoter,dna damage response regulation,oncogenic mrna stability
ENSG00000213339,QTRT1,chromatin remodeling,transcriptional regulation,apoptosis dysregulation,cell proliferation enhancement,metastasis promotion,genomic instability
ENSG00000151576,QTRT2,genomic instability,oncogene role,telomerase activity regulation,chromosomal alterations,telomere length maintenance,prognostic marker
ENSG00000089195,TRMT6,tumor aggressiveness,protein synthesis regulation,trna charging,oncogene activation,aberrant protein accumulation,mitochondrial localization
ENSG00000166166,TRMT61A,trna modification,tumor progression,poor prognosis,ancillary pathway regulation,cellular growth regulation,methyl group transfer
ENSG00000163964,PIGX,glycosylphosphatidylinositol anchor biosynthesis,oncogenic mutations,disrupted protein function,cell proliferation regulation,metastatic progression,tumor cell survival
ENSG00000143315,PIGM,**

glycolytic regulation,glucose metabolism,oncogenesis contribution,cell proliferation enhancement,enzymatic activity dysregulation,metabolic pathway alteration
ENSG00000151665,PIGF,angiogenic process,oncogenesis,tumor progression,therapeutic target,growth factor signaling,vascular endothelial cell function
ENSG00000165282,PIGO,dna replication error repair,genomic instability,cell cycle regulation,tumor progression,oncogenic transformation,chromosomal instability
ENSG00000174227,PIGG,tumor progression,cell migration,oncogenic signaling,glycosylphosphatidylinositol (gpi) anchor biosynthesis,cell surface protein modification,signaling pathway regulation
ENSG00000156976,EIF4A2,mrna translation regulation,tumor promotion,cell proliferation enhancement,angiogenesis facilitation,eif3a interaction,onco-proteome alteration
ENSG00000161960,EIF4A1,oncogenic mrna translation,cell proliferation promotion,stat3 activation,chemotherapy resistance,tumor growth facilitation,genomic instability
ENSG00000080815,PSEN1,notch signaling pathway deregulation,cell proliferation promotion,oncogene activation,genetic instability,cell survival enhancement,amyloid precursor protein processing disruption
ENSG00000162736,NCSTN,notch signaling,tumor progression,oncogenic function,cell proliferation,cancer-related signaling pathway regulation,epithelial-to-mesenchymal transition
ENSG00000186298,PPP1CC,cell cycle regulation,apoptosis modulation,serine/threonine phosphatase,oncogenesis promotion,tumor suppressor regulation,holoenzyme component
ENSG00000087074,PPP1R15A,apoptosis regulation,cell cycle progression,genomic stability,inhibitory function,protein phosphatase regulation,stress response modulation
ENSG00000168288,MMADHC,cell proliferation,mtor pathway activation,growth regulation,metabolic regulation,tumorigenesis,therapeutic target
ENSG00000132763,MMACHC,dna damage,genomic instability,methylcobalamin metabolism,cell cycle regulation,apoptosis modulation,tumor progression
ENSG00000203618,GP1BB,tumor progression,metastasis regulation,cell migration,angiogenesis,platelet adhesion,epithelial-to-mesenchymal transition (emt)
ENSG00000185245,GP1BA,angiogenesis,protein-protein interactions,blood coagulation,cell adhesion,tumor progression,genetic predisposition
ENSG00000232957,HLA-DOA,antigen presentation,tumor evasion,immune suppression,prognostic marker,mhc class ii regulation,immunogenicity loss
ENSG00000243612,HLA-DOB,antigen presentation,tumor immune evasion,immunosurveillance failure,downregulation,antigen processing,t-cell interaction
ENSG00000146232,NFKBIE,nf-κb signaling pathway,inhibitor protein function,loss-of-function mutations,tumor progression,promoter activity regulation,cancer driver gene
ENSG00000162924,REL,constitutive activation,nf-κb signaling,oncogenic transformation,cell proliferation,survival factor,transcriptional regulation
ENSG00000196781,TLE1,transcriptional corepressor,overexpression,tumor suppressor suppression,cell growth promotion,oncogene activation,poor prognosis biomarker
ENSG00000116266,STXBP3,cellular growth regulation,protein secretion regulation,sm protein interaction,golgi apparatus function,apoptosis modulation,tumor promotion
ENSG00000147614,ATP6V0D2,tumor growth,metabolic regulation,energy metabolism dysfunction,cellular respiration regulation,ph homeostasis disruption,proton pump activity
ENSG00000159720,ATP6V0D1,oncogene,metabolic regulation,cell proliferation,lysosome function,tumor progression,glycolysis
ENSG00000115942,ORC2,genomic instability,rapid cell division,cell cycle progression,tumor aggressiveness,prognostic marker,poor patient outcomes
ENSG00000125885,MCM8,replication licensing,tumor progression,genomic instability,cell proliferation,dna repair,cell cycle regulation
ENSG00000172116,CD8B,tumor immunity,dysregulated expression,mhc interaction,t cell activation,antigen presentation,poor prognosis
ENSG00000153563,CD8A,tumor immune evasion,impaired t-cell function,altered tumor microenvironment,cell cycle regulation,transcriptional regulation,immune surveillance
ENSG00000198851,CD3E,tcr assembly,cell surface receptor,immune system activation,cancer biomarker,tumor cell proliferation,somatic mutation
ENSG00000160654,CD3G,t-cell signaling pathway,disruption of,immune evasion,t-cell receptor complex,gamma subunit mutation,immune checkpoint blockade
ENSG00000167286,CD3D,immune system regulation,t-cell activation,adaptive immune response,gene expression alteration,immunotherapy modulation,cancer microenvironment
ENSG00000138674,SEC31A,copii vesicle formation,cargo selection defect,endoplasmic reticulum stress,protein trafficking regulation,autophagy dysregulation,tumor progression
ENSG00000157020,SEC13,copii-dependent vesicle formation,cell cycle regulation,dna repair mechanisms,tumor suppressor function,vesicle export regulation,cell division impairment
ENSG00000134539,KLRD1,immune regulation,inhibitory receptor function,disrupted immune surveillance,tumor evasion,therapeutic target for immunotherapy,cell growth and survival modulation
ENSG00000205809,KLRC2,nk cell activation,immune evasion,kir/kir-ligand interaction,tumor progression,immune checkpoint regulation,antitumor immunity
ENSG00000136854,STXBP1,pi3k/akt pathway,membrane fusion regulation,tumor progression,aberrant activation,cell growth regulation,gene expression alteration
ENSG00000168283,BMI1,transcriptional repressor,genomic stability maintenance,cell cycle regulation,oncogene activation,apoptosis suppression,angiogenesis promotion
ENSG00000141582,CBX4,chromatin remodeling,oncogenic role,tumor progression,cell cycle regulation,dna repair mechanisms,core histone interaction
ENSG00000080824,HSP90AA1,hsp90 interaction,oncoprotein stabilization,tumor progression marker,cell cycle regulation,apoptosis inhibition,therapeutic target
ENSG00000077800,FKBP6,cell proliferation,apoptosis inhibition,pro-survival signaling,tumor suppression disruption,calcineurin interaction,chaperone function
ENSG00000123607,TTC21B,disrupted ciliogenesis,cancer driver mutation,tumor suppressor gene function,cell proliferation enhancement,cell survival increase,genomic alteration target
ENSG00000118965,WDR35,cell cycle regulation,constitutive activation,dna damage response,genomic instability,oncogene driver,prognostic marker
ENSG00000169398,PTK2,focal adhesion regulation,overexpression,signaling pathway activation,tumor progression,metastasis regulation,therapeutic target
ENSG00000204103,MAFB,epigenetic regulation,tumor suppressor gene suppression,cell cycle progression,chromatin modification,oncogenic transcription factor,apoptosis resistance
ENSG00000220205,VAMP2,cell migration,metastasis regulation,protein-protein interaction,cell adhesion modulation,tumor progression facilitation,snare complex formation
ENSG00000167986,DDB1,genomic instability,dna repair deficiency,tumor suppressor function,aberrant expression,cancer driver mutations,cul4-rbx1 complex interaction
ENSG00000112115,IL17A,tumor-promoting microenvironment,pro-inflammatory cytokines,enhanced cell proliferation,chemotherapy resistance,angiogenesis promotion,immune suppression
ENSG00000112116,IL17F,pro-inflammatory cytokine,immune cell recruitment,oncogenesis promotion,angiogenesis stimulation,inflammation regulation,cell proliferation enhancement
ENSG00000088247,KHSRP,alternative splicing regulation,cell proliferation enhancement,gene expression modulation,microrna pathway interaction,post-transcriptional control,tumor suppressor repression
ENSG00000185630,PBX1,hox-related transcription factor binding,transcriptional regulation,oncogenic potential,cell proliferation,apoptosis evasion,chromatin remodeling
ENSG00000160199,PKNOX1,pknox1 overexpression,transcriptional regulation,cell proliferation promotion,apoptosis inhibition,metastasis enhancement,tumor progression
ENSG00000082458,DLG3,disrupted epithelial polarity,metastatic progression,tumor suppressor function,cell-cell adhesion regulation,cancer metastasis promotion,signaling pathway disruption
ENSG00000132535,DLG4,cellular interaction,gain of function mutations,pi3k/akt pathway activation,tumor progression,disrupted cell-cell adhesion,oncogenic driver gene
ENSG00000158477,CD1A,immune regulation,tumor progression,immunosuppression,lipid antigen presentation,antigen presentation pathway,none
ENSG00000158485,CD1B,cell surface antigen presentation,tumor progression,immune microenvironment modulation,oncogenic pathway activation,immune checkpoint regulation,overexpression association
ENSG00000158473,CD1D,immunomodulation,antigen presentation,lipid antigens,invariant natural killer t cells,tumor suppression,immune homeostasis
ENSG00000158481,CD1C,immune regulation,antigen presentation,tumor immunosuppression,myeloid-derived suppressor cells,cell cycle regulation,genomic instability
ENSG00000175097,RAG2,chromosomal instability,dna damage,genomic stability,immune system disruption,lymphocyte maturation,tumor progression
ENSG00000166349,RAG1,genomic instability,v(d)j recombination,oncogenic recombination,cell proliferation,dna breaks,chromosomal instability
ENSG00000107566,ERLIN1,tumor suppressor,erbb receptor inhibition,downregulation in cancer,pi3k/akt/mtor pathway interaction,cell proliferation regulation,aggressive tumor behavior
ENSG00000147475,ERLIN2,ubiquitination regulation,cell cycle progression,dna damage response,oncogenic processes,cancer aggressiveness,tumor suppressor regulation
ENSG00000140836,ZFHX3,pi3k/akt signaling,transcriptional regulation,tumor suppressor function,genomic instability,cell proliferation regulation,metastatic potential
ENSG00000167770,OTUB1,protein stabilization,ubiquitin-proteasome system regulation,oncogenic protein activation,cell cycle progression facilitation,chemoresistance development,deubiquitinating enzyme function
ENSG00000133135,RNF128,genomic instability,dna damage repair,tumor suppression,cell cycle regulation,apoptosis induction,p53 interaction
ENSG00000072506,HSD17B10,genomic amplification,oncogenic function,cellular metabolism regulation,cell proliferation enhancement,mitochondrial dysfunction,therapeutic target
ENSG00000174173,TRMT10C,mitochondrial dysfunction,metabolic alterations,cellular proliferation,trna biosynthesis,oncogenic mutations,energy production
ENSG00000198026,ZNF335,regulation of gene expression,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,transcription factor interaction,chromatin modification,therapeutic target
ENSG00000113300,CNOT6,ccr4-not complex regulation,mrna deadenylation,oncogene overexpression,tumor progression,apoptosis inhibition,therapeutic target
ENSG00000185002,RFX6,tumor suppressor,cell proliferation regulation,transcriptional regulation,genetic interaction,cellular stress response,none
ENSG00000134352,IL6ST,il-6 signaling pathway,aberrant activation,cell proliferation,cell survival,metastasis,jak/stat3 interaction
ENSG00000166266,CUL5,cell cycle regulation,degradation pathway target,protein-protein interaction,apoptosis regulator,tumor suppressor dysfunction,ubiquitination complex component
ENSG00000036257,CUL3,cancer driver gene,tumor suppressor function,ubiquitination regulation,cell cycle regulation,apoptosis induction,dna damage response
ENSG00000108094,CUL2,cancer-related processes,cul-rbx complex interaction,tumor suppressor function,ubiquitin-proteasome pathway regulation,apoptosis resistance,proliferation enhancement
ENSG00000215021,PHB2,protein degradation regulation,oncogenic mutations,tumor progression,apoptosis inhibition,cell cycle dysregulation,ubiquitin-proteasome pathway interaction
ENSG00000167085,PHB,p53 interaction,cell cycle regulation,apoptosis modulation,glycolytic shift,mitochondrial dysfunction,cancer cell proliferation
ENSG00000100401,RANGAP1,cellular proliferation,ran gtpase-activating protein function,genomic instability,nuclear transport regulation,mitotic spindle assembly,tumor growth promotion
ENSG00000137100,DCTN3,dynein motor complex,protein quality control,cell cycle regulation,apoptosis modulation,biomarker expression,tumor progression
ENSG00000175203,DCTN2,cell cycle regulation,genomic instability,microtubule dynamics,mitotic checkpoint,tumor aggressiveness,therapeutic target
ENSG00000205755,CRLF2,oncogenic transcriptional activation,cell proliferation enhancement,apoptosis inhibition,tumor progression association,poor prognosis indicator,potential therapeutic target
ENSG00000145623,OSMR,pi3k/akt/mtor pathway regulation,cell migration enhancement,tumor progression facilitation,metastasis promotion,cell adhesion modulation,biomarker potential
ENSG00000048649,RSF1,chromatin remodeling,genomic instability,tumor progression,dna repair disruption,cell proliferation regulation,promoter activation
ENSG00000137752,CASP1,apoptosis regulation,inflammatory response,oncogenic mutation,tumor progression,prognostic marker,cell death promotion
ENSG00000025434,NR1H3,vitamin d signaling pathway,tumor suppression,cell differentiation regulation,apoptosis induction,pro-apoptotic protein regulation,dna repair regulation
ENSG00000131408,NR1H2,vitamin d signaling pathway,tumor suppressor function,calcium metabolism regulation,cell differentiation modulation,downregulated expression,transcriptional regulation
ENSG00000142655,PEX14,altered cellular metabolism,disrupted peroxisome function,aberrant cell growth,impaired detoxification processes,cellular energy dysregulation,metabolic reprogramming
ENSG00000162928,PEX13,altered cellular processes,aberrant protein expression,cellular homeostasis disruption,tumor progression association,peroxisomal dysfunction involvement,genomic instability contribution
ENSG00000176884,GRIN1,aberrant glutamate signaling,mutation-driven oncogenesis,cell proliferation enhancement,migration facilitation,poor prognosis marker,tumor aggressiveness
ENSG00000273079,GRIN2B,nmda receptor function,aberrant overexpression,cell proliferation enhancement,tumor progression promotion,signaling pathway modulation,molecular driver of oncogenesis
ENSG00000106299,WASL,actin cytoskeleton regulation,arp2/3 complex interaction,oncogenic potential,cell migration enhancement,cytoskeletal rearrangement promotion,pi3k/akt signaling pathway modulation
ENSG00000205726,ITSN1,cell migration,oncogenic processes,cytoskeletal organization,pi3k/akt pathway,prognostic marker,apoptosis regulation
ENSG00000027697,IFNGR1,immune evasion,tumor progression,jak/stat pathway,apoptosis suppression,immune surveillance disruption,genetic variation
ENSG00000262795,IFNGR2,immune modulation,tumor progression,innate immune response,therapeutic target,cell proliferation regulation,cancer immunotherapy
ENSG00000134852,CLOCK,circadian rhythm disruption,cell cycle regulation,tumor growth promotion,dna damage response modulation,apoptosis inhibition,protein-protein interaction
ENSG00000029153,ARNTL2,tumor progression,circadian rhythm regulation,transcriptional regulation,cell proliferation,oncogenesis,metastasis
ENSG00000057468,MSH4,genomic instability,dna mismatch repair,loss of function mutations,tumor suppression,therapeutic target,cancer prognosis
ENSG00000237333,MSH5,microsatellite instability,genomic maintenance,dna repair,tumor suppression,chromosomal instability,mismatch repair
ENSG00000119684,MLH3,**

1. **genomic instability**,2. **dna mismatch repair**,3. **microsatellite instability**,4. **tumor suppression**,5. **cell proliferation**,6. **msi-h phenotype**
ENSG00000168495,POLR3D,ribosome biogenesis,genomic instability,aneuploidy driver,cell proliferation regulation,oncogenic protein interaction,pi3k/akt pathway modulation
ENSG00000058600,POLR3E,cell cycle regulation,chromatin remodeling,dna repair mechanisms,genomic instability,metabolic reprogramming,transcriptional dysregulation
ENSG00000100413,POLR3H,ribosomal rna transcription,rna polymerase activity,cell proliferation enhancement,therapeutic target identification,genomic instability association,chromatin remodeling interaction
ENSG00000241258,CRCP,immune suppression,tumor progression,cell adhesion modulation,metastatic potential,cancer immunology,protein-protein interaction
ENSG00000165168,CYBB,nadph oxidase complex activity,ros production,oncogenic driver,tumor growth promotion,cell proliferation enhancement,apoptosis inhibition
ENSG00000051523,CYBA,redox regulation,oncogene,proliferation,survival,apoptosis resistance,electron transfer
ENSG00000083123,BCKDHB,branched-chain amino acid metabolism,constitutive activation,gain of function mutations,tumor progression,metabolic regulation,mtor signaling pathway
ENSG00000248098,BCKDHA,altered expression,amino acid metabolism,cellular energy homeostasis,disrupted function,metabolic reprogramming,oncogenesis
ENSG00000168906,MAT2A,oncogenic transformation,histone modification,transcriptional regulation,cellular proliferation,signaling pathway activation,genomic instability
ENSG00000038274,MAT2B,histone methylation,epigenetic regulation,tumor progression,cancer cell proliferation,methylation of proteins,cell survival
ENSG00000140505,CYP1A2,metabolic activation,polycyclic aromatic hydrocarbon metabolism,dna damage induction,tumor promotion,xenobiotic metabolism,carcinogen activation
ENSG00000127948,POR,peroxisomal biogenesis,oxidative stress,energy metabolism regulation,cellular metabolic adaptation,oncogenic protein interaction,mitochondrial dysfunction
ENSG00000165841,CYP2C19,altered metabolism,cell growth regulation,dna damage response,cancer progression,drug resistance,genetic alterations
ENSG00000163114,PDHA2,oncogenesis,glycolytic shift,mitochondrial dysfunction,energy metabolism dysregulation,therapeutic target,promoter methylation
ENSG00000168291,PDHB,aerobic glycolysis,cell proliferation,energy metabolism regulation,glycolytic shift,lipid biosynthesis,metabolic reprogramming
ENSG00000131828,PDHA1,glucose metabolism disruption,oncogenic reprogramming,genomic instability promotion,therapeutic target identification,cell survival enhancement,metabolic adaptation
ENSG00000117118,SDHB,mitochondrial energy metabolism,competitive inhibition of phd,hif activation pathway,angiogenic factor promotion,cellular proliferation,oncogenic driver gene
ENSG00000073578,SDHA,mitochondrial respiration,succinate accumulation,oncogenic pathway activation,tumor suppressive function loss,energy production enhancement,prognostic biomarker potential
ENSG00000164951,PDP1,transcriptional coactivator,chromatin remodeling,oncogenic processes,cell proliferation,apoptosis inhibition,cancer driver gene
ENSG00000090857,PDPR,**
pyruvate dehydrogenase complex regulation,cellular metabolism modulation,energy homeostasis maintenance,tumor cell adaptation,cancer metabolic reprogramming,mitochondrial function regulation 
**
ENSG00000105568,PPP2R1A,pp2a regulation,tumor suppressor activity,oncogenic potential,constitutive activation,dna damage response,cell signaling regulation
ENSG00000113575,PPP2CA,pp2a regulation,tumor initiation,akt/mtor pathway modulation,cell cycle progression,apoptosis inhibition,signaling pathway deregulation
ENSG00000112818,MEP1A,cell growth regulation,tumor progression,metastasis promotion,cell cycle modulation,apoptosis suppression,oncogene activation
ENSG00000141434,MEP1B,molecular chaperone function,oxidative stress protection,protein repair mechanism,dna damage resistance,cell survival pathway activation,therapeutic target potential
ENSG00000105675,ATP4A,cellular ph regulation,proton pump function,tumor microenvironment modulation,ion transport regulation,cell survival promotion,therapeutic target
ENSG00000288359,ATP4B,oncogene activation,enhanced cell migration,tumor progression,v-atpase regulation,biomarker expression,therapeutic target
ENSG00000143437,ARNT,dual role oncogene/tumor suppressor,angiogenesis regulation,cell growth/survival promotion,heterodimeric complex formation,hypoxia response,glucose metabolism regulation
ENSG00000116016,EPAS1,hypoxia-inducible factor regulation,angiogenic pathway activation,cell proliferation promotion,tumor growth facilitation,metastasis enhancement,therapeutic target identification
ENSG00000169245,CXCL10,angiogenesis,immune evasion,tumor progression,cell migration,protein interaction,cancer cell invasion
ENSG00000186810,CXCR3,tumor progression,metastasis promotion,angiogenesis regulation,immune cell recruitment,prognostic marker,signaling pathway modulation
ENSG00000186469,GNG2,pi3k/akt pathway activation,g-protein coupled receptor signaling,cell proliferation enhancement,apoptosis resistance,prognostic biomarker candidate,signaling pathway modulation
ENSG00000181104,F2R,tumor progression,cell migration,immune evasion,therapeutic target,oncogene activity,receptor signaling
ENSG00000164220,F2RL2,procoagulant activity,tumor progression,cell adhesion regulation,oncogenic protein interaction,enhanced cell survival,metastasis promotion
ENSG00000070886,EPHA8,epha8 overexpression,angiogenesis promoter,cell adhesion modulation,tumor progression driver,signaling pathway regulator,genomic instability
ENSG00000184349,EFNA5,oncogenic potential,overexpression,tumor growth promotion,cell migration regulation,angiogenesis induction,chemotherapy resistance
ENSG00000033800,PIAS1,tumor suppressor,protein-protein interaction,transcriptional regulation,cell cycle progression,apoptosis regulation,dna repair modulation
ENSG00000035403,VCL,cell adhesion disruption,cancer cell migration,signaling pathway interaction,tumor invasion promotion,mechanotransduction regulation,focal adhesion assembly
ENSG00000072401,UBE2D1,ubiquitin-proteasome pathway,chromatin remodeling complex,cell cycle regulation,oncoprotein interaction,tumor suppressor downregulation,mutational activation
ENSG00000118513,MYB,transcriptional regulation,cell cycle progression,apoptosis evasion,tumor growth,poor prognosis marker,genomic amplification
ENSG00000113580,NR3C1,glucocorticoid receptor regulation,pi3k/akt pathway modulation,tumor microenvironment modulation,inflammation regulation,immune response modulation,cell growth and survival enhancement
ENSG00000140396,NCOA2,transcriptional coactivation,oncogene overexpression,cell growth promotion,nuclear receptor interaction,tumor progression driver,genetic amplification
ENSG00000164161,HHIP,hedgehog signaling pathway,oncogenic potential,tumor suppressive function,cell growth regulation,cell survival modulation,metastatic processes
ENSG00000163501,IHH,wnt/β-catenin signaling pathway,cell proliferation,metastasis promotion,tumor progression,morphogen activity,gene overexpression
ENSG00000115170,ACVR1,tgf-β signaling,constitutive activation,gain of function mutations,epithelial-to-mesenchymal transition (emt),metastasis promotion,cancer progression
ENSG00000198648,STK39,cellular proliferation,dysregulated kinase activity,constitutive activation,tumor progression,cancer cell survival,genomic instability
ENSG00000065675,PRKCQ,nf-κb signaling pathway,protein kinase activation,cell cycle regulation,apoptosis modulation,gene expression regulation,tumor progression
ENSG00000106070,GRB10,loss of function mutations,tumor suppression,egfr signaling inhibition,cell proliferation regulation,oncogenic process promotion,poor prognosis association
ENSG00000101096,NFATC2,tumor progression,transcriptional regulation,oncogenic processes,epithelial-to-mesenchymal transition (emt),signaling pathway dysregulation,prognostic biomarker
ENSG00000049768,FOXP3,tumor suppressor function,immune tolerance regulation,cell cycle regulation,dna repair interaction,apoptosis modulation,prognostic marker significance
ENSG00000086758,HUWE1,tumor suppressor,cell cycle regulation,apoptosis regulation,protein degradation,genomic instability,dna damage response
ENSG00000107968,MAP3K8,mapk pathway modulation,kinase activity regulation,cell growth promotion,tumor progression facilitation,genomic instability contribution,signaling pathway activation
ENSG00000120063,GNA13,gpcr regulation,cell migration,tumor progression,signaling pathway modulation,protein-protein interaction,oncogenic processes
ENSG00000146535,GNA12,g protein activation,constitutive activation,signaling pathway regulation,cell migration promotion,tumor progression facilitation,therapeutic target
ENSG00000130396,AFDN,cell adhesion disruption,protein overexpression,cell migration facilitation,tumor proliferation enhancement,cytoskeletal regulation,epithelial-to-mesenchymal transition
ENSG00000197943,PLCG2,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000254087,LYN,protein kinase activation,cell proliferation,tumor progression,angiogenesis,metastasis,non-receptor tyrosine kinase
ENSG00000180210,F2,cellular proliferation,apoptosis regulation,blood coagulation pathway,thrombosis,serine protease activity,vitamin k-dependent function
ENSG00000171720,HDAC3,tumor aggressiveness,enhancer-promoter interactions,epigenetic regulation,antitumor activity,chromatin remodeling,transcriptional repression
ENSG00000164331,ANKRA2,genomic instability,cell cycle regulation,mitotic spindle formation,apc complex regulation,tumor progression,oncoprotein interaction
ENSG00000164867,NOS3,angiogenesis,cell proliferation,dna damage,epigenetic regulation,genetic instability,nf-kappab activation
ENSG00000135966,TGFBRAP1,tgf-β signaling,epithelial-to-mesenchymal transition,cell adhesion regulation,oncogenic transformation,cell migration enhancement,genomic instability
ENSG00000124145,SDC4,epithelial-to-mesenchymal transition (emt),cell adhesion modulation,tumor progression,metastasis facilitation,angiogenesis regulation,growth factor interaction
ENSG00000274233,CCL5,angiogenesis promotion,chemokine function,pro-tumorigenic effects,metastasis facilitation,cell migration enhancement,immune evasion mechanisms
ENSG00000148737,TCF7L2,wnt signaling pathway disruption,aberrant gene expression,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),transcription factor dysregulation,cyclin-dependent kinase inhibitor regulation
ENSG00000139549,DHH,hedgehog pathway activation,constitutive activation,gain of function mutations,cell proliferation,tumor growth,metastasis promotion
ENSG00000175592,FOSL1,ap-1 transcription factor,cell proliferation regulation,coactivator function,epithelial-to-mesenchymal transition,oncogenic processes involvement,transcriptional regulation
ENSG00000180340,FZD2,wnt signaling pathway,aberrant activation,gain of function mutations,tumor progression,therapeutic target,prognostic biomarker
ENSG00000114251,WNT5A,wnt/β-catenin pathway,oncogenic activity,epithelial-to-mesenchymal transition,cell proliferation,cell migration,therapeutic target
ENSG00000028528,SNX1,endosomal sorting,oncogenic pathway interaction,pi3k/akt signaling activation,tumor progression promotion,epithelial-to-mesenchymal transition regulation,protein trafficking dysregulation
ENSG00000205302,SNX2,cell migration,cell proliferation,egfr regulation,pi3k/mtor signaling,proliferation enhancer,tumor suppressor dysfunction
ENSG00000080503,SMARCA2,chromatin remodeling,swi/snf complex,atpase/helicase function,genomic instability,cell cycle regulation,transcriptional control
ENSG00000245848,CEBPA,tumor suppressor function,cell differentiation regulation,apoptosis regulation,senescence induction,metabolic regulation disruption,epigenetic silencing
ENSG00000075426,FOSL2,apoptosis inhibition,cell proliferation enhancement,transcriptional regulation,oncogene overexpression,prognostic marker,genetic amplification
ENSG00000090776,EFNB1,angiogenesis promotion,cell adhesion disruption,metastasis facilitation,tumor progression driver,vegf signaling regulation,biomarker potential
ENSG00000154928,EPHB1,ephrin signaling,aberrant signaling,mutation-driven oncogenesis,cell migration and invasion,tumor progression,rho gtpase activation
ENSG00000174808,BTC,tumor progression,cell proliferation,signaling pathway activation,metastasis promotion,oncogene upregulation,protein interaction
ENSG00000100811,YY1,tumor suppressor regulation,transcriptional activation,apoptosis inhibition,cell cycle progression,dna repair modulation,genomic instability
ENSG00000115594,IL1R1,il-1/il1r1 pathway,overexpression,oncogenic signaling,tumor microenvironment modulation,therapeutic target,genomic instability
ENSG00000136689,IL1RN,il-1 signaling pathway,tumor suppressor function,chronic inflammation regulation,immune evasion mechanisms,myeloid-derived suppressor cell modulation,anti-tumor immune response enhancement
ENSG00000130427,EPO,angiogenesis promotion,vascular endothelial growth factor signaling,cell survival enhancement,tumor progression facilitation,oncogenic potential activation,red blood cell production regulation
ENSG00000187266,EPOR,tumor progression,cell proliferation,growth factor signaling,protein activation,cell survival,upregulated expression
ENSG00000198400,NTRK1,oncogenic fusion gene formation,constitutive activation,anti-apoptotic signaling,cell proliferation,tumor growth,therapeutic target
ENSG00000168040,FADD,apoptosis regulation,tumor suppression,genomic stability maintenance,cell death pathway,oncogenesis prevention,cell growth inhibition
ENSG00000169242,EFNA1,tumor progression,cellular migration,angiogenesis regulation,vascular development,tumor-induced angiogenesis,poor prognosis
ENSG00000142627,EPHA2,tumor progression,cell migration regulation,receptor tyrosine kinase activity,cell adhesion modulation,pi3k/akt pathway interaction,epigenetic regulation
ENSG00000151693,ASAP2,rho gtpase signaling pathway,oncogene activity,cell proliferation regulation,protein-protein interaction,gene expression modulation,tumor aggressiveness promotion
ENSG00000128917,DLL4,vascular development,angiogenesis promotion,tumor growth enhancement,notch signaling pathway interaction,poor prognosis marker,therapeutic target
ENSG00000235396,NOTCH4,notch signaling pathway,aberrant activation,gain of function mutations,tumor progression,therapeutic target,cancer driver gene
ENSG00000081059,TCF7,wnt/β-catenin pathway activation,constitutive activation,genetic amplification,cell proliferation enhancement,tumor progression,transcriptional regulation
ENSG00000127191,TRAF2,nf-κb activation,tumor necrosis factor receptor signaling,constitutive activation,oncogenic processes,apoptosis resistance,protein-protein interactions
ENSG00000128602,SMO,hedgehog pathway activation,constitutive activation,gain of function mutations,cell proliferation,therapeutic target,signaling pathway modulation
ENSG00000141480,ARRB2,oncogenic driver,receptor tyrosine kinase regulation,adaptor molecule function,cellular proliferation,apoptosis inhibition,signaling pathway activation
ENSG00000196367,TRRAP,tumor suppressor dysfunction,chromatin remodeling,transcriptional activation,genomic instability,apoptosis inhibition,nf-κb pathway interaction
ENSG00000108773,KAT2A,chromatin remodeling,tumor promoter,cell proliferation,histone acetyltransferase activity,transcriptional regulation,apoptosis suppression
ENSG00000196411,EPHB4,epithelial-to-mesenchymal transition,tumor progression,prognostic marker,therapeutic target,angiogenesis regulation,cell migration activation
ENSG00000125266,EFNB2,emt regulation,cell adhesion disruption,oncogenic signaling pathway,tumor aggressiveness marker,overexpression associated with poor prognosis,therapeutic target for cancer treatment
ENSG00000175354,PTPN2,tumor suppressor function,regulation of immune response,dephosphorylation of rtks,oncogenic properties in cancer cells,reduced cell proliferation and survival,downregulation/mutation in cancer
ENSG00000177425,PAWR,epithelial-to-mesenchymal transition (emt),cell adhesion molecule regulation,transcription factor activity,prognostic marker,tumor progression,gene expression modulation
ENSG00000067606,PRKCZ,cell migration regulation,apoptosis modulation,calcium-activated protein kinase activity,oncogene potential,cell proliferation enhancement,pi3k/akt pathway interaction
ENSG00000116809,ZBTB17,cellular repressor,chromatin remodeling,tumor suppression,apoptosis induction,cell cycle regulation,genomic stability
ENSG00000140968,IRF8,transcriptional regulation,tumor suppression,immune response modulation,cell cycle control,apoptosis regulation,pi3k/akt pathway interaction
ENSG00000160867,FGFR4,fgfr4 overexpression,cell proliferation enhancement,constitutive activation pathway,protein kinase activation,mapk/erk signaling interaction,oncogenic synergy
ENSG00000138685,FGF2,fgf/fgfr signaling,cell proliferation,angiogenesis stimulation,mapk/erk pathway activation,tumor growth promotion,oncogenic activity enhancement
ENSG00000068078,FGFR3,constitutive activation,genomic instability,oncogene activation,pi3k/akt pathway,protein tyrosine kinase activity,receptor dimerization
ENSG00000066468,FGFR2,fgfr signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000171223,JUNB,transcription factor function,cell proliferation regulation,oncogenic transformation promotion,ap-1 family member,tumor suppressor dysfunction,chromatin remodeling interaction
ENSG00000100393,EP300,transcriptional co-activator,histone acetyltransferase activity,tumorigenesis promotion,cell proliferation enhancement,apoptosis suppression,genetic mutation impact
ENSG00000099942,CRKL,crkl overexpression,adaptor protein function,tyrosine kinase regulation,oncogenic potential,cell growth promotion,pi3k/akt/mtor pathway activation
ENSG00000107263,RAPGEF1,cellular proliferation,rap gtpase activation,tumor growth promotion,apoptosis evasion,cell migration enhancement,signaling pathway regulation
ENSG00000157193,LRP8,tumor progression,signaling pathway activation,cell adhesion regulation,calcium homeostasis disruption,metastasis promotion,therapeutic target
ENSG00000164093,PITX2,oncogenic function,tumor progression,cell proliferation,angiogenesis inhibition,transcriptional regulation,signaling pathway interaction
ENSG00000140992,PDPK1,**
pdk1-akt pathway activation,agc kinase regulation,constitutive signaling,cell proliferation enhancement,therapeutic target validation,genomic instability promotion
**
ENSG00000121067,SPOP,pi3k/akt pathway disruption,protein degradation dysfunction,loss of function mutations,tumor suppressor loss,cell cycle regulation impairment,therapeutic target potential
ENSG00000281324,LRP6,wnt/β-catenin signaling,transmembrane receptor function,cell proliferation driver,protein interaction modulation,cancer progression facilitator,therapeutic target potential
ENSG00000107984,DKK1,wnt/β-catenin pathway inhibition,oncogenesis promotion,cell proliferation enhancement,tumor growth facilitation,notch signaling activation,p53 suppression
ENSG00000116288,PARK7,oxidative stress resistance,cell survival promotion,apoptosis inhibition,protein-protein interactions,cell cycle regulation,genomic instability
ENSG00000063660,GPC1,**
gbs biosynthesis,cell-to-cell adhesion,pi3k/akt signaling,cell migration,oncogenesis,tumor progression
**
ENSG00000241186,TDGF1,wnt/β-catenin pathway,co-oncogene,cell proliferation,elevated expression,tumor progression,oncogenic potential
ENSG00000138795,LEF1,wnt/β-catenin signaling pathway,transcriptional regulator,oncogene activation,tumor progression,protein interaction,cell cycle regulation
ENSG00000119630,PGF,angiogenesis promotion,prostaglandin synthesis regulation,vegf upregulation,tumor progression facilitation,oncogene interaction,cell growth regulation
ENSG00000071564,TCF3,cell cycle regulation,tumor progression,dysregulated transcription factor,oncogenic mutation,apoptosis inhibition,proliferation enhancement
ENSG00000129152,MYOD1,epithelial-to-mesenchymal transition (emt),stem cell-like phenotype,transcription factor regulation,muscle cell differentiation,chromatin remodeling,gene amplification
ENSG00000157168,NRG1,aberrant signaling,cell growth promotion,erbb4 activation,met interaction,oncogenic potential,receptor tyrosine kinase regulation
ENSG00000123349,PFDN5,pi3k/akt pathway,constitutive activation,epithelial-to-mesenchymal transition,tumor progression,cell migration,vesicle trafficking
ENSG00000153317,ASAP1,apoptosis regulation,gain of function mutations,oncogenic potential,cell cycle progression modulation,tumorigenesis contribution,therapeutic target
ENSG00000113578,FGF1,pro-tumorigenic effects,tumor progression,angiogenesis,cell proliferation,oncogenic protein interaction,pi3k/akt pathway activation
ENSG00000075388,FGF4,**

fgf/fgfr pathway,gain of function mutations,oncogenic driver,tumor growth,angiogenesis,epithelial-to-mesenchymal transition

**
ENSG00000162344,FGF19,tumor progression,metastatic potential,fgf/fgfr signaling,cell growth regulation,oncogenic driver,angiogenesis promotion
ENSG00000123416,TUBA1B,microtubule dynamics,cell proliferation,oncogenesis,apoptosis resistance,metastasis enhancement,protein kinase activation
ENSG00000112245,PTP4A1,pi3k/akt/mtor pathway regulation,oncogene potential,tumor progression facilitation,cell proliferation enhancement,therapeutic target modulation,signaling pathway modulation
ENSG00000121858,TNFSF10,...<end>:

<begin>
apoptosis regulation,tumor suppression,cancer cell death,immune system modulation,cell proliferation regulation,trail signaling pathway
ENSG00000139567,ACVRL1,alk1-tgf-β signaling pathway,angiogenesis regulation,dysregulated smad-dependent cascades,genetic alterations,immunotherapy resistance,metastasis promoter
ENSG00000157764,BRAF,constitutive activation,gain of function mutations,mapk/erk signaling,oncogenic driver,therapeutic target,cell proliferation
ENSG00000166579,NDEL1,microtubule stabilization,chromosome separation,mitotic progression,cell proliferation,genetic instability,apoptosis resistance
ENSG00000013810,TACC3,microtubule dynamics,cell proliferation,oncogenic protein interactions,pro-survival signaling pathways,mitotic spindle formation,cell cycle progression
ENSG00000119383,PTPA,dephosphorylation,receptor tyrosine kinase activation,tumor progression,oncogenic signaling pathway,cell proliferation,protein interaction
ENSG00000121989,ACVR2A,cell proliferation,tumor progression,receptor signaling,transmembrane receptor,oncogenic processes,protein phosphorylation
ENSG00000133794,ARNTL,circadian regulation,transcriptional regulation,cell proliferation,oncogene overexpression,metabolic regulation,genomic instability
ENSG00000065526,SPEN,tumor suppressor function,chromatin remodeling complex component,cellular growth regulation,transcriptional repression,oncogenic process involvement,therapeutic target candidate
ENSG00000150455,TIRAP,immune evasion,promotes cell proliferation,antiviral response,pro-inflammatory signaling,nf-κb activation,apoptosis inhibition
ENSG00000167393,PPP2R3B,dephosphorylation regulation,tumor suppressor function loss,dna repair defects,cell proliferation enhancement,metastatic potential increase,therapeutic resistance
ENSG00000064490,RFXANK,genomic instability,transcriptional regulation,cell cycle progression,apoptosis evasion,chromatin remodeling,oncogenic function
ENSG00000170558,CDH2,epithelial-to-mesenchymal transition (emt),cell adhesion molecule,tumor progression,metastasis,oncogene,wnt/β-catenin signaling pathway
ENSG00000150760,DOCK1,cell migration,cancer cell invasion,tumor progression,signaling pathway regulation,protein-protein interaction,gtpase activation
ENSG00000155849,ELMO1,rac gtpase activation,constitutive activation,oncogenic process,tumor progression,cell migration,invasion capability
ENSG00000169439,SDC2,oncogene potential,tumor progression,cell proliferation,angiogenesis promotion,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000178999,AURKB,cell cycle dysregulation,oncogene activation,chromosomal instability,mitotic checkpoint disruption,kinase activity modulation,genomic abnormalities
ENSG00000173535,TNFRSF10C,apoptosis resistance,tumor progression,trail decoy receptor,chemoresistance,biomarker potential,cancer cell survival
ENSG00000112592,TBP,chromatin remodeling,dna binding activity,gene expression regulation,oncogenic potential,transcription factor function,tumor suppressor role
ENSG00000066336,SPI1,tumor immune evasion,immunosuppressive mechanism,transcriptional regulation,cytokine production,cell migration suppression,poor prognosis indicator
ENSG00000147443,DOK2,pi3k/akt signaling pathway,oncogenic process,cell proliferation and survival,biomarker for cancer diagnosis,src family kinase activation,epithelial-to-mesenchymal transition (emt) regulation
ENSG00000198561,CTNND1,cell-cell adhesion disruption,emt facilitation,oncogenic process promotion,tumor progression facilitation,overexpression or mutation involvement,adherens junction disruption
ENSG00000167193,CRK,cell proliferation,cell migration,oncogenic processes,pi3k/akt pathway activation,shp2 interaction,focal adhesion kinase (fak) signaling
ENSG00000108840,HDAC5,histone deacetylase activity,transcription factor interaction,epithelial-to-mesenchymal transition,pro-apoptotic gene repression,tumor suppressor gene regulation,chromatin remodeling
ENSG00000101199,ARFGAP1,cell signaling pathway disruption,tumor progression facilitation,epithelial-to-mesenchymal transition regulation,aggressive tumor behavior correlation,poor prognosis association,therapeutic target potential
ENSG00000105438,KDELR1,er quality control,kdel receptor function,tumor suppressor protein degradation,oncoprotein accumulation,cell cycle regulation,autophagy regulation
ENSG00000094631,HDAC6,microtubule dynamics,cell proliferation,epigenetic regulation,pi3k/akt signaling pathway,chromatin remodeling,protein deacetylation
ENSG00000114423,CBLB,cell cycle regulation,apoptosis evasion,protein degradation defect,tumor suppressor dysfunction,genetic mutations,signaling pathway dysregulation
ENSG00000157240,FZD1,wnt signaling,cell proliferation,tumor progression,receptor activity,signaling pathway,transmembrane protein
ENSG00000154342,WNT3A,wnt/β-catenin pathway,ligand activation,oncogenesis,tumor progression,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance
ENSG00000163517,HDAC11,tumor suppressor gene downregulation,cell cycle regulation disruption,apoptosis pathway modulation,dna repair mechanism impairment,chromatin remodeling involvement,protein-protein interaction facilitation
ENSG00000172179,PRL,tumor progression,cancer cell growth,cell survival pathways,apoptosis evasion,prognostic marker,biomarker overexpression
ENSG00000179094,PER1,circadian regulation,cell cycle progression,anti-apoptotic function,dna repair mechanisms,transcriptional regulation,tumor suppressor activity
ENSG00000135144,DTX1,oncogene activity,transcription factor regulation,cell proliferation promotion,survival pathway activation,tumor progression association,wnt/β-catenin pathway interaction
ENSG00000182944,EWSR1,etv4 fusion partner,transcriptional regulation,rna binding protein,gene expression modulation,tumor progression,chromatin remodeling
ENSG00000100485,SOS2,pi3k/akt pathway regulation,mutations leading to oncogenic activation,dna repair mechanisms interaction,tumor progression contribution,therapeutic target for cancer treatment,genomic stability modulation
ENSG00000110330,BIRC2,apoptosis regulation,inflammation response,nf-κb pathway interaction,tumor promotion,anti-apoptotic function,cell proliferation enhancement
ENSG00000023445,BIRC3,apoptosis inhibition,cell survival promotion,tumor aggressiveness,chemotherapy resistance,metastasis facilitation,poor prognosis association
ENSG00000164327,RICTOR,mtor signaling pathway,akt activation,gain of function mutations,tumor progression,epithelial-to-mesenchymal transition (emt),oncogene
ENSG00000105810,CDK6,cell cycle regulation,oncogene activation,tumor growth promotion,g1 phase transition,e2f transcription factor release,prb phosphorylation
ENSG00000134516,DOCK2,rho gtpase activation,oncogenic signaling,tumor progression,metastasis promotion,apoptosis resistance,prognostic marker
ENSG00000166167,BTRC,oncogenic substrate recognition,ubiquitin ligase activation,cell cycle regulation,transcriptional control,apoptosis suppression,tumor progression
ENSG00000126767,ELK1,transcription factor activation,cell proliferation enhancement,oncogene role,gene expression regulation,apoptosis suppression,cell cycle progression
ENSG00000112658,SRF,transcription factor activation,cell proliferation enhancement,epithelial-to-mesenchymal transition,cell migration promotion,oncogene function,signaling pathway interaction
ENSG00000113658,SMAD5,receptor-regulated smad,tgf-β signaling pathway,aberrant cell growth,epigenetic regulation,oncogenic mutations,tumor progression
ENSG00000105698,USF2,regulation of gene expression,epithelial-to-mesenchymal transition,transcriptional activation,cell survival,cancer stem cell maintenance,chromatin remodeling
ENSG00000101138,CSTF1,tumor progression,oncogenic pathway activation,cell cycle regulation,genomic instability,rna processing regulation,protein-protein interaction
ENSG00000131462,TUBG1,microtubule regulation,cell cycle modulation,chromosomal instability,aneuploidy promotion,tumor progression,therapeutic target
ENSG00000101004,NINL,cell cycle regulation,apc/c activity,mitosis promotion,anaphase-promoting complex/cyclosome regulation,tumor suppressor degradation prevention,cdc16 interaction
ENSG00000120693,SMAD9,tumor suppressor function,tgf-β signaling pathway inhibition,cellular proliferation regulation,apoptosis induction,gene expression regulation,protein-protein interaction
ENSG00000158517,NCF1,oxidative stress,inflammation pathway,nadph oxidase regulation,phagocytosis dysfunction,immune response modulation,cancer progression
ENSG00000116701,NCF2,oncogenic process,reactive oxygen species production,oxidative stress modulation,nadph oxidase activation,dysregulation in cancer,protein interaction with p47phox<p67phox
ENSG00000137267,TUBB2A,microtubule dynamics,tumor progression,cell division regulation,biomarker potential,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000173273,TNKS,telomere maintenance,genomic instability,oncogenic pathway activation,cell death regulation,centrosome amplification,parp activity enhancement
ENSG00000147601,TERF1,telomere elongation,genome instability,tumor aggressiveness,proliferative advantage,oncogene overexpression,dna damage response
ENSG00000095739,BAMBI,tumor suppressor function,antagonist of tgf-beta pathway,downregulation in cancer,regulation of emt,cell growth inhibition,cancer progression
ENSG00000136754,ABI1,cell signaling,regulatory function,protein interactions,oncogenesis,cell proliferation,potential tumor suppressor
ENSG00000107643,MAPK8,constitutive activation,oncogenic driver,cell proliferation,chemotherapy resistance,signal transduction pathway,phosphorylation event
ENSG00000136827,TOR1A,protein quality control,cellular stress responses,protein misfolding,aaa+ atpase activity,hsp90 interaction network,none
ENSG00000108821,COL1A1,type i collagen production,angiogenesis promotion,metastasis facilitation,extracellular matrix remodeling,tumor progression marker,emt induction
ENSG00000164692,COL1A2,type i collagen expression,tumor progression facilitation,poor prognosis association,therapeutic target identification,epithelial-to-mesenchymal transition regulation,tgf-β pathway interaction
ENSG00000161800,RACGAP1,rac gtpase activation,cell migration regulation,cell invasion promotion,oncogenic signaling pathway modulation,tumor progression enhancement,aggressive tumor behavior
ENSG00000137807,KIF23,genomic instability,antimitotic therapy target,mitotic spindle regulation,cell cycle progression,chromosomal segregation,kinesin-related protein
ENSG00000078902,TOLLIP,nf-κb pathway modulation,adaptor protein interaction,cancer progression regulation,inflammation and immune response regulation,apoptosis modulation,signaling pathway regulation
ENSG00000117748,RPA2,dna repair,genomic instability,homologous recombination,non-homologous end joining,replication protein a complex,single-stranded dna binding
ENSG00000132383,RPA1,genomic instability,dna replication,mutational hotspot,cancer progression,dna damage response,tumor suppressor function
ENSG00000069702,TGFBR3,tumor suppression,loss of function mutations,cell growth regulation,smad signaling pathway,cell differentiation inhibition,tgf-beta pathway modulation
ENSG00000186871,ERCC6L,nucleotide excision repair,dna damage response,genomic instability,transcription-coupled repair,cancer driver mutation,dna repair protein
ENSG00000142319,SLC6A3,dopamine transport regulation,overexpression,cell proliferation,angiogenesis,metabolic reprogramming,oncogenic signaling
ENSG00000169083,AR,androgen receptor activation,epithelial-to-mesenchymal transition,aberrant transcription regulation,cell proliferation and survival,gene amplification and mutation,therapeutic target for anti-androgen therapies
ENSG00000196712,NF1,ras/mapk signaling pathway,tumor suppressor function,constitutive activation of ras,genomic instability,cell growth regulation,therapeutic target
ENSG00000136002,ARHGEF4,rho gtpase activation,cell migration,signaling pathway interaction,proliferation promotion,metastasis facilitation,prognosis correlation
ENSG00000126214,KLC1,microtubule-based transport,cell migration and invasion,oncogene,tumor progression,metastasis facilitation,protein-protein interaction
ENSG00000008294,SPAG9,pi3k/akt interaction,tumor progression marker,cell proliferation regulation,apoptosis inhibition,dna repair modulation,therapeutic target
ENSG00000169429,CXCL8,angiogenesis promotion,chemokine signaling,cell proliferation enhancement,tumor progression facilitation,metastasis induction,prognostic marker
ENSG00000180871,CXCR2,angiogenesis promotion,chemokine signaling,immune cell recruitment,oncogenic signaling,prognostic marker,tumor growth facilitation
ENSG00000115590,IL1R2,il1 receptor modulation,immune evasion mechanism,tumor progression,metastasis facilitation,prognostic marker,nf-κb pathway interaction
ENSG00000115008,IL1A,pro-inflammatory cytokine,tumor progression,immune evasion,constitutive activation,genetic amplification,molecular targeting
ENSG00000104312,RIPK2,necroptosis regulation,inflammation modulation,immune evasion mechanisms,tumor aggressiveness promotion,pro-tumorigenic microenvironment creation,therapeutic target identification
ENSG00000167207,NOD2,innate immunity modulation,pro-inflammatory cytokine production,nf-κb pathway activation,tumor microenvironment modulation,cell proliferation enhancement,immune evasion promotion
ENSG00000114315,HES1,notch signaling pathway,transcriptional repressor function,cell proliferation enhancement,tumor suppressor gene suppression,oncogenic role,notch pathway activation
ENSG00000044524,EPHA3,tumor suppression,signaling pathway regulation,cell migration regulation,angiogenesis promotion,immunoregulation interaction,genomic instability association
ENSG00000010017,RANBP9,cell cycle regulation,gene expression regulation,genomic instability,microtubule dynamics regulation,mrna export regulation,tumor progression
ENSG00000156052,GNAQ,gq signaling pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation regulation,oncogenic processes
ENSG00000105443,CYTH2,cellular respiration modulation,electron transfer chain regulation,oxidative stress response,energy production regulation,tumor progression association,therapeutic target potential
ENSG00000275338,RAB11FIP3,cell migration,endocytic recycling pathway,tumor progression,protein trafficking regulation,metastasis promotion,cancer cell invasion
ENSG00000103769,RAB11A,emt promoter,cell proliferation enhancer,genomic amplifier,mitotic regulator,growth factor receptor recycling,signaling pathway activator
ENSG00000140464,PML,chromatin remodeling,tumor suppressor function,p53 pathway modulation,genomic stability maintenance,transcriptional regulation disruption,prognostic marker
ENSG00000205250,E2F4,cell cycle regulation,transcriptional repression,tumor suppression,dna repair mechanisms,chromatin remodeling,apoptosis induction
ENSG00000074706,IPCEF1,gef protein interaction,cell cycle regulation,apoptosis regulation,cytoskeletal organization,rab gtpase activation,tumor suppressor potential
ENSG00000078043,PIAS2,stat signaling modulation,transcriptional regulation,ubiquitin ligase activity,cell proliferation control,oncogenic pathway modulation,cancer progression regulation
ENSG00000130779,CLIP1,microtubule regulation,cell division promotion,cytoskeleton reorganization,oncogenic potential,prognostic marker,therapeutic target
ENSG00000007168,PAFAH1B1,mitotic spindle regulation,chromosomal instability,cancer driver mutations,cell cycle dysregulation,tumor suppressor dysfunction,protein-protein interactions
ENSG00000125931,CITED1,cell cycle progression,transcriptional regulation,apoptosis inhibition,tumor aggressiveness,oncogene activation,angiogenesis promotion
ENSG00000109971,HSPA8,cellular proliferation,oncogenesis,cell cycle regulation,protein folding facilitation,metastasis promotion,apoptosis resistance
,SEPT1,microtubule dynamics regulation,oncogenic signaling,cell proliferation enhancement,tumor progression facilitation,cell cycle dysregulation,protein interaction modification
ENSG00000136280,CCM2,cell cycle regulation,dna repair mechanisms,genotoxic stress response,tumor growth promotion,amplication or mutation,prognostic marker
ENSG00000118689,FOXO3,tumor suppressor function,cell cycle regulation,apoptosis promotion,genomic stability maintenance,dna repair modulation,cancer progression prevention
ENSG00000070778,PTPN21,pi3k/akt/mtor pathway disruption,constitutive activation,loss of function mutations,cell cycle regulation,apoptosis inhibition,tumor suppressor interaction
ENSG00000075651,PLD1,cell signaling,metabolic regulation,oncogenesis,tumor progression,protein kinase activation,membrane dynamics
ENSG00000145242,EPHA5,epha5 expression,cell migration,pi3k/akt activation,tumor progression,metastasis promotion,emt induction
ENSG00000152284,TCF7L1,wnt/β-catenin signaling pathway,transcriptional regulation,gain of function mutations,tumor progression,oncogenic driver,genomic instability
ENSG00000059728,MXD1,transcriptional regulation,tumor progression,oncogene,chromatin remodeling,proliferation enhancement,apoptosis resistance
ENSG00000107295,SH3GL2,oncogene activation,protein-protein interactions,cell membrane trafficking,tumor progression,receptor internalization,signal transduction pathway
ENSG00000147010,SH3KBP1,cell survival promotion,oncogenic protein complex assembly,akt/mtor/erk pathway modulation,nf-κb activation,pro-oncogenic scaffolding function,phosphorylation-dependent regulation
ENSG00000160999,SH2B2,immune response regulation,jak/stat pathway interaction,oncogenic signaling,constitutive activation,tumor progression facilitation,cell survival promotion
ENSG00000178188,SH2B1,pi3k/akt pathway,oncogenic driver,cell proliferation,metastasis,signaling regulator,gene amplification
ENSG00000196655,TRAPPC4,vesicle formation,tumor progression,cell proliferation,protein-protein interaction,gene overexpression,poor prognosis
ENSG00000196498,NCOR2,transcriptional corepressor,cell cycle regulation,oncogenic process,therapeutic target,tumor progression,genetic regulation
ENSG00000101144,BMP7,tumor suppressive properties,epithelial-to-mesenchymal transition inhibition,pro-apoptotic gene expression,cell proliferation regulation,survival signaling pathway activation,immune response modulation
ENSG00000171243,SOSTDC1,wnt signaling pathway,constitutive activation,tumor suppressor function,cell proliferation regulation,oncogenic effects,genomic instability
ENSG00000248333,CDK11B,cell cycle regulation,chromatin remodeling,g2/m phase transition,histone modification,oncogenic processes,serine/threonine kinase activity
ENSG00000184937,WT1,tumor suppressor,loss-of-function mutations,cell proliferation,apoptosis regulation,transcriptional regulation,dna damage response
ENSG00000169047,IRS1,aberrant signaling pathway,oncogenic mutations,tumor growth promotion,cell survival enhancement,metabolic regulation disruption,insulin/igf-1 receptor interaction
ENSG00000071051,NCK2,signaling pathway regulation,cell proliferation enhancement,oncogenic mutation driver,tumor progression facilitation,protein-protein interaction,tyrosine kinase activation
ENSG00000069399,BCL3,genetic regulation,tumor progression,nf-κb pathway modulation,anti-apoptotic function,cell cycle regulation,transcriptional activation
ENSG00000037280,FLT4,angiogenic signaling pathway,constitutive activation,enhanced vascular permeability,increased cell proliferation,lymphatic metastasis,tyrosine kinase activity
ENSG00000150630,VEGFC,**
lymphangiogenesis,angiogenesis promotion,tumor progression marker,pro-angiogenic factor,metastasis enhancer,immune evasion mechanism 
**
ENSG00000124882,EREG,**
egfr/mapk/erk pathway,overexpression in cancer,cell proliferation,tumor progression,oncogenic potential,growth factor regulation
**
ENSG00000131558,EXOC4,cell proliferation enhancement,genomic instability induction,cell migration facilitation,pi3k/akt pathway interaction,vesicle fusion regulation,oncogenic protein overexpression
ENSG00000180104,EXOC3,cell proliferation,mitotic process,genomic instability,cancer cell migration,membrane trafficking,prognostic biomarker
ENSG00000151725,CENPU,genomic instability,chromosome segregation,aneuploidy,cell cycle progression,oncogenic processes,apoptosis resistance
ENSG00000160691,SHC1,oncogenic potential,signaling pathway modulation,cell growth regulation,immune response modulation,tumor progression contribution,apoptosis resistance enhancement
ENSG00000105701,FKBP8,genomic instability,apoptosis regulation,cell cycle modulation,protein chaperone regulation,tumor suppressor function,pi3k/akt pathway inhibition
ENSG00000185591,SP1,transcription factor activity,cell cycle regulation,apoptosis modulation,gene expression regulation,angiogenesis promotion,tumor growth support
ENSG00000269335,IKBKG,nf-κb signaling pathway,constitutive activation,gain of function mutations,tumor progression,apoptosis resistance,cell proliferation enhancement
ENSG00000145431,PDGFC,angiogenesis,cell proliferation,epithelial-to-mesenchymal transition (emt),oncogenic signaling pathway,tumor progression,metastasis
ENSG00000141052,MYOCD,regulation of epithelial-to-mesenchymal transition (emt),overexpression in bladder urothelial carcinoma (blca),interaction with srf transcription factor,modulation of cell proliferation and survival pathways,dysregulation contributes to tumorigenesis,association with tumor aggressiveness and metastasis
ENSG00000177565,TBL1XR1,transcriptional regulation,corepressor function,chromatin remodeling,tumor suppressor repression,constitutive activation,cancer progression
ENSG00000101849,TBL1X,histone deacetylase activity,tumor progression,transcriptional repression,gene expression regulation,protein-protein interactions,oncogenic potential
ENSG00000123159,GIPC1,wnt/β-catenin signaling,oncogene activation,scaffolding protein function,cell migration and proliferation,signaling pathway modulation,tumor growth and metastasis
ENSG00000058272,PPP1R12A,cell cycle regulation,protein phosphatase 1 activation,cell proliferation promotion,apoptosis suppression,g1-s phase transition modulation,therapeutic target
ENSG00000213639,PPP1CB,pp1 regulation,tumor suppressor activity,cell cycle progression,apoptosis modulation,oncogenic protein interaction,genetic alteration association
ENSG00000132604,TERF2,telomere maintenance,genomic instability,tumor progression,cell proliferation,anti-tumor therapy,chromosomal fusion
ENSG00000099956,SMARCB1,chromatin remodeling,gene expression regulation,tumor suppressor function,swi/snf complex component,genome instability,cell proliferation regulation
ENSG00000116604,MEF2D,tumor suppression,cell growth regulation,transcriptional regulation,apoptosis modulation,proliferation promotion,tumor progression
ENSG00000099991,CABIN1,negative regulator,akt/mtor pathway regulation,tumor suppressor function,genomic stability maintenance,cellular proliferation inhibition,oncogenic transformation prevention
ENSG00000162337,LRP5,wnt/β-catenin pathway activation,gain of function mutations,tumor progression,oncogenic signaling,protein-protein interaction,genomic instability
ENSG00000165197,VEGFD,vegf signaling pathway,anti-angiogenic activity,angiogenesis facilitation,tumor progression,therapeutic target,protein-protein interaction
ENSG00000147526,TACC1,microtubule stability,oncogene activation,cell proliferation enhancement,chemoresistance induction,aurora kinase a activation,pi3k/akt pathway modulation
ENSG00000100592,DAAM1,microtubule dynamics regulation,wnt signaling pathway activation,epithelial-to-mesenchymal transition (emt) promotion,cell migration and invasion facilitation,prognostic marker upregulation,oncogenic pathway dysregulation
ENSG00000073584,SMARCE1,chromatin remodeling,oncogene activation,epigenetic regulation,gene expression modulation,tumor progression enhancement,metastasis promotion
ENSG00000073282,TP63,cell cycle regulation,dna damage response,genomic instability,tumor suppressor function,apoptosis dysregulation,stemness and self-renewal
ENSG00000278114,MUC20,mucin family member,cell-cell adhesion,glycosylation pattern alteration,immune evasion mechanism,tumor progression driver,signaling pathway modulation
ENSG00000106991,ENG,angiogenesis promoter,cell proliferation enhancer,tumor progression facilitator,genetic alteration associated,vascular system regulator,oncogenic driver
ENSG00000115884,SDC1,cell adhesion disruption,tumor microenvironment interaction,e epithelial-to-mesenchymal transition (emt),growth factor receptor interaction,poor prognosis correlation,angiogenesis regulation
ENSG00000111664,GNB3,cell proliferation,signaling pathway regulation,tumor progression,dysregulated expression,mutations,g-protein interaction
ENSG00000167083,GNGT2,regulation of cellular processes,oncogenic signaling pathway,cell proliferation,protein-protein interaction,tumor progression,dysregulated expression
ENSG00000178573,MAF,oncogene activation,transcriptional regulation,cell proliferation inhibition,angiogenesis promotion,apoptosis suppression,poor prognosis biomarker
ENSG00000119335,SET,genomic instability,epigenetic regulation,oncogene overexpression,cell cycle regulation,chromatin remodeling,histone methylation
ENSG00000173801,JUP,altered expression,cell-cell adhesion,constitutive activation,epithelial integrity,tumor progression,wnt/β-catenin pathway
ENSG00000096696,DSP,tumor progression,cell adhesion regulation,oncogene upregulation,metastasis facilitation,extracellular matrix assembly,cell migration regulation
ENSG00000137834,SMAD6,tgf-β signaling pathway,inhibitory smad function,regulation of cell growth,dysregulation in cancer,oncogenesis and tumor progression,interaction with smad4 protein
ENSG00000183207,RUVBL2,genomic instability,chromatin remodeling,oncogene,aggressive disease,overexpression,cell cycle progression
ENSG00000173511,VEGFB,angiogenic promotion,tumor metastasis,poor prognosis,blood supply increase,cell proliferation,protein-protein interaction
ENSG00000150907,FOXO1,tumor suppressor dysfunction,genetic alterations,cell proliferation,apoptosis resistance,transcriptional regulation,therapeutic target
ENSG00000184371,CSF1,macrophage recruitment,tumor-associated macrophages,immune suppression,cancer metastasis,cell signaling pathway,ablation therapy
ENSG00000182578,CSF1R,tumor-associated macrophage recruitment,angiogenesis promotion,polarization of monocytes,immune evasion enhancement,pi3k/akt/mtor pathway activation,therapeutic target identification
ENSG00000166888,STAT6,transcriptional activation,constitutive phosphorylation,cell proliferation regulation,immune response modulation,tumor growth promotion,oncogenic target gene upregulation
ENSG00000173193,PARP14,epigenetic regulation,chromatin remodeling,oncogene overexpression,apoptosis resistance,immune evasion,metastatic potential
ENSG00000137265,IRF4,oncogene,tumor immune evasion,cell proliferation enhancement,constitutive activation,immune system regulation disruption,transcriptional activity modulation
ENSG00000050748,MAPK9,apoptosis regulation,cell proliferation enhancement,oncogene activation,tumor progression facilitation,pi3k/akt pathway activation,therapeutic target
ENSG00000072736,NFATC3,nfat signaling pathway,tumor progression,molecular signature,cell proliferation,wnt/β-catenin interaction,dna damage response
ENSG00000163956,LRPAP1,aberrant signaling,cell proliferation,endocytosis regulation,ldl receptor interaction,oncogenic driver,tumor progression
ENSG00000169856,ONECUT1,oncogene activation,transcriptional regulation,cell proliferation enhancement,chemoresistance induction,apoptosis suppression,epigenetic modification
ENSG00000276971,TRPV6,calcium channel regulation,oncogenic pathway activation,cell proliferation enhancement,metastasis facilitation,therapeutic target identification,calcium homeostasis disruption
ENSG00000109332,UBE2D3,ubiquitination pathway,tumor growth promotion,protein degradation regulation,cell cycle progression,oncogenic potential,therapeutic target
ENSG00000137841,PLCB2,pi3k/akt pathway,constitutive activation,oncogene overexpression,tumor progression,therapeutic target,cell signaling
ENSG00000163932,PRKCD,overexpression,apoptosis regulation,protein-protein interaction,phosphorylation regulation,cell survival pathway,tumor progression
ENSG00000116106,EPHA4,tumor invasion,receptor tyrosine kinase activity,cell adhesion disruption,metastasis promotion,pi3k/akt pathway activation,poor prognosis marker
ENSG00000118260,CREB1,cell proliferation,transcriptional regulation,oncogenesis,tumor progression,apoptosis evasion,inflammation pathway activation
ENSG00000204628,RACK1,pkc/akt/mtor pathway regulation,gain of function mutations,cell growth promotion,tumor progression enhancement,apoptosis resistance,signaling pathway modulation
ENSG00000115306,SPTBN1,cell adhesion disruption,cytoskeletal remodeling,epithelial-to-mesenchymal transition (emt),oncoprotein interaction,tumor aggressiveness,overexpression biomarker
ENSG00000177302,TOP3A,dna replication repair,genome instability,tumor progression,immunotherapy target,cancer-specific mutations,biomarker potential
ENSG00000197299,BLM,genomic instability,chromosomal aberrations,dna damage response,oncogenic mutations,homologous recombination repair,gain of function mutations
ENSG00000162772,ATF3,**
apoptosis induction,cell cycle regulation,dna damage response,genome stability maintenance,protein-protein interactions,tumor suppression 
**
ENSG00000108262,GIT1,git1 overexpression,promotes tumor progression,regulates cell adhesion,pi3k/akt pathway,enhances cell motility,emt modulation
ENSG00000102606,ARHGEF7,rho gtpase activation,cancer cell motility,cellular invasion,guanine nucleotide exchange factor,epithelial-to-mesenchymal transition,tumor progression
ENSG00000138039,LHCGR,lhr activation,mapk/erk pathway activation,pi3k/akt pathway involvement,cell proliferation enhancement,tumor progression facilitation,therapeutic target status
ENSG00000284901,RUVBL1,chromatin remodeling,genomic instability,oncogene interaction,gene expression regulation,dna repair disruption,tumor progression
ENSG00000183337,BCOR,genomic instability,chromatin remodeling,histone modification,gene expression regulation,cell cycle regulation,apoptosis inhibition
ENSG00000171450,CDK5R2,cell cycle regulation,genomic instability,oncogenic pathway,cell proliferation,survival signaling,tumor suppressor regulation
ENSG00000121022,COPS5,tumor suppressor function,protein stabilization,cell proliferation regulation,ubiquitin-proteasome pathway modulation,nf-kb signaling cascade interaction,gain-of-function mutations
ENSG00000154473,BUB3,mitotic checkpoint regulation,chromosome segregation error,apoptosis evasion,ploidy alterations,prognostic marker,cancer cell survival
ENSG00000169679,BUB1,cell cycle regulation,checkpoint protein,genomic instability,chromosome segregation,mitosis regulation,tumor suppressor gene
ENSG00000164342,TLR3,tlr3 activation,inflammatory response,immune modulation,prognostic marker,epigenetic regulation,nf-kappab signaling
ENSG00000127666,TICAM1,nf-κb signaling,innate immunity,cell survival,tumor progression,pi3k/akt interaction,inflammation regulation
ENSG00000171552,BCL2L1,apoptosis inhibition,cell survival,tumor progression,mitochondrial outer membrane permeabilization,oncogenesis promotion,therapeutic resistance
ENSG00000069966,GNB5,signaling pathway regulation,gβ5 subunit function,cellular signal transduction,oncogenic signaling activation,tumor suppressor protein interaction,apoptosis resistance
ENSG00000131788,PIAS3,stat3 regulation,tumor suppressor function,cell survival regulation,gene expression modulation,ubiquitin ligase activity,apoptosis regulation
ENSG00000282130,NSMCE3,proteasome regulation,tumor suppressor gene,dna repair mechanism,genomic instability,apoptosis regulation,cancer progression marker
ENSG00000101412,E2F1,cell cycle regulation,transcriptional regulation,oncogenesis,cell proliferation,apoptosis regulation,genomic instability
ENSG00000170962,PDGFD,cellular proliferation,epithelial-to-mesenchymal transition,angiogenesis,tumor progression,metastasis,genomic alterations
ENSG00000134954,ETS1,angiogenesis promotion,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,transcription factor activity,pro-angiogenic gene regulation,hypoxia-induced gene expression
ENSG00000161888,SPC24,cell cycle regulation,genomic instability,microtubule dynamics,mitosis regulation,aneuploidy induction,spindle assembly errors
ENSG00000080986,NDC80,genomic instability,tumor progression,chromosome segregation,kinetochore assembly,microtubule attachment,anti-apoptotic activity
ENSG00000185737,NRG3,signaling pathway activation,oncogene expression,cell proliferation regulation,tumor progression driver,epidermal growth factor family member,therapeutic target
ENSG00000182957,SPATA13,endosomal sorting,cell membrane trafficking,overexpression,oncogenic driver,emt regulator degradation,signaling pathway interaction
ENSG00000112062,MAPK14,cellular stress response,tumor aggressiveness,protein phosphorylation,transcriptional regulation,cell proliferation,oncogenesis
ENSG00000131196,NFATC1,cellular proliferation,transcriptional regulation,tumor growth promotion,survival pathway modulation,oncogene activation,genomic instability
ENSG00000081189,MEF2C,loss of transcriptional function,tumor suppressor gene,cell cycle regulation,apoptosis suppression,epithelial-to-mesenchymal transition,chromatin remodeling
ENSG00000170289,CNGB3,cgmp-gated channel regulation,cell proliferation regulation,visual transduction pathway,autosomal dominant retinitis pigmentosa,bladder urothelial carcinoma,regulation of cgmp levels
ENSG00000144191,CNGA3,regulation of chloride channels,constitutive activation,oncogene potential,cell proliferation,cellular migration,hyperactivation of pathways
ENSG00000105221,AKT2,pi3k/akt signaling,constitutive activation,oncogenesis,cell proliferation,metabolic regulation,tumor progression
ENSG00000135547,HEY2,cell cycle regulation,tumor progression,transcriptional regulation,oncogenic driver,metastasis promotion,apoptosis inhibition
ENSG00000133216,EPHB2,epithelial-to-mesenchymal transition,receptor tyrosine kinase activation,tumor progression,metastasis promotion,therapeutic target,tissue invasion
ENSG00000157933,SKI,tgf-β pathway dysregulation,oncogenic transcriptional co-activator,cell proliferation enhancement,tumor progression facilitation,prognostic marker,genomic amplification
ENSG00000150593,PDCD4,loss of function mutations,tumor suppression,apoptosis regulation,cell cycle progression inhibition,genomic instability protection,oncogenic pathway regulation
ENSG00000196961,AP2A1,cell cycle regulation,apoptosis dysregulation,tumor suppressor activation,protein phosphatase activity,cell signaling modulation,transcriptional regulation
ENSG00000161203,AP2M1,endocytic regulation,mapk signaling activation,oncogenic driver mutation,tumor growth promotion,cell surface receptor internalization,cancer therapeutic target
ENSG00000147044,CASK,chromatin remodeling,cell adhesion regulation,oncogenic signaling inhibition,tumor suppressor function,genome stability maintenance,transcriptional regulation modulation
ENSG00000158458,NRG2,immunosuppression,tumor progression,cell proliferation,erbb4 signaling pathway,pi3k/akt/mtor pathway,oncogenesis
ENSG00000188130,MAPK12,mapk/erk signaling,proliferation regulation,oncogenic transformation,cell growth regulation,survival pathways,therapeutic target
ENSG00000101400,SNTA1,oncogenic signaling pathway regulation,cell proliferation enhancement,tumor progression facilitation,biomarker potential,cancer cell migration promotion,protein-protein interaction with oncogenes
ENSG00000186625,KATNA1,proteasome assembly,cell cycle regulation,dna damage response,tumor suppressor downregulation,genomic instability,apoptosis inhibition
ENSG00000125538,IL1B,pro-inflammatory cytokine,immune evasion,angiogenesis promotion,cancer stem cell regulation,epithelial-to-mesenchymal transition,poor prognosis marker
ENSG00000097007,ABL1,oncogenic transformation,bcr-abl fusion,cell proliferation,tyrosine kinase activation,signaling pathway regulation,genetic mutation
ENSG00000187555,USP7,deubiquitinating enzyme function,ar pathway modulation,tumor growth promotion,protein stabilization,oncogene interaction,signaling pathway regulation
ENSG00000206279,DAXX,genomic instability,tumor suppressor function,telomere maintenance,chromatin remodeling,heterochromatin formation,dna repair regulation
ENSG00000061273,HDAC7,chromatin remodeling,epigenetic regulation,oncogene activation,tumor suppressor silencing,cell proliferation,therapeutic target
ENSG00000130726,TRIM28,tumor suppressor function,genomic instability,cell cycle regulation,dna damage repair,epigenetic modification,protein stability regulation
ENSG00000144485,HES6,emt regulation,oncogenic transcription factor,cancer cell stemness,poor prognosis marker,tumor progression driver,transcriptional regulation
ENSG00000123124,WWP1,oncogenic regulation,pi3k/akt pathway modulation,ubiquitin ligase activity,substrate degradation,poor prognosis association,emt regulation
ENSG00000138755,CXCL9,immune surveillance,tumor microenvironment modulation,chemokine signaling pathway,t-cell activation,cell recruitment,prognostic marker
ENSG00000179348,GATA2,loss of transcriptional repression,genomic instability,tumor suppressor dysfunction,epigenetic regulation,transcription factor aberration,cell proliferation enhancement
ENSG00000164362,TERT,telomere maintenance,immortalizing cells,telomerase activity,tumor progression,genetic instability,oncogenic driver
ENSG00000044115,CTNNA1,cell-cell adhesion disruption,loss of function mutations,wnt/β-catenin pathway dysregulation,epithelial-to-mesenchymal transition (emt),tumor suppressor activity,cancer cell migration and invasion
ENSG00000068903,SIRT2,deacetylation,histone modification,cell survival,apoptosis inhibition,chromosomal stability,tumor progression
ENSG00000253293,HOXA10,regulation of emt,oncogenic activity,upregulation in cancer tissues,interaction with transcription factors,prognostic biomarker,cell cycle regulation
ENSG00000121671,CRY2,genomic instability,cell cycle regulation,dna damage response,circadian rhythm disruption,protein-protein interaction,tumor suppressor function
ENSG00000072803,FBXW11,aberrant expression,cell cycle regulation,loss of function mutation,protein degradation,scf complex interaction,tumor suppressor dysfunction
ENSG00000184481,FOXO4,tumor suppressor activity,cell cycle regulation,apoptosis modulation,akt pathway interaction,mapk signaling involvement,phosphorylation-dependent regulation
ENSG00000160014,CALM3,calcium signaling disruption,tumor progression,cell survival enhancement,signaling pathway dysregulation,oncogenic mutations,protein-protein interactions
ENSG00000172020,GAP43,cell migration,constitutive activation,metastasis,cell proliferation,cytoplasmic localization,signaling pathway modulation
ENSG00000113712,CSNK1A1,wnt/β-catenin signaling,constitutive activation,phosphorylation of p53 and brca1,cell proliferation enhancement,tumor development modulation,therapeutic target
ENSG00000100567,PSMA3,proteasome regulation,constitutive activation,cell cycle progression,apoptosis inhibition,tumor growth promotion,genetic instability
ENSG00000126561,STAT5A,constitutive activation,oncogenic transcription factor,gain of function mutations,tumor aggressiveness,cell proliferation,survival signaling pathway
ENSG00000092820,EZR,cell migration,cell surface structure,tumor progression,cell polarity regulation,epithelial-to-mesenchymal transition,adhesion complex formation
ENSG00000065717,TLE2,wnt/β-catenin signaling pathway,transcriptional repression,co-repressor function,cell proliferation regulation,tumor suppressor gene regulation,biomarker potential
ENSG00000120798,NR2C1,nr2c1,nuclear receptor signaling,tumor progression,promoter hypermethylation,gene expression profiling,cell cycle regulation
ENSG00000075711,DLG1,cellular adhesion disruption,egfr signaling pathway,oncogenic process activation,epithelial-to-mesenchymal transition,protein-protein interaction regulation,cell growth enhancement
ENSG00000253729,PRKDC,genomic instability,aberrant dna repair,cell cycle regulation,dna double-strand breaks,nhej pathway,tumor progression
ENSG00000152457,DCLRE1C,genomic instability,dna repair pathway,apoptosis regulation,cell cycle modulation,therapeutic target,protein-protein interactions
ENSG00000288401,CTTN,cortactin overexpression,actin dynamics regulation,cell migration enhancement,metastasis promotion,prognostic marker,therapeutic target
ENSG00000131910,NR0B2,oncogenic process,cell survival enhancement,tumor progression modulation,signaling pathway regulation,transcription factor interaction,coactivator function
ENSG00000185950,IRS2,insulin signaling pathway,oncogenic function,pi3k/akt interaction,aerobic glycolysis,cell survival enhancement,glucose metabolism regulation
ENSG00000140044,JDP2,p53 suppression,transcriptional repression,oncogenic process promotion,tumorigenesis association,co-repressor interaction,cellular behavior modulation
ENSG00000124440,HIF3A,vegf signaling,hypoxia adaptation,oncogene activation,glucose metabolism regulation,angiogenesis promotion,tumor progression facilitation
ENSG00000169071,ROR2,aberrant signaling,activates downstream effectors,cell growth and survival enhancement,oncogenic transformation,wnt/β-catenin pathway regulation,transmembrane receptor tyrosine kinase activation
ENSG00000143384,MCL1,apoptosis regulation,anti-apoptotic protein,oncogenic potential,chemoresistance,tumor progression,mitochondrial integrity
ENSG00000079841,RIMS1,mitochondrial dynamics,cell survival promotion,metabolic adaptation,warburg effect modulation,calcium signaling regulation,tumor progression enhancement
ENSG00000198722,UNC13B,vesicle fusion regulation,pi3k/akt pathway modulation,oncogenic signaling,cell proliferation enhancement,therapeutic targeting potential,stress response regulation
ENSG00000140009,ESR2,estrogen receptor activation,constitutive activation,transcriptional regulation,cell proliferation,apoptosis resistance,tumor progression
ENSG00000131981,LGALS3,oncogenic signaling,overexpression,tumor progression,autophagy regulation,cancer cell survival,promoter methylation
ENSG00000147099,HDAC8,epigenetic regulation,chromatin remodeling,protein deacetylation,cell cycle progression,tumor aggressiveness,therapeutic target
ENSG00000198952,SMG5,nmd pathway regulation,oncogenic mrna stabilization,tumor suppressor gene suppression,cell proliferation enhancement,metastatic potential increase,therapeutic target
ENSG00000056558,TRAF1,nf-kappa b pathway,gain-of-function mutations,tumor progression,survival signal,immune evasion,proliferation enhancement
ENSG00000138964,PARVG,androgen regulation,prostate tissue expression,cell proliferation pathways,oncogenesis potential,transcriptional modulation,low or absent expression outside prostate
ENSG00000198901,PRC1,chromatin remodeling,transcriptional regulation,tumor suppression,oncogenic process,genomic instability,protein-protein interaction
ENSG00000140350,ANP32A,chromatin remodeling,histone phosphorylation,oncogenic transcriptional regulation,cell cycle progression,epigenetic regulation,dna repair
ENSG00000182636,NDN,genomic instability,dna repair mechanisms,cell cycle regulation,epigenetic modifications,transcriptional control,therapeutic target
ENSG00000160633,SAFB,transcriptional regulation,epigenetic modulation,tumor progression,cell cycle regulation,genomic instability,oncogene overexpression
ENSG00000089220,PEBP1,pi3k/akt pathway interaction,gene amplification,protein overexpression,tumor progression,signature protein,pathway regulation
ENSG00000281766,RYBP,tumor suppressor function,chromatin remodeling,transcriptional repression,epigenetic regulation,cellular homeostasis,signaling pathway regulation
ENSG00000027869,SH2D2A,tumor suppressor,immune response regulation,cell growth inhibition,phosphatidylinositol 3-kinase activation,pi3k/akt pathway modulation,protein kinase b regulation
ENSG00000169967,MAP3K2,mapk pathway dysregulation,jnk and p38 mapk activation,oncogene activation,cell survival enhancement,tumor progression facilitation,aberrant expression pattern
ENSG00000065618,COL17A1,basement membrane formation,cell-cell adhesion,epithelial-to-mesenchymal transition (emt),oncogenic processes,poor prognosis association,tumor progression
ENSG00000139687,RB1,cell cycle regulation,tumor suppression,genomic instability,loss of heterozygosity,g1/s checkpoint regulation,protein-protein interaction
ENSG00000118971,CCND2,cell cycle progression,tumor aggressiveness,cancer cell proliferation,oncogene overexpression,gene amplification,therapeutic target
ENSG00000160791,CCR5,immune modulation,tumor microenvironment,cell proliferation,therapeutic target,signal transduction,epigenetic regulation
ENSG00000197386,HTT,cell cycle regulation,epigenetic regulation,apoptosis modulation,autophagy induction,histone modification,ubiquitin-proteasome system regulation
ENSG00000106211,HSPB1,heat shock protein function,tumor suppressor activity,oncogene potential,cell growth regulation,apoptosis inhibition,signaling pathway interaction
ENSG00000014216,CAPN1,calcium-dependent proteolysis,oncogenic signaling,cell growth regulation,tumor progression,therapeutic target,proteolytic activation
ENSG00000126247,CAPNS1,calpain activation,cell growth regulation,metastasis promotion,tumor progression marker,proteolytic activity modulation,cancer driver gene
ENSG00000184500,PROS1,**
coagulation pathway,angiogenesis,thrombin generation,tumor microenvironment modulation,gain of function mutations,protein-protein interaction 
**
ENSG00000110711,AIP,ahr pathway inhibition,apoptosis regulation,cell cycle control,dna damage response,tumor suppressor function,genetic mutation impact
ENSG00000162909,CAPN2,tumor progression,oncogenic process,cell proliferation,proteolytic activity,cell survival pathway,apoptosis regulation
ENSG00000141655,TNFRSF11A,oncogenic function,immune evasion,tumor progression,metastasis promotion,cancer stem cell maintenance,genetic amplification
ENSG00000120659,TNFSF11,immune suppression,osteoclast differentiation,epithelial-to-mesenchymal transition (emt),tumor metastasis,prognostic marker,bone resorption
ENSG00000171476,HOPX,cell cycle regulation,chromatin remodeling,tumor suppressor function,transcriptional regulation,apoptosis induction,protein-protein interaction
ENSG00000259384,GH1,gh stimulation,cell proliferation,jak/stat pathway activation,tumor progression,angiogenesis promotion,apoptosis suppression
ENSG00000110934,BIN2,notch signaling regulation,cell adhesion regulation,tumor suppressor function,oncogene potential,apoptosis modulation,amyloid precursor protein interaction
ENSG00000048052,HDAC9,tumor suppressor gene regulation,histone deacetylation,chromatin remodeling,cancer cell proliferation,prognostic biomarker,epigenetic regulation
ENSG00000198821,CD247,tcr signaling pathway dysregulation,immune response modulation,tumor microenvironment regulation,prognostic marker,therapeutic target,none
ENSG00000204217,BMPR2,tgf-β/bmp signaling pathway,aberrant activation,loss of function mutations,cell proliferation,tumor progression,therapeutic target
ENSG00000107779,BMPR1A,tumor suppressor,bmp signaling pathway,cell growth regulation,apoptosis regulation,angiogenesis inhibition,therapeutic target
ENSG00000140443,IGF1R,tumor progression,angiogenesis,constitutive activation,oncogenic signaling,cell proliferation,receptor tyrosine kinase
ENSG00000136603,SKIL,genomic instability,mitotic spindle assembly,kinetochore complex regulation,chromosome segregation,sister chromatid attachment,aneuploidy
ENSG00000168398,BDKRB2,cell proliferation,g-protein coupled receptor,poor prognosis,tumor growth,metastasis,angiogenesis
ENSG00000170581,STAT2,immune regulation,oncogenic transformation,antiviral response modulation,cell growth regulation,tumor immunity enhancement,jak/stat pathway activation
ENSG00000159692,CTBP1,wnt/β-catenin signaling pathway activation,cell proliferation promotion,tumor progression facilitation,oncogenic function implicated,epigenetic regulation alteration,transcriptional co-repressor role
ENSG00000285109,GATA4,transcription factor activity,oncogene activation,cell proliferation promotion,tumor progression enhancement,metastasis facilitation,prognostic marker
ENSG00000183072,NKX2-5,overexpression,transcriptional regulation,cell proliferation,apoptosis inhibition,emt modulation,oncogenic potential
ENSG00000003402,CFLAR,apoptosis regulation,chemoresistance,tumor growth promotion,cell survival enhancement,signaling pathway interaction,therapeutic target
ENSG00000111348,ARHGDIB,rho gtpase regulation,gdi activity inhibition,oncogenesis promotion,cell migration increase,rhoa activation reduction,cellular proliferation enhancement
ENSG00000067560,RHOA,constitutive activation,gain of function mutations,cell migration,tumor progression,therapeutic target,signaling pathway
ENSG00000141456,PELP1,transcriptional regulation,gene overexpression,tumor progression,protein-protein interaction,oncogenic transformation,cellular proliferation
ENSG00000163599,CTLA4,immune checkpoint inhibition,tumor evasion mechanisms,impaired antigen presentation,modulation of t cell activation,dysregulation in cancer immunology,cell survival and proliferation pathways
ENSG00000065361,ERBB3,receptor tyrosine kinase,constitutive activation,loss of negative regulation,tumor progression,therapeutic target,cell proliferation
ENSG00000196132,MYT1,oncogene activation,transcriptional regulation,cell proliferation enhancement,wnt signaling pathway interaction,epigenetic modification,chromatin remodeling
ENSG00000186951,PPARA,regulatory mechanism,lipid metabolism regulation,cellular response modulation,tumor suppressor activity promotion,therapeutic target potential,nf-κb pathway interaction
ENSG00000185291,IL3RA,epithelial-to-mesenchymal transition,cell proliferation enhancement,tumor progression,prognostic marker,signaling pathway activation,immune response modulation
ENSG00000174697,LEP,lep/lepr signaling,tumor progression,cell proliferation,epithelial-to-mesenchymal transition (emt),angiogenesis,therapeutic target
ENSG00000101773,RBBP8,genomic instability,tumor progression,dna repair regulation,cancer cell invasion,apoptosis regulation,chromatin remodeling interaction
ENSG00000135218,CD36,angiogenesis facilitation,cell adhesion molecule,lipid metabolism regulation,metastasis promotion,tumor progression facilitation,prognostic biomarker
ENSG00000128245,YWHAH,pi3k interaction,oncogenesis driver,cell survival regulation,metabolic modulation,prognostic biomarker,tumor aggressiveness predictor
ENSG00000159110,IFNAR2,type i interferon signaling,immune evasion,tumor suppression,cell proliferation regulation,cancer immunity dysfunction,genomic instability
ENSG00000080839,RBL1,chromatin regulation,dna damage response,cell cycle arrest,tumor suppressor function,loss of heterozygosity,proliferation control
ENSG00000116044,NFE2L2,transcriptional regulator,oxidative stress response,detoxification pathway upregulation,chemoresistance promotion,tumorigenesis regulation,epigenetic modification
ENSG00000079999,KEAP1,tumor suppressor function,nrf2 regulation,cell survival pathways,oxidative stress modulation,cancer driver gene,genetic alteration significance
ENSG00000164690,SHH,shh signaling pathway,constitutive activation,tumor progression,angiogenesis,epithelial-to-mesenchymal transition (emt),cell growth regulation
ENSG00000144891,AGTR1,g protein-coupled receptor,tumor growth promotion,mapk/erk pathway activation,cell migration regulation,pro-inflammatory cytokine production,renin-angiotensin system activation
ENSG00000121966,CXCR4,cxcl12 ligand interaction,g-protein coupled receptor,tumor metastasis,constitutive activation,akt signaling pathway,angiogenesis regulation
ENSG00000134480,CCNH,genomic instability,cell cycle progression,oncogene activation,transcriptional regulation,therapeutic target,protein kinase activation
ENSG00000134058,CDK7,cell cycle regulation,cancer driver mutation,transcriptional activation,cell proliferation,uncontrolled growth,genomic instability
ENSG00000123908,AGO2,microrna regulation,tumor suppressor gene suppression,oncogenic pathway promotion,pi3k/akt signaling interaction,mapk/erk pathway modulation,cell proliferation enhancement
ENSG00000100697,DICER1,mirna processing,loss-of-function mutations,oncogenic mirnas accumulation,epithelial-to-mesenchymal transition,cell proliferation enhancement,genomic instability
ENSG00000016490,CLCA1,clca1 function,ion transport regulation,cell adhesion modulation,tumor progression promotion,poor prognosis association,immune evasion interaction
ENSG00000164078,MST1R,oncogenic driver,tumor progression,pi3k/akt/mtor pathway activation,cell growth promotion,metastasis facilitation,therapeutic target
ENSG00000168028,RPSA,ribosomal regulation,rna binding,cell proliferation,oncogenic processes,signal transduction,biomarker
ENSG00000151914,DST,microtubule regulation,cell adhesion modulation,tumor invasion promotion,protein aggregation induction,chaperone function loss,akt/pi3k pathway interaction
ENSG00000178209,PLEC,epithelial-to-mesenchymal transition,overexpression,glycocalyx formation,cancer cell migration,plectin-interacting proteins,cytoskeletal protein functions
ENSG00000136238,RAC1,gain of function mutations,constitutive activation,cell proliferation,metastasis promotion,tumor progression,therapeutic target
ENSG00000112851,ERBIN,cell surface receptor regulation,oncogene activation,egfr signaling pathway modulation,cell proliferation enhancement,cytoplasmic adaptor function,tumorigenesis promotion
ENSG00000026025,VIM,emt process,cell migration,tumor progression,prognostic marker,epithelial-to-mesenchymal transition,cell adhesion modulation
ENSG00000177697,CD151,integrin regulation,cell adhesion,tumor progression,metastasis facilitation,angiogenesis promotion,prognostic marker
ENSG00000176105,YES1,tumor promotion,overexpression,pi3k/akt activation,cell proliferation,oncogenic protein interaction,biomarker for disease progression
ENSG00000134308,YWHAQ,pi3k/akt pathway modulation,oncogenic transformation,cell cycle regulation,apoptosis suppression,signal transduction,therapeutic target
ENSG00000242372,EIF6,translation initiation,mrna stabilization,oncogene translation,cell survival enhancement,pi3k/akt pathway modulation,cancer therapeutic target
ENSG00000166813,KIF7,motor protein regulation,tumor progression,microtubule dynamics,cell division regulation,mitotic spindle assembly,overexpression
ENSG00000117425,PTCH2,tumor suppressor,constitutive activation,genomic instability,hedgehog signaling pathway,therapeutic target,cellular growth regulation
ENSG00000173020,GRK2,**
g protein-coupled receptor signaling,receptor tyrosine kinase regulation,cell survival enhancement,oncogenic process promotion,tumorigenesis association,subcellular localization modulation
**
ENSG00000157540,DYRK1A,cell cycle progression,overexpression,oncogene,dna replication,kinase activity,pi3k/akt pathway interaction
ENSG00000163482,STK36,wnt/β-catenin signaling pathway,oncogenic processes,cell proliferation regulation,serine/threonine kinase activity,dna damage response modulation,cancer progression facilitation
ENSG00000235568,NFAM1,tumor progression,coactivator function,cell proliferation,transcriptional regulation,oncogenic transformation,genomic instability
ENSG00000115085,ZAP70,oncogenic driver,non-receptor tyrosine kinase,tumor progression,immune evasion,cell proliferation,signal transduction
ENSG00000165025,SYK,constitutive activation,oncogenic process,tyrosine kinase activity,immune evasion,cell survival and proliferation,non-receptor tyrosine kinase interaction
ENSG00000111859,NEDD9,tumor progression,cell migration,metastasis promotion,apoptosis resistance,signaling pathway regulation,protein-protein interaction
ENSG00000115935,WIPF1,microtubule regulation,tumor progression,chromosomal instability,aneuploidy regulation,cell cycle modulation,p53 interaction
ENSG00000116473,RAP1A,mapk/erk pathway regulation,gtp-binding protein function,tumor progression enhancement,cell proliferation promotion,mutation involvement,emt regulation
ENSG00000068831,RASGRP2,rap1 activation,cell survival promotion,tumor progression driver,immune evasion mediator,calmodulin interaction,gtpase regulation
ENSG00000110448,CD5,tumor progression,metastatic potential,aggressive tumor behavior,microenvironment modulation,therapeutic resistance,cell proliferation
ENSG00000155926,SLA,cell adhesion regulation,pi3k/akt signaling,protein kinase activation,cell migration modulation,apoptosis inhibition,tumor progression driver
ENSG00000113263,ITK,t-cell signaling,oncogenic driver,protein tyrosine kinase activation,pi3k/akt pathway activation,cell proliferation regulation,immune evasion mechanism
ENSG00000160856,FCRL3,immune evasion,b-cell receptor modulation,cell survival enhancement,tumor progression facilitation,protein-protein interaction regulation,aberrant signaling pathway activation
ENSG00000154016,GRAP,cellular signaling,src family kinase interaction,metastasis promotion,tumor progression,survival pathway regulation,proliferation enhancement
ENSG00000141293,SKAP1,wnt/β-catenin pathway,cell migration,oncogenic adaptation,tumor progression,therapeutic target,signaling regulation
ENSG00000172575,RASGRP1,rap1 activation,cell adhesion modulation,epithelial-to-mesenchymal transition (emt),tumor aggressiveness,cancer cell motility,small gtpase regulation
ENSG00000079805,DNM2,enhanced cell migration,tumor progression,biomarker potential,resistance to chemotherapy,membrane trafficking regulation,cell division regulation
ENSG00000198286,CARD11,nf-κb pathway activation,oncogenic signaling,tumor cell proliferation,cell migration promotion,immune evasion,pro-inflammatory response
ENSG00000139436,GIT2,gtp-binding protein regulation,cell adhesion modulation,tumor suppressor activity,epithelial cell junction maintenance,polarity regulation,emt inhibition
ENSG00000125753,VASP,actin cytoskeleton regulation,cell migration facilitation,invasive capabilities enhancement,metastasis promotion,oncogenic process involvement,tumor progression support
ENSG00000154380,ENAH,cell motility enhancement,cytoskeletal reorganization,cell adhesion disruption,metastatic potential increase,apoptosis evasion,tumor progression facilitation
ENSG00000196405,EVL,actin cytoskeleton regulation,cell adhesion modulation,cell migration promotion,cancer progression marker,genomic instability inducer,protein-protein interaction hotspot
ENSG00000232575,TUBB,microtubule dysregulation,angiogenesis promotion,metastasis facilitation,cell cycle progression,chemotherapy resistance,genomic instability
ENSG00000070159,PTPN3,tumor suppressor inhibition,oncogene activation,protein tyrosine dephosphorylation,cell proliferation regulation,signaling pathway modulation,therapeutic target
ENSG00000108861,DUSP3,dephosphorylation of map kinases,tumor progression,overexpression in cancer,map kinase regulation,therapeutic target,cell survival promotion
ENSG00000163519,TRAT1,pi3k/akt pathway activation,cell migration and invasion,oncogene overexpression,tumor progression,genomic instability,protein-protein interactions
ENSG00000127947,PTPN12,negative regulation,oncogenic pathway regulation,tumor suppressor function,dephosphorylation,cell growth inhibition,interactions with dna repair mechanisms
ENSG00000074966,TXK,txk overexpression,cell proliferation,protein kinase activation,mapk/erk pathway,oncogenesis,cell survival
ENSG00000185499,MUC1,cell surface protein,epithelial protection,oncogenic signaling,mucin overexpression,immune suppression,tumor progression
ENSG00000015285,WAS,cell signaling pathway,actin cytoskeleton regulation,oncogenesis,metastasis,therapeutic target,apoptosis regulation
ENSG00000005020,SKAP2,src family kinases regulation,guanine nucleotide exchange factor interaction,scaffolding protein function,cancer driver gene potential,cell proliferation promotion,mutation involvement
ENSG00000115053,NCL,autophagy regulation,cellular stress response,dna damage repair,lysosomal trafficking,oncogenic mutations,protein degradation
ENSG00000109103,UNC119,cellular trafficking,guanine nucleotide exchange factor,membrane transport regulation,oncogenic protein trafficking,tumor progression promotion,vesicle docking facilitation
ENSG00000101082,SLA2,cell proliferation,genomic instability,epithelial-to-mesenchymal transition (emt),cytoskeleton regulation,oncogenic process promotion,cell adhesion disruption
ENSG00000095370,SH2D3C,cell proliferation regulation,tumor progression involvement,apoptosis modulation,signaling pathway regulation,oncoprotein association,protein interaction domain
ENSG00000107338,SHB,pi3k/akt pathway activation,protein-protein interaction,cell signaling regulation,oncogenic process promotion,tumor aggressiveness increase,cellular response alteration
ENSG00000127824,TUBA4A,microtubule dynamics regulation,oncogenic transformation,cell proliferation enhancement,apoptosis resistance,invasive potential increase,microtubule stabilization
ENSG00000134215,VAV3,gef activity,cancer progression,molecular regulation,tumor microenvironment,immune response modulation,prognostic marker
ENSG00000023892,DEF6,genomic instability,tumor suppressor function,cell cycle regulation,pi3k/akt pathway modulation,dna repair interactions,protein-protein interactions
ENSG00000198087,CD2AP,cell adhesion regulation,pi3k/akt pathway activation,tumor progression,metastasis promotion,overexpression association,cell migration regulation
ENSG00000122188,LAX1,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition (emt),oncogene activation,gene overexpression,dna repair dysregulation,tumor progression and metastasis
ENSG00000080031,PTPRH,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,tumor suppressor activity,loss-of-function mutations,signaling pathway regulation,angiogenesis modulation
ENSG00000113594,LIFR,ligand activation,tumor progression,cellular survival,signaling pathway modulation,apoptosis inhibition,cancer-related upregulation
ENSG00000198793,MTOR,cellular proliferation,constitutive activation,gain of function mutations,metabolic reprogramming,oncogenic driver,therapeutic target
ENSG00000099985,OSM,epithelial-to-mesenchymal transition,immunosuppression,angiogenesis promotion,tumor progression facilitation,cytokine regulation,mitogen-activated protein kinase activation
ENSG00000276536,HRAS,**

* **constitutive activation**,* **gain of function mutations**,* **cell proliferation**,* **tumor progression**,* **protein kinase activation**,* **signaling pathway dysregulation**
* **oncogenic transformation**
ENSG00000121853,GHSR,growth factor regulation,metabolic regulation,cell survival promotion,pi3k/akt pathway activation,wnt/β-catenin signaling modulation,tumor progression enhancement
ENSG00000124089,MC3R,cell proliferation,melanocortin signaling pathway,cancer metastasis,glycogen phosphorylase activation,somatic mutations,amino acid regulation
ENSG00000184845,DRD1,pi3k/akt pathway,cell proliferation,mitochondrial localization,dopaminergic signaling,opioid receptor interaction,tumor progression
ENSG00000147246,HTR2C,g protein-coupled receptor,overexpression,cell proliferation,apoptosis regulation,angiogenesis promotion,signal transduction pathway
ENSG00000114353,GNAI2,g-protein signaling,cell proliferation regulation,tumor suppression potential,signaling pathway dysregulation,protein-protein interaction modulation,cancer cell migration promotion
ENSG00000157017,GHRL,ghrl overexpression,tumor progression,cell proliferation,metastasis promotion,growth factor signaling,poor prognosis marker
ENSG00000123901,GPR83,g protein-coupled receptor function,cell proliferation regulation,pi3k/akt pathway interaction,tumor growth promotion,prognostic marker candidate,signaling pathway modulation
ENSG00000162009,SSTR5,tumor suppressor function,constitutive activation,loss of heterozygosity,mapk/erk pathway regulation,cell proliferation inhibition,somatostatin receptor interaction
ENSG00000137486,ARRB1,gpcr signaling regulation,tumor suppressor function,aberrant expression association,cell proliferation control,signaling pathway modulation,prognostic marker potential
ENSG00000165119,HNRNPK,heterogeneous nuclear ribonucleoprotein k overexpression,oncogenic splicing events,pre-mrna splicing factor activity,alternative splicing regulation,cell proliferation enhancement,apoptosis evasion mechanism
ENSG00000070190,DAPP1,cell adhesion,apoptosis regulation,oncogenic transformation,tumor progression,dna damage response,chemotherapy resistance
ENSG00000101336,HCK,tumor progression,immune suppression,cytokine regulation,jak/stat pathway activation,non-receptor tyrosine kinase activity,cell signaling modulation
ENSG00000182022,CHST15,cell adhesion modulation,cell migration and invasion,tumor progression,genomic upregulation,oncogenic pathway interaction,cancer-related signaling
ENSG00000160293,VAV2,rho gtpase activation,cell migration,tumor invasion,oncogenic signaling,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway modulation
ENSG00000105369,CD79A,bcr pathway alterations,oncogenic transformation,aberrant cellular processes,cellular proliferation,cellular survival,gene overexpression
ENSG00000007312,CD79B,aberrant signaling,cell proliferation,constitutive activation,immunoglobulin-alpha chain,pi3k/akt pathway,protein interaction
ENSG00000086730,LAT2,metabolic regulation,acidic microenvironment,tumor-promoting functions,citrate transport,cellular ph homeostasis,protein-protein interaction
ENSG00000010671,BTK,b-cell receptor signaling,tumor cell growth,constitutive activation,akt phosphorylation,oncogenic mutations,tumor microenvironment modulation
ENSG00000166908,PIP4K2C,pi(5)p signaling pathway,dysregulation of cell growth,aberrant cellular processes,biomarker for disease diagnosis,genetic mutations driving oncogenesis,cellular survival and proliferation pathways
ENSG00000276293,PIP4K2B,pi3k/akt pathway,constitutive activation,overexpression mutations,tumor progression,metabolic regulation,genomic amplification
,IGHM,b-cell differentiation,cancer stem cell marker,immunoglobulin production,mhc class ii antigen presentation,overexpression,tumor aggressiveness
ENSG00000012124,CD22,b cell signaling,cell proliferation,oncogenic driver,molecular targeting,tyrosine kinase regulation,immune evasion
ENSG00000143398,PIP5K1A,phosphoinositide metabolism,cell proliferation enhancement,oncogenic transformation,pi3k/akt pathway interaction,tumor progression facilitation,cancer cell migration increase
ENSG00000072135,PTPN18,immune modulation,tumor suppression,loss-of-function mutations,biomarker potential,cell signaling regulation,protein-protein interaction
ENSG00000035720,STAP1,epithelial-to-mesenchymal transition (emt),scaffold protein function,cell adhesion regulation,therapeutic target,chemotherapy resistance,oncogenic signaling pathway interactions
ENSG00000107242,PIP5K1B,cell proliferation,cancer development,signaling pathway regulation,genomic amplification,phospholipid metabolism,protein kinase activation
ENSG00000184304,PRKD1,oncogene activation,cell survival pathway,protein kinase activity,signaling pathway regulation,tumor progression,therapeutic target
ENSG00000072694,FCGR2B,immune evasion,genomic instability,tumor suppressor function,mhc class ii interaction,dysregulation of antigen presentation,impaired t-cell activation
ENSG00000285369,BLK,blk overexpression,cell signaling activation,immune system modulation,tumor growth promotion,poor prognosis association,oncogenic signaling pathway
ENSG00000166501,PRKCB,tumor progression,pi3k/akt pathway activation,cell survival regulation,protein kinase activity,oncogenic processes promotion,angiogenesis stimulation
ENSG00000263001,GTF2I,genetic instability,transcriptional dysregulation,cell proliferation,tumor progression,prognostic marker,dna repair mechanisms
ENSG00000120088,CRHR1,tumor progression,immune evasion,epithelial-to-mesenchymal transition (emt),g-protein coupled receptor,cortisol regulation,signaling pathway modulation
ENSG00000087460,GNAS,camp/pka signaling,constitutive activation,cell proliferation,oncogenic driver,tumor development,cell survival
ENSG00000088256,GNA11,oncogene activation,heterotrimeric g protein subunit,signal transduction regulation,cell proliferation enhancement,tumor suppressor dysfunction,downstream signaling cascade
ENSG00000087258,GNAO1,heterotrimeric complex activation,constitutive activation,gain of function mutations,oncogenic signaling,tumor progression,therapeutic target
ENSG00000198055,GRK6,grk6 overexpression,constitutive activation,g protein-coupled receptor phosphorylation,cell growth regulation,tumor progression,therapeutic target
ENSG00000127955,GNAI1,g-protein signaling pathway,tumor suppressor function,loss of function mutations,pi3k/akt inhibition,cellular differentiation,prognostic marker
ENSG00000159069,FBXW5,wnt/β-catenin pathway,loss of function mutations,tumor suppressor function,cell cycle regulation,apoptosis regulation,protein degradation
ENSG00000070061,ELP1,chromatin regulation,histone modification,oncogenic processes,genomic instability,cell proliferation,protein interaction
ENSG00000119414,PPP6C,dephosphorylation,cell cycle regulation,tumor progression,cancer driver,pi3k/akt pathway activation,oncoprotein interaction
ENSG00000198001,IRAK4,toll-like receptor signaling,nf-κb activation,pro-inflammatory response,oncogenic proliferation,aberrant signaling,tumorigenesis driver
ENSG00000196083,IL1RAP,il-1 receptor complex,inflammation modulation,oncogenic signaling pathway,tumor microenvironment regulation,cell proliferation enhancement,apoptosis resistance
ENSG00000157625,TAB3,nf-κb activation,tumor progression,oncogenic signaling,cell proliferation,apoptosis suppression,immune evasion
ENSG00000197329,PELI1,nf-κb pathway modulation,innate immune regulator,oncogenic driver,kinase activation,tumor progression facilitation,cancer-associated protein
ENSG00000232960,CSNK2B,phosphorylation regulation,tumor progression facilitation,oncogenic function,cell cycle dysregulation,protein interaction modulation,poor prognosis association
ENSG00000082898,XPO1,export receptor activity,nuclear export facilitation,oncoprotein transport,cell survival promotion,tumor progression,protein degradation
ENSG00000132341,RAN,chromatin regulation,cell cycle regulation,nuclear export function,oncogenic transformation,gtpase activity,cancer cell survival
ENSG00000108829,LRRC59,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),oncogenic role in cancer progression,prognostic significance,pi3k/akt signaling pathway interaction,cell proliferation and survival regulation
ENSG00000172500,FIBP,angiogenesis promotion,cell adhesion regulation,tumor progression facilitation,therapeutic target potential,metastasis enhancement,cell migration induction
ENSG00000176170,SPHK1,sphingolipid metabolism,oncogenic signaling pathways,cell proliferation,metastasis,angiogenesis,tumor progression
ENSG00000230514,AGER,pro-inflammatory response,receptor activation,oxidative stress,tumor progression,metastasis promotion,tumor microenvironment regulation
ENSG00000147065,MSN,cell migration,epithelial-to-mesenchymal transition (emt),oncogenic behavior,cytoskeletal regulation,protein-protein interaction,poor prognosis marker
ENSG00000067900,ROCK1,hippo signaling pathway activation,cell migration regulation,pro-survival gene expression,apoptosis inhibition,tumor progression promotion,actin cytoskeleton regulation
ENSG00000173757,STAT5B,transcriptional regulation,cell growth and differentiation,oncogenic signaling,tumor aggressiveness,epigenetic regulation,therapeutic target
ENSG00000108443,RPS6KB1,mtor signaling pathway,constitutive activation,gain of function mutations,tumor progression,protein synthesis regulation,oncogenic protein translation
ENSG00000123609,NMI,tumor progression,overexpression,transcriptional regulation,cell signaling,cell growth,potential biomarker
ENSG00000136156,ITM2B,cell surface glycosylation,oncogenic processes,tumor growth promotion,signaling pathway modulation,cell proliferation enhancement,metastasis facilitation
ENSG00000134460,IL2RA,**
enhanced t-cell activation,tumor progression marker,immune evasion mechanism,overexpressed in bladder cancer,cell surface receptor activation,cancer immune evasion
ENSG00000127831,VIL1,epithelial-to-mesenchymal transition,increased resistance to therapy,tumor aggressiveness,cancer stem cell properties,cellular motility and invasiveness,intermediate filament organization
ENSG00000182511,FES,protein tyrosine kinase activation,cell signaling regulation,oncogenic mutations,tumor progression,therapeutic target,gene amplification
ENSG00000120833,SOCS2,cellular regulation,cytokine signaling disruption,enhanced cell proliferation,immune evasion mechanism,jak/stat pathway modulation,tumorigenesis promotion
ENSG00000153094,BCL2L11,apoptosis regulation,tumor progression,dna damage response,cell cycle regulation,loss of function mutations,oncogene regulation
ENSG00000196628,TCF4,wnt signaling pathway,transcriptional activation,cell cycle regulation,tumor progression,oncogenesis,epigenetic modification
ENSG00000184502,GAST,gastrin signaling,tumor growth promotion,cell proliferation enhancement,epithelial-to-mesenchymal transition,cancer stem cell maintenance,wnt/β-catenin pathway interaction
ENSG00000124151,NCOA3,transcriptional coactivation,chromatin remodeling,cell proliferation,genomic instability,oncogenic driver gene,tumor progression
ENSG00000197157,SND1,metabolic reprogramming,glycolytic shift,mitochondrial dysfunction,energy metabolism regulation,oncogenic mutations,cancer cell survival
ENSG00000113520,IL4,tumor-promoting effects,cytokine-mediated inflammation,immunomodulatory function,cell proliferation regulation,angiogenesis stimulation,apoptosis induction
ENSG00000185338,SOCS1,stat3 pathway activation,tumor suppressor function,phosphorylation-dependent degradation,jak/stat pathway regulation,cell proliferation inhibition,angiogenesis suppression
,HIST3H3,histone modification,chromatin regulation,genomic stability,cell cycle progression,dna repair pathways,proliferation and growth
ENSG00000124766,SOX4,transcriptional regulation,oncogenic function,cell proliferation,epithelial-to-mesenchymal transition (emt),immune evasion,cancer progression
ENSG00000065559,MAP2K4,mapk signaling pathway,gain of function mutations,phosphorylation and activation,cell cycle progression,apoptosis regulation,tumor progression
ENSG00000087095,NLK,**
wnt/β-catenin signaling,oncogenic driver,tumor progression,cell proliferation regulation,transcription factor activation,apoptosis inhibition 
**
ENSG00000104432,IL7,aberrant expression,cell proliferation,immune evasion,microenvironment modulation,receptor activation,tumor progression
ENSG00000013561,RNF14,e3 ubiquitin ligase activity,cell cycle regulation,dna damage response,genomic stability maintenance,immune evasion,protein degradation pathway
ENSG00000172531,PPP1CA,pp1 activity regulation,constitutive activation,cell cycle progression,apoptosis inhibition,protein degradation modulation,transcriptional regulation
ENSG00000167333,TRIM68,p53 regulation,tumor suppression,oncogene expression,cell growth promotion,apoptosis inhibition,transcriptional modulation
ENSG00000105401,CDC37,cell cycle regulation,oncogene potential,molecular chaperone function,protein complex assembly,cell proliferation enhancement,genomic instability promotion
ENSG00000184895,SRY,oncogene activity,increased cell proliferation,transcriptional regulation,dna binding protein,cell cycle dysregulation,tumor progression
,AES,cellular regulation,genomic stability,transcriptional control,dna repair mechanisms,protein interaction,cell cycle regulation
ENSG00000114166,KAT2B,epigenetic regulation,histone modification,cell proliferation,dna repair,transcriptional activation,chromatin remodeling
ENSG00000151729,SLC25A4,mitochondrial transport,energy metabolism,metabolic reprogramming,mutational alterations,oncogenic potential,apoptosis regulation
ENSG00000108654,DDX5,transcriptional regulation,gene expression modulation,dna repair mechanism,genomic instability,cell proliferation enhancement,tumor progression facilitation
ENSG00000160310,PRMT2,protein arginine methyltransferase activity,asymmetric dimethylation,oncogene potential,tumor suppressor regulation,cell signaling modulation,nuclear localization
ENSG00000063978,RNF4,ubiquitin ligase activity,cell cycle regulation,tumor suppressor degradation,genomic instability,therapeutic target,protein degradation pathways
ENSG00000165671,NSD1,histone modification,chromatin regulation,gain of function mutations,epigenetic regulator,oncogenic role,tumor progression
ENSG00000186976,EFCAB6,cell migration,actin cytoskeleton regulation,prognostic marker,tumor progression,cancer cell invasion,pi3k/akt pathway interaction
ENSG00000197321,SVIL,actin filament regulation,cell migration enhancement,cytoskeletal reorganization,protein interaction modulation,therapeutic target,upregulated expression
ENSG00000108175,ZMIZ1,wnt/β-catenin pathway regulation,protein degradation activity,oncogene overexpression,cell proliferation enhancement,apoptosis inhibition,tumor suppressor function alteration
ENSG00000144747,TMF1,transcription factor,cell cycle regulation,anti-apoptotic function,protein expression regulation,tumor progression,genomic instability
ENSG00000115641,FHL2,transcriptional regulator,tumor suppressor function loss,pi3k/akt pathway modulation,cell growth and differentiation regulation,mutant p53 protein accumulation,genomic instability promotion
ENSG00000101224,CDC25B,cell cycle regulation,tumor proliferation,g2/m phase transition,dual-specificity phosphatase activity,pi3k/akt signaling interaction,oncogene potential
ENSG00000101158,NELFCD,chromatin remodeling,transcription elongation regulation,gene expression dysregulation,cell proliferation promotion,metastasis facilitation,therapeutic target
ENSG00000109685,NSD2,epigenetic regulation,histone modification,tumor progression,oncogenic protein interaction,aggressive tumor behavior,dna damage response
ENSG00000129514,FOXA1,transcriptional regulation,oncogene,cell cycle progression,dna repair evasion,apoptosis evasion,pro-survival signaling
ENSG00000107077,KDM4C,chromatin remodeling,epigenetic regulation,oncogenic transcription,cell proliferation,histone demethylation,metabolic reprogramming
ENSG00000115548,KDM3A,tumor suppressor function,epigenetic regulation,histone demethylation,cell cycle regulation,apoptosis modulation,oncogenic potential
ENSG00000100105,PATZ1,transcription factor activity,cell proliferation regulation,tumor progression driver,therapeutic target potential,gene expression modulation,apoptosis suppression
ENSG00000170606,HSPA4,protein folding regulation,molecular chaperone function,cell survival promotion,tumor progression facilitation,drug resistance enhancement,proteostasis maintenance
ENSG00000107262,BAG1,apoptosis inhibition,cell survival promotion,proliferation enhancement,angiogenesis facilitation,metastasis regulation,oncogene stabilization
ENSG00000078725,BRINP1,cell proliferation,rna-binding protein function,overexpression in cancer,pi3k/akt pathway activation,metastasis promotion,tumor suppressor suppression
ENSG00000185247,MAGEA11,overexpression,tumor progression,transcriptional activation,cell survival enhancement,histone modification regulation,oncogenic protein function
ENSG00000146587,RBAK,cell cycle regulation,tumor progression,apoptosis dysregulation,dna damage response,protein kinase activation,proliferation enhancement
ENSG00000135940,COX5B,mitochondrial function,energetic metabolism,glucose reprogramming,tumor adaptation,electron transport chain,cellular respiration
ENSG00000122515,ZMIZ2,cell cycle regulation,transcriptional coactivation,tumor progression,subnuclear localization,apoptosis repression,oncogenic function
ENSG00000136504,KAT7,chromatin remodeling,histone acetylation,genomic instability,cell cycle regulation,transcriptional modulation,dna damage response
ENSG00000110768,GTF2H1,dna damage response,genomic instability,nucleotide excision repair,transcriptional regulation,cell proliferation,apoptosis resistance
ENSG00000266412,NCOA4,cell cycle regulation,dna replication facilitation,genomic instability contribution,oncogene role,transcriptional coactivation,protein-protein interaction
ENSG00000140682,TGFB1I1,transcription factor activity,tgf-β signaling pathway,dna binding,oncogenic mutation,epithelial-to-mesenchymal transition (emt),apoptosis regulation
ENSG00000164045,CDC25A,dna repair mechanism,constitutive activation,uncontrolled proliferation,cancer progression,cell cycle regulation,genotoxic stress
ENSG00000134248,LAMTOR5,autophagy regulation,amino acid-dependent mtor activation,cellular metabolism regulation,protein-protein interaction,tumor progression association,rag gtpase regulation
ENSG00000124664,SPDEF,tumor suppressor function,apoptosis induction,cell proliferation inhibition,gene expression regulation,transcriptional modulation,biomarker potential
ENSG00000147140,NONO,telomere maintenance,dna repair mechanism,genomic instability,multifunctional protein,cellular homeostasis,chromatin structure stability
ENSG00000177426,TGIF1,tumor suppressor function,bmp signaling repression,tgf-β pathway modulation,oncogenesis inhibition,genomic alterations,cancer development
ENSG00000169375,SIN3A,transcriptional regulation,apoptosis evasion,cell cycle progression,oncogenesis driver,metastasis facilitation,protein-protein interaction
ENSG00000132437,DDC,neurotransmitter synthesis,oncogene activation,cell proliferation signaling,overexpression,constitutive activation,signaling pathway modulation
ENSG00000126457,PRMT1,epigenetic regulation,histone modification,transcriptional activation,cell proliferation,oncogenic pathway modulation,chromatin remodeling
ENSG00000105229,PIAS4,ubiquitin ligase adaptor function,stat protein regulation,cell cycle checkpoint regulation,apoptosis prevention,chromatin remodeling,genomic stability maintenance
ENSG00000146278,PNRC1,chromatin remodeling,cell cycle regulation,transcriptional modulation,gene expression regulation,oncogenic signaling,coactivator function
ENSG00000168066,SF1,cell growth regulation,transcription factor activity,oncogenesis promotion,tumor progression contribution,steroidogenic cell maintenance,cell proliferation facilitation
ENSG00000117450,PRDX1,antioxidant enzyme,cell survival,tumor progression,oxidative stress,pi3k/akt pathway,chemoresistance
ENSG00000110031,LPXN,cell adhesion,cell migration,tumor progression,epithelial-to-mesenchymal transition (emt),oncogene overexpression,cytoskeleton regulation
ENSG00000273173,SNURF,snorna regulation,alternative splicing modulation,genomic instability,rna processing,protein-protein interactions,cellular stress response
ENSG00000106546,AHR,ahr signaling,tumor immunosuppression,metabolic reprogramming,immune evasion mechanisms,overexpression correlation,therapeutic target
ENSG00000167657,DAPK3,apoptosis regulation,cell differentiation,downregulated tumor suppressor,genetic instability,protein kinase activation,tumor progression
ENSG00000169750,RAC3,cellular proliferation,mitogen-activated protein kinase pathway,small gtpase function,tumor progression,oncogenic transformation,proliferation and survival signaling pathways
ENSG00000137992,DBT,bcaa catabolism,metabolic regulation,cell proliferation,tumor progression,apoptosis resistance,oncogenic process
ENSG00000177463,NR2C2,regulation of gene expression,tumor progression,cell proliferation,oncogene function,hormonal signaling,aberrant transcription profiles
ENSG00000148180,GSN,actin filament dynamics,cell migration,cytoskeletal regulation,metastasis promotion,prognostic marker,tumor progression
ENSG00000083799,CYLD,**

ubiquitin-proteasome pathway,nf-κb signaling,tumor suppression,deubiquitinating enzyme,apoptosis induction,cell cycle regulation 

**
ENSG00000131100,ATP6V1E1,tumor progression,proton pump activity,cell migration,lysosomal acidification,metastatic potential,oncogenic signaling
ENSG00000082512,TRAF5,nf-κb activation,oncogenic protein interaction,cell proliferation enhancement,apoptosis resistance,genetic alteration,metastasis promotion
ENSG00000260548,IRS4,cellular proliferation,insulin/igf-1 signaling pathway,genomic instability,metabolic regulation,tumor progression,therapeutic target
ENSG00000172572,PDE3A,cancer driver gene,cell proliferation,oncogene activation,therapeutic target,angiogenesis promotion,apoptosis suppression
ENSG00000132693,CRP,**

inflammation,angiogenesis,cell proliferation,metastasis,tumor progression,acute phase response
ENSG00000163399,ATP1A1,na+/k+-atpase regulation,tumor progression,cell migration,prognostic biomarker,signaling pathway modulation,cancer cell invasion
ENSG00000165409,TSHR,therapeutic target,tumor progression,cell proliferation,oncogenic processes,signal transduction,genomic profiling
ENSG00000065135,GNAI3,g protein signaling,tumor growth promotion,mapk/erk pathway activation,cell proliferation enhancement,prognostic biomarker candidate,tumor metastasis facilitation
ENSG00000170820,FSHR,overexpression,constitutive activation,growth factor signaling,cell proliferation,angiogenesis promotion,tumor progression
ENSG00000239697,TNFSF12,apoptosis inhibition,cell proliferation enhancement,cancer immunotherapy target,immune response regulation,metastasis promotion,tumor suppressor interaction
ENSG00000006327,TNFRSF12A,tumor progression,nf-κb signaling pathway activation,mitogenic signaling,inflammation regulation,tumor necrosis factor receptor activation,pro-inflammatory cytokine response
ENSG00000177575,CD163,tumor microenvironment modulation,immune suppression,oncolytic functions,metastatic potential,poor prognosis indicator,macrophage polarization
ENSG00000198681,MAGEA1,oncogene activation,cell proliferation enhancement,immunotherapeutic target,cellular interaction modulation,tumor antigen expression,gene overexpression
ENSG00000138433,CIR1,nucleotide excision repair,dna damage response,resistance to therapy,cell cycle regulation,pi3k/akt pathway interaction,genetic instability
ENSG00000022267,FHL1,oncogene activity,tumor progression,cell cycle regulation,apoptosis dysregulation,gene expression regulation,transcriptional co-regulator function
ENSG00000184384,MAML2,notch signaling pathway,coactivator activity,cell proliferation regulation,transcriptional regulation,oncogene activation,tumor driver mutation
ENSG00000196782,MAML3,notch signaling pathway,oncogene activation,transcriptional coactivator,cell proliferation enhancement,tumor progression marker,therapeutic target candidate
ENSG00000164105,SAP30,epigenetic regulation,chromatin remodeling,tumor progression,cell proliferation,oncogenic processes,histone deacetylase complex
ENSG00000283780,MAML1,notch signaling pathway,transcriptional co-activator,cell proliferation,apoptosis regulation,bladder cancer mutations,oncogene activation
ENSG00000109670,FBXW7,tumor suppressor,loss-of-function mutations,cell cycle regulation,oncogene degradation,wnt/β-catenin signaling pathway regulation,therapeutic target
ENSG00000113558,SKP1,proteasome regulation,cell cycle progression,oncogenic potential,ubiquitination pathway,tumor suppressor degradation,therapeutic target
ENSG00000231115,RING1,epigenetic regulation,polycomb group protein,e3 ubiquitin ligase,chromatin compaction,gene silencing,tumor progression
ENSG00000223654,FLOT1,cell membrane signaling,phospholipid metabolism,protein-protein interactions,lipid raft formation,adhesion molecule regulation,metastasis promotion
ENSG00000132589,FLOT2,membrane trafficking regulation,lipid raft formation,cell migration promotion,tumor progression,metastasis facilitation,biomarker overexpression
ENSG00000281877,RPS6KA1,rsk activation,cell proliferation,translation initiation,apoptosis evasion,metabolic adaptation,protein phosphorylation
ENSG00000071242,RPS6KA2,cell cycle regulation,oncogenic process,tumor progression,protein kinase activation,mapk signaling pathway interaction,therapeutic target
ENSG00000165458,INPPL1,pi3k/akt pathway disruption,aberrant signaling activation,tumor progression enhancement,cell growth promotion,apoptosis resistance,metastatic potential increase
ENSG00000169891,REPS2,wnt/β-catenin pathway interaction,rho gtpase regulation dysregulation,emt process involvement,cell migration and invasion enhancement,oncogenic transformation contribution,protein-protein interaction modulation
ENSG00000142273,CBLC,cellular adhesion,calcium-mediated signaling,oncogenic transformation,tumor progression,signaling pathway modulation,cell growth regulation
ENSG00000143333,RGS16,tumor progression,gpcr signaling pathway activation,cell proliferation regulation,immune microenvironment modulation,therapeutic target,oncogenic signaling pathways activation
ENSG00000168374,ARF4,genomic instability,cell proliferation,tumor progression,protein-protein interactions,mitotic spindle regulation,cancer cell survival
ENSG00000111057,KRT18,cancer cell migration,cellular proliferation,overexpression,tumor progression,e2f1 regulation,β-catenin interaction
ENSG00000149480,MTA2,chromatin remodeling,metastasis promotion,tumor progression,histone modification,dna methylation,cell migration enhancement
ENSG00000136044,APPL2,pi3k/akt signaling,upregulation,oncogenic process,tumor progression,metastasis regulation,cell survival enhancement
ENSG00000034152,MAP2K3,**

mapk signaling pathway,constitutive activation,gain of function mutations,oncogenic driver,cell proliferation,tumor progression

**
ENSG00000127946,HIP1,actin cytoskeleton regulation,cell migration promotion,gtpase signaling modulation,oncogenic driver,pi3k/akt pathway interaction,tumor progression facilitation
ENSG00000166225,FRS2,ras/mapk pathway,constitutive activation,receptor tyrosine kinase signaling,cellular proliferation,signaling pathway modulation,growth factor regulation
ENSG00000138193,PLCE1,plcε activation,signaling pathway regulation,cell growth promotion,protein kinase c activation,calcium signaling modulation,tumor progression enhancement
ENSG00000105971,CAV2,aberrant signaling,cell migration,cholesterol transport,mechanotransduction,oncogenic processes,signaling pathway regulation
ENSG00000140600,SH3GL3,endocytic trafficking,oncogenic protein regulation,aggressive tumor behavior,dysregulation of endocytic pathways,cell signaling pathway interaction,poor prognosis biomarker
ENSG00000106976,DNM1,cellular dynamics,endocytosis regulation,mitochondrial fission,protein-protein interactions,tumor progression,cancer cell survival
ENSG00000156508,EEF1A1,translation regulation,cell proliferation,oncogenic signaling,metastasis promotion,apoptosis resistance,protein synthesis upregulation
ENSG00000109917,ZPR1,cell proliferation regulation,gene expression modulation,chromatin remodeling,transcriptional regulation,epigenetic alteration,tumor progression promotion
ENSG00000166484,MAPK7,cell growth regulation,constitutive activation,dual-specificity kinase activation,oncogenic processes promotion,tumor progression contribution,therapeutic target
ENSG00000153233,PTPRR,phosphatase activity,cell signaling regulation,oncogenic transformation,genomic instability,apoptosis modulation,chromosomal rearrangement
ENSG00000017797,RALBP1,tumor progression,cellular signaling,protein-protein interaction,gtpase activity,oncogenic process,proliferation regulation
ENSG00000144118,RALB,mapk signaling pathway,constitutive activation,gain of function mutations,tumor aggressiveness,cell migration,pi3k/akt interaction
ENSG00000108946,PRKAR1A,pka pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation,dna damage response
ENSG00000061938,TNK2,integrin interaction,oncogenic role,cell migration regulation,prognostic biomarker,metastasis promotion,cytoskeleton remodeling
ENSG00000070831,CDC42,cell migration,tumor invasion,oncogenic processes,cytoskeletal dynamics,cell cycle regulation,filopodia formation
ENSG00000133056,PIK3C2B,intracellular trafficking,membrane remodeling,lipid kinase activity,oncogenic driver,mutation/amplification,pi3k/akt signaling pathway
ENSG00000144730,IL17RD,il-17 signaling pathway,immune suppression,angiogenesis promotion,tumor progression,therapeutic target,genomic profiling
ENSG00000116285,ERRFI1,egfr pathway inhibition,cellular homeostasis,tumor suppressor function,oncogenic signaling,downregulation in cancer,cell cycle regulation
ENSG00000174238,PITPNA,phosphoinositide regulation,cell signaling pathway,oncogenic activation,tumor progression,protein-protein interaction,apoptosis inhibition
ENSG00000065243,PKN2,pi3k/akt interaction,cell survival regulation,oncogenic signaling,tumor progression marker,serine/threonine kinase activity,protein-protein interactions
ENSG00000129219,PLD2,pld2 mediated pi3k/akt/mtor signaling,oncogenic mutation,tumor progression,metastasis regulation,cell survival pathway,phospholipid metabolism disruption
ENSG00000140575,IQGAP1,cell adhesion disruption,epithelial-to-mesenchymal transition,metastasis promotion,tumor progression,prognostic marker,cytoskeletal regulation
ENSG00000288293,CC2D1A,transcriptional regulation,scaffold protein function,oncogenic mutations,chromatin remodeling complex interaction,cell cycle progression,dna repair dysregulation
ENSG00000133703,KRAS,**

kras is associated with:
constitutive activation,gain of function mutations,oncogene activation,cell proliferation,resistance to apoptosis,ras/raf/mek signaling pathway
ENSG00000095015,MAP3K1,mapk pathway activation,serine/threonine kinase activity,cell growth promotion,survival signaling,tumor initiation,signaling network modulation
ENSG00000115290,GRB14,grb14 associated,signal transduction pathway,receptor tyrosine kinase activation,pi3k/akt pathway modulation,tumor growth promotion,therapeutic target
ENSG00000160271,RALGDS,ral gtpase activation,oncogenic potential,tumor progression,cell survival,cell proliferation,protein-protein interaction
ENSG00000141738,GRB7,rtk activation,cell survival promotion,oncogenic driver,metastasis regulation,growth factor receptor interaction,protein kinase activation
ENSG00000144566,RAB5A,endocytic trafficking,tumor progression,metastasis promotion,cell migration,survival signaling,pi3k/akt interaction
ENSG00000174791,RIN1,ras/mapk signaling,oncogenic transformation,growth factor regulation,cellular stress response,dna damage response pathways,protein-protein interactions
ENSG00000137218,FRS3,glycolytic regulation,oncogenic potential,amplification and overexpression,pi3k/akt pathway activation,cell proliferation and survival enhancement,therapeutic target
ENSG00000188313,PLSCR1,cell proliferation,oncogenic processes,signaling pathway modulation,nf-κb activation,pi3k/akt pathway involvement,protein-protein interactions
ENSG00000128422,KRT17,**

1. **cell proliferation**,2. **oncogenesis**,3. **epithelial disruption**,4. **intermediate filament network formation**,5. **tumor progression**,6. **protein interaction and signaling**

**
ENSG00000170421,KRT8,tumor progression,cellular adhesion,apoptosis inhibition,dna damage response,metastasis promotion,intermediate filament stabilization
ENSG00000137764,MAP2K5,mapk/erk pathway activation,oncogenic transformation,tumor progression,cell proliferation enhancement,dual specificity kinase activity,therapeutic target
ENSG00000163558,PRKCI,constitutive activation,gain of function mutations,cell proliferation enhancement,tumor progression,signaling pathway modulation,genomic instability
ENSG00000135480,KRT7,epithelial integrity maintenance,aberrant expression in cancer,cellular morphology changes,prognostic marker potential,emt facilitation,type ii intermediate filament protein
ENSG00000125743,SNRPD2,alternative splicing,dysregulated gene expression,pre-mrna processing,spliceosome complex,snrnp component,tumor progression
ENSG00000204842,ATXN2,atxn2 is involved in regulating mrna metabolism,translation regulation,polyglutamine-containing protein family member,cellular proliferation and survival pathways,polycomb repressive complex interaction,genomic instability contributor
ENSG00000076201,PTPN23,tumor suppressor function,dephosphorylation activity,cell adhesion modulation,pro-survival signaling pathway activation,oncogenic kinase inhibition,metastasis promotion
ENSG00000145901,TNIP1,nf-κb pathway regulation,tumor suppressor function,cancer association,cell proliferation inhibition,survival modulation,nf-κb signaling inhibition
ENSG00000076984,MAP2K7,erk pathway activation,gain of function mutations,tumor growth,constitutive activation,cell proliferation,therapeutic target
ENSG00000085511,MAP3K4,activation of downstream effectors,cell proliferation,mapk/erk pathway,mitogen-activated protein kinase (mapk) signaling,overexpression in cancer,poor prognosis
ENSG00000158711,ELK4,ets family transcription factor,cell cycle regulation,oncogenic process activation,tumor progression enhancement,poor prognosis association,signaling pathway modulation
ENSG00000283060,ID3,transcriptional regulation,tumor growth promotion,pro-apoptotic inhibition,cell proliferation enhancement,poor prognosis association,therapeutic target
ENSG00000115738,ID2,cell cycle regulation,oncogenic driver,tumor progression,transcriptional regulation,tumorigenesis facilitation,metastasis promotion
ENSG00000111145,ELK3,emt regulation,oncogene activation,constitutive activation,cell proliferation,transcriptional regulation,apoptosis resistance
ENSG00000172201,ID4,tumor suppressor function,transcriptional regulation,cell proliferation inhibition,oncogenic processes inhibition,genomic instability prevention,pi3k/akt signaling regulation
ENSG00000103479,RBL2,cell cycle regulation,tumor suppressor function,e2f transcription factor inhibition,cell proliferation control,chromosomal instability,cancer driver mutation
ENSG00000196092,PAX5,transcription factor regulation,tumor progression,cell proliferation,epithelial-to-mesenchymal transition (emt),cell cycle regulation,genomic instability
ENSG00000159352,PSMD4,26s proteasome complex,protein degradation regulation,oncogenesis,cell cycle regulation,apoptosis modulation,immune evasion
ENSG00000166794,PPIB,protein folding regulation,cell cycle progression regulation,apoptosis modulation,tumor progression facilitation,therapeutic target,cellular stress response regulation
ENSG00000164615,CAMLG,calcium channel regulation,cell proliferation,tumor growth,signaling pathway modulation,protein-protein interaction,growth factor regulation
ENSG00000170027,YWHAG,cell signaling regulation,apoptosis modulation,tumor aggression facilitation,therapeutic target,prognostic marker,cell cycle regulation
ENSG00000136098,NEK3,cell cycle regulation,mitotic checkpoint,oncogene potential,cell proliferation enhancement,genetic alteration impact,survival pathway modulation
ENSG00000151090,THRB,androgen receptor signaling,oncogenic pathway activation,thyroid hormone response element,transcriptional regulation,cell proliferation,epigenetic modification
ENSG00000151849,CENPJ,microtubule organization,aneuploidy,genetic instability,mitotic spindle formation,centrosome duplication,chromosomal abnormalities
ENSG00000007264,MATK,cell proliferation,serine/threonine kinase activity,tumor progression,oncogenic properties,prognostic marker,signal transduction regulation
ENSG00000000938,FGR,oncogenic signaling,pi3k/akt pathway activation,stat5 phosphorylation,tumor progression driver,cell proliferation enhancer,emt mediator
ENSG00000166068,SPRED1,ras/mapk signaling pathway inhibition,cell proliferation regulation,loss-of-function mutations,oncogenic activation,tumor suppressor function,cancer progression
ENSG00000198369,SPRED2,rtk signaling regulation,cellular homeostasis,oncogene potential,cell proliferation enhancement,angiogenesis promotion,emt induction
ENSG00000197323,TRIM33,epigenetic regulation,chromatin remodeling,tumor suppressor function,cell proliferation inhibition,genome stability maintenance,metastasis suppression
ENSG00000114520,SNX4,akt pathway regulation,pten degradation,oncogenic protein degradation,endosomal trafficking modulation,cell cycle regulation,protein-protein interactions
ENSG00000129515,SNX6,endosomal recycling,ubiquitin-dependent sorting,cell surface receptor regulation,protein trafficking dysregulation,tumor suppressor dysfunction,oncogenic signaling activation
ENSG00000111424,VDR,tumor suppression,epigenetic regulation,transcriptional modulation,cell proliferation inhibition,vitamin d interaction,immune response regulation
ENSG00000163877,SNIP1,cell cycle regulation,tumor suppressor function,nuclear protein localization,cell proliferation modulation,apoptosis regulation,genomic instability
ENSG00000100614,PPM1A,cell cycle regulation,phosphatase activity,tumor suppressor function,oncogenic pathway modulation,apoptosis regulation,protein interaction
ENSG00000132953,XPO4,p53 transport,apoptosis resistance,nuclear export,protein-protein interactions,cell survival regulation,tumor progression enhancement
ENSG00000102974,CTCF,chromatin regulation,coactivator function,dna repair mechanism,cell cycle control,tumor suppressor activity,genomic instability
ENSG00000126883,NUP214,nuclear pore complex component,oncogene activation,genomic instability,cellular proliferation,chromatin remodeling,signaling pathway modulation
ENSG00000166887,VPS39,hops complex regulation,autophagy dysregulation,lysosome function,cellular homeostasis,vacuole-mediated trafficking,cell survival enhancement
ENSG00000157077,ZFYVE9,mitotic progression,genomic stability maintenance,chromosomal instability,cell division regulation,microtubule dynamics modulation,tumor suppressor function
ENSG00000272886,DCP1A,genomic stability maintenance,homologous recombination pathway,cell cycle regulation,dna repair mechanism,chromosomal instability,tumor suppressor function
ENSG00000066136,NFYC,regulation of cell cycle,transcriptional control,dna repair suppression,apoptosis evasion,cell proliferation enhancement,protein-protein interaction
ENSG00000120837,NFYB,ccaat box binding,cell cycle progression,gene expression regulation,oncogenic transcription factor,tumor progression,transcriptional activation
ENSG00000169554,ZEB2,epithelial-to-mesenchymal transition,e-cadherin suppression,n-cadherin enhancement,pi3k/akt signaling modulation,tumor invasion,mesenchymal phenotype
ENSG00000006125,AP2B1,transcriptional regulation,cell proliferation,apoptosis suppression,wnt/β-catenin pathway interaction,oncogenic properties,poor prognosis association
ENSG00000125971,DYNLRB1,cul4-ring ubiquitin ligase complex,loss-of-function mutations,cell cycle regulation,protein degradation,transcriptional repression,apoptosis inhibition
ENSG00000023734,STRAP,cell cycle regulation,dna repair modulation,tumor suppressor interaction,genomic stability maintenance,apoptosis induction,pi3k/akt pathway modulation
ENSG00000130177,CDC16,cell cycle regulation,anaphase-promoting complex (apc),mitotic progression,proteasome degradation,genomic instability,oncogenic process
ENSG00000176396,EID2,cell proliferation,oncogenic activity,transcriptional coactivator function,tumor growth inhibition of apoptosis,androgen receptor signaling pathway,genomic instability
ENSG00000004897,CDC27,apoptosis pathway disruption,cell cycle dysregulation,genomic instability,oncogenic protein stabilization,proteasome inhibition target,tumor suppressor degradation
ENSG00000078399,HOXA9,cellular transformation,transcriptional regulation,oncogenic potential,growth suppression,apoptosis evasion,tumor progression
ENSG00000221914,PPP2R2A,tumor suppressive function,regulatory subunit,signal transduction,oncogenic pathways,cell cycle progression,apoptosis regulation
ENSG00000108984,MAP2K6,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling pathway regulation,cell survival enhancement
ENSG00000133740,E2F5,cell cycle regulation,overexpression,transcription factor activity,genomic instability,proliferation promotion,tumor progression
ENSG00000119699,TGFB3,tumor suppression,angiogenesis promotion,epithelial-to-mesenchymal transition,cell differentiation modulation,growth factor activity,cancer metastasis facilitation
ENSG00000114302,PRKAR2A,pka activation,cell proliferation,constitutive activation,oncogenic processes,tumor progression,therapeutic target
ENSG00000188191,PRKAR1B,**

pka signaling pathway,oncogenic transformation,gain of function mutations,tumor progression,chemoresistance,poor prognosis 
**
ENSG00000170604,IRF2BP1,transcriptional regulation,promotes tumor development,cell cycle progression,inhibits e2f activity,suppresses p53 function,oncogenic role
ENSG00000101076,HNF4A,tumor suppression,gene regulation,cell differentiation,metabolic regulation,prognostic marker,oncogenic pathway modulation
ENSG00000125398,SOX9,wnt/β-catenin pathway,constitutive activation,gain of function mutations,tumor progression,stem cell maintenance,epithelial-to-mesenchymal transition
ENSG00000105325,FZR1,cell cycle regulation,ubiquitination,oncogenic process,cell proliferation,tumor progression,protein interaction
ENSG00000026508,CD44,hyaluronic acid binding,tumor progression,cancer stem cell maintenance,cell migration and invasion,angiogenesis promotion,pi3k/akt pathway modulation
ENSG00000084623,EIF3I,translation initiation factor,oncogenic process,cell proliferation,tumor progression,protein synthesis regulation,apoptosis inhibition
ENSG00000118046,STK11,tumor suppressor function,loss of function mutations,cellular homeostasis disruption,energy metabolism deregulation,genomic instability induction,apoptosis evasion
ENSG00000144589,STK11IP,stk11 regulation,cell survival promotion,genomic instability induction,tumor suppressor inhibition,metabolic regulation enhancement,apoptosis pathway disruption
ENSG00000001167,NFYA,nf-y transcription factor complex,cell cycle progression,transcriptional regulation,dna damage response,oncogenic signaling,prognostic marker
ENSG00000148516,ZEB1,emt induction,mesenchymal transition,transcriptional repressor,cellular invasion,tumor metastasis,adhesion suppression
ENSG00000168589,DYNLRB2,genomic instability,tumor suppressor function,cell cycle regulation,dna repair mechanism,protein-protein interaction,homologous recombination
ENSG00000124789,NUP153,nuclear pore regulation,chromatin remodeling,gene transcription regulation,cell cycle progression,protein-protein interaction,therapeutic target
ENSG00000181191,PJA1,cell proliferation regulation,oncogenic process driver,apoptosis evasion modulation,tumor progression facilitation,immune response modulation,adaptor molecule function
ENSG00000039319,ZFYVE16,tumor progression,endosomal trafficking regulation,cell signaling modulation,metastasis promotion,oncogenic driver mutation,therapeutic target potential
ENSG00000184221,OLIG1,**

wnt/beta-catenin pathway regulation,tumor progression facilitation,cell cycle regulation disruption,apoptosis evasion enhancement,transcriptional program activation,constitutive activation

**
ENSG00000168556,ING2,cell cycle regulation,tumor suppressor function,dna damage response,apoptosis inhibition,genome stability maintenance,chemoresistance modulation
ENSG00000169783,LINGO1,cell adhesion disruption,apoptosis inhibition,enhanced cell survival,tumor progression,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000134243,SORT1,cellular cholesterol regulation,cholesterol-dependent cell membrane remodeling,cell cycle regulation,oncogenic signaling pathways,tumor progression and metastasis,therapeutic target
ENSG00000185634,SHC4,sh2 domain-containing protein signaling,cell proliferation enhancement,oncogenic pathway activation,tumor growth promotion,metastasis facilitation,pi3k/akt/mtor pathway modulation
ENSG00000073969,NSF,cellular stress response,protein-protein interactions,oncogenic pathway regulation,tumor progression,metastatic potential,therapeutic target
ENSG00000174804,FZD4,wnt signaling pathway,cell migration,oncogenic driver,tumor progression,cancer stem cell regulation,therapeutic target
ENSG00000126583,PRKCG,oncogene activation,cell proliferation,oncogenic signaling pathway,protein kinase activation,apoptosis regulation,tumor aggressiveness
ENSG00000125084,WNT1,wnt/β-catenin pathway activation,oncogenic driver,tumor progression marker,cell proliferation regulator,survival pathway activator,cancer stem cell maintenance
ENSG00000188763,FZD9,wnt signaling pathway,constitutive activation,wnt ligand binding,oncogenic driver,cell proliferation enhancement,tumor suppressor dysregulation
ENSG00000105989,WNT2,wnt/β-catenin pathway,oncogene activation,epithelial-to-mesenchymal transition,cell proliferation,tumor progression,therapeutic target
ENSG00000164930,FZD6,wnt signaling pathway,tumor progression,promoter of proliferation,aberrant expression,oncogenic processes,cancer driver gene
ENSG00000104332,SFRP1,wnt signaling pathway inhibition,tumor suppressor function,cell proliferation regulation,differentiation regulation,survival promotion inhibition,genomic profiling alterations
ENSG00000182968,SOX1,cellular proliferation,transcriptional regulation,tumor growth promotion,genomic instability,oncogene activation,signaling pathway modulation
ENSG00000107404,DVL1,wnt signaling activation,cell proliferation promotion,oncogenic potential enhancement,tumorigenesis and metastasis association,β-catenin pathway regulation,therapeutic target
ENSG00000155760,FZD7,fzd7 overexpression,wnt/β-catenin pathway activation,cell proliferation enhancement,tumor progression association,poor prognosis correlation,genomic amplification
ENSG00000277626,WNT3,wnt signaling pathway,constitutive activation,gain of function mutations,tumor progression,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000155252,PI4K2A,pi4k/pip signaling pathway,type ii phosphatidylinositol 4-kinase,cell proliferation driver,lipid metabolism regulation,cancer cell survival enhancer,tumor progression marker
ENSG00000104290,FZD3,wnt signaling pathway,tumor aggressiveness,cell survival enhancement,oncogenic driver,mutation hotspot,promotes metastasis
ENSG00000116128,BCL9,wnt/β-catenin pathway,constitutive activation,chromatin remodeling,transcriptional coactivator,gene amplification,protein-protein interaction
ENSG00000162552,WNT4,canonical wnt signaling pathway,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,mutation or amplification,immunomodulation,poor prognosis marker
ENSG00000123384,LRP1,tumor aggressiveness,overexpression,wnt/β-catenin signaling pathway,pi3k/akt pathway modulation,cell proliferation regulation,therapeutic target
ENSG00000154764,WNT7A,wnt signaling,epithelial-to-mesenchymal transition,cell proliferation,oncogenic potential,transcription factor regulation,protein-protein interaction
ENSG00000163251,FZD5,wnt signaling pathway,glycosphingolipid binding,oncogenic mutation,tumor progression,cell proliferation,signaling cascade activation
ENSG00000185483,ROR1,oncogenic signaling,overexpression,tumor progression,metastasis,cell migration,prognostic biomarker
ENSG00000150764,DIXDC1,wnt/β-catenin activation,cell proliferation,prognostic biomarker,protein-protein interactions,transcriptional regulation,oncogenesis
ENSG00000096384,HSP90AB1,heat shock protein regulation,molecular chaperoning,protein stabilization,oncogenic signaling,cell survival enhancement,tumor progression facilitation
ENSG00000104365,IKBKB,nf-κb pathway activation,constitutive activation,amplification,inflammation regulation,cell proliferation,oncogenic driver
ENSG00000282905,NFKBIB,nf-κb pathway regulation,constitutive activation,tumor suppression,cell survival promotion,oncogenic transformation,genetic mutations
ENSG00000145703,IQGAP2,pi3k/akt signaling pathway modulation,cancer cell migration,tumor progression,cell adhesion regulation,signaling molecule interaction,oncogene interaction
ENSG00000161057,PSMC2,proteasome function,tumor suppression,cell cycle progression,immune evasion,oncogene upregulation,apoptosis resistance
ENSG00000102871,TRADD,apoptosis dysregulation,cell proliferation promotion,inflammation modulation,immune evasion mechanism,tumor progression facilitation,nf-κb pathway activation
ENSG00000102753,KPNA3,nuclear transport regulation,tumor progression driver,oncogene overexpression,cell cycle dysregulation,apoptosis evasion,protein-protein interaction modulation
ENSG00000100804,PSMB5,tumor suppressor protein degradation,cell proliferation promotion,cancer progression facilitation,oncogenic pathway activation,poor prognosis association,proteasome complex regulation
ENSG00000185104,FAF1,apoptosis regulation,tumor suppressor function,caspase-8 interaction,cell cycle progression,dna damage response evasion,mitochondrial outer membrane permeabilization
ENSG00000100764,PSMC1,proteasomal degradation,constitutive activation,overexpression,oncogenic driver,cell cycle progression,apoptosis inhibition
ENSG00000137054,POLR1E,ribosomal biogenesis,cell growth promotion,dna damage response,cell proliferation regulation,tumor progression,therapeutic target
ENSG00000171453,POLR1C,rrna transcription regulation,transcription initiation,genomic instability,cell proliferation modulation,gene expression dysregulation,pre-initiation complex formation
ENSG00000053918,KCNQ1,cellular excitability,membrane potential regulation,tumor suppressor function,apoptosis regulation,cell growth inhibition,potassium channel subunit
ENSG00000110700,RPS13,gain of function mutations,altered protein synthesis,enhanced translation efficiency,increased proliferation,tumor suppressor function,ribosome assembly
ENSG00000089009,RPL6,increased protein synthesis,cell growth regulation,ribosomal subunit component,tumor progression marker,poor prognosis indicator,protein overexpression
ENSG00000263528,IKBKE,nf-kappa b activation,cancer cell proliferation,oncogenic transcription factor,cell survival pathway,inflammation regulation,protein kinase activity
ENSG00000136560,TANK,nf-κb signaling inhibition,tumor suppressor function,immune response regulation,cell survival promotion,apoptosis resistance,genomic instability
ENSG00000096060,FKBP5,nf-κb regulation,gr interaction,cell growth promotion,dna repair enhancement,emt facilitation,glucocorticoid resistance
ENSG00000176046,NUPR1,tumor aggressiveness,cell cycle progression,dna repair evasion,apoptosis resistance,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000074266,EED,polycomb repressive complex 2,tumor suppressor gene silencing,oncogenic transcriptional program,genomic instability,cell cycle regulation,apoptosis repression
ENSG00000103056,SMPD3,ceramide metabolism,apoptosis regulation,dna repair mechanisms,cell signaling pathways,tumorigenesis driver,stress response modulation
ENSG00000025800,KPNA6,nuclear transport,cell cycle regulation,tumor progression,oncogenic protein accumulation,signaling pathway interaction,epigenetic regulation
ENSG00000075391,RASAL2,loss of tumor suppressor function,downregulation,ras signaling pathway inhibition,ras protein activation,cell proliferation increase,migration enhancement
ENSG00000138757,G3BP2,mtor pathway regulation,gain of function mutations,apoptosis regulation,autophagy modulation,cell proliferation enhancement,tumor progression marker
ENSG00000168884,TNIP2,nf-κb signaling pathway regulation,apoptosis suppression,tumor suppressor function loss,genomic instability,cancer cell proliferation enhancement,immune evasion mechanism
ENSG00000173163,COMMD1,cell cycle regulation,oncogenic signaling,ubiquitin ligase regulation,tumor progression,apoptosis suppression,epigenetic modification
ENSG00000173692,PSMD1,ubiquitin-proteasome pathway,cell proliferation,overexpression,protein degradation,cell survival enhancement,oncogene potential
ENSG00000197170,PSMD12,proteasome subunit,tumor aggressiveness,cell proliferation,apoptosis inhibition,angiogenesis facilitation,pi3k/akt pathway interaction
ENSG00000163636,PSMD6,proteasome function,cellular degradation pathway,tumor suppressor protein degradation,apoptosis regulation,cancer progression,therapeutic target
ENSG00000076604,TRAF4,nf-κb signaling pathway,constitutive activation,epithelial-to-mesenchymal transition (emt),cell proliferation,metastasis promotion,oncogenic cooperation
ENSG00000142534,RPS11,ribosome assembly,ribosome dysfunction mutations,oncogenesis,translation initiation regulation,protein synthesis regulation,cellular proliferation enhancement
ENSG00000173473,SMARCC1,chromatin remodeling,epigenetic regulation,histone modification,cell cycle regulation,tumor suppressor function,genome stability maintenance
ENSG00000185627,PSMD13,ubiquitin-proteasome pathway,protein degradation regulation,tumor suppressor degradation,cell cycle progression,apoptosis inhibition,rubicon binding
ENSG00000108344,PSMD3,protein degradation,ubiquitin-proteasome pathway,oncogenic protein regulation,cell survival,proliferation enhancement,metastasis promotion
ENSG00000184432,COPB2,anti-apoptotic function,cellular stress response regulation,chaperone interaction,co-chaperone activity,proliferation enhancement,survival signaling pathway
ENSG00000141030,COPS3,cancer driver,cell cycle regulation,deubiquitinating activity,dna repair dysregulation,oncogene activation,transcriptional regulation
ENSG00000124602,UNC5CL,netrin-1 signaling pathway,tumor suppressor,cell migration regulation,apoptosis promotion,cell proliferation inhibition,metastasis suppression
ENSG00000139613,SMARCC2,swi/snf complex,chromatin remodeling,oncogene amplification,cell proliferation enhancer,tumor growth promoter,genome instability regulator
ENSG00000104881,PPP1R13L,cell proliferation inhibition,tumor suppressor function,loss of expression,oncogenic signaling pathway activation,dna damage response regulation,poor prognosis marker
ENSG00000105127,AKAP8,regulation of transcription,cell cycle progression,centrosome duplication and separation,oncogenesis promotion,protein kinase anchoring,tumor cell survival
ENSG00000136518,ACTL6A,chromatin remodeling complex,oncogenic properties,cell cycle progression,transcriptional regulation,dna repair,genomic instability
ENSG00000161016,RPL8,cellular proliferation,ribosomal function,protein synthesis regulation,tumor suppression,cancer development,cell growth modulation
ENSG00000105202,FBL,dysregulation of ribosome biogenesis,cell proliferation enhancement,therapeutic target,cancer progression driver,poor prognosis marker,protein interaction partner
ENSG00000156482,RPL30,ribosome biogenesis,proliferation and survival,genetic instability,chemosensitivity,protein synthesis regulation,cellular stress response
ENSG00000174444,RPL4,cell cycle regulation,apoptosis evasion,oncogenic function,ribosomal biogenesis,overexpression,biomarker potential
ENSG00000133884,DPF2,regulation of vesicular trafficking,gef activity,rab gtpase interaction,cell proliferation enhancement,pi3k/akt pathway modulation,tumor progression association
ENSG00000131653,TRAF7,nf-?b signaling pathway,constitutive activation,gain of function mutations,epithelial-to-mesenchymal transition (emt),cell proliferation,protein-protein interactions
ENSG00000148396,SEC16A,cell cycle regulation,genomic stability,protein-protein interactions,dna repair mechanisms,cell proliferation,senescence prevention
ENSG00000100991,TRPC4AP,calcium channel regulation,tumor suppressor function,cell proliferation regulation,cancer progression marker,genetic alterations,cell signaling modulation
ENSG00000126777,KTN1,cell-cell adhesion disruption,cytoskeletal reorganization,desmosome disassembly,epithelial-to-mesenchymal transition,tumor progression,cell migration enhancement
ENSG00000101255,TRIB3,tumor progression,cell survival suppression,apoptosis inhibition,therapeutic target,genomic profiling,none
ENSG00000125995,ROMO1,cellular respiration,mitochondrial function,energy metabolism regulation,cell proliferation promotion,tumor progression driver,therapeutic target
ENSG00000123091,RNF11,cell cycle regulation,loss of tumor suppressor proteins,tumor progression,ubiquitin ligase activity,protein degradation,g2/m phase transition
ENSG00000103035,PSMD7,protein degradation,tumor progression,poor prognosis,ubiquitin-proteasome pathway,cell survival and proliferation,oncofetal antigen expression
ENSG00000165916,PSMC3,proteasome subunit,cellular homeostasis regulation,oncogenic processes promotion,tumor suppression degradation,ubiquitin-proteasome pathway dysregulation,genomic amplification
ENSG00000068654,POLR1A,ribosomal rna transcription,dna repair regulation,cell proliferation enhancement,tumor progression facilitation,gain-of-function mutations,therapeutic resistance
ENSG00000071994,PDCD2,apoptosis regulation,cell proliferation,dna damage response,necroptosis modulation,pi3k/akt pathway interaction,therapeutic target
ENSG00000143256,PFDN2,tumor progression,biomarker overexpression,cell cycle regulation,protein degradation,oncometabolism,tumor suppression
ENSG00000171444,MCC,loss of function mutations,tumor suppressor function,cell cycle regulation,apoptosis regulation,cdk4 interaction,genomic instability
ENSG00000138095,LRPPRC,mitochondrial translation regulation,cellular metabolism regulation,tumor growth modulation,therapeutic resistance,genomic instability,metabolic reprogramming
ENSG00000085760,MTIF2,mitochondrial protein synthesis,tumor growth,cellular proliferation,oncogenesis,tumor progression,anti-apoptotic
ENSG00000036672,USP2,deubiquitination,pi3k/akt pathway,oncogenic driver,cell cycle progression,tumor suppressor inhibition,proteasome regulation
ENSG00000106144,CASP2,apoptosis initiation,dna damage response,protein activation,tumor progression,therapeutic target,genomic instability
ENSG00000168067,MAP4K2,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000102226,USP11,cell cycle regulation,deubiquitinating enzyme,oncogenic processes,nf-κb pathway modulation,apoptosis suppression,biomarker potential
ENSG00000090863,GLG1,glycolytic regulation,energy metabolism,oncogenic pathway,metabolic reprogramming,tumor aggressiveness,treatment resistance
ENSG00000090060,PAPOLA,genomic instability,dna damage response,polyadenylation regulation,gene expression modulation,tumor progression,oncogenic pathway activation
ENSG00000186184,POLR1D,ribosome biogenesis,genomic stability,cell growth regulation,rna polymerase activity increase,protein synthesis enhancement,transcriptional upregulation
ENSG00000135002,RFK,dna damage response,cell proliferation,genomic stability maintenance,pi3k/akt pathway activation,tumor suppressor function,cancer driver mutation
ENSG00000175166,PSMD2,apoptosis regulation,cell cycle progression,oncogene activation,protein degradation pathway,tumor suppressor degradation,therapeutic target
ENSG00000215301,DDX3X,cellular growth regulation,oncogenic function,rna processing,tumor progression,overexpression,pi3k/akt pathway interaction
ENSG00000119401,TRIM32,e3 ubiquitin ligase activity,apoptosis modulation,tumor suppressor function,deregulation in cancer,cell cycle regulation,bcl-2 family interaction
ENSG00000166508,MCM7,dna replication,cell cycle progression,genomic instability,tumor aggressiveness,protein interaction,therapeutic target
ENSG00000100297,MCM5,dna replication licensing,tumor aggressiveness,genomic instability,oncogene activation,apoptosis resistance,cell proliferation enhancement
ENSG00000163481,RNF25,chromatin remodeling,cell cycle regulation,tumor suppressor function,oncogenic substrate targeting,ubiquitin ligase activity,genetic instability
ENSG00000162551,ALPL,tumor suppressor function,loss-of-function mutations,increased cell proliferation,resistance to apoptosis,disrupted cellular homeostasis,dysregulated signaling pathways
ENSG00000163882,POLR2H,oncogenic regulation,transcriptional dysregulation,overexpression mutations,tumor progression,therapeutic target,genomic instability
ENSG00000177700,POLR2L,genomic instability,cell proliferation,dna repair mechanism,transcriptional activity,therapeutic target,genotoxic stress response
ENSG00000125630,POLR1B,ribosome biogenesis,tumor progression,cell proliferation,therapeutic target,rna polymerase i regulation,prognostic marker
ENSG00000136485,DCAF7,cell cycle regulation,ubiquitination,transcriptional regulation,dna damage response,oncogenic signaling pathway,wnt/β-catenin pathway interaction
ENSG00000072518,MARK2,microtubule regulation,tumor promotion,kinase activity,cell cycle regulation,apoptosis modulation,cancer progression
ENSG00000100784,RPS6KA5,mtor pathway activation,cell proliferation enhancement,protein synthesis regulation,oncogenic role identification,tumorigenesis promotion,genomic amplification association
ENSG00000144802,NFKBIZ,nf-κb signaling pathway,inhibition of p65 subunit,transcriptional regulation,cancer cell survival,pro-inflammatory gene repression,tumor progression
ENSG00000017427,IGF1,igf-1 mediated cell proliferation,tumor progression,hormone-dependent pathway,cell survival enhancement,angiogenesis stimulation,poorer prognosis marker
ENSG00000090020,SLC9A1,ph regulation,tumor progression,cell migration,proton pump activation,cancer driver gene,metastasis promotion
ENSG00000169252,ADRB2,cellular proliferation,signal transduction,g protein-coupled receptor activation,downstream pathway stimulation,cell migration and invasion,protein-protein interaction
ENSG00000131095,GFAP,gfap overexpression,oncogenesis promotion,cell proliferation enhancement,epithelial-to-mesenchymal transition regulation,glial cell differentiation suppression,tumor progression facilitation
ENSG00000100412,ACO2,iron-sulfur cluster biogenesis,warburg effect,cellular metabolism,reactive oxygen species (ros),glycolysis regulation,aconitase activity
ENSG00000099995,SF3A1,gain of function mutations,aberrant pre-mrna splicing,oncogene activation,altered protein composition,cell proliferation,apoptosis evasion
ENSG00000012504,NR1H4,bile acid regulation,cell cycle progression,downregulation,epigenetic modulation,genome instability,transcriptional regulation
ENSG00000125503,PPP1R12C,pi3k/akt pathway regulation,constitutive activation,protein degradation dysregulation,cell cycle progression enhancement,tumor suppressor loss of function,mutation-driven oncogenesis
ENSG00000138802,SEC24B,aberrant protein trafficking,deregulated growth factor secretion,oncogenic process modulation,tumor progression driver,therapeutic target,protein secretion regulation
ENSG00000123240,OPTN,autophagic regulation,driver mutation,tumor progression,prognostic marker,cellular survival,ubiquitin-binding protein
ENSG00000124733,MEA1,spindle assembly defect,genomic instability,cell cycle dysregulation,microtubule dynamics regulation,tumor progression,therapeutic target
ENSG00000270647,TAF15,transcriptional regulation,cellular transformation,rna polymerase ii coactivator,tumor progression,cell proliferation,oncogenic transcription
ENSG00000241945,PWP2,transcriptional regulation,chromatin remodeling,genomic stability,protein interaction network,cell proliferation,gene expression modulation
ENSG00000140279,DUOX2,cell migration,dna damage,oncogenic processes,pi3k/akt signaling,reactive oxygen species production,tumor progression
ENSG00000072062,PRKACA,cancer cell proliferation,genomic instability,constitutive activation,oncogenic transformation,therapeutic target,cell survival
ENSG00000107485,GATA3,transcriptional regulation,constitutive activation,overexpression mutations,epithelial cell differentiation,cell proliferation,emt induction
ENSG00000186652,PRG2,emt regulation,proteolytic activity,cell migration facilitation,tumor progression promotion,signaling pathway activation,prognostic marker
ENSG00000069329,VPS35,oncogenic signaling pathway regulation,cellular trafficking disruption,protein misfolding promotion,pi3k/akt pathway activation,therapeutic target identification,genomic instability correlation
ENSG00000141543,EIF4A3,**

translation initiation,cap-dependent translation,regulated expression,oncogenic function,cell proliferation,mrna unwinding
ENSG00000121481,RNF2,chromatin remodeling,genomic instability,cell cycle regulation,e3 ubiquitin ligase activity,dna repair regulation,protein degradation
,H3F3A,gain of function mutations,histone modifications,chromatin remodeling,tumor progression,cell proliferation,cancer-testis antigen regulation
,H3F3B,histone modification,chromatin remodeling,epigenetic regulation,oncogenic function,cellular proliferation,gene overexpression
ENSG00000179583,CIITA,immunosuppression,overexpression,tumor progression,antigen presentation evasion,immune evasion mechanism,mhc class ii regulation
ENSG00000115840,SLC25A12,metabolic reprogramming,hypoxia-inducible factor activation,mitochondrial carrier function,succinate transport facilitation,cellular adaptation to hypoxia,oxidative stress modulation
ENSG00000135047,CTSL,tumor progression,proteolytic activity,immune modulation,cell migration,extracellular matrix degradation,oncogenic signaling
ENSG00000143507,DUSP10,mapk pathway regulation,tumor suppressor function,cellular proliferation inhibition,dual specificity phosphatase activity,mutation or downregulation association with poor prognosis,interactions with regulatory elements and proteins
ENSG00000100721,TCL1A,tumor growth promotion,cell survival enhancement,oncogenic pathway activation,pi3k/akt signaling modulation,immune evasion mechanism,prognostic biomarker
ENSG00000112578,BYSL,oncogenesis,tumor progression,cellular migration,actin cytoskeleton regulation,protein-protein interaction,upregulation
ENSG00000178104,PDE4DIP,camp phosphodiesterase regulation,cellular signaling pathway disruption,oncogenic protein overexpression,uncontrolled cell growth promotion,survival pathway activation,cancer driver gene involvement
ENSG00000170315,UBB,protein degradation,ubiquitination,tumor progression,cellular proliferation,apoptosis inhibition,genomic instability
ENSG00000177971,IMP3,cell proliferation,epithelial-to-mesenchymal transition (emt),oncogene activation,pi3k/akt pathway interaction,metastasis facilitation,biomarker and therapeutic target
ENSG00000133026,MYH10,**
cell adhesion disruption,mechanical tension generation,tumor progression,metastasis facilitation,pi3k/akt pathway interaction,overexpression 
**
ENSG00000108771,DHX58,genomic instability,dna damage response,rna metabolism regulation,chromatin remodeling,transcriptional control,tumor progression
ENSG00000105270,CLIP3,tumor progression,cell migration,metastasis promotion,biomarker potential,cytoskeletal regulation,oncogenic contribution
ENSG00000010318,PHF7,chromatin remodeling,tumor suppressor,genomic instability,epigenetic alterations,dna repair,cell cycle regulation
ENSG00000269190,FBXO17,ubiquitination regulation,cell cycle checkpoint regulation,tumor suppressor degradation,cancer progression association,scf complex component,cell cycle progression regulation
ENSG00000111642,CHD4,chromatin remodeling,loss of function mutations,aberrant gene regulation,tumor aggressiveness,genetic instability,biomarker potential
ENSG00000056097,ZFR,tumor suppressor function,loss of function mutations,rna binding and regulation,dysregulated gene expression,cell cycle disruption,apoptosis inhibition
ENSG00000100142,POLR2F,transcriptional regulation,gain of function mutations,cell proliferation,epithelial-to-mesenchymal transition,cancer stem cell maintenance,poor prognosis
ENSG00000185787,MORF4L1,**
histone-fold protein,chromatin remodeling,transcriptional regulation,oncogene overexpression,cell growth regulation,metabolic adaptation 
**
ENSG00000071243,ING3,tumor suppressor function,genomic instability,cell cycle regulation,protein-protein interaction,pi3k/akt/mtor pathway,poor prognosis
ENSG00000122026,RPL21,ribosomal function,overexpression,cell proliferation,tumor aggressiveness,poor prognosis,oncogene interaction
ENSG00000184990,SIVA1,tumor suppressor function,apoptosis inhibition,cell survival enhancement,signaling pathway modulation,nf-κb pathway interaction,jnk pathway activation
ENSG00000070495,JMJD6,h3k9 demethylation,oncogenic function,p53 degradation,histone modification,tumor progression,prognostic biomarker
ENSG00000142405,NLRP12,inflammation modulation,mitophagy regulation,genomic instability induction,tumor suppression,immune evasion,inflammatory cytokine regulation
ENSG00000144524,COPS7B,protein degradation,cell cycle regulation,ubiquitination pathway,tumor suppressor regulation,cancer development,promoter of tumorigenesis
ENSG00000132970,WASF3,actin cytoskeleton regulation,cell migration promotion,metastasis facilitation,rho gtpase activation,poor prognosis marker,therapeutic target
ENSG00000108107,RPL28,ribosomal subunit composition,cell proliferation regulation,signaling pathway modulation,poor prognosis indicator,biomarker for treatment response,elevated expression levels
ENSG00000109339,MAPK10,cellular stress responses,apoptosis regulation,tumor suppression,genotoxic stress modulation,protein-protein interactions,oncogenic pathway modulation
ENSG00000071082,RPL31,translation initiation,ribosomal assembly,protein synthesis regulation,cell growth promotion,apoptosis suppression,cell cycle progression
ENSG00000082153,BZW1,chromatin remodeling,apoptosis modulation,cell cycle regulation,oncogenic pathway interaction,tumor progression marker,brd4 binding protein
ENSG00000004838,ZMYND10,tumor suppressor,epigenetic regulator,gene transcription regulation,histone modification,chromatin structure maintenance,genome stability regulation
ENSG00000173267,SNCG,dna replication,oncogene overexpression,cell proliferation,apoptosis regulation,angiogenesis promotion,tumor progression
ENSG00000128604,IRF5,inflammation regulation,immune evasion,transcriptional modulation,oncogene overexpression,tumor progression,prognostic marker
ENSG00000130303,BST2,immune evasion,reduced antigen presentation,epigenetic silencing,tumor suppressor function,loss of mhc class i expression,cell surface regulation
ENSG00000274185,LILRA4,immunoregulatory function,immune evasion,tumor microenvironment modulation,leukocyte modulation,oncogenic potential,tumor progression
ENSG00000091592,NLRP1,inflammasome activation,oncogenic processes,cell survival pathways,apoptosis and necrosis regulation,tumor growth and metastasis,prognostic biomarker
ENSG00000197444,OGDHL,dna repair mechanism,tumor suppressor function,cell proliferation regulation,protein degradation pathway,ubiquitination process,genomic stability maintenance
ENSG00000178462,TUBAL3,microtubule stability,microtubule dynamics,cell proliferation,cell migration,survival mechanism,tumor progression
ENSG00000106615,RHEB,mtor activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell cycle regulation
ENSG00000112685,EXOC2,oncogenic function,cell migration and invasion,exocyst complex regulation,prognostic marker,tumor progression,therapeutic target
ENSG00000006451,RALA,rac1 activation,cell proliferation,oncogenic transformation,tumor progression,therapeutic target,gtpase regulation
ENSG00000116954,RRAGC,ras-related signaling,constitutive activation,gtpase activity,cell cycle progression,apoptosis inhibition,therapeutic target
ENSG00000248746,ACTN3,actin cytoskeleton regulation,cell migration enhancement,cancer cell invasion,tumor aggressiveness association,poor prognosis indicator,cellular proliferation increase
ENSG00000166200,COPS2,protein degradation regulation,cell cycle control disruption,oncoprotein stabilization,tumor suppressor degradation,dna damage response modulation,transcriptional regulation dysregulation
ENSG00000060138,YBX3,cell cycle regulation,chromatin remodeling,dna damage response,transcriptional regulation,tumor suppressor function,apoptosis modulation
ENSG00000092445,TYRO3,constitutive activation,tumor progression,immune evasion,angiogenesis promotion,oncogene role,therapeutic target
ENSG00000107874,CUEDC2,p53 regulation,ubiquitin-proteasome pathway disruption,oncoprotein accumulation,cell cycle modulation,protein degradation regulation,tumor suppressor regulation
ENSG00000069667,RORA,apoptosis regulation,circadian rhythm disruption,tumor suppressor function,cell cycle arrest,genetic instability,prognostic marker
ENSG00000087191,PSMC5,altered protein stability,proteasome dysfunction,ubiquitin-proteasome pathway regulation,cell cycle progression,tumor suppressor inactivation,genetic mutation impact
ENSG00000213928,IRF9,interferon-stimulated genes,immune cell modulation,tumor suppression,proliferation inhibition,survival reduction,transcriptional regulation
ENSG00000138814,PPP3CA,oncogenic activation,cell proliferation,epithelial-to-mesenchymal transition (emt),tumor progression,therapeutic target,protein phosphatase activity
ENSG00000169288,MRPL1,cell proliferation,epithelial-to-mesenchymal transition (emt),mitochondrial protein synthesis,apoptosis inhibition,oncogene overexpression,biomarker potential
ENSG00000149273,RPS3,altered protein synthesis,cell proliferation,increased cell survival,oncogene overexpression,prognostic marker,ribosome assembly
ENSG00000144028,SNRNP200,aberrant splicing events,genomic instability,oncogenic transformation,pre-mrna splicing regulation,alternative splicing modulation,dna repair pathway interaction
ENSG00000066044,ELAVL1,pro-tumorigenic microenvironment,rna-binding protein,oncogenic mrna stabilization,tumor aggressiveness promotion,therapeutic target,cellular signaling pathway modulation
ENSG00000125347,IRF1,tumor progression,jak/stat pathway modulation,cell cycle regulation,apoptosis suppression,dna repair dysregulation,transcriptional regulation
ENSG00000107201,DDX58,immune evasion,cell growth regulation,viral replication,dsrna recognition,oncogenesis,malignant transformation
ENSG00000136153,LMO7,transcriptional regulation,protein-protein interaction,cell cycle regulation,apoptosis evasion,tumorigenesis modulation,cancer aggressiveness
ENSG00000082014,SMARCD3,chromatin remodeling,tumor suppression,genomic instability,altered gene expression,cell cycle regulation,dna repair
ENSG00000178307,TMEM11,cellular trafficking,oncogene expression,tumor progression,aberrant protein transport,signaling pathway interaction,genomic instability
ENSG00000087077,TRIP6,cell cycle regulation,apoptosis inhibition,protein-protein interaction,chromatin remodeling,oncogenic overexpression,poor prognosis marker
ENSG00000103423,DNAJA3,tumor progression,oncogenic function,protein folding,cellular proliferation,apoptosis inhibition,therapeutic target
ENSG00000197561,ELANE,immune modulation,angiogenesis regulation,metastasis regulation,tumor progression,cell migration,apoptosis regulation
ENSG00000158578,ALAS2,**
heme biosynthesis,reactive oxygen species production,iron regulatory protein interaction,apoptosis inhibition,cell cycle progression enhancement,angiogenesis promotion
**
ENSG00000132703,APCS,heparan sulfate proteoglycan biosynthesis,cellular adhesion regulation,growth factor binding modulation,tumor progression facilitation,proteoglycan dysregulation,glycosaminoglycan synthesis disruption
ENSG00000165471,MBL2,mannose-binding lectin function,carbohydrate recognition mechanism,innate immune response regulation,cancer cell evasion,tumor growth promotion,immune cell modulation
ENSG00000050405,LIMA1,oncogene,transcription factor,cell cycle regulation,apoptosis modulation,protein-protein interaction,survival pathway
ENSG00000153201,RANBP2,nuclear transport regulation,ran gtpase interaction,cell cycle control,genomic instability,tumor aggressiveness,cancer driver gene
ENSG00000173599,PC,collagen regulation,tissue integrity maintenance,protein processing enhancer,cellular matrix modulation,cancer cell growth influence,metastasis impact
ENSG00000011304,PTBP1,cell cycle regulation,spliceosome regulation,apoptosis evasion,tumor aggressiveness,gene expression modulation,prognostic biomarker
ENSG00000105963,ADAP1,pi3k/akt pathway activation,epithelial-to-mesenchymal transition (emt) regulation,tumor progression facilitation,cell-cell adhesion modulation,metastasis promotion,pleiotropic signaling regulator
ENSG00000100316,RPL3,ribosome biogenesis,aberrant expression,tumorigenesis promotion,cell growth enhancement,protein synthesis regulation,cancer cell adaptation
ENSG00000262406,MMP12,mmp12 overexpression,tumor progression,extracellular matrix degradation,cell migration and invasion,therapeutic target,pi3k/akt signaling regulation
ENSG00000102119,EMD,chromatin remodeling,cellular proliferation,histone modification,nuclear envelope disruption,oncogenic transformation,tumor progression
ENSG00000115661,STK16,cell cycle regulation,centrosome maturation,chromosome instability,mitotic spindle assembly,aneuploidy promotion,microtubule dynamics regulation
ENSG00000198668,CALM1,pi3k/akt pathway regulation,calcium-dependent signaling modulation,protein kinase activation,cell proliferation promotion,oncogenic driver status,signaling pathway interaction
ENSG00000172183,ISG20,cellular regulation,apoptosis regulation,genomic instability,dna repair modulation,tumor suppressor protein degradation,biomarker discovery
ENSG00000179562,GCC1,cellular redox regulation,glutathione synthesis,chemoresistance,cell survival,antioxidant capacity,tumor cell metabolism
ENSG00000128272,ATF4,cellular adaptation,transcriptional regulation,oncogenic signaling,tumor progression,cancer therapy target,metabolic stress response
ENSG00000275796,NLRP2,nlrp2 mediated inflammation,cancer associated inflammation,immune suppression,apoptosis evasion,signaling pathway modulation,tumor progression
ENSG00000132530,XAF1,apoptosis inhibition,casitas b-lineage lymphoma (cbl) interaction,cell survival promotion,cancer progression driver,dna damage response dysregulation,xiap antagonist activity
ENSG00000083444,PLOD1,collagen degradation,extracellular matrix remodeling,tumor progression,cell migration and invasion,angiogenesis promotion,poor prognosis marker
ENSG00000221869,CEBPD,transcriptional regulation,tumor suppressor function,apoptosis inhibition,promoter binding,nf-κb pathway interaction,cell cycle modulation
ENSG00000084463,WBP11,wd40-repeat family,transcriptional regulation,cell proliferation regulation,tumor progression marker,e3 ubiquitin ligase modulation,cancer cell survival pathway
ENSG00000120217,CD274,immune suppression,tumor immune evasion,pd-1/pd-l1 interaction,oncogene overexpression,angiogenesis promotion,metastasis facilitation
ENSG00000276977,PDCD1,immune checkpoint regulation,tumor immune evasion,immunosuppression enhancement,prognostic marker,cancer immunotherapy target,genetic variation association
ENSG00000089022,MAPKAPK5,mapk signaling pathway,oncogene regulation,cell proliferation,transcription factor activation,genomic instability,dna repair
ENSG00000185386,MAPK11,p38 signaling pathway,oncogenic potential,cell proliferation regulation,apoptosis suppression,tumor aggressiveness marker,signaling cascade modulation
ENSG00000106462,EZH2,histone modification,gene silencing,oncogene expression,epigenetic regulation,cell proliferation,tumor suppressor suppression
ENSG00000034713,GABARAPL2,autophagy regulation,oncogenic driver,pi3k/akt pathway modulation,cell survival enhancement,apoptosis resistance,poor prognosis marker
ENSG00000234846,NEU1,oncogenesis,cell adhesion modulation,glycosylation regulation,prognostic marker,tumor progression,cell migration modulation
ENSG00000198911,SREBF2,metabolic reprogramming,cell proliferation,fatty acid synthesis,cholesterol biosynthesis,oncogenic signaling,transcription factor activation
ENSG00000184381,PLA2G6,cell migration,cell invasion,pi3k/akt pathway,oncogenesis,lysophospholipids production,prostaglandins regulation
ENSG00000132522,GPS2,pi3k/akt pathway activation,gain of function mutations,cell growth regulation,tumor progression,oncogenic signaling,cancer driver gene
ENSG00000156265,MAP3K7CL,**

nf-kappab activation,cell survival promotion,metastatic potential,immune evasion,oncogene regulation,apoptosis suppression
**
ENSG00000162889,MAPKAPK2,cell cycle progression,oncogenic transformation,tumor progression,therapeutic target,enhanced cell proliferation,cell survival mechanism
ENSG00000129167,TPH1,serotonin synthesis,cell proliferation,tumor progression,metastasis promotion,angiogenesis,protein interaction
ENSG00000110906,KCTD10,btb/poz domain,transcriptional regulation,tumor suppressor,cell proliferation inhibition,ubiquitination regulation,oncoprotein regulation
ENSG00000143878,RHOB,tumor suppressor or oncogene,rho gtpase signaling,cell cycle progression regulation,apoptosis modulation,cytoskeletal organization,metastasis promotion
ENSG00000043591,ADRB1,gain of function mutations,constitutive activation,cellular proliferation,cell survival,signaling pathway regulation,genomic profiling
ENSG00000136541,ERMN,increased expression,tumor progression,cell migration,cytoskeleton regulation,oncogene activation,pi3k/akt interaction
ENSG00000107164,FUBP3,transcriptional regulation,cell cycle control,nuclear protein function,oncogenic pathway modulation,tumor progression,metastasis
ENSG00000129083,COPB1,chaperone regulation,gene amplification,cell survival,signaling pathway modulation,wnt/β-catenin pathway regulation,protein homeostasis
ENSG00000140859,KIFC3,microtubule-based transport,genomic instability,mitotic checkpoint regulation,chromosomal segregation,oncogenic protein interaction,aneuploidy driver
ENSG00000079462,PAFAH1B3,**

cell migration,pro-inflammatory mediator degradation,tumor progression,therapeutic target,genomic instability,signaling pathway regulation

**
ENSG00000072201,LNX1,pi3k/akt pathway,tumor progression,oncogenesis,cancer biology,akt interaction,mutations
ENSG00000178952,TUFM,tumor progression,protein quality control,mitochondrial homeostasis disruption,cell survival enhancement,apoptosis suppression,oxidative stress induction
ENSG00000130165,ELOF1,mitochondrial transcription regulation,pi3k/akt pathway interaction,cellular metabolism modulation,tumor progression contribution,genomic instability influence,oncogenic process involvement
ENSG00000239732,TLR9,cancer-testis antigen expression,immune evasion mechanism,innate immune regulation,nf-κb pathway activation,pro-inflammatory cytokine production,tumor progression facilitation
ENSG00000052723,SIKE1,ribonuclease l inhibition,immune evasion mechanisms,tumor microenvironment modulation,oncogenic processes promotion,host immune response regulation,viral persistence facilitation
ENSG00000100453,GZMB,apoptosis regulation,cytotoxic t cell function,effector molecule activation,cell death induction,tumor progression,promoter of apoptosis
ENSG00000174106,LEMD3,chromatin remodeling,cell growth regulation,tumor progression marker,therapeutic target,cell proliferation enhancement,nuclear architecture modulation
ENSG00000152492,CCDC50,dna damage response,genomic instability,homologous recombination repair,cell cycle progression,brca1 interaction,oncogenic mutations
ENSG00000225921,NOL7,cellular proliferation,oncogenic transformation,rna processing,cell cycle regulation,protein synthesis,tumor progression
ENSG00000145907,G3BP1,rna-binding protein,oncogenesis promotion,cell growth regulation,mrna stability modulation,translation efficiency enhancement,cell survival inhibition
ENSG00000117335,CD46,cell adhesion regulation,complement system modulation,immune evasion facilitation,invasion promotion,kinase activity regulation,signaling pathway interaction
ENSG00000137309,HMGA1,transcriptional regulation,cell proliferation,oncogene activation,chromatin remodeling,tumor invasion,metastasis facilitation
ENSG00000130340,SNX9,retromer complex regulation,endosomal trafficking regulation,actin cytoskeleton modulation,oncogenic protein expression regulation,cell migration and invasion enhancement,prognostic marker potential
ENSG00000079739,PGM1,glucose metabolism,cancer cell proliferation,glycolytic upregulation,enzyme activity,energy production,cell survival
ENSG00000272804,KRTAP10-7,keratin-associated protein function,overexpression in cancer,cell proliferation enhancement,pi3k/akt pathway involvement,tumor progression marker,biomarker for disease prognosis
ENSG00000164346,NSA2,chromatin remodeling,transcriptional regulation,oncogenic driver,tumor progression,cell proliferation,genomic instability
ENSG00000111640,GAPDH,tumor metabolism,metabolic regulation,cell proliferation,apoptosis regulation,protein-protein interaction,transcriptional regulation
ENSG00000085978,ATG16L1,enhanced autophagy,oncogenic process,tumor growth,cell proliferation,metabolic reprogramming,resistance to chemotherapy
ENSG00000100290,BIK,loss of expression,tumor suppressor,apoptosis regulation,promoter hypermethylation,tumor progression,mitochondrial outer membrane permeabilization
ENSG00000140379,BCL2A1,apoptosis inhibition,cell survival pathway,gain of function mutations,oncogenic driver,tumor progression,promotes resistance to chemotherapy
ENSG00000143556,S100A7,overexpression,oncogenic role,tumor suppressor,epithelial cell expression,cell proliferation regulation,interaction with other proteins
ENSG00000073861,TBX21,tumor-promoting transcription factor,overexpression in cancer,immune suppression mechanism,inflammation regulation,oncogenic function,tumor microenvironment modulation
ENSG00000148798,INA,cell adhesion,oncogene potential,tumor progression,prognostic marker,cell migration,immunoglobulin superfamily
ENSG00000124214,STAU1,microrna regulation,cell cycle regulation,mrna binding protein,oncogenic transformation driver,cell growth promotion,signal transduction pathway interaction
ENSG00000115524,SF3B1,oncogenic splicing,alternative splice sites,constitutive activation,tumor growth,splicing machinery,genomic instability
ENSG00000173327,MAP3K11,**

apoptosis regulation,cell proliferation,immune response modulation,mitogen-activated protein kinase pathway,protein kinase activation,tumor suppressor function 

**
ENSG00000115946,PNO1,palmitoylation regulation,protein-protein interaction,oncogenic signaling pathway,cell proliferation regulation,tumor progression,therapeutic target
ENSG00000120616,EPC1,epithelial-to-mesenchymal transition,cell detachment and migration,adhesion molecule regulation,tumor progression and metastasis,signaling pathway modulation,cancer aggressiveness marker
ENSG00000117115,PADI2,citrullination regulation,post-translational modification,chromatin remodeling,transcriptional regulation,cell proliferation modulation,metastasis facilitation
ENSG00000143631,FLG,tumor progression,cell invasion,epithelial barrier disruption,cell proliferation enhancement,protein expression reduction,cancer association
ENSG00000084674,APOB,apob-related lipid metabolism,cholesterol homeostasis regulation,cell proliferation enhancement,tumor progression facilitation,protein-lipid interactions modification,oncogenic potential contribution
ENSG00000175197,DDIT3,dna damage response,tumor suppressor function,transcriptional regulation,apoptosis modulation,cancer stem cell maintenance,oncogenic signaling pathway modulation
ENSG00000136450,SRSF1,alternative splicing regulation,cancer driver mutation,gene expression modulation,oncogenic function,rna-binding protein interaction,splice site selection
ENSG00000141570,CBX8,genomic instability,chromatin remodeling,polycomb repressive complex 1,histone h2a monoubiquitination,cell cycle regulation,tumor progression
ENSG00000008988,RPS20,ribosomal function,cell proliferation regulation,cancer stem cell regulation,epigenetic modifications,angiogenesis promotion,tumor progression acceleration
ENSG00000128973,CLN6,lysosome regulation,autophagic flux modulation,mitochondrial dynamics influence,autophagy modulation,tumor aggressiveness,genomic instability
ENSG00000058262,SEC61A1,protein translocation,er-associated degradation,cellular growth regulation,tumor progression,kinase activation,transcriptional modulation
ENSG00000130811,EIF3G,protein synthesis regulation,gain of function mutations,oncogenic driver,mtor signaling pathway,cell proliferation enhancement,tumor growth promotion
ENSG00000162601,MYSM1,epigenetic regulation,chromatin remodeling,genomic instability,tumor progression,dna damage response,ubiquitination pathway
ENSG00000166598,HSP90B1,hsp90 chaperone,constitutive activation,cell proliferation,genomic instability,dna repair regulation,protein homeostasis
ENSG00000167987,VPS37C,endosomal sorting,oncogenic function,cell proliferation,metastatic potential,epithelial-to-mesenchymal transition (emt),protein degradation regulation
ENSG00000121807,CCR2,tumor microenvironment modulation,immune cell recruitment,angiogenesis promotion,fibrosis induction,metastasis facilitation,prognostic marker
ENSG00000120438,TCP1,protein folding regulation,cell cycle progression,tumor growth promotion,aberrant protein aggregation,chaperone function loss,subcellular localization disruption
ENSG00000171435,KSR2,oncogenic signaling,cell proliferation,kinase activation,scaffold protein function,mapk pathway regulation,tumor progression
ENSG00000113595,TRIM23,ubiquitination regulation,tumor suppressor function,cell cycle modulation,apoptosis evasion,metastatic enhancement,genomic instability
ENSG00000120896,SORBS3,oncogenic activity,cellular proliferation,apoptosis modulation,cancer progression,tumor aggressiveness,protein-protein interaction domain
ENSG00000170482,SLC23A1,**

glycosylation,cell surface expression,transmembrane transporter,nucleotide sugar uptake,cancer cell proliferation,poor prognosis indicator

**
ENSG00000104812,GYS1,glycogen biosynthesis,cell proliferation,tumor aggressiveness,metabolic regulation,oncogenesis,energy metabolism
ENSG00000150459,SAP18,chromatin remodeling,oncogene regulation,transcriptional regulation,cell proliferation,gene expression profiling,tumor suppressor interaction
ENSG00000188529,SRSF10,splice site selection,oncogene activation,cancer cell survival,alternative splicing regulation,tumor progression,rna-binding protein interaction
ENSG00000013364,MVP,apoptosis modulation,cell proliferation,cancer aggressiveness,dna repair mechanisms,tumor prognosis,cell cycle regulation
ENSG00000162664,ZNF326,transcriptional regulation,overexpression associated,tumor progression,epithelial-to-mesenchymal transition (emt),oncogenic pathway activation,protein-protein interactions
ENSG00000168310,IRF2,genomic instability,resistance to apoptosis,enhanced proliferation,transcriptional regulation,tumor promotion,cell cycle progression
ENSG00000142541,RPL13A,rpl13a overexpression,protein synthesis regulation,cell growth enhancement,apoptosis resistance,tumor aggressiveness promotion,genomic amplification
ENSG00000214753,HNRNPUL2,cell proliferation,epigenetic regulation,gene expression regulation,microrna interaction,post-transcriptional modification,oncogenic activity
ENSG00000088833,NSFL1C,protein degradation regulation,tumor progression,cell proliferation promotion,autophagy inhibition,apoptosis inhibition,ubiquitin-proteasome pathway involvement
ENSG00000150991,UBC,protein degradation,tumor suppressor protein regulation,cancer cell proliferation,cell cycle progression,ubiquitination pathway regulation,tumorigenesis facilitation
ENSG00000164118,CEP44,cell cycle regulation,chromosomal instability,mitotic checkpoint activation,microtubule dynamics,centrosomal localization,overexpression
ENSG00000047315,POLR2B,dna repair mechanisms,genome instability,oncogenesis,transcriptional regulation,cell cycle control,cancer driver gene
ENSG00000164111,ANXA5,epithelial-to-mesenchymal transition,cell proliferation,cell survival,pi3k/akt pathway modulation,metastasis facilitation,tumor progression
ENSG00000008438,PGLYRP1,immune response modulation,antimicrobial activity,cell-cell interaction regulation,tumor microenvironment modulation,oncogenic potential,inflammatory response influence
ENSG00000163257,DCAF16,cell cycle regulation,chromatin remodeling,dna repair mechanisms,oncogenic phenotypes,proteasomal degradation pathway,tumor suppressor protein interaction
ENSG00000130939,UBE4B,ubiquitin conjugation regulation,cellular homeostasis disruption,apoptosis evasion,genomic instability induction,tumor progression facilitation,therapeutic target potential
ENSG00000010278,CD9,cell adhesion disruption,tumor progression facilitation,epithelial-to-mesenchymal transition regulation,biomarker potential,metastasis promotion,cell survival enhancement
ENSG00000169403,PTAFR,phospholipid metabolism regulation,tumor progression modulation,cell proliferation influence,oncogenic processes involvement,genetic alteration impact,therapeutic target potential
ENSG00000240583,AQP1,tumor aggressiveness,overexpression,enhanced cell migration,therapeutic target,glycosylation regulation,prognostic marker
ENSG00000109906,ZBTB16,cellular homeostasis regulation,tumor suppression,genomic stability maintenance,dna repair regulation,transcriptional modulation,apoptosis induction
ENSG00000164877,MICALL2,epithelial-to-mesenchymal transition (emt),cell migration and invasion,prognostic marker,pi3k/akt pathway regulation,cell survival and proliferation regulation,cancer cell metastasis promotion
ENSG00000077522,ACTN2,actin cytoskeleton regulation,cell adhesion molecule regulation,oncogene activation,tumor cell proliferation,cell migration and invasion,prognostic marker
ENSG00000231408,LTA,tumor progression,immune suppression,angiogenesis promotion,cell survival regulation,oncogenic function,immunomodulation
ENSG00000053372,MRTO4,cellular growth regulation,dna damage response modulation,genotoxic stress activation,apoptosis suppression,tumor progression correlation,biomarker potential
ENSG00000134107,BHLHE40,oncogene,overexpression,transcriptional regulation,cell cycle progression,tumor proliferation,pi3k/akt pathway interaction
ENSG00000188747,NOXA1,bcl2 family interaction,apoptosis induction,pro-apoptotic function,cancer cell death,mitochondrial outer membrane permeabilization,cytochrome c release
ENSG00000168135,KCNJ4,cellular proliferation,cell survival,ion homeostasis disruption,pi3k/akt pathway activation,oncogenic signaling pathways,cell differentiation inhibition
ENSG00000116711,PLA2G4A,arachidonic acid release,cell proliferation,tumor progression,nf-κb signaling pathway,cancer metastasis,inflammation regulation
ENSG00000055332,EIF2AK2,integrated stress response pathway,cell survival signaling,tumor progression regulation,cell cycle modulation,apoptosis evasion mechanism,kinase activation
ENSG00000129673,AANAT,**

melatonin synthesis regulation,oncogenic pathway activation,cell cycle progression enhancement,apoptosis evasion,chemoresistance induction,prognostic marker status 

**
ENSG00000181789,COPG1,regulation of ubiquitin-proteasome pathway,disruption of protein degradation,accumulation of defective proteins,cancer driver gene,cell cycle progression regulation,dna damage response regulation
ENSG00000130222,GADD45G,dna damage repair,tumor suppressor function,genomic instability,cell cycle arrest,apoptosis regulation,cellular interaction with p53 pathway
ENSG00000160339,FCN2,tumor microenvironment manipulation,immune evasion mechanisms,cell adhesion regulation,growth factor interaction,oncogenic signaling pathway modulation,cancer associated gene expression
ENSG00000163661,PTX3,angiogenesis enhancement,cell migration promotion,complement system interaction,immune evasion mechanism,pro-inflammatory cytokine secretion,tumor progression facilitation
ENSG00000136709,WDR33,cell cycle regulation,tp53 interaction,oncogene role,genomic instability,apoptosis inhibition,cell proliferation enhancement
ENSG00000101596,SMCHD1,chromatin remodeling,genomic instability,tumor suppressor function,chromosomal abnormalities,dna repair mechanism,cancer progression
ENSG00000138764,CCNG2,genomic instability,regulatory subunit inhibition,aberrant cell cycle progression,tumor suppressor function loss,dna damage response pathway disruption,multifaceted interactions
ENSG00000172809,RPL38,ribosomal protein regulation,protein synthesis modulation,gene expression alteration,cellular metabolism influence,rna binding activity,tumor progression association
ENSG00000170634,ACYP2,constitutive activation,genomic instability,altered metabolism,oncogenic signaling,mutations driving cancer,promoter hypermethylation
ENSG00000110169,HPX,iron metabolism disruption,tumor progression,metastasis induction,cell proliferation enhancement,iron regulatory protein interaction,protein-protein binding
ENSG00000005022,SLC25A5,mitochondrial metabolism,citrate export regulation,altered metabolic profile,oncogenic process activation,warburg effect participation,cancer progression enhancement
ENSG00000263465,SRSF8,alternative splicing regulation,cell proliferation promotion,dna damage response disruption,gene expression modulation,protein-protein interaction enhancement,tumor progression facilitation
ENSG00000007952,NOX1,nox1-generated ros,redox regulation,cell proliferation,tumor progression,prognostic marker,oncogenic driver
ENSG00000106538,RARRES2,rar-related transcriptional regulation,oncogenic transformation,cell proliferation regulation,tumor progression,apoptosis inhibition,transcriptional modulation
ENSG00000178028,DMAP1,epigenetic regulation,chromatin remodeling,tumor suppressor silencing,oncogenic pathway activation,cell proliferation enhancement,apoptosis evasion
ENSG00000144635,DYNC1LI1,cell cycle regulation,dna damage response,mitotic spindle formation,chromosomal instability,microtubule dynamics,pi3k/akt pathway activation
ENSG00000149534,MS4A2,immune evasion,tumor progression,b-cell regulation,autoimmune disorders,cancer biology,gene expression
ENSG00000145649,GZMA,chemosensitization,tumor immune evasion,cell lysis regulation,cytotoxic t lymphocytes activation,gene amplification,immunosuppression
ENSG00000173641,HSPB7,heat shock response,tumor suppressor activity,cytoplasmic localization,cellular stress regulation,protein-protein interactions,mitochondrial protection
ENSG00000156711,MAPK13,p38 mapk pathway,oncogenic process,tumor progression,cellular stress response,inflammation regulation,dysregulation of apoptosis
ENSG00000065328,MCM10,genomic instability,aneuploidy,cell proliferation,replicative helicase loader,oncogene role,dna replication
ENSG00000108578,BLMH,dna repair mechanisms,chromosomal instability,genomic alterations,cell proliferation enhancement,tumor progression facilitation,prognostic marker
ENSG00000112874,NUDT12,genomic instability,nucleotide removal,dna repair dysfunction,cancer progression,mutagenesis enhancement,prognostic marker
ENSG00000091732,ZC3HC1,ubiquitin ligase activity,cell proliferation,tumor suppressor degradation,aggressive disease phenotype,poor prognosis,molecular interaction
ENSG00000213465,ARL2,amplification driven,cell proliferation,egfr interaction,genomic instability,microtubule regulation,oncogenic signaling
ENSG00000152795,HNRNPDL,alternative splicing regulation,cell migration facilitation,oncogenic transcript promotion,microrna processing regulation,tumor suppressor mirna targeting,overexpression in blca tumors
ENSG00000092067,CEBPE,emt regulation,tumor progression,gene expression regulation,dysregulation associated,cell cycle modulation,metastasis promotion
ENSG00000138326,RPS24,cellular proliferation,mrna translation regulation,protein synthesis modulation,ribosomal function,nuclear localization,apoptosis regulation
ENSG00000213923,CSNK1E,wnt/β-catenin signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,protein kinase regulation
ENSG00000186847,KRT14,epithelial integrity loss,gene amplification,cell adhesion disruption,emt activation,molecular marker,prognostic significance
ENSG00000158773,USF1,transcriptional regulation,aberrant activation,oncogenic driver,cell proliferation,chromatin modification,therapeutic target
ENSG00000116251,RPL22,ribosomal biogenesis,cell proliferation,oncogene upregulation,poor prognosis,protein interaction network,cell cycle regulation
ENSG00000169760,NLGN1,oncogenic function,cellular proliferation,neuronal transmission regulation,transmembrane protein interaction,signaling pathway modulation,adhesion molecule expression
ENSG00000163512,AZI2,cellular proliferation inhibition,tumor suppression,dna repair regulation,transcriptional modulation,oncogenic insult response,genomic stability maintenance
,QARS,translation initiation,regulation of gene expression,cellular proliferation,protein synthesis,tumor progression,oncogenic potential
ENSG00000175899,A2M,tumor-promoting effects,poor prognosis association,cell migration regulation,inflammation modulation,protease binding protein,cell proliferation enhancement
ENSG00000169220,RGS14,pi3k/akt pathway regulation,g-protein signaling modulation,oncogenic protein interaction,tumor aggressiveness promotion,biomarker potential,cell migration enhancement
ENSG00000262845,KRT40,overexpression,cell proliferation,epithelial differentiation,tumor progression,biomarker potential,cancer-specific expression
ENSG00000105383,CD33,immune evasion,oncogenic signaling,cell adhesion,monoclonal antibody target,myeloid cell regulation,immunotherapy
ENSG00000122566,HNRNPA2B1,alternative splicing,oncogenic protein interaction,genomic instability,poor prognosis marker,splicing pattern dysregulation,cell cycle progression
ENSG00000134419,RPS15A,ribosomal function,translational regulation,tumor progression,genomic instability,protein synthesis dysregulation,cancer cell adaptation
ENSG00000104884,ERCC2,genomic instability,dna repair disruption,tumor suppressor function,cell cycle regulation,nucleotide excision repair,mutations leading to cancer
ENSG00000075856,SART3,transcriptional regulation,tumor progression,oncogenic driver,gene expression dysregulation,pi3k/akt pathway activation,prognostic biomarker
ENSG00000147082,CCNB3,**
cell proliferation,genomic instability,cyclin regulation,mitotic entry,apoptosis resistance,g2/m phase transition
**
ENSG00000090924,PLEKHG2,oncogenic potential,cell migration and invasion,pleckstrin homology domain,pi3k signaling pathway,cytoskeletal dynamics modulation,tumorigenesis promotion
ENSG00000162511,LAPTM5,lysosomal function regulation,apoptosis suppression,mitochondrial membrane interaction,tumor progression enhancement,metastasis promotion,biomarker candidate
ENSG00000099204,ABLIM1,cytoskeletal regulation,cell migration,epithelial-to-mesenchymal transition (emt),therapeutic target,prognostic biomarker,cellular invasion
ENSG00000159200,RCAN1,calcineurin regulation,tumor growth promotion,cell adhesion modulation,protein-protein interaction,cell migration enhancement,prognostic marker
ENSG00000117632,STMN1,microtubule dynamics,microtubule degradation,cellular proliferation,apoptosis resistance,tumor progression,microtubule-associated proteins interaction
ENSG00000163694,RBM47,cellular regulation,pre-mrna processing,oncogenic processes,tumor aggressiveness,metabolic reprogramming,apoptosis resistance
ENSG00000084093,REST,tumor suppressor,cell cycle regulation,transcriptional repressor,genomic instability,apoptosis modulation,epigenetic regulation
ENSG00000180772,AGTR2,oncogenic potential,cell proliferation,tumor progression,angiotensin ii receptor activation,pi3k/akt pathway activation,mapk/erk signaling activation
ENSG00000156709,AIFM1,apoptosis regulation,genomic stability maintenance,mitochondrial localization,cell death pathway modulation,tumor suppressor function,genetic instability promotion
ENSG00000143033,MTF2,transcriptional regulation,cell proliferation,dna repair,tumor progression,genomic instability,cell cycle regulation
ENSG00000009724,MASP2,complement activation,oncogenic activity,extracellular matrix degradation,cell migration enhancement,pro-tumor immune response modulation,tumor progression promotion
ENSG00000085265,FCN1,immune evasion,cell surface dynamics,tumor microenvironment modulation,lectin-like activity,adhesion molecule regulation,cancer progression
ENSG00000171566,PLRG1,protein-protein interaction,scaffold protein function,nf-κb pathway regulation,mapk/erk signaling modulation,cell proliferation enhancement,tumor progression
ENSG00000126581,BECN1,autophagy regulation,apoptosis modulation,cellular metabolism alteration,tumor suppression,genomic instability,lipid degradation
ENSG00000138642,HERC6,tumor suppressor,ubiquitin ligase activity,cell cycle regulation,dna repair pathway,prognostic marker,cancer susceptibility gene
ENSG00000138641,HERC3,enhanced cell proliferation,metastasis promotion,ubiquitination pathway,nf-κb signaling activation,oncogenic protein regulation,cell survival enhancement
ENSG00000168090,COPS6,cell cycle regulation,neddylation pathway activation,genomic instability,protein degradation dysregulation,cancer progression facilitation,tumor suppressor function
ENSG00000142937,RPS8,translation initiation,constitutive expression,cell cycle progression,protein synthesis regulation,oncogenic potential,tumor growth promotion
ENSG00000127152,BCL11B,transcription factor regulation,cell proliferation promotion,apoptosis resistance,epithelial-to-mesenchymal transition (emt),poor prognosis marker,tumor progression facilitation
ENSG00000159140,SON,oncogene,cell proliferation,signaling pathway regulation,cell survival,protein interaction,metastasis promotion
ENSG00000074317,SNCB,cell cycle regulation,dna repair modulation,ion channel interaction,oncogene overexpression,tumor progression,pi3k/akt pathway activation
ENSG00000101444,AHCY,methylation regulation,cell growth modulation,dna methylation alteration,therapeutic target,aberrant expression,cancer cell proliferation
ENSG00000062725,APPBP2,cellular regulation,chromosomal instability,apoptosis modulation,gene expression regulation,tumor progression,metastasis promotion
ENSG00000089094,KDM2B,histone demethylation,chromatin regulation,oncogenic pathway activation,cell proliferation enhancement,metastasis promotion,therapeutic target
ENSG00000205542,TMSB4X,emt regulation,wnt/β-catenin pathway interaction,cell proliferation enhancement,tumor growth promotion,epithelial-to-mesenchymal transition facilitation,transcription factor binding
ENSG00000166037,CEP57,centrosome stability,mitotic checkpoint dysfunction,chromosomal instability,growth factor signaling,cellular migration,genomic mutation
ENSG00000180209,MYLPF,overexpression,cell migration,tumor progression,oncogene interaction,metastasis promotion,cell proliferation enhancement
ENSG00000163565,IFI16,genomic instability,pi3k/akt inhibition,cell proliferation,tumor suppression,apoptosis regulation,dna repair dysfunction
ENSG00000167460,TPM4,microtubule stabilization,cell migration promotion,metastasis regulation,prognostic marker,poor prognosis association,aggressive tumor behavior
ENSG00000198814,GK,redox regulation,glutathione reduction,tumor progression,metastasis,cellular antioxidant defense,cancer cell survival
ENSG00000123358,NR4A1,nr4a1 oncogenic function,pi3k/akt pathway activation,transcriptional regulation,tumor progression,therapeutic target,genomic profiling
ENSG00000214944,ARHGEF28,rho gtpase signaling pathway,constitutive activation,gain of function mutations,cell proliferation enhancement,tumor invasion and metastasis,oncogene overexpression
ENSG00000197647,ZNF433,oncogenic function,transcriptional regulation,cell growth promotion,tumor progression,metastasis facilitation,overexpression in cancer
ENSG00000012779,ALOX5,leukotriene biosynthesis,pro-inflammatory mediator,inflammation promotion,tumor growth promotion,oncogenic process,therapeutic target
ENSG00000116688,MFN2,mitochondrial biogenesis,tumor growth promotion,cell survival regulation,metabolic regulation,prognostic marker,therapeutic target
ENSG00000121957,GPSM2,regulation of heterotrimeric g-proteins,oncogenic signaling,cell migration and invasion,therapeutic target,tumor progression,signaling modulation
ENSG00000106263,EIF3B,translation initiation,cell proliferation,oncogenic transformation,protein synthesis regulation,apoptosis resistance,tumor progression
ENSG00000100028,SNRPD3,pre-mrna splicing disruption,oncofetal gene,tumor progression,metastasis regulation,cancer-associated transcriptome,aberrant splice variant formation
ENSG00000019549,SNAI2,emt,transcription factor regulation,cell migration,adhesion molecule suppression,metastatic potential,genetic instability
ENSG00000198932,GPRASP1,egfr pathway,overexpression,protein-protein interactions,scaffold function,tumor progression,poor prognosis
ENSG00000169567,HINT1,apoptosis regulation,cancer suppression,dna repair interaction,genomic instability prevention,nuclear localization,tumor suppressor function
ENSG00000166483,WEE1,dna damage checkpoint,cell cycle regulation,g2/m phase transition,chemosensitivity,apoptosis suppression,cancer driver mutation
ENSG00000151846,PABPC3,oncogene,cell proliferation,mrna translation regulation,prognostic marker,protein-protein interaction,therapeutic target
ENSG00000102010,BMX,**
 tyrosine kinase activity,oncogene activation,pi3k/akt pathway interaction,cell proliferation promotion,tumor progression facilitation,poor prognosis association
ENSG00000159176,CSRP1,pi3k/akt signaling pathway activation,oncogenic transcriptional coactivator,epithelial-to-mesenchymal transition regulation,cell proliferation and migration promotion,tumor progression and aggressiveness enhancement,potential therapeutic target
ENSG00000125691,RPL23,ribosomal translation,cell cycle regulation,mutations associated,oncogenic activity,protein synthesis regulation,tumor maintenance
ENSG00000236014,VPS52,protein sorting disruption,endosomal trafficking dysfunction,cellular stress induction,proliferation enhancement,genomic instability contribution,signaling pathway modulation
ENSG00000127837,AAMP,genomic stability,homologous recombination repair,cell proliferation regulation,antitumor response modifier,tumor suppressor function,genomic instability mediator
ENSG00000127483,HP1BP3,chromatin remodeling,epigenetic regulation,gene expression modulation,tumor progression facilitation,cancer-related protein interactions,genomic instability contribution
ENSG00000072210,ALDH3A2,oxidative stress protection,epithelial-to-mesenchymal transition,cell proliferation enhancement,detoxification of aldehydes,chemosensitivity reduction,redox balance regulation
ENSG00000196218,RYR1,calcium release channel,genomic instability,cell proliferation,chemoresistance,pi3k/akt pathway interaction,intracellular calcium regulation
ENSG00000130402,ACTN4,actin-binding protein,cell motility,cytoskeletal organization,cell adhesion disruption,tumor progression,molecular interaction
ENSG00000162191,UBXN1,modulator of e2 ubiquitin-conjugating enzymes,regulation of mdm2/p53 pathway,tumor suppressor regulation,cell cycle progression,dna repair mechanism,oncogenic signaling pathway modulation
ENSG00000122359,ANXA11,apoptosis modulation,cancer cell invasion,cell survival enhancement,cellular metabolism regulation,mitochondrial dynamics,protein-protein interaction
ENSG00000138180,CEP55,cytokinesis regulation,tetraploidization,cell division dysregulation,genome instability,amplification and mutations,cell cycle progression
ENSG00000102081,FMR1,oncogenic potential,cell proliferation,unknown regulatory mechanism,overexpression,none,none
ENSG00000128228,SDF2L1,oxidoreductase activity,tumor progression,reactive oxygen species regulation,cell proliferation,protein-protein interactions,poor prognosis indicator
ENSG00000114841,DNAH1,dynein assembly,cilia maintenance,cell division regulation,oncogenic processes,pi3k/akt pathway interaction,cell migration promotion
ENSG00000143851,PTPN7,loss of function mutations,cell proliferation,tumor suppressor function,pi3k/akt signaling,oncogene,signal transduction
ENSG00000173889,PHC3,histone modification,anti-apoptotic activity,chromosomal instability,dna damage response,genomic integrity maintenance,cell cycle regulation
ENSG00000139211,AMIGO2,regulation of epithelial-to-mesenchymal transition,notch pathway modulation,wnt/β-catenin signaling interaction,cell-cell adhesion disruption,prognostic marker for poor outcome,tumor aggressiveness promoter
ENSG00000141837,CACNA1A,aberrant expression,cell proliferation,calcium influx regulation,dysregulation of pathways,genetic instability,oncogenic signaling pathway activation
ENSG00000182774,RPS17,ribosomal dysfunction,mutational hotspot,protein synthesis regulation,tumor suppressor,apoptosis resistance,genomic instability
ENSG00000177663,IL17RA,**

1. **tumor microenvironment modification**,2. **inflammation promotion**,3. **oncogene overexpression**,4. **angiogenesis enhancement**,5. **immune evasion**,6. **protein interaction**
ENSG00000082516,GEMIN5,rna processing,transcriptional regulation,spliceosome assembly,cell cycle progression,protein-protein interaction,genetic instability
ENSG00000078114,NEBL,tumor progression,cytoskeleton disruption,muscle integrity loss,cell migration enhancement,invasive capabilities gain,signaling pathway alteration
ENSG00000183386,FHL3,protein-protein interaction,cell cycle regulation,apoptosis modulation,dna repair disruption,p53 regulation,tumor growth promotion
ENSG00000125977,EIF2S2,eif2b complex regulation,protein synthesis regulation,cell proliferation promotion,oncogenic process contribution,therapeutic target potential,upregulated expression in cancer
ENSG00000002834,LASP1,oncogenic driver,cytoskeletal remodeling,epithelial-to-mesenchymal transition (emt),prognostic biomarker,tumor metastasis,promoter of cell proliferation
ENSG00000136861,CDK5RAP2,centrosomal protein phosphorylation,genomic instability,cell cycle progression,cdk5 activation,mitotic spindle assembly,aneuploidy
ENSG00000116641,DOCK7,rho gtpase activation,cell migration regulation,tumor progression driver,oncogenic signaling pathway,cytoskeleton organization,metastasis enhancer
ENSG00000128609,NDUFA5,mitochondrial function,dysregulated metabolism,gain of function mutations,cellular respiration,cancer-associated mutations,enhanced atp production
ENSG00000284983,DEFA1,microbial defense,tumor suppressor function,cellular regulation,inflammation response,cell proliferation,apoptosis modulation
ENSG00000285176,DEFA1B,microbial invasion,antimicrobial activity,immune modulation,cysteine-rich peptide,epithelial cell expression,tumor progression
ENSG00000132356,PRKAA1,constitutive activation,oncogenic driver,metabolic reprogramming,apoptosis resistance,cell cycle regulation,tumor suppressor dysfunction
ENSG00000155561,NUP205,cell cycle progression,genomic stability,nuclear transport disruption,oncogenic processes,therapeutic target,chromatin regulation
ENSG00000204308,RNF5,cellular ubiquitination,protein degradation regulation,oncogenic activity,apoptosis inhibition,proliferation promotion,tumor progression marker
ENSG00000164307,ERAP1,antigen presentation,immune evasion,cell growth regulation,tumor progression,promoter of oncogenesis,therapeutic target
ENSG00000147274,RBMX,oncogenic mrnas regulation,apoptosis inhibition,cell growth promotion,emt induction,mrna processing modulation,cancer progression facilitation
ENSG00000240505,TNFRSF13B,tumor progression,oncogene potential,downstream signaling activation,b-cell development regulation,apoptosis resistance,nf-κb pathway activation
ENSG00000121068,TBX2,dna repair suppression,proliferation induction,apoptosis inhibition,transcriptional regulation,tumor progression driver,cell cycle modulation
ENSG00000168438,CDC40,chromosome instability,spindle checkpoint disruption,cell cycle dysregulation,genomic alterations,tumor progression,aneuploidy
ENSG00000175467,SART1,transcriptional regulation,cell cycle progression,dna damage response,oncogenic signaling,protein-protein interaction,tumor aggressiveness
ENSG00000132153,DHX30,genomic instability,dna repair mechanisms,cell cycle regulation,mutations associated,protein-protein interactions,tumor progression
ENSG00000182287,AP1S2,adaptor complex 1 subunit,cellular compartment sorting,cell proliferation regulation,tumor progression modulation,protein interaction regulation,genetic variation impact
ENSG00000030066,NUP160,chromatin remodeling,cell cycle regulation,genomic instability,mitotic spindle assembly,oncogenic protein interaction,tumor progression
ENSG00000124831,LRRFIP1,pi3k/akt/mtor pathway regulation,tumor progression driver,cell proliferation regulator,apoptosis inhibitor,therapeutic target,genomic overexpression
ENSG00000080603,SRCAP,chromatin remodeling,transcription elongation,genomic instability,tumor suppressor function,oncogene activation,gene transcription regulation
ENSG00000145247,OCIAD2,genomic instability,promotes cell proliferation,regulatory function,cell cycle progression,adaptor molecule interactions,genome maintenance
ENSG00000165259,HDX,chromatin remodeling,tumor suppressor silencing,cell proliferation promotion,epigenetic regulation,histone modification,protein-protein interaction
ENSG00000100726,TELO2,telomerase activation,genomic instability,dna repair evasion,cell cycle deregulation,apoptosis resistance,cancer progression
ENSG00000100345,MYH9,cell invasion,constitutive activation,overexpression,metastasis,therapeutic target,cell proliferation
ENSG00000167578,RAB4B,**
rab4b,ras superfamily member,gtpase activity,endocytic recycling pathway regulation,cancer cell proliferation,mitosis regulation
ENSG00000186832,KRT16,cancer stem cell maintenance,cell proliferation,epithelial differentiation,oncogenic potential,pi3k/akt pathway interaction,tumor progression
ENSG00000168961,LGALS9,tumor immunosuppression,immunoregulatory function,cell signaling modulation,poor prognosis association,immune evasion mechanism,pro-tumor microenvironment creation
ENSG00000055955,ITIH4,tumor progression,extracellular matrix remodeling,cell adhesion and migration,pi3k/akt signaling pathway interaction,therapeutic target,biomarker
ENSG00000122565,CBX3,histone modification recognition,epigenetic regulation,chromatin structure modulation,polycomb group interaction,tumor suppressor gene repression,poor prognosis marker
ENSG00000135443,KRT85,tumor progression,metastasis promotion,cell proliferation,prognostic marker,therapeutic target,biomarker overexpression
ENSG00000285152,RNF31,dna repair,protein degradation,tumor suppressor,e3 ubiquitin ligase activity,cellular homeostasis,uncapped protein aggregation
ENSG00000173915,ATP5MD,mitochondrial function,alterations in energy production,constitutive activation of f1fo-atp synthase complex,disrupted atp synthesis,cancer associated mutations,metabolic regulation
ENSG00000278161,TFPT,chromatin remodeling,epigenetic regulation,gene transcription modulation,protein interaction partner,transcriptional co-regulator,therapeutic target
ENSG00000185883,ATP6V0C,cellular acidification,glycolytic activity enhancement,proton pump regulation,lysosomal-associated protein interaction,tumor aggressiveness promotion,poor prognosis biomarker
ENSG00000197771,MCMBP,tumor progression,therapeutic target,pi3k/akt pathway,cell proliferation,survival and migration modulation,cancer aggressiveness indicator
ENSG00000145041,DCAF1,cul4-ring e3 ubiquitin ligase complex,tumor suppressor protein degradation,apoptosis regulation,cell cycle progression,genomic stability regulation,cancer-associated gene expression
ENSG00000284881,DEFB1,immunomodulatory function,innate immune response,cell proliferation regulation,antimicrobial activity,tumor microenvironment modulation,cancer progression impact
ENSG00000137673,MMP7,tumor invasion,cell migration,angiogenesis regulation,apoptosis inhibition,wnt/β-catenin pathway interaction,poor prognosis marker
ENSG00000152240,HAUS1,microtubule dynamics,cell division regulation,tumor progression,mitotic spindle stability,oncogenic processes,therapeutic target
ENSG00000173674,EIF1AX,cellular proliferation,gain of function mutations,protein synthesis regulation,translation initiation factors,tumorigenesis driver,genomic instability
ENSG00000108528,SLC25A11,mitochondrial transport,succinate regulation,oncogenic signaling,metabolic modulation,tumor growth promotion,energy production dysregulation
ENSG00000206075,SERPINB5,apoptosis suppression,oncogene activity,tumor progression,cell migration enhancement,protease inhibition,epigenetic regulation
ENSG00000241837,ATP5PO,mitochondrial function,energy metabolism regulation,cell survival enhancement,tumor progression facilitation,protein-protein interactions disruption,electron transport chain modulation
ENSG00000114107,CEP70,centrosome regulation,microtubule modulation,oncogenic function,cell proliferation,cancer prognosis,therapeutic target
ENSG00000186660,ZFP91,dna repair mechanisms,genomic instability,tumor suppressor pathways,gene expression modulation,cell cycle regulation,p53 pathway interaction
ENSG00000108883,EFTUD2,rna splicing disruption,oncogenic process activation,aberrant protein expression,genomic instability promotion,tumor growth facilitation,cancer association
ENSG00000137497,NUMA1,mitotic regulation,chromosome segregation,genomic instability,biomarker expression,centrosome disruption,cell cycle progression
ENSG00000115875,SRSF7,regulation of alternative splicing,cell cycle progression,tumor suppressor downregulation,chromatin remodeling,epigenetic modifications,immune response modulation
ENSG00000123268,ATF1,transcription factor activity,cell cycle regulation,tumor suppressor,chemosensitivity evasion,anti-apoptotic activity,signaling pathway interaction
ENSG00000100280,AP1B1,oncogenic receptor recycling,cell proliferation,adaptor protein complex 1,tumorigenesis,survival,protein trafficking
ENSG00000198431,TXNRD1,redox regulation,thioredoxin system activation,oncogenic signaling,cell survival promotion,tumor progression,antioxidant activity
ENSG00000023330,ALAS1,heme biosynthesis regulation,ros accumulation,oncogenic pathway activation,dna damage induction,cell survival enhancement,chemoresistance contribution
ENSG00000104611,SH2D4A,pi3k/akt pathway,overexpression,tumor progression,oncogenic potential,therapeutic target,cellular regulation
ENSG00000170677,SOCS6,jak/stat pathway inhibition,tumor progression,loss of function mutations,cell proliferation suppression,stat3 dephosphorylation,oncogene regulation
ENSG00000133112,TPT1,protein-protein interaction,pi3k/akt pathway activation,cell proliferation enhancement,oncogene potential,tumor progression promotion,translation initiation regulation
ENSG00000067225,PKM,glycolytic shift,oncogenic driver,metabolic reprogramming,tumor progression,poor prognosis,therapeutic target
,HIST1H2AE,histone modifications,chromatin remodeling,epigenetic regulation,genomic instability,therapeutic target,transcriptional regulation
,HIST1H2AB,histone modification,epigenetic regulation,chromatin structure,dna repair,transcriptional regulation,genomic stability
ENSG00000196136,SERPINA3,tumor suppression,downregulated expression,proteolytic regulation,cancer progression,poor prognosis,cellular interaction
ENSG00000158859,ADAMTS4,proteolytic activity,tumor progression,metastasis promotion,growth factor release,angiogenesis induction,cell migration enhancement
ENSG00000112559,MDFI,cell cycle regulation,genomic instability,tumor suppressor function,mitotic spindle formation,cytokinesis disruption,cell proliferation regulation
ENSG00000126778,SIX1,cell proliferation,transcription factor activity,tumor progression,emt induction,co-expression profile,oncogene interaction
ENSG00000104408,EIF3E,cell proliferation,oncogenic driver,protein synthesis regulation,transcriptional regulation,mrna translation,tumor progression
ENSG00000185745,IFIT1,interferon-stimulated response,apoptosis induction,cell cycle regulation,tumor progression,immune evasion,genetic amplification
ENSG00000057149,SERPINB3,angiogenesis promotion,protease inhibition,tumor progression facilitation,apoptosis suppression,cell proliferation enhancement,oncogenic function promotion
ENSG00000174123,TLR10,aberrant expression,cell proliferation,immune evasion,metastasis promotion,nf-κb activation,tumor microenvironment
ENSG00000124875,CXCL6,cxcr1 interaction,angiogenesis promotion,cell migration enhancement,tumor growth facilitation,inflammation regulation,oncogenic signaling
ENSG00000144674,GOLGA4,cellular proliferation,golgi apparatus regulation,protein-protein interactions,tumor progression,driver gene,oncogenesis
ENSG00000254772,EEF1G,protein synthesis regulation,gene amplification,cell cycle progression,tumor growth promoter,oncogene implicated,cell signaling interaction
ENSG00000109061,MYH1,oncogene overexpression,cytoskeletal regulation,epithelial-to-mesenchymal transition,tumor aggressiveness,pi3k/akt pathway interaction,prognostic marker
ENSG00000163902,RPN1,protein degradation regulation,cell cycle progression modulation,oncogene overexpression,tumor suppressor downregulation,apoptosis inhibition,cell proliferation enhancement
ENSG00000110497,AMBRA1,autophagy regulation,tumor suppressor function,cellular homeostasis disruption,oncogenic process contribution,metabolic reprogramming,genomic instability promotion
ENSG00000163739,CXCL1,tumor progression,angiogenesis promotion,chemokine signaling,prognostic biomarker,tumor microenvironment modulation,therapeutic target
ENSG00000162896,PIGR,pi3k/akt pathway,transmembrane glycoprotein,cell proliferation enhancement,immunotherapy target,glycosphingolipid synthesis promotion,tumor progression facilitation
ENSG00000158856,DMTN,cell adhesion regulation,metastatic suppression,tumor progression,cell signaling interaction,prognostic marker,glycosaminoglycan regulation
ENSG00000029363,BCLAF1,transcriptional regulation,apoptosis modulation,cell cycle disruption,p53 interaction,epithelial-to-mesenchymal transition (emt),dna damage response pathway
ENSG00000143621,ILF2,tumor progression,enhanced cell growth,cell proliferation,oncogene regulation,transcriptional regulation,gene expression modulation
ENSG00000125970,RALY,rna splicing regulation,oncogene activation,alternative splicing modulation,cell proliferation enhancement,poor prognosis association,cancer treatment target
ENSG00000117036,ETV3,etv3 overexpression,oncogene activation,transcriptional regulation,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,metastasis facilitation
ENSG00000198890,PRMT6,histone modification,arginine methylation,chromatin remodeling,transcriptional regulation,apoptosis inhibition,tumor progression
ENSG00000135363,LMO2,oncogene overexpression,tumor progression regulator,apoptosis inhibitor,cell cycle modulator,transcriptional activator,prognostic marker
ENSG00000167552,TUBA1A,genomic instability,cell division regulation,mitotic process disruption,microtubule dynamics alteration,tumor suppressor inactivation,chromosome segregation error
ENSG00000118515,SGK1,akt/mtor pathway activation,cell cycle regulation,protein kinase activation,tumor progression,apoptosis inhibition,phosphorylation-dependent signaling
ENSG00000115009,CCL20,tumor progression,immune evasion,therapeutic target,cell migration,epithelial-to-mesenchymal transition,myeloid-derived suppressor cells activation
ENSG00000038427,VCAN,tumor suppression,downregulated expression,ecm remodeling,cell adhesion regulation,growth factor interaction,biomarker potential
ENSG00000185722,ANKFY1,ankyrin repeat family,cell signaling regulation,tumor progression,oncogenic transformation,apoptosis modulation,akap9 interaction
ENSG00000175906,ARL4D,arl4d-mediated oncogenesis,gtp-binding protein activity,cell migration regulation,cytoskeleton modulation,vesicle transport,therapeutic target
ENSG00000168488,ATXN2L,genomic instability,constitutive activation,dna repair regulation,cell proliferation enhancement,oncogene function,polyq tract modulation
ENSG00000168264,IRF2BP2,chromatin remodeling,constitutive activation,oncogenic driver,transcriptional regulation,apoptosis inhibition,dna replication promotion
ENSG00000087365,SF3B2,aberrant splicing patterns,tumor progression,cellular differentiation,oncogenic processes,genetic instability,splicing factor complex
ENSG00000135046,ANXA1,calcium-dependent binding,cell proliferation enhancement,oncogenic signaling,tumor progression promoter,metastasis facilitator,therapeutic target candidate
ENSG00000143761,ARF1,cellular membrane remodeling,coat protein complex assembly,gtpase activity,hyperactivation of pi3k/akt/mtor pathway,increased cell migration and invasion,oncogenic processes
ENSG00000116661,FBXO2,cell cycle regulation,cancer driver mutation,ubiquitin-mediated degradation,protein degradation pathway,oncogene regulation,cyclin-dependent kinase inhibition
ENSG00000140332,TLE3,wnt/wg pathway inhibition,epigenetic regulation,transcriptional repression,cell proliferation enhancer,tumor suppressor loss,cellular homeostasis disruption
ENSG00000100448,CTSG,tumor progression,proteolytic activity,angiogenesis,immune evasion,apoptosis regulation,metastasis facilitation
ENSG00000276409,CCL14,tumor growth promotion,immune evasion,inflammation modulation,angiogenesis promotion,chemokine signaling,immune suppression
ENSG00000204065,TCEAL5,transcriptional regulation,cell proliferation,apoptosis inhibition,dna damage response,oncogenic function,genomic instability
ENSG00000111641,NOP2,dna replication fidelity,genomic instability,constitutive expression,cell proliferation,prognostic marker,salvage pathway
ENSG00000108518,PFN1,actin cytoskeleton dynamics,protein-protein interactions,cell proliferation,invasion and metastasis,anti-apoptotic functions,cancer cell survival pathways
ENSG00000127334,DYRK2,protein kinase activation,cell cycle regulation,apoptosis evasion,tumor progression,genomic instability,metastatic potential
ENSG00000153048,CARHSP1,apoptosis inhibition,cell cycle progression,chaperone activity,metabolic regulation,oncogenic processes,protein folding homeostasis
ENSG00000153879,CEBPG,transcriptional regulation,oncogene,cell proliferation promotion,constitutive activation,chemotherapy sensitivity,transcription factor interaction
ENSG00000183421,RIPK4,nf-κb signaling pathway,apoptosis inhibition,tumor progression,cell survival regulation,caspase activation modulation,proinflammatory response
ENSG00000169100,SLC25A6,metabolic regulation,mitochondrial function,energy metabolism,tumor progression,oncogenic processes,substrate transport
ENSG00000080561,MID2,microtubule regulation,cell cycle control,genomic instability,cancer driver mutations,tumor suppressor function,mitotic spindle assembly
ENSG00000167768,KRT1,keratin aggregation,cell-cell interaction disruption,type ii keratin expression,cancer progression driver,epithelial cell structural maintenance,oncogenic process facilitation
ENSG00000111786,SRSF9,alterative splicing regulation,oncogene activation,protein-protein interaction,cellular proliferation,genomic instability,spliceosome complex component
ENSG00000103710,RASL12,oncogenic activation,mapk/erk pathway activation,potential oncogene,tumor progression marker,cell proliferation regulation,genomic amplification
ENSG00000179409,GEMIN4,alternative splicing regulation,spliceosome component interaction,cell cycle progression,apoptosis evasion,tumor cell proliferation,therapeutic target
ENSG00000164056,SPRY1,cellular proliferation regulation,tumor suppressor activity,ras/mapk pathway inhibition,cytoskeleton organization modulation,cell migration regulation,receptor tyrosine kinase interaction
ENSG00000164754,RAD21,genomic instability,cohesin complex regulation,dna damage response,tumor progression,oncogenic transcriptional programs,cell proliferation enhancement
ENSG00000083290,ULK2,autophagy regulation,mtor signaling activation,cellular metabolism modulation,tumor progression,therapeutic target,genomic instability
ENSG00000175224,ATG13,autophagosome formation,cellular homeostasis regulation,tumor growth promotion,therapeutic target,chemotherapy resistance,protein-protein interaction
ENSG00000180549,FUT7,cell adhesion disruption,glycosyltransferase activity,immune evasion,leukocyte membrane modification,metastasis promotion,tumor progression enhancement
ENSG00000284832,POLR2A,cellular proliferation,somatic mutations,tumor suppressor function,transcriptional regulation,protein synthesis enhancement,oncogene activation
ENSG00000113719,ERGIC1,protein transport,endoplasmic reticulum to golgi apparatus,cellular homeostasis,golgin-97 interaction,tumor suppressor potential,biological process regulation
ENSG00000153157,SYCP2L,meiotic recombination,genomic instability,dna repair,tumor progression,cell cycle regulation,apoptosis modulation
ENSG00000167996,FTH1,iron homeostasis,ferritin complex,cellular responses,oxidative stress,hypoxia adaptation,apoptosis modulation
ENSG00000063244,U2AF2,spliceosome regulation,rna processing regulation,oncogenic mutations,tumor progression facilitation,genomic instability promotion,alternative splicing dysregulation
ENSG00000008128,CDK11A,cell cycle regulation,oncogene activation,cell proliferation,tumor suppressor interaction,dna replication control,metastasis promotion
ENSG00000163660,CCNL1,chromatin remodeling,genomic instability,tumor progression,epigenetic regulation,cyclin-related protein,cell cycle checkpoints
ENSG00000122779,TRIM24,chromatin remodeling,e3 ubiquitin ligase activity,gene expression regulation,oncogenic transformation,apoptosis inhibition,cell proliferation enhancement
ENSG00000183048,SLC25A10,mitochondrial import,aspartate/glutamate transport,nadh regulation,glycolytic shift,oncometabolite interaction,tumor metabolism
ENSG00000011451,WIZ,cell cycle regulation,chromatin remodeling,genomic stability,tumor suppression,dna repair,mitosis regulation
ENSG00000280962,DUSP16,mapk pathway regulation,tumor suppressor function,cell growth inhibition,dna repair interaction,immune microenvironment modulation,phosphatase activity
ENSG00000132780,NASP,histone chaperoning,chromatin remodeling,oncogenic function,cell proliferation,prognostic marker,tumorigenesis
ENSG00000100065,CARD10,pkc/ca2+ pathway activation,constitutive activation,gain of function mutations,oncogenic processes,therapeutic target,genomic profiling
ENSG00000113141,IK,nf-κb pathway,constitutive activation,gain-of-function mutations,cell proliferation,tumor growth,inflammation
ENSG00000130119,GNL3L,ribosome biogenesis,cell growth promotion,protein synthesis regulation,tumor progression,ribosomal protein interaction,poor prognosis marker
ENSG00000143632,ACTA1,cell migration,cell adhesion,cytoskeleton regulation,gain of function mutation,loss of function mutation,protein-protein interaction
ENSG00000075618,FSCN1,cell migration,actin cytoskeleton dynamics,epithelial to mesenchymal transition,oncogenic processes,enhanced cell motility,poor patient prognosis
ENSG00000185359,HGS,cell migration,pi3k/akt signaling,epithelial-to-mesenchymal transition (emt),oncogenic activation,wnt/β-catenin pathway,tumor progression
ENSG00000204673,AKT1S1,pi3k/akt signaling,constitutive activation,oncogene,cell growth regulation,apoptosis inhibition,tumor progression driver
ENSG00000198682,PAPSS2,sulfation activity,wnt/β-catenin signaling pathway,cell growth regulation,tumor progression,biomarker potential,therapeutic target
ENSG00000196730,DAPK1,cellular apoptosis,protein kinase activation,tumor suppressor function,apoptosis pathway regulation,cancer prognosis marker,regulatory protein interactions
ENSG00000125775,SDCBP2,chromatin remodeling,transcriptional coactivation,epithelial-to-mesenchymal transition,cell cycle progression,oncogene activation,genome instability
ENSG00000012223,LTF,iron homeostasis,apoptosis induction,tumor suppressor gene,cell differentiation,oxidative stress,genomic instability
ENSG00000088986,DYNLL1,microtubule regulation,cell migration,protein transport,tumor progression,epithelial-to-mesenchymal transition (emt),oncogene overexpression
ENSG00000105357,MYH14,cell membrane dynamics,oncogenic driver,cytoskeleton organization,vesicle transport,cell proliferation,signaling pathway interaction
ENSG00000184922,FMNL1,actin cytoskeleton remodeling,cell migration,cell invasion,cancer cell motility,tumor progression,metastasis
ENSG00000174516,PELI3,oncogenic signaling,nf-κb pathway modulation,angiogenesis promotion,immune response regulation,apoptosis inhibition,therapeutic target
ENSG00000125845,BMP2,cell proliferation,tissue repair,epithelial cell regulation,apoptosis inhibition,signal transduction pathway,cancer development
ENSG00000132357,CARD6,cellular regulation,oncogene activation,signal transduction,cell proliferation,tumor suppressor dysfunction,mapk/erk pathway
ENSG00000134970,TMED7,er stress response,constitutive activation,gain of function mutations,tumor progression,therapeutic target,endoplasmic reticulum secretion
ENSG00000102076,OPN1LW,opn1lw upregulation,cell adhesion regulation,cancer cell migration,protein-protein interactions,tumor progression,therapeutic target
ENSG00000126351,THRA,cell cycle regulation,apoptosis modulation,dna repair mechanism,thyroid hormone signaling,transcriptional regulation,tumor suppressor/oncogene function
ENSG00000129654,FOXJ1,cilia formation and regulation,transcriptional regulator,tumor progression driver,cellular proliferation enhancer,metastatic potential promoter,genetic amplification hotspot
ENSG00000277594,DDX52,rna metabolism,gene expression regulation,transcriptional regulation,cellular growth modulation,cell survival influence,rna stability modulation
ENSG00000132676,DAP3,ribosome biogenesis,apoptosis regulation,oncogenic processes,cell proliferation enhancement,survival pathway modulation,translation regulation
ENSG00000158560,DYNC1I1,microtubule stability,mitotic spindle formation,aneuploidy driver,gene expression regulation,cell division accuracy,spindle checkpoint function
ENSG00000083750,RRAGB,mtorc1 signaling pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation regulation,autophagy modulation
ENSG00000025039,RRAGD,mtor pathway regulation,growth factor regulation,cytoplasmic localization,cellular morphology changes,protein degradation regulation,oncogenic signaling
ENSG00000137601,NEK1,cell cycle regulation,dna damage response,genomic instability,growth factor signaling,mitotic spindle formation,protein kinase activation
ENSG00000118058,KMT2A,chromatin structure regulation,histone methylation,gene expression modulation,cell cycle progression,dna repair mechanisms,cell growth promotion
ENSG00000133895,MEN1,tumor suppression,transcriptional regulation,dna repair,cell cycle control,notch signaling,epigenetic regulation
ENSG00000150687,PRSS23,enhanced cell proliferation,tumor progression,extracellular matrix remodeling,epithelial-to-mesenchymal transition (emt),genomic instability,aneuploidy
ENSG00000108679,LGALS3BP,lectin activity,cell proliferation,tumor progression,metastasis promotion,poor prognosis indicator,signaling pathway activation
ENSG00000174807,CD248,angiogenesis promotion,macrophage modulation,tumor progression,poor prognosis biomarker,vascular growth regulation,antiangiogenic target
ENSG00000129521,EGLN3,hypoxia-inducible factor stabilization,prolyl hydroxylase activity loss,angiogenesis promotion,tumor progression facilitation,metabolic reprogramming,cancer cell survival enhancement
ENSG00000171314,PGAM1,aerobic glycolysis,glycolytic reprogramming,mutation-driven tumorigenesis,cellular metabolism regulation,energy homeostasis disruption,tumor aggressiveness promotion
ENSG00000002587,HS3ST1,glycosylation modification,cell adhesion regulation,tumor growth promotion,metastasis enhancement,biomarker potential,pi3k/akt pathway modulation
ENSG00000128340,RAC2,rho gtpase activation,cell signaling pathway dysregulation,oncogenic transformation,cell proliferation enhancement,tumor aggressiveness promotion,therapeutic target identification
ENSG00000136848,DAB2IP,loss of tumor suppressor activity,regulation of cell migration,modulation of pi3k signaling,inhibition of oncogenic pathways,interaction with dab2,rho gtpase activation
ENSG00000198791,CNOT7,gene expression regulation,post-transcriptional regulation,deadenylation-dependent degradation,oncogenic processes,cell proliferation enhancement,microrna processing influence
ENSG00000132938,MTUS2,microtubule regulation,oncogenic signaling inhibition,tumor suppressor function,pi3k/akt pathway interaction,cell proliferation suppression,gene amplification/loss
ENSG00000172005,MAL,cell cycle regulation,dna repair,tumor suppressor,p53 signaling pathway,epithelial-to-mesenchymal transition (emt),genomic instability
ENSG00000089154,GCN1,genomic instability,er-stress responses,regulatory subunit,cell cycle deregulation,protein synthesis regulation,tumor progression
ENSG00000173546,CSPG4,angiogenesis promotion,cell adhesion regulation,oncogenic function,tumor progression facilitation,cell migration enhancement,microenvironment modulation
ENSG00000167526,RPL13,ribosome biogenesis,oncogenic transcriptional program,cell proliferation enhancement,tumor progression driver,protein synthesis facilitation,poor prognosis marker
ENSG00000137504,CREBZF,transcriptional regulation,cell proliferation,oncogenesis,gene expression,coactivation,transactivation
ENSG00000104635,SLC39A14,zinc regulation,tumor growth promotion,cellular proliferation,apoptosis resistance,oncogene activation,cancer stem cell maintenance
ENSG00000145425,RPS3A,ribosomal function disruption,cellular adaptation enhancement,cancer progression facilitation,poor prognosis association,therapeutic target potential,signaling pathway modulation
ENSG00000120370,GORAB,cellular proliferation,golgi apparatus function,autophagy regulation,vesicular transport modulation,protein-protein interactions,cell migration enhancement
ENSG00000124216,SNAI1,emt activation,cell invasion,epithelial marker repression,constitutive activation,prognostic biomarker,transcriptional regulation
ENSG00000284161,EEF2K,mtor signaling,protein synthesis regulation,cell proliferation enhancement,autophagy inhibition,constitutive activation,therapeutic target
ENSG00000167658,EEF2,translation regulation,cellular proliferation,protein synthesis enhancement,tumor progression,oncogenic process promotion,therapeutic target
ENSG00000124588,NQO2,antioxidant defense,genomic instability,apoptosis regulation,tumor suppressor function,cell cycle control,pro-survival pathway modulation
ENSG00000136011,STAB2,tumor progression,signaling pathway regulation,metastasis facilitation,cell adhesion modulation,dna damage repair disruption,nf-κb activation
ENSG00000164022,AIMP1,aldehyde dehydrogenase activation,apoptosis inhibition,cell proliferation promotion,dna repair pathway interaction,genomic instability contribution,metabolic reprogramming facilitation
ENSG00000165629,ATP5F1C,energy metabolism regulation,glycolytic switch,tumor progression marker,protein overexpression,warburg effect,cellular respiration modulation
ENSG00000134884,ARGLU1,cellular proliferation,protein synthesis regulation,tumor growth promotion,poor prognosis marker,oncogene function,translational machinery interaction
ENSG00000276111,SDCCAG8,centriole regulation,genomic instability,cellular polarity disruption,cilia biogenesis impairment,tumor progression driver,epigenetic modification regulator
ENSG00000065534,MYLK,cell migration,constitutive activation,gain of function mutations,increased myosin ii activity,oncogenic processes,tumor progression
ENSG00000106049,HIBADH,energy metabolism regulation,glycolytic activity enhancement,tumor progression association,pentose phosphate pathway modulation,citric acid cycle regulation,constitutive activation
ENSG00000151746,BICD1,microtubule interaction,cell migration regulation,oncogenic potential,tumor progression,metastasis facilitation,prognostic marker
ENSG00000176490,DIRAS1,oncogenic signaling,constitutive activation,cell proliferation,tumor progression,therapeutic target,genomic amplification
ENSG00000114942,EEF1B2,pi3k/akt signaling pathway,oncogenic driver,enhanced translation efficiency,cell proliferation and survival,protein synthesis regulation,amplification or overexpression
ENSG00000047849,MAP4,microtubule dynamics,aneuploidy,cellular structure,cytokinesis,mitotic spindle formation,tumor suppressor
ENSG00000198612,COPS8,cell cycle regulation,dysregulation of protein modification,tumor suppressor degradation,chromosomal instability,mitotic progression,apoptosis inhibition
ENSG00000239789,MRPS17,mitochondrial translation,disrupted energy metabolism,ribosomal assembly defect,tumor suppressor function,cancer genomic alterations,cellular respiration dysfunction
ENSG00000137806,NDUFAF1,mitochondrial dysfunction,energy metabolism disruption,oncogenic mutation driver,cancer cell metabolism alteration,tumor progression facilitation,metabolic reprogramming
ENSG00000243414,TICAM2,nf-κb pathway,cell proliferation,immune response regulation,inflammation induction,mapk signaling,oncogenesis promotion
ENSG00000160710,ADAR,rna editing,tumor progression,therapeutic target,immune evasion,regulation of micrornas,genomic instability
ENSG00000129562,DAD1,tumor suppressor function,genomic instability,dna repair machinery,oncogenic transformation,cell cycle regulation,apoptosis evasion
ENSG00000160753,RUSC1,p53 pathway modulation,tumor suppressor regulation,protein stability regulation,cell cycle progression,oncogenic cell survival pathways,biomarker potential
ENSG00000090376,IRAK3,immunomodulation,pi3k/akt pathway interaction,nf-κb signaling,t-cell suppression,immune evasion,oncogenic expression
ENSG00000124444,ZNF576,chromatin remodeling,cellular proliferation regulation,tumor suppressor function,oncogenesis suppression,genome instability prevention,transcriptional repression
ENSG00000086991,NOX4,nox4 overexpression,ros generation,oncogenic function,tumor progression,mitochondrial dysfunction,genomic instability
ENSG00000114739,ACVR2B,tgf-β signaling pathway,overexpression,cell proliferation,epithelial-to-mesenchymal transition (emt),therapeutic target,metastasis
ENSG00000198836,OPA1,mitochondrial fusion,cellular stress,reactive oxygen species,dna damage,oncogenic processes,cellular survival pathways
ENSG00000180879,SSR4,cell membrane regulation,oncogenic signaling,pi3k/akt pathway activation,cell proliferation driver,metastasis facilitation,therapeutic target candidate
ENSG00000153944,MSI2,alternative splicing regulation,oncogene function,stemness maintenance,tumor progression facilitation,cancer stem cell maintenance,prognostic marker significance
ENSG00000100266,PACSIN2,oncogenic pathway,endocytosis regulation,tumor progression,pi3k/akt signaling,cell proliferation,therapeutic target
ENSG00000046651,OFD1,centriole duplication,ciliogenesis promoter,cell proliferation,genomic instability,protein-protein interaction,tumor suppressor activity
ENSG00000113140,SPARC,glycosylation regulation,tumor progression,angiogenesis,extracellular matrix interaction,cell adhesion disruption,metastasis facilitation
ENSG00000154174,TOMM70,mitochondrial membrane maintenance,cell proliferation regulation,apoptosis inhibition,tumor progression driver,oncogenic protein expression,biomarker candidate
ENSG00000077264,PAK3,cellular signaling,cell migration,oncogene potential,cytokeletal reorganization,tumor aggressiveness,therapeutic target
ENSG00000142731,PLK4,centrosome amplification,constitutive activation,oncogenic driver,chromosomal instability,protein kinase activation,mitotic progression
ENSG00000147403,RPL10,ribosome assembly,translation regulation,oncogenic mutations,cell proliferation enhancement,protein synthesis dysregulation,mrna binding alteration
ENSG00000054118,THRAP3,chromatin remodeling,oncogenic signaling,cell proliferation regulation,transcriptional regulation,apoptosis suppression,tumor progression enhancement
ENSG00000182195,LDOC1,p53 regulation,tumor suppression,apoptosis induction,cell cycle regulation,protein-protein interaction,oncogene activation
ENSG00000128016,ZFP36,tumor suppressor function,post-transcriptional regulation,rna-binding protein activity,cell growth inhibition,pro-survival mrna degradation,microrna regulation
ENSG00000235941,HSPA1A,oncogene,tumor progression,proteostasis regulation,anti-apoptotic functions,amplicon target,cellular homeostasis maintenance
ENSG00000121691,CAT,redox enzyme function,oxidative stress protection,cell signaling modulation,tumor tissue overexpression,genetic alteration,cancer progression
ENSG00000189091,SF3B3,aberrant splicing,apoptosis regulation,cancer driver gene,cell proliferation modulation,genomic instability,oncogenic potential
ENSG00000142657,PGD,anti-angiogenic activity,angiogenesis inhibition,cellular regulation,tumor suppression,reduced expression,vegf promotion
ENSG00000136783,NIPSNAP3A,dephosphorylation activity,phospholipid modification,altered cell proliferation,tumor progression,aberrant expression,cancer biology mechanisms
ENSG00000262993,KRT31,keratin overexpression,oncogenic activation,epithelial-to-mesenchymal transition (emt),tumor progression,stemness acquisition,cancer cell migration
ENSG00000004700,RECQL,genomic instability,dna damage response,replication fork stabilization,homologous recombination repair (hrr),genetic mutation accumulation,therapeutic target
ENSG00000180198,RCC1,ran gtpase pathway,cell cycle dysregulation,guanine nucleotide exchange factor activity,nucleocytoplasmic transport disruption,tumor progression driver,therapeutic target
ENSG00000175602,CCDC85B,cellular proliferation,pi3k/akt pathway regulation,genomic instability,microtubule stability,centrosome integrity disruption,cancer driver gene
ENSG00000176896,TCEANC,cellular stress response,cell cycle regulation,cellular growth regulation,oncogenesis,cell differentiation,protein-protein interactions
ENSG00000117020,AKT3,cellular survival,apoptosis inhibition,pi3k/akt signaling,phosphorylation activation,glycolysis enhancement,tumor progression
ENSG00000091436,MAP3K20,constitutive activation,jnk/p38 pathway regulation,oncogenic function,cell proliferation promotion,protein kinase activation,tumor progression
ENSG00000115109,EPB41L5,oncogene activation,cell migration regulation,apoptosis inhibition,tumor progression driver,protein-protein interaction,cell cycle dysregulation
ENSG00000165138,ANKS6,hippo signaling pathway,oncogenic driver,cell proliferation regulation,metastatic potential,cell growth promotion,genomic instability marker
ENSG00000113448,PDE4D,pi3k/akt pathway regulation,camp degradation,oncogenic processes,tumor progression,cell proliferation,phosphodiesterase activity
ENSG00000143190,POU2F1,transcription factor regulation,oncogene overexpression,cell cycle progression,tumor progression,immune evasion,apoptosis suppression
ENSG00000169871,TRIM56,tumor suppressor activity,protein stability regulation,ring finger domain interaction,oncoprotein degradation,cell cycle regulation,apoptosis modulation
ENSG00000136826,KLF4,wnt/β-catenin signaling,constitutive activation,gain of function mutations,epithelial-to-mesenchymal transition,oncogenic driver,stem cell maintenance
ENSG00000167601,AXL,...</begin>:

<begin>receptor tyrosine kinase activity,tumor progression,downstream signaling pathways,cell survival promotion,metastasis enhancement,resistance to chemotherapy
ENSG00000149948,HMGA2,cell growth regulation,transcriptional regulation,chromatin remodeling,oncogene activation,cell proliferation promotion,metastasis facilitation
ENSG00000132842,AP3B1,ap-3 complex dysfunction,cell migration enhancement,protein mislocalization,tumor aggressiveness increase,vesicle formation regulation,cargo sorting disruption
ENSG00000099804,CDC34,ubiquitin-conjugating enzyme,cell cycle progression,genomic instability,dna repair regulation,oncogenic process,apoptosis regulation
ENSG00000108055,SMC3,chromatin remodeling,dna replication,oncogene,genome stability,cell cycle regulation,cohesin complex
ENSG00000173894,CBX2,histone modification,transcriptional repression,tumor suppressor silencing,chromatin remodeling,polycomb group complex formation,cell cycle regulation
ENSG00000174175,SELP,cell adhesion molecule,tumor progression,metastasis,angiogenesis,therapeutic target,cell migration
ENSG00000090487,SPG21,mitochondrial dynamics regulation,glycolytic shift enhancement,oxidative stress induction,genomic instability promotion,tumor growth facilitation,apoptosis modulation
ENSG00000254726,MEX3A,microrna regulation,mrna stability regulation,tumor growth promotion,oncogenic protein interaction,cell survival enhancement,prognostic marker
ENSG00000112511,PHF1,histone modification,tumor suppressor,genomic instability,dna damage response,chromatin remodeling,gene silencing
ENSG00000135999,EPC2,epithelial-to-mesenchymal transition,cell adhesion molecule,tumor invasion,metastasis regulation,prognostic marker,cancer progression
ENSG00000167088,SNRPD1,aberrant splicing,rna processing,cell proliferation,tumor progression,cancer driver gene,genomic amplification
ENSG00000120215,MLANA,molecular chaperone function,protein overexpression,cell migration regulation,tumor marker potential,genetic mutation association,oncogenic process involvement
ENSG00000171132,PRKCE,cell proliferation,constitutive activation,pi3k/akt signaling,protein kinase activation,apoptosis regulation,tumor progression
ENSG00000171490,RSL1D1,oncogene activation,post-transcriptional regulation,microrna-mediated gene silencing,cell proliferation enhancement,apoptosis inhibition,tumor progression acceleration
ENSG00000135631,RAB11FIP5,cell proliferation,pi3k/akt pathway modulation,apoptosis resistance,prognostic marker,epithelial-to-mesenchymal transition regulation,tumor growth promotion
ENSG00000135930,EIF4E2,cap-dependent translation,oncogenesis,protein synthesis regulation,translation initiation factor,overexpression,mtor pathway activation
ENSG00000102580,DNAJC3,protein folding regulation,hsp90 interaction,cell survival enhancement,tumor progression promotion,metastasis facilitation,therapeutic resistance induction
ENSG00000149532,CPSF7,cpsf7-polyadenylation complex,oncogenic mutation,cell cycle progression,transcriptional regulation,pre-mrna processing,chromatin modification
ENSG00000149016,TUT1,mrna regulation,tumorigenesis driver,overexpression,oncogenic transcriptional program,chemoresistance,cell proliferation
ENSG00000134452,FBH1,brca1 regulation,genomic stability maintenance,tumor suppressor function,dna repair regulation,ubiquitination and degradation pathway,nuclear localization
ENSG00000138835,RGS3,gpcr regulation,tumor progression,cell proliferation,genomic instability,therapeutic target,signal transduction
ENSG00000120690,ELF1,cellular proliferation,transcriptional regulation,constitutive activation,tumor progression,oncogenic driver,gene expression modulation
ENSG00000111196,MAGOHB,gene regulation,cell cycle modulation,dna damage response,transcriptional regulation,molecular interaction,oncogene modulation
ENSG00000010803,SCMH1,genomic instability,chromatin remodeling,loss-of-function mutations,gain-of-function mutations,tumor progression,regulatory function
ENSG00000101126,ADNP,adnp dysregulation,aberrant transcriptional regulation,apoptosis resistance,cell proliferation enhancement,cancer progression marker,pro-survival signaling pathways
ENSG00000164978,NUDT2,**
dna repair,oncogenic potential,genomic instability,cell cycle regulation,apoptosis modulation,adp-ribose regulation
**
ENSG00000182712,CMC4,microtubule regulation,cell migration promotion,focal adhesion disruption,cytoskeletal reorganization,tumor progression facilitation,therapeutic target potential
ENSG00000033030,ZCCHC8,spliceosome regulation,rna stability,oncogenic alternative splicing,microrna-mediated repression,tumor progression,metastasis promoter
ENSG00000127914,AKAP9,cellular organization,disrupted cellular function,chromosomal amplification,tumor suppressor,cellular signaling regulation,scaffold protein interaction
ENSG00000169900,PYDC1,glycosylation pathway,oncogenic properties,overexpression,aggressive tumor behavior,poor prognosis,genomic profiling
ENSG00000166197,NOLC1,nucleolar assembly,ribosome biogenesis,cell cycle regulation,transcriptional modulation,oncoprotein overexpression,tumor progression
ENSG00000164047,CAMP,calcium signaling pathway,oncogenic signaling,cell migration,angiogenesis promotion,protein-protein interaction,tumor progression
ENSG00000167965,MLST8,mtor pathway activation,akt phosphorylation,cell proliferation,genomic alterations,cell survival promotion,metabolic regulation
ENSG00000265241,RBM8A,cellular regulation,oncogenic properties,apoptosis suppression,cell proliferation enhancement,dna damage response modulation,therapeutic target
ENSG00000137161,CNPY3,proteolytic activity,oncogene activation,cell proliferation regulation,signal transduction modulation,tumor progression association,clinical prognostic marker
ENSG00000204099,NEU4,sialic acid modification,cell surface protein expression,tumor progression,metastasis,protein kinase regulation,glycoprotein interaction
ENSG00000149554,CHEK1,g2/m checkpoint,aberrant cell cycle regulation,cell proliferation,genomic instability,phosphorylation-dependent degradation,ubiquitin ligase interaction
ENSG00000105483,CARD8,nf-κb pathway inhibition,aberrant cell proliferation,tumor suppressor function,immune evasion mechanism,pro-tumorigenic microenvironment,inflammation regulation
ENSG00000135100,HNF1A,hnf1a transcription factor,downregulated expression,cellular proliferation,tumor progression,epithelial polarity loss,apoptosis regulation disruption
ENSG00000109062,SLC9A3R1,tumor suppressor,ion transport regulation,cell signaling disruption,oncogenic process contribution,pi3k/akt pathway interaction,prognostic marker potential
ENSG00000103154,NECAB2,pi3k/akt pathway interaction,gene overexpression,tumor progression enhancement,cell cycle regulation,cytosolic protein function,prognostic marker significance
ENSG00000102878,HSF4,heat shock factor activity,transcriptional regulation,cell proliferation,apoptosis resistance,chromatin modification,genomic instability
ENSG00000148187,MRRF,mitochondrial regulation,tumor suppressor dysfunction,mitochondrial translation,cell proliferation promotion,overexpression implicated,oncogene potential
ENSG00000011478,QPCTL,oncogenic properties,gene expression regulation,cell proliferation regulation,apoptosis inhibition,oxysterol biosynthesis,tumor progression driver
ENSG00000213619,NDUFS3,mitochondrial energy metabolism,oxidative phosphorylation,electron transport chain,reactive oxygen species,glycolytic shift,metabolic reprogramming
ENSG00000139180,NDUFA9,mitochondrial function,electron transport chain,cellular respiration,energy metabolism regulation,tumor progression,cancer driver gene
ENSG00000263012,KRT33B,cellular invasion,maintenance of epithelial integrity,epigenetic regulation,chromatin remodeling,cellular stress response,pi3k/akt pathway activation
ENSG00000186432,KPNA4,nuclear transport regulation,oncogenic signaling activation,metastasis promotion,cell proliferation facilitation,epithelial-to-mesenchymal transition,genomic instability induction
ENSG00000163161,ERCC3,genomic instability,mutagenesis,transcription regulation,dna repair mechanism,biomarker potential,tumor suppressor function
ENSG00000275023,MLLT6,chromatin remodeling,dna repair regulation,cell cycle progression,histone modification,oncogenic transformation,epigenetic regulation
ENSG00000135018,UBQLN1,protein degradation regulation,ubiquitination pathway interaction,cancer cell proliferation,apoptosis evasion,tumor suppressor dysregulation,ubiquitin-proteasome system modulation
ENSG00000102034,ELF4,cell proliferation,p53 degradation,mdm2 interaction,rna stability,oncogene activation,multifunctional protein
ENSG00000101182,PSMA7,proteasome function,oncogenesis promotion,cell cycle regulation,apoptosis inhibition,angiogenesis enhancement,therapeutic target
ENSG00000079387,SENP1,tumor progression,dna repair mechanism,cell cycle regulation,biomarker potential,oncogenic properties,protein modification
ENSG00000101871,MID1,centrosome regulation,loss of tumor suppressor function,cell cycle disruption,dna repair dysfunction,pi3k/akt pathway activation,oncogenic protein interaction
ENSG00000173581,CCDC106,chromatin remodeling,cell cycle regulation,centrosome function disruption,microtubule stability regulation,oncogenic overexpression,dna repair mechanisms dysregulation
ENSG00000146223,RPL7L1,ribosome biogenesis,translation regulation,oncogenic protein regulation,cell proliferation,poor prognosis marker,high expression levels
ENSG00000015171,ZMYND11,chromatin remodeling,transcriptional regulation,oncogene potential,tumor progression,metastasis,emt regulation
ENSG00000142611,PRDM16,oncogene activation,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,transcription factor function,chromatin remodeling complex interaction,cancer stem cell maintenance
ENSG00000173372,C1QA,immune evasion,tumor progression,metastasis facilitation,poor prognosis marker,tumor microenvironment modulation,complement system activation
ENSG00000184009,ACTG1,genomic instability,microtubule dynamics,cellular homeostasis disruption,tumor progression,therapeutic target,cytoskeleton regulation
,WDYHV1,uncharacterized protein function,potential tumor suppressor/oncogene,signal transduction regulation,cell proliferation/survival regulation,wd40 repeat-containing family member,unclear role in blca biology
ENSG00000244405,ETV5,epigenetic regulation,transcription factor function,oncogene activation,tumor progression,apoptosis regulation,cell cycle modulation
ENSG00000051108,HERPUD1,ubiquitin-proteasome pathway,protein degradation,cell cycle regulation,apoptosis modulation,tumor suppressor function,genomic stability maintenance
ENSG00000157349,DDX19B,ddx19b-rna helicase activity,chromatin remodeling,histone modification regulation,gene expression regulation,cell cycle progression,microrna-mediated gene silencing
ENSG00000143870,PDIA6,protein chaperone activity,cell proliferation,cell migration,redox balance regulation,signaling pathway interaction,oncogenic function
ENSG00000135108,FBXO21,apoptosis regulation,cell cycle progression inhibition,cell proliferation suppression,oncosuppressor function,protein degradation regulation,tumor suppressor activity
ENSG00000143373,ZNF687,zinc finger protein,transcriptional silencing,krab domain-containing family,chromatin remodeling,tumor suppression,tumor progression
ENSG00000276146,LILRB2,immune evasion,tumor microenvironment modulation,nk cell inhibition,immunosuppression,gene expression regulation,protein-protein interaction
ENSG00000103942,HOMER2,cellular adhesion modulation,pi3k/akt/mtor pathway interaction,gene expression regulation,cell growth promotion,metastasis facilitation,signaling pathway dysregulation
ENSG00000149930,TAOK2,cell proliferation enhancement,signaling pathway activation,oncogenic process promotion,therapeutic target potential,chromosomal instability induction,dna damage response regulation
ENSG00000126775,ATG14,autophagy regulation,oncogenic mutations,cell survival pathways,tumorigenesis driver,cancer progression mechanisms,genomic instability
ENSG00000003756,RBM5,gene expression regulation,rna processing,arginine methylation,cell proliferation,cell survival,tumor suppressor mimicry
ENSG00000148450,MSRB2,protein homeostasis disruption,tumor suppressor function loss,cancer cell survival enhancement,cell growth regulation,dna damage response modulation,genomic instability promotion
ENSG00000274081,PUF60,cell cycle regulation,genomic instability,tumor suppressor function,dna repair mechanism,apoptosis promotion,chemotherapy resistance
ENSG00000236149,ABCF1,ner pathway disruption,genomic instability,dna repair impairment,protein degradation regulation,gene expression regulation,tumor suppressor function
ENSG00000128564,VGF,angiogenesis inhibition,apoptosis regulation,cellular differentiation,oncogene function,tumor progression,stress response modulation
ENSG00000205356,TECPR1,ubiquitin-proteasome pathway regulation,cell proliferation enhancement,protein degradation modulation,oncogenic process promotion,tumor progression association,poor prognosis indicator
ENSG00000157954,WIPI2,autophagy regulation,protein localization,cellular compartmentalization,cancer progression,tumor suppressor activity,post-translational modification
ENSG00000196363,WDR5,histone modification regulation,chromatin accessibility modulation,transcriptional activation facilitation,tumor promoter role identification,protein complex interaction involvement,methyl group exchange mediator
ENSG00000163464,CXCR1,angiogenesis promotion,cancer progression driver,cell recruitment enhancer,chemokine receptor function,immune response regulator,inflammation mediator
ENSG00000114354,TFG,transcriptional regulation,oncogene potential,cell cycle modulation,dna repair regulation,signaling pathway activation,downstream target activation
ENSG00000213316,LTC4S,tumor growth promotion,inflammation regulation,cancer cell proliferation,immune response modulation,leukotriene biosynthesis,oncogenic processes
ENSG00000119487,MAPKAP1,cellular proliferation,stress response pathway,protein kinase activity,tumor progression,therapeutic target,prognostic biomarker
ENSG00000187678,SPRY4,pathway regulation,constitutive activation,cell proliferation modulation,signaling pathway interaction,genomic instability,tumor progression driver
ENSG00000160208,RRP1B,tumor suppression,ribosome biogenesis regulation,cell growth regulation,aberrant cell proliferation,prognostic biomarker,oncogenic pathway regulation
ENSG00000040341,STAU2,oncogenic function,mrna stability regulation,cell migration promotion,translation regulation,protein interaction,poor prognosis marker
ENSG00000114439,BBX,oncogenic transcription factor,pi3k/akt pathway activation,cell proliferation promotion,chemotherapy resistance development,dna repair dysregulation,cell cycle progression alteration
ENSG00000181143,MUC16,cell surface protein,immune evasion,epithelial integrity regulation,glycosylation alteration,cell proliferation facilitation,protein-protein interaction network
ENSG00000100097,LGALS1,lgals1 overexpression,tumor progression marker,oncogene involvement,glycoprotein modulation,immune response modulation,prognostic significance
ENSG00000144331,ZNF385B,transcriptional regulator,oncogene activation,tumor progression,apoptosis suppression,cell cycle regulation,chromatin modification
ENSG00000204843,DCTN1,microtubule regulation,mitotic spindle formation,apoptosis resistance,centrosome integrity,cell migration promotion,genomic instability contribution
ENSG00000108298,RPL19,ribosomal protein function,overexpression in cancer,translation regulation,cell proliferation enhancement,gene expression modulation,protein synthesis promotion
ENSG00000179526,SHARPIN,nf-κb activation,linear ubiquitin chain assembly complex (lubac) dysfunction,gain of function mutations,cell survival enhancement,antitumor immune evasion,genomic instability
ENSG00000125826,RBCK1,tumor suppressor function,e3 ubiquitin ligase activity,cell proliferation regulation,protein stability regulation,oncogene regulation,therapeutic target
ENSG00000160360,GPSM1,g-protein coupled receptor regulation,cellular migration enhancement,oncogenic process promotion,cytoskeletal organization disruption,tumorigenesis facilitation,adhesion molecule modulation
ENSG00000033122,LRRC7,cell adhesion disruption,tumor progression,prognostic marker,metastasis promotion,wnt/β-catenin signaling interaction,transmembrane protein function
ENSG00000075292,ZNF638,transcriptional regulation,zinc finger dna binding,oncogenic pathway activation,tumor progression,therapeutic target,genomic instability
ENSG00000180318,ALX1,dna binding,apoptosis suppression,cell proliferation regulation,tumor progression,tumor suppressor gene suppression,therapeutic target
ENSG00000117408,IPO13,aberrant cell proliferation,cytoskeleton dynamics,dysregulation of rhoa/rac1 signaling,genome instability,loss of gap activity,mitotic abnormalities
ENSG00000070961,ATP2B1,calcium ion transport,cell signaling pathways,ion homeostasis regulation,tumor progression influence,potential oncogenic role,dysregulated calcium signaling
ENSG00000198730,CTR9,oncogenic driver,overexpression,cell proliferation enhancement,apoptosis suppression,mrna degradation regulation,translational control alteration
ENSG00000265681,RPL17,ribosomal subunit component,constitutive activation,protein translation regulation,cell proliferation enhancement,oncogenic protein production,therapeutic target
ENSG00000134909,ARHGAP32,loss-of-function mutation,constitutive activation of rho gtpases,aberrant cell migration,cell invasion enhancement,cytoskeleton regulation disruption,tumor progression acceleration
ENSG00000105392,CRX,cellular differentiation,transcriptional regulation,p53 interaction,tumor progression,oncogenic processes,genomic instability
ENSG00000108798,ABI3,oncogene activity,promotes tumor progression,cell proliferation regulation,apoptosis inhibition,cancer aggressiveness association,biological interaction with pi3k/akt pathway
ENSG00000117984,CTSD,lysosomal proteolysis,cell migration,protein degradation,tumor progression,therapeutic target,epithelial-to-mesenchymal transition (emt)
ENSG00000065548,ZC3H15,oncogenic transformation,cell cycle regulation,apoptosis inhibition,tumor growth promotion,metastasis facilitation,chromatin remodeling
ENSG00000185624,P4HB,protein folding regulation,cellular stress response modulation,tumor progression driver,therapeutic resistance promoter,oncogenic pathway activation,chaperone-protein interaction
ENSG00000101347,SAMHD1,dntp pool regulation,oncogenic driver,immune suppressive,genomic instability,error-prone dna replication,therapeutic target
ENSG00000204397,CARD16,cardiomyocyte damage,immune system modulation,tumor microenvironment regulation,phagocytic activation,inflammation induction,antimicrobial response
ENSG00000089289,IGBP1,pi3k/akt pathway activation,overexpression,tumor progression promotion,cell survival enhancement,dna damage response regulation,genomic instability contribution
ENSG00000038382,TRIO,rhoa/cdc42 activation,oncogenic signaling,cell growth promotion,cytoplasmic localization,gef activity regulation,signaling pathway modulation
ENSG00000241123,KRTAP10-5,loss of heterogeneity,reduced expression,tumor suppressor,cellular integrity disruption,proliferation enhancement,epithelial cell abnormality
ENSG00000184060,ADAP2,cell adhesion regulation,apoptosis inhibition,metastasis facilitation,tumor progression,protein-protein interaction,cell migration enhancement
ENSG00000135441,BLOC1S1,aberrant protein trafficking,endocytic pathway regulation,lysosomal dysfunction,tumor progression,oncogene or tumor suppressor,poor prognosis biomarker
ENSG00000099622,CIRBP,apoptosis regulation,cellular proliferation,hypoxia adaptation,oncogenic process,rna stability regulation,tumorigenesis
ENSG00000164548,TRA2A,alternative splicing regulation,cell cycle progression,enhanced oncogenicity,genomic instability,microrna processing,oncogenic co-amplification
ENSG00000122068,FYTTD1,tumor progression,membrane trafficking,endocytosis regulation,cancer metastasis,cellular homeostasis,poor prognosis marker
ENSG00000014164,ZC3H3,oncogenic function,transcriptional regulation,cell proliferation,apoptosis inhibition,signaling pathway interaction,prognostic biomarker
ENSG00000173120,KDM2A,histone modification,proto-oncogene activation,cell cycle regulation,chromatin remodeling,tumor suppressor regulation,dna damage response
ENSG00000185129,PURA,tumor progression,therapeutic target,glycolytic dysregulation,dna repair modulation,cell cycle regulation,metabolic reprogramming
ENSG00000167196,FBXO22,cell cycle regulation,dna damage response,proteasomal degradation,transcriptional control,tumor suppressor function,ubiquitination
ENSG00000167985,SDHAF2,mitochondrial dysfunction,succinate accumulation,reactive oxygen species generation,oncogenic processes promotion,hypoxia-inducible factor stabilization,angiogenesis and metastasis promotion
ENSG00000139946,PELI2,nf-κb pathway regulation,cell proliferation modulation,apoptosis resistance,chemotherapy resistance,e3 ubiquitin ligase activity,protein homeostasis regulation
ENSG00000188846,RPL14,ribosome biogenesis,cell cycle regulation,oncogene overexpression,translation modulation,cell growth promotion,metabolic reprogramming
ENSG00000187554,TLR5,immune evasion,tumor microenvironment modulation,inflammation regulation,chemotherapy resistance,pi3k/akt pathway interaction,cancer immune surveillance
ENSG00000156398,SFXN2,ferroxidase activity,mitochondrial function,dna damage response,oxidative stress regulation,iron metabolism regulation,cancer cell survival enhancement
ENSG00000121390,PSPC1,chromatin remodeling,genome instability,dna repair mechanisms,transcriptional regulation,oncogenic transformation,cell cycle regulation
ENSG00000152402,GUCY1A2,gtp-dependent enzyme activity,cell proliferation,cancer metastasis,signaling pathway activation,constitutive activation,tumor progression
ENSG00000181847,TIGIT,immune checkpoint regulation,tumor immune evasion,cell adhesion and migration,immunosuppressive cytokine expression,t-cell exhaustion,cancer cell survival
ENSG00000164338,UTP15,ribosome biogenesis,overexpression,cell proliferation,dna synthesis,poor prognosis,cell cycle regulation
ENSG00000156515,HK1,glucose metabolism,promotes cell proliferation,enhances energy production,overexpression,cellular metabolism,regulatory protein interaction
ENSG00000131203,IDO1,tumor immune evasion,kynurenine pathway activation,tryptophan depletion,immunosuppression,cellular metabolism regulation,oncogenic pathway interaction
ENSG00000129474,AJUBA,cell proliferation,oncogene activation,pi3k/akt signaling,tumor progression,genomic amplification,therapeutic target
ENSG00000043093,DCUN1D1,ubiquitination pathway dysregulation,constitutive activation,oncogenic transformation,tumor progression,therapeutic target,protein degradation regulation
ENSG00000172867,KRT2,overexpression,cell proliferation,resistance to apoptosis,metastasis,biomarker,pi3k/akt signaling pathway
ENSG00000147364,FBXO25,wnt/β-catenin pathway,tumor suppressor function,genomic instability,protein degradation regulation,signaling pathway modulation,chromosomal instability
ENSG00000135914,HTR2B,serotonin receptor activation,tumor microenvironment modulation,immune response regulation,angiogenesis promotion,cell migration enhancement,metastasis facilitation
ENSG00000150753,CCT5,protein folding and stability regulation,cellular stress response regulation,therapeutic target,tumor progression,oncogenic process facilitation,ubiquitin-proteasome pathway regulation
ENSG00000185479,KRT6B,tumor progression,epithelial-to-mesenchymal transition,e-cadherin regulation,migratory phenotype,pi3k/akt pathway,cell proliferation
ENSG00000158019,BABAM2,fanconi anemia pathway,dna damage response,genome stability maintenance,tumor suppressor function,dna repair regulation,protein-protein interactions
ENSG00000165660,ABRAXAS2,genomic instability,dna repair mechanism,tumor suppressor function,loss-of-function mutations,cell cycle regulation,apoptosis signaling
ENSG00000074590,NUAK1,hippo signaling pathway,oncogenic potential,serine/threonine kinase activity,cell migration and invasion,therapeutic target,genomic instability
ENSG00000144848,ATG3,autophagic flux disruption,cellular homeostasis regulation,cancer metastasis suppression,immune response modulation,microenvironment remodeling,tumor suppressor function
ENSG00000141542,RAB40B,ras superfamily member,mapk/akt signaling regulation,cell proliferation regulator,protein-protein interactions,tumor growth promotion,mutation associated cancer driver
ENSG00000128591,FLNC,cell migration,pi3k/akt pathway,actin-binding protein,cell invasion,signaling regulator,tumor progression
ENSG00000158022,TRIM63,**
cell cycle regulation,gene amplification,dysregulated protein degradation,akt signaling pathway,constitutive activation,oncogenic properties
ENSG00000082146,STRADB,hippo signaling pathway,constitutive activation,loss-of-function mutations,oncogenic transformation,tumor suppressor function,cell proliferation regulation
ENSG00000119326,CTNNAL1,wnt/β-catenin signaling pathway,overexpression,cell proliferation,tumor progression,cell adhesion regulation,oncogene activation
ENSG00000166164,BRD7,**

chromatin remodeling,transcriptional regulation,oncogene silencing,genome instability,loss of function mutation,tumor suppressor

**
ENSG00000105323,HNRNPUL1,alternative splicing,rna stabilization,tumor progression,cell survival,dna damage response,oncogenic processes
ENSG00000079385,CEACAM1,cellular adhesion,cell migration,tumor progression,metastasis,immune evasion,therapeutic target
ENSG00000213578,CPLX3,neurotransmitter regulation,synaptic transmission,membrane fusion regulation,neural signaling,protein-protein interaction,gene expression regulation
ENSG00000006468,ETV1,aberrant activation,apoptosis regulation,cell cycle progression,epithelial-to-mesenchymal transition (emt),oncogene function,transcriptional regulation
ENSG00000157554,ERG,transcriptional regulation,oncogenic transcription factor,tumor progression,gene fusion event,protein overexpression,cell proliferation
ENSG00000117595,IRF6,tumor suppressor,loss of function mutations,cellular proliferation regulation,apoptosis modulation,dna repair pathway regulation,molecular subtype association
ENSG00000151929,BAG3,microtubule assembly,oncogenic signaling,apoptosis regulation,tumor aggressiveness,cancer cell proliferation,therapeutic target
ENSG00000183785,TUBA8,microtubule stabilization,cell division regulation,microtubule assembly,intracellular transport,tumor progression,protein binding
ENSG00000023287,RB1CC1,cell cycle regulation,gene mutation,loss of function mutations,ubiquitination and degradation,protein-protein interaction,tumor suppressor
ENSG00000165527,ARF6,metastasis promotion,tumor invasion,cell migration regulation,pi3k/akt pathway interaction,cancer cell survival,actin cytoskeleton reorganization
ENSG00000138834,MAPK8IP3,signaling regulation,tumor promotion,cellular proliferation,pro-survival pathways,metabolic modulation,scaffold protein function
ENSG00000099783,HNRNPM,**

• rna binding,cell growth regulation
• splice site recognition,gene expression modulation
• oncogene potential,metastasis promotion
• apoptosis suppression,protein-protein interactions 
• pre-mrna processing,genomic stability maintenance

**
ENSG00000109255,NMU,neuropeptide regulation,cell proliferation,receptor interaction,mapk/erk signaling,pi3k/akt pathway,tumor progression
ENSG00000131051,RBM39,alternative splicing regulation,oncogene activity,cell proliferation enhancement,splice factor interaction,tumor cell invasion promotion,rna-binding protein function
ENSG00000177138,FAM9B,cell cycle regulation,dna damage response,cyclin-dependent kinase regulation,genomic instability,oncogenic potential,tumor progression
ENSG00000167641,PPP1R14A,pp1 regulation,cell proliferation,apoptosis modulation,tumor growth modulation,pi3k/akt pathway interaction,cancer cell survival
ENSG00000172243,CLEC7A,immune modulation,ctld family member,tumor infiltration,anti-tumor activity,prognostic marker,poor prognosis indicator
ENSG00000162385,MAGOH,oncogenic activity,cell cycle progression,proliferation enhancement,cancer driver,cell growth regulation,protein-protein interaction modulation
ENSG00000100836,PABPN1,nuclear organization,gene expression regulation,cell growth modulation,oncogenic potential,transcriptional control,chromatin structure interaction
ENSG00000135766,EGLN1,prolyl hydroxylase activity,angiogenesis promotion,hypoxia adaptation,cell proliferation enhancement,protein stability regulation,tumor progression facilitation
ENSG00000106100,NOD1,immune modulation,inflammation regulation,tumor progression,cell migration,nf-κb activation,cancer prognosis
ENSG00000167553,TUBA1C,microtubule dynamics,chromosomal instability,aneuploidy,oncogenic processes,microtubule structure,therapeutic target
ENSG00000129084,PSMA1,protein degradation,cell cycle progression,tumor suppressor protein degradation,cancer prognosis marker,apoptosis regulation,proteasome function
ENSG00000171703,TCEA2,cell migration,epithelial-to-mesenchymal transition,oncogenic processes,apoptosis resistance,cell survival enhancement,signaling pathway regulation
ENSG00000158796,DEDD,altered splicing patterns,rna-binding protein interaction,alternative splicing regulation,oncogene overexpression,dna damage response modulation,transcriptional regulation disruption
ENSG00000160570,DEDD2,genome stability maintenance,constitutive activation,gain of function mutations,tumor progression,therapeutic target,dna damage response regulation
ENSG00000091136,LAMB1,overexpression,tumor progression,angiogenesis promotion,cell adhesion disruption,prognostic marker,genomic amplification
ENSG00000197619,ZNF615,overexpression,gata family transcription factor,cell cycle progression,oncogenic pathway regulation,transcriptional modulation,aggressive tumor behavior
ENSG00000107562,CXCL12,tumor progression,immunosuppressive niche,metastasis promotion,cancer cell migration,chemokine signaling,anti-tumor immune response
ENSG00000169925,BRD3,cell cycle regulation,dna damage repair,epigenetic regulation,gene transcription modulation,oncogenic pathway activation,tumor suppressor inactivation
ENSG00000132275,RRP8,altered expression,ribosome biogenesis,epithelial-to-mesenchymal transition (emt),cell proliferation,apoptosis suppression,rna processing modification
ENSG00000140853,NLRC5,apoptosis regulation,cell cycle progression,inflammation modulation,immune response regulation,tumor suppressor function,genetic instability
ENSG00000108848,LUC7L3,altered splicing events,alternative splicing modulation,mirna processing regulation,tumor progression marker,gene expression regulation,spliceosomal complex interaction
ENSG00000136436,CALCOCO2,p53 modulation,cell survival promotion,pi3k/akt pathway interaction,biomarker potential,apoptosis inhibition,scaffolding protein function
ENSG00000170448,NFXL1,transcriptional regulator,cell proliferation regulation,oncogenic process promotion,tumor progression facilitation,apoptosis inhibition,gene expression modulation
ENSG00000135111,TBX3,cell proliferation,epithelial-to-mesenchymal transition (emt),oncogenic transcription factor,tumor suppressor suppression,prognostic biomarker,therapeutic target
ENSG00000275730,LILRB4,immune evasion,tumor immune suppression,nk cell inhibition,immunosurveillance escape,prognostic marker,immunoregulatory protein
ENSG00000213024,NUP62,nuclear pore regulation,cell cycle progression,dna repair facilitation,transcription regulation,therapeutic target,tumor aggressiveness
ENSG00000125864,BFSP1,desmosomal protein,cell-cell adhesion,tumor progression,metastasis regulator,cytoskeleton organization,cellular morphology
ENSG00000285049,CPSF1,aberrant expression,rna polyadenylation,gene regulation,therapeutic target,cell proliferation,oncogenic processes
ENSG00000188878,FBF1,genomic instability,oncogenic potential,cell cycle regulation,dna repair mechanism,tumor progression,biomarker significance
ENSG00000162989,KCNJ3,overexpression,amplification,cell proliferation,enhanced potassium conductance,g-protein-gated inward rectifier potassium channels,pi3k/akt pathway interaction
ENSG00000157542,KCNJ6,cellular excitability,potassium channel function,tumor growth promotion,therapeutic target,cellular proliferation regulation,apoptosis resistance
,HIST1H1B,epigenetic regulation,chromatin dynamics,histone modification,transcriptional activity,oncogenic transformation,cancer biomarker
,HIST3H2BB,chromatin remodeling,epigenetic regulation,dna replication,histone variant modification,tumorigenesis association,transcriptional regulation alteration
ENSG00000140740,UQCRC2,mitochondrial dysfunction,tumor progression,cell proliferation enhancement,genomic instability,energy metabolism dysregulation,apoptosis evasion
ENSG00000282853,ECH1,fatty acid metabolism,lipid oxidation,cancer cell proliferation,survival advantage,prognostic marker,tumor microenvironment modulation
ENSG00000188042,ARL4C,cell signaling pathway activation,oncogenic process promotion,tumorigenesis facilitation,protein interaction,cancer progression association,cell cycle regulation alteration
ENSG00000174137,FAM53A,oncogenic overexpression,regulation of cell growth,dysregulation associated with cancer progression,signaling pathway activation,potential therapeutic target,transcriptional regulation modification
ENSG00000169714,CNBP,genomic instability,transcriptional regulation,cell cycle progression,multifunctional protein,tumor progression,dna/rna binding interactions
ENSG00000165732,DDX21,dna repair,oncogenic transcription,transcriptional activation,overexpression,genomic stability,therapeutic target
ENSG00000143476,DTL,cell cycle regulation,dna damage response,apoptosis regulation,transcriptional regulation,g2/m phase transition,chromosomal stability
,WDR34,centriole biogenesis disruption,ciliogenesis regulation,cell cycle progression,genome instability,microtubule organization,tumor suppressor
ENSG00000130826,DKC1,genomic instability,telomere maintenance disruption,epigenetic regulation alterations,cellular proliferation promotion,ribosomal rna processing dysfunction,transcriptome alterations
ENSG00000083642,PDS5B,chromatin remodeling,genomic instability,tumor suppressor function,aberrant cell cycle regulation,dna repair impairment,genome stability maintenance
ENSG00000165637,VDAC2,mitochondrial porin,metabolic reprogramming,tumor growth promotion,oncogenic signaling,cell survival pathway interaction,therapeutic target for cancer treatment
ENSG00000137942,FNBP1L,actin polymerization regulation,cell migration promotion,prognostic marker overexpression,metastasis facilitation,cytoskeleton organization modulation,tumor aggressiveness correlation
ENSG00000068366,ACSL4,lipid metabolic regulation,tumor progression driver,cancer cell membrane modification,therapeutic target,oncogene activation,cellular lipid reprogramming
ENSG00000164062,APEH,genomic instability,dna damage repair,base excision repair (ber),cell cycle progression,oncogenesis,genomic integrity
ENSG00000182149,IST1,cell-cell adhesion,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,metastasis promotion,tumor progression,biomarker potential
ENSG00000185187,SIGIRR,dysregulated signaling pathway,enhanced cell survival,immune evasion mechanism,loss of inhibitory function,nf-κb activation,mapk pathway dysregulation
ENSG00000138385,SSB,genomic instability,dna damage response,single-strand dna binding,cell cycle regulation,mutated forms,oncogenic potential
ENSG00000173156,RHOD,ras gtp-binding activity,cell signaling regulation,tumor progression facilitation,adhesion molecule regulation,metastasis promotion,focal adhesion formation
ENSG00000239306,RBM14,coactivator function,androgen receptor interaction,rna processing regulation,cell proliferation enhancement,tumor aggressiveness promotion,therapeutic resistance association
ENSG00000185615,PDIA2,cell cycle regulation,oncogenic pathway activation,tumor progression association,protein folding regulation,apoptosis inhibition,er stress response modulation
ENSG00000277334,NCR1,immune evasion,cell proliferation,neutrophil activation,tumor progression,il-22 signaling pathway,gene overexpression
ENSG00000145912,NHP2,ribosome biogenesis,nucleotide modification,rna processing,cellular metabolism,cancer driver,oncogenic potential
ENSG00000023902,PLEKHO1,pi3k/akt pathway activation,oncogenic mutations,cell cycle regulation disruption,apoptosis suppression,protein-protein interaction dysregulation,tumor suppressor gene interaction
ENSG00000092621,PHGDH,metabolic reprogramming,tumor metabolic adaptation,serine synthesis pathway,cell proliferation,anabolic processes,glycolysis regulation
ENSG00000125686,MED1,transcriptional regulation,promoter hypomethylation,constitutive activation,oncogenic signaling,cell proliferation,tumor progression
ENSG00000138279,ANXA7,cell cycle regulation,oncogenic processes,protein-protein interactions,calcium-dependent binding,apoptosis evasion,tumor progression
ENSG00000143624,INTS3,transcriptional activation,cell cycle regulation,apoptosis,dna repair,tumor suppression,gene expression regulation
ENSG00000241794,SPRR2A,emt regulation,wnt/β-catenin signaling pathway,oncogenic properties,cancer stem cell maintenance,cell proliferation regulation,epithelial differentiation
ENSG00000187522,HSPA14,tumor aggressiveness,cell migration and invasion,oncogene potential,cellular resilience maintenance,protein homeostasis regulation,dna damage response modulation
ENSG00000106245,BUD31,mitotic regulation,cell proliferation,aneuploidy driver,cytokinesis regulator,spindle assembly,cell cycle progression
ENSG00000100225,FBXO7,genomic instability,loss of function mutations,tumor suppression,cell cycle regulation,apoptosis regulation,stem cell maintenance
ENSG00000107833,NPM3,genomic instability,chromatin remodeling,cell cycle regulation,oncogenesis,genomic alterations,protein-protein interaction
ENSG00000153406,NMRAL1,chromosomal instability,genomic amplification,proliferation enhancement,aneuploidy promotion,tumor progression enhancer,cell cycle disruption
ENSG00000154277,UCHL1,pi3k/akt signaling,cell proliferation,protein degradation,oncogenesis,metastasis,apoptosis
ENSG00000083896,YTHDC1,transcriptional regulation,cellular proliferation,gene expression modulation,m6a modification,chemosensitivity regulation,tumor progression
ENSG00000151623,NR3C2,transcriptional regulation,growth factor regulation,cellular proliferation,cancer progression,metastatic regulation,tumor suppressor function
ENSG00000165516,KLHDC2,cell cycle regulation,chromatin remodeling,epithelial-to-mesenchymal transition (emt),gene expression modulation,oncogenic driver,tumor progression
ENSG00000106554,CHCHD3,cellular proliferation,mitochondrial dynamics,chemoresistance development,epithelial-to-mesenchymal transition,oncogenic overexpression,apoptosis regulation
ENSG00000280680,HHAT,histone acetyltransferase function,epigenetic regulation,chromatin remodeling,prc2 interaction,oncogene activation,tumor suppressor gene silencing
ENSG00000058404,CAMK2B,cell proliferation,apoptosis inhibition,calcium/calmodulin-dependent signaling,cell migration and invasion,g2/m cell cycle regulation,pro-inflammatory cytokine induction
ENSG00000138646,HERC5,aberrant protein degradation,dna repair mechanism disruption,cell proliferation regulation,tumor progression promotion,protein kinase activation modulation,oncogenic pathway interaction
ENSG00000158445,KCNB1,hyperpolarization-activated channels,increased cell proliferation,ion flux regulation,oncogenic processes,pi3k/akt pathway interaction,voltage-gated potassium channel function
ENSG00000175497,DPP10,cellular excitability,potassium channel regulation,calcium influx modulation,tumor progression driver,oncogenic pathway activation,cell proliferation regulator
ENSG00000127314,RAP1B,aberrant activation,cell proliferation,constitutive activation,oncogenic transformation,ras signaling pathway,signaling modulation
ENSG00000115806,GORASP2,golgi apparatus dysregulation,oncogenic protein trafficking,pi3k/akt pathway interaction,cell proliferation enhancement,tumor progression facilitation,gene expression regulation alteration
ENSG00000278129,ZNF8,tumor suppressor activity,oncogene function,cell cycle regulation,transcriptional control,dna repair mechanism,prognostic marker
ENSG00000137171,KLC4,microtubule dynamics,tumor suppressor function,cellular migration regulation,mitosis regulation,cytokinesis regulation,genomic instability promotion
ENSG00000108312,UBTF,ribosomal rna regulation,transcriptional activation,cell proliferation enhancement,tumor progression driver,therapeutic target identification,genomic instability association
ENSG00000163060,TEKT4,tekt4/angiopoietin-1 interaction,tumor progression,angiogenesis promoter,oncogene activation,cell migration regulator,vascular endothelial cell proliferation
ENSG00000167858,TEKT1,epithelial-to-mesenchymal transition,cell migration,metastasis promotion,oncogene potential,tumor progression,genomic amplification
ENSG00000198382,UVRAG,autophagy regulation,tumor suppressor function,genomic stability maintenance,dna damage response,cellular homeostasis modulation,cancer development suppression
ENSG00000125676,THOC2,p-tefb recruitment,chromatin remodeling,transcriptional activation,tumor progression,emt induction,apoptosis evasion
ENSG00000187741,FANCA,genomic instability,dna repair pathway,tumor progression,chromosomal alterations,oncogenic signaling,genome maintenance
ENSG00000113368,LMNB1,dna repair,oncogenic potential,genomic instability,nuclear structure regulation,cell cycle progression,protein overexpression
ENSG00000113645,WWC1,brca1 interaction,homologous recombination repair,cell cycle regulation,genome instability,oncogenesis,poor prognosis marker
ENSG00000070371,CLTCL1,transcriptional regulation,chromatin remodeling,oncogenic protein-protein interactions,cell cycle progression,apoptosis evasion,genomic instability
ENSG00000181481,RNF135,oncogenic signaling,cell proliferation,protein degradation,apoptosis regulation,transcriptional modulation,ubiquitination machinery
ENSG00000120457,KCNJ5,potassium channel activation,tumor progression,cell proliferation,therapeutic target,signaling pathway interaction,genomic profiling
ENSG00000124171,PARD6B,overexpression,cell polarity,epithelial-to-mesenchymal transition,prognostic marker,wnt/β-catenin signaling pathway,metastasis promoter
ENSG00000161940,BCL6B,genomic instability,tumor suppression,chromatin regulation,cell survival modulation,dna damage response,oncomodulatory transcription
ENSG00000160679,CHTOP,transcription factor regulation,cancer cell proliferation,epithelial-to-mesenchymal transition,cell cycle regulation,tumor growth promotion,apoptosis suppression
ENSG00000101844,ATG4A,autophagy regulation,cell proliferation promotion,oncogenic function,epithelial-to-mesenchymal transition modulation,immune response modulation,tumor progression facilitation
ENSG00000189403,HMGB1,emt induction,inflammation modulation,cell cycle regulation,tumor growth promotion,epithelial marker downregulation,mesenchymal marker upregulation
ENSG00000172236,TPSAB1,enhancement of proteolytic activity,cell migration,angiogenesis promotion,invasion facilitation,urokinase-type plasminogen activator regulation,poor prognosis marker
ENSG00000119138,KLF9,genomic instability,tumor suppressor activity,apoptosis regulation,cell cycle modulation,epigenetic regulation,dna repair deficiency
ENSG00000171346,KRT15,cellular morphology regulation,cytoskeletal network disruption,epithelial integrity disruption,oncogenic pathway activation,tumor progression enhancement,therapeutic target potential
ENSG00000111321,LTBR,immune modulation,nf-κb signaling activation,pro-inflammatory cytokine production,tumor microenvironment regulation,cell survival and proliferation promotion,therapeutic target
ENSG00000196664,TLR7,tlr signaling,immune modulation,innate immune activation,cytokine production,apoptosis regulation,tumor microenvironment interaction
ENSG00000180182,MED14,transcriptional regulation,chromatin remodeling,dna repair dysfunction,cell cycle dysregulation,therapeutic target potential,gene overexpression
ENSG00000142856,ITGB3BP,integrin signaling pathway,cell migration and invasion,epithelial-to-mesenchymal transition,tumor progression,metastasis,cancer cell invasiveness
ENSG00000170776,AKAP13,cell migration,cell proliferation,cytoskeleton regulation,metastasis,oncogenic driver,pka/rock activation
ENSG00000101460,MAP1LC3A,autophagy regulation,cellular proliferation,oncogenic transformation,apoptosis modulation,lysosomal pathway interaction,protein degradation
ENSG00000146701,MDH2,energy metabolism,cellular proliferation,apoptosis regulation,glycolysis activation,mitochondrial function,protein-protein interaction
ENSG00000143970,ASXL2,chromatin remodeling,epigenetic regulation,loss-of-function mutations,oncogene activation,tumor suppressor repression,wnt/β-catenin signaling
ENSG00000274651,PRPF31,altered splicing,cell proliferation,cancer driver gene,genomic instability,oncogenic pathway activation,rna processing
ENSG00000090621,PABPC4,tumor progression,cell proliferation,oncogenic processes,translation regulation,mrna stability,cytoplasmic localization
ENSG00000141522,ARHGDIA,gtpase regulation,rho gdi activity,oncogenic transformation,cell migration promotion,tumor progression,therapeutic target
ENSG00000168421,RHOH,constitutive activation,mapk/erk pathway activation,poor prognosis,genomic instability,gtp-binding activity,cell migration promotion
ENSG00000182670,TTC3,cell cycle regulation,dna repair mechanism disruption,genomic instability,oncogene function,tumor progression facilitation,apoptosis inhibition
ENSG00000103351,CLUAP1,p53 regulation,oncogene potential,cell survival promotion,tumor suppressor inhibition,endocytic pathway interaction,stress response modulation
ENSG00000105492,SIGLEC6,cell adhesion,tumor progression,immune evasion,oncogene overexpression,survival pathway modulation,cancer cell recognition
ENSG00000116663,FBXO6,protein ubiquitination,cell cycle regulation,tumor suppression,oncoprotein degradation,dna repair regulation,apoptosis modulation
ENSG00000099817,POLR2E,transcriptional regulation,gene expression dysregulation,aberrant rna processing,oncogenic pathway promotion,rna polymerase ii activity,dysregulated gene expression
ENSG00000189043,NDUFA4,mitochondrial complex i regulation,oxidative phosphorylation modulation,metabolic reprogramming,cellular stress response,chemotherapy resistance,tumor metabolism
ENSG00000165588,OTX2,oncogene,transcription factor function,cell proliferation regulator,apoptosis inhibitor,tumor aggressiveness promoter,prognostic biomarker
ENSG00000108604,SMARCD2,transcriptional regulation,chromatin remodeling,cell growth control,metastasis promotion,oncogene activation,genomic amplification
ENSG00000140743,CDR2,cell cycle regulation,genomic instability,oncogene overexpression,tumor suppressor dysfunction,anti-apoptotic function,dna repair pathway interaction
ENSG00000184743,ATL3,alpha-tocopherol regulation,cellular transport,vitamin e imbalance,tumor progression,oxidative stress,therapeutic target
ENSG00000172346,CSDC2,chromatin remodeling,gain of function mutations,pi3k/akt pathway,tumor progression,therapeutic target,cell proliferation
ENSG00000119929,CUTC,tumor suppressor function,cell cycle regulation,apoptosis induction,angiogenesis inhibition,pi3k/akt pathway modulation,prognostic biomarker potential
ENSG00000105829,BET1,metabolic regulation,chromatin remodeling,oncogene activation,apoptosis inhibition,therapeutic target,transcriptional modulation
ENSG00000179262,RAD23A,aberrant protein degradation,molecular chaperone function,oncogenic potential,cell proliferation driver,apoptosis resistance,proteasome complex subunit
ENSG00000231555,HSPA1B,oncogenic chaperone function,hypoxia-inducible protein,protein folding regulation,tumor cell survival,cell cycle progression facilitation,apoptosis suppression
ENSG00000121892,PDS5A,dna repair regulation,cohesin complex regulation,genomic instability,tumor progression,oncogene activation,therapeutic target
ENSG00000149187,CELF1,oncogene activation,splicing regulation,rna-binding protein function,cell proliferation enhancement,tumor aggressiveness,gene expression modulation
ENSG00000135250,SRPK2,splicing regulation,tumor progression,oncogenic activity,overexpression,cell proliferation,dna repair regulation
ENSG00000102038,SMARCA1,swi/snf complex,chromatin remodeling,oncogenic mutations,epigenetic silencing,tumor progression,cell cycle regulation
ENSG00000182199,SHMT2,tumor aggressiveness,gene amplification,cell proliferation,purine synthesis,dna repair,metabolic reprogramming
ENSG00000188554,NBR1,autophagic regulation,tumor progression,prognostic biomarker,cellular homeostasis,ubiquitination regulation,adaptor protein function
ENSG00000170296,GABARAP,autophagy regulation,tumor microenvironment modulation,cell cycle dysregulation,lysosomal degradation,protein-protein interaction,autophagic pathway activation
ENSG00000137947,GTF2B,chromatin remodeling,transcriptional regulation,tumor suppressor interaction,genomic instability,cellular proliferation,epigenetic regulation
,HIST1H2BD,histone modification,chromatin remodeling,epigenetic regulation,gene expression control,dna packaging,transcriptional regulation
ENSG00000273575,KIR2DL4,tumor suppressor,ion channel regulation,cellular ion balance,oncogenic processes,immune response modulation,cell proliferation regulation
ENSG00000115165,CYTIP,cell cycle regulation,dna damage repair,transcriptional modulation,biomarker function,tumor progression marker,oncogenic protein
ENSG00000143376,SNX27,phosphatidylinositol 3-phosphatase domain,cell proliferation enhancement,oncogenic process promotion,epithelial-to-mesenchymal transition regulation,tumor progression facilitation,pi3k/akt signaling modulation
ENSG00000143549,TPM3,alk kinase activation,epithelial-to-mesenchymal transition,emt,cellular growth promotion,constitutive activation,tumor progression
ENSG00000137767,SQOR,tumor progression,energy metabolism,oxidative stress,reactive oxygen species,dna damage,epi-genetic regulation
ENSG00000143553,SNAPIN,cellular regulation,protein degradation,ubiquitin ligase recruitment,signaling pathway modulation,tumor progression,therapeutic potential
ENSG00000124228,DDX27,constitutive activation,chromatin remodeling,oncogene overexpression,genomic instability,gene regulation disruption,aggressive tumor behavior
ENSG00000237344,PBX2,oncogenic transcription factor,overexpression,cell proliferation,epigenetic regulation,wnt/β-catenin signaling,prognostic marker
ENSG00000106785,TRIM14,tumor suppressor function loss,pi3k/akt pathway modulation,genomic instability induction,cell proliferation promotion,apoptosis inhibition,oncogene overexpression
ENSG00000112081,SRSF3,alternative splicing,pro-tumorigenic isoforms,rna-binding protein interactions,oncogenic pathways activation,poor prognosis marker,tumor progression driver
ENSG00000072134,EPN2,epithelial-to-mesenchymal transition (emt),metastasis promotion,cell adhesion regulation,signaling pathway modulation,poor prognosis correlation,rho gtpase activation
ENSG00000121653,MAPK8IP1,mapk/jnk/p38 pathway,oncogenic signaling,tumor progression,poor prognosis,therapeutic target,cell proliferation
ENSG00000173933,RBM4,cell proliferation,tumor progression,oncogene,rna-binding motif,apoptosis regulation,gene expression modulation
ENSG00000274853,MRM1,mitochondrial biogenesis,translation regulation,oncogenic pathway activation,cell growth promotion,aggressive tumor behavior,prognostic marker
ENSG00000138768,USO1,er protein transport,protein quality control,unfolded protein response,cellular stress response,tumor suppressor dysregulation,apoptosis inhibition
ENSG00000070756,PABPC1,regulated rna translation,oncogenic mrnas stabilization,enhanced cell proliferation,poor prognosis indicator,ribonucleoprotein complex assembly,dysregulated mrna processing
ENSG00000100968,NFATC4,regulatory transcription factor activity,cell cycle regulation,transcriptional activation,tumor progression,apoptosis resistance,epithelial-to-mesenchymal transition
ENSG00000149548,CCDC15,genomic instability,microtubule dynamics,mitotic spindle assembly,cell cycle regulation,centrosomal protein interaction,oncogene activation
ENSG00000140319,SRP14,protein targeting,cancer progression,cell survival,tumor aggressiveness,metastatic potential,biomarker
ENSG00000139197,PEX5,peroxisomal protein import,cell survival and proliferation,oxidative stress and impaired cellular metabolism,tumor progression and oncogenic processes,cancer-related gene function,peroxisome dysfunction
ENSG00000164251,F2RL1,metastasis driver,tumor progression,prognostic marker,thrombin signaling pathway,cell proliferation regulation,platelet activation regulator
ENSG00000152086,TUBA3E,mitotic spindle assembly,aneuploidy,genomic instability,proliferation regulation,survival pathways,tumor progression
ENSG00000163156,SCNM1,alternative splicing,genomic instability,mutations in tumor suppressors,rna processing dysregulation,oncogenic isoform expression,spliceosome component
ENSG00000136147,PHF11,chromatin remodeling,tumor suppressor function,oncogenic process,genome stability,histone modification recognition,chromatin-remodeling complex interaction
ENSG00000185651,UBE2L3,ubiquitination pathway,protein degradation regulation,cell cycle progression,tumorigenesis driver,transcriptional regulation,genomic instability marker
,HIST1H2AH,chromatin compaction,genomic stability maintenance,histone variant expression,epigenetic regulation influence,oncogenic gene expression,tumorigenesis initiation
ENSG00000277956,MAPT,microtubule regulation,cell cycle progression,apoptosis modulation,chromosomal instability,dna damage response,therapeutic target
ENSG00000131773,KHDRBS3,heterogeneous nuclear ribonucleoprotein (hnrnp) function,aberrant expression,apoptosis evasion,cell cycle regulation,mrna splicing and stability,oncogenic effects
ENSG00000055118,KCNH2,genomic instability,tumor suppressor function,pi3k/akt pathway regulation,cancer risk modifier,cell cycle regulation,anti-apoptotic mechanism
ENSG00000114738,MAPKAPK3,mapk pathway activation,constitutive activation,oncogenic mutations,cell proliferation enhancement,apoptosis resistance,protein kinase function
ENSG00000136891,TEX10,transcriptional regulation,chromatin modification,oncogene activation,metastasis promotion,tumor progression,genetic overexpression
ENSG00000125166,GOT2,cellular metabolism,glutamate catabolism,amino acid regulation,warburg effect,hypoxia adaptation,tumor growth support
ENSG00000116459,ATP5PB,mitochondrial function,energy metabolism,proton transport,oxidative phosphorylation,tumor aggressiveness,cancer prognosis
ENSG00000152256,PDK1,pi3k/akt signaling pathway,constitutive activation,gain of function mutations,cell survival and proliferation,therapeutic target,drug resistance
ENSG00000116977,LGALS8,tumor progression,immune evasion,cell adhesion and migration modulation,oncogenic pathway regulation,glycosylation pattern recognition,genomic overexpression
ENSG00000149968,MMP3,tumor progression,extracellular matrix degradation,cell migration invasion,metastasis promoter,epithelial-to-mesenchymal transition (emt),proteolytic enzyme activity
ENSG00000140564,FURIN,proprotein convertase activity,tumor aggressiveness,oncogenic growth factor activation,proteolytic processing regulation,angiogenesis promotion,tumor microenvironment modulation
ENSG00000095139,ARCN1,glycosylation regulation,tumor progression,gene amplification,cell proliferation,protein interaction,aberrant glycoprotein production
ENSG00000166091,CMTM5,cell growth inhibition,tumor suppression,apoptosis induction,signaling pathway regulation,epithelial-to-mesenchymal transition modulation,protein-protein interaction
ENSG00000104894,CD37,cell surface antigen,tumor progression,immunoglobulin superfamily member,cell adhesion molecule,overexpressed in cancer,apoptosis regulation
ENSG00000231543,C2,c3 convertase complex formation,complement activation,epithelial-to-mesenchymal transition,immune evasion mechanisms,pro-inflammatory cytokine regulation,tumor progression and metastasis
ENSG00000129460,NGDN,chromatin remodeling,pi3k/akt pathway,histone modification,tumor progression,transcriptional regulation,cell proliferation
ENSG00000106803,SEC61B,cellular proliferation,oncogene function,protein transport regulation,tumor progression,metastasis promotion,unfolded protein response regulation
ENSG00000163479,SSR2,chromatin remodeling,transcriptional regulation,genome stability,histone modification,tumor suppression,oncogenic pathway modulation
ENSG00000107872,FBXL15,cell cycle regulation,oncogenic processes,tumorigenesis,cell proliferation,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000102786,INTS6,wnt signaling pathway,chromatin remodeling,cell proliferation,tumor growth,apoptosis evasion,mll complex regulation
ENSG00000169599,NFU1,mitochondrial iron-sulfur cluster assembly,energy production regulation,dna synthesis modulation,oxidative stress induction,cellular metabolism disruption,tumor progression association
ENSG00000111615,KRR1,cell cycle regulation,cancer proliferation,microtubule transport,mitotic spindle assembly,oncogenic driver,prognostic marker
ENSG00000102554,KLF5,transcription factor regulation,oncogenic driver,cell cycle progression,apoptosis inhibition,emt regulation,pi3k/akt pathway interaction
ENSG00000147224,PRPS1,nucleotide biosynthesis,oncogenic signaling,tumor growth,purine metabolism,mutations in tumors,cancer cell metabolism
ENSG00000134138,MEIS2,wnt/β-catenin signaling,oncogene activation,transcriptional regulation,cell proliferation enhancement,metastasis promotion,embryonic development pathway dysregulation
ENSG00000105193,RPS16,ribosome biogenesis,cancer dependency,genomic amplification,poor prognosis marker,protein synthesis regulation,cell cycle progression
ENSG00000126945,HNRNPH2,genomic instability,tumor suppressor regulation,oncogene splicing modulation,cell proliferation promotion,pro-survival signaling enhancement,rna binding activity
ENSG00000122692,SMU1,dna damage repair,oncogene activation,cell proliferation enhancement,tumor suppression disruption,gene expression regulation,epigenetic alteration promotion
ENSG00000169344,UMOD,oncogene,cell adhesion,cell migration,proliferation signaling,mapk/erk activation,pi3k/akt pathway
ENSG00000108061,SHOC2,pi3k/akt pathway,oncogene activation,cell survival promotion,tumor progression driver,mapk/erk signaling regulation,cell cycle dysregulation
ENSG00000145741,BTF3,transcriptional regulation,tumor progression,cell proliferation,apoptosis inhibition,chromatin modification,oncogenic transformation
ENSG00000197785,ATAD3A,genomic instability,loss of function mutations,dna damage response,homologous recombination repair,brca2 interaction,mitotic regulation
,SEPT4,cell cycle regulation,gtpase activity,septin complex formation,cell proliferation,oncogenesis,tumor progression
ENSG00000108671,PSMD11,upp regulation,oncoprotein stabilization,protein degradation pathway,tumor progression facilitation,cellular homeostasis disruption,cancer cell growth promotion
ENSG00000004487,KDM1A,histone modification regulation,chromatin remodeling,cell proliferation enhancement,tumor suppressor repression,epigenetic regulation,oncogene overexpression
ENSG00000104756,KCTD9,chromatin remodeling,dna methylation,histone modification,tumor suppressor function,cell cycle regulation,gene expression regulation
ENSG00000104687,GSR,oxidative stress modulation,detoxification enzyme,chemotherapy resistance,dna repair mechanism,cell survival pathway,antioxidant process
ENSG00000153395,LPCAT1,pi3k/akt interaction,overexpression,lysophosphatidylcholine metabolism,cell membrane modification,tumor progression,biomarker
ENSG00000277586,NEFL,aberrant expression,cancer pathogenesis,cellular stress response,filament organization,oncogene potential,tumor progression
ENSG00000124507,PACSIN1,pi3k/akt pathway interaction,constitutive activation,gain of function mutations,cell proliferation,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000115317,HTRA2,apoptosis regulation,cellular stress response,mitochondrial association,oncogenic function,serine protease activity,tumor progression
ENSG00000282947,HNRNPL,altered splicing patterns,cell proliferation,epigenetic regulation,genomic instability,oncogenic phenotypes,rna-binding protein function
ENSG00000132849,PATJ,loss of function mutations,tumor suppressor,cell polarity regulation,epithelial integrity maintenance,emt inhibition,cancer cell migration suppression
ENSG00000167081,PBX3,oncogenic transcriptional regulation,transcription factor activity,cell differentiation disruption,gene expression modulation,poor prognosis marker,tumor aggressiveness
ENSG00000068028,RASSF1,cell cycle regulation,tumor suppressor function,microtubule stability,p53-dependent apoptosis,ras/mapk signaling pathway,promoter methylation loss
ENSG00000139546,TARBP2,microrna-mediated regulation,rna degradation,cell proliferation,tumor aggressiveness,transcriptional repression,oncogenic function
ENSG00000114388,NPRL2,akt/mtor pathway activation,oncogene function,cellular proliferation regulation,protein degradation control,ubiquitin ligase complex interaction,genomic mutation impact
ENSG00000106327,TFR2,iron regulation,cell proliferation,oncogenic pathway interaction,prognostic marker,metastasis promotion,nutritional deficiency association
ENSG00000088002,SULT2B1,tumor suppression,estrogen metabolism,steroid hormone regulation,detoxification process,cancer prevention,apoptosis promotion
ENSG00000164114,MAP9,microtubule stabilization,mitotic checkpoint regulation,cell proliferation enhancement,oncogenic properties promotion,genomic instability contribution,tumor progression facilitation
ENSG00000096088,PGC,telomerase activity,genetic instability,dna repair mechanisms,cell cycle regulation,epigenetic regulation,chromatin remodeling
ENSG00000177468,OLIG3,dysregulation of cell cycle progression,disruption of normal dna repair mechanisms,oncogenesis through aberrant transcriptional regulation,tumor progression,transcription factor function,cell proliferation and survival
,SEPT9,ciliogenesis regulation,dysregulated expression,cell proliferation enhancement,genomic instability promotion,tumor biomarker,septin dysregulation
ENSG00000143614,GATAD2B,chromatin regulation,gene expression regulation,tumor suppressor function,transcriptional dysregulation,proliferation and survival pathways regulation,cancer driver mutation
ENSG00000151923,TIAL1,cell cycle regulation,genomic instability,oncogenic transcriptional regulator,tumor growth promotion,therapeutic target candidate,transcriptional activation
ENSG00000112146,FBXO9,apoptosis regulation,cell cycle control,dna damage response,genomic stability,protein degradation,regulatory function
ENSG00000197540,GZMM,tumor suppression,cell cycle regulation,dna damage repair,genetic instability,apoptosis resistance,proliferation promotion
ENSG00000124469,CEACAM8,tumor suppressor function,cell adhesion modulation,immune response regulation,proliferation inhibition,apoptosis enhancement,epithelial cell differentiation
ENSG00000137776,SLTM,**
cell proliferation,cell migration,pi3k/akt pathway activation,rho gtpase interaction,tumor aggressiveness,overexpression 
**
ENSG00000075702,WDR62,genomic stability maintenance,tumor suppressor function,cell cycle regulation,chromosome segregation accuracy,spindle checkpoint interaction,aneuploidy promotion
ENSG00000090273,NUDC,mitotic regulation,genomic instability,chromatin remodeling,cell cycle progression,protein kinase interaction,tumor suppression defect
ENSG00000125257,ABCC4,efflux transporter function,tumor chemoresistance,cell proliferation regulation,apoptosis modulation,cancer drug efflux,resistance mechanism
ENSG00000087087,SRRT,transcriptional regulation,chromatin remodeling,histone modification,gene expression modulation,cellular proliferation,protein-protein interactions
ENSG00000275176,ACACA,metabolic rewiring,lipid synthesis enhancement,oncogenic signaling,tumor growth promotion,cellular metabolic adaptation,protein-ligand interaction
ENSG00000168397,ATG4B,autophagic flux regulation,cell survival and proliferation,protein degradation pathways,mitochondrial localization,cysteine protease activity,tumor progression
ENSG00000160214,RRP1,rna degradation,m6a modification,mrna stability,gene expression regulation,cancer prognosis,oncogenesis
ENSG00000135503,ACVR1B,tgf-β signaling pathway,constitutive activation,overexpression,cell proliferation,metastasis,transcriptional regulation
ENSG00000114867,EIF4G1,translation initiation factor,enhances protein synthesis,promotes cell proliferation,supports tumorigenesis,regulates mrna translation,cell cycle progression
ENSG00000189369,GSPT2,cell cycle regulation,translation initiation factor,protein synthesis enhancement,tumor aggressiveness,cancer driver gene,high proliferation rates
ENSG00000149428,HYOU1,cellular stress response,protein folding and degradation,tumor progression,chemotherapy resistance,apoptosis regulation,oncogenic process
ENSG00000181026,AEN,angiogenesis promoter,cell migration facilitator,extracellular matrix degradation,metastasis driver,proteolytic activity,tumor microenvironment modulation
ENSG00000162734,PEA15,multifunctional protein,cellular proliferation,oncogenic properties,signaling pathway modulation,epithelial-to-mesenchymal transition,tumor promoter
ENSG00000089234,BRAP,brap/mapk signaling pathway,cell cycle progression,chromatin remodeling,dna repair mechanism,epigenetic regulation,transcriptional modulation
ENSG00000157601,MX1,apoptosis modulation,cell cycle regulation,oxidative stress response,prognostic marker,tumor progression association,stress response regulation
ENSG00000132313,MRPL35,mitochondrial function,ribosome biogenesis,cellular stress response,growth promotion,tumor progression,dna damage repair
ENSG00000092969,TGFB2,tgf-β signaling pathway,constitutive activation,dual-functional molecule,tumor suppression,oncogenic properties,immune modulation
ENSG00000277359,RPS9,ribosomal subunit assembly,protein synthesis regulation,tumor development association,cell growth regulation,transcriptional control modulation,ribosome stability maintenance
ENSG00000100138,SNU13,ribosomal rna pseudouridylation,small nucleolar rna component,rapid cell proliferation,cancer driver gene,tumor progression,enhanced ribosome production
ENSG00000100650,SRSF5,alternative splicing,pro-oncogenic splice variants,cellular proliferation,tumor suppressor gene regulation,dysregulation in cancer,biomarker potential
ENSG00000133878,DUSP26,mapk pathway regulation,tumor progression driver,mutation hotspot,cell proliferation enhancement,oncogenic signaling modulation,kinase activation dysregulation
ENSG00000077312,SNRPA,alternative splicing,apoptosis regulation,cell proliferation,gene expression modulation,prognostic marker,tumor progression
ENSG00000198099,ADH4,oxidative stress,reactive oxygen species production,dna damage response,tumor progression,chemotherapy resistance,alcohol metabolism
ENSG00000143106,PSMA5,proteasome regulation,cellular degradation,oncogenic signaling,tumor progression,cell proliferation,apoptosis inhibition
ENSG00000107816,LZTS2,cellular proliferation,tumor suppression,cell cycle regulation,oncogenic pathway involvement,downregulation/mutation in cancer,apoptosis inhibition
ENSG00000165169,DYNLT3,microtubule regulation,tumor progression,cancer cell motility,mutation-driven oncogenesis,pi3k/akt pathway modulation,cellular invasiveness
ENSG00000197114,ZGPAT,genomic stability regulation,centromere-specific histone 3 (cenpa) recruitment,cell division regulation,chromosome segregation maintenance,genome instability contribution,tumorigenesis promotion
ENSG00000124535,WRNIP1,genomic instability,maintenance of genomic integrity,cellular proliferation,tumor progression regulation,oncogene interaction,dna repair modulation
ENSG00000169813,HNRNPF,rna-binding protein,oncogenic regulation,tumor progression,biomarker potential,cell growth modulation,gene expression alteration
,AARS,amino acid synthesis,trna charging,oncogenesis,protein synthesis regulation,cell proliferation,mtor pathway interaction
ENSG00000160216,AGPAT3,phospholipid metabolism,cell growth promotion,lysophosphatidylglycerol acylation,tumor progression predictor,fatty acid ester regulation,cancer cell survival enhancement
ENSG00000006744,ELAC2,genomic instability,dna repair regulation,tumor suppression,cell cycle progression,apoptosis modulation,microrna interaction
ENSG00000008083,JARID2,prc1 component,transcriptional regulator,epigenetic modifier,oncogene function,chromatin remodeling,genome instability
ENSG00000160584,SIK3,cell cycle regulation,oncogenic function,metabolic reprogramming,transcriptional control,kinase activity,tumor growth promotion
ENSG00000183010,PYCR1,alpha-aminoadipic acid biosynthesis,mitochondrial localization,oncogene,gain of function mutations,cell metabolism regulation,mtor pathway activation
ENSG00000137818,RPLP1,ribosome biogenesis,cell cycle regulation,oncogene activation,tumor progression marker,signaling pathway interaction,cellular metabolism modulation
ENSG00000114125,RNF7,pi3k/akt pathway interaction,genomic instability,oncogenic potential,ubiquitination and proteasomal degradation,dna repair and replication regulation,tumor growth and proliferation enhancement
ENSG00000037474,NSUN2,rrna modification,dna damage response,nucleolar function,cell proliferation,genomic stability,protein interaction
ENSG00000159189,C1QC,immune evasion,cell adhesion modulation,tumor progression,secreted protein function,complement component interaction,protein-protein interaction
ENSG00000167208,SNX20,oncogenic processes,regulation of cell surface receptors,pi3k/akt pathway modulation,cancer stem cell regulation,enhanced cell growth and survival,altered expression in bladder urothelial carcinoma
ENSG00000176624,MEX3C,tumor suppressor,rna-binding protein,gene expression regulation,cell proliferation regulation,apoptosis regulation,dna repair regulation
ENSG00000131721,RHOXF2,cellular motility,gtpase activity,oncogenic transformation,tumor invasiveness,poor prognosis,clinical correlation
ENSG00000276452,LILRB1,immune evasion mechanisms,aberrant expression,tumor progression,checkpoint inhibitor resistance,pi3k/akt pathway interaction,immune cell modulation
ENSG00000071626,DAZAP1,genomic instability,tumor suppressor regulation,cell cycle progression,transcriptional control,oncogenesis,cell growth promotion
ENSG00000196470,SIAH1,tumor suppressor targeting,protein degradation pathway,cell cycle regulation,apoptosis evasion,oncogene interaction,ubiquitination activity
ENSG00000084774,CAD,de novo pyrimidine biosynthesis,cellular proliferation,oncogenic processes,pyrimidine synthesis regulation,metabolic adaptation,cancer cell growth
ENSG00000135829,DHX9,telomere maintenance,transcription regulation,oncogenic function,cell proliferation,genomic instability,spliceosome component
ENSG00000153187,HNRNPU,genomic instability,tumor suppressor gene regulation,cell proliferation enhancement,post-transcriptional rna processing,alternative splicing regulation,signaling pathway interaction
ENSG00000077235,GTF3C1,transcriptional regulation,constitutive overexpression,cell growth and differentiation,oncogenic potential,metabolic reprogramming,enhanced cell survival
ENSG00000071054,MAP4K4,gain of function mutations,cell proliferation,tumor progression,genomic instability,protein kinase activation,signaling pathway modulation
ENSG00000012232,EXTL3,heparan sulfate synthesis,oncogenic driver,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,tumor progression enhancement
ENSG00000145088,EAF2,wnt/β-catenin signaling pathway,tumor suppressor regulation,dna repair mechanisms,transcriptional coactivation,oncogenic process promotion,genomic instability
ENSG00000121310,ECHDC2,mitochondrial biogenesis,oncogenic signaling pathway activation,glycolytic shift,cellular energy homeostasis disruption,reactive oxygen species accumulation,warburg effect
ENSG00000141564,RPTOR,mtor pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular growth regulation
ENSG00000101306,MYLK2,actomyosin dynamics,tight junction disruption,emt process,constitutive activation,cell motility enhancement,resistance to apoptosis
ENSG00000197102,DYNC1H1,chromosomal instability,aneuploidy,genomic amplification,tumor aggressiveness,cell migration regulation,microtubule dynamics
ENSG00000101557,USP14,protein degradation regulation,genome stability maintenance,apoptosis inhibition,cell proliferation promotion,cancer progression facilitation,dna repair interaction
ENSG00000281320,DYRK1B,protein kinase activation,regulation of cell cycle,oncogenic pathway activation,cell proliferation enhancement,apoptosis suppression,tumor progression association
ENSG00000120756,PLS1,cell cycle regulation,promotes oncogenesis,tumor growth facilitation,aberrant expression,apoptosis resistance,cancer driver gene
ENSG00000176171,BNIP3,apoptosis regulation,autophagy induction,mitochondrial dynamics,cell death promotion,hypoxia response,tumor aggressiveness
ENSG00000049449,RCN1,nuclear pore complex,cellular homeostasis disruption,tumor progression marker,prognosis predictor,apoptosis modulation,gene expression regulation
ENSG00000128045,RASL11B,constitutive activation,gain of function mutations,tumor progression,cell proliferation,metastasis,gtpase activity
ENSG00000186716,BCR,bcr-abl fusion,cell proliferation,oncogene activation,tyrosine kinase activity,phosphatase regulation,tumor aggressiveness
ENSG00000151694,ADAM17,proteolytic activity,tumor growth,cell migration,extracellular matrix degradation,cancer cell dissemination,inflammatory microenvironment
ENSG00000064607,SUGP2,enhanced cell adhesion,epithelial-to-mesenchymal transition,oncogenic processes,promotes metastasis,pi3k/akt pathway activation,tumor progression
ENSG00000162728,KCNJ9,amplification,cellular homeostasis,potassium channel regulation,oncogenesis,cell proliferation,ion channel modulation
ENSG00000276825,DRD4,g-protein coupled receptor,cell proliferation,tumor progression,metastasis,apoptosis regulation,signaling pathway activation
ENSG00000155366,RHOC,tumor aggressiveness,cell proliferation,epithelial-to-mesenchymal transition (emt),cancer cell metastasis,rho-kinase signaling,overexpression
ENSG00000111913,RIPOR2,ripk1 signaling activation,cell survival promotion,apoptosis evasion,tumor progression driver,therapeutic target,inflammation modulation
ENSG00000196839,ADA,dna damage response,purine metabolism regulation,cell proliferation enhancement,tumor progression facilitation,therapeutic target identification,genomic instability promotion
ENSG00000151150,ANK3,disrupted cellular structure,promotes cancer cell survival,cell membrane scaffolding,mutations leading to uncontrolled growth,interaction with pi3k/akt pathway,kinase activity modulation
ENSG00000119402,FBXW2,oncogenic signaling pathway disruption,cell cycle regulation loss,ubiquitination machinery disruption,tumor suppressor function,genomic instability,therapeutic target
ENSG00000169057,MECP2,epigenetic regulation,genomic instability,chromatin remodeling,tumor suppressor function,cell cycle regulation,transcriptional silencing
ENSG00000151466,SCLT1,cellular interaction,overexpression,oncogene activation,therapeutic target,molecular regulation,cancer cell survival
ENSG00000132694,ARHGEF11,rap1 activation,gtpase regulation,metastatic potential,enhanced cell migration,apoptosis resistance,protein interaction
ENSG00000166670,MMP10,tumor progression,cell migration,ecm degradation,proteolytic enzyme,upregulated expression,signal transduction
ENSG00000178031,ADAMTSL1,extracellular matrix regulation,cell invasion,metastasis promotion,tumor progression,prognostic marker,protein-protein interaction
ENSG00000173914,RBM4B,post-transcriptional regulation,rna stability modulation,cell cycle progression regulation,tumor suppressor activity,oncogenic pathway modulation,apoptosis regulation
ENSG00000170485,NPAS2,overexpression,regulation of cell cycle progression,modulator of gene expression,oncogene,interaction with dna damage response pathways,cellular differentiation regulation
ENSG00000081154,PCNP,pi3k/akt pathway interaction,tumor suppressor function,cell cycle regulation,apoptosis modulation,protein-protein interactions,cancer risk association
ENSG00000149084,HSD17B12,androgen biosynthesis,cell proliferation,steroid hormone metabolism,overexpression,poor prognosis,therapeutic target
ENSG00000092841,MYL6,**

cell cycle progression,cell migration,oncogenic activity,pi3k/akt signaling,protein-protein interaction,tumor aggressiveness

**
ENSG00000115073,ACTR1B,oncogene activity,proliferation promotion,survival enhancement,transcriptional regulation,cellular growth modulation,polymerase complex interaction
ENSG00000100823,APEX1,genomic instability,base excision repair pathway,tumor suppressor activity,dna damage response,apurinic/apyrimidinic endonuclease activity,cellular defense mechanism
ENSG00000188229,TUBB4B,microtubule stability,cellular proliferation,mutation hotspot,tumor resistance,cancer therapeutic target,apoptosis inhibition
ENSG00000104267,CA2,angiogenesis facilitation,cell proliferation promotion,ion transport regulation,ph modulation,tumor microenvironment alteration,prognostic marker potential
ENSG00000113013,HSPA9,mitochondrial chaperone function,epithelial-to-mesenchymal transition (emt) promoter,cellular homeostasis regulator,protein folding and degradation,tumor metastasis enhancer,chemosensitivity modifier
ENSG00000166441,RPL27A,ribosomal function,oncogene overexpression,cell proliferation promotion,chemotherapy resistance,protein synthesis facilitation,apoptosis inhibition
ENSG00000053501,USE1,e3 ubiquitin ligase activity,cell cycle regulation,oncogenic protein regulation,tumor growth promotion,apoptosis resistance,genomic instability maintenance
ENSG00000072501,SMC1A,genomic instability,chromosomal rearrangements,oncogenic mutations,homologous recombination,cohesin complex disruption,dna repair regulation
ENSG00000281459,PADI1,citrullination,aberrant expression,cell signaling regulation,transcriptional modification,tumor microenvironment modulation,prognostic biomarker potential
ENSG00000182446,NPLOC4,oncogene,cell proliferation,protein synthesis regulation,ribosome biogenesis,tumor progression,prognostic marker
ENSG00000070087,PFN2,microtubule stability,cell migration enhancement,metastatic potential,prognostic marker,signaling pathway regulation,oncogene overexpression
ENSG00000134899,ERCC5,ner pathway,dna damage repair,genetic instability,cell cycle regulation,apoptosis modulation,oncogene interaction
ENSG00000081181,ARG2,glutaminolysis,metabolic reprogramming,immune evasion mechanisms,cell proliferation,mtor signaling pathway,arginine transport
ENSG00000215182,MUC5AC,epithelial cell hydration,mucin protein overexpression,tumor progression,tumor microenvironment modulation,cell proliferation and survival,epithelial-to-mesenchymal transition
ENSG00000122852,SFTPA1,tumor microenvironment modulation,innate immunity regulation,apoptosis inhibition,cell proliferation enhancement,protein interaction facilitation,tissue remodeling involvement
ENSG00000154447,SH3RF1,endosomal trafficking,cell cycle regulation,apoptosis suppression,growth promotion,protein-protein interaction,gene amplification
ENSG00000161509,GRIN2C,nmda receptor activation,cell proliferation enhancement,metastatic potential,therapeutic resistance,apoptosis evasion,cell cycle regulation
ENSG00000044090,CUL7,cell cycle regulation,genomic integrity maintenance,tumor suppressor activity,dna repair mechanisms,transcription factor regulation,protein degradation pathway
ENSG00000104321,TRPA1,tumor progression,aberrant expression,dysregulated signaling pathways,tissue homeostasis disruption,apoptosis inhibition,cell growth promotion
ENSG00000198034,RPS4X,cell cycle regulation,apoptosis dysregulation,oncogene/tumor suppressor function,protein synthesis regulation,ribosomal protein s family member,male-specific expression
ENSG00000111669,TPI1,warburg effect,metabolic reprogramming,glycolytic shift,oncogenic mutations,gain-of-function,energy metabolism
ENSG00000139722,VPS37B,pi3k/akt signaling enhancement,oncogenic driver mutation,cell growth promotion,protein degradation regulation,endosomal sorting facilitation,tumor progression promotion
ENSG00000144381,HSPD1,mitochondrial function,dna repair,promotes survival,cancer cell maintenance,genomic instability,tumor progression
ENSG00000196482,ESRRG,cell proliferation enhancement,tumor progression,constitutive activation,transcriptional regulation,therapeutic target,genomic amplification
ENSG00000169297,NR0B1,p53 interaction,genomic stability,cell cycle regulation,apoptosis regulation,therapeutic target,tumor progression
ENSG00000186468,RPS23,ribosome biogenesis,cell growth regulation,protein synthesis,structural component,cellular proliferation,oncogenic process
ENSG00000169564,PCBP1,alternative splicing,apoptosis suppression,cell proliferation enhancement,dna repair dysregulation,gene expression modulation,metastatic promotion
ENSG00000171345,KRT19,epithelial integrity disruption,cellular structure alteration,tumor progression marker,emt process,metastasis facilitation,prognostic biomarker
ENSG00000182809,CRIP2,transcriptional regulation,oncogene overexpression,promoter region interaction,cell proliferation promotion,tumor growth enhancement,phosphorylation modulation
ENSG00000204536,CCHCR1,genomic instability,oncogene,dna repair,homologous recombination,chromosome cohesion,tumor progression
ENSG00000092208,GEMIN2,snrnp biogenesis,cell proliferation,rna processing,oncogenic processes,tumor progression,poor prognosis
ENSG00000163737,PF4,angiogenesis promotion,tumor metastasis facilitation,heparin-binding protein interaction,transcription factor regulation,tumor-stroma interactions,cancer progression marker
ENSG00000106948,AKNA,oncogene activation,epigenetic regulation,chromatin remodeling,protein-protein interactions,apoptosis suppression,tumor progression
ENSG00000198931,APRT,purine metabolism,tumor aggressiveness,cell proliferation,therapeutic target,prognostic marker,genomic instability
ENSG00000154310,TNIK,aberrant activation,cell proliferation enhancement,chromatin remodeling disruption,dna repair impairment,nf-κb pathway interaction,oncogenic driver
ENSG00000188739,RBM34,p53 regulation,tumor suppression,apoptosis regulation,cell cycle control,genomic stability,rna binding activity
ENSG00000178184,PARD6G,cellular polarity disruption,oncogenic mutations,enhanced cell proliferation,epithelial-to-mesenchymal transition,tumor progression,overexpression
ENSG00000139218,SCAF11,genomic instability,tumor suppressor function,dna repair enzyme activity,base excision repair pathway,mutational burden increase,oncogenesis promotion
ENSG00000183741,CBX6,epigenetic regulation,chromatin remodeling,transcriptional repression,oncogene activation,cell proliferation enhancement,tumor progression facilitation
ENSG00000125901,MRPS26,mitochondrial ribosome assembly,upregulation in cancer,enhanced cell proliferation,metabolic adaptation,cell survival promotion,protein synthesis regulation
ENSG00000138100,TRIM54,regulation of p53 activity,cell survival and proliferation,disruption of mirna expression,aberrant expression in cancer,prognostic biomarker potential,loss of cellular regulation
ENSG00000082805,ERC1,genomic instability,dna repair pathway,homologous recombination,tumor suppressor function,cell cycle regulation,apoptosis modulation
ENSG00000168439,STIP1,chaperone function,protein stability regulation,oncogene activation,tumor progression facilitation,therapeutic resistance contribution,cell survival promotion
ENSG00000115816,CEBPZ,tumor suppressor function loss,oncogenic transcription factor,cell cycle progression regulation,apoptosis inhibition,prognostic biomarker,therapeutic target
ENSG00000146007,ZMAT2,cell cycle regulation,tumor suppressor function,transcriptional regulation,apoptosis induction,chromatin modification,dna binding protein
ENSG00000171860,C3AR1,complement activation,cell proliferation,immune modulation,signaling pathway regulation,tumor progression,metastasis promotion
ENSG00000273562,NAP1L4,chromatin remodeling,cell proliferation regulation,mitosis regulation,genomic stability maintenance,oncogenic mutations,amplification driver
ENSG00000230624,DDX39B,cell cycle regulation,transcriptional regulation,rna processing,apoptosis evasion,metastasis promotion,tumor suppressor
ENSG00000130706,ADRM1,**

cell adhesion disruption,epithelial-to-mesenchymal transition (emt),cell migration enhancement,overexpression in tumors,metastasis facilitation,poor prognosis association

**
ENSG00000160213,CSTB,lysosomal cysteine protease inhibition,protease regulation disruption,tumor progression facilitation,metastasis promotion,biomarker for poor prognosis,therapeutic target identification
ENSG00000104852,SNRNP70,spliceosome regulation,altered expression,dna repair disruption,oncogenic mutations,genetic instability,aberrant splicing
ENSG00000101916,TLR8,innate immune evasion,tumor microenvironment modulation,immune suppression,oncogene downregulation,anti-tumor immune response impairment,cancer immunotherapy target
ENSG00000100129,EIF3L,translational regulation,constitutive activation,protein synthesis pathway,oncogenic protein expression,cell proliferation enhancement,tumor progression driver
ENSG00000146676,PURB,genomic instability,dna damage response,cell cycle regulation,apoptosis modulation,tumor progression,therapeutic target
ENSG00000086061,DNAJA1,cell survival,apoptosis regulation,protein homeostasis,chaperone activity,nf-κb pathway interaction,pi3k/akt pathway modulation
ENSG00000215271,HOMEZ,dna replication regulation,oncogene activation,cell cycle progression regulation,genomic instability induction,transcriptional regulation enhancement,poor prognosis marker
ENSG00000109606,DHX15,genomic instability,homologous recombination,dna repair,holliday junction resolution,cancer progression,therapeutic target
ENSG00000177105,RHOG,gtpase activity,cell migration,oncogenic properties,constitutive activation,pi3k/akt pathway interaction,mapk/erk pathway modulation
ENSG00000142409,ZNF787,p53-dependent apoptosis,cell growth regulation,transcriptional repression,chromatin remodeling complex interaction,oncogenic suppression,tumor suppressor function
ENSG00000172301,COPRS,ubiquitination regulation,cell cycle progression,protein stabilization,tumor suppressor degradation,tumorigenesis facilitation,oncoprotein accumulation
ENSG00000101350,KIF3B,cell division regulation,mitotic spindle assembly,chromosomal stability disruption,tumor growth promotion,metastasis facilitation,dna repair dysregulation
ENSG00000167792,NDUFV1,mitochondrial dysfunction,metabolic reprogramming,cell proliferation,warburg effect,tumor progression,poor prognosis
ENSG00000082175,PGR,cell proliferation enhancement,proliferation inhibition,estrogen receptor interaction,tumor progression promotion,apoptosis inhibition,protein kinase activation
ENSG00000168286,THAP11,epithelial-to-mesenchymal transition,histone modification,chromatin remodeling,oncogenic driver,tumor progression,therapeutic target
ENSG00000167967,E4F1,cell cycle regulation,dna replication,transcriptional activation,tumor progression,promoter binding,metastasis facilitation
ENSG00000117650,NEK2,mitotic checkpoint regulation,histone modification,oncogene activation,cell cycle progression,chromatin structure alteration,therapeutic target
ENSG00000076003,MCM6,cell cycle dysregulation,genomic instability,dna replication licensing,minichromosome maintenance complex,oncogene overexpression,tumor aggressiveness
ENSG00000101197,BIRC7,apoptosis inhibition,oncogenic function,nf-κb pathway interaction,wnt/β-catenin pathway interaction,cell survival promotion,tumorigenesis facilitation
ENSG00000228267,C4B,cell adhesion evasion,immune evasion mechanisms,tumor progression marker,prognostic indicator,complement activation,cancer aggressiveness driver
ENSG00000233312,C4B_2,cell adhesion regulation,complement activation,immune microenvironment modulation,tumor progression facilitation,protein interaction,overexpression in tumor tissues
ENSG00000146063,TRIM41,tumor suppressor function,cell proliferation regulation,genomic instability prevention,epithelial-to-mesenchymal transition,interacts with p53,loss-of-function mutation
ENSG00000104388,RAB2A,rab gtpase regulation,constitutive activation,overexpression correlation,membrane trafficking dysregulation,oncogenic protein transport,poor prognosis biomarker
ENSG00000139990,DCAF5,tumor suppressor function,ubiquitination pathway,cell cycle regulation,genomic stability maintenance,dna repair mechanism,oncogenic protein degradation
ENSG00000136111,TBC1D4,tumor suppressor,vesicle trafficking regulation,autophagy modulation,pi3k/akt pathway inhibition,cell proliferation suppression,oncogenic process regulation
ENSG00000140299,BNIP2,bnip2 interaction with bcl2 proteins,tumor suppression or oncogenesis,mitochondrial function regulation,mitophagy promotion,cellular adaptation under hypoxia,apoptosis modulation
ENSG00000142864,SERBP1,p53 binding,tumor suppressor function,mrna translation regulation,cell proliferation enhancement,oncogene interaction,potential therapeutic target
ENSG00000229314,ORM1,oligosaccharide transport,cell adhesion regulation,metastasis promotion,tumor progression enhancement,protein-protein interactions,cancer biomarker potential
ENSG00000285258,ATXN7,histone acetylation,chromatin remodeling,gene transcription regulation,cell proliferation promotion,genome stability maintenance,cancer development contribution
ENSG00000111581,NUP107,nuclear pore complex,chromatin remodeling,tumor progression,nucleus-cytoplasm transport regulation,epigenetic modification,transcriptional regulation
ENSG00000187754,SSX7,cell cycle regulation,co-activation of oncogenic pathways,enhanced cell proliferation,nucleolar localization,oncogene activation,transcriptional regulation
ENSG00000163736,PPBP,cell adhesion regulation,tumor metastasis,epithelial-to-mesenchymal transition,prognostic marker,vascular endothelium interaction,transmembrane glycoprotein
ENSG00000188404,SELL,**

* cell adhesion,* immune evasion,* leukocyte recruitment,* metastasis facilitation,* oncogene upregulation,* prognostic marker 

**
ENSG00000152234,ATP5F1A,mitochondrial dysfunction,warburg effect,glycolysis regulation,cellular energy homeostasis,metabolic adaptation,therapeutic target
ENSG00000162302,RPS6KA4,p90rsk activation,cell proliferation regulation,oncogenic signaling,tumor progression driver,cell migration modulation,phosphorylation activity enhancement
ENSG00000141551,CSNK1D,apoptosis regulation,cell cycle modulation,downstream target phosphorylation,oncogenesis promotion,cell proliferation enhancement,overexpression marker
ENSG00000177733,HNRNPA0,rna processing,oncogenesis,cell proliferation,translation regulation,post-transcriptional regulation,prognostic marker
ENSG00000132182,NUP210,nuclear transport deregulation,constitutive activation,chromatin remodeling disruption,cell cycle progression dysregulation,oncogenic transcriptional regulation,therapeutic target candidate
ENSG00000065154,OAT,oat overexpression,cellular homeostasis regulation,organic anion transporter function,tumor cell growth promotion,dna damage induction,therapeutic target potential
ENSG00000180228,PRKRA,double-stranded rna binding,tumor suppressor function,protein synthesis regulation,viral infection response,cellular stress response,translation initiation inhibition
ENSG00000177169,ULK1,autophagy regulation,cell survival mechanism,oncogene activation,cancer cell growth,cellular homeostasis,protein kinase activation
ENSG00000049540,ELN,tumor progression,cell migration,metastasis facilitation,prognostic marker,extracellular matrix modulation,cell invasion
ENSG00000087303,NID2,tumor progression,cell adhesion disruption,microenvironment modulation,extracellular matrix interaction,basement membrane stability,poor prognosis marker
ENSG00000165861,ZFYVE1,oncogenic processes,protein degradation pathways,cell proliferation enhancement,tumor aggressiveness,therapeutic target,ubiquitination regulation
ENSG00000139880,CDH24,cell-cell adhesion disruption,tumor cell migration,epithelial-to-mesenchymal transition,cancer metastasis,biomarker potential,signaling pathway modulation
ENSG00000118705,RPN2,proteasome function disruption,cell cycle progression regulation,apoptosis inhibition,transcriptional regulation modulation,ubiquitin-proteasome pathway dysregulation,oncogenic process promotion
ENSG00000163939,PBRM1,tumor suppressor,chromatin remodeling,transcriptional regulation,genomic instability,cell cycle regulation,epigenetic modification
ENSG00000100220,RTCB,genomic instability,dna repair defect,homologous recombination,cell cycle regulation,apoptosis resistance,prognostic biomarker
ENSG00000186010,NDUFA13,mitochondrial dysfunction,oncogenic reprogramming,energy metabolism alterations,redox balance disruptions,electron transport chain dysregulation,cellular respiration defects
ENSG00000240694,PNMA2,cell proliferation,tumor progression,pentrxin-related gene family,cell signaling pathway,genomic instability,biomarker candidate
ENSG00000090054,SPTLC1,sphingolipid biosynthesis,cell differentiation,tumor growth,altered metabolism,protein interaction,apoptosis regulation
ENSG00000095627,TDRD1,microrna processing,epigenetic modifications,tudor-sn interaction,genome instability,oncogenic expression,cellular proliferation
ENSG00000099937,SERPIND1,endoplasmic reticulum localization,serine protease inhibition,tumor suppression,cell proliferation regulation,genomic downregulation,mutational inactivation
ENSG00000081913,PHLPP1,pi3k/akt pathway regulation,tumor suppressor function,protein kinase b activation inhibition,dephosphorylation mechanism,cell growth inhibition,cancer prognosis
ENSG00000121410,A1BG,cellular stress response,overexpression,hypoxia regulation,protein-protein interactions,tumor progression,lipid metabolism modulation
ENSG00000108839,ALOX12,tumor progression,pro-inflammatory lipid mediators,oncogene,cell proliferation,inflammation,angiogenesis
ENSG00000164265,SCGB3A2,apoptosis inhibition,cell migration enhancement,metastasis promotion,secretoglobin protein function,tumor progression association,cell adhesion regulation
ENSG00000019169,MARCO,immunomodulation,suppression of oncogenic pathways,tumor microenvironment modulation,loss of function mutations,pi3k/akt pathway dysregulation,pro-tumorigenic immune cell infiltration
ENSG00000056998,GYG2,oncogenic transformation,aberrant glycosylation,cell proliferation,invasion and migration,tumor progression,therapeutic target
ENSG00000074800,ENO1,enhanced glycolysis,warburg effect contribution,prognostic marker,glycolytic pathway enzyme,tumor aggressiveness indicator,therapeutic target
ENSG00000167004,PDIA3,cellular stress responses,oncogenic protein folding,epigenetic regulation,pi3k/akt signaling pathway activation,metastasis facilitation,apoptosis evasion
ENSG00000171621,SPSB1,pi3k/akt pathway modification,cancer progression promoter,cell proliferation enhancer,tyrosine residue modification,oncogene involvement,protein function regulator
ENSG00000111802,TDP2,dna repair,gene regulation,oncogenesis,cell survival,genomic integrity,transcriptional regulation
ENSG00000133142,TCEAL4,apoptosis regulation,cell proliferation enhancement,gene expression modulation,oncogenesis association,transcription factor activity,tumorigenesis promotion
ENSG00000174255,ZNF80,epithelial differentiation,histone modification,cell growth regulation,tumorigenesis association,transcriptional repressor,dna binding protein
ENSG00000147604,RPL7,ribosome biogenesis,protein synthesis regulation,cell proliferation promotion,cancer cell adaptation,tumor microenvironment modulation,mrna translation facilitation
ENSG00000135625,EGR4,apoptosis inhibition,cell cycle modulation,oncogenic transformation,tumor growth promotion,transcriptional regulation,prognostic marker
ENSG00000263163,SLC27A3,lipid metabolism,fatty acid activation,cell proliferation,oncogenic process,therapeutic target,redox balance regulation
ENSG00000101856,PGRMC1,cell growth regulation,signaling pathway modulation,tumor progression association,protein-protein interaction,mitogen-activated protein kinase activation,cancer cell survival enhancement
ENSG00000145012,LPP,pi3k/akt pathway interaction,lipid signaling regulation,cell proliferation modulation,oncogene activation,tumor progression driver,gene expression regulation
ENSG00000153208,MERTK,apoptotic regulation,constitutive activation,immune evasion,oncogenic signaling,phosphatidylserine recognition,tumor suppressive function
ENSG00000105197,TIMM50,mitochondrial regulation,cellular metabolism,mitochondrial dynamics,protein-protein interactions,tumor aggressiveness,poor prognosis
ENSG00000170759,KIF5B,kinesin motor protein function,microtubule dynamics regulation,chromosomal stability disruption,cellular migration promotion,tbc1d3 interaction,map7 association
ENSG00000105372,RPS19,ribosomal dysfunction,gain of function mutations,protein synthesis enhancement,tumor progression,translation initiation,genetic instability
ENSG00000067082,KLF6,**

klf6 overexpression,gain-of-function mutations,cell proliferation,epithelial-to-mesenchymal transition (emt),tumor suppression pathway inhibition,transcription factor activity
ENSG00000110107,PRPF19,spliceosome assembly,rna splicing regulation,genomic instability,cell cycle dysregulation,dna damage response,tumor suppressor downregulation
ENSG00000205937,RNPS1,nucleotide biosynthesis,cell proliferation,oncogenesis,dna damage resistance,nucleotide homeostasis regulation,therapeutic target
ENSG00000114316,USP4,tumor growth,metastasis promoter,dubiquitinating enzyme activity,cell cycle regulation,tumor progression,cancer therapy target
ENSG00000162999,DUSP19,erk1/2 activation,mapk signaling regulation,cell proliferation promotion,tumor growth facilitation,chemoresistance modulation,kinase activity regulation
ENSG00000106344,RBM28,overexpression,oncogenic transformation,transcriptional regulation,rna processing,splicing modulation,tumor suppressor interaction
ENSG00000108651,UTP6,ribosome biogenesis regulation,cell cycle progression,protein synthesis dysregulation,cancer cell growth,tumor development,genomic instability
ENSG00000056736,IL17RB,il17/il17rb axis,tumor progression,metastasis,promoter of oncogenic processes,stat3/nf-κb activation,tumor immunosuppression
ENSG00000285433,DEFB4B,antitumor activity,immune surveillance loss,innate immunity regulation,tumor suppression function,downregulated expression,cancer progression promotion
ENSG00000285181,DEFB4A,cancer progression,oncogene function,tumor cell invasion,antimicrobial peptide activity,cell signaling disruption,immune evasion
ENSG00000131437,KIF3A,epithelial-to-mesenchymal transition,centrosome separation,cell proliferation,resistance to chemotherapy,prognostic biomarker,genomic instability
ENSG00000172943,PHF8,histone demethylation,epigenetic regulation,cell proliferation enhancement,tumor progression driver,oncogenic interaction,chromatin remodeling
ENSG00000008118,CAMK1G,cell cycle regulation,apoptosis inhibition,signaling pathway modulation,protein kinase activation,cancer biomarker,tumor progression
ENSG00000157916,RER1,retrograde transport,receptor trafficking,cell surface receptor recycling,growth factor signaling,tumor progression,metastasis
ENSG00000145016,RUBCN,autophagic regulation,cellular homeostasis modulation,cancer cell survival promotion,oncogenic potential,therapeutic target identification,actin cytoskeleton regulation
ENSG00000197451,HNRNPAB,transcriptional regulation,rna processing and regulation,tumor progression,oncogene expression,protein-protein interaction,poor prognosis marker
ENSG00000163931,TKT,cell proliferation,dna synthesis regulation,nucleotide metabolism alteration,genomic instability contribution,immune response modulation,apoptosis resistance
ENSG00000121741,ZMYM2,transcriptional regulation,chromatin remodeling,epigenetic silencing,cell proliferation,cell migration,protein-protein interaction
,HIST2H2AB,epigenetic regulation,histone modification,chromatin structure,oncogenic maintenance,tumor suppressor silencing,nucleosome formation
ENSG00000177189,RPS6KA3,apoptosis inhibition,cell migration enhancement,mapk/erk pathway interaction,oncogenic driver,poor prognosis marker,protein kinase activation
ENSG00000212935,KRTAP10-3,cytoskeletal disruption,cellular architecture alteration,epithelial cell polarity loss,intermediate filament dysregulation,keratin-associated protein overexpression,tumor aggressiveness promotion
ENSG00000277377,SERPINA1,apoptosis regulation,cell proliferation regulation,tumor progression,protein-protein interaction,cellular homeostasis regulation,oncogenesis modulation
ENSG00000197694,SPTAN1,pi3k/akt pathway activation,gain of function mutations,cell adhesion disruption,chromatin remodeling,cytoskeletal reorganization,tumor progression promotion
ENSG00000131504,DIAPH1,microtubule stability,actin cytoskeleton regulation,tumor progression,cell proliferation,oncogenic signaling pathway,mitotic spindle dynamics
ENSG00000128739,SNRPN,spliceosomal dysfunction,pre-mrna splicing regulation,genomic instability,gene expression dysregulation,cellular proliferation,oncogenic process modulation
ENSG00000105854,PON2,antioxidant activity,cell survival,cancer progression,peroxidase activity,detoxification,oxidative stress protection
ENSG00000189266,PNRC2,pi3k/akt pathway,cell cycle regulation,oncogene activation,apoptosis inhibition,tumor progression,cancer prognosis
ENSG00000134014,ELP3,transcriptional elongation,elongation complex component,chromatin-modifying enzyme recruitment,epigenetic regulation,cellular proliferation pathway modulation,prognostic marker
ENSG00000125944,HNRNPR,cell migration,tumor progression,rna processing,overexpression,oncogenesis,genome instability
ENSG00000163815,CLEC3B,immune response modulation,cell adhesion regulation,carbohydrate recognition,tumor progression influence,potential oncogene involvement,cell signaling interaction
ENSG00000186395,KRT10,epithelial integrity loss,cell adhesion disruption,tumor progression,downregulation of expression,poor prognosis indicator,epithelial-to-mesenchymal transition regulation
ENSG00000169018,FEM1B,cell cycle progression,transcription factor activity,apoptosis inhibition,tumor aggressiveness,proliferation promotion,genomic instability
ENSG00000173812,EIF1,translation initiation factor,oncogene activation,cell proliferation,translational regulation,protein synthesis modulation,apoptosis evasion
ENSG00000078804,TP53INP2,oncogenic activity,epithelial-to-mesenchymal transition,genomic instability,tumor aggressiveness,cell proliferation promotion,p53 inhibition
ENSG00000128573,FOXP2,tumor aggressiveness,gene expression regulation,dna repair mutations,cell proliferation enhancement,epi-genetic regulators interaction,cancer driver mutation
ENSG00000096080,MRPS18A,mitochondrial dysfunction,genomic instability,altered metabolism,dna mutations,energy production,cellular respiration
ENSG00000131507,NDFIP1,pi3k/akt pathway modification,tumor progression association,cell proliferation regulation,ubiquitination and degradation facilitation,prognostic significance,potential therapeutic target
ENSG00000119725,ZNF410,oncogenic activity,transcriptional regulation,cell cycle progression,epigenetic silencing,tumor suppressor downregulation,metastatic progression
ENSG00000062524,LTK,akt/mtor pathway activation,oncogenic transformation,cell proliferation enhancement,pro-survival signaling,tumor progression promotion,genomic instability induction
ENSG00000177674,AGTRAP,regulation of at1r signaling pathway,interaction with transcription factors,contribution to tumorigenesis,modulation of cell adhesion,cell survival promotion,tumor progression facilitation
ENSG00000127743,IL17B,tumor growth,metastasis promotion,inflammation regulation,cell proliferation enhancement,angiogenesis stimulation,stat3 pathway modulation
ENSG00000142945,KIF2C,microtubule dynamics regulation,oncogenic driver,tumor growth promotion,chromosome segregation disruption,amplification associated,prognostic biomarker potential
ENSG00000147679,UTP23,ribosome biogenesis,cellular proliferation,translation initiation,tumor progression,therapeutic target,genomic instability
ENSG00000185825,BCAP31,protein sorting,apoptosis regulation,cell survival,pi3k/akt signaling,therapeutic target,biomarker candidate
ENSG00000109107,ALDOC,glycolytic enzyme,warburg effect,tumor progression marker,energy metabolism regulation,oncogenic role,therapeutic target
ENSG00000149925,ALDOA,**
glycolytic reprogramming,energy metabolism,cell survival,tumor aggressiveness,therapeutic target,metabolic reconfiguration 
**
ENSG00000115825,PRKD3,overexpression,cell proliferation,protein kinase activation,signaling pathway regulation,tumor aggressiveness,poor prognosis
ENSG00000147130,ZMYM3,chromatin remodeling,cell cycle progression,dna repair regulation,transcriptional regulation,biomarker potential,prognostic significance
ENSG00000163132,MSX1,epithelial differentiation,tumor suppressor function,transcriptional regulation,cellular proliferation inhibition,oncogenic pathway suppression,emt modulation
ENSG00000276618,RAD17,genomic instability,dna repair mechanisms,cell cycle regulation,replication fork protection complex,tumor suppressor function,aberrant expression
ENSG00000132254,ARFIP2,emt regulation,oncogene overexpression,cell migration promotion,tumor progression driver,cytoplasmic localization,microtubule dynamics modulation
ENSG00000159111,MRPL10,regulation of mitochondrial translation,constitutive activation of signaling pathways,promotion of cell proliferation and survival,enhanced energy metabolism,correlation with poor prognosis,involvement in key cancer-related pathways
ENSG00000163221,S100A12,tumor microenvironment modulation,epithelial-to-mesenchymal transition,cancer stem cell regulation,angiogenesis promotion,immune suppression,overexpression marker
ENSG00000181788,SIAH2,loss of p53 function,e3 ubiquitin ligase activity,oncogenic process,cell cycle progression,tumor suppression,genetic alteration
ENSG00000111247,RAD51AP1,genomic instability,homologous recombination repair,dna double-strand break repair,cell survival enhancement,tumor adaptation mechanism,cancer genome instability driver
ENSG00000197498,RPF2,cell cycle regulation,chromatin remodeling,transcriptional elongation,oncogenesis,dna repair regulation,histone modification
ENSG00000117395,EBNA1BP2,regulation of ebv replication,interaction with oncoprotein ebna1,cell proliferation and survival promotion,tumor progression contribution,therapeutic target potential,genomic instability modulation
ENSG00000143742,SRP9,protein translation regulation,cell signaling modulation,tumor progression enhancement,cancer driver mutation,er membrane association,secretion pathway dysregulation
ENSG00000142168,SOD1,oxidative stress,redox regulation,cell survival,dna damage,genomic instability,antioxidant defense
ENSG00000152214,RIT2,oncogenic signaling,constitutive activation,gtpase activity,cell migration regulation,therapeutic target,protein-protein interactions
ENSG00000120800,UTP20,transcriptional regulation,oncogenic gene expression,aberrant rna polymerase ii activity,dna damage response,genomic instability,tumor progression
ENSG00000011007,ELOA,tgf-β signaling pathway,cell proliferation,oncogenic driver,signaling modulation,kinase activity,cell survival enhancement
ENSG00000140988,RPS2,protein synthesis regulation,cell proliferation promotion,oncogenic protein interaction,tumor progression facilitation,poor prognosis indicator,ribosomal subunit component
ENSG00000067596,DHX8,alternative splicing,cell cycle regulation,genomic instability,oncogenic process,post-transcriptional regulation,rna-protein interactions
ENSG00000176783,RUFY1,autophagic regulation,cell cycle progression,genomic instability,oncogenic properties,pi3k/akt signaling,tumor cell survival
ENSG00000107625,DDX50,genetic instability,tumor progression,dna repair disruption,cell survival enhancement,oncogenesis contribution,rna metabolism regulation
ENSG00000137804,NUSAP1,genomic instability,tumor progression,proliferation enhancement,prognostic biomarker,cell migration promotion,aneuploidy
ENSG00000131018,SYNE1,cytoplasmic structure modulation,cell migration facilitation,metastasis promotion,cancer cell survival enhancement,protein interaction with cytoskeleton components,tumor progression association
ENSG00000141644,MBD1,epigenetic regulation,tumor progression,proliferation,genomic instability,histone modification,dna methylation
ENSG00000115234,SNX17,early endosomal recycling,membrane trafficking regulation,cell proliferation enhancement,tumor suppressor protein degradation,poor prognosis association,aggressive tumor phenotype promotion
ENSG00000278741,ABR,**
cellular homeostasis disruption,metabolic reprogramming,atp-binding function,chemoresistance,oncogenic role,transmembrane transport
ENSG00000165006,UBAP1,ubiquitin-associated domain-containing protein,cellular proliferation,protein degradation pathway,tumor progression marker,oncogenic driver gene,apoptosis resistance
ENSG00000102908,NFAT5,oncogenic transcription factor,hypertonic environment response,tumor growth promotion,emt regulation,cell migration enhancement,therapeutic target identification
ENSG00000169692,AGPAT2,lipid metabolism,cell growth regulation,therapeutic target,oncogenesis,lipid biosynthesis,cellular energy storage
ENSG00000196581,AJAP1,cell adhesion disruption,epithelial-to-mesenchymal transition,cancer cell migration,tumor suppression,actin cytoskeleton regulation,protein interaction
ENSG00000108700,CCL8,tumor progression,immune evasion,angiogenesis promotion,myeloid-derived suppressor cells recruitment,pro-inflammatory signaling,cytokine regulation
ENSG00000175183,CSRP2,epithelial-to-mesenchymal transition,cell migration regulation,actin filament binding,smooth muscle contraction regulation,poor prognosis indicator,emt process involvement
,H2AFY,histone variant regulation,genomic instability induction,tumor progression facilitation,dna damage response suppression,chromatin remodeling,apoptosis evasion
ENSG00000130830,MPP1,tumor suppressor,cell adhesion regulation,oncogenic expression,protein-protein interaction,metastatic potential,poor prognosis indicator
ENSG00000230456,DDR1,tumor progression,cell migration,ecm component interaction,receptor tyrosine kinase activation,poor prognosis indicator,therapeutic target
ENSG00000150594,ADRA2A,cell growth regulation,cancer cell proliferation,g protein-coupled receptor signaling,angiogenesis promotion,pi3k/akt pathway modulation,tumor progression enhancement
ENSG00000104327,CALB1,overexpression,cell proliferation,calcium-dependent signaling,aggressive tumor behavior,poor prognosis,biomarker potential
ENSG00000079332,SAR1A,copii vesicle formation,aberrant protein secretion,tumor progression,cellular trafficking regulation,molecular targeting,prognostic biomarker
ENSG00000274442,PRPF8,spliceosome assembly,malignant transformation,cancer cell proliferation,oncogenic mutations,cell cycle regulation,pre-mrna processing
ENSG00000196154,S100A4,tumor progression,metastasis,epithelial-to-mesenchymal transition,cell proliferation,calcium-binding protein,apoptosis resistance
ENSG00000073803,MAP3K13,nf-κb pathway activation,oncogenic signaling,cell cycle regulation,apoptosis suppression,inflammation modulation,protein-protein interactions
ENSG00000130656,HBZ,epigenetic regulation,tumor aggressiveness,cellular proliferation,transcriptional regulation,oncogene activation,cancer progression
ENSG00000100410,PHF5A,chromatin remodeling,oncogenic overexpression,brd4 interaction,prc2 complex,transcriptional regulation,therapeutic target
ENSG00000102531,FNDC3A,emt regulation,cell migration promotion,tumor progression enhancement,signaling pathway activation,apoptosis resistance,biomarker potential
ENSG00000164506,STXBP5,autophagy induction,oncogenic signaling pathway regulation,protein secretion enhancement,cell growth modulation,genetic alterations,signaling pathway interaction
ENSG00000076944,STXBP2,angiogenesis modulation,cell cycle regulation,mapk signaling pathway interaction,oncogenic driver mutation,proliferation and survival pathways dysregulation,tumor progression facilitation
ENSG00000198258,UBL5,ubiquitination pathway disruption,genome stability maintenance,p53 regulation,cell cycle control,tumor progression facilitation,apoptosis modulation
ENSG00000102879,CORO1A,rho gtpase pathway regulation,epithelial-to-mesenchymal transition promotion,actin cytoskeleton dynamics modulation,cell migration and invasion enhancement,metastasis association,cancer cell motility regulation
ENSG00000120948,TARDBP,oncogene activation,tumor growth promotion,gene regulation disruption,splicing modulation,cell proliferation enhancement,metastasis facilitation
ENSG00000148337,CIZ1,genomic instability,promotes rapid cell cycle progression,cell proliferation enhancement,oncogenic properties promotion,chromatin licensing facilitation,dna replication efficiency increase
ENSG00000103507,BCKDK,branched-chain amino acid metabolism,cell proliferation,metabolic reprogramming,oncogenic kinase activity,tumor progression,protein regulation
ENSG00000104903,LYL1,epithelial-to-mesenchymal transition,transcriptional regulator,cell cycle regulation,tumor progression,apoptosis inhibition,poor prognosis
ENSG00000141127,PRPSAP2,genomic instability,cell proliferation,purine biosynthesis regulation,pi3k/akt pathway activation,nucleotide pool modulation,tumor aggressiveness
ENSG00000163938,GNL3,ciliogenesis disruption,cell cycle dysregulation,apoptosis suppression,oncogene potential,therapeutic target candidate,genomic instability
ENSG00000111907,TPD52L1,cell cycle regulation,dna damage response,mitotic checkpoint evasion,tumor progression,apoptosis inhibition,biomarker potential
ENSG00000108433,GOSR2,golgi apparatus regulation,cellular transport modulation,tumor aggressiveness promotion,protein trafficking dysregulation,pi3k/akt pathway interaction,oncogenic process facilitation
ENSG00000269858,EGLN2,hypoxia response,prolyl hydroxylase activity,hif-α stabilization,angiogenesis promotion,glycolysis induction,tumor aggressiveness
ENSG00000142794,NBPF3,glycolysis regulation,cell proliferation,energy metabolism,tumor growth,poor prognosis marker,breast cancer metastasis associated
ENSG00000126752,SSX1,oncogenic driver,apoptosis regulator,transcriptional co-activator,cell cycle dysregulation,pi3k/akt pathway activation,wnt/β-catenin pathway interaction
ENSG00000196998,WDR45,homologous recombination repair,chromosomal instability,dna damage response,oncogenic process,prognostic marker,replication stress
ENSG00000182901,RGS7,g-protein regulation,signal transduction,cell proliferation,oncogenic processes,tumor suppression,cancer biology
ENSG00000145191,EIF2B5,cellular stress response,protein synthesis regulation,tumor cell proliferation,survival pathway alteration,leucine zipper interaction,stress granule formation
ENSG00000130037,KCNA5,dysregulation,oncogenic driver,voltage-gated potassium channel,apoptosis inhibition,cell proliferation enhancement,ion channel interaction
ENSG00000169504,CLIC4,overexpression,tumor progression,epithelial-to-mesenchymal transition (emt),cell migration,proliferation regulation,disruption of tight junctions
ENSG00000125898,FAM110A,cell cycle regulation,aneuploidy,chromosomal instability,centrosome duplication,oncogenic mutations,dna damage repair
ENSG00000174891,RSRC1,mrna processing regulation,oncogenic function,rna-binding protein activity,tumor suppressor regulation,cell proliferation promotion,prognostic marker significance
ENSG00000133574,GIMAP4,apoptosis regulation,cellular growth modulation,dna damage response,oxidative stress resistance,tumor progression,autophagy regulation
ENSG00000119408,NEK6,mitotic progression,cell cycle regulation,chromosomal instability,apoptosis resistance,tumorigenicity enhancement,therapeutic target
ENSG00000133818,RRAS2,activation of downstream signaling pathways,amplifications or mutations,cell proliferation and oncogenesis,enhanced cell survival and growth,interactions with other proteins and pathways,mapk/erk pathway activation
ENSG00000170748,RBMXL2,cellular proliferation,tumor progression,prognostic marker,transcriptional regulation,rna metabolism,chemosensitivity
ENSG00000153914,SREK1,aberrant splicing,cell growth regulation,enhanced proliferation,hnrnp complex interaction,mapk/erk pathway modulation,tumor progression
ENSG00000166634,SERPINB12,tumor suppressor,protease inhibition,cell invasion regulation,metastasis suppression,transcriptional regulation,biomarker potential
ENSG00000105281,SLC1A5,cell proliferation,metabolic regulation,tumor progression,protein interaction,gene expression,apoptosis regulation
ENSG00000123405,NFE2,antioxidant response element (are) activation,detoxification pathway regulation,pro-survival signaling enhancement,chemo-resistance mechanism involvement,oxidative stress tolerance promotion,tumor progression facilitation
ENSG00000110057,UNC93B1,immune modulation,tumor microenvironment regulation,innate immunity regulation,immunosuppression promotion,nf-κb signaling pathway interaction,oncogenic transformation
ENSG00000099901,RANBP1,ran-gtpase interaction,oncogenic signaling,cell proliferation enhancement,chromatin remodeling complex,cancer cell survival,dna repair regulation
ENSG00000100714,MTHFD1,folate metabolism regulation,tumor suppressor gene silencing,methylation pattern alteration,epigenetic modification influence,nucleotide synthesis enhancement,cancer cell proliferation promotion
ENSG00000107537,PHYH,mitochondrial dysfunction,genomic instability,cancer driver gene,tumor progression,cellular metabolism regulation,pi3k/akt pathway alteration
ENSG00000099624,ATP5F1D,increased energy metabolism,tumor growth promotion,enhanced survival,poor prognosis,regulation of cellular redox balance,interactions with other proteins
ENSG00000157087,ATP2B2,oncogenesis,calcium signaling pathway,prognostic biomarker,therapeutic target,cell proliferation,apoptosis inhibition
ENSG00000161647,MPP3,wnt signaling pathway,cellular regulation,tumor progression,oncogenic driver,epithelial homeostasis,apoptosis regulation
ENSG00000069275,NUCKS1,cell cycle regulation,dna repair mechanism,oncogenic processes,tumor growth promotion,genomic instability,chemoresistance development
ENSG00000089775,ZBTB25,transcriptional repressor,tumor suppressor,cell proliferation regulation,apoptosis modulation,genome stability maintenance,oncogenic pathway activation
ENSG00000162231,NXF1,oncogenesis,promotion of cell survival,dysregulation of mirna expression,nuclear export factor function,cell proliferation regulation,resistance to apoptosis
ENSG00000145979,TBC1D7,cellular trafficking regulation,rhogap interaction,actin cytoskeleton modulation,pi3k/akt pathway activation,mapk/erk signaling enhancement,apoptosis evasion
ENSG00000134686,PHC2,chromatin regulation,methylated histone modification,prc1 complex,epigenetic silencing,tumor suppressor gene expression,dna damage response
ENSG00000063177,RPL18,translation regulation,oncogene activation,cell proliferation,apoptosis resistance,pi3k/akt pathway modulation,ribosomal protein function
ENSG00000197111,PCBP2,rna-binding protein,post-transcriptional regulation,cancer driver gene,cell proliferation,metastasis promoter,rna stability regulator
ENSG00000105141,CASP14,apoptosis regulation,cancer biomarker,cellular stress response,caspase activity,dna damage response,oncogenic process modulation
ENSG00000275700,AATF,transcriptional regulation,cell cycle progression,apoptosis inhibition,dna repair modulation,tumor suppression,prognostic biomarker
ENSG00000136929,HEMGN,histone modification,epigenetic regulation,gene silencing,tumor suppressor inactivation,cell proliferation promoter,oncogenic complex component
ENSG00000160299,PCNT,aneuploidy regulation,cell division regulation,chromosomal instability promotion,centrosome maintenance,mitotic spindle assembly,tumor aggressiveness marker
ENSG00000163468,CCT3,cell survival,protein folding regulation,therapeutic target,tumorigenesis involvement,chaperone activity modulation,stress response regulation
ENSG00000131626,PPFIA1,cell signaling regulation,tyrosine phosphatase regulation,cell adhesion modulation,cancer metastasis,therapeutic target,gene expression upregulation
ENSG00000112640,PPP2R5D,pp2a regulation,tumor suppressor function,cell cycle progression,dna repair dysfunction,oncogenic potential,therapeutic target
ENSG00000123136,DDX39A,dna helicase activity,transcriptional regulation,genomic instability,chromatin remodeling,cell proliferation,tumor progression
ENSG00000163702,IL17RC,inflammation induction,tumor progression,pro-inflammatory cytokine production,immune evasion,cell proliferation enhancement,poor prognosis biomarker
ENSG00000134545,KLRC1,tumor immune evasion,gene downregulation,t-cell recognition impairment,immunosuppressive microenvironment,prognostic biomarker,immune surveillance modulation
ENSG00000147378,FATE1,emt regulation,wnt/β-catenin pathway activation,pi3k/akt signaling modulation,oncogenic transcription factor,cell proliferation promotion,epithelial cell maintenance
,H1FX,histone modification,chromatin compaction,epigenetic regulation,tumor suppressor repression,genomic instability,cell proliferation promotion
ENSG00000101882,NKAP,chromatin regulation,dna repair disruption,genomic instability,loss-of-function mutations,nucleosome remodeling interaction,tumor progression
ENSG00000008735,MAPK8IP2,mapk signaling pathway,promoter hypermethylation,cell proliferation,biomarker overexpression,scaffolding protein function,oncogenic potential
ENSG00000119599,DCAF4,cell cycle regulation,p53 degradation,substrate recognition component,cul4-ring e3 ubiquitin ligase complex,tumorigenesis,oncogene potential
ENSG00000168542,COL3A1,type iii collagen overexpression,extracellular matrix modulation,cell migration facilitation,tumor microenvironment creation,angiogenesis regulation,pro-tumorigenic properties
ENSG00000083720,OXCT1,tca cycle dysfunction,metabolic reprogramming,warburg effect activation,cell proliferation enhancement,apoptosis inhibition,therapeutic target
ENSG00000075415,SLC25A3,mitochondrial carrier,aspartate transport,cell growth promotion,therapeutic target,energy metabolism modulation,proton gradient regulation
ENSG00000138442,WDR12,mitochondrial regulation,oncogenic amplifier,transcriptional regulator,cellular proliferation,apoptosis inhibition,mitochondrial integrity
ENSG00000138160,KIF11,genomic instability,oncogene activation,chromosome congression disruption,dna repair pathway regulation,cell division deregulation,mitosis dysfunction
ENSG00000017260,ATP2C1,calcium signaling pathway,oncogenesis,tumor aggressiveness,cell growth promotion,prognostic marker,calcium homeostasis disruption
ENSG00000176887,SOX11,transcription factor regulation,epithelial-to-mesenchymal transition (emt),genomic instability,pi3k/akt signaling pathway modulation,cell cycle regulation,apoptosis suppression
ENSG00000175216,CKAP5,cellular transport,genomic instability,oncogenic signaling,pi3k/akt pathway,protein-protein interactions,cell growth regulation
ENSG00000120158,RCL1,cell cycle regulation,cell proliferation,tumor progression,prognostic marker,genomic instability,mitotic activation
ENSG00000111605,CPSF6,regulation of oncogenic transcripts,oncogene regulation,post-transcriptional control,cell survival and proliferation,rna-binding protein therapy target,genomic instability
ENSG00000214022,REPIN1,phosphorylation regulation,akt pathway activation,cell survival promotion,metastasis facilitation,oncogenic protein interaction,apoptosis suppression
ENSG00000175390,EIF3F,anabolic pathway activation,cell proliferation enhancement,cancer cell survival,therapeutic target identification,oncogenic signaling interaction,protein synthesis regulation
ENSG00000164934,DCAF13,dna damage response,cellular homeostasis,protein degradation pathways,autophagy regulation,cell cycle progression disruption,genetic instability contribution
ENSG00000197635,DPP4,cancer-promoting signaling,overexpression-driven tumorigenesis,cell migration facilitation,metastatic potential enhancement,therapeutic target identification,cancer cell survival promotion
ENSG00000171385,KCND3,cell cycle progression,cellular metabolism,constitutive activation,dysregulation of ion channels,inhibition of apoptosis,modulation of signaling pathways
ENSG00000134365,CFHR4,alternative pathway regulation,cell adhesion modulation,complement system interaction,high expression levels,metastasis promotion,tumor progression
ENSG00000150768,DLAT,altered energy production,disrupted metabolic regulation,impaired cellular respiration,cancer cell adaptation,mutations in oncogenic pathway,genetic instability
ENSG00000078018,MAP2,cell cycle regulation,microtubule dynamics,cell proliferation,tumor progression,protein-protein interaction,oncogenic potential
ENSG00000183765,CHEK2,dna damage response,genomic instability,cell cycle regulation,tumor suppressor function,dna repair mechanisms,checkpoint activation
ENSG00000244038,DDOST,aberrant glycosylation,cancer cell proliferation,cell survival pathway,glycoprotein modification,n-glycosylation regulation,protein misfolding
ENSG00000064547,LPAR2,inflammation regulation,cell proliferation,oncogene potential,g-protein coupled receptor function,tumor progression,therapeutic target
ENSG00000182134,TDRKH,chromatin modification,genomic instability,transcriptional regulation,histone recognition,tumorigenesis,therapeutic target
ENSG00000140382,HMG20A,chromatin remodeling,transcriptional regulation,oncogenic process activation,genome stability maintenance,therapeutic target potential,dna repair mechanism interaction
ENSG00000066322,ELOVL1,**
metabolic reprogramming,fatty acid synthesis regulation,oncogenic cell proliferation,therapeutic target,lipid metabolism modulation,tumor progression 
**
ENSG00000174827,PDZK1,cell signaling modulation,scaffolding protein function,driver mutation association,cell proliferation regulation,cell migration modulation,tumor suppressor activity
ENSG00000280987,MATR3,cell cycle regulation,genome stability,gene expression modulation,oncogene activity,tumor suppressor interaction,poor prognosis marker
ENSG00000143006,DMRTB1,transcriptional regulation,epithelial-to-mesenchymal transition,cell cycle progression,apoptosis suppression,prognostic marker,therapeutic target
ENSG00000174547,MRPL11,ribosome assembly dysfunction,aberrant protein synthesis,cell proliferation driver,stress response dysregulation,tumor progression,therapeutic target
ENSG00000100916,BRMS1L,cell cycle regulation,dna repair mechanisms,tumor suppression,genomic instability,apoptosis modulation,oncogenic pathway interference
ENSG00000143537,ADAM15,cell adhesion disruption,ectodomain shedding,metalloprotease activity,tumor invasion facilitation,biomarker potential,signaling pathway modulation
ENSG00000117139,KDM5B,epigenetic regulation,tumor aggressiveness,metastasis resistance,oncogenic transcription factors,cell cycle progression,histone tail modifications
ENSG00000148572,NRBF2,dna damage response,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis induction,transcriptional regulation
,HIST1H2BB,histone modification,chromatin remodeling,epigenetic regulation,tumor progression,cell cycle regulation,gene expression control
ENSG00000174437,ATP2A2,**

calcium homeostasis disruption,cell proliferation regulation,prognostic marker,tumor progression,calcium signaling pathway activation,cell growth modulation 
**
ENSG00000119285,HEATR1,dna repair defect,genomic instability,chromatin remodeling,cell cycle regulation,mitotic checkpoint disruption,tumor suppressor
ENSG00000171953,ATPAF2,chromatin remodeling,transcriptional activation,dna repair interaction,cell cycle progression,oncogenic mechanism,genomic instability
ENSG00000163625,WDFY3,tumor suppressor,dna repair regulation,ubiquitination pathway,cell cycle regulation,protein-protein interaction,oncosuppression potential
ENSG00000139112,GABARAPL1,autophagy regulation,oncogenic potential,cell survival pathways,therapy resistance,prognostic marker,cellular degradation processes
ENSG00000113790,EHHADH,mitochondrial function,oxidative stress,cell cycle regulation,tumor aggressiveness,fatty acid metabolism,therapeutic target
ENSG00000215375,MYL5,oncogenic potential,prognostic marker,cell proliferation,migration and invasion,pi3k/akt pathway interaction,molecular regulation
ENSG00000108819,PPP1R9B,tumor suppressor function,cell cycle regulation,apoptosis regulation,gene expression modulation,oncogenic mutations,aggressive tumor behavior
ENSG00000145349,CAMK2D,cellular signaling pathway,oncogenesis regulation,calcium homeostasis disruption,tumor progression promotion,protein kinase activation,cell growth regulation
ENSG00000004142,POLDIP2,genomic stability maintenance,tumor progression,aberrant dna synthesis,cell cycle regulation,dna repair modulation,protein-protein interactions
ENSG00000124193,SRSF6,splice site recognition,alternative splicing regulation,cell proliferation promotion,oncogenic signaling pathway activation,poor prognosis marker,aggressive tumor behavior
ENSG00000108852,MPP2,cellular trafficking,oncogenic function,tumor progression,cell proliferation,apoptosis inhibition,pi3k/akt signaling pathway interaction
ENSG00000116584,ARHGEF2,rho gtpase activation,cell surface receptor signaling,cytoplasmic signaling complex formation,apoptosis suppression,cytoskeleton reorganization,cell cycle regulation
ENSG00000104969,SGTA,hsp70 chaperone system,scf complex assembly,ubiquitination regulation,oncogenic signaling,apoptosis evasion,cell cycle progression
ENSG00000175029,CTBP2,transcriptional co-repressor,oncogenic pathway activation,emt program maintenance,cellular proliferation enhancement,metastasis promotion,tumor progression facilitation
ENSG00000178035,IMPDH2,increased expression,genomic instability,purine biosynthesis regulation,cell proliferation enhancement,therapeutic target,dna repair mechanism
ENSG00000076928,ARHGEF1,oncogenic function,constitutive activation,cell migration,invasion and metastasis,epithelial-to-mesenchymal transition (emt),rho gtpase regulation
ENSG00000007314,SCN4A,oncogene activation,epithelial-to-mesenchymal transition (emt),cell migration and invasion,voltage-gated sodium channel subunit,prognostic biomarker potential,cell proliferation regulation
ENSG00000103222,ABCC1,multidrug resistance,nf-κb pathway activation,cancer cell proliferation,apoptosis suppression,drug efflux transporter,transcriptional regulation
ENSG00000169727,GPS1,protein-protein interaction,cell migration regulation,g-protein coupled receptor signaling,tumorigenesis association,cancer cell survival,metastatic process
ENSG00000100664,EIF5,translation initiation factor,protein synthesis regulation,cell proliferation enhancement,apoptosis inhibition,metastasis promotion,oncogenic role
ENSG00000115694,STK25,constitutive activation,dna damage response,oncogene potential,pi3k/akt signaling regulation,cell cycle progression regulation,apoptosis inhibition
ENSG00000108106,UBE2S,nedd8 pathway regulation,c-myc activation,oncogenic function,tumor aggressiveness,ubiquitination modulation,protein degradation regulation
ENSG00000174989,FBXW8,tumor suppressor,cell cycle regulation,ubiquitination and degradation,cyclin e regulation,oncogenic processes,protein-protein interaction
ENSG00000166135,HIF1AN,angiogenesis inhibitor,tumor suppressor,hypoxia response regulation,vegf transcriptional regulation,oncogenic driver mutation,protein degradation pathway
ENSG00000164946,FREM1,tumor suppressor activity,cell adhesion regulation,extracellular matrix interaction,cell migration inhibition,cancer cell invasion modulation,tissue homeostasis maintenance
ENSG00000256235,SMIM3,cell cycle regulation,mitotic spindle formation,pi3k/akt signaling pathway activation,chromosome segregation,tumor progression,centrosome localization
ENSG00000213585,VDAC1,mitochondrial outer membrane,ion channel function,metabolic reprogramming,cell survival signaling,tumor aggressiveness,prognostic marker
ENSG00000168496,FEN1,genomic instability,tumor progression,oncogene function,dna repair regulation,cell proliferation,prognostic marker
ENSG00000165934,CPSF2,pre-mrna processing,cleavage and polyadenylation specificity factor complex,mrna stability,gene expression regulation,cell proliferation,metastasis
ENSG00000115355,CCDC88A,centrosome regulation,cell cycle regulation,akt signaling pathway activation,cell proliferation enhancement,tumor aggressiveness,cell survival promotion
ENSG00000166681,BEX3,cell proliferation,oncogene overexpression,metastasis enhancement,cell survival,protein interaction,genomic aberration
ENSG00000113810,SMC4,genomic instability,chromatin remodeling,cohesin complex regulation,cell cycle progression,sister chromatid cohesion,dna repair pathway
ENSG00000175581,MRPL48,mitochondrial translation,cellular growth,energy metabolism,apoptosis regulation,tumor progression,protein synthesis
ENSG00000021776,AQR,genomic instability,dna repair,helicase activity,replication stress,double-strand breaks,genetic mutations
ENSG00000155974,GRIP1,enhanced oncogenic potential,overexpression,cell cycle regulation,transcriptional modulation,signaling pathway interaction,apoptosis resistance
,SPERT,apoptosis regulation,tumor suppression,cell cycle regulation,genomic stability,dna repair mechanisms,protein-protein interactions
ENSG00000132716,DCAF8,ubiquitin ligase activity,tumor suppressor degradation,oncogene overexpression,cell proliferation promotion,apoptosis evasion,genetic instability
ENSG00000205846,CLEC6A,immune modulation,tumor microenvironment regulation,oncogene function,cellular adhesion facilitation,pro-tumorigenic environment,metastasis promotion
ENSG00000166527,CLEC4D,oncogenic signaling,immune evasion,tumor microenvironment modulation,poor prognosis marker,cell proliferation regulation,apoptosis suppression
ENSG00000160201,U2AF1,alternative splicing,cancer mutations,gene expression changes,oncogene activation,pre-mrna processing,splicing factor dysfunction
ENSG00000137154,RPS6,rps6 overexpression,tumor progression,protein synthesis activation,cell growth regulation,mtor pathway interaction,cancer prognosis correlate
ENSG00000015153,YAF2,genomic instability,promotes oncogenic pathways,cell proliferation,survival,pi3k/akt pathway interaction,therapeutic target
ENSG00000125457,MIF4GD,transcription regulation,oncogene activation,cell proliferation,apoptosis evasion,chromatin remodeling,transcription factor interaction
ENSG00000129988,LBP,immune recognition,pro-inflammatory cytokines,tumor microenvironment modulation,inflammation regulation,innate immunity activation,gut microbiota modulation
ENSG00000123131,PRDX4,antioxidant activity,cell survival promotion,oncogene function,therapeutic target,tumor progression facilitation,prognostic marker
ENSG00000142748,FCN3,tumor progression,immunomodulation,cell proliferation,apoptosis regulation,immune evasion,poor prognosis marker
ENSG00000140632,GLYR1,n-glycosylation,aberrant glycosylation patterns,tumor progression,cell migration and invasion,biomarker for cancer prognosis,therapeutic target
ENSG00000135404,CD63,cell migration,epithelial origin,lysosomal sorting,tumor progression,membrane trafficking,phagocytosis
ENSG00000112742,TTK,genomic instability,dna replication regulation,cell cycle progression,mitosis regulation,meiosis regulation,therapeutic target
ENSG00000105404,RABAC1,membrane trafficking regulation,tumor progression promotion,metastasis facilitation,cell signaling modulation,gene expression alteration,chemosensitivity reduction
ENSG00000161265,U2AF1L4,spliceosomal complex regulation,pre-mrna processing,poly-pyrimidine tract recognition,alternative splicing events,intron-exon boundary modulation,genomic instability
ENSG00000130816,DNMT1,epigenetic regulation,maintenance of dna methylation,dna methyltransferase activity,gene silencing,tumor suppressor gene inactivation,chromatin modification
ENSG00000162946,DISC1,altered gene expression,cell proliferation,genetic alterations,tumor progression,potential tumor suppressor,oncogenic processes
ENSG00000100813,ACIN1,apoptosis regulation,genomic instability,dna damage response,chromosomal alterations,protein interactions,cell cycle progression
ENSG00000123395,ATG101,autophagy regulation,apoptosis modulation,cell survival promotion,gene expression alteration,protein-protein interaction,tumor progression enhancement
ENSG00000151651,ADAM8,tumor progression,cell adhesion modulation,extracellular matrix degradation,biomarker potential,cancer cell invasion facilitation,therapeutic target
ENSG00000100227,POLDIP3,genomic instability,dna synthesis regulation,cell cycle progression,chromosomal rearrangements,genetic alterations,tumor suppressor function
ENSG00000147416,ATP6V1B2,v-atpase complex activation,ion homeostasis disruption,acidification regulation,cell invasion enhancement,metastasis facilitation,therapeutic target candidacy
ENSG00000262327,AGK,metabolic regulation,tumor progression,constitutive activation,aberrant energy production,dysregulation of metabolic pathways,cellular proliferation
ENSG00000165283,STOML2,microtubule stability regulation,cell cycle progression modulation,oncogenic pathway activation,cell proliferation promotion,tumor progression facilitation,biomarker potential for cancer diagnosis
ENSG00000239713,APOBEC3G,mutations inducing,genomic instability,oncogenic transformation,protein interaction,dna repair modulation,post-translational modification
ENSG00000155363,MOV10,rna-binding protein,tumor suppressor function,loss-of-function mutations,prognostic marker,cell proliferation regulation,genomic instability
ENSG00000102738,MRPS31,mitochondrial biogenesis,altered metabolic flux,glycolytic switch,mitochondrial dna instability,oncogenic mutation load,tumor aggressiveness
ENSG00000100450,GZMH,apoptosis regulation,cell death induction,granzyme activity,immune evasion,oncogenic potential,tumor progression
ENSG00000115414,FN1,cell adhesion,tumor progression,metastasis,integrin interaction,cancer cell invasion,poor prognosis
ENSG00000143842,SOX13,tumor suppressor function,epithelial cell differentiation,genomic instability,cellular homeostasis regulation,apoptosis induction,protein-protein interactions
ENSG00000124253,PCK1,gluconeogenesis promotion,metabolic reprogramming,warburg effect enhancement,cell proliferation increase,tumor progression facilitation,therapeutic target potential
ENSG00000164587,RPS14,genomic instability,apoptosis regulation,cell growth regulation,translation initiation,protein synthesis inhibition,ribosome biogenesis
ENSG00000040199,PHLPP2,pi3k/akt regulation,tumor suppressor function,phosphatase activity,substrate regulation,cell proliferation inhibition,oncogenic pathway modulation
ENSG00000148660,CAMK2G,cell proliferation,constitutive activation,gene amplification,oncogene,protein kinase activation,therapeutic target
ENSG00000134759,ELP2,transcription elongation,aberrant regulation,chromatin remodeling,oncogene overexpression,rna polymerase ii complex,genomic instability
ENSG00000143412,ANXA9,oncogene,prognostic marker,cell proliferation,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway,dna damage response
ENSG00000170542,SERPINB9,tumor suppressor function,apoptosis regulation,caspace inhibition,cell survival enhancement,pro-inflammatory microenvironment,cancer progression
ENSG00000262145,ATP23,atp dependent processes,protein folding regulation,cellular stress response modulation,chaperone function,protein quality control mechanism,cellular adaptation to stress
ENSG00000005810,MYCBP2,oncogenic function,cell proliferation regulation,transcriptional coactivation,apoptosis resistance,prognostic biomarker potential,therapeutic target candidate
ENSG00000203690,TCP10,mitochondrial regulation,redox balance disruption,apoptosis modulation,oxidative stress response,gene expression dysregulation,tumor progression marker
ENSG00000147509,RGS20,pi3k/akt pathway interaction,g-protein signaling regulation,oncogenic signaling modulation,tumorigenesis promotion,cell growth regulation,apoptosis resistance
ENSG00000067048,DDX3Y,cellular proliferation,oncogenic driver,rna processing regulation,protein-protein interaction,therapeutic target,tumor progression
,HIST1H3A,histone modification,chromatin remodeling,epigenetic regulation,cell proliferation,dna replication repair,protein-protein interaction
,HIST1H3B,histone modification,epigenetic regulation,chromatin structure,gene expression control,genomic integrity maintenance,tumorigenesis facilitation
,HIST1H3C,epigenetic regulation,genomic instability,tumor progression,chromatin modification,histone exchange,gene expression regulation
,HIST1H3I,histone modification,chromatin remodeling,tumor progression,genomic instability,transcriptional regulation,biomarker potential
,HIST1H3H,histone modification,epigenetic regulation,tumor progression,proliferation inhibition,genome stability maintenance,apoptosis modulation
,HIST1H3G,histone modification,chromatin remodeling,epigenetic regulation,tumor suppressor function,genomic stability maintenance,transcriptional activation
,HIST1H3F,chromatin regulation,cell cycle progression,genome instability,dna repair,epigenetic regulation,histone modification
,HIST1H3E,histone regulation,chromatin remodeling,epigenetic modification,gene expression regulation,tumor progression driver,oncogenic function
,HIST1H3J,acetylation of histones,chromatin remodeling,epigenetic regulation,gene expression changes,histone modification patterns,oncogenesis driver
,HIST1H3D,histone modification,chromatin compaction,gene regulation,transcriptional activation,dna packaging,epigenetic regulation
ENSG00000100422,CERK,cell signaling regulation,oncogene overexpression,protein kinase activation,tumor progression,receptor tyrosine kinases interaction,pi3k/akt pathway modulation
ENSG00000129195,PIMREG,cellular regulation,protein processing,substrate degradation,apoptosis regulation,cell cycle progression,tumor development
ENSG00000137745,MMP13,tumor progression,metastasis facilitation,extracellular matrix remodeling,angiogenesis promotion,signal transduction modulation,cancer cell invasion enhancement
ENSG00000172059,KLF11,tumor suppressor,cell proliferation regulation,transcription factor activity,apoptosis modulation,dna binding,oncogenic process regulation
ENSG00000135316,SYNCRIP,rna stability regulation,oncogenic protein expression,cell proliferation promotion,survival pathway activation,translational control mechanisms,tumor suppressor dysregulation
ENSG00000095002,MSH2,genomic instability,mismatch repair deficiency,tumor suppressor function,dna damage repair,microsatellite instability,cancer driver gene
ENSG00000067191,CACNB1,calcium channel regulation,cell migration,cell survival,growth factor signaling pathway,protein-protein interactions,tumor progression
ENSG00000196504,PRPF40A,**

* **aberrant splicing**,constitutive expression,oncogene activation,cell cycle progression,tumor suppressor gene suppression
*,none
,HIST1H2BC,histone modification,chromatin regulation,epigenetic regulation,tumorigenesis driver,cancer epigenetics,oncogene expression
,HIST1H2BE,histone modification,chromatin regulation,cell growth regulation,gene expression control,transcriptional activation,tumor progression
,HIST1H2BG,chromatin regulation,tumor suppressor,cell cycle progression,genomic instability,gene expression regulation,dna repair
,HIST1H2BF,epigenetic regulation,histone modification,chromatin structure,cell growth regulation,dna packaging,apoptosis modulation
,HIST1H2BI,histone regulation,tumor suppressor dysfunction,dna repair deficiency,chromatin compaction,epigenetic modification,eukaryotic gene expression
ENSG00000100083,GGA1,golgi apparatus regulation,cell membrane trafficking,oncogenic signaling pathway,cell growth modulation,tumor progression influence,membrane protein sorting
ENSG00000125445,MRPS7,mitochondrial translation,tumor suppressor gene,cellular metabolism,energy production,oncogenic mutations,mitochondrial dynamics
ENSG00000116560,SFPQ,transcriptional regulation,alternative splicing,cell proliferation,tumor progression,oncogene function,dysregulation
ENSG00000173482,PTPRM,cell adhesion,dysregulated signaling pathways,enhanced cell migration,genomic alterations,phosphatidylinositol 3-kinase activation,therapeutic target
ENSG00000164610,RP9,mirna regulation,rna-binding protein complex,post-transcriptional regulation,oncogenic pathway activation,biomarker potential,tumor progression
ENSG00000173545,ZNF622,aberrant gene expression,apoptosis evasion,cell cycle regulation,chromatin remodeling,cyclin-dependent kinase regulation,oncogenic transcription factor
ENSG00000105393,BABAM1,genomic instability,dna repair mechanisms,brisc complex component,ubiquitin removal,cell proliferation regulation,oncogenesis prevention
ENSG00000100354,TNRC6B,mirna regulation,tumor progression,genome stability,cell growth regulation,protein-protein interaction,therapeutic target
ENSG00000124160,NCOA5,transcriptional regulation,oncogenic coactivator,cell proliferation,angiogenesis,steroid hormone receptor interaction,tumor aggressiveness
ENSG00000198755,RPL10A,ribosomal protein function,elongation phase regulation,translation process modulation,cell proliferation promotion,apoptosis inhibition,translational efficiency enhancement
ENSG00000102931,ARL2BP,oncogenic signaling,cell proliferation,amplification or overexpression,metastasis promotion,tumor progression factor,biomarker for disease progression
ENSG00000121058,COIL,cell adhesion disruption,actin cytoskeleton regulation,tumor progression,signaling pathway modulation,cell migration enhancement,proliferation promotion
ENSG00000160789,LMNA,genomic instability,nuclear structure regulation,cell growth modulation,oncogenic transcription factor activation,tumor suppressor gene repression,chromatin organization disruption
ENSG00000135083,CCNJL,cell cycle regulation,dna repair mechanism,oncogenic driver,tumor progression marker,protein-protein interaction,genomic instability
ENSG00000142186,SCYL1,protein degradation regulation,ubiquitination process modulation,oncogenic protein stabilization,cell cycle progression facilitation,therapeutic target identification,ubiquitin ligase complex interaction
ENSG00000119403,PHF19,chromatin modification,transcriptional regulation,cell cycle dysregulation,tumor progression,oncogenic driver,protein-protein interaction
ENSG00000038945,MSR1,angiogenesis promotion,immune suppression,lipid metabolism regulation,metastasis facilitation,prognostic marker,tumor progression
ENSG00000226033,STK19,genomic instability,tumor suppressor,cell cycle regulation,dna damage response,phosphorylation activity,kinase activation
ENSG00000198856,OSTC,cell adhesion,metastasis,tumor aggressiveness,protein interaction,signaling pathway regulation,cell invasion
ENSG00000107937,GTPBP4,protein regulation,cell proliferation,tumor progression,overexpression,therapeutic target,genomic alteration
ENSG00000184408,KCND2,aberrant expression,aggressive tumor behavior,cell proliferation,cancer cell survival,therapeutic resistance,pi3k/akt pathway interaction
ENSG00000100346,CACNA1I,calcium channel regulation,tumor cell migration,oncogenic signaling,cell proliferation enhancement,genomic instability contributor,protein-protein interaction partner
ENSG00000110429,FBXO3,tumor suppression,cell cycle regulation,dna repair mechanisms,nucleotide excision repair,cell proliferation enhancement,cancer-associated mutations
ENSG00000198830,HMGN2,chromatin remodeling,apoptosis suppression,tumor progression,proliferation enhancement,gene regulation modulation,transcriptional activation
ENSG00000183751,TBL3,cell cycle regulation,oncogenic transcription factor,chromatin remodeling,dna repair regulation,prognostic marker,nuclear localization
ENSG00000092847,AGO1,mirna binding,tumor suppressor regulation,mrna degradation,protein-protein interaction,cancer progression,therapeutic target
ENSG00000247077,PGAM5,warburg effect,glycolytic regulation,gluconeogenesis inhibition,tumor progression,poor prognosis,cancer metabolism modulation
ENSG00000134086,VHL,tumor suppressor activity,hif-α regulation,angiogenesis promotion,cell proliferation enhancement,vascular growth factor regulation,protein degradation dysfunction
ENSG00000132109,TRIM21,ubiquitin ligase activity,tumor microenvironment modulation,oncogenic progression,nf-κb pathway regulation,e3 ubiquitin ligase function,protein degradation regulation
ENSG00000167283,ATP5MG,mitochondrial function,energy metabolism regulation,metabolic reprogramming,tumor progression,cellular signaling interaction,glycolytic flux enhancement
ENSG00000088992,TESC,transcriptional regulation,chromatin remodeling,cellular homeostasis,tumor suppression,metastasis suppression,genomic instability
ENSG00000124126,PREX1,rac gtpase activation,cell migration,constitutive activation,gef activity,oncogenic signaling,therapeutic target
ENSG00000197769,MAP1LC3C,autophagosome formation,cell survival,metastasis promotion,oncogenic process,tumor progression,autophagy regulation
ENSG00000111445,RFC5,genomic instability,nucleotide excision repair (ner),dna damage response,replication factor c interaction,base excision repair (ber),genome stability maintenance
ENSG00000104413,ESRP1,alternative splicing regulation,cell migration promotion,emt modulation,gene expression regulation,metastasis facilitation,rna binding protein activity
ENSG00000100503,NIN,microtubule organization,cell proliferation,cell survival,protein-protein interactions,pi3k/akt pathway intersection,tumor progression
ENSG00000093010,COMT,oncogene potential,cell growth regulation,dna repair modulation,apoptosis evasion,angiogenesis promotion,therapeutic target
ENSG00000273772,SMN2,tumor suppressor activity,disrupted spliceosome function,rna processing regulation,genetic instability,cancer cell survival,genome maintenance
ENSG00000172062,SMN1,mrna splicing regulation,cell cycle progression disruption,apoptosis modulation,tumor progression contribution,dysregulated expression,snrnp assembly dysfunction
ENSG00000156299,TIAM1,gef activity,rho gtpase activation,cytoskeleton reorganization,nf-κb signaling pathway,tumor invasion,prognostic marker
ENSG00000197381,ADARB1,rna editing,genome stability,tumor suppression,genomic instability,oncogenic transformation,adenosine deaminase activity
ENSG00000124207,CSE1L,cell proliferation,therapeutic target,nuclear pore complex function,overexpression,apoptosis suppression,tumorigenesis promotion
ENSG00000167863,ATP5PD,mitochondrial metabolism,atp synthesis,glycolytic activity,cellular proliferation,energy production,tumor aggressiveness
ENSG00000136527,TRA2B,altered gene expression,cellular heterogeneity,dysregulated spliceosome activity,enhanced cell proliferation,increased tumorigenic potential,regulatory mechanism alterations
ENSG00000114391,RPL24,altered expression,cell growth regulation,protein synthesis modulation,ribosomal subunit component,tumor proliferation,translational efficiency alteration
ENSG00000111752,PHC1,cell cycle regulation,chromatin remodeling,dna repair disruption,genomic instability,oncogene overexpression,prognostic marker
ENSG00000144713,RPL32,ribosomal protein dysregulation,translation initiation complex,cell proliferation,apoptosis resistance,chemotherapy resistance,oncogenic role
ENSG00000131263,RLIM,genomic instability,tumor progression,maintenance of genomic integrity,tumor suppressor activity,regulation of transcriptional regulators,cellular regulation and signaling pathways
ENSG00000079785,DDX1,chromatin modification,oncogenic transcription factor,cell proliferation,transcriptional activation,metastasis suppression,dna repair
ENSG00000241553,ARPC4,actin cytoskeleton remodeling,aberrant activation,protein-protein interactions,cell migration and invasion,oncogenic behaviors,cancer driver gene
ENSG00000163644,PPM1K,pi3k/akt signaling,oncogene activation,cell proliferation regulation,protein phosphorylation regulation,epithelial-to-mesenchymal transition (emt),genomic instability
ENSG00000100519,PSMC6,proteasome activity,ubiquitin-proteasome pathway disruption,oncogenic protein accumulation,cell proliferation enhancement,survival pathway dysregulation,tumor progression facilitation
ENSG00000152291,TGOLN2,oncogene upregulation,retrograde transport modulation,cell proliferation enhancement,protein trafficking deregulation,tumor aggressiveness association,therapeutic resistance contribution
ENSG00000088179,PTPN4,cellular signaling pathway,oncogene activity,pi3k/akt pathway modulation,tumor-promoting functions,downstream effector activation,aggressive tumor behavior
ENSG00000108349,CASC3,cellular homeostasis disruption,tumor progression association,protein interaction regulation,apoptosis inhibition,cell cycle dysregulation,prognostic marker
ENSG00000124614,RPS10,ribosome biogenesis,protein synthesis upregulation,cell growth acceleration,tumorigenesis association,biomarker potential,poor prognosis
ENSG00000114446,IFT57,ciliogenesis,oncogenic potential,cell cycle regulation,dna damage response,mitotic spindle formation,cancer predisposition
ENSG00000081320,STK17B,cell cycle regulation,genomic amplification,oncogene overexpression,protein kinase activation,cell proliferation enhancement,dna repair regulation
,HIST1H1C,chromatin dynamics alteration,histone protein function,genomic instability contribution,epigenetic regulation influence,tumor suppressor gene silencing,cellular transformation role
ENSG00000005007,UPF1,genomic instability,nonsense-mediated mrna decay,tumor progression,aberrant transcription,dna repair mechanism,cancer prognosis
ENSG00000125388,GRK4,cell surface receptor regulation,g protein-coupled receptor kinase function,enhanced cell proliferation,oncogenic signaling pathway involvement,altered gene expression,tumor progression
ENSG00000093144,ECHDC1,lipid metabolism,cellular growth promotion,oncogenic expression regulation,metabolic reprogramming,cancer cell survival enhancement,tumor progression facilitation
ENSG00000166855,CLPX,genomic instability,cellular stress response,chaperone function,molecular chaperone,protein aggregation,telomere maintenance
ENSG00000141867,BRD4,transcriptional regulation,chromatin remodeling,oncogenic protein,constitutive activation,cell proliferation,therapeutic target
ENSG00000110958,PTGES3,tumor progression,gene expression regulation,cell proliferation,survival signaling,pge2 production,biomarker identification
ENSG00000119950,MXI1,tumor suppressor,loss-of-function mutations,cell cycle regulation,apoptosis promotion,max interaction,myc interaction
ENSG00000172232,AZU1,microtubule dynamics,mitotic spindle assembly,tumor progression,cell cycle regulation,chromosomal instability,oncogenic function
ENSG00000107859,PITX3,transcriptional regulation,cell cycle regulation,tumor progression,apoptosis modulation,dna repair regulation,therapeutic target
ENSG00000105538,RASIP1,rasgap activity,cell migration,cell proliferation,signaling pathway regulation,apoptosis inhibition,oncogenic transformation
ENSG00000213516,RBMXL1,rbmx/upf1 interaction,tumor suppressor function,cellular stress response,alternative splicing regulation,oncogene potential,metastasis promotion
ENSG00000285301,BOP1,genomic instability,homologous recombination,tumor suppressor function,cell cycle regulation,dna repair,genome maintenance
ENSG00000137193,PIM1,cell proliferation regulation,oncogenic function,apoptosis inhibition,cell cycle progression regulation,signaling pathway activation,prognostic biomarker
ENSG00000086504,MRPL28,mitochondrial biogenesis,rrna processing,oxidative metabolism,cell proliferation,signaling pathway regulation,angiogenesis
ENSG00000281763,DHX36,mirna processing,rna helicase function,dysregulation in cancer,pi3k/akt pathway interaction,overexpression in tumors,prognostic value as biomarker
ENSG00000165209,STRBP,telomere maintenance,protein-protein interaction,apoptosis regulation,cell survival pathway,dna repair mechanism,cancer progression
ENSG00000171560,FGA,fibrinogen regulation,tumor growth promotion,metastasis facilitation,cell adhesion modulation,protein-protein interaction,serine protease activation
ENSG00000185515,BRCC3,dna repair,genomic instability,oncogene/tumor suppressor role,cell cycle regulation,apoptosis modulation,proliferation regulation
ENSG00000174243,DDX23,cellular degradation,cancer driver gene,pi3k/akt pathway regulation,transcriptional regulation,apoptosis suppression,protein degradation mediator
ENSG00000179271,GADD45GIP1,tumor suppressor function,cell cycle regulation,apoptosis induction,genomic integrity maintenance,dna damage response,cancer progression suppression
ENSG00000099875,MKNK2,p38 mapk signaling pathway,constitutive activation,gain of function mutations,tumor progression,protein phosphorylation,cell survival
,HIST2H2BE,chromatin remodeling,histone expression,nucleosome assembly,epigenetic control,gene regulation,dna packaging
ENSG00000137270,GCM1,transcriptional regulation,tumor suppressor function,cellular differentiation,genetic mutations,potential target for therapy,apoptosis regulation
ENSG00000101695,RNF125,ubiquitin-proteasome regulation,cancer driver,pi3k/akt signaling,cell cycle regulation,tumor suppressor interaction,dna repair pathway
ENSG00000170248,PDCD6IP,loss of function mutation,cell proliferation enhancement,oncogenic process promotion,regulatory subunit function,poor prognosis association,tumor cell survival promotion
ENSG00000127511,SIN3B,histone deacetylation,epigenetic regulation,tumor suppressor silencing,dna damage response,cell cycle regulation,apoptosis modulation
ENSG00000089280,FUS,oncogenic properties,genomic instability,cellular regulation,protein-protein interaction,telomerase regulation,pre-mrna splicing
,HIST1H1D,epigenetic regulation,chromatin organization,transcriptional control,cellular proliferation,genomic instability,protein-dna interactions
ENSG00000173272,MZT2A,e3 ubiquitin ligase activity,tumor suppression,histone modification regulation,cancer-associated alterations,cell cycle regulation,antitumor protein expression
ENSG00000166130,IKBIP,nf-κb pathway regulation,tumor progression inhibition,cell proliferation modulation,immune response suppression,cancer cell survival enhancement,transcriptional regulation disruption
ENSG00000169710,FASN,lipid metabolism,oncogenic signaling pathway,cell proliferation,therapeutic target,signaling pathway regulation,fatty acid synthesis
ENSG00000100109,TFIP11,microtubule dynamics regulation,genomic instability induction,biomarker expression,apoptosis resistance promotion,cell cycle progression modulation,tumor suppressor interaction disruption
ENSG00000074201,CLNS1A,cellular regulation,dysregulated expression,aberrant cell survival,growth control,tumor suppressor,protein interaction
ENSG00000000003,TSPAN6,tetraspanin signaling pathway,cell migration promotion,cancer progression,poor prognosis association,pro-tumorigenic signaling,integrin-mediated interaction
ENSG00000189067,LITAF,inflammatory response regulation,transcription factor activity,oncogenesis promotion,cell growth regulation,protein expression modulation,signaling pathway interaction
ENSG00000273594,EEF1D,translation regulation,cell proliferation,pi3k/akt signaling,tumor progression,protein synthesis regulation,overexpression association
ENSG00000102030,NAA10,protein acetylation,dysregulation of protein stability,cellular homeostasis modulation,tumor progression factor,apoptosis regulation,poor prognosis marker
ENSG00000172399,MYOZ2,cell migration,epithelial-to-mesenchymal transition,transcriptional regulation,tumor progression,therapeutic target,genomic instability
ENSG00000133398,MED10,mediator complex assembly,gene expression regulation,transcriptional activation,cell proliferation enhancement,dna repair dysregulation,epigenetic modification
ENSG00000163811,WDR43,dna damage response,genomic stability maintenance,homologous recombination repair,chromosomal instability,sensitivity to genotoxic stress,genomic integrity regulation
ENSG00000143321,HDGF,cell proliferation,genomic instability,tumor growth,apoptosis suppression,transcriptional regulation,signaling pathway modulation
ENSG00000180628,PCGF5,epigenetic regulation,chromatin remodeling,tumor suppressor gene repression,e3 ubiquitin ligase activity,cell cycle regulation,gene expression modulation
ENSG00000198642,KLHL9,genomic instability,transcriptional regulation,tumor suppressor function,loss of expression,cell cycle progression,biomarker significance
ENSG00000097033,SH3GLB1,cellular signaling pathway regulation,oncogenic protein modulation,ubiquitin ligase complex interaction,pi3k/akt pathway activation,tumor growth and survival enhancement,genomic instability promotion
ENSG00000176444,CLK2,oncogenic activation,cell proliferation enhancement,rna binding regulation,phosphorylation-dependent signaling,apoptosis suppression,therapeutic target discovery
ENSG00000196975,ANXA4,oncogenic properties,cell migration,apoptosis resistance,signaling pathway interaction,overexpression,cancer cell survival
ENSG00000280908,PADI4,cellular regulation,tumor progression marker,cancer metastasis,apoptosis inhibition,protein modification enzyme,chromatin remodeling
ENSG00000125735,TNFSF14,tnf superfamily member,immune modulation,tumor progression,co-stimulatory molecule regulation,prognostic biomarker candidate,apoptosis inhibition
ENSG00000198373,WWP2,cellular regulation,tumor suppressor function,e3 ubiquitin ligase activity,mapk/erk pathway interaction,epigenetic silencing,apoptosis induction
ENSG00000137941,TTLL7,microtubule dynamics,tumor progression,cell division,microtubule stability,dysregulation,cancer therapy
ENSG00000143164,DCAF6,oncogene activation,ubiquitin-proteasome system modulation,tumor progression driver,cell cycle regulation,p53 degradation suppression,apoptosis evasion
ENSG00000060688,SNRNP40,aberrant splicing,cell growth regulation,dysregulation of gene expression,involvement in tumorigenesis,precise mrna splicing,protein complex formation
ENSG00000143815,LBR,chromatin remodeling,dna repair mechanism,epigenetic regulation,genomic instability,nuclear architecture,tumor suppressor function
ENSG00000115289,PCGF1,polycomb function,overexpression,oncogene role,chromatin regulation,gene repression,cell proliferation
ENSG00000131473,ACLY,metabolic regulation,tumor growth,cell proliferation,pyruvate dehydrogenase complex activation,nucleotide biosynthesis,cancer metabolism
ENSG00000174996,KLC2,microtubule transport,cell division regulation,oncogenesis promotion,tumor aggressiveness marker,prognostic indicator,cancer cell proliferation enhancement
ENSG00000183943,PRKX,phosphorylation activity,cell survival pathway,amplification events,serine/threonine kinase activity,protein-protein interactions,tumor progression driver
ENSG00000132382,MYBBP1A,transcriptional regulation,oncogene function,cell cycle progression,chromatin modification,tumor suppressor gene regulation,cancer cell proliferation
ENSG00000134318,ROCK2,cellular migration,oncogene activation,tumor progression,metastasis promotion,angiogenesis regulation,cytoskeletal reorganization
ENSG00000055917,PUM2,oncogene overexpression,pro-apoptotic gene suppression,cancer cell proliferation,cell cycle regulation,tumor aggressiveness,genomic instability
ENSG00000107863,ARHGAP21,rho gtpase-activating protein,constitutive activation,tumor progression,metastasis,cell migration,pi3k/akt signaling
ENSG00000109111,SUPT6H,chromatin remodeling,transcriptional elongation,oncogenic processes,cell proliferation,apoptosis resistance,signaling pathway activation
ENSG00000186197,EDARADD,nf-κb signaling pathway,overexpression,upstream regulator interaction,tumor promotion,poor prognosis marker,cancer cell survival
ENSG00000187796,CARD9,innate immunity,tumor progression,immunosuppressive microenvironment,cancer cell growth,resistance to therapy,signaling pathway interaction
ENSG00000170142,UBE2E1,cell cycle regulation,gene expression regulation,protein degradation regulation,tumor suppressor protein regulation,dna damage response regulation,oncogenic pathway regulation
ENSG00000132334,PTPRE,**

tumor suppressor,cell proliferation regulation,receptor tyrosine kinase modulation,dephosphorylation activity,oncogenic signaling pathway inhibition,cell migration regulation
ENSG00000028839,TBPL1,transcription regulation,chromatin remodeling,dna damage response,oncogenic transformation,genomic instability,protein-protein interactions
ENSG00000163904,SENP2,sumoylation regulation,oncogenic pathway modulation,cell cycle regulation,genomic stability maintenance,apoptosis suppression,tumor progression driver
ENSG00000131469,RPL27,cell growth promotion,protein synthesis regulation,ribosome assembly,tumor suppressor-like function,anti-apoptotic properties,oncogenic overexpression
ENSG00000167005,NUDT21,genomic instability,dna repair,atr-chk1 signaling pathway,cellular responses to dna damage,tumor progression,therapeutic target
ENSG00000102098,SCML2,chromatin regulation,pi3k/akt pathway modulation,oncogenic potential,cell proliferation regulation,epigenetic processes,genomic instability
ENSG00000130935,NOL11,genomic stability,telomere maintenance,cell cycle regulation,dna damage response,oncogenic potential,tumor progression
ENSG00000251322,SHANK3,cellular migration,pi3k/akt signaling,protein-protein interaction,tumor progression,scaffold protein function,mutations leading to oncogenesis
ENSG00000108448,TRIM16L,apoptosis regulation,chromatin remodeling,genomic instability,p53 modulation,cell cycle control,transcriptional regulation
ENSG00000133661,SFTPD,immune evasion,inflammation regulation,tumor growth promotion,host-pathogen interaction,cell adhesion modulation,phagocytic activity enhancement
ENSG00000125124,BBS2,hedgehog signaling pathway activation,ciliogenesis dysregulation,tumor suppressor function loss,oncogenic signaling pathway activation,cell proliferation enhancement,genomic instability promotion
ENSG00000131467,PSME3,cell cycle regulation,protein degradation,tumor progression,immune evasion,resistance to therapy,apoptosis suppression
ENSG00000183496,MEX3B,negative regulator,mir-200 family suppression,subcellular localization,cytoplasmic compartment,mirna processing regulation,drosha complex interaction
ENSG00000102837,OLFM4,epithelial-to-mesenchymal transition (emt),overexpression,cell adhesion disruption,oncogene activation,pi3k/akt pathway involvement,tumor progression marker
ENSG00000105245,NUMBL,cell cycle regulation,oncogenic function,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway interaction,cell proliferation promotion,apoptosis inhibition
ENSG00000101210,EEF1A2,translation regulation,cell proliferation enhancement,oncogenic signaling pathway,therapeutic target,angiogenesis promotion,protein synthesis upregulation
ENSG00000181163,NPM1,transcriptional regulation,protein-protein interaction,ribosome biogenesis,cell cycle regulation,oncogenic process,cancer cell survival
ENSG00000071655,MBD3,chromatin regulation,histone demethylation,oncogene repression,tumor suppressor function,cell proliferation regulation,epigenetic modifier
ENSG00000187778,MCRS1,mitochondrial metabolism regulation,glycolytic pathway activation,tumor progression facilitation,cellular energy production alteration,mitochondrial protein interaction,prognostic value in cancer
ENSG00000164104,HMGB2,tumor promoter,transcription factor interaction,protein stabilization,apoptosis suppression,cell migration enhancement,inflammation induction
ENSG00000266472,MRPS21,mitochondrial translation,cellular energy production,tumor suppressor function,oncogenic mutation driver,apoptosis modulation,protein synthesis regulation
ENSG00000063046,EIF4B,cap-dependent translation,enhanced protein synthesis,cell proliferation driver,angiogenesis regulation,metastatic potential enhancer,global mrna translation regulator
ENSG00000135945,REV1,dna repair,translesion synthesis,genome stability,oncogene overexpression,tumor progression,cell cycle regulation
ENSG00000130758,MAP3K10,apoptosis regulation,oncogene activation,cell survival promotion,ask1 pathway interaction,jnk-mediated signaling,therapeutic target
ENSG00000171873,ADRA1D,adrenergic signaling pathway,gain of function mutations,tumor progression,cell proliferation,metastasis,g protein coupled receptor
ENSG00000170525,PFKFB3,warburg effect,glycolytic activation,metabolic reprogramming,cell proliferation enhancement,tumor progression facilitation,oncogenic transformation
ENSG00000119041,GTF3C3,transcription regulation,indirect influence on oncogenesis,cell proliferation modulation,genomic instability susceptibility,gene expression dysregulation,cellular survival pathway interaction
ENSG00000196557,CACNA1H,voltage-gated calcium channel regulation,calcium influx modulation,cell proliferation promotion,angiogenesis activation,oncogenic pathway involvement,therapeutic target
ENSG00000100941,PNN,cell migration,invadopodia formation,rho gtpase activation,tumor progression,signaling pathway modulation,cytoskeleton dynamics
ENSG00000198363,ASPH,tumor progression,cell signaling regulation,protein degradation,cell migration and invasion,oncogene activation,tumor aggressiveness
,ASNA1,altered metabolic reprogramming,amino acid biosynthesis,asparagine production enhancement,cell survival promotion,genetic amplification,tumor aggressiveness marker
ENSG00000096063,SRPK1,cell cycle regulation,rna splicing modulation,phosphorylation-dependent regulation,protein-protein interactions,tumor progression driver,oncogene upregulation
ENSG00000104081,BMF,cellular proliferation,apoptosis resistance,protein degradation regulation,tumor progression,cell migration enhancement,signaling pathway interaction
ENSG00000139921,TMX1,tumor suppressor function loss,cell migration regulation,prognostic biomarker potential,epithelial-to-mesenchymal transition,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction
,HIST1H2BM,chromatin remodeling,transcriptional regulation,tumor suppressor function,cell cycle progression,histone modification,apoptosis regulation
ENSG00000115484,CCT4,protein chaperone activity,tumor development,promotes protein stability,cell cycle regulation,apoptosis regulation,mitotic process
ENSG00000112365,ZBTB24,tumor suppressor,cell cycle regulation,dna repair mechanisms,genomic instability,apoptosis evasion,chromatin remodeling interaction
ENSG00000131876,SNRPA1,altered splicing patterns,oncogenic processes,cell survival and growth,genomic instability,dna repair mechanisms,protein-protein interactions
ENSG00000149452,SLC22A8,drug resistance,organic cation transporter,chemotherapy response,multidrug resistance,apoptosis regulation,prognostic marker
ENSG00000107957,SH3PXD2A,oncogene,cell proliferation,signaling pathway regulation,epithelial-to-mesenchymal transition (emt),tumor progression,therapeutic target
ENSG00000215474,SKOR2,cell proliferation,oncogenic processes,tumor progression,cell migration,signaling pathway regulation,kinase activity
ENSG00000160224,AIRE,autoimmune regulator,wnt/β-catenin signaling,oncogenic pathways,cell proliferation,survival factor,immune tolerance regulation
ENSG00000134371,CDC73,cell cycle regulation,genomic stability loss,tumor suppressor function,pbaf complex disruption,helicase activity dysregulation,pi3k/akt pathway modulation
ENSG00000135521,LTV1,genomic instability,dna replication regulation,tumor suppressor function,transcriptional regulation,cell cycle progression,protein-protein interaction
ENSG00000062038,CDH3,oncogenic pathway activation,cell-cell adhesion disruption,tumor aggressiveness enhancement,proliferation and migration regulation,poor prognosis association,therapeutic target
ENSG00000168763,CNNM3,cellular magnesium regulation,magnesium-dependent signaling,genomic instability,cell proliferation enhancement,oncogenic pathway modulation,tumor progression facilitation
ENSG00000149792,MRPL49,cellular respiration,mitochondrial biogenesis,oncogenic driver,protein synthesis regulation,energy metabolism dysregulation,tumor biomarker
ENSG00000010030,ETV7,etv7 transcription factor,apoptosis inhibition,cell cycle regulation,dna repair suppression,epigenetic modification,oncogene activation
ENSG00000179639,FCER1A,immune evasion,alpha subunit function,dysregulated expression,oncogenic signaling,therapeutic target potential,tumor microenvironment modulation
ENSG00000244537,KRTAP4-2,keratin cytoskeleton modification,oncogene overexpression,cell proliferation promotion,tumor invasion facilitation,epithelial cell function regulation,apoptosis regulation
ENSG00000185650,ZFP36L1,tumor suppressor function,mrna regulation,cell cycle regulation,apoptosis induction,dna repair modulation,cancer progression inhibition
ENSG00000151702,FLI1,oncogenic activity,transcriptional regulation,cell proliferation,apoptosis suppression,angiogenesis,tumor progression
ENSG00000079277,MKNK1,**

mapk signaling,oncogenesis,cell proliferation,kinase activation,stress response,prognostic marker
**
ENSG00000159023,EPB41,cell signaling regulation,metastasis facilitation,tumor progression,cytoskeleton regulation,oncogene role,cell adhesion molecule modulation
ENSG00000047579,DTNBP1,mitochondrial dynamics,tumor suppressor,protein degradation,cellular homeostasis,chemotherapy resistance,autophagy regulation
ENSG00000161970,RPL26,ribosomal protein regulation,translation initiation,cell proliferation,oncogenesis,tumor aggressiveness,genomic instability
ENSG00000108669,CYTH1,cellular proliferation,signaling pathway modulation,oncogenic transformation,metastasis promotion,biomarker significance,therapeutic target
ENSG00000129245,FXR2,enhanced cell proliferation,disrupted rna processing,altered expression levels,rna-binding protein interactions,nuclear localization,potential therapeutic target
ENSG00000184363,PKP3,epithelial cell adhesion,cell-to-cell interaction,desmosomal complex disruption,epithelial-to-mesenchymal transition,tumor progression,metastasis
ENSG00000120437,ACAT2,lipid signaling pathway,cellular metabolism regulation,enzymatic activity,prognostic marker,dna repair mechanism,fatty acid homeostasis
ENSG00000075785,RAB7A,late endosomal trafficking,oncogenic recycling,growth factor recycling,chemotherapy resistance,aggressive tumor behavior,poor prognosis
ENSG00000108064,TFAM,mitochondrial dna replication,transcriptional regulation,metabolic reprogramming,genomic instability,tumor adaptation,apoptosis resistance
ENSG00000007392,LUC7L,splicing regulator,tumorigenesis,transcriptional control,cell cycle progression,stress response modulation,cancer-related alterations
ENSG00000133243,BTBD2,chromatin remodeling,apoptosis regulation,cell cycle progression,tumor suppression,protein-protein interactions,oncogenesis
ENSG00000143622,RIT1,oncogene,pi3k/akt signaling pathway,constitutive activation,cell proliferation,tumor progression,gtpase activity
ENSG00000133835,HSD17B4,metabolic regulation,oncogenic gene expression,tumor growth promotion,poor prognosis marker,cell proliferation enhancement,apoptosis suppression
ENSG00000148335,NTMT1,histone modification,oncogenic regulation,prognostic biomarker,epithelial-to-mesenchymal transition,pi3k/akt/mtor pathway,transcriptional activation
ENSG00000106397,PLOD3,ecm remodeling,hydroxylation activity,metastatic progression,tumor microenvironment,collagen cross-linking,growth factor signaling
ENSG00000088205,DDX18,genomic instability,oncogene activation,cell proliferation,metastasis facilitation,protein-protein interaction,rna metabolism regulation
ENSG00000089818,NECAP1,actin dynamics regulation,cancer cell migration,cell adhesion modulation,cytoskeletal organization,rho gtpase activation,tumor suppressor function
ENSG00000156697,UTP14A,alternative splicing,epigenetic regulation,genomic instability,oncogenic transformation,rna helicase activity,tumor suppressor function
ENSG00000130255,RPL36,protein synthesis regulation,ribosomal subunit assembly,gene expression regulation,oncogenesis driver,apoptosis inhibition,cell cycle progression
ENSG00000164675,IQUB,ubiquitin ligase activity,protein degradation regulation,cell cycle regulation,tumor growth promotion,none,none
ENSG00000138443,ABI2,pi3k/akt pathway modulation,oncogenic processes,cell proliferation enhancement,metastasis promotion,signaling molecule interaction,adhesion regulation
ENSG00000112282,MED23,genomic instability,tumor progression,transcriptional regulation,cell proliferation,oncogene activation,prognostic marker
ENSG00000243943,ZNF512,epigenetic regulation,transcriptional regulator,cell cycle progression,apoptosis modulation,tumor microenvironment modulation,prognostic marker
ENSG00000122180,MYOG,tumor suppressor,cellular differentiation,downregulation,epithelial-to-mesenchymal transition,chromatin remodeling,dna repair regulation
ENSG00000140463,BBS4,bardet-biedl syndrome,ciliogenesis,constitutive activation,hedgehog signaling pathway,intraflagellar transport,tumor progression
ENSG00000167306,MYO5B,tumor progression,cell migration and invasion,pi3k/akt pathway interaction,emt regulation,prognostic biomarker,motor protein function
ENSG00000105501,SIGLEC5,immune modulation,cell adhesion,tumor immunity,cytokine regulation,macrophage function,siglec family member
ENSG00000198646,NCOA6,chromatin remodeling,transcriptional activation,nuclear receptor coactivation,oncogenesis,tumor growth promotion,apoptosis evasion
ENSG00000231370,PRRC2A,cell adhesion disruption,tumor progression,metastasis facilitation,overexpression association,biomarker potential,signaling pathway interaction
ENSG00000081277,PKP1,cell adhesion disruption,tumor suppressor function,biomarker potential,emt regulation,prognostic significance,therapeutic target
ENSG00000145908,ZNF300,transcriptional regulation,zinc finger protein activity,cell proliferation regulation,tumor suppressor function,apoptosis modulation,cancer prognosis marker
ENSG00000169020,ATP5ME,mitochondrial function,energy production,cellular metabolism regulation,tumorigenesis contribution,therapeutic target,genomic instability
ENSG00000125484,GTF3C4,overexpression,transcriptional regulation,rna polymerase iii activity,cell growth promotion,tumor suppressor function,loss of heterozygosity
ENSG00000128951,DUT,pyrimidine biosynthesis,constitutive overexpression,dna synthesis,tumor growth inhibition,apoptosis evasion,genetic instability
ENSG00000185532,PRKG1,cell proliferation,signaling pathway activation,cell cycle regulation disruption,oncogene expression,poor prognosis association,tumor suppressor interaction
ENSG00000141385,AFG3L2,mitochondrial function regulation,tumor progression,cell survival enhancement,protein degradation modulation,biomarker potential,therapeutic target
ENSG00000169045,HNRNPH1,gene regulation,oncogene potential,rna metabolism regulation,cell proliferation influence,tumor progression contribution,poor prognosis association
ENSG00000177600,RPLP2,ribosome biogenesis,rna binding protein,protein synthesis regulation,tumor suppressor function,cell proliferation regulation,genomic instability
ENSG00000067715,SYT1,cellular proliferation,oncogenic driver,amplification event,cell cycle regulation,apoptosis modulation,calcium-dependent exocytosis
ENSG00000273761,DDX24,rna processing,transcriptional regulation,chromatin remodeling,apoptosis regulation,cell cycle progression,dna repair interaction
ENSG00000143226,FCGR2A,adcc suppression,antibody-dependent cellular cytotoxicity,cancer immune evasion,effector cell dysfunction,immune modulation,tumor progression
ENSG00000110876,SELPLG,cell migration,integrin regulation,therapeutic target,cancer progression,adhesion molecule,tumor invasion
ENSG00000143442,POGZ,tumor progression,mutation hotspot,epigenetic regulation,chromatin modification,cell cycle regulation,biomarker potential
ENSG00000100600,LGMN,mitotic regulation,microtubule dynamics,kinetochore complex formation,cell cycle progression,cancer-associated overexpression,tumor suppressor dysfunction
ENSG00000154556,SORBS2,cell adhesion disruption,cell migration facilitation,oncogene overexpression,pi3k/akt pathway modulation,protein-protein interaction regulation,tumor progression association
ENSG00000109171,SLAIN2,aneuploidy,cell cycle regulation,dna damage response,genomic instability,mitotic spindle assembly,tumor suppressor
ENSG00000130956,HABP4,dna damage response,genomic instability,oncogenic pathway activation,tumor progression marker,cell cycle regulation,transcriptional activation
ENSG00000123700,KCNJ2,cellular excitability,regulatory protein interactions,tumor progression,potassium channel modulation,oncogenic signaling,biomarker potential
ENSG00000115268,RPS15,cell cycle regulation,tumor growth promotion,oncogene interaction,ribosome biogenesis enhancement,apoptosis evasion,therapeutic target
ENSG00000183495,EP400,chromatin remodeling,histone deacetylation,transcriptional repression,oncogenesis,cell proliferation,tumor growth
ENSG00000057608,GDI2,microtubule stabilization,tumor suppressor activity,rab gtpase regulation,apoptosis modulation,cell cycle regulation,protein-protein interactions
ENSG00000094880,CDC23,cell cycle regulation,ubiquitination,cell proliferation,tumor suppressor dysfunction,genomic instability,somatic mutations
ENSG00000073350,LLGL2,cell polarity disruption,adherens junctions disruption,tumor progression,wnt signaling dysregulation,metastatic potential increase,poor prognosis
ENSG00000096433,ITPR3,calcium signaling pathway,cell proliferation regulation,tumor progression association,gene expression alteration,metastasis promotion,prognosis impact
ENSG00000137815,RTF1,transcriptional regulation,oncogene activation,cell proliferation promotion,apoptosis evasion,dna repair pathway modulation,genomic instability enhancement
ENSG00000050130,JKAMP,dysregulated ion flux,cell adhesion molecule,altered cellular polarity,potassium channel dysfunction,tumor suppressor function,cellular proliferation
ENSG00000182952,HMGN4,chromatin modulation,oncogene expression,epithelial-to-mesenchymal transition,prognostic biomarker,tumor progression,cell cycle regulation
ENSG00000164134,NAA15,cell cycle regulation,constitutive activation,dna repair dysregulation,gene expression modulation,nucleolar function disruption,tumor progression enhancement
ENSG00000244234,GMCL2,protein-protein interaction,cell signaling regulation,tumor suppressor potential,genomic instability,cell proliferation modulation,cancer progression association
ENSG00000103569,AQP9,glycerol transport,oncogenic potential,cell proliferation,chemotherapy resistance,apoptosis regulation,autophagy modulation
ENSG00000134001,EIF2S1,cellular stress responses,protein synthesis regulation,tumor growth modulation,apoptosis resistance,therapeutic target,oncogenic processes
ENSG00000117707,PROX1,tumor suppression,epithelial-to-mesenchymal transition (emt),cell differentiation,apoptosis regulation,pi3k/akt pathway interaction,biomarker significance
ENSG00000124198,ARFGEF2,regulation of cell proliferation,constitutive activation,interaction with pi3k/akt pathway,tumor aggressiveness,biomarker potential,resistance to therapy
ENSG00000121211,MND1,chromosomal instability,genomic alterations,aneuploidy induction,cell cycle regulation,mitotic spindle assembly,tumour progression
ENSG00000123562,MORF4L2,histone modification regulation,chromatin structure maintenance,oncogenic pathway activation,cell proliferation promotion,tumor aggressiveness association,prognostic marker identification
ENSG00000108395,TRIM37,pi3k/akt pathway inhibition,tumor suppressor function,oncoprotein degradation,genomic stability maintenance,cell proliferation regulation,apoptosis induction
ENSG00000116750,UCHL5,deubiquitinating enzyme activity,oncogenic properties,protein degradation regulation,nf-κb signaling pathway activation,cell proliferation and survival enhancement,chromatin remodeling interaction
ENSG00000170144,HNRNPA3,mrna processing alteration,cell proliferation enhancement,tumor progression facilitation,oncogenic transformation promotion,poor prognosis indicator,cancer metastasis regulation
ENSG00000106305,AIMP2,oncogenesis,cell proliferation,protein synthesis regulation,metastasis promotion,cell survival enhancement,translation factor interaction
ENSG00000138398,PPIG,protein stabilization,cell cycle progression,dna repair regulation,biomarker for diagnosis,oncogenic mutations,apoptosis modulation
ENSG00000152936,LMNTD1,chromatin remodeling,genomic instability,dna repair regulation,oncogenic pathway activation,cellular proliferation promotion,aggressive tumor behavior marker
ENSG00000196408,NOXO1,nadph oxidase activation,reactive oxygen species regulation,tumor progression,cell proliferation promotion,oncogene overexpression,prognostic biomarker
ENSG00000182196,ARL6IP4,ciliogenesis pathway,cell signaling pathway,cancer progression,vesicular transport regulation,biomarker candidate,endocytosis regulation
ENSG00000153207,AHCTF1,genomic instability,tumor progression,biomarker candidate,transcriptional regulator,cellular proliferation,chromatin remodeling
ENSG00000128487,SPECC1,epithelial-to-mesenchymal transition,oncogenic activity,cell surface regulation,tumor marker,cell migration and proliferation,metastasis promotion
ENSG00000079819,EPB41L2,constitutive activation,gain of function mutations,tumor progression,cell adhesion regulation,cell motility enhancement,genomic instability
ENSG00000175634,RPS6KB2,cell growth regulation,aberrant activation,cell cycle progression,metabolic reprogramming,protein synthesis regulation,tumor progression
ENSG00000285317,DNAJC8,mitochondrial dynamics,apoptosis regulation,cell cycle progression,oncogenic signaling,therapeutic target,genomic profiling
ENSG00000172465,TCEAL1,transcriptional regulator,cell cycle progression,apoptosis inhibition,tumor suppressor function loss,proliferation enhancement,chromatin remodeling
ENSG00000105364,MRPL4,mitochondrial function regulation,oxidative stress induction,energy production impairment,therapeutic target identification,tumor progression promotion,metabolic pathway dysregulation
ENSG00000139154,AEBP2,transcriptional regulation,oncogene activation,wnt/β-catenin pathway modulation,cell proliferation enhancement,metastasis promotion,tumor suppressor suppression
ENSG00000196547,MAN2A2,tumor progression,cell surface glycoproteins,oncogenesis,promotes cell survival,protein glycosylation,interacts with pi3k/akt pathway
ENSG00000148925,BTBD10,pi3k/akt signaling activation,ubiquitin ligase activity,tumor progression association,poor prognosis biomarker,cancer cell proliferation,cell cycle modulation
ENSG00000114416,FXR1,g-quadruplex rna binding,oncogenic processes,cellular proliferation,autophagy regulation,genomic instability,mrna stability
ENSG00000112232,KHDRBS2,rna binding,cell proliferation,apoptosis regulation,mutation hotspot,alternative splicing,tumor suppressor suppression
ENSG00000158615,PPP1R15B,cellular stress response,regulation of protein phosphatase 1 activity,tumor suppressor function,oncogenic pathway modulation,apoptosis inhibition,cell proliferation enhancement
ENSG00000143819,EPHX1,oncogenic pathway regulation,tumor growth promotion,metabolic rewiring,cell proliferation enhancement,inflammation regulation,oxidative stress response modification
ENSG00000126522,ASL,amino acid metabolism alteration,cellular redox balance modulation,genetic alterations,metabolic regulation,oncogenic processes,tumor progression
ENSG00000197958,RPL12,ribosomal protein function,cell proliferation,protein synthesis enhancement,oncogenic process promotion,tumor growth support,cancer association
ENSG00000142676,RPL11,ribosome biogenesis,60s pre-rrna processing complex,cell cycle progression,p53 regulation,oncogenic potential,genomic instability
ENSG00000135604,STX11,cellular trafficking disruption,tumor progression,metastasis regulator,apoptosis modulation,cancer-related pathway interaction,oncogenic signaling modulation
ENSG00000112079,STK38,cell cycle regulation,oncogene activity,pi3k/akt pathway modulation,apoptosis inhibition,genomic stability regulation,centrosomal localization
ENSG00000144597,EAF1,genome instability,tumor suppression,dna repair regulation,transcriptional elongation regulation,cancer driver gene,genomic maintenance
ENSG00000168939,SPRY3,tumor suppression,downregulation mutations,rtk signaling inhibition,cell cycle regulation,apoptosis modulation,signaling pathway modulation
ENSG00000138594,TMOD3,microtubule regulation,microtubule dynamics,cell division,cell migration,oncogenic process,tumor progression
ENSG00000063245,EPN1,wnt signaling pathway,tumor suppressor function,downregulation/loss,cell-cell adhesion regulation,epithelial polarity maintenance,epithelial-to-mesenchymal transition suppression
ENSG00000182247,UBE2E2,altered expression,biomarker potential,dna repair regulation,oncogenic pathway modulation,protein degradation regulation,therapeutic target
ENSG00000161542,PRPSAP1,prpp synthesis regulation,oncogene potential,purine biosynthesis enhancement,nucleotide metabolism dysregulation,cell proliferation promotion,tumor progression facilitation
ENSG00000249709,ZNF564,epigenetic regulation,chromatin remodeling,transcriptional activation,tumor progression,apoptosis inhibition,cell cycle dysregulation
ENSG00000187766,KRTAP10-8,keratin filament regulation,cell proliferation enhancement,tumor progression marker,epithelial integrity disruption,keratin-associated protein family member,cancer biomarker
ENSG00000111249,CUX2,cell cycle regulation,dna repair,transcriptional regulation,oncogenesis,apoptosis evasion,tumor progression
ENSG00000198945,L3MBTL3,chromatin regulation,epigenetic silencing,genomic stability,tumor suppression,cell cycle modulation,ubiquitination regulation
ENSG00000165731,RET,ret signaling pathway,constitutive activation,cell proliferation,tumor progression,oncogenic mutations,genomic alteration
ENSG00000124191,TOX2,cell cycle regulation,gene expression modulation,transcriptional regulation,chromatin remodeling,aggressive tumor behavior,growth factor-independent proliferation
ENSG00000143569,UBAP2L,endosomal sorting,ubiquitin-associated domain,protein degradation pathway,tumor suppressor role,genetic mutations,therapeutic target
ENSG00000101811,CSTF2,aberrant mrna splicing,altered gene expression,cancer progression,gene regulatory mechanism,mutation/alteration in cancer,pre-mrna processing
ENSG00000126016,AMOT,hippo signaling pathway,cell migration inhibition,tumor suppressor function,yap/taz regulation,cancer progression suppression,cell polarity regulation
ENSG00000148843,PDCD11,tumor suppressor activity,apoptosis regulation,cell proliferation control,dna damage response,autophagy modulation,prognostic marker
ENSG00000100842,EFS,transcriptional regulation,cell proliferation,translation initiation,apoptosis suppression,tumor progression,prognostic biomarker
ENSG00000170819,BFSP2,cellular differentiation,oncogenic mutations,cell proliferation inhibition,therapeutic target,cellular stress response,cytostructural integrity
ENSG00000111077,TNS2,apoptosis regulation,cell death modulation,immune response regulation,inflammation regulation,oncogenic potential,tumour progression
ENSG00000168301,KCTD6,constitutive activation,nf-kappab signaling,epithelial-to-mesenchymal transition,cell proliferation,tumor progression,therapeutic target
ENSG00000145919,BOD1,bet family interaction,dysregulated gene expression,epithelial-to-mesenchymal transition (emt),chromatin remodeling,transcriptional regulation,gene amplification
ENSG00000163159,VPS72,autophagy regulation,genomic instability,escrt-iii complex member,cellular membrane dynamics,protein degradation regulation,tumor progression association
ENSG00000143153,ATP1B1,cellular transport regulation,ion channel modulation,tumor progression,cell proliferation enhancement,survival pathway activation,genomic instability
ENSG00000101343,CRNKL1,wnt/β-catenin pathway,overexpression,oncogene,cell proliferation,tumor progression,kinase activity
ENSG00000163823,CCR1,chemokine signaling pathway,overexpression,cellular migration regulation,tumor progression facilitation,immune system evasion mechanism,inflammation modulation
ENSG00000102007,PLP2,cell surface modulation,metastasis promoter,tumor progression,apoptosis regulation,cell cycle regulation,protein-protein interaction
ENSG00000166848,TERF2IP,genomic instability,telomere maintenance,oncogenic potential,chromosomal alterations,dna repair mechanisms,cell cycle regulation
ENSG00000185619,PCGF3,epigenetic silencing,ubiquitination regulation,chromatin remodeling,oncogenic driver,tumor progression marker,prognostic significance
ENSG00000140416,TPM1,cytoskeletal organization,microfilament dynamics,cell migration,tumor invasion,pi3k/akt pathway interaction,adhesion regulation
ENSG00000157110,RBPMS,apoptosis regulation,cell proliferation,tumor progression,transcriptional regulation,rna binding,epithelial cell expression
ENSG00000148303,RPL7A,**

cellular growth,translation regulation,cancer progression,metabolic reprogramming,oncogene interaction,protein synthesis
ENSG00000129354,AP1M2,cell surface receptor regulation,mitotic checkpoint evasion,endosomal sorting dysfunction,protein trafficking deregulation,oncogenic protein expression,epigenetic modification
ENSG00000124422,USP22,deubiquitination,oncogenic functions,chromatin remodeling,cell cycle regulation,transcriptional regulation,tumor aggressiveness
ENSG00000123415,SMUG1,dna repair mechanism,genomic instability,oncogene maintenance,apoptosis evasion,cell survival pathway,tumor progression marker
ENSG00000018510,AGPS,metabolic reprogramming,oncogenic potential,signaling pathway dysregulation,tumor progression marker,cell proliferation enhancement,glycosphingolipid biosynthesis dysfunction
ENSG00000135413,LACRT,genomic instability,chromosomal maintenance,cell cycle regulation,tumor progression,prognostic marker,oncogenic mutation
ENSG00000182255,KCNA4,tumor growth,cellular excitability regulation,proliferation modulation,dysregulation,ion channel interaction,cell cycle progression
ENSG00000099381,SETD1A,**

setd1a,chromatin modification,histone methylation,transcriptional regulation,cell proliferation,tumor progression 
**
ENSG00000197879,MYO1C,cell migration,constitutive activation,genomic amplification,oncogenic function,tumor progression,aberrant cytoskeleton reorganization
ENSG00000161634,DCD,dynein motor activity,autophagy regulation,cytokinesis dysregulation,mitotic spindle formation,microtubule stability,cell migration enhancement
ENSG00000070081,NUCB2,tumor progression,immune suppression,cell proliferation,signaling pathway activation,oncogenic function,growth factor regulation
ENSG00000211455,STK38L,genomic instability,akt/mtor signaling,cell proliferation,oncogene overexpression,serine/threonine kinase activation,epigenetic regulation
ENSG00000149599,DUSP15,mapk pathway regulation,loss of function mutations,tumor suppression,cellular response modulation,protein phosphatase activity,signaling pathway dysregulation
ENSG00000262814,MRPL12,mitochondrial ribosome complex,regulation of mitochondrial function,cellular metabolism regulation,apoptosis inhibition,tumor progression driver,therapeutic target for treatment
ENSG00000155508,CNOT8,mrna degradation,oncogenic mrna stabilization,gene expression regulation,ccr4-not complex interaction,tumor progression,poly(a) tail length control
ENSG00000239886,KRTAP9-2,keratin filament regulation,epithelial cell integrity,cytoskeletal disruption,cell morphogenesis,tumorigenesis association,protein-protein interactions
ENSG00000107175,CREB3,endoplasmic reticulum stress response,lipid metabolism regulation,oncogenic signaling,transcriptional regulation,cell growth promotion,anti-apoptotic pathway
ENSG00000103264,FBXO31,cell cycle regulation,apoptosis induction,ubiquitination and degradation,tumor suppressor function,dna repair regulation,p53 regulation
ENSG00000277936,MRPL45,ribosomal function,cell growth promotion,protein synthesis enhancement,cancer cell proliferation,genomic instability,tumor suppressor dysfunction
ENSG00000240682,ISY1,cellular proliferation,oncogenic signaling,tumor aggressiveness,poor prognosis,cell migration,invasion mechanisms
ENSG00000086065,CHMP5,escrt-iii complex regulation,chromatin remodeling,genomic stability maintenance,tumor suppressor function,dna repair regulation,pro-tumorigenic signaling
ENSG00000116752,BCAS2,cell cycle regulation,genomic instability,hormone receptor interaction,oncogenesis,poor prognosis,transcriptional co-activation
ENSG00000130159,ECSIT,nf-κb pathway regulation,protein degradation regulation,apoptosis inhibition,cell proliferation enhancement,tumor suppressor regulation disruption,oncogene activity
ENSG00000182872,RBM10,tumor suppressor function,transcriptional regulation,epigenetic regulation,chromatin structure modulation,rna processing and stability regulation,prognostic marker candidate
ENSG00000137077,CCL21,angiogenesis promotion,immune evasion,metastasis facilitation,prognostic marker,tumor progression,immune cell recruitment
ENSG00000143337,TOR1AIP1,cellular proliferation,oncogenic pathway activation,mtor signaling regulation,protein-protein interaction,tumorigenesis promotion,gene expression modulation
ENSG00000198873,GRK5,oncogenic driver,regulatory kinase function,cellular signaling modulation,tumor progression facilitation,therapeutic target potential,protein phosphorylation regulation
ENSG00000006638,TBXA2R,cell proliferation,protein-protein interaction,g-protein coupled receptor activation,pi3k/akt pathway modulation,tumor progression,upregulated expression
,H1F0,epigenetic regulation,chromatin structure,histone modification,gene expression regulation,dna compaction,genomic instability
,SEPT5,cancer progression,therapeutic target,cell cycle regulation,ciliogenesis dysfunction,oncogene activation,genomic instability
ENSG00000182899,RPL35A,cellular metabolism regulation,chemo-resistance activation,oncogene overexpression,protein synthesis enhancement,ribosomal subunit component,tumor progression promotion
ENSG00000085872,CHERP,tumor suppressor function,cell proliferation regulation,homologous recombination,dna repair mechanism,pi3k/akt pathway modulation,mapk/erk pathway regulation
ENSG00000069011,PITX1,cell cycle regulation,transcriptional regulation,apoptosis evasion,tumor progression,emt regulation,metastasis promotion
ENSG00000187164,SHTN1,receptor signaling modulation,cell adhesion regulation,protein-protein interactions,tumor progression facilitation,genomic instability contribution,metabolic reprogramming
ENSG00000090432,MUL1,mitochondrial function maintenance,cellular homeostasis regulation,protein degradation,apoptosis resistance induction,tumor progression association,oncogene activation promotion
ENSG00000155256,ZFYVE27,lysosomal degradation,endocytic pathway regulation,protein trafficking modulation,tumor progression,oncogenic driver,cancer therapy target
ENSG00000136167,LCP1,cell cycle regulation,oncogene activity,apoptosis dysregulation,genomic integrity maintenance,tumor suppressor function,protein-protein interaction modulation
ENSG00000176619,LMNB2,genomic instability,nuclear architecture disruption,dna repair regulation,chromatin organization modulation,transcriptional regulation alteration,cellular growth promotion
ENSG00000072121,ZFYVE26,rho gtpase regulation,oncogene activity,tumor progression,cell migration promotion,cell invasion facilitation,phosphatidylinositol 3-kinase interaction
ENSG00000197757,HOXC6,epithelial-to-mesenchymal transition,transcription factor activity,cell migration regulation,oncogenic processes,tumor progression,growth factor signaling
ENSG00000103202,NME4,**

1. **dna repair mechanism**,2. **p53 regulation**,3. **pi3k/akt pathway interaction**,4. **cell proliferation enhancement**,5. **ndk4 enzymatic activity**,6. **tumor suppressor function disruption**
ENSG00000117601,SERPINC1,loss of function,pro-coagulant state,angiogenesis promotion,cell migration enhancement,tumor progression association,biomarker potential
ENSG00000138796,HADH,metabolic reprogramming,energy metabolism alteration,cellular redox imbalance regulation,tumor cell behavior modulation,fatty acid oxidation enzyme function,mitochondrial matrix localization
ENSG00000182117,NOP10,ribosome biogenesis disruption,tumorigenesis promotion,cellular homeostasis disruption,oncogenic process enhancement,proliferation and survival increase,genomic instability contribution
ENSG00000142949,PTPRF,phosphatase activity,loss-of-function mutations,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor suppressor function,tissue integrity maintenance
ENSG00000095794,CREM,cellular regulation,dna binding,transcriptional modulation,apoptosis regulation,gene expression regulation,proliferation promotion
ENSG00000055950,MRPL43,mtor signaling pathway,overexpression,cell proliferation,proliferation regulation,translation process,protein-protein interaction
ENSG00000004864,SLC25A13,metabolic reprogramming,mitochondrial carrier function,citrate transport,energy metabolism regulation,cell proliferation enhancement,tumor growth promotion
ENSG00000281244,ADAMTS13,altered expression,angiogenesis modulation,platelet aggregation regulation,thrombosis promotion,vwf cleavage,cancer progression
ENSG00000102921,N4BP1,cell cycle regulation,apoptosis inhibition,e3 ubiquitin ligase modulation,protein stability regulation,oncoprotein accumulation,tumor promotion
ENSG00000112530,PACRG,**

proteasome assembly,ubiquitin-proteasome pathway,cell cycle regulation,tumor growth promotion,genetic instability,potential therapeutic target 
**
ENSG00000109534,GAR1,glycolysis enhancement,fatty acid synthesis promotion,oncogenic driver,warburg-like metabolism,cell growth promoter,energy metabolism regulation
ENSG00000145920,CPLX2,enhanced clathrin-mediated endocytosis,internalization and recycling of receptors,tumor growth and metastasis,cell proliferation and survival,constitutive activation of signaling pathways,growth factor receptor regulation
ENSG00000115241,PPM1G,loss of tumor suppressor function,g1/s transition phase regulation,p53 activation,cell cycle regulation,dephosphorylation activity,tumor progression
ENSG00000104381,GDAP1,microtubule dynamics,cell survival,apoptosis resistance,tumor aggressiveness,pi3k/akt pathway interaction,genomic instability
,HIST1H1E,chromatin remodeling,transcription regulation,epigenetic regulation,histone modifications,cell proliferation,genomic instability
ENSG00000112096,SOD2,oxidative stress response,redox balance regulation,gene expression dysregulation,tumor progression,apoptosis resistance,cancer cell survival
ENSG00000229524,BAG6,autophagy regulation,protein quality control,chaperone activity,tumor suppression,genomic stability maintenance,mitochondrial function
,TARS,increased protein synthesis,potential oncogene,cell proliferation,translation apparatus dysregulation,tumor growth,genomic instability
ENSG00000112305,SMAP1,protein degradation regulation,tumor suppressor function,cellular stress response,ubiquitination pathway disruption,oncogene upregulation,cancer progression
ENSG00000148908,RGS10,gpcr regulation,g-protein signaling pathway,cellular proliferation,tumor aggressiveness,regulatory mechanism alteration,oncogenic transformation
ENSG00000142875,PRKACB,pka signaling pathway,tumor suppressor loss,cell proliferation regulation,apoptosis inhibition,signaling modulation,genomic instability
ENSG00000165512,ZNF22,tumor progression,epigenetic regulation,histone modification,dna methylation,tumor suppressor gene suppression,oncogene function
ENSG00000065183,WDR3,chromatin remodeling,genomic instability,cell proliferation,oncogenic properties,tumor progression,metastasis
ENSG00000119314,PTBP3,tumor progression,alternative splicing regulation,epithelial-to-mesenchymal transition,protein-rna interaction,nuclear rna-binding protein,poor prognosis marker
ENSG00000152217,SETBP1,histone modification,transcriptional regulation,oncogenic transformation,cell growth promotion,signaling pathway activation,genomic instability
ENSG00000131652,THOC6,mrna export regulation,cell cycle control,tumor progression,oncogene activation,protein interaction,genomic instability
ENSG00000129159,KCNC1,cell proliferation,apoptosis regulation,signaling pathway modulation,tumor progression,electrical property alteration,genomic alterations
ENSG00000166407,LMO1,transcriptional co-regulator,overexpression,oncogenic processes,cell proliferation,epithelial-to-mesenchymal transition,immune modulation
ENSG00000106080,FKBP14,cell cycle regulation,apoptosis inhibition,genomic instability,protein-protein interaction,tumor suppressor repression,oncogenic pathway modulation
ENSG00000145491,ROPN1L,overexpression,oncogene potential,cell proliferation,pi3k/akt pathway activation,emt regulation,poor prognosis
ENSG00000180353,HCLS1,cell migration,tumor progression,oncogenic properties,apoptosis regulation,cell cycle modulation,actin cytoskeleton regulation
ENSG00000048462,TNFRSF17,tumor progression,promoter cell proliferation,overexpression,signaling pathway activation,immune response modulation,nf-κb pathway activation
ENSG00000110713,NUP98,nuclear transport,chromatin regulation,genomic instability,tumor progression,oncogene overexpression,transcription factor modification
ENSG00000168062,BATF2,nf-κb pathway activation,transcription factor activity,cell proliferation,epithelial-to-mesenchymal transition (emt),immune response regulation,apoptosis suppression
ENSG00000171863,RPS7,ribosomal biogenesis,cell proliferation,oncogenic transformation,excessive protein synthesis,tumorigenesis,transcriptional regulation
ENSG00000136155,SCEL,cell-cell adhesion disruption,epithelial cell maintenance,tissue structure modulation,oncogenesis promotion,cell invasion facilitation,transcription regulation interaction
ENSG00000159166,LAD1,lysosomal acid lipase activity,lipid metabolic regulation,sphingolipid accumulation,proliferation promotion,migration facilitation,survival enhancement
ENSG00000004139,SARM1,nad+-dependent parp1-p53 pathway,dna damage response,apoptosis and necroptosis regulation,cell death modulation,therapeutic target,metabolic regulation
ENSG00000138081,FBXO11,tumor suppressor,cell cycle regulation,dna repair process,transcriptional control,genome stability maintenance,e2f1 regulation
ENSG00000112983,BRD8,**

overexpression,chromatin remodeling,oncogenic function,apoptosis inhibition,cell cycle regulation,transcriptional activation
ENSG00000143013,LMO4,**

* oncogenic signaling,* transcriptional regulation,* protein-protein interactions,* cell survival and proliferation,* pi3k/akt pathway activation,* chromatin remodeling

**
ENSG00000104177,MYEF2,oncogenic regulation,cytoskeleton regulation,cell proliferation,apoptosis regulation,protein-protein interactions,transcriptional regulation
ENSG00000089157,RPLP0,cell growth regulation,ribosomal component,protein synthesis facilitation,mutations associated with oncogenesis,increased cell proliferation,tumor progression facilitation
ENSG00000175866,BAIAP2,cell adhesion disruption,oncogenic signaling pathway,rhoa/cdc42 interaction,epithelial-to-mesenchymal transition (emt),prognostic marker,tumor progression
ENSG00000161405,IKZF3,chromatin modification,tumor suppressor function,transcriptional regulation,dysregulated gene expression,apoptosis regulation,genomic instability
ENSG00000137831,UACA,tumor progression,cellular contraction,enhanced motility,protein-protein interaction,cytoplasmic localization,cancer metastasis
ENSG00000137133,HINT2,chromatin remodeling,tumor progression,dna damage response,cell cycle regulation,gene expression modulation,genomic instability
ENSG00000161955,TNFSF13,tnf superfamily,cell survival,immune modulation,inflammation regulation,nf-κb activation,ectopic expression
ENSG00000065989,PDE4A,camp regulation,cell proliferation,oncogenic processes,tumorigenesis,therapeutic target,signaling pathway
ENSG00000155438,NIFK,tumor growth,cell cycle progression,apoptosis inhibition,transcriptional regulation,protein-protein interactions,oncogene activity
ENSG00000144283,PKP4,cell-cell adhesion disruption,e-cadherin interaction,epithelial integrity loss,metastatic progression,oncogenic signaling pathway regulation,wnt/β-catenin pathway activation
ENSG00000071282,LMCD1,genomic instability,cell proliferation,dna damage response,therapeutic target,cell cycle regulation,tumorigenesis
ENSG00000197728,RPS26,**
translation initiation complex,ribosomal subunit mutation,tumor cell proliferation,constitutive activation,aberrant translation,cellular stress response disruption 
**
ENSG00000169129,AFAP1L2,cellular migration,cell adhesion,tumor invasion,apoptosis regulation,actin filament interaction,oncogenic potential
ENSG00000128283,CDC42EP1,cdc42 regulation,gap function loss,proliferation enhancement,metastasis promotion,cell migration regulation,tumor progression facilitation
ENSG00000132002,DNAJB1,cell cycle regulation,co-chaperone activity,dna damage response,tumor suppressor potential,protein folding regulation,checkpoint activation
ENSG00000120742,SERP1,cellular survival pathway disruption,oncogenic protein-protein interactions,apoptosis inhibition,tumor microenvironment modulation,gene expression regulation,therapeutic target identification
ENSG00000221983,UBA52,post-translational modification,ubiquitin-dependent degradation,protein stability regulation,cellular stress response,oncoprotein stabilization,ubiquitin-conjugating enzyme complex activation
ENSG00000166226,CCT2,protein folding regulation,cellular stress response modulation,signaling pathway facilitation,tumor growth promotion,protein synthesis enhancement,therapeutic target identification
ENSG00000278644,PCGF2,**

transcriptional regulation,chromatin remodeling,oncogenic function,histone modification,polycomb complex member,tumor suppressor gene inhibition
**
ENSG00000100347,SAMM50,mitochondrial function,cellular stress response,apoptosis regulation,tumor progression,protein-protein interaction,autophagy pathway
ENSG00000167515,TRAPPC2L,pi3k/akt pathway modulation,cell proliferation regulation,apoptosis inhibition,membrane trafficking regulation,genomic instability contribution,protein-protein interaction
ENSG00000170145,SIK2,cellular proliferation,mtor pathway activation,gain-of-function mutations,constitutive activation,therapeutic target,cell cycle regulation
ENSG00000205403,CFI,regulation of complement system,complement cascade degradation,tumor cell growth regulation,immune evasion mechanism,antitumor immune response modulation,cancer immunotherapy target
ENSG00000112877,CEP72,genomic instability,centrosome regulation,mitotic spindle formation,aneuploidy development,microtubule dynamics modulation,cell cycle checkpoint disruption
ENSG00000141101,NOB1,enhanced enzymatic activity,genomic instability,increased cell proliferation,oncogenic processes,pi3k/akt pathway interaction,rna processing regulation
ENSG00000113761,ZNF346,epigenetic regulation,transcriptional modulation,cell proliferation,apoptosis resistance,prognostic marker,genomic amplification
ENSG00000105053,VRK3,tumor progression,cell cycle regulation,apoptosis inhibition,dna repair modulation,therapeutic target,genomic instability
,WARS,mitochondrial function,metabolic reprogramming,energy metabolism,translation regulation,cancer driver gene,oncogenic potential
ENSG00000187601,MAGEH1,cell growth promotion,oncogene function,cell cycle regulation,centrosome duplication,spindle formation regulation,high expression levels
ENSG00000111361,EIF2B1,cellular adaptation,protein synthesis regulation,tumor progression,stress response pathways,oncogenic potential,metabolic reprogramming
ENSG00000109381,ELF2,cellular proliferation,translation regulation,oncogenic activation,protein synthesis enhancement,kinase activation,signaling pathway interaction
ENSG00000064726,BTBD1,genomic stability maintenance,tumor suppressor function,apoptosis induction,cell cycle regulation,dna repair promotion,protein-protein interaction
ENSG00000146731,CCT6A,chaperone activity,cell proliferation,chromosomal instability,protein folding,dna replication,prognostic marker
ENSG00000112782,CLIC5,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),biomarker potential,protein interaction,metastasis promotion
ENSG00000105705,SUGP1,cell adhesion,epithelial-to-mesenchymal transition,metastasis promotion,scaffolding protein function,tumor progression,cell migration regulation
ENSG00000075945,KIFAP3,mitotic spindle formation,cell proliferation,chromosomal instability,oncogenic potential,microtubule-based transport,kinase activity
ENSG00000090520,DNAJB11,dna repair,cell cycle regulation,tumor suppressor protein interaction,oncogenic mutations,antibody-mediated degradation,proliferation inhibition
ENSG00000136146,MED4,cellular regulation,co-activator function,oncogenic potential,transcriptional regulation,rna processing,dna damage response
ENSG00000117906,RCN2,chromatin remodeling,transcriptional activation,cell proliferation enhancement,oncogenic role,gene amplification,metastasis promotion
ENSG00000071127,WDR1,apoptosis regulation,cell cycle regulation,dna repair function,mapk/erk signaling pathway,protein degradation,tumor suppression dysfunction
ENSG00000179776,CDH5,ve-cadherin function,cell-cell adhesion disruption,tumor progression,metastasis facilitation,angiogenesis regulation,poor prognosis association
ENSG00000011243,AKAP8L,centrosome localization,cell cycle regulation,mitotic spindle formation,apoptosis resistance,oncogenic signaling,tumor progression driver
ENSG00000116544,DLGAP3,epigenetic regulation,cell adhesion modulation,signaling pathway interaction,oncogenic potential,tumor progression promotion,protein-protein interaction
ENSG00000107854,TNKS2,overexpression,telomere length regulation,cell survival promotion,oncogene,pi3k/akt pathway interaction,apoptosis inhibition
ENSG00000086827,ZW10,kinase regulation,mitotic progression,genomic instability,chromosomal segregation,kinetochore-microtubule attachment,tumor suppressor function
ENSG00000156304,SCAF4,hippo pathway activation,oncogenic transformation,cell proliferation regulation,yap/taz transcription factor activation,scaffolding protein function,genomic amplification/mutation
ENSG00000137168,PPIL1,protein misfolding,cell cycle regulation,oncogenesis,therapeutic resistance,tumorigenesis,protein quality control
ENSG00000136935,GOLGA1,golgi apparatus regulation,overexpression,tumor progression,cellular stress responses,protein interaction,oncogenic effects
ENSG00000049245,VAMP3,vesicle fusion,exocytosis promotion,oncogenic signaling regulation,pi3k/akt pathway activation,tumor progression facilitation,cancer cell proliferation enhancement
ENSG00000128596,CCDC136,microtubule stability,chromosomal instability,cilia formation,oncogene activation,cell proliferation,pi3k/akt pathway interaction
ENSG00000006837,CDKL3,genomic instability,cell cycle regulation,dna repair,transcriptional regulation,cell proliferation,protein-protein interactions
ENSG00000196793,ZNF239,tumor suppressor function,loss of expression,disrupted gene regulation,aggressive disease progression,biomarker potential,chromatin modification
ENSG00000182923,CEP63,aberrant localization,centrosome regulation,cell cycle progression,ciliogenesis disruption,genomic instability,mitotic spindle formation
ENSG00000162408,NOL9,protein degradation pathway,deregulation in cancer,oncogene,cell cycle regulation,ubiquitination,26s proteasome complex
ENSG00000088930,XRN2,mrna degradation,tumor suppressor downregulation,cell proliferation regulation,genomic stability maintenance,oncogenic mrna accumulation,xrn2-rbp interaction
ENSG00000159461,AMFR,cell migration,invasion promotion,poor prognosis indicator,therapeutic target,apoptosis suppression,tumor progression driver
ENSG00000099246,RAB18,rab gtpase activity,membrane trafficking regulation,cell migration promotion,endocytic pathway modulation,cargo transport facilitation,cancer progression support
ENSG00000113569,NUP155,nuclear transport regulation,oncoprotein accumulation,cell proliferation promotion,tumor progression facilitation,genetic instability association,chromatin remodeling interaction
ENSG00000072364,AFF4,transcriptional regulation,chromatin remodeling,cohesin complex interaction,tumor aggressiveness,therapeutic target,genomic instability
ENSG00000198265,HELZ,chromatin remodeling,transcriptional regulation,tumor progression,cell proliferation,signaling pathway modulation,genetic mutations
ENSG00000004478,FKBP4,regulation of cell growth,oncogene/tumor suppressor function,enhanced cell proliferation,interaction with signaling molecules,p53 pathway regulation,prognostic marker
ENSG00000151239,TWF1,chromosomal instability,dna damage response,genomic maintenance,homologous recombination,meiotic checkpoint,mitotic surveillance
ENSG00000124659,TBCC,emt regulation,rab gtpase regulation,cell proliferation enhancement,prognostic marker,tumor progression correlation,cancer cell migration facilitation
ENSG00000079337,RAPGEF3,rap1 activation,cell adhesion regulation,hippo signaling pathway,guanine nucleotide exchange factor,oncogenic driver,tumor progression facilitation
ENSG00000172315,TP53RK,tumor suppressor function,p53 pathway regulation,genomic stability maintenance,cell cycle regulation disruption,apoptosis dysregulation,dna damage response impairment
ENSG00000101361,NOP56,ribosome biogenesis,oncogenic activation,cell proliferation,protein synthesis regulation,genomic instability,therapeutic target
ENSG00000155008,APOOL,pi3k/akt pathway interaction,cell proliferation regulation,tumor progression,apoptosis modulation,metastasis facilitation,therapeutic target
ENSG00000157106,SMG1,nonsense-mediated mrna decay,translation initiation,cell proliferation,genomic stability,oncogenic mrnas,therapeutic target
ENSG00000143811,PYCR2,pyruvate carboxylation,glutamine metabolism,cell proliferation,metabolic reprogramming,oncogenic potential,therapeutic target
ENSG00000136448,NMT1,cellular regulation,methyl group transfer,protein post-translational modification,cell signaling pathway interaction,oncogenic potential,protein function regulation
ENSG00000067829,IDH3G,cellular metabolism,loss-of-function mutations,epigenetic alterations,metabolic reprogramming,tumor aggressiveness,mitochondrial dysfunction
ENSG00000125249,RAP2A,cell proliferation,mapk/erk signaling,protein-protein interaction,gtp-binding activity,tumor progression,cell survival
ENSG00000113758,DBN1,microtubule dynamics,chromosomal instability,mitotic checkpoint disruption,dynactin complex component,cellular transport regulation,protein-protein interactions
ENSG00000105398,SULT2A1,wnt/β-catenin pathway,steroid sulfatase activity,cellular proliferation,estrogen regulation,testosterone metabolism,oncogenic potential
ENSG00000126856,PRDM7,epigenetic regulation,tumor progression,immune evasion,chromatin remodeling,cell cycle regulation,antitumor immunity
ENSG00000152465,NMT2,nicotinamide oxidation,metabolic reprogramming,dna repair regulation,epigenetic modulation,tumor growth promotion,therapeutic target
ENSG00000153814,JAZF1,tumor suppressor,chromatin remodeling,pi3k/akt pathway activation,cell proliferation regulation,epigenetic regulation,genomic instability
ENSG00000213463,SYNJ2BP,meiotic recombination,chromosome pairing,tumor suppressor function,genomic instability,chromatin remodeling,cell cycle regulation
ENSG00000113356,POLR3G,pol ii transcriptional regulation,dna damage response,cell proliferation enhancement,metastasis promotion,apoptosis inhibition,oncogene overexpression
ENSG00000132664,POLR3F,transcriptional regulation,oncogenic overexpression,cell proliferation,tumor progression,genetic amplification,therapeutic target
ENSG00000136271,DDX56,ribosome biogenesis,pre-mrna splicing,aberrant expression,enhanced protein synthesis,tumor suppressor regulation,dysregulation
ENSG00000145824,CXCL14,epithelial-to-mesenchymal transition,immune suppressive microenvironment,chemokine-mediated recruitment,tumor progression,metastasis,oncogene
ENSG00000172893,DHCR7,loss of function mutations,downregulation,cell proliferation,autophagy regulation,oncogenic processes,tumor aggressiveness
ENSG00000149485,FADS1,lipid metabolism regulation,cell proliferation enhancement,metabolic reprogramming,oncogenesis promotion,tumor progression enhancement,dysregulation in cancer
ENSG00000171109,MFN1,mitochondrial dynamics,cellular metabolism alteration,oncogenic potential,enhanced atp production,reactive oxygen species (ros) generation,apoptosis evasion
ENSG00000163110,PDLIM5,tumor progression,cytoskeleton regulation,cell migration,oncogene function,biomarker potential,protein-protein interaction
ENSG00000282972,GNG4,gpcr signaling pathway dysregulation,g-protein complex regulator,heterotrimeric g-protein interaction,tumor progression driver,cellular proliferation regulation,molecular interaction network alteration
ENSG00000153922,CHD1,dna repair,epigenetic regulation,cell proliferation,genomic instability,chromatin remodeling,tumor progression
ENSG00000136045,PWP1,genomic instability,dna repair,cell cycle regulation,oncogenic potential,tumor growth promotion,cancer-related overexpression
ENSG00000197043,ANXA6,oncogene activation,apoptosis regulation,cell proliferation enhancement,tumor progression promotion,poor prognosis marker,therapeutic target
ENSG00000126107,HECTD3,ubiquitin ligase function,tumor suppressor role,substrate recognition mechanism,cell cycle regulation,apoptosis modulation,protein stability regulation
ENSG00000108468,CBX1,epigenetic regulator,tumor suppressor dysfunction,transcriptional repression,cell cycle progression,apoptosis evasion,histone modification patterns
ENSG00000141380,SS18,smarcb1/baf complex disruption,oncogenic fusion protein,chromatin remodeling dysfunction,transcriptional regulation aberration,cell cycle progression,tumor aggressiveness
ENSG00000196072,BLOC1S2,cellular proliferation,tumor progression,dna repair regulation,chromatin modulation,cell cycle regulation,none
ENSG00000162244,RPL29,ribosome biogenesis,elevated expression levels,protein synthesis upregulation,cell growth and proliferation,tumorigenesis involvement,oncogenic potential
ENSG00000162521,RBBP4,chromatin remodeling,transcriptional regulation,cell cycle control,apoptosis evasion,genomic instability,oncogenic behavior
ENSG00000169035,KLK7,oncogenic protein activation,tumor progression,proteolytic function regulation,cell proliferation enhancement,metastasis facilitation,transcriptional regulation modulation
ENSG00000165912,PACSIN3,endocytic pathway regulation,oncogene activation,epithelial-to-mesenchymal transition (emt),chemotherapy resistance,cell proliferation promotion,tumor progression facilitation
ENSG00000064218,DMRT3,oncogenic overexpression,wnt/β-catenin pathway activation,cell growth regulation,transcriptional regulator function,dna repair interaction,aggressive tumor behavior
ENSG00000106605,BLVRA,mirna regulation,genomic instability,dna repair mechanisms,cell growth modulation,protein-protein interactions,tumor progression
ENSG00000181852,RNF41,ubiquitination regulation,tumor suppression,cell cycle progression,apoptosis regulation,oncogenic transformation,prognostic biomarker
ENSG00000087245,MMP2,tumor invasion,angiogenesis,tissue degradation,extracellular matrix remodeling,proteolytic activity,metastasis promotion
ENSG00000099910,KLHL22,cell cycle regulation,protein degradation pathway,tumor progression,oncoprotein interaction,substrate receptor function,ubiquitin ligase complex
ENSG00000172482,AGXT,redox regulation,genome stability maintenance,oxidative stress modulation,cellular metabolism regulation,tumorigenesis promotion,dna damage response
ENSG00000107581,EIF3A,mrna translation regulation,oncogene overexpression,cell proliferation,apoptosis evasion,ribosome recruitment,tumor progression
ENSG00000122406,RPL5,ribosome assembly,genomic instability,upregulated expression,aberrant mrna accumulation,oncogenic signaling,cell proliferation
ENSG00000196616,ADH1B,regulation of cell growth,metabolic regulation,alcohol detoxification,cell survival regulation,insulin signaling pathway modulation,cancer development link
ENSG00000188428,BLOC1S5,lysosomal trafficking regulation,autophagy regulation,tumor progression promotion,poor prognosis marker,cellular response modulation,chemoresistance contribution
ENSG00000118113,MMP8,tumor progression,basement membrane degradation,cell migration,protease activation,metastasis promotion,tissue invasion
ENSG00000173821,RNF213,genomic instability,cell proliferation,dna replication,apoptosis inhibition,chromosomal abnormalities,tumor aggressiveness
ENSG00000158864,NDUFS2,**
mitochondrial function,electron transport chain disruption,reactive oxygen species production,oncogenic metabolic shift,cellular proliferation enhancement,glycolytic enzyme upregulation 
**
ENSG00000166090,IL25,tumor progression,immune modulation,chronic inflammation,cytokine signaling,apoptosis regulation,proliferation enhancement
ENSG00000136931,NR5A1,steroidogenesis regulation,tumor growth promotion,transcriptional regulation,cancer cell survival,therapeutic target,oncogenic pathway modulation
ENSG00000148346,LCN2,hypoxia-induced expression,tumor progression,angiogenesis promotion,mmp regulation,prognostic marker,iron homeostasis disruption
ENSG00000181555,SETD2,histone methyltransferase activity,loss of function mutations,genomic instability,chromatin relaxation,oncogenic activation,tumor suppressor silencing
ENSG00000164466,SFXN1,iron-sulfur cluster biogenesis,oxidative stress,genomic instability,tumor suppression,protein-protein interactions,oncogenic processes
ENSG00000078668,VDAC3,mitochondrial function,apoptosis resistance,tumor progression,energy metabolism,cell survival,protein-protein interactions
ENSG00000177542,SLC25A22,metabolic reprogramming,energy production,mitochondrial function disruption,cancer cell metabolism,glycolysis regulation,protein-protein interaction alteration
ENSG00000080293,SCTR,tumor progression,overexpression biomarker,cellular interaction,biomolecular signaling,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000133773,CCDC59,coiled-coil domain protein,cell cycle regulation,oncogenic processes,cell proliferation,aggressive tumor behavior,tumor overexpression
ENSG00000170956,CEACAM3,tumor progression,cell adhesion and migration,therapeutic target,overexpression,angiogenesis,epithelial-to-mesenchymal transition (emt)
ENSG00000068308,OTUD5,protein degradation regulation,oncogene activity,cell survival promotion,tumor progression facilitation,biomarker potential,signaling pathway modulation
ENSG00000134245,WNT2B,aberrant expression,cell growth promotion,cell migration enhancement,epithelial cell differentiation regulation,gene transcriptional activation,oncogene role assignment
ENSG00000106789,CORO2A,cell membrane regulation,biomarker expression,wnt/pcp signaling,cell proliferation,protein sorting,membrane trafficking
ENSG00000116329,OPRD1,receptor activation,g protein-coupled receptor,tumor progression,cell migration,oncogenic processes,prognostic marker
ENSG00000166313,APBB1,wnt/β-catenin pathway,cell signaling dysregulation,tumor suppressor function loss,protein degradation regulation,biomarker potential,cancer cell proliferation
ENSG00000137409,MTCH1,mitochondrial function,tumor suppressor activity,metabolic dysregulation,cellular respiration,apoptosis regulation,energetic homeostasis
ENSG00000172638,EFEMP2,cellular proliferation,akt signaling activation,epithelial-to-mesenchymal transition (emt),extracellular matrix regulation,tumor progression,protein-protein interactions
ENSG00000144791,LIMD1,mitochondrial dynamics,mitophagy regulation,tumor growth promotion,cellular stress response modulation,cancer driver gene,prognostic marker
ENSG00000111667,USP5,ubiquitination regulation,cell cycle progression,protein homeostasis maintenance,oncogenic processes contribution,signaling pathway modulation,overexpression association
ENSG00000075142,SRI,cell proliferation enhancement,tumor growth promotion,protein interaction regulation,genetic upregulation,signaling pathway modulation,cancer tumorigenesis involvement
ENSG00000111652,COPS7A,protein stability regulation,ubiquitination pathway dysregulation,tumor suppressor function,cancer driver mutation,cell cycle regulation disruption,dna repair impairment
ENSG00000116218,NPHS2,glomerular filtration,podocyte function,slit diaphragm integrity,protein-protein interaction,renal disease association,nephrotic syndrome
ENSG00000083845,RPS5,p53 pathway modulation,oncogenic regulation,cell survival enhancement,translation initiation regulation,ribosomal function,protein-protein interaction
ENSG00000136872,ALDOB,altered glucose metabolism,cancer cell energy,glycolytic pathway alteration,metabolic reprogramming,tumor progression,tissue-specific expression
ENSG00000109133,TMEM33,er stress response,cellular proliferation,tumor progression,genetic alterations,protein interaction,cell survival
ENSG00000101057,MYBL2,transcriptional regulation,cell cycle progression,oncogene overexpression,therapeutic resistance,tumor growth promotion,chromosomal amplification
ENSG00000100029,PES1,cell proliferation,growth regulation,genomic instability,apoptosis regulation,protein-protein interactions,tumor progression
ENSG00000102158,MAGT1,tumor suppressor function,metastasis regulation,apoptosis regulation,cell cycle progression,protein phosphatase activity,genomic instability
ENSG00000160305,DIP2A,tumor progression,cell migration,epithelial-to-mesenchymal transition,metalloprotease activity,overexpression,biomarker
ENSG00000068305,MEF2A,chromatin remodeling,epigenetic regulation,genomic instability,oncogenic progression,transcriptional modulation,tumor migration
ENSG00000076382,SPAG5,genomic instability,mitotic index increase,cell cycle checkpoint regulation,microtubule dynamics alteration,chromosomal aberrance,therapeutic target
ENSG00000101146,RAE1,cellular regulation,chromatin remodeling,nucleocytoplasmic transport,oncogenic driver,tumor progression,transcriptional regulation
ENSG00000124713,GNMT,methylation cycle regulation,tumor suppressor function,cell proliferation promotion,apoptosis inhibition,genomic stability modulation,dna methylation error increase
ENSG00000147669,POLR2K,alternative splicing,cell proliferation,enhanced transcriptional activity,genomic instability,mutational landscape,transcriptional elongation
ENSG00000124688,MAD2L1BP,cell cycle regulation,genomic stability,scaffold protein function,oncogenic mechanism,therapeutic target,mitotic progression
ENSG00000071539,TRIP13,dna repair pathway,tumor suppressor function,genomic instability,oncogenic transformation,therapeutic target,chromatin remodeling
ENSG00000120875,DUSP4,erk1/2 activation,dual-specificity phosphatase,tumor progression,mapk signaling pathway,oncogenic transformation,cell proliferation
ENSG00000002822,MAD1L1,mitotic checkpoint regulation,anti-apoptotic function,cell cycle progression,genomic instability,tumor growth promotion,spindle assembly checkpoint modulation
ENSG00000111726,CMAS,choline metabolism,cellular homeostasis,tumor progression,metastasis promotion,enzymatic activity alteration,lipid regulation dysfunction
ENSG00000166432,ZMAT1,constitutive activation of wnt/β-catenin pathway,loss of transcriptional regulation,downregulation in blca,microrna regulation,apoptosis suppression,cell cycle progression
ENSG00000171497,PPID,pi3k/akt pathway activation,cell proliferation regulation,metabolic reprogramming,oncogenic driver mutation,therapeutic target identification,cancer prognosis
ENSG00000139874,SSTR1,tumor suppressor function,cell growth inhibition,apoptosis induction,pi3k/akt/mtor pathway modulation,prognostic marker,targeted therapy candidate
ENSG00000197535,MYO5A,cellular trafficking,rna transport,intracellular vesicles,motor protein regulation,tumor progression,therapeutic target
ENSG00000196642,RABL6,microtubule dynamics,cell proliferation,mitotic regulation,oncogenic properties,cell migration,tumorigenesis
ENSG00000188603,CLN3,autophagy regulation,cell survival,cellular homeostasis disruption,lysosomal membrane protein function,oncogenic potential,stress response activation
ENSG00000134824,FADS2,lipid metabolism,tumor progression,inflammation regulation,eicosanoid production,cell proliferation,protein expression alteration
ENSG00000184160,ADRA2C,tumor progression,g protein-coupled receptor,cell proliferation,mapk/erk pathway,receptor overexpression,tumor aggressiveness
ENSG00000134046,MBD2,dna methylation regulation,tumor suppressor function,transcriptional repression,histone modification interactions,chromatin remodeling,genome stability maintenance
ENSG00000145220,LYAR,histone acetylation,genomic instability,oncogenic process,cell proliferation,dna repair disruption,prognostic marker
ENSG00000171861,MRM3,mitochondrial transport,mitochondrial function regulation,energy metabolism regulation,cellular adaptation to stress,therapeutic resistance associated,metabolic pathway interaction
ENSG00000113851,CRBN,loss of function mutations,ubiquitination pathway dysregulation,tumor suppressor activity,wnt/β-catenin pathway activation,protein degradation impairment,genome instability promotion
ENSG00000077514,POLD3,genomic instability,dna polymerase activity,cell cycle regulation,chromosomal alterations,mutations in dna repair genes,tumor progression
ENSG00000125967,NECAB3,signaling modulation,cellular regulation disruption,tumor progression association,therapeutic target potential,prognostic marker correlation,gene expression alteration
ENSG00000137674,MMP20,extracellular matrix remodeling,cell migration and invasion,metastasis promotion,tumor aggressiveness,proteolytic processing,poor prognosis
ENSG00000152591,DSPP,dentin mineralization,non-collagenous protein,cell surface interaction,oncogene potential,tumor overexpression,protein-protein interaction
ENSG00000135077,HAVCR2,tumor suppression,immune evasion,anti-tumor response,prognostic biomarker,cell death induction,proliferation inhibition
ENSG00000111181,SLC6A12,glutamine metabolism,tumor progression,prognostic marker,therapeutic target,cell proliferation regulation,sodium-dependent amino acid transport
ENSG00000138663,COPS4,crl complex regulation,cell cycle progression,oncogenic driver gene,ubiquitination and degradation,protein-protein interactions,tumorigenesis promotion
ENSG00000274286,ADRA2B,overexpression,tumor progression,pi3k/akt pathway modulation,cell proliferation inhibition,poor prognosis correlation,g protein-coupled receptor activation
ENSG00000131931,THAP1,therapeutic target,transcriptional regulation,apoptosis modulation,cell cycle progression,genomic instability,dna binding activity
ENSG00000162627,SNX7,cell surface receptor regulation,oncogene,pro-survival signaling,endosomal sorting,rab gtpase interaction,apoptosis suppression
ENSG00000159337,PLA2G4D,lipid hydrolysis,cell migration,metastasis,tumor progression,oncogenesis,angiogenesis
ENSG00000105497,ZNF175,tumor suppressor function,epigenetic regulation,cell cycle regulation,dna repair mechanism,apoptosis induction,gene silencing
ENSG00000165271,NOL6,oncogenic function,cell proliferation regulation,apoptosis evasion,protein-protein interaction,cell cycle progression regulation,genomic instability promotion
ENSG00000163875,MEAF6,genomic instability,chromatin remodeling,nuclear protein function,cell cycle progression,protein-protein interactions,tumor suppressor regulation
ENSG00000165702,GFI1B,cell cycle regulation,tumor suppressor function,apoptosis induction,gene expression regulation,transcriptional repression,mitotic checkpoint control
ENSG00000143933,CALM2,cell migration,metastasis promoter,calcium signaling regulation,intracellular interaction,protein kinase activation,tumor progression
ENSG00000130203,APOE,lipid metabolism regulation,cholesterol availability modulation,cell growth promotion,survival pathway interaction,therapeutic target,tumor progression facilitation
ENSG00000099889,ARVCF,cell migration,protein tyrosine kinase activity,tumor progression,metastasis,epithelial-to-mesenchymal transition,e-cadherin/catenin complex interaction
ENSG00000100206,DMC1,...,none,none,none,none,none
ENSG00000124702,KLHDC3,**
cell cycle regulation,metastasis promotion,oncogenic signaling,tumor progression,cell polarity modulation,adhesion disruption 
**
ENSG00000205420,KRT6A,cell morphology alteration,epithelial cell integrity disruption,heterodimer formation,metastatic potential enhancement,proliferation increase,structural instability
ENSG00000077348,EXOSC5,rna processing regulation,oncogene expression modulation,tumor suppressor gene regulation,cell proliferation enhancement,metastasis promotion,pi3k/akt pathway activation
ENSG00000124256,ZBP1,apoptosis regulation,tumor suppressor function,pro-survival pathway modulation,cell growth regulation,dna repair involvement,immune response modulation
ENSG00000276336,SCARF1,regulation of cell migration,overexpression,oncogenic potential,angiogenesis promotion,metastasis enhancement,epithelial-to-mesenchymal transition (emt) regulation
ENSG00000122873,CISD1,cellular stress response,autophagy regulation,oncogenic signaling enhancement,tumor growth promotion,chemotherapy resistance,biomarker potential
ENSG00000184056,VPS33B,membrane trafficking regulation,oncogenic recycling pathways,tumor progression facilitation,endosomal sorting modulation,rab gtpase interaction,protein kinase activation
ENSG00000198876,DCAF12,genomic instability,regulation of cell cycle progression,dna damage response,cancer initiation,cullin-ring ubiquitin ligase complex,substrate recognition component
ENSG00000108515,ENO3,glycolytic enzyme,increased expression,tumor progression,metabolic shift,warburg effect,apoptosis evasion
ENSG00000160752,FDPS,isoprenoid biosynthesis,prenylation regulation,tumor progression,protein kinase activation,cell proliferation,genomic instability
ENSG00000164649,CDCA7L,chromosomal instability,oncogenic transformation,gain of function mutations,cell survival and proliferation,genomic profiling,anaphase bridges
ENSG00000130589,HELZ2,chromatin remodeling,genomic instability,cell proliferation,transcriptional regulation,apoptosis suppression,tumor metastasis
ENSG00000147223,RIPPLY1,epigenetic regulation,oncogene activation,enhancer activation,cell proliferation,gene expression modulation,transcriptional regulation
ENSG00000130429,ARPC1B,actin cytoskeleton regulation,cell invasion enhancement,migratory capacity increase,tumor progression facilitation,protein-protein interaction modulation,oncogenic protein cooperation
ENSG00000132300,PTCD3,apoptosis evasion,cell proliferation,oncogene potential,protein-protein interactions,tumor progression,upregulated expression
ENSG00000171148,TADA3,transcriptional regulator,oncogene,cell proliferation,tumor progression,cell migration,apoptosis regulation
ENSG00000086589,RBM22,oncogene regulation,cell cycle modulation,rna-binding activity,pi3k/akt pathway interaction,genetic alterations,tumorigenesis driver
ENSG00000076685,NT5C2,pi3k/akt modulation,tumor microenvironment regulation,immunosuppression induction,extracellular adenosine regulation,oncogenic process enhancement,therapeutic target identification
ENSG00000023228,NDUFS1,mitochondrial dysfunction,aerobic glycolysis,tumor suppressor function,increased metabolic demand,oxidative stress resistance,regulation of cellular homeostasis
ENSG00000152944,MED21,transcriptional regulation,dna repair,cell cycle progression,oncogenic target,co-activator complex,tumor suppression
ENSG00000214827,MTCP1,tumor progression,transcriptional regulation,oncogene activity,cell proliferation,metastasis,dna binding
ENSG00000131023,LATS1,hippo signaling pathway inhibition,tumor suppressor function,cell proliferation regulation,genomic instability,prognostic marker,cell cycle control
ENSG00000133063,CHIT1,cellular degradation,tumor progression,immune evasion,glycosidic bond hydrolysis,enzymatic regulation,apoptosis modulation
ENSG00000105641,SLC5A5,lactic acid transport,warburg effect,tumor progression,cell proliferation,monocarboxylate export,hypoxia adaptation
ENSG00000076662,ICAM3,immune evasion,cell adhesion modulation,tumor progression facilitation,poor prognosis association,signaling pathway regulation,genomic instability promotion
ENSG00000110321,EIF4G2,mtor pathway modulation,oncogene overexpression,cap-dependent translation regulation,cell growth promotion,chemotherapy resistance,genomic amplification events
ENSG00000104442,ARMC1,cell cycle regulation,tumor suppressor function,oncogene potential,genomic instability,mitotic spindle checkpoint,cellular proliferation
ENSG00000262788,UTP4,snrnp assembly,aberrant splicing patterns,rna processing regulation,cell growth modulation,proliferation enhancement,tumor progression facilitation
ENSG00000117362,APH1A,gamma-secretase complex,notch receptor activation,oncogenic processes,tumor progression,therapeutic target,regulatory mechanism
ENSG00000189171,S100A13,cell migration,epithelial-to-mesenchymal transition,autophagy regulation,tumor progression,protein interaction,oncogenic role
ENSG00000178996,SNX18,cell migration,oncogenic properties,tumor progression,pi3k/akt signaling,metastasis promotion,therapeutic target
ENSG00000175110,MRPS22,mitochondrial ribosome function,energy metabolism dysregulation,tumor progression association,dna repair interaction,cell cycle regulation influence,mitochondrial biogenesis component
ENSG00000120075,HOXB5,emt regulation,transcriptional regulator,oncogenic mutations,tumor progression,immune evasion,angiogenesis promotion
ENSG00000111271,ACAD10,metabolic reprogramming,fatty acid beta-oxidation modulation,oncogenic driver,therapeutic target,cellular metabolism regulation,autophagy and mitophagy regulation
ENSG00000115041,KCNIP3,potassium channel regulation,calcium influx modulation,cell proliferation suppression,tumor suppressor function,cell survival regulation,apoptosis induction
ENSG00000129450,SIGLEC9,sialic acid-binding,immune modulation,immunosuppression,tumor microenvironment,myeloid cell interaction,tumor-associated immunity
ENSG00000090615,GOLGA3,npc component,nucleocytoplasmic transport regulation,tumor progression promotion,p53 interaction,apoptosis inhibition,cell cycle regulation disruption
ENSG00000136811,ODF2,mitotic regulation,chromosome segregation,cell proliferation,tumor aggressiveness,apoptosis suppression,oncogenic signaling pathways
ENSG00000104738,MCM4,cell cycle regulation,dna replication initiation,prognostic marker,therapeutic target,aggressive disease phenotypes,tumor progression
ENSG00000065357,DGKA,cell survival,protein kinase activation,tumor progression,oncogenic processes,cell proliferation,signaling pathway regulation
ENSG00000001497,LAS1L,hippo-yap/taz signaling,gain of function mutations,tumor progression,poor prognosis,genomic instability,aneuploidy
ENSG00000110075,PPP6R3,genomic instability,cell cycle regulation,tumor suppressor function,chromatin remodeling,dephosphorylation of oncogenes,oncogenic transformation
ENSG00000110367,DDX6,microrna-mediated regulation,oncogenic process,pi3k/akt pathway modulation,tumor progression,mrna processing dysfunction,chromatin remodeling dysregulation
ENSG00000085224,ATRX,chromatin remodeling complex,genomic instability,epigenetic regulation,telomere maintenance,oncogene activation,tumor suppressor inactivation
ENSG00000187908,DMBT1,aberrant glycosylation recognition,cell adhesion regulation,apoptosis induction,immune response modulation,epithelial homeostasis,tumor suppression
ENSG00000041357,PSMA4,psma4 mutations,proteolytic activation,ubiquitin-proteasome pathway,tumor suppressor degradation,cancer progression,oncogenic driver
ENSG00000187239,FNBP1,microtubule regulation,cell proliferation,cell migration,invasion,prognostic marker,cytoskeleton reorganization
ENSG00000169474,SPRR1A,tumor suppressor,cellular differentiation,epithelial integrity,cell adhesion regulation,proliferation control,biomarker potential
ENSG00000198721,ECI2,tumor suppressor,cell cycle regulation,apoptosis regulation,dna damage response,genetic instability,cancer initiation
ENSG00000183918,SH2D1A,tumor suppressor functions,immune response modulation,oncogenic protein interaction,cell growth regulation,cancer progression,signaling pathway regulation
ENSG00000169446,MMGT1,oncogenic driver,epigenetic regulator,tumor progression marker,dna methylation activity,cell cycle regulation,genomic instability mediator
ENSG00000164096,C4orf3,oncogenesis,promoter overexpression,tumor aggressiveness,cell proliferation promotion,unknown protein function,correlated with prognosis
ENSG00000184113,CLDN5,cell polarity disruption,epithelial-to-mesenchymal transition,adhesion molecule regulation,tight junction disruption,cancer cell invasion,cell migration enhancement
ENSG00000177519,RPRM,post-transcriptional regulation,cellular proliferation,tumor suppressor activity,microtubule dynamics,prognostic marker,biological pathway interaction
ENSG00000163069,SGCB,cell adhesion disruption,loss of function mutations,tumor invasion,metastasis promotion,prognostic marker,oncogenic pathway modulation
ENSG00000079134,THOC1,nuclear rna export regulation,cancer driver gene,cell cycle progression,protein interaction,mrna processing,tumor proliferation
ENSG00000161526,SAP30BP,chromatin regulation,genome stability maintenance,tumor suppression,cell cycle regulation,apoptosis modulation,histone modification interaction
ENSG00000120694,HSPH1,cellular stress response,apoptosis modulation,autophagy regulation,cancer stem cell maintenance,poor prognosis marker,tumor progression promotion
ENSG00000114062,UBE3A,dna repair deficiency,genomic instability,oncogene overexpression,protein degradation regulation,tumorigenesis,biomarker potential
ENSG00000165821,SALL2,transcriptional repression,tumor suppressor gene silencing,cellular development disruption,chromosomal amplification,protein-dna interaction,oncogenic transcription factor
ENSG00000177875,CCDC184,mitotic regulation,chromosomal instability,centrosome dysfunction,cell cycle dysregulation,cancer predisposition,tumor progression
ENSG00000111142,METAP2,pi3k/akt pathway,tumor progression,cell proliferation,protein processing,apoptosis regulation,metastasis promotion
ENSG00000139631,CSAD,mmp activation,proteolytic activity,extracellular matrix degradation,tumor metastasis,biomarker overexpression,poor prognosis
ENSG00000167900,TK1,nucleotide metabolism,cell proliferation,dna replication,tumor progression,therapeutic target,genomic instability
ENSG00000165370,GPR101,pi3k/akt pathway,constitutive activation,gpcr signaling,tumor progression,oncogenic driver,overexpression
ENSG00000164294,GPX8,mitochondrial function,hydrogen peroxide reduction,oxidative stress mitigation,cell survival modulation,tumor suppressive functions,redox regulation
ENSG00000164815,ORC5,cell proliferation,origin recognition complex,tumor progression,genomic instability,dna replication,cancer driver gene
ENSG00000093009,CDC45,dna replication machinery,homologous recombination repair (hrr),cell proliferation,cell survival,genetic material replication,frequently overexpressed
ENSG00000115392,FANCL,genomic instability,homologous recombination,fanconi anemia pathway,interstrand crosslink repair,dna damage response,homologous end joining
ENSG00000182591,KRTAP11-1,cellular regulation,proliferation marker,tumor differentiation,epithelial cell signaling,overexpressed protein,cell survival pathway
ENSG00000181896,ZNF101,tumor suppressor,apoptosis regulation,dna repair modulation,cell cycle regulation,transcriptional regulation,prognostic marker
ENSG00000186908,ZDHHC17,palmitoylation activity,oncogenic protein regulation,cell proliferation enhancement,tumor progression promotion,protein-protein interaction,therapeutic target candidacy
ENSG00000132639,SNAP25,neurotransmitter release regulation,cell growth modulation,oncogene activation,tumor invasion facilitation,protein-protein interaction,apoptosis regulation
ENSG00000104343,UBE2W,ubiquitination pathway disruption,oncogenic protein stabilization,cellular homeostasis dysregulation,epigenetic regulation,protein turnover modulation,therapeutic target
ENSG00000176641,RNF152,protein stabilization,mitotic progression,oncogenic properties,cell proliferation,molecular regulation,tumor progression
ENSG00000095637,SORBS1,cell adhesion disruption,rho gtpase interaction,oncogenic protein interaction,epithelial polarity loss,cytoskeleton reorganization,invasive potential enhancement
ENSG00000073921,PICALM,clathrin-mediated endocytosis,cell signaling modulation,growth factor regulation,tumor progression,therapeutic target,protein-protein interaction
ENSG00000127922,SEM1,genomic instability,homologous recombination repair,cell cycle regulation,dna repair,tumor suppression,oncogene activation
ENSG00000101132,PFDN4,protein folding regulation,tumor progression,cell proliferation enhancement,dna repair interaction,genomic instability contribution,proliferation and survival promotion
ENSG00000155959,VBP1,regulatory binding,multifunctional protein,transcription regulation,oncogene activation,cell proliferation,prognostic marker
ENSG00000102804,TSC22D1,tumor suppressor function,transcriptional regulation,cell cycle repression,metastasis inhibition,oncogenic pathway modulation,apoptosis induction
ENSG00000134376,CRB1,disrupted cellular polarity,tumor suppressor function,pi3k/akt pathway regulation,cell migration and invasion enhancement,poor prognosis association,epithelial integrity maintenance
ENSG00000133943,DGLUCY,metabolic reprogramming,glucose uptake regulation,tumor progression,cellular signaling modulation,glycolysis enhancement,anti-apoptotic function
ENSG00000198835,GJC2,gap junctional communication,metastasis promoter,cell migration enhancer,prognostic biomarker,pi3k/akt pathway interaction,mapk/erk pathway interaction
ENSG00000178623,GPR35,g protein-coupled receptor activation,dopamine signaling,pi3k/akt pathway regulation,cell proliferation enhancement,tumor progression facilitation,cancer stem cell maintenance
ENSG00000124074,ENKD1,wnt signaling pathway,genomic instability,tumor progression,dna damage response,oncogenic mutation,therapeutic target
ENSG00000139579,NABP2,dna damage response,genomic instability,transcriptional regulation,oncogene activation,prognostic marker,tumor progression
ENSG00000171867,PRNP,prnp overexpression,cell cycle regulation,apoptosis evasion,tumor aggressiveness,oncogenic transformation,cell signaling modulation
ENSG00000181392,SYNE4,genomic instability,dna damage response,cell migration adhesion,chromosomal alterations,nuclear integrity maintenance,mechanotransduction regulation
ENSG00000182685,BRICD5,dna damage response,oncogenic overexpression,cell proliferation regulation,deubiquitinating enzyme activity,apoptosis resistance,ubiquitin-proteasome pathway regulation
ENSG00000139116,KIF21A,chromosomal instability,cell cycle regulation,microtubule dynamics,tumor aggressiveness,protein-protein interaction,apoptosis regulation
ENSG00000163072,NOSTRIN,cell adhesion,epithelial-to-mesenchymal transition,tumor invasion,prognostic marker,molecular interaction,cell migration
ENSG00000107223,EDF1,mitochondrial biogenesis,cellular metabolism modulation,oncogenic mutations,metabolic reprogramming,apoptosis resistance,protein-protein interactions
ENSG00000116833,NR5A2,transcriptional regulation,tumor progression,cell cycle regulation,apoptosis inhibition,dna repair dysregulation,epithelial-to-mesenchymal transition
ENSG00000214253,FIS1,mitochondrial dynamics,promotes cell survival,regulation of cell growth,enhances metabolic adaptation,modulator of oncogenic signaling,cellular stress response regulator
ENSG00000100335,MIEF1,mitochondrial function,regulation of fission,oncogenic potential,cell survival,enhanced proliferation,altered metabolism
ENSG00000166689,PLEKHA7,cell signaling,regulatory mechanism,tumor progression,biomarker potential,pi3k/akt pathway,cell migration
,LARS,ribosome biogenesis,mtor pathway activation,gene amplification,mutation hotspot,protein synthesis regulation,oncogenic transformation
ENSG00000145888,GLRA1,glycine receptor signaling pathway,tumor progression,cellular proliferation,altered expression levels,gene expression regulation,neurotransmission disruption
ENSG00000197587,DMBX1,chromatin remodeling,genome stability,apoptosis regulation,cell cycle progression,tumor suppressor function,histone modification
ENSG00000100522,GNPNAT1,glycosylation regulation,metabolic reprogramming,therapeutic target,cellular proliferation,oncogenic process,enzymatic activity
ENSG00000110047,EHD1,overexpression,cellular trafficking regulation,endocytic machinery modulation,egfr signaling pathway activation,tumor cell migration promotion,cancer progression enhancement
ENSG00000131381,RBSN,rna degradation,cell survival,apoptosis regulation,protein synthesis modulation,tumorigenesis promotion,genomic instability
ENSG00000147155,EBP,microtubule dynamics,cell proliferation,protein degradation,tumor progression,microtubule polymerization,overexpression
ENSG00000136052,SLC41A2,magnesium homeostasis disruption,oncogenic signaling pathway activation,cell proliferation enhancement,survival pathway activation,e pigenetic alteration influence,tumor progression facilitation
,SEPT12,mitotic regulation,chromosomal stability,cell cycle progression,oncogenic alterations,genomic integrity maintenance,brca2 interaction
ENSG00000082556,OPRK1,overexpression,constitutive activation,interaction with signaling pathways,proliferation and apoptosis regulation,tumor progression,therapeutic target
ENSG00000171033,PKIA,pka regulation,tumor suppression,camp signaling pathway,cell cycle regulation,apoptosis modulation,metabolic regulation
ENSG00000158716,DUSP23,mapk signaling pathway regulation,cancer driver mutation,erk1/2 activation,nuclear localization,cell cycle control modulation,dysregulated expression
ENSG00000196290,NIF3L1,cell growth regulation,transcriptional regulation,oncogenic processes,tumor cell proliferation,gene expression modulation,protein interaction
ENSG00000117475,BLZF1,loss of function mutations,tumor suppressor activity,cell cycle regulation,genomic instability,dna damage response,apoptosis regulation
ENSG00000075624,ACTB,cell migration,cell proliferation,oncogenesis,protein interaction,cytoskeletal dynamics,therapeutic target
ENSG00000130545,CRB3,cell polarity maintenance,tumor suppressor function,epithelial-to-mesenchymal transition,loss-of-function mutations,cell adhesion regulation,prognostic marker
ENSG00000120942,UBIAD1,lipid metabolism,cell survival promotion,apoptosis modulation,ceramide regulation,oncogenesis facilitation,metabolic shift maintenance
ENSG00000163535,SGO2,genomic instability,oncogenesis,cell proliferation,dna damage response,genome maintenance,chromosome cohesion
ENSG00000177694,NAALADL2,bdnf regulation,leucine aminopeptidase function,oncogenic process,tumor progression,cell proliferation enhancement,metastasis promotion
ENSG00000164082,GRM2,metabotropic glutamate signaling,cell proliferation,immune suppression,t-regulatory cell modulation,synaptic plasticity regulation,prognostic marker
ENSG00000145414,NAF1,tfiiib complex regulation,cell cycle progression,c-myc interaction,transcriptional dysregulation,oncogenic driver,tumor growth promotion
ENSG00000244362,KRTAP19-7,keratin filament regulation,cancer driver gene,cell proliferation enhancer,tumor aggressor,intermediate filament protein,genomic amplification associated
ENSG00000181929,PRKAG1,pka activation,cell proliferation,protein kinase regulation,tumor progression,oncogene involvement,regulatory function
ENSG00000167107,ACSF2,pi3k/akt pathway,cellular regulation,oncogenic processes,tumor progression,cell survival modulation,genomic alterations
ENSG00000088682,COQ9,mitochondrial function,genetic mutations,electron transport chain,oncogenic processes,therapeutic target,ros production
ENSG00000007944,MYLIP,lipid metabolism regulation,tumor suppressor function,protein degradation regulation,genomic instability prevention,oncogene regulation inhibition,therapeutic target candidate
ENSG00000103043,VAC14,regulation of pi(3,5)p2,membrane structure maintenance,tumor progression,cell growth regulation,cell survival enhancement
ENSG00000159202,UBE2Z,protein degradation regulation,cell cycle progression regulation,oncogenic process promotion,genomic integrity maintenance,ubiquitin-conjugating enzyme activity,apo-1/promoter apoptosis regulation
ENSG00000145358,DDIT4L,metabolic regulation,tumor suppression,mtor pathway inhibition,autophagy regulation,cellular adaptation,protein-protein interaction
ENSG00000204873,KRTAP9-3,keratin-associated protein,intermediate filament stability,epithelial differentiation,mitotic regulation,cancer metastasis potential,genetic instability
ENSG00000254997,KRTAP5-9,keratin-associated protein family,epithelial cell integrity,tumor aggressiveness,driver gene candidate,prognostic marker,cell signaling modulation
ENSG00000158552,ZFAND2B,genomic instability,oncogenic pathway activation,protein-protein interaction regulation,cell cycle progression regulation,dna repair mechanism modulation,tumor growth promotion
ENSG00000135636,DYSF,dysferlin function disruption,cell signaling dysregulation,cancer progression association,emt regulation,muscle membrane integrity loss,poor prognosis marker
ENSG00000161547,SRSF2,alternative splicing,epithelial-to-mesenchymal transition (emt),spliceosomal rna helicase activity,oncogenic mutations,cancer progression,gene expression regulation
ENSG00000185811,IKZF1,transcriptional regulation,cell cycle progression,apoptosis dysregulation,genetic alterations,tumor suppressor function,gene expression signature
ENSG00000143156,NME7,cellular metabolism regulation,dna repair pathway modulation,oncogenesis promotion,cell cycle regulation enhancement,protein kinase activity,gene overexpression
ENSG00000278570,NR2E3,transcriptional regulation,overexpression,oncogenesis,cell proliferation,wnt signaling pathway,poor prognosis
ENSG00000187175,KRTAP12-1,cell proliferation,overexpression,apoptosis resistance,cell cycle regulation,tumor promotion,epithelial integrity
ENSG00000105991,HOXA1,oncogenic transcription factor,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway regulation,gene expression regulation,tumor progression,transcriptional regulation
ENSG00000126804,ZBTB1,tumor suppressor,dna binding activity,cell cycle regulation,oncogenesis inhibition,transcriptional regulation,protein-protein interaction
ENSG00000183434,TFDP3,transcriptional regulation,cell cycle progression,apoptosis inhibition,oncogenic function,tumor growth promotion,e2f transcription factor interaction
ENSG00000148175,STOM,mitochondrial function regulation,dysregulation in cancer,oncogenic processes involvement,cell migration and invasion regulation,reactive oxygen species regulation,mitochondrial dynamics modulation
ENSG00000100243,CYB5R3,iron regulation,mitochondrial metabolism,therapeutic target,cell growth regulation,tumor aggressiveness marker,oncogenic function
ENSG00000165495,PKNOX2,oncogenic activity,tumor progression,genomic instability,apoptosis resistance,transcriptional regulation,cell cycle modulation
ENSG00000143079,CTTNBP2NL,transcriptional regulation,chromatin remodeling,oncogenic processes,cell proliferation,nuclear localization,apoptosis regulation
ENSG00000213281,NRAS,constitutive activation,gain of function mutations,ras-raf-mek-erk signaling pathway,cell proliferation,therapeutic target,tumor growth
ENSG00000155833,CYLC2,mitochondrial function regulation,oncogenic pathway interaction,cell proliferation promotion,survival signal modulation,tumor aggressiveness association,biomarker potential
ENSG00000125409,TEKT3,cytoskeletal remodeling,cell migration,oncogenesis,overexpression,protein-protein interactions,tumor progression
ENSG00000186930,KRTAP6-2,epithelial differentiation,cell proliferation regulation,tumor progression marker,poor prognosis association,dna repair modulation,therapeutic target potential
ENSG00000092203,TOX4,epithelial-to-mesenchymal transition,oncogene,pi3k/akt signaling pathway,promoter of cell proliferation,regulation of emt,molecular dysregulation
ENSG00000115507,OTX1,cell cycle regulation,chromatin remodeling,transcriptional regulation,tumor progression,biomarker potential,oncogenic properties
ENSG00000198089,SFI1,**
microrna regulation,risc-loading complex component,mrna degradation,gene expression regulation,protein-protein interaction,cellular transformation
**
ENSG00000147400,CETN2,tumor progression,cell division regulation,chromosomal instability,metastasis promotion,prognostic biomarker,cancer cell proliferation
,HIST2H3A,histone modification,genomic instability,chromatin remodeling,epigenetic regulation,therapeutic target,cancer therapy
,HIST2H3C,histone regulation,epigenetic modification,chromatin structure,gene expression modulation,transcriptional control,tumorigenesis involvement
,HIST2H3D,chromatin remodeling,histone replacement,epigenetic regulation,oncogenic reprogramming,tumor progression,genomic instability
ENSG00000105223,PLD3,cell signaling,proliferation regulation,oncogene activation,tumor suppressor inhibition,signaling pathway interaction,cell survival modulation
ENSG00000143786,CNIH3,notch signaling pathway,tumor progression,biomarker potential,cell growth regulation,oncogenic process,therapeutic target
ENSG00000148690,FRA10AC1,tumor suppressor,cell cycle regulation,apoptosis modulation,dna repair mechanism,cell proliferation enhancement,signaling pathway activation
ENSG00000149929,HIRIP3,genomic instability,dna replication regulation,origin firing modulation,tumor progression marker,cell cycle regulation,apoptosis suppression
ENSG00000168701,TMEM208,cell signaling,transmembrane protein,signaling pathway regulation,membrane trafficking,cancer progression,cellular function maintenance
ENSG00000262045,KRT34,keratin filament assembly,cell growth regulation,epithelial integrity maintenance,cell migration inhibition,prognostic marker,tumor invasion suppression
ENSG00000123685,BATF3,immune evasion,epithelial-to-mesenchymal transition,tumor progression,immune suppression,transcription factor regulation,gene expression modulation
ENSG00000204571,KRTAP5-11,cellular adhesion disruption,epithelial integrity maintenance,intermediate filament interaction,mechanical stability modulation,signaling pathway influence,structural protein function
ENSG00000117016,RIMS3,regulation of synaptic transmission,protein interaction,cell growth regulation,biomarker potential,high expression levels,signaling pathway involvement
ENSG00000100151,PICK1,rtk activation,microtubule interaction,oncogenic pathway modulation,cell migration promotion,emt regulation,scaffold protein function
ENSG00000171729,TMEM51,mitotic progression,cytokinesis regulator,genomic stability maintenance,cell cycle regulation,oncogene activation,cell proliferation enhancer
ENSG00000108010,GLRX3,oxidative stress response,redox regulation,cell survival,antioxidant defense,protein interaction,tumor progression
ENSG00000129355,CDKN2D,cell cycle regulation,cyclin-dependent kinase inhibition,genomic instability,tumor suppression loss,cancer driver potential,cell proliferation enhancement
ENSG00000196388,INCA1,genomic instability,chromosome segregation,cell cycle regulation,mitotic spindle checkpoint,aneuploidy promotion,tumor progression driver
ENSG00000153823,PID1,tumor suppressor,loss-of-function mutations,cell proliferation inhibition,transcriptional regulation,epithelial-to-mesenchymal transition,dna damage response
ENSG00000128185,DGCR6L,microrna processing,apoptosis regulation,cell cycle progression,genomic stability,oncogenic potential,tumorigenesis
,HIST1H2BH,chromatin regulation,epigenetics,gene expression modulation,histone modification,nucleosome assembly,tumor suppressor function
ENSG00000168646,AXIN2,tumor suppressor,wnt/β-catenin pathway regulation,loss-of-function mutations,tumor progression,poor prognosis,epithelial-to-mesenchymal transition (emt) modulation
ENSG00000085382,HACE1,tumor suppressor function,pi3k/akt pathway regulation,mapk/erk signaling modulation,protein stability regulation,dna damage response,cell migration regulation
ENSG00000149295,DRD2,g protein-coupled receptor,cell growth regulation,tumor progression,biomarker potential,signaling pathway modulation,dopamine receptor activation
ENSG00000123473,STIL,centrosome regulation,chromosomal instability,mitotic checkpoint disruption,therapeutic target,cell cycle dysregulation,prognostic marker
ENSG00000104412,EMC2,genomic instability,dna repair regulation,nuclear factor interaction,cellular proliferation,chromatin remodeling,oncogene regulation
ENSG00000135052,GOLM1,golgi membrane regulation,cancer cell metabolism,tumor progression,cell proliferation regulation,p53 interaction,apoptosis evasion
ENSG00000143801,PSEN2,cell signaling pathway,cell proliferation,apoptosis modulation,tumor progression,genetic mutation,protein processing
ENSG00000164896,FASTK,apoptosis regulation,mitochondrial pathway modulation,cell death suppression,tumor growth promotion,therapeutic target,stress response regulation
ENSG00000181915,ADO,gain of function mutations,energy metabolism regulation,glycolytic pathway enhancement,cell proliferation promotion,apoptosis inhibition,oncogenic signaling pathway modulation
ENSG00000104763,ASAH1,oncogenic process,pi3k/akt pathway modulation,ceramide metabolism regulation,tumor progression promotion,prognostic marker,therapeutic target
ENSG00000280516,TMEM42,cell growth regulation,transmembrane protein,oncogenic potential,genomic instability,cell proliferation modulation,membrane-bound localization
ENSG00000126950,TMEM35A,mapk signaling regulation,cell proliferation modulation,cancer driver gene,tumor progression involvement,therapeutic target potential,cell growth regulation
ENSG00000197976,AKAP17A,pka signaling pathway regulation,tumor progression facilitation,oncogene potential,apoptosis evasion,cell cycle regulation modification,genetic mutation involvement
ENSG00000123154,WDR83,chromatin modification,protein degradation regulation,ubiquitin ligase complex,oncogenic protein accumulation,pi3k/akt pathway interaction,aggressive tumor behavior
ENSG00000276644,DACH1,transcription factor regulation,tumor suppression,constitutive activation of oncogenic pathways,cell proliferation and differentiation,apoptosis inhibition,genetic regulatory mechanisms
ENSG00000090905,TNRC6A,microrna-mediated gene silencing,ccr4-not complex interaction,oncogene regulation,tumor suppressor gene regulation,prognostic marker,cccr4-not complex regulator
ENSG00000228964,HLA-B,tumor antigen presentation,immunosuppression,peptide recognition,cell surface expression,t-cell activation,anti-tumor immunity
ENSG00000102024,PLS3,nf-κb signaling,regulation of apoptosis,cell survival pathways,tumor progression,metastasis,stress response
ENSG00000125356,NDUFA1,mitochondrial function,energy metabolism regulation,tumor metabolic reprogramming,mitochondrial dna mutations,electron transport chain dysfunction,oxidative stress induction
ENSG00000171135,JAGN1,notch signaling,oncogenic potential,overexpression,cell growth promotion,molecular interaction,genetic aberration
,CCDC155,microtubule dynamics disruption,chromosomal instability,cellular proliferation enhancement,aneuploidy induction,oncogenic transformation facilitation,therapeutic target candidacy
ENSG00000143641,GALNT2,oncogene,cell adhesion disruption,e-cadherin modification,wnt/β-catenin pathway regulation,poor prognosis marker,glycosyltransferase activity
ENSG00000117155,SSX2IP,transcriptional regulation,chromatin remodeling,tumor suppression,cell proliferation,protein interaction,androgen receptor signaling
ENSG00000103018,CYB5B,mitochondrial respiration,electron transport chain,cellular energy production,metabolic reprogramming,tumor aggressiveness,cell growth promotion
ENSG00000155755,TMEM237,cell adhesion,signaling pathway activation,oncogenesis,tumor progression,therapeutic target,prognostic marker
ENSG00000100528,CNIH1,oncogenic driver,cell proliferation,cell survival,calcium-dependent signaling,protein-protein interaction,tumor aggressiveness
ENSG00000175514,GPR152,g protein-coupled receptor signaling,tumor-promoting activity,oncogene function,angiogenesis regulation,multifunctional role in cancer,overexpression in tumor tissues
ENSG00000166289,PLEKHF1,epithelial-to-mesenchymal transition,cell proliferation,oncogene activation,pi3k/akt signaling enhancement,cytoplasmic protein interaction,genomic amplification
ENSG00000115274,INO80B,chromatin remodeling,dna replication,epigenetic regulation,genomic stability,cell cycle progression,apoptosis regulation
ENSG00000166900,STX3,oncogenic signaling,cell cycle progression,apoptosis regulation,membrane trafficking,snare complex assembly,vesicle fusion
ENSG00000143198,MGST3,detoxification process,cancer progression,oxidative stress protection,pro-inflammatory cytokine regulation,dna repair mechanism modulation,tumor microenvironment modification
ENSG00000198133,TMEM229B,cell adhesion regulation,oncogenic properties,epithelial-to-mesenchymal transition,metastasis promotion,overexpression,signaling pathway interaction
ENSG00000169371,SNUPN,snrnp assembly,pre-mrna splicing,gene expression regulation,oncogenic transformation,tumor progression,therapeutic target
ENSG00000122375,OPN4,gpcr signaling,transmembrane receptor,phototransduction pathway,cell signaling regulation,gene expression modulation,cancer-related gene expression changes
ENSG00000188021,UBQLN2,tumor progression,ubiquitin-proteasome system regulation,protein degradation modulation,oncogene regulation,cancer risk factor,cellular homeostasis maintenance
ENSG00000164983,TMEM65,cell membrane trafficking,overexpression,cell signaling pathway,pi3k/akt activation,genetic mutations,tumor progression
ENSG00000180532,ZSCAN4,dna repair dysregulation,genomic instability,cell cycle progression,transcriptional regulation,apoptosis modulation,chromatin remodeling
ENSG00000118402,ELOVL4,vlcfa biosynthesis,oncogenic function,cell migration,therapeutic target,tumor progression,protein-protein interaction
ENSG00000196329,GIMAP5,genomic instability,akt pathway interaction,cell proliferation enhancement,cancer cell survival,protein localization,cell membrane interaction
ENSG00000197079,KRT35,aberrant expression,aggressive tumor behavior,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),poor prognosis indicator,tumor progression marker
ENSG00000143393,PI4KB,enhanced cell proliferation,oncogenic processes,phospholipid metabolism,cell membrane synthesis,vesicle transport,therapeutic target
ENSG00000115307,AUP1,pi3k/akt pathway interaction,oncogene,transcriptional regulation,cell proliferation enhancement,poor prognosis marker,epithelial-to-mesenchymal transition regulation
ENSG00000112038,OPRM1,tumor progression,molecular target,cell proliferation,signaling pathway regulation,promoter methylation,gene expression alteration
ENSG00000074319,TSG101,escrt complex interaction,endosomal sorting,protein degradation regulation,tumor progression contribution,cell migration facilitation,genomic amplification association
ENSG00000169885,CALML6,cell cycle regulation,apoptosis modulation,ca2+-dependent signaling,oncogene activation,epithelial-to-mesenchymal transition (emt),stem cell maintenance
ENSG00000183036,PCP4,overexpression,tumor progression,cell proliferation,metastasis promotion,calcium regulation,prognostic marker
ENSG00000152359,POC5,redox regulation,epithelial-to-mesenchymal transition,cell proliferation,metastasis promoter,biomarker,tumor progression
ENSG00000146592,CREB5,regulatory function,transcriptional regulator,apoptosis evasion,cell proliferation,protein-dna interaction,overexpression
ENSG00000102858,MGRN1,genomic instability,oncogenic function,mitotic spindle dynamics regulation,cell cycle regulation,tumor suppressor degradation,protein ubiquitination
ENSG00000087111,PIGS,gpi anchor synthesis,lipid biosynthesis regulation,cell surface modification,tumor growth enhancement,cellular metabolism alteration,cancer progression
ENSG00000109654,TRIM2,tumor suppression,protein degradation,apoptosis regulation,cell growth control,genome integrity maintenance,therapeutic target
ENSG00000104228,TRIM35,tumor suppressor,cell proliferation regulation,apoptosis induction,genomic stability maintenance,oncogene/tumor suppressor dual role,dna damage response and repair interaction
ENSG00000109736,MFSD10,lipid metabolism regulation,oncogenic pathway activation,cell proliferation promotion,tumor progression facilitation,therapeutic target potential,biomarker expression
ENSG00000121542,SEC22A,oncogenic function,amplicon presence,cell secretion regulation,protein-protein interaction,cell migration promotion,signaling pathway modulation
ENSG00000169217,CD2BP2,pi3k signaling,constitutive activation,cell proliferation,oncogenic process,tumor progression,regulatory subunit
ENSG00000152049,KCNE4,ion channel regulation,gene amplification,mutation implication,cellular electrical excitability,oncogene activation,protein interaction modulation
ENSG00000101161,PRPF6,aberrant pre-mrna splicing,cell cycle regulation,dna damage response,genomic instability,oncogenesis,transcriptional dysregulation
ENSG00000162881,OXER1,cell proliferation,pi3k/akt pathway activation,genomic instability,tumor suppressor interaction,g-protein coupling,anti-apoptotic signaling
ENSG00000213186,TRIM59,p53 regulation,cell cycle progression,apoptosis regulation,tumor suppressor dysfunction,oncogenic pathways activation,tumor stage progression
ENSG00000102934,PLLP,lipid metabolism regulation,membrane dynamics modulation,tumor progression promotion,cell proliferation enhancement,biomarker for prognosis,oncogenic pathway interaction
ENSG00000182473,EXOC7,**
regulation of vesicle docking,exocyst complex assembly,tumor cell invasion,epithelial-to-mesenchymal transition,cell signaling modulation,wnt/β-catenin pathway interaction
**
,MARCH3,tumor progression,protein degradation pathways,erad regulation,ubiquitination modification,oncogenic activity,apoptosis suppression
ENSG00000284868,DHRS1,oncogenic properties,pi3k/akt signaling,cell proliferation,apoptosis inhibition,steroid hormone metabolism,lipid biosynthesis
ENSG00000169683,LRRC45,tumor growth,epithelial-to-mesenchymal transition (emt),cell adhesion,overexpression,poor prognosis,cell migration
ENSG00000179071,CCDC89,chromosomal instability,centrosome regulation,oncogene overexpression,cilia biogenesis dysfunction,cell proliferation enhancement,genomic alterations
ENSG00000135249,RINT1,genomic instability,homologous recombination repair,cell cycle regulation,tumor suppressor,dna damage response,genome maintenance
ENSG00000196843,ARID5A,arid complex disruption,loss-of-function mutations,transcriptional regulation,chromatin accessibility,tumor suppressor function,cell cycle progression
ENSG00000152954,NRSN1,neurexin signaling pathway,constitutive activation,amplification and overexpression,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000101236,RNF24,ubiquitin ligase function,cell cycle regulation,oncogenic complex formation,tp53 interaction,mdm2 complex formation,protein degradation pathway
ENSG00000029725,RABEP1,cell growth promotion,prognostic marker,pi3k/akt pathway regulation,tumor aggressiveness enhancement,biomarker potential,cell migration facilitation
ENSG00000103365,GGA2,late endosomal traffic regulation,tumor progression facilitation,egfr receptor interaction,oncogenic pathway activation,cellular membrane trafficking regulation,protein sorting and recycling modulation
ENSG00000114993,RTKN,mapk signaling pathway,pro-survival function,cell proliferation enhancement,tumor progression marker,rap gtpase regulator,gtp exchange facilitation
ENSG00000086015,MAST2,cellular polarity regulation,dysregulated expression,gene expression modulation,overexpression association,proliferation promotion,tumor progression association
ENSG00000103034,NDRG4,tumor suppression,cell proliferation inhibition,therapeutic target,dna repair regulation,apoptosis induction,cell cycle arrest
ENSG00000127561,SYNGR3,regulated cell adhesion,oncogene activation,enhanced cell proliferation,epithelial-to-mesenchymal transition,cell migration and invasion,potential biomarker
ENSG00000092607,TBX15,tumor suppression,cell cycle regulation,apoptosis modulation,gene expression regulation,muscle mass regulation,transcription factor interaction
ENSG00000282379,DTX2,oncogene overexpression,apoptosis resistance,tumor progression regulation,cell cycle modulation,transcriptional regulation,potent ar signaling modulator
ENSG00000099968,BCL2L13,apoptosis inhibition,cell survival enhancement,oncogene potential,metastasis promotion,prognostic marker,autophagy modulation
ENSG00000170310,STX8,pi3k/akt signaling pathway,cell survival regulation,tumor progression marker,apoptosis suppression,membrane trafficking regulation,protein-protein interaction
ENSG00000166833,NAV2,oncogenic regulation,chromatin remodeling,pi3k/akt pathway modulation,cell cycle progression,dna repair regulation,genomic instability driver
ENSG00000092010,PSME1,proteasome regulation,genomic instability,tumor suppressor degradation,oncogenic processes,cellular proliferation,immune evasion
ENSG00000160185,UBASH3A,regulation of sfk activity,overexpression in blca tissues,oncogenic potential,cell signaling pathway modulation,deubiquitinase enzyme function,cancer cell proliferation
ENSG00000184492,FOXD4L1,regulates emt,promotes metastasis,transcriptional regulator,epigenetic modifier,chromatin remodeler,signaling pathway modulator
ENSG00000162366,PDZK1IP1,tumor aggressiveness,promotes cell survival,pi3k/akt pathway interaction,tyrosine kinase activation,plasma membrane localization,epithelial polarity disruption
ENSG00000127774,EMC6,genomic instability,non-homologous end joining (nhej),dna repair machinery,tumor progression,cell cycle regulation,oncogenic processes
ENSG00000111701,APOBEC1,apobec activity,dna damage repair,genetic instability,mutagenesis,oncogene upregulation,tumor suppressor gene mutation
ENSG00000186977,KRTAP19-5,intermediate filament complex,cellular integrity regulation,oncogenic transformation potential,tumor progression contribution,genetic alteration driver,epithelial cell differentiation regulation
ENSG00000020256,ZFP64,cell cycle regulation,transcriptional modulation,apoptosis inhibition,growth factor regulation,tumor suppressor interaction,cell proliferation enhancement
ENSG00000141378,PTRH2,genomic instability,aneuploidy,tumor progression,centrosome duplication,mitotic checkpoint regulation,protein-protein interactions
ENSG00000105374,NKG7,immune evasion,cell proliferation,oncogene activation,tumor cell invasion,pro-tumorigenic microenvironment,immune regulatory protein interaction
ENSG00000177842,ZNF620,p53 regulation,tumor suppressor modulation,cell cycle regulation,apoptosis inhibition,transcriptional activation,oncogenic signature
ENSG00000147133,TAF1,genomic instability,chromatin remodeling,constitutive activation,cell proliferation,transcriptional regulation,apoptosis resistance
ENSG00000179930,ZNF648,epithelial-to-mesenchymal transition,cell migration and invasion,oncogenic transcription factor,tumor suppression,transcriptional regulation,zinc finger domain
ENSG00000127993,RBM48,rna processing dysregulation,overexpression oncogene,cell proliferation enhancement,epigenetic regulation modulation,cancer metastasis promotion,metabolic rewiring
ENSG00000100461,RBM23,rna-binding protein activity,promotes oncogenesis,regulates mrna stability,enhances cell proliferation,inhibits apoptosis resistance,modulates pi3k/akt/mtor pathway
ENSG00000163993,S100P,tumor progression,cell proliferation,immune evasion,angiogenesis regulation,biomarker potential,calcium signaling
ENSG00000173250,GPR151,cell proliferation enhancement,immune evasion facilitation,immunosuppression induction,pi3k/akt pathway activation,tumor progression promotion,ovarian cancer related gene
ENSG00000124103,FAM209A,loss of function mutations,downregulation,tumor suppressor activity,cell proliferation regulation,pi3k/akt pathway interaction,cytoskeletal protein regulation
ENSG00000288427,CLSTN3,cell adhesion modulation,metastasis driver,cell migration facilitation,oncogenic function,integrin interaction,epithelial-to-mesenchymal transition
ENSG00000174599,TRAM1L1,cellular regulation,oncogenic driver,pi3k/akt pathway modulation,gene expression regulation,protein stability modulation,tumor progression regulator
ENSG00000131115,ZNF227,zinc finger domain,transcriptional regulation,krab-containing protein family,cell proliferation regulation,chromatin modification,therapeutic target
ENSG00000225998,LSM2,cellular assembly,rna splicing process,oncogenic mutations,cell cycle regulation,protein complex formation,tumor progression
ENSG00000100281,HMGXB4,chromatin remodeling,transcriptional regulation,oncogene overexpression,cell proliferation promotion,genetic amplification,prognostic biomarker
ENSG00000102977,ACD,cell surface modification,tumor progression,cellular homeostasis,protein acylation,mitochondrial function,regulatory mechanism
ENSG00000065150,IPO5,hypoxia response,phd5 inhibition,hif-alpha stabilization,angiogenesis promoter,tumor progression,cancer stem cell maintenance
ENSG00000152684,PELO,genomic instability,oncogene activation,chromatin remodeling,emt modulation,cell proliferation,epithelial-to-mesenchymal transition
ENSG00000122971,ACADS,metabolic reprogramming,fatty acid oxidation,cellular energy production,tumor progression,oxidative stress,dna damage
ENSG00000263236,KRTAP4-12,keratin-associated protein function,cytoskeletal disruption,altered keratin expression,epithelial-to-mesenchymal transition,cellular morphology changes,tumor progression facilitation
ENSG00000184012,TMPRSS2,cellular proliferation,overexpression,protease activation,protein processing,gene amplification,therapeutic target
ENSG00000163217,BMP10,angiogenesis promotion,cardiovascular development,immune evasion mechanism,tumor progression enhancement,wnt/β-catenin pathway interaction,tgf-β signaling modulation
ENSG00000109099,PMP22,microtubule stability,cell proliferation,protein-protein interaction,signal transduction pathway,tumor progression,myelin sheath maintenance
ENSG00000131165,CHMP1A,cellular regulation,genomic instability,escrt-i complex disruption,lipid metabolism deregulation,protein degradation impairment,dna damage response suppression
ENSG00000160318,CLDND2,tumor progression,cell migration regulation,tight junction disruption,metastasis enhancement,therapeutic target,genomic profiling
ENSG00000168476,REEP4,er calcium regulation,dysregulation of cell growth,regulation of pi3k/akt pathway,therapeutic target,tumor progression,cancer pathogenesis
ENSG00000115091,ACTR3,mitotic regulation,dna repair defects,genomic instability,tumor progression,oncogene overexpression,cell cycle deregulation
ENSG00000178951,ZBTB7A,tumor suppressor,cell proliferation regulation,apoptosis induction,gene expression regulation,biomarker potential,chromatin remodeling interaction
ENSG00000011295,TTC19,microtubule dynamics,mitotic spindle regulation,gene amplification mutations,tumor suppressor function,genomic instability,proliferation control
ENSG00000163703,CRELD1,tumor progression,cell adhesion regulation,pi3k/akt pathway interaction,gain of function mutations,epithelial cell expression,cell migration modulation
ENSG00000176903,PNMA1,cell adhesion disruption,tumor progression association,signaling cascade activation,immune evasion contribution,oncogenic potential,overexpression involvement
ENSG00000184402,SS18L1,chromatin remodeling,tumor progression,genomic instability,oncofusion protein,cell cycle regulation,dna repair disruption
ENSG00000172156,CCL11,tumor progression,chemokine signaling,immune suppression,metastasis promotion,prognostic marker,immunotherapy target
ENSG00000221978,CCNL2,cell cycle regulation,cell proliferation,oncogenic processes,protein-protein interaction,cdk1/cdc25a activation,tumor suppressor downregulation
ENSG00000084764,MAPRE3,cell cycle regulation,microtubule dynamics,oncogenic driver,tumor progression,cell proliferation enhancement,dna damage response
ENSG00000115266,APC2,wnt signaling pathway,tumor suppressor,genomic instability,cell proliferation,oncogenesis,beta-catenin/t-cell factor complex
ENSG00000168412,MTNR1A,cellular response,inflammation regulation,oxidative stress modulation,tumor suppressor function,apoptosis induction,cell proliferation inhibition
ENSG00000145283,SLC10A6,sodium-dependent phosphate transport,cellular proliferation,oncogenic process,genetic alterations,regulatory mechanism,cell survival
,C16orf58,gain of function mutations,tumor suppression,altered expression patterns,cellular signaling pathways,none,none
ENSG00000140941,MAP1LC3B,autophagy regulation,oncogenic potential,cell survival modulation,tumor progression facilitation,protein-protein interaction,gene expression alteration
ENSG00000154153,RETREG1,ret signaling pathway deregulation,tumor growth promotion,cellular proliferation enhancement,therapeutic target potential,protein-protein interaction regulation,downstream signaling activation
ENSG00000060237,WNK1,cellular proliferation,pi3k/akt signaling,constitutive activation,tumor progression,ion transport regulation,apoptosis resistance
ENSG00000185963,BICD2,pi3k/akt activation,gene overexpression,microtubule stability regulation,epigenetic reprogramming,cell proliferation enhancement,tumor progression facilitation
ENSG00000241595,KRTAP9-4,cancer-promoting,oncogene expression,pi3k/akt signaling activation,cell proliferation enhancement,epithelial-to-mesenchymal transition (emt) induction,keratin-associated protein function
ENSG00000066117,SMARCD1,cellular proliferation,chromatin remodeling,dna damage response,transcriptional regulation,apoptosis suppression,tumor suppressor dysfunction
ENSG00000168411,RFWD3,genome instability,p53 pathway deregulation,cell cycle progression,protein degradation pathways,oncogene function,apoptosis suppression
ENSG00000178538,CA8,metabolic regulation,tumor microenvironment modulation,angiogenesis promotion,energy metabolism support,cell proliferation enhancement,prognostic marker potential
ENSG00000109083,IFT20,centrosome cohesion disruption,genomic instability,intraflagellar transport impairment,loss of heterozygosity,cancer cell transformation,cell migration promotion
ENSG00000138750,NUP54,nuclear pore regulation,dna damage response,nucleocytoplasmic transport,chromatin disruption,oncogenic transcription,prognostic marker
ENSG00000162882,HAAO,metabolic reprogramming,redox regulation,cell proliferation,chemoresistance,tumor progression,enzyme overexpression
ENSG00000128513,POT1,telomerase regulation,aberrant telomere maintenance,genomic instability,cancer cell survival,tumor progression,cell cycle regulation
ENSG00000106536,POU6F2,transcription factor regulation,cell cycle regulation,apoptosis modulation,oncogene/tumor suppressor function,dna repair regulation,cell proliferation influence
ENSG00000101216,GMEB2,transcription regulation,nuclear protein function,gata-binding protein family,oncogenic promoter,cell differentiation,chromatin modification
ENSG00000141198,TOM1L1,erad regulation,oncogenic phenotypes,tumor suppression,metastasis,predictive biomarker,loss of function mutations
ENSG00000160447,PKN3,protein kinase activation,tumor growth promotion,apoptosis resistance,cell cycle progression regulation,biomarker potential,genomic instability association
ENSG00000130669,PAK4,cell migration,epigenetic alteration,oncogenic function,pi3k/akt activation,protein kinase activity,tumor aggressiveness
ENSG00000181885,CLDN7,cell-cell adhesion disruption,tumor progression,angiogenesis promotion,metastasis facilitation,prognostic marker,signaling pathway regulation
ENSG00000147123,NDUFB11,cellular energy metabolism,tumor suppressor function,mitochondrial dysfunction,genomic instability,redox regulation,cancer development
ENSG00000084072,PPIE,cellular signaling,apoptosis inhibition,protein folding regulation,tumor growth promotion,cell proliferation enhancement,chromosomal amplification
ENSG00000171840,NINJ2,genomic instability,cell cycle regulation,dna repair mechanism,chromatin remodeling complex,genetic predisposition,apoptosis evasion
ENSG00000080345,RIF1,replication fork restart,homologous recombination repair,genomic instability,tumor suppressor function,double-strand break repair,cancer cell survival
ENSG00000160207,HSF2BP,heat shock protein regulation,oncogenic signaling,protein folding and degradation,cell proliferation and survival,genomic instability,therapeutic target
ENSG00000180448,ARHGAP45,rhogtpase regulation,constitutive activation,loss-of-function mutations,tumor suppressor function,cell migration enhancement,therapeutic target identification
ENSG00000129204,USP6,oncogene,tumor progression,protein degradation inhibition,cell proliferation promotion,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000111245,MYL2,mlc regulation,actomyosin cytoskeleton modulation,cell migration promotion,epithelial-mesenchymal transition facilitation,tumor progression support,metastasis enhancement
ENSG00000166394,CYB5R2,electron transfer,redox reactions,mitochondrial function,tumor metabolism,glycolytic flux,cell survival
ENSG00000159289,GOLGA6A,dysregulated cell cycle progression,overexpression in cancer,activates key signaling pathways,poor prognosis marker,therapeutic target potential,golgin family member distinct
ENSG00000112837,TBX18,epithelial-to-mesenchymal transition regulation,transcription factor activity,smooth muscle cell differentiation,cell growth promotion,chromatin remodeling,tumor metastasis suppression
ENSG00000198576,ARC,apoptosis regulation,autophagy modulation,oncogenic signaling,cell proliferation promotion,protein-protein interactions,arginine-rich domain function
ENSG00000164066,INTU,tumor suppressor function,p53 modulation,genomic instability,cell cycle regulation,oncogenic mutations,dna repair mechanism
ENSG00000147459,DOCK5,cell polarity disruption,cancer progression enhancement,gef activation,proliferation regulation,cell migration promotion,rho gtpase signaling
ENSG00000111252,SH2B3,immune cell regulation,phosphorylation-dependent interactions,oncogenic kinase interactions,cell proliferation,t-cell activation,cancer progression
ENSG00000125991,ERGIC3,**

ergic3 expression,overexpression,hippo signaling pathway,cell migration,secretory pathway regulation,cancer progression
**
ENSG00000175305,CCNE2,cell cycle progression,constitutive overexpression,deregulated proliferation,genomic instability,apoptosis resistance,therapeutic target
ENSG00000138668,HNRNPD,spliceosome regulation,chromatin remodeling,oncogenic splicing,transcriptional regulation,cell growth modulation,tumor progression marker
ENSG00000164949,GEM,epithelial-to-mesenchymal transition (emt),cell proliferation,signal transduction pathway,oncogene function,protein-protein interaction,growth factor regulation
ENSG00000112304,ACOT13,lipid synthesis regulation,fatty acid metabolism disruption,tumor progression marker,energy metabolism adaptation,cell membrane integrity maintenance,oncogenic pathway modulation
ENSG00000122257,RBBP6,**

ubiquitination regulation,cell cycle progression,transcriptional control,apoptosis induction,protein degradation,oncogenic/ tumor suppressor activity

**
ENSG00000100504,PYGL,cell metabolism,anabolic process,glycolytic shift,pentose phosphate pathway,metabolic reprogramming,nadph production
ENSG00000068976,PYGM,glycogen metabolism,energy production,cell proliferation,poor prognosis marker,tumor growth promotion,therapeutic target
ENSG00000130948,HSD17B3,androgen receptor activation,angiogenesis promotion,castration resistance,enhanced cell proliferation,metastasis facilitation,steroid hormone regulation
ENSG00000050628,PTGER3,prostaglandin signaling pathway,g protein-coupled receptor function,oncogenic cell proliferation,tumor progression marker,prognostic indicator,signaling pathway interaction
ENSG00000120699,EXOSC8,alternative splicing regulation,tumor suppressor suppression,oncogene promotion,exosome complex interaction,gene expression modulation,chemosensitivity regulation
ENSG00000132510,KDM6B,tumor suppressor function,chromatin remodeling,epigenetic regulation,gene expression regulation,cell cycle disruption,metastasis promotion
ENSG00000263341,KRTAP17-1,cell adhesion,epithelial-to-mesenchymal transition (emt),tumor progression,biomarker,keratin-associated protein family,cell migration
ENSG00000114698,PLSCR4,regulation of pi3k/akt signaling pathway,modulation of protein kinase c activation,oncogene function,cell proliferation regulation,apoptosis inhibition,gene expression modulation
ENSG00000172568,FNDC9,cell adhesion,angiogenesis,cell migration,tumor invasion,integrin interaction,immune modulation
ENSG00000142227,EMP3,cancer progression,cell membrane trafficking,escrt machinery,protein transport,tumor aggressiveness,biomarker potential
ENSG00000141084,RANBP10,nuclear transport,cell cycle regulation,cancer driver gene,chromatin remodeling,mitotic progression,centrosome maturation
ENSG00000130066,SAT1,polyamine regulation,cellular growth promotion,dna replication facilitation,genomic stability maintenance,molecular mechanisms involvement,biological function regulation
ENSG00000141504,SAT2,polyamine metabolism regulation,oncogenic pathway activation,cellular proliferation enhancement,tumor growth promotion,polyamine accumulation,cellular homeostasis disruption
ENSG00000111653,ING4,cell cycle regulation,tumor suppressor function,transcriptional co-repressor,apoptosis regulation,chromatin modification,e2f transcription factor interaction
ENSG00000095951,HIVEP1,immune regulation,transcriptional modulation,tumor progression,apoptosis inhibition,cell proliferation,genomic instability
ENSG00000165630,PRPF18,spliceosome component,rna processing,genomic instability,tumor suppressor function,dna repair interaction,cancer prognosis marker
ENSG00000149781,FERMT3,cell migration,oncogene activation,gene amplification,tumor progression,pi3k/akt pathway,therapeutic target
ENSG00000111837,MAK,pi3k/akt pathway,oncogene,cell proliferation,cell survival,tumor progression,poor prognosis
,ICK,cellular potassium regulation,apoptosis regulation,cell proliferation modulation,tumor progression association,signaling pathway interaction,cell migration influence
,KIF1BP,cell cycle regulation,microtubule dynamics,chromosome segregation,mitosis,oncogene function,cell proliferation
ENSG00000105856,HBP1,genome instability,histone modification regulation,cell cycle suppression,tumor suppressor function,metastasis inhibition,transcriptional repression
ENSG00000083520,DIS3,ribosomal rna processing,altered expression levels,aberrant growth promotion,tumor progression regulation,therapeutic target,rna degradation pathways
ENSG00000107371,EXOSC3,aberrant rna synthesis,genome instability,oncogene expression,rna degradation,tumor suppressor regulation,cell survival modulation
ENSG00000212933,KRTAP12-4,altered expression,proliferation regulation,differentiation regulation,cell signaling pathway modulation,tumor behavior influence,unclear cancer mechanism
ENSG00000092853,CLSPN,cytoskeleton regulation,cell migration promotion,tumor progression driver,overexpression associated,poor prognosis marker,genomic amplification related
ENSG00000131966,ACTR10,tumor progression,transcriptional regulation,cell cycle control,apoptosis resistance,genomic instability,signaling pathway activation
ENSG00000126262,FFAR2,g-protein coupled receptor,cell growth promotion,tumor cell migration,oncogenic role,fatty acid sensing,signaling pathway modulation
ENSG00000111371,SLC38A1,glutamine metabolism,cell proliferation,transporter regulation,amino acid homeostasis,tumor growth,sodium-coupled neutral amino acid transport
ENSG00000274352,ZNF707,transcriptional regulation,krab domain-containing family,transcriptional repressor,chromatin remodeling,cell proliferation,apoptosis evasion
ENSG00000166946,CCNDBP1,tumor suppression,apoptosis induction,wnt/β-catenin pathway regulation,cell proliferation inhibition,genomic loss of function mutations,protein-protein interaction network
ENSG00000145029,NICN1,cell proliferation,protein kinase activation,signaling pathway modulation,oncogenic function,tumor progression,genomic upregulation
ENSG00000175691,ZNF77,epigenetic regulation,chromatin remodeling,transcriptional repression,cell cycle regulation,apoptosis suppression,oncogene activation
ENSG00000119912,IDE,pi3k/akt pathway regulation,constitutive activation of signaling pathways,pro-tumorigenic activity enhancement,cell proliferation promotion,survival pathway modulation,tumor biomarker status
ENSG00000125207,PIWIL1,epigenetic regulation,polycomb-mediated gene repression,tumor suppressor,oncogene,genome integrity,cell cycle control
ENSG00000113387,SUB1,genomic instability,chromosome segregation,dna repair mechanisms,oncogenic pathway regulation,tumor suppressor function,cell cycle progression
ENSG00000119820,YIPF4,mtor signaling pathway,oncogenesis,cell proliferation,autophagy regulation,endoplasmic reticulum maintenance,aggressive tumor behavior
ENSG00000036565,SLC18A1,vmat2 function,cellular signaling pathway,transport of monoamines,tumor progression,monoamine interaction,therapeutic target
ENSG00000205864,KRTAP5-6,cell adhesion regulation,epithelial cell stability,tumor progression,cell migration modulation,protein expression alteration,genomic instability
ENSG00000151650,VENTX,genome stability maintenance,dna repair facilitation,tumor suppressor function,cell cycle regulation,apoptosis modulation,cell differentiation influence
ENSG00000037965,HOXC8,transcriptional regulation,tumor growth promotion,cellular differentiation suppression,epithelial cell transformation,undifferentiated cell maintenance,protein-protein interaction modulation
ENSG00000102144,PGK1,metabolic reprogramming,oncogenic drive,glycolytic pathway,energy metabolism,cell proliferation,therapeutic target
ENSG00000064835,POU1F1,transcriptional regulation,cellular differentiation,tumor progression,cell proliferation,oncogenic function,molecular interaction
ENSG00000197822,OCLN,tumor progression,chemoresistance,cell migration,cell invasion,epithelial integrity disruption,tight junction regulation
ENSG00000196417,ZNF765,chromatin remodeling,epigenetic regulation,tumor suppression,cell cycle regulation,mutational activation,cancer proliferation
ENSG00000185043,CIB1,cell signaling pathway alteration,oncogene overexpression,cell proliferation enhancement,calcium influx regulation,calmodulin binding disruption,apoptosis evasion promotion
ENSG00000100348,TXN2,oncogene,tumor progression,redox regulation,cell proliferation,pi3k/akt pathway interaction,apoptosis inhibition
ENSG00000155636,RBM45,rna splicing disruption,tumor growth promotion,cell survival enhancement,protein-protein interaction,biomarker potential,gene expression modulation
ENSG00000136371,MTHFS,cellular proliferation,dna repair mechanism disruption,therapeutic target,metabolic regulation,oncogenesis,chemoresistance
ENSG00000081386,ZNF510,transcription factor activity,epigenetic regulation,chromatin remodeling,cell proliferation,tumor progression,molecular interactions
ENSG00000152253,SPC25,kinetochore assembly,chromosome segregation,cell cycle regulation,genomic instability,aberrant cell division,oncogenic signaling
ENSG00000043143,JADE2,cell cycle regulation,chromosomal instability,genomic stability,protein degradation,anaphase-promoting complex interaction,tumor suppressor
ENSG00000163960,UBXN7,ubiquitination regulation,tumor suppressor function,cell cycle regulation,apoptosis inhibition,oncogenic processes,therapeutic target
ENSG00000170469,SPATA24,pi3k/akt pathway regulation,apoptosis regulation,cell cycle progression,oncogenic potential increase,diagnostic marker candidate,genomic instability
ENSG00000117394,SLC2A1,glucose metabolism regulation,tumor growth promotion,oncogene overexpression,cellular response modulation,metabolic adaptation,transmembrane transport facilitation
ENSG00000213906,LTB4R2,ltb4 mediated signaling,tumor progression,cell migration,apoptosis regulation,inflammation modulation,chemotaxis activation
ENSG00000148848,ADAM12,tumor progression,cell adhesion,metastasis promotion,epithelial-to-mesenchymal transition,cell migration regulation,integrin-mediated signaling
ENSG00000188581,KRTAP1-1,keratin filament regulation,cellular proliferation,tumor progression,cancer driver gene,gene expression dysregulation,therapeutic target
ENSG00000071203,MS4A12,tumor progression,apoptosis suppression,immune response modulation,nf-κb pathway activation,tumor aggressiveness,cancer metastasis
ENSG00000144063,MALL,genomic instability,oncogenic signaling pathway,cell proliferation,chromatin remodeling,epigenetic alterations,protein-protein interaction
ENSG00000177238,TRIM72,tumor suppression,protein degradation regulation,apoptosis modulation,cell cycle control,ubiquitination-proteasome pathway regulation,biomarker potential
ENSG00000140262,TCF12,transcriptional regulator,oncogenic role,cell cycle progression,apoptosis inhibition,epithelial-to-mesenchymal transition,wnt/β-catenin signaling activation
ENSG00000100652,SLC10A1,bile acid transport,cellular metabolism,tumor progression,oncogenic function,genomic amplification,metabolic regulation
ENSG00000164007,CLDN19,overexpression,disrupted cell-cell adhesion,epithelial-to-mesenchymal transition,tumor progression,altered gene expression,cancer-associated protein
ENSG00000147905,ZCCHC7,mrna stabilization,pi3k/akt pathway regulation,cell growth promotion,oncogene expression enhancement,chemotherapy resistance,tumor cell survival
ENSG00000137960,GIPC2,cell adhesion regulation,wnt/β-catenin pathway activation,pi3k/akt signaling modulation,microtubule stabilization,epithelial-to-mesenchymal transition promotion,golgi apparatus interaction
ENSG00000127838,PNKD,mitochondrial function disruption,aberrant protein kinase activation,cell survival promotion,genomic instability maintenance,cancer progression facilitation,apoptosis resistance
ENSG00000180440,SERTM1,epigenetic regulation,histone lysine methyltransferase activity,set domain-containing protein family,transcriptional regulation,cell cycle progression,dna repair
ENSG00000197992,CLEC9A,tumor progression,microenvironment modulation,immunomodulation,cell adhesion regulation,cancer cell growth promotion,therapeutic target
ENSG00000119397,CNTRL,mitotic checkpoint regulation,genomic instability,aneuploidy,dna repair mechanisms,spindle assembly checkpoint,cell cycle progression
ENSG00000164440,TXLNB,chromosomal instability,cell cycle regulation,mitotic checkpoint disruption,microtubule dynamics regulation,spindle checkpoint interaction,genomic instability
ENSG00000116062,MSH6,genetic instability,mismatch repair function,dna replication errors,apoptosis suppression,tumor progression,genomic instability
ENSG00000161055,SCGB3A1,cell proliferation,oncogenic potential,protein-protein interaction,upregulation in cancer tissues,invasion and metastasis,cell protection against oxidative stress
ENSG00000149823,VPS51,tumor progression,aberrant protein interactions,cell proliferation,metastasis,prognostic marker,membrane trafficking
ENSG00000124508,BTN2A2,cellular regulation,tumor progression,cancer cell growth,metastasis facilitation,protein interaction,calcium signaling modulation
ENSG00000134531,EMP1,cell-cell adhesion disruption,epithelial integrity loss,extracellular matrix interaction,migration and invasion promotion,oncogenic driver,prognostic marker
ENSG00000157680,DGKI,cell proliferation,genomic instability,signaling pathway activation,cell survival regulation,epithelial-to-mesenchymal transition,protein kinase activity
ENSG00000119705,SLIRP,dna damage repair modulation,cancer biomarker,therapeutic target,cell survival enhancement,protein-protein interaction,apoptosis regulation
ENSG00000196182,STK40,pi3k/akt pathway,promotes cell proliferation,constitutive activation,oncogenic driver,tumor progression,therapeutic target
ENSG00000079150,FKBP7,tumor aggressiveness,oncogene activation,pi3k/akt pathway modulation,cell survival enhancement,prognostic significance,apoptosis regulation
ENSG00000177427,MIEF2,mitochondrial dynamics,mitophagy regulation,cellular respiration modulation,oncogenic potential,tumor suppressor,genomic instability
ENSG00000008197,TFAP2D,transcriptional regulation,cell growth modulation,gene expression dysregulation,oncogenic transcription factor,aberrant cell proliferation,chromatin remodeling
ENSG00000186970,KRTAP15-1,cellular differentiation,growth regulation,proliferation promotion,migration and invasion,cell adhesion modulation,protein-protein interaction
ENSG00000167984,NLRC3,loss of function mutations,tumor suppressor activity,apoptosis regulation,immune response modulation,autophagy regulation,cell cycle regulation
ENSG00000057019,DCBLD2,cell-cell interaction,epithelial-to-mesenchymal transition,protein-protein interaction,transcription factor regulation,tumor progression,metastasis facilitation
ENSG00000013293,SLC7A14,glutamine metabolism,cell proliferation,tumor aggressiveness,metabolic regulation,oncogenic process,prognostic marker
ENSG00000122877,EGR2,tumor progression,therapeutic target,transcriptional regulation,cell migration,genomic instability,growth factor signaling
ENSG00000206053,JPT2,mitochondrial dysfunction,energy metabolism alteration,redox balance disruption,cell survival promotion,therapeutic resistance enhancement,oncogene activation
ENSG00000101438,SLC32A1,glutamate regulation,tumor progression,oncogenic signaling,cell growth promotion,metastasis facilitation,neurotransmitter transport disruption
ENSG00000196456,ZNF775,cellular proliferation,tumor suppressor function,dna binding activity,transcriptional regulation,cell cycle modulation,oncogenesis
ENSG00000107186,MPDZ,wnt/β-catenin pathway activation,transmembrane protein function,cell adhesion disruption,tumor progression promoter,poor prognosis marker,src kinase interaction
ENSG00000184166,OR1D2,olfactory receptor function,cancer biomarker,cellular proliferation,tumor progression,epithelial-to-mesenchymal transition,immune modulation
ENSG00000177300,CLDN22,tight junction regulation,epithelial cell adhesion,cell proliferation,tumor progression,protein-protein interaction,epithelial-to-mesenchymal transition
ENSG00000139644,TMBIM6,apoptosis regulation,cellular proliferation regulation,tumor suppressor function,autophagy modulation,pi3k/akt pathway interaction,endoplasmic reticulum localization
ENSG00000170540,ARL6IP1,regulatory function,ciliogenesis,cell migration,metastasis,tumor aggressiveness,protein-protein interaction
ENSG00000121413,ZSCAN18,tumor suppressor,transcriptional regulation,cell cycle progression,apoptosis induction,dna repair modulation,oncogene repression
ENSG00000137338,PGBD1,genomic instability,homologous recombination defect,dna repair regulation,oncogenic mutations promotion,genome stabilization disruption,cellular mutagenesis facilitation
ENSG00000108587,GOSR1,golgi membrane fusion,vesicular trafficking regulation,cell proliferation promotion,tumor progression enhancement,therapeutic target identification,protein transportation facilitation
ENSG00000166856,GPR182,adhesion-gpcr family,cancer progression,cell migration,g-protein coupled receptor,mapk/erk signaling,molecular regulation
ENSG00000137824,RMDN3,microtubule organization,apoptosis regulation,cell cycle progression,tumor aggressiveness,overexpression in tumors,therapeutic target
ENSG00000183733,FIGLA,transcriptional regulation,cell proliferation,oncogenic driver,apoptosis evasion,tumor aggressiveness,therapeutic target
ENSG00000107187,LHX3,tumor suppressor function,cell cycle regulation,genomic stability maintenance,cancer progression inhibition,apoptosis induction,dna damage response
ENSG00000147676,MAL2,tumor suppression,cell-cell adhesion,e-cadherin complex,pi3k/akt pathway inhibition,metastatic potential reduction,epithelial integrity maintenance
ENSG00000130957,FBP2,glycolytic adaptation,oncogenic transformation,pi3k/akt pathway interaction,glucose metabolism enhancement,aggressive tumor behavior,therapeutic target potential
ENSG00000165140,FBP1,metabolic regulation,tumor suppressor function,glucose uptake modulation,cell proliferation inhibition,oncogenesis repression,hif1a interaction
ENSG00000166261,ZNF202,tumor suppression,genomic stability maintenance,dna repair regulation,chromatin modification,cellular proliferation regulation,gene expression regulation
ENSG00000175294,CATSPER1,oncogene,cell proliferation,elevated expression,therapeutic target,poor prognosis,aggressive tumor behavior
ENSG00000196923,PDLIM7,oncogenic role,overexpression in cancer,cell adhesion disruption,signaling pathway modulation,tumor progression,metastasis facilitation
ENSG00000189042,ZNF567,chromatin remodeling,dna-binding activity,tumor suppressor function,cell proliferation regulation,gene expression regulation,krab domain interaction
ENSG00000170264,FAM161A,genomic instability,chromosomal rearrangement,homologous recombination,dna replication,dna repair mechanisms,cell proliferation
ENSG00000095066,HOOK2,microtubule regulation,cell cycle progression,spindle checkpoint modulation,katanin interaction,protein-protein interactions,tumor aggressiveness
ENSG00000105185,PDCD5,apoptosis regulation,genetic instability,metastasis promotion,microrna target,pi3k/akt pathway modulation,tumor suppressor
,HIST2H2BF,histone modification,chromatin regulation,epigenetic regulation,genomic instability,cell proliferation,tumor progression
ENSG00000033170,FUT8,glycosylation regulation,tumor progression,metastasis,cell surface modification,immune evasion,prognostic marker
ENSG00000251369,ZNF550,transcriptional regulation,amplification,overexpression,tumor progression,oncogenic pathway activation,dna-binding capabilities
ENSG00000173207,CKS1B,cell cycle regulation,phosphorylation activity,tumor growth promotion,cell proliferation enhancement,protein-protein interaction,therapeutic target
ENSG00000141699,RETREG3,cell cycle regulation,oncogenic processes,genomic instability,tumor progression,prognostic marker,proliferation and survival pathways
ENSG00000241598,KRTAP5-4,indirect association with tumor suppression,disruption of epithelial integrity,cellular adhesion alterations,potential role in oncogenesis,keratin filament interaction,limited cancer-related literature
ENSG00000278489,KRTAP5-2,keratin-associated protein function,epithelial cell integrity maintenance,cellular structure regulation,oncogenic potential,tumor suppressor downregulation,cell proliferation enhancement
ENSG00000163206,SMCP,tumor-associated antigen,pi3k/akt pathway interaction,cell proliferation enhancement,survival promotion,metastasis facilitation,upregulated expression
ENSG00000126890,CTAG2,oncogene,chromatin organization,cell cycle regulation,transcription factor binding,gene expression modulation,epigenetic regulator
ENSG00000182816,KRTAP13-2,tumor suppressor,cytoskeleton regulation,epithelial integrity loss,cell differentiation impairment,poor prognosis marker,genomic instability promotion
ENSG00000178053,MLF1,mlf1 tumour suppressor,cell proliferation regulation,pi3k/akt signaling pathway interaction,apoptosis regulation disruption,tumor aggressiveness enhancement,prognostic biomarker potential
ENSG00000131016,AKAP12,cell migration,oncogene activation,scaffolding protein function,signaling pathway regulation,protein kinase interaction,biomarker potential
ENSG00000124222,STX16,tumor progression,genomic instability,cancer driver mutations,cell proliferation regulation,dna repair regulation,epigenetic modifications
ENSG00000168237,GLYCTK,altered glycosylation,glycan structure modulation,oncogenic processes,cell proliferation,tumor progression,immune evasion
ENSG00000262771,SSBP1,genomic instability,cell proliferation,dna damage response,oncogenesis,single-stranded dna binding,overexpression
ENSG00000124827,GCM2,cell cycle regulation,gene expression dysregulation,transcription factor function,apoptosis evasion,tumor proliferation enhancement,oncogene activation
ENSG00000105355,PLIN3,lipid metabolism dysregulation,tumor progression driver,overexpression,cell growth promotion,poor prognosis biomarker,signaling pathway modulation
ENSG00000169877,AHSP,aldehyde dehydrogenase activity,redox regulation,oxidative stress resistance,tumor suppressor function,aldehyde oxidation,cellular protection mechanisms
ENSG00000049541,RFC2,dna replication,cell proliferation,genomic instability,cell cycle progression,protein-protein interactions,tumor growth enhancement
ENSG00000162433,AK4,cellular signaling pathway,camp-dependent protein kinase a,oncogenic process,tumor progression,cell proliferation inhibition,apoptosis inhibition
ENSG00000167670,CHAF1A,genomic instability,oncogenic function,cell cycle regulation,dna damage response,apoptosis modulation,chromatin remodeling
ENSG00000198920,KIAA0753,cellular proliferation,transcriptional regulation,mrna deadenylation,cell cycle progression,therapeutic target,tumor invasion
ENSG00000149115,TNKS1BP1,telomere length regulation,wnt signaling pathway,cell proliferation inhibition,apoptosis suppression,oncogenic properties,genomic instability
ENSG00000138767,CNOT6L,regulation of mrna degradation,cell proliferation regulation,interaction with pi3k/akt pathway,tumor progression association,dna damage response,genomic instability modulation
ENSG00000179627,ZBTB42,transcriptional repression,tumorigenesis driver,oncogene overexpression,epigenetic regulation,apoptosis evasion,cell cycle progression
ENSG00000205220,PSMB10,proteolytic regulation,cellular degradation,proteasome complex,oncogenic mutations,therapeutic target,cellular homeostasis
ENSG00000197343,ZNF655,transcription factor activation,tumor progression,oncogene function,cell cycle regulation,apoptosis dysregulation,genomic instability
ENSG00000146457,WTAP,alternative splicing regulation,tumor progression driver,pi3k/akt pathway modulation,u2af65 interaction,molecular diagnostics target,cancer cell survival enhancement
ENSG00000162775,RBM15,rna-binding protein,transcriptional regulation,chromatin remodeling,oncogenic transcription,cell proliferation,survival pathway
ENSG00000165156,ZHX1,nf-κb pathway inhibition,tumor suppressor function loss,epithelial-to-mesenchymal transition regulation,immune checkpoint modulation,gene expression regulation,transcription factor activity
ENSG00000171307,ZDHHC16,palmitoylation regulation,oncogenic process activation,cell proliferation enhancement,tumor progression facilitation,lipid modification enzyme,overexpression in tumors
ENSG00000125107,CNOT1,cell cycle regulation,dna damage response,tumor aggressiveness,proliferation,mrna degradation,translation inhibition
ENSG00000151876,FBXO4,cell cycle regulation,tumor suppressor function,apoptosis induction,protein degradation pathway,genomic stability maintenance,biomarker potential
ENSG00000117533,VAMP4,**

vesicle trafficking regulation,tumor suppressor function,cell adhesion disruption,prognostic biomarker,signaling pathway modulation,cancer cell aggressiveness enhancement

**
ENSG00000169122,FAM110B,cell proliferation,pi3k/akt pathway activation,tumor progression,oncogene,microtubule regulation,poor prognosis
ENSG00000221837,KRTAP10-9,epithelial cell integrity,cell adhesion disruption,oncogenesis promotion,proliferation enhancement,emt modulation,therapeutic target
ENSG00000198805,PNP,purinergic signaling,nucleotide regulation,cellular metabolism,tumor microenvironment modulation,apoptosis regulation,therapeutic target
ENSG00000054523,KIF1B,mitotic spindle regulation,genomic instability,amplification driven oncogenesis,chromosome segregation accuracy,motor-dependent transport,cellular proliferation
ENSG00000288295,MCTS1,metabolic reprogramming,cell proliferation,altered cellular metabolism,tumor progression,prognostic marker,biomarker
ENSG00000156261,CCT8,protein folding regulation,cell cycle regulation,tumor progression,cancer driver gene,chemoresistance modulation,oncogenic processes
ENSG00000172354,GNB2,aberrant signaling,cell migration,g protein regulation,mapk/erk pathway activation,mutations associated,oncogenesis promoted
ENSG00000013275,PSMC4,protein degradation,cell proliferation,cell cycle regulation,oncogene activation,tumor progression,ubiquitination
ENSG00000101843,PSMD10,proteasome function,cell cycle regulation,genomic instability,apoptosis modulation,metastasis facilitation,tumor progression marker
ENSG00000008323,PLEKHG6,pi3k/akt pathway interaction,cell migration regulation,oncogenesis promotion,apoptosis resistance,cell proliferation enhancement,gtpase activity
ENSG00000131791,PRKAB2,pka activation,regulatory subunit function,constitutive activation,oncogenic driver,cell proliferation,metabolic regulation
ENSG00000203805,PLPP4,lipid metabolism regulation,phospholipid dysregulation,cell membrane alteration,tumor progression association,signaling pathway interaction,poor prognosis marker
ENSG00000131061,ZNF341,pi3k/akt pathway interaction,tumor progression promotion,cell cycle regulation,apoptosis inhibition,prognostic biomarker candidate,oncogenesis contribution
ENSG00000179335,CLK3,ets1 activation,cell cycle regulation,rna processing,protein kinase activity,transcriptional regulation,oncogenic signaling
ENSG00000172789,HOXC5,wnt/β-catenin pathway modulation,oncogene activation,transcriptional regulation,cell proliferation promotion,tumor aggressiveness association,poor prognosis indicator
ENSG00000174307,PHLDA3,cell cycle regulation,tumor suppression,apoptosis regulation,cyclin-dependent kinase inhibition,microrna regulation,genomic stability
ENSG00000079257,LXN,epithelial-to-mesenchymal transition,genomic instability,cell migration,tumor suppression,oncogene activation,transcriptional regulation
ENSG00000196859,KRT39,keratin overexpression,apologetic resistance,cytoskeletal disruption,oncogenic transformation,tumor progression marker,epithelial cell aberration
ENSG00000205426,KRT81,altered expression,cytoskeletal disruption,cell proliferation,apoptosis inhibition,dna damage response modulation,oncogenic process promotion
ENSG00000198908,BHLHB9,cell cycle regulation,transcriptional repression,tumor suppressor function,apoptosis induction,genomic stability maintenance,dna replication control
ENSG00000156273,BACH1,epithelial-to-mesenchymal transition,transcription factor activity,cell proliferation regulation,apoptosis suppression,genetic instability driver,angiogenesis promotion
ENSG00000278458,KANSL1,**

chromatin remodeling,transcriptional regulator,dna damage repair,genome stability,epigenetic modification,cancer susceptibility

**
ENSG00000114626,ABTB1,chromosomal instability,tumor suppressor function,cell cycle regulation,dna damage response,spindle checkpoint maintenance,genomic integrity maintenance
ENSG00000100815,TRIP11,centrosomal dysfunction,chromosomal instability,constitutive activation,mitotic spindle formation,oncogenic driver,protein-protein interaction
ENSG00000086967,MYBPC2,cellular signaling,cytokeletal regulation,tumor progression,overexpression,cell proliferation,genomic instability
ENSG00000156983,BRPF1,chromatin remodeling,epigenetic regulation,oncogenic process,tumor suppressor silencing,gene expression modulation,nucleus localization
ENSG00000169744,LDB2,tumor progression,promotes oncogenesis,transcriptional coactivator,regulates gene expression,cell proliferation,cell differentiation
ENSG00000148481,MINDY3,genomic instability,chromosomal alterations,dna damage response,cell proliferation,oncogenic mutations,transcriptional regulation
ENSG00000197714,ZNF460,transcriptional repressor,oncogenic function,cell proliferation promoter,apoptosis inhibitor,epigenetic regulation,dna interaction
ENSG00000157212,PAXIP1,chromatin remodeling,protein-protein interaction,cell cycle regulation,genomic stability,tumor progression,oncogene expression
ENSG00000121057,AKAP1,epithelial-to-mesenchymal transition,signaling pathway regulation,cell cycle progression,cell survival enhancement,protein kinase activation,tumor aggressiveness
ENSG00000165632,TAF3,genomic instability,cell proliferation,transcriptional regulation,apoptosis regulation,dna repair,prognostic marker
ENSG00000171517,LPAR3,cell migration,g protein coupled receptor,high expression levels,protein kinase activation,tumor progression,signaling pathway modulation
ENSG00000215712,TMEM242,cell-cell interaction regulation,epithelial-to-mesenchymal transition,plasma membrane localization,oncogenic signaling modulation,therapeutic target,cancer progression
ENSG00000166224,SGPL1,golgi-resident enzyme,signaling pathway regulation,sphingosine-1-phosphate hydrolysis,tumor progression promotion,cell survival enhancement,cancer gene dysregulation
ENSG00000162367,TAL1,oncogene activation,enhanced cell proliferation,apoptosis resistance,tumor progression,cell cycle regulation,gata3 interaction
ENSG00000261934,PCDHGA9,cell-cell adhesion,pi3k/akt signaling,cell proliferation,metastasis,tumor progression,genomic instability
ENSG00000175582,RAB6A,microtubule dynamics,cancer cell migration,pi3k/akt pathway interaction,emt regulation,cell survival signaling,proliferation enhancement
ENSG00000147050,KDM6A,epigenetic regulation,histone demethylation,tumor suppressor gene silencing,oncogenic reprogramming,cellular proliferation enhancement,metastatic potential increase
ENSG00000139190,VAMP1,autophagosome formation,cell proliferation,cell migration,enhanced expression,increased activity,metastasis promotion
ENSG00000099365,STX1B,cellular proliferation,overexpression,metastasis regulation,phosphorylation modulation,signal transduction,exocytic process
ENSG00000114853,ZBTB47,tumor growth promotion,apoptosis suppression,cell cycle regulation,transcriptional regulation,oncogenic pathway activation,cancer driver gene
ENSG00000213672,NCKIPSD,cell adhesion regulation,gene amplification,signaling complex assembly,emt regulation,protein-protein interaction,tumor progression
ENSG00000123080,CDKN2C,cell cycle regulation,dysregulated expression,loss-of-function mutations,tumor development,uncontrolled cell growth,checkpoints deregulation
ENSG00000109854,HTATIP2,dna damage response,cell cycle regulation,biomarker potential,tumor aggressiveness,acetyltransferase interaction,brca1 association
ENSG00000180035,ZNF48,transcriptional regulation,cell cycle progression,tumor suppressor interaction,apoptosis regulation,dna repair modulation,genomic stability maintenance
ENSG00000178971,CTC1,genomic instability,telomere maintenance,dna repair pathways,oncogenic mutations,tumor suppression,chromosomal stability
ENSG00000107960,STN1,genomic instability,dna replication regulation,helicase activation,cell proliferation enhancement,oncogenic driver mutation,therapeutic target
ENSG00000077274,CAPN6,calpain activity,cell cycle regulation,tumor progression,p53 interaction,epigenetic regulation,ca2+ dependent proteolysis
,SEPT7,septin function,oncogenic overexpression,cell cycle dysregulation,genomic instability,apoptosis resistance,protein-protein interaction
ENSG00000285394,C3orf52,long non-coding rna,upregulation,microrna sponge,molecular interaction,pi3k/akt pathway,apoptosis regulation
ENSG00000113845,TIMMDC1,mitochondrial regulation,p53 interaction,oncogenesis promotion,energy metabolism modulation,tumor suppressor protein modulation,therapeutic target
ENSG00000196150,ZNF250,transcriptional regulation,cell cycle progression,dna repair mechanisms,apoptosis modulation,chromatin remodeling,tumor suppression
ENSG00000159399,HK2,metabolic reprogramming,glycolytic flux regulation,energy metabolism pathway,tumor aggressiveness,therapeutic target potential,hypoxia adaptation
ENSG00000126368,NR1D1,cell cycle regulation,transcriptional modulation,oncogenic functions,tumor suppressor suppression,biomarker potential,genome instability
ENSG00000127564,PKMYT1,cell proliferation,oncogenic process,phosphorylation activation,pi3k/akt pathway interaction,tumor progression,cancer cell survival
ENSG00000058799,YIPF1,oncogene,protein-protein interaction,tumor progression,cell proliferation,metastasis promotion,er organization disruption
ENSG00000129680,MAP7D3,overexpressed,cell proliferation regulation,apoptosis regulation,microtubule dynamics regulator,poor prognosis marker,tumor progression association
ENSG00000121297,TSHZ3,tumor suppressor repression,oncogene overexpression,cell cycle regulation,apoptosis inhibition,transcriptional regulation,chromatin remodeling
ENSG00000083857,FAT1,tumor suppressor function,cell adhesion regulation,emt inhibition,oncogenic pathway suppression,cell proliferation regulation,adhesion molecule interaction
ENSG00000073111,MCM2,dna replication,cell proliferation,tumor progression,oncogenic pathway activation,genome stability disruption,therapeutic target
ENSG00000010282,HHATL,histone modification regulation,chromatin organization,gene expression dysregulation,cell growth modulation,wdr5 interaction,tumor suppressor gene regulation
ENSG00000148704,VAX1,transcriptional regulation,cell proliferation,oncogene function,upregulated expression,tissue differentiation,developmental pathway regulation
ENSG00000006704,GTF2IRD1,gata-binding protein family,transcriptional regulation,tumor progression,cell growth regulation,oncogene or tumor suppressor,chromatin remodeling
ENSG00000170948,MBD3L1,histone modification,epigenetic regulation,dna methylation,tumor suppressor,oncogenic potential,cellular proliferation
ENSG00000230475,ABHD16A,tumor suppressor function,metabolic regulation,cell proliferation regulation,pi3k/akt signaling modulation,lipid metabolism regulation,oncogenic potential
ENSG00000174567,GOLT1A,aberrant glycosylation,cancer-associated mutations,cell proliferation enhancement,genetic alterations,oncogene function disruption,protein stability modulation
ENSG00000103657,HERC1,cell cycle regulation,dna damage response,oncogene activation,tumor suppressor interaction,protein degradation regulation,genomic instability
ENSG00000151967,SCHIP1,zinc homeostasis regulation,tumor cell proliferation,epithelial cell expression,genomic stability maintenance,signaling pathway modulation,protein-protein interaction
ENSG00000120688,WBP4,ww domain binding,transcriptional regulation,cell proliferation promotion,protein-protein interaction modulation,overexpression in cancer tissues,cell migration and invasion promotion
ENSG00000099139,PCSK5,igf-1 activation,protease activation,cell proliferation,apoptosis resistance,tumor invasion,signal transduction
ENSG00000173898,SPTBN2,cell migration,cellular adhesion disruption,cytoskeleton dysregulation,epithelial-to-mesenchymal transition,mechanical stability loss,tumor progression
ENSG00000151117,TMEM86A,cellular homeostasis regulation,transmembrane protein function,tumor progression facilitation,oncogenic pathway modulation,signaling pathway interaction,dysregulated expression
ENSG00000162735,PEX19,peroxisomal biogenesis,protein-protein interaction,cell proliferation,lipid metabolism,apoptosis regulation,signal transduction pathway
ENSG00000168958,MFF,mitochondrial dynamics,tumor suppressor function,apoptosis regulation,mitochondrial biogenesis,energy metabolism regulation,cancer cell survival
ENSG00000188807,TMEM201,tumor suppressor function,polarity regulation,hippo signaling pathway,cell adhesion disruption,therapeutic target,genomic instability
ENSG00000135506,OS9,protein regulation,cell cycle progression,apoptosis modulation,oncogenic protein stabilization,therapeutic target,tumor progression
ENSG00000118200,CAMSAP2,microtubule stabilization,cell migration,oncogenic signaling,epithelial-to-mesenchymal transition,apoptosis regulation,protein-protein interaction
ENSG00000163126,ANKRD23,cellular proliferation,cell survival,oncogene potential,biomarker significance,apoptosis regulation,cell cycle modulation
ENSG00000262862,KRTAP2-3,cytoprotective mechanisms,proliferative signaling pathway,cellular adhesion regulation,cytoskeletal reorganization,intermediate filament stability,aberrent cell migration
ENSG00000178279,TNP2,actin filament regulation,cell migration,cytoskeletal organization,cell invasion,protein interaction,tumorigenesis
ENSG00000127588,GNG13,gpcr signaling pathway,regulation of cell migration,interactions with urokinase-type plasminogen activator receptor (upar),cell cycle regulation,heterotrimeric g protein complex component,tumor progression marker
ENSG00000136930,PSMB7,cell cycle regulation,protein degradation,tumorigenesis,tumor progression,ubiquitin-proteasome pathway,biomarker candidacy
ENSG00000006194,ZNF263,genomic instability,transcriptional regulation,cell cycle progression,apoptosis inhibition,protein-dna interaction,tumor aggressiveness
ENSG00000171456,ASXL1,chromatin remodeling,epigenetic regulation,genomic instability,oncogenic driver,tumor suppressor,apoptosis resistance
ENSG00000126251,GPR42,lipid metabolism regulation,cell proliferation enhancement,tumor progression association,therapeutic target potential,energy metabolism modulation,biomarker indication
ENSG00000146859,TMEM140,cell membrane integrity regulation,oncogene activation,tumor progression,apoptosis inhibition,cell proliferation modulation,protein-protein interaction
ENSG00000095787,WAC,genomic instability,tumor suppressor function,dna repair disruption,epigenetic alterations,prognostic marker,cell cycle regulation
ENSG00000183640,KRTAP8-1,keratin filament assembly,epithelial-to-mesenchymal transition,cytoskeleton modulation,tumor progression,prognostic marker,cellular morphology regulation
ENSG00000115310,RTN4,tumor progression,cell migration,cell invasion,adherens junction regulation,focal adhesion modulation,cell survival pathway interaction
ENSG00000086506,HBQ1,genomic instability,cell proliferation,mitotic checkpoint regulation,aneuploidy,tumor progression,therapeutic target
ENSG00000270765,GAS2L2,apoptosis regulation,tumor suppressor function,genomic stability maintenance,dna damage response,biomarker potential,pro-apoptotic protein regulation
ENSG00000109771,LRP2BP,lrp2 interaction,cell survival promotion,apoptosis suppression,tumor progression,protein-protein interaction,cell growth regulation
ENSG00000125870,SNRPB2,genomic instability,splicing regulation,tumor progression,cellular growth disruption,rna processing alterations,aberrant protein isoform production
ENSG00000133115,STOML3,oncogenic behavior,cell membrane dynamics,cell signaling pathway,tumor progression,cancer-associated protein,overexpression
ENSG00000156113,KCNMA1,cell cycle regulation,calcium-activated potassium channels,oncogene overexpression,tumor progression,cell survival pathways,signaling pathway dysregulation
ENSG00000102241,HTATSF1,genomic instability,cell cycle progression regulation,transcriptional regulation,oncogene overexpression,apoptosis inhibition,dna repair modulation
ENSG00000247596,TWF2,microtubule regulation,dna damage response,cell proliferation,pi3k/akt pathway activation,cytoskeletal organization,genomic instability
ENSG00000133627,ACTR3B,actin polymerization,tumor progression,metastasis,cell migration,prognostic marker,pi3k/akt signaling
ENSG00000142089,IFITM3,viral entry regulation,oncogenic processes promotion,tumor suppressor genes suppression,epithelial-to-mesenchymal transition (emt),cancer driver gene candidate,pi3k/akt pathway modulation
ENSG00000125255,SLC10A2,altered expression,cell survival,dysregulation,oxidative stress response,transport function,bile acid metabolism
ENSG00000135972,MRPS9,mitochondrial ribosome function,energy metabolism regulation,cellular homeostasis modulation,tumor progression facilitation,cancer driver gene candidate,gene expression upregulation
ENSG00000144567,RETREG2,transcriptional regulation,cell cycle progression,tumor progression,apoptosis resistance,cell growth promotion,chromatin remodeling
ENSG00000123485,HJURP,genomic instability,aneuploidy,chromatin assembly factor,tumor aggressiveness,prognostic marker,cell cycle regulation
ENSG00000141552,ANAPC11,cell cycle regulation,chromosome segregation,tumor suppressor function,dna damage accumulation,genome instability,poor prognosis
ENSG00000107758,PPP3CB,pp2b activation,nf-κb signaling pathway,cell cycle regulation,oncogenic properties,tumor progression,transcriptional activation
ENSG00000112561,TFEB,autophagy regulation,mtor pathway activation,oncogenic transcription factor,cell survival enhancement,protein degradation regulation,pi3k/akt signaling modulation
ENSG00000170035,UBE2E3,aberrant regulation,tumor suppressor loss,protein accumulation,dna repair defect,cell cycle dysregulation,cancer-related signaling pathway interaction
ENSG00000178498,DTX3,chromatin remodeling,transcriptional regulation,aggressive tumor behavior,epigenetic modification,tumor progression,biomarker for prognosis
ENSG00000106609,TMEM248,disrupted wnt signaling pathway,constitutive activation of oncogenes,cell growth promotion,genomic instability maintenance,cdk2 and ccnd1 interaction,wnt signaling regulation
ENSG00000204070,SYS1,checkpoint response,oncogene,cell proliferation,dna replication,fha domain,phosphorylation
ENSG00000187109,NAP1L1,chromatin remodeling,oncogenic mutations,cell cycle regulation,transcriptional regulation,therapeutic target,genomic instability
ENSG00000105255,FSD1,tumor suppression,genomic stability,cellular proliferation control,dna repair regulation,protein interaction modulation,oncogenic pathway suppression
ENSG00000072609,CHFR,genomic instability,cell cycle checkpoint disruption,tumor suppressor function loss,dna damage response impairment,chromosomal abnormalities,therapeutic target
ENSG00000101310,SEC23B,protein trafficking,genomic mutations,tumor aggressiveness,therapeutic target,autophagy regulation,cellular homeostasis
ENSG00000124562,SNRPC,spliceosome regulation,snrnp assembly,dysregulated gene expression,tumor-specific mutations,cancer-associated aberrations,molecular diagnosis
ENSG00000088766,CRLS1,...<end>,sorted by importance:

<begin>
tumor suppression,apoptosis regulation,cell growth inhibition,protease regulation,genomic instability modulation
ENSG00000059145,UNKL,cell cycle regulation,transcriptional regulation,dna repair mechanism,ubiquitin ligase function,tumor microenvironment interaction,genomic instability marker
ENSG00000090674,MCOLN1,oncogenic driver,tumor growth promotion,immune evasion facilitation,cell cycle progression enhancement,apoptosis suppression,epithelial-to-mesenchymal transition regulation
ENSG00000263296,KRTAP3-2,epithelial-to-mesenchymal transition,cell adhesion regulation,metastasis promotion,poor prognosis marker,type ii transmembrane protein,keratin-associated protein function
ENSG00000111450,STX2,oncogenic behavior,pi3k/akt pathway interaction,cell proliferation regulation,survival promotion,vesicle trafficking dysregulation,prognostic marker
ENSG00000145087,STXBP5L,chromosomal instability,tumor progression,cell proliferation,oncogenic pathway,signal transduction,protein-protein interaction
ENSG00000188566,NDOR1,coactivator function,cell proliferation,nuclear receptor interaction,tumor progression,epithelial-to-mesenchymal transition (emt),oncogenic process
ENSG00000236843,NRM,oncogene,cell proliferation,nuclear receptor coactivator,transcriptional regulation,pi3k/akt pathway activation,apoptosis resistance
ENSG00000165304,MELK,mitosis regulation,cancer cell proliferation,apoptosis suppression,tumor aggressiveness,proliferative signaling pathway,chromosomal instability
ENSG00000171843,MLLT3,histone methyltransferase activity,chromatin modification,oncogenic properties,cell proliferation enhancer,dna damage response,epigenetic regulation
ENSG00000168032,ENTPD3,apoptosis regulation,tumor suppressor function,pi3k/akt pathway modulation,cell death regulation,nucleotide metabolism alteration,cancer-related protein interaction
ENSG00000167741,GGT6,cell cycle dysregulation,microrna regulation,oncogenic properties,protein-protein interaction,cell membrane transport,cellular proliferation
ENSG00000157985,AGAP1,regulation of protein trafficking,tumor progression,alterations in expression levels,interaction with cancer-related proteins,cell growth regulation,membrane trafficking pathway regulation
ENSG00000064961,HMG20B,chromatin remodeling,cell proliferation,dna repair pathway,transcription regulation,oncogenic process,therapeutic target
ENSG00000106628,POLD2,dna replication,genomic instability,cell survival enhancement,tumor progression driver,chemotherapy resistance,dna repair mechanism
ENSG00000064270,ATP2C2,calcium transport,cellular signaling,endoplasmic reticulum localization,gene regulation,protein-protein interaction,tumorigenesis
ENSG00000160948,VPS28,endosomal trafficking,oncogenic processes,autophagy regulation,cell growth promotion,escrt complex component,pi3k/akt pathway interaction
ENSG00000171056,SOX7,pi3k/akt/mtor pathway regulation,transcriptional regulation,cell differentiation modulation,oncogene activation,pro-apoptotic gene expression,tumor progression enhancement
ENSG00000197753,LHFPL5,lipid phosphate regulation,oncogene involvement,protein interaction,cell growth modulation,tumor progression,biomarker potential
ENSG00000105254,TBCB,regulation of rab gtpases,enhanced cell proliferation,somatically acquired mutations,tumor progression,cancer cell survival,mitotic machinery interaction
ENSG00000261609,GAN,o-glycosylation,glycoprotein anchor function,cell surface modification,protein transport regulation,tumor microenvironment modulation,therapeutic target
ENSG00000104237,RP1,cellular processes regulation,microtubule dynamics disruption,tumor suppressor function,dna damage response,genomic instability,chromosome segregation
ENSG00000234602,MCIDAS,cell cycle regulation,dna damage response,cell proliferation,tumor suppressor activity,genomic instability,cancer driver gene
ENSG00000282956,MAGI1,tumor suppressor,cell-cell adhesion regulation,downregulated in cancer,wnt/β-catenin pathway modulation,pi3k/akt pathway interaction,transcriptional repression by tgf-β
ENSG00000105137,SYDE1,hippo/yap signaling pathway,oncogene,centrosome duplication,spindle assembly,chromosomal instability,genomic alterations
ENSG00000100739,BDKRB1,angiogenesis promotion,apoptosis inhibition,cell migration enhancement,cell proliferation stimulation,growth factor signaling,inflammation regulation
ENSG00000156970,BUB1B,chromosomal instability,genomic instability,mitotic checkpoint regulation,cell proliferation,therapeutic target,aneuploidy prevention
ENSG00000188641,DPYD,metabolic regulation,chemotherapy sensitivity,toxicity modulation,5-fluorouracil degradation,pyrimidine catabolism,oncogene mutagenesis
ENSG00000249915,PDCD6,programmed cell death regulation,apoptosis modulation,dna damage response,tumor suppressor function,cell survival enhancement,cancer stem cell maintenance
ENSG00000179455,MKRN3,chromatin remodeling,ubiquitination,cell proliferation regulation,apoptosis modulation,transcriptional regulation,ring finger protein interaction
ENSG00000170091,NSG2,guanylate cyclase activation,cyclic gmp production,cell growth regulation,vascular tone modulation,signaling pathway disruption,oncogenesis facilitation
ENSG00000177954,RPS27,ribosomal protein translation,oncogene potential,mtor pathway activation,cell cycle regulation,gain of function mutations,protein synthesis promotion
ENSG00000118579,MED28,chromatin remodeling,tumor progression,transcriptional regulation,histone acetylation,genome instability,cell proliferation
ENSG00000100038,TOP3B,dna replication,genomic instability,apoptosis pathway,cell cycle progression,dna damage tolerance,therapeutic target
ENSG00000144021,CIAO1,mitochondrial function alterations,energy metabolism regulation,cell survival promotion,drug resistance development,tumor progression influence,pi3k/akt pathway interaction
ENSG00000161692,DBF4B,cell cycle regulation,chromosomal instability,gene expression dysregulation,protein-protein interaction,transcription factor target,aneuploidy induction
ENSG00000146112,PPP1R18,pi3k/akt pathway interaction,apoptosis regulation,cell cycle progression,metabolic regulation,tumor metastasis,prognostic marker
ENSG00000134748,PRPF38A,altered splicing patterns,apoptosis resistance,cell growth enhancement,genomic instability,molecular marker,oncogenic function
ENSG00000118762,PKD2,cellular proliferation,calcium regulation,oncogenic signaling,transmembrane protein,channel activity disruption,tumor suppressor function
ENSG00000008710,PKD1,cell signaling,mutations leading to cell growth,aberrant activation,genetic alteration,ion transport regulation,mechanosensation disruption
ENSG00000127903,ZNF835,dna-binding activity,transcriptional regulation,oncogene function,cell cycle progression,apoptosis inhibition,protein-dna interaction
ENSG00000211456,SACM1L,genomic instability,oncogene activation,cell proliferation,microtubule stability,centrosome cohesion,therapeutic target
ENSG00000116161,CACYBP,cell cycle progression,apoptosis inhibition,tumor growth promotion,b-box domain interaction,p53 inhibition,prognostic biomarker potential
ENSG00000157538,VPS26C,endosomal trafficking regulation,oncogenic protein accumulation,pi3k/akt pathway activation,cell proliferation enhancement,apoptosis inhibition,metastasis facilitation
ENSG00000149089,APIP,epigenetic regulation,pseudogene functions,non-coding rna regulation,chromatin remodeling,cellular signaling pathways,altered expression levels
ENSG00000100577,GSTZ1,oxidative stress,detoxification process,antioxidant defense,cellular homeostasis,gene expression regulation,fatty acid-coa conjugation
ENSG00000145391,SETD7,epigenetic regulation,chromatin modification,oncogenic function,tumor progression,cell survival,apoptosis resistance
ENSG00000212721,KRTAP4-11,epithelial integrity loss,cell proliferation enhancement,dysregulated expression,tumor progression promotion,cellular morphology alteration,signaling pathway interaction
ENSG00000081377,CDC14B,mitotic exit regulation,cell proliferation,genomic instability,gain of function mutations,cytokinesis dysfunction,cell cycle regulation
ENSG00000138944,SHISAL1,cell adhesion,oncogenic protein interaction,cell migration,tumor progression,biomarker potential,protein-protein interaction
ENSG00000255112,CHMP1B,cellular trafficking,oncogenic potential,tumorigenesis,cancer cell survival,membrane dynamics,autophagy regulation
ENSG00000119328,ABITRAM,cell motility regulation,regulation of cytoskeleton dynamics,potential tumor suppressor,actin-binding domain,reduced expression associated with tumor progression,metastasis regulation
ENSG00000023318,ERP44,er stress regulation,cell survival promotion,apoptosis resistance,tumor progression contribution,protein interaction modulation,stress response activation
ENSG00000162961,DPY30,genomic instability,tumor suppressor function,pi3k/akt pathway activation,protein degradation regulation,cell cycle progression impairment,oncogenic signaling pathways enhancement
ENSG00000166886,NAB2,epigenetic regulation,histone acetylation,tumor suppressor gene repression,chromatin remodeling,dysregulation mutations,poor prognosis factor
ENSG00000235650,RPS18,cellular proliferation,oncogenic processes,ribosomal protein synthesis,tumor aggressiveness,therapeutic target,mutational drivers
ENSG00000150961,SEC24D,oncogenesis,protein transport regulation,cell growth promotion,apoptosis inhibition,cell proliferation enhancement,er stress response modulation
ENSG00000213694,S1PR3,cell proliferation,mutation,immune evasion,angiogenesis,cell migration,therapeutic target
ENSG00000171634,BPTF,chromatin remodeling,transcriptional regulation,cell cycle progression,dna replication and repair,oncogenic potential,nucleosome remodeling complex 1
ENSG00000173614,NMNAT1,cellular metabolism,dna repair,oncogenesis,cellular proliferation,metabolic adaptation,nad biosynthesis
ENSG00000150433,TMEM218,epithelial-to-mesenchymal transition,transmembrane protein function,cell polarity regulation,metastasis driver,prognostic marker,cancer cell growth
ENSG00000198818,SFT2D1,histone modification,chromatin remodeling,transcriptional regulation,genomic instability,cell cycle progression,dna repair mechanisms
ENSG00000086159,AQP6,aquaporin regulation,ion transport,cellular hydration,stress response modulation,protein-protein interaction,pi3k/akt pathway alteration
ENSG00000130559,CAMSAP1,actin dynamics regulation,oncogene activation,pi3k/akt pathway enhancement,cell migration promotion,cytoskeletal rearrangement,metastasis facilitation
ENSG00000061676,NCKAP1,oncogene,scaffolding protein,cell signaling regulation,mapk/erk pathway activation,pi3k/akt signaling facilitation,emt promotion
ENSG00000155975,VPS37A,pi3k/akt pathway regulation,cancer cell proliferation,multivesicular body formation,protein degradation,therapeutic target,oncogenic processes
ENSG00000249581,CLRN2,cell migration,invasion and metastasis,cell adhesion disruption,tumor progression,prognostic marker,epithelial integrity loss
ENSG00000137078,SIT1,tumor progression,immune evasion,t-cell activation,cell proliferation,signal transduction,overexpression
ENSG00000100116,GCAT,glutathione synthesis,redox regulation,cancer cell survival,antioxidant response,cellular stress response,protein folding regulation
ENSG00000170128,GPR25,tumor marker,protein-protein interaction,cell proliferation,aggressive clinicopathological features,pi3k/akt/mtor pathway activation,g protein-coupled receptor signaling
ENSG00000071553,ATP6AP1,pi3k/akt activation,tumor progression,cancer metastasis,cellular ph regulation,v-atpase activity regulation,tumor aggressiveness
ENSG00000240432,KRTAP13-3,intermediate filament formation,epithelial cell maintenance,cellular structure regulation,tumor progression,genetic expression alterations,protein function dysregulation
ENSG00000057935,MTA3,tumor progression,oncogenic function,transcriptional regulation,metastasis-associated protein,chromatin modification,histone deacetylase interaction
ENSG00000158014,SLC30A2,zinc ion transport,cell proliferation regulation,tumor progression,oncogenic processes,genomic instability,therapeutic target
ENSG00000164756,SLC30A8,cellular metabolism,zinc regulation,transcriptional modulation,tumor progression,cancer cell growth,oncogenesis
ENSG00000116857,TMEM9,cell adhesion,epithelial polarity,transmembrane protein,cytoskeletal organization,cell migration,biomarker
ENSG00000111049,MYF5,muscle differentiation regulation,tumor suppressor activity loss,cell proliferation promotion,transcriptional regulation disruption,myogenic factor overexpression,basic helix-loop-helix family membership
ENSG00000176472,ZNF575,**

genomic instability,chromatin remodeling,oncogene expression,cell proliferation,dna repair mechanisms,transcriptional regulation
**
ENSG00000172023,REG1B,pi3k/akt/mtor signaling,genomic instability,cell proliferation,dna repair,transcriptional regulation,oncogenic transformation
ENSG00000090661,CERS4,cancer progression,cell proliferation enhancement,metastasis promotion,signaling pathway modulation,therapeutic target,lipid biosynthesis
ENSG00000133678,TMEM254,cell adhesion disruption,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,tumor growth promotion,metastasis enhancement,transmembrane protein overexpression
ENSG00000129472,RAB2B,rab family gtpase,small g protein,cell migration regulator,tumor suppressor or oncogene context-dependent,overexpression in cancer,membrane trafficking and endocytosis regulator
ENSG00000144061,NPHP1,basal body complex,ciliopathies,cell signaling disruption,cancer progression,dysregulation,mutations
ENSG00000131697,NPHP4,cilia disruption,cell proliferation,centrosome dysfunction,genomic instability,mitotic spindle assembly,pi3k/akt pathway modulation
ENSG00000186141,POLR3C,ribosomal rna transcription,transcriptional regulation,cell proliferation,genomic instability,oncogenic process,therapeutic target
ENSG00000198783,ZNF830,transcriptional regulation,zinc finger protein interaction,cell proliferation enhancement,tumor suppressor function disruption,oncogene overexpression,genomic instability promotion
ENSG00000061455,PRDM6,pr/set domain regulation,histone h3 lysine 4 methylation,chromatin remodeling,oncogenic potential,tumorigenesis driver,genomic instability
ENSG00000151461,UPF2,nonsense-mediated mrna decay,rna quality control,oncogenesis,cancer progression,translation regulation,cellular processes
ENSG00000124098,FAM210B,mitochondrial function regulation,pi3k/akt pathway activation,oncogenic potential,cell survival enhancement,genomic stability maintenance,prognostic biomarker
ENSG00000061918,GUCY1B1,cgmp signaling pathway,cell proliferation,mutations or altered expression,tumor progression,cellular homeostasis disruption,apoptosis resistance
ENSG00000164116,GUCY1A1,cgmp signaling,tumor progression,angiogenesis,apoptosis resistance,oncogene activation,signal transduction
ENSG00000164187,LMBRD2,bcaa metabolism,mitochondrial transport,cellular homeostasis,cancer cell metabolism,energy regulation,gene expression regulation
ENSG00000116830,TTF2,transcriptional regulation,oncogene overexpression,cell growth promotion,gene expression modulation,poor prognosis indicator,therapeutic target
ENSG00000165695,AK8,energy metabolism regulation,oncogenic role,cellular proliferation enhancement,proliferation and survival promotion,tumor suppressor inactivation,metabolic adaptation enhancer
ENSG00000166199,ALKBH3,alkylation repair,cell survival,genetic instability,proliferation promotion,tumor progression,dna damage response
ENSG00000062194,GPBP1,dna damage response,cell proliferation,oncogene overexpression,glycogen metabolism regulation,protein-protein interaction,therapeutic target
ENSG00000096092,TMEM14A,oxidative stress regulation,copper transport disruption,cellular redox balance,loss-of-function mutations,protein-protein interactions,akt pathway interaction
ENSG00000157613,CREB3L1,transcriptional regulation,tumor suppressor interaction,p53 pathway modulation,cancer development,cellular differentiation,apoptosis regulation
ENSG00000129187,DCTD,genomic instability,dna replication,cell cycle dysregulation,protein interactions,oncogenic properties,tumor progression
ENSG00000170860,LSM3,aberrant splicing,alternative splicing events,gene expression regulation,mir-101 target,protein isoform modulation,splicing factor regulation
ENSG00000111790,FGFR1OP2,tumor progression,cell proliferation,oncogenic processes,signaling pathway activation,protein interaction,tissue expression alteration
ENSG00000185897,FFAR3,cellular metabolism regulation,oncogene activation,pi3k/akt pathway modulation,fatty acid metabolism regulation,tumor progression promotion,cancer stem cell self-renewal
ENSG00000022840,RNF10,tumor suppressor function,genomic instability,p53 regulation,dna repair regulation,cell cycle progression regulation,ancillary e3 ubiquitin ligase activity
ENSG00000137411,VARS2,constitutive activation,gain of function mutations,genomic instability,altered transcriptional profiles,cell cycle dysregulation,genome integrity disruption
ENSG00000135365,PHF21A,chromatin regulation,oncogenic activity,transcriptional repression,histone methylation,cell cycle progression,stem cell maintenance
ENSG00000143228,NUF2,genomic instability,aneuploidy,cell cycle dysregulation,chromosomal abnormalities,kinetochore dysfunction,prognostic marker
ENSG00000058091,CDK14,cell cycle regulation,cyclin-dependent kinase activity,oncogene overexpression,proliferation enhancement,apoptosis resistance,therapeutic target
ENSG00000170854,RIOX2,cellular growth regulation,genomic instability,cell survival,transcriptional regulation,chromatin remodeling,dna repair mechanism
ENSG00000158806,NPM2,overexpression,oncogene function,cell proliferation regulation,dna damage response,pi3k/akt pathway activation,biomarker potential
ENSG00000149177,PTPRJ,loss of tumor suppressor function,downregulation or mutations,cell migration and invasion,metastasis promotion,pi3k/akt pathway interaction,dephosphorylation regulation
ENSG00000159173,TNNI1,tumor progression,overexpression,cell proliferation,signaling pathway activation,biomarker potential,muscle contraction regulation
ENSG00000160410,SHKBP1,signaling molecule interaction,cell growth promotion,metabolic regulation,oncogenic process facilitation,tumor progression,therapeutic target
ENSG00000169583,CLIC3,cell proliferation regulation,tumor progression association,apoptosis modulation,dna repair interaction,signaling pathway regulation,chloride transport role
ENSG00000146285,SCML4,atr/chk1 pathway,genomic instability,dna repair regulation,cancer driver mutation,genome maintenance,replication stress
ENSG00000149636,DSN1,mitochondrial dynamics,cancer progression,mitochondrial function regulation,cell signaling dysregulation,tumor suppressor dysfunction,apoptosis evasion
ENSG00000197683,KRTAP26-1,disrupted cell-cell interactions,keratin filament dynamics disruption,cellular adhesion loss,tumor progression association,epithelial tissue maintenance,cancer aggressiveness correlation
ENSG00000181778,TMEM252,driver mutation,cell adhesion disruption,pi3k/akt signaling interaction,oncogene activation,tumor growth promotion,metastasis facilitation
ENSG00000113369,ARRDC3,receptor regulation,endocytic recycling,tumor progression,potential oncogene suppression,cell surface modulation,prognostic marker
ENSG00000116903,EXOC8,exocyst complex assembly,cell migration enhancement,protein secretion regulation,signaling pathway modulation,tumor invasion facilitation,vesicle targeting dysfunction
ENSG00000165113,GKAP1,disrupted rho gtpase cycle,hippo-yap/taz signaling,cell migration dysregulation,oncogenic overexpression,growth factor regulation,cancer progression
ENSG00000103494,RPGRIP1L,cell proliferation enhancement,oncogene,genomic instability,pi3k/akt pathway activation,cell cycle regulation disruption,dna repair mechanism dysregulation
ENSG00000007255,TRAPPC6A,genomic amplification,oncogenic processes,cell proliferation enhancement,vesicle trafficking regulation,protein-protein interactions,aberrant signaling activation
ENSG00000276043,UHRF1,genomic instability,oncogenic function,dna repair disruption,epigenetic regulation,chromatin remodeling,prognostic marker
ENSG00000160961,ZNF333,transcriptional regulator,altered expression,cell growth regulation,oncogenesis,prognostic biomarker,cell cycle regulation
ENSG00000148677,ANKRD1,chromatin remodeling,cell proliferation regulation,tumor suppressor pathway,oncogenic process,mutations,transcriptional regulation
ENSG00000168530,MYL1,regulatory light chain,cell migration,cytoskeleton reorganization,microtubule regulation,oncogene expression,genomic amplification
ENSG00000141002,TCF25,cell proliferation,genomic instability,tumor progression,epithelial-to-mesenchymal transition (emt),apoptosis evasion,wnt/β-catenin signaling pathway
ENSG00000173404,INSM1,tumor suppressor,epigenetic regulation,cellular differentiation,apoptosis promotion,emt modulation,prognostic marker
ENSG00000117713,ARID1A,chromatin remodeling,swi/snf complex,genome instability,cell proliferation,tumor suppressor gene,oncogene activation
ENSG00000077454,LRCH4,wnt/β-catenin signaling pathway,cell proliferation regulation,oncogene expression,tumor progression initiation,signaling molecule interaction,protein-protein regulation
ENSG00000151502,VPS26B,pi3k/akt signaling pathway regulation,escrt-iii complex subunit,cell proliferation enhancement,oncogenic process promotion,cell migration and invasion facilitation,tp53 interaction and modulation
ENSG00000134108,ARL8B,enhanced cell proliferation,overexpression,pi3k/akt pathway activation,oncogenic transformation,tumor metastasis,protein synthesis regulation
ENSG00000137145,DENND4C,primary cilia formation,denn-rab interaction,pi3k/akt signaling enhancement,oncogenic mutations,cell proliferation promotion,cancer progression facilitation
ENSG00000159224,GIP,tumor progression,autocrine signaling,cell proliferation,growth factor regulation,protein-protein interaction,metastasis promotion
ENSG00000231377,DHX16,genomic instability,telomere maintenance,rna processing,helicase activity,transcriptional regulation,dna repair
ENSG00000183814,LIN9,histone h2a ubiquitination,chromatin remodeling,transcriptional regulation,oncogenic signaling,epigenetic modification,cell cycle progression
ENSG00000184708,EIF4ENIF1,regulatory mechanism,tumor progression,cell proliferation,mrna translation,oncogenesis,gene regulation
ENSG00000109686,SH3D19,erad pathway regulation,protein degradation modulation,tumorigenesis contribution,cell growth regulation,therapeutic target potential,genetic alteration association
ENSG00000123411,IKZF4,oncogenic function,transcriptional regulation,chromatin remodeling,wnt/β-catenin signaling,notch signaling,gene expression modulation
ENSG00000008018,PSMB1,proteasome function,degradation of misfolded proteins,modulation of unfolded protein response,cellular stress responses,protein homeostasis regulation,apoptosis suppression
ENSG00000152969,JAKMIP1,cell proliferation,mapk/erk pathway activation,emt regulation,apoptosis resistance,oncogenic driver,tumor aggressiveness
ENSG00000107165,TYRP1,mapk/erk signaling,constitutive activation,gain of function mutations,melanin synthesis,tumor progression,signaling pathway modulation
ENSG00000284984,RHOU,cell migration,proliferation,signaling pathway activation,rho gtpase activity,dysregulation,overexpression
ENSG00000079432,CIC,tumor suppressor gene repression,oncogene activation,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway regulation,transcription factor activity,cell growth and proliferation promotion
ENSG00000131351,HAUS8,microtubule organization,genomic instability,tumor progression,dysregulated protein interactions,gene mutations,cell cycle disruption
ENSG00000167625,ZNF526,transcriptional repression,krab domain-containing zinc finger proteins,tumor suppressor function,overexpression in cancer,genomic mutations affecting regulatory domains,gene expression modulation
ENSG00000133065,SLC41A1,magnesium homeostasis,cell proliferation regulation,biomarker for diagnosis and prognosis,resistance to chemotherapy and targeted therapies,tumor progression and tumorigenesis,regulation of signaling pathways
ENSG00000185046,ANKS1B,cell migration,metastasis,oncogenic process,protein-protein interaction,tumor progression,cytoskeleton organization
ENSG00000196584,XRCC2,genetic instability,dna damage response,homologous recombination,oncogene mutation,cancer progression,tumor suppressor function
ENSG00000170260,ZNF212,tumor suppressor activity loss,cell cycle regulation disruption,chromatin remodeling involvement,oncogene function,transcriptional regulation alteration,apoptosis inhibition
ENSG00000140553,UNC45A,oncogenic regulation,cell migration facilitation,muscle structure regulation,protein-protein interaction,cytoskeleton reorganization,tumor progression correlation
ENSG00000197448,GSTK1,altered expression,cell proliferation,detoxification pathway,dna repair,glutathione conjugation,oxidative stress regulation
ENSG00000183775,KCTD16,potassium channel regulation,tumor progression,cell proliferation,migration and invasion,apoptosis inhibition,p53 interaction
ENSG00000141279,NPEPPS,metalloprotease activity,tumor growth promotion,cell adhesion regulation,angiogenesis promotion,growth factor degradation,tumor progression
ENSG00000160741,CRTC2,cell cycle regulation,transcriptional coactivation,oncogene activation,tumor progression,prognostic marker,genomic amplification
ENSG00000143545,RAB13,regulation of cell migration,cytoskeleton remodeling,cell proliferation,tumor progression,oncogenic processes,membrane trafficking regulation
ENSG00000163884,KLF15,tumor suppressor function,loss of expression,cell cycle regulation,apoptosis induction,cell proliferation inhibition,transcriptional modulation
ENSG00000178057,NDUFAF3,mitochondrial dysfunction,oncogenesis promotion,cell proliferation enhancement,reactive oxygen species production,prognostic biomarker,cancer progression association
ENSG00000158825,CDA,cancer-relevant mechanisms,cellular redox balance regulation,prognostic marker,tumor aggressiveness,potential therapeutic target,oxidative stress response modulation
ENSG00000165584,SSX3,transcriptional regulation,tumor progression,cell proliferation,genetic amplification,protein interaction,apoptosis modulation
ENSG00000064195,DLX3,dysregulation of gene expression,cell proliferation regulation,tumor progression,transcription factor activity,epithelial-to-mesenchymal transition,apoptosis inhibition
ENSG00000080189,SLC35C2,glycosylation process,nucleotide sugar transport,oncogenic function,tumor progression,prognostic marker,cell proliferation
ENSG00000215203,GRXCR1,cellular stress response,redox regulation,oxidative stress tolerance,tumor promotion,nf-κb signaling pathway modulation,antioxidant defense mechanism
ENSG00000255690,TRIL,epithelial integrity maintenance,tumor suppression,cell proliferation regulation,transcriptional regulation,apoptosis modulation,emt regulation
ENSG00000163682,RPL9,cellular proliferation,enhanced expression,oncogenic driver,translation regulation,protein-protein interactions,apoptosis modulation
ENSG00000135486,HNRNPA1,rna processing,tumor progression,molecular regulation,cell proliferation,protein interaction,splicing regulation
ENSG00000166783,MARF1,oxidative stress regulation,dna damage response,mitochondrial function regulation,cell survival modulation,tumor progression contribution,therapeutic target potential
ENSG00000257923,CUX1,tumor suppressor,cell differentiation regulation,epithelial-to-mesenchymal transition,cell proliferation regulation,apoptosis modulation,oncogenic function
ENSG00000162819,BROX,oncogenic activity,transcriptional regulation,cell cycle progression,apoptosis inhibition,epithelial-to-mesenchymal transition,tumor progression
ENSG00000101421,CHMP4B,egfr signaling pathway activation,aberrant membrane trafficking,oncogenic driver mutations,tumor progression enhancement,poor prognosis marker,ubiquitin ligase target
ENSG00000156256,USP16,chromatin remodeling,tumor suppressor gene regulation,cell proliferation enhancement,anti-apoptotic function,dna repair facilitation,cancer biomarker
ENSG00000072832,CRMP1,microtubule interaction,oncogenic behavior,cell migration promotion,metastasis facilitation,prognostic marker,tumor aggressiveness
ENSG00000125447,GGA3,tumor progression,oncogenic transformation,cell proliferation,apoptosis inhibition,signaling pathway modulation,gef activity
ENSG00000188906,LRRK2,autophagy regulation,mitochondrial function,pi3k/akt pathway activation,kinase activity,tumor progression,genetic mutation frequency
ENSG00000087470,DNM1L,membrane trafficking,cell proliferation,receptor endocytosis,cancer driver gene,prognostic marker,cell migration
ENSG00000266094,RASSF5,tumor suppressor,epigenetic silencing,microtubule regulation,chromosomal instability,aneuploidy,cell cycle regulation
ENSG00000165792,METTL17,mrna methylation,oncogenic activity,cell growth regulation,protein-protein interaction,cancer cell invasiveness,tumor aggressiveness
ENSG00000061337,LZTS1,tumor suppression,transcriptional regulation,cell cycle control,cyclin-dependent kinase 2 inhibition,proliferation modulation,apoptosis promotion
ENSG00000139531,SUOX,cellular metabolism,oncogenesis,tumor progression,cellular signaling,biomarker potential,redox regulation
ENSG00000268651,CTAG1A,chromatin regulation,telomere maintenance,dna replication,genomic instability,oncogenic function,cell proliferation
ENSG00000105576,TNPO2,cell cycle regulation,nuclear import receptor,protein-protein interactions,tumor progression,metastasis,therapeutic target
ENSG00000184033,CTAG1B,genomic instability,dna damage response,tumor progression,homologous recombination repair,non-homologous end joining repair,predictive biomarker
ENSG00000127515,OR7A10,altered expression levels,tumor microenvironment modulation,apoptosis regulation,cell growth dysregulation,olfactory receptor function,epithelial tissue expression
ENSG00000186150,UBL4B,ubiquitination regulation,tumor progression,oncogenic protein stability,genomic instability,cell proliferation enhancement,apoptosis inhibition
ENSG00000123297,TSFM,tumor suppressor,cell cycle regulation,dna repair,tumor progression,genomic stability maintenance,cancer predisposition
ENSG00000166228,PCBD1,oncogenic potential,overexpression,tyrosine metabolism regulation,cellular homeostasis disruption,protein-protein interaction,metabolic reprogramming
ENSG00000276194,HNF1B,hepatocyte nuclear factor 1-beta,tumor suppressor function,impaired cellular differentiation,cellular proliferation enhancement,dna damage response disruption,apoptosis modulation
ENSG00000154358,OBSCN,muscle contraction regulation,cell migration regulation,tumor progression driver,prognostic marker,therapeutic target,genomic instability associated
ENSG00000106153,CHCHD2,mitochondrial integrity,regulation of gene expression,protein import into mitochondria,tumor suppression,altered mitochondrial dynamics,cancer cell metabolism modification
ENSG00000169895,SYAP1,cell adhesion disruption,oncogenic driver,cancer biomarker,loss-of-function mutations,tumor progression,protein-protein interaction
ENSG00000170037,CNTROB,centrosome integrity,microtubule dynamics,cell cycle progression,tumorigenesis,spindle pole assembly,oncogene expression
ENSG00000105939,ZC3HAV1,rna processing regulation,oncogene potential,tumor progression association,rna-binding protein interaction,motif similarity,overexpression marker
ENSG00000198271,KRTAP4-5,overexpression,cell proliferation,cell differentiation,protein interaction,cell growth,survival pathway
ENSG00000244462,RBM12,transcriptional regulation,gene expression enhancement,cell cycle progression,genomic instability,apoptosis reduction,oncogenic process
ENSG00000112182,BACH2,transcriptional repression,chromatin modification,loss of function mutation,tumor suppressor role,cell cycle regulation,apoptosis suppression
ENSG00000198517,MAFK,cell proliferation,transcriptional regulation,oncogene activation,apoptosis inhibition,immune evasion,tumor growth promotion
ENSG00000173991,TCAP,titin-cap protein interaction,cell proliferation promotion,oncogenic signaling pathway activation,aggressive tumor behavior,poor patient prognosis,cytoskeletal disruption
ENSG00000169271,HSPB3,cellular stress response,protein stabilization,apoptosis inhibition,actin dynamics regulation,cancer prognosis,signaling pathway interaction
ENSG00000144893,MED12L,transcription regulation,mediator complex function,genomic instability,cell proliferation,protein-protein interaction,dna repair and replication
ENSG00000040608,RTN4R,regulation of cellular adhesion,neurite outgrowth regulation,apoptosis modulation,pi3k/akt signaling regulation,cellular proliferation facilitation,cancer cell survival enhancement
ENSG00000174483,BBS1,bardet-biedl syndrome complex,genomic instability,cellular trafficking pathways,tumor suppressor function,oncogenic signaling activation,protein localization regulation
ENSG00000113966,ARL6,gain-of-function mutations,oncogenic signaling,cell proliferation,constitutive activation,tumorigenesis,cell survival
ENSG00000021645,NRXN3,neural adhesion,cell migration,synaptic function,tumor invasion,metastasis regulation,neurotransmission disruption
ENSG00000158748,HTR6,serotonin signaling,receptor activation,cell proliferation,tumor progression,poor prognosis,g-protein coupled receptor
ENSG00000067208,EVI5,nuclear protein regulation,dna repair facilitation,genome stability maintenance,cell cycle progression modulation,tumor suppressor function,cancer cell survival enhancement
ENSG00000147536,GINS4,chromosomal instability,genomic alterations,dna replication regulation,sister chromatid separation,cell cycle dysregulation,aneuploidy
ENSG00000131153,GINS2,genomic instability,overexpression,cell proliferation,dna replication regulation,tumor progression,poor prognosis
ENSG00000115145,STAM2,tumor progression,oncogenic signaling,aberrant expression,signaling pathway regulation,cell migration,endocytic trafficking
ENSG00000115762,PLEKHB2,cellular trafficking,membrane localization,phosphatidylinositol 3-phosphate binding,pi3k/akt pathway modulation,tumor invasion enhancement,overexpression status
ENSG00000132781,MUTYH,genomic instability,tumor suppressor function,dna repair deficiency,base excision repair pathway,mutational burden,cancer predisposition
ENSG00000166169,POLL,genomic instability,tumor suppressor,dna polymerase activity,genome maintenance,elevated expression,poor prognosis
ENSG00000138741,TRPC3,calcium influx,cell proliferation,epithelial-to-mesenchymal transition,inflammatory responses,oncogenic process,tumor aggressiveness
ENSG00000165120,SSMEM1,pi3k/akt pathway,endocytic regulation,tumor progression,molecular trafficking,gene amplification,promoter methylation
ENSG00000143595,AQP10,tumor progression,oncogenic effects,glucose metabolism,cancer cell growth,proliferation regulation,cellular signaling pathways
ENSG00000166257,SCN3B,voltage-gated sodium channel,tumor progression,cell proliferation,apoptosis modulation,oncogenic signaling,poor prognosis
ENSG00000117360,PRPF3,aberrant rna processing,cell proliferation enhancement,mutational hotspot,nuclear export regulation,oncogenic transcript overexpression,resistance to chemotherapy
ENSG00000025770,NCAPH2,chromosomal instability,genomic disruption,oncogene overexpression,cell proliferation promotion,tumor progression facilitation,cancer genomic profiling
ENSG00000178935,ZNF552,**

cell proliferation regulation,transcriptional regulation,zinc finger motif,nuclear localization,dna binding specificity,genetic aberration 

**
ENSG00000034693,PEX3,peroxisomal function,protein import,cellular homeostasis,cancer biology,autophagy regulation,pexophagy
ENSG00000167272,POP5,ribosome biogenesis,oncogene activation,cell growth promotion,tumor progression,pre-rrna processing,pseudouridylation activity
ENSG00000156603,MED19,enhanced transcriptional activity,oncogenic signaling pathways,chromatin structure regulation,cell growth promotion,tumor aggressiveness marker,therapeutic target
ENSG00000281813,KAT6B,histone acetylation,cell cycle progression,dna repair evasion,apoptosis resistance,chromatin remodeling,tumor suppressor regulation
ENSG00000180089,TMEM86B,lipid metabolism regulation,gene amplification,cell proliferation enhancement,tumor cell survival,transmembrane protein function,molecular interaction modulation
ENSG00000101152,DNAJC5,cellular stress response,tumor suppressor function,apoptosis regulation,protein quality control,mitotic checkpoint regulation,cancer cell survival
ENSG00000155657,TTN,tumor progression,genomic instability,cell proliferation,protein truncation mutations,cell survival,oncogenic process
ENSG00000121073,SLC35B1,altered glycosylation patterns,dysregulated gene expression,oncogenic signaling pathway,cell proliferation,tumor progression,aberrant transport activity
ENSG00000083838,ZNF446,oncogenic transcription factor,overexpressed in tumors,zinc finger domain essential,pro-oncogenic pathways activated,cell cycle regulation disrupted,genomic instability prevention
ENSG00000172466,ZNF24,transcriptional regulation,tumor suppressor function,cell cycle inhibition,apoptosis induction,gene expression modulation,protein-dna interactions
ENSG00000130720,FIBCD1,fibronectin binding,cell adhesion modulation,tumor progression,angiogenesis promotion,poor prognosis biomarker,protein-protein interaction
ENSG00000176182,MYPOP,cellular proliferation,oncogene activation,transcriptional regulation,apoptosis resistance,dna damage response,cell cycle dysregulation
ENSG00000100246,DNAL4,genomic instability,microtubule dynamics,cell cycle regulation,protein trafficking,dna replication,apoptosis resistance
ENSG00000184731,FAM110C,cell proliferation,gene expression regulation,dna repair mechanisms,protein interaction modulation,tumor growth promotion,genomic instability
ENSG00000174099,MSRB3,oxidative stress protection,protein folding regulation,dna repair pathway interaction,genomic instability contribution,tumor progression association,cell survival regulation
ENSG00000049618,ARID1B,dna repair,chromatin remodeling,epigenetic dysregulation,genomic instability,oncogenesis,prognostic marker
ENSG00000160131,VMA21,tumor progression,cellular proliferation,apoptosis inhibition,metastatic potential enhancement,lysosomal acidification regulation,tumor aggressiveness promotion
ENSG00000001461,NIPAL3,genomic instability,cell cycle regulation,apoptosis suppression,dna repair mechanisms,chromatin remodeling,tumor suppressor dysfunction
ENSG00000102898,NUTF2,transcriptional regulation,cell growth and proliferation,nuclear transport factor,importin-alpha interaction,oncogene overexpression,tumorigenesis modulation
ENSG00000134453,RBM17,post-transcriptional regulation,oncogenic translation,tumor suppressor suppression,cell cycle dysregulation,dna repair disruption,therapeutic target
ENSG00000110171,TRIM3,pi3k/akt pathway inhibition,tumor suppressor activity,apoptosis induction,cell cycle regulation,genomic instability protection,protein interaction modulation
ENSG00000113924,HGD,ho-1 induction,nrf2 transcription factor,oxidative stress response,cell survival promotion,tumor progression marker,heme degradation pathway
ENSG00000186115,CYP4F2,altered expression,arachidonic acid metabolism,bioactive lipid regulation,cell growth modulation,lipid metabolism dysregulation,oncogenic potential
ENSG00000100867,DHRS2,deshydroretinoid dehydrogenase function,cell proliferation enhancement,oncogenic process promotion,tumor progression,poor prognosis indicator,therapeutic target
ENSG00000173214,MFSD4B,lipid transport,cell membrane regulation,tumor progression,tumor metabolism,protein-lipid interactions,oncogenic signaling
ENSG00000182492,BGN,cell adhesion disruption,extracellular matrix modulation,metastasis promotion,poor prognosis marker,tumor progression enhancement,cellular interaction regulation
ENSG00000028116,VRK2,dual role oncogene/tumor suppressor,cell proliferation regulation,apoptosis regulation,genomic stability maintenance,protein kinase activity,substrate interaction with p53
ENSG00000104973,MED25,mediator complex regulation,tumor aggressiveness,transcriptional dysregulation,prognostic marker,cell cycle progression,proliferation enhancement
ENSG00000267796,LIN37,long non-coding rna,chromatin modification,epigenetic regulation,cell proliferation,signaling pathway modulation,molecular scaffold interaction
ENSG00000093000,NUP50,chromatin remodeling,cell proliferation,dna damage response,transcriptional regulation,nuclear pore complex,oncogenesis
ENSG00000075420,FNDC3B,cell adhesion regulation,tumor progression,therapeutic target,protein-protein interaction,apoptosis regulation,angiogenesis modulation
ENSG00000165724,ZMYND19,epigenetic regulation,chromatin remodeling,tumor suppression,dna repair mechanisms,gene expression regulation,cell cycle control
ENSG00000164040,PGRMC2,inflammatory regulation,cell proliferation modulation,signal transduction,prostaglandin metabolism,tumor progression,cell survival pathway
ENSG00000135587,SMPD2,sphingomyelin metabolism,ceramide production,cell proliferation,therapeutic target,signal transduction,genomic alterations
ENSG00000135211,TMEM60,cell survival,mitochondrial dynamics,pro-survival pathways,tumor progression,therapeutic target,cell growth enhancement
ENSG00000166069,TMCO5A,transmembrane protein interaction,cell cycle progression,dna replication,tumor growth and proliferation,cell survival and apoptosis resistance,genomic amplification and overexpression
ENSG00000135406,PRPH,axon formation,apoptosis evasion,cancer progression,cell migration,cytoplasmic protein,dysregulated expression
ENSG00000171446,KRT27,cytoplasmic intermediate filament,cell migration regulation,tumor progression association,epithelial-to-mesenchymal transition,adhesion complex formation,molecular chaperone function
ENSG00000196646,ZNF136,pi3k/akt signaling pathway modulation,tumor suppressor function,cellular proliferation regulation,apoptosis modulation,genomic stability maintenance,metastatic potential regulation
ENSG00000161896,IP6K3,cellular signaling regulation,oncogenic transformation,cell proliferation enhancement,pp-insps overproduction,autophagy dysregulation,therapeutic target candidate
ENSG00000130741,EIF2S3,regulation of protein synthesis,cell proliferation,signaling pathway modulation,tumorigenesis enhancement,clinical prognosis impact,oncogenic potential
ENSG00000171295,ZNF440,transcriptional regulation,zinc finger protein family,cell cycle progression,dna repair,apoptosis regulation,oncogenic mechanisms
ENSG00000109445,ZNF330,transcriptional regulation,tumor suppressor function,nuclear localization,gene expression modulation,oncogenic process contribution,aberrant gene expression pattern
ENSG00000134986,NREP,tumor suppressor activity,transcriptional regulation,cell growth inhibition,nuclear receptor co-repressor domain,f-box domain interaction,pi3k/akt pathway modulation
ENSG00000181092,ADIPOQ,tumor suppression,metabolic regulation,anti-proliferative,apoptosis induction,angiogenesis inhibition,metastasis suppression
ENSG00000285053,TBCE,iron metabolism,protein quality control,transferrin receptor biogenesis,cell surface targeting,protein stability,misfolded protein aggregation
ENSG00000111676,ATN1,chromosome segregation,centromeric function,genomic instability,aneuploidy driver,kinetochore assembly,mitotic errors
ENSG00000100865,CINP,centrosome duplication suppression,chromosomal instability promotion,cell proliferation enhancement,genomic stability maintenance,cell cycle regulation modulation,oncogenic driver
ENSG00000137726,FXYD6,protein regulation,cell proliferation enhancement,ion channel modulation,poor prognosis marker,therapeutic target,genomic amplification
ENSG00000142494,SLC47A1,cellular detoxification,chemoresistance,efflux transporter,prognostic marker,therapeutic target,drug interaction
ENSG00000178718,RPP25,ribosomal regulation,translation efficiency modulation,aberrant protein synthesis,cell growth promotion,tumor progression facilitation,genomic instability association
ENSG00000143401,ANP32E,chromatin regulation,transcriptional activation,histone modification,tumor aggressiveness,cell proliferation,metastasis promotion
ENSG00000142583,SLC2A5,glucose metabolism,enhanced glycolysis,cell proliferation,tumor aggressiveness,metabolic reprogramming,oncogene activation
ENSG00000133103,COG6,glycosylation regulation,oncogenic mutations,tumor progression driver,cell growth promotion,signaling pathway activation,membrane trafficking disruption
ENSG00000117862,TXNDC12,oncogenic driver,akt/mtor pathway activation,redox regulation disruption,cell survival enhancement,protein folding modulation,genomic instability induction
ENSG00000063322,MED29,mediator complex component,transcriptional regulation,genetic instability,oncogene expression,tumor growth,protein interaction
ENSG00000126603,GLIS2,transcriptional repression,tumor suppressor function,loss-of-function mutations,wnt/β-catenin pathway regulation,pi3k/akt/mtor pathway modulation,chromatin remodeling interactions
ENSG00000140854,KATNB1,microtubule dynamics regulation,genomic instability induction,centrosome regulation disruption,aurka pathway interaction,cell cycle progression dysregulation,cancer driver gene status
ENSG00000118523,CCN2,angiogenesis promotion,cell migration facilitation,extracellular matrix modulation,nf-κb regulation,poor prognosis biomarker,protein interaction enhancement
ENSG00000188761,BCL2L15,apoptosis regulation,cell death inhibition,oncogene activation,tumor progression facilitation,cancer cell survival promotion,overexpression in tumor tissues
ENSG00000007372,PAX6,tumor progression,promoter hypermethylation,wnt/β-catenin signaling,transcriptional regulation,epithelial-to-mesenchymal transition,overexpression
ENSG00000169410,PTPN9,pi3k/akt pathway regulation,tumor suppressor function,cell signaling modulation,oncogenic pathway regulation,phosphatase activity,genetic alterations
ENSG00000171992,SYNPO,genomic instability,aneuploidy,meiotic cell division,chromosome alignment,synaptonemal complex formation,genome stability maintenance
ENSG00000173275,ZNF449,zinc finger protein,tumor promoter,genomic instability,aneuploidy contributor,cell proliferation regulator,dna-binding domain
ENSG00000105146,AURKC,mitosis regulation,chromosomal instability,oncogenic driver,cell proliferation enhancement,kinase activation dysregulation,genetic alterations facilitation
,SEPT14,septin family,cytoskeleton dynamics,gene overexpression,tumor progression,cellular homeostasis disruption,potential oncogene target
,SEPT2,septin family member,tumor growth and invasion,pi3k/akt pathway interaction,cell cycle regulation,cytoskeleton organization,scaffolding protein function
ENSG00000162517,PEF1,oncogenic protein modification,cancer stem cell maintenance,tumor progression,chromatin remodeling,autophagy regulation,apoptosis inhibition
ENSG00000135439,AGAP2,arf6 regulation,cell surface receptor modulation,cytoskeleton reorganization,oncogene overexpression,pi3k/akt pathway activation,tumor progression enhancement
ENSG00000186207,LCE5A,lipid metabolism regulation,calcium ion homeostasis,epithelial differentiation,inflammatory response modulation,cellular differentiation maintenance,skin barrier integrity
ENSG00000187180,LCE2C,cellular adhesion,dysregulation of expression,gene modulation,invasion and migration,tumor progression,protein interaction
ENSG00000103591,AAGAB,protein degradation regulation,tumorigenesis promotion,cell survival modulation,unfolded protein response,endoplasmic reticulum stress,cellular stress response
ENSG00000152056,AP1S3,ap-1 complex regulation,cell proliferation,epithelial-to-mesenchymal transition (emt),oncogene potential,pi3k/akt pathway interaction,tumor progression
ENSG00000125878,TCF15,transcriptional regulation,apoptosis dysregulation,cell cycle disruption,immune response modulation,oncogenic potential,genomic instability
ENSG00000185475,TMEM179B,pi3k/akt pathway,chromatin remodeling,dna damage response,genomic instability,oncogenic transformation,tumor suppressor function
ENSG00000151778,SERP2,apoptosis inhibition,cell proliferation promotion,pi3k/akt pathway interaction,tumor suppressor potential,oncogene activity,biomarker candidate
ENSG00000155229,MMS19,genomic instability,dna repair mechanism,homologous recombination,tumor suppressor function,cell cycle regulation,replication fidelity
ENSG00000168899,VAMP5,enhanced invasive potential,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt) regulation,tumor progression facilitation,metastatic spread promotion,cancer cell migration enhancement
ENSG00000110025,SNX15,oncogenic role,regulation of vesicle transport,golgi apparatus localization,enhanced cell growth,poor prognosis marker,tumor metastasis promoter
ENSG00000137074,APTX,telomerase activation,genomic instability,dna damage response,telomere shortening,protein-protein interactions,genetic mutations
ENSG00000183304,FAM9A,cell cycle regulation,ubiquitination and degradation,oncogene function,tumor progression,protein-protein interactions,pi3k/akt pathway involvement
ENSG00000148341,SH3GLB2,regulation of rtk endocytosis,modulation of cell proliferation,contribution to oncogenic processes,maintenance of rtk activity,altered expression levels,implication in tumor progression
ENSG00000275895,U2AF1L5,alternative splicing regulation,splice site recognition,mrna processing alteration,poor prognosis association,cell proliferation promotion,survival enhancement
ENSG00000149313,AASDHPPT,tumor progression,transcriptional regulation,oncogenic signaling,therapeutic target,cell proliferation,prognostic biomarker
ENSG00000134709,HOOK1,microtubule regulation,cell proliferation,cell survival,metastasis promotion,pi3k/akt pathway modulation,tumor progression
,DUPD1,energy metabolism regulation,nucleotide biosynthesis pathway,cell growth support,cell survival enhancement,tumor progression link,potential therapeutic target
ENSG00000108381,ASPA,metabolic regulation,cell proliferation,protein function,energy metabolism,tca cycle,oncogenesis
ENSG00000203786,KPRP,ion transport regulation,calcium homeostasis,cell signaling modulation,tumor progression association,metabolic regulation,potential therapeutic target
ENSG00000159921,GNE,sialic acid biosynthesis,tumor progression,cellular growth promotion,glycoconjugate synthesis,oncogenic transformation,protein-protein interaction
ENSG00000009709,PAX7,cellular proliferation,transcriptional regulation,oncogenesis,genomic instability,therapeutic target,biomarker potential
ENSG00000113552,GNPDA1,aberrant glycosylation,altered expression levels,cell invasion and metastasis,cell proliferation,glycosylation regulation,oncogenic driver
ENSG00000065029,ZNF76,oncogene,cellular proliferation,tumor suppressor regulation,genetic overexpression,transcriptional regulator,apoptosis inhibition
ENSG00000136732,GYPC,tumor progression,cell-cell adhesion disruption,epithelial barrier dysfunction,metastasis facilitation,prognostic biomarker,cancer metastasis enhancer
ENSG00000153060,TEKT5,microtubule dynamics regulation,oncogenic amplification,epithelial-to-mesenchymal transition (emt),cell cycle progression enhancement,apoptosis resistance,growth factor signaling interaction
ENSG00000184675,AMER1,cell cycle regulation,genomic instability,tumor suppressor function,dna damage response,cilia formation regulation,protein-protein interaction
ENSG00000172057,ORMDL3,lipid metabolism regulation,cell proliferation enhancement,metabolic reprogramming,oncogenic process promotion,endoplasmic reticulum integrity maintenance,protein interaction modulation
ENSG00000149489,ROM1,pi3k/akt signaling pathway,cholesterol metabolism regulation,tumor progression promotion,membrane fluidity modulation,cancer driver potential,cellular interaction enhancement
ENSG00000168395,ING5,apoptosis regulation,tumor suppressor function,cell cycle arrest,g2/m phase regulation,dna repair modulation,epigenetic modification
ENSG00000009844,VTA1,genomic instability,dna repair mechanism,telomere maintenance,tumor suppressor function,oncogene activation,cancer progression
ENSG00000104490,NCALD,cell adhesion disruption,prognostic marker,oncogenic signaling,cell migration enhancement,genomic alteration association,metastasis facilitation
ENSG00000169704,GP9,immune response regulation,cell adhesion and migration,t-cell activation,cancer metastasis,glycoprotein domain interaction,signaling pathway modulation
ENSG00000213588,ZBTB9,epigenetic regulation,oncogene activation,transcriptional regulation,apoptosis evasion,cell cycle progression,tumor initiation
ENSG00000178149,DALRD3,cell cycle regulation,dna replication facilitation,overexpression in cancer,tumor progression facilitation,proliferation enhancement,oncogenic potential
ENSG00000120129,DUSP1,mapk regulation,constitutive activation,tumor suppression,prognostic marker,therapeutic target,cellular responses
ENSG00000127989,MTERF1,mitochondrial transcription regulation,genomic instability,metabolic reprogramming,cellular differentiation,tumor progression,transcriptional dysregulation
ENSG00000107140,TESK1,oncogenic function,cell migration regulation,actin cytoskeleton dynamics,phosphorylation regulation,cancer cell invasion,overexpression association
ENSG00000070367,EXOC5,exocyst complex,cell-cell adhesion,tumor progression,metastasis,epithelial-to-mesenchymal transition,signaling pathway regulation
ENSG00000169087,HSPBAP1,apoptosis suppression,cell cycle regulation,cellular homeostasis,dna repair interaction,oncogenic overexpression,tumorigenesis promotion
ENSG00000105894,PTN,tumor progression,cell migration,secreted growth factor,signal transduction,receptor activation,pleiotrophin overexpression
ENSG00000123560,PLP1,myelin protein function,cell proliferation regulation,cell survival enhancement,therapeutic target potential,pi3k/akt pathway interaction,tumorigenesis association
ENSG00000164591,MYOZ3,cell cycle regulation,genomic stability,epigenetic regulation,tumor suppression,pi3k/akt pathway inhibition,apoptosis promotion
ENSG00000198081,ZBTB14,tumor suppressor function,transcriptional repression,cell cycle regulation,apoptosis inhibition,oncogene silencing,chromatin modification
ENSG00000173226,IQCB1,genomic instability,cell proliferation,uncontrolled growth,protein interactions,cdk activation,dna repair
ENSG00000163093,BBS5,ciliary dysfunction,golgi apparatus regulation,protein trafficking disorder,tumor suppressor candidate,cellular homeostasis disruption,genetic disorder associated
ENSG00000109501,WFS1,er stress response,calcium regulation,tumor progression,metastasis,cell cycle modulation,apoptosis
ENSG00000147642,SYBU,cell cycle regulation,gene amplification,genomic instability,promoter hypomethylation,protein-protein interactions,tumor progression
ENSG00000182621,PLCB1,plcβ1 activation,phosphatidylinositol phosphorylation,cell proliferation regulation,signaling pathway modulation,calcium release regulation,pkc activation
ENSG00000204859,ZBTB48,oncogene activity,cell proliferation regulation,transcriptional modulation,tumor metastasis enhancement,apoptosis evasion,therapeutic target
ENSG00000113734,BNIP1,hypoxia adaptation,mitochondrial regulation,apoptosis modulation,cellular stress response,tumor suppression,oncogenic activation
ENSG00000100292,HMOX1,heme degradation,oxidative stress regulation,antioxidant defense,tumor progression,angiogenesis facilitation,inflammation modulation
ENSG00000173110,HSPA6,tumor progression,protein folding regulation,oncogenic pathway modulation,stress response activation,cellular homeostasis maintenance,proteotoxicity prevention
ENSG00000065882,TBC1D1,altered cell survival,disrupted membrane trafficking,enhanced cell growth,increased oncogenic activity,regulation of gtpases,tumor progression
ENSG00000196792,STRN3,cellular proliferation,oncogenic transformation,cell migration and invasion,pi3k/akt pathway,genomic stability,protein interaction
ENSG00000151690,MFSD6,lipid metabolism regulation,fatty acid transport,cellular signaling modulation,tumor promotion,protein interaction,genomic instability
ENSG00000004779,NDUFAB1,mitochondrial dysfunction,complex i subunit,oxidative phosphorylation,reactive oxygen species,dna damage,tumor progression
ENSG00000144034,TPRKB,pi3k/akt/mtor pathway regulation,oncogene overexpression,serine/threonine kinase activity,cell proliferation promotion,apoptosis inhibition,tumor aggressiveness increase
ENSG00000104897,SF3A2,pre-mrna splicing,aberrant splice site recognition,tumor progression,oncogenic mutation,altered protein processing,cellular transformation
ENSG00000167414,GNG8,gpcr signaling pathway,oncogene activation,cell proliferation,g-protein regulation,tumor suppressor downregulation,cancer stem cell maintenance
ENSG00000160683,CXCR5,chemokine receptor function,immune cell recruitment,cell migration and invasion,tumor progression,poor prognosis,signal transduction pathway interaction
ENSG00000159082,SYNJ1,pi3k/akt/mtor pathway activation,receptor tyrosine kinase recycling,cellular signaling regulation,membrane trafficking involvement,protein-protein interaction,oncogenic potential enhancement
ENSG00000171475,WIPF2,actin dynamics regulation,cell migration facilitation,oncogenic pathway activation,tumor progression promotion,protein interaction modulation,genomic amplification
ENSG00000102243,VGLL1,wnt/β-catenin signaling pathway,coactivator activity,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,tumor aggressiveness promoter,transcriptional coactivation
ENSG00000128928,IVD,cell adhesion disruption,epithelial differentiation,molecular heterogeneity,tumor progression marker,prognostic biomarker,genetic instability
ENSG00000063515,GSC2,cell cycle regulation,apoptosis inhibition,cell proliferation enhancement,oncogenic driver,prognostic marker,tumor growth promotion
ENSG00000167123,CERCAM,cell adhesion,epithelial-to-mesenchymal transition (emt),protein-protein interactions,signaling pathways,cell migration,cancer progression
ENSG00000110801,PSMD9,protein degradation,cell cycle progression,ubiquitin-proteasome pathway,dysregulation,regulatory subunit,aberrant proteins
ENSG00000128585,MKLN1,heparan sulfate proteoglycans degradation,cell invasion and migration,angiogenesis and metastasis,tumor progression and poor prognosis,prognostic marker,vascular endothelial growth factor regulation
ENSG00000143514,TP53BP2,genomic instability,tumor suppressor function,p53 regulation,dna damage response,mutation or downregulation associated with cancer progression,apoptosis modulation
ENSG00000108039,XPNPEP1,tumor suppressor function,pi3k/akt pathway regulation,oncogenic peptide degradation,dna repair interaction,genomic stability maintenance,prognostic biomarker
ENSG00000103540,CCP110,chromosomal instability,mitotic spindle assembly,cell division regulation,aneuploidy induction,microtubule dynamics regulator,genome stability maintenance
ENSG00000146918,NCAPG2,chromatin regulation,mitotic chromosome segregation,genomic stability,cell cycle regulation,oncogenic alterations,chromatin remodeling
ENSG00000206560,ANKRD28,cell cycle regulation,protein-protein interactions,tumor aggressiveness,apoptosis suppression,nuclear localization,transcriptional regulation
ENSG00000033050,ABCF2,genomic instability,dna repair regulation,atp-dependent helicase activity,oncogenic transformation,prognostic biomarker potential,chromosomal integrity preservation
ENSG00000198162,MAN1A2,lysosomal targeting,epigenetic regulation,cellular proliferation,protein interaction,signal transduction pathway,apoptosis suppression
ENSG00000181541,MAB21L2,genomic instability,tumor suppressor function,cell cycle regulation,dna repair interactions,epithelial-to-mesenchymal transition inhibition,cancer invasion suppression
ENSG00000130713,EXOSC2,exosome complex regulation,gene amplification,cell survival pathways,oncogenic driver,rna metabolism regulation,therapeutic target
ENSG00000175213,ZNF408,chromatin remodeling,epigenetic regulation,transcriptional modulation,genomic instability,oncogenic driver,tumor suppressor function
ENSG00000103995,CEP152,ciliogenesis regulation,centrosome function disruption,genomic instability,cell cycle dysregulation,microtubule dynamics alteration,chromosome segregation error
ENSG00000053254,FOXN3,tumor suppressor function,cell cycle regulation,apoptosis promotion,genome stability maintenance,p53 interaction,biomarker potential
ENSG00000198466,ZNF587,cell cycle regulation,gene expression modulation,transcriptional regulation,dna repair pathways,zinc finger domain interaction,tumor suppressor function
ENSG00000198315,ZKSCAN8,tumor suppressor function,cell cycle regulation,dna binding activity,transcriptional regulation,apoptosis induction,genome stability maintenance
ENSG00000075914,EXOSC7,cell proliferation modulation,tumor progression association,rna degradation regulation,oncogene regulation,metastasis promotion,biomarker candidate
ENSG00000262635,TDO2,immune regulation,tryptophan catabolism,immune evasion,tumor progression,oncogenic potential,enzymatic activity
ENSG00000214513,NOTO,notch signaling pathway,homeobox transcription factor,oncogenic function,epithelial-to-mesenchymal transition,cell proliferation,poor prognosis
ENSG00000174306,ZHX3,cell cycle regulation,gene expression modulation,apoptosis suppression,dna damage response,tumor development,oncogene function
ENSG00000160801,PTH1R,pth1r overexpression,cell proliferation,metastasis promotion,mapk/erk pathway activation,pi3k/akt signaling enhancement,calcium homeostasis dysregulation
ENSG00000143776,CDC42BPA,cell migration,oncogenic transformation,cytoskeleton regulation,tumor invasion,epithelial-to-mesenchymal transition (emt),gtpase signaling pathway
ENSG00000172890,NADSYN1,tumor suppressor,energy metabolism regulation,biosynthesis of nad+,reduced expression in cancer,interaction with other proteins,role in genomic stability modulation
ENSG00000114850,SSR3,rna degradation,genomic instability,tumor progression,oncogenic process,rna processing,cellular homeostasis
ENSG00000197579,TOPORS,genomic stability,ubiquitin-proteasome pathway,tumor progression,dna replication,topoisomerase iibeta regulation,oncogenic role
ENSG00000188033,ZNF490,tumor progression,transcriptional regulation,oncogene function,cell cycle control,chromatin remodeling,wnt/β-catenin pathway interaction
ENSG00000285248,IPO4,pi3k/akt pathway,tumor suppressor,loss-of-function mutations,oncogenesis,cell proliferation,inositol phosphate metabolism
ENSG00000162959,MEMO1,tumor suppressor dysfunction,genomic instability,chromatin remodeling,p53 pathway regulation,apoptosis inhibition,transcriptional regulation
ENSG00000136003,ISCU,**
mitochondrial function,iron-sulfur cluster assembly,metabolic reprogramming,tumor growth,energy metabolism,glycolysis promotion 
**
ENSG00000147649,MTDH,oncogenic transformation,cell proliferation,survival signaling pathway,tumor suppressor disruption,pi3k/akt pathway regulation,genomic overexpression
ENSG00000158636,EMSY,genomic instability,oncogene activation,chromatin remodeling,dna repair regulation,tumor progression,therapeutic resistance
ENSG00000103152,MPG,mtor pathway activation,cell proliferation enhancement,oncogenic process promotion,genomic instability maintenance,therapeutic target,cell growth regulation
ENSG00000206505,HLA-A,altered expression,antigen presentation disruption,immune evasion mechanism,tumor progression facilitation,immunotherapy resistance,mhc class i molecule
ENSG00000175895,PLEKHF2,microtubule dynamics,cell proliferation,cytoplasmic organization,oncogenic signaling,genomic instability,tumor progression
ENSG00000152430,BOLL,transcriptional elongation factor interaction,chromatin remodeling complex binding,cell proliferation promotion,oncogenic overexpression,rna polymerase ii phosphorylation,nuclear protein localization
ENSG00000181938,GINS3,genomic instability,dna repair mechanisms,tumor growth enhancement,cell cycle progression facilitation,oncogenic signaling pathway interaction,poor prognosis association
ENSG00000134910,STT3A,protein synthesis regulation,tumor progression driver,cell proliferation enhancer,translation initiation complex assembly,metastasis promoter,oncogene overexpression
ENSG00000177030,DEAF1,cell cycle regulation,gene expression modulation,chromatin remodeling,apoptosis inhibition,tumor proliferation,genomic instability
ENSG00000164880,INTS1,cell cycle regulation,transcriptional regulation,dna damage response,tumorigenesis,oncogene activation,epigenetic regulation
ENSG00000172073,TEX37,genomic instability,tumor suppressor,dna damage response,chromatin remodeling,transcriptional regulation,cancer development
ENSG00000114279,FGF12,fgf/fgfr signaling,oncogenic activation,cell migration,tumor progression,metastasis promotion,signaling pathway activation
ENSG00000103042,SLC38A7,glutamine transport,cell proliferation,oncogenic driver,tumor metabolism,nutrient acquisition,cancer cell survival
ENSG00000110218,PANX1,atp release modulation,cell proliferation regulation,biomarker potential,poor prognosis indicator,cell migration involvement,apoptosis regulation
ENSG00000101624,CEP76,centrosome function,chromosomal instability,gain of function mutations,microtubule stability,oncogenic driver,tumor progression
ENSG00000164167,LSM6,genomic instability,tumor progression,oncogenic process,enhanced cell survival,therapeutic target,rna processing
ENSG00000186510,CLCNKA,tumor progression,oncogenesis,cell proliferation,apoptosis regulation,chloride channel function,protein interaction
ENSG00000196459,TRAPPC2,genetic instability,enhanced cell proliferation,dna repair mechanism,cell survival pathway,protein transport regulation,tumor progression
ENSG00000137288,UQCC2,oncogenic signaling,aberrant protein accumulation,cell cycle progression,therapeutic target,protein degradation regulation,ubiquitin-proteasome system interaction
ENSG00000184451,CCR10,tumor progression,immune evasion,metastatic potential,angiogenesis promotion,epithelial-to-mesenchymal transition (emt),upregulated expression
ENSG00000116001,TIA1,apoptosis inhibition,autophagy modulation,cell survival promotion,mrna stabilization,oncogene overexpression,protein synthesis regulation
ENSG00000140987,ZSCAN32,epithelial-to-mesenchymal transition,genomic instability,oncogenic transformation,pi3k/akt pathway interaction,tumor progression,zinc finger protein function
ENSG00000002933,TMEM176A,ion channel regulation,pi3k/akt signaling,oncogenesis,cell proliferation,tumor progression,overexpression
ENSG00000173276,ZBTB21,cell cycle regulation,transcriptional repression,tumor suppressor activity,apoptosis induction,dna damage response,epigenetic regulation
ENSG00000100242,SUN2,nuclear architecture regulation,chromatin remodeling,cell proliferation promotion,tumor progression association,metastasis facilitation,nuclear membrane localization
ENSG00000002549,LAP3,cell signaling regulation,cell survival promotion,lysosomal function modulation,metastatic potential enhancement,oncogenic process facilitation,protein-protein interaction
ENSG00000196152,ZNF79,transcriptional regulation,cell cycle progression,antitumor activity,cell proliferation regulation,oncogenic transformation,protein-protein interaction
ENSG00000176009,ASCL3,transcription factor activation,gene overexpression,cell proliferation enhancement,migration and invasion promotion,poor prognosis marker,tumor growth stimulation
ENSG00000128050,PAICS,metabolic regulation,tumor progression,prognostic marker,amino acid metabolism,vitamin b6 biosynthesis,cancer biology
ENSG00000140265,ZSCAN29,transcriptional regulation,genomic stability,oncogene activation,chromosomal instability,cell proliferation enhancement,apoptosis evasion
ENSG00000163346,PBXIP1,cellular proliferation,tumor progression,oncogenic processes,transcriptional regulation,pi3k/akt pathway interaction,protein-protein interactions
ENSG00000169136,ATF5,apoptosis evasion,cell cycle modulation,dna repair suppression,oncogenic transcription factor,pi3k/akt pathway modulation,pro-apoptotic gene suppression
ENSG00000154118,JPH3,calcium signaling modulation,dysregulated expression,tumor suppressor function,cell survival promotion,prognostic marker candidate,cancer progression facilitation
ENSG00000138069,RAB1A,cell proliferation,tumor progression,constitutive activation,gain of function mutations,genomic amplification,protein secretion regulation
ENSG00000265491,RNF115,ubiquitin ligase activity,oncogene overexpression,tumor suppressor degradation,cell cycle regulation disruption,signaling pathway activation,cancer progression enhancement
ENSG00000135932,CAB39,ca2+/calmodulin-dependent signaling,cell proliferation regulation,calcium homeostasis modulation,mtor pathway interaction,oncogenic potential,prognostic marker
ENSG00000148110,MFSD14B,mitochondrial function,energy homeostasis regulation,lipid metabolism modulation,cellular proliferation influence,tumor progression correlation,therapeutic target potential
ENSG00000130733,YIPF2,er membrane protein,cellular transport regulation,protein folding regulation,mitochondrial function modulation,cellular dynamics regulation,endoplasmic reticulum maintenance
ENSG00000129116,PALLD,microtubule dynamics,cell migration promotion,tumor progression,oncogene candidate,genomic instability,protein-protein interaction
ENSG00000120805,ARL1,oncogenic transformation,cell proliferation,metastasis promotion,protein-protein interaction,signaling pathway regulation,genomic aberration
ENSG00000120860,WASHC3,cellular trafficking,endosomal sorting,actin dynamics regulation,tumor progression facilitation,oncogenic pathway activation,genomic instability promotion
ENSG00000166747,AP1G1,endocytic regulation,cell growth,apoptosis resistance,protein recycling,oncogenic processes,clathrin-mediated endocytosis
ENSG00000137648,TMPRSS4,enhances cell migration,metastasis promoter,tumor progression factor,cell surface protease,proteolytic activity enhancer,signaling pathway modulator
ENSG00000005486,RHBDD2,protein stability regulation,tumor suppressor function,cell proliferation regulation,apoptosis inhibition,genomic instability,dna damage response
ENSG00000077616,NAALAD2,metallopeptidase activity,gutamate regulation,tumor progression,promotes cell proliferation,migrates cells,alters prognosis
ENSG00000115233,PSMD14,proteolytic regulation,cellular homeostasis,tumor growth,survival pathways,apoptosis regulation,ubiquitin-proteasome pathway
ENSG00000107829,FBXW4,wnt/β-catenin pathway,protein degradation dysregulation,cellular proliferation enhancement,oncogenic protein accumulation,tumor metastasis promotion,genetic instability contribution
ENSG00000167604,NFKBID,nf-κb pathway,constitutive activation,tumor suppression,apoptosis inhibition,cell proliferation enhancement,immune evasion
ENSG00000106688,SLC1A1,cell membrane transport,oncogenic behavior,tumor progression,aggressive tumor characteristics,poor prognosis,protein synthesis
ENSG00000160877,NACC1,chromatin remodeling,cell proliferation,apoptosis evasion,protein-protein interactions,genome stability regulation,tumor progression
ENSG00000170836,PPM1D,p53 suppression,cell cycle regulation,gain of function mutations,genomic instability,dna repair pathways,oncogenic function
ENSG00000099957,P2RX6,tumor progression,cell proliferation,atp-mediated signaling,receptor activation,heterodimer formation,protein interaction
ENSG00000104164,BLOC1S6,lysosomal regulation,vesicle trafficking,cell signaling pathways,protein recycling,cellular processes,cancer progression
ENSG00000154710,RABGEF1,rab5 activation,endocytic trafficking,oncogenic signaling,cell proliferation,tumor progression,therapeutic target
ENSG00000170214,ADRA1B,receptor activation,cell proliferation,g protein signaling pathway,tumor progression,genomic instability,cell migration
ENSG00000178127,NDUFV2,mitochondrial electron transport chain,energy metabolism,cellular respiration,electron transfer,atp synthesis,tumor suppressor activity
ENSG00000161956,SENP3,desumoylation,cell proliferation,tumor aggressiveness,apoptosis inhibition,genomic instability,pi3k/akt pathway activation
ENSG00000106511,MEOX2,epithelial-to-mesenchymal transition,oncogene,transcription factor regulation,cell migration enhancement,poor prognosis indicator,tgf-β signaling interaction
ENSG00000102935,ZNF423,tumor suppressor,transcriptional regulation,dna repair mechanism,cell proliferation,brca1/brca2 interaction,proliferative suppression
ENSG00000168209,DDIT4,regulation of protein synthesis,tumor suppressor function,interaction with mtor pathway,suppression of energy metabolism,oncogenesis regulation,bladder urothelial carcinoma progression
ENSG00000173480,ZNF417,cell cycle regulation,transcriptional regulation,apoptosis modulation,tumor progression,tissue differentiation,metastasis suppression
ENSG00000205189,ZBTB10,oncogenic function,transcriptional regulation,cell cycle progression,apoptosis inhibition,angiogenesis promotion,overexpression
ENSG00000132256,TRIM5,cell cycle regulation,genetic variation,protein-protein interaction,apoptosis regulation,tumor suppressor function,cancer progression
ENSG00000086548,CEACAM6,cell adhesion disruption,immune evasion,epigenetic regulation,metastasis promotion,tumor progression,therapeutic target
ENSG00000177485,ZBTB33,transcription regulation,epithelial-to-mesenchymal transition,chromatin remodeling,stem cell maintenance,cell proliferation,apoptosis suppression
ENSG00000136710,CCDC115,centrosome regulation,chromosome instability,ciliogenesis,microtubule assembly,spindle assembly checkpoint,cell proliferation enhancement
ENSG00000075399,VPS9D1,pi3k/akt/mtor signaling pathway,dysregulation of cell survival and growth,aberrant expression in tumorigenesis,potential therapeutic target,regulation of phosphatidylinositol 3-kinase activity,overexpression in tumor tissues
ENSG00000185379,RAD51D,genomic instability,dna damage tolerance,homologous recombination,chromosomal aberrations,loss-of-function mutations,therapeutic target
ENSG00000168071,CCDC88B,ciliogenesis regulation,hippo-yap pathway modulation,cell proliferation enhancement,primary cilia maintenance,tumor progression facilitation,genomic instability promotion
,H2AFX,chromatin remodeling,epigenetic regulation,dna damage response,genomic instability,histone variant,prognostic marker
ENSG00000162300,ZFPL1,transcriptional regulation,cell cycle progression,genomic instability,oncogene function,apoptosis regulation,tumor development
ENSG00000127328,RAB3IP,gef activity,rab gtpase regulation,cell migration and invasion,actin cytoskeleton dynamics,filopodia formation,tumor progression marker
ENSG00000072958,AP1M1,ap-1 complex regulation,cell proliferation promotion,signaling pathway activation,gene expression modulation,tumor progression facilitation,oncogenic potential enhancement
ENSG00000116649,SRM,altered splicing patterns,chemosensitivity modulation,cellular proliferation enhancement,oncogene regulation,tumor suppressor gene modulation,genomic instability induction
ENSG00000147162,OGT,pi3k/akt pathway modulation,oncogenic processes promotion,cell proliferation enhancement,tumor growth facilitation,gene expression regulation,therapeutic target potential
ENSG00000214717,ZBED1,tumor suppressor function,dna damage response,transcriptional regulation,cell cycle control,apoptosis regulation,oncogenic transformation
ENSG00000125863,MKKS,cilia formation disruption,centriole assembly regulation,cellular polarity maintenance,genomic instability prevention,tumor suppressor function,oncogenic process contributor
ENSG00000198010,DLGAP2,tumor suppressor,regulatory subunit,cell adhesion regulation,cytoskeletal modulation,oncogenic protein interaction,genomic instability
ENSG00000177917,ARL6IP6,cell cycle regulation,overexpression,genomic instability,microtubule dynamics,apoptosis inhibition,pi3k/akt pathway activation
ENSG00000122786,CALD1,cell migration,calcium-dependent signaling,cell invasion,prognostic biomarker,oncogenic factor,therapeutic target
,HIST1H2AM,chromatin modification,histone packaging,gene regulation,transcription factor binding,dna accessibility,epigenetic regulation
,HIST1H2AK,chromatin remodeling,epigenetic regulation,transcriptional modulation,histone modification,gene expression alteration,tumorigenic potential
,HIST1H2AI,histone modification,chromatin remodeling,cell cycle regulation,genomic stability,epigenetic regulation,tumor progression
,HIST1H2AL,histone modification,epigenetic regulation,gene expression modulation,chromatin structure alteration,tumorigenesis driver,therapeutic target
,HIST1H2AG,**

histone modification,chromatin remodeling,transcription regulation,dysregulated expression,biomarker potential,epi-genetic alterations
ENSG00000264364,DYNLL2,microtubule dynamics,cell migration,protein-protein interaction,oncometabolism,mitotic spindle regulation,retrograde transport
ENSG00000110079,MS4A4A,cell surface protein,candidate driver gene,immune modulation,oncogenic potential,epithelial-to-mesenchymal transition,poor prognosis marker
ENSG00000125733,TRIP10,tumor progression,cell migration,pi3k/akt pathway,oncogene,protein regulation,metastasis
ENSG00000105677,TMEM147,disrupted epithelial polarity,impaired tight junctions,increased cell migration,enhanced wnt signaling,metastatic progression,adherens junction modulation
ENSG00000109846,CRYAB,heat shock protein regulation,cellular stress response modulation,oncogenic potential,tumor progression driver,therapeutic target,protein-protein interaction
ENSG00000152137,HSPB8,cellular protection,stress response modulation,tumor suppressor stabilization,cell cycle regulation,dna repair facilitation,protein homeostasis maintenance
ENSG00000100526,CDKN3,cell cycle regulation,oncogene activity,genomic instability,dna replication,g2/m checkpoint control,therapeutic target
ENSG00000134640,MTNR1B,regulation of cell growth,oncogenic processes,overexpression in cancer,cell survival promotion,proliferation modulation,dysregulated signaling pathways
ENSG00000033867,SLC4A7,tumor progression,cell migration,angiogenesis promotion,prognostic marker,gene expression signature,proliferation regulation
ENSG00000184209,SNRNP35,alternative splicing regulation,tumor aggressiveness promotion,gene expression dysregulation,spliceosomal component interaction,oncogene overexpression promotion,apoptosis evasion mechanism
ENSG00000288335,TWIST2,epithelial-to-mesenchymal transition,tumor progression,transcription factor activity,cell proliferation,dna binding,metastasis
ENSG00000104783,KCNN4,calcium channel regulation,cell proliferation promotion,dysregulated expression,oncogenic activity,therapeutic target potential,apoptosis inhibition
ENSG00000089356,FXYD3,ion channel regulation,upregulated expression,cell proliferation enhancement,sodium-potassium balance disruption,protein-protein interaction,tumor progression facilitation
ENSG00000117625,RCOR3,transcriptional regulation,tumor suppressor repression,chromatin modification,cell proliferation enhancement,oncogenic interaction,therapeutic target
ENSG00000147596,PRDM14,epigenetic regulation,transcriptional modulation,cell cycle regulation,tumor cell proliferation,dna repair dysregulation,protein-protein interactions
ENSG00000170266,GLB1,glycosylation regulation,cell surface protein modification,protein processing enzyme,tumor modulation,cell adhesion influence,therapeutic target candidate
ENSG00000138375,SMARCAL1,genomic instability,replication fork stalling,genetic alterations,dna repair mechanism,tumor progression,oncogenesis
ENSG00000183323,CCDC125,microtubule dynamics regulation,genomic instability contributor,mitotic checkpoint regulator,cell cycle progression,aneuploidy inducer,hippo signaling target
ENSG00000088727,KIF9,chromosome segregation dysfunction,microtubule stability regulation,cell cycle progression alteration,tumor metastasis promotion,genetic instability induction,pi3k/akt signaling pathway activation
ENSG00000084731,KIF3C,cellular motility regulation,mitotic spindle assembly,chromosomal stability maintenance,dna repair pathway interaction,oncogenic transformation facilitation,cell proliferation enhancement
ENSG00000163050,COQ8A,mitochondrial function,loss-of-function mutations,succinate dehydrogenase (sdh),electron transport chain,epigenetic changes,genomic instability
ENSG00000127054,INTS11,histone modification,transcriptional regulation,cell cycle deregulation,tumor suppressor function,oncogene activation,genomic instability
ENSG00000104299,INTS9,dna damage response,oncogene potential,genomic instability,cell proliferation,long non-coding rna regulation,integrator complex function
ENSG00000130528,HRC,genomic instability,cellular response regulation,dna repair modulation,tumor suppression,brca1/brca2 interaction,apoptosis regulation
ENSG00000133104,SPART,cellular proliferation,cell cycle regulation,tumor suppressor function,apoptosis dysregulation,protein-protein interactions,genomic instability
ENSG00000165556,CDX2,transcriptional regulation,epithelial maintenance,tumor suppression,loss of function mutations,prognostic marker,therapeutic target
ENSG00000180332,KCTD4,tumor suppressor,gene regulation,cell proliferation inhibition,chromatin remodeling,transcriptional repression,protein interaction
ENSG00000151422,FER,cell adhesion modulation,tumor progression facilitation,mapk/erk pathway interaction,prognostic marker correlation,cancer cell migration promotion,oncogenic potential
ENSG00000167995,BEST1,dna repair mechanism,telomere maintenance,genomic instability,gene mutations,cancer predisposition,dna damage response
ENSG00000100744,GSKIP,oncogenic driver,tumor progression,cell proliferation,wnt/β-catenin pathway,apoptosis inhibition,prognostic biomarker
ENSG00000107281,NPDC1,genomic instability,constitutive activation,dna synthesis promotion,oncogenic properties,cellular proliferation enhancement,overexpression association
ENSG00000205352,PRR13,nf-κb pathway activation,tumor progression driver,immune evasion mechanism,cell survival promotion,cancer cell proliferation,metastasis enhancer
ENSG00000197024,ZNF398,transcriptional regulation,dna-binding activity,apoptosis inhibition,cell cycle progression,prognostic biomarker,tumor initiation
ENSG00000204946,ZNF783,dna binding,transcription regulation,tumor aggressiveness,cell proliferation enhancement,oncogenic role,chromosomal location
ENSG00000106336,FBXO24,tumor suppressor,decreased expression levels,cell cycle regulation,dna repair pathway,e3 ubiquitin ligase activity,loss of function mutations
ENSG00000130299,GTPBP3,pi3k/akt pathway interaction,mitochondrial membrane regulation,cell proliferation enhancement,tumor progression association,oncogenic potential,biomarker prediction
ENSG00000164707,SLC13A4,lactate transport,cellular metabolism,diagnostic biomarker,therapeutic target,tumor progression,prognostic marker
ENSG00000108255,CRYBA1,beta-crystallin function,cell migration,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction,protein aggregation facilitation,tumor progression
ENSG00000168246,UBTD2,cell survival,genetic instability,protein degradation,ubiquitin-proteasome system,tumor suppressor regulation,tissue specificity
ENSG00000123636,BAZ2B,epigenetic regulation,histone modifications,chromatin remodeling,oncogene activation,transcriptional repression,brd4 interaction
ENSG00000010932,FMO1,redox regulation,detoxification process,cellular metabolism,pi3k/akt pathway interaction,tumor tissue expression,cell signaling pathways
ENSG00000167580,AQP2,water transport,cellular proliferation,upregulated expression,therapeutic target,tumor progression,molecular interactions
ENSG00000225697,SLC26A6,cell proliferation,altered expression,dysregulation,cell survival,chloride transport,transport regulation
ENSG00000117569,PTBP2,alternative splicing,mirna processing,oncogene expression,tumor suppressor regulation,cell proliferation,gene expression regulation
ENSG00000175575,PAAF1,oncogene,protein-protein interaction,rna-binding protein,splicing regulation,epithelial-to-mesenchymal transition,tumor progression
ENSG00000155660,PDIA4,overexpression,biomarker,tumor progression,apoptosis resistance,cell survival,metastasis promotion
ENSG00000170442,KRT86,keratin interaction disruption,tumor progression marker,epithelial integrity maintenance,cellular differentiation marker,basal cell marker expression,intermediate filament network stabilization
ENSG00000160917,CPSF4,rna processing regulation,genomic instability,tumor progression,cell proliferation enhancement,dna damage response modulation,chemo-radiation resistance
ENSG00000189280,GJB5,gap junction disruption,tumor progression,oncogene activity,cell proliferation,apoptosis regulation,dna repair modulation
ENSG00000160678,S100A1,overexpression,tumor progression,prognostic marker,cell growth promotion,signaling pathway activation,cellular differentiation regulation
ENSG00000167972,ABCA3,regulation of lipid metabolism,transporter function,cellular cholesterol homeostasis,tumor progression,protein-protein interactions,pi3k/akt pathway modulation
ENSG00000078081,LAMP3,lysosomal regulation,apoptosis evasion,tumor progression,metastasis promotion,biomarker expression,therapeutic target
ENSG00000143119,CD53,immune evasion,tumor progression,cell adhesion regulation,protein-protein interaction,signaling pathway modulation,metastasis facilitation
ENSG00000167656,LY6D,tumor progression,cell adhesion regulation,metastasis promotion,cell growth modulation,immune system interaction,oncogene activation
ENSG00000139291,TMEM19,tumor progression,cellular proliferation,transmembrane protein function,oncogenic activity,biomarker potential,protein-protein interactions
ENSG00000187170,LCE4A,cellular proliferation,apoptosis regulation,tumor suppression,genomic instability,oncogenic pathway modulation,protein-protein interaction
ENSG00000159455,LCE2B,cell cycle regulation,overexpression,epithelial barrier function,proliferation promotion,tissue remodeling,mitochondrial membrane stability
ENSG00000099810,MTAP,purine metabolism regulation,pyrimidine salvage pathway,tumor suppressor silencing,cell proliferation enhancement,genomic instability association,therapeutic target identification
ENSG00000171431,KRT20,keratin overexpression,epithelial cell marker,tumor progression marker,cell adhesion regulation,apoptosis modulation,biomarker potential
ENSG00000111229,ARPC3,constitutive activation,cell proliferation,cell survival,apoptosis resistance,tumor progression,poor prognosis marker
ENSG00000154040,CABYR,cell proliferation regulation,tumor progression regulator,calcium-binding protein,pi3k/akt pathway modulation,biomarker candidate,signal transduction mediator
ENSG00000133935,ERG28,transcription factor regulation,dna-binding domain,ets family member,chromatin-modifying complex interaction,gene expression modulation,prognostic marker
ENSG00000057294,PKP2,cell adhesion disruption,oncogene activation,tumor aggressiveness increase,prognosis worsening,cell migration promotion,therapeutic target identification
ENSG00000163554,SPTA1,oncogenic mutations,tumor progression,cell adhesion regulation,signaling pathway activation,apoptosis evasion,metastatic potential enhancement
ENSG00000170523,KRT83,keratin regulation,epithelial integrity maintenance,stratified squamous epithelium expression,tumor invasion promotion,cell adhesion modulation,signaling pathway interaction
ENSG00000235588,AIF1,immune regulation,tumor microenvironment modulation,oncogenic program activation,prognostic biomarker potential,cellular proliferation promotion,nf-κb signaling pathway interaction
ENSG00000174652,ZNF266,transcriptional repressor function,overexpression in tumor cells,tumor suppressor gene silencing,epithelial-to-mesenchymal transition (emt),chromatin modification regulation,biomarker for disease progression
ENSG00000105656,ELL,rna polymerase ii regulation,transcriptional elongation,genomic instability,cell cycle progression,promoter recognition,oncogenic cell growth
ENSG00000101639,CEP192,centriole duplication,genomic instability,cell proliferation,microtubule organization,chromosomal abnormalities,aneuploidy
ENSG00000277649,TIMM22,mitochondrial dysfunction,oxidative stress,dna damage response,cellular proliferation,metabolic reprogramming,apoptosis resistance
ENSG00000132912,DCTN4,microtubule dynamics,cell division regulation,tumor suppressor interaction,genomic instability,centrosome organization,prognostic biomarker
ENSG00000146054,TRIM7,transcriptional regulation,cell cycle progression,apoptosis evasion,protein degradation regulation,ubiquitin ligase activity,tumor suppressor function
ENSG00000163254,CRYGC,cell cycle regulation,apoptosis evasion,thermal stress resistance,oxidative damage protection,protein stabilization,tumor progression marker
ENSG00000125741,OPA3,mitochondrial function regulation,cell growth and survival pathway,mtor signaling activation,cell cycle regulation disruption,apoptosis modulation,energy metabolism regulation
ENSG00000280616,VPS11,vps complex regulation,tumorigenesis association,cellular homeostasis maintenance,lysosomal regulation,autophagy modulation,cancer progression involvement
ENSG00000170484,KRT74,epithelial cell integrity,cell adhesion,proliferation regulation,immunotherapeutic target,epigenetic regulation,overexpression in cancer
ENSG00000171401,KRT13,cytoskeletal organization,oncogenic overexpression,cellular proliferation,tumor aggressiveness,epithelial cell differentiation,therapeutic target
ENSG00000102383,ZDHHC15,palmitoylation modification,oncogenic signaling,cell cycle regulation,metabolic reprogramming,egfr interaction,protein localization
ENSG00000078549,ADCYAP1R1,oncogene overexpression,gain-of-function mutations,tumor progression,cell proliferation regulation,apoptosis evasion,signal transduction activation
ENSG00000140022,STON2,cell migration and invasion,oncogenic processes,chemotherapy resistance,cellular metabolism regulation,therapeutic target,genomic profiling
ENSG00000085832,EPS15,clathrin-mediated endocytosis,egfr internalization,oncogenic signaling pathways,cell membrane dynamics regulation,receptor internalization enhancement,therapeutic target
ENSG00000118900,UBN1,protein degradation regulation,ubiquitination pathway,oncogenic process,apoptosis inhibition,cell proliferation enhancement,tumor progression
ENSG00000274137,MYOM2,cellular migration,protein-protein interaction,regulation of cell morphology,dysregulation in cancer,tumor progression,pi3k/akt pathway regulation
ENSG00000164941,INTS8,dna damage response,chromatin remodeling,tumor suppressor function,genomic instability,cell cycle regulation,transcriptional modulation
ENSG00000263155,MYZAP,genomic instability,tumor suppression,cell cycle regulation,dna damage response,loss of function mutations,cancer progression
ENSG00000154001,PPP2R5E,pi3k/akt signaling pathway activation,constitutive activation,tumor progression promoter,cell cycle regulation disruption,oncogenic process contributor,protein phosphatase 2a regulation dysregulation
ENSG00000148734,NPFFR1,g protein-coupled receptor,tumor progression,cell migration,cell proliferation,angiogenesis,promising therapeutic target
ENSG00000124678,TCP11,transcriptional regulation,chromatin remodeling,tumor suppressor loss,cell proliferation promotion,apoptosis inhibition,cancer progression driver
ENSG00000167182,SP2,emt modulation,oncogenic transcription factor,cell proliferation promotion,metastasis facilitation,transcriptional regulation,cancer cell survival enhancement
ENSG00000174744,BRMS1,rhogap activity,tumor suppressor function,cell proliferation inhibition,transcription regulation,signaling pathway modulation,constitutive activation loss
ENSG00000133134,BEX2,cellular regulation,apoptosis suppression,protein interaction,tumor progression,cell growth promotion,poor prognosis biomarker
ENSG00000008277,ADAM22,**
cell migration,cell adhesion disruption,metastasis facilitation,neuronal development regulation,oncogenic protein interaction,signal transduction alteration
**
ENSG00000092330,TINF2,telomere maintenance,chromosomal instability,genomic instability,telomerase activation,cancer progression,oncogenic pathway
ENSG00000042781,USH2A,wnt/pcp signaling,constitutive activation,loss of adhesion,epithelial-to-mesenchymal transition,cancer cell migration,stereocilia maintenance
ENSG00000006611,USH1C,oncogenesis,proliferation,cell adhesion,molecular modulation,overexpression,genomic instability
ENSG00000158480,SPATA2,cell cycle regulation,dna replication regulation,tumor progression driver,apoptosis regulation,chromatin remodeling,genomic instability mediator
ENSG00000171222,SCAND1,transcriptional coactivator,oncogene activation,cell cycle regulation,chromatin remodeling,dna repair suppression,therapeutic target
ENSG00000166529,ZSCAN21,overexpression,transcriptional regulation,cell proliferation modulation,tumor suppressor gene conversion,oncogenic signaling pathway interaction,zinc finger protein function
ENSG00000108691,CCL2,immune modulation,tumor progression,metastasis promotion,immunosuppression induction,angiogenesis stimulation,cell migration regulation
ENSG00000181220,ZNF746,oncogene activation,chromatin remodeling,transcriptional regulation,cell proliferation enhancement,survival pathway activation,tumor suppressor interaction
ENSG00000117758,STX12,membrane fusion regulation,pi3k/akt pathway interaction,cellular proliferation enhancement,apoptosis inhibition,oncogenic process facilitation,therapeutic target candidacy
ENSG00000182544,MFSD5,iron metabolism regulation,cellular stress response modulation,tumor progression facilitation,hypoxia adaptation,therapeutic resistance enhancement,prognostic biomarker potential
ENSG00000232062,HLA-DQA1,impaired antigen presentation,tumor evasion,nf-κb signaling pathway,immune surveillance failure,apoptosis regulation disruption,cell cycle progression alteration
ENSG00000262156,APOBEC3A,apobec family,dna editing,mutagenesis,oncogenic process,cytoplasmic localization,protein-protein interaction
ENSG00000063854,HAGH,dna repair,genomic stability,cell cycle regulation,oncogenic signaling,chromatin remodeling,tumorigenesis driver
ENSG00000189037,DUSP21,**

dephosphorylation,tumor suppressor,oncogenic pathway modulation,cell proliferation regulation,apoptosis regulation,kinase activation
ENSG00000174738,NR1D2,transcriptional regulation,circadian rhythm disruption,oncogenic function,cell proliferation,metabolic dysregulation,genomic instability
ENSG00000089248,ERP29,er stress response,protein folding,endoplasmic reticulum integrity,unfolded protein response,tumor progression,oncogenesis
ENSG00000118596,SLC16A7,metabolic reprogramming,glycolytic metabolism,lactate export mechanism,tumor aggressiveness,cellular ph regulation,energy metabolism modulation
ENSG00000197142,ACSL5,aberrant expression,oncogenic lipid metabolism,pi3k/akt signaling,tumor growth promotion,lipid synthesis regulation,cell proliferation enhancement
ENSG00000185880,TRIM69,oncogenic regulation,protein-protein interaction,tumor progression,cell growth regulation,metastasis induction,apoptosis suppression
ENSG00000170271,FAXDC2,cell migration,cellular adhesion,cytoplasmic protein localization,oncogene activation,tumor progression,protein-protein interaction
ENSG00000011275,RNF216,genomic instability,tumor suppressor dysfunction,cell cycle regulation,oncogenic pathway activation,protein accumulation,signaling pathway interaction
ENSG00000097021,ACOT7,oncogene activation,lipid metabolism dysregulation,chemotherapy resistance,cell proliferation enhancement,protein degradation modulation,tumor progression promotion
ENSG00000167325,RRM1,dna synthesis,ribonucleotide reductase activity,therapeutic target,resistance to chemotherapy,cell proliferation,prognostic marker
ENSG00000145780,FEM1C,enhanced cell survival,cell adhesion regulation,promoter of tumor progression,metastasis facilitation,wnt/β-catenin pathway modulation,aggressive cancer phenotype
ENSG00000213145,CRIP1,dna damage response,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis modulation,gene expression regulation
ENSG00000133800,LYVE1,tumor progression,metastasis facilitation,angiogenesis promotion,lymphatic regulation,therapeutic target,prognosis indicator
ENSG00000163472,TMEM79,pi3k/akt pathway,tumor progression,cell proliferation,metabolic regulation,biomarker,cell growth differentiation
,PQLC1,cellular growth control,polyamine metabolism oncogene,cell proliferation regulator,apoptosis inhibitor,prognostic marker poor prognosis,polyamine biosynthesis regulatation
ENSG00000151490,PTPRO,emt regulation,tumor suppressor function,cell adhesion modulation,pi3k/akt pathway inhibition,metastatic suppression,oncogenic signaling regulation
ENSG00000047936,ROS1,genomic instability,constitutive activation,gene fusion,oncogene,therapeutic target,signal transduction
ENSG00000162645,GBP2,cell migration,inflammation regulation,microtubule interaction,metastasis promotion,autophagy modulation,immune evasion
ENSG00000263028,TAS2R19,bitter taste receptor,g protein-coupled receptor family,cellular regulation,taste perception,cancer progression,adenylate cyclase inhibition
ENSG00000113048,MRPS27,mitochondrial ribosome assembly,oncogenic potential,tumor suppressor function,mitochondrial biogenesis,genomic instability,ribosomal protein regulation
ENSG00000135517,MIP,tumor progression,metastasis,cell migration,water transport regulation,oncogene activity,cancer cell signaling pathway modulation
ENSG00000039560,RAI14,chromatin remodeling,epigenetic regulation,transcriptional regulation,dna damage response,cell proliferation,genomic instability
ENSG00000165794,SLC39A2,metal ion transport,oncogenic role,zinc homeostasis dysregulation,cell proliferation enhancement,tumor progression facilitation,prognostic marker
ENSG00000179151,EDC3,enhanced cell proliferation,constitutive activation,rna processing and export,epigenetic alterations,oncogenic signaling,cancer stem cell regulation
ENSG00000197162,ZNF785,regulation of cell growth,altered gene expression,mutation contribution,cell survival pathway,transcriptional regulation,dna binding protein
ENSG00000003147,ICA1,cellular proliferation,metabolic regulation,oncogenic activity,protein degradation,toxin metabolism,enzymatic function
ENSG00000175376,EIF1AD,translational regulation,oncogenic mrna translation,cell cycle modulation,tumor suppressor microrna target,epithelial-to-mesenchymal transition facilitation,cancer aggressiveness promotion
ENSG00000171885,AQP4,water channel function,tumor progression,prognostic marker,therapeutic target,cell migration,ion homeostasis
ENSG00000143862,ARL8A,microtubule regulation,constitutive activation,oncogenic signaling,cell proliferation,apoptosis modulation,autophagy regulation
ENSG00000173660,UQCRH,electron transport chain,mitochondrial function,cellular respiration,metabolic regulation,tumor suppressor,redox balance
ENSG00000121634,GJA8,gap junction dysfunction,cellular communication disruption,tumor progression facilitation,metastasis enhancement,oncogenic signaling modulation,cell differentiation alteration
ENSG00000015592,STMN4,microtubule dynamics regulation,cell proliferation enhancement,oncogenic potential modulation,tumor progression correlation,poor prognosis association,cancer development contribution
ENSG00000090989,EXOC1,tumor progression,cell migration,vesicle trafficking,endosomal sorting,autophagy modulation,poor prognosis
ENSG00000099203,TMED1,copii coat assembly,cell growth regulation,oncogene interaction,protein export regulation,tumor suppressor interaction,cancer biomarker
ENSG00000150787,PTS,glycolytic shift,sugar uptake regulation,energy metabolism modulation,proliferation enhancement,cancer cell metabolism,altered expression
ENSG00000174851,YIF1A,ribosome biogenesis,protein synthesis promotion,oncogenic pathway activation,chemotherapy resistance,cell proliferation enhancement,poor prognosis association
ENSG00000145982,FARS2,protein synthesis regulation,oncogenic processes,cell proliferation,autophagy modulation,constitutive activation,tumor progression
ENSG00000119782,FKBP1B,immune evasion,oncogene cooperation,tumor microenvironment,antigen presentation inhibition,cell cycle regulation,protein-protein interactions
ENSG00000198626,RYR2,calcium channel regulation,aberrant calcium signaling,cell proliferation modulation,apoptosis induction,therapeutic target,genomic instability
ENSG00000169248,CXCL11,angiogenesis promotion,immune evasion mechanism,oncogenic activity,prognostic biomarker,tumor growth facilitation,immune cell recruitment
ENSG00000006606,CCL26,angiogenesis promotion,immune suppression,tumor progression,metastasis facilitation,pro-inflammatory signaling,cancer metastasis
ENSG00000118777,ABCG2,multidrug resistance,cellular efflux pump,apoptosis regulation,cellular proliferation,chemotherapy resistance,tumor progression
ENSG00000198959,TGM2,apoptosis regulation,cell adhesion regulation,cytoplasmic cross-linking,protein stabilization,transcriptional regulation,tumor progression
ENSG00000237508,HLA-F,immune suppression,tumor evasion,non-classical mhc molecule,cd4+ t-cell modulation,poor prognosis,immune surveillance inhibition
ENSG00000283889,KIR3DS1,activatory receptor,mhc class i binding,nk cell activation,tumor immunology,immune evasion mechanisms,kir family member
ENSG00000100055,CYTH4,nucleotide metabolism,protein interaction,cell proliferation,oncogenic process,wnt/β-catenin pathway,tumorigenesis
ENSG00000124782,RREB1,transcription factor,oncogene,cell cycle progression,apoptosis evasion,tumorigenesis promotion,prognostic marker
ENSG00000000457,SCYL3,oncoprotein stabilization,ubiquitination and proteasomal degradation,cellular stress response modulation,therapeutic target potential,protein regulation and degradation,e3 ubiquitin ligase interaction
ENSG00000130684,ZNF337,loss of function mutations,tumor suppression,tumor progression,genomic instability,transcriptional regulation,cell proliferation
ENSG00000107249,GLIS3,transcriptional regulation,tumor progression,oncogenic signaling pathway,cell proliferation,metastasis,pi3k/akt activation
ENSG00000122126,OCRL,epithelial-to-mesenchymal transition,tumor suppressor function,endosomal trafficking regulation,cell polarity maintenance,cell migration regulation,cancer stem cell maintenance
ENSG00000164609,SLU7,altered splicing patterns,chromatin remodeling,cancer predisposition,rna processing regulation,tumorigenesis involvement,genome instability
ENSG00000187559,FOXD4L3,oncogenic transcription factor,cellular growth regulation,apoptosis suppression,metastasis promotion,angiogenesis enhancement,therapeutic target
ENSG00000151882,CCL28,immune modulation,tumor microenvironment,cell migration,adhesion molecules,prognostic marker,tumor progression
ENSG00000160796,NBEAL2,cellular transport regulation,genomic instability,oncogenic mutations,therapeutic target,cellular homeostasis disruption,protein-protein interaction
ENSG00000109805,NCAPG,genomic instability,aneuploidy,chromosome segregation,condensin ii complex,dysregulated gene expression,tumor suppressor suppression
ENSG00000121152,NCAPH,chromosomal instability,centromere function,genomic profiling,mitotic errors,protein interactions,aneuploidy
ENSG00000119396,RAB14,pi3k/akt pathway modulation,overexpression in cancer tissues,cell proliferation and migration regulation,interaction with trim27,prognostic biomarker,membrane trafficking regulation
ENSG00000146109,ABT1,genomic instability,homologous recombination,chromatin remodeling,gene expression regulation,dna damage response,tumor progression
ENSG00000197275,RAD54B,homologous recombination repair,genomic instability,tumor driver gene,dna double-strand break repair,brca1/brcan interactors,cancer therapeutic target
ENSG00000147041,SYTL5,aberrant activation,apoptosis suppression,cellular proliferation,constitutive expression,endocytosis regulation,exocytosis modulation
ENSG00000041353,RAB27B,aberrant activation,cell proliferation,epithelial-to-mesenchymal transition,metastasis,oncogenic signaling,regulation of vesicle trafficking
ENSG00000168993,CPLX1,pi3k/akt signaling,cell proliferation,growth factor regulation,cell migration,tumor progression,g-protein modulation
ENSG00000104892,KLC3,mitotic spindle assembly,cell migration,enhanced chemotherapy resistance,microtubule stability,oncogenic properties,cell cycle regulation
ENSG00000118922,KLF12,transcription factor regulation,tumor suppressor function,cell proliferation modulation,apoptosis induction,genomic stability maintenance,chromosomal instability association
ENSG00000039650,PNKP,genomic instability,dna repair mechanism,tumor suppressor function,cellular proliferation,oncogenic driver,cancer-related pathway
ENSG00000138686,BBS7,bbsome dysfunction,ciliogenesis impairment,cell cycle regulation,intracellular trafficking,oncogenic processes,genomic instability
ENSG00000181029,TRAPPC5,cellular membrane trafficking,oncogenic signaling,tumor progression,cell proliferation,protein transport regulation,genetic mutations
ENSG00000164975,SNAPC3,alterative splicing regulation,oncogenic isoform expression,tumor suppressor isoform suppression,cell proliferation enhancement,metastasis promotion,spliceosome modulation
ENSG00000023608,SNAPC1,disrupted snrnp assembly,aberrant gene expression,enhanced cell proliferation,increased metastatic potential,pre-mrna splicing dysregulation,core spliceosome complex subunit
ENSG00000133318,RTN3,er membrane regulation,apoptosis suppression,cell proliferation enhancement,tumor progression facilitation,oncogenic signaling modulation,cancer cell survival promotion
ENSG00000103502,CDIPT,cell membrane synthesis,gain of function mutations,phospholipid metabolism regulation,cell proliferation enhancement,tumor progression facilitation,metabolic demand increase
ENSG00000088538,DOCK3,oncogene,epithelial-to-mesenchymal transition,cell migration,tumor aggressiveness,gtpase activation,cancer cell migration
ENSG00000276432,RDM1,genomic instability,cell cycle regulation,apoptosis suppression,dna repair mechanism,nuclear localization,chromatin remodeling
ENSG00000242689,CNTF,oncogene,cell survival enhancement,tumor growth promotion,angiogenesis regulation,jak/stat pathway activation,prognostic marker
ENSG00000014123,UFL1,ubiquitination pathway,oncogenic protein regulation,cell cycle progression,tumor aggressiveness,pi3k/akt pathway modulation,therapeutic target
ENSG00000182985,CADM1,tumor suppressor,downregulation,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),immune evasion,poor prognosis
ENSG00000109943,CRTAM,tumor progression,immune evasion,cell adhesion,transmembrane receptor,signaling pathway modulation,poor prognosis marker
ENSG00000134690,CDCA8,cell cycle progression,aberrant mitosis,centrosome amplification,genomic instability,tumor aggressiveness,prognostic marker
ENSG00000106069,CHN2,protein misfolding,cellular homeostasis disruption,tumor suppressor function,loss of function mutations,stress response activation,apoptosis regulation
ENSG00000158691,ZSCAN12,tumor suppression,cell cycle regulation,apoptosis induction,transcriptional regulation,epigenetic modification,chromatin remodeling
ENSG00000143320,CRABP2,retinoid signaling,oncogene overexpression,cell proliferation regulation,apoptosis inhibition,angiogenesis promotion,tumor progression driver
ENSG00000159479,MED8,transcriptional regulation,oncogene,cell cycle progression,tumor progression,gene amplification,cancer driver
ENSG00000134201,GSTM5,genetic instability,detoxification pathway,oxidative stress protection,tumor suppressor function,dna damage repair,epigenetic regulation
ENSG00000134202,GSTM3,detoxification,tumor suppressor,genomic stability,dna damage response,epigenetic regulation,gene expression modulation
ENSG00000186844,LCE1A,proliferation promotion,cell differentiation regulation,emt process involvement,biomarker potential,protein kinase activation regulation,cell survival enhancement
ENSG00000196734,LCE1B,cellular proliferation,regulation of lipid metabolism,modulator of cellular stress responses,lipid-protein interactions,promoter of cell growth and metastasis,biomarker for patient outcomes
ENSG00000099860,GADD45B,dna damage response,transcriptional regulation,tumor suppression,tumor progression,genomic stability,mitotic checkpoint
ENSG00000096093,EFHC1,microtubule stabilization,centrosomal localization,cell proliferation enhancement,protein-protein interaction,mitotic spindle formation regulation,cancer cell survival promotion
ENSG00000147854,UHRF2,dna replication regulation,genomic stability maintenance,proliferation promotion,apoptosis resistance,survival enhancement,cancer prognosis impact
ENSG00000162236,STX5,membrane fusion,snare complex formation,tumor progression,cell survival,cancer therapy target,golgi apparatus localization
ENSG00000096872,IFT74,cilia dysfunction,tumor suppressor gene,hedgehog signaling dysregulation,cell cycle progression regulation,genomic instability induction,protein complex component
,H2AFZ,chromatin remodeling,tumor progression,genomic instability,epigenetic regulation,dna packaging,transcriptional modulation
ENSG00000075089,ACTR6,actin polymerization,cell migration,cytoplasmic structure,oncogene activation,apoptosis regulation,protein interaction
ENSG00000171195,MUC7,altered cellular behavior,increased cell proliferation,migration and invasion,modulation of cellular responses,oncogenic processes,transmembrane mucin glycoprotein
ENSG00000165672,PRDX3,redox regulation,tumor progression,oncogenesis,antioxidant enzyme function,cellular protection,protein-protein interactions
ENSG00000108417,KRT37,keratin expression alteration,tumor aggressiveness association,cell proliferation influence,epithelial cell integrity maintenance,overexpression in tumor tissues,pi3k/akt pathway interaction
ENSG00000170276,HSPB2,chaperone activity,cellular stress response,apoptosis inhibition,tumor progression,metastasis facilitation,oncogenic potential
ENSG00000102362,SYTL4,cell migration,calcium-dependent membrane dynamics,cell invasion,oncogenic signaling pathways,tumor progression,chemoresistance
ENSG00000124164,VAPB,er stress response modulation,protein quality control regulation,cellular survival enhancement,tumorigenesis promotion,oncogenic transformation facilitation,erad pathway involvement
ENSG00000133027,PEMT,lipid metabolism regulation,oncogenesis promotion,pi3k/akt pathway modulation,tumor progression facilitation,metastasis enhancement,cell proliferation stimulation
ENSG00000168269,FOXI1,oncogenic transcription factor,epithelial-to-mesenchymal transition (emt),cell proliferation,metastatic potential,prognostic marker,gene regulation
ENSG00000213203,GIMAP1,mitochondrial nucleotide metabolism,guanylate balance regulation,lymphocyte function modulation,mitochondrial integrity maintenance,tumor suppressor candidate,cancer-related genetic instability
ENSG00000106004,HOXA5,tumor suppressor,downregulated or silenced,cell proliferation,epithelial-to-mesenchymal transition,apoptosis modulation,wnt/β-catenin pathway
ENSG00000096401,CDC5L,mitotic regulation,cell cycle progression,genomic stability,dna replication repair,protein kinase activity,tumor aggressiveness
ENSG00000110955,ATP5F1B,mitochondrial function,metabolic reprogramming,aerobic glycolysis,oncogenesis,genetic instability,ros production
ENSG00000127603,MACF1,cytoplasmic localization,cell cycle progression,cytoskeletal component,microtubule stabilization,apoptosis inhibition,oncogenic driver
ENSG00000119638,NEK9,cell cycle regulation,genomic instability,apoptosis evasion,tumor aggressiveness,chemotherapy resistance,oncogenic signaling pathway
ENSG00000137210,TMEM14B,regulation of dna repair,interaction with brca2/atm,enhanced cell growth,increased oxidative stress tolerance,cell cycle regulation g1 phase,oncogenic mutations leading to overexpression
ENSG00000171403,KRT9,cellular proliferation,tumor progression,oncoprotein overexpression,biomarker potential,cellular adhesion modulation,pi3k/akt signaling interaction
ENSG00000180884,ZNF792,cell cycle regulation,apoptosis regulation,oncogenic function,tumor progression,protein interaction,genomic instability
ENSG00000160803,UBQLN4,autophagy regulation,cell survival enhancement,chemo-resistance induction,tumor growth acceleration,protein degradation modulation,cancer driver role
ENSG00000143858,SYT2,cellular fusion regulation,pi3k/akt pathway activation,tumor aggressiveness,oncogenic protein interactions,genomic overexpression,signaling pathway modulation
ENSG00000013441,CLK1,oncogene regulation,cell proliferation enhancement,signaling pathway modulation,protein phosphorylation,transcriptional control disruption,tumor aggressiveness promotion
ENSG00000183091,NEB,pi3k/akt signaling,genomic instability,oncogenesis,microtubule dynamics,cell migration,tumor progression
ENSG00000167371,PRRT2,cell surface protein,overexpressed in tumor tissues,enhanced cell migration,cellular signaling regulation,proliferation promotion,survival pathway activation
ENSG00000206203,TSSK2,tumor progression,apoptosis regulation,cell proliferation enhancement,serine/threonine kinase activity,gene expression upregulation,prognostic biomarker
ENSG00000198860,TSEN15,trna splicing endonuclease,aberrant pre-trna processing,oncogenic pathways activation,cell growth promotion,tumor suppressor function,loss-of-function mutations
ENSG00000204104,TRAF3IP1,immune modulation,tumor progression,nf-κb signaling,protein-protein interaction,inflammation regulation,cancer driver gene
ENSG00000086288,NME8,cellular growth regulation,dna repair mechanism,cell cycle modulation,oncogenic function,p53 interaction,overexpression signature
ENSG00000115947,ORC4,genomic instability,cell cycle progression,dna replication initiation,oncogene activation,tumor growth promotion,epigenetic regulation
ENSG00000176256,HMGB4,chromatin remodeling,cell cycle progression,genomic instability,dna repair mechanism,transcriptional regulation,prognostic biomarker
ENSG00000148308,GTF3C5,transcription factor activity,genome stability,cell proliferation,tumor progression,protein-protein interactions,gene expression regulation
ENSG00000159231,CBR3,retinoic acid metabolism,apoptosis regulation,oncogenic processes,cell proliferation,tumor suppressor function,protein-protein interaction
ENSG00000111737,RAB35,cell membrane trafficking,constitutive activation,gtpase activity,oncogene activity,cell migration regulation,therapeutic target
ENSG00000171792,RHNO1,oncogenic processes,regulation of cell growth,cellular differentiation regulation,tumor aggressiveness,nuclear receptor interaction,transcriptional regulation
ENSG00000108179,PPIF,protein stability regulation,cell cycle regulation,dna repair modulation,oncogenic mutations,tumor aggressiveness,cancer progression marker
ENSG00000155087,ODF1,microtubule stability regulation,cell proliferation enhancement,chromosomal instability promotion,oncogenic function implicated,tumor aggressiveness association,genetic alteration link
ENSG00000187742,SECISBP2,antioxidant defense,cell growth regulation,disrupted gene expression,increased cell survival,post-transcriptional regulation,protein-protein interactions
ENSG00000087152,ATXN7L3,ubiquitin ligase activity,protein homeostasis regulation,oncogenic mutations,cell proliferation enhancement,ubiquitination pathway dysregulation,protein degradation impairment
ENSG00000162714,ZNF496,transcriptional regulation,cell proliferation,oncogenesis,chromatin modification,zinc finger protein interaction,tumor overexpression
ENSG00000113739,STC2,vegf regulation,angiogenesis promotion,cell migration facilitation,iron homeostasis disruption,calcium signaling modulation,wnt pathway interaction
ENSG00000198879,SFMBT2,enhanced tumorigenesis,cell proliferation,overexpression,transcriptional regulation,chromatin remodeling,poor prognosis
ENSG00000174429,ABRA,cholesterol efflux,abc transporter family,lipid metabolism regulation,oncogene activation,cell proliferation promotion,cancer progression enhancement
ENSG00000112514,CUTA,regulation of cell growth,activation of signaling pathways,cell survival mechanisms,tumor progression modulation,protein cross-linking,transcriptional regulation
ENSG00000176476,SGF29,genomic stability,chromatin remodeling,dna repair,tumorigenesis promoter,overexpression,cancer driver gene
ENSG00000146618,FERD3L,loss of function mutations,impaired ubiquitination,cell cycle progression,apoptosis regulation,cellular stress responses,protein aggregation
ENSG00000078295,ADCY2,cell proliferation,apoptosis inhibition,growth factor regulation,tumor progression,signaling pathway activation,mutation hotspot
ENSG00000091317,CMTM6,tumor suppressor function,epigenetic silencing,pi3k/akt pathway inhibition,apoptosis induction,cell cycle regulation disruption,genomic stability promotion
ENSG00000184489,PTP4A3,oncogenic signaling pathway,cell proliferation regulation,tumor progression marker,dephosphorylation activity,signaling molecule interaction,epithelial-to-mesenchymal transition
ENSG00000135324,MRAP2,melanocortin receptor regulation,signaling pathway interaction,cell proliferation regulation,tumor progression,metabolic regulation disruption,gene overexpression
ENSG00000167178,ISLR2,tumor suppression,wnt/β-catenin signaling,immune evasion,mutation and deletion,cancer progression,cell migration
ENSG00000148229,POLE3,genomic instability,oncogenic driver,genetic hypermutability,microsatellite instability,immunotherapy response,tumor progression
ENSG00000115350,POLE4,genomic instability,error-prone dna replication,cell proliferation enhancement,dna damage response modulation,therapeutic target,genomic instability
ENSG00000186442,KRT3,overexpression,cell proliferation,epithelial-to-mesenchymal transition,co-amplification,oncogenic driver,genomic instability
ENSG00000196236,XPNPEP3,glutamine regulation,tumor progression,oncogene,cell proliferation,metabolic regulation,protein interaction
ENSG00000137965,IFI44,apoptosis regulation,cell cycle progression,immunomodulation,oncogenesis promotion,signaling pathway interaction,transmembrane protein function
ENSG00000176049,JAKMIP2,jak-stat signaling,dysregulation,aberrant expression,cell proliferation,tumor progression,therapeutic target
ENSG00000116035,VAX2,transcription factor regulation,promoter hypermethylation,tumor suppressor function,cell cycle progression,epithelial cell interaction,chromatin remodeling
ENSG00000182107,TMEM30B,calcium signaling alteration,cell proliferation driver,dna repair impairment,oncogenic mutation driver,therapeutic target candidate,genomic instability enhancer
ENSG00000099194,SCD,lipid metabolism regulation,tumor growth promotion,cell survival enhancement,apoptosis resistance,fatty acid biosynthesis,signaling pathway modulation
ENSG00000159363,ATP13A2,metal ion regulation,transmembrane transport,oncogenic properties,cell survival enhancement,proliferation promotion,tumor progression
ENSG00000173706,HEG1,apoptosis inhibition,oncogenic activity,cell survival enhancement,tumor progression,therapeutic target,genetic alterations
ENSG00000001631,KRIT1,angiogenesis promotion,cell proliferation enhancement,tight junction disruption,rap1 gtpase regulation,vascular stability impairment,pi3k/akt pathway interaction
ENSG00000237110,TAAR9,immune modulation,tumor progression,prognostic marker,therapeutic target,signaling pathway regulation,cancer cell growth
ENSG00000136021,SCYL2,protein degradation regulation,cell cycle regulation,g1/s phase transition,oncogenic overexpression,therapeutic target,cell proliferation enhancement
ENSG00000153574,RPIA,metabolic reprogramming,oncogenic transformation,cell growth promotion,nadph production,ribose-5-phosphate synthesis,transcription factor modulation
ENSG00000165389,SPTSSA,proteolytic regulation,tumor suppressor function,cell signaling pathway,epithelial-to-mesenchymal transition (emt),invasive growth promotion,cancer metastasis inhibition
ENSG00000122557,HERPUD2,apoptosis regulation,autophagy modulation,protein degradation,cellular survival,tumor progression,ubiquitin-proteasome interaction
ENSG00000184787,UBE2G2,ubiquitination regulation,apoptosis evasion,cell cycle regulation,nf-κb pathway activation,oncogene potential,proteasome degradation pathway
ENSG00000080819,CPOX,cellular proliferation,heme biosynthesis pathway,oncogenic potential,mitochondrial function,redox regulation,apoptosis modulation
ENSG00000176390,CRLF3,cell growth regulation,signaling pathway activation,tumor aggressiveness,poor prognosis,oncogene interaction,genomic dysregulation
ENSG00000122507,BBS9,cell cycle regulation,constitutive activation,ciliopathy involvement,oncogenic pathway activation,growth regulation,metastatic promotion
ENSG00000133169,BEX1,apoptosis regulation,oncogenic role,tumor progression marker,cell death modulation,overexpression correlation,pi3k/akt pathway interaction
ENSG00000168453,HR,genomic instability,homologous recombination repair,oncogenic mutations,genomic alterations,tumor progression,dna repair mechanism
ENSG00000114638,UPK1B,cellular barrier function,transmembrane protein,tumor progression,signaling pathway modulation,cancer cell behavior regulation,urothelial layer integrity
ENSG00000221829,FANCG,homologous recombination repair,genomic instability,dna damage response,tumor burden,genome maintenance,homologous recombinantion deficient
ENSG00000101608,MYL12A,cell contraction,oncogenic processes,cell migration,invasion facilitation,tumor aggressiveness,therapeutic target
ENSG00000183726,TMEM50A,tumor suppression,genomic stability maintenance,cell cycle regulation,mitotic exit regulation,sister chromatid separation,chromosomal integrity preservation
ENSG00000172155,LCE1D,tumor microenvironment,immune response regulation,cell death regulation,inflammation modulation,cancer cell interaction,genetic variation analysis
ENSG00000100749,VRK1,cell cycle regulation,apoptosis dysregulation,kinase activity,oncogene activation,tumor suppressor interaction,protein phosphorylation
ENSG00000181449,SOX2,transcriptional regulator,epithelial-to-mesenchymal transition,tumor suppressor role reversal,oncogenic function,cellular proliferation enhancement,apoptosis resistance promotion
ENSG00000078246,TULP3,microtubule stabilization,oncogenic protein interaction,tumor growth promotion,pi3k/akt pathway modulation,genomic alteration,cancer cell survival enhancement
ENSG00000174780,SRP72,signal recognition particle complex,translocation regulation,oncogene overexpression,protein synthesis enhancement,cell proliferation promotion,tumor progression driver
ENSG00000156469,MTERF3,mitochondrial dna regulation,transcriptional termination,cellular proliferation,metabolic reprogramming,apoptosis resistance,genomic instability
ENSG00000013503,POLR3B,rnapiii transcription,chromatin remodeling,cell proliferation driver,transcriptional regulation,oncogenic mutations,tumor suppressor interaction
ENSG00000089041,P2RX7,ion channel activity,tumor progression,cell proliferation,signal transduction,metastasis promotion,oncogenic signaling
ENSG00000068001,HYAL2,hyaluronic acid degradation,extracellular matrix regulation,tumor progression,cell proliferation,angiogenesis promotion,pi3k/akt pathway interaction
ENSG00000135185,TMEM243,pi3k/akt pathway regulation,apoptosis inhibition,cell cycle progression,oncogenic interaction,transmembrane protein function,poor prognosis marker
ENSG00000166889,PATL1,**

dna damage response,cell cycle regulation,genomic stability maintenance,checkpoint activation,oncogenic mutations,tumor suppressor function

**
ENSG00000083937,CHMP2B,escrt pathway regulation,cell membrane trafficking,tumor progression,metastasis promotion,cell proliferation enhancement,apoptosis inhibition
ENSG00000214063,TSPAN4,tspan4 overexpression,tumor progression,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),prognostic marker,signal transduction pathway modification
ENSG00000178966,RMI1,genomic instability,homologous recombination repair,dna double-strand break repair,tumor suppressor function,genetic predisposition,genome maintenance
ENSG00000175643,RMI2,genomic instability,dna double-strand breaks,cell cycle regulation,genetic alterations,homologous recombination,tumor progression
ENSG00000152104,PTPN14,tumor suppressor,dephosphorylation activity,oncogenesis regulation,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction,dna damage response
ENSG00000085563,ABCB1,multidrug resistance,chemotherapy efflux,prognostic marker,poor drug accumulation,apoptosis regulation,cancer cell survival
ENSG00000104341,LAPTM4B,tumor progression,cell growth promotion,oncogenic signaling pathway activation,poor prognosis indicator,therapeutic target,lysosome-related function regulation
ENSG00000029364,SLC39A9,slc39a9 expression,zinc influx,oncogenic signaling pathways,cell proliferation,immune evasion,apoptosis resistance
ENSG00000213996,TM6SF2,lipid transfer,tumor progression,metabolic reprogramming,cellular homeostasis disruption,oncogenic processes,protein-lipid interactions
ENSG00000121570,DPPA4,cellular proliferation,maintenance of pluripotency,epigenetic regulation,oncogenic signaling pathway,transcriptional regulation,genomic instability
ENSG00000176302,FOXR1,fox transcription factor,transcriptional regulation,gene expression modulation,tumor progression,cell cycle regulation,metastasis promotion
ENSG00000137185,ZSCAN9,oncogene,transcription factor activity,cell cycle regulation,apoptosis inhibition,epigenetic regulation,chromatin modification
ENSG00000134198,TSPAN2,cell migration,epithelial-to-mesenchymal transition,integrin regulation,mesenchymal marker expression,pi3k/akt signaling,oncogenic cell growth
ENSG00000166448,TMEM130,cell migration,autophagy pathway,membrane fusion,prognostic biomarker,cancer progression,regulatory protein
ENSG00000119522,DENND1A,endocytic regulation,constitutive activation,cell migration,protein-protein interaction,cell proliferation,tumor progression
ENSG00000162399,BSND,h+ k+ atpase enzyme regulation,cell proliferation enhancement,metastasis promotion,tumor microenvironment alteration,prognostic biomarker,acid-base homeostasis disruption
ENSG00000157978,LDLRAP1,lipid metabolism regulation,cholesterol homeostasis modulation,adaptor protein function,therapeutic target identification,prognostic biomarker,cellular cholesterol regulation
ENSG00000101367,MAPRE1,microtubule regulation,cell cycle progression,genomic stability,cancer cell proliferation,cell survival mechanisms,therapeutic target
ENSG00000128944,KNSTRN,cell cycle regulation,genomic instability,oncogene function,protein-protein interactions,tumorigenesis,mitotic spindle assembly
ENSG00000221864,KRTAP12-2,keratin-associated protein structure,epithelial tissue integrity,tissue architecture maintenance,cell adhesion regulation,protein-protein interaction,cytokeratin complexation
ENSG00000139192,TAPBPL,genomic instability,dna repair pathway,transcription-coupled repair,oncogenic processes,therapeutic target,genetic alterations
ENSG00000110422,HIPK3,cell cycle regulation,tumor progression,apoptosis inhibition,pi3k/akt pathway interaction,mapk/erk pathway regulation,serine/threonine kinase activity
ENSG00000198331,HYLS1,genomic instability,aneuploidy,cell cycle regulation,centromere binding,chromosomal instability,tumor suppressor dysfunction
ENSG00000187713,TMEM203,transmembrane protein,cell growth regulation,tumor progression marker,protein-protein interaction,cell differentiation regulation,apoptosis suppression
ENSG00000171124,FUT3,tumor progression,glycosylation regulation,cell surface interactions,protein-protein interaction,immune response modulation,therapeutic target
ENSG00000103528,SYT17,transcriptional regulation,genome instability,mutations,oncogenesis,cell cycle progression,gene expression modulation
ENSG00000100365,NCF4,nadph oxidase activity,reactive oxygen species production,tumor progression,apoptosis regulation,inflammation modulation,cell proliferation
ENSG00000177301,KCNA2,ion channel regulation,oncogene activity,cell proliferation enhancement,apoptosis inhibition,prognostic marker,therapeutic target
ENSG00000050327,ARHGEF5,rho gtpase activation,oncogenic signaling,cell migration,pi3k/akt modulation,cell proliferation,epithelial-to-mesenchymal transition
ENSG00000125818,PSMF1,protein degradation pathway,tumor progression,cell cycle regulation,apoptosis evasion,oncogenic function,genomic instability
ENSG00000137098,SPAG8,cell cycle regulation,oncogene activity,microtubule dynamics,mitosis promotion,phosphorylation-dependent activation,tumor aggressiveness
ENSG00000163848,ZNF148,transcriptional regulation,dna binding activity,cell cycle regulation,apoptosis resistance,tumor progression,oncogene function
ENSG00000146469,VIP,tumor suppression,apoptosis induction,proliferation inhibition,vasodilation regulation,immune modulation,neuropeptide function
ENSG00000136636,KCTD3,p53 regulation,tumor suppressor loss,cell proliferation increase,apoptosis evasion,genomic instability induction,therapeutic target identification
ENSG00000160471,COX6B2,mitochondrial biogenesis,oncogenic potential,metabolic regulation,electron transport chain function,reactive oxygen species generation,biomarker for prognosis
ENSG00000280635,PROP1,cellular regulation,transcriptional dysregulation,oncogenic function,cell growth modulation,enhanced cell proliferation,aberrant expression patterns
ENSG00000115255,REEP6,mitochondrial dynamics,tumor progression,cell signaling pathway,oncogenesis,molecular adaptor function,er morphology regulation
ENSG00000125848,FLRT3,wnt/β-catenin signaling pathway,co-receptor activity,tumor progression,cell migration and invasion,protein-protein interaction,cancer metastasis
ENSG00000109756,RAPGEF2,rap1 activation,oncogenic driver,cell survival promotion,pi3k/akt pathway regulation,epithelial-to-mesenchymal transition (emt),guanine nucleotide exchange factor (gef)
ENSG00000148153,INIP,pi3k/akt pathway regulation,nedd4 interaction,protein degradation regulation,tumor suppressor protein degradation,cell proliferation promotion,apoptosis inhibition
ENSG00000183628,DGCR6,drosha-mediated cleavage,mirna biogenesis,tumor suppressor dysregulation,cell cycle progression,gene expression regulation,apoptosis inhibition
ENSG00000077585,GPR137B,pi3k/akt pathway modulation,epithelial-to-mesenchymal transition,cell proliferation regulation,gene overexpression,poor prognosis association,signaling pathway activation
ENSG00000070019,GUCY2C,cgmp-dependent pathway,oncogenic driver mutations,cell signaling regulation,tumor growth promotion,metastasis enhancement,protein-protein interaction
ENSG00000172367,PDZD3,cell adhesion disruption,epithelial-to-mesenchymal transition,protein-protein interaction regulation,tumor invasion facilitation,apoptosis inhibition,signaling pathway dysregulation
ENSG00000105717,PBX4,tale superclass,transcriptional regulation,cellular proliferation,tumorigenesis,apoptosis evasion,genomic instability
ENSG00000187210,GCNT1,oncogenic glycosylation,glycoprotein modification,tumor progression,metastasis promotion,apoptosis suppression,cell signaling regulation
ENSG00000177469,CAVIN1,pi3k/akt signaling pathway,oncogene overexpression,cell proliferation enhancement,tumor progression promotion,signal transduction regulation,epithelial-to-mesenchymal transition (emt) modulation
ENSG00000149516,MS4A3,tumor progression,immune suppression,cell signaling pathway,oncogene activation,poor prognosis,cancer immune evasion
ENSG00000163684,RPP14,trna processing,mirna regulation,cell proliferation,tumor progression,cancer driver gene candidate,chemosensitivity regulation
ENSG00000173141,MRPL57,mitochondrial ribosome assembly,oncogenic translation,overexpression in cancer,tumor progression,signaling pathway activation,poor prognosis marker
ENSG00000213921,LEUTX,tumor progression,transcriptional regulation,cell proliferation,oncogenic potential,apothosis modulation,gene amplification
ENSG00000149179,C11orf49,cellular transformation,oncogenic pathway activation,apoptosis regulation,cell cycle progression,tumor suppressor dysfunction,gene amplification
ENSG00000143319,ISG20L2,apoptosis regulation,cell proliferation,chemotherapy resistance,immune evasion,oncogenic function,tumor progression
ENSG00000278062,ZNF251,apoptosis regulation,transcriptional regulation,oncogene function,cell proliferation promotion,tumor suppressor interaction,chromatin remodeling
ENSG00000196418,ZNF124,gene expression regulation,cell proliferation regulation,protein-protein interaction,epigenetic regulation,transcriptional modulation,tumor progression association
ENSG00000184507,NUTM1,oncogenic driver,transcriptional regulation,cell proliferation enhancer,tumor progression marker,prognostic indicator,genomic amplification
ENSG00000110680,CALCA,cell proliferation,genomic instability,apoptosis regulation,tumor growth,protein kinase activation,stress response modulation
ENSG00000138190,EXOC6,exocyst complex,cell proliferation,signaling pathway modulation,apoptosis evasion,tumor aggressiveness,oncogenic processes
ENSG00000158882,TOMM40L,cellular metabolism,energy production,oncogene/tumor suppressor,mitochondrial regulation,tumor progression,genetic alterations
ENSG00000168758,SEMA4C,tumor suppressor function,loss of expression,angiogenesis regulation,immune response modulation,apoptosis suppression,pi3k/akt pathway interaction
ENSG00000109084,TMEM97,cellular proliferation,tumor progression,signaling pathway interaction,transmembrane protein function,oncogene activation,molecular regulation
,C6orf203,cell cycle regulation,dna damage response,tumor progression,poor prognosis,genomic alteration,oncogenic potential
ENSG00000130675,MNX1,overexpression,epithelial-to-mesenchymal transition (emt),oncogenic function,tumor suppressor gene suppression,tissue patterning disruption,cell proliferation enhancement
ENSG00000196639,HRH1,histamine signaling pathway,receptor overexpression,g-protein coupled receptor activation,cell proliferation enhancement,tumor metastasis promotion,therapeutic target identification
ENSG00000122033,MTIF3,mitochondrial protein synthesis regulation,cellular metabolic reprogramming,genetic instability modulation,tumor aggressiveness enhancement,cell proliferation promotion,metabolic adaptation
ENSG00000164741,DLC1,tumor suppressor,cell cycle regulation,rho gtpase activation,apoptosis modulation,angiogenesis inhibition,cell migration suppression
ENSG00000131142,CCL25,cancer-promoting,chemokine signaling,epithelial-to-mesenchymal transition,immune cell recruitment,tumor progression,metastasis facilitation
ENSG00000205323,SARNP,splicing regulation,genomic instability,chromatin remodeling,cell proliferation,oncogenic splicing variants,protein-protein interaction
ENSG00000134049,IER3IP1,chromatin remodeling,tumor progression,transcriptional regulation,cell cycle progression,apoptosis suppression,proliferation enhancement
ENSG00000183474,GTF2H2C,genomic instability,dna repair pathway,transcriptional regulation,tumor suppression,cell growth regulation,protein-protein interaction
ENSG00000101945,SUV39H1,**
epigenetic regulation,tumor suppression,genomic stability,histone modification,cell cycle regulation,apoptosis inhibition
**
ENSG00000274675,GTF2H2C_2,genomic instability,nucleotide excision repair (ner),dna damage response,transcriptional regulation,cell cycle progression,genome integrity
ENSG00000278369,KIR2DL3,apoptosis regulation,cellular homeostasis modulation,potassium channel function,tumor cell survival,therapeutic target,genomic instability
ENSG00000100372,SLC25A17,metabolic regulation,glycolytic shift,mitochondrial carrier protein,cellular metabolism,oncogenic processes,tumor growth
ENSG00000145945,FAM50B,cell cycle regulation,dna replication,apoptosis modulation,tumor progression marker,protein-protein interaction,oncogenic function
ENSG00000206538,VGLL3,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition (emt),transcriptional regulation,oncogene role,tumor progression marker,poor prognosis indicator
ENSG00000181704,YIPF6,er dynamics disruption,oncogene overexpression,tumor progression,metastasis promotion,therapeutic target,protein processing regulation
ENSG00000108960,MMD,tumor metabolism,energy production alteration,cellular growth regulation,p53 interaction,epigenetic modification,overexpression relationship
ENSG00000132376,INPP5K,phosphatidylinositol regulation,pi3k/akt pathway activation,oncogenic signaling,cell proliferation modulation,metastasis facilitation,tumor suppressor loss
ENSG00000143365,RORC,immune evasion,microenvironment modulation,epithelial-to-mesenchymal transition,oncogenic transcription factor,inflammation promotion,tumor growth regulation
ENSG00000189143,CLDN4,tumor progression,cell adhesion disruption,metastasis promotion,cell migration enhancement,oncogenic expression,signaling pathway interaction
ENSG00000176435,CLEC14A,immune modulation,overexpression,tumor progression,cell surface recognition,protein-protein interaction,poor prognosis predictor
ENSG00000147465,STAR,snrnp assembly,gene expression regulation,mrna processing,cell growth regulation,tumor progression correlation,prognostic marker
ENSG00000077721,UBE2A,cellular proliferation,genomic instability,epigenetic alteration,protein degradation,apoptosis suppression,tumor progression
ENSG00000179168,GGN,gpcr function,pi3k/akt pathway interaction,cell proliferation regulation,tumor progression association,gene expression alteration,oncogenic pathway activation
ENSG00000273899,NOL12,cell cycle regulation,chromosomal instability,dna replication,epigenetic reprogramming,genomic alterations,nucleolar function
ENSG00000126070,AGO3,microrna-mediated silencing,genomic stability regulation,oncogenic transformation,tumor progression modulation,dna damage response interaction,epigenetic regulation
ENSG00000169957,ZNF768,oncogene,genomic instability,signaling pathway modulation,tumor progression,epithelial-to-mesenchymal transition (emt),poor prognosis
ENSG00000164438,TLX3,tlx3 transcription factor,oncogenic function,cell proliferation promotion,epithelial-to-mesenchymal transition induction,poor prognosis association,therapeutic target
ENSG00000150337,FCGR1A,immune evasion mechanism,tumor immune suppression,antitumor t-cell responses,pro-inflammatory cytokine inhibition,fcγri receptor function,immunosuppressive signaling pathways
ENSG00000000005,TNMD,tumor progression,cell proliferation,apoptosis inhibition,cell migration enhancement,prognostic biomarker,pi3k/akt pathway interaction
ENSG00000177025,C19orf18,anti-apoptotic function,apoptosis regulation,mitochondrial outer membrane permeabilization,poor prognosis correlation,tumor aggressiveness,chemotherapy resistance
ENSG00000169249,ZRSR2,splicing regulation,gene expression modulation,aberrant splicing patterns,tumor progression,potential therapeutic target,genomic instability
ENSG00000106541,AGR2,oncogene activation,cell proliferation enhancement,protein stabilization regulation,gene expression modulation,tumor progression driver,cell cycle regulation disruption
ENSG00000131748,STARD3,lipid transport,cell growth promotion,tumor progression,oncogenic signaling,cholesterol delivery,metastasis facilitation
ENSG00000198887,SMC5,genomic instability,dna repair mechanism,tumor progression,prognostic biomarker,cell cycle regulation,chromatin remodeling
,HIST1H1A,epigenetic regulation,chromatin structure,histone modification,oncogene activation,tumor progression,cancer epigenetics
ENSG00000187912,CLEC17A,tumor immune evasion,cell adhesion regulation,immune modulation,tumor progression,cell migration enhancement,oncogenesis facilitation
ENSG00000162063,CCNF,cyclin family member,cell cycle regulation,dna repair mechanism,protein degradation pathway,genome stability maintenance,tumor suppressor dysfunction
ENSG00000136938,ANP32B,epigenetic regulation,chromatin remodeling,phosphoprotein function,cellular proliferation,apoptosis resistance,prognostic biomarker
ENSG00000106829,TLE4,wnt/β-catenin pathway,oncogene,transcriptional co-repressor,cell proliferation,metastasis,biomarker
ENSG00000111670,GNPTAB,lysosomal targeting,autophagy regulation,cell proliferation enhancement,apoptosis inhibition,glycosylation pattern alteration,molecular instability modification
ENSG00000173218,VANGL1,tumor progression,cell polarity disruption,epithelial integrity loss,planar cell polarity pathway,cytokeletal structure modulation,biomarker and therapeutic target
ENSG00000085117,CD82,tumor suppressor function,cell adhesion regulation,migration inhibition,matrix remodeling modulation,prognostic marker,cancer progression suppression
ENSG00000198919,DZIP3,oncogenic function,cell migration and invasion,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway activation,biomarker for prognosis,overexpression in tumor tissues
ENSG00000120992,LYPLA1,**
overexpression,tumor progression,cell signaling modulation,lysophosphatidic acid production,prognostic marker,cell proliferation regulation 
**
ENSG00000104131,EIF3J,enhanced protein expression,tumorigenesis regulation,cellular proliferation modulation,oncogenic potential enhancement,prognostic marker significance,genetic instability contribution
ENSG00000182183,SHISAL2A,pi3k/akt signaling,oncogenesis,epigenetic regulation,cell cycle control,biomarker potential,tumor progression
ENSG00000164627,KIF6,kinesin activity,microtubule destabilization,genomic instability,mitotic progression,cell division regulation,prognostic marker
ENSG00000152977,ZIC1,tumor suppression,reduced expression,cellular homeostasis disruption,transcriptional regulation failure,oncogenic pathway interaction,loss of function mutations
ENSG00000198429,ZNF69,transcriptional regulation,overexpression in cancer,cell proliferation enhancement,apoptosis inhibition,poor prognosis association,epithelial-to-mesenchymal transition involvement
ENSG00000066629,EML1,chromatin remodeling,transcriptional regulation,histone modification,dna repair interactions,oncogenic process modulation,tumor progression marker
ENSG00000182040,USH1G,cell adhesion disruption,chromosomal instability,genomic rearrangements,loss of function mutations,tumor suppressor activity,cytoskeletal organization
ENSG00000130803,ZNF317,inhibition of p53 expression,apoptosis regulation,tumor suppressor regulation,aggressive disease characteristics,poor prognosis,cellular growth regulation
ENSG00000087086,FTL,tumor progression,cell survival,iron homeostasis disruption,genomic instability association,hypoxia-induced protein interaction,oncogenic mutation involvement
ENSG00000120913,PDLIM2,cellular adhesion alteration,oncogenic process regulation,metastatic potential enhancement,cell proliferation and survival promotion,therapeutic target identification,genomic instability contribution
ENSG00000178175,ZNF366,pi3k/akt/mtor pathway interactions,transcriptional regulation,zinc finger motifs,tumor progression,metastasis promotion,protein structure
ENSG00000080493,SLC4A4,ph regulation,tumor progression,metastasis facilitation,oncogenic interaction,cell proliferation modulation,sodium-chloride exchange
ENSG00000167434,CA4,angiogenesis facilitation,cancer cell survival enhancement,erythrocyte-specific expression,hypoxia-inducible factor-1 alpha interaction,metastasis promotion,tumor growth facilitation
ENSG00000169188,APEX2,genomic instability,cell survival enhancement,proteolytic activity modulation,apoptosis inhibition,dna damage response regulation,therapeutic target
ENSG00000094916,CBX5,histone modification,chromatin remodeling,epigenetic regulation,oncogenic pathway activation,cell cycle dysregulation,tumor suppressor gene repression
ENSG00000196549,MME,aberrant signaling pathway activation,cell proliferation enhancement,cell survival promotion,peptide hormone degradation,proteolytic enzyme interaction,regulatory mechanism disruption
ENSG00000275724,NDUFA3,mitochondrial function,energy metabolism regulation,cellular stress induction,oncogenic reprogramming,pi3k/akt pathway modulation,redox balance disruption
ENSG00000169592,INO80E,genomic stability disruption,chromatin remodeling complex,dna replication facilitation,transcription regulation,oncogene activation,tumor suppressor function suppression
ENSG00000151365,THRSP,lipid metabolism regulation,transcriptional coactivation,cell proliferation promotion,energy homeostasis modulation,fatty acid synthase regulation,tumorigenesis contribution
ENSG00000139767,SRRM4,cell proliferation,apoptosis regulation,dna repair,oncogene activation,genomic instability,transcriptional regulation
ENSG00000147573,TRIM55,apoptosis regulation,tumor microenvironment modulation,cellular proliferation suppression,immune response modulation,protein interaction regulation,tumor suppressor function
ENSG00000126858,RHOT1,rho gtpase activation,cell migration,constitutive activation,tumor progression,cell proliferation,p53 interaction
ENSG00000125814,NAPB,genomic instability,cell proliferation,nucleic acid binding,diagnostic marker,replication-coupled repair,nuclear localization
ENSG00000105755,ETHE1,cancer-associated overexpression,cell survival,apoptosis inhibition,detoxification pathway,glutathione regulation,protein degradation
ENSG00000164181,ELOVL7,cellular metabolism regulation,oncogene activation,tumor progression driver,lipid biosynthesis modulation,signaling pathway interaction,genetic upregulation
ENSG00000127507,ADGRE2,cell adhesion modulation,immune response regulation,tumor progression facilitation,growth factor signaling modulation,cancer-associated gene expression alteration,epigenetic modification influence
ENSG00000100479,POLE2,genomic instability,mutator phenotype,dna replication error,tumor progression,therapeutic target,mutational signature
ENSG00000132773,TOE1,genomic amplification,cell proliferation,epithelial-to-mesenchymal transition,ubiquitination regulation,oncogenic signaling,tumor suppressor degradation
ENSG00000102683,SGCG,disrupted cell membrane,altered cellular behavior,cytoplasmic alterations,muscle cell deterioration,glycoprotein complex disruption,signaling pathway modulation
ENSG00000166603,MC4R,mapk/erk pathway activation,tumor growth promotion,cell proliferation enhancement,signaling pathway modulation,integrin interaction,g protein-coupled receptor function
ENSG00000137207,YIPF3,er stress regulation,tumor progression marker,cancer cell proliferation,cell survival pathway modulation,er function regulation,mitochondrial dynamics interaction
ENSG00000091844,RGS17,g-protein coupled receptor regulation,tumor suppressor function,cell growth modulation,oncogene inhibition,prognostic marker potential,genomic instability suppression
ENSG00000206181,ELOA2,hypoxia-inducible factor stabilization,angiogenesis promotion,vegf regulation,tumor progression association,poor prognosis marker,anti-angiogenic target
ENSG00000276463,TAF9,genomic instability,aberrant transcription regulation,cell cycle progression,oncogene activation,tumor suppressor silencing,transcription initiation factor
ENSG00000271605,MILR1,cell cycle regulation,tumor progression,microenvironment interaction,therapeutic target,dysregulation in cancer,protein-protein interactions
ENSG00000113303,BTNL8,tumor immune evasion,immune modulation,oncogene function,cell proliferation regulation,tumor suppressor activity,cancer immunotherapy targets
ENSG00000110851,PRDM4,tumor suppressor/oncogene,cell proliferation,chromatin regulation,pi3k/akt pathway activation,epigenetic modulation,biomarker for prognosis
ENSG00000155957,TMBIM4,calcium signaling,cellular stress responses,apoptosis regulation,mitochondrial function modulation,autophagy induction,endoplasmic reticulum localization
ENSG00000134697,GNL2,spliceosome regulation,alternative splicing,proto-oncogene activation,cell proliferation,oncogenic functions,genomic instability
ENSG00000115750,TAF1B,transcriptional activator,amplification,cell cycle regulation,dna repair,chromatin remodeling,oncogenic transcription
ENSG00000163687,DNASE1L3,apoptosis regulation,nucleus localization,tumor progression,prognostic biomarker,dna degradation,cell death pathway
ENSG00000125656,CLPP,mitochondrial localization,serine protease activity,apoptosis regulation,protein quality control,cell proliferation enhancement,therapeutic target
ENSG00000151552,QDPR,bh4 metabolism,dna repair mechanism,tumor suppressor dysfunction,cell cycle regulation,oxidative stress management,genetic alterations
ENSG00000103269,RHBDL1,intramamembrane protease activity,notch signaling pathway activation,cell proliferation promotion,tumor progression enhancement,protein processing dysregulation,cancer cell survival induction
ENSG00000003393,ALS2,rab5 activation,endocytic trafficking,gtpase regulation,membrane dynamics,cellular growth regulation,autophagy regulation
ENSG00000145362,ANK2,tumor progression,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,metastatic potential,oncogenic driver,aggressive tumor behavior
ENSG00000163697,APBB2,cell signaling pathway modulation,oncogenic pathway activation,cell survival promotion,tumor progression contribution,protein regulation disruption,stress response modulation
ENSG00000111262,KCNA1,overexpression,tumor progression,cell proliferation,apoptosis inhibition,epithelial-to-mesenchymal transition,pi3k/akt pathway modulation
ENSG00000115677,HDLBP,**
lipid regulation,transcriptional coactivator,nuclear receptor interaction,lipid metabolism,cell proliferation,tumor growth
**
ENSG00000144224,UBXN4,ubiquitination,genomic instability,oncogenic signaling,ubiquitin ligase activity,protein degradation,ring-type e3 ligase
ENSG00000147164,SNX12,egfr pathway modulation,oncogenic signaling,cell proliferation promotion,membrane trafficking regulation,endocytic recycling dysregulation,prognostic marker potential
ENSG00000284017,PLCL2,**
cell migration,constitutive activation,genetic mutations,epithelial-to-mesenchymal transition,actin cytoskeleton regulation,signaling pathway modulation 
**
ENSG00000204969,PCDHA2,protocadherin function,cell adhesion regulation,wnt signaling pathway interaction,tumor progression facilitation,oncogene/tumor suppressor duality,cancer cell migration enhancement
ENSG00000013297,CLDN11,loss of heterozygosity,cell migration,ion transport regulation,tumor suppression inactivated,epithelial barrier disruption,oncogenic pathway activation
ENSG00000066405,CLDN18,tumor aggressiveness,cell adhesion disruption,biomarker potential,oncogene overexpression,protein-protein interaction,signaling pathway modulation
ENSG00000090447,TFAP4,transcription factor regulation,promotion of cell proliferation,elevated expression in cancer tissues,interaction with chromatin-modifying proteins,regulation of apoptosis and dna repair pathways,cell cycle progression modulation
ENSG00000158457,TSPAN33,cell adhesion disruption,tumor progression,metastasis facilitation,prognostic marker,biomarker identification,epithelial-to-mesenchymal transition
ENSG00000129691,ASH2L,epigenetic regulation,chromatin remodeling,tumor progression,oncogenic protein interaction,metastasis promotion,cell proliferation enhancement
ENSG00000122884,P4HA1,angiogenesis promotion,tumor growth enhancement,hypoxia adaptation,prolyl hydroxylation,collagen synthesis regulation,resistance to therapy development
ENSG00000149380,P4HA3,extracellular matrix remodeling,prolyl 4-hydroxylation,collagen metabolism,tumor progression,hypoxia-inducible factor regulation,angiogenesis stimulation
ENSG00000092529,CAPN3,cellular signaling pathways,oncogenesis,tumor progression,metastasis,epithelial-to-mesenchymal transition (emt),chemoresistance
ENSG00000135318,NT5E,purinergic signaling,tumor promotion,ecto-5'-nucleotidase activity,cell proliferation,adenosine production,prognostic marker
ENSG00000061936,SFSWAP,cell migration,cancer cell invasion,tumor progression,signaling pathway modulation,actin cytoskeleton reorganization,oncogenic processes
ENSG00000170322,NFRKB,cell cycle regulation,apoptosis suppression,genomic instability,transcriptional regulation,biomarker for cancer diagnosis,therapeutic target
ENSG00000132485,ZRANB2,epigenetic regulation,chromatin remodeling,oncogene activation,genomic instability,cell cycle progression,apoptosis inhibition
ENSG00000163630,SYNPR,tumor progression,molecular interaction,cell proliferation,signaling pathway activation,biomarker potential,genomic amplification
ENSG00000175283,DOLK,n-glycan metabolism,tumor suppressor function,glycoprotein synthesis,aberrant glycosylation patterns,cell cycle regulation,apoptosis modulation
ENSG00000204197,KIFC1,chromosomal instability,microtubule dynamics,cell division regulation,aneuploidy driver,genomic alterations,tumor progression
ENSG00000152818,UTRN,cancer cell invasion,er stress regulation,tumor metastasis,poor prognosis association,cellular migration modulation,cytoskeletal protein function
ENSG00000187626,ZKSCAN4,zinc finger domain,epigenetic regulation,chromatin remodeling,transcriptional regulation,cell proliferation,oncogenic function
ENSG00000196345,ZKSCAN7,epigenetic regulation,transcriptional regulation,tumor suppressor function,cell cycle progression,dna methylation,histone modification
ENSG00000184351,KRTAP19-1,aberrant expression,cellular adhesion,epithelial structure,integration,molecular interaction,tumor progression
ENSG00000143368,SF3B4,altered splicing patterns,oncogenesis,rna processing disruption,pre-mrna splicing,tumor aggressiveness,cancer progression
ENSG00000136819,C9orf78,tumor suppressor function loss,cell survival enhancement,oncogenic signaling pathway activation,poor prognosis marker,protein interaction influence,metabolic regulation alteration
ENSG00000078699,CBFA2T2,transcriptional coactivation,chromatin remodeling,cell proliferation regulation,apoptosis suppression,dna damage response modulation,oncogene overexpression
ENSG00000030582,GRN,bmp signaling pathway inhibition,epithelial-to-mesenchymal transition,cell proliferation enhancement,cell migration and invasion,tumor progression facilitation,therapeutic target potential
ENSG00000118434,SPACA1,cell cycle regulation,oncoprotein overexpression,apoptosis suppression,proliferation enhancement,tumor suppressor loss,immune evasion
ENSG00000147027,TMEM47,cell-cell adhesion disruption,epithelial integrity loss,phosphorylation-mediated activation,tumor growth promotion,metastasis facilitation,biomarker identification
ENSG00000170417,TMEM182,activates pi3k/akt pathway,modulates cell cycle progression,evasion of apoptosis,oncogenic driver,poor prognosis marker,tumor suppressor downregulation
ENSG00000136026,CKAP4,cell cycle regulation,apoptosis modulation,cytoskeleton organization,cancer progression,metastasis promotion,tumor suppressor function
ENSG00000128271,ADORA2A,activation of oncogenic pathways,cell proliferation,apoptosis suppression,inflammation modulation,tumor progression marker,cancer cell migration
ENSG00000132965,ALOX5AP,leukotriene biosynthesis,tumor growth promotion,cell migration and invasion,genetic mutation risk factor,inflammation induction,tumor microenvironment alteration
ENSG00000091483,FH,mitochondrial function,energy metabolism regulation,tumor growth promotion,hif activation,angiogenesis induction,genetic predisposition
ENSG00000167461,RAB8A,oncogene activation,tumor progression,cell survival enhancement,angiogenesis promotion,cytoplasmic vesicle trafficking regulation,metastasis facilitation
ENSG00000178467,P4HTM,regulatory function,transcriptional regulation,cell growth regulation,protein interactions,cell division regulation,potential oncogenic involvement
ENSG00000147677,EIF3H,cellular growth,tumor progression,protein synthesis regulation,cell proliferation,signal transduction modulation,therapeutic target
ENSG00000177963,RIC8A,gsα regulation,cancer driver gene,gef activity,constitutive activation,cell proliferation,tumor progression
ENSG00000186638,KIF24,tumor suppressor function,genomic stability maintenance,microtubule motor activity,cellular proliferation regulation,dna repair mechanism impairment,prognostic marker potential
ENSG00000006659,LGALS14,tumor progression,cell adhesion regulation,gene expression modulation,oncogenic role,therapeutic target,prognostic biomarker
ENSG00000123119,NECAB1,cell growth regulation,oncogene activation,pi3k/akt pathway regulation,tumor progression driver,membrane trafficking regulator,lipid metabolism modulator
ENSG00000067840,PDZD4,cellular localization,oncogenic signaling pathways,potential driver gene,protein-protein interactions,signaling pathway modulation,subcellular distribution
ENSG00000141252,VPS53,autophagy regulation,glycolytic reprogramming,tumor progression marker,lipidation pathway activation,protein-protein interaction,apoptosis inhibition
ENSG00000066455,GOLGA5,golgi apparatus dysfunction,oncogenic protein processing,cell proliferation enhancement,protein secretion regulation,signaling pathway interaction,cancer progression facilitation
ENSG00000152518,ZFP36L2,tumor suppressor function,au-rich element-mediated mrna decay,cellular regulation,constitutive activation,loss of function mutations,oncogenic signaling pathway interaction
ENSG00000091138,SLC26A3,anion transport,cell volume regulation,oncogenesis,apoptosis inhibition,therapeutic target,epithelial cell function
ENSG00000107738,VSIR,cell invasion,constitutive activation,dysregulated activity,pi3k/akt signaling,rho gtpase activating function,tumor progression
ENSG00000095906,NUBP2,genomic instability,impaired dna repair,therapeutic target,cell cycle regulation,nuclear function,dna replication
ENSG00000160179,ABCG1,**

cholesterol efflux,lipid metabolism,tumor aggressiveness,cell proliferation,genomic dysregulation,therapeutic target

**
ENSG00000172164,SNTB1,calcium channel regulation,gene overexpression,ion channel modulation,oncogenic behavior,protein interaction,synaptic transmission modulation
ENSG00000166974,MAPRE2,microtubule regulation,mitotic spindle formation,genomic instability,cell division dysregulation,oncogenic driver,therapeutic target
ENSG00000171970,ZNF57,tumor-infiltrating lymphocytes,zinc finger protein binding,cell proliferation regulation,immune response modulation,oncogenesis promotion,apoptosis inhibition
ENSG00000050426,LETMD1,cell proliferation,oncogenic role,prognostic marker,mitochondrial function regulation,signaling pathway interaction,cancer progression
ENSG00000176542,USF3,genomic instability,gene amplification,cell proliferation,oncogene overexpression,apoptosis resistance,transcriptional regulation
ENSG00000130227,XPO7,nuclear export regulation,cell proliferation regulation,tumor suppressor interaction,oncogene modulation,apoptosis regulation,cell cycle control
ENSG00000228250,LY6G6C,pi3k/akt interaction,growth factor regulation,mutation-mediated activation,tumor-promoting function,cancer cell survival,genomic alteration
ENSG00000167394,ZNF668,cell cycle regulation,tumor suppressor function,transcriptional repression,dna repair interaction,gene expression regulation,genomic stability maintenance
ENSG00000285206,PTPMT1,tumor suppressor activity,dephosphorylation of tyrosine residues,negative regulation of cell growth,interaction with multiple signaling pathways,regulation of cell cycle progression,anti-tumor effects
ENSG00000173726,TOMM20,mitochondrial biogenesis,tumor progression,cellular metabolism,apoptosis inhibition,protein import regulation,cancer biomarker
ENSG00000113282,CLINT1,tumor suppressor,mrna stability control,cell cycle regulation,dna repair mechanism,poly(a)-binding protein interaction,genomic instability
ENSG00000171360,KRT38,apoptosis regulation,cell differentiation,epithelial cell integrity,genetic instability,high-expression marker,tumor progression
ENSG00000170545,SMAGP,genomic destabilization,loss-of-function mutations,tumor suppressor function,apoptosis regulation,cell cycle progression,angiogenesis promotion
ENSG00000100296,THOC5,mrna export regulation,trex-2 complex interaction,transcriptional regulation modulation,cell proliferation enhancement,anti-apoptotic function,prognostic marker overexpression
ENSG00000090316,MAEA,chromatin remodeling,apoptosis inhibition,cell cycle progression,oncogenic role,biomarker candidate,epigenetic regulation
ENSG00000144579,CTDSP1,oncogenic regulator,transcriptional activator,cell cycle progression,epigenetic regulation,dna damage response,prognostic biomarker
ENSG00000171604,CXXC5,epigenetic regulation,chromatin remodeling,dna demethylation,histone modification,oncogenic pathway modulation,pi3k/akt signaling interaction
ENSG00000146670,CDCA5,cell cycle regulation,chromosome segregation,mitotic checkpoint control,dna damage response,apoptosis resistance,oncogene overexpression
ENSG00000111843,TMEM14C,redox regulation,mitochondrial transport,copper homeostasis disruption,cell growth promotion,tumor progression association,prognostic marker
ENSG00000159251,ACTC1,tumor progression,metastasis promotion,cell adhesion modulation,protein-protein interaction,signaling pathway regulation,cancer stem cell maintenance
ENSG00000124721,DNAH8,dynein heavy chain protein,cilia formation and stability,oncogenic signaling pathways,cell migration and invasion,tumorigenesis,cancer progression
ENSG00000130560,UBAC1,mitochondrial regulation,apoptosis modulation,cellular respiration regulation,oncogenic mutations,tumor suppressor role,cell survival enhancement
ENSG00000180817,PPA1,mitochondrial regulation,energy metabolism modulation,tumor cell energy status,proline dehydrogenase activity,cellular respiration alteration,cancer cell proliferation
ENSG00000140931,CMTM3,wnt/β-catenin signaling,cell migration and invasion,immune response regulation,oncogenesis,metastasis promoter,prognostic marker
ENSG00000288141,MRPL23,mitochondrial biogenesis,cellular metabolism,tumor suppressor,ribosomal protein function,oncogenic process,metabolic reprogramming
ENSG00000144040,SFXN5,mitochondrial function,tumor suppressor activity,cell growth regulation,cancer metabolism reprogramming,mitochondrial matrix protein,apoptosis pathway interaction
ENSG00000128335,APOL2,apoptosis regulation,cellular homeostasis modulation,oncogenic properties,inflammation pathway interaction,immune response modulation,tumor progression facilitation
ENSG00000160191,PDE9A,cgmp regulation,tumor progression,potential therapeutic target,cell proliferation,smooth muscle modulation,angiogenesis regulation
ENSG00000109193,SULT1E1,estrogen metabolism regulation,tumor growth influence,hormone-dependent signaling,enzymatic activity modulation,cancer development link,cellular differentiation regulation
ENSG00000139428,MMAB,vitamin b12-dependent,methylmalonyl-coa conversion,cellular metabolism regulation,tumor progression marker,therapeutic target,genomic instability
ENSG00000141503,MINK1,signaling pathway modulation,tumor progression,oncogene overexpression,protein degradation regulation,therapeutic target,pi3k/akt pathway modulation
ENSG00000204361,NXPE2,nuclear export regulation,cellular homeostasis,protein accumulation prevention,apoptosis modulation,cell cycle regulation,oncogenic signaling contribution
ENSG00000284009,PLSCR3,apoptosis regulation,calcium signaling modulation,cell adhesion facilitation,mitosis regulation,oncogenic properties promotion,tumor progression enhancement
ENSG00000177854,TMEM187,**
tumor progression,oncogenic processes,cell proliferation,metastasis,immune modulation,signaling pathway interaction
**
ENSG00000164713,BRI3,emt induction,cell adhesion disruption,tumor progression facilitation,oncogene activation,signaling pathway dysregulation,adhesion molecule regulation
ENSG00000213064,SFT2D2,cellular regulation,transcriptional regulation,chromatin remodeling,tumor suppressor function,loss-of-function mutations,tumorigenic potential
ENSG00000132563,REEP2,mitochondrial regulation,tumor suppressor interaction,cancer cell survival,pi3k/akt pathway modulation,cell migration and invasion,therapeutic target
ENSG00000224470,ATXN1L,chromatin remodeling,oncogene overexpression,cell proliferation,transcriptional regulation,biomarker potential,genomic instability
ENSG00000198326,TMEM239,transmembrane protein,cell-cell adhesion,signal transduction pathways,overexpression,bladder cancer,tumorigenesis
ENSG00000196338,NLGN3,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor invasion facilitation,immune evasion mechanism,neurodevelopmental gene expression,synaptic transmission regulation
ENSG00000052749,RRP12,cell proliferation regulation,protein synthesis enhancement,oncogenic process activation,poor prognosis marker,therapeutic target,tumor aggressiveness enhancer
ENSG00000198707,CEP290,cell proliferation,hippo/yap pathway activation,cancer progression,centrosome organization,microtubule stability,ciliary maintenance
ENSG00000100711,ZFYVE21,cell cycle regulation,tumor suppressor function,autophagy regulation,endocytosis modulation,apoptosis induction,genomic stability maintenance
ENSG00000196116,TDRD7,regulation of gene expression,overexpression in bladder tumors,cell proliferation and migration,epithelial-to-mesenchymal transition (emt),small rna binding activity,therapeutic target
ENSG00000143322,ABL2,oncogene,cell proliferation,signaling pathway activation,cell survival enhancement,genomic amplification,kinase activity regulation
ENSG00000185009,AP3M1,cellular trafficking regulation,oncogene potential,protein degradation dysregulation,apoptosis evasion,cell cycle regulation,therapeutic target
ENSG00000161202,DVL3,wnt/β-catenin pathway,oncogenic driver,cell migration regulation,metastasis promotion,signaling pathway modulation,protein-protein interaction
ENSG00000105176,URI1,tumor suppressor function,pi3k/akt pathway regulation,cell proliferation regulator,dna repair regulation,genomic instability mediator,prognostic marker candidate
ENSG00000151092,NGLY1,pi3k/akt pathway,cell signaling,protein-protein interactions,dysregulation,genomic instability,tumor growth
ENSG00000167565,SERTAD3,chromatin remodeling,apoptosis regulation,cell cycle progression,oncogenic potential,tumor suppressive function,protein-protein interactions
ENSG00000091656,ZFHX4,overexpression,chromatin remodeling,transcriptional regulation,cell differentiation,tumor progression,therapeutic target
ENSG00000277462,ZNF670,transcriptional regulation,cell proliferation,apoptosis regulation,zinc finger protein family,cancer gene dysregulation,tumor suppressor potential
ENSG00000187024,PTRH1,p53 pathway,tumor suppressor function,gain of function mutations,loss of genome stability,cell proliferation regulation,uncontrolled cell growth
ENSG00000103194,USP10,dna repair regulation,cell survival promotion,genomic instability induction,apoptosis inhibition,protein degradation regulation,therapeutic target
ENSG00000008130,NADK,nad+ biosynthesis,cellular metabolism,dna repair mechanism,transcriptional regulation,energy homeostasis disruption,tumor progression
ENSG00000153066,TXNDC11,mitochondrial dysfunction,ros regulation,cell cycle progression,therapeutic target,redox balance,oncogenic properties
ENSG00000104549,SQLE,cholesterol biosynthesis regulation,cell membrane integrity modulation,oncogenic potential,tumor progression association,therapeutic target,lipid metabolism regulation
ENSG00000197324,LRP10,lrp interaction,tumor progression,oncogenic signaling,cell proliferation,angiogenesis facilitation,prognostic marker
ENSG00000142082,SIRT3,mitochondrial regulation,energy metabolism modulation,oncogenic function promotion,cellular homeostasis disruption,tumor progression facilitation,apoptosis resistance enhancement
ENSG00000182318,ZSCAN22,oncogene overexpression,transcription factor activity,cell proliferation promotion,apoptosis suppression,microrna regulation,tumor progression association
ENSG00000181894,ZNF329,tumor suppressor,transcriptional regulation,cell cycle modulation,apoptosis regulation,dna repair disruption,epigenetic modification
ENSG00000073670,ADAM11,adam11/emt regulation,metastatic progression,chemo-resistance,cell adhesion modulation,epithelial-mesenchymal plasticity,oncogenic potential
ENSG00000132744,ACY3,fatty acid oxidation,cell proliferation,lipid metabolism regulation,genetic instability induction,cellular stress response modulation,therapeutic target
ENSG00000116754,SRSF11,alternative splicing regulation,tumorigenesis association,genomic instability contribution,oncogenic protein production,therapeutic target potential,cellular proliferation modulation
ENSG00000171291,ZNF439,dna binding,transcription regulation,cell proliferation,apoptosis resistance,epithelial-to-mesenchymal transition,tumor progression
ENSG00000161847,RAVER1,pi3k/akt signaling enhancement,tumor progression promotion,metastasis facilitation,epithelial-to-mesenchymal transition (emt) regulation,rna-induced silencing complex (risc) modulation,angiogenesis promotion
ENSG00000175329,ISX,cellular processes regulation,apoptosis modulation,tumor suppressor function,genomic instability prevention,protein stability maintenance,cancer association
ENSG00000288210,ASF1B,chromatin assembly,genomic stability,dna replication,epigenetic regulation,histone chaperone function,oncogenic potential
ENSG00000186564,FOXD2,cell cycle regulation,transcriptional regulator,overexpression,tumor progression,apoptosis inhibition,protein-protein interaction
ENSG00000138311,ZNF365,tumor suppression,cell cycle regulation,dna repair,genomic stability,transcriptional modulation,oncogene activity
ENSG00000072864,NDE1,microtubule regulation,genomic instability,oncogene overexpression,pi3k/akt pathway interaction,mitotic disruption,therapeutic target
ENSG00000170374,SP7,epigenetic regulation,cellular proliferation,transcriptional activation,metabolic reprogramming,tumor progression,genomic instability
ENSG00000164488,DACT2,wnt/β-catenin signaling pathway,tumor suppressor activity,beta-catenin regulation,epithelial-to-mesenchymal transition (emt),cellular differentiation inhibition,immune modulation
ENSG00000253548,PYDC2,oncogenic activation,constitutive signaling,cell proliferation,tumor progression,protein tyrosine phosphatase activity,genomic instability
ENSG00000148688,RPP30,ribosomal subunit regulation,translation initiation dysfunction,oncogenic transformation,cell proliferation promotion,apoptosis inhibition,tumor suppressor gene suppression
ENSG00000136986,DERL1,erad pathway regulation,endoplasmic reticulum homeostasis,protein misfolding-related stress,er stress response modulation,cellular proliferation regulation,apoptosis regulation
ENSG00000101463,SYNDIG1,tumor progression,epithelial-to-mesenchymal transition (emt),cell migration,oncogene activation,signal transduction,genetic amplification
ENSG00000167693,NXN,oncoprotein activation,cell signaling regulation,redox regulation,tumor progression facilitation,protein stabilization,poor prognosis association
ENSG00000112290,WASF1,actin cytoskeleton dynamics,constitutive activation,cell migration and invasion,oncogenic signaling pathway,epithelial-to-mesenchymal transition,rho gtpase regulation
ENSG00000146830,GIGYF1,mirna regulation,protein translation modulation,oncogene expression enhancement,pi3k/akt pathway activation,tumor progression promotion,genomic instability facilitation
ENSG00000105771,SMG9,nonsense-mediated mrna decay,rna helicase activity,genome integrity maintenance,cellular proliferation promotion,survival pathway dysregulation,oncogenic process enhancement
ENSG00000242616,GNG10,mapk/erk pathway modulation,signaling transduction,cell proliferation regulation,tumor growth promotion,protein interaction,dysregulation in tumorigenesis
ENSG00000139133,ALG10,altered glycosylation,aberrant glycans,immune evasion,cell signaling disruption,metabolic rewiring,tumor promotion
ENSG00000196422,PPP1R26,pp1 regulation,substrate specificity modulation,oncogenic protein interaction,cell proliferation enhancement,tumor suppressor regulation,cancer progression
ENSG00000177239,MAN1B1,man1b1 overexpression,oncogenic signaling,cellular glycosylation regulation,protein quality control dysregulation,pi3k/akt pathway modulation,cell proliferation enhancement
ENSG00000206395,DDAH2,nitric oxide regulation,cell survival,pi3k/akt pathway interaction,mtor pathway modulation,oncogene dysregulation,adma degradation
ENSG00000143570,SLC39A1,zinc ion transporter,tumor promoter,cell proliferation,poor prognosis,genetic alteration,oncogenic driver
ENSG00000100209,HSCB,genomic instability,dna damage response pathway,oncogenic processes,genomic stability,interactions with dna repair proteins,cell cycle regulation
ENSG00000067646,ZFY,oncogene,cell proliferation,apoptosis resistance,transcriptional regulation,pi3k/akt pathway interaction,zinc finger protein function
ENSG00000149474,KAT14,chromatin remodeling,tumor suppressor activity,epigenetic regulation,dna repair deficiency,cancer progression marker,histone modification
ENSG00000257218,GATC,cell cycle regulation,uncontrolled growth,protein synthesis regulation,tumor progression,tumorigenesis,mitosis regulation
ENSG00000130348,QRSL1,cellular proliferation,transcriptional regulation,oncogenic driver,tumor growth promotion,poor prognosis indicator,transcription factor interaction
ENSG00000242515,UGT1A10,phase ii metabolism,drug resistance,cellular proliferation,apoptosis regulation,dna repair modulation,xenobiotic conjugation
ENSG00000167165,UGT1A6,altered gene expression,detoxification pathway regulation,carcinogen metabolism,cellular detoxification mechanism,xenobiotic conjugation,phase ii metabolism
ENSG00000196659,TTC30B,overexpression,cell cycle regulation,mitotic entry,tumor cell proliferation,survival promotion,protein interaction
ENSG00000111906,HDDC2,genomic instability,tumor progression,cell proliferation,cell cycle regulation,dna repair,genetic alterations
ENSG00000184575,XPOT,nucleocytoplasmic transport,protein export,apoptosis regulation,nuclear export signals,cellular export process,cancer research target
ENSG00000123106,CCDC91,cellular maintenance,chromosomal instability,dna repair dysfunction,genomic instability,mitotic checkpoint disruption,tumor progression
ENSG00000170454,KRT75,cellular adhesion,tumor progression,epithelial cells,keratin expression,downregulation,metastasis
ENSG00000156928,MALSU1,microtubule dynamics regulation,chromosomal stability maintenance,genomic instability promotion,tumor progression facilitation,cell cycle modulation,spindle assembly checkpoint interaction
ENSG00000146416,AIG1,chromatin remodeling,histone modification,cell proliferation,myc interaction,transcriptional regulation,oncogene activation
ENSG00000125629,INSIG2,insulin signaling pathway disruption,lipid metabolism regulation,oncogene/tumor suppressor function,apoptosis modulation,cell proliferation enhancement,angiogenesis promotion
ENSG00000170465,KRT6C,keratin filament reorganization,cellular stress response regulation,apoptosis resistance enhancement,tumor growth promotion,epithelial integrity disruption,therapeutic target identification
ENSG00000079102,RUNX1T1,dna binding,transcriptional regulation,oncogenic transformation,cell cycle regulation,tumor progression,therapeutic target
ENSG00000185567,AHNAK2,akt signaling,oncogene,tumor progression,cell proliferation,metastasis,protein-protein interaction
ENSG00000189114,BLOC1S3,autophagy regulation,tumor progression,protein degradation,cell survival,cancer-associated protein stabilization,lysosomal function
ENSG00000197191,CYSRT1,vesicle transport regulation,cellular trafficking dysregulation,oncogenic protein overexpression,tumor cell proliferation,cancer progression facilitation,genomic instability link
ENSG00000150457,LATS2,hippo signaling pathway,tumor suppressor function,cell growth regulation,yap/taz inhibition,oncogenic suppression,genome stability maintenance
ENSG00000198088,NUP62CL,chromatin remodeling,tumor growth enhancement,nuclear transport modulation,oncogenic signaling pathway interaction,cell cycle dysregulation,metastasis promotion
ENSG00000107438,PDLIM1,cell migration,protein-protein interaction,cytoskeleton regulation,microtubule stability,src kinase activation,oncogenic process
ENSG00000008056,SYN1,neurotransmitter release regulation,cell signaling modulation,protein-protein interaction,cell proliferation enhancement,migration promotion,therapeutic target identification
ENSG00000178397,FAM220A,protein regulation,gene expression modulation,cell proliferation,signaling pathway activation,transcriptional regulation,protein-protein interaction
ENSG00000148773,MKI67,cell cycle progression,dna replication,marker of proliferation,amplification/overexpression,poor prognosis biomarker,genomic instability
ENSG00000280610,KIF15,microtubule stability,mitotic spindle assembly,oncogenesis,cell proliferation,genomic instability,metastasis
ENSG00000115561,CHMP3,chromatin remodeling,escrt iii complex,oncogene activation,pi3k/akt pathway,cell proliferation,tumor progression
ENSG00000171045,TSNARE1,regulation of endocytosis,altered cell signaling,oncogenesis,autophagy dysregulation,enhanced proliferation,cell membrane trafficking
ENSG00000175115,PACS1,autophagy modulation,epithelial-to-mesenchymal transition (emt),oncogene activation,protein-protein interaction,cell signaling regulation,cancer cell invasion
ENSG00000197081,IGF2R,genomic instability,tumor suppressor function,pi3k/akt pathway modulation,cell growth regulation,protein-protein interaction,therapeutic target
ENSG00000203985,LDLRAD1,er stress response,genome stability regulation,dna repair mechanism modulation,tumor suppressor function,genomic instability association,cellular homeostasis maintenance
ENSG00000102870,ZNF629,chromatin remodeling,tumor suppressor regulation,genomic instability,transcriptional repression,oncogenic transformation,protein-protein interaction
ENSG00000024048,UBR2,ubiquitin-protein ligase function,tumor suppressor degradation,p53 regulation,cell cycle progression,oncogenic pathway interaction,poor prognosis marker
ENSG00000170681,CAVIN4,cell cycle regulation,apoptosis suppression,calcium homeostasis regulation,signaling pathway modulation,cancer biomarker potential,therapeutic target candidate
ENSG00000106459,NRF1,gain of function mutations,tumor progression,cell survival,mitochondrial biogenesis,cell growth,hypoxia response
ENSG00000179044,EXOC3L1,exocytosis regulation,aberrant cell growth,pi3k/akt signaling pathway interaction,oncogenic function,cell survival enhancement,tumor progression facilitation
ENSG00000108733,PEX12,peroxisomal dysfunction,metabolic regulation disruption,oncogenic mutations,tumor progression facilitation,metastatic potential enhancement,cancer cell proliferation promotion
ENSG00000103089,FA2H,cellular proliferation,genomic instability,dysregulated gene expression,tumor progression,epigenetic regulation,signal transduction pathway
ENSG00000133313,CNDP2,metabolic regulation,redox balance,cell proliferation,biomarker potential,oxidative stress response,signaling pathway modulation
ENSG00000107949,BCCIP,dna damage response,genomic instability,cell cycle regulation,tumor suppressor function,apoptosis regulation,dna repair facilitation
ENSG00000164761,TNFRSF11B,rank/rankl signaling,constitutive nf-κb activation,osteoclast differentiation regulation,immune response modulation,tumor progression enhancement,cancer metastasis promotion
ENSG00000089177,KIF16B,microtubule dynamics,mitotic regulation,chromosomal instability,cell cycle progression,oncogenic potential,kinase activity
ENSG00000163762,TM4SF18,tumor progression,cell adhesion disruption,prognostic marker,cell migration enhancement,tumor growth promotion,cancer metastasis facilitation
ENSG00000120549,KIAA1217,oncogene,cell cycle regulation,genomic instability,protein-protein interactions,tumor progression,mutation hotspot
ENSG00000115468,EFHD1,aberrant calcium binding,cell proliferation regulation,oncogenic signaling,tumor progression,therapeutic target,biomarker expression levels
ENSG00000164144,ARFIP1,cell migration,arf6 interaction,tumor invasion,therapeutic target,oncogenic potential,cell motility
ENSG00000144724,PTPRG,tumor suppressor function,dephosphorylation of tyrosine kinases,cell-cell interactions regulation,metastasis inhibition,downregulation in blca,cell growth and proliferation control
ENSG00000203896,LIME1,oncogene,tumor suppressor function,transcriptional regulation,cyclin-dependent kinase interaction,cell cycle progression,enhancer binding affinity
ENSG00000184210,DGAT2L6,lipid metabolism regulation,oncogene activation,cellular proliferation enhancement,tumor progression facilitation,signaling pathway modulation,cancer cell survival promotion
ENSG00000117410,ATP6V0B,lysosomal ph regulation,cellular transport,protein degradation,oncogene interaction,apoptosis inhibition,tumor progression
ENSG00000100139,MICALL1,**
cell adhesion disruption,mapk/erk pathway activation,oncogenic signaling,pi3k/akt pathway activation,scaffolding protein function,tumor aggressiveness 
**
ENSG00000183621,ZNF438,oncogenic pathway activation,transcriptional regulation,cell proliferation promotion,dna damage response disruption,genomic instability contribution,overexpression hallmark
ENSG00000137876,RSL24D1,cellular regulation,mrna stability,translation modulation,rna-binding protein function,limited oncogenic association,no direct tumor driver role
ENSG00000125351,UPF3B,aberrant mrna stabilization,cellular stress response,genomic instability,mrna quality control,nonsense-mediated decay,post-transcriptional regulation
ENSG00000112309,B3GAT2,biomarker,glycosylation modification,oncogene activity enhancement,protein-protein interaction modulation,cell adhesion disruption,cancer aggressiveness promoter
ENSG00000128266,GNAZ,pi3k/akt pathway disruption,cell cycle dysregulation,gain of function mutations,oncogenic signaling,tumor progression,aberrant expression
ENSG00000263101,KRTAP3-3,cellular migration,epithelial integrity disruption,tumor microenvironment modulation,protein interaction modification,cancer progression involvement,cell adhesion influence
ENSG00000077080,ACTL6B,chromatin remodeling,oncogene activation,cell proliferation,apoptosis inhibition,tumor progression,transcriptional regulation
ENSG00000175334,BANF1,genomic stability,lamina structure regulation,cell cycle progression,nuclear morphology,chromosomal instability,aneuploidy
ENSG00000184486,POU3F2,transcriptional regulation,oncogene function,tumor aggressiveness,proliferation enhancement,cell survival promotion,gene expression modulation
ENSG00000100146,SOX10,transcriptional regulator,cell fate decision,tumor suppressor downregulation,oncogenic pathway activation,epithelial-to-mesenchymal transition,stem cell-like properties
ENSG00000196531,NACA,chromatin remodeling,gene expression regulation,cell cycle progression,apoptosis regulation,dna repair interaction,pi3k/akt pathway involvement
ENSG00000136279,DBNL,cell migration,pi3k/akt pathway activation,cytoskeleton remodeling,cell proliferation enhancement,prognostic marker,overexpression associated
ENSG00000182087,TMEM259,tumor suppressor function,genome instability,loss of expression,dna repair interaction,genetic mutations accumulation,cell proliferation enhancement
ENSG00000108551,RASD1,cell migration,focal adhesion dynamics,actin cytoskeleton reorganization,rho gtpase regulation,pi3k/akt pathway activation,therapeutic target
ENSG00000128881,TTBK2,cell cycle regulation,oncogenic signaling,microtubule dynamics,cell polarity regulation,chromosomal segregation,therapeutic target
ENSG00000110274,CEP164,cilia formation regulation,centrosomal protein function,oncogenic amplification,cell proliferation enhancement,ift complex modulation,centriole assembly disruption
ENSG00000031081,ARHGAP31,loss of rho gtpase activating function,gain of oncogenic activity,disruption of cellular interactions,promotion of tumor progression,increased cell migration and invasion,regulator of cytoskeleton dynamics
ENSG00000276234,TADA2A,cell cycle regulation,chromatin remodeling,genome instability,transcriptional regulation,tumor suppressor function,dna repair mechanisms
ENSG00000054116,TRAPPC3,trapp complex,cell proliferation,autophagy regulation,apoptosis modulation,cellular migration,vesicle transport
ENSG00000256660,CLEC12B,tumor progression,immune evasion,protein-carbohydrate interactions,inflammation regulation,cancer metastasis,poor prognosis marker
ENSG00000215193,PEX26,peroxisome dysfunction,oxidative stress response,fatty acid metabolism regulation,tumor suppressor function,genomic instability induction,cellular survival enhancement
ENSG00000139970,RTN1,cell adhesion disruption,tight junction dysregulation,pi3k/akt pathway interaction,membrane trafficking alteration,cell migration promotion,oncogene activation
ENSG00000096070,BRPF3,histone acetylation disruption,chromatin remodeling,oncogenic transcription,proto-oncogene activation,genomic instability,dna repair pathway interaction
ENSG00000119938,PPP1R3C,cellular regulation,glycogen metabolism,pp1 holoenzyme regulation,oncogenic processes,tumor progression,gsk3b activity modulation
ENSG00000132792,CTNNBL1,wnt signaling pathway,cell proliferation,epithelial-to-mesenchymal transition,oncogenic driver,β-catenin interaction,cancer aggressiveness
ENSG00000100219,XBP1,upr pathway,tumor progression,cancer stem cell maintenance,dna repair modulation,chemotherapy resistance,promotion of apoptosis suppression
ENSG00000281861,SLC9A3,cell migration,cytoplasmic ph regulation,enhanced cell invasiveness,metastatic potential,tumor aggressiveness,vascular endothelial growth factor signaling pathway interaction
ENSG00000166927,MS4A7,**
adhesion regulation,cell migration enhancement,epithelial cell interaction,immune evasion mechanism,oncogene overexpression,signal transduction modulation
**
ENSG00000137875,BCL2L10,anti-apoptotic function,apoptosis regulation,cell survival promotion,oncogenic role,tumor resistance,genomic instability
ENSG00000155099,PIP4P2,cellular proliferation,apoptosis regulation,cell survival,phosphoinositide metabolism,oncogenesis promotion,signaling pathway interaction
ENSG00000144451,SPAG16,**

microtubule stabilization,genomic instability,cell cycle regulation,mitotic checkpoint disruption,chromosomal segregation errors,cancer genetics

**
ENSG00000139437,TCHP,tumor progression,oncogenic pathway regulation,cell proliferation enhancement,transcriptional coactivation,metastasis promotion,pi3k/akt/mtor pathway interaction
ENSG00000184271,POU6F1,**

cellular proliferation,transcriptional regulation,dna binding,oncogenic potential,chromatin remodeling,overexpression
ENSG00000136451,VEZF1,transcriptional regulator,tumor promoter,cell cycle regulation,anti-apoptotic function,epithelial-to-mesenchymal transition (emt),chromatin remodeling
ENSG00000197062,ZSCAN26,tumor suppressor,dna binding activity,cell cycle regulation,apoptosis induction,transcriptional repression,genomic stability maintenance
ENSG00000159063,ALG8,n-glycosylation,aberrant glycosylation,tumor progression,metastasis,poor prognosis,gain-of-function mutations
ENSG00000163646,CLRN1,cell adhesion regulation,mitogenic signaling,epithelial-to-mesenchymal transition,overexpression associated,tumor progression marker,transmembrane receptor function
ENSG00000167971,CASKIN1,disruption of adherens junctions,cell migration and invasion,epithelial-to-mesenchymal transition,cell adhesion protein regulation,serine protease activity,oncogenic overexpression
ENSG00000138175,ARL3,microtubule dynamics regulation,cell proliferation promotion,microtubule assembly modulation,tumor progression association,kinase inhibition interaction,protein-protein interaction
ENSG00000167535,CACNB3,calcium channel activation,constitutive activation,overexpression,cell proliferation,therapeutic target,prognostic marker
ENSG00000115138,POMC,cell growth regulation,metabolic adaptation,pain modulation,stress response pathway,hormone regulation,precursor protein signaling
ENSG00000100299,ARSA,altered expression,degradation of sulfated glycosaminoglycans,hyaluronan regulation,immune modulation,lysosomal enzyme activity,tumor microenvironment modulation
ENSG00000250565,ATP6V1E2,tumor progression,oncogenic processes,cellular metabolism regulation,cellular stress responses,gene expression regulation,ion homeostasis modulation
ENSG00000182938,OTOP3,calcium influx regulation,cell proliferation enhancement,tumor progression promotion,oncogenic potential,signal transduction modulation,cell growth regulation
ENSG00000134152,KATNBL1,chromatin remodeling,histone modification,transcriptional regulation,cell proliferation,tumor growth,poor prognosis marker
ENSG00000107560,RAB11FIP2,endocytic recycling pathway,cell migration,therapeutic target,tumor aggressiveness,signaling pathway regulation,cellular homeostasis
ENSG00000180938,ZNF572,cell cycle regulation,dna binding,epigenetic modification,oncogene activation,tumor progression,transcriptional repression
ENSG00000152475,ZNF837,oncogene,transcription factor activity,tumor progression,biomarker potential,transcriptional regulation,dna binding and recognition
ENSG00000106025,TSPAN12,cell adhesion disruption,tumor progression,oncogenesis association,cell signaling regulation,protein-protein interactions,cancer-associated expression
ENSG00000004961,HCCS,histone catabolism,hypoxia regulation,cellular adaptation,tumor microenvironment modulation,gene expression regulation,chromatin remodeling
ENSG00000198298,ZNF485,krab domain-containing zinc finger protein,transcriptional regulation,cell proliferation,tissue-specific expression,genomic instability,cancer-related gene expression
ENSG00000181638,ZFP41,p53 pathway interaction,zinc finger transcription factor,cell growth regulation,tumor suppression,apoptosis modulation,cell cycle control
ENSG00000128656,CHN1,calcium-dependent signaling,cell cycle regulation,constitutive activation,genomic instability,oncogene amplification,transcriptional regulation
ENSG00000126878,AIF1L,tumor progression,inflammatory response modulation,metastasis promotion,prognostic biomarker,oncogenic role modulation,cell migration regulation
ENSG00000122859,NEUROG3,overexpression,cell proliferation,transcription factor activity,oncogenic processes,tumor progression,poor prognosis
ENSG00000085999,RAD54L,homologous recombination repair,dna repair mechanism,genome instability,tumorigenesis pathway,epistasis group component,genomic integrity maintenance
ENSG00000175455,CCDC14,cell proliferation,microtubule stabilization,mitotic entry promotion,oncogene overexpression,cell survival enhancement,microtubule dynamics regulation
ENSG00000107890,ANKRD26,pi3k/akt interaction,cell proliferation,oncogene activation,apoptosis inhibition,cell cycle regulation,dna repair impairment
ENSG00000166860,ZBTB39,tumor suppressor activity,epigenetic regulation,cell cycle regulation,genomic stability maintenance,dna repair mechanisms,chromatin remodeling interaction
ENSG00000104660,LEPROTL1,cell migration,cell proliferation,oncogenesis,tumor progression,protein-protein interactions,poor prognosis
ENSG00000172007,RAB33B,endocytic trafficking,cell proliferation,autophagy regulation,oncogenic driver,metastasis promotion,tumor progression marker
ENSG00000198833,UBE2J1,ubiquitination regulation,cell cycle progression,tumor suppressor degradation,cancer biomarker,dna repair evasion,protein accumulation
ENSG00000125817,CENPB,centromere formation,kinetochores assembly,genomic instability,chromosome segregation,tumor aggressiveness,therapeutic target
ENSG00000189030,VHLL,hypoxia response,cell proliferation,tumor suppressor function,protein degradation pathway,angiogenesis regulation,metabolic adaptation
,HIST1H2AC,histone modification,chromatin remodeling,transcriptional regulation,oncogene,cell cycle progression,apoptosis resistance
ENSG00000266173,STRADA,cell survival regulation,protein-protein interactions,kinase activation,tumor progression,stress response modulation,cellular signaling pathway
ENSG00000177602,HASPIN,genomic instability,cell division regulation,chromatin remodeling,tumor progression,prognostic marker,mitotic checkpoint
ENSG00000186204,CYP4F12,apoptosis modulation,cell proliferation enhancement,dna damage induction,fatty acid hydroxylation,lipid metabolism dysregulation,oxidative stress generation
ENSG00000171219,CDC42BPG,cell cycle regulation,constitutive activation,genomic instability,cell proliferation enhancement,oncogene,therapeutic target
ENSG00000197959,DNM3,clathrin-mediated endocytosis,cancer progression,cell migration,microtubule dynamics,prognostic marker,cytoplasmic protein regulation
ENSG00000182156,ENPP7,oncogenic overexpression,cell signaling modulation,extracellular environment regulation,tumor progression correlation,poor prognosis indicator,cellular growth regulation
ENSG00000143418,CERS2,ceramide biosynthesis,tumor progression,cell proliferation,survival signaling pathway,apoptosis modulation,therapeutic target
ENSG00000128011,LRFN1,cell adhesion disruption,emt regulation,metastasis facilitation,tumor growth promotion,signaling pathway modulation,cancer progression association
ENSG00000167315,ACAA2,lipid biosynthesis regulation,cell proliferation enhancement,protein interaction with pparγ,energy metabolism modulation,tumorigenesis association,poor prognosis correlation
ENSG00000169981,ZNF35,tumor suppressor,transcriptional repressor,cell cycle regulation,apoptosis modulation,oncogene overexpression,genomic instability
ENSG00000261857,MIA,emt induction,cell migration enhancement,metastatic potential increase,therapeutic target,cell adhesion disruption,protein-protein interaction modulation
ENSG00000111596,CNOT2,transcription regulation,mrna decay,cell proliferation,tumor progression,oncogenic mrnas,genomic instability
ENSG00000163166,IWS1,ubiquitin-proteasome system regulation,cellular stress response modulation,tumor progression facilitation,apoptosis resistance induction,metabolic reprogramming promotion,oncogenic process contribution
ENSG00000147874,HAUS6,cell proliferation,chromosomal instability,dna repair mechanism,genomic amplification,microtubule dynamics,spindle assembly checkpoint
ENSG00000137814,HAUS2,ciliogenesis,wnt signaling pathway,oncogene,overexpression,cell proliferation,centrosome duplication
ENSG00000021762,OSBPL5,oncogenic signaling,cell growth promotion,lipid metabolism regulation,tumor progression facilitation,pi3k/akt pathway interaction,cholesterol homeostasis disruption
ENSG00000138109,CYP2C9,metabolic regulation,oxidative metabolism,drug metabolism,cellular detoxification,chemotherapy resistance,xenobiotic regulation
ENSG00000115850,LCT,lipid metabolism regulation,cancer-associated fibroblast recruitment,tumor progression,adipocyte function modulation,lipolysis enhancement,rapid cell proliferation support
ENSG00000100902,PSMA6,proteasome activity,cell cycle regulation,tumor suppressor degradation,proliferation enhancement,genomic instability,therapeutic resistance
ENSG00000198523,PLN,calcium regulation,cell survival,proliferation modulation,phosphorylation activation,pi3k/akt interaction,oncogenesis support
ENSG00000186193,SAPCD2,sphingolipid metabolism,cellular proliferation,tumor progression,apoptosis regulation,oncomodulation,none
ENSG00000132661,NXT1,cellular proliferation,nuclear transport factor 2 family member,cell survival enhancement,apoptosis suppression,cancer driver gene candidate,signal transduction pathway interaction
ENSG00000078403,MLLT10,cell cycle regulation,chromatin modification,genome instability,oncogenic driver,epigenetic regulator,histone interaction
ENSG00000174796,THAP6,transcriptional regulation,oncogene activation,cell cycle progression,epigenetic modification,e3 ubiquitin ligase activity,tumor growth and resistance to apoptosis
ENSG00000104369,JPH1,calcium signaling modulation,tumor suppressor function,cellular homeostasis regulation,apoptosis induction,cancer cell proliferation inhibition,genomic instability protection
ENSG00000116350,SRSF4,pre-mrna splicing regulation,genomic instability,oncogenic transformation,cell cycle control,tumor progression,apoptosis modulation
ENSG00000148248,SURF4,cellular adhesion,chromatin regulation,cytoskeleton modification,epithelial cell differentiation,gene expression modulation,protein-protein interaction
ENSG00000183258,DDX41,genomic instability,tumor suppressor function,cellular proliferation,rna processing,dna repair regulation,biological process modulation
ENSG00000111291,GPRC5D,receptor function,tumor progression,cell signaling pathway,apoptosis regulation,metastasis promotion,prognostic marker
ENSG00000175489,LRRC25,cell adhesion,cell migration,dna repair regulation,invasiveness,metastasis promotion,tumor progression
ENSG00000060339,CCAR1,p53 interaction,oncogene function,cell proliferation,apoptosis resistance,dna damage response,chromosomal location
ENSG00000157851,DPYSL5,microtubule dynamics,cell division regulation,mitotic spindle checkpoint,overexpression implications,tumor progression enhancement,cancer cell proliferation
ENSG00000092964,DPYSL2,tumor progression,cell proliferation,protein-protein interaction,microtubule dynamics,oncogenesis,metastasis driver
ENSG00000116729,WLS,wnt/β-catenin signaling pathway,oncogenic mutations,cell proliferation,subcellular localization,β-catenin regulation,prognostic marker
ENSG00000120647,CCDC77,microtubule dynamics,chromosomal instability,tumor progression,mitotic checkpoint disruption,oncogenic potential,therapeutic target
ENSG00000145833,DDX46,rna helicase activity,chromatin remodeling,transcriptional regulation,genomic instability,immune evasion mechanisms,cell cycle progression
ENSG00000173960,UBXN2A,ubiquitination regulation,tumor growth promotion,apoptosis suppression,cell cycle dysregulation,genome instability maintenance,oncoprotein stabilization
ENSG00000067445,TRO,calcium signaling pathway,cell proliferation enhancement,tumor growth promotion,metastasis facilitation,muscle contraction regulation,protein-protein interaction
ENSG00000105605,CACNG7,cellular invasion,calcium channel dysfunction,epithelial integrity disruption,oncogenic signaling pathway,tumor progression,protein interaction
ENSG00000068745,IP6K2,insp7-dependent phosphorylation,oncogenic signaling,tumor progression,cell proliferation,genomic instability,protein kinase activation
ENSG00000065621,GSTO2,**

cell cycle regulation,dna repair mechanisms,apoptosis evasion,chemotherapy resistance,protein-protein interactions,stress response modulation 

**
,WRB,er-associated degradation,disrupted protein folding,apoptosis regulation,autophagy modulation,oncogenic signaling,er stress response
ENSG00000109272,PF4V1,angiogenesis promotion,oncogene overexpression,tumor growth facilitation,therapeutic target potential,cell proliferation regulation,biomarker relevance
ENSG00000165685,TMEM52B,cell adhesion disruption,hippo signaling pathway regulation,tumor progression driver,oncogenic function alteration,cellular invasion promotion,prognostic marker
ENSG00000174453,VWC2L,cell adhesion disruption,tumor progression,metastasis promotion,poor prognosis,overexpression in tumors,aggressive behavior
ENSG00000180872,DEFB112,altered expression,immune surveillance,antimicrobial activity,tumor suppressor,signaling pathway modulation,prognostic marker
ENSG00000166881,NEMP1,angiogenesis facilitation,immune suppression,apoptosis inhibition,tumor progression promotion,prognostic biomarker,metastasis enhancement
ENSG00000178726,THBD,angiogenesis promotion,cell migration regulation,cell adhesion modulation,coagulation pathway interaction,metastasis facilitation,thrombin activation
ENSG00000137812,KNL1,chromatin remodeling,genomic instability,mitotic checkpoint regulation,oncogenic transformation,kinetochore-microtubule interaction,therapeutic target
,KCNA6,overexpression,oncogenic signaling,tumor progression,cell proliferation,therapeutic target,biomarker candidate
ENSG00000166145,SPINT1,tumor suppressor function,regulation of emt,inhibition of proteases,cell migration inhibition,cancer progression regulation,genetic downregulation
ENSG00000126756,UXT,oncogene,protein degradation,cell proliferation,transcriptional regulation,ubiquitination machinery,metastasis
ENSG00000111237,VPS29,retromer complex,cell growth regulation,endosomal sorting dysfunction,oncogene potential,receptor trafficking dysregulation,tumorigenesis promotion
ENSG00000006042,TMEM98,hippo/yap signaling pathway regulation,cellular integrity maintenance,transmembrane protein function,prognostic biomarker,cell growth and survival regulation,tumor progression association
ENSG00000143032,BARHL2,transcription factor regulation,oncogene activation,tumor progression,cell cycle regulation,dna repair dysregulation,apoptosis suppression
ENSG00000205060,SLC35B4,aberrant glycosylation,constitutive activation,oncogenic signaling,tumor progression,therapeutic target,glycosylation regulation
ENSG00000147654,EBAG9,mtor pathway inhibition,tumor suppressor function,genomic instability,apoptosis promotion,cell growth regulation,dna repair interaction
ENSG00000151379,MSGN1,cell migration,epithelial-to-mesenchymal transition (emt),overexpression,pi3k/akt signaling,prognostic marker,tumor progression
ENSG00000179826,MRGPRX3,pi3k/akt pathway,epithelial-to-mesenchymal transition (emt),cell proliferation,g-protein coupled receptor,biomarker candidate,tumor progression
ENSG00000258724,PINX1,dna repair mechanism,cell cycle regulation,tumor suppressor function,genomic stability maintenance,pcna interaction,chromosomal instability promotion
ENSG00000112212,TSPO2,immune evasion,tumor progression,cell proliferation,overexpression,biomarker potential,pi3k/akt pathway interaction
ENSG00000176248,ANAPC2,chromosomal instability,cell cycle regulation,ubiquitination pathway,oncogene accumulation,tumor suppressor inhibition,apoptosis evasion
ENSG00000160993,ALKBH4,genomic instability,dna repair mechanisms,alkylation damage,epigenetic regulation,tumor suppressor function,therapeutic target
ENSG00000123130,ACOT9,cellular energy homeostasis,lipid metabolism regulation,tumor progression,therapeutic target,cancer cell survival,protein interaction modulation
ENSG00000041515,MYO16,myosin activity,cell migration regulation,epithelial-to-mesenchymal transition,tumor progression facilitation,overexpression correlation,metastasis promotion
ENSG00000274829,PARN,oncogene activation,rna regulation,mrna stability,cellular proliferation,therapeutic target,genomic instability
ENSG00000135698,MPHOSPH6,chromatin remodeling,epigenetic regulation,gene amplification,genomic instability,nuclear protein function,oncogene overexpression
ENSG00000171824,EXOSC10,cancer biomarker,exosome complex regulation,rna degradation,cell growth control,prognostic marker,signaling pathway modulation
ENSG00000166478,ZNF143,znf143 regulation,transcriptional activation,overexpressed in cancer,cell proliferation inhibition,apoptosis suppression,epigenetic modification
,SEPT10,septin family member,cell cycle regulator,apoptosis suppressor,tumor progression marker,biomarker,genomic instability driver
ENSG00000081041,CXCL2,pro-inflammatory signaling,angiogenesis promotion,tumor growth stimulation,metastasis facilitation,poor prognosis indicator,immune cell recruitment
ENSG00000153029,MR1,immune regulation,lipid antigen presentation,tumor immunosurveillance,anti-tumor immunity,oncogenic potential,cellular interaction
ENSG00000101290,CDS2,genomic instability,cell cycle regulation,replisome complex,dna repair mechanisms,protein-dna interactions,s-phase progression
ENSG00000158062,UBXN11,p53 stabilization,tumor progression,cell cycle regulation,apoptosis inhibition,cancer stem cell maintenance,dysregulation of ubiquitin pathway
ENSG00000105509,HAS1,ha-dependent tumor microenvironment,constitutive activation of catalytic activity,gain-of-function mutations,tumor progression,therapeutic target,cell migration and invasion
ENSG00000103044,HAS3,cell cycle progression,chromatin remodeling,dna replication,epithelial-to-mesenchymal transition,gene expression regulation,overexpression
ENSG00000176974,SHMT1,cellular metabolism,one-carbon cycle,nucleotide synthesis,dna repair,oncogenic driver,protein-protein interaction
ENSG00000145354,CISD2,mitochondrial regulation,dysregulated iron metabolism,apoptosis modulation,protein-protein interaction,cell survival enhancement,tumor suppressor function
ENSG00000170876,TMEM43,er stress response,protein folding regulation,cell survival regulation,oncogenic process,therapeutic target,stress response modulation
ENSG00000064655,EYA2,transcriptional activator,cell proliferation,epithelial-to-mesenchymal transition (emt),cell migration,gene expression regulation,tumor progression
ENSG00000185742,C11orf87,androgen receptor coactivator,cell proliferation enhancer,cancer progression factor,transcriptional regulator,protein-protein interaction mediator,tumor growth promoter
ENSG00000104221,BRF2,transcriptional regulation,tumor progression,aggressive disease features,prognostic marker,nuclear factor function,oncogenic pathway interaction
ENSG00000114573,ATP6V1A,v-atpase activation,tumor progression,metastasis promotion,ph regulation alteration,cell migration enhancement,chemo-resistance increase
ENSG00000166971,AKTIP,akt activation,cell proliferation,phosphorylation regulation,pi3k/akt signaling,tumor progression,genomic amplification
ENSG00000134962,KLB,katp channel regulation,gene expression regulation,tumor suppressor function,cell growth modulation,autophagy regulation,apoptosis modulation
ENSG00000286112,KYAT1,centrosome regulation,chromosomal instability,spindle assembly checkpoint,cell cycle progression,genomic stability maintenance,protein-protein interaction
ENSG00000263160,TMEM50B,mitochondrial fusion,calcium homeostasis regulation,cell survival enhancement,metabolic adaptation,oncogenic progression,therapeutic target
ENSG00000198925,ATG9A,autophagy initiation,cellular metabolism regulation,lipid metabolism enhancement,amino acid transport modulation,tumor growth promotion,tumor suppressor function
ENSG00000106608,URGCP,apoptosis regulation,cell cycle progression,dna damage response,oncogenic transformation,pi3k/akt pathway modulation,protein overexpression
ENSG00000145725,PPIP5K2,cellular proliferation,signaling pathway modulation,genomic instability,therapeutic target,protein-protein interaction,inositol polyphosphate metabolism
ENSG00000154957,ZNF18,transcriptional regulation,tumor suppressor activity,cell proliferation,dna binding and recognition,epigenetic alterations,chromatin remodeling
ENSG00000143727,ACP1,mitochondrial enzyme,cellular metabolism regulation,cancer driver gene candidate,oncogenic process contributor,redox balance modulation,energy metabolism regulation
ENSG00000110344,UBE4A,protein degradation,cell cycle regulation,transcriptional regulation,tumor suppressor degradation,ubiquitination process,oncogene activation
ENSG00000005238,FAM214B,genomic instability,mitotic progression,microtubule dynamics,centrosome integrity,cell cycle regulation,cancer driver gene
ENSG00000175315,CST6,**
cancer-related glycosylation,cysteine protease inhibition,cell survival regulation,apoptosis evasion,angiogenesis modulation,tumor progression enhancement
ENSG00000204381,LAYN,emt pathway,oncogene overexpression,tumor progression,metastasis,cell adhesion disruption,gene expression alteration
ENSG00000205808,PLPP6,lipid metabolism regulation,phospholipid phosphatase activity,tumor progression marker,cell signaling pathway modulation,protein-protein interaction,lipid raft assembly
ENSG00000206394,CLIC1,cell cycle regulation,tumor progression,protein-protein interaction,signaling pathway modulation,dna replication enhancement,chloride channel regulation
ENSG00000156127,BATF,oncogene activation,gain of function mutations,constitutive activation,transcriptional regulation,chromatin remodeling,tumor progression
ENSG00000126803,HSPA2,hsp70 family,apoptosis regulation,cell cycle control,dna repair pathway,pi3k/akt signaling pathway,protein degradation and translocation
ENSG00000124279,FASTKD3,apoptosis regulation,mitochondrial dysfunction,oncogenic function,therapeutic target,cellular survival,poor prognosis
ENSG00000106348,IMPDH1,nucleotide biosynthesis,cell proliferation,guanine nucleotide regulation,oncogenic signaling,tumor progression,genomic amplification
ENSG00000169951,ZNF764,transcriptional regulation,dna binding recognition,oncogenesis,overexpression,prognostic biomarker,transcription factor interaction
ENSG00000159210,SNF8,endosomal trafficking regulation,oncoprotein degradation,cell proliferation regulation,survival pathway modulation,genetic instability contribution,lysosomal dysfunction association
ENSG00000100580,TMED8,er export pathway disruption,tumor suppressor regulation,protein trafficking dysregulation,oncogene interaction,poor prognosis biomarker,cancer progression facilitation
ENSG00000184752,NDUFA12,mitochondrial function,cellular respiration,redox regulation,oxidative stress,metabolic reprogramming,tumor suppressor
ENSG00000179010,MRFAP1,oncogenic activity,aberrant localization,cell cycle regulation,apoptosis evasion,mrna processing disruption,protein-protein interaction
ENSG00000217930,PAM16,cell cycle regulation,protein-protein interactions,dna repair mechanisms,tumor growth promotion,poor prognosis biomarker,therapeutic target
ENSG00000168334,XIRP1,apoptosis inhibition,cell cycle progression,emt regulation,cell survival enhancement,tumor growth promotion,cytoskeletal organization disruption
ENSG00000120265,PCMT1,tumor progression,histone modification regulation,cell growth promotion,metastasis enhancement,protein stabilization and degradation,oncogene activation
ENSG00000102970,CCL17,cc chemokine,immune evasion,tumor progression,angiogenesis induction,cell migration promotion,pro-inflammatory cytokine
ENSG00000011485,PPP5C,cell cycle regulation,tumor suppressor modulation,apoptosis suppression,protein interaction network,transcriptional regulation,oncogenic signaling pathway activation
ENSG00000197601,FAR1,cell cycle progression,apoptosis regulation,tumor growth,resistance to apoptosis,oncogenic driver,g2/m checkpoint
ENSG00000186889,TMEM17,lysosomal membrane stability,ca2+ signaling pathway,cell proliferation regulation,genomic instability prevention,tumor growth inhibition,therapeutic target
ENSG00000182979,MTA1,epigenetic regulation,transcriptional repression,oncogenesis,metastasis,epithelial-to-mesenchymal transition (emt),chromatin remodeling
ENSG00000185608,MRPL40,mitochondrial translation,ribosomal assembly,cellular metabolism,oncogenic potential,protein-protein interaction,tumor growth
ENSG00000077463,SIRT6,dna repair,tumor progression,genomic stability,cell metabolism regulation,chromatin remodeling,apoptosis suppression
ENSG00000092531,SNAP23,membrane fusion regulation,exocytosis facilitation,oncogenic protein trafficking,cell survival enhancement,proliferation promotion,tumorigenesis contribution
ENSG00000145911,N4BP3,e3 ubiquitin ligase interaction,protein degradation regulation,oncogenic transformation,cellular proliferation modulation,genotoxic stress response,apoptosis inhibition
ENSG00000134369,NAV1,aberrant expression,cell proliferation,disrupted signaling pathways,enhanced sodium permeability,oncogenic processes,tumor progression
ENSG00000176386,CDC26,protein degradation,cell cycle regulation,tumor progression,ubiquitin-proteasome pathway,cancer driver,rna degradation
ENSG00000181472,ZBTB2,oncogenic transcription factor,cell proliferation enhancement,tumor suppressor inhibition,epigenetic regulation modulation,chromatin remodeling activation,poor prognostic biomarker
ENSG00000126254,RBM42,oncogene activation,mrna stability regulation,splicing factor interaction,cell proliferation enhancement,metastasis promotion,tumor growth facilitation
ENSG00000171425,ZNF581,transcriptional regulation,cancer driver gene,oncogenesis,tumor progression,dna binding,epithelial-to-mesenchymal transition
ENSG00000101189,MRGBP,chromatin remodeling,transcriptional regulation,tumor progression,genomic stability,prognostic marker,therapeutic target
ENSG00000118680,MYL12B,cell migration,metastasis,overexpression,actin cytoskeleton dynamics,focal adhesion turnover,oncogenic drivers
ENSG00000276480,MYH11,cell migration and contraction,cancer cell invasion,poor prognosis marker,cytoplasmic regulation,genomic alterations,oncogenic processes
ENSG00000162298,SYVN1,ubiquitination pathway,cellular proliferation,proteasomal degradation,tumor progression,apoptosis resistance,pi3k/akt signaling
ENSG00000176095,IP6K1,pi3k/akt signaling pathway,cancer driver mutations,constitutive activation,cell proliferation,oncogenesis,genomic amplification
ENSG00000243067,PSMB9,proteasome activation,cell cycle progression,tumor suppression evasion,protein degradation,ubiquitination pathway,oncogene overexpression
ENSG00000167840,ZNF232,genomic instability,gene expression regulation,tumor suppressor activity,cell cycle regulation,dna damage response,transcriptional modulation
ENSG00000159267,HLCS,genomic instability,oncogenic mutations,enhanced cell proliferation,therapeutic target,tumor progression,cell survival enhancement
ENSG00000134532,SOX5,transcriptional regulation,oncogenic transcription factor,wnt/β-catenin pathway activation,epithelial-to-mesenchymal transition (emt),metastatic potential enhancement,therapeutic target
ENSG00000136936,XPA,genomic instability,dna repair pathway,tumor suppressor function,nucleotide excision repair,mutational hotspot,cancer predisposition
ENSG00000087903,RFX2,transcriptional regulation,oncogenesis,cell cycle regulation,genomic instability,chromatin remodeling,protein-dna interaction
ENSG00000168824,NSG1,tumor progression,cell proliferation,oncogenic role,nucleolar protein,ribosome biogenesis,apoptosis evasion
ENSG00000168000,BSCL2,autophagy modulation,cell metabolic regulation,lipid droplet formation,mutations contributing to tumorigenesis,oncogenic pathway interaction,protein structure and function changes
ENSG00000205439,KRTAP12-3,keratin-associated protein,cell adhesion regulation,cytoskeletal dynamics disruption,epithelial cell integrity loss,tumor progression association,oncogenic potential
ENSG00000130770,ATP5IF1,mitochondrial function,energy production alteration,tumor cell metabolism,glycolysis increase,apoptosis resistance,cellular growth promotion
ENSG00000280759,AP2A2,regulation of oncogenic pathways,epigenetic modifications,dephosphorylation and inhibition of protein kinases,interactions with other proteins and complexes,regulation of gene expression,contribution to drug resistance
,GARS,trna modification,growth factor signaling pathway,oncogenic mutations,cellular proliferation,genetic instability,cancer driver gene
ENSG00000165376,CLDN2,tumor progression,upregulated expression,oncogene function,wnt/β-catenin pathway interaction,cellular polarity regulation,chemoresistance mechanism
ENSG00000112763,BTN2A1,tumor progression,immune evasion,cell adhesion regulation,t-cell activation disruption,cell proliferation dysregulation,antigen presentation modulation
ENSG00000154127,UBASH3B,pi3k/akt pathway modulation,tumor suppressor function loss,ubiquitin ligase activity regulation,cell cycle progression,protein stability regulation,genomic instability
ENSG00000141934,PLPP2,tumor progression,cell proliferation,signaling pathway activation,enzymatic activity modulation,prognostic biomarker,lipid metabolism regulation
ENSG00000136404,TM6SF1,lipid droplet formation,lipolysis regulation,oncogenic potential,tumor progression,transmembrane protein,cell proliferation
ENSG00000163466,ARPC2,actin polymerization,cell migration,protein-protein interaction,therapeutic target,cell survival,tumorigenesis
ENSG00000155304,HSPA13,cellular chaperone function,oncogenic behavior,protein stability regulation,apoptosis evasion,pi3k/akt pathway interaction,cell cycle progression influence
ENSG00000180806,HOXC9,transcriptional regulation,mutation and amplification,tumor progression,cell proliferation,epithelial cell integrity,developmental biology
ENSG00000125618,PAX8,oncogenic driver,transcription factor overexpression,cell proliferation enhancement,tumor progression facilitation,apoptosis inhibition,wnt/β-catenin pathway interaction
ENSG00000173917,HOXB2,oncogene,cell proliferation,gene regulation,transcriptional activation,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000131013,PPIL4,peptidase inhibitor activity,cell proliferation regulation,oncogenic function,cell cycle progression modulation,protein degradation regulation,apoptosis suppression
ENSG00000184436,THAP7,cell cycle regulation,transcriptional regulation,oncogenic pathways,apoptosis resistance,tumor growth promotion,prognostic marker
ENSG00000125888,BANF2,chromatin structure regulation,genomic integrity,cell cycle checkpoint modulation,chromosome segregation,oncogenic potential,therapeutic target
ENSG00000136942,RPL35,ribosome biogenesis,cell proliferation,protein synthesis,genomic amplification,metabolic reprogramming,tumor progression
ENSG00000217128,FNIP1,mtor pathway activation,tumor suppressor function loss,gain of function mutations,tumor growth promotion,autophagy inhibition,cancer driver gene status
ENSG00000135823,STX6,aberrant expression,apoptosis regulation,cell cycle progression,metabolic reprogramming,oncogenic processes,pi3k/akt pathway interaction
ENSG00000229802,SLC39A7,zinc transporter function,oncogenesis,cell proliferation,metastasis promotion,therapeutic target,genomic upregulation
ENSG00000170893,TRH,metabolic regulation,cell growth modulation,neuroendocrine signaling,immune response modulation,proliferation control,growth hormone secretion
ENSG00000281758,KCNIP4,camkii regulation,cell proliferation,calcium signaling pathways,protein kinase modulation,oncogenic driver,poor prognosis
ENSG00000114854,TNNC1,tumor progression,apoptosis resistance,cell cycle regulation,muscle contraction regulation,prognostic marker,oncogenic protein overexpression
ENSG00000143977,SNRPG,alternative splicing,apoptosis regulation,cancer prognosis,cell growth promotion,cell survival enhancement,mutation association
ENSG00000182004,SNRPE,spliceosomal protein,alternative splicing regulation,rna recognition and binding,aberrant mrna isoform production,tumor progression influence,potential therapeutic target
ENSG00000176679,TGIF2LY,wnt/β-catenin signaling pathway,transcriptional regulation,cell proliferation,hedgehog signaling pathway repression,cell survival,tumor progression
ENSG00000166446,CDYL2,histone modification,epigenetic regulation,transcriptional control,oncogenic function,chromatin remodeling,tumor progression
,DARS,tumor progression,overexpression,protein synthesis regulation,cellular proliferation promotion,dna repair interaction,biomarker candidacy
ENSG00000136874,STX17,aberrant cell signaling,cell polarity disruption,chromosomal alteration,tumor suppressor function,vesicle transport dysregulation,cancer gene amplification
ENSG00000198728,LDB1,chromatin remodeling,co-activation,enhancer activation,oncogenic function,transcriptional regulation,pi3k/akt signaling pathway
ENSG00000159556,ISL2,cellular patterning,transcriptional regulation,developmental processes,cell growth regulation,oncogenic potential,tissue expression
ENSG00000165533,TTC8,cell-cell adhesion disruption,epithelial polarity loss,oncogenic potential,tumor suppressor function,cancer progression modulation,transmembrane protein structure
ENSG00000131067,GGT7,tumor suppressor protein degradation,cellular trafficking regulation,oncogenic process promotion,protein modification facilitation,poor prognosis association,therapeutic target potential
ENSG00000164237,CMBL,apoptosis modulation,cell cycle regulation,tumor progression,metastasis regulator,oncogenic interaction,pi3k/akt pathway interaction
ENSG00000185640,KRT79,intermediate filament formation,apoptosis regulation,tumor progression marker,therapeutic target,cytoskeletal organization,cancer cell survival
ENSG00000105793,GTPBP10,rhoa/rac1 pathway,apoptosis regulation,cancer driver,cellular proliferation,nuclear localization,gene mutation
ENSG00000185905,C16orf54,oncogene regulation,long non-coding rna,lncrna regulation,promoter binding,epigenetic landscape regulation,cell cycle progression
ENSG00000131264,CDX4,**

cdx4 overexpression,wnt/β-catenin signaling pathway modulation,transcriptional regulation,cell proliferation control,tumor suppressor/oncogene function,genomic instability
**
ENSG00000115841,RMDN2,dna repair,cell cycle regulation,genomic instability,chromosomal segregation,protein-protein interactions,nuclear localization
ENSG00000174943,KCTD13,loss of tumor suppressor function,cellular proliferation,ion channel regulation,metastasis promotion,cell survival resistance,pi3k/akt pathway interaction
ENSG00000126067,PSMB2,proteasome regulation,cell cycle progression,oncogene upregulation,tumor suppression evasion,apoptosis resistance,genomic instability
ENSG00000277791,PSMB3,proteasome upregulation,cell survival enhancement,apoptosis suppression,cell cycle regulation disruption,tumor aggressiveness promotion,poor prognosis indicator
ENSG00000198853,RUSC2,cell cycle regulation,apoptosis modulation,rab gtpase interaction,protein overexpression,oncogenic function,signaling network regulation
ENSG00000105983,LMBR1,hedgehog signaling,gain of function mutations,tumor progression,cell proliferation,oncogenesis,transmembrane protein
ENSG00000196391,ZNF774,cell cycle regulation,apoptosis regulation,transcriptional repression,tumor suppression,dna repair interaction,chromatin remodeling
ENSG00000152147,GEMIN6,snrnp assembly,splicing regulation,tumor suppressor activity,cancer association,dna damage response,cell cycle modulation
ENSG00000243244,STON1,apoptosis inhibition,cell survival enhancement,pi3k/akt pathway interaction,tumor progression promotion,serine protease inhibitor function,metastasis facilitation
ENSG00000134508,CABLES1,genome stability regulation,tumor suppressor activity,cell cycle inhibition,apoptosis induction,biomarker potential,oncogenic pathway modulation
ENSG00000147262,GPR119,signaling pathway modulation,cell proliferation,tumor progression,energy balance regulation,g protein-coupled receptor function,metabolic regulation
ENSG00000110324,IL10RA,regulation of inflammation,modulation of immune response,suppression of anti-tumor immunity,tumor progression,immune evasion,inflammation regulation
ENSG00000175445,LPL,metabolic regulation,tumor growth,cell proliferation,survival signaling pathway,immune modulation,adipocyte differentiation
ENSG00000163735,CXCL5,chemokine signaling pathway,angiogenesis promotion,tumor progression,immune cell recruitment,prognostic marker,cancer metastasis
ENSG00000102189,EEA1,early endosomal function,cell proliferation regulation,cell survival modulation,endocytic trafficking dysregulation,tumor progression,protein-protein interaction
ENSG00000281139,STH,iron homeostasis,aberrant expression,cellular metabolism,metabolic regulation,oxidative stress,signaling pathway modulation
ENSG00000197951,ZNF71,**

1. transcriptional regulation,2. cell cycle regulation,3. oncogenic processes,4. dna binding activity,5. co-regulatory protein interactions,6. tumorigenesis
ENSG00000197063,MAFG,transcriptional regulation,oncogene activation,cell proliferation promotion,prognostic marker,tumor suppressor interaction,genomic amplification
ENSG00000132274,TRIM22,tumor suppressor,cell cycle regulation,apoptosis induction,immune response modulation,pi3k/akt pathway interaction,dna repair regulation
ENSG00000069535,MAOB,enzymatic activity,reactive oxygen species generation,dna damage,genomic instability,cell signaling regulation,tumor progression
ENSG00000203667,COX20,mitochondrial dysfunction,altered cellular respiration,genomic instability,rapid cell proliferation,oxidative stress,cellular metabolism disruption
ENSG00000087206,UIMC1,histone methylation,chromatin regulation,transcriptional control,cell growth regulation,tumor suppressor function,protein-protein interaction
ENSG00000136270,TBRG4,chromatin remodeling,oncogenic role,overexpression,cell proliferation,epigenetic regulation,transcriptional modulation
ENSG00000063176,SPHK2,sphingosine-1-phosphate signaling,oncogenic transformation,cell survival promotion,tumor progression enhancement,protein kinase activation,sphingolipid metabolism
ENSG00000174485,DENND4A,genomic instability,cellular trafficking regulation,mitotic spindle formation,oncogenic driver,autophagy regulation,cell proliferation enhancement
ENSG00000072133,RPS6KA6,mtor pathway,cell proliferation,oncogene activation,therapeutic target,poor prognosis marker,signaling pathway interaction
ENSG00000114127,XRN1,mirna regulation,oncogenic mirna stability,cellular proliferation,non-coding rna processing,tumor progression,genomic instability
ENSG00000171806,METTL18,m6a methylation,oncogenic gene expression,cancer progression,poor prognosis,rna stability modulation,tumor suppressor interaction
ENSG00000235155,B3GALT4,glycosylation regulation,dysregulated expression,oncogenic role,tumor progression,metastasis promotion,cell surface modification
ENSG00000145192,AHSG,cellular homeostasis regulation,tumor cell proliferation,overexpression in cancer,extracellular matrix modulation,pi3k/akt pathway interaction,poor prognosis marker
ENSG00000204219,TCEA3,wnt/β-catenin signaling pathway,overexpression,cell proliferation,oncogene,tumor progression,transcriptional regulation
ENSG00000004939,SLC4A1,glycolytic reprogramming,ion transport regulation,cellular invasion promotion,metabolic adaptation,apoptosis modulation,cancer aggressiveness marker
ENSG00000048162,NOP16,**

ribosome biogenesis,nucleolar regulation,oncogenic processes,cell proliferation,protein synthesis regulation,overexpression marker

**
ENSG00000140830,TXNL4B,cell proliferation enhancement,redox regulation,oncogenic signaling pathway,poor prognosis marker,tumor growth promotion,epigenetic regulation
ENSG00000071967,CYBRD1,cyclin-dependent kinase regulation,cell cycle progression,oncogenesis,cell survival enhancement,genomic instability maintenance,apoptosis inhibition
ENSG00000160688,FLAD1,dna repair deficiency,oxidative stress induction,genetic instability promotion,cell cycle dysregulation,apoptosis suppression,tumor progression facilitation
ENSG00000146352,CLVS2,chromatin remodeling,tumor suppressor,genomic instability,dna repair defects,cell cycle dysregulation,proliferation enhancer
ENSG00000170011,MYRIP,regulation of actin filament dynamics,cancer cell migration,tumor invasion and metastasis,cell proliferation and survival,oncogenic pathway activation,genomic instability
ENSG00000184724,KRTAP6-1,cellular structure maintenance,epithelial differentiation,type ii intermediate filaments,gene expression regulation,tumor progression facilitation,cell adhesion disruption
ENSG00000144036,EXOC6B,tumor suppressor function,membrane trafficking regulation,aberrant protein secretion,pi3k/akt pathway interaction,genomic instability,proliferation enhancement
ENSG00000171116,HSFX1,mitochondrial localization,antioxidant function,apoptosis regulation,growth factor regulation,tumor suppressor dysfunction,cell proliferation enhancement
ENSG00000268738,HSFX2,chromatin remodeling,transcriptional regulation,histone-modifying activity,cellular proliferation,tumor progression,genomic instability
ENSG00000094841,UPRT,nucleotide biosynthesis,cell proliferation,dna repair pathway,genomic instability,oncogenic mutations,therapeutic target
ENSG00000188312,CENPP,**
chromosomal instability,cell cycle regulation,aneuploidy,tumor progression,genomic instability,centrosome duplication
**
ENSG00000276045,ORAI1,calcium-dependent signaling pathway,store-operated calcium entry,overexpression associated,therapeutic target identified,tumor aggressiveness,cell proliferation regulation
ENSG00000057252,SOAT1,cholesterol metabolism,oncogenic lipid synthesis,tumor growth promotion,cell proliferation enhancement,poor prognosis association,therapeutic target potential
ENSG00000094804,CDC6,chromosome replication,cell cycle progression,genomic instability,tumor cell proliferation,apoptosis resistance,cancer stem cell maintenance
ENSG00000185721,DRG1,secreted glycoprotein,regulates cellular processes,modulates pi3k/akt pathway,tumor progression,aberrant expression,cell growth regulation
ENSG00000241935,HOGA1,cellular metabolism alteration,protein catabolism dysregulation,mitochondrial dysfunction,tumor aggressiveness enhancer,oncogenic function mediator,cancer progression promoter
ENSG00000177947,ODF3,mitotic checkpoint regulation,cell proliferation enhancement,chromosome segregation modulation,biomarker for disease progression,centrosomal protein function,cancer cell survival promotion
ENSG00000122550,KLHL7,cell cycle regulation,tumor suppressor activity,ubiquitination pathway disruption,protein interaction with cul3,oncogenic transformation suppression,genomic stability maintenance
ENSG00000130695,CEP85,microtubule organization,genomic instability,centrosome duplication,oncogenic processes,spindle assembly checkpoint,ciliogenesis dysregulation
ENSG00000106993,CDC37L1,cell cycle progression,molecular chaperone function,protein kinase activation,oncogenic signaling pathways,therapeutic target potential,cell proliferation enhancement
ENSG00000139329,LUM,tumor suppressor,cell adhesion regulation,angiogenesis regulation,extracellular matrix interaction,cell migration modulation,genomic instability
ENSG00000112214,FHL5,transcriptional regulation,protein-protein interactions,oncogenic processes,tumor progression,therapeutic target,biomarker expression
ENSG00000128610,FEZF1,cellular differentiation regulation,tumor progression modulation,transcriptional regulation,biomarker potential,genetic interaction,cancer cell survival
ENSG00000075240,GRAMD4,pi3k/akt pathway modulation,cell survival promotion,tumor progression association,exocytosis regulation,granule fusion facilitation,apoptosis evasion
ENSG00000087302,RTRAF,nf-kappab activation,tumor progression,poor prognosis marker,cell survival enhancement,apoptosis resistance,pi3k/akt signaling interaction
,KARS,cellular proliferation,genomic instability,protein synthesis regulation,cellular metabolism reprogramming,tumor suppressor dysfunction,gene expression dysregulation
ENSG00000189120,SP6,transcriptional regulation,cell cycle progression,dna binding activity,oncogenic transcription factor,proliferation promotion,apoptosis evasion
ENSG00000243489,KRTAP10-11,cell envelope modification,epithelial barrier disruption,proliferation regulation,dysregulated expression,tumor progression,cellular differentiation
ENSG00000101605,MYOM1,cytoplasmic reorganization,phosphorylation-dependent regulation,pi3k/akt pathway activation,cell proliferation enhancement,cytoskeleton stabilization disruption,actin filament dynamics modulation
ENSG00000102021,LUZP4,cellular proliferation,transcriptional regulation,chromatin remodeling,apoptosis inhibition,tumor suppressor function,epithelial cell differentiation
ENSG00000183214,MICA,immune evasion,tumor immune escape,nkg2d receptor interaction,cancer immunotherapy target,prognostic marker,cellular stress signaling
ENSG00000119878,CRIPT,calcium signaling,cell migration,microtubule dynamics,calmodulin binding,oncogenic overexpression,prognostic marker
ENSG00000138449,SLC40A1,iron regulation,oncogenic adaptation,hypoxia-induced survival,cellular iron homeostasis,tumor progression,therapeutic resistance
ENSG00000186393,KRT26,**
epithelial integrity disruption,type ii keratin expression,mechanical stress resistance,cytoskeletal reorganization,cellular transformation,tumor aggressiveness 
**
ENSG00000083093,PALB2,homologous recombination,genomic instability,dna repair,brca1 complex,protein-protein interaction,tumor suppression
ENSG00000164414,SLC35A1,nucleotide sugar transport,glycosylation regulation,cell surface modification,oncogenic processes,aberrant expression levels,biomarker correlation
ENSG00000158769,F11R,tumor progression,cell adhesion modulation,oncogene overexpression,immune evasion,angiogenesis facilitation,signal transduction
ENSG00000100568,VTI1B,ph regulation,tumor progression,cancer stem cell maintenance,lysosomal function,endosomal recycling,cellular homeostasis
ENSG00000127452,FBXL12,cell cycle regulation,protein degradation,cancer therapy target,apoptosis inhibition,substrate recognition complex,ubiquitin ligase activity
ENSG00000064703,DDX20,pre-mrna processing,rna helicase activity,aberrant splicing patterns,genomic instability,tumor aggressiveness,therapeutic target
ENSG00000178741,COX5A,oxidative phosphorylation,tumor metabolism,cellular respiration,energy production,potential oncogene,genomic instability
,RARS,ribosome biogenesis,cellular proliferation,methylation regulation,oncogenic transformation,translation initiation,protein interaction
ENSG00000010292,NCAPD2,chromosome condensation,oncogene activation,cell cycle regulation,wnt/β-catenin pathway,chromatin dynamics,ccan complex interaction
ENSG00000141753,IGFBP4,igf-binding activity,tumor suppression,mitogenic inhibition,ectopic expression loss,cell proliferation control,cancer therapy target
ENSG00000084112,SSH1,cell proliferation regulation,prognostic marker,cell signaling regulation,sam domain family member,pi3k/akt pathway interaction,tumorigenesis involvement
ENSG00000123992,DNPEP,cellular signaling,peptide degradation,tumor progression,gene regulation,protein interaction,metastasis facilitation
ENSG00000179564,LSMEM2,leucine-rich repeat protein,cell membrane trafficking,signaling pathway modulation,gene expression regulation,cell proliferation regulation,oncogenic property potential
ENSG00000163539,CLASP2,microtubule regulation,aurora kinase a interaction,tumor progression,spindle checkpoint disruption,cell migration modulation,genomic instability
ENSG00000171823,FBXL14,proteasomal degradation,cell cycle regulation,dna damage response,tumor suppressor,cyclin e2 regulation,molecular switch
ENSG00000162227,TAF6L,transcriptional regulation,subunit function,tfiid assembly,gene expression initiation,cell differentiation,chromatin remodeling
ENSG00000092140,G2E3,cell growth regulation,g2/m checkpoint disruption,oncogenic mutation,cell cycle progression,genomic instability,tumor suppressor function
ENSG00000054654,SYNE2,**

1. **metastasis driver**,2. **tumor progression**,3. **cell migration**,4. **structural integrity**,5. **mechanical stability**,6. **adhesion regulation** 

**
ENSG00000067167,TRAM1,apoptosis regulation,tumor growth promotion,angiogenesis facilitation,oncogenic function,tumorigenesis association,cell survival pathway
ENSG00000143375,CGN,transcription initiation,tfiih complex activation,genomic instability,tumor progression,cell proliferation,dna repair
ENSG00000145685,LHFPL2,cell proliferation,pi3k/akt signaling,oncogenesis,cell survival,protein regulation,lipid signaling
ENSG00000265107,GJA5,tumor progression,cell proliferation,oncogene,therapeutic target,cell adhesion regulation,pi3k/akt pathway activation
ENSG00000168818,STX18,cell migration,gain of function mutations,vesicle trafficking regulation,cell proliferation,metastasis promotion,oncogenic phenotype
ENSG00000108100,CCNY,cell cycle progression,oncogene activation,cell proliferation enhancement,dna damage response modulation,prognostic marker,tumor progression promoter
ENSG00000102317,RBM3,oncogenic function,translational regulation,protein homeostasis regulation,cell cycle progression,dna repair dysregulation,therapeutic target
ENSG00000243927,MRPS6,mitochondrial function,regulatory mechanism,cellular metabolism,protein translation,tumor progression,cellular proliferation
ENSG00000133119,RFC3,dna repair mechanism,cell cycle regulation,mutation hotspots,tumor suppression pathways,genomic instability,proliferation rate enhancement
ENSG00000186081,KRT5,epithelial disruption,gain-of-function mutation,oncogenic process,tumorigenesis,epithelial cell polarity,genomic profiling
ENSG00000130707,ASS1,arginine auxotrophy,urea cycle regulation,cellular redox balance,metabolic reprogramming,therapeutic target,tumor growth inhibition
ENSG00000115648,MLPH,tumor suppressor function,microtubule regulation,cell cycle disruption,genomic instability,oncogene mutations,protein-protein interaction
ENSG00000118271,TTR,angiogenesis promotion,cell migration facilitation,metastasis enhancement,prognostic marker,tumor progression association,unknown regulatory mechanism
ENSG00000116741,RGS2,regulatory function,tumor suppressor,gpcr signaling pathway,g-protein regulation,cell proliferation inhibition,molecular interaction
ENSG00000054356,PTPRN,cell adhesion disruption,enhanced migration and invasion,tumor progression,metastasis regulation,pi3k/akt pathway interaction,biomarker potential
ENSG00000110514,MADD,nf-κb signaling pathway,apoptosis inhibition,molecular chaperone function,cell survival promotion,caspase regulation,oncogene overexpression
ENSG00000186792,HYAL3,epithelial-to-mesenchymal transition,tumor microenvironment modulation,metastasis facilitation,angiogenesis regulation,glycosaminoglycan degradation,tumor progression enhancer
ENSG00000138942,RNF185,e3 ubiquitin ligase activity,tumor progression,cell cycle regulation,apoptosis suppression,dna repair regulation,protein stability control
ENSG00000091428,RAPGEF4,rap gtpase activation,oncogenic progression,cell migration enhancement,poor prognosis association,fak/erk signaling regulation,cancer cell invasion facilitation
ENSG00000120733,KDM3B,histone demethylation,chromatin remodeling,cell proliferation,genomic instability,protein-protein interaction,oncogenic driver
ENSG00000163714,U2SURP,rna processing,nuclear function,splicing machinery interaction,aberrant expression,oncogenic potential,transcriptional regulation
ENSG00000167755,KLK6,proteolytic activity,tumor aggressiveness,cell invasion and migration,metastatic potential,oncoprotein expression,prognostic marker
ENSG00000075891,PAX2,proliferation,epithelial-to-mesenchymal transition,transcription factor activity,cell migration,cancer stem cell maintenance,therapeutic target
ENSG00000168876,ANKRD49,genome stability,dna replication regulation,cell cycle modulation,tumor suppressor activity,apoptosis regulation,chromatin remodeling
ENSG00000230907,FKBPL,cellular stress regulation,tumor suppressor function,autophagy modulation,mtor pathway regulation,poor prognostic marker,predictive biomarker
ENSG00000143183,TMCO1,mitochondrial dynamics,warburg effect,overexpression,glycolysis regulation,aerobic respiration modulation,cancer metabolism hallmark
ENSG00000205581,HMGN1,tumor suppressor regulation,chromatin remodeling,cell cycle modulation,prognostic biomarker,dna repair pathway,genomic instability
ENSG00000169908,TM4SF1,cell adhesion disruption,gain of function mutations,epithelial-to-mesenchymal transition,tumor progression,metastatic potential,signal transduction
ENSG00000013573,DDX11,genomic instability,chromosomal alterations,dna replication,transcriptional regulation,oncogenic signaling pathways,tumor suppression
ENSG00000139926,FRMD6,microtubule regulation,cell migration promotion,epithelial-to-mesenchymal transition,tumor progression driver,protein-protein interaction,actin cytoskeleton dynamics
ENSG00000115593,SMYD1,oncogenic potential,epigenetic regulation,chromatin remodeling,histone modification,cell proliferation,overexpression
ENSG00000078140,UBE2K,oncogenic mutation,cell proliferation,ubiquitination pathway,dna repair,apoptosis regulation,protein turnover
ENSG00000090104,RGS1,g-protein signaling regulation,cell proliferation promotion,apoptosis inhibition,pi3k/akt pathway interaction,oncogenic function,tumor suppressor downregulation
ENSG00000139625,MAP3K12,**

1. **map3k12-pi3k/akt pathway interaction**,2. **tumor progression driver**,3. **cell proliferation regulator**,4. **apoptosis inhibitor**,5. **genomic instability contributor**,6. **therapeutic target candidate** 

**
ENSG00000205279,CTXN3,cellular adhesion regulation,oncogenic function,cell migration promotion,transcription factor modulation,poor prognosis association,aggressive tumor features
ENSG00000140750,ARHGAP17,rhogap regulation,tumor suppressor function,cell migration and invasion modulation,proliferation and survival regulation,cytokeletal organization maintenance,genomic instability contribution
ENSG00000148943,LIN7C,**

lin7c's role in disrupting cell-cell adhesion,promoting emt process,interacting with wnt/β-catenin pathway,regulating cancer stem cell maintenance,implicated in tumor progression and metastasis,associated with poor prognosis 

**
ENSG00000168938,PPIC,molecular chaperone,protein folding regulation,tumor progression marker,genomic instability,cellular homeostasis regulator,therapeutic target
ENSG00000108557,RAI1,alternative splicing,cell survival,diagnostic biomarker,nuclear rna-binding protein,oncogenesis,protein overexpression
ENSG00000153046,CDYL,epigenetic regulation,tumor suppressor gene silencing,dna methylation aberration,cell proliferation enhancement,chromatin remodeling,protein-protein interaction modulation
ENSG00000266028,SRGAP2,rho gtpase regulation,cell morphology modulation,actin cytoskeleton disruption,tumor invasion promotion,genomic mutation impact,adhesion molecule regulation
ENSG00000107554,DNMBP,loss of adhesion,cell migration regulation,wnt/β-catenin pathway,adherens junction formation,tumor suppressor function,tissue integrity maintenance
ENSG00000186487,MYT1L,myt1l loss,tumor suppressor function,cellular differentiation regulation,transcriptional repression,apoptosis induction,proliferation inhibition
ENSG00000215114,UBXN2B,e3 ubiquitin ligase regulation,cell cycle control,tumor suppressor interaction,protein degradation,cell proliferation modulation,dna damage response
ENSG00000164080,RAD54L2,dna double-strand break repair,homologous recombination,genomic integrity,cell cycle regulation,tumor suppressor function,cross-talk with brca1/2
,MARCH2,protein degradation pathway,immune evasion mechanism,notch signaling regulation,tumor growth promotion,metastasis enhancer,ubiquitination activity
ENSG00000168517,HEXIM2,pi3k/akt pathway modulation,transcriptional regulator,cellular proliferation regulation,oncogene/tumor suppressor potential,cell survival influence,cancer progression contribution
ENSG00000068697,LAPTM4A,tumor progression,promotes cell proliferation,endocytosis regulator,prognostic marker,cell signaling mediator,membrane trafficking protein
ENSG00000087338,GMCL1,cell cycle regulation,oncogene activation,protein-protein interaction,nuclear localization,tumor growth promotion,survival pathway modulation
ENSG00000165553,NGB,redox regulation,cellular metabolism,oxidative stress modulation,therapeutic target,energy homeostasis,cancer metabolism
ENSG00000177791,MYOZ1,cell migration,cytoskeletal regulation,oncogenic function,actin filament regulation,cell proliferation promotion,tumor progression facilitation
ENSG00000102572,STK24,mitotic spindle checkpoint regulation,cell cycle progression,oncogenic driver mutation,tumor progression,protein-protein interaction,therapeutic target
ENSG00000163681,SLMAP,cellular migration,tumor progression,transmembrane protein function,adhesion regulation,prognostic marker,overexpression associated
ENSG00000179456,ZBTB18,oncogene function,transcriptional regulation,cell growth modulation,apoptosis inhibition,tumor suppressor repression,epigenetic modification
ENSG00000151715,TMEM45B,cellular homeostasis,maintenance of cell growth,differentiation and survival pathways,tumor suppressor function,transmembrane protein interaction,regulation of cellular processes
ENSG00000108878,CACNG1,calcium signaling pathway,cancer-promoting mutations,upregulated expression,tumor growth promotion,metastasis regulation,calcium channel subunit interaction
ENSG00000186812,ZNF397,altered gene expression,cell growth regulation,chromatin remodeling,metastasis,oncogenic mutations,pi3k/akt pathway interaction
ENSG00000170832,USP32,deubiquitination,oncogenic function,protein stabilization,apoptosis inhibition,cell cycle regulation,dna repair modulation
ENSG00000105327,BBC3,apoptosis regulation,tumor suppression,cellular stress response,dna damage repair,p53 pathway interaction,oncogenic potential
ENSG00000204390,HSPA1L,cell survival,apoptosis inhibition,protein homeostasis regulation,dna repair modulation,tumor progression,chemoresistance modulation
ENSG00000101746,NOL4,cell proliferation,oncogene,prognostic marker,transcription regulation,pi3k/akt pathway interaction,apoptosis evasion
ENSG00000174446,SNAPC5,genomic instability,ribosome biogenesis disruption,nucleotide activation,cell cycle dysregulation,oncogene potential,tumor progression
ENSG00000104980,TIMM44,mitochondrial function regulation,energy metabolism modulation,oncogenic mutations,tumor progression association,cell survival promotion,prognostic biomarker status
ENSG00000258839,MC1R,loss-of-function mutations,dysregulation of melanin production,tumor suppression,cell growth regulation,mapk/erk pathway activation,downregulation
ENSG00000170262,MRAP,regulation of cell growth,dysregulation leads to tumor suppression,interaction with melanocortin receptors,role in energy metabolism regulation,tumor suppressor function,regulation of apoptosis
ENSG00000054938,CHRDL2,wnt/β-catenin signaling pathway,tumor suppressor function,downregulation in cancer,poor prognosis marker,axin binding partner,cell cycle regulation involvement
ENSG00000137822,TUBGCP4,microtubule nucleation,overexpression,cell proliferation,resistance to chemotherapy,biomarker for cancer progression,tumor cell migration
ENSG00000170477,KRT4,loss of cell polarity,alteration in epithelial structure,tumor progression,cell-cell adhesion disruption,biomarker potential,cytoskeleton regulation
ENSG00000167766,ZNF83,transcriptional regulation,overexpression,poor prognosis,tumor progression,apoptosis resistance,immune evasion
ENSG00000124092,CTCFL,genomic instability,dna damage response,chromatin remodeling,transcriptional regulation,oncogenic pathway activation,tumor aggressiveness
ENSG00000178896,EXOSC4,p53 pathway modulation,dna repair regulation,cell cycle control,apoptosis modulation,rna degradation complex,cancer progression driver
ENSG00000105290,APLP1,cell adhesion disruption,cell survival promotion,notch signaling pathway,tumor progression facilitation,protein-protein interaction enhancement,oncogenic potential presence
ENSG00000144619,CNTN4,cell adhesion disruption,oncogenic signaling,tumor progression,prognostic marker,therapeutic target,altered expression
ENSG00000132874,SLC14A2,cellular transport,tumor progression,metabolic regulation,oncogenesis,ion balance,urea transport
ENSG00000159840,ZYX,cell cycle regulation,genomic instability,chromatin remodeling,transcriptional regulation,oncogenic pathway activation,tumor progression
ENSG00000149257,SERPINH1,tumor suppressor activity,protease inhibition,cellular homeostasis,apoptosis regulation,prognostic biomarker potential,endoplasmic reticulum localization
ENSG00000206177,HBM,extracellular matrix degradation,heparan sulfate proteoglycans,angiogenesis promotion,tumor progression enhancement,vascular endothelial growth factor upregulation,cell migration facilitation
ENSG00000196565,HBG2,hemoglobin production,oncogene potential,metabolic regulation,dna repair modulation,cell cycle dysregulation,tumor growth promotion
ENSG00000129250,KIF1C,microtubule-based transport,mitotic spindle assembly,centrosome separation,chromosomal instability,tumor progression,cell cycle regulation
ENSG00000118518,RNF146,cell cycle regulation,protein degradation,tumor suppression,oncogenesis,ubiquitination,cell proliferation
ENSG00000105048,TNNT1,actin cytoskeleton modulation,cell proliferation enhancement,signaling pathway regulation,tumor invasion promotion,sarcomeric complex component,cell growth regulation
ENSG00000133083,DCLK1,microrna regulation,tumor aggressiveness,cancer stem cells,cell cycle progression,protein-protein interaction,kinase activity
ENSG00000139514,SLC7A1,cell growth regulation,amino acid transport,metabolic reprogramming,immunosuppression,tumor progression,protein-protein interactions
ENSG00000149357,LAMTOR1,mtorc1 activation,cellular metabolism regulation,oncogenic signaling pathway,autophagy inhibition,tumor progression driver,therapeutic target candidate
ENSG00000168765,GSTM4,detoxification pathway,dna damage response,oxidative stress modulation,cellular detoxification capacity,genomic instability,cancer diagnosis biomarker
ENSG00000101349,PAK5,**
cell migration,epithelial-to-mesenchymal transition,oncogenesis,rho gtpase activation,prognostic biomarker,therapeutic resistance
**
ENSG00000197930,ERO1A,endoplasmic reticulum stress response,calcium homeostasis regulation,oncogenic signaling pathways,cellular proliferation enhancement,protein folding modulation,apoptosis inhibition
ENSG00000277424,HMOX2,heme degradation,antioxidant response,oxidative stress protection,tumor adaptation,inflammatory regulation,redox balance modulation
ENSG00000131475,VPS25,endosomal sorting,loss-of-function mutations,cellular homeostasis regulation,protein degradation,autophagy-lysosome pathway,therapeutic target
ENSG00000115685,PPP1R7,regulatory function,oncogene overexpression,cell cycle modulation,tumor suppressor regulation,signal transduction pathway,therapeutic target
ENSG00000147533,GOLGA7,er stress response,protein trafficking,cell signaling,apoptosis regulation,cancer progression,tumor suppressor interaction
ENSG00000173542,MOB1B,cell cycle regulation,oncogenic driver,genomic stability,tumor progression,cell proliferation,mitotic entry
ENSG00000187514,PTMA,angiogenic modulation,cell growth regulation,immune microenvironment,precursor protein processing,peptide hormone signaling,tumor progression
ENSG00000204979,MS4A13,immunomodulation,tumor suppression,cell proliferation regulation,apoptosis induction,angiogenesis regulation,prognostic marker
ENSG00000213390,ARHGAP19,rhogtpase regulation,tumor suppressor function,cellular growth regulation,cytoskeleton reorganization inhibition,oncogenic pathway modulation,apoptosis disruption
ENSG00000138785,INTS12,ints12/integrator complex,snrna biogenesis,cell proliferation,tumor suppressor/oncogene activity,transcriptional regulation,chromatin remodeling
ENSG00000181374,CCL13,angiogenesis,immune microenvironment,chemokine signaling,tumor progression,cell proliferation,overexpression
ENSG00000108774,RAB5C,rapid endocytic recycling,tumorigenic potential,cell surface receptor trafficking,gtpase activation,small gtpase signaling,mitotic division regulation
ENSG00000138592,USP8,oncogenic signaling,cell proliferation regulation,deubiquitinating activity,egfr stabilization,pi3k/akt pathway modulation,malignant transformation
ENSG00000130511,SSBP4,genomic instability,dna damage response,double-strand break repair,transcriptional regulation,protein-protein interaction,tumor cell survival
ENSG00000134323,MYCN,cell cycle regulation,transcription factor activity,oncogenic potential,tumor aggressiveness,genomic instability,apoptosis resistance
ENSG00000205084,TMEM231,hippo signaling pathway,transmembrane protein,microrna target,oncogenic expression,cellular proliferation,genomic instability
ENSG00000204852,TCTN1,aberrant cilia formation,cell polarity disruption,hippo/yap signaling activation,planar cell polarity pathway regulation,wnt/pcp signaling modulation,cancer driver gene
ENSG00000153044,CENPH,chromosomal instability,aneuploidy,centrosome function,tumor suppressor,oncogene,kinetochores
ENSG00000083844,ZNF264,transcriptional regulator,cell cycle progression,dna repair inhibition,apoptosis suppression,notch pathway modulation,p53 tumor suppressor interaction
ENSG00000116679,IVNS1ABP,cell proliferation,protein synthesis regulation,tumor growth promotion,mrna translation regulation,nucleolar localization,overexpression in cancer
ENSG00000087076,HSD17B14,androgen receptor modulation,dysregulated steroid hormone metabolism,steroidogenesis regulation,tumor aggressiveness,poor prognosis biomarker,therapeutic resistance marker
ENSG00000154305,MIA3,microtubule regulation,cell proliferation enhancement,apoptosis suppression,emt modulation,signaling pathway activation,protein interaction regulation
ENSG00000167377,ZNF23,transcriptional repression,dna-binding protein,epigenetic regulation,apoptosis modulation,cell proliferation enhancement,cancer-associated transcription factor
ENSG00000105379,ETFB,purine synthesis,dna synthesis,cell proliferation,tumor growth,oncogenic process,mtor signaling
ENSG00000078304,PPP2R5C,pp2a activation,dephosphorylation activity,oncogenic driver mutation,tumor progression marker,cell growth regulation,protein-protein interaction
ENSG00000146950,SHROOM2,actin cytoskeleton regulation,mitogenic signaling,cell migration,epithelial-to-mesenchymal transition (emt),protein-protein interaction,tumor progression
ENSG00000186501,TMEM222,tumor progression,cell proliferation,signaling pathway interaction,prognostic biomarker,gain of function mutations,therapeutic target
ENSG00000101150,TPD52L2,cell cycle regulation,apoptosis inhibition,oncogenic effects,genomic instability,nuclear localization,pi3k/akt pathway interaction
ENSG00000124006,OBSL1,cell migration,protein stabilization,actin cytoskeleton organization,tumor progression,oncogenic signaling pathway,cancer prognosis
ENSG00000092036,HAUS4,centrosome duplication,genomic instability,cell proliferation,apoptosis resistance,oncogenic protein,cell cycle regulation
ENSG00000184515,BEX5,cell proliferation,chemoresistance,oncogenesis,gene expression regulation,dna repair modulation,protein interaction
ENSG00000154839,SKA1,chromosomal instability,genomic stability disruption,cell division checkpoint regulation,aneuploidy induction,oncogenic cell proliferation,therapeutic target
ENSG00000110148,CCKBR,oncogenic signaling,tumor progression,cell proliferation,g protein coupled receptor,peptide hormone regulation,mapk/erk pathway activation
ENSG00000182667,NTM,apoptosis regulation,cell growth promotion,tumor progression association,cancer stem cell maintenance,genetic instability facilitation,transcriptional regulation activation
ENSG00000176083,ZNF683,overexpression,transcriptional regulation,cell proliferation,survival,aggressive tumor behavior,tumor suppressor dysfunction
ENSG00000142920,AZIN2,dna damage response,copper chaperone function,genomic stability regulation,cell proliferation enhancement,oncogenic potential,pi3k/akt signaling pathway interaction
ENSG00000143450,OAZ3,chromatin remodeling,gene regulation,oncogenic process,rna binding protein,splicing regulator,tumor microenvironment
ENSG00000113068,PFDN1,mitotic spindle formation,cellular structure integrity,microtubule stabilization,protein degradation regulation,cell proliferation enhancement,oncomitogenic function
ENSG00000215305,VPS16,vesicle trafficking regulation,oncogenic signaling pathway modulation,cell migration enhancement,tumor progression facilitation,protein transport modulation,genomic instability promotion
ENSG00000139719,VPS33A,pi3k/akt signaling pathway interaction,tumor progression driver,cellular stress response modulation,autophagy regulation,vacuolar membrane trafficking regulator,oncogene overexpression
ENSG00000100934,SEC23A,protein secretion,overexpression,cell proliferation,biomarker,oncogenic properties,therapeutic target
ENSG00000119042,SATB2,oncogene activation,transcriptional regulation,chromatin remodeling,cell proliferation enhancement,apoptosis inhibition,tumor progression promotion
ENSG00000186814,ZSCAN30,genomic instability,loss of function mutations,oncogenic pathway activation,transcriptional regulation,cell cycle disruption,protein-protein interaction
ENSG00000066735,KIF26A,cell proliferation,mitotic spindle checkpoint,kinesin motor protein,genomic stability,aggressive tumor behavior,cancer driver gene
ENSG00000139131,YARS2,genomic stability,tumor suppressor function,translation accuracy,cell growth regulation,apoptosis modulation,cytoplasmic localization
ENSG00000126860,EVI2A,transcriptional regulation,cell proliferation,apoptosis evasion,genomic amplification,prognostic biomarker,tumor progression
ENSG00000283727,KIR2DS4,potassium channel function,cell proliferation regulation,apoptosis modulation,oncogenic potential,cell signaling pathway regulation,tumor aggressiveness marker
ENSG00000130544,ZNF557,epigenetic regulation,transcriptional regulation,cell proliferation,oncogene function,protein-protein interaction,tumor progression
ENSG00000230900,ATP6V1G2,cellular ph regulation,cancer cell survival,mitochondrial function,proton pump activity,v-atpase assembly,tumor growth promotion
ENSG00000178719,GRINA,protein scaffolding,g-protein coupled receptor signaling,cell proliferation regulation,tumorigenesis promotion,oncogene activation,genomic instability
ENSG00000188243,COMMD6,tumor suppressor,loss-of-function mutation,wnt/β-catenin pathway regulation,protein-protein interaction regulation,cell proliferation suppression,oncogene regulation
ENSG00000059804,SLC2A3,enhanced glycolysis,hypoxia adaptation,glucose transporter activity,warburg effect promotion,cell proliferation support,tumor metabolism regulation
ENSG00000046774,MAGEC2,epigenetic regulation,chromatin modulation,tumor progression,poor prognosis marker,gene expression regulation,histone modification
ENSG00000132603,NIP7,mitochondrial dysfunction,rna processing disorder,cellular proliferation,altered transcriptional regulation,reduced atp production,genomic instability
ENSG00000285132,CTSB,cancer progression,invasion and metastasis,proteolytic activity,tumor aggressiveness,cell growth regulation,lysosomal function
ENSG00000185862,EVI2B,p53 regulation,tumor suppressor inhibition,co-regulatory complex interaction,cell cycle regulation,apoptosis evasion,poor prognostic marker
ENSG00000136048,DRAM1,er stress regulation,mitophagy promotion,cellular response modulation,cancer progression association,poor prognosis marker,oncogenic function
ENSG00000186925,KRTAP19-6,altered expression,cell adhesion disruption,cytoskeletal dynamics alteration,morphological changes,oncogenic interaction,prognostic significance
ENSG00000120725,SIL1,cellular homeostasis disruption,genomic instability promotion,oncogene overexpression,pi3k/akt pathway activation,protein folding regulation failure,tumor growth enhancement
ENSG00000099795,NDUFB7,mitochondrial electron transport chain,tumor progression,oncogenic reprogramming,energy metabolism,cell growth promotion,poor prognosis
ENSG00000197808,ZNF461,transcriptional regulation,oncogenic pathway activation,tumor suppressor gene silencing,pi3k/akt signaling,prognostic marker,cell proliferation
ENSG00000272333,KMT2B,histone methylation,chromatin regulation,tumor suppressor suppression,epigenetic reprogramming,genomic instability,dna damage response
ENSG00000168002,POLR2G,transcriptional activity,enhanced rna synthesis,cell proliferation,metastatic regulation,tumor progression,oncogenic pathway interaction
ENSG00000165795,NDRG2,tumor suppressor,apoptosis regulation,cell migration inhibition,angiogenesis modulation,pi3k/akt pathway interaction,mapk/erk signaling pathway interaction
ENSG00000112531,QKI,cell cycle regulation,apoptosis induction,rna processing regulation,tumor suppressor function,metastasis inhibition,cancer prognosis
ENSG00000126003,PLAGL2,transcription factor activity,gain of function mutations,chromatin remodeling,cell proliferation regulation,epigenetic regulator,oncogenic transformation
ENSG00000141425,RPRD1A,genomic instability,dna damage response,transcriptional regulation,chromatin remodeling,proliferation enhancement,evasion of apoptosis
ENSG00000130520,LSM4,rna splicing,oncogenesis,cell growth regulation,protein-protein interactions,transcriptional modulation,overexpression
ENSG00000111358,GTF2H3,genomic instability,tumor suppressor function disruption,dna repair,transcription regulation,genome integrity,nucleotide excision repair
ENSG00000136824,SMC2,chromosome segregation,genomic instability,dna damage response,tumor progression,poor prognosis marker,mitotic regulation
ENSG00000164076,CAMKV,calcium signaling pathway,tumor growth promotion,apoptosis inhibition,cell proliferation enhancement,genomic instability,oncogene activation
ENSG00000151353,TMEM18,transmembrane protein regulation,cell proliferation modulation,tumor progression association,biomarker identification,poor prognosis indicator,therapeutic target
ENSG00000168314,MOBP,cellular proliferation,cell migration,myelin protein family,oncogene or tumor suppressor,cellular growth regulation,protein-protein interactions
ENSG00000188155,KRTAP10-6,cell adhesion disruption,tumor progression marker,intermediate filament regulation,cell migration enhancer,pi3k/akt pathway interaction,mapk/erk pathway modulation
ENSG00000114395,CYB561D2,cellular proliferation,metabolic regulation,mitochondrial function,loss-of-function mutations,tumor suppressor,genomic instability
ENSG00000119318,RAD23B,protein degradation,ubiquitination,cell cycle progression,tumor suppressor regulation,genomic instability,oncogene expression
ENSG00000153130,SCOC,apoptosis regulation,mitochondrial function,disease prognosis,tumor aggressiveness,cell survival enhancement,mitochondrial biogenesis modulation
ENSG00000264522,OTUD7B,p53 stabilization,oncogene regulation,deubiquitinating enzyme activity,cell cycle progression,ubiquitin-proteasome pathway,apoptosis resistance
ENSG00000186106,ANKRD46,dna repair,apoptosis regulation,cell cycle arrest,tumor suppressor function,genomic instability,cell proliferation regulation
ENSG00000112357,PEX7,peroxisomal biogenesis factor function,cell signaling pathway interaction,genomic instability contribution,apoptosis regulation modulation,protein import dysfunction association,tumor progression potential
ENSG00000105518,TMEM205,disrupted epithelial polarity,loss of tumor suppressor function,regulation of membrane trafficking,enhanced cell migration,metastasis promoter,wnt/β-catenin pathway modulation
ENSG00000145794,MEGF10,oncogenic signaling,cell surface receptor modulation,tumor proliferation,disrupted cellular trafficking,metastatic potential,altered expression levels
ENSG00000180530,NRIP1,transcriptional regulation,cell proliferation enhancer,nuclear receptor interaction,oncogenic protein overexpression,cell cycle progression modulator,apoptosis inhibitor
ENSG00000070759,TESK2,microtubule regulation,phosphorylation activity,cell migration,oncometastasis,protein kinase activation,tumor aggressiveness
ENSG00000144824,PHLDB2,tumor suppressor function loss,oncogenic transcription factor regulation,cell cycle progression modulation,epithelial-to-mesenchymal transition (emt) regulation,overexpression correlation with poor prognosis,therapeutic target potential
ENSG00000156966,B3GNT7,cell surface modification,glycosphingolipid biosynthesis,cell signaling modulation,tumor cell adhesion,glycoprotein modification,tumor metastasis
ENSG00000132718,SYT11,chromatin remodeling,transcriptional regulation,protein-protein interaction,apoptosis suppression,cell proliferation,genome stability
ENSG00000101883,RHOXF1,cellular motility,cancer progression,proliferation regulation,motif interaction,transcriptional regulation,tumor aggressiveness
ENSG00000155792,DEPTOR,mtor signaling pathway,cell proliferation,tumor progression,apoptosis inhibition,protein kinase activation,cell growth regulation
ENSG00000138101,DTNB,mitochondrial dysfunction,metabolic reprogramming,energy production regulation,cellular respiration,oxidation-reduction reactions,electron transfer
ENSG00000171522,PTGER4,prostaglandin signaling,gpcr activation,cell proliferation,apoptosis evasion,inflammation regulation,tumor growth
ENSG00000064545,TMEM161A,er calcium signaling,ca2+ homeostasis disruption,store-operated ca2+ entry regulation,unfolded protein response activation,tumor progression promotion,therapeutic target identification
ENSG00000185019,UBOX5,cell cycle progression,genomic stability,apoptosis regulation,tumor growth promotion,dna repair interaction,oncogenic expression
ENSG00000020181,ADGRA2,tumor metastasis,constitutive activation,adhesion regulation,oncogene function,cell migration modulation,signaling pathway interaction
ENSG00000163395,IGFN1,tumor suppressor function,igf binding regulation,cell proliferation inhibition,angiogenesis modulation,genetic variation association,protein-protein interaction
ENSG00000143355,LHX9,genomic maintenance,tumor suppressor function,cell cycle regulation,apoptosis regulation,transcriptional regulation,lim-homeodomain protein
ENSG00000155666,KDM8,epigenetic regulation,histone demethylation,chromatin remodeling,transcriptional modulation,apoptosis resistance,tumor progression
ENSG00000169241,SLC50A1,cellular amino acid uptake,transmembrane transporter function,tumor cell metabolism,cell growth promotion,oncogenic pathway interaction,mtor signaling regulation
ENSG00000079616,KIF22,cell division regulator,mitotic spindle assembly,dna damage response,cell cycle progression,cancer prognosis marker,genomic instability
ENSG00000173559,NABP1,rna splicing regulation,pre-mrna processing,nuclear rna binding,gene expression modulation,cellular response modulation,dna damage repair
ENSG00000258890,CEP95,centrosomal protein regulation,genomic stability maintenance,microtubule dynamics modulation,primary cilia assembly regulation,tumor suppressor function loss,cancer genomic instability driver
ENSG00000183486,MX2,tumor progression,constitutive activation,gain of function mutations,oncogene overexpression,cell proliferation enhancement,epithelial-to-mesenchymal transition
ENSG00000164107,HAND2,transcription factor activity,tumor progression,cell growth regulation,oncogene overexpression,metastasis promotion,signaling pathway interaction
,SEPT11,cell division regulation,cytokinesis mediator,mitotic process,cancer cell migration,protein localization,microtubule organization
ENSG00000115194,SLC30A3,epithelial-to-mesenchymal transition (emt),zinc-dependent processes,tumor growth and metastasis,cell proliferation,angiogenesis,protein interaction with other oncogenes
ENSG00000196586,MYO6,pi3k/akt pathway interaction,endocytic regulation,tumor promoter,migratory enhancement,cell proliferation driver,epithelial-to-mesenchymal transition
ENSG00000100554,ATP6V1D,proton transport,cell signaling,tumor growth,metastasis,cancer progression,cellular ph homeostasis
ENSG00000204936,CD177,neutrophil regulation,tumor-promoting activity,immune evasion mechanisms,cell proliferation enhancement,apoptosis inhibition,genetic variation hotspot
ENSG00000134207,SYT6,pi3k/akt pathway interaction,cell proliferation promotion,cancer progression association,therapeutic target,protein-protein interaction,calcium-dependent membrane fusion
ENSG00000172336,POP7,map4 pathway regulation,genomic stability maintenance,gene amplification,cell cycle progression facilitation,aurka interaction,tumor suppressor function disruption
ENSG00000138035,PNPT1,genomic instability,aberrant splicing,proliferation enhancement,telomerase regulation,cell survival modulation,nucleotide modification dysfunction
ENSG00000163374,YY1AP1,pi3k/akt pathway interaction,oncogenic transcriptional coactivation,epithelial-to-mesenchymal transition regulation,tumor progression facilitation,cancer biomarker potential,therapeutic target for intervention
ENSG00000281484,BTG3,genomic stability regulation,tumor suppressor function,cell cycle regulation,anti-proliferative activity,microtubule stability maintenance,centrosome integrity preservation
ENSG00000076321,KLHL20,tumor suppressor,oncogenic signaling,cell proliferation regulation,genomic integrity maintenance,ubiquitin ligase activity,proliferation promotion
ENSG00000108439,PNPO,genomic instability,metabolic adaptation,enhanced proliferation,survival pathway interaction,transamination reactions,tumorigenic transformation
ENSG00000181817,LSM10,cancer driver gene,oncogene activation,cell proliferation regulation,mrna degradation regulation,tumor progression promotion,biomarker potential
ENSG00000212901,KRTAP3-1,keratin-associated protein,cell adhesion disruption,tumor suppressor function,cellular migration regulation,genomic instability,epithelial-to-mesenchymal transition
ENSG00000068323,TFE3,transcriptional regulation,oncogene activation,genomic instability,cell cycle progression,apoptosis regulation,chromatin remodeling
ENSG00000078674,PCM1,microtubule organization,centrosome function,amplified gene,cell cycle regulation,genomic instability,mitotic checkpoint control
ENSG00000163322,ABRAXAS1,genomic instability,tumor suppressor function,dna repair regulation,helicase activity,genetic mutation driver,cellular dna damage response
ENSG00000142507,PSMB6,tumor promoter,proteasome dysfunction,ubiquitin-proteasome pathway,oncogenic signaling,cell cycle regulation,apoptosis inhibition
ENSG00000112335,SNX3,tumor suppressor function,cell growth regulation,pi3k/akt pathway modulation,endosomal trafficking,metastasis suppression,oncogenic mutation
ENSG00000137501,SYTL2,microtubule regulation,microtubule dynamics,cytoskeleton modulation,vesicle fusion,exocytosis regulation,cancer progression marker
ENSG00000282175,HNRNPCL1,oncogene activation,rna regulation,cell cycle progression,apoptosis inhibition,tumor aggressiveness,pathway modulation
ENSG00000154548,SRSF12,alternative splicing regulation,tumor progression marker,splicing complex formation,oncogenic protein expression,cancer cell proliferation,poor prognosis indicator
ENSG00000111775,COX6A1,mitochondrial function,glycolytic adaptation,oxidative stress induction,genomic instability promotion,cell growth enhancement,tumor tissue expression
ENSG00000115541,HSPE1,cell survival enhancement,pi3k/akt pathway interaction,oncogenic protein stabilization,therapeutic target identification,chemotherapy resistance,tumor progression promotion
ENSG00000198130,HIBCH,bcaa degradation,glycolysis modulation,lipid metabolism alterations,promotes cell proliferation,oncogenic driver,metabolic reprogramming
ENSG00000172667,ZMAT3,apoptosis inhibition,chromatin remodeling,cell proliferation enhancement,dna repair dysregulation,oncogenic properties,tumor suppression evasion
ENSG00000110917,MLEC,cell-cell interaction,gain of function mutations,tumor progression,epithelial-to-mesenchymal transition (emt),immune modulation,adhesion regulation
ENSG00000163527,STT3B,protein targeting,cell proliferation,gene overexpression,tumor progression,apoptosis resistance,endoplasmic reticulum stress
ENSG00000133422,MORC2,microtubule regulation,motor domain protein,cell cycle progression,oncogene function,dna repair mechanisms,genomic instability
ENSG00000116191,RALGPS2,gef activity,oncogene function,ras signaling activation,cell proliferation enhancement,epithelial-to-mesenchymal transition promotion,prognostic marker status
ENSG00000083635,NUFIP1,cell cycle regulation,rna metabolism regulation,apoptosis resistance,metastasis suppression,therapeutic target,oncogene interaction
ENSG00000117174,ZNHIT6,histone demethylation,chromatin remodeling,oncogenic processes,cell proliferation,apoptosis regulation,genomic stability modulation
ENSG00000165643,SOHLH1,genomic instability,tumor progression,transcriptional regulation,cell cycle regulation,dysregulated expression,oncogenic transformation
ENSG00000244474,UGT1A4,detoxification process,glucuronidation pathway,metabolic regulation,drug resistance,tumor progression,cancer chemoprotection
ENSG00000241119,UGT1A9,cancer metabolism,glucuronidation process,altered bilirubin levels,tumor microenvironment modulation,poor prognosis,reduced survival rates
ENSG00000188167,TMPPE,iron homeostasis regulation,hepcidin modulation,ferroportin degradation,cell proliferation promotion,tumor growth support,oncogenic potential
ENSG00000196313,POM121,genomic instability,nuclear pore function disruption,dna damage response regulation,cell proliferation enhancement,apoptosis resistance,prognostic marker significance
ENSG00000099341,PSMD8,p27 ubiquitination pathway,protein degradation regulation,apoptosis evasion,cell proliferation enhancement,metabolic activity increase,biomarker expression
ENSG00000158234,FAIM,apoptosis regulation,caspase interaction,cell survival pathway,tumor progression impact,therapeutic target candidate,proteolytic activity
ENSG00000142528,ZNF473,zinc finger protein regulation,oncogenic pathway activation,cell proliferation enhancement,androgen receptor interaction,g2/m checkpoint dysregulation,genomic instability contribution
ENSG00000198832,SELENOM,protein folding regulation,cancer-associated mutations,cellular redox balance,antioxidant function,dna repair mechanism,genetic instability modulation
ENSG00000172493,AFF1,gene amplification,chromatin remodeling,oncogenic potential,cell proliferation,genomic instability,transcriptional regulation
ENSG00000167034,NKX3-1,tumor suppressor function,epithelial homeostasis regulation,cyclin d1 modulation,apoptosis induction,p53 interaction,tumor growth inhibition
ENSG00000160908,ZNF394,tumor suppression,genomic instability,cell proliferation regulation,dna repair interaction,transcriptional repression,cancer progression association
ENSG00000072080,SPP2,cell adhesion,integrin interaction,tumor progression,cell migration,protein-protein interaction,promoter methylation
ENSG00000145244,CORIN,serine protease activity,downregulated expression,tumor suppressor function,cell growth regulation,metastasis suppression,bladder epithelium expression
ENSG00000198324,PHETA1,ion channel regulation,cell migration and invasion,membrane trafficking,cellular signaling pathways,tumor metastasis,therapeutic target
ENSG00000104043,ATP8B4,calcium-dependent signaling,epithelial-to-mesenchymal transition (emt),cell proliferation,cell survival,golgi apparatus localization,mitochondrial function
ENSG00000112697,TMEM30A,mitochondrial membrane potential regulation,tumor suppressor function,loss of function mutations,cancer cell growth,apoptosis resistance,cell cycle regulation
ENSG00000081923,ATP8B1,phospholipid transport,oncogene upregulation,cell proliferation enhancement,tumor progression promotion,pi3k/akt pathway interaction,lipid metabolism dysregulation
ENSG00000124406,ATP8A1,epithelial cell polarity,lipid metabolism,cellular homeostasis,cancer progression,proliferation,migration
ENSG00000288146,NOC4L,genomic instability,chromatin remodeling,gene expression regulation,epigenetic modification,dna replication,tumorigenesis predisposition
ENSG00000114023,FAM162A,pi3k/akt signaling pathway modulation,oncogenic potential,cell growth regulation,tumor progression driver,gene amplification,therapeutic target
ENSG00000288283,RFX1,tumor suppressor function,cell cycle regulation,dna repair enhancement,genome stability maintenance,transcriptional activation,protein-protein interaction
ENSG00000285199,CIDEB,lipid metabolism regulation,golgi-associated protein,endoplasmic reticulum-golgi interaction,cell proliferation enhancement,tumor progression promotion,apoptosis resistance induction
ENSG00000187026,KRTAP21-2,oncogenic overexpression,cell proliferation enhancement,epithelial-mesenchymal transition facilitation,protein-protein interaction regulation,gene expression dysregulation,tumor suppressor inhibition
ENSG00000136205,TNS3,pi3k/akt pathway regulation,cell adhesion modulation,emt regulation,oncogene overexpression,protein-protein interactions,cancer cell invasion
ENSG00000163624,CDS1,dna repair,genomic instability,okazaki fragment processing,proofreading activity,dna replication coordination,cancer susceptibility
ENSG00000047249,ATP6V1H,altered ph levels,lysosomal function disruption,cellular signaling modulation,metastasis facilitation,tumor progression enhancement,protein functional modification
ENSG00000144648,ACKR2,cellular adhesion,immune modulation,tumor progression,cell migration,chemokine binding,metastasis facilitation
ENSG00000135436,FAM186B,chromatin regulation,dna repair pathways,transcriptional regulation,genomic instability,tumor suppressor function,cell cycle progression
ENSG00000146094,DOK3,rho gtpase activation,pi3k/akt/mtor pathway activation,epithelial-to-mesenchymal transition promotion,oncogenic signaling,cell migration regulation,p53 interaction
ENSG00000157593,SLC35B2,glycosylation pathway,cell proliferation,tumor progression,nucleotide sugar transport,oncogenic transformation,metastasis
ENSG00000128578,STRIP2,protein transport regulation,golgi apparatus interaction,cell growth promotion,aberrant protein accumulation,oncogenic protein interaction,cell survival enhancement
ENSG00000154723,ATP5PF,mitochondrial function,energy production regulation,tumor progression,metabolic dysregulation,cellular respiration,oncogenic driver
ENSG00000152455,SUV39H2,epigenetic regulation,tumor suppressor,histone modification,heterochromatin formation,gene silencing,chromatin compaction
ENSG00000137720,C11orf1,cell cycle regulation,dna damage response,oncogenic driver,tumor progression,genomic instability,apoptosis suppression
ENSG00000121361,KCNJ8,**
inward rectifier potassium channel function,cellular homeostasis regulation,oncogene activation,tumor cell proliferation,chemoresistance modulation,cell survival pathway regulation
**
ENSG00000170961,HAS2,hyaluronic acid production,tumor growth promotion,cell migration facilitation,metastasis enhancement,therapeutic target,genomic upregulation
ENSG00000119715,ESRRB,steroid hormone regulation,transcriptional activation,cell proliferation,apoptosis modulation,tumor suppressor interaction,cancer biomarker
ENSG00000142453,CARM1,oncogenic activity,gene regulation,cell proliferation,transcriptional activation,metastasis promotion,epigenetic regulation
ENSG00000104883,PEX11G,lipid metabolism modulation,ancillary peroxisomal function,metabolic reprogramming,oxidative stress response,cell survival signaling,amplification in cancer
ENSG00000160932,LY6E,immune evasion,tumor progression,cell adhesion modulation,protein-protein interaction,cancer aggressiveness,immune response regulation
ENSG00000148483,TMEM236,cell growth regulation,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway interaction,tumor progression marker,protein overexpression,apoptosis evasion
ENSG00000070501,POLB,oncogenesis,proliferation,genome stability,cell survival,dna repair,biomarker
ENSG00000079263,SP140,histone modification regulation,oncogene upregulation,chromatin remodeling,transcriptional activation,dna damage response,genomic instability
ENSG00000164620,RELL2,cell cycle regulation,dna damage response,tumor progression,apoptosis inhibition,cell proliferation enhancement,ubiquitination regulation
ENSG00000151320,AKAP6,cellular regulation,cancer progression,apoptosis inhibition,camp signaling modulation,pi3k/akt pathway interaction,biomarker potential
ENSG00000214114,MYCBP,genomic instability,cell cycle regulation,deregulation,transcriptional regulation,tumor suppressor function,loss of function mutations
ENSG00000149571,KIRREL3,wnt signaling pathway,cell adhesion regulation,epithelial polarity maintenance,tumor progression driver,potential therapeutic target,genomic instability regulator
ENSG00000131711,MAP1B,microtubule dynamics,tumor suppressor function,cellular migration regulation,oncogenic mutations,therapeutic targeting,cancer progression association
ENSG00000265763,ZNF488,dna binding,epigenetic regulation,cell proliferation,chromatin structure,gene expression regulation,transcriptional repression
ENSG00000171503,ETFDH,mitochondrial dysfunction,redox imbalance,oxidative stress,dna damage response,iron-sulfur cluster assembly,cancer cell metabolism
ENSG00000172602,RND1,rho gtpase signaling,constitutive activation,cell migration,tumor progression,epithelial-to-mesenchymal transition (emt),oncogenic transformation
ENSG00000144228,SPOPL,chromatin remodeling,mitotic spindle checkpoint,cell cycle progression,apoptosis regulation,oncogene expression,cancer cell growth
ENSG00000139174,PRICKLE1,wnt signaling disruption,chromatin remodeling defect,oncogenic mutations,tumor progression facilitation,epithelial-to-mesenchymal transition,transcriptional co-repression
ENSG00000230034,PSMB8,proteasome regulation,cell cycle progression,apoptosis modulation,ubiquitin-proteasome pathway,tumor suppression,protein degradation
ENSG00000102309,PIN4,p53 regulation,cell cycle regulation,tumor growth promotion,oncogenic signaling pathway activation,protein-protein interaction facilitation,apoptosis suppression
ENSG00000088808,PPP1R13B,regulation of pp1 activity,oncogenic processes,cell growth and survival,genomic stability,dna repair mechanisms,pi3k/akt signaling pathway
ENSG00000099219,ERMP1,increased expression,cell migration,cancer metastasis,epithelial-to-mesenchymal transition (emt),oncogene,therapeutic resistance
ENSG00000119508,NR4A3,oncogene activation,tumor suppressor mirna regulation,pi3k/akt pathway interaction,cell cycle progression modulation,apoptosis evasion,transcriptional regulation
ENSG00000133315,MACROD1,p53 regulation,dna repair,chromatin remodeling,oncogene function,cell proliferation,tumor suppressor modulation
ENSG00000122952,ZWINT,apc/c complex interaction,cell cycle regulation,mitosis,chromosome segregation,cytokinesis,ubiquitination pathway
ENSG00000112130,RNF8,genomic instability,dna damage response,ubiquitin ligase activity,homologous recombination repair,chromatin modification,tumor suppressor function
ENSG00000256812,CAPNS2,oncogenesis,cell proliferation,proteolytic activity,cancer progression,apoptosis regulation,tumor microenvironment
ENSG00000166311,SMPD1,lysosomal degradation,cellular homeostasis regulation,autophagy modulation,pi3k/akt pathway interaction,ceramide accumulation promotion,tumor growth enhancement
ENSG00000081721,DUSP12,cell signaling modulation,dephosphorylation activity,cytoplasmic localization,tumor progression marker,oncogenic process regulation,protein kinase inhibition
ENSG00000262334,RPH3AL,microtubule stability,cell cycle regulation,genomic instability,cancer progression,mitotic spindle checkpoint,protein-protein interactions
ENSG00000060566,CREB3L3,transcriptional regulation,pi3k/akt signaling,epithelial-to-mesenchymal transition,cell growth and survival,apoptosis inhibition,gene expression modulation
ENSG00000215717,TMEM167B,tumor progression,cell adhesion modulation,epithelial-to-mesenchymal transition (emt),protein-protein interactions,overexpression in cancer tissues,cellular migration regulation
ENSG00000173113,TRMT112,trna methylation,cellular homeostasis,protein synthesis regulation,cell proliferation promotion,apoptosis resistance,metabolic reprogramming
ENSG00000284850,DCP1B,cellular trafficking,microtubule interaction,axon transport regulation,cell division modulation,cancer metastasis support,genetic alteration implication
ENSG00000105723,GSK3A,wnt signaling pathway,cell proliferation,tumor progression,glycogen metabolism,oncogenic potential,tumor suppressor function
ENSG00000145779,TNFAIP8,apoptosis resistance,cellular proliferation,dna repair,inflammation regulation,oncogenic function,protein interaction
ENSG00000159882,ZNF230,dna binding,oncogenic process,cell proliferation,gene regulation,transcription factor interaction,tumor suppressor regulation
ENSG00000159228,CBR1,detoxification pathway regulation,redox balance modulation,rna metabolism regulation,cancer cell survival enhancement,oxidative stress reduction,cell proliferation promotion
ENSG00000285302,CHMP4A,autophagy modulation,cell proliferation,endosomal sorting complexes required for transport (escrt),multifunctional protein,oncogenic process,tumor invasion
ENSG00000173457,PPP1R14B,pp1 regulation,oncogenic overexpression,cell proliferation modulation,mtor pathway interaction,tumor suppressor pten association,apoptosis inhibition
ENSG00000174586,ZNF497,overexpression,regulatory protein interactions,cell cycle progression regulation,apoptosis modulation,potential biomarker,transcriptional regulation
ENSG00000143889,HNRNPLL,oncogenic activity,rna regulation,cell proliferation,transcriptional modulation,pre-mrna splicing,protein-rna interaction
ENSG00000113811,SELENOK,genomic instability,mitochondrial dysfunction,oxidative stress induction,dna repair impairment,proliferation enhancement,tumor suppressor function
ENSG00000134571,MYBPC3,amplification,cancer progression,overexpression,cell cycle disruption,dna damage response,muscle contraction regulation
ENSG00000120049,KCNIP2,regulatory subunit,oncogenic processes,biomarker,cell cycle progression,apoptosis modulation,potassium channel regulation
ENSG00000132879,FBXO44,cellular regulation,mitotic checkpoint,tumor suppressor function,ubiquitination pathway,scf complex interaction,cancer driver gene mutations
ENSG00000129255,MPDU1,apoptosis regulation,genomic stability maintenance,oncogenic signaling pathway activation,protein kinase b (akt) modulation,ubiquitination pathway interaction,cell proliferation enhancement
ENSG00000140939,NOL3,oncogenesis,dysregulated expression,ribosome biogenesis regulation,cell cycle progression modulation,anti-apoptotic function,genomic instability promotion
ENSG00000026652,AGPAT4,lipid metabolism,cell proliferation,oncogenic processes,therapeutic target,lipid synthesis,membrane biogenesis
ENSG00000255009,UBTFL1,pi3k/akt pathway activation,cell proliferation regulation,dna repair interaction,genome stability maintenance,oncogenic protein degradation modulation,ubiquitin-like protein modification
ENSG00000095261,PSMD5,ubiquitin-proteasome pathway,oncogenic function,protein degradation,apoptosis regulation,cell cycle progression,tumor aggressiveness
ENSG00000105520,PLPPR2,phospholipid metabolism,tumor progression,cell proliferation,protein-protein interaction,cellular signaling pathway regulation,oncogenic function
ENSG00000122862,SRGN,tumor progression,cell migration,proteolysis regulation,aggressive phenotype,signaling pathway modulation,cancer cell motility
ENSG00000106258,CYP3A5,cancer susceptibility,overexpression,tumor growth regulation,metabolic modulation,cell cycle progression alteration,p450 enzyme activity
ENSG00000166347,CYB5A,metabolic regulation,cellular interaction,detoxification process,electron transfer,tumor progression,gene expression
,ZNRD1,genome stability,tumor suppressor,chromatin remodeling,dna repair pathway,transcriptional regulation,cell cycle progression
ENSG00000182606,TRAK1,rho gtpase activation,cell migration regulation,tumor suppressor function,constitutive activation,protein localization modulation,trafficking pathway interaction
ENSG00000101751,POLI,genetic instability,mutagenesis,dna replication,genomic stability,tumor progression,therapeutic target
ENSG00000263761,GDF2,tgf-β superfamily member,embryonic development regulation,cellular proliferation inhibition,apoptosis induction,oncogenic properties,tumor-suppressive role
ENSG00000119392,GLE1,ribosome biogenesis,cell cycle regulation,oncogene overexpression,biomarker potential,metabolic reprogramming,therapeutic target
ENSG00000153086,ACMSD,metabolic adaptation,redox balance disruption,cellular energy regulation,oxidative stress induction,fatty acid synthesis modulation,tumor metabolism support
ENSG00000147894,C9orf72,chromatin remodeling,transcriptional regulation,cell proliferation,rna toxicity,toxic foci formation,oncogenic processes
ENSG00000025772,TOMM34,mitochondrial import pathway regulation,tumor aggressiveness predictor,oncogene upregulation,cell proliferation driver,tumor progression facilitator,cancer cell survival enhancement
ENSG00000143178,TBX19,tbx20 downregulation,transcription factor function,cell growth regulation,proliferation suppression,epigenetic modification,biomarker potential
ENSG00000143367,TUFT1,microtubule assembly,cell division regulation,oncogenic mutations,apoptosis inhibition,tumorigenesis promotion,cancer-related pathways
ENSG00000115956,PLEK,pleckstrin adapter function,membrane trafficking regulation,tumor progression marker,pi3k/akt signaling interaction,metastasis enhancer,cancer stem cell regulator
ENSG00000068383,INPP5A,tumor suppressor function,pi3k/akt/mtor regulation,cell proliferation inhibition,protein phosphorylation regulation,phosphoinositide metabolism,apoptosis promotion
ENSG00000283024,ATAD1,genomic instability,cell cycle regulation,dna replication,oncogenic driver,therapeutic target,apoptosis inhibition
ENSG00000146215,CRIP3,cellular regulation,apoptosis modulation,tumor progression,prognostic biomarker,pi3k/akt pathway interaction,therapeutic target
ENSG00000206527,HACD2,hacd2 mutations,oncogenic processes,cell proliferation enhancement,metastasis promotion,lipid biosynthesis dysregulation,therapeutic target
ENSG00000144468,RHBDD1,genomic stability maintenance,tumor suppressor function,nf-κb signaling interaction,dna repair regulation,cell differentiation regulation,oncogenesis promotion
ENSG00000147383,NSDHL,mevalonate accumulation,cholesterol biosynthesis,loss-of-function mutations,isoprenoid overproduction,cell proliferation promotion,steroid hormone regulation
ENSG00000052802,MSMO1,histone methylation,cell cycle progression,apoptosis resistance,therapeutic target,prognostic marker,pi3k/akt pathway interaction
ENSG00000282230,ADAM9,adam9-mediated proteolysis,e-cadherin cleavage,cell adhesion disruption,tumor progression facilitation,signaling pathway modulation,epithelial-to-mesenchymal transition enhancement
ENSG00000134775,FHOD3,fhod3 overexpression,actin cytoskeleton regulation,cell migration and invasion,constitutive activation,driver gene candidate,genetic regulation
ENSG00000107745,MICU1,mitochondrial function,cellular metabolism,calcium signaling,reactive oxygen species (ros),metabolic reprogramming,cancer prognosis
ENSG00000156026,MCU,mitochondrial calcium regulation,tumor progression,metabolic adaptation,cell growth promotion,oncogenic process,cancer cell survival
ENSG00000134030,CTIF,cellular growth regulation,genome stability modulation,dna damage response,therapeutic target potential,cell cycle progression control,gene expression regulation
ENSG00000258947,TUBB3,microtubule stability,oncogene overexpression,promoter hypomethylation,tumor aggressiveness,cell division regulation,prognostic marker
ENSG00000123999,INHA,tumor suppressor function,epithelial-to-mesenchymal transition,cell proliferation regulation,tgf-β pathway interaction,cancer progression driver,cell differentiation disruption
ENSG00000080371,RAB21,cell migration,oncogene activation,cytoplasmic localization,gtpase activity,metastasis promotion,signaling regulation
ENSG00000145692,BHMT,methionine metabolism,oncogenesis driver,cell growth regulation,dna methylation influence,tumor aggressiveness link,metabolic vulnerability target
ENSG00000101333,PLCB4,oncogenic signaling,constitutive activation,tumor progression,cell proliferation,metastasis,gene expression regulation
ENSG00000149100,EIF3M,protein synthesis regulation,tumor aggressiveness,cell growth promotion,oncogenic protein production,cell cycle regulation,metabolic regulation
ENSG00000160075,SSU72,pp1 regulation,cell cycle control,tumor suppression,chromatin remodeling,oncogenic transformation,genomic instability
ENSG00000101972,STAG2,cohesin complex disruption,chromosomal instability,genome maintenance,dna repair,tumor progression,oncogenic interaction
ENSG00000154930,ACSS1,metabolic reprogramming,histone acetylation regulation,oncogenic activity,tumor suppressor interaction,energy production modulation,epigenetic modification
ENSG00000163577,EIF5A2,cell proliferation,enhanced protein synthesis,dna repair interaction,tumor growth promotion,oncogene function,cancer cell metabolism
ENSG00000127884,ECHS1,metabolic regulation,oncogenic function,tumor progression,reactive oxygen species regulation,energy metabolism alteration,cellular survival enhancement
ENSG00000122417,ODF2L,microtubule dynamics disruption,aneuploidy induction,spindle assembly regulation,chromosomal instability promotion,cell cycle dysregulation,genomic instability maintenance
ENSG00000163209,SPRR3,cancer progression,akt signaling pathway,cell proliferation,integrin-alpha-6 interaction,e-cadherin regulation,urothelial carcinoma marker
ENSG00000147206,NXF3,nuclear rna export,oncogenic activity,cell proliferation regulation,gene expression modulation,transcriptional regulation,amplification events
ENSG00000101888,NXT2,chromatin remodeling,tumor suppressor function,dna repair dysregulation,genome stability maintenance,apoptosis resistance,cell proliferation enhancement
ENSG00000206280,ZBTB22,cell cycle regulation,chromatin remodeling,epigenetic regulation,oncogenic transcription factor,tumor suppressor loss of function,genomic instability
ENSG00000147586,MRPS28,mitochondrial translation,cellular metabolism,protein synthesis regulation,mitochondrial dynamics,energy production regulation,oncogenic processes
ENSG00000132612,VPS4A,autophagy regulation,escrt pathway modulation,oncogene function,cell signaling disruption,membrane trafficking regulation,tumor progression contribution
ENSG00000151413,NUBPL,mitochondrial metabolism,tumor suppressor function,electron transport chain,cancer cell energy,rna degradation regulation,loss of function mutations
ENSG00000102978,POLR2C,genomic instability,transcriptional dysregulation,cell cycle progression,tumor aggressiveness,prognostic marker,therapeutic target
ENSG00000156384,SFR1,genomic instability,therapeutic target,chaperoning activity,protein stability regulation,dna repair mechanism regulation,cell survival promotion
ENSG00000005075,POLR2J,transcriptional regulation,rna polymerase ii complex,tumor suppressor function,prognostic biomarker,oncogenesis,gene expression alteration
ENSG00000089169,RPH3A,autophagy regulation,rab gtpase activation,cell cycle progression,oncogenic behavior,prognostic biomarker,tumor cell survival
ENSG00000255221,CARD17,card17 mutation,apoptosis regulation,immune response modulation,innate immunity activation,tumor suppressor dysfunction,caspase recruitment domain function
ENSG00000105649,RAB3A,regulation of vesicle transport,oncogene activation,tumor progression,cell proliferation,microtubule-associated motor complex formation,metastasis promotion
ENSG00000167779,IGFBP6,tumor suppressor function,cell cycle regulation,angiogenesis inhibition,apoptosis induction,igf binding protein,cellular senescence modulation
ENSG00000142252,GEMIN7,mrna processing,cell cycle regulation,apoptosis modulation,protein interaction,tumor progression marker,poor prognosis indicator
ENSG00000206208,TAPBP,mhc class i antigen presentation,immune evasion,cell surface expression,peptide loading,apoptosis regulation,tumor progression
ENSG00000112242,E2F3,transcriptional regulation,cell cycle progression,oncogenic driver,tumor suppressor dysfunction,apoptosis inhibition,dna synthesis enhancement
ENSG00000186965,KRTAP19-2,overexpression,cell proliferation,oncogenic potential,epithelial-to-mesenchymal transition,apoptosis inhibition,genomic instability
ENSG00000179912,R3HDM2,transcriptional regulation,cellular proliferation,overexpression,protein-protein interactions,gene expression,tumor tissues
ENSG00000168101,NUDT16L1,genomic instability,nucleotide metabolism regulation,base excision repair pathway,dna damage accumulation,tumor suppressor function,therapeutic target potential
ENSG00000138604,GLCE,glycosylation disruption,tumor progression,metastasis promotion,cell proliferation enhancement,oncogenic protein modification,biomarker potential
ENSG00000113209,PCDHB5,cell-cell adhesion disruption,tumor progression enhancement,immune evasion facilitation,overexpression marker,cancer stem cell maintenance,epithelial-to-mesenchymal transition regulation
ENSG00000136267,DGKB,cellular signaling,phosphorylation activity,protein kinase activation,cell proliferation,cell survival,tumor progression
ENSG00000266967,AARSD1,tumor aggressiveness,genomic instability,transcriptional regulation,cell cycle progression,apoptosis resistance,chromatin remodeling
ENSG00000108825,PTGES3L-AARSD1,overexpression,prognostic marker,inflammation regulation,cell signaling modulation,tumor progression,immune response regulation
ENSG00000112499,SLC22A2,drug transport,chemotherapy resistance,tumor cell sensitivity,transport mechanism regulation,cancer therapy modulation,genomic instability
ENSG00000170633,RNF34,genomic stability,cell cycle regulation,ubiquitination and degradation,tumor suppressor protein regulation,dna repair pathway,protein-protein interaction
ENSG00000176087,SLC35A4,glycosylation pathway,cell growth regulation,membrane transport regulation,protein-protein interaction,cancer metastasis,therapeutic target
ENSG00000171396,KRTAP4-4,cellular adhesion,epithelial cell biology,tumor progression,oncogenic processes,prognostic marker,cytoskeleton regulation
ENSG00000105419,MEIS3,wnt/β-catenin signaling pathway,transcriptional regulation,cellular differentiation,proto-oncogene activation,tumor suppressor repression,oncogenesis
ENSG00000163125,RPRD2,replication stress response,genetic instability,oncogene activation,cell proliferation,atr/chk1 pathway activation,dna helicase function
ENSG00000158850,B4GALT3,cellular proliferation,tumor progression,cell adhesion modification,glycoprotein biosynthesis,overexpression alterations,extracellular matrix interaction
ENSG00000007237,GAS7,tumor progression,immunomodulation,inflammation suppression,cell differentiation,apoptosis modulation,cancer immunology
ENSG00000092850,TEKT2,pi3k/akt pathway interaction,genomic instability,cell proliferation promotion,tumor progression correlation,protein phosphorylation activation,oncogene co-occurrence
ENSG00000143702,CEP170,centrosome integrity,mitotic spindle formation,genomic instability,apoptosis evasion,cell proliferation,tumor suppressor function
ENSG00000129295,LRRC6,cell signaling pathway activation,oncogenic driver,tumor metastasis promotion,cancer cell migration facilitation,prognostic biomarker candidate,epigenetic regulation involvement
ENSG00000117597,UTP25,ribosome biogenesis,cellular proliferation,protein synthesis regulation,tumorigenesis driver,genomic instability,oncogenic process
ENSG00000204897,KRT25,**

type ii keratin,epithelial-to-mesenchymal transition,overexpression signature,tumor progression marker,biomarker for prognosis,cell signaling regulation

**
ENSG00000173928,SWSAP1,chromatin remodeling,cell-cell adhesion disruption,swi/snf complex component,g2/m cell cycle regulation,mutation implicated driver,adhesion molecule interaction
ENSG00000214941,ZSWIM7,genomic instability,cell cycle regulation,apoptosis suppression,tumor progression,oncogenic signaling,therapeutic target
ENSG00000113732,ATP6V0E1,ph regulation,oncogenesis,cell growth regulation,epigenetic modulation,tumor microenvironment,proton transport
ENSG00000173221,GLRX,redox regulation,therapeutic resistance,oncogenic function,protein disulfide reduction,cellular proliferation,cancer cell survival
ENSG00000166012,TAF1D,transcriptional regulation,genomic instability,cell cycle control,oncogene potential,tumor suppressor function,chromatin remodeling
ENSG00000107938,EDRF1,cdk regulation,cell cycle progression,cancer associated mutations,dna repair alterations,tumor metastasis,cell proliferation
ENSG00000173418,NAA20,mitochondrial protein processing,cell proliferation,apoptosis inhibition,chemosensitivity modulation,tumor suppressor interaction,redox regulation
ENSG00000236424,TSPY10,meiotic gene expression,cancer testis antigen,cell proliferation regulation,growth factor modulation,chromatin remodeling,germline cell differentiation
ENSG00000130844,ZNF331,zinc finger transcription factor,epithelial cell growth,cell cycle regulation,tumor aggressiveness,enhanced proliferation,gene expression regulation
ENSG00000152433,ZNF547,transcriptional regulation,zinc finger protein binding,cell growth regulation,tumor progression marker,prognostic significance,genetic regulatory mechanism
ENSG00000204178,MACO1,mitochondrial regulation,oncogenic processes,cell growth promotion,apoptosis inhibition,energy metabolism modulation,signaling pathway interaction
ENSG00000146143,PRIM2,rna degradation,cellular growth regulation,polyadenylation,epigenetic modification,cancer driver mutation,ribonuclease activity
ENSG00000198056,PRIM1,genomic instability,dna replication regulation,tumor suppressor function,cell cycle progression,genome maintenance,oncogenic potential
ENSG00000186226,LCE1E,altered expression,disrupted skin barrier function,epithelial-to-mesenchymal transition (emt),reduced cell adhesion,increased cellular proliferation,cancer biomarker
ENSG00000104853,CLPTM1,chromosomal instability,dna damage response,genetic mutation accumulation,tumor progression,transcriptional regulation inhibition,oncogene interaction
ENSG00000244025,KRTAP19-3,cell adhesion,tumor progression,oncogenesis,cell migration,epithelial integrity,stratifid squamous epithelia
ENSG00000157741,UBN2,protein quality control,genomic instability,dna repair mechanisms,cell cycle regulation,ubiquitination pathway,transcriptional regulation
ENSG00000100084,HIRA,histone regulation,chromatin remodeling,dna repair facilitation,cell proliferation enhancement,genome stability maintenance,tumor suppressor dysfunction
ENSG00000276781,CHGA,neuroendocrine differentiation,cell proliferation,poor prognosis,immunotherapy target,signaling pathway modulation,secretory protein regulation
ENSG00000050344,NFE2L3,transcription factor activity,oncogenic properties,cell survival enhancement,apoptosis regulation,antioxidant response element binding,poor prognosis indicator
ENSG00000101473,ACOT8,cellular signaling,energy production,lipid metabolism regulation,oncogenic reprogramming,therapeutic target,metabolic adaptation
ENSG00000197892,KIF13B,kif13b associated,oncogene function,microtubule dynamics regulation,cancer driver gene,genomic instability,cell cycle progression modulation
ENSG00000171224,FAM241B,dna repair defects,genomic instability,cell cycle dysregulation,protein degradation regulation,tumor suppressor interaction,oncogenic process initiation
ENSG00000165810,BTNL9,immune modulation,tumor progression,overexpression,prognosis,therapeutic target,immunoglobulin superfamily
ENSG00000154814,OXNAD1,epigenetic regulation,genome instability,cell survival enhancement,transcription factor interaction,dna repair facilitation,apoptosis inhibition
ENSG00000163171,CDC42EP3,cell cycle regulation,dual specificity phosphatase activity,pi3k/akt signaling,cytoskeletal organization,rho gtpase interaction,epithelial-to-mesenchymal transition
ENSG00000162373,BEND5,mitochondrial protein regulation,oxidative phosphorylation,tca cycle regulation,cellular metabolism modulation,cancer cell survival,therapeutic target
ENSG00000115808,STRN,tumor suppressor function loss,cell proliferation promotion,protein-protein interactions,scaffold protein activity,gene overexpression,epithelial cell transformation
ENSG00000164626,KCNK5,calcium channel regulation,cell survival,oncogenic role,potassium channel function,protein-protein interaction,tumor progression
ENSG00000080845,DLGAP4,cell adhesion disruption,tumor progression,cell migration,epithelial integrity loss,scaffolding protein function,oncogene interaction
ENSG00000003056,M6PR,tumor progression,cell surface glycoproteins regulation,cell proliferation enhancement,oncogene activation,pi3k/akt pathway interaction,metastasis facilitation
ENSG00000163029,SMC6,genomic stability,dna repair,chromatin remodeling,cancer driver gene,sister chromatid cohesion,oncogenic potential
ENSG00000007384,RHBDF1,cellular cholesterol regulation,protein-protein interactions,oncogenesis promotion,tumor progression,poor prognosis marker,metastasis facilitation
ENSG00000160218,TRAPPC10,autophagy regulation,tumor progression,cell proliferation,protein-protein interaction,vesicle-mediated transport,overexpression
ENSG00000099917,MED15,transcriptional regulation,constitutive activation,cell cycle progression,oncogenic transcription,tumor growth promotion,prognostic marker
ENSG00000117472,TSPAN1,tetraspanin family,tumor aggressiveness,epithelial-to-mesenchymal transition,cell adhesion regulation,prognostic marker,cancer progression
ENSG00000126233,SLURP1,wnt signaling pathway,tumor suppressor function,cell proliferation inhibition,cell migration regulation,apoptosis induction,genomic deletion
ENSG00000179941,BBS10,cell cycle regulation,genomic stability maintenance,tumor suppressor function,centrosome duplication regulation,chromosomal instability prevention,cilia structure and function
ENSG00000283153,FRG1,cell cycle regulation,onco-protein degradation,f-box protein function,proliferation promotion,therapeutic target,tumor progression
ENSG00000185049,NELFA,transcriptional elongation,chromatin remodeling,rna polymerase ii interaction,cell proliferation enhancement,metastasis promotion,oncogene activation
ENSG00000136630,HLX,tumor suppressor inhibition,transcriptional regulation,oncogenic signaling,cell proliferation enhancement,epigenetic modulation,chromatin remodeling
ENSG00000132434,LANCL2,apoptosis regulation,cell survival evasion,immune response modulation,inflammation regulation,autophagy involvement,chemoresistance mechanism
ENSG00000148606,POLR3A,transcriptional regulation,oncogene overexpression,genomic instability,epigenetic alterations,myc pathway activation,therapeutic target
ENSG00000032742,IFT88,cellular signaling,ciliogenesis regulation,oncogenic pathway activation,tumor progression,metabolic regulation,cell proliferation enhancement
ENSG00000138002,IFT172,disrupted cilia function,intraflagellar transport regulation,rare mutations,oncogenic mechanism uncertainty,cilia assembly maintenance,protein-protein interaction
ENSG00000163320,CGGBP1,genomic instability,dna repair mechanism,tumor suppressor function,oncogenic driver,homologous recombination,cell cycle regulation
ENSG00000160194,NDUFV3,energy metabolism dysfunction,mitochondrial dysfunction,cell signaling pathway alteration,tumor progression,ros production increase,biomarker candidate
ENSG00000150347,ARID5B,aberrant gene expression,chromatin remodeling disruption,genomic instability,increased tumor aggressiveness,loss of function mutations,tumor progression
ENSG00000164024,METAP1,protein processing,dysregulation,cell migration,angiogenesis,poor prognosis,tumor progression
ENSG00000237155,IER3,cell cycle progression,immune evasion,apoptosis regulation,tumor growth regulation,interferon-dependent responses,prognostic biomarker
ENSG00000187010,RHD,cell invasion,angiogenesis,cytoplasmic localization,cytoskeleton regulation,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000125148,MT2A,mitochondrial copper transport,oxidative stress regulation,cancer progression,tumor resistance,ros modulation,signaling pathway activation
ENSG00000284967,FDFT1,farnesyl pyrophosphate biosynthesis,protein prenylation,oncogenic pathway activation,cell proliferation enhancement,therapeutic target potential,cellular signaling modulation
ENSG00000078808,SDF4,tumor progression,cell migration,prognostic marker,metastasis promotion,cell proliferation,chemotaxis regulation
ENSG00000167791,CABP2,gene regulation,dysregulated transcription,cell proliferation,tumor progression,transcriptional coactivation,calcium signaling
ENSG00000167674,HDGFL2,pi3k/akt pathway,oncogenic overexpression,dna repair disruption,cell cycle checkpoint modulation,constitutive activation,chromatin remodeling
ENSG00000109118,PHF12,tumor suppressor function,genome stability regulation,histone modifications,dna repair mechanisms,cell cycle regulation,epigenetic regulation
ENSG00000135127,BICDL1,apoptosis inhibition,dna damage response,cell survival,oncogenic process,tumorigenesis,genotoxic stress
ENSG00000156738,MS4A1,b-cell receptor signaling,cell proliferation,cancer immunotherapy,immunomodulation,tumor progression,oncogenesis
ENSG00000144057,ST6GAL2,cell surface modification,core 2-based o-glycans,glycosyltransferase activity,interaction with pi3k/akt pathway,oncogenic role in tumor progression,therapeutic target for cancer treatment
ENSG00000168778,TCTN2,wnt/pcp signaling,pcd pathway dysregulation,cell migration regulation,oncogenic function,tumor progression driver,signaling pathway interaction
ENSG00000065665,SEC61A2,cellular proliferation,protein trafficking regulation,er membrane translocon function,signal sequence recognition,oncogenic contribution,metastasis promotion
ENSG00000168724,DNAJC21,er-mitochondrial interactions,unfolded protein response,cellular stress response,oncogenic mutations,chaperone function,er stress regulation
ENSG00000118420,UBE3D,ubiquitination process,cell cycle regulation,protein degradation pathway,oncogenic potential,tumor progression,cancer prognosis
ENSG00000281191,KRTAP5-3,keratin assembly,cell migration,tumor invasion,microenvironmental interaction,cytoskeletal regulation,protein-protein interaction
ENSG00000166669,ATF7IP2,oncogenic function,cell proliferation regulation,transcriptional modulation,prognostic marker,dna damage response,signaling pathway regulation
ENSG00000160606,TLCD1,telomere maintenance,dna repair pathways,transcriptional regulation,cell cycle progression,apoptosis inhibition,genomic instability
ENSG00000090372,STRN4,cancer progression,cell migration,epithelial-to-mesenchymal transition,protein overexpression,cell proliferation,disrupted adhesion complexes
ENSG00000182628,SKA2,chromosome instability,genomic instability,microtubule dynamics regulation,oncogene overexpression,spindle checkpoint complex interaction,tumor progression drive
ENSG00000239857,GET4,ubiquitination regulation,protein degradation pathway,cell cycle control,transcriptional regulation,stress response modulation,cancer cell proliferation
ENSG00000205155,PSENEN,notch signaling activation,loss-of-function mutations,tumor progression,cell cycle regulation,cell survival,gamma-secretase interaction
ENSG00000161217,PCYT1A,lipid metabolism,promotes tumor growth,prognostic biomarker,constitutive activation,oncogenic lipid synthesis,cell proliferation modulation
ENSG00000128829,EIF2AK4,mtor pathway regulation,tumor suppressor function,cellular translation regulation,protein kinase activation,cancer-related mutation,genetic variation impact
ENSG00000156284,CLDN8,tumor progression,epithelial-to-mesenchymal transition,apoptosis regulation,cell migration and invasion,protein interaction with cytoskeleton,paracellular transport regulation
,PQLC2,mitochondrial regulation,cell cycle progression,tumor aggressiveness,oncogenic driver,prognostic marker,cancer cell metabolism
ENSG00000041802,LSG1,amplification,acetyltransferase activity,chromatin remodeling,histone modification,cell proliferation,tumor growth
ENSG00000128534,LSM8,genomic instability,rna processing regulation,oncogenic transformation,gene expression alterations,prognostic marker,tumor suppressor function
,MARCH5,oncogenic processes,ubiquitination activity,e3 ligase function,protein stability regulation,cell surface receptor modulation,tumor suppressor protein regulation
ENSG00000142546,NOSIP,genomic instability,angiogenesis promotion,apoptosis inhibition,cell proliferation enhancement,signaling pathway modulation,enzyme regulation interaction
ENSG00000099625,CBARP,**

apoptosis modulation,cell cycle progression,dna repair,p53 regulation,protein interaction,tumor progression 

**
ENSG00000102312,PORCN,wnt/β-catenin pathway,constitutive activation,oncogenic mutations,cell proliferation,therapeutic target,prognostic marker
ENSG00000187391,MAGI2,cell-cell adhesion disruption,tumor suppressor function,genomic instability,cytoskeletal remodeling,signal transduction modulation,prognostic marker
ENSG00000085662,AKR1B1,aldehyde reduction,cell proliferation,tumor aggressiveness,redox balance,metabolic adaptation,oncogenic process
ENSG00000143369,ECM1,cell adhesion regulation,epithelial-mesenchymal transition,metastatic potential,tumor progression,cancer cell migration,gene expression dysregulation
ENSG00000101193,GID8,genome stability maintenance,cell growth regulation,protein degradation regulation,oncogenic transformation,genomic alteration prevention,tumor suppressor function
ENSG00000178982,EIF3K,mtor pathway regulation,protein synthesis modulation,cell proliferation promotion,apoptosis inhibition,oncogenic driver,cancer cell growth
ENSG00000177479,ARIH2,cellular regulation,dysregulated expression,e3 ligase interaction,ubiquitin-proteasome pathway modulation,tumor progression,apoptosis evasion
ENSG00000183230,CTNNA3,wnt/β-catenin signaling,disrupted cell junctions,epithelial-to-mesenchymal transition,cell adhesion regulation,protein-protein interaction,tumor progression
ENSG00000102781,KATNAL1,tumor suppressor function,cell migration regulation,microtubule stability modulation,cytoplasmic protein interaction,cancer cell invasion facilitation,genomic instability contribution
ENSG00000115423,DNAH6,ciliary dysfunction,dynein regulation,oncogenic signaling,tumor suppressor role,cell division disruption,genomic instability
ENSG00000165410,CFL2,cell migration,actin cytoskeleton dynamics,apoptosis regulation,prognostic biomarker,cancer progression,rho gtpase interaction
ENSG00000109511,ANXA10,epithelial-to-mesenchymal transition (emt),overexpression,cell migration,apoptosis resistance,tumor progression,therapeutic target
ENSG00000128833,MYO5C,genomic instability,aneuploidy,motor protein function,chromosomal segregation,cell division regulation,tumor suppressor inactivation
ENSG00000104722,NEFM,intermediate filament stability,axonal transport regulation,cell proliferation promotion,apoptosis modulation,chromatin remodeling,biomarker potential
ENSG00000178750,STX19,regulation of exocytosis,promotion of cell migration,drug resistance,oncogenic process,epithelial-to-mesenchymal transition (emt),snare complex interaction
ENSG00000111732,AICDA,genomic instability,somatic hypermutation,dna damage response,oncogenic driver,tumor progression,cancer cell survival
ENSG00000173334,TRIB1,tumor progression,cell proliferation inhibition,apoptosis suppression,metastasis promotion,transcriptional regulation,signaling pathway interaction
ENSG00000145107,TM4SF19,tumor progression,metastasis,cell adhesion disruption,prognostic marker,signaling pathway modulation,proliferation promotion
ENSG00000141562,NARF,p53 inhibition,cell proliferation,apoptosis resistance,dna damage response regulation,transcriptional activation modulation,cancer progression facilitation
ENSG00000106483,SFRP4,wnt/β-catenin pathway inhibition,tumor suppressor function,cell proliferation regulation,aberrant activation,oncogenic mutation,genetic loss
ENSG00000160200,CBS,cellular metabolism,cysteine synthesis,genetic instability,mitochondrial function,radical scavenging,chemoresistance
ENSG00000163618,CADPS,calcium signaling pathway,calcium channel regulation,cell proliferation enhancement,tumor aggression enhancement,genetic mutation association,protein-protein interaction
ENSG00000051341,POLQ,genomic instability,dna repair dysregulation,tumor suppressor gene inactivation,homologous recombination disruption,brca interaction impairment,mutational signature alteration
ENSG00000143105,KCNA10,kcna10 overexpression,constitutive activation,ion channel regulation,oncogenic processes,cellular excitability modulation,therapeutic target
ENSG00000110104,CCDC86,pi3k/akt pathway regulation,genomic instability driver,cellular proliferation enhancement,oncogenic properties exhibited,signaling pathway modulation,epigenetic alterations associated
ENSG00000141985,SH3GL1,mtor pathway regulation,adaptor protein function,protein degradation regulation,cell growth promotion,cellular transformation enhancement,tumor suppressor gene disruption
ENSG00000166233,ARIH1,cell cycle regulation,protein degradation,oncogenic processes,cell proliferation,dna damage response,tumor progression
ENSG00000112077,RHAG,cancer stem cell maintenance,cell migration regulation,cell surface protein expression,gene amplification,genomic instability,tumor aggressiveness
ENSG00000101160,CTSZ,tgf-β signaling pathway,latent tgf-β processing,cell proliferation,aggressive disease behavior,poor prognosis,cancer cell survival
ENSG00000150672,DLG2,cell adhesion regulation,egfr interaction,pi3k/akt signaling modulation,tumor progression promoter,oncogenic process enhancement,therapeutic target potential
ENSG00000089127,OAS1,antiviral response,immune modulation,oncogenic mutations,tumor suppressor,gene expression regulation,enzyme catalysis
ENSG00000162975,KCNF1,potassium channel regulation,wnt/β-catenin pathway modulation,tumor suppressor or oncogene role,cell proliferation control,signaling pathway interaction,membrane potential regulation
ENSG00000170515,PA2G4,wnt/β-catenin pathway regulation,epithelial integrity disruption,overexpression in cancer tissues,metastasis promotion,therapeutic target potential,cell adhesion regulation
ENSG00000113384,GOLPH3,oncogene activation,pi3k/akt/mtor pathway interaction,growth promotion,autophagy regulation,endocytosis modulation,tumor progression marker
ENSG00000181409,AATK,apoptosis induction,dna repair regulation,oncogenic signaling pathway,tumor suppressor function,cell cycle modulation,cancer prognosis biomarker
ENSG00000108759,KRT32,cellular adhesion,epithelial integrity,tumor progression,disrupted polarity,cancer-associated protein,adhesion molecule function
ENSG00000099256,PRTFDC1,cell proliferation,tumor progression,genomic instability,dna damage response,cell cycle regulation,nuclear localization
ENSG00000142178,SIK1,regulation of cell growth,phosphorylation activity,cell proliferation enhancement,oncogenic processes modulation,signaling pathway interaction,therapeutic target potential
ENSG00000130347,RTN4IP1,cellular adhesion,metastasis promotion,epithelial-to-mesenchymal transition (emt),protein-protein interaction,receptor tyrosine kinase signaling,oncogenic transformation
ENSG00000118785,SPP1,epithelial-to-mesenchymal transition,cell migration,oncofetal antigen,angiogenesis regulator,tumor progression factor,immunomodulation
ENSG00000124942,AHNAK,association with e-cadherin complex,oncogenic activity,ion channel regulation,cell adhesion disruption,pi3k/akt pathway modulation,scaffolding protein function
ENSG00000153551,CMTM7,cell cycle regulation,apoptosis inhibition,tumor suppressor function,protein-protein interaction,cytoskeleton organization,metastasis regulation
ENSG00000171928,TVP23B,centrosome integrity,microtubule dynamics,aneuploidy induction,genomic instability,tumor progression factor,dna damage response
ENSG00000164292,RHOBTB3,cell cycle regulation,tumor suppressor function,pi3k/akt pathway modulation,apoptosis regulation,cytoskeleton organization,prognostic marker
ENSG00000133121,STARD13,wnt/β-catenin signaling pathway,overexpression,cell proliferation,tumor metastasis,epithelial-to-mesenchymal transition,oncogenesis
ENSG00000115963,RND3,cell polarity disruption,tumor suppressor function,mitotic spindle regulation,cytoskeletal disorganization,apoptosis resistance,genomic instability
ENSG00000198939,ZFP2,oncogene,transcription factor activity,cell proliferation regulation,apoptosis inhibition,metastasis promotion,gene expression regulation
ENSG00000125755,SYMPK,cell proliferation,dna damage response,phosphorylation activity,oncogenic driver,signaling pathway activation,genomic instability
ENSG00000151414,NEK7,cell cycle regulation,genomic instability,dna damage response,atr/chk1 activation,breast cancer (brca2) interaction,scaffold protein function
,H2BFS,histone modification,chromatin remodeling,cell cycle regulation,dna replication repair,transcriptional regulation,nucleosome assembly
ENSG00000130818,ZNF426,dna binding activity,cell proliferation regulation,apoptosis inhibition,tumor progression,oncogene overexpression,zinc finger domain function
ENSG00000075239,ACAT1,lipid metabolism activation,oncogenesis promotion,pi3k/akt pathway activation,cell proliferation enhancement,chemoresistance induction,biomarker expression
ENSG00000186187,ZNRF1,wnt signaling regulation,tumor suppressor function,loss-of-function mutations,cell proliferation enhancement,β-catenin activation,oncogenic pathway activation
ENSG00000161911,TREML1,immune evasion,tumor progression,poor prognosis,nk/t-cell modulation,cancer immunotherapy,cell adhesion and migration
ENSG00000176101,SSNA1,phosphorylation regulation,cell surface modulation,protein trafficking disruption,pi3k/akt pathway interaction,oncogenic behavior promotion,cell proliferation enhancement
ENSG00000243335,KCTD7,wnt/β-catenin signaling,transcriptional regulation,cell cycle progression,dna repair inhibition,tumor suppressor function,biological pathway modulation
ENSG00000072849,DERL2,erad pathway regulation,oncoprotein stabilization,cell proliferation,apoptosis evasion,metastasis facilitation,poor prognosis marker
ENSG00000204511,MCCD1,chromatin remodeling complex,genome instability,aberrant gene expression,cell growth regulation,oncogenic mutations,dna repair mechanisms
ENSG00000120729,MYOT,tumor growth promoter,metastasis regulator,emt inducer,cell migration modulator,prognostic marker candidate,muscle transcription factor
ENSG00000107099,DOCK8,guanine nucleotide exchange factor,rho gtpase activation,cytoskeleton reorganization,cell migration promotion,e epithelial-to-mesenchymal transition (emt),oncogenic signaling pathway regulation
ENSG00000163879,DNALI1,cell migration,metastasis promotion,oncogene function,tumor progression,prognostic marker,microtubule regulation
ENSG00000205076,LGALS7,immune modulation,apoptosis regulation,tumor microenvironment modulation,cell cycle control,dna repair mechanisms,glycoprotein interaction
ENSG00000282902,LGALS7B,cell adhesion disruption,apoptosis suppression,angiogenesis promotion,tumor progression,metastasis facilitation,prognostic marker
ENSG00000170577,SIX2,transcription factor activity,epithelial-to-mesenchymal transition,cell proliferation enhancement,genetic amplification/mutation,prognostic marker,tumor aggressiveness promoter
ENSG00000181754,AMIGO1,tumor progression,angiogenesis,cell adhesion disruption,metastasis promotion,therapeutic target,oncogenic processes
ENSG00000105486,LIG1,nhej pathway,genomic instability,dna repair dysregulation,tumor progression,therapeutic target,genomic profiling
ENSG00000165802,NSMF,nf-κb regulation,inflammation pathway,cell migration,angiogenesis promotion,immune evasion,signal transduction mediator
ENSG00000102710,SUPT20H,**
histone modification,chromatin remodeling,cell cycle regulation,dna repair mechanisms,tumor suppressor,genomic instability 
**
ENSG00000183668,PSG9,androgen receptor modulation,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),biomarker potential,protein-protein interaction,gene expression dysregulation
ENSG00000165943,MOAP1,immune modulation,apoptosis regulation,cell death pathway,tumor suppression,cancer immunotherapy,genomic instability
ENSG00000147872,PLIN2,lipid metabolism regulation,tumor progression,oncogenesis,adipocyte differentiation,metabolic reprogramming,pi3k/akt pathway activation
ENSG00000256061,DNAAF4,ciliary assembly,dysregulated gene expression,tumor suppressor function,cellular homeostasis disruption,oncogenic processes promotion,genomic instability induction
ENSG00000128699,ORMDL1,er stress response,oncogene activity,lipid biosynthesis regulation,cellular metabolism modulation,tumor progression promotion,genetic mutation impact
ENSG00000117152,RGS4,gpcr regulation,tumor suppressor function,cell proliferation inhibition,signaling pathway modulation,g-protein gtp hydrolysis acceleration,oncogenic process inhibition
ENSG00000133019,CHRM3,signaling pathway regulation,receptor activation,cell proliferation,g protein activation,phospholipase c activation,protein kinase modulation
ENSG00000186834,HEXIM1,transcriptional regulation,apoptosis modulation,tumor suppressor function,gene expression changes,rna polymerase ii interaction,cell cycle progression inhibition
ENSG00000196101,HLA-DRB3,immune evasion,tumor antigen presentation,antigen processing,mhc class ii expression,immunosuppression,genetic susceptibility
ENSG00000132514,CLEC10A,immune modulation,cell adhesion molecule regulation,tumor progression,metastasis,cancer cell invasion,biomarker potential
ENSG00000121680,PEX16,peroxisomal biogenesis,lipid metabolism regulation,cellular detoxification,organelle dysfunction,tumor progression correlation,prognostic marker potential
ENSG00000198189,HSD17B11,steroid hormone biosynthesis,tumor suppressor function,genomic instability,cell proliferation,progesterone regulation,pregnolone conversion
ENSG00000188001,TPRG1,trpg1 overexpression,cell proliferation enhancement,tumor suppressor degradation,oncogenesis promotion,pi3k/akt pathway interaction,wnt/β-catenin pathway interaction
ENSG00000173908,KRT28,cytoskeletal disruption,oncogenic potential,cellular differentiation,tumor progression,mechanical stress response,aberrant expression
ENSG00000163071,SPATA18,centrosome stability,chromosomal instability,aneuploidy driver,genomic alterations,oncogenic mutations,microtubule stabilization
ENSG00000163840,DTX3L,cellular proliferation,epigenetic regulation,oncogenic processes,protein interaction,transcriptional modulation,metabolic adaptation
ENSG00000008441,NFIX,genomic instability,transcriptional regulation,oncogenic potential,cell proliferation,aberrant gene expression,developmental differentiation
ENSG00000176108,CHMP6,escrt-iii complex regulation,growth promotion,cell division regulation,proliferation enhancement,survival pathway activation,multivesicular body formation
ENSG00000175206,NPPA,tumor suppression,cellular signaling,apoptosis induction,proliferation inhibition,hormone regulation,cardiovascular homeostasis
ENSG00000159348,CYB5R1,mitochondrial function,metabolic enzyme regulation,redox reaction modulation,cancer cell growth promotion,tumor progression facilitation,oncogenic biomarker potential
ENSG00000106355,LSM5,spliceosome regulation,overexpression,oncogene function,cellular proliferation,genomic instability,chromatin modification
ENSG00000119185,ITGB1BP1,epithelial-to-mesenchymal transition,cell adhesion regulation,integrin-binding interactions,oncogenic driver gene,therapeutic target,tumor aggressiveness
ENSG00000198393,ZNF26,oncogenesis,chromatin remodeling,cell cycle regulation,apoptosis inhibition,transcriptional modulation,epithelial-to-mesenchymal transition
ENSG00000135093,USP30,cellular signaling,deubiquitinating activity,protein degradation,apoptosis inhibition,dna repair modulation,cell survival pathway modulation
ENSG00000178150,ZNF114,tumor suppressor,krab domain-containing zinc finger protein family,transcriptional regulation,cell cycle progression,apoptosis regulation,bladder urothelial carcinoma prognostic biomarker
ENSG00000137285,TUBB2B,mitotic spindle regulation,genomic instability,aneuploidy,chromosome segregation disruption,tumor suppressor function,microtubule dynamics modulation
ENSG00000257335,MGAM,glycolysis alteration,energy metabolism change,rapid cell proliferation,glucose uptake facilitation,tumor progression support,dysregulated expression
ENSG00000129534,MIS18BP1,chromatin remodeling,histone modification,cell cycle regulation,nucleosome assembly,epigenetic alteration,genomic instability
ENSG00000164070,HSPA4L,protein degradation,cell survival enhancement,pi3k/akt pathway interaction,tumor progression facilitation,oncogenesis promotion,poor prognosis association
ENSG00000185105,MYADML2,transcriptional regulation,chromatin remodeling,cell growth modulation,gene expression regulation,cellular stress response,potential oncogene
ENSG00000151332,MBIP,cell cycle regulation,protein-protein interactions,cell proliferation,survival pathways,tumor progression,dysregulation mutations
ENSG00000213782,DDX47,transcriptional regulation,cell cycle modulation,rna helicase activity,tumor suppressor protein interaction,proliferation enhancement,survival pathway activation
ENSG00000152061,RABGAP1L,rab gtpase activation,tumor suppressor activity,cellular trafficking regulation,cell growth modulation,protein-protein interaction,oncogene/tumor suppressor status
ENSG00000164985,PSIP1,chromatin remodeling,transcriptional activation,cell proliferation,oncogenic processes,epigenetic regulation,protein-protein interactions
ENSG00000186222,BLOC1S4,lysosome-related organelles,autophagy regulation,endocytosis modulation,protein sorting dysfunction,cellular metabolism alteration,potential oncogene
ENSG00000132554,RGS22,g-protein coupled receptor signaling pathway regulation,cell proliferation regulation,tumor suppressor function,signal transduction modulation,oncogenic potential,g protein interaction
ENSG00000187634,SAMD11,dna damage response,cell growth regulation,chromatin remodeling,epithelial-to-mesenchymal transition,sterile alpha motif domain,transcriptional regulation
ENSG00000181004,BBS12,cellular trafficking alterations,tumor suppressor activity,ciliogenesis dysregulation,gain of function mutations,cell cycle disruption,metabolic pathway alterations
ENSG00000217442,SYCE3,dna repair disruption,genomic instability,cell cycle deregulation,cell proliferation,oncogenic function,prognostic marker
ENSG00000197084,LCE1C,cell adhesion regulation,alterations in gene expression,differential expression,tumor microenvironment,genomic alterations,cellular differentiation
ENSG00000123353,ORMDL2,lipid biosynthesis regulation,er stress response modulation,cell proliferation promotion,survival pathway activation,therapeutic target identification,tumor progression enhancement
ENSG00000147439,BIN3,baf complex subunit,chromatin remodeling,oncogenic driver,constitutive activation,genetic overexpression,histone modification
ENSG00000124383,MPHOSPH10,autophagy regulation,cell growth and survival,tumor progression,pi3k/akt pathway modulation,protein interaction,endosomal sorting
ENSG00000182054,IDH2,metabolic disruption,gain of function mutations,tumor suppressor dysfunction,redox imbalance,epigenetic regulation,therapeutic target
ENSG00000101489,CELF4,cell survival,pro-survival gene expression,metastasis regulation,apoptosis inhibition,oncogene activation,genetic instability
ENSG00000134627,PIWIL4,epigenetic regulation,germ cell development,tumor stemness,self-renewal properties,oncogene activation,poor prognosis
ENSG00000105993,DNAJB6,tumor progression,tissue-specific regulation,cancer cell survival,aberrant protein folding,protein quality control disruption,gain-of-function mutations
ENSG00000174132,FAM174A,cell cycle regulation,dysregulation of apoptosis,cell proliferation regulation,tumor progression,potential therapeutic target,apoptosis modulation
ENSG00000012822,CALCOCO1,er stress response,calcium homeostasis disruption,autophagy regulation,tumor promotion,cell survival enhancement,apoptosis modulation
ENSG00000135090,TAOK3,apoptosis regulation,cell cycle progression,dna damage response,oncogenic pathway activation,tumor aggressiveness,therapeutic target
ENSG00000184650,ODF4,microtubule stabilization,cell division regulation,pi3k/akt pathway modulation,tumor progression,poor prognosis marker,cell signaling disruption
ENSG00000169223,LMAN2,er protein quality control,cellular trafficking regulation,tumor suppressor degradation,hypoxia adaptation,signaling pathway modulation,protein aggregation prevention
ENSG00000187238,LCE3B,epidermal differentiation,cell proliferation,apoptosis modulation,invasion enhancement,tumor aggressiveness,pi3k/akt pathway activation
ENSG00000160472,TMEM190,cellular growth regulation,gene expression modulation,genomic instability prevention,kinase interaction,oncogene activation,protein-protein interactions
ENSG00000115540,MOB4,erk activation,cell proliferation,mapk/erk signaling pathway,oncogenic driver,therapeutic target,protein-protein interaction
ENSG00000120907,ADRA1A,regulation of cell growth,tumor progression,g protein-coupled receptor,smooth muscle contraction,overexpression in cancer tissues,therapeutic target
ENSG00000125875,TBC1D20,genetic instability,tumor suppressor function,cell cycle regulation,pi3k/akt pathway modulation,protein-protein interactions,oncogenic potential
ENSG00000105613,MAST1,oncogene activation,cell proliferation,gene expression regulation,chromatin modification,tumor aggressiveness,signaling pathway activation
ENSG00000004455,AK2,adenosine regulation,tumor progression,protein interaction,cell proliferation,metastasis regulation,oncogenic function
ENSG00000134588,USP26,**

genomic instability,cell cycle regulation,protein degradation,oncogenic processes,therapeutic target,cancer development 

**
ENSG00000198000,NOL8,cellular proliferation,oncogene,ribosome biogenesis,nuclear protein localization,tumor progression,biomarker potential
ENSG00000121742,GJB6,gap junction disruption,tumor suppressor function,cellular communication disruption,oncogenic processes promotion,poor prognosis association,therapeutic target potential
ENSG00000113441,LNPEP,cell signaling regulation,tumor progression,protein degradation regulation,cancer biomarker,therapeutic target,oncogenic process
ENSG00000163947,ARHGEF3,cell migration,oncogenic driver,rho gtpase activation,cell proliferation,signaling pathway regulation,tumor progression
ENSG00000196715,VKORC1L1,calcium homeostasis regulation,protein carboxylation,indirect implication in cell growth,general protein modification,less studied in cancer context,minimal therapeutic target
ENSG00000116771,AGMAT,cellular proliferation,polyamine biosynthesis,oncogenic driver,tumor progression,protein interaction,signaling pathway modulation
ENSG00000154237,LRRK1,autophagy regulation,cellular proliferation,genetic mutations,mitochondrial dynamics,oncogenic role,protein kinase activation
ENSG00000139350,NEDD1,centrosomal regulation,genomic instability,microtubule assembly,oncogenic protein-protein interaction,tumor progression marker,therapeutic target
ENSG00000187569,DPPA3,transcription factor regulation,oncogenic function,epithelial-to-mesenchymal transition (emt),genomic instability,apoptosis suppression,tumor suppressor gene repression
ENSG00000164972,C9orf24,cellular proliferation,constitutive akt activation,epithelial-to-mesenchymal transition (emt),gene amplification,oncogene upregulation,tumor suppressor inhibition
ENSG00000010219,DYRK4,tyrosine phosphorylation,cell proliferation,tumor progression,dysregulation,kinase activity,signaling pathway
ENSG00000240386,LCE1F,oncogenic expression,cell proliferation enhancement,apoptosis inhibition,signaling pathway regulation,tumor growth promotion,genomic overexpression
ENSG00000187223,LCE2D,lipid metabolism alteration,oncogenic potential,cell membrane composition disruption,upregulation in cancer,tumor progression facilitation,cancer cell proliferation enhancement
ENSG00000171311,EXOSC1,altered rna processing,tumor progression,therapeutic target,dna damage repair,cellular stress response,cancer driver gene
ENSG00000275513,KIR3DL3,immune regulation,tumor immune evasion,nk cell activation,tumor progression,gene expression modulation,immune surveillance failure
ENSG00000160888,IER2,cell cycle regulation,transcriptional repressor function,growth factor signaling,dna damage response,oncogene activation,genomic instability
ENSG00000154832,CXXC1,chromatin remodeling,oncogenic mutations,epigenetic regulation,cell cycle dysregulation,wnt/β-catenin pathway interaction,tumor progression marker
ENSG00000146147,MLIP,mitochondrial regulation,cellular metabolism,apoptosis evasion,energy production modulation,glycolytic shift promotion,oncogenic potential
ENSG00000077063,CTTNBP2,cortactin binding,cell migration,actin cytoskeleton dynamics,oncogenic properties,focal adhesions regulation,tumor progression
ENSG00000138669,PRKG2,cell cycle regulation,signaling pathway activation,oncogenic transformation,therapeutic target,protein kinase activity,cell proliferation
ENSG00000167618,LAIR2,immune modulation,tumor progression,cell adhesion,prognostic marker,immune microenvironment,integrin interaction
ENSG00000138080,EMILIN1,tumor suppressor,epithelial-to-mesenchymal transition regulation,extracellular matrix component interaction,cell migration inhibition,collegen iv binding,laminin interaction disruption
ENSG00000115446,UNC50,pi3k/akt pathway modulation,scaffold protein function,constitutive activation,pro-survival signaling enhancement,cell cycle regulation,protein-protein interactions
ENSG00000109519,GRPEL1,mitochondrial import,unfolded protein response,cell survival regulation,stress response modulation,chemoresistance induction,biomarker expression
ENSG00000092200,RPGRIP1,genomic instability,cell cycle regulation,dna repair mechanisms,chromosomal abnormalities,tumor progression,protein-protein interactions
ENSG00000107831,FGF8,cell proliferation,fgf/fgfr signaling,epithelial-to-mesenchymal transition,tumor progression,angiogenesis,oncogenic pathway
ENSG00000138036,DYNC2LI1,microtubule stabilization,tumor invasion,cell migration regulation,poor prognosis marker,protein-protein interaction,cellular integrity regulation
ENSG00000132010,ZNF20,cell cycle regulation,transcriptional regulation,zinc finger protein,dna binding,oncogenic potential,apoptosis modulation
ENSG00000172748,ZNF596,gene amplification,transcriptional regulation,cell proliferation,apoptosis inhibition,chromatin modification,protein-protein interaction
ENSG00000179833,SERTAD2,epigenetic regulation,chromatin remodeling,transcriptional regulation,cell proliferation,survival signaling,poor prognosis marker
ENSG00000010322,NISCH,cell adhesion disruption,tumor progression,cancer cell invasion,protein-protein interactions,cell migration regulation,dna repair modulation
ENSG00000123595,RAB9A,late endosome trafficking,protein recycling,oncogenic properties,endosomal recycling,gtpase activity,cell survival
ENSG00000101901,ALG13,altered glycosylation patterns,cell surface receptor modulation,tumor growth regulation,glycoprotein assembly,dysregulation of gene expression,cancer cell behavior alteration
ENSG00000121454,LHX4,oncogenic transcription factor,cell growth regulation,dna repair modulation,tumor aggressiveness marker,cell cycle progression regulator,pro-survival pathway activator
ENSG00000161981,SNRNP25,spliceosome dysfunction,aberrant splicing,genomic instability,cell growth regulation,tumor invasion,pre-mrna processing
ENSG00000149503,INCENP,genomic instability,tumor progression,dna damage response,cell cycle regulation,centromere function,aneuploidy
ENSG00000164256,PRDM9,genomic instability,meiotic recombination regulation,transcriptional regulation,genome rearrangement,epigenetic modification,cancer susceptibility
ENSG00000168679,SLC16A4,tumor progression,metabolic reprogramming,energy source for tumor cells,lactate export,dysregulation,tumor aggressiveness
ENSG00000165633,VSTM4,tumor progression,apoptosis resistance,angiogenesis promotion,tnf superfamily member,oncogenic overexpression,nf-κb pathway interaction
ENSG00000162702,ZNF281,tumor progression,metastasis driver,cell proliferation enhancement,krab domain interaction,transcriptional regulation alteration,gene silencing disruption
ENSG00000111452,ADGRD1,metastatic progression,cell migration,signaling pathway regulation,tumor aggressiveness,prognostic marker,epithelial-to-mesenchymal transition (emt)
ENSG00000243279,PRAF2,oncogene activation,cell proliferation,protein kinase activation,signaling pathway modulation,transcriptional regulation,tumor progression
ENSG00000244411,KRTAP5-7,type ii keratin-associated protein,cell adhesion disruption,oncogenic signaling pathway activation,tumorigenesis contributor,epithelial cell differentiation regulator,aberrant expression in cancer
ENSG00000185900,POMK,oncogenic potential,cell growth regulation,protein modification,tumorigenesis promotion,apoptosis inhibition,cell cycle progression
,FGFR1OP,fgfr signaling pathway,cell proliferation regulation,genomic alterations,tumor suppressor,oncogenic potential,cell cycle control
ENSG00000198937,CCDC167,microtubule regulation,tumor aggressiveness,emt induction,cell proliferation driver,genomic instability mediator,cytoskeleton remodeling
ENSG00000267467,APOC4,lipid metabolism regulation,cell growth promotion,tumor growth enhancement,warburg effect modulation,therapeutic target identification,prognostic marker significance
ENSG00000106588,PSMA2,proteasome regulation,tumor suppressor degradation,cell proliferation,cancer progression,therapeutic target,protein degradation
ENSG00000276358,PLEKHM1,regulation of endosomal trafficking,autophagy regulation,biomarker potential,overexpression,cell membrane integrity,escrt interaction
ENSG00000033627,ATP6V0A1,oncogenic function,cell proliferation,metabolic regulation,prognostic marker,therapeutic target,genomic alterations
ENSG00000085415,SEH1L,ribosome biogenesis,oncogene overexpression,cellular proliferation,protein synthesis regulation,tumor growth promotion,therapeutic target potential
ENSG00000166123,GPT2,glutathione metabolism pathway,cellular redox balance,oncogene overexpression,tumor cell proliferation,dna damage repair mechanisms,cell survival pathways
ENSG00000138495,COX17,metabolic reprogramming,mitochondrial homeostasis,tumorigenesis driver,cellular proliferation,biomarker candidate,therapeutic target
ENSG00000148384,INPP5E,pi3k/akt pathway regulation,oncogenic signaling,cell growth modulation,tumorigenesis contribution,phosphatidylinositol regulation,cancer progression facilitation
ENSG00000116514,RNF19B,ubiquitin ligase activity,protein modification,cell cycle regulation,oncogene amplification,tumor aggressiveness,genomic instability
ENSG00000136319,TTC5,protein degradation regulation,tumor suppressor inhibition,p53 interaction,cell cycle progression,binding activity,stability modification
ENSG00000132436,FIGNL1,mitotic spindle regulation,chromosome segregation,cell cycle progression,protein-protein interactions,tumor growth promotion,apoptosis inhibition
ENSG00000102890,ELMO3,**
actin cytoskeleton regulation,cell migration,metastasis promotion,oncogenic signaling interaction,pi3k/akt pathway activation,prognostic biomarker
ENSG00000182585,EPGN,egfr pathway,oncogene,tumor progression,metastasis,cell proliferation,survival signals
ENSG00000187272,KRTAP9-8,tumor cell adhesion disruption,cell migration enhancement,apoptosis regulation,cell cycle progression modulation,protein interaction,genomic instability
ENSG00000213741,RPS29,ribosome biogenesis,overexpression,cell growth promotion,protein synthesis enhancement,tumor progression contribution,oncogene potentialisation
ENSG00000188895,MSL1,chromatin regulation,transcriptional activation,oncogenic processes,genomic instability,protein interaction,tumor suppressor gene suppression
ENSG00000180616,SSTR2,somatostatin signaling,oncogenic driver,tumor progression,cell proliferation,angiogenesis inhibition,mapk/erk activation
ENSG00000235169,SMIM1,mitochondrial dynamics,calcium homeostasis regulation,cellular metabolism modulation,tumor progression involvement,metabolic reprogramming driver,mitochondrial function disruption
ENSG00000181016,LSMEM1,chromosomal instability,oncogene activation,cell proliferation regulation,protein-protein interaction,rna processing modulation,biomarker for disease progression
ENSG00000008283,CYB561,iron regulation,transmembrane protein,cellular signaling,cell growth modulation,oxidative stress response,metabolic regulation
ENSG00000161980,POLR3K,ribosomal rna synthesis,dna damage response,cell growth regulation,oncogenic potential,genomic stability maintenance,apoptosis regulation
ENSG00000176986,SEC24C,copii complex subunit,cell proliferation promoter,vesicular transport facilitator,oncogenic protein targeting,poor prognosis marker,driver gene for blca
ENSG00000136352,NKX2-1,tumor suppressor function,cell cycle regulation,apoptosis induction,epithelial tissue maintenance,downregulated expression,biomarker potential
ENSG00000133731,IMPA1,cell-cell adhesion disruption,enhanced cell migration,altered membrane transport,tumor progression modulation,cancer cell aggressiveness,resistance to apoptosis
ENSG00000141401,IMPA2,pi3k/akt pathway dysregulation,cell migration regulation,tumor suppressor function,prognostic marker,cytoskeleton organization,constitutive activation mutations
ENSG00000117448,AKR1A1,oncogenic function,redox regulation,overexpression,tumor progression,cell survival,metastasis
ENSG00000101191,DIDO1,apoptosis regulation,cell death pathway modulation,dna damage response,genomic instability,protein-protein interaction,tumor suppressor potential
ENSG00000121766,ZCCHC17,genomic instability,cell cycle regulation,dna repair pathway,therapeutic target,prognostic marker,tumor suppressor activity
ENSG00000088356,PDRG1,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),overexpression in cancer,pi3k/akt pathway interaction,tumor progression facilitation,metastatic spread enhancement
ENSG00000092054,MYH7,contractile apparatus regulation,muscle cell motility,cancer metastasis promotion,tumor progression facilitation,cell migration enhancement,actin remodeling interaction
ENSG00000139648,KRT71,keratin expression,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression,oncogenic mutations,therapeutic target
ENSG00000148584,A1CF,alternative splicing,rna processing,spliceosome interaction,tumorigenesis driver,gene expression regulation,clinical correlation
ENSG00000117868,ESYT2,lipid metabolism regulation,membrane trafficking dysregulation,oncogenic signaling pathway activation,constitutive protein expression,cell proliferation promotion,metastatic potential enhancement
ENSG00000139641,ESYT1,er membrane adaptor,er-associated degradation,cell growth regulation,metabolic regulation,oncogenic mutations,therapeutic target
ENSG00000177108,ZDHHC22,aberrant protein modification,cell proliferation enhancement,dysregulated cell interactions,enhanced cell migration,oncogenic signaling modulation,palmitoylation dysregulation
ENSG00000272031,ANKRD34A,ankyrin repeat domain,cell growth regulation,dna damage response,epigenetic regulation,oncogene activation,protein-protein interactions
ENSG00000011009,LYPLA2,phospholipid hydrolysis,oncogenic potential,cell survival promotion,tumor progression enhancement,signaling pathway modulation,protein-protein interaction
ENSG00000112655,PTK7,**

ptk7 interaction,cell adhesion disruption,tumor progression association,metastasis regulation,oncogenic signaling activation,emt pathway involvement
**
ENSG00000171956,FOXB1,cell cycle regulation,transcription factor function,cell proliferation regulation,tumor suppressor role,oncogene involvement,genomic instability promotion
ENSG00000117525,F3,coagulation initiator,epithelial-to-mesenchymal transition regulator,tumor growth promoter,metastatic facilitator,pro-coagulant state inducer,thrombin generator
ENSG00000189283,FHIT,genomic instability,cell cycle regulation,tumor suppression,apoptosis resistance,protein-protein interactions,dna repair mechanisms
ENSG00000132963,POMP,tumor aggressiveness,cell proliferation regulation,protein degradation,cell cycle progression,apoptosis pathway interaction,dysregulated expression
ENSG00000176273,SLC35G1,nucleotide sugar transport,cell surface protein modification,glycosylation pathway regulation,oncogenic properties,tumor progression,poor prognosis
ENSG00000183864,TOB2,genomic instability,tumor suppressor function,dna repair mechanism,apoptosis regulation,cancer progression factor,transcriptional regulation
ENSG00000035141,FAM136A,genomic instability,cell cycle regulation,oncogenesis potential,dna repair dysregulation,prognostic biomarker,tumorigenesis involvement
ENSG00000175324,LSM1,gene regulation,chromatin modification,apoptosis modulation,pre-mrna splicing,cell cycle regulation,protein-protein interaction
ENSG00000158220,ESYT3,autophagy regulation,oncogenic mutations,cell proliferation,metabolic dysregulation,pi3k/akt pathway interaction,endoplasmic reticulum remodeling
ENSG00000055609,KMT2C,epigenetic modification,histone methylation,chromatin remodeling,transcriptional dysregulation,oncogenic transformation,poor prognosis
ENSG00000182173,TSEN54,translation regulation,oncogene expression,cellular metabolism modulation,protein synthesis alteration,tumor progression facilitation,genomic instability promotion
ENSG00000064787,BCAS1,bcas1 overexpression,cell proliferation,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway activation,transcription factor regulation,protein-protein interaction
ENSG00000128908,INO80,chromatin remodeling,dna repair,genome stability,histone regulation,epigenetic modification,genomic instability
ENSG00000101442,ACTR5,activin/tgf-β signaling pathway,upregulation of expression,tumor progression,cell proliferation enhancement,apoptosis inhibition,oncogenic driver gene status
ENSG00000155090,KLF10,transcription factor,tumor suppressor,cell proliferation,apoptosis regulation,cell cycle progression,dna repair
ENSG00000054598,FOXC1,transcription factor activity,oncogene activation,wnt/β-catenin pathway regulation,cell proliferation promotion,apoptosis inhibition,transcriptional regulation
ENSG00000159259,CHAF1B,chromatin remodeling,oncogenesis,tumor growth,cell proliferation,gene amplification,poor prognosis
ENSG00000198947,DMD,dystrophin expression loss,pro-survival signaling activation,cell proliferation enhancement,muscle cell membrane instability,dystrophin-glycoprotein complex disruption,therapeutic target
ENSG00000113327,GABRG2,ion channel regulation,dysregulated signaling,tumor microenvironment modulation,neurotransmitter release inhibition,synaptic plasticity alterations,cancer progression facilitation
ENSG00000100814,CCNB1IP1,mitotic checkpoint regulator,genomic instability,chromosome segregation,g2/m transition,cell proliferation,checkpoint activation
ENSG00000160285,LSS,cell cycle regulation,tumor suppression,actin cytoskeleton organization,cancer cell proliferation,apoptosis evasion,chromatin remodeling
ENSG00000133059,DSTYK,phosphorylation regulation,oncogenic properties,pi3k/akt pathway,cellular proliferation,protein kinase activation,tumor progression
ENSG00000163933,RFT1,oncogenic translation,tumor progression,protein synthesis regulation,cell proliferation,metabolic reprogramming,ribosome assembly
ENSG00000179532,DNHD1,microtubule dynamics,oncogenic processes,cell division regulation,kinase interaction,chemotherapy resistance,prognostic marker
,COL4A3BP,basement membrane formation,tumor progression,cell migration,metastasis,angiogenesis,oncogene
ENSG00000133275,CSNK1G2,wnt/β-catenin signaling pathway,constitutive activation,co-expression with oncogenes,gene overexpression,tumor progression,therapeutic target
ENSG00000139318,DUSP6,mapk pathway inhibition,tumor suppressor function,cell cycle regulation,apoptosis induction,protein phosphatase activity,cancer progression suppression
ENSG00000058453,CROCC,centrosome integrity,genomic instability,cell proliferation,tumorigenesis,oncogenesis,prognostic marker
ENSG00000117281,CD160,immune evasion,tumor progression,biomarker potential,angiogenesis regulation,cell surface expression,immunosuppression mechanism
ENSG00000113240,CLK4,pi3k/akt pathway enhancement,tumor progression promotion,cell cycle regulation,therapeutic target identification,stat3 and erk1/2 phosphorylation,oncogenic transformation facilitation
ENSG00000213625,LEPROT,cell proliferation regulation,signaling pathway activation,cancer progression,overexpression,apoptosis resistance,pi3k/akt interaction
ENSG00000123545,NDUFAF4,mitochondrial function,oxidative phosphorylation,complex i assembly,ros production,dna damage response,oncogenic signaling pathway
ENSG00000105866,SP4,transcription factor regulation,cell cycle modulation,oncogenic driver,apoptosis inhibition,angiogenesis promotion,tumor progression
ENSG00000233813,MRPS18B,mitochondrial ribosomal protein function,cell proliferation regulation,metabolic regulation,apoptosis modulation,oncogene activation,genomic instability
ENSG00000275979,CNOT3,regulation of rna metabolism,phosphorylation of substrates,transcriptional regulation,tumor progression,signaling pathway modulation,oncogenic potential
ENSG00000187173,LCE2A,tumor suppressor function,regulation of cellular adhesion,overexpression in cancer tissues,cell migration regulation,interaction with pi3k/akt pathway,genomic amplification
ENSG00000114771,AADAC,fatty acid oxidation,mitochondrial function,lipid metabolism regulation,tumor growth promotion,cell survival enhancement,therapeutic target for blca
ENSG00000134900,TPP2,nucleotide metabolism regulation,genomic instability induction,dna repair modulation,cell cycle progression influence,apoptosis regulation disruption,tumor suppressor interaction
ENSG00000100505,TRIM9,tumor suppression,pi3k/akt pathway regulation,cell cycle regulation,apoptosis induction,protein-protein interaction,signaling pathway modulation
ENSG00000203883,SOX18,lymphatic vessel formation,transcriptional regulation,vascular endothelial cell development,angiogenesis promotion,tumor progression association,metastasis facilitation
ENSG00000214413,BBIP1,dna repair,genomic instability,tumor suppressor,chromatin remodeling,cell cycle regulation,oncogenic transformation
ENSG00000167916,KRT24,cytoplasmic intermediate filaments,oncogenic signaling,cellular morphology,epithelial expression,protein-protein interaction,cancer cell invasion
ENSG00000124275,MTRR,msr enzyme,one-carbon metabolism,genomic stability,epigenetic regulation,dna methylation,methionine cycle
ENSG00000116984,MTR,methylation regulation,antioxidant defense,oxidative stress resistance,dna repair,epigenetic modification,redox balance maintenance
ENSG00000062282,DGAT2,protein kinase activation,phosphatidylinositol 3-kinase (pi3k) pathway regulation,lipid biosynthesis,tumorigenesis,rna expression alterations,cancer cell proliferation
ENSG00000243509,TNFRSF6B,apoptosis regulation,tumor suppression,trail interaction,cell death modulation,cancer aggressiveness,poor patient outcomes
ENSG00000104936,DMPK,microtubule regulation,dual-specificity phosphatase function,cell proliferation enhancement,tumor progression driver,nucleus localization,oncogene role
ENSG00000166562,SEC11C,oncogenic mutations,epigenetic regulation,dna methylation,cell proliferation,metastasis promotion,signaling pathway modulation
ENSG00000147650,LRP12,cell proliferation,signal transduction,endocytosis regulation,aggressive tumor behavior,aberrant expression,mutation hotspot
ENSG00000181804,SLC9A9,ph regulation,ion transport,overexpression,epithelial-to-mesenchymal transition (emt),oncogenic potential,therapeutic target
ENSG00000023191,RNH1,genomic stability,rna-dna hybrids degradation,cancer driver gene,tumor progression,interaction with dna repair/replication proteins,aberrant expression/mutations
ENSG00000064995,TAF11,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cellular proliferation,genomic stability maintenance,chromatin remodeling,rna polymerase ii-dependent transcription
ENSG00000281309,SURF6,cell membrane fluidity regulation,cell migration facilitation,genomic instability contributor,oncogenic protein interactions,tumor progression association,biomarker for disease prognosis
ENSG00000138587,MNS1,chromatin remodeling,genomic instability,cell cycle progression,oncogene potential,dna-binding protein function,transcriptional regulation
ENSG00000163485,ADORA1,tumor progression,gain of function mutations,immune suppression,adenosine signaling pathway,cell survival,angiogenesis
ENSG00000174667,OR7D4,cell adhesion disruption,tumor progression influence,cellular migration modulation,proliferation regulation,oncogene potential,genomic instability impact
ENSG00000110887,DAO,polyamine degradation,tumor progression,cancer metabolism,cell proliferation,enzyme activity,oncogene overexpression
ENSG00000105669,COPE,cell cycle regulation,apoptosis inhibition,tumor suppressor interaction,oncogenic functions,overexpression in cancer,cell signaling pathways
ENSG00000138696,BMPR1B,tgf-β/bmp signaling pathway,oncogene,cell proliferation,cell migration,tumor invasion,chemotherapy resistance
ENSG00000108590,MED31,mediator complex regulation,tumor suppressor activity,transcriptional regulation,rna polymerase ii assembly,genome stability maintenance,corepressor recruitment
ENSG00000122958,VPS26A,retromer complex,endosomal sorting,protein transport,tumor aggressiveness,poor prognosis,cell growth regulation
ENSG00000152583,SPARCL1,cell adhesion regulation,tumor progression promotion,invasive potential enhancement,metastasis facilitation,mmp activation modulation,integrin interaction facilitation
ENSG00000065000,AP3D1,lysosomal trafficking,cell proliferation,amplification-driven oncogenesis,epithelial-to-mesenchymal transition,metabolic regulation,therapeutic target
ENSG00000099290,WASHC2A,endosomal transport regulation,cell proliferation enhancement,apoptosis suppression,actin remodeling disruption,tumor suppressor inactivation,genomic instability promotion
ENSG00000164695,CHMP4C,endosomal sorting complexes,tumor progression,oncogenesis,cell proliferation,apoptosis resistance,microtubule regulation
ENSG00000143363,PRUNE1,autophagy dysregulation,tumor suppressor function,loss of function mutations,pi3k/akt pathway activation,genomic instability,cell survival and proliferation enhancement
ENSG00000104960,PTOV1,chromatin remodeling,transcriptional regulation,tumor progression,oncogenic pathway,cell cycle regulation,dna repair mechanism
ENSG00000183813,CCR4,tumor antigen,immunosuppressive niche,angiogenesis promotion,cell migration enhancement,metastasis facilitation,immune evasion mechanism
ENSG00000103932,RPAP1,genomic instability,pi3k/akt pathway activation,dna repair dysfunction,cell proliferation enhancement,tumor progression marker,oncogenic protein interaction
ENSG00000164162,ANAPC10,loss-of-function mutations,cell cycle regulation,genome instability,therapeutic resistance,dna damage response,ubiquitin-proteasome pathway
ENSG00000135862,LAMC1,laminin network formation,epithelial-to-mesenchymal transition (emt),cell adhesion and migration,angiogenesis promotion,signaling pathway regulation,extracellular matrix integrity
ENSG00000148356,LRSAM1,ubiquitination regulation,genomic instability,apoptosis regulation,cell cycle modulation,proteasome pathway interaction,brca1/brca2 interaction
ENSG00000168826,ZBTB49,transcriptional regulation,immune response modulation,tumor progression,gene expression control,cell survival promotion,proliferation enhancement
ENSG00000172795,DCP2,poly(a) polymerase regulation,oncogenic mutations,enhanced cell proliferation,tumor progression,gene expression modulation,mrna stability and processing
ENSG00000258405,ZNF578,transcriptional repression,krab domain,cellular proliferation,gene expression regulation,dna binding protein,oncogenic potential
ENSG00000061794,MRPS35,mitochondrial dysfunction,cancer driver gene,constitutive activation,cell proliferation,reactive oxygen species production,dna damage
ENSG00000198752,CDC42BPB,cdc42/rac signaling pathway,gain of function mutations,cell migration and invasion,oncogenesis,actin cytoskeleton regulation,rho gtpase activation
ENSG00000241233,KRTAP5-8,type ii keratin,overexpression,cell structure maintenance,biomarker potential,prognostic indicator,promotes cell proliferation
ENSG00000085741,WNT11,emt promoter,cell proliferation regulator,signaling pathway activator,oncogenic driver,genomic instability inducer,epithelial marker loss
ENSG00000186416,NKRF,cell cycle regulation,tumor progression,apoptosis modulation,transcriptional regulation,gene expression,protein-protein interaction
ENSG00000167191,GPRC5B,cell adhesion,tumor suppressor function,epithelial-to-mesenchymal transition (emt),interaction with egfr signaling pathway,modulation of wnt/β-catenin signaling,prognostic marker or therapeutic target
ENSG00000166923,GREM1,tumor suppressor,tgf-β signaling inhibition,epithelial-to-mesenchymal transition,cancer cell invasion,metastasis regulation,growth factor modulation
ENSG00000175745,NR2F1,tumor suppression,transcriptional regulation,cell proliferation inhibition,apoptosis induction,genetic alterations,cancer development
ENSG00000204370,SDHD,mitochondrial complex ii subunit,oncogenic pathway activation,tumor suppressor function,metabolic regulation,cell growth promotion,electron transport chain disruption
ENSG00000154743,TSEN2,trna splicing endonucleases,genome instability,tumor suppressor,rna processing,cell growth promotion,non-coding rna regulation
ENSG00000134548,SPX,histone acetylation regulation,chromatin remodeling,epigenetic modification,transcriptional regulation,gene expression disruption,tumor progression
ENSG00000178928,TPRX1,calcium channel regulation,oncogenic transformation,cell proliferation enhancement,signal transduction modulation,cancer cell survival promotion,growth factor receptor signaling interaction
,MARCH6,cell adhesion regulation,immune response modulation,pi3k/akt pathway interaction,tumor progression,protein degradation facilitation,apoptosis modulation
ENSG00000181467,RAP2B,rap gtpase regulation,oncogene activation,cell proliferation promotion,apoptosis inhibition,signaling pathway modulation,tumor progression contribution
ENSG00000136193,SCRN1,tumor suppressor,cell cycle regulation,genomic instability,dna damage response,protein degradation pathway,apoptosis regulation
ENSG00000175395,ZNF25,transcriptional repression,tumor suppressor function,downregulation or mutation,oncogenic pathway activation,cell growth and proliferation regulation,epigenetic regulation
ENSG00000084234,APLP2,wnt/β-catenin pathway,cell adhesion regulation,tumor progression,oncogene overexpression,therapeutic target,signaling pathway modulation
ENSG00000164929,BAALC,oncogenic transcription factor,wnt/β-catenin signaling pathway activation,cell proliferation and survival promotion,tumor progression and metastasis facilitation,poor prognosis association,genomic instability mediation
ENSG00000111218,PRMT8,**

prmt8,oncogenic function,symmetric dimethylation,cell proliferation,tumor suppressor regulation,pi3k/akt pathway modulation
ENSG00000162144,CYB561A3,oncogenic regulation,metabolic reprogramming,energy production,cell proliferation,protein interaction,redox reaction
ENSG00000188379,IFNA2,antitumor immunity,immunogenic cell death,tumor microenvironment modulation,cell proliferation inhibition,apoptosis induction,immune surveillance suppression
ENSG00000134602,STK26,hippo signaling pathway,constitutive activation,gain-of-function mutations,epithelial-to-mesenchymal transition (emt),tumor progression,apoptosis suppression
ENSG00000169752,NRG4,cellular proliferation,tumor progression,oncogenic signaling,epidermal growth factor family,receptor activation,protein-protein interaction
ENSG00000135917,SLC19A3,folate transport,oncogenic function,chemotherapeutic resistance,cell proliferation,genomic instability,tumor growth
ENSG00000165915,SLC39A13,zinc homeostasis regulation,cell proliferation promotion,tumor progression association,oncogenesis involvement,apoptosis resistance contribution,protein-protein interaction
ENSG00000110375,UPK2,cell adhesion regulation,oncogenic activity,transcriptional regulation,apoptosis inhibition,metastatic potential,tumor progression
ENSG00000166452,AKIP1,p53 inhibition,cell cycle disruption,oncogene activation,tumor progression,therapeutic target,nuclear localization
ENSG00000113504,SLC12A7,ion transport regulation,cellular homeostasis disruption,therapeutic target identification,chemoresistance promotion,tumor progression facilitation,genomic instability association
ENSG00000158186,MRAS,oncogenic activation,ras family member,cell signaling regulation,cell growth promotion,downstream pathway activation,tumor progression
ENSG00000203879,GDI1,rho gtpase regulation,oncogenic signaling,tumor progression,cell migration,cell motility,protein-protein interaction
ENSG00000007171,NOS2,inflammation,oxidative stress,tumor progression,reactive nitrogen species,dna damage,nf-κb pathway activation
ENSG00000280830,ADI1,tumor suppressor pathways,chromosomal instability,oncogenic transcriptional programs,cell cycle regulation,gene expression regulation,chromatin remodeling
ENSG00000160460,SPTBN4,cellular adhesion,cytoskeletal regulation,protein-protein interactions,tumor progression,metastatic potential,oncogenic driver
ENSG00000179085,DPM3,aberrant glycosylation,cell growth promotion,dna repair interaction,n-glycosylation process,oncogenic transformation,tumor progression
ENSG00000105821,DNAJC2,chaperone-mediated autophagy,cellular homeostasis,protein folding regulation,tumor suppressor function,autophagic pathway modulation,genomic instability
ENSG00000010256,UQCRC1,mitochondrial function,electron transport chain,energy metabolism regulation,cellular respiration,oxidative stress modulation,glycolytic shift
,FAM84B,pi3k/akt pathway,constitutive activation,overexpression,oncogenesis,cell proliferation,gene expression regulation
ENSG00000089225,TBX5,oncogenic transcription factor,cell proliferation promotion,apoptosis resistance,epithelial-to-mesenchymal transition,cancer stem cell maintenance,transcriptional regulation
ENSG00000100425,BRD1,chromatin remodeling,oncogenic driver,tumor suppressor downregulation,cell cycle progression,apoptosis inhibition,metastasis enhancement
ENSG00000254986,DPP3,amino acid regulation,cell proliferation,metastasis promotion,oncogenic signaling,protein interaction,tumor progression
ENSG00000130332,LSM7,snrna complex,spliceosome regulation,cell cycle progression,tumor metastasis,poor prognosis indicator,oncogene overexpression
ENSG00000165175,MID1IP1,genomic instability,apoptosis regulation,tumor suppressor function,cell cycle regulation,protein-protein interaction,chromosomal instability
ENSG00000213022,KLK9,proteolytic activity,extracellular matrix degradation,cell proliferation,metastasis facilitation,biomarker potential,cancer aggressiveness enhancement
ENSG00000135338,LCA5,leberconesin function,photoreceptor cilia maintenance,cancer cell proliferation,cellular survival enhancement,overexpression in tumors,potential oncogenic role
ENSG00000005194,CIAPIN1,cell cycle regulation,apoptosis inhibition,tumor progression,dna repair facilitation,genomic instability,pi3k/akt pathway interaction
,MMD2,chromatin regulation,gene expression modulation,histone modification recruitment,cell cycle progression,dna repair regulation,apoptosis modulation
ENSG00000272047,GTF2H5,disrupts gene expression regulation,oncogenic driver mutations,transcription initiation complex,phosphorylates rna polymerase ii ctd,tumor progression,therapeutic target
ENSG00000112425,EPM2A,glycogen metabolism dysregulation,genomic instability,cell growth regulation,tumor progression,energy homeostasis disruption,loss of function mutation
ENSG00000187566,NHLRC1,pi3k/akt pathway dysregulation,loss of function mutations,protein degradation impairment,tumor progression driver,cell cycle regulation disruption,e3 ubiquitin ligase activity loss
ENSG00000183145,RIPPLY3,notch signaling,chromatin remodeling,oncogene overexpression,tumor progression,transcriptional regulation,aberrant gene expression
ENSG00000114115,RBP1,regulation of retinoic acid,cellular differentiation,transcriptional regulation,apoptosis modulation,proliferation enhancement,tumor suppression impairment
ENSG00000099992,TBC1D10A,cellular proliferation,oncogene function,protein-protein interaction,rab gtpase regulation,vesicular transport modulation,tumor suppressor gene downregulation
ENSG00000005812,FBXL3,dna damage repair,cell cycle regulation,cki degradation,apoptosis suppression,genomic instability,therapeutic target
ENSG00000057593,F7,pro-coagulant activity,tumor progression,angiogenesis regulation,vitamin k-dependent proteolysis,coagulation cascade activation,tumor microenvironment remodeling
ENSG00000243135,UGT1A3,metabolic regulation,glucuronidation process,xenobiotic metabolism,chemotherapy response,detoxification mechanism,enzyme interaction
ENSG00000148158,SNX30,akt pathway regulation,oncogene overexpression,metastasis promotion,tumor cell proliferation,apoptosis resistance,gene expression modulation
ENSG00000114209,PDCD10,mitochondrial regulation,apoptosis suppression,tumor suppressor function,cell death regulation,protein-protein interaction,therapeutic target
ENSG00000122970,IFT81,cilia structure maintenance,cell proliferation,overexpression,metastasis promotion,oncogenic process,biomarker potential
ENSG00000167720,SRR,rna splicing regulation,alternative splicing,tumor progression,oncogene activation,spliceosome complex interaction,protein phosphorylation
ENSG00000153495,TEX29,telomere maintenance,genomic stability,dna repair,cell proliferation,chromosomal integrity,oncogenesis
ENSG00000168172,HOOK3,microtubule dynamics,overexpression,aggressive behavior,wnt/β-catenin pathway,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000006712,PAF1,chromatin remodeling,genetic instability,rna polymerase ii interaction,transcriptional elongation,tumor suppressor function,dna repair regulation
ENSG00000196376,SLC35F1,glycosylation regulation,cell surface molecule modulation,tumor progression,extracellular matrix interaction,cancer cell detachment,immune evasion mechanism
ENSG00000183828,NUDT14,altered parylation,genomic instability,adp-ribose hydrolase function,tumorigenesis,oncogenic transformation,dna repair regulation
ENSG00000170873,MTSS1,metastasis suppression,tumor suppressor function,cell migration regulation,epithelial-to-mesenchymal transition (emt),angiogenesis inhibition,anti-tumor effects
ENSG00000080822,CLDND1,adhesion regulation,epithelial-to-mesenchymal transition,cell migration,tumor progression,prognostic marker,signaling pathway interaction
ENSG00000108511,HOXB6,transcriptional regulation,cell proliferation,oncogenic driver,tumor invasion,epigenetic modification,metastatic potential
ENSG00000140718,FTO,regulatory function,nucleic acid binding protein,oncogenesis,tumor progression,cellular proliferation,metabolic regulation
ENSG00000137492,THAP12,chromatin remodeling,transcriptional regulation,oncogenic activity,tumor progression,aggressive behavior,therapeutic target
ENSG00000148985,PGAP2,receptor tyrosine kinase modulation,glycoprotein processing,cell surface receptor regulation,tumor progression,cancer cell migration,metastasis promotion
ENSG00000196141,SPATS2L,dna damage response,cell cycle regulation,genomic instability,tumor growth promotion,oncogenic function,cell proliferation enhancement
ENSG00000038358,EDC4,cell cycle progression disruption,ubiquitin ligase activity loss,tumor suppressor degradation,genomic instability promotion,cancer driver potential,apoptosis inhibition
ENSG00000184887,BTBD6,genetic instability,mutation loss of function,transcriptional repression,tumor suppressor activity,cell cycle regulation,apoptosis modulation
ENSG00000169067,ACTBL2,cell migration,actin cytoskeleton regulation,oncogene activation,tumor progression,epithelial-to-mesenchymal transition,gene expression upregulation
ENSG00000147394,ZNF185,chromatin remodeling,epigenetic regulation,oncogenic transcription factor,genomic instability,tumor progression,therapeutic target
ENSG00000170423,KRT78,keratin overexpression,epithelial cell integrity,cell migration,prognostic marker,emt regulation,cytoskeleton modulation
ENSG00000159377,PSMB4,protein degradation pathway,oncogenic processes,cellular homeostasis,tumor progression,cancer cell survival,ubiquitin-proteasome interaction
ENSG00000134769,DTNA,cell adhesion disruption,downregulated expression,tumor aggressiveness,loss of function mutations,biomarker potential,cell migration regulation
ENSG00000135245,HILPDA,glucose and glutamine metabolism,oncogenesis,metabolic regulation,energy production,biomass synthesis,cell proliferation
ENSG00000091583,APOH,angiogenesis promotion,immune response modulation,tumor progression,cell signaling pathway interaction,proliferation enhancement,overexpression in cancer
ENSG00000090971,NAT14,epigenetic regulation,histone modification,oncogenic transformation,cell cycle progression,tumor growth promotion,chromatin remodeling
ENSG00000198768,APCDD1L,wnt signaling pathway,tumor progression,oncogenic function,wnt/β-catenin activation,cellular proliferation regulation,cancer-related gene expression
ENSG00000184205,TSPYL2,tumor suppressor function,cell growth regulation,dna damage response,apoptosis regulation,chromatin remodeling interaction,histone modification regulation
ENSG00000223609,HBD,oncogenic processes,genomic instability,cell migration,angiogenesis,reactive oxygen species,biomarker
ENSG00000183049,CAMK1D,cellular proliferation,signaling pathway activation,oncogenic driver mutation,aggressive tumor behavior,poor prognosis,cancer progression
ENSG00000198586,TLK1,cell cycle progression,dna replication repair,oncogene potential,histone phosphorylation,microtubule regulation,cell proliferation
ENSG00000123064,DDX54,alternative splicing,genomic instability,rna metabolism regulation,spliceosomal interactions,cancer-related gene expression modulation,cell proliferation enhancement
ENSG00000170486,KRT72,overexpression,cell membrane integrity modulation,prognostic biomarker,pi3k/akt pathway activation,tumor aggressiveness,proliferation and survival promotion
ENSG00000132911,NMUR2,wnt/β-catenin pathway activation,constitutive receptor activation,g protein signaling,epithelial-to-mesenchymal transition (emt),cell proliferation and survival enhancement,tumor aggressiveness modulation
ENSG00000168917,SLC35G2,altered glycosylation,constitutive activation,dysregulated metabolism,glycosaminoglycan biosynthesis,nucleotide sugar transport,tumor progression
ENSG00000182504,CEP97,centrosome regulation,cell proliferation inhibition,apoptosis suppression,oncogenic overexpression,protein-protein interaction,cilia formation disruption
ENSG00000185069,KRT76,keratin assembly,tumor suppressor activity,cellular morphology regulation,epithelial cell integrity maintenance,intermediate filament disruption,apoptosis evasion
ENSG00000078596,ITM2A,tumor progression,cell adhesion disruption,protein-protein interaction,overexpression profile,aggressive phenotype,cell migration regulation
ENSG00000112667,DNPH1,genomic stability maintenance,dna repair mechanism,nucleotide excision repair,base excision repair,genetic instability promotion,prognostic marker
ENSG00000155313,USP25,deubiquitinating enzyme,tumor growth promotion,cell cycle regulation,oncogenic protein stabilization,chemoresistance,pi3k/akt pathway interaction
ENSG00000189299,FOXR2,transcription factor regulation,oncogene overexpression,cell growth regulation,epigenetic regulation,chromatin remodeling,pi3k/akt pathway interaction
ENSG00000163719,MTMR14,cellular regulation,phosphatase activity,3-phosphoinositide targeting,tumor suppressor potential,apoptosis modulation,cell proliferation regulation
ENSG00000171564,FGB,angiogenesis promotion,tumor cell proliferation,metastasis facilitation,extracellular matrix regulation,cell adhesion modulation,blood clot formation
ENSG00000143224,PPOX,oxidative stress,heme biosynthesis,metabolic regulation,cellular damage,protein interaction,tumor progression
ENSG00000126001,CEP250,cancer driver gene,genomic instability,tumor progression,anti-apoptotic function,mitotic regulation,protein overexpression
ENSG00000155265,GOLGA7B,cellular reorganization,oncogenic driver,cell proliferation,cellular morphology,growth regulation,cytoskeletal modulation
ENSG00000113318,MSH3,microsatellite instability,dna mismatch repair,oncogenic mutation driver,tumor genome instability,cell cycle regulation,gene expression modulation
ENSG00000119689,DLST,folate biosynthesis,genomic instability,tumor progression,nucleotide synthesis,dna damage repair,cell cycle regulation
ENSG00000144580,CNOT9,oncogenic processes,cellular metabolism,gene regulation,protein interaction,apoptosis modulation,translation regulation
ENSG00000151835,SACS,mitochondrial dynamics,tumor progression,genomic instability,dna repair mechanisms,reactive oxygen species production,ubiquitin-proteasome system interaction
ENSG00000130762,ARHGEF16,rho gtpase activation,tumor progression,cell migration,cytoskeleton reorganization,gef activity,pi3k/akt interaction
ENSG00000213023,SYT3,calcium-dependent exocytosis,cell adhesion disruption,epithelial-to-mesenchymal transition,biomarker potential,overexpression association,vesicle fusion regulation
ENSG00000213967,ZNF726,tumor suppression,gene regulation,dna-binding activity,apoptosis inhibition,emt regulation,cell proliferation
ENSG00000068394,GPKOW,tumor progression,immune suppression,cell adhesion regulation,genomic upregulation,cancer metastasis,immunoregulatory function
ENSG00000115183,TANC1,cell surface interaction,tumor progression,immune evasion,signaling pathway modulation,protein-protein interaction,cell adhesion
ENSG00000134897,BIVM,dna methylation regulation,epigenetic silencing,chromatin remodeling,tumor suppressor function,histone modification regulation,cancer epigenetics
ENSG00000179922,ZNF784,transcriptional regulation,oncogenic properties,tumor progression,diagnostic marker,therapeutic target,cell proliferation
ENSG00000178021,TSPYL6,chromatin remodeling,gene expression regulation,oncogenic activity,poor prognosis marker,therapeutic target,protein-protein interactions
ENSG00000116031,CD207,immune surveillance,dendritic cell marker,mannose binding protein,skin barrier maintenance,tumor infiltrating cells,cellular recognition
ENSG00000132768,DPH2,telomerase activity,genomic instability,oncogene activation,cellular immortality,dna repair regulation,telomere maintenance
ENSG00000117298,ECE1,vascular remodeling,cell proliferation,metastasis promotion,angiogenesis stimulation,immune suppression,tumor progression
ENSG00000002919,SNX11,endosomal trafficking regulation,cell proliferation promotion,tumor progression facilitation,metastasis enhancement,oncogene/tumor suppressor potential,pi3k/akt/mtor pathway interaction
ENSG00000143740,SNAP47,vesicle transport regulation,membrane fusion facilitation,tumor microenvironment formation,apoptosis inhibition,cell signaling pathway modulation,biomarker potential
ENSG00000089902,RCOR1,transcriptional repression,tumor suppressor function,cell cycle regulation,genome stability maintenance,e2f interaction,epigenetic regulation
ENSG00000167397,VKORC1,cellular carboxylation,coagulation protein regulation,apoptosis modulation,metabolic regulation,cell proliferation,genetic locus
ENSG00000085644,ZNF213,cell cycle regulation,apoptosis modulation,transcriptional regulation,protein-protein interaction,tumor aggressiveness,poor prognosis
ENSG00000122008,POLK,genetic instability,genomic stability,dna repair,mutagenesis,tumor aggressiveness,poor prognosis
ENSG00000141433,ADCYAP1,g-protein coupled receptor activation,oncogenic potential,protein kinase regulation,cell survival pathway activation,tumor progression promotion,therapeutic target
ENSG00000100095,SEZ6L,cell signaling dysregulation,pi3k/akt pathway activation,oncogenic driver mutation,tumor progression facilitation,cell survival enhancement,metastasis promotion
ENSG00000197008,ZNF138,oncogene activation,transcriptional regulation,cell proliferation,apoptosis inhibition,metastasis promotion,wnt/β-catenin pathway activation
ENSG00000170881,RNF139,tumor suppressor degradation,dna damage repair pathway,cell cycle regulation,apoptosis evasion,cancer cell proliferation,ubiquitination and proteasomal degradation
ENSG00000101294,HM13,genomic instability,chromatin remodeling,transcriptional regulation,dna repair mechanism,cell cycle progression,apoptosis regulation
ENSG00000171236,LRG1,lrg family member,transcriptional regulator,dna repair mechanism,chromosome stability,cell proliferation,overexpression marker
ENSG00000143416,SELENBP1,cell cycle regulation,dna damage response,tumor progression,genomic instability,oxidative stress modulation,apoptosis suppression
ENSG00000035664,DAPK2,apoptosis dysregulation,tumor suppressor function,cell cycle regulation,protein-protein interaction,dna damage response,genomic instability
ENSG00000121851,POLR3GL,transcriptional regulation,cell cycle progression,dna repair,oncogene regulation,tumor suppressor genes,polymerase iii subunit interactions
ENSG00000223572,CKMT1A,mitochondrial regulation,energy metabolism modulation,oncogenic pathway interaction,cell growth promotion,tumorigenic potential enhancement,tumor biomarker status
ENSG00000237289,CKMT1B,altered cellular metabolism,enhanced glycolysis,mitochondrial function,cellular energy homeostasis disruption,oncogenic effects,tumor growth promotion
ENSG00000068885,IFT80,cilia destabilization,genomic instability,oncogenic signaling,tumor progression,cell proliferation,therapeutic target
ENSG00000218891,ZNF579,overexpression,cell proliferation,transcriptional regulation,dna damage response,apoptosis suppression,genetic alterations
ENSG00000168484,SFTPC,altered expression,cell migration,metastasis,epithelial-to-mesenchymal transition (emt),surfactant protein regulation,oncogenic mutations
ENSG00000112494,UNC93A,tlr regulation,innate immune modulation,endosomal trafficking,immune evasion,tumor inflammation,oncogenesis
ENSG00000063587,ZNF275,cell cycle regulation,apoptosis modulation,tumor suppressor function,genomic instability,dna damage response,biomarker candidate
ENSG00000142684,ZNF593,transcriptional regulation,promoter activity,dna binding,cell proliferation,apoptosis regulation,protein-protein interactions
ENSG00000132824,SERINC3,cell membrane lipid regulation,hiv-1 entry inhibition,immune response modulation,oncogenic protein interactions,pi3k/akt pathway activation,tumor proliferation enhancement
ENSG00000080298,RFX3,dna replication regulation,genomic stability maintenance,tumor suppressor function,loss-of-function mutations,cancer prognosis marker,cell cycle control
ENSG00000214160,ALG3,n-glycosylation pathway,altered protein function,tumor progression,enhanced cell survival,dysregulated expression,glycoprotein modification
ENSG00000170369,CST2,tumor progression,inflammation mediation,cell migration promotion,wound healing regulation,pro-inflammatory cytokine induction,oncogene activation
ENSG00000186471,AKAP14,oncogenic transformation,cell proliferation,regulation of pka activity,protein-protein interactions,cell survival,genomic instability
ENSG00000173805,HAP1,histone acetyltransferase activity,chromatin regulation,oncogene overexpression,cell proliferation enhancement,poor prognosis biomarker,transcriptional activation
ENSG00000111328,CDK2AP1,cell cycle regulation,tumor suppressor,apoptosis regulation,dna repair modulation,negative regulator of cdk2,genomic stability promoter
ENSG00000167767,KRT80,cellular invasion,epithelial barrier disruption,genomic instability,loss of cell-cell adhesion,oncogenic signaling activation,tumor aggressiveness
ENSG00000229346,TRIM10,cell cycle regulation,apoptosis modulation,genomic stability,oncogenesis involvement,tumor suppressor function,mutations associated
ENSG00000169180,XPO6,nuclear transport,protein export regulation,tumorigenesis promotion,metastasis enhancement,cancer drug resistance,cell proliferation facilitation
ENSG00000117222,RBBP5,chromatin regulation,histone modification,dna repair,genome stability maintenance,tumor suppressor function,transcriptional regulation
ENSG00000108813,DLX4,tumor progression,promoter activity,transcriptional regulation,gene expression modulation,oncogenic function,genetic amplification
ENSG00000130518,IQCN,cell cycle regulation,genome stability maintenance,chromatin remodeling,oncogenic signaling pathway modulation,dna repair facilitation,tumor suppression
ENSG00000239474,KLHL41,tumor suppressor function,protein degradation regulation,cell migration modulation,oncogenic mutations,ubiquitination pathway involvement,cancer-related protein stability regulation
ENSG00000112118,MCM3,dna replication,cell cycle progression,oncogenic role,amplification/overexpression,potential biomarker,tumor progression
ENSG00000135374,ELF5,transcription factor regulation,oncogenic transcription,epithelial-to-mesenchymal transition,cell cycle regulation,apoptosis resistance,therapeutic target
ENSG00000053702,NRIP2,cell proliferation,estrogen receptor interaction,gene expression regulation,nuclear receptor binding,prognostic marker,tumor progression
ENSG00000168883,USP39,cell proliferation,genomic instability,dna repair deficiency,tumor progression,oncogene activation,metastasis promotion
ENSG00000078328,RBFOX1,cellular differentiation,alternative splicing regulation,transcription factor activity,rna binding protein,tumorigenesis driver,gene expression modulation
ENSG00000167977,KCTD5,protein-protein interaction,transcriptional regulation,e3 ubiquitin ligase activity,cancer progression,prognostic marker,genomic stability maintenance
ENSG00000106682,EIF4H,mrna translation regulation,protein synthesis dysregulation,oncogenic protein overproduction,tumor aggressiveness increase,poor prognosis association,therapeutic target potential
ENSG00000107731,UNC5B,netrin receptor function,tumor suppressor activity,reduced expression,loss of function mutations,aberrant signaling pathways,tumor progression inhibition
ENSG00000067141,NEO1,endocytic pathway regulation,vesicle transport modulation,cancer driver mutation,therapeutic target,cell surface receptor recycling,oncogenic signaling
ENSG00000105427,CNFN,lysosomal degradation,protein recycling,tumor microenvironment modulation,immune response regulation,cancer progression association,cellular proteolysis
ENSG00000072682,P4HA2,angiogenesis,hypoxia-inducible factor 1 alpha regulation,cell proliferation,metastasis promotion,prolyl hydroxylation,vhl protein interaction
ENSG00000056277,ZNF280C,oncogenic activity,transcriptional regulation,cell proliferation promotion,apoptosis evasion,poor prognosis marker,histone modification target
ENSG00000282307,SERPINF1,angiogenesis suppression,tumor suppressor activity,cell migration inhibition,plasminogen activator inhibition,proteolytic regulation,downregulated in cancer tissues
ENSG00000147853,AK3,cellular energy homeostasis,oncogenic potential,energy metabolism regulation,therapeutic target,tumor progression,metabolic adaptation
ENSG00000165801,ARHGEF40,rho gtpase activation,cell migration promotion,tumor aggressiveness,cell cycle regulation,focal adhesions formation,metastasis suppression
ENSG00000085998,POMGNT1,cell-cell interactions,oncogenic function,tumor suppressor modulation,aberrant glycosylation,pi3k/akt pathway interaction,protein modification enzyme
ENSG00000100036,SLC35E4,glycosylation regulation,cell survival promotion,metastasis facilitation,protein modification dysfunction,nucleotide sugar transport,aberrant signaling pathways
ENSG00000196510,ANAPC7,**

genomic instability,cell cycle dysregulation,chromosome segregation defects,tumor suppressor function,cell proliferation driver,ubiquitination pathway 
**
ENSG00000168306,ACOX2,metabolic regulation,peroxisomal function,fatty acid beta-oxidation,cell survival promotion,oncogenic processes,lipid metabolism regulation
ENSG00000107736,CDH23,emt,cell adhesion disruption,loss of function mutations,tumor progression,metastatic potential,epithelial transformation
ENSG00000107614,TRDMT1,trna modification,oncogene,cell cycle regulation,dna damage response,protein synthesis regulation,methylation dysregulation
ENSG00000144035,NAT8,nad+ salvage pathway,metabolic reprogramming,epigenetic regulation,genomic instability,cell cycle progression,dna repair
ENSG00000120675,DNAJC15,molecular chaperone,oncogenic properties,cell cycle regulation,mitochondrial function,autophagy regulation,tumor suppressor interaction
ENSG00000116171,SCP2,cholesterol transport,lipid metabolism regulation,tumor progression promoter,cellular lipid regulation,therapeutic target,biomarker potential
ENSG00000185231,MC2R,hormone regulation,receptor modulation,tumor progression,metastasis promotion,therapeutic target,signaling pathway interaction
ENSG00000140932,CMTM2,oncogenic overexpression,epithelial-to-mesenchymal transition,chemotherapy resistance,tumor metastasis,cell adhesion disruption,prognostic biomarker
ENSG00000101464,PIGU,protein degradation regulation,cell cycle inhibition,tumor suppressor function,genomic instability prevention,scf complex interaction,cell proliferation control
ENSG00000163344,PMVK,mevalonate pathway alteration,oncogenic potential,metabolic dysregulation,cell growth promotion,cholesterol synthesis enhancement,isoprenoid production increase
ENSG00000110011,DNAJC4,cell cycle regulation,apoptosis resistance,chromatin remodeling,molecular chaperone function,tumor progression,genomic instability
ENSG00000198471,RTP2,trna degradation,cell proliferation,genomic instability,apoptosis suppression,oncogenic role,mitochondrial function
ENSG00000106278,PTPRZ1,cell signaling,transmembrane receptor,tyrosine phosphatase activation,oncogenesis,cell migration,adhesion molecule regulation
ENSG00000163781,TOPBP1,homologous recombination repair,genomic instability,oncogenesis,dna damage response,non-homologous end joining,cell cycle regulation
ENSG00000142675,CNKSR1,oncogenic transformation,cell proliferation,cell migration,pi3k/akt pathway,phosphorylation regulation,scaffolding protein function
ENSG00000008256,CYTH3,**
map degradation,aneuploidy induction,cell cycle regulation,oncogene interaction,genomic instability,mitotic spindle checkpoint disruption
**
ENSG00000139405,RITA1,transcriptional coactivator function,oncogenic processes,promotes cell proliferation,enhances transcriptional recruitment,angiogenesis regulation,tumor progression marker
ENSG00000274126,C14orf180,wnt/β-catenin pathway,cell signaling regulator,transmembrane protein function,pi3k/akt pathway interaction,oncogenic mutations,cell proliferation promoter
ENSG00000140374,ETFA,mitochondrial function,energy metabolism regulation,oxidative stress response,cell cycle progression regulation,apoptosis induction,tumor suppressor activity
ENSG00000167842,MIS12,mitotic spindle assembly,kinetochore function,chromosomal instability,genomic alteration,cell division regulation,aneuploidy promotion
ENSG00000160783,PMF1,transcriptional regulation,constitutive activation,cell cycle progression,apoptosis suppression,oncogene overexpression,proliferative advantage
ENSG00000141448,GATA6,oncogenic transcription factor,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition,tumor progression marker,cell proliferation regulation,growth differentiation factor
ENSG00000169926,KLF13,transcription factor regulation,gene expression modulation,tumor suppression role,cell proliferation regulation,mutated in cancer,downregulated in cancer
ENSG00000103051,COG4,cog4 mutations,disrupted golgi function,impaired protein transport,oncogene activation,cell cycle dysregulation,apoptosis inhibition
ENSG00000108786,HSD17B1,steroid hormone regulation,hormone-dependent proliferation,tumor growth promotion,estrogen receptor modulation,metabolic reprogramming,therapeutic resistance
ENSG00000281935,DNAH10,aberrant ciliary function,cilia formation disruption,genomic instability,cell cycle dysregulation,motor protein dysfunction,oncogenic signaling
ENSG00000183955,KMT5A,histone modification,tumor progression,epigenetic regulation,chromatin reorganization,genome instability,transcriptional dysregulation
ENSG00000137699,TRIM29,dna damage response,oncogene,histone modification,cell cycle regulation,transcriptional regulation,genetic instability
ENSG00000206283,PFDN6,cellular homeostasis,protein degradation,tumor progression,cell cycle regulation,dna repair,apoptosis evasion
ENSG00000185869,ZNF829,tumor suppressor function,cell cycle regulation,loss-of-function mutations,apoptosis dysregulation,enhancer-promoter interactions,transcriptional activation
ENSG00000146243,IRAK1BP1,modulation of the irak1 pathway,tumor suppressor,inflammation regulation,downregulation in cancer,cell proliferation,tumor progression
ENSG00000149541,B3GAT3,aberrant glycosylation,dna damage response,cell migration invasion,metastasis promotion,glycosaminoglycan modification,tumor progression
ENSG00000100591,AHSA1,hsp70 chaperone function,oncogenic signaling pathway regulation,kinase activation facilitation,cell growth promotion,protein degradation modulation,hsp90 interaction
ENSG00000253797,UTP14C,cell cycle regulation,dysregulated expression,enhanced cell survival,telomerase activity,rna processing modulation,poor prognosis biomarker
ENSG00000182600,SNORC,cell growth regulation,modulated gene expression,oncogenic properties,tumor progression modulation,genomic instability,cellular pathway disruption
ENSG00000138622,HCN4,electrical excitability regulation,cell proliferation regulation,cancer progression involvement,oncogenic process interaction,cell migration influence,signaling pathway modulation
ENSG00000169155,ZBTB43,tumor suppression,cell cycle regulation,anti-proliferative gene regulation,transcriptional activity modulation,oncogenic process inhibition,tumor suppressor interaction
ENSG00000165819,METTL3,rna methylation,post-transcriptional regulation,tumor progression,proliferation and survival pathways,overexpression association,poor prognosis marker
ENSG00000145388,METTL14,m6a methylation,rna epigenetic regulation,oncogenic process,cell proliferation,target rna stabilization,cancer prognosis
ENSG00000186980,KRTAP23-1,cellular adhesion modulation,cancer cell proliferation,protein-protein interaction alteration,epithelial-to-mesenchymal transition,tumor progression,gene regulation changes
ENSG00000179820,MYADM,apoptosis regulation,mitochondrial function,autophagy induction,cell survival enhancement,prognostic marker,tumorigenesis driver
ENSG00000119953,SMNDC1,oncogenic mutations,spliceosomal dysfunction,aberrant transcript production,cell proliferation,apoptosis resistance,poor prognosis
ENSG00000130479,MAP1S,microtubule regulation,cell proliferation promotion,oncogenesis driver,cell cycle progression facilitation,tumor growth support,protein-protein interaction enhancement
ENSG00000175782,SLC35E3,glycosylation,cell surface modification,metabolic regulation,cancer driver gene,potential therapeutic target,tumor progression
ENSG00000112739,PRPF4B,aberrant splicing,rna processing,oncogene potential,tumor progression,cell growth regulation,splice site recognition
ENSG00000221926,TRIM16,trim family protein,cytoplasmic localization,apoptosis regulation,cell cycle control,p53 interaction,tumor suppressor potential
ENSG00000171988,JMJD1C,h3k9me2/3 demethylation,histone modification regulation,tumor progression marker,oncogene activation,cell proliferation promotion,genome instability maintenance
ENSG00000114544,SLC41A3,mg2+ regulation,overexpression,cell growth,metastasis,pi3k/akt pathway activation,prognostic marker
ENSG00000101363,MANBAL,protein regulation,tumor progression,cell proliferation,cyclin-dependent kinase inhibitor degradation,erk/stat signaling pathway modulation,aminopeptidase activity
ENSG00000183034,OTOP2,spliceosome assembly,rna processing,gene expression regulation,cellular stress response,transcriptional modulation,pre-mrna splicing
ENSG00000107282,APBA1,ap-2 complex regulation,cell proliferation enhancement,constitutive activation signaling,genetic mutation association,metastatic progression driver,prognostic marker
ENSG00000188827,SLX4,**

genomic stability,interstrand crosslink resolution,dna repair mechanism,structural maintenance,genome integrity maintenance,tumorigenesis promotion 

**
ENSG00000148948,LRRC4C,cellular migration,prognostic biomarker,tumor invasion,metastasis promotion,upregulated expression,potential therapeutic target
ENSG00000133048,CHI3L1,tumor progression,glycoprotein function,protease modulation,inflammatory response modulation,angiogenesis promotion,cell migration and invasion
ENSG00000130038,CRACR2A,constitutive activation,gain of function mutations,chemosensitivity alterations,cell migration and invasion,genomic instability driver,calcium channel regulation
ENSG00000159596,TMEM69,cellular proliferation,tumor growth,pi3k/akt pathway interaction,notch signaling modulation,transmembrane protein function,overexpression
ENSG00000121769,FABP3,cellular lipid transport,intracellular fatty acid binding,cancer metastasis,tumor growth promotion,poor prognostic marker,lipid metabolism regulation
ENSG00000184840,TMED9,protein transport regulation,vesicle formation modulation,copii complex component,oncogenic driver mutation,cell growth enhancement,tumor progression facilitation
ENSG00000151692,RNF144A,ubiquitin ligase activity,cell cycle regulation,apoptosis modulation,genomic instability,dna repair regulation,pi3k/akt pathway interaction
,H3F3C,chromatin remodeling,histone modification,tumor suppressor function,gene expression regulation,dna repair mechanism,epigenetic alterations
ENSG00000174417,TRHR,chromosomal instability,epigenetic regulation,g protein-coupled receptor signaling,tumor progression,cell proliferation regulation,therapeutic target
ENSG00000146197,SCUBE3,tumor-promoting factor,pi3k/akt signaling pathway regulation,cell adhesion and migration regulation,biomarker for bladder cancer,aberrant cellular behavior facilitation,therapeutic target candidate
ENSG00000159217,IGF2BP1,rna-binding protein function,post-transcriptional regulation,mrna stabilization,oncogene regulation,tumor suppressor modulation,cell cycle progression
ENSG00000183255,PTTG1IP,genomic stability,cell cycle regulation,tumor suppressor activity,plk1 interaction,mitotic regulation,gene expression regulation
ENSG00000178826,TMEM139,apoptosis resistance,cell signaling regulation,overexpression,tumorigenesis,wnt/β-catenin pathway interaction,transmembrane protein function
ENSG00000243364,EFNA4,tumor progression,metastasis driver,cell adhesion regulation,cell migration regulation,protein-protein interaction,signaling pathway modulation
ENSG00000135333,EPHA7,negative regulator,tumor suppressor function,wnt/β-catenin signaling inhibition,epithelial-to-mesenchymal transition regulation,cell adhesion modulation,protein-protein interaction disruption
ENSG00000168995,SIGLEC7,immunosuppression,myeloid-derived suppressor cells modulation,tumor-associated macrophages regulation,glycoconjugate recognition,angiogenesis and lymphangiogenesis,immune receptor interaction
ENSG00000141568,FOXK2,overexpression,transcriptional regulation,oncogenic signaling,cell cycle progression,apoptosis suppression,tumor suppressor gene silencing
ENSG00000136152,COG3,protein trafficking,aberrant expression,retrograde transport,tumor progression,cellular proliferation,apoptosis regulation
ENSG00000144560,VGLL4,tumor suppressor,transcriptional regulation,cell proliferation,apoptosis inhibition,wnt/β-catenin signaling pathway,oncogenic protein
ENSG00000115977,AAK1,oncogenic signaling,cell proliferation,overexpression mutations,actin cytoskeleton regulation,endocytosis modulation,protein trafficking activation
ENSG00000197912,SPG7,mitochondrial function,mitophagy regulation,dna repair interaction,apoptosis dysregulation,tumor progression,tissue specificity
ENSG00000160202,CRYAA,tumor suppressor,cell growth regulation,cancer driver gene,apoptosis modulation,mitochondrial interaction,cell survival enhancement
ENSG00000118655,DCLRE1B,dna double-strand break repair,genomic instability,non-homologous end joining,oncogenic mutations,tumorigenesis promotion,protein interaction
ENSG00000066135,KDM4A,histone modification,chromatin remodeling,transcriptional regulation,cell proliferation,tumorigenesis,therapeutic target
ENSG00000143753,DEGS1,lipid metabolism,tumor growth,overexpression,cellular energy homeostasis,lipid biosynthesis,protein-protein interaction
ENSG00000162430,SELENON,er membrane protein,formylation process,cell proliferation,apoptosis resistance,er stress response,oncogenic transformation
ENSG00000106012,IQCE,microtubule dynamics,tumor aggressiveness,genomic instability,cell cycle progression,chromosomal instability,therapeutic target
ENSG00000121864,ZNF639,dna repair dysfunction,oncogenic transcription factor,chromatin remodeling activity,transcriptional upregulation,cell cycle dysregulation,apoptosis resistance
ENSG00000148290,SURF1,mitochondrial dysfunction,cellular metabolism,glycolytic reprogramming,tumor progression,mitochondrial biogenesis,energy production
ENSG00000183978,COA3,mitochondrial function,oxidative phosphorylation,complex iv assembly,dysfunctional mitochondria,energy metabolism regulation,therapeutic target
ENSG00000148841,ITPRIP,calcium signaling,regulation of cell proliferation,oncogenesis,cell survival,genomic instability,cancer progression
ENSG00000111540,RAB5B,ras superfamily member,endocytic recycling regulation,cell migration promotion,tumor aggressiveness correlation,poor prognosis association,pi3k/akt pathway interaction
ENSG00000104142,VPS18,autophagy regulation,cancer cell proliferation,cell survival enhancement,tumor progression,therapeutic target,genomic instability
ENSG00000079950,STX7,endocytosis,membrane trafficking,oncogenic processes,cell proliferation,cell survival,signaling pathways
ENSG00000176208,ATAD5,genomic instability,dna repair,telomere maintenance,therapeutic target,oncogene activation,chromatin remodeling
ENSG00000125450,NUP85,nuclear pore complex,oncogene overexpression,cell proliferation,tumor progression,signaling pathway interaction,genomic amplification
ENSG00000160211,G6PD,oxidative stress regulation,glycolytic reprogramming,driver gene,metabolic modulation,warburg effect promotion,redox balance maintenance
ENSG00000233927,RPS28,ribosome biogenesis,mtor pathway activation,translation regulation,protein synthesis enhancement,tumor growth promotion,poor prognosis marker
ENSG00000095380,NANS,mitochondrial localization,energy metabolism regulation,oncogene/tumor suppressor potential,cellular proliferation promotion,metabolic reprogramming,signaling pathway interaction
ENSG00000151503,NCAPD3,chromosome condensation,genomic instability,condensin complex,cell division regulation,tumor aggressiveness,epigenetic regulation
ENSG00000275152,CCL16,immunosuppression,chemokine signaling,tumor metastasis,inflammation regulation,angiogenesis promotion,immune cell recruitment
ENSG00000173585,CCR9,chemokine receptor function,immune checkpoint regulation,lymphocyte homing,tumor progression facilitation,poor prognosis association,immune evasion promotion
ENSG00000227500,SCAMP4,endocytic pathway,overexpression,tumor stage progression,oncogenic protein recycling,adaptor molecule function,cell membrane trafficking regulation
ENSG00000124783,SSR1,dna damage response,cell proliferation,chromatin remodeling,genomic instability,signaling pathway activation,therapeutic target
ENSG00000171357,LURAP1,genomic instability,transcriptional regulation,dna damage response,cell growth control,chromosomal alterations,tumor suppressor
ENSG00000111052,LIN7A,cell polarity regulation,adhesion complex disruption,cytoskeleton reorganization,tumor progression driver,metastasis promotion,therapeutic target
ENSG00000257727,CNPY2,cell adhesion,oncogenic potential,epithelial-to-mesenchymal transition,protein-protein interactions,signaling pathway modulation,tumor aggressiveness
ENSG00000170522,ELOVL6,oncogene,cell growth promotion,lipid biosynthesis regulation,long-chain fatty acid production,cell survival enhancement,tumor progression
ENSG00000014641,MDH1,mitochondrial function,energy metabolism,tumor suppressor,dna repair interactions,redox balance disruption,oxidative stress induction
ENSG00000180957,PITPNB,pi3k/akt modulation,tumor progression,cell membrane trafficking,signaling regulation,phosphoinositide transfer,protein lipid interaction
ENSG00000184939,ZFP90,transcriptional regulation,oncogene activation,cell proliferation,p53 pathway inhibition,protein-protein interaction,cancer prognosis marker
ENSG00000070814,TCOF1,ribosome biogenesis,chromosomal instability,cell division regulation,genomic stability maintenance,oncogenic processes,rna processing regulation
ENSG00000118007,STAG1,cohesin complex dysfunction,genomic instability,chromosome missegregation,aneuploidy,tumor suppressor,genome maintenance
ENSG00000103876,FAH,mitochondrial function,loss of function mutations,hif pathway activation,metabolic reprogramming,genomic instability,therapeutic target
ENSG00000164442,CITED2,transcriptional coactivator function,cell growth regulation,epithelial-to-mesenchymal transition,oncogene activation,apoptosis inhibition,overexpression in cancer
ENSG00000166426,CRABP1,cellular retinoic acid-binding protein 1,oncogene activation,tumor progression,biomarker potential,gene expression regulation,protein-protein interactions
ENSG00000134020,PEBP4,cellular regulation,phosphorylation-dependent interactions,tumor growth,cell cycle control,apoptosis regulation,oncogenic processes
ENSG00000162595,DIRAS3,gtpase activation,mapk/erk pathway activation,cell proliferation enhancement,oncogenic signaling,tumor progression,cell survival promotion
ENSG00000128617,OPN1SW,red-sensitive opsin subunit,signal transduction,cell signaling,phototransduction cascade,visual perception,cellular regulation
ENSG00000066027,PPP2R5A,regulatory subunit,oncogenic signaling pathway,loss-of-function mutations,constitutive activation,cell proliferation regulation,protein interaction
ENSG00000168591,TMUB2,ubiquitination regulation,oncogenic signaling,cell proliferation promotion,protein degradation modulation,tumor progression driver,therapeutic target potential
ENSG00000242485,MRPL20,mitochondrial ribosome assembly,proper protein translation,energy metabolism regulation,cellular respiration modulation,genetic variability influence,tumor cell adaptation
ENSG00000180644,PRF1,tumor immunoevasion,apoptosis evasion,immune checkpoint blockade target,cytotoxic t cell regulation,natural killer cell modulation,membrane pore formation
ENSG00000149809,TM7SF2,erbb2 signaling,g-protein coupled receptor regulation,tumor progression,cell proliferation and survival,immune evasion modulation,prognostic marker
ENSG00000180720,CHRM4,tumor progression,cell proliferation,g protein-coupled receptor signaling,genomic alterations,metastasis,receptor activation
ENSG00000241399,CD302,epithelial-to-mesenchymal transition,immune modulation,cell-cell interactions,tumor microenvironment regulation,growth factor signaling,cell adhesion molecule
ENSG00000102103,PQBP1,rna binding,transcriptional regulation,oncogenic function,cell proliferation,tumor progression,apoptosis inhibition
ENSG00000126524,SBDS,ribosome biogenesis,disrupted cellular processes,cell cycle regulation,dna damage response,tumor progression,biomarker potential
ENSG00000087884,AAMDC,wnt signaling pathway,transcription factor regulation,cell proliferation,apoptosis regulation,cancer biomarker,therapeutic target
ENSG00000284096,PRKAR2B,pka activation,cell growth promotion,signaling pathway regulation,cell proliferation enhancement,cyclic amp interaction,tumor suppressor dysfunction
ENSG00000198182,ZNF607,gene regulation suppression,tumor suppressor gene interaction,dna binding activity,histone modification complex recruitment,zinc finger protein structure,oncogenic pathway enhancement
ENSG00000108924,HLF,transcriptional regulation,oncogenesis,cell proliferation,apoptosis evasion,dna repair disruption,angiogenesis promotion
ENSG00000167969,ECI1,p53 pathway inhibition,genomic instability,cell proliferation enhancement,tumor growth promotion,chromosomal alterations,protein-protein interaction
ENSG00000274749,KRTAP7-1,keratin filament disruption,tumor progression,epithelial cell dysregulation,cell adhesion alteration,signaling pathway modulation,genetic aberration
ENSG00000102699,PARP4,**

telomere maintenance,dna repair facilitation,genomic stability modulation,oncogenic promoter,cell proliferation enhancement,histone modification regulation
**
ENSG00000197646,PDCD1LG2,immune evasion,tumor microenvironment modulation,pd-1/pd-l1 interaction,oncogene function,t-cell exhaustion,cancer immunotherapy target
,IARS,oncogenic transformation,cellular proliferation,metabolic reprogramming,genomic instability,epigenetic dysregulation,mtor pathway interaction
ENSG00000154856,APCDD1,wnt signaling pathway,cell proliferation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000188488,SERPINA5,tumor suppressor function,proteolytic regulation,cell migration inhibition,extracellular matrix degradation,cell adhesion modulation,signaling pathway interaction
ENSG00000113194,FAF2,genomic instability,dna damage response,oncogenic transformation,tumor growth promotion,tumor progression facilitation,genomic integrity maintenance
ENSG00000164325,TMEM174,immune checkpoint regulation,tumor microenvironment modulation,pd-1/pd-l1 pathway interaction,transmembrane protein function,oncogenic potential enhancement,biomarker expression
ENSG00000074842,MYDGF,nf-κb pathway activation,oncogenic transcriptional regulation,cell growth promotion,protein-protein interaction,tumor aggressiveness,poor patient prognosis
ENSG00000157992,KRTCAP3,oncogene,cell adhesion disruption,keratin filament assembly,tumor progression,cell proliferation promotion,aberrant expression
ENSG00000137094,DNAJB5,protein chaperone function,oncogene activation,proteostatic network modulation,apoptosis inhibition,chemotherapy resistance,protein-protein interaction
ENSG00000007968,E2F2,cell cycle regulation,dna repair modulation,apoptosis evasion,pi3k/akt signaling,transcriptional activation,tumor progression driver
,MAATS1,metalloprotease activity,epithelial-to-mesenchymal transition,cell adhesion modification,tumor progression promotion,prognostic marker,poor outcome association
ENSG00000171509,RXFP1,angiogenesis inhibition,apoptosis suppression,cell growth promotion,pi3k/akt/mtor activation,relaxin interaction,tumor progression
ENSG00000106009,BRAT1,brat1 overexpression,oncogenic pathway,microrna regulation,cell cycle progression,rna stability,prognostic marker
ENSG00000280501,CEACAM7,nf-κb pathway activation,protein-protein interaction,tumor progression,epithelial-to-mesenchymal transition,immune evasion,angiogenesis regulation
ENSG00000101546,RBFA,cell cycle regulation,tumor suppressor function,genomic stability maintenance,dna damage response,chromosomal integrity preservation,oncogene or tumor suppressor status
ENSG00000100319,ZMAT5,cellular stress response,tumor suppressor regulation,dna damage response,oncogenic activity,genomic instability,transcriptional regulation
ENSG00000197279,ZNF165,tumor suppressor function,transcriptional regulation,cellular differentiation,dna repair mechanism,genomic instability,prognostic biomarker
ENSG00000184517,ZFP1,tumor aggressiveness,oncogenic potential,transcriptional regulation,dna repair modulation,cell cycle progression,epigenetic regulation
ENSG00000132793,LPIN3,lipid metabolism regulation,cell proliferation enhancement,tumor suppressor function,upregulation in cancer,metabolic reprogramming,bioenergetic adaptation
ENSG00000160396,HIPK4,tumor suppression,cell cycle regulation,apoptosis induction,protein-protein interaction,dna repair modulation,cancer biomarker
ENSG00000121903,ZSCAN20,cell cycle regulation,dna repair,tumor suppressor function,loss of heterozygosity,genomic instability,protein-protein interaction
ENSG00000256977,LIMS3,cell adhesion disruption,cytoskeletal modulation,metastasis promotion,tumor progression,cell migration enhancement,rho gtpase interaction
ENSG00000131370,SH3BP5,actin cytoskeleton regulation,cell migration modulation,oncogenic mutations,src kinase interaction,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement
ENSG00000089006,SNX5,oncogene expression,receptor recycling,cell migration,tumor progression,poor prognosis,therapeutic target
ENSG00000183873,SCN5A,aberrant sodium influx,pi3k/akt pathway activation,epithelial-to-mesenchymal transition,cell proliferation enhancement,sodium channel dysfunction,tumor progression facilitation
ENSG00000184226,PCDH9,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,metastatic potential enhancement,tumor progression facilitation,chemoresistance modulation,dna damage repair interaction
ENSG00000152779,SLC16A12,monocarboxylate transport,lactate efflux,glycolytic adaptation,tumor aggressiveness,therapeutic target,metabolic adaptation
ENSG00000285069,SESN2,tumor suppressor,apoptosis induction,metabolic regulation,cell proliferation inhibition,oncogenesis suppression,stress response modulation
ENSG00000010244,ZNF207,cellular proliferation,transcriptional regulation,oncogenic potential,tumor suppressor activity,cell cycle progression,anti-apoptotic function
ENSG00000154328,NEIL2,dna repair enzyme,genomic instability,tumor progression,oncogenic process,epigenetic regulation,stem cell maintenance
ENSG00000143499,SMYD2,oncogenic activity,chromatin remodeling,histone modification,genomic instability,pi3k/akt pathway regulation,tumor suppressor repression
ENSG00000167653,PSCA,cell surface glycoprotein,overexpression,adhesion molecule regulation,epithelial-to-mesenchymal transition,signaling pathway activation,tumor progression marker
ENSG00000169905,TOR1AIP2,mitochondrial fission regulation,drp1 interaction,tumor suppressor function,cancer cell survival,cellular stress response,autophagy modulation
ENSG00000162739,SLAMF6,adhesion molecule,immune evasion mechanisms,tumor progression,metastatic potential,inflammation regulation,surface receptor interaction
ENSG00000122756,CNTFR,jak/stat pathway,cell proliferation,cell survival,signaling pathways,tumor suppressor,therapeutic target
ENSG00000114978,MOB1A,genomic instability,cell cycle regulation,apoptosis dysregulation,tumor progression,oncogenic mutations,dna damage response
ENSG00000140521,POLG,mtdna replication,polymerase gamma function,mtdna mutations,cancer driver mutation,mitochondrial dysfunction,oxidative stress
ENSG00000256525,POLG2,genomic instability,dna replication fidelity,cell cycle regulation,therapeutic target,apoptosis resistance,tumor suppressor function
ENSG00000182919,C11orf54,tumor progression,cellular responses modulation,overexpression biomarker,therapeutic target,cell cycle regulation,apoptosis regulation
ENSG00000241685,ARPC1A,actin cytoskeleton remodeling,mutation driver,tumor progression,cancer cell migration,cell invasion,metastasis promotion
ENSG00000084733,RAB10,cellular trafficking,endocytic pathway regulation,metastasis promotion,pi3k/akt/mtor signaling modulation,therapeutic target,protein recycling
ENSG00000178695,KCTD12,cellular regulation,tumor suppressor function,loss-of-function mutation,potassium channel regulation,cell growth modulation,apoptosis regulation
ENSG00000149922,TBX6,tumor suppressor function,downregulation in cancer,cell cycle regulation,apoptosis regulation,genome stability maintenance,transcriptional regulation
ENSG00000074855,ANO8,wnt/β-catenin pathway interaction,gene amplification,oncogenic function,mutation driver,cell proliferation regulation,biomarker candidate
ENSG00000126062,TMEM115,apoptosis regulation,cell cycle modulation,cell proliferation enhancement,genomic instability induction,oncogenic transformation,tumor progression facilitation
ENSG00000152804,HHEX,hhex gene downregulation,epithelial cell polarity loss,wnt/β-catenin pathway inhibition,chromosomal instability induction,tumor progression suppression,transcriptional regulator function
ENSG00000188986,NELFB,cell cycle regulation,downregulated expression,dna repair disruption,tumor suppressor function,epigenetic silencing,genomic instability
ENSG00000155097,ATP6V1C1,lysosomal integrity disruption,v-atpase regulation,cellular homeostasis modulation,oncogenic transformation contribution,ion transport regulation,pi3k/akt pathway interaction
ENSG00000102984,ZNF821,chromatin remodeling,dna binding interactions,cell proliferation,epigenetic regulation,tumor progression,zinc finger protein
ENSG00000160145,KALRN,rho gtpase activation,actin cytoskeleton regulation,cancer cell migration,cellular morphogenesis,protein kinase interaction,oncogenic signaling pathway
ENSG00000112367,FIG4,tumor progression,dual-specificity phosphatase activity,mtorc1 activation,genomic instability,potential oncogene,cell proliferation regulation
ENSG00000157657,ZNF618,transcription factor regulation,cell cycle progression,tumor progression,oncogenesis,signaling pathway modulation,dna repair
ENSG00000187783,TMEM72,tumor overexpression,cell proliferation enhancement,signaling pathway interaction,wnt/β-catenin pathway regulation,membrane trafficking alteration,cell-to-cell communication modulation
ENSG00000134321,RSAD2,vip receptor activation,cell cycle progression,apoptosis regulation,cancer progression,genomic instability,therapeutic target
ENSG00000129071,MBD4,dna damage response,epigenetic regulation,genomic instability,cellular context dependence,dna repair mechanisms,tumor suppressor function
ENSG00000169826,CSGALNACT2,cell adhesion modulation,glycosaminoglycan binding,pi3k/akt pathway interaction,protein-protein interaction,tumor progression facilitation,glycomic regulation
ENSG00000134595,SOX3,oncogene,tumor progression,epithelial-to-mesenchymal transition (emt),cell cycle regulation,transcriptional activation,stemness maintenance
ENSG00000159445,THEM4,erad pathway regulation,dysregulation associated with chemoresistance,protein quality control,oncogenic processes promotion,therapeutic target potential,mitochondrial localization
ENSG00000182885,ADGRG3,cell migration,immune regulation,tumor progression,protein-protein interaction,cytoskeleton regulation,rho gtpase activation
ENSG00000183779,ZNF703,overexpression,pi3k/akt pathway modulation,transcriptional regulation,oncogene activation,cell growth promotion,tumor progression
ENSG00000173611,SCAI,epithelial-to-mesenchymal transition,src family kinase interaction,cell survival pathway activation,dna repair dysregulation,prognostic marker candidate,pi3k/akt signaling pathway interaction
ENSG00000144591,GMPPA,pi3k/akt signaling pathway,glycosylation modification,oncogenic process regulation,tumor progression marker,cellular metabolism modulation,biomarker identification
ENSG00000104517,UBR5,tumor suppressor,dna damage repair,cellular proliferation,protein ubiquitination,oncogenic mutations,therapeutic target
ENSG00000187147,RNF220,e3 ubiquitin ligase activity,loss of function mutations,cell cycle regulation,dna damage response,tumor suppressor protein,protein degradation pathway
ENSG00000187189,TSPYL4,genomic instability,dna damage response,homologous recombination repair,chromatin remodeling,protein-protein interaction,cancer drug resistance
ENSG00000163913,IFT122,cilia maintenance,intraflagellar transport,wnt/pcp pathway activation,dna damage response,genomic instability,therapeutic target
ENSG00000082397,EPB41L3,epithelial-to-mesenchymal transition,cell invasion,cytoskeleton organization,metastatic progression,adhesion molecule regulation,biomarker potential
ENSG00000099260,PALMD,cellular morphology,protein-protein interaction,cell migration,cancer progression,tumor invasion,cytokeletal regulation
ENSG00000173210,ABLIM3,cytoskeletal regulation,cell adhesion disruption,epithelial-to-mesenchymal transition,metastasis facilitation,matrix metalloproteinase upregulation,prognostic marker
ENSG00000197713,RPE,autophagy regulation,cell survival enhancement,dna repair interaction,cell cycle modulation,protein-protein interaction,tumor suppressor activity
ENSG00000168566,SNRNP48,spliceosome component,aberrant rna splicing,apoptosis evasion,cell cycle regulation alteration,spliceosomal dysregulation,cancer progression
ENSG00000146733,PSPH,tumor suppressor activity,oncogenic pathway activation,cell proliferation regulation,serine phosphorylation regulation,substrate specificity for serine residues,apoptosis modulation
ENSG00000011465,DCN,tumor suppressor function,extracellular matrix integrity,cell growth regulation,anti-angiogenic properties,prognostic marker potential,dysregulated expression patterns
ENSG00000134874,DZIP1,cell membrane interaction,microtubule disruption,cell proliferation,apoptosis modulation,dna repair regulation,tumor suppressor function
ENSG00000139370,SLC15A4,glutamine-dependent growth,cell survival and proliferation,amino acid transport regulation,tumor metabolism modulation,cell cycle progression regulation,dna repair dysregulation
ENSG00000110446,SLC15A3,slc15a3 overexpression,tumor growth promotion,metastatic potential,ion and nutrient transport,cellular proliferation regulation,solute exchange facilitation
ENSG00000166188,ZNF319,tumor suppression,cell proliferation inhibition,apoptosis induction,transcriptional regulation,metastasis regulation,cancer metastasis
ENSG00000187258,NPSR1,npsr1 overexpression,immune suppression,tumor progression,cell proliferation,metastasis promotion,stat3 activation
ENSG00000129810,SGO1,septin family,genomic stability,centromere localization,chromosome segregation,kinetochore function,aneuploidy prevention
ENSG00000277607,VSTM1,immunomodulation,tumor immunosuppression,regulatory t cells,immune checkpoint inhibitors,cd28/b7 costimulatory pathway,biomarker for prognosis
ENSG00000142599,RERE,rna-binding protein,tumor suppressor function,cell proliferation inhibition,apoptosis induction,gene expression regulation,loss-of-function mutation
ENSG00000150316,CWC15,**

alternative splicing,cell proliferation,cell survival,genomic instability,oncogenic isoforms,spliceosome assembly 
**
ENSG00000164879,CA3,oncogenic process,cell proliferation,calcium homeostasis dysregulation,signaling pathway interaction,channel subunit overexpression,apoptosis resistance
ENSG00000279486,OR2AG1,cellular invasion,tumor progression,cell migration,protein interaction,genomic instability,olfactory signaling
ENSG00000165507,DEPP1,cell-cell adhesion regulation,epithelial-to-mesenchymal transition,tumor progression,metastatic potential,cell migration enhancement,therapeutic target
ENSG00000134504,KCTD1,cellular regulation,transcriptional regulation,tumor suppression,chromatin remodeling,apoptosis modulation,proliferation inhibition
ENSG00000169682,SPNS1,sphingolipid metabolism,s1p transport facilitation,tumor cell growth promotion,akt activation,oncogenesis contribution,signaling pathway interaction
ENSG00000125779,PANK2,coenzyme a biosynthesis,dysregulation of metabolism,cellular energy production,fatty acid synthesis,antioxidant defenses,cell proliferation
ENSG00000126088,UROD,heme degradation pathway,enzymatic activity regulation,cellular homeostasis disruption,tumor growth modulation,therapeutic target potential,genetic mutation impact
ENSG00000152558,TMEM123,transmembrane protein function,maintenance of cellular homeostasis,tumor progression,cellular transport regulation,enhanced cell migration,metastatic potential
ENSG00000171365,CLCN5,ion homeostasis,cellular ph regulation,cell proliferation,metastatic potential,tumor cell survival,genetic alterations
ENSG00000068615,REEP1,er stress modulation,cell proliferation,apoptosis regulation,copy number variations,therapeutic target,genomic profiling
ENSG00000089693,MLF2,cell cycle regulation,chromatin remodeling,epigenetic regulation,transcriptional modulation,tumor suppressor silencing,oncogene activation
ENSG00000009790,TRAF3IP3,nf-κb signaling,oncogenic driver,cell proliferation,immune evasion,signaling pathway activation,tumor aggressiveness
ENSG00000095059,DHPS,folate metabolism,dna synthesis,increased expression,chemotherapeutic target,cell proliferation,nucleotide synthesis
ENSG00000132507,EIF5A,translational regulation,cellular proliferation,therapeutic resistance,oncogene activation,protein synthesis,malignant transformation
ENSG00000186130,ZBTB6,transcriptional regulation,tumor suppressor function,apoptosis regulation,cell cycle modulation,genetic alterations,binding specificity to gc-boxes
ENSG00000131471,AOC3,oncogene activation,metabolic regulation,tumor progression,protein-protein interactions,oxidative stress,inflammation
ENSG00000100321,SYNGR1,cell growth regulation,protein-protein interaction,upregulation in tumors,rhoa activation,pak1 pathway modulation,epithelial-to-mesenchymal transition
ENSG00000160113,NR2F6,cell proliferation inhibition,pi3k/akt pathway regulation,tumor suppressor function loss,oncogenic process promotion,transcriptional regulation,dna damage response modulation
ENSG00000196233,LCOR,epigenetic regulation,chromatin remodeling,gene expression modulation,histone modification,prognostic marker,therapeutic target
ENSG00000031823,RANBP3,genomic instability,cell cycle regulation,tumor development,potential therapeutic target,nuclear transport regulation,ran gtpase cycle modulation
ENSG00000136273,HUS1,genomic instability,checkpoint kinases activation,dna damage response regulation,tumor progression facilitation,atr/chk1 pathway disruption,poor prognosis association
ENSG00000174607,UGT8,xenobiotic metabolism,glucuronidation process,detoxification pathway,tumor suppressor potential,limited oncogenic role,xenobiotic accumulation
ENSG00000284980,AGPAT5,lipid metabolism dysregulation,pi3k/akt pathway activation,oncogene overexpression,tumor progression enhancement,cell proliferation and survival promotion,lipid accumulation in cancer cells
ENSG00000127586,CHTF18,chromatin remodeling,transcriptional elongation,dna damage response,genomic instability,oncogenic processes,therapeutic target
ENSG00000164330,EBF1,tumor suppressor function,genomic stability regulation,cellular process regulation,apoptosis modulation,transcription factor activity,dna damage response
ENSG00000115687,PASK,oncogenic protein,warburg effect,glycolytic flux,therapeutic target,constitutive activation,chemotherapy resistance
ENSG00000107130,NCS1,calcium signaling pathway,mitotic regulation,tumor cell proliferation,apoptosis evasion,cancer tissue overexpression,cell migration modulation
ENSG00000121289,CEP89,centrosomal regulation,microtubule dynamics,chromosomal instability,genomic alterations,cell cycle progression,spindle assembly checkpoint
ENSG00000101265,RASSF2,chromosomal instability,microtubule dynamics,epigenetic silencing,tumor suppressor function,cell cycle regulation,dna damage response
ENSG00000163806,SPDYA,tumor suppressor function,mapk/erk pathway inhibition,kinase interaction regulation,cell growth inhibition,cancer progression regulation,poor prognosis association
ENSG00000198546,ZNF511,transcription factor activity,dna-binding domain,cell cycle regulation,apoptosis modulation,tumor progression correlation,oncogenic properties
ENSG00000016082,ISL1,transcription factor regulation,oncogene activation,cell cycle progression,apoptosis inhibition,tumor aggressiveness promotion,poor prognosis marker
ENSG00000010270,STARD3NL,lipid metabolism regulation,golgi apparatus localization,gain of function mutations,cell proliferation promotion,survival signaling pathway modulation,membrane trafficking regulation
ENSG00000088876,ZNF343,cellular proliferation,transcriptional regulation,dna binding,tumor progression,gene expression regulation,oncogenic transformation
ENSG00000132517,SLC52A1,riboflavin transport,electron transport chains,cellular redox balance,prognostic marker,therapeutic target,cancer cell survival
ENSG00000138030,KHK,fructose metabolism,rapid cell proliferation,warburg effect,glycolytic shift,cancer metabolism,tumor energy dependency
ENSG00000166619,BLCAP,cell growth regulation,apoptosis modulation,pi3k/akt pathway activation,tumor progression facilitation,oncogenic pathway dysregulation,cell survival enhancement
ENSG00000149547,EI24,**
etv4 transcription factor,oncogenic driver,epithelial-to-mesenchymal transition,wnt/β-catenin signaling pathway,cell proliferation regulator,prognostic biomarker candidate 
**
ENSG00000080802,CNOT4,genomic instability,oncogenic transformation,dna repair mechanisms,cell cycle regulation,apoptosis regulation,mrna stability modulation
ENSG00000162624,LHX8,transcriptional regulation,cell proliferation,tumor suppressor function,apoptosis inhibition,cell cycle progression,dna repair regulation
ENSG00000110848,CD69,immune microenvironment modulation,tumor progression,cell migration invasion,angiogenesis promotion,immune evasion mechanism,emt regulation
ENSG00000171206,TRIM8,loss of function,tumor suppressor activity,pi3k/akt pathway regulation,cell proliferation promotion,survival mechanism dysregulation,molecular interaction with transcription factors
ENSG00000120925,RNF170,cellular regulation,ubiquitination and proteasomal degradation,akt/mtor pathway modulation,tumor progression,cell survival inhibition,histone modification regulation
ENSG00000165996,HACD1,lipid metabolism alteration,cell proliferation promotion,metastasis facilitation,tumor progression contribution,oncogenic pathway activation,enzyme overexpression
ENSG00000102466,FGF14,oncogenic activity,cell migration,epithelial-to-mesenchymal transition,protein-protein interaction,synaptic plasticity regulation,genomic amplification
ENSG00000137561,TTPA,cellular proliferation,oncogenesis,thiol metabolism,redox balance regulation,dna repair interaction,tumor progression resistance
ENSG00000170290,SLN,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling pathway modulation,transcriptional regulation
ENSG00000119574,ZBTB45,oncogene,differential expression,cell proliferation regulation,survival pathway modulation,biological process modulation,gene regulation interaction
ENSG00000025156,HSF2,genomic instability,cellular stress response,transcriptional regulation,chromatin remodeling,dna repair mechanisms,tumor suppression
ENSG00000163754,GYG1,glycogen biosynthesis,altered expression levels,cellular metabolism regulation,tumor progression enhancement,cell proliferation promotion,metabolic reprogramming
ENSG00000131779,PEX11B,peroxisome biogenesis,cell growth regulation,overexpressed in cancer,metabolic reprogramming,signaling pathway interaction,lipid metabolism modulation
ENSG00000146857,STRA8,cell proliferation,tumor suppression,oncogene regulation,transcriptional modulation,tumor progression,biomarker potential
ENSG00000167470,MIDN,enhanced cell migration,tumor progression,metastatic cascade,cytoskeleton reorganization,cell adhesion modulation,oncogenic transformation
ENSG00000129226,CD68,tumor associated macrophages,phagocytosis,cell adhesion,angiogenesis,metastasis,immune modulation
ENSG00000167105,TMEM92,cellular proliferation,pi3k/akt pathway modulation,anti-apoptotic function,cell migration and invasion,tumor progression driver,gene amplification and overexpression
ENSG00000099958,DERL3,erad pathway regulation,aaa-atpase p97 interaction,cellular stress response,unfolded protein response (upr),tumor progression,cancer cell adaptation
ENSG00000242265,PEG10,cell proliferation,cell migration,tumor progression,oncogenic driver,prognostic marker,genomic amplification
ENSG00000085871,MGST2,detoxification mechanism,glutathione conjugation,cellular protection,chemoresistance modulation,apoptosis regulation,dna repair involvement
ENSG00000204316,MRPL38,mitochondrial ribosome assembly,tumor cell metabolism,increased protein synthesis,oncogenic mutations,tumor suppressor regulation,genomic instability
ENSG00000146872,TLK2,dna replication,chromatin remodeling,cell cycle progression,tumor aggressiveness,genome instability,atr/chk1 pathway activation
ENSG00000159263,SIM2,tumor suppressor function,regulatory transcription factor,cell differentiation regulation,apoptosis promotion,epigenetic mark regulation,oncogene repression
ENSG00000187987,ZSCAN23,tumor metastasis,transcriptional regulation,cell growth regulation,oncogenic process,apoptosis evasion,genomic instability
ENSG00000126749,EMG1,histone modification,chromatin regulation,cellular growth promotion,gene expression dysregulation,genomic instability,tumor progression
ENSG00000213699,SLC35F6,glycosylation regulation,tumor progression,cell proliferation enhancement,metastasis promotion,biomarker potential,therapeutic target
ENSG00000184162,NR2C2AP,pparγ activation,cell proliferation,aberrant expression,apoptosis regulation,transcriptional modulation,protein-protein interaction
ENSG00000120333,MRPS14,mitochondrial translation regulation,energy metabolism impairment,cell growth promotion,tumor survival enhancement,reactive oxygen species production,unfolded protein response activation
ENSG00000101445,PPP1R16B,regulatory subunit,cell proliferation,tumor progression,chromatin remodeling,protein phosphatase regulation,oncogenic signaling
ENSG00000149596,JPH2,autophagic regulation,cell cycle modulation,junctophilin function,mitochondrial interaction,nf-κb signaling pathway,oncogenic overexpression
ENSG00000182973,CNOT10,enhanced cell proliferation,aberrant gene expression,regulation of mirna,apoptosis resistance,tumor suppressor interaction,loss of function mutations
ENSG00000134817,APLNR,cellular proliferation,g protein-coupled receptor signaling,oncogenic effects,tumor aggressiveness,angiogenesis regulation,apoptosis evasion
ENSG00000157216,SSBP3,dna unwinding,genomic stability maintenance,cell cycle regulation,apoptosis modulation,tumor aggressiveness,chromosomal instability
ENSG00000111432,FZD10,wnt signaling pathway,tumor progression,cell proliferation,cancer biomarker,prognostic marker,adhesion molecule activation
ENSG00000227460,SYNGAP1,ras/mapk signaling,constitutive activation,loss of function mutations,tumor suppressor,genome instability,dna repair mechanisms
ENSG00000144711,IQSEC1,rho gtpase activation,cytoskeletal dynamics,cell migration enhancement,oncogenic signaling pathways,tumor progression promotion,prognostic marker
ENSG00000161243,FBXO27,ubiquitination pathway,substrate regulation,cell cycle regulation,dna repair mechanisms,tumor suppression,genomic instability
ENSG00000137710,RDX,cell adhesion disruption,oncogene activation,cytoplasmic actin binding,protein kinase regulation,pi3k/akt pathway modulation,tumor progression enhancement
ENSG00000101977,MCF2,swi/snf complex,chromatin remodeling,gene expression regulation,tumor progression,cell proliferation,epigenetic modification
ENSG00000074054,CLASP1,microtubule dynamics regulation,cell cycle regulation disruption,genomic instability contribution,tumor progression promotion,therapeutic target identification,cell migration and invasion enhancement
ENSG00000010310,GIPR,oncogene,constitutive activation,cell proliferation regulation,signaling pathway modulation,apoptosis modulation,tumorigenesis promotion
ENSG00000172159,FRMD3,tumor suppressor function,genomic stability maintenance,microtubule regulation,mitotic spindle checkpoint regulation,wnt/β-catenin pathway activation,chromosomal instability prevention
ENSG00000196811,CHRNG,pi3k/akt/mtor pathway modulation,neurotransmission regulation,cell proliferation promotion,tumor growth support,apoptosis suppression,genomic alterations association
ENSG00000158411,MITD1,oncogene overexpression,dna repair mechanism,chromatin remodeling,cell proliferation regulation,genome instability maintenance,pi3k/akt pathway activation
ENSG00000130724,CHMP2A,escrt machinery interaction,endosomal transport regulation,cell membrane dynamics modulation,oncogenic function implicated,tumor growth promotion,cancer stem cell maintenance
ENSG00000288505,NANOS3,akt signaling,apoptosis suppression,cell survival promotion,dna damage response regulation,oncogenic transcription factor,p53-p63 pathway modulation
ENSG00000111275,ALDH2,redox balance regulation,tumor suppressor function,cellular metabolism regulation,dna damage prevention,genomic stability maintenance,cancer prognosis improvement
ENSG00000165092,ALDH1A1,oxidative stress resistance,tumor progression,stem cell maintenance,cancer stem cell self-renewal,epithelial-to-mesenchymal transition (emt),treatment resistance
ENSG00000133997,MED6,protein degradation dysregulation,oncogenic signaling activation,cell cycle progression alteration,genomic instability contribution,transcriptional regulation modulation,chromosomal abnormalities association
ENSG00000134363,FST,cell adhesion modulation,emt regulation,growth factor inhibition,metastasis facilitation,signaling pathway interaction,therapeutic target
ENSG00000164347,GFM2,increased glutathione recycling,enhanced dna repair capacity,resistance to chemotherapy,cell proliferation regulation,antioxidant function preservation,tumorigenesis promotion
ENSG00000143771,CNIH4,calcium-dependent signaling,cell-cell adhesion modulation,tumor progression promoter,therapeutic target,metastasis regulator,signaling pathway component
ENSG00000171368,TPPP,microtubule stabilization,cell proliferation,chromosome segregation,epithelial-to-mesenchymal transition (emt),prognostic marker,pi3k/akt signaling pathway modulation
ENSG00000143184,XCL1,immunosurveillance,tumor suppression,immune cell recruitment,cell migration regulation,adhesion molecule interaction,pro-inflammatory signaling
ENSG00000274726,ARHGEF10,gef activity,rho gtpase activation,oncogenic signaling,cell migration regulation,cytoskeletal reorganization,tumor progression
ENSG00000171234,UGT2B7,detoxification process,metabolic regulation,cellular sensitivity,tumorigenesis,resistance to chemotherapy,therapeutic target
ENSG00000011677,GABRA3,neurotransmission disruption,receptor assembly dysfunction,cell proliferation enhancement,survival pathway activation,therapeutic target identification,genomic instability association
ENSG00000113269,RNF130,cell cycle regulation,protein degradation,chromatin remodeling,oncogenic processes,therapeutic target,cell proliferation
ENSG00000189334,S100A14,cancer-associated protein,cell proliferation regulation,tumor progression marker,epithelial-to-mesenchymal transition regulation,calcium signaling modulation,oncogene upregulation
ENSG00000174327,SLC16A13,glycolytic regulation,metabolic reprogramming,tumor progression,energy metabolism,plasma membrane localization,protein-protein interaction
ENSG00000061656,SPAG4,cellular adhesion,cell migration,overexpressed,poor prognosis,pi3k/akt pathway interaction,wnt/β-catenin pathway interaction
ENSG00000112378,PERP,apoptosis regulation,tumor aggressiveness,biomarker potential,p53 interaction,cell survival enhancement,genomic stability maintenance
ENSG00000180053,NKX2-6,transcription factor activity,cell cycle regulation,apoptosis inhibition,tumor progression,epithelial-to-mesenchymal transition,biomarker potential
ENSG00000100926,TM9SF1,transmembrane regulation,oncogenic properties,cell proliferation,lipid metabolism modulation,cancer progression,therapeutic target
ENSG00000127527,EPS15L1,cell proliferation,egfr pathway activation,epithelial-to-mesenchymal transition,endocytosis regulation,protein-protein interaction,transcription factor regulation
ENSG00000110786,PTPN5,ptpn5 is involved in signaling pathway modulation,tyrosine phosphatase activity regulation,cell growth and survival promotion,tumor progression suppression,receptor tyrosine kinase interaction,src family kinase activation
ENSG00000134873,CLDN10,cellular polarity disruption,tight junction disruption,epithelial-to-mesenchymal transition (emt) promotion,increased cell migration,increased cell proliferation,therapeutic target
ENSG00000164270,HTR4,cellular signaling pathway,g-protein coupled receptor,prognostic biomarker,oncogenesis,proliferation regulation,survival pathway modulation
ENSG00000198042,MAK16,chromosomal instability,genomic alterations,spindle assembly checkpoint regulation,aneuploidy induction,loss-of-function mutations,cell cycle dysregulation
ENSG00000116213,WRAP73,genomic instability,chromatin remodeling,dna repair mechanism,cell proliferation,oncogene potential,tumor progression
ENSG00000172461,FUT9,cell adhesion disruption,glycosylation regulation,tumor progression driver,metastasis facilitation,oncogene activation,glycan biosynthesis
ENSG00000109738,GLRB,glutathione system,redox homeostasis,oxidative stress,dna damage,genetic instability,therapeutic target
ENSG00000187954,CYHR1,g2/m phase transition,cell cycle regulation,cyclin-dependent kinase interaction,oncogene overexpression,tumor progression,potential therapeutic target
ENSG00000158710,TAGLN2,cell migration,oncogenic factor regulation,tumor progression,focal adhesion dynamics,integrin interaction,cell invasion
ENSG00000196812,ZSCAN16,chromatin remodeling,tumor progression,oncogenic transcription factor,epigenetic regulator,cancer cell proliferation,proliferation inhibitor
ENSG00000173409,ARV1,lipid biosynthesis pathway,anabolic pathway activation,cell growth promotion,metabolic regulation,therapeutic target,genomic mutation
ENSG00000151224,MAT1A,tumor metabolism,cancer energy production,mitochondrial dysfunction,rna stability regulation,cell cycle progression,protein biosynthesis
ENSG00000078269,SYNJ2,phosphoinositide metabolism,pi3k/akt signaling modulation,oncogenic processes,cell survival and proliferation regulation,protein-protein interactions,tumor suppressor protein association
ENSG00000104154,SLC30A4,**

zinc transport,cell proliferation,ros generation,oncogenic processes,metabolic regulation,cancer progression
ENSG00000163873,GRIK3,glutamate receptor activation,cell proliferation,synaptic transmission regulation,tumor progression driver,genomic amplification,signaling pathway dysregulation
ENSG00000233276,GPX1,redox regulation,oxidative stress protection,cellular antioxidant function,dna damage prevention,cancer cell survival,therapeutic target
ENSG00000163792,TCF23,cell cycle regulation,dna damage response,tumor amplification,cancer driver gene,transcriptional regulation,apoptosis suppression
ENSG00000170899,GSTA4,cellular detoxification,antioxidant defense,tumor suppressor,metastasis regulation,drug resistance,cell survival modification
ENSG00000183463,URAD,ubiquitination pathway,protein degradation,cell cycle progression,tumorigenesis,cell proliferation,genomic instability
ENSG00000198807,PAX9,transcription factor,cell proliferation,apoptosis inhibition,wnt/β-catenin pathway interaction,oncogenic regulation,tumor progression
ENSG00000121931,LRIF1,loss of function mutations,tumor suppression,dna repair regulation,cell cycle control,apoptosis regulation,genomic instability
ENSG00000152270,PDE3B,proliferation regulation,epithelial-to-mesenchymal transition,signaling pathway modulation,tumor progression facilitation,angiogenesis regulation,biomarker potential
ENSG00000101040,ZMYND8,histone modification,chromatin remodeling,oncogenic pathway regulation,apoptosis inhibition,metastasis promotion,therapeutic target
ENSG00000203933,CXorf66,transcription factor,regulatory function,cell growth modulation,oncogenic potential,apoptosis regulation,metabolic reprogramming
ENSG00000177556,ATOX1,iron homeostasis disruption,oncogenic driver,heme biosynthesis regulation,tumor growth promotion,dna damage accumulation,genetic instability induction
ENSG00000086289,EPDR1,pi3k/akt pathway,oncogene activation,mutation leading to overexpression,cell proliferation and survival,tumor progression and metastasis,therapeutic target and prognostic marker
ENSG00000165655,ZNF503,tumor suppressor function,genomic instability,apoptosis regulation,cell cycle regulation,dna repair mechanism,gata3-binding interaction
ENSG00000162571,TTLL10,microtubule destabilization,chromosomal instability,mitotic spindle assembly,cell cycle dysregulation,tumor aggressiveness,protein overexpression
ENSG00000182463,TSHZ2,overexpression,cell proliferation,transcriptional regulation,tumor progression,apoptosis resistance,chromatin remodeling
ENSG00000126264,HCST,apoptosis regulation,cell growth modulation,enzymatic activity,histidine triad domain,immune response signaling,oncogenic pathway activation
ENSG00000128309,MPST,prostaglandin biosynthesis,oncogenic driver,cell proliferation,angiogenesis regulation,metastasis promotion,pi3k/akt pathway interaction
ENSG00000167395,ZNF646,transcriptional regulation,oncogenic potential,cell proliferation,apoptosis inhibition,poor prognosis,transcription factor activity
ENSG00000088970,KIZ,microtubule dynamics,cellular morphology,tumor suppressor gene,protein-protein interactions,regulation of cell proliferation,anti-cancer target
ENSG00000167491,GATAD2A,chromatin remodeling,p53 interaction,tumor suppressor regulation,cancer progression,genomic instability,transcriptional repression
ENSG00000116906,GNPAT,overexpression,lipid metabolism regulation,cancer cell proliferation,protein kinase c activation,ceramide regulation,poor prognosis marker
ENSG00000172613,RAD9A,genomic instability,dna repair machinery,checkpoint kinase activation,cell cycle regulation,tumor suppressor function,brca1/2 interaction
ENSG00000033178,UBA6,ubiquitination pathway,protein stability modulation,tumor suppressor functions,ups regulation,cancer driver gene,proteasome interaction
ENSG00000104472,CHRAC1,chromatin remodeling complex,oncogene activation,cell proliferation enhancement,transcriptional regulation,prognostic biomarker potential,cellular stress response modulation
ENSG00000179051,RCC2,chromosomal instability,genomic maintenance,kinetochores assembly,cell cycle regulation,microtubule attachment,aneuploidy promotion
ENSG00000136881,BAAT,bile acid regulation,tumor suppressor function,cell proliferation modulation,therapeutic target,protein-protein interactions,oncogenic potential
ENSG00000163347,CLDN1,claudin-1 overexpression,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition,cell migration and invasion,tumor aggressiveness,metastasis promotion
ENSG00000081870,HSPB11,microtubule regulation,actin cytoskeleton dynamics,oncogenic processes,metastasis promotion,tumorigenesis driver,chemotherapy resistance
ENSG00000198963,RORB,tumor suppressor function,loss of expression,cell cycle regulation,apoptosis promotion,genomic stability maintenance,transcriptional regulation
ENSG00000147548,NSD3,histone modification,chromatin remodeling,transcriptional regulation,oncogenic transformation,epigenetic reprogramming,cellular regulation
ENSG00000120686,UFM1,genomic instability,dna damage response,apoptosis regulation,cell cycle progression,ubiquitin modification,protein degradation
ENSG00000164687,FABP5,lipid metabolism,oncogenic transformation,protein-protein interaction,cell proliferation,dna damage,epithelial-to-mesenchymal transition
ENSG00000139445,FOXN4,transcription factor regulation,cell cycle modulation,oncogenic driver,uncontrolled cell growth,therapeutic target,tumor aggressiveness
ENSG00000011523,CEP68,mitotic checkpoint regulation,microtubule stability,genomic instability,tumor progression,cell cycle disruption,protein overexpression
ENSG00000135775,COG2,cell growth regulation,apoptosis modulation,calcium homeostasis,er stress response,protein folding regulation,tumor progression influence
ENSG00000124209,RAB22A,rab22a overexpression,gain-of-function mutations,oncogenic signaling,cellular polarity disruption,endocytic pathway modulation,therapeutic target
ENSG00000113272,THG1L,amplification,cell metabolism reprogramming,glycolytic flux promotion,dna damage response inhibition,apoptosis evasion,metabolic adaptation
ENSG00000165704,HPRT1,purine metabolism,nucleotide synthesis,cell survival,cell proliferation,dna repair,oncogenic processes
ENSG00000197901,SLC22A6,transporter activity,organic cation transport,chemoresistance contribution,overexpression association,poor prognosis indicator,drug efflux enhancement
ENSG00000251380,DCANP1,cellular interaction,extracellular matrix regulation,tumor progression,signaling pathway modulation,cell adhesion disruption,metastasis facilitation
ENSG00000042429,MED17,cell proliferation,transcription regulation,tumor progression,oncogenic signaling,chromatin remodeling,gene expression
ENSG00000148297,MED22,transcriptional regulation,cell growth modulation,oncogenic processes,tumorigenesis driver,gene expression alteration,mediator complex interaction
ENSG00000170689,HOXB9,oncogenic transcription factor,tumor progression driver,epithelial-to-mesenchymal transition regulator,cell migration promoter,poor prognosis marker,wnt/β-catenin pathway activator
ENSG00000100284,TOM1,ubiquitin-dependent protein degradation,oncogenic behavior,protein homeostasis regulation,signaling pathway modulation,cell proliferation facilitation,tumor suppressor protein regulation
ENSG00000039600,SOX30,chromatin remodeling,transcriptional regulation,tumor suppressor activity,epigenetic modification,apoptosis induction,cell cycle regulation
ENSG00000111481,COPZ1,cell cycle regulation,cancer prognosis marker,deubiquitination activity,mapk/erk pathway activation,tumor aggressiveness,protein degradation regulation
ENSG00000243989,ACY1,anabolic metabolism,cell proliferation,fatty acid synthesis,overexpression,poor prognosis,therapeutic target
ENSG00000186815,TPCN1,calcium signaling pathway,tumor progression,cell proliferation,oncogenic process,cell survival,gene expression
ENSG00000162341,TPCN2,calcium channel regulation,calcium signaling pathway,cell membrane excitability,oncogenic processes,cancer cell proliferation,cell migration enhancement
ENSG00000153896,ZNF599,transcriptional repression,krab domain-containing family,zinc finger protein structure,chromatin modification,tumor progression,aberrant expression
ENSG00000167528,ZNF641,chromatin regulation,histone modification,cell proliferation,transcriptional dysregulation,metastasis promoter,tumor suppressor repression
ENSG00000134551,PRH2,proline-rich homeobox 2 protein regulation,tumor growth promotion,apoptosis inhibition,cell cycle progression modulation,wnt/beta-catenin pathway activation,oncogenic processes facilitation
ENSG00000258429,PDF,oncogenic protein,cell proliferation enhancement,apoptosis inhibition,tumor progression driver,metastasis promoter,rna-binding activity
ENSG00000170473,PYM1,glycolytic regulation,energy metabolism,cell proliferation,aerobic glycolysis,pyruvate phosphorylation,tumor growth
ENSG00000149798,CDC42EP2,rho gtpase activation,cancer cell migration,epithelial-to-mesenchymal transition,apoptosis resistance,angiogenesis promotion,therapeutic target
ENSG00000165804,ZNF219,transcription factor regulation,cell cycle progression,apoptosis regulation,tumor suppressor activity,oncogenic signaling,cellular proliferation
ENSG00000074416,MGLL,histone methylation regulation,loss of enzyme activity,aberrant chromatin remodeling,tumor suppressor mutation,protein-protein interaction,chromatin modification pathway
ENSG00000135926,TMBIM1,apoptosis regulation,mitochondrial dynamics,tumor suppression,cell proliferation,cellular energy metabolism,oncogenesis
ENSG00000162885,B3GALNT2,altered glycosylation,biosynthesis of gangliosides,cancer cell proliferation,cell adhesion and signaling,dysregulated expression,therapeutic target
ENSG00000165502,RPL36AL,ribosome biogenesis,pseudogene overexpression,poor prognosis,biomarker candidate,cell growth promotion,tumor aggressiveness
ENSG00000066777,ARFGEF1,cell proliferation,vesicle trafficking,protein interaction,tumor progression,poor prognosis,therapeutic target
ENSG00000283868,ZBTB4,transcriptional regulation,tumor growth promotion,cell cycle progression,oncogene activation,pi3k/akt pathway involvement,apoptosis inhibition
ENSG00000276600,RAB7B,autophagy regulation,cell survival pathway,endocytic trafficking,late endosome-lysosome transport,oncogenic signaling,prognostic marker
ENSG00000100360,IFT27,ift complex dysregulation,cilia dysfunction,cellular signaling pathway modulation,therapeutic target,oncogenic driver mutation,cell cycle regulation disruption
ENSG00000204815,TTC25,**

degradation of tumor suppressors,ubiquitination and protein degradation,protein-protein interactions,tumor progression,cell cycle regulation,poor prognosis 
**
ENSG00000183625,CCR3,chemokine signaling,immune cell recruitment,tumor progression,poor prognosis,chemokine receptor function,inflammation modulation
ENSG00000188730,VWC2,cell adhesion,tumor progression,metastasis,epithelial-to-mesenchymal transition,upregulated expression,poor prognosis
ENSG00000168792,ABHD15,lipid metabolism modulation,endocannabinoid regulation,cell survival pathway activation,tumor suppressor activity loss,oncogenic signaling enhancement,genomic instability promotion
ENSG00000171049,FPR2,cell migration,cell proliferation,chemoresistance,formyl peptide receptor activation,g-protein coupled signaling,oncogenic pathway activation
ENSG00000130382,MLLT1,histone methyltransferase activity,tumor suppressor function,transcriptional regulation,genome stability maintenance,oncogenic pathway disruption,epigenetic dysregulation
ENSG00000103966,EHD4,cell migration,tumor progression,endocytic trafficking,signaling pathway interaction,metastasis facilitation,therapeutic target
ENSG00000039987,BEST2,ion transport regulation,potassium channel function,cancer progression,cell proliferation regulation,cell survival pathway modulation,tumor microenvironment interaction
ENSG00000156675,RAB11FIP1,recycling endosomes,growth factor receptor recycling,cell proliferation,oncogenic signaling,tumor progression,endosomal transport
ENSG00000137393,RNF144B,pi3k/akt pathway interaction,oncogene function,cell cycle regulation,dna damage response,protein degradation dysfunction,therapeutic target
ENSG00000153339,TRAPPC8,cellular trafficking,oncogenic pathway activation,endocytic regulation,tumor aggressiveness,prognostic marker,cell membrane dynamics
ENSG00000135924,DNAJB2,apoptosis inhibition,cell proliferation enhancement,protein folding regulation,chaperone activity,oncogene overexpression,tumor growth promotion
ENSG00000103740,ACSBG1,ceramide metabolism,lipid raft dynamics,cell membrane integrity,oncogenic processes,cell growth promotion,metastasis facilitation
ENSG00000175567,UCP2,mitochondrial regulation,oncogenic process,energy metabolism,tumor progression,cell survival,metabolic regulation
ENSG00000188038,NRN1L,alternative splicing regulation,oncogene potential,cell growth and proliferation regulation,rna-binding protein interactions,tumorigenesis association,gene expression modulation
ENSG00000141956,PRDM15,tumor suppressor function,genomic instability,cell cycle regulation,dna repair mechanisms,apoptosis modulation,transcriptional regulation
ENSG00000102468,HTR2A,cell proliferation,pi3k/akt pathway activation,tumor progression,metastasis promotion,serotonin receptor function,cancer aggressiveness
ENSG00000110063,DCPS,wnt signaling pathway,aberrant activation,cell proliferation,apoptosis regulation,cancer development,signaling protein
ENSG00000132467,UTP3,rna metabolism regulation,constitutive activation of pro-survival pathways,overexpression-driven oncogenesis,gene expression dysregulation,nuclear exosome complex interaction,therapeutic target
ENSG00000114268,PFKFB4,glycolytic shift,oncogene overexpression,growth factor activation,lactate production,mtor pathway regulation,cancer metabolism
ENSG00000118985,ELL2,cell cycle regulation,epigenetic silencing,chromatin remodeling,tumor suppressor gene regulation,apoptosis suppression,poor prognostic marker
ENSG00000147124,ZNF41,transcription factor,apoptosis regulation,cell cycle modulation,tumor progression,metastasis promoter,biomarker potential
ENSG00000132837,DMGDH,altered expression,redox regulation,cellular metabolism,oncogenic signaling,tumor progression,metabolic reprogramming
ENSG00000244476,ERVFRD-1,oncogene,cell growth regulation,non-coding rna gene,tumor progression,signaling pathway activation,chromatin remodeling
ENSG00000124243,BCAS4,cell cycle regulation,dna damage response,tumor proliferation,genomic instability,homologous recombination repair,protein-protein interaction
ENSG00000141971,MVB12A,altered subcellular localization,cellular trafficking regulation,cancer progression,escrt complex interaction,endosomal sorting disruption,oncogenic signaling facilitation
ENSG00000155629,PIK3AP1,pi3k regulation,cancer development,cellular survival,tumorigenesis modulation,cell growth regulation,genomic instability
ENSG00000143603,KCNN3,calcium-activated potassium channels,constitutive activation,ion transport regulation,cell migration promotion,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000213397,HAUS7,microtubule regulation,genomic instability,tumor progression,cell proliferation,centrosome cohesion,none
ENSG00000065883,CDK13,cell cycle regulation,constitutive activation,dna damage response,genomic instability,oncogenic processes,pi3k/akt pathway interaction
ENSG00000109618,SEPSECS,cell cycle regulation,genome instability,proteasomal degradation,sumoylation,tumor suppression,ubiquitination
ENSG00000163406,SLC15A2,overexpressed,tumor aggressiveness,protein interaction,oncogene candidate,cellular transport regulation,cancer prognosis
ENSG00000153234,NR4A2,nr4a2 overexpression,immune response modulation,apoptosis resistance,cell differentiation regulation,tumor progression facilitation,transcriptional regulation enhancement
ENSG00000119121,TRPM6,cellular homeostasis disruption,calcium signaling pathway activation,oncogene overexpression,cell cycle progression promotion,apoptosis evasion,epithelial-to-mesenchymal transition (emt)
ENSG00000115163,CENPA,kinetochores formation,centromere assembly,genomic instability,cell cycle regulation,tumor progression,chromosomal abnormalities
ENSG00000152409,JMY,cellular regulation,tumor promotion,epithelial-to-mesenchymal transition,protein-protein interaction,dysregulated expression,oncogenic activity
ENSG00000134072,CAMK1,cellular signaling,calcium/calmodulin activation,kinase activity modulation,tumor progression,apoptosis evasion,therapeutic target
ENSG00000109163,GNRHR,angiogenesis promotion,cell proliferation regulation,g protein signaling pathway,hormone-sensitive pathways modulation,metastasis facilitation,tumor progression promotion
ENSG00000197858,GPAA1,lipid metabolism,cellular proliferation,tumor progression,therapeutic target,oncogenic signaling,prognostic biomarker
ENSG00000135437,RDH5,cellular responses,oxidative stress regulation,therapeutic resistance,pi3k/akt pathway interaction,tumor growth promotion,redox balance modulation
ENSG00000174970,OR10AG1,olfactory receptor activation,cell proliferation,tumor progression,signaling pathway modulation,protein-protein interaction,cancer prognosis
ENSG00000107317,PTGDS,prostaglandin biosynthesis,tumor progression,inflammation regulation,angiogenesis modulation,cell proliferation enhancement,prognostic biomarker
ENSG00000121351,IAPP,cellular modulation,tumor progression,metabolic regulation,cell survival,genetic alterations,protein interaction
ENSG00000197165,SULT1A2,hormone regulation,estrogen metabolism,cellular detoxification,metabolic regulation,gene expression regulation,signaling pathway modulation
ENSG00000116005,PCYOX1,heme metabolism regulation,oncogenic pathway activation,oxidative stress induction,cell proliferation promotion,tumor aggressiveness association,therapeutic target identification
ENSG00000198700,IPO9,mitochondrial dynamics,tumor suppressor function,cell cycle regulation,apoptosis resistance,protein-protein interactions,cell proliferation enhancement
ENSG00000160282,FTCD,thf biosynthesis inhibition,dna synthesis impairment,metabolic reprogramming,tumor suppressor function,microenvironment modulation,genomic instability
ENSG00000169621,APLF,genomic instability,telomere maintenance,dna repair pathway,apoptosis resistance,cell cycle regulation,protein-protein interaction
ENSG00000148344,PTGES,tumor progression,prostaglandin synthesis,cell migration,angiogenesis promotion,immune evasion,cell signaling regulation
ENSG00000156298,TSPAN7,tumor progression,tetraspanin function,cell adhesion regulation,pi3k/akt pathway interaction,biomarker potential,cancer cell proliferation
ENSG00000164182,NDUFAF2,mitochondrial complex i dysfunction,decreased oxidative phosphorylation,enhanced glycolysis,altered cellular metabolism,therapeutic target,oncogenic potential
ENSG00000169688,MT1B,oncogenic function,tumor progression,heavy metal regulation,cell survival,zinc binding,resistance to therapy
ENSG00000163683,SMIM14,cellular proliferation regulation,metabolic pathway modulation,oncogenesis association,aberrant expression,tumor progression link,therapeutic target possibility
ENSG00000154099,DNAAF1,cell signaling pathway disruption,gene expression dysregulation,cancer cell motility,epithelial tissue alteration,dysfunctional cilia,apoptosis resistance
ENSG00000171962,DRC3,cell cycle progression,crl regulation,dna repair,ubiquitination,genomic instability,tumor suppressor interaction
ENSG00000170927,PKHD1,primary cilium dysfunction,oncogenic signaling,aberrant cell proliferation,loss of tumor suppressor function,dysregulation of cell-cell interactions,cilia-mediated signaling pathway disruption
ENSG00000109832,DDX25,rna helicase function,tumor progression,cell proliferation,alternative splicing regulation,genome instability,oncogene overexpression
ENSG00000184445,KNTC1,genome stability,dna damage response,cell cycle regulation,chromosome segregation,checkpoint activation,cell proliferation
ENSG00000174442,ZWILCH,chromatin remodeling,genomic instability,oncogenesis,tumor progression,transcriptional regulation,cell proliferation
ENSG00000115363,EVA1A,genomic instability,aneuploidy,cell division regulation,microtubule dynamics,spindle checkpoint,chromosome segregation
ENSG00000070182,SPTB,cytoskeleton remodeling,cell migration promotion,metastasis facilitation,tumor progression,cell proliferation enhancement,apoptosis resistance
ENSG00000170178,HOXD12,genomic instability,tumor suppressor function,cell cycle regulation,dna repair mechanism,transcriptional repression,homologous recombination
ENSG00000176894,PXMP2,**
pxmp2 overexpression,lipid metabolism disruption,phospholipid asymmetry regulation,tumor progression association,membrane fluidity modulation,cellular lipid homeostasis maintenance
**
ENSG00000244045,TMEM199,tumor suppressor,cell growth regulation,adhesion molecule interaction,prognostic biomarker,cell signaling pathway,loss-of-function mutation
ENSG00000143543,JTB,ciliogenesis dysfunction,cellular signaling disruption,tissue patterning regulation,genetic heterogeneity,protein-protein interaction,regulatory mechanism alteration
ENSG00000244122,UGT1A7,tumor metabolism,carcinogen metabolism,environmental carcinogens,toxic compound processing,detoxification pathway,genetic variation
ENSG00000137040,RANBP6,tumor suppressor inhibition,oncogenic activity promotion,cell cycle regulation disruption,cell proliferation enhancement,nuclear transport modulation,p53 interaction
ENSG00000171631,P2RY6,immune regulation,g-protein coupled receptor activation,pi3k/akt pathway modulation,tumor immune evasion,immune suppression,oncogenic signaling
ENSG00000131386,GALNT15,cell adhesion disruption,glycosylation regulation,cell migration promotion,tumor progression enhancement,oncogene activation,genomic instability induction
ENSG00000137166,FOXP4,transcriptional regulation,cell proliferation,tumor progression,pro-survival pathways,apoptosis inhibition,epigenetic regulation
ENSG00000136535,TBR1,tumor progression,cellular differentiation,gene regulation,transcriptional activation,oncogene function,chromatin remodeling
ENSG00000035499,DEPDC1B,pi3k/akt pathway interaction,cell growth regulation,tumor suppressor function,loss-of-function mutations,oncogene activation,genomic instability
ENSG00000132872,SYT4,cellular regulation,constitutive activation,oncogene function,potential therapeutic target,calcium-dependent signaling,protein-protein interaction
ENSG00000165272,AQP3,water channel function,cellular hydration regulation,tumor progression,metastasis promotion,epithelial cell involvement,poor prognosis marker
ENSG00000170017,ALCAM,overexpression,tumor progression,cell adhesion molecule,metastasis promotion,therapeutic target,angiogenesis regulation
ENSG00000013725,CD6,t-cell activation,immune evasion,prognostic marker,immune suppression,cell surface expression,signal transduction
ENSG00000072415,MPP5,endocytosis regulation,cell membrane trafficking,cytoplasmic protein function,signal transduction pathway interaction,tumor invasion facilitation,oncogenic process contribution
ENSG00000122696,SLC25A51,metabolic reprogramming,cellular energy metabolism,tumor progression,therapeutic target,aberrant expression,mitochondrial carrier protein
ENSG00000143167,GPA33,apoptosis regulation,cell cycle progression,growth factor regulation,pi3k/akt pathway interaction,tumor aggressiveness marker,golgi apparatus association
ENSG00000151612,ZNF827,transcriptional regulation,cell cycle progression,apoptosis regulation,dna repair mechanisms,nuclear localization,oncogenic transformation
ENSG00000276537,TTYH1,protein kinase activation,cell proliferation,tumor progression,apoptosis evasion,membrane dynamics regulation,oncogenic properties
ENSG00000108639,SYNGR2,cell adhesion disruption,cell migration facilitation,oncogene activation,pi3k/akt pathway activation,metastasis promotion,cytoskeletal protein interaction
ENSG00000168077,SCARA3,scavenger receptor function,oncogenic processes promotion,cell adhesion regulation,metastasis facilitation,therapeutic target potential,pi3k/akt pathway interaction
ENSG00000180176,TH,thioredoxin overexpression,cell proliferation enhancement,metastasis promotion,redox regulation disruption,cell survival enhancement,oncogenic pathway activation
ENSG00000104870,FCGRT,immunomodulatory function,tumor progression marker,immune evasion mechanism,angiogenesis promotion,apoptosis inhibition,prognostic biomarker
ENSG00000076864,RAP1GAP,rap protein regulation,cell proliferation inhibition,tumor suppressor function,cell cycle control,oncogenic pathway regulation,gtpase activation
ENSG00000164902,PHAX,mrna export regulation,cell proliferation regulation,oncogene modulation,pi3k/akt pathway interaction,gene expression profiling,cancer progression marker
ENSG00000127578,WFIKKN1,cell cycle regulation,oncogenic function,transcriptional activation,protein kinase activity,epithelial-to-mesenchymal transition,dna repair regulation
ENSG00000126458,RRAS,constitutive activation,pi3k/akt pathway interaction,gtp-binding protein function,cell proliferation regulation,oncogenic mutation driver,tumor growth promotion
ENSG00000087495,PHACTR3,gtpase regulation,signaling pathway activation,cell migration facilitation,protein interaction partner,therapeutic target potential,tumorigenesis association
ENSG00000273514,FOXD4L6,epigenetic regulation,pi3k/akt signaling,transcriptional upregulation,cell cycle progression,apoptosis inhibition,tumor development
ENSG00000160563,MED27,chromatin remodeling,regulatory subunit,mediator complex component,transcriptional regulation,cell cycle progression,apoptosis regulation
ENSG00000101181,MTG2,transcriptional regulation,oncogene suppression,tumor growth inhibition,cell proliferation regulation,tumor suppressor function,transcription factor inhibition
ENSG00000131914,LIN28A,let-7 repression,oncogene activation,mirna regulation,cancer stem cell maintenance,cell cycle progression,apoptosis inhibition
ENSG00000135269,TES,genomic instability,oncogene overexpression,transcriptional regulation,cell cycle disruption,apoptosis inhibition,tumor progression
ENSG00000187003,ACTL7A,cell cycle regulation,oncogenesis,tumour progression,potential oncogene,apoptosis inhibition,cell proliferation promotion
ENSG00000182631,RXFP3,cell proliferation,survival pathway,oncogene,dysregulated signaling,protein-protein interaction,tumor progression
ENSG00000164405,UQCRQ,mitochondrial dysfunction,increased mitochondrial membrane potential,cell survival and proliferation,tumor progression,apoptosis resistance,metabolic regulation
ENSG00000167476,JSRP1,aberrant splicing,cell proliferation,prognostic marker,spliceosome regulation,rna binding protein interaction,tumor growth promotion
,HIST1H4L,chromatin remodeling,transcription regulation,histone modification,genome stability,binding partner identification,dna packing
,HIST1H4A,histone modification,epigenetic regulation,chromatin remodeling,transcriptional regulation,dna packaging,nucleosome formation
,HIST1H4J,histone modification,chromatin remodeling,gene overexpression,cell proliferation,epigenetic regulation,tumor aggressiveness
,HIST4H4,epigenetic regulator,chromatin remodeling,transcriptional regulation,histone modification,nucleosome composition,tumor aggressiveness
,HIST1H4F,histone modification,chromatin remodeling,gene expression regulation,tumor progression,epigenetic control,cell cycle regulation
,HIST1H4C,histone modification,chromatin regulation,epigenetic changes,tumor suppressor modulation,oncogenic process enhancement,cell cycle regulation
,HIST2H4B,histone modification,epigenetic regulation,transcriptional elongation,oncogenic process,cancer development,therapeutic target
,HIST1H4D,chromatin regulation,epigenetic dysregulation,histone modifications,genomic instability,dna repair defects,oncogenesis
,HIST2H4A,histone modification,tumor suppression,chromatin regulation,epigenetic reprogramming,genomic instability,oncogenic potential
,HIST1H4B,histone regulation,chromatin remodeling,epigenetic control,oncogenic transformation,cell proliferation,apoptosis regulation
,HIST1H4H,histone regulation,chromatin remodeling,epigenetic modulation,transcriptional regulation,dna packaging,cancer cell proliferation
,HIST1H4I,histone modification,genomic instability,chromatin structure,epigenetic regulation,cell growth regulation,none
,HIST1H4K,epigenetic regulation,chromatin modification,gene silencing,transcriptional dysregulation,histone modification,tumor microenvironment
,HIST1H4E,nucleosome assembly,chromatin remodeling,histone modification,dna repair mechanism,oncogenic transcriptional regulation,epigenetic dysregulation
ENSG00000176410,DNAJC30,oncogene overexpression,ubiquitin-proteasome inhibition,apoptosis regulation,protein stabilization,cell survival enhancement,tumor progression
ENSG00000107290,SETX,genomic instability,telomere maintenance,dna repair,helicase activity,oncogenic driver,mutation hotspot
ENSG00000062485,CS,altered expression,cell-cell adhesion,downregulated,epithelial-to-mesenchymal transition,loss of function mutations,tumor suppressor gene
ENSG00000132670,PTPRA,tumor suppressor function,loss of function mutations,constitutive activation of signaling pathways,regulation of apoptosis and proliferation,interaction with p53 protein,downregulation in blca
ENSG00000092020,PPP2R3C,pi3k/akt pathway regulation,loss of function mutations,cell proliferation enhancement,tumor progression driver,genomic instability promoter,akt activation enhancer
ENSG00000100427,MLC1,**

microtubule dynamics,oncogenesis,cell proliferation,tumor progression,therapeutic target,microtubule stability

**
ENSG00000183527,PSMG1,cell growth regulation,pi3k/akt pathway activation,tumor progression promotion,potential biomarker,cell cycle regulation,apoptosis inhibition
ENSG00000128789,PSMG2,26s proteasome activity,ubiquitin-proteasome pathway,tumor suppressor degradation,cell cycle progression,apoptosis resistance,cancer prognosis
ENSG00000027075,PRKCH,pkc-θ overexpression,pi3k/akt pathway interaction,cell adhesion disruption,oncogenic signaling activation,tumor progression facilitation,immune response regulation alteration
ENSG00000154114,TBCEL,tumor progression,protein trafficking regulation,cell signaling enhancement,pi3k/akt pathway interaction,cell migration facilitation,golgi apparatus targeting
ENSG00000179304,FAM156B,apoptosis evasion,transcriptional regulation,cell cycle progression,protein-protein interactions,oncogenesis,tumor overexpression
ENSG00000268350,FAM156A,cell proliferation,tumor progression,oncogene,cancer driver gene,mutation analysis,therapeutic target
ENSG00000105982,RNF32,cell cycle regulation,e3 ubiquitin ligase activity,apoptosis modulation,oncogenic potential,protein-protein interaction,tumor progression
ENSG00000076554,TPD52,tumor suppressor regulation,cell cycle progression,g2/m phase transition,oncogenic overexpression,protein-protein interactions,apoptosis resistance
ENSG00000140905,GCSH,enhanced oxidative resistance,antioxidant activity,glutathione synthesis,redox regulation,tumor progression,treatment resistance
ENSG00000186185,KIF18B,chromosomal instability,cell division regulation,microtubule dynamics,mitotic spindle assembly,tumor growth promotion,cancer cell proliferation
ENSG00000008952,SEC62,er translocon complex,upr regulation,protein folding and transport,cell survival and proliferation,oncogenic potential,genomic instability
ENSG00000071575,TRIB2,loss of function mutations,constitutive activation,akt/mtor pathway regulation,cell survival regulation,protein-protein interactions,pseudokinase activity
ENSG00000145020,AMT,metabolic regulation,tumor progression,oncogenic processes,cell proliferation,glutamine transport,amino acid uptake
ENSG00000112972,HMGCS1,ketogenesis,metabolic reprogramming,cell proliferation,oncogenic role,energy metabolism regulation,lipid biosynthesis
ENSG00000105556,MIER2,cell cycle regulation,apoptosis resistance,oncogenic driver,pi3k/akt pathway interaction,tumor progression,therapeutic target
ENSG00000222028,PSMB11,ubiquitin-proteasome pathway,protein degradation regulation,tumor progression,metastasis promotion,cell cycle modulation,oncoprotein accumulation
ENSG00000091651,ORC6,genomic instability,cell cycle regulation,dna replication initiation,oncogene overexpression,tumor suppressor function disruption,cell proliferation enhancement
ENSG00000162688,AGL,glycolytic shift,metabolic adaptation,oncogenic driver,therapeutic target,epithelial-to-mesenchymal transition,cancer metabolism
ENSG00000163281,GNPDA2,altered glycolytic flux,enhanced cellular proliferation,regulation of autophagy,impaired cell survival,upregulated expression,prognostic biomarker
ENSG00000105122,RASAL3,ras gtpase regulation,tumor suppressor function,loss of expression,mutation hotspot,prognostic significance,therapeutic target
ENSG00000171777,RASGRP4,rap gtpase activation,cell adhesion disruption,oncogenic driver mutations,tumor progression enhancement,cytoskeletal remodeling,gene expression alteration
ENSG00000042088,TDP1,dna repair deficiency,genomic instability,tumor progression,cell survival enhancement,oncogenesis promotion,apurinic/apyrimidinic site processing
ENSG00000172548,NIPAL4,cell proliferation,tumor progression,apoptosis evasion,signaling pathway modulation,protein-protein interaction,therapeutic target
ENSG00000104133,SPG11,mitochondrial dysfunction,autophagy dysregulation,gain of function mutations,oncogenesis promotion,cell survival enhancement,mtor pathway activation
ENSG00000170775,GPR37,autophagy regulation,oncogenic role,g-protein coupled receptor signaling,cell proliferation regulation,prognostic marker,therapeutic target
ENSG00000105373,NOP53,ribosome biogenesis,overexpression,cell proliferation,tumor progression,protein synthesis regulation,nuclear protein interaction
ENSG00000120334,CENPL,centromere dysfunction,genomic instability,oncogene potential,chromosome missegregation,cell cycle dysregulation,tumor progression marker
ENSG00000206418,RAB12,aberrant cellular proliferation,altered signaling pathways,endocytic trafficking regulation,gene expression modulation,membrane dynamics control,oncogenesis contribution
ENSG00000131375,CAPN7,tumor progression,cellular stress response,dna damage repair,oncogene activation,cancer cell survival,proteolytic activity
ENSG00000139351,SYCP3,meiotic protein function,chromatin remodeling,genomic instability,mitotic checkpoint regulation,cell cycle dysregulation,tumor suppression
ENSG00000165730,STOX1,cellular differentiation,tumor growth,apoptosis inhibition,transcription factor activity,oncogenic process,poor prognosis marker
ENSG00000085377,PREP,aberrant expression,apoptosis modulation,cell signaling regulation,oncogene/tumor suppressor duality,proteolytic enzyme activity,tumor suppressive activity
ENSG00000129351,ILF3,**

apoptosis modulation,inflammatory response,cell proliferation regulation,oncogenic transcription factor,signaling pathway interaction,transcriptional regulation 
**
ENSG00000273993,PTPRK,cell-cell signaling,tumor progression,mutation-driven effects,tyrosine phosphatase activity,cell adhesion disruption,protein-protein interaction
ENSG00000187045,TMPRSS6,iron homeostasis regulation,dna damage response,genomic instability,tumor progression,proteolytic activity,cellular iron overload
ENSG00000130208,APOC1,tumor progression,chemotherapy resistance,cell proliferation,apoptosis inhibition,biomarker potential,lipid metabolism regulation
ENSG00000179580,RNF151,ubiquitination regulation,oncogenic effects,cell cycle regulation,tumor progression,poor prognosis,transcriptional control
ENSG00000135541,AHI1,primary cilia formation,cell cycle regulation,tumor suppressor function,oncogenic signaling inhibition,prognostic marker potential,ciliogenesis machinery interaction
ENSG00000204920,ZNF155,zinc finger binding,transcriptional regulation,oncogene activation,cell proliferation enhancement,dna repair suppression,epigenetic modification
ENSG00000177058,SLC38A9,glutamine metabolism,tumor growth promotion,cellular transport regulation,oncogenic process,protein interaction modulation,therapeutic target
ENSG00000103647,CORO2B,actin cytoskeleton remodeling,cell migration promotion,epithelial-to-mesenchymal transition,tumor aggressiveness enhancement,cancer stemness regulation,genomic instability modulation
ENSG00000161860,SYCE2,homologous recombination repair,genetic instability,oncogenic function,genomic alterations,tumor suppressor dysregulation,cell cycle regulation
ENSG00000101745,ANKRD12,loss-of-function mutations,genomic instability,cell cycle regulation,apoptosis pathway,tumor progression,epithelial-to-mesenchymal transition
ENSG00000118181,RPS25,ribosomal protein,cell proliferation,translation initiation complex,metabolic regulation,cellular metabolism,anabolic pathways
ENSG00000136943,CTSV,lysosomal proteolysis,protein degradation,tumor progression,metastasis,signaling pathway modulation,cancer cell proliferation
ENSG00000131015,ULBP2,tumor immune evasion,cell surface expression,immune checkpoint modulation,nk cell activation,angiogenic promotion,tumor progression enhancement
ENSG00000178381,ZFAND2A,histone modification regulation,chromatin remodeling,cell cycle regulation,genomic stability maintenance,epigenetic alterations,tumor suppressor function
ENSG00000196569,LAMA2,tumor progression,cell migration and invasion,overexpression,tumor metastasis,cellular interaction and modulation,basement membrane formation
ENSG00000276856,TUBGCP5,microtubule regulation,proliferation promotion,migration enhancement,survival pathway activation,aggressive tumor behavior,therapeutic target
ENSG00000114735,HEMK1,mitochondrial regulation,metabolic reprogramming,glycolysis upregulation,glutaminolysis modulation,oncogenic protein,tumor growth promotion
ENSG00000126467,TSKS,cell growth regulation,protein-protein interaction,oncogenic processes,kinase activity modulation,tumor progression promotion,serine/threonine phosphorylation
ENSG00000171700,RGS19,aberrant signaling,altered expression,cell migration,cell proliferation,genomic instability,g protein signaling pathway
ENSG00000170385,SLC30A1,zinc homeostasis,cell proliferation,diagnostic marker,apoptosis regulation,pi3k/akt signaling interaction,cancer cell survival
ENSG00000156313,RPGR,dna repair,cell cycle regulation,tumor suppressor,genomic instability,chromatin remodeling,mutation hotspots
ENSG00000099617,EFNA2,ephrin receptor interaction,receptor tyrosine kinase activity,tumor invasion and metastasis,poor prognosis marker,cell proliferation regulation,signaling pathway activation
,HRASLS,cellular regulation,protein interaction,cell signaling pathway modulation,oncogenic process involvement,genomic instability contribution,tumor progression association
ENSG00000125812,GZF1,epithelial-to-mesenchymal transition,estrogen receptor interaction,tumor progression,metastasis driver,cell growth regulator,zinc finger protein
ENSG00000106261,ZKSCAN1,tumor suppressor gene repression,oncogenic pathway activation,chromatin modification,cell proliferation promotion,aggressive disease behavior,therapeutic target
ENSG00000084092,NOA1,oncogene,enzyme regulation,nucleotide metabolism,dna damage response,tumor progression,chemo-resistance
ENSG00000140365,COMMD4,nf-κb pathway regulation,tumor suppressor function,protein degradation,signal transduction,cellular survival,genetic alterations
ENSG00000167850,CD300C,immune response regulation,tumor cell adhesion,migratory pathway modulation,cellular interaction,potential tumor suppressor role,extracellular matrix involvement
ENSG00000105186,ANKRD27,cell cycle regulation,transcriptional regulation,tumorigenesis promoter,protein-protein interaction,cell proliferation enhancer,epigenetic regulator modulator
ENSG00000172350,ABCG4,transport regulation,chemotherapy response,cell membrane integrity,sterol transport,tumor progression,therapeutic target
ENSG00000198398,TMEM207,pi3k/akt signaling,ion transport regulation,cell growth modulation,tumorigenesis involvement,cell proliferation regulation,transmembrane protein function
ENSG00000105607,GCDH,energy production,amino acid metabolism,oxidative stress regulation,cellular growth promotion,apoptosis inhibition,metabolic reprogramming
ENSG00000181552,EDDM3B,genomic instability,cell cycle regulation,tumor suppression,dna repair mechanisms,transcriptional regulation,chromatin remodeling
ENSG00000113083,LOX,ecm remodeling,angiogenesis promotion,tumor invasion facilitation,immune suppression,cell migration enhancement,glycoprotein cross-linking
ENSG00000102003,SYP,cell migration,prognostic biomarker,pi3k/akt pathway regulation,cytoskeleton regulation,neurotransmitter release modulation,synaptic plasticity
ENSG00000163430,FSTL1,fstl1 overexpression,biomarker potential,tumor progression,cell proliferation,apoptosis regulation,signaling pathway interaction
ENSG00000100429,HDAC10,histone deacetylation,chromatin remodeling,tumor progression,oncogenic pathway activation,cellular proliferation enhancement,genomic instability promotion
ENSG00000136231,IGF2BP3,regulatory rna-binding,post-transcriptional control,oncogenic function,tumor progression,apoptosis resistance,emt activation
ENSG00000278759,TBCD,disrupted gtpase regulation,dysregulation of cell cycle,cytoskeleton remodeling,promotes oncogenesis,mutations in tbcd,co-occurs with other mutations
ENSG00000085365,SCAMP1,calcium-mediated trafficking,oncogenic overexpression,tumor progression,vesicle secretion regulation,apoptosis modulation,autophagy regulation
ENSG00000189129,PLAC9,cellular metabolism,energy production,upregulated expression,metabolic reprogramming,therapeutic target,poor prognosis
ENSG00000165525,NEMF,cellular proliferation,dna damage response,oncogene activation,transcriptional regulation,protein-protein interaction,cell cycle progression
ENSG00000131508,UBE2D2,ubiquitin transfer,tumor suppression modulation,cell cycle regulation,dna damage response,apoptosis inhibition,oncogenic signaling modulation
ENSG00000004660,CAMKK1,cell proliferation,mitogenic signaling pathway,genomic instability,protein kinase activation,oncogenic potential,energetic regulation
ENSG00000052850,ALX4,transcription factor activity,wnt/β-catenin signaling,cell proliferation promotion,overexpression associated with poor prognosis,chromatin remodeling,pi3k/akt pathway regulation
ENSG00000101413,RPRD1B,transcriptional elongation,gene expression regulation,nuclear protein function,cell growth modulation,oncogene regulation,cancer susceptibility
ENSG00000288185,IL27RA,immunomodulation,tumor suppression,stat1 activation,tumor microenvironment modulation,cancer immunotherapy target,poor prognosis indicator
ENSG00000169550,MUC15,tumor progression,immune modulation,oncogenic signaling,cell adhesion regulation,biomarker potential,therapeutic target
ENSG00000188822,CNR2,overexpression,constitutive activation,oncogenic signaling,tumor progression,therapeutic target,cell survival
ENSG00000133316,WDR74,wd repeat domain,tumor suppressor function,nuclear localization,dna repair mechanisms,genomic instability,oncogenic transformation
ENSG00000152952,PLOD2,tissue remodeling,collagen modification,extracellular matrix formation,fibrosis,cell proliferation enhancement,angiogenesis promotion
ENSG00000013016,EHD3,endocytic recycling pathway,oncogenic process,membrane remodeling,cell growth and survival,protein trafficking,biomarker candidate
ENSG00000174059,CD34,angiogenesis,cell adhesion,cell migration,tumor microenvironment,multifaceted role,prognostic marker
ENSG00000125871,MGME1,genomic instability,tumor progression,cancer driver,cell proliferation,survival signaling,polycomb protein interaction
ENSG00000119866,BCL11A,apoptosis regulation,chromatin remodeling,gain-of-function mutations,loss of tumor suppressor function,transcriptional repression,tumor progression
ENSG00000120669,SOHLH2,cellular proliferation,apoptosis evasion,transcriptional regulation,oncogenic processes,angiogenesis,prognostic biomarker
ENSG00000189377,CXCL17,tumor progression,immune suppression,chemokine signaling,prognostic biomarker,inflammatory regulation,immune cell recruitment
ENSG00000123219,CENPK,genomic instability,centrosome regulation,tumor progression,aneuploidy,genetic instability,therapeutic target
ENSG00000109063,MYH3,cell migration,metastasis,overexpression,epithelial-to-mesenchymal transition (emt),non-muscle myosin heavy chain function,adhesion complex disruption
ENSG00000143147,GPR161,g protein-coupled receptor activation,gq signaling pathway,cell cycle regulation,dna replication,mtor/akt pathway interaction,tumor progression
ENSG00000225141,PRRT1,tumor progression,cell proliferation,signaling pathway activation,angiogenesis regulation,oncogenic function,metastasis promotion
ENSG00000213927,CCL27,pro-inflammatory,immune evasion,chemokine signaling,tumor growth promotion,angiogenesis induction,mdsc recruitment
ENSG00000105171,POP4,nuclear transport regulation,genomic instability driver,cell cycle progression,dna damage response disruption,therapeutic target potential,protein-protein interaction
ENSG00000104356,POP1,genomic instability,resolution of holliday junctions,dna replication regulation,mitotic recombination regulation,meiotic crossing-over regulation,aneuploidy promotion
ENSG00000100379,KCTD17,cellular signaling pathway modulation,oncogenic function,ion channel regulation,tumor progression association,protein interaction,genomic instability
ENSG00000180785,OR51E1,g-protein coupled signaling,cell growth regulation,olfactory receptor function,tumor progression association,signaling pathway involvement,genomic alteration
ENSG00000124787,RPP40,ribosome biogenesis,rna processing,tumor suppressor,cell proliferation,oncogenic mutations,genomic instability
ENSG00000138386,NAB1,enhanced cellular proliferation,regulatory protein interactions,transcriptional activation,oncogenic signaling pathways,cellular survival mechanisms,genomic instability
ENSG00000085274,MYNN,chromatin regulation,dna repair mechanisms,oncogenic potential,cell cycle regulation,apoptosis suppression,prognostic biomarker
ENSG00000281178,MLXIP,cell proliferation inhibition,tumor suppressor function,transcriptional regulation,max interaction inhibition,oncogenesis suppression,cancer association
,TMEM206,pi3k/akt pathway,overexpression,oncogene,tumor progression,poor prognosis,cell growth regulation
ENSG00000108405,P2RX1,purinergic signaling,oncogenic potential,cell proliferation,metastasis promotion,calcium influx,prognostic marker
ENSG00000145506,NKD2,wnt/β-catenin pathway,loss of function mutations,negative regulator,cellular proliferation,tumor progression,epithelial-to-mesenchymal transition
ENSG00000161594,KLHL10,ubiquitin ligase activity,tumor progression,cell cycle regulation,genomic instability,protein interaction,oncogenesis
ENSG00000181333,HEPHL1,tumor progression,overexpression,growth factor regulation,angiogenesis promotion,cell migration enhancement,prognostic marker
ENSG00000089486,CDIP1,dna repair dysfunction,genomic instability,cell cycle regulation disruption,tumor aggressiveness promotion,poorer prognosis indicator,brca1/2 pathway interaction
ENSG00000176915,ANKLE2,wnt/β-catenin signaling pathway,nuclear localization,transcriptional regulation,cell proliferation,oncogenic process,tumor progression
ENSG00000167700,MFSD3,mitochondrial lipid import,lipid metabolism regulation,cancer cell proliferation,therapeutic target identification,oncogenic driver mutation,cellular energy production modulation
ENSG00000240184,PCDHGC3,**

 cadherin superfamily,cell-cell adhesion regulation,central nervous system expression,oncogenic processes involvement,genomic instability association,epithelial-to-mesenchymal transition (emt) role

**
ENSG00000131236,CAP1,cell proliferation,protein degradation,cell invasion,oncogenic process,tumor progression,therapeutic target
ENSG00000139055,ERP27,er stress response,tumor progression,biomarker potential,protein quality control,cell proliferation regulation,anti-apoptotic activity
ENSG00000100196,KDELR3,protein re-importation,endoplasmic reticulum quality control,chaperone activity,molecular recognition,tumor suppressor,cancer association
ENSG00000102221,JADE3,chromatin remodeling,transcriptional regulation,tumor suppressor function,apoptosis regulation,cell cycle progression,genetic instability
ENSG00000120053,GOT1,mitochondrial function,anabolic metabolism,cellular proliferation,therapeutic target,protein interaction,dysregulated expression
ENSG00000132740,IGHMBP2,chromatin remodeling,transcriptional regulation,tumor suppressor pathways,dna repair mechanisms,cell cycle control,p53 interaction
ENSG00000146909,NOM1,ribosome biogenesis regulation,metabolic reprogramming,mitochondrial function modulation,cell proliferation enhancement,nucleolar localization,glycolytic enzyme upregulation
ENSG00000186439,TRDN,cell adhesion,epithelial-to-mesenchymal transition,metastasis,biomarker candidate,proteoglycan function,overexpression
ENSG00000239951,IGKV3-20,immunoglobulin function,adaptive immune response,immune modulation,tumor microenvironment regulation,cancer progression,biomarker significance
ENSG00000108823,SGCA,adhesive dysfunction,cell adhesion disruption,desmosomal complex interaction,loss of cellular integrity,increased cell migration,cancer progression marker
ENSG00000047410,TPR,tumor progression,pi3k/akt pathway interaction,protein-protein interaction disruption,cell cycle regulation,oncogenic protein overexpression,therapeutic target
ENSG00000140798,ABCC12,ion homeostasis regulation,cellular ion transport,tumor progression modulation,chemotherapy resistance,wnt/β-catenin pathway interaction,prognostic biomarker
ENSG00000173575,CHD2,chromatin remodeling,oncogene,tumor progression,overexpression,prognostic marker,gene regulation
ENSG00000149932,TMEM219,cell membrane integrity regulation,transmembrane protein interaction,epithelial-to-mesenchymal transition (emt),overexpression and tumor progression,cell proliferation and invasion,signaling pathway dysregulation
ENSG00000100300,TSPO,cholesterol transport,immune response modulation,cell proliferation,survival pathway,inflammation regulation,mitochondrial function
ENSG00000112200,ZNF451,transcriptional regulation,tumor suppressor activity,cell cycle regulation,apoptosis modulation,dna damage response,maintenance of genomic stability
ENSG00000117280,RAB29,tumor suppression,loss-of-function mutations,cellular trafficking regulation,protein-protein interactions,akt pathway modulation,mitochondrial dynamics disruption
ENSG00000064652,SNX24,cellular growth inhibition,tumor suppressor activity,apoptosis induction,endosomal sorting regulation,pi3k/akt pathway modulation,protein recycling disruption
,HIST1H4G,chromatin organization,epigenetic regulation,histone modification,genomic instability,cell proliferation,gene expression
ENSG00000163467,TSACC,transcriptional regulation,cell proliferation,oncogenic signaling,overexpression,nuclear localization,gene amplification
ENSG00000168497,CAVIN2,enhanced pi3k/akt signaling,caveolar structure disruption,tumor progression driver,prognostic marker potential,increased lipid metabolism,interacts with pkc and src pathways
ENSG00000165678,GHITM,cell cycle regulation,oncogenic driver,pi3k/akt pathway modulation,tumor progression promotion,cell proliferation enhancement,genomic amplification
ENSG00000174500,GCSAM,dna methylation,epigenetic regulation,cell growth regulation,tumor suppressor function,protein modification,cellular signaling pathways
ENSG00000100605,ITPK1,cellular proliferation,overexpression,phosphorylation activity,regulation of growth,genomic instability,therapeutic target
ENSG00000160972,PPP1R16A,tumor suppressor function,loss of function mutations,pp1 regulation,cell cycle regulation,apoptosis inhibition,genomic instability
ENSG00000108559,NUP88,chromatin remodeling regulation,oncogene activation,nuclear transport facilitation,cell proliferation enhancement,aggressive disease characteristics,poor prognosis associated
ENSG00000176658,MYO1D,unconventional myosin function,cell membrane trafficking,oncogene activation,tumor progression,metastasis promotion,chemotherapy resistance
ENSG00000183570,PCBP3,cell cycle regulation,gene expression regulation,mrna stability modulation,oncogene overexpression,transcription factor interaction,apoptosis evasion
ENSG00000106772,PRUNE2,pi3k/akt signaling,oncogene activation,genomic instability,apoptosis regulation,cell proliferation,protein-protein interactions
ENSG00000165219,GAPVD1,cellular proliferation,protein regulation,membrane trafficking,endocytosis regulation,tumor progression,genomic instability
ENSG00000177728,TMEM94,ion transport regulation,calcium signaling disruption,tumor progression association,metabolic reprogramming,therapeutic target potential,oncogene overexpression
ENSG00000106399,RPA3,dna repair deficiency,genomic instability,cell cycle regulation,therapeutic target,homologous recombination repair (hrr),dna replication
ENSG00000114904,NEK4,chromosomal instability,cell cycle regulation,tumor suppression,mitotic entry,spindle formation,biomarker potential
ENSG00000166828,SCNN1G,enac activation,sodium uptake promotion,cell growth stimulation,oncogenic driver,chemoresistance development,metastasis facilitation
ENSG00000276461,TCF20,cell proliferation,transcriptional regulation,cell survival,oncogenic driver,poor prognosis marker,epigenetic modification
ENSG00000152503,TRIM36,cell cycle regulation,tumor suppression,epithelial-to-mesenchymal transition,apoptosis inhibition,protein ubiquitination,oncogenic pathway modulation
ENSG00000117411,B4GALT2,altered glycosylation,cell surface modification,tumor progression,cell adhesion disruption,molecular interaction alterations,glycoprotein synthesis
ENSG00000170122,FOXD4,cellular reprogramming,epithelial-to-mesenchymal transition,tumor progression,oncogenic driver,transcription factor activity,metastasis initiation
ENSG00000197893,NRAP,cellular ph regulation,na+/h+ exchange activity,glycolytic metabolism,oncogenic driver,proton transport function,antiporter activity
ENSG00000284290,ANKS4B,mitotic regulation,cell cycle progression,tumor suppressor dysfunction,oncogenic overexpression,signaling pathway disruption,genomic instability
ENSG00000214736,TOMM6,mitochondrial integrity,cell growth promotion,oncogene potential,tumor cell survival,protein import regulation,mitochondrial biogenesis
ENSG00000153015,CWC27,**
alternative splicing,cancer driver gene,cell cycle regulation,dna repair deficiency,oncogenesis,spliceosome component 
**
ENSG00000196937,FAM3C,cell proliferation,tumor progression,protein interaction,cytoplasmic localization,biomarker potential,oncogenic process
ENSG00000068796,KIF2A,kinesin superfamily,microtubule stability regulation,tumor growth promotion,aneuploidy induction,therapeutic target identification,cell cycle progression modulation
ENSG00000012660,ELOVL5,fatty acid synthesis,tumor progression,cell proliferation,survival pathway,dysregulation,lipid metabolism
ENSG00000156234,CXCL13,angiogenesis promotion,immune cell recruitment,chemokine gradient formation,prognostic biomarker potential,tumor microenvironment modulation,signaling pathway interaction
ENSG00000076344,RGS11,g-protein signaling,loss-of-function mutations,oncogenic pathway,tumor aggressiveness,apoptosis dysregulation,cell cycle progression
ENSG00000130940,CASZ1,genomic instability,dna repair,homologous recombination repair,chromosomal instability,oncogenic protein interaction,elevated expression levels
ENSG00000254521,SIGLEC12,tumor progression,metastasis,immune cell interaction,signaling pathway modulation,prognostic biomarker,tumorigenesis
ENSG00000174792,ODAPH,ubiquitination regulation,oncogenesis driver,protein degradation,cell cycle progression,tumor suppression evasion,prognostic marker
ENSG00000122133,PAEP,overexpression,cell proliferation,tumor progression,protein interaction,hormone regulation,poor prognosis
ENSG00000154027,AK5,tumor progression,cytokine signaling pathway,cell cycle regulation,gene amplification,apoptosis suppression,tumor microenvironment interaction
ENSG00000109814,UGDH,nucleotide homeostasis disruption,gene expression regulation,dna replication alteration,epigenetic modification,cell proliferation promotion,nucleotide metabolism regulation
ENSG00000110693,SOX6,tumor suppressor,cell cycle regulation,apoptosis evasion,transcriptional regulation,dysregulated expression,mutation hotspot
ENSG00000185960,SHOX,tumor suppressor,chromatin regulation,cell cycle progression,apoptosis induction,transcriptional regulation,protein-protein interaction
ENSG00000167302,TEPSIN,protease activity,cell proliferation,tumor suppressor degradation,lysosomal function,cellular stress,oncogenesis
ENSG00000132600,PRMT7,genomic instability,chromatin remodeling,oncogene interaction,dna repair modulation,cell proliferation driver,therapeutic target
ENSG00000108219,TSPAN14,tumor progression,tetraspanin function,cell migration,cell proliferation,apoptosis resistance,plasma membrane localization
ENSG00000233573,TRIM31,apoptosis regulation,cell cycle modulation,tumor suppressor function,pi3k/akt pathway involvement,dna damage response,protein-protein interaction
ENSG00000196684,HSH2D,t cell activation,immunoglobulin superfamily,immune checkpoint modulation,tumor progression,immune evasion,mhc class i interaction
ENSG00000185761,ADAMTSL5,cell migration,protein modification,tumor progression,extracellular matrix regulation,genomic instability,aberrant splicing
ENSG00000166147,FBN1,connective tissue remodeling,autosomal dominant disorder,tumor microenvironment impact,cardiovascular system association,genetic instability contribution,microfibril formation regulation
ENSG00000118508,RAB32,rab gtpase activity,constitutive activation,tumor progression,autophagy regulation,cell migration,genomic amplification
ENSG00000020129,NCDN,cell cycle regulation,apoptosis inhibition,protein-protein interaction,tumor suppression,genomic instability,proliferation promotion
ENSG00000114491,UMPS,dna replication,cell proliferation,pyrimidine biosynthesis,nucleotide metabolism,protein interaction,oncogenic function
ENSG00000092439,TRPM7,ion channel regulation,cell proliferation enhancement,apoptosis suppression,metastasis facilitation,calcium signaling dysregulation,therapeutic target
ENSG00000163283,ALPP,cell proliferation,survival pathway interaction,biomarker candidate,growth factor regulation,protein expression modulation,tumor metastasis promotion
ENSG00000186174,BCL9L,wnt/β-catenin signaling pathway,constitutive activation,amplification-driven overexpression,oncogenic transcriptional program,therapeutic target,tumorigenesis promotion
ENSG00000160469,BRSK1,dna damage response,kinase activity,cell cycle regulation,genomic instability,tumor progression,therapeutic target
ENSG00000110243,APOA5,altered lipid metabolism,cell proliferation modulation,apoptosis regulation,tumor progression marker,genomic instability promotion,hdl particle size modulation
ENSG00000074276,CDHR2,loss of adhesion,cancer progression,cell invasion,metastasis,poor prognosis,tissue remodeling
ENSG00000177613,CSTF2T,oncogene overexpression,mrna processing regulation,protein-protein interactions,gene expression modulation,dna repair inhibition,none
ENSG00000185420,SMYD3,histone modification,oncogenic transformation,cell proliferation,tumor progression,apoptosis regulation,genomic instability
ENSG00000163518,FCRL4,immune regulation,tumor suppressor function,oncogene suppression,apoptosis promotion,genetic mutations,epigenetic silencing
ENSG00000163734,CXCL3,tumor microenvironment modulation,angiogenesis promotion,immune suppression induction,cell migration enhancement,tumor progression facilitation,constitutive expression
ENSG00000116209,TMEM59,amplification,cell growth regulation,cell proliferation,genomic instability,oncogenesis,pi3k/akt pathway modulation
ENSG00000147684,NDUFB9,mitochondrial respiratory chain complex i,energy metabolism dysregulation,glycolytic shift,increased glycolysis,tumorigenic potential,prognostic marker
ENSG00000105388,CEACAM5,cell adhesion,carbonyl modification,cell migration,apoptosis evasion,tumor progression,epigenetic regulation
ENSG00000182566,CLEC4G,tumor-associated macrophage modulation,immunosuppressive microenvironment promotion,pattern recognition receptor function,inflammatory response regulation,cancer progression facilitation,tumor immune evasion mechanism
ENSG00000275618,BFAR,p27kip1 regulation,oncogene conversion,cell cycle dysregulation,tumor suppressor loss,cyclin-dependent kinase activation,protein ubiquitination
ENSG00000197889,MEIG1,apoptosis regulation,cell proliferation regulation,mynd zinc finger protein family member,oncogene activation,tumor progression promotion,zinc finger domain interaction
ENSG00000111269,CREBL2,tumor suppressor function,calcium-binding protein activity,transcriptional regulation,e3 ubiquitin ligase interaction,protein stability modulation,cancer risk association
ENSG00000259431,THTPA,nucleotide metabolism,accelerated cell proliferation,tumor growth,poor prognosis,dna replication repair,therapeutic target
ENSG00000178913,TAF7,aberrant transcription,tumor progression,genetic mutations,prognostic biomarker,transcriptional regulation,chromatin remodeling
ENSG00000171960,PPIH,proteolysis regulation,tumor suppressor degradation,cell proliferation enhancement,cancer progression facilitation,therapeutic target identification,dna damage response modulation
ENSG00000170786,SDR16C5,metabolic reprogramming,cell proliferation,lipid biosynthesis,tumor progression,therapeutic target,genomic instability
ENSG00000196187,TMEM63A,disrupted cell polarity,tumor progression,cell adhesion disruption,genomic alterations,cellular structural maintenance,therapeutic target
ENSG00000167702,KIFC2,microtubule dynamics regulation,chromosomal instability induction,mitotic spindle checkpoint disruption,cell cycle progression enhancement,tumor suppressor inhibition,onco-metastatic pathway involvement
ENSG00000091140,DLD,one-carbon metabolism,oncogenesis,tetrahydrofolate synthesis,folate regulation,homocysteine balance,cancer cell metabolism
ENSG00000131187,F12,angiogenesis promotion,circulating tumor cells,tumor progression facilitation,biomarker potential,prognostic significance,blood coagulation regulation
ENSG00000167118,URM1,mitochondrial translation regulation,loss-of-function mutations,impaired mitochondrial function,genomic instability,cell cycle regulation,apoptosis resistance
ENSG00000142544,CTU1,ubiquitination pathway,oncogenic mutations,e3 ligase function,cell cycle regulation,protein quality control,therapeutic target
ENSG00000137440,FGFBP1,oncogene activation,cell proliferation regulation,tumor progression enhancement,signaling pathway modulation,cell survival promotion,apoptosis resistance
ENSG00000012171,SEMA3B,tumor suppressor function,pi3k/akt pathway regulation,cell migration inhibition,epithelial-to-mesenchymal transition regulation,protein-protein interaction modulation,gene expression downregulation
ENSG00000138621,PPCDC,pp2a regulatory subunit,loss of function mutations,tumor aggressiveness,anti-tumor properties,cell cycle regulation,apoptosis modulation
ENSG00000186007,LEMD1,nuclear membrane integrity,oncogenic processes,cell proliferation,apoptosis regulation,tumor growth,therapeutic target
ENSG00000170162,VGLL2,transcriptional coactivator,hippo signaling pathway,oncogenic driver,cell proliferation,metastasis,prognostic marker
ENSG00000165030,NFIL3,nfil3 regulation,tumor suppressor repression,oncogenic processes promotion,cell proliferation dysregulation,apoptosis evasion,epigenetic modulation
ENSG00000104872,PIH1D1,transcriptional activation,chromatin remodeling,epigenetic regulation,cell cycle progression,apoptosis modulation,dna repair
ENSG00000161920,MED11,mediator complex subunit,chromatin remodeling,cell proliferation,oncogene amplification,transcription regulation,epigenetic modulation
ENSG00000173166,RAPH1,genomic instability,sensitivity to dna-damaging agents,regulation of dna repair,impaired replication fork stability,enhanced resistance to chemotherapy,increased genomic instability
ENSG00000089063,TMEM230,tumor progression,oncogene,chemoresistance,cell signaling,pi3k/akt pathway,prognostic marker
ENSG00000135312,HTR1B,serotonin receptor regulation,cell proliferation,g protein-coupled signaling,tumor metastasis,epithelial-to-mesenchymal transition,mapk/erk pathway modulation
ENSG00000006747,SCIN,cellular adhesion,tumor progression,cell migration,oncogenesis,protein-protein interactions,adhesion dynamics
ENSG00000256269,HMBS,**

heme biosynthesis pathway,upregulation,cell growth regulation,cell proliferation enhancement,enzymatic activity,erythroid cell expression
ENSG00000196693,ZNF33B,**
cell cycle regulation,dna binding,oncogenic function,transcriptional regulation,tumor progression,epithelial-to-mesenchymal transition 
**
ENSG00000109101,FOXN1,transcriptional regulation,oncogenic activity,cell cycle progression,dna repair mechanism,anti-apoptotic signaling,pi3k/akt pathway interaction
ENSG00000119969,HELLS,cell cycle regulation,dna repair,genomic instability,homologous recombination,oncogenic process,protein-protein interaction
ENSG00000102172,SMS,tumor suppressor function,negative regulation,tgf-β signaling pathway,apoptosis induction,proliferation control,epithelial tissue maintenance
ENSG00000170631,ZNF16,transcriptional regulation,epithelial development,tumor suppression,cell proliferation control,dna binding,epigenetic modification
ENSG00000197961,ZNF121,zinc finger protein,transcription factor activity,cell cycle regulation,apoptosis modulation,emt and metastasis,prognostic marker
ENSG00000136870,ZNF189,krab-c2h2-type zinc finger,oncogenic potential,cell proliferation,dna binding,tumorigenesis,cancer development
ENSG00000158874,APOA2,lipid metabolism,hdl formation,cholesterol efflux,transcription factor regulation,cell proliferation,prognostic marker
ENSG00000115216,NRBP1,gene regulation,tumor suppression,multifunctionality,nuclear receptor interaction,apoptosis modulation,dna repair pathway
ENSG00000183023,SLC8A1,calcium regulation,cell proliferation,cell survival advantage,disease progression,oncogenic processes,apoptosis modulation
ENSG00000130338,TULP4,microtubule regulation,ciliary function disruption,oncogenic signaling,cell proliferation enhancement,therapeutic target identification,genomic instability association
ENSG00000170370,EMX2,emt (epithelial-to-mesenchymal transition),oncogene,transcription factor activity,cell proliferation,apoptosis evasion,tumor progression
ENSG00000196914,ARHGEF12,small gtpase regulation,cytoskeleton organization,cell migration promotion,oncogenic driver,tumor progression facilitation,cell proliferation enhancement
ENSG00000212122,TSSK1B,pi3k/akt pathway modulation,cell signaling regulation,oncogenic process promotion,gene expression upregulation,biomarker potential,kinase activity importance
ENSG00000157191,NECAP2,pi4p regulation,dna damage response,genomic instability,cell survival pathways,tumor progression,autophagy modulation
ENSG00000169189,NSMCE1,genomic instability,chromatin remodeling,tumor suppressor function,apoptosis regulation,cell cycle control,dna repair mechanism
ENSG00000138600,SPPL2A,wnt/β-catenin signaling,gain of function mutations,regulation of cell proliferation,interaction with β-catenin,cell growth modulation,oncogenic potential
ENSG00000197385,ZNF860,chromatin modification,cell cycle regulation,transcriptional regulation,oncogenic protein expression,tumor progression,poor prognosis marker
ENSG00000132541,RIDA,genomic instability,dna repair regulation,cell cycle modulation,tumor suppressor activity,cancer cell survival,protein interaction inhibition
ENSG00000230124,ACBD6,metabolic reprogramming,tumor growth promotion,energy metabolism disruption,aldehyde dehydrogenase activity,overexpression in cancer,glycolytic shift
ENSG00000077152,UBE2T,ubiquitination pathway,constitutive activation,gain of function mutations,proteasomal degradation,cell cycle progression,therapeutic target
ENSG00000187151,ANGPTL5,angiogenesis promotion,lipid metabolism regulation,tumor progression enhancement,cell growth stimulation,apoptosis suppression,therapeutic target identification
ENSG00000161681,SHANK1,aberrant cell adhesion,cellular growth regulation,oncogenic potential,scaffolding protein function,tumorigenesis,wnt/β-catenin pathway interaction
ENSG00000110244,APOA4,tumor suppressor,lipid raft interaction,pi3k/akt pathway inhibition,anti-inflammatory effects,cell membrane dynamics modulation,tumor microenvironment modulation
ENSG00000175482,POLD4,dna synthesis,genomic instability,dna repair mechanisms,genetic mutations,tumor progression,biomarker potential
ENSG00000155096,AZIN1,polyamine regulation,constitutive activation,tumor progression,prognostic marker,oncogenic process,therapeutic resistance
ENSG00000144366,GULP1,pi3k/akt pathway modification,tumor progression promotion,cell adhesion regulation,cancer type specificity,therapeutic target potential,protein interaction network modulation
ENSG00000165476,REEP3,er stress response,mitochondrial function regulation,cell growth promotion,oncogene overexpression,apoptosis suppression,tumor progression enhancement
ENSG00000104859,CLASRP,genomic instability,dna repair regulation,checkpoint response activation,cell cycle regulation,tumor suppressor function,oncogenic mutation
ENSG00000181610,MRPS23,mitochondrial translation,tumor progression,energy metabolism regulation,cell growth promotion,apoptosis suppression,genomic instability
ENSG00000198824,CHAMP1,chromatin-associated protein function,epigenetic regulation,cell cycle progression,dna repair,apoptosis regulation,tumor growth promotion
ENSG00000106484,MEST,apoptosis regulation,cellular differentiation,chromatin remodeling,gene expression regulation,microrna modulation,oncosuppressor function
ENSG00000154813,DPH3,dna replication,cell cycle regulation,genomic instability,protein phosphorylation,tumor progression,therapeutic target
ENSG00000166340,TPP1,protein degradation regulation,cell proliferation promotion,oncogenic pathway activation,lysosomal function dysregulation,autophagy modulation,tumor metastasis enhancement
ENSG00000129566,TEP1,tumor suppressor function,cell growth inhibition,immune system interaction,cell cycle regulation,apoptosis modulation,protein-protein interaction
ENSG00000143748,NVL,transcriptional regulation,wnt/β-catenin pathway modulation,oncogenic driver,prognostic biomarker,tumor progression,genomic instability
ENSG00000113649,TCERG1,transcriptional regulation,rna processing disruption,cell growth promotion,apoptosis inhibition,malignant transformation,tumor progression
ENSG00000144852,NR1I2,nuclear receptor regulation,xenobiotic metabolism,tumor resistance,cell survival promotion,apoptosis inhibition,transcriptional regulation
ENSG00000110719,TCIRG1,lysosomal acidification,apoptosis suppression,cell proliferation enhancement,tumor metastasis,genetic upregulation,prognostic marker
ENSG00000170791,CHCHD7,mitochondrial function,apoptosis regulation,metabolic regulation,oxidative stress resistance,tumor suppressor function,cancer progression
ENSG00000108797,CNTNAP1,cell adhesion disruption,emt process regulation,prognostic biomarker candidate,tumor progression facilitation,metastasis promotion,neurexin family member
,SEPT3,septin function,cytokinesis regulation,oncogenic potential,cell growth promotion,apoptosis inhibition,pro-oncogenic processes
ENSG00000074527,NTN4,cellular growth regulation,pi3k/akt pathway interaction,tumor progression promotion,metastasis facilitation,cell survival enhancement,cellular adhesion disruption
ENSG00000166922,SCG5,neuroendocrine regulation,tumor microenvironment modulation,cell growth regulation,secretogranin function,oncogenic pathway interaction,cancer driver gene potential
ENSG00000110435,PDHX,mitochondrial function,cellular metabolism reprogramming,tumor energy metabolism,therapeutic target,oncogenic driver,biomarker candidate
ENSG00000126218,F10,tumor progression,cell adhesion,protein-protein interaction,coagulation pathway,metastasis promotion,biomarker candidate
ENSG00000113456,RAD1,homologous recombination repair,tumor progression,therapeutic target,genomic instability,cell cycle regulation,dna damage response
ENSG00000046604,DSG2,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),pi3k/akt/mtor pathway interaction,loss of expression or mutation,increased cell motility and invasion,tumor progression
ENSG00000034677,RNF19A,ubiquitination regulation,tumor suppressor degradation,cell cycle progression,genomic instability,protein-protein interactions,aneuploidy
ENSG00000128563,PRKRIP1,interferon-induced antiviral response,apoptosis induction,tumor suppressor function,protein kinase r inhibition,cell cycle regulation,cancer therapy target
ENSG00000213983,AP1G2,cell adhesion regulation,epithelial-mesenchymal transition (emt),adaptor protein complex 1 (ap-1) interaction,oncogenic transcription factor activation,poor prognosis biomarker,therapeutic target
ENSG00000116981,NT5C1A,oncogenic function,immune evasion,tumor progression,cell migration,adenosine regulation,therapeutic target
ENSG00000131778,CHD1L,homologous recombination repair,genome instability,chromatin remodeling,oncogenesis,protein-protein interactions,dna repair mechanisms
ENSG00000171094,ALK,alk activation,constitutive signaling,oncogenic driver,cell proliferation,angiogenesis promotion,therapeutic target
ENSG00000106852,LHX6,**

lhx6 mutations,altered chromatin structure,transcriptional regulation,cancer cell growth,proliferation and differentiation,genomic instability

**
ENSG00000099331,MYO9B,constitutive activation,rho gtpase signaling pathway,rna binding motif,cell migration and adhesion,cytoskeleton organization,dysregulation in cancer
ENSG00000106665,CLIP2,microtubule dynamics regulation,oncogenic protein interaction,cell migration facilitation,tumor invasion promotion,gene amplification,constitutive activation
ENSG00000155890,TRIM42,tumor suppressor function,protein degradation regulation,cell cycle control loss,genomic instability contributor,therapeutic target candidate,ubiquitination pathway interaction
ENSG00000123989,CHPF,lipid metabolism regulator,cell membrane dynamics,tumor progression driver,oncogene activation,genomic instability mediator,cell survival enhancement
ENSG00000178394,HTR1A,tumor suppression,anti-proliferative effects,pi3k/akt pathway inhibition,serotonin receptor function,jak/stat and mapk pathway interaction,altered expression in cancer
ENSG00000144712,CAND2,cell cycle regulation,tumor progression,transcriptional activation,apoptosis inhibition,cancer cell proliferation,overexpression
ENSG00000110108,TMEM109,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),metastasis promotion,oncogenic signaling pathway activation,prognostic marker,transmembrane protein function
ENSG00000111554,MDM1,p53 degradation,cell cycle progression,apoptosis inhibition,tumor aggressiveness,prognostic marker,genomic instability
ENSG00000177084,POLE,dna replication error rate,mutational signature,genomic instability,oncogenic mutation,dna repair mechanism,therapeutic target
ENSG00000079112,CDH17,cell adhesion dysfunction,overexpressed in cancer,promotes tumor progression,metastasis and invasion,tumor aggressiveness,poor prognosis marker
ENSG00000163510,CWC22,rna processing regulation,exosome complex component,helicase domain protein,oncogenic mutation,cancer associated gene,exonuclease activity
ENSG00000173597,SULT1B1,cellular regulation,conjugation of small molecules,hormone metabolism,cancer development,potential therapeutic target,tumor progression pathways
ENSG00000105610,KLF1,oncogene activity,cell proliferation,tumor suppressor function,epithelial-to-mesenchymal transition (emt) regulation,apoptosis inhibition,transcription factor regulation
ENSG00000107807,TLX1,tlx1 overexpression,oncogene activation,transcriptional regulation,cell proliferation,apoptosis inhibition,metastasis promotion
ENSG00000283009,ZNF436,tumor suppressor function,transcriptional regulation,cell cycle control,apoptosis modulation,oncogenic potential,metastatic promotion
ENSG00000143995,MEIS1,transcriptional regulation,cell growth promotion,apoptosis suppression,tumor progression driver,oncogenic transcription factor,gene expression modulation
ENSG00000146755,TRIM50,tumor suppressor,cell cycle regulation,dna repair mechanism,genomic instability,ubiquitination pathway,oncogenic processes
ENSG00000100417,PMM1,metabolic adaptation,glycolytic pathway,protein glycosylation,n-linked glycans synthesis,cell growth regulation,pmm1's role in cellular metabolism
ENSG00000174950,CD164L2,wnt/β-catenin signaling,cell adhesion,oncogenic process,epithelial-to-mesenchymal transition (emt),genomic instability,therapeutic target
ENSG00000181444,ZNF467,transcriptional regulation,chromatin remodeling,oncogenic mechanism,differentially expressed gene,histone-modifying enzyme interaction,pi3k/akt signaling pathway
ENSG00000132323,ILKAP,pi3k/akt pathway regulation,tumor progression,metastasis promotion,cell survival enhancement,protein kinase inhibition,tumor suppressor function
ENSG00000175879,HOXD8,wnt/β-catenin pathway activation,overexpression in tumor tissues,promotes cell proliferation,oncogene activity,cell migration and invasion,therapeutic target
ENSG00000243003,LY6G6F,epithelial-to-mesenchymal transition (emt),cell adhesion,tumor growth,metastasis regulation,cancer cell proliferation,overexpression marker
ENSG00000123933,MXD4,transcriptional regulation,epigenetic modification,chromatin remodeling,cell proliferation regulation,tumor suppression,genome instability
ENSG00000139675,HNRNPA1L2,cell cycle regulation,transcriptional regulation,apoptosis evasion,tumor progression,metastasis promotion,biomarker candidate
ENSG00000168447,SCNN1B,oncogene,ion transport regulation,cell proliferation driver,wnt/β-catenin pathway interaction,gain of function mutations,epithelial sodium channel subunit
ENSG00000174799,CEP135,microtubule regulation,cell cycle progression,apoptosis dysregulation,tumor growth promotion,cancer genome instability,dna damage response
ENSG00000136758,YME1L1,mitochondrial dynamics,metabolic reprogramming,oncogenesis,apoptosis evasion,cell cycle regulation,warburg effect
ENSG00000168118,RAB4A,cell surface receptor recycling,constitutive activation,oncogenic processes,tumor progression,pi3k/akt pathway,endocytosis regulation
ENSG00000103994,ZNF106,wnt signaling pathway,transcriptional regulation,oncogenic function,cell proliferation,protein-protein interaction,tumor progression
ENSG00000163820,FYCO1,pi3k/akt signaling pathway modulation,oncogenic role,gain of function mutations,cell proliferation enhancement,tumor progression facilitation,ubiquitination regulation
ENSG00000119688,ABCD4,lipid metabolism,cell membrane transport,oncogenic potential,tumor aggressiveness,poor prognosis,lipid signaling pathways
ENSG00000174007,CEP19,**

microtubule dynamics,genome instability,cell proliferation,centrosome organization,kinetochore attachments,spindle checkpoint modulation
ENSG00000051620,HEBP2,genomic instability,dna replication regulation,genome maintenance regulation,cell cycle control disruption,tumor progression association,therapeutic target
ENSG00000175229,GAL3ST3,glycoprotein modification,sulfation process,cell-cell interaction,tumor progression,proteoglycan regulation,signal transduction
ENSG00000116198,CEP104,centrosome regulation,aneuploidy induction,genomic instability,oncogene potential,microtubule dynamics modulation,cell cycle dysregulation
ENSG00000188171,ZNF626,transcriptional regulation,zinc finger protein,co-regulator of androgen receptor,tumor progression,cell proliferation regulation,upregulated expression
ENSG00000100380,ST13,tumor suppressor function,apoptosis regulation,cell growth inhibition,oncogene inhibitor,pi3k/akt signaling pathway interaction,chemotherapy resistance association
ENSG00000172296,SPTLC3,sphingolipid metabolism pathway,cell proliferation,apoptosis regulation,therapeutic target,cell survival promotion,tumorigenesis facilitation
ENSG00000007047,MARK4,microtubule dynamics regulation,cell division regulation,pi3k/akt pathway interaction,oncogenic process promotion,therapeutic target potential,overexpression association
ENSG00000260027,HOXB7,hoxb7 overexpression,oncogenic transcription factor,emt induction,apoptosis evasion,cell proliferation enhancement,metastatic potential
ENSG00000065485,PDIA5,oncogenic potential,tumor growth promotion,cell proliferation enhancement,apoptosis inhibition,angiogenesis facilitation,stress response regulation
ENSG00000198464,ZNF480,transcriptional regulation,tumor progression,cell growth modulation,apoptosis dysregulation,signaling pathway alteration,metastasis promotion
,VARS,genomic instability,aminoacylation efficiency,cell proliferation,tumor survival,chromosomal rearrangements,amino acid incorporation
ENSG00000172497,ACOT12,metabolic regulation,lipid biosynthesis,epigenetic regulation,promotes cell growth,pi3k/akt signaling,energy homeostasis
ENSG00000156269,NAA11,tumor progression,cell growth regulation,arginine acetylation,protein modification,oncogenic pathway activation,therapeutic target
ENSG00000152904,GGPS1,metabolic reprogramming,cellular proliferation,glutamine synthesis,glycolytic switch,tumor growth promotion,target for therapy
ENSG00000157429,ZNF19,transcriptional regulation,tumor progression,cell proliferation,aberrant expression,chromatin modification,oncogenic transformation
ENSG00000100911,PSME2,aberrant activation,cancer driver,cellular degradation,immunomodulation,tumor suppressor degradation,ubiquitin-proteasome pathway
ENSG00000008838,MED24,dna damage response,transcription regulation,cell cycle progression,tumor aggressiveness,apoptosis evasion,genomic instability
ENSG00000175221,MED16,mediator complex regulation,dna repair inhibition,tumor promoter,apoptosis suppression,cell cycle progression,protein-protein interaction
ENSG00000106266,SNX8,pi3k/akt pathway activation,membrane trafficking regulation,oncogene overexpression,signal transduction modulation,cell proliferation enhancement,protein-protein interaction
ENSG00000171557,FGG,fibrotic microenvironment,pro-tumorigenic niche,tumor progression,cell migration,extracellular matrix remodeling,growth factor regulation
ENSG00000072163,LIMS2,cell adhesion regulation,tumor progression,epithelial-to-mesenchymal transition,protein-protein interaction,cytoskeletal organization,malignant behavior
ENSG00000137547,MRPL15,mitochondrial ribosomal biogenesis,tumor progression,pi3k/akt signaling,oncogenesis,genomic instability,cell growth modulation
ENSG00000158571,PFKFB1,glycolytic pathway enhancement,glycogen metabolism,hexokinase activation,tumor cell proliferation,metabolic reprogramming,cancer metastasis
ENSG00000104863,LIN7B,tight junction regulation,pi3k/akt pathway modulation,cancer cell invasion promotion,oncogenic transformation facilitation,scaffold protein function,cellular signaling pathway regulation
ENSG00000118564,FBXL5,tumor suppression,genomic instability,cell cycle regulation,apoptosis induction,dna repair pathway,ubiquitin-proteasome pathway
ENSG00000143340,FAM163A,lipid metabolism disruption,cell membrane trafficking regulation,cancer driver mutation,tumor growth promotion,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000104218,CSPP1,centriole regulation,oncogenic signaling,cell proliferation,tumor progression,genetic amplification,protein-protein interaction
ENSG00000087085,ACHE,cellular regulation,apoptosis resistance,therapeutic target,neurotransmitter modulation,oxidative stress response,signaling pathway interaction
ENSG00000206561,COLQ,oncogene potential,neurexin-1 interaction,protein clustering dysfunction,cell growth regulation,angiogenesis promotion,metastasis facilitation
ENSG00000167815,PRDX2,mitochondrial localization,oxidative stress regulation,antioxidant function,apoptosis inhibition,cell proliferation promotion,tumor progression association
ENSG00000083097,DOP1A,angiogenesis,cell proliferation,neurotransmitter regulation,dopamine biosynthesis,oncogene amplification,tumor microenvironment
ENSG00000183161,FANCF,fanconi anemia pathway,genetic instability,interstrand dna crosslink repair,dna damage response,tumor suppressor function,genomic stability maintenance
ENSG00000166260,COX11,mitochondrial dysfunction,increased glycolysis,enhanced cell proliferation,aerobic fermentation,glycogen metabolism,apoptosis resistance
ENSG00000126432,PRDX5,antioxidant activity,cellular redox balance disruption,tumor progression,therapeutic resistance,pi3k/akt pathway interaction,genomic instability
ENSG00000123739,PLA2G12A,oncogenic pathway modulation,cell proliferation enhancement,angiogenesis induction,protein-protein interaction,tumor progression facilitation,phospholipid hydrolysis
ENSG00000130717,UCK1,nucleotide sugar metabolism,dna synthesis regulation,cell proliferation enhancement,genetic instability contribution,tumor growth promotion,nucleotide pool imbalance
ENSG00000139496,NUP58,nuclear pore regulation,genomic instability,cell survival enhancement,protein-protein interactions,oncogenic transcriptional programs,altered cellular metabolism
ENSG00000158417,EIF5B,tumorigenesis,protein synthesis regulation,cell proliferation enhancement,genetic alteration association,poor prognosis indicator,therapeutic target potential
ENSG00000066933,MYO9A,cell migration,adhesion molecule regulation,cytoskeletal organization,tumor metastasis,poor prognosis indicator,cell invasion facilitation
ENSG00000095777,MYO3A,unconventional myosin regulation,apoptosis suppression,cell survival enhancement,actin cytoskeleton dynamics,genomic amplification,overexpression
ENSG00000186867,QRFPR,cell surface receptor,cell proliferation,g protein signaling,metastasis promotion,oncogenic mutation,tumor progression
ENSG00000047617,ANO2,calcium-activated chloride channel activity,cellular proliferation enhancement,signaling pathway modulation,wnt/β-catenin pathway interaction,tumor progression facilitation,chemotherapy resistance contribution
ENSG00000008853,RHOBTB2,loss of function mutations,cell migration regulation,tumor suppressor function,cell adhesion disruption,cancer aggression marker,therapeutic target
ENSG00000166263,STXBP4,snare complex regulation,exocytosis pathway,cellular proliferation,oncogenic potential,genomic instability,tumor progression
ENSG00000105835,NAMPT,glycolytic shift,therapeutic target,energy metabolism regulator,epigenetic modulator,histone acetyltransferase activator,cell survival enhancer
ENSG00000125648,SLC25A23,mitochondrial carrier protein,metabolic reprogramming,tumor aggressiveness,oncogenic interaction,hypoxia adaptation,energy metabolism support
ENSG00000154978,VOPP1,autophagy regulation,oncogenic function,cellular homeostasis disruption,mutational alterations,protein-protein interactions,autophagic flux dysregulation
ENSG00000288485,ELP5,genetic instability,transcriptional regulation,elongation factor complex,chromatin remodeling,cell proliferation,poor prognosis
ENSG00000187736,NHEJ1,dna repair pathway,genomic instability,oncogenic driver,prognostic biomarker,tumor progression,epigenetic regulation
ENSG00000198353,HOXC4,emt regulation,epigenetic regulation,transcriptional regulation,wnt/β-catenin signaling,tumor progression,angiogenesis modulation
ENSG00000161649,CD300LG,immune cell modulation,tumor microenvironment,overexpression,poor prognosis,anti-tumor immunity,immunosuppression
ENSG00000138061,CYP1B1,metabolic regulation,protein-protein interaction,epigenetic modifications,chemoresistance,oncogenic function,tumor progression
ENSG00000166181,API5,apoptosis regulation,tumor suppression,prognostic marker,mitochondrial pathway interaction,cell death promotion,bcl-2 family interaction
ENSG00000133639,BTG1,cellular regulation,tumor suppressor function,apoptosis induction,dna repair mechanisms,cell cycle inhibition,oncogene suppression
ENSG00000167685,ZNF444,cell cycle regulation,tumor progression,transcriptional regulation,oncogenic function,apoptosis evasion,ccna2 upregulation
ENSG00000124802,EEF1E1,translation regulation,oncogenic potential,tumor progression,protein synthesis enhancement,cell proliferation promotion,genomic instability
ENSG00000011590,ZBTB32,zinc finger domain,transcriptional regulation,cell cycle progression,apoptosis suppression,wnt/β-catenin pathway activation,epithelial-to-mesenchymal transition
ENSG00000137656,BUD13,centrosome regulation,genomic instability,cell proliferation,prognostic biomarker,mitotic spindle formation,dna replication
ENSG00000119541,VPS4B,escrt function,endosomal-sorting complexes,oncogenic processes,cell survival,protein recycling,therapeutic target
ENSG00000158315,RHBDL2,rhbdl2 involvement,cell growth regulation,wnt/β-catenin pathway modulation,upregulated expression,oncogenic process activation,cancer progression enhancement
ENSG00000144810,COL8A1,altered expression,basement membrane remodeling,cell migration facilitation,epithelial-mesenchymal transition,extracellular matrix modulation,tumor progression promotion
ENSG00000168795,ZBTB5,tumor suppressor function,cell cycle regulation,apoptosis induction,transcription factor activity,gc-rich motif binding,gene expression modulation
ENSG00000074621,SLC24A1,cell adhesion,tumor progression,metastasis,cell migration,therapeutic target,oncogene expression
ENSG00000134780,DAGLA,mitochondrial dysfunction,impaired fatty acid oxidation,loss-of-function mutation,cellular lipid accumulation,oncogenic transformation,genetic heterogeneity
ENSG00000211584,SLC48A1,ion balance regulation,cellular transport,tumor progression,epithelial-to-mesenchymal transition (emt),signaling pathway interaction,genomic instability
ENSG00000011638,TMEM159,autophagy regulation,tumor suppressor activity,lysosomal integrity maintenance,cellular stress response modulation,genomic instability modulation,endosomal sorting regulation
ENSG00000166928,MS4A14,immune evasion,tumor progression,cell adhesion modulation,nf-κb signaling activation,promotes metastasis,cancer cell survival enhancement
ENSG00000186272,ZNF17,pi3k/akt pathway regulation,tumor suppressor function,cell proliferation suppression,gene expression modulation,prognostic biomarker potential,transcriptional repression
ENSG00000144771,LRTM1,oncogene upregulation,cell surface receptor regulation,signaling pathway modulation,tumor progression promotion,therapeutic target potential,epidermal growth factor receptor interaction
ENSG00000197705,KLHL14,cell cycle regulation,ubiquitin-proteasome pathway,tumor suppressor function,dna repair mechanisms,chromosomal instability,genomic integrity maintenance
ENSG00000174021,GNG5,cell proliferation,signal transduction pathway,tumor suppressor interaction,cell cycle regulation,molecular interaction network,protein-protein interaction
ENSG00000135750,KCNK1,oncogene activation,proliferation promotion,apoptosis suppression,cell migration enhancement,channel regulation dysfunction,ion balance disruption
ENSG00000136731,UGGT1,protein folding regulation,glycoprotein modification,molecular chaperone interaction,cellular stress response,cancer progression contribution,therapeutic target potential
ENSG00000073792,IGF2BP2,oncogene,targeted regulation,overexpressed,cell proliferation,apoptosis suppression,emt modulation
ENSG00000106648,GALNTL5,o-glycosylation regulation,galnac transferase activity,cell proliferation promotion,oncogenic process involvement,tumor progression facilitation,cancer cell migration enhancement
ENSG00000187595,ZNF385C,oncogene,dna methylation regulation,epigenetic regulator,transcriptional regulation,cell proliferation enhancement,apoptosis inhibition
ENSG00000159592,GPBP1L1,genomic instability,chromatin remodeling,oncogene activation,cell cycle regulation,dna replication repair,protein-protein interaction
ENSG00000042753,AP2S1,notch signaling regulation,cell surface receptor internalization,oncogenic process promotion,pi3k/akt pathway interaction,tumor suppressor function,endocytic pathway regulation
ENSG00000163950,SLBP,chromatin modification,cell cycle regulation,gene expression modulation,apoptosis evasion,dna repair dysregulation,transcriptional activation
ENSG00000042493,CAPG,cytopathic effects,cell migration,cytoskeletal dynamics,apoptosis inhibition,tumor progression,oncogenic process
ENSG00000145014,TMEM44,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor progression,metastasis regulation,oncogene potential,cell migration modulation
,HIST1H2BN,epigenetic regulation,chromatin remodeling,histone modification,transcriptional regulation,gene expression control,dna packaging
ENSG00000007923,DNAJC11,mitochondrial dysfunction,chaperone activity,cell survival enhancement,genomic stability maintenance,oncogenic mutation association,therapeutic resistance mediation
ENSG00000110911,SLC11A2,nramp1 function,iron homeostasis regulation,tumor progression association,overexpression correlation,therapeutic target potential,hypoxia response modulation
ENSG00000176293,ZNF135,transcriptional regulation,apoptosis inhibition,oncogenic potential,cell cycle regulation,protein-protein interaction,dna binding
ENSG00000136933,RABEPK,microtubule regulation,apoptosis evasion,cell cycle progression,oncogenic driver,genomic instability,protein kinase activation
ENSG00000183580,FBXL7,cell cycle regulation,tumor suppressor function,g2/m phase transition,dysregulation,targeted degradation,oncogenic process
ENSG00000172673,THEMIS,genomic instability,dna damage response,epigenetic regulation,cell proliferation,oncogenic transformation,tumor progression
ENSG00000038210,PI4K2B,membrane trafficking,cell signaling,lipid metabolism,tumor progression,metastasis,genomic instability
ENSG00000198408,OGA,glycosphingolipid metabolism regulation,cellular homeostasis maintenance,tumor growth promotion,therapeutic target,signaling pathway modulation,transcription factor regulation
ENSG00000162639,HENMT1,histone modification,chromatin regulation,epigenetic alterations,gene transcription,tumor progression,therapeutic target
ENSG00000113838,TBCCD1,cell cycle progression,dna replication,cell proliferation,oncogene,tumor formation,chromatin remodeling
ENSG00000137261,KIAA0319,ubiquitination regulation,cancer driver mutation,aurora a kinase interaction,mitotic checkpoint regulation,tumor suppressor function,cell cycle regulation
ENSG00000196968,FUT11,glycoprotein biosynthesis,cell adhesion regulation,tumor progression,metastasis facilitation,oncogenic mutation,poor prognosis marker
ENSG00000137204,SLC22A7,multidrug resistance,poor prognosis marker,nucleoside analog uptake regulation,cellular efflux transporter,prognostic biomarker,therapeutic target
ENSG00000215251,FASTKD5,apoptosis regulation,mitochondrial function,cell death pathways,reactive oxygen species regulation,oncogenesis promotion,electron transport chain regulation
ENSG00000196935,SRGAP1,tumor suppressor,rho gtpase regulation,cytoskeleton dynamics modulation,mitotic spindle regulation,cell adhesion disruption,proliferation inhibition
ENSG00000143149,ALDH9A1,oxidative stress regulation,tumor cell survival,cancer stemness promotion,dna damage enhancement,chemoresistance development,aldehyde metabolism modulation
ENSG00000140459,CYP11A1,reactive oxygen species regulation,steroid hormone biosynthesis,cholesterol desmolase activity,oncogenic properties,cell proliferation enhancement,poor prognosis marker
ENSG00000083307,GRHL2,wnt/β-catenin pathway activation,transcriptional regulation,cell cycle progression,tumor promoter,pro-oncogenic signaling,apoptosis inhibition
ENSG00000126787,DLGAP5,disrupted cell adhesion,loss of function mutations,pi3k/akt pathway regulation,cytoskeletal protein interaction,epithelial integrity disruption,tumor progression
ENSG00000115271,GCA,chromatin remodeling,cell cycle regulation,apoptosis suppression,tumorigenesis promotion,genomic instability,transcriptional modulation
ENSG00000197956,S100A6,metastasis promoter,cell proliferation regulator,tumor progression facilitator,epithelial-to-mesenchymal transition modulator,signaling pathway activator,poor prognosis marker
ENSG00000105298,CACTIN,chromatin remodeling,tumor progression,oncogene/tumor suppressor potential,epigenetic regulation,gene expression modulation,cell proliferation enhancement
ENSG00000278210,KRTAP5-1,tumor progression,oncogene activation,epithelial-to-mesenchymal transition,upregulated expression,cell growth regulation,cancer stem cell maintenance
ENSG00000136813,ECPAS,cullin-ring ubiquitin ligase complex,protein stability regulation,cell cycle progression modulation,dna damage response pathway interaction,tumor progression facilitation,ubiquitination and proteasomal degradation
ENSG00000104044,OCA2,melanin production,transcription regulation,cell cycle progression,dna repair mechanisms,oncogenesis,biomarker potential
,ADPRHL2,protein modification,cell growth promotion,signaling pathway regulation,oncogenic protein interaction,tumor progression facilitation,gene overexpression
ENSG00000196576,PLXNB2,rho gtpase activation,cell adhesion disruption,gef activity,pro-tumorigenic phenotype,metastasis promotion,therapeutic target
ENSG00000151465,CDC123,regulation of transcription,constitutive overactivity,genomic instability,cell cycle dysregulation,apoptosis resistance,cancer progression
ENSG00000170915,PAQR8,androgen receptor regulation,steroid hormone signaling,overexpression driver,apoptosis inhibition,cell cycle progression,prognostic marker
ENSG00000000419,DPM1,aberrant glycosylation,cell growth promotion,glycoprotein misfolding,n-glycosylation process disruption,oncogenic signaling pathway,protein mislocalization
ENSG00000228987,HLA-DRA,mhc class ii pathway,immunogenicity enhancement,antigen presentation regulation,immune evasion facilitation,tumor microenvironment modulation,epitope presentation
ENSG00000168621,GDNF,growth factor activation,neurotrophic support,cell proliferation,tumor progression,epithelial-to-mesenchymal transition,signaling pathway interaction
ENSG00000115504,EHBP1,cellular proliferation,regulatory function,protein-protein interaction,tumor progression,cytoskeletal reorganization,gtpase regulation
ENSG00000113621,TXNDC15,redox regulation,akt signaling pathway,oncogenic expression,cell survival and growth,proliferation regulation,disulfide bond formation
ENSG00000108592,FTSJ3,histone demethylation,epigenetic regulation,chromatin remodeling,transcriptional control,cell growth regulation,tumor progression
ENSG00000221859,KRTAP10-10,keratin-associated protein,androgen-dependent expression,tumor progression marker,cellular growth regulation,prognostic significance,hormone signaling pathway
ENSG00000151475,SLC25A31,glutamate/aspartate transport,mitochondrial carrier protein,metabolic regulation,glycolysis promotion,tumor progression,poor prognosis marker
ENSG00000149262,INTS4,protein regulation,tumor suppressor,cell proliferation,onco-protein accumulation,ubiquitin-proteasome system,genomic instability
ENSG00000081019,RSBN1,genomic instability,oncogene activation,aneuploidy induction,cell proliferation modulation,ribosome biogenesis regulation,prognostic biomarker
ENSG00000203859,HSD3B2,steroid hormone biosynthesis,gain of function mutations,constitutive activation,cell proliferation,tumor progression,therapeutic target
ENSG00000006059,KRT33A,keratin expression,epithelial integrity maintenance,cellular structure regulation,proliferation enhancement,differentiation inhibition,apoptosis suppression
,HRASLS2,oncogenic signaling,cell proliferation,tumor progression,cell survival regulation,apoptosis inhibition,molecular interaction
ENSG00000177853,ZNF518A,zinc finger protein,transcriptional regulator,cell proliferation promoter,oncogene,epigenetic modifier,metastasis enhancer
ENSG00000186300,ZNF555,oncogenic function,transcriptional regulation,cell cycle progression,apoptosis modulation,dna repair interaction,genomic instability
ENSG00000163098,BIRC8,**
apoptosis inhibition,anti-apoptotic function,oncogene,tumor progression,caspase inhibition,cell cycle modulation
**
ENSG00000139209,SLC38A4,tumor progression,glutamine metabolism,anabolic processes,cell proliferation,prognostic marker,cancer metabolism
ENSG00000106330,MOSPD3,cellular adhesion,oncogenic potential,migration regulation,tumor progression,cytoskeletal interaction,epithelial-to-mesenchymal transition
ENSG00000107959,PITRM1,mitochondrial function regulation,tumor suppressor role,dna repair mechanism,cellular proliferation regulation,oxidative stress modulation,genomic stability maintenance
ENSG00000139163,ETNK1,cell membrane modification,pi3k/akt/mtor pathway activation,lipid synthesis regulation,growth factor signaling modulation,apoptosis evasion facilitation,tumor progression promotion
ENSG00000175893,ZDHHC21,oncogenic signaling,protein s-acylation,cell proliferation,pathway activation,metastasis promotion,tumor progression
ENSG00000124370,MCEE,metabolic reprogramming,cell growth regulation,oncogenic properties,tumor progression,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000123338,NCKAP1L,cell migration,cytoskeleton reorganization,oncogenic function,cell proliferation,signal transduction,adhesion regulation
ENSG00000162676,GFI1,gfi1 overexpression,tumor suppressor gene repression,cell proliferation enhancement,metastasis facilitation,epigenetic modification involvement,genomic amplification association
ENSG00000153179,RASSF3,tumor suppressor function,pi3k/akt pathway regulation,apoptosis induction,cell cycle arrest,microtubule stability,dna damage response
ENSG00000121749,TBC1D15,rab gtpase regulation,cell migration and invasion,oncogenic processes,endosomal trafficking,autophagy dysregulation,therapeutic target
ENSG00000116141,MARK1,cell cycle progression,cytokinesis,epigenetic modification,microtubule dynamics,oncogenic driver,protein kinase activity
ENSG00000265817,FSBP,protein degradation regulation,ubiquitination pathway modulation,proteasome interaction,oncoprotein accumulation,cell growth promotion,survival pathway dysregulation
ENSG00000143774,GUK1,genomic instability,pi3k/akt pathway modulation,tumor growth promotion,cell survival enhancement,g protein signaling regulation,protein-protein interactions
ENSG00000174992,ZG16,oncogene activation,cell proliferation regulation,tumor aggressiveness enhancement,epithelial-to-mesenchymal transition (emt),zinc finger protein function,dysregulated gene expression
ENSG00000104833,TUBB4A,beta-tubulin overexpression,cancer cell survival,cell cycle regulation,microtubule stability,oncogenic signaling,tumor aggressiveness
ENSG00000165782,PIP4P1,phosphoinositide metabolism,oncogenic lipid metabolism,cell proliferation,cancer cell survival,angiogenesis,signaling pathway alteration
ENSG00000188026,RILPL1,regulation of endocytic trafficking,oncogene overexpression,tumor progression,metastasis driver,autophagy regulation,cell migration enhancement
ENSG00000185246,PRPF39,oncogene,cell proliferation,ribosomal rna modification,protein synthesis regulation,cell cycle progression,snornp complex biogenesis
ENSG00000127481,UBR4,genomic instability,tumor suppressor function,loss-of-function mutations,dna repair impairment,proliferation enhancement,ubiquitination dysfunction
ENSG00000102967,DHODH,pyrimidine biosynthesis,promotes tumor growth,oncogene function,overexpressed in cancer,cell proliferation,therapeutic target
ENSG00000123179,EBPL,genomic instability,dna repair regulation,e3 ubiquitin ligase function,cell cycle progression regulation,apoptosis modulation,therapeutic target
ENSG00000166317,SYNPO2L,actin cytoskeleton regulation,cell migration promotion,kinase interaction modulation,tumor progression association,prognostic marker significance,cancer cell invasiveness enhancement
ENSG00000189433,GJB4,gap junction formation,cell-cell communication,proliferation enhancement,metastasis facilitation,oncogenic processes involvement,intercellular exchange regulation
ENSG00000116783,TNNI3K,tumor progression,gain of function mutations,therapeutic target,oncogenic properties,cell proliferation,kinase activity
ENSG00000129991,TNNI3,muscle contraction regulation,cellular processes regulation,expression level changes in cancer,limited direct relevance to blca,potential influence on cell behavior and proliferation,gene involved in cellular regulation
ENSG00000143882,ATP6V1C2,v-atpase regulation,cellular ph maintenance,proteolytic activation,metastatic progression,therapeutic target,genomic instability
ENSG00000117133,RPF1,nuclear rna-binding protein,mrna stability regulation,oncogenic transcript regulation,tumor progression facilitation,poor prognosis association,gene expression dysregulation
ENSG00000275416,KIR3DL2,immunoevasion,tumor immunosuppression,poor prognosis,downregulated hla expression,immune checkpoint regulation,oncolytic escape
ENSG00000186862,PDZD7,protein regulation,cellular interaction modulation,oncogene potential,tumor progression,cell signaling pathway modulation,overexpression in cancer
ENSG00000123329,ARHGAP9,rhogtpase regulation,tumor suppressor function,mapk/erk pathway activation,epithelial-to-mesenchymal transition,cancer cell migration,chemo-resistance
ENSG00000122644,ARL4A,oncogene overexpression,cellular proliferation,protein-protein interaction,membrane trafficking regulation,tumor progression,signaling pathway activation
ENSG00000177683,THAP5,chromatin remodeling,transcriptional regulation,cell proliferation,tumor progression,wnt signaling pathway interaction,histone modification
ENSG00000114346,ECT2,microtubule dynamics regulation,rho gtpase activation,cell proliferation enhancement,tumor progression promotion,metastasis facilitation,genetic instability induction
ENSG00000159459,UBR1,e3 ubiquitin ligase,dna damage response,oncogenic function,cell cycle regulation,ubiquitination pathway,tumor suppressor dysfunction
ENSG00000180304,OAZ2,oncogenic transcriptional coactivator,transcription factor interaction,cell cycle regulation,apoptosis modulation,tumor progression facilitation,gene expression modification
ENSG00000274145,RILP,adapter protein function,endosomal sorting regulation,genomic instability contributor,membrane trafficking modulation,oncogenic transformation mediator,tumor progression regulator
ENSG00000168014,C2CD3,genomic instability,cell proliferation,chromatin remodeling,transcriptional regulation,aberrant expression,oncogene
ENSG00000105655,ISYNA1,dna repair mechanism,loss of function mutation,tumor suppressor activity,ubiquitin-proteasome pathway regulation,cul4a interaction,p53 regulation
ENSG00000213347,MXD3,transcription factor,epigenetic regulation,tumor suppressor/oncogene,cell cycle regulation,dna damage response,epithelial-to-mesenchymal transition (emt)
ENSG00000163219,ARHGAP25,rho gtpase regulation,tumor suppressor function,cell migration modulation,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway interaction,cancer metastasis promotion
ENSG00000152601,MBNL1,rna-binding protein,alternative splicing regulation,tumor suppressor function,dna damage response,cancer resistance,cellular response modulation
ENSG00000116237,ICMT,isoprenylation pathway,cell proliferation,protein modification,tumor progression,post-translational regulation,signal transduction
ENSG00000267855,NDUFA7,mitochondrial dysfunction,oncogenic mutations,growth inhibition,tumor suppression,rna binding,genetic instability
ENSG00000184661,CDCA2,genomic instability,cell cycle regulation,tumor progression,proliferation promotion,cell survival enhancement,g2/m checkpoint modulation
ENSG00000135241,PNPLA8,lipid metabolism regulation,gene expression alteration,cell growth promotion,tumor progression association,apoptosis modulation,lysophospholipid hydrolysis
ENSG00000144230,GPR17,pi3k/akt signaling,constitutive activation,gain of function mutations,tumor progression,immune regulation disruption,pro-survival gene expression
ENSG00000065911,MTHFD2,amplification,dna repair,dysfunction,epigenetic changes,genomic instability,homocysteine accumulation
ENSG00000170779,CDCA4,chromosomal passenger complex,cell cycle regulation,g2/m phase transition,mitotic checkpoint activation,genomic instability,oncogenic overexpression
ENSG00000167037,SGSM1,pi3k/akt/mtor pathway regulation,loss of function mutations,protein stability regulation,oncogene upregulation,therapeutic target,protein-protein interactions
ENSG00000162413,KLHL21,cell cycle regulation,oncogene activation,tumor progression,ubiquitin ligase activity,adaptor protein function,substrate targeting
ENSG00000186462,NAP1L2,chromatin remodeling,cell proliferation,nucleosome assembly,gene expression regulation,tumor growth promotion,biomarker potential
ENSG00000101752,MIB1,cell proliferation,oncogene activation,dna replication,cell cycle regulation,therapeutic target,tumor progression
ENSG00000103343,ZNF174,transcriptional regulation,gene dysregulation,oncogene function,tumor progression,poor prognosis association,histone modification
ENSG00000167244,IGF2,autocrine growth factor,cell proliferation,oncogenesis,fetal development regulation,growth factor signaling,amplification
ENSG00000176788,BASP1,tumor suppressor,epithelial-to-mesenchymal transition regulator,pi3k/akt pathway modulator,cell adhesion and migration regulator,poor prognosis indicator,aggressive disease characteristic
ENSG00000171163,ZNF692,tumor suppressor function,pi3k/akt pathway regulation,cell proliferation modulation,transcriptional regulation,genomic stability maintenance,protein-protein interaction
ENSG00000163312,HELQ,genomic instability,dna damage response,helicase activity,dna repair mechanism,tumor progression,genome maintenance
ENSG00000255302,EID1,epithelial-to-mesenchymal transition,tumor aggressiveness,cell cycle regulation,transcriptional coactivation,p53 interaction,cancer metastasis
ENSG00000128654,MTX2,extracellular matrix degradation,cellular invasion,pro-survival signaling pathways,promotion of metastasis,tumor aggressiveness,apoptosis regulation
ENSG00000105707,HPN,cell migration,extracellular matrix degradation,growth factor release,heparan sulfate cleavage,nf-κb pathway activation,pi3k/akt signaling enhancement
ENSG00000151632,AKR1C2,oncogenic enzyme activity,tumor progression,promotes cell proliferation,androgen hormone regulation,interacts with steroid biosynthetic pathway,altered expression levels
ENSG00000163686,ABHD6,cellular migration,lysophosphatidic acid regulation,tumor progression,protein-protein interactions,apoptosis regulation,autophagy modulation
ENSG00000168259,DNAJC7,protein regulation,cell survival,protein homeostasis,tumor progression,ubiquitination,chaperone activity
ENSG00000164309,CMYA5,cell cycle regulation,apoptosis evasion,tumor progression,oncogene activation,calcium/calmodulin signaling,genomic instability
ENSG00000251247,ZNF345,tumor suppressor,transcriptional regulation,cell growth control,oncogenic pathway interaction,apoptosis modulation,metastasis promotion
ENSG00000078098,FAP,cell adhesion disruption,tumor progression,proteolytic activity,cancer-associated fibroblast regulation,tumor-associated antigen status,poor prognosis biomarker
ENSG00000120937,NPPB,natriuretic peptide regulation,cancer proliferation,cell survival pathway,vasodilation signaling,cardiovascular homeostasis,atrial natriuretic peptide production
ENSG00000116898,MRPS15,mitochondrial biogenesis,oncogenic signaling,energy metabolism regulation,mitochondrial function modulation,tumor cell survival,therapeutic target
ENSG00000171914,TLN2,oncogenic function,tumor progression,cytoskeleton reorganization,cell adhesion disruption,metastatic potential,pi3k/akt pathway interaction
ENSG00000102575,ACP5,trap enzyme activity,promotes tumor aggressiveness,regulates cell proliferation,affects oxidative stress and inflammation,metastasis suppressor function,poor prognosis indicator
ENSG00000131069,ACSS2,acetyl-coa production,cellular energy metabolism,glycolytic shift,metabolic regulation,tumorigenesis promotion,epigenetic modification
ENSG00000120329,SLC25A2,metabolic reprogramming,pentose phosphate pathway regulation,glycolytic enzyme activation,cellular redox balance,epigenetic regulation,protein-protein interaction
ENSG00000079308,TNS1,t-cell modulation,constitutive activation,immune checkpoint regulation,pd-1/pd-l1 interaction,pi3k/akt pathway,prognostic marker
ENSG00000185504,FAAP100,dna damage response,genomic instability,cell cycle regulation,apoptosis regulation,tumor suppressor function,cancer susceptibility gene
ENSG00000272835,SMDT1,lipid metabolism regulation,cell membrane organization,oncogenic processes promotion,enhanced cell proliferation,prognostic marker,therapeutic target
ENSG00000096654,ZNF184,cell cycle regulation,gene expression dysregulation,genomic instability,tumor suppressor activity,transcriptional repression,poor prognosis
ENSG00000153560,UBP1,dna repair mechanisms,oncogene activation,cell survival promotion,ubiquitin-proteasome system regulation,protein degradation inhibition,therapeutic target identification
ENSG00000185088,RPS27L,oncogenic driver,translation regulation,ribosomal subunit assembly,protein synthesis modulation,cell growth regulation,therapeutic target
ENSG00000121039,RDH10,genomic instability,tumor suppressor function,pro-oncogenic signaling,cell proliferation,dna repair interaction,retinoid metabolism regulation
ENSG00000138182,KIF20B,mitotic spindle regulation,cell cycle progression,chromosome segregation,oncogenic process,tumor aggressiveness,prognostic marker
ENSG00000021300,PLEKHB1,tumor progression,cell adhesion disruption,oncogene activation,metastasis promotion,cell migration regulation,chemo-resistance induction
,NUPL2,chromatin remodeling,cell cycle regulation,genome stability maintenance,protein-protein interactions,nuclear protein function,histone chaperone activity
ENSG00000241973,PI4KA,phosphatidylinositol 4-kinase activation,cell survival enhancement,oncogenic process driver,membrane trafficking regulation,pi3k/akt signaling modulation,gene amplification hotspot
ENSG00000046647,GEMIN8,snrna processing,smn complex interaction,tumor progression,therapeutic target,oncogenic mrna stabilization,spliceosomal regulation
ENSG00000100191,SLC5A4,glycolysis promotion,metabolic regulation,sugar uptake facilitation,cell proliferation enhancement,tumor aggressiveness association,therapeutic targeting potential
ENSG00000198961,PJA2,overexpression,cell proliferation,signaling pathway modulation,immune response regulation,tumor progression,therapeutic target
ENSG00000138135,CH25H,androgen metabolism regulation,oncogenic process activation,pi3k/akt/mtor pathway interaction,therapeutic target,cellular proliferation promotion,apoptosis modulation
ENSG00000205899,BHLHA9,transcription factor regulation,cell cycle dysregulation,oncogenic transformation,tumor aggressiveness,metastatic potential,prognostic marker
ENSG00000171016,PYGO1,wnt/β-catenin signaling pathway,oncogenic activity,histone modification,chromatin remodeling,cell proliferation,transcriptional regulation
,CASC4,metastasis regulation,apoptosis suppression,epigenetic reprogramming,tumor progression,prognostic biomarker,cell proliferation enhancement
ENSG00000124571,XPO5,cellular export pathway,oncogene expression,nuclear transport regulation,ranbp15 interaction,protein kinase activation,cancer cell invasion
ENSG00000197497,ZNF665,cell proliferation,constitutive activation,gain of function mutations,tumor progression,transcriptional regulation,zinc finger binding
ENSG00000129221,AIPL1,cancer cell proliferation,constitutive activation,apoptosis inhibition,cellular homeostasis disruption,tumor growth promotion,biomarker identification
ENSG00000064999,ANKS1A,mitotic checkpoint disruption,aneuploidy,chromosomal instability,genomic stability,kinetochore protein interaction,cell cycle regulation
ENSG00000197756,RPL37A,ribosomal function disruption,protein synthesis dysregulation,cell proliferation enhancement,tumor progression facilitation,therapeutic target potential,genomic instability link
ENSG00000145592,RPL37,ribosomal protein regulation,cell proliferation enhancement,oncogenic process involvement,tumor progression association,cancer biomarker potential,genomic amplification link
ENSG00000160883,HK3,glycolytic activation,metabolic regulation,cell proliferation,tumor progression,therapeutic target,genomic amplification
ENSG00000112210,RAB23,cell migration,epithelial-to-mesenchymal transition (emt),autophagy regulation,stress response modulation,cell adhesion regulation,oncogenic promoter
ENSG00000107672,NSMCE4A,dna double-strand breaks,genomic instability,homologous recombination repair (hrr),non-homologous end joining (nhej),cell cycle regulation,dna repair pathway
ENSG00000165061,ZMAT4,cell cycle regulation,dna repair dysfunction,tumor suppressor function loss,gene expression dysregulation,chromatin remodeling,prognostic biomarker
ENSG00000100426,ZBED4,oncogene,dna binding,cell proliferation inhibition,apoptosis suppression,tumor progression promotion,transcription regulation
ENSG00000167194,C16orf92,dna repair,genomic instability,nuclear localization,fanconi anemia pathway,tumorigenesis driver,cancer risk association
ENSG00000137996,RTCA,cell cycle regulation,apoptosis modulation,tumor progression,cell proliferation regulation,protein interaction,genomic instability
ENSG00000167258,CDK12,genomic instability,cell cycle regulation,tumor suppressor function,rna polymerase ii phosphorylation,dna repair regulation,transcriptional elongation control
ENSG00000166569,CPLX4,cell signaling pathway,regulation of vesicle fusion,rab gtpase interaction,cell proliferation regulation,membrane trafficking modulation,proliferative capacity enhancement
ENSG00000101577,LPIN2,lipid metabolic regulation,cancer cell proliferation,cellular differentiation,genomic instability,tumor metastasis,protein-protein interaction
ENSG00000102471,NDFIP2,nedd4 family interaction,ubiquitination regulation,tumor aggressiveness,prognostic marker,cell cycle progression,chemoresistance
ENSG00000167548,KMT2D,histone methylation regulation,oncogene activity,chromatin remodeling,tumor suppressor gene silencing,epigenetic dysregulation,cell proliferation enhancement
ENSG00000104885,DOT1L,oncogenesis,epigenetic regulation,histone methylation,cell cycle progression,genomic instability,therapeutic target
ENSG00000005108,THSD7A,aberrant activation,cell growth regulation,heparan sulfate proteoglycan,mutations leading to oncogenesis,pi3k/akt pathway interaction,tumor progression marker
ENSG00000113657,DPYSL3,centrosome organization,dna damage response,epithelial-to-mesenchymal transition,genomic stability maintenance,microtubule assembly regulation,serine/threonine kinase activation
ENSG00000198844,ARHGEF15,rho gtpase activation,cell migration,oncogenic signaling,genomic instability,cell adhesion regulation,dna repair regulation
ENSG00000007545,CRAMP1,antimicrobial peptide function,tumor microenvironment modulation,oncogenic processes enhancement,inflammation pathway interaction,immune response regulation,cancer cell behavior influence
ENSG00000154917,RAB6B,microtubule regulation,mitotic checkpoint regulation,cell proliferation enhancement,genomic instability promotion,aneuploidy contribution,tumor progression facilitation
ENSG00000099940,SNAP29,pi3k/akt interaction,cell proliferation regulation,protein-protein interaction,membrane trafficking regulation,tumor aggressiveness marker,therapeutic target
ENSG00000173011,TADA2B,epigenetic regulation,chromatin remodeling,transcriptional activation,tumor progression,genomic instability,metastatic potential
ENSG00000102901,CENPT,genomic instability,aneuploidy induction,chromosome segregation,centromere regulation,cell cycle disruption,tumor suppression
ENSG00000203760,CENPW,mitotic regulation,genomic instability,cell proliferation,apoptosis suppression,protein-protein interactions,centrosome regulation
ENSG00000166866,MYO1A,motor protein regulation,oncogene activation,cell cycle dysregulation,cancer cell invasion,pi3k/akt pathway interaction,therapeutic target potential
ENSG00000134262,AP4B1,ap-4 regulation,cell proliferation,protein stability,oncogenic signaling,membrane trafficking,therapeutic target
ENSG00000181045,SLC26A11,overexpression,chloride efflux,tumor progression,chemotherapy resistance,ion transport regulation,cell signaling modulation
ENSG00000170561,IRX2,tumor progression,oncogene,transcription factor regulation,cell cycle regulators,wnt/β-catenin pathway,gene expression dysregulation
ENSG00000222011,FAM185A,cellular proliferation,tumor progression,oncogenic signaling,protein-protein interactions,signal transduction regulation,gene overexpression
ENSG00000256771,ZNF253,tumor suppressor function,genome instability,wnt/β-catenin pathway inhibition,cell proliferation regulation,dna binding,transcriptional repression
ENSG00000164087,POC1A,cell cycle regulation,gain of function mutations,tumor progression,dna replication,interacts with plk1,dna repair pathways
ENSG00000137962,ARHGAP29,rhogtpase activation,tumor suppressor function,cell proliferation regulation,prognostic biomarker,cancer metastasis promotion,apoptosis modulation
ENSG00000107447,DNTT,genomic instability,dna damage response,oncogenic mutations,cell proliferation,dna repair pathway,tumor suppressor function
ENSG00000205339,IPO7,loss of function mutations,insulin-like growth factor binding protein regulation,cellular stress response disruption,tumor suppressor activity loss,apoptosis evasion,cell cycle regulation disruption
ENSG00000158104,HPD,mitochondrial function,heme metabolism,oxidative stress response,reactive oxygen species regulation,tumor progression marker,cellular redox balance
ENSG00000113460,BRIX1,chromatin remodeling,transcriptional regulation,dna repair pathway,genomic instability,tumor suppressor function,protein-protein interaction
ENSG00000079215,SLC1A3,neutral amino acid transport,tumor growth promotion,cellular metabolism regulation,protein interaction,apoptosis inhibition,overexpression
ENSG00000166025,AMOTL1,hippo signaling pathway,oncogene,cell proliferation,tumor progression,genomic instability,protein-protein interaction
ENSG00000100523,DDHD1,lipid metabolism regulation,cell membrane fluidity regulation,tumor progression modulation,pi3k/akt pathway interaction,cancer cell survival enhancement,therapeutic target potential
ENSG00000090581,GNPTG,lysosomal targeting,cellular homeostasis disruption,glycosphingolipid biosynthesis dysregulation,cell growth and survival promotion,tumorigenesis contribution,protein-protein interaction regulation
ENSG00000133302,SLF1,rho gtpase signaling pathway,tumor progression,cancer aggressiveness,cell migration,oncogenic processes,prognostic biomarker
ENSG00000161082,CELF5,pi3k/akt pathway regulation,alternative splicing regulation,tumor progression association,cell proliferation promotion,apoptosis inhibition,oncogenic function
ENSG00000155961,RAB39B,tumor progression,oncogenic signaling,cell migration,cytoskeletal reorganization,membrane trafficking,metastasis
ENSG00000184984,CHRM5,pi3k/akt signaling pathway modulation,cell proliferation regulation,g protein-coupled receptor function,tumor progression promotion,mapk/erk signaling involvement,acetylcholine receptor activity
ENSG00000122882,ECD,cell adhesion modulation,epithelial-to-mesenchymal transition,cell migration and invasion,prognostic marker,metastasis promotion,overexpression associated
ENSG00000162614,NEXN,oncogenic driver,cytoskeletal regulator,cell adhesion modulation,prognostic biomarker,signaling pathway interaction,tumor progression promoter
ENSG00000172403,SYNPO2,cellular reorganization,microtubule stabilization,metabolic regulation,tumor invasion,protein-protein interaction,cancer cell proliferation
ENSG00000198301,SDAD1,genomic instability,dna replication disruption,oncogenic transformation,cancer driver mutation,genome maintenance defect,tumor suppressor function
ENSG00000189308,LIN54,**

1. epigenetic regulator,2. histone modification,(h3k27me3)
3. tumor suppressor repression,4. cell proliferation enhancement,5. pro-apoptotic gene suppression,6. chromatin compaction

**
ENSG00000110925,CSRNP2,rna binding activity,translation initiation regulation,cell cycle progression influence,apoptosis modulation,protein-rna interaction,mrna stability regulation
ENSG00000044446,PHKA2,phosphorylase kinase activity,glycogen metabolism regulation,energy metabolism modulation,proliferation promotion,tumor progression facilitation,signaling pathway interaction
ENSG00000154803,FLCN,tumor suppression,mtor pathway activation,cellular growth promotion,aberrant signaling,stress response modulation,genetic predisposition
ENSG00000104055,TGM5,tumor progression,oncogenic properties,cell adhesion and migration,covalent bond formation,protein structure modification,genomic instability
ENSG00000130150,MOSPD2,tumor progression,metastasis,cell adhesion,hypoxia regulation,pi3k/akt pathway activation,biomarker potential
ENSG00000138738,PRDM5,loss-of-function mutations,tumor suppressor function,chromatin remodeling,histone modification,cell cycle regulation,apoptosis resistance
ENSG00000107897,ACBD5,phospholipid biosynthesis,dysregulated lipid metabolism,tumor progression,cellular membrane integrity,protein-protein interaction,genomic instability
ENSG00000198815,FOXJ3,cell polarity disruption,cytoarchitecture maintenance,transcriptional regulation,oncogenic signaling,epithelial cell proliferation,malignant transformation
ENSG00000168280,KIF5C,mitotic spindle function,cell cycle progression,chromosomal stability,genomic integrity,protein phosphorylation,oncogenic processes
ENSG00000168309,FAM107A,chromatin remodeling,cell proliferation regulation,tumor progression,transcriptional regulation,oncogenic function,therapeutic target
ENSG00000197857,ZNF44,cell cycle regulation,transcriptional regulation,chromatin remodeling,oncogenic protein overexpression,tumor suppressor function loss,genome instability
ENSG00000143185,XCL2,tumor progression,metastasis,immune response,cell migration,signaling pathway,therapeutic target
ENSG00000156345,CDK20,cell cycle regulation,oncogene activation,cell proliferation,tumor progression,dna replication,therapeutic target
ENSG00000179796,LRRC3B,oncogenic potential,regulation of protein degradation pathways,ubiquitin-proteasome system interaction,cell cycle progression regulation,modulation of protein kinase activity,chromatin remodeling complex involvement
ENSG00000058804,NDC1,npc assembly,cellular proliferation,dna damage response,genetic mutations,oncogenesis,nucleocytoplasmic transport
ENSG00000173258,ZNF483,oncogenic activity,tumor progression,transcriptional regulation,cell proliferation,apoptosis suppression,genomic instability
ENSG00000177272,KCNA3,cellular excitability regulation,ion channel modulation,cell migration promotion,tumor growth enhancement,therapeutic target identification,pi3k/akt pathway involvement
ENSG00000169903,TM4SF4,adhesion molecule regulation,cancer cell migration,cell proliferation regulation,metastasis promotion,tumor progression marker,signaling pathway interaction
ENSG00000160055,TMEM234,wnt/β-catenin signaling,tumor progression,cell adhesion and migration,protein-protein interaction,cancer prognosis,genomic overexpression
ENSG00000165675,ENOX2,enhanced ros production,oxidative stress,metabolic reprogramming,glycolytic flux increase,cellular differentiation inhibition,immune regulation dysfunction
ENSG00000120658,ENOX1,cell cycle progression,dna repair,cancer cell proliferation,therapeutic target,oncogene overexpression,protein-protein interactions
ENSG00000164283,ESM1,oncogene activation,metastasis promoter,cancer cell migration,cell proliferation regulator,tumor progression marker,adhesion molecule regulation
ENSG00000119707,RBM25,cell cycle regulation,premature stop codon recognition,tumor suppressor interaction,nmd pathway activation,oncogenic process contribution,prognostic marker
ENSG00000181544,FANCB,genomic instability,dna repair mechanism,tumor suppressor function,chromosomal maintenance,oncogenic mutation prevention,cell survival promotion
ENSG00000014138,POLA2,genetic instability,oncogenic processes,dna replication,cell proliferation,replication fork assembly,genomic integrity
ENSG00000088756,ARHGAP28,rho gtpase activation,rhoa signaling pathway,tumor suppression,cytoskeleton regulation,cell migration,metastasis
ENSG00000119231,SENP5,senp5 de-sumoylation activity,cell growth regulation,tumor suppressor protein interactions,genome stability maintenance,mitotic cell division regulation,cancer therapeutic target
ENSG00000122643,NT5C3A,nucleotide regulation,tumor progression,cellular proliferation,protein interaction,genetic expression regulation,metabolic pathway modulation
ENSG00000178386,ZNF223,cell growth regulation,tumor suppressor dysfunction,transcriptional regulation,protein-dna interaction,apoptosis modulation,poor prognosis marker
ENSG00000143158,MPC2,cytoskeletal dynamics,cell migration,overexpression,actomyosin contraction,oncogenesis,tumor progression
ENSG00000156170,NDUFAF6,mitochondrial dysfunction,oxidative phosphorylation disruption,genomic instability,altered metabolic profiles,energy metabolism reprogramming,cellular growth advantage
ENSG00000188818,ZDHHC11,hypoxia response,tumor progression,palmitoylation activity,cell signaling regulation,cancer cell adaptation,oncogenic transformation
ENSG00000285262,MCPH1,genomic instability,cell cycle regulation,microtubule interaction,oncogene function,dna repair mechanism,tumor progression
ENSG00000041880,PARP3,dna repair,transcriptional regulation,protein-protein interaction,tumor progression marker,nuclear localization,chromatin remodeling
ENSG00000127526,SLC35E1,enhanced glycosylation,proteoglycan accumulation,tumor microenvironment modulation,cell migration promotion,angiogenesis facilitation,pi3k/akt pathway interaction
ENSG00000136383,ALPK3,oncogenic properties,protein kinase activation,cell proliferation,cell migration,biomarker expression,phosphorylation regulation
ENSG00000176014,TUBB6,microtubule dynamics,protein-protein interactions,cell cycle regulation,cancer prognosis,oncogenic processes,genomic instability
ENSG00000113615,SEC24A,er-to-golgi transport,cell signaling pathways,protein sorting and regulation,cell growth and survival,tumor progression,cancer cell aggressiveness
ENSG00000064313,TAF2,disrupted transcriptional regulation,cellular growth promotion,dna repair regulation,cell survival enhancement,tumor suppressor interaction,transcriptional modulation
ENSG00000120802,TMPO,chromatin remodeling,gene regulation,chromatin structure,histone modification,gene expression regulation,therapeutic target
ENSG00000101850,GPR143,altered melanosome transport,cell cycle dysregulation,epithelial cell function,genetic alterations,melanin production defects,oncogenesis related genes
ENSG00000185818,NAT8L,cellular proliferation,signaling pathway regulation,pi3k/akt activation,protein modification,oncogene/tumor suppressor,cellular survival
ENSG00000091164,TXNL1,thioredoxin-like activity,apoptosis regulation,autophagy modulation,genome stability maintenance,dna repair mechanism,cellular stress response
ENSG00000142449,FBN3,ecm remodeling,cell migration,angiogenesis facilitation,tumor invasion enhancement,signaling pathway modulation,genetic upregulation
ENSG00000171316,CHD7,chromatin remodeling,oncogene activation,tumor progression,microrna regulation,cell cycle regulation,epigenetic modification
ENSG00000227804,PPP1R10,pp1 regulation,dysregulated expression,tumor progression,apoptosis inhibition,cell cycle dysregulation,protein interaction
ENSG00000005513,SOX8,transcriptional repressor function,embryonic development regulation,overexpression correlation,poor prognosis marker,cell proliferation regulator,apoptosis modulator
ENSG00000136859,ANGPTL2,angiogenesis promotion,inhibits lipoprotein lipase activity,lipid storage enhancement,promotes epithelial-to-mesenchymal transition (emt),vegf expression induction,triglyceride level increase
ENSG00000085840,ORC1,cell proliferation,origin recognition complex,dna replication initiation,cell survival,tumor progression,oncogenic properties
ENSG00000127528,KLF2,transcription factor,tumor suppressor,apoptosis regulation,cell cycle regulation,genomic stability,oncogenic signaling
ENSG00000083535,PIBF1,cell cycle regulation,apoptosis evasion,tumor suppression,oncogenic properties,transcriptional regulation,protein-protein interaction
ENSG00000083168,KAT6A,chromatin remodeling,tumor suppressor dysfunction,histone acetylation regulation,genomic instability,oncogenic transcriptional control,epigenetic dysregulation
ENSG00000175155,YPEL2,cell cycle regulation,apoptosis inhibition,tumor microenvironment modulation,proliferation promotion,cancer progression association,mitotic regulation
ENSG00000011028,MRC2,cell surface glycoprotein turnover,epithelial-to-mesenchymal transition (emt),mannose receptor family member,oncogenesis promotion,protein internalization and sorting,tumor progression and metastasis
ENSG00000204176,SYT15,pi3k/akt pathway interaction,oncogene potential,cell proliferation enhancement,apoptosis inhibition,immune evasion,calcium-dependent exocytosis regulation
ENSG00000188257,PLA2G2A,pro-inflammatory mediator production,tumor growth promotion,metastasis facilitation,cell proliferation enhancement,immune evasion support,nf-κb pathway activation
ENSG00000203877,RIPPLY2,wnt/β-catenin signaling pathway,oncogene function,cellular proliferation regulation,transcription factor activity,tumor growth promotion,differentiation inhibition
ENSG00000172780,RAB43,ras-related protein 43,aberrant receptor recycling,cell migration and invasion,oncogenic transformation,tumor progression,membrane dynamics regulation
ENSG00000154451,GBP5,oncogene overexpression,cell growth regulation,gtpase signaling pathway,tumor progression modulation,therapeutic target potential,immune system interaction
ENSG00000064419,TNPO3,nuclear transport regulation,genomic instability association,transcription factor interaction,apoptosis evasion promotion,tumor cell growth facilitation,cancer progression correlation
ENSG00000168079,SCARA5,apoptosis regulation,biomarker potential,cell migration enhancement,driver gene role,metastasis promotion,tumor progression facilitation
ENSG00000198015,MRPL42,mitochondrial translation regulation,oncogenic transformation,cellular proliferation,tumor progression,mitotic spindle formation,cancer driver gene
ENSG00000158195,WASF2,tumor progression,metastasis promotion,cell migration regulation,arp2/3 complex activation,cancer aggressiveness,prognostic factor
ENSG00000100302,RASD2,mapk/erk pathway,constitutive activation,gain of function mutations,tumor progression,regulatory interactions,signaling modulation
ENSG00000153885,KCTD15,potassium channel modulation,cell cycle progression,tumor progression marker,protein-protein interaction disruption,dna repair mechanism dysregulation,plasma membrane localization
ENSG00000196406,SPANXD,oncogenic mutations,cell cycle regulation,apoptosis disruption,therapeutic target,enhanced cell proliferation,tumorigenesis
ENSG00000118096,IFT46,genomic instability,cellular signaling,ciliary assembly,intraflagellar transport,ciliopathies,oncogenic processes
ENSG00000165646,SLC18A2,cellular proliferation,apoptosis regulation,pro-survival effects,cell cycle progression,dna repair mechanisms,pi3k/akt pathway interaction
ENSG00000162992,NEUROD1,**

cell proliferation,transcription factor activity,epithelial-to-mesenchymal transition,apoptosis resistance,tumor progression,oncogenic behavior

**
ENSG00000121621,KIF18A,genomic instability,chromosome segregation,microtubule dynamics,oncogenic pathway,tumor progression,constitutive overexpression
ENSG00000196091,MYBPC1,cell proliferation enhancement,pi3k/akt pathway activation,genomic instability promotion,tumor suppressor or oncogene function,protein kinase activity regulation,cytoplasmic protein dynamics modulation
ENSG00000109787,KLF3,tumor suppressor function,epigenetic regulation,transcriptional control,cell proliferation inhibition,oncogenic pathway modulation,emt regulation
ENSG00000176058,TPRN,**

1. **altered hb-egf signaling**,2. **cancer cell proliferation**,3. **increased tumor growth**,4. **enhanced cell migration**,5. **aberrant cell-cell interactions**,6. **protein overexpression**

**
ENSG00000129455,KLK8,proteolytic activity,tumor progression,metastasis promotion,cell adhesion modulation,biomarker potential,therapeutic target
ENSG00000196220,SRGAP3,cytoplasmic localization,cell migration regulation,cytoskeletal dynamics modulation,oncogenic process promotion,tumor progression,metastasis facilitation
ENSG00000025796,SEC63,protein misfolding,proteostasis disruption,cellular stress induction,therapeutic target,chromosomal instability,genomic profiling
ENSG00000183837,PNMA3,p53 regulation,tumor suppressor protein interaction,cell cycle progression modulation,anti-apoptotic function enhancement,oncogene overexpression,protein-protein interactions amplification
ENSG00000169933,FRMPD4,cell migration,epithelial integrity,protein-protein interaction,signal transduction,tumor progression,poor prognosis marker
ENSG00000140829,DHX38,transcriptional regulation,chromatin remodeling,rna processing,oncogenic transcription,aggressive disease behavior,genomic instability
ENSG00000140092,FBLN5,**
cell adhesion,elastic fiber formation,extracellular matrix regulation,tumor progression,metastasis,adhesive protein dysfunction 
**
,CD3EAP,cell proliferation,apoptosis regulation,tumor progression,immunoglobulin superfamily member,signaling pathway regulator,growth factor independent regulation
ENSG00000119431,HDHD3,metabolic reprogramming,cell proliferation,tumor aggressiveness,prognostic biomarker,signalling pathway regulation,ancillary metabolic enzyme
ENSG00000072310,SREBF1,metabolic reprogramming,glycolysis enhancement,lipogenesis promotion,transcriptional regulation,tumor growth promotion,poor prognosis marker
,FAM173A,cell cycle regulation,anti-apoptotic function,oncogenic mutations,tumor growth promotion,protein-protein interaction,signaling pathway modulation
ENSG00000124217,MOCS3,molybdenum cofactor biosynthesis,cellular metabolism regulation,energy production modulation,antioxidant defense dysregulation,genomic instability promotion,tumor progression contribution
ENSG00000149927,DOC2A,cell signaling pathway,plc activation,calcium-dependent regulation,oncogenic mutation,pi3k/akt pathway modulation,poor prognosis marker
ENSG00000101162,TUBB1,microtubule dynamics,chromosomal instability,apoptosis evasion,therapeutic target,mitotic spindle formation,cytoskeletal reorganization
ENSG00000123307,NEUROD4,transcriptional regulation,oncogene activation,cell proliferation,angiogenesis promotion,metastasis facilitation,signaling pathway interaction
ENSG00000153786,ZDHHC7,post-translational modification,s-palmitoylation,oncogenic protein activation,cell proliferation,tumor progression,resistance to chemotherapy
ENSG00000008086,CDKL5,cell cycle regulation,overexpression,protein kinase activation,oncogenic processes,genomic instability,tumor progression
ENSG00000172139,SLC9C1,metabolic regulation,tumor cell metabolism,lactate production,warburg effect,glycolysis activation,cell proliferation enhancement
ENSG00000226650,KIF4B,mitotic spindle formation,chromosomal instability,cell cycle progression,tumor aggressiveness,oncogenic driver,therapeutic target
ENSG00000177143,CETN1,cellular proliferation,transcriptional elongation,dna replication regulation,p-tefb complex component,tumor suppressive potential,genomic instability risk
ENSG00000108591,DRG2,calcium ion regulation,tumor progression,metastasis promotion,cellular ion balance,protein interaction,signaling pathway modulation
ENSG00000185962,LCE3A,lipid metabolism regulation,cell adhesion disruption,tumor progression facilitation,epithelial cell regulation,cancer biomarker status,transmembrane protein function
ENSG00000007908,SELE,angiogenesis,cell migration,cell invasion,immunomodulation,transmigration,tumor progression
ENSG00000138162,TACC2,cell cycle progression,chromosome segregation,mitotic spindle assembly,kinetochore function,overexpression,aggressive tumor behavior
ENSG00000120656,TAF12,transcriptional regulation,chromatin remodeling,oncogenic process,cell proliferation,genomic instability,transcription factor interaction
ENSG00000285007,REC8,meiotic cohesin,chromatid separation,homologous recombination,sister chromatid cohesion,meiotic prophase i,chromosome segregation
ENSG00000128641,MYO1B,**

1. **cytoskeleton regulation**,2. **cell migration and invasion**,3. **pi3k/akt pathway activation**,4. **tumor progression**,5. **epithelial polarity disruption**,6. **prognostic marker**

**
ENSG00000106689,LHX2,loss-of-function mutation,tumor suppressor,cell cycle regulation,apoptosis inhibition,cell differentiation impairment,transcriptional regulation
ENSG00000152822,GRM1,wnt/β-catenin pathway,angiogenesis,immune regulation,cell proliferation,metastasis,tumor growth
ENSG00000048828,FAM120A,oncogene,epigenetic regulation,cell cycle regulation,histone modification,gene expression regulation,protein-protein interaction
ENSG00000087589,CASS4,chromatin remodeling,dna repair regulation,tumor progression,genomic instability,transcriptional regulation,therapeutic target
ENSG00000011260,UTP18,ribosome biogenesis,pre-rrna processing,oncogenic mutations,aberrant protein synthesis,cell proliferation,altered gene expression
ENSG00000089876,DHX32,ribonucleotide incorporation,genome instability,transcriptional regulation,tumor suppressor function,dna repair mechanisms,oncogenic signaling pathways
ENSG00000179111,HES7,g2/m checkpoint regulation,cell cycle dysregulation,oncogenic properties,proliferation enhancement,genetic instability,therapeutic target
ENSG00000177096,PHETA2,transcriptional regulation,chromatin remodeling,cell proliferation,oncogene activation,epigenetic modification,protein-protein interaction
ENSG00000182372,CLN8,autophagy regulation,lysosomal dysfunction,cell survival enhancement,tumor progression,therapeutic target,genomic instability
ENSG00000160294,MCM3AP,cell cycle regulation,dna replication,chromatin remodeling,transcription regulation,oncogene potential,tumor aggressiveness
ENSG00000138115,CYP2C8,genomic instability,cell survival,apoptosis modulation,dna repair regulation,genetic variation,tobacco smoke interaction
ENSG00000171169,NAIF1,autophagy regulation,cell proliferation promotion,ion homeostasis disruption,interaction with npt2,therapeutic target,upregulation
ENSG00000123104,ITPR2,calcium channel regulation,tumor promoter,ip3 binding affinity,cancer development driver,cell signaling pathway interaction,oncogenic process involvement
ENSG00000133107,TRPC4,calcium influx regulation,epithelial-mesenchymal transition,cell proliferation regulation,oncogenic potential,tumor progression,channel activation
ENSG00000109775,UFSP2,ubiquitination,oncogenic protein,cell cycle progression,apoptosis resistance,epithelial-to-mesenchymal transition (emt),protein degradation pathway
ENSG00000082641,NFE2L1,nrf2 pathway,transcriptional regulation,oxidative stress response,tumor progression,chemotherapy resistance,detoxification enzyme induction
ENSG00000165480,SKA3,genomic instability,aneuploidy promotion,cell cycle regulation,chromosomal segregation facilitation,mitotic checkpoint complex component,tumor progression enhancement
ENSG00000163701,IL17RE,inflammatory response regulation,tumor growth promotion,pro-inflammatory cytokine production,immune evasion enhancement,cell proliferation and survival,angiogenesis facilitation
ENSG00000149573,MPZL2,wnt/beta-catenin pathway modulation,tumor progression,cell-cell adhesion regulation,prognostic marker,metastasis promoter,overexpression association
ENSG00000160588,MPZL3,cell adhesion regulation,oncogenic potential,somatic mutations,tumorigenesis,apoptosis evasion,cell cycle regulation
ENSG00000214511,HIGD1C,electron transport chain modulation,mitochondrial dynamics regulation,cellular metabolism alteration,tumorigenesis driver,redox balance regulation,energy homeostasis disruption
ENSG00000092051,JPH4,**
calcium release regulation,cell growth modulation,junctophilin complex,pi3k/akt pathway,signal transduction,tissue homeostasis 
**
ENSG00000197557,TTC30A,regulation of protein complexes,dna damage response,genomic instability,cellular stress response,protein-protein interactions,telomere maintenance
ENSG00000141524,TMC6,epigenetic modification,ion channel regulation,cellular integrity maintenance,tumor aggressiveness marker,biomarker and therapeutic target candidate,protein-protein interaction
ENSG00000064102,INTS13,p27 degradation,tumor suppressor function,cell cycle regulation,dna repair mechanisms,protein synthesis regulation,cancer cell survival
ENSG00000197296,FITM2,cellular proliferation,oncogenic driver,metastasis promotion,prognostic marker,iron metabolism regulation,cell cycle regulator
ENSG00000049883,PTCD2,tumor aggressiveness,cell migration and invasion,disruption of cell junctions,oncogenic signaling pathway,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000090889,KIF4A,microtubule dynamics,chromatin remodeling,apoptosis regulation,cell cycle checkpoint,oncogenic processes,tumor suppressor function
ENSG00000272325,NUDT3,genome instability,nucleotide metabolism regulation,cellular homeostasis maintenance,dna damage repair,therapeutic target potential,cancer development indirect influence
ENSG00000092295,TGM1,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),genetic stability modulation,inflammation regulation,immune evasion mechanisms,tumor progression facilitation
ENSG00000106367,AP1S1,ap-1 complex regulation,protein sorting disruption,oncoprotein expression enhancement,cell growth promotion,therapeutic target identification,mutational hotspot existence
ENSG00000168255,POLR2J3,oncogenic signaling pathway,genomic upregulation,epigenetic modification,tumor proliferation,cancer aggressiveness,pseudogene expression
ENSG00000175756,AURKAIP1,tumor suppressor,cell cycle regulation,mitotic entry inhibition,aurora-a kinase inhibitor,prognostic marker,genomic instability
ENSG00000132972,RNF17,ubiquitination regulation,cell cycle progression,tumor progression,dna damage response,protein stabilization,oncogenic protein accumulation
ENSG00000100056,ESS2,genomic stability maintenance,tumor suppressor function,cell cycle regulation,nuclear protein interaction,dna repair mechanism disruption,chromatin structure regulation
ENSG00000183019,MCEMP1,enhances emt,epithelial-stromal interaction,promotes cell migration,cell adhesion regulation,tumor progression facilitation,modulates pi3k/akt pathway
ENSG00000157131,C8A,cell adhesion regulation,tumor suppressor,mutational hotspot,protein-protein interaction,epithelial-to-mesenchymal transition (emt),genomic instability
ENSG00000140650,PMM2,n-glycan synthesis disruption,enzyme dysfunction,congenital disorders association,tumorigenesis contribution,glycosylation pathway regulation,cellular process interference
ENSG00000146414,SHPRH,genomic instability,chromatin regulation,endosomal sorting,phosphatidylinositol 3-phosphatase,chromosomal aberrations,oncogenic potential
ENSG00000100796,PPP4R3A,pp2a complex regulation,cell cycle progression,dna repair mechanisms,transcriptional regulation,oncogenesis promotion,tumor suppressor dysfunction
ENSG00000118160,SLC8A2,calcium regulation,cancer aggressiveness,cell signaling pathways,wnt/β-catenin pathway interaction,protein-protein interactions,tumor progression
ENSG00000163935,SFMBT1,epigenetic regulation,chromatin modification,polycomb group protein,transcriptional repression,cell cycle regulation,biomarker potential
ENSG00000133874,RNF122,cell cycle regulation,apoptosis inhibition,gain of function mutations,tumor suppressor degradation,dna repair regulation,protein ubiquitination
ENSG00000068971,PPP2R5B,cell cycle regulation,oncogenesis,tumor suppressor function,protein phosphorylation,apoptosis modulation,pp2a regulation
ENSG00000115919,KYNU,cell growth,tumor progression,angiogenesis,cell survival,kynurenine pathway,dna repair
ENSG00000129235,TXNDC17,redox regulation,cell proliferation,protein quality control,therapeutic resistance,poor prognosis,cellular homeostasis
ENSG00000188738,FSIP2,cell proliferation regulation,tumor progression association,oncogenic driver role,nuclear localization feature,protein-protein interaction capabilities,genomic instability modulation
ENSG00000131730,CKMT2,mitochondrial creatine kinase overexpression,cell proliferation support,energy metabolism regulation,mitochondrial dynamics modulation,apoptosis regulation,resistance to therapy
ENSG00000112164,GLP1R,glucose metabolism regulation,overexpression in tumors,promotes cell proliferation,cell survival and migration regulator,pi3k/akt signaling pathway involvement,therapeutic target
ENSG00000168959,GRM5,mglur5 overexpression,poor prognosis marker,pi3k/akt signaling activation,tumor microenvironment modulation,cancer stem cell maintenance,cell survival enhancement
ENSG00000177599,ZNF491,oncogenic pathway activation,transcriptional regulation disruption,cell proliferation enhancement,prognostic marker identification,tumor suppressor interaction disruption,epigenetic regulation alteration
ENSG00000185101,ANO9,calcium-activated chloride channel,cell signaling regulation,ion transport modulation,tumor growth promotion,poor patient outcomes association,protein-protein interaction
ENSG00000163412,EIF4E3,mrna translation regulation,oncogenic protein interaction,tumor progression driver,poor prognosis indicator,cell growth promotion,protein synthesis modulation
ENSG00000175220,ARHGAP1,tumor suppressor,rhogap regulation,cytoplasmic localization,phosphorylation regulation,epithelial-to-mesenchymal transition,metastasis suppression
ENSG00000101842,VSIG1,tumor suppressor function,immune modulation,cell adhesion disruption,apoptosis inhibition,cell migration promotion,genomic loss of expression
ENSG00000169021,UQCRFS1,mitochondrial dysfunction,electron transport chain disruption,increased energy metabolism,therapeutic target,biomarker for prognosis,epigenetic regulation
ENSG00000105967,TFEC,transcriptional regulation,cell proliferation,mapk/erk signaling,tumor progression,genetic aberration,epigenetic modification
ENSG00000156136,DCK,nucleotide salvage pathway,tumor progression,genome stability maintenance,dna replication enhancement,cell proliferation promotion,rapid cell division support
ENSG00000132518,GUCY2D,cgmp signaling,gain of function mutations,tumor progression,cell proliferation,survival pathway,genomic instability
ENSG00000198185,ZNF334,oncogenic transcription factor,transcriptional regulation,cell proliferation,dna binding,zinc finger domain,apoptosis evasion
ENSG00000104938,CLEC4M,tumor adhesion,immune modulation,cell proliferation,apoptosis resistance,metastasis promotion,growth factor regulation
ENSG00000067992,PDK3,pyruvate dehydrogenase kinase activation,aerobic glycolysis,glycolytic shift,metabolic reprogramming,overexpression association,tumor proliferation
ENSG00000214274,ANG,tumor angiogenesis,cell invasion,genetic instability,rna binding protein,protein-protein interaction,dna repair mechanism
ENSG00000175215,CTDSP2,transcriptional regulation,oncogenic activity,cell proliferation,apoptosis inhibition,genomic instability,tumorigenesis
ENSG00000172260,NEGR1,cellular adhesion,epithelial-to-mesenchymal transition,oncogenic processes,tumor progression,metastasis,biomarker
ENSG00000167881,SRP68,translation regulation,mrna stability,oncogenic mrnas,tumor progression,cell survival promotion,translation initiation factor interaction
ENSG00000150361,KLHL1,e3 ubiquitin ligase activity,cell cycle regulation,epithelial-to-mesenchymal transition (emt),metastasis suppression,protein-protein interactions,ubiquitination
ENSG00000198455,ZXDB,cellular differentiation,oncogenic transformation,transcriptional regulation,apoptosis inhibition,metastasis promotion,therapeutic target
ENSG00000131941,RHPN2,rho gtpase regulation,metastasis promotion,cell migration enhancement,actin cytoskeleton modulation,cancer progression facilitation,tumor aggressiveness enhancement
ENSG00000131669,NINJ1,notch signaling pathway,constitutive activation,oncogene function,tumor progression,cell growth regulation,genomic mutations
ENSG00000108641,B9D1,genomic instability,kinetochores assembly,chromosome segregation,cell proliferation,apoptosis resistance,tumor progression
ENSG00000118194,TNNT2,constitutive activation,cell proliferation,pi3k/akt pathway regulation,mitochondrial dysfunction,glycolytic reprogramming,tumor progression driver
ENSG00000155846,PPARGC1B,mitochondrial biogenesis,tumor progression,nuclear receptor coactivation,cellular energy metabolism regulation,oxidative phosphorylation modulation,ppar interaction
ENSG00000069764,PLA2G10,arachidonic acid metabolism,cell invasion,oncogenic properties,tumor progression,metastasis promotion,protein-protein interaction
ENSG00000166582,CENPV,genomic instability,aneuploidy,spindle assembly checkpoint regulation,centromere formation,microtubule stabilization,mitotic checkpoint dysregulation
ENSG00000136449,MYCBPAP,cell cycle progression,genomic instability,oncogenesis,protein interaction,transcriptional regulation,tumor suppression inhibition
ENSG00000125912,NCLN,cell adhesion disruption,metastatic progression,biomarker candidate,protein-protein interaction,tumor growth promotion,gene expression modulation
ENSG00000168955,TM4SF20,tumor progression,overexpression,cell migration,metastasis,epithelial-to-mesenchymal transition,chemotherapy resistance
ENSG00000105711,SCN1B,ion channel modulation,cell signaling disruption,tumor progression,metastasis,cell cycle dysregulation,apoptosis evasion
ENSG00000122481,RWDD3,nucleus localization,transcriptional regulation,dna repair defects,poor prognosis association,overexpression in tumors,therapeutic target potential
ENSG00000146263,MMS22L,hrr pathway,genomic instability,nucleotide excision repair,dna damage response,tumor suppressor,homologous recombination
ENSG00000166170,BAG5,co-chaperone activity,oncogene activation,cell cycle regulation,apoptosis inhibition,protein stabilization,therapeutic target
ENSG00000119787,ATL2,actin dynamics regulation,cytoskeleton organization modulation,cellular migration and invasion regulation,cell cycle progression enhancement,oncogene role in cancer,pi3k/akt pathway interaction
ENSG00000111305,GSG1,genomic instability,cell cycle regulation,dna damage response,tumor progression,protein-protein interactions,therapeutic target
ENSG00000100034,PPM1F,tumor suppressor function,pi3k/akt/mtor pathway regulation,cell signaling modulation,dephosphorylation activity,oncogenic pathway inhibition,genomic stability maintenance
ENSG00000181035,SLC25A42,metabolic regulation,mitochondrial function,cancer driver gene,cellular respiration,energy production,oncogenic processes
ENSG00000273572,CDHR5,cell adhesion disruption,oncogene overexpression,epithelial-to-mesenchymal transition,tumor progression facilitation,prognostic marker,genomic amplification
ENSG00000139679,LPAR6,oncogene,cell proliferation,g-protein coupled receptor,lysophosphatidic acid signaling,cell migration,tumor progression
ENSG00000167080,B4GALNT2,tumor progression,cell adhesion modulation,glycosylation regulation,prognostic marker,oncogenic mechanism,therapeutic target
ENSG00000173137,ADCK5,energy metabolism regulation,mitochondrial function modulation,oncogenic pathway activation,cell proliferation enhancement,apologetic resistance promotion,tumor progression facilitation
ENSG00000186088,GSAP,guanine nucleotide exchange factor,pi3k/akt signaling pathway,cell proliferation regulation,tumor growth promotion,signaling pathway modulation,oncogenic transformation driver
ENSG00000241878,PISD,negative regulation,kinase inhibitor,pi3k/akt pathway,cell signaling,tumor progression,therapeutic target
ENSG00000068079,IFI35,interferon response,tumor suppressor function,protein synthesis regulation,viral replication inhibition,cellular stress response regulation,apoptosis promotion
ENSG00000164749,HNF4G,transcriptional regulation,cell growth control,aberrant expression,tumor suppressor gene disruption,ccnd1/cdk6 activation,nuclear receptor function
ENSG00000143257,NR1I3,regulation of xenobiotic metabolism,transcriptional regulation,cell growth promotion,metabolic shift towards glycolysis,transcription factor activity,promotion of cell proliferation
ENSG00000159335,PTMS,tumor progression,oncogenesis,cellular metabolism,energy production,cell proliferation,mitochondrial dysfunction
ENSG00000132423,COQ3,mitochondrial biogenesis,electron transport chain,cellular energy metabolism,oxidative stress response,cancer progression,regulatory function
ENSG00000163611,SPICE1,oncogenic activity,prognostic biomarker,transcriptional regulation,cell cycle progression,apoptosis inhibition,cancer prognosis
ENSG00000140519,RHCG,tumor progression,therapeutic target,cell proliferation inhibition,apoptosis suppression,prognostic biomarker,igf-1r pathway interaction
ENSG00000197977,ELOVL2,vlcfa biosynthesis,lipid signaling pathway,oncogenic process,cell proliferation,metabolic regulation,tumor progression
ENSG00000198040,ZNF84,zinc finger binding,tumor suppressor interaction,oncogenic gene regulation,aberrant transcription patterns,cell cycle progression,metastatic potential
ENSG00000112303,VNN2,nitric oxide regulation,reactive oxygen species modulation,oxidative stress response,cancer progression influence,cellular redox balance,host defense interaction
ENSG00000159261,CLDN14,tumor progression,increased cell migration,overexpressed gene,cellular permeability regulation,epithelial-to-mesenchymal transition,signaling pathway interaction
ENSG00000137500,CCDC90B,cell cycle regulation,genomic instability,microtubule dynamics,spindle assembly checkpoint,aurora kinase activation,biomarker overexpression
ENSG00000118507,AKAP7,oncogene,cell cycle regulation,tumor progression,protein kinase anchoring,apoptosis regulation,overexpression in cancer
ENSG00000166963,MAP1A,microtubule dynamics,cellular transport regulation,cancer progression,oncogenic process,tumorigenesis,cell division regulation
ENSG00000187607,ZNF286A,transcriptional regulation,cell growth suppression,tumor suppressor activity,apoptosis promotion,genomic instability,protein-protein interactions
ENSG00000242550,SERPINB10,tumor progression,oncogenic driver,cell survival pathway,apoptosis regulation,tumor microenvironment modulation,immune evasion strategy
ENSG00000124641,MED20,transcriptional regulation,cell proliferation,cell cycle progression,tumor suppressor regulation,chromatin modification,prognostic marker
ENSG00000156475,PPP2R2B,hyperactivated signaling pathways,overexpression,regulation of cell growth,cell survival and proliferation,dysregulation of cellular processes,tumor progression
ENSG00000197915,HRNR,ha degradation,epithelial-to-mesenchymal transition (emt),cell migration,protein interaction,signaling pathway activation,immune evasion
ENSG00000140451,PIF1,genomic instability,cell proliferation regulation,oncogenic transcription factor,dna replication,chromatin remodeling,transcriptional activation
ENSG00000037241,RPL26L1,ribosome biogenesis,cellular proliferation,oncogene interaction,tumor suppressor regulation,cell cycle dysregulation,apoptosis evasion
ENSG00000101892,ATP1B4,sodium-potassium pump regulation,cell migration and invasion,therapeutic target,cellular ion balance disruption,apoptosis regulation,epithelial-to-mesenchymal transition interaction
ENSG00000205922,ONECUT3,oncogene,transcription factor activation,cell proliferation,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway interaction,cancer stem cell regulation
ENSG00000116039,ATP6V1B1,proton transport,cell proliferation,acidic microenvironment,tumor progression,target for therapy,v-atpase complex
ENSG00000137106,GRHPR,metabolic regulation,mitochondrial function,oxidative stress,cellular redox balance,pleiotropic effects,energy production
ENSG00000157303,SUSD3,wnt/beta-catenin pathway,tumor progression,cell adhesion disruption,downregulated expression,poor prognosis,immune evasion
ENSG00000111845,PAK1IP1,cell cycle regulation,gene amplification,oncogenic signaling,protein-protein interaction,proliferation promotion,tumor progression
ENSG00000187735,TCEA1,tumor suppressor function,loss of function mutations,increased proliferation,angiogenesis promotion,metastasis enhancement,cell cycle regulation
ENSG00000154645,CHODL,cell adhesion modulation,epithelial-to-mesenchymal transition,tumor progression,prognostic marker,metastasis promotion,upregulated expression
ENSG00000129353,SLC44A2,ceramide metabolism alteration,tumor aggressiveness enhancement,poor prognosis association,cell signaling regulation,overexpression involvement,cancer progression facilitation
ENSG00000173714,WFIKKN2,nf-κb pathway modulation,tumor growth promotion,angiogenesis stimulation,cell migration enhancement,metastasis facilitation,genetic amplification
ENSG00000134812,CBLIF,ubiquitin ligase adaptor,cell cycle progression,oligomerization,protein degradation,tumor suppression,prognostic biomarker
ENSG00000178921,PFAS,cellular proliferation,oncogene role,epigenetic regulation,microrna-mediated regulation,non-coding rna function,pseudogenic nature
ENSG00000163520,FBLN2,tumor progression,upregulated expression,cell migration,connective tissue formation,elastic fiber regulation,prognostic marker
ENSG00000164758,MED30,regulation of gene transcription,rna polymerase ii interaction,transcriptional enhancement,cancer-related dysregulation,mediator complex subunit,chromatin remodeling
ENSG00000065970,FOXJ2,hippo signaling pathway disruption,transcriptional regulation,genomic instability,apoptosis suppression,cell proliferation enhancement,emt induction
ENSG00000166987,MBD6,gene silencing,cell proliferation,genomic instability,dna repair disruption,prognostic marker,tumor progression
ENSG00000165521,EML5,oncogene activation,cell cycle regulation,histone modification,chromatin remodeling,tumor progression,therapeutic target
ENSG00000135837,CEP350,aberrant microtubule dynamics,cell proliferation,chromosomal instability,oncogenic pathway activation,prognostic marker,spindle assembly
ENSG00000185177,ZNF479,genomic instability,transcriptional repression,oncogenic reprogramming,epigenetic dysregulation,cell cycle deregulation,tumor progression
ENSG00000144746,ARL6IP5,cell signaling,cell proliferation,gene expression regulation,protein-protein interaction,tumor progression,apoptosis suppression
ENSG00000006607,FARP2,rho gtpase signaling pathway,cell migration and invasiveness,oncogenic process promotion,prognostic marker,cytoplasmic localization,gef activity
ENSG00000095209,TMEM38B,calcium channel regulation,store-operated calcium entry,cell migration,tumor growth,proliferation regulation,cancer metastasis
ENSG00000164600,NEUROD6,transcription factor,cell proliferation,apoptosis inhibition,dna repair regulation,epithelial-to-mesenchymal transition,tumor suppressor interaction
ENSG00000114650,SCAP,sterol regulation,lipid synthesis regulation,cholesterol homeostasis disruption,cell membrane composition alteration,oncogenic lipid metabolism modulation,tumor progression facilitation
ENSG00000167780,SOAT2,lipid metabolism regulation,tumor progression promotion,cell proliferation enhancement,survival pathway modulation,genomic amplification associated,lipid-mediated signaling influence
ENSG00000169641,LUZP1,wnt/β-catenin signaling pathway,cell growth regulation,potential biomarker,cell proliferation promotion,cell migration facilitation,protein interaction regulator
ENSG00000144559,TAMM41,**
nuclear pore complex assembly,cell proliferation,metastasis promotion,genomic stability maintenance,protein-protein interaction,tumor growth facilitation
**
ENSG00000115657,ABCB6,aberrant expression,apoptosis inhibition,atp-binding cassette transport,cell proliferation enhancement,drug resistance modulation,pi3k/akt pathway interaction
ENSG00000136770,DNAJC1,microtubule stability,chaperone function,cell cycle regulation,protein-protein interaction,tumor progression,therapeutic target
ENSG00000170242,USP47,ubiquitination regulation,oncogene function,cellular degradation pathway,protein stability modulation,cellular interaction network,tumor suppressor dysregulation
ENSG00000136875,PRPF4,rna processing,cellular response to dna damage,genome stability maintenance,cellular proliferation regulation,oncogene potential,tumorigenesis promotion
ENSG00000241468,ATP5MF,mitochondrial function,cellular energy metabolism,tumor growth,oncogenesis,metabolic regulation,energy production pathways
ENSG00000176692,FOXC2,transcriptional repressor function,loss of function mutations,disrupted gene expression,cell growth regulation,apoptosis inhibition,transcriptional modulation
ENSG00000196407,THEM5,mitochondrial dysfunction,oncogenesis,energy metabolism reprogramming,therapeutic target,genomic instability,cellular homeostasis
ENSG00000108826,MRPL27,mitochondrial ribosome assembly,gene amplification,cell proliferation,mitochondrial function,immune evasion,inflammation
ENSG00000197362,ZNF786,cell cycle regulation,dna binding,apoptosis modulation,genomic stability,transcriptional regulation,oncogenic pathway modulation
ENSG00000125846,ZNF133,tumor suppressor function loss,aberrant transcription factor activity,oncogenic potential,cell proliferation enhancement,tumor progression promotion,therapeutic target
ENSG00000085185,BCORL1,chromosomal instability,transcriptional regulation,tumor progression,apoptosis resistance,dna repair modulation,cell cycle dysregulation
ENSG00000188833,ENTPD8,nucleotide regulation,signaling pathway modulation,tumor progression,therapeutic target,cell proliferation enhancement,metastasis promotion
ENSG00000213015,ZNF580,transcriptional regulation,tumor progression,cell cycle regulation,apoptosis evasion,epigenetic modification,chromatin remodeling
ENSG00000184497,TMEM255B,cellular growth regulation,transmembrane signaling,apoptosis evasion,oncogenic driver,tumor progression,therapeutic target
ENSG00000037757,MRI1,genomic instability,microtubule regulation,cell cycle progression,mitotic spindle integrity,aneuploidy risk,therapeutic target
ENSG00000141485,SLC13A5,mtor signaling pathway,glutamate uptake,cell proliferation,hypoxia adaptation,cellular ph regulation,tumor progression
ENSG00000126461,SCAF1,pi3k/akt pathway modulation,oncogenic signaling,cell proliferation enhancement,tumor progression facilitation,angiogenesis promotion,emt regulation
ENSG00000154370,TRIM11,oncogenic pathway regulation,protein degradation regulation,e3 ubiquitin ligase activity,cell growth modulation,tumor suppressor function,ubiquitination and proteasomal degradation
ENSG00000198246,SLC29A3,prognostic marker,tumor microenvironment regulation,immune suppression modulation,cell signaling pathway regulation,nucleoside transport function,anti-tumor response inhibition
ENSG00000119471,HSDL2,fatty acid metabolism,lipid biosynthesis,tumor growth promotion,metastasis facilitation,energy source modulation,poor prognosis marker
ENSG00000129158,SERGEF,cell cycle regulation,transcriptional coactivator,apoptosis inhibition,cell proliferation enhancement,genomic instability,chromosomal alterations
ENSG00000150048,CLEC1A,immunosuppression,tumor progression,angiogenesis promotion,metastasis enhancement,pi3k/akt/mtor activation,c-type lectin domain interaction
ENSG00000198231,DDX42,aberrant rna regulation,apoptosis dysregulation,cell cycle modulation,gene expression alteration,genomic instability,rna helicase activity
ENSG00000082212,ME2,mek2/mapk pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation
ENSG00000180767,CHST13,glycosaminoglycan modification,cell adhesion modulation,tumor progression enhancement,therapeutic target identification,aberrant expression association,protein function alteration
ENSG00000139718,SETD1B,chromatin remodeling,histone methylation,gene expression regulation,tumorigenesis driver,cellular proliferation promotion,oncogenic program activation
ENSG00000130414,NDUFA10,complex i dysfunction,electron transfer impairment,energy metabolism disruption,cellular respiration blockade,glycolytic shift induction,therapeutic target exploration
ENSG00000110048,OSBP,lipid metabolism regulation,cholesterol export facilitation,cellular signaling modulation,tumor growth promotion,oncogenic function,sterol regulation disruption
ENSG00000172954,LCLAT1,cell proliferation,lipid metabolism regulation,oncogenic pathway activation,poor prognosis marker,protein expression upregulation,tumor progression promotion
ENSG00000179361,ARID3B,chromatin remodeling,dna repair suppression,oncogenic transcriptional regulation,tumor suppressor function loss,metastasis promotion,gene expression disruption
ENSG00000114988,LMAN2L,cholesterol transport,tumor progression,lipid metabolism regulation,protein-protein interactions,cellular homeostasis disruption,genomic amplification
ENSG00000185176,AQP12B,cellular hydration,tumor progression,overexpression,water transport,pi3k/akt pathway,cell migration
ENSG00000103342,GSPT1,dna repair,oncogene,cell cycle regulation,ribosome biogenesis,cell proliferation,genome stability
ENSG00000013374,NUB1,cdk4/6 complex regulation,ubiquitin-proteasome pathway dysregulation,tumor suppressor protein degradation,cell proliferation enhancement,oncogenic process promotion,cancer cell survival increase
ENSG00000159433,STARD9,cell growth regulation,oncogene overexpression,pi3k/akt pathway interaction,aberrant lipid metabolism,metastasis promotion,therapeutic target identification
ENSG00000187513,GJA4,cell-cell communication,tumor progression,ion transfer,cell proliferation,gap junction formation,protein-protein interaction
ENSG00000186480,INSIG1,er homeostasis regulation,oncogene potential,lipid metabolism regulation,srebp interaction,cholesterol biosynthesis,endoplasmic reticulum transmembrane protein
ENSG00000185896,LAMP1,lysosome regulation,autophagy facilitation,tumor adaptation,cellular stress response,lysosomal degradation,proliferative advantage
ENSG00000092108,SCFD1,pi3k/akt signaling,tumor aggressiveness,cell cycle progression,protein degradation,e3 ubiquitin ligase activity,proliferation
ENSG00000242173,ARHGDIG,rho gtpase activation,cell migration promotion,tumor aggressiveness,oncogenic pathway modulation,genetic instability,adhesion disruption
ENSG00000155980,KIF5A,genomic instability,cell proliferation,microtubule transport,oncogenic signaling,chromatin remodeling,dna repair
ENSG00000146802,TMEM168,cell membrane integrity,ion channel regulation,tumor progression,epithelial-to-mesenchymal transition (emt),overexpression,cancer cell migration
ENSG00000162852,CNST,genomic instability,aneuploidy,centrosome regulation,microtubule nucleation,cell division regulation,cancer driver mutation
ENSG00000282725,CORO7,actin cytoskeleton regulation,cell migration promotion,oncogenic pathway activation,biomarker for prognosis,cell proliferation enhancement,tumor progression facilitation
ENSG00000131242,RAB11FIP4,rab11-dependent endocytosis,cell proliferation enhancement,oncogenic protein transport,biomarker for cancer,endosomal recycling regulation,cancer cell migration promotion
ENSG00000108469,RECQL5,genome instability,dna replication regulation,exonuclease activity,genomic maintenance,tumor suppressor function,homologous recombination
ENSG00000049769,PPP1R3F,cell proliferation regulation,dephosphorylation activity modulation,oncogenic process involvement,protein interaction regulation,cellular metabolism influence,tumor progression impact
ENSG00000282752,CTDP1,epigenetic regulation,chromatin remodeling,transcriptional modulation,cell proliferation,apoptosis resistance,gene expression regulation
ENSG00000187091,PLCD1,pkc activation,cell proliferation,phospholipid metabolism regulation,rho gtpase interaction,tumor progression,protein kinase regulation
ENSG00000071794,HLTF,genomic instability,dna repair regulation,oncogene expression,cell proliferation,cell cycle regulation,transcriptional activation
ENSG00000100100,PIK3IP1,pi3k/akt/mtor pathway,inhibition of pi3k activity,tumor progression,cell proliferation,cell survival,modulation of cellular metabolism
ENSG00000196365,LONP1,mitochondrial function,oncogenic potential,pi3k/akt pathway interaction,cell proliferation,apoptosis resistance,genomic instability
ENSG00000166926,MS4A6E,immune modulation,tumor progression,cell adhesion regulation,signaling pathway interaction,poor prognosis marker,oncogenic function
ENSG00000176402,GJC3,gap junction communication,intercellular signaling,tumor progression marker,cell migration regulator,oncogene potential,signaling pathway modulation
ENSG00000115844,DLX2,transcription factor regulation,epithelial development,cell proliferation,tissue patterning,growth regulation,cancer progression
ENSG00000139515,PDX1,transcription factor activity,overexpression,epithelial-to-mesenchymal transition (emt),cell differentiation regulation,apoptosis resistance,wnt/β-catenin pathway interaction
ENSG00000100330,MTMR3,dephosphorylation of pi3k/akt pathway,tumor growth promotion,oncogenic processes regulation,biomarker overexpression,protein phosphatase activity modulation,cellular proliferation and survival regulation
ENSG00000119718,EIF2B2,impaired protein synthesis regulation,tumor progression,cell cycle regulation disruption,unfolded protein response activation,therapeutic target,genomic instability
ENSG00000115211,EIF2B4,overexpression,pi3k/akt pathway activation,cell growth promotion,protein synthesis regulation,metastasis facilitation,tumor development enhancement
ENSG00000183729,NPBWR1,aberrant gene expression,adaptor protein function,cellular signaling integration,estrogen receptor interaction,hormone-dependent transcriptional regulation,oncogenic processes
ENSG00000154783,FGD5,pi3k/akt/mtor pathway activation,amplification and overexpression,rho gtpase regulation,cell growth and survival promotion,prognostic biomarker,oncogenic protein interaction
ENSG00000120915,EPHX2,oncogene,ros regulation,dna damage repair,cell survival,chemoresistance,tumor progression
ENSG00000163909,HEYL,wnt/β-catenin pathway regulation,transcriptional co-repression,cell cycle progression,chromatin remodeling,epigenetic modification,tumor suppression dysfunction
ENSG00000197457,STMN3,microtubule destabilization,oncogenic processes,cell proliferation,poor prognosis,chemotherapy resistance,pi3k/akt pathway interaction
ENSG00000205944,DAZ2,mirna regulation,ago2 interaction,cell proliferation,tumor suppressor,oncogenic pathway modulation,genetic instability
ENSG00000103671,TRIP4,transcriptional regulation,chromatin remodeling,oncogene overexpression,cell proliferation,histone modification,prognostic marker
ENSG00000163291,PAQR3,cellular signaling dysregulation,lipid metabolism modulation,prognostic marker overexpression,poor prognosis association,signaling pathway activation,therapeutic target potential
ENSG00000135723,FHOD1,cell cycle regulation,apoptosis modulation,actin cytoskeleton regulation,signaling pathway interaction,tumorigenesis involvement,genomic instability
ENSG00000125375,DMAC2L,mitochondrial biogenesis,enhanced metabolic reprogramming,overexpression,apoptosis regulation,glycolytic activity increase,cancer cell proliferation
ENSG00000174279,EVX2,homeobox transcription factor,transcriptional repressor function,cell proliferation enhancement,chromatin remodeling,cell cycle regulation,genomic instability
ENSG00000277893,SRD5A2,steroid hormone regulation,tumor microenvironment modulation,poor prognosis association,cell proliferation influence,dihydrotestosterone production,androgen receptor interaction
ENSG00000196743,GM2A,ganglioside metabolism,cell surface expression,tumor suppressor function,oncogenic signaling,pi3k/akt pathway interaction,cell proliferation regulation
ENSG00000203857,HSD3B1,androgen biosynthesis,androgen receptor signaling,cell growth promotion,metastatic progression,oncogenic driver,therapeutic target
ENSG00000116199,FAM20B,cell cycle regulation,apoptosis suppression,tumor progression,cell proliferation enhancement,oncogenic protein interaction,phosphatase enzyme activity
ENSG00000104140,RHOV,genomic amplification,cell migration disruption,cytoskeleton reorganization,oncogenic transformation,therapeutic target,tumor progression
ENSG00000170903,MSANTD4,chromatin remodeling complex,dna repair pathway,genome instability,oncogene overexpression,transcriptional regulation,tumor progression
ENSG00000119729,RHOQ,rho gtpase family,tumor progression,microtubule cytoskeleton,cell proliferation,p53 modulation,pten regulation
ENSG00000115486,GGCX,gene regulation,carboxylation activity,post-translational modification,oncogenic signaling,tumor progression,metastasis
ENSG00000198597,ZNF536,cell cycle regulation,transcriptional activation,oncogenic pathway activation,epithelial-to-mesenchymal transition,chromatin remodeling,transcription factor activity
,MARS,translation regulation,overexpression,cell proliferation,tumor progression,chemosensitivity reduction,stability regulation
ENSG00000197712,FAM114A1,gtp-binding protein signaling pathway,cell proliferation regulation,potential oncogene,cytoplasmic localization,signaling network disruption,therapeutic target discovery
ENSG00000167632,TRAPPC9,aberrant membrane trafficking,disrupted endocytosis,impaired autophagy regulation,enhanced proliferation,constitutive activation,tumor metastasis
ENSG00000130772,MED18,mediator complex interaction,transcriptional regulation,cell proliferation enhancement,tumor growth promotion,poor prognosis marker,overexpression
ENSG00000133250,ZNF414,tumor suppressor activity,transcriptional regulation,zinc finger motifs,cell proliferation,gene expression dysregulation,protein-protein interactions
ENSG00000158486,DNAH3,dynein function,aberrant cilia formation,cytoskeletal regulation,cellular signaling,aneuploidy driver,genomic instability
ENSG00000076770,MBNL3,cellular regulation,oncogene activation,alternative splicing,rna-binding protein function,tumor progression,poor prognosis
ENSG00000183520,UTP11,rna splicing dysregulation,oncogenic signaling pathway activation,cell proliferation enhancement,tumor progression association,cancer cell survival promotion,genomic instability link
ENSG00000164329,TENT2,mta degradation,genomic instability,purine metabolism regulation,tumor suppressor function,promotes cell survival,interaction with signaling pathways
ENSG00000128567,PODXL,cell adhesion disruption,emt process,metastasis promotion,oncogenic function,tumor progression,epithelial-to-mesenchymal transition
ENSG00000106927,AMBP,cellular proliferation,proteolytic activity regulation,tumor cell survival,tissue remodeling,protease inhibition,promoter binding
,C5orf30,cellular proliferation regulation,nuclear localization,chromatin modification interaction,apoptosis modulation,long non-coding rna function,tumor progression association
ENSG00000171443,ZNF524,androgen receptor regulation,chromatin remodeling,tumor progression,promoter targeting,somatic mutation hotspot,transcriptional modulation
ENSG00000049323,LTBP1,tgf-β regulation,cellular differentiation suppression,extracellular matrix regulation,protein-protein interactions,metastasis promotion,therapeutic target
ENSG00000204531,POU5F1,oncogene activation,cellular proliferation,chemosensitivity,tumor maintenance,stem cell properties,genomic instability
ENSG00000130598,TNNI2,tumor suppressor function,cell growth regulation,apoptosis induction,epithelial-to-mesenchymal transition suppression,oncogenic pathway modulation,metastasis inhibition
ENSG00000116586,LAMTOR2,autophagy regulation,cell growth modulation,mtor signaling pathway,oncogenic processes,protein synthesis regulation,cellular metabolism regulation
ENSG00000107862,GBF1,er-golgi trafficking,oncogenic transformation,cell proliferation,guanine nucleotide exchange factor,rab1a regulation,cancer prognosis
ENSG00000119673,ACOT2,metabolic regulation,oncogenic driver,cell proliferation,therapeutic target,prognostic marker,fatty acid metabolism
ENSG00000161558,TMEM143,genomic instability,homologous recombination pathway,dna double-strand break repair,atm kinase activation,oncogenic mutation susceptibility,cell cycle regulation
ENSG00000143028,SYPL2,apoptosis regulation,cancer metastasis,cell cycle regulation,cytoskeleton dynamics,guanine nucleotide exchange factor interaction,tumor progression
ENSG00000118193,KIF14,microtubule dynamics regulation,cell cycle progression alteration,chromosomal instability induction,oncogenic signaling pathway activation,prognostic marker candidate,tumor growth promotion
ENSG00000123096,SSPN,cell migration,nuclear envelope integrity,tumor progression,cell adhesion regulation,pi3k/akt pathway interaction,prognostic marker
ENSG00000123171,CCDC70,microtubule organization,chromosomal instability,mitotic progression,cell migration,aneuploidy,tumor aggressiveness
ENSG00000141759,TXNL4A,oncogenic processes,cellular proliferation,therapeutic target,redox regulation,antioxidant activity,tumor progression
ENSG00000129484,PARP2,genetic instability,dna damage response,chromatin remodeling,oncogenic function,therapeutic target,histone modification
ENSG00000231924,PSG1,oncogenic driver,promotes cell proliferation,induces epithelial-to-mesenchymal transition,overexpressed in tumors,interacts with pi3k/akt pathway,secreted protein involved in tumorigenesis
ENSG00000183454,GRIN2A,tumor progression,oncogene activation,cell proliferation,genomic instability,prognostic marker,signaling pathway modulation
ENSG00000257949,TEN1,icl repair,tumor suppressor function,genomic stability maintenance,cancer driver mutations,dna replication regulation,chromatin remodeling
ENSG00000125378,BMP4,tumor promotion,epithelial-to-mesenchymal transition (emt),cell migration,cancer progression,tgf-β pathway interaction,signaling pathway regulation
ENSG00000164647,STEAP1,iron metabolism regulation,cellular proliferation enhancement,aggressive tumor behavior promotion,oxidative stress induction,dna damage facilitation,tumor progression contribution
ENSG00000144736,SHQ1,genomic instability,tumor suppression,dna repair mechanisms,transcriptional regulation,chromatin remodeling,histone modification
ENSG00000079313,REXO1,ribosome biogenesis,overexpressed,oncogenic potential,protein synthesis regulation,microrna downregulation,cellular proliferation
ENSG00000168872,DDX19A,rna helicase function,gene expression regulation,cell cycle progression,tumor growth promotion,metastasis facilitation,protein-rna interaction
ENSG00000138379,MSTN,tumor progression,cell invasion,genomic mutation,signaling pathway interaction,protein regulation,muscle growth inhibition
ENSG00000111707,SUDS3,protein degradation modulation,cell proliferation enhancement,genomic instability influence,therapeutic target identification,signaling pathway regulation,apoptosis evasion
ENSG00000174371,EXO1,genomic instability,tumor aggressiveness,dna repair,mutational burden,oncogenic potential,cancer progression
ENSG00000166479,TMX3,t-box transcription factor,epithelial-to-mesenchymal transition (emt),cell migration,wnt/β-catenin pathway interaction,chromatin modification,oncogenic role
ENSG00000123388,HOXC11,genomic instability,oncogenic potential,cell proliferation,apoptosis inhibition,transcriptional regulation,cell cycle dysregulation
ENSG00000152332,UHMK1,alternative splicing regulation,apoptosis regulation,cell cycle progression,oncogene overexpression,protein-protein interaction,splicing factor binding
ENSG00000166337,TAF10,aberrant gene expression,apoptosis regulation,cell cycle modulation,poor prognosis marker,transcription factor complex,tumor progression driver
ENSG00000009307,CSDE1,oncogene overexpression,constitutive activation,cell proliferation regulation,rna-binding protein function,apoptosis inhibition,tumor aggressiveness
ENSG00000010404,IDS,glycosaminoglycan degradation,lysosomal storage disorder,cellular glycosylation,tumorigenesis progression,cell microenvironment modulation,none
ENSG00000053371,AKR7A2,**

reduction activity,oxidative stress mitigation,cellular detoxification,enhanced cell proliferation,apoptosis resistance,cytoplasmic localization 

**
ENSG00000162482,AKR7A3,akr superfamily member,cell growth regulation,oncogenic transcription factor regulation,steroid hormone metabolism,xenobiotic detoxification,cancer progression biomarker
ENSG00000275066,SYNRG,cell adhesion disruption,tumor aggressiveness predictor,cytoskeleton remodeling,metastatic potential enhancer,prognostic marker,genomic amplification
ENSG00000129170,CSRP3,cellular adhesion disruption,cancer cell proliferation,transcriptional coactivator function,gene expression regulation,signaling pathway activation,tumor progression enhancement
ENSG00000136950,ARPC5L,actin filament polymerization,growth factor regulation,gain of function mutations,tumor progression,cell migration,metastasis
ENSG00000155868,MED7,chromatin remodeling,cellular proliferation,transcriptional regulation,apoptosis suppression,metastasis promotion,therapeutic target
ENSG00000128595,CALU,oncogene activation,glycolytic switch,cell proliferation,metabolic adaptation,protein-protein interaction,tumor progression
ENSG00000135824,RGS8,gpcr signaling pathway,regulation of g-protein activity,dysregulation of oncogenic signaling,tumor progression,molecular targeting,therapeutic response modulation
ENSG00000005893,LAMP2,tumor progression,tumor cell invasion,poor prognosis,biomarker for outcome prediction,cell adhesion,immune modulation
ENSG00000053900,ANAPC4,genomic instability,tumor suppressor function,cell cycle regulation,microtubule stability,proteasome-mediated degradation,chromosome segregation
ENSG00000123191,ATP7B,metal ion transport,cellular proliferation,signaling pathway modulation,oxidative stress response,protein-protein interaction,cancer progression
ENSG00000128805,ARHGAP22,rho gtpase regulation,tumor suppressor activity,cell migration inhibition,cytoskeleton reorganization,apoptosis promotion,genomic expression alteration
ENSG00000110881,ASIC1,aberrant ion channel activation,altered sodium influx,cell proliferation,oncogenic signaling,tumor progression,cellular excitability
ENSG00000060971,ACAA1,fatty acid metabolism,cell proliferation,metabolic regulation,lipid biosynthesis,therapeutic target,poor prognosis
ENSG00000130540,SULT4A1,tumor suppressor function,regulation of cell growth,cell cycle regulation,apoptosis modulation,hormone metabolism,detoxification mechanism
ENSG00000155066,PROM2,epithelial-to-mesenchymal transition,cell surface organization,genomic instability,proliferation regulation,tumor progression,protein interaction
,ACPP,chitin hydrolysis,overexpression,oncogene potential,lysosomal enzyme activity,tumor progression,cellular interaction
ENSG00000157765,SLC34A2,sodium-phosphate cotransport,glycoprotein expression,tumor progression,cellular transport regulation,wnt/β-catenin pathway modulation,epithelial-to-mesenchymal transition regulation
ENSG00000145321,GC,metabolic regulation,warburg effect,glycolysis promotion,gluconeogenesis upregulation,tumor fueling,tumor proliferation
ENSG00000168481,LGI3,apoptosis regulation,cell cycle progression,gene expression modulation,nuclear receptor interaction,oncogenic potential,transcriptional regulation
ENSG00000154252,GAL3ST2,glycoprotein sulfation regulation,pi3k/akt pathway activation,oncogene overexpression,tumor progression and metastasis,glycosylation modulation,cell survival and proliferation enhancement
ENSG00000118418,HMGN3,chromatin remodeling,transcription regulation,genomic instability,cell cycle progression,apoptosis evasion,protein-protein interactions
ENSG00000181790,ADGRB1,angiogenesis regulation,cell surface receptor function,gain of function mutations,tumor progression,metastasis driver,signaling pathway modulation
ENSG00000152990,ADGRA3,agpcr signaling,cell adhesion modulation,cell migration regulation,tumor progression marker,biomarker potential,oncogenic pathway involvement
ENSG00000139352,ASCL1,oncogene,epithelial-to-mesenchymal transition (emt),transcription factor activity,cell proliferation regulation,notch signaling pathway interaction,poor prognostic marker
ENSG00000116685,KIAA2013,tumor suppressor function,cell cycle regulation,gene expression regulation,chromosomal instability,aneuploidy prevention,dna repair regulation
ENSG00000182393,IFNL1,immunomodulatory effects,tumor microenvironment modulation,anti-tumor immune evasion,oncogenic processes,prognostic marker,immune checkpoint regulation
ENSG00000156049,GNA14,gpcr signaling pathway,tumor progression,mapk/erk activation,cell migration,protein-protein interaction,signal transduction
ENSG00000129422,MTUS1,tumor suppressor function,cell adhesion regulation,metastatic suppression,epithelial-to-mesenchymal transition inhibition,microtubule interaction,apoptosis regulation
ENSG00000138675,FGF5,fgf/fgfr signaling,overexpression,tumor progression,cell proliferation,protein-protein interactions,growth factor regulation
ENSG00000159387,IRX6,oncogenic function,transcriptional repression,cell proliferation enhancement,apoptosis evasion,genomic instability promotion,prognostic marker
ENSG00000174564,IL20RB,inflammatory response regulation,tumor growth promotion,pro-tumorigenic microenvironment,therapeutic target,cytokine receptor complex interaction,signaling pathway modulation
ENSG00000168924,LETM1,mitochondrial function,cell survival pathways,pi3k/akt signaling,dna replication and repair,apoptosis resistance,oncogenic protein expression
ENSG00000177182,CLVS1,cellular proliferation inhibition,tumor suppressor function,apoptosis induction,transcriptional regulation,cell growth modulation,cancer-related gene expression
ENSG00000138119,MYOF,muscle cell membrane degradation,loss of function mutations,tumor progression,metastasis suppression,poor prognosis,reduced expression
ENSG00000018189,RUFY3,autophagy regulation,oncogenic function,tumor progression,cell survival enhancement,genomic instability,protein degradation modulation
ENSG00000113812,ACTR8,rna-binding protein,cell proliferation regulator,cancer progression marker,tumor suppressor downregulation,chemosensitivity modulator,prognostic indicator
ENSG00000174151,CYB561D1,cytochrome b561 domain containing 1,oncogene activation,cell proliferation enhancement,tumor progression facilitation,iron and oxygen homeostasis regulation,cancer cell invasion promotion
ENSG00000160087,UBE2J2,chromatin remodeling,dna repair defects,epigenetic regulation,protein degradation dysregulation,tumor suppressor function loss,pi3k/akt signaling pathway modulation
ENSG00000005469,CROT,mitochondrial dysfunction,oxidative stress regulation,cellular metabolism dysregulation,poor prognosis marker,energy metabolism alteration,ros production modulation
ENSG00000168575,SLC20A2,phosphate transport,tumor progression,cell proliferation,signaling pathway activation,biomarker overexpression,therapeutic target
ENSG00000120662,MTRF1,mitochondrial function,cell proliferation,metabolic regulation,tumor progression,genomic stability,methyltransferase activity
ENSG00000149418,ST14,tumor suppressor function,epithelial-to-mesenchymal transition suppression,cell differentiation regulation,protease inhibition,apoptosis induction,oncogenic activity suppression
ENSG00000166762,CATSPER2,calcium channel regulation,cell proliferation,tumor progression,aberrant expression,oncogenic signaling,prognostic marker
ENSG00000186496,ZNF396,cellular regulation,transcriptional modulation,krab domain-containing protein family,oncogene dysregulation,zinc finger protein,epigenetic modifier interaction
ENSG00000006740,ARHGAP44,loss-of-function mutations,constitutive activation of rhoa,cell proliferation,tumor suppression,cell migration and invasion,pi3k/akt signaling pathway
ENSG00000163288,GABRB1,gaba receptor complex regulation,cell proliferation regulation,apoptosis modulation,synaptic plasticity disruption,neuronal excitability regulation,tumor growth promotion
ENSG00000164051,CCDC51,mitotic spindle assembly,microtubule dynamics regulation,constitutive activation,oncogene overexpression,cell cycle progression modulation,tumor aggressiveness promotion
ENSG00000166405,RIC3,ric3 overexpression,receptor-tyrosine kinase modulation,cell surface receptor regulation,tumor growth and survival,cancer prognosis,er-resident protein interaction
ENSG00000169604,ANTXR1,angiopoietin-like protein interaction,pi3k/akt pathway modulation,apoptosis suppression,tumor growth promotion,biomarker potential,therapeutic target
ENSG00000143420,ENSA,cell cycle regulation,genomic instability,vascular permeability,apoptosis regulation,angiogenesis modulation,dna repair interaction
ENSG00000059122,FLYWCH1,chromatin remodeling,epigenetic modification,cell growth and survival,immune response modulation,transcriptional activation,genomic instability
ENSG00000197372,ZNF675,co-repressor recruitment,krab domain interaction,transcriptional regulation,chromatin remodeling,cell proliferation modulation,apoptosis evasion
ENSG00000166526,ZNF3,transcriptional regulation,dna binding,methylation-driven silencing,cell growth disruption,cell survival pathway modulation,tumor suppressor activity
ENSG00000187650,VMAC,cellular ph regulation,ca2+ homeostasis,cell proliferation,pi3k/akt pathway interaction,gene overexpression,tumor progression
ENSG00000140264,SERF2,splicing regulation,alternative splicing patterns,oncogenic processes,tumor progression,epithelial-to-mesenchymal transition,biomarker potential
ENSG00000067798,NAV3,nat activity,chromatin remodeling,tumor progression,biomarker,cell proliferation,somatic mutation
ENSG00000204822,MRPL53,mitochondrial dysfunction,genomic instability,metabolic reprogramming,oncogenic driver,cancer cell survival,proliferation enhancement
ENSG00000065923,SLC9A7,cellular ph regulation,tumor progression,cancer stem cell maintenance,proton pump activation,enhanced cell migration,wnt/β-catenin signaling pathway interaction
ENSG00000205857,NANOGNB,pluripotency factor,cancer stem cell maintenance,cell proliferation promotion,apoptosis resistance,tumor growth facilitation,poor prognosis marker
ENSG00000124140,SLC12A5,tumor microenvironment regulation,chloride transport function,oncogenic process involvement,cancer metastasis facilitation,potential therapeutic target,cellular homeostasis maintenance
ENSG00000197780,TAF13,genetic instability,oncogene overexpression,transcriptional dysregulation,cell proliferation enhancement,clinical prognostic marker,epigenetic alterations
ENSG00000160994,CCDC105,ciliogenesis dysregulation,hippo-yap signaling pathway modulation,cell proliferation enhancement,tumor progression marker,mitotic spindle regulation,centriolar satellite protein function
ENSG00000188120,DAZ1,dna repair,genome stability,cell proliferation,meiotic process,oncogenic transformation,stem cell self-renewal
ENSG00000068354,TBC1D25,...</begin>,sorted by importance:

<begin>
rab gtpase regulation,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,genomic amplification association
ENSG00000145241,CENPC,chromosomal instability,aneuploidy,mitotic checkpoint regulation,kinetochore complex,cell division abnormalities,centrosomal dysfunction
ENSG00000182263,FIGN,microtubule stability,oncogenic driver,cell division regulation,chemoresistance,apoptosis resistance,cytoskeleton modulation
ENSG00000165349,SLC7A3,glutamine transport,cell proliferation enhancement,metabolic adaptation,chemotherapy resistance,tumor progression promotion,oncogenic role
ENSG00000165887,ANKRD2,transcriptional regulation,apoptosis suppression,cell proliferation enhancement,pro-proliferative gene expression,poor prognosis marker,therapeutic target
ENSG00000167550,RHEBL1,mtor signaling pathway,cell proliferation,protein synthesis regulation,therapeutic target,growth factor regulation,upstream activator
ENSG00000167874,TMEM88,cellular regulation,metastasis promotion,plasma membrane localization,oncogenic signaling,tumor progression,cell migration
ENSG00000242366,UGT1A8,ugt1a8,chemoresistance,glucuronidation,oxidative stress modulation,dna damage repair,detoxification
ENSG00000196860,TOMM20L,mitochondrial regulation,tumor progression,oncogenesis,cell survival,protein-protein interaction,mitochondrial dynamics
ENSG00000124177,CHD6,chromatin remodeling,genetic instability,transcriptional regulation,dna repair mechanisms,chromosomal translocations,oncogenesis
ENSG00000062822,POLD1,genomic instability,dna repair mechanisms,telomere integrity,dna replication error-prone,tumor progression,cancer therapy target
ENSG00000216490,IFI30,apoptosis regulation,cell proliferation suppression,immune response modulation,dna repair pathway involvement,cancer stem cell regulation,epithelial-to-mesenchymal transition modulation
ENSG00000128886,ELL3,chromatin remodeling,dna repair mechanisms,transcriptional regulation,cell proliferation enhancement,apoptosis inhibition,oncogenic processes promotion
ENSG00000112183,RBM24,rrm family member,rna recognition motif,cell cycle regulation,chromatin remodeling,epigenetic modification,oncogene activity
ENSG00000147813,NAPRT,cellular metabolism regulation,genomic stability maintenance,dna synthesis facilitation,therapeutic target identification,nucleotide biosynthesis involvement,protein interaction regulation
ENSG00000162972,MAIP1,tumor suppressor function,epithelial cell integrity disruption,paracellular permeability increase,oncogenic pathway regulation,cancer cell invasion facilitation,genomic downregulation
ENSG00000146021,KLHL3,wnt/β-catenin signaling,adaptor function,substrate targeting,protein degradation,cell proliferation,oncogenic transcription
ENSG00000140199,SLC12A6,ion transport regulation,tumor microenvironment modulation,electrolyte balance maintenance,ph regulation,cancer cell proliferation enhancement,cellular homeostasis disruption
ENSG00000143479,DYRK3,oncogene activation,cell proliferation,apoptosis regulation,signaling pathway modulation,phosphorylation activity,tumor growth promotion
ENSG00000089048,ESF1,dna repair,cell cycle regulation,oncogenic potential,tumor progression,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000168275,COA6,mitochondrial trna synthesis,gain of function mutations,altered cellular metabolism,therapeutic target,aberrant cell growth,energy production regulation
ENSG00000180357,ZNF609,oncogenic function,cell cycle regulation,transcriptional modulation,pi3k/akt/mtor activation,tumor growth promotion,metastasis enhancement
ENSG00000285243,SLC39A4,cellular metal homeostasis,dysregulated zinc uptake,enhanced cell proliferation,involvement in apoptosis signaling pathway,oxidative stress response,regulation of tumorigenesis
ENSG00000169764,UGP2,glycosylation regulation,tumor growth promotion,metastasis facilitation,pentose phosphate pathway activation,cancer cell survival enhancement,oncogenic protein interaction
ENSG00000007541,PIGQ,gpi anchor biosynthesis,membrane-bound protein anchoring,tumorigenesis,protein glycosylation disruption,cell surface protein composition change,cancer-associated alterations
ENSG00000108702,CCL1,immunomodulation,tumor progression,immune evasion,cancer immunology,chemokine signaling,cell recruitment
ENSG00000187730,GABRD,gabaergic signaling,tumor progression,cell proliferation,apoptosis inhibition,cancer-related pathway interaction,metastasis promotion
ENSG00000171320,ESCO2,genomic instability,dna double-strand break repair,homologous recombination pathway,tumor suppressor function,s phase cell cycle regulation,dna repair protein interactions
ENSG00000117148,ACTL8,cytoplasmic regulation,cell division modulation,oncogenesis promotion,cytoskeleton disruption,prognostic marker overexpression,therapeutic target potential
ENSG00000223852,ZFP57,transcriptional regulation,gene expression,genomic stability,dna repair,cell cycle progression,apoptosis inhibition
ENSG00000241635,UGT1A1,dna damage repair,cell proliferation regulation,xenobiotic metabolism,bilirubin glucuronidation,cancer risk modifier,tumor progression regulator
ENSG00000171298,GAA,altered glycosylation,cell adhesion,oncogenic process,cell proliferation,tumor progression,epithelial cell marker
ENSG00000164576,SAP30L,chromatin regulation,epigenetic modification,histone interaction,genomic instability,tumor aggression,prognostic marker
ENSG00000186352,ANKRD37,tumor suppressor,genomic stability,chromosomal instability,cell proliferation regulation,dna damage response,phosphorylation activation
ENSG00000164530,PI16,cellular growth regulation,oncogene function,pp2a inhibition,tumor progression,metastasis association,therapeutic target
ENSG00000274972,FRG2,cell cycle regulation,oncogenic activity,tumor progression,metastasis,cell growth regulation,signaling pathway alteration
ENSG00000127863,TNFRSF19,tumor microenvironment regulation,nf-κb signaling pathway activation,oncogene potential,myeloid-derived suppressor cells interaction,cell cycle regulation evasion,apoptosis modulation
ENSG00000066583,ISOC1,metabolic regulation,gain of function mutation,tumor progression,epigenetic regulation disruption,energy production alteration,2-hydroxyglutarate production
ENSG00000133872,SARAF,cellular membrane trafficking,rho gtpase activation,oncogenic signaling pathways,tumor invasion,prognostic marker,cell migration
ENSG00000277800,TBX22,tumor progression,constitutive activation,cellular transformation,transcriptional regulation,epigenetic modulation,oncogene activation
ENSG00000110328,GALNT18,glycosyltransferase activity,cellular processes alteration,tumor cell behavior modification,glycosylation pattern disruption,therapeutic resistance enhancement,prognostic relevance increase
ENSG00000147202,DIAPH2,cellular morphology disruption,actin polymerization dysregulation,oncogenic transformation,tumor progression facilitation,protein-protein interaction modulation,apoptosis evasion promotion
ENSG00000111962,UST,ribosome biogenesis,pre-rrna processing regulation,protein synthesis modulation,cancer cell growth,aberrant expression association,genomic instability link
ENSG00000180509,KCNE1,kcne1 expression,apoptosis inhibition,cell proliferation enhancement,chemoresistance development,prognostic marker,cellular potassium channel regulation
ENSG00000073756,PTGS2,inflammation,tumor progression,angiogenesis,metastasis,resistance to apoptosis,cancer initiation
ENSG00000171067,C11orf24,cell cycle regulation,potential oncogene,tumor growth modulation,cell proliferation enhancement,apoptosis evasion mechanism,cancer-related pathway involvement
ENSG00000182253,SYNM,altered expression,cellular adhesion,cytoskeleton disruption,muscle differentiation,prognostic biomarker,tumor progression
ENSG00000131503,ANKHD1,cell migration,signaling pathway modulation,tumor progression,adhesion regulation,invasion promotion,biomarker candidate
ENSG00000116761,CTH,chitin degradation,tumor microenvironment modulation,oncogenesis promotion,metastasis facilitation,immune response regulation,extracellular matrix remodeling
ENSG00000099282,TSPAN15,cell surface signaling,tumor progression,metastasis facilitation,aggressive behavior promoter,poor prognosis marker,protein-protein interaction
ENSG00000174939,ASPHD1,dna repair,tumor suppressor,cell cycle regulation,genomic stability,cell proliferation,post-translational modification
ENSG00000118939,UCHL3,ubiquitin-proteasome pathway,oncogene stabilization,overexpression in cancer tissues,deubiquitinating enzyme activity,cell cycle regulation,protein degradation
ENSG00000043039,BARX2,epithelial differentiation,oncogenic function,transcriptional regulation,pi3k/akt pathway activation,cell proliferation enhancement,epithelial-to-mesenchymal transition
ENSG00000196502,SULT1A1,hormone regulation,detoxification process,xenobiotic metabolism,therapeutic resistance,cell proliferation,metabolic regulation
ENSG00000147576,ADHFE1,mitochondrial function regulation,cancer cell proliferation,detoxification process modulation,oxidative stress protection,redox balance regulation,aldo-keto reductase activity
ENSG00000067248,DHX29,microrna processing,apoptosis regulation,dna repair modulation,tumor suppression,cellular proliferation,genomic instability
ENSG00000283018,MRPS12,mitochondrial dysfunction,glycolytic switch,ribosome assembly disruption,cancer driver mutation,oncogenic cell proliferation,therapeutic target potential
ENSG00000151292,CSNK1G3,oncogenic signaling,cell proliferation,protein phosphorylation,apoptosis regulation,tumor suppressor loss,genetic mutation hotspot
ENSG00000118640,VAMP8,cell-cell fusion regulation,pro-tumorigenic factor secretion,pi3k/akt pathway interaction,tumor progression facilitation,invasion enhancement,therapeutic target identification
ENSG00000169919,GUSB,heparan sulfate degradation,tumor progression,cell migration,cell proliferation,therapeutic target,signaling pathway modulation
ENSG00000197223,C1D,chromatin remodeling,genomic instability,epigenetic regulation,dna repair,transcriptional dysregulation,tumor promotion
ENSG00000104435,STMN2,microtubule destabilization,g2/m checkpoint regulation,cell proliferation enhancement,apoptosis resistance,emt regulation,tumor progression facilitation
ENSG00000106477,CEP41,centrosome regulation,genomic instability,aberrant ciliogenesis,microtubule disruption,cell cycle dysregulation,tumor progression
ENSG00000182389,CACNB4,calcium channel regulation,cell migration modulation,cell proliferation enhancement,oncogenic process promotion,therapeutic target identification,signaling pathway interaction
ENSG00000139793,MBNL2,alternative splicing,pre-mrna processing,oncogenesis,tumor progression,gene expression regulation,cellular proliferation
ENSG00000285250,MSRA,protein folding regulation,chaperone function,oncogenic protein stabilization,transcription factor modulation,cell growth promotion,tumor progression marker
ENSG00000059573,ALDH18A1,redox regulation,oxidative stress modulation,amino acid metabolism alteration,tumor progression contribution,prognostic biomarker potential,cancer aggressiveness marker
ENSG00000004799,PDK4,energy metabolism dysregulation,glycolytic shift,tumor growth promotion,cellular proliferation enhancement,pyruvate dehydrogenase regulation,oncogenic mutations
ENSG00000134594,RAB33A,overexpression,oncogene activation,microtubule-dependent trafficking,cell growth regulation,tumor progression,pi3k/akt pathway modulation
ENSG00000196814,MVB12B,oncogenic function,endosomal regulation,autophagy modulation,multivesicular body formation,cell survival promotion,tumorigenesis contributor
ENSG00000124496,TRERF1,genomic instability,mutation sensitivity,dna repair mechanisms,tumor suppressor function,cancer predisposition,cellular pathway disruption
ENSG00000285493,NRL,transcriptional regulation,cell growth modulation,differentiation regulation,cancer-related transcription factor,regulatory function alteration,tumor progression association
ENSG00000155761,SPAG17,microtubule stabilization,gain of function mutations,therapeutic target,cell proliferation enhancement,apoptosis inhibition,genomic profiling
ENSG00000141458,NPC1,cholesterol transport,endosomal sorting complexes,lipid rafts internalization,cancer progression,therapeutic target,membrane-bound protein recycling
ENSG00000113161,HMGCR,cholesterol biosynthesis,tumor aggressiveness,isoprenoid production,oncogenic activation,pi3k/akt pathway interaction,therapeutic target
ENSG00000156006,NAT2,xenobiotic metabolism,metabolic detoxification,dna damage response,cell cycle regulation,tumorigenesis,genotoxic stress
ENSG00000067334,DNTTIP2,cell cycle regulation,tumor progression,mutations,genomic instability,dna replication,protein interaction
ENSG00000004534,RBM6,alternative splicing regulation,cell proliferation promotion,oncogenesis facilitation,prognosis predictor,poor survival outcome,tumor progression promotion
ENSG00000119421,NDUFA8,mitochondrial complex i regulation,energy production regulation,metabolic reprogramming,tumor metabolism adaptation,cellular respiration maintenance,hypoxia response modulation
ENSG00000180481,GLIPR1L2,immune modulation,tumor suppressor function,cell proliferation regulation,apoptosis induction,protein-protein interaction,cancer prognosis marker
ENSG00000197776,KLHDC1,klk9 overexpression,serine protease activity,cell proliferation enhancement,metastasis promotion,chemoresistance induction,tumor microenvironment remodeling
ENSG00000011143,MKS1,ciliogenesis disruption,oncogenic pathway activation,aberrant cell signaling,primary cilia dysfunction,cell proliferation enhancement,therapeutic target potential
ENSG00000152669,CCNO,genomic instability,chromosomal instability,cell cycle regulation,mitotic checkpoint disruption,spindle checkpoint aberrance,protein-protein interactions
ENSG00000187531,SIRT7,nucleolar localization,genomic stability regulation,cellular metabolism regulation,tumor suppressor function,apoptosis resistance,oncogenic potential
ENSG00000125522,NPBWR2,oncogene activation,gene expression modulation,cell proliferation enhancement,apoptosis evasion,tumor progression facilitation,protein interaction network alteration
ENSG00000107819,SFXN3,mitochondrial integrity,cell growth regulation,iron-sulfur cluster biogenesis,mtor pathway interaction,tumor suppressor/oncofunction,cell proliferation modulation
ENSG00000106631,MYL7,smooth muscle contractility,actomyosin dynamics regulation,tumor progression marker,cell migration and invasion facilitation,prognostic significance,cellular process disruption
ENSG00000027847,B4GALT7,cell surface integrity regulation,glycoprotein synthesis,tumor progression modulation,apoptosis regulation,cell adhesion regulation,tumorigenesis association
ENSG00000121318,TAS2R10,bitter taste receptor function,gpcr signaling pathway,aberrant expression,oncogenesis,cell growth regulation,signaling modulation
ENSG00000112984,KIF20A,microtubule dynamics,tumor growth promotion,uncontrolled cell proliferation,centrosome separation,chromosomal instability,mitotic checkpoint regulation
ENSG00000204406,MBD5,gene amplification,chromatin remodeling,dna methylation regulation,homologous recombination,epigenetic landscape modulation,oncogenic transcription factor
ENSG00000110723,EXPH5,endocytic pathway regulation,receptor recycling,pi3k/akt activation,cell proliferation enhancement,protein trafficking modulation,cargo protein function
ENSG00000169228,RAB24,mapk/erk signaling,constitutive activation,gain of function mutations,tumor progression,protein-protein interactions,cell migration and invasion
ENSG00000254999,BRK1,cell proliferation,pi3k/akt pathway interaction,oncogenic driver,tyrosine kinase activity,cell survival enhancement,prognostic biomarker
ENSG00000140577,CRTC3,creb transcription factor regulation,cell growth promotion,gene expression enhancement,oncogenic activity,tumor progression contribution,amplification/overexpression
ENSG00000152413,HOMER1,protein scaffolding,mapk/erk signaling pathway,pi3k/akt signaling pathway,cell proliferation regulation,metastasis promotion,oncogenic protein complex assembly
ENSG00000184697,CLDN6,tumor progression,mutation or expression alterations,cell migration and invasion,pi3k/akt pathway regulation,therapeutic target,epithelial cell polarity maintenance
ENSG00000165905,LARGE2,cell surface modification,glycoprotein biosynthesis,tumor progression,poor prognosis marker,dna repair modulation,cell adhesion disruption
ENSG00000174684,B4GAT1,tumor progression,metastasis,cell migration,extracellular matrix regulation,signaling pathway interaction,prognostic biomarker
ENSG00000198846,TOX,chromatin regulation,oncogene activation,cell cycle progression,tumor suppressor gene repression,cancer prognosis,proliferation modulation
ENSG00000101439,CST3,protein degradation inhibition,cell cycle regulation,tumor growth promotion,apoptosis inhibition,biomarker potential,overexpression association
ENSG00000198208,RPS6KL1,ribosome biogenesis,kinase activity,oncogenic potential,cell proliferation,dna repair regulation,tumor progression
ENSG00000151893,CACUL1,cancer driver,tumor suppressor,cell cycle regulation,dna repair,genomic stability,proteasomal degradation pathway
ENSG00000118729,CASQ2,calcium homeostasis regulation,tumor suppressor role,apoptosis regulation,cell cycle progression,protein interaction,intracellular signaling
ENSG00000188321,ZNF559,zinc finger protein,transcriptional regulation,cell growth modulation,apoptosis regulation,dna binding specificity,cancer-related transcription factor
ENSG00000141424,SLC39A6,iron importer,metal transporters,cellular homeostasis,cell growth and proliferation,hypoxia response,tumor survival
ENSG00000089335,ZNF302,transcriptional regulation,dna binding,cell cycle control,apoptosis evasion,genomic stability disruption,protein-protein interactions
ENSG00000087253,LPCAT2,overexpression,lipid metabolism regulation,oncogene activation,pi3k/akt pathway modulation,cell proliferation promotion,prognostic biomarker
ENSG00000109466,KLHL2,ubiquitination regulation,oncogene modulation,e3 ligase activity,protein degradation,cell proliferation regulation,metastasis promotion
ENSG00000161640,SIGLEC11,angiogenesis promotion,immune evasion mechanism,oncogenic pathway modulation,sialic acid-binding protein,tumor progression facilitation,vascular permeability regulation
ENSG00000144820,ADGRG7,cell-cell interaction regulation,signaling pathway modulation,tumor progression,epithelial-to-mesenchymal transition,cell migration enhancement,metastasis facilitation
ENSG00000128849,CGNL1,cell-cell interactions,cytoskeleton dynamics,focal adhesion complex formation,tumor suppressor function,cell migration regulation,adhesion disruption
ENSG00000198794,SCAMP5,endosomal trafficking regulation,cancer progression promotion,cell migration facilitation,tumor growth enhancement,vesicular transport role,prognostic biomarker
ENSG00000165071,TMEM71,cellular membrane integrity,signaling pathway regulation,oncogenic properties,tumor progression,cellular senescence modulation,dna repair mechanism alteration
ENSG00000172046,USP19,nf-κb pathway regulation,ubiquitin-proteasome system modulation,tumor progression facilitation,oncogene interaction,cell proliferation promotion,overexpression in cancer tissues
ENSG00000100075,SLC25A1,mitochondrial metabolism,oxidative stress,genomic instability,tumor aggressiveness,energy production,cellular interaction
ENSG00000002746,HECW1,ubiquitin ligase activity,apoptosis regulation,cell cycle regulation,tumor suppression,dna damage response,genomic instability
ENSG00000007933,FMO3,metabolic regulation,drug metabolism,n-oxidation activity,flavin-containing monooxygenase function,xenobiotic processing,cellular detoxification
ENSG00000138136,LBX1,coactivator function,cell cycle regulation,apoptosis regulation,transcriptional modulation,dna repair,tumor growth promotion
ENSG00000176925,OR51F2,odorant receptor activity,promoter methylation,cell signaling activation,tumor progression marker,overexpression pattern,cell proliferation regulation
ENSG00000140943,MBTPS1,coactivator function,transcriptional regulation,nuclear receptor interaction,oncogenic potential,signaling pathway modulation,cell cycle progression
ENSG00000198892,SHISA4,wnt/β-catenin pathway,cell proliferation,apoptosis resistance,tumor progression,promoter of oncogenesis,overexpression
ENSG00000124523,SIRT5,mitochondrial metabolism regulation,deacetylation activity,glycolysis enhancement,glutaminolysis promotion,akt pathway activation,cancer cell survival enhancement
ENSG00000171848,RRM2,dna synthesis,cell proliferation,deoxyribonucleotide production,tumor progression,therapeutic target,ribonucleotide reductase activity
ENSG00000213937,CLDN9,tumor progression,metastasis,cell migration,genomic instability,cell survival,protein-protein interaction
,SEPT8,microtubule stabilization,cell division regulation,septin family member,protein interaction partner,cytoplasmic organization,cell cycle progression
ENSG00000257473,HLA-DQA2,antigen presentation,immune system modulation,tumor progression association,dysregulated expression,protein-protein interaction,immune checkpoint regulation
ENSG00000158055,GRHL3,tumor suppressor,epithelial-to-mesenchymal transition,cell cycle regulation,apoptosis modulation,biomarker potential,therapeutic target
ENSG00000120705,ETF1,iron-sulfur cluster assembly,mitochondrial dysfunction,tumor growth promotion,cancer cell survival,cellular respiration regulation,oxidative stress modulation
ENSG00000130592,LSP1,tumor progression,therapeutic target,oncogene activation,cell growth regulation,apoptosis suppression,genomic instability
ENSG00000144792,ZNF660,tumor progression,epithelial-to-mesenchymal transition,wnt/β-catenin pathway activation,chromatin remodeling,transcription factor regulation,gene expression modulation
ENSG00000280618,CYFIP1,racgap binding,alternative splicing regulation,cytoplasmic localization,cell migration facilitation,oncogenic role in cancer,pi3k/akt pathway involvement
ENSG00000143294,PRCC,tumor suppressor function,hypoxia-inducible factor alpha stabilization,angiogenesis promotion,cell proliferation enhancement,survival pathway activation,prolyl hydroxylation inhibition
ENSG00000181195,PENK,tumor progression,cell proliferation,metastasis suppression,apoptosis regulation,signaling pathway modulation,oncogenic potential
ENSG00000178096,BOLA1,iron-sulfur cluster biogenesis,mitochondrial function,oxidative stress,dna repair,cellular metabolism,apoptosis evasion
ENSG00000165775,FUNDC2,autophagy regulation,mitochondrial dynamics,oncogenic properties,cellular metabolism modulation,therapeutic target,genomic instability
ENSG00000182768,NGRN,cellular proliferation,pi3k/akt pathway,calcium-binding protein,oncogenic signaling,cellular migration,cell survival
ENSG00000213931,HBE1,histone modification,chromatin regulation,oncogenesis driver,cancer progression,gene expression regulation,epigenetic alterations
ENSG00000116871,MAP7D1,microtubule regulation,mitotic checkpoint,cell proliferation,apoptosis resistance,oncogene interaction,tumor suppressor modulation
ENSG00000080823,MOK,constitutive activation,map3k signaling pathway,overexpression,jnk/sapk pathway,tumor progression,therapeutic target
ENSG00000142065,ZFP14,epigenetic regulation,transcriptional modulation,cell cycle progression,apoptosis inhibition,prognostic biomarker,tumor aggressiveness
ENSG00000006715,VPS41,autophagy regulation,vesicular transport,heterotrimeric complex,endosomal function,lysosomal maintenance,cellular homeostasis
ENSG00000105514,RAB3D,exocytosis regulation,gtpase activity,oncogenic signaling,cell survival modulation,tumor growth promotion,therapeutic target
ENSG00000163202,LCE3D,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),tumor progression marker,metastasis promotion,adhesion molecule regulation,signaling pathway modulation
ENSG00000177710,SLC35G5,enhanced cell growth,interactions with signaling pathways,cellular response modulation,dysregulated expression,nucleotide sugar transport,ancillary tumor development
ENSG00000173486,FKBP2,cell cycle regulation,tumor growth promotion,apoptosis inhibition,transcriptional control modulation,prognostic marker,therapeutic target
ENSG00000184292,TACSTD2,tumor progression,epithelial-to-mesenchymal transition,pi3k/akt pathway,cell adhesion regulation,immune evasion mechanisms,cancer stem cell maintenance
ENSG00000169946,ZFPM2,cell cycle regulation,transcription factor function,tumor suppressor activity,apoptosis modulation,growth factor regulation,genomic instability
ENSG00000175938,ORAI3,calcium signaling,constitutive activation,oncogenic function,cell proliferation,tumor progression,amplification
ENSG00000095539,SEMA4G,tumor progression,immune evasion,cancer driver gene,angiogenesis,cell migration,plexind1 interaction
ENSG00000160190,SLC37A1,sulfate transport,tumor progression,pro-tumorigenic microenvironment,cellular proliferation,therapeutic target,metabolic regulation
ENSG00000137819,PAQR5,androgen receptor regulation,cell proliferation enhancement,poor prognosis marker,signaling pathway modulation,tumor progression facilitation,androgen-independent expression
ENSG00000003509,NDUFAF7,mitochondrial dysfunction,cellular metabolism disruption,pro-survival signaling activation,therapeutic target,genomic instability,metabolic reprogramming
ENSG00000101292,PROKR2,g protein-coupled receptor signaling,cell proliferation,epithelial-to-mesenchymal transition,poor prognosis marker,tumor progression,signaling pathway modulation
ENSG00000196199,MPHOSPH8,genomic instability,chromosomal missegregation,meiotic recombination regulation,homologous chromosome pairing,aneuploidy prevention,tumor suppressor
ENSG00000273607,CHCHD10,mitochondrial metabolism,warburg effect,mitochondrial dynamics,tumor suppressor function,cellular stress response,glycolytic shift
ENSG00000115207,GTF3C2,regulation of rna polymerase iii transcription,constitutive activation,oncogenic process regulation,cellular proliferation promotion,tumor progression association,genomic stability modulation
ENSG00000132466,ANKRD17,chromatin remodeling,genomic instability,loss of function mutation,cell cycle regulation,apoptosis inhibition,tumor suppressor inactivation
ENSG00000116132,PRRX1,transcriptional repressor activity,cell growth regulation,tumor suppressor gene suppression,oncogenic pathway promotion,epigenetic regulation,cellular response modulation
ENSG00000288435,GJA10,gap junctional communication,cell proliferation,oncogenic overexpression,calcium signaling pathway,tumor progression,intercellular transfer
ENSG00000158555,GDPD5,gdp-diaphorase activity,oxidative stress reduction,cell signaling modulation,tumor growth promotion,metastasis enhancement,cell survival pathway interaction
ENSG00000178860,MSC,transcription factor activity,urothelial cell maintenance,cell proliferation regulation,embryonic development gene expression,oncogenic process involvement,aberrant upregulation pattern
ENSG00000160408,ST6GALNAC6,cell signaling alteration,o-glycosylation pathway,metastasis promotion,tumor progression association,poor prognosis marker,wnt/β-catenin pathway interaction
,HIST1H2BL,histone modification,chromatin regulation,dna packaging,epigenetic regulation,cell cycle progression,apoptosis repression
ENSG00000108509,CAMTA2,tumor progression,transcriptional regulation,cell proliferation,apoptosis modulation,biomarker candidate,genomic amplification
ENSG00000067064,IDI1,post-translational modification,protein modification enzyme,oncogenesis promotion,cellular proliferation,tumor progression facilitation,apoptosis evasion
ENSG00000164332,UBLCP1,ubiquitin ligase activity,tumor progression,protein degradation regulation,oncogenic protein interaction,p53 pathway dysregulation,therapeutic resistance
ENSG00000153250,RBMS1,tumor suppressor,mrna regulation,dna damage response,cell cycle regulation,protein translation modulation,mtor pathway interaction
ENSG00000101335,MYL9,cellular motility enhancement,signaling pathway regulation,oncogenic activation,apoptosis inhibition,protein-protein interaction,cytoskeletal remodeling
ENSG00000106404,CLDN15,altered expression,cell adhesion regulation,epithelial-to-mesenchymal transition,immune modulation,metastasis promotion,tumor progression
ENSG00000204965,PCDHA5,tumor suppressor function,cell-cell adhesion regulation,metastasis promoter,prognostic marker,gene expression alteration,tissue interaction disruption
ENSG00000077380,DYNC1I2,genomic amplification,tumor suppressor dysfunction,cell proliferation enhancement,mitotic checkpoint disruption,microtubule dynamics alteration,aneuploidy promotion
ENSG00000187097,ENTPD5,purinergic signaling,oncogenic potential,tumor growth promotion,angiogenesis stimulation,immune evasion mechanism,signaling pathway modulation
ENSG00000074370,ATP2A3,calcium homeostasis regulation,oncogene overexpression,cell proliferation promotion,tumor progression,emt regulation,transcription factor activation
ENSG00000111711,GOLT1B,n-glycosylation disruption,tumor progression,apoptosis evasion,angiogenesis,cell growth regulation,glycoprotein accumulation
ENSG00000173467,AGR3,wnt/β-catenin pathway,glycosyltransferase activity,tumor progression,cell proliferation,survival signaling,immunotherapy target
ENSG00000179213,SIGLECL1,immune modulation,cancer immunotherapy target,tumor suppression,nk cell activation,dendritic cell maturation,glycoprotein recognition
ENSG00000183317,EPHA10,tumor suppressor function,loss of contact inhibition,enhanced angiogenesis,metastatic potential,biomarker for early detection,immunotherapy target
ENSG00000166189,HPS6,autophagy regulation,cellular stress response,lysosomal biogenesis,pi3k/akt/mtor pathway interaction,tumor suppressor function,oncogenic process promotion
ENSG00000213523,SRA1,androgen receptor signaling,constitutive activation,dna repair dysregulation,chromatin remodeling,transcriptional regulation,prognostic marker
ENSG00000112149,CD83,dendritic cell regulation,cell adhesion modulation,tumor progression marker,apoptosis regulation,immune response modification,prognostic value
ENSG00000162444,RBP7,post-transcriptional regulation,rna splicing and transport,cell proliferation and survival,tumor progression,poly(a) binding proteins interaction,genomic instability
ENSG00000100722,ZC3H14,transcriptional regulation,cell proliferation,apoptosis inhibition,tumor growth promotion,cell cycle progression regulation,cancer oncogene
ENSG00000132698,RAB25,cellular migration,oncogenic properties,emt regulation,microtubule dynamics,cell polarity,pi3k/akt pathway activation
ENSG00000163530,DPPA2,cellular differentiation,cancer stem cell maintenance,transcriptional regulation,tumorigenesis,cell proliferation,metastasis
ENSG00000273274,ZBTB8B,transcriptional regulation,oncogenic mutations,cell proliferation,apoptosis evasion,histone modification,chromatin remodeling
ENSG00000181404,WASHC1,genomic instability,oncogenic driver,endosomal trafficking disruption,cellular proliferation enhancement,therapeutic target,dna damage response dysregulation
ENSG00000143924,EML4,alk kinase activation,cancer driver mutation,cell proliferation enhancement,mitotic progression regulation,oncogenic fusion partner,tumor cell survival
ENSG00000167721,TSR1,cell adhesion modulation,oncogenic overexpression,tumor aggressiveness promoter,metastasis facilitator,epithelial-to-mesenchymal transition pathway interaction,reduced survival predictor
ENSG00000129682,FGF13,cell proliferation,tumor progression,fgf signaling pathway,metastasis,biomarker potential,genomic amplification
ENSG00000088826,SMOX,cell proliferation,overexpression,transcriptional regulation,tumorigenesis,poor prognosis,chemosensitivity
ENSG00000185236,RAB11B,rab gtpase family,cell cycle regulation,vesicle transport facilitation,tumor progression driver,chemotherapy resistance modulation,pi3k/akt pathway modulation
ENSG00000031691,CENPQ,cancer driver gene,chromosomal instability,genomic alterations,cell division regulation,kinetochore complex component,spindle microtubule interaction
ENSG00000077942,FBLN1,extracellular matrix formation,cell adhesion,tumor progression,prognostic biomarker,metastasis promotion,transcriptional regulation
ENSG00000175264,CHST1,cell adhesion disruption,epithelial-to-mesenchymal transition,glycosylation modification,oncogenic expression,tumor progression enhancement,tissue invasion facilitation
ENSG00000205143,ARID3C,chromatin remodeling,oncogene activation,transcriptional regulation,tumor progression,prognostic marker,genomic instability
ENSG00000169994,MYO7B,cell proliferation,overexpression,oncogene potential,pi3k/akt pathway interaction,stereocilia structure disruption,tumor progression support
ENSG00000135049,AGTPBP1,pi3k/akt signaling,oncogene activation,growth factor regulation,angiogenesis promotion,cell survival enhancement,metabolic reprogramming
ENSG00000112186,CAP2,calcium-dependent signaling,proliferation regulation,apoptosis modulation,tumor development enhancer,malignant transformation contributor,genetic alteration in cancer
ENSG00000154096,THY1,cell adhesion regulation,cell surface antigen,early t-cell development,tumor progression,glycoprotein function,expression alteration
ENSG00000130433,CACNG6,cell cycle regulation,dysregulated calcium channels,pi3k/akt signaling,oncogene potential,tumor progression,calcium channel modulation
ENSG00000172716,SLFN11,tumor suppressor,dna replication regulation,apoptosis induction,cell cycle progression,genomic stability maintenance,biomarker candidate
ENSG00000288121,MDN1,mediator complex interaction,oncogenic processes,cell proliferation regulation,transcriptional activation,cancer cell growth inhibition target,tumor progression driver
ENSG00000198513,ATL1,microtubule dynamics regulation,tumor suppressor function loss,aneuploidy induction,dna damage resistance,cell cycle progression enhancement,ciliogenesis disruption
ENSG00000184979,USP18,deubiquitinating enzyme activity,apoptosis regulation,cell cycle progression,dna repair mechanisms,oncogenic transformation,protein stabilization
ENSG00000153132,CLGN,cell cycle regulation,microtubule dynamics,apoptosis inhibition,tumor suppressor function,mitotic progression,cytoskeleton modulation
ENSG00000117090,SLAMF1,tumor progression,cell surface receptor activation,immune evasion mechanisms,tumor microenvironment modulation,cancer cell growth enhancement,inflammation signaling pathways
ENSG00000095321,CRAT,metabolic reprogramming,cellular proliferation,enhanced energy production,fatty acid metabolism,tumor growth promotion,prognostic marker
ENSG00000112651,MRPL2,mitochondrial function regulation,glycolysis promotion,cellular metabolism modulation,tumor growth enhancement,oncogene activation,energy production disruption
ENSG00000165526,RPUSD4,nuclear localization,transcriptional regulation,genomic stability maintenance,dna repair modulation,tumor suppression,cellular interaction regulation
ENSG00000196670,ZFP62,zinc finger protein regulation,epithelial-to-mesenchymal transition (emt),oncogenic function,tumorigenesis modulation,apoptosis suppression,chromatin remodeling interactions
ENSG00000167645,YIF1B,mitochondrial translation regulation,loss of function mutations,altered metabolic profiles,tumor progression,oxidative stress susceptibility,mitochondrial dynamics disruption
ENSG00000102780,DGKH,lipid signaling pathway,tumor progression,cell proliferation,survival mechanism,phosphorylation activity,protein-protein interaction
ENSG00000140543,DET1,transcriptional regulation,chromatin remodeling,oncogenic process promotion,cell proliferation enhancement,apoptosis suppression,histone modification interaction
ENSG00000083099,LYRM2,mitochondrial dynamics,cancer-promoting mutations,apoptosis regulation,oncogenic signaling,tumor growth promotion,genomic instability
ENSG00000090339,ICAM1,tumor progression,cell adhesion,metastasis facilitation,pi3k/akt pathway activation,immune modulation,tumor microenvironment modulation
ENSG00000123810,B9D2,cell cycle regulation,cell proliferation,oncogene,cancer progression,tumorigenesis,protein-protein interactions
ENSG00000106268,NUDT1,genomic instability,dna damage repair,cell cycle regulation,tumor suppressor function,nucleotide metabolism regulation,promoter hypermethylation
ENSG00000285482,DGAT1,lipid metabolism regulation,triglyceride synthesis promotion,cell proliferation enhancement,apoptosis inhibition,signaling pathway interaction,cell survival promotion
ENSG00000164086,DUSP7,dephosphorylation,erk signaling inhibition,mapk pathway regulation,oncogene-tumor suppressor paradox,protein kinase activation,tumor suppression via dephosphorylation
ENSG00000128594,LRRC4,cell adhesion regulation,oncogenic driver,tumor progression,signaling pathway modulation,cell-cell interaction,therapeutic target
ENSG00000162631,NTNG1,tumor suppressor,cell adhesion regulation,angiogenesis inhibition,cell migration modulation,signaling pathway regulation,cancer cell invasion suppression
ENSG00000130748,TMEM160,er stress regulation,lipid metabolism modulation,cell proliferation enhancement,oncogenic properties,cancer associated interactions,genomic amplification
ENSG00000213398,LCAT,lipid raft formation,cholesterol accumulation,signaling pathway modulation,tumor growth promotion,cell membrane fluidity,oncogenic process enhancement
ENSG00000138315,OIT3,chromatin remodeling,oncogenic properties,cell proliferation,dna repair,transcriptional regulation,protein-protein interaction
ENSG00000242247,ARFGAP3,constitutive activation,loss-of-function mutations,gtp hydrolysis regulation,tumor progression driver,signaling pathway modulation,cell migration promotion
ENSG00000164326,CARTPT,chimeric antigen receptor t cell protomer transport,immune modulation,protein transport facilitation,tumor progression facilitation,cellular membrane regulation,cancer immunotherapy target
ENSG00000176401,EID2B,necroptosis induction,apoptosis inhibition,cell death regulation,tumor progression marker,oncogenic function,cancer cell survival
ENSG00000101052,IFT52,cilia dysfunction,cell cycle progression,genomic instability,hippo pathway dysregulation,intracellular transport regulation,metastasis promotion
ENSG00000125780,TGM3,tumor progression,epithelial-to-mesenchymal transition (emt),stemness maintenance,protein cross-linking,angiogenesis promotion,signaling pathway modulation
ENSG00000168434,COG7,glycolytic reprogramming,cell proliferation,golgi apparatus dysfunction,apoptosis evasion,tumor growth promotion,cancer cell metabolism
ENSG00000071537,SEL1L,erad pathway regulation,tumor progression facilitation,cellular homeostasis disruption,oncogenic process contribution,protein quality control dysfunction,genomic instability enhancement
ENSG00000171617,ENC1,emt regulation,overexpression in cancer,pi3k/akt pathway modulation,cell migration and invasion promotion,metastasis facilitation,tumor aggressiveness correlation
ENSG00000164849,GPR146,g protein signaling,tumor growth modulation,cell adhesion regulation,cell migration regulation,apoptosis suppression,signaling pathway interaction
ENSG00000171853,TRAPPC12,endosomal trafficking,autophagic processes,tumor progression,oncogenic signaling,cellular adaptation,mutation hotspot
ENSG00000134294,SLC38A2,glutamine transporter,sodium-dependent amino acid uptake,tumor promotion,cellular redox balance,oxidative stress tolerance,antioxidant enzyme regulation
ENSG00000170745,KCNS3,altered expression,cell migration,cell proliferation,ion channel regulation,oncogenic process,tumor progression
ENSG00000166148,AVPR1A,protein-protein interaction,signaling pathway activation,tumor progression,cancer cell invasion,metastasis promotion,chemotherapy resistance
ENSG00000183579,ZNRF3,**

wnt/β-catenin pathway,tumor suppressor function,negative regulator,frizzled receptor degradation,cell proliferation suppression,poor prognosis association

**
ENSG00000133687,TMTC1,notch signaling pathway,dysregulated function,glycosylation and notch receptor modification,oncogenic transformation,bladder cancer driver genes,tumor progression regulator
ENSG00000198183,BPIFA1,cellular stress response,immune regulation,tumor suppression,apoptosis,cancer immunotherapy,protein-protein interaction
ENSG00000182557,SPNS3,sphingosine-1-phosphate receptor signaling,cell proliferation,tumor progression,apoptosis inhibition,therapeutic target,genomic overexpression
ENSG00000108370,RGS9,oncogenic signaling,regulatory dysfunction,tumor progression,proliferation enhancement,survival pathway modulation,biomarker potential
ENSG00000117500,TMED5,protein processing regulation,oncogene function,cell surface protein modification,tumor progression promotion,cancer cell proliferation enhancement,glycoprotein biogenesis facilitation
ENSG00000197429,IPP,pi3k/akt pathway,constitutive activation,interaction with oncogenes,tumor progression,genomic instability,cell proliferation
ENSG00000135720,DYNC1LI2,microtubule-dependent transport,oncogenic mechanism,tumor progression,cell proliferation,genomic instability,protein-protein interaction
ENSG00000123836,PFKFB2,allosteric regulation,glycolytic flux,glucose metabolism,tumor growth,enhanced tumorigenesis,poor prognosis
ENSG00000137177,KIF13A,mitotic spindle assembly,gene overexpression,microtubule-based transport,cell proliferation acceleration,prognostic marker,tumor aggressiveness
ENSG00000224654,UBD,cell cycle regulation,chromatin remodeling,dna repair,genome stability,protein degradation,ubiquitin binding
ENSG00000197037,ZSCAN25,tumor suppression,cell cycle regulation,apoptosis regulation,dna binding protein,zinc finger motif,transcriptional regulation
ENSG00000070366,SMG6,nonsense-mediated mrna decay,rna processing regulation,aberrant protein expression,tumorigenesis driver,oncogenic process alteration,genomic instability promotion
ENSG00000172725,CORO1B,actin cytoskeleton dynamics,cell migration and invasion,tumor progression,poor prognosis,apoptosis regulation,cell growth modulation
ENSG00000135821,GLUL,glutamine metabolism,mtor pathway activation,cell growth promotion,tumor progression,autophagy regulation,prognostic marker
ENSG00000144452,ABCA12,cholesterol transport,cell membrane fluidity,cellular proliferation,oncogenic protein,poor prognosis marker,genomic amplification
ENSG00000187824,TMEM220,cell growth regulation,transmembrane protein function,cell proliferation enhancement,tumor progression association,therapeutic target potential,genomic overexpression
ENSG00000118804,STBD1,dna damage recognition,genomic instability,cell cycle regulation,cancer predisposition,protein-protein interaction,dna repair mechanism
ENSG00000184110,EIF3C,cell proliferation,pi3k/akt signaling,overexpression,genomic instability,oncogenic pathway activation,tumor progression
ENSG00000189190,ZNF600,apoptosis regulation,cell proliferation control,transcriptional repression,dna repair pathway,gene expression modulation,cell cycle regulation
ENSG00000119321,FKBP15,cell cycle regulation,oncogene activation,tumor progression,angiogenesis promotion,protein-protein interaction,cell survival enhancement
ENSG00000102178,UBL4A,genomic instability,cell cycle regulation,oncogenic mutations,apoptosis disruption,protein degradation dysregulation,tumor progression promotion
ENSG00000019991,HGF,**
cancer driver gene,metastasis promotion,protein kinase activation,tumor growth stimulation,signaling pathway regulation,epithelial-mesenchymal transition facilitation
ENSG00000102359,SRPX2,oncogene,cell migration,epithelial-to-mesenchymal transition,cell adhesion disruption,poor prognosis association,tumor aggressiveness
ENSG00000188064,WNT7B,wnt signaling pathway,activation of β-catenin,cell proliferation promotion,tumor progression association,metastasis facilitation,therapeutic target possibility
ENSG00000164841,TMEM74,regulatory protein,tumor suppressor function,cell cycle progression,apoptosis regulation,er membrane localization,signaling pathway modulation
ENSG00000100478,AP4S1,protein trafficking regulation,altered protein localization,cellular homeostasis disruption,oncogenic process promotion,signaling pathway disruption,genetic mutation association
ENSG00000103510,KAT8,chromatin remodeling,oncogene amplification,cell cycle regulation,transcriptional modulation,protein acetylation,epigenetic dysregulation
ENSG00000010361,FUZ,wnt/β-catenin signaling pathway,oncogene activation,transcriptional regulation,cell proliferation,tumor progression,genetic mutations
ENSG00000111912,NCOA7,aberrant activation,coactivator function,cell proliferation,metastasis promotion,oncogene overexpression,transcriptional regulation
ENSG00000275544,BDH1,metabolic reprogramming,aerobic glycolysis,warburg effect,tumor progression,therapeutic target,energy metabolism adaptation
ENSG00000121716,PILRB,immune modulation,tumor microenvironment regulation,il-2 signaling pathway inhibition,cancer immune evasion,therapeutic target for immunotherapy,immune cell activation suppression
ENSG00000185344,ATP6V0A2,**
enhanced v-atpase activity,increased cell survival,glycolytic shift,warburg effect,oncogenic protein isoform production,cell growth regulation 
**
ENSG00000183542,KLRC4,immunomodulation,cellular activation,proliferation regulation,tumor immunosurveillance,biomarker potential,immune cell interaction
ENSG00000101447,FAM83D,oncogene activation,tumor initiation,chromatin remodeling,apoptosis suppression,nf-κb interaction,p53 regulation
ENSG00000171951,SCG2,cell migration,proteolytic processing,tumor progression,signaling pathway modulation,gene expression regulation,protein-protein interaction
ENSG00000064199,SPA17,microtubule dynamics,cell proliferation regulation,genomic instability,driver mutation candidate,oncogene overexpression,prognostic marker
ENSG00000106823,ECM2,tumor progression,cell migration,cell invasion,prognostic biomarker,transmembrane protein,cell adhesion
,IGHD,immunoglobulin diversity,somatic hypermutation,adaptive immune evasion,oncogenesis promotion,antibody specificity,tumor growth facilitation
ENSG00000135378,PRRG4,cellular adhesion,epigenetic regulation,tumor suppressor function,cell migration regulation,protein-protein interaction,metastasis promotion
ENSG00000140259,MFAP1,cellular adhesion,cell migration,tumor progression,metastasis suppression,gene expression profiling,immune modulation
ENSG00000067113,PLPP1,pi3k/akt pathway interaction,lipid metabolism regulation,tumor progression promotion,cell proliferation enhancement,prognostic biomarker,therapeutic target
ENSG00000100170,SLC5A1,tumor progression,glycolytic shift,metabolic regulation,oncogenic potential,protein interaction,therapeutic target
ENSG00000125149,C16orf70,genomic instability,tumor suppressor function,negative regulation of tumorigenesis,dna repair impairment,loss of function mutations,epigenetic regulation
ENSG00000103168,TAF1C,constitutive activation,transcriptional regulation,cell proliferation,oncogenic targets,epigenetic modification,pi3k/akt signaling
ENSG00000154222,CC2D1B,tumor suppressor,pi3k/akt/mtor pathway inhibition,cell proliferation regulation,gene expression modulation,transcription factor interaction,oncogenic process suppression
ENSG00000135596,MICAL1,actin cytoskeleton regulation,oncogene function,epithelial-to-mesenchymal transition (emt),cell migration regulation,protein-protein interaction,cancer driver gene
,H2AFV,histone variant,chromatin regulation,genomic instability,mitotic regulation,cancer progression,tumorigenesis
ENSG00000162695,SLC30A7,zinc homeostasis,tumor suppressor function,apoptosis regulation,cell cycle inhibition,dna repair mechanisms,oncogenic signaling pathways
ENSG00000213759,UGT2B11,xenobiotic metabolism,cell growth regulation,bile acid signaling,cellular detoxification,protein conjugation,stress response modulation
ENSG00000172292,CERS6,ceramide synthesis,sphingolipid metabolism alteration,cell survival enhancement,apoptosis suppression,oncogenic pathway interaction,poor prognosis marker
ENSG00000111846,GCNT2,glycosylation regulation,cell-cell interactions,epithelial-to-mesenchymal transition,adhesion modulation,tumor growth promotion,metastasis enhancement
ENSG00000090013,BLVRB,metabolic reprogramming,gene expression regulation,lipid metabolism alterations,apoptosis modulation,tumor suppression,cellular differentiation
ENSG00000118363,SPCS2,glycolytic regulation,metabolic reprogramming,oncogene overexpression,tumor growth promotion,cell proliferation enhancement,glucose metabolism alteration
ENSG00000113722,CDX1,oncogene activity,tumor aggressiveness,cell proliferation enhancement,apoptosis inhibition,emt regulation,wnt/β-catenin pathway activation
ENSG00000084073,ZMPSTE24,genomic instability,tumor suppressor function,dna damage response,cellular senescence,protein processing regulation,nuclear structure maintenance
ENSG00000165995,CACNB2,calcium channel regulation,oncogene activation,tumor progression,metastasis,cellular calcium influx,signaling pathway modulation
ENSG00000151067,CACNA1C,calcium channel regulation,gain-of-function mutations,oncogenic signaling,cell proliferation,therapeutic target,genomic profiling
ENSG00000102409,BEX4,emt process regulation,oncogenic mrna stabilization,cell survival promotion,rna-binding protein interaction,prognostic marker,overexpression association
ENSG00000164303,ENPP6,extracellular nucleotides regulation,oncogenic process promotion,tumor growth and metastasis,cell adhesion and migration regulation,phosphodiesterase activity,nucleotide precursor catabolism
ENSG00000008405,CRY1,dna damage response,cell cycle regulation,oncogenic mutations,apoptosis suppression,protein interaction,genomic instability
ENSG00000138347,MYPN,cell adhesion disruption,oncogenic driver,pi3k/akt signaling,poor prognosis biomarker,sarcomere structure regulation,tumor progression enhancer
ENSG00000064651,SLC12A2,oncogene overexpression,cell migration and invasion enhancement,pi3k/akt pathway interaction,chloride ion transporter function,cell proliferation promotion,ion balance regulation
ENSG00000056050,HPF1,genomic instability,fanconi anemia pathway,dna repair dysregulation,tumor progression driver,cancer genomic alterations,alternative dna repair pathway
ENSG00000011332,DPF1,ar signaling,coactivator function,transcriptional regulation,cell proliferation,metastasis,oncogene activation
ENSG00000110195,FOLR1,folate receptor overexpression,cell proliferation regulation,tumor growth promotion,poor prognosis association,metastasis facilitation,signaling pathway activation
ENSG00000162174,ASRGL1,glycosylation regulation,cell adhesion modulation,metastatic capacity enhancement,apoptosis evasion,tumor progression driver,therapeutic target
ENSG00000197121,PGAP1,pi3k/akt pathway activation,tumor progression,cell survival promotion,metastasis facilitation,protein glycosylation regulation,er-golgi apparatus interaction
ENSG00000138231,DBR1,genome instability,regulation of gene expression,ribosome biogenesis,chromatin remodeling,rna processing,transcriptional control
ENSG00000154438,ASZ1,histone methyltransferase activity,epigenetic regulation,oncogenic potential,chromatin remodeling,bivalent domain enrichment,gene silencing
ENSG00000111727,HCFC2,cell cycle regulation,transcriptional coactivator function,tumor progression association,oncogenic protein interaction,prognostic marker significance,cell proliferation promotion
ENSG00000196139,AKR1C3,steroid metabolism,hormone conversion,tumor progression,androgen receptor regulation,emt modulation,chemoresistance
ENSG00000164897,TMUB1,tumor progression,growth factor receptor internalization,receptor localization regulation,cell surface receptor trafficking,cancer aggressiveness,prognostic biomarker
ENSG00000143436,MRPL9,mitochondrial translation regulation,cancer prognosis,protein synthesis modulation,tumor progression,ribosomal biogenesis,oncomarker potential
ENSG00000107951,MTPAP,aberrant expression,disrupted transcriptional control,enhanced cell growth,genomic instability,oncogenic potential,potential therapeutic target
ENSG00000162923,WDR26,g2/m checkpoint regulation,tumor suppressor function,cell cycle control,dna repair mechanism,apoptosis modulation,genome instability
ENSG00000167600,CYP2S1,oxidative stress,apoptosis regulation,cell growth promotion,metabolic regulation,ros generation,tumor progression
ENSG00000138207,RBP4,lipid metabolism regulation,tumor progression,cell proliferation,energy metabolism modulation,ancillary protein interaction,biomarker for diagnosis and prognosis
ENSG00000153815,CMIP,transcriptional regulation,cell proliferation promotion,tumor progression facilitation,poor prognosis association,corepressor/coactivator function,steroid hormone receptor interaction
ENSG00000040275,SPDL1,cell cycle regulation,genomic stability,aneuploidy prevention,dna damage response,tumor suppressor function,chromosomal instability
,FAM129A,chromatin regulation,cell cycle regulation,dna repair interaction,oncogene function,genomic instability,protein-protein interaction
ENSG00000151500,THYN1,epithelial-to-mesenchymal transition (emt),transcription factor activity,wnt/β-catenin pathway modulation,tumor metastasis,cellular differentiation regulation,cancer progression driver
ENSG00000086619,ERO1B,protein folding regulation,cell proliferation enhancement,signaling pathway modulation,epithelial-to-mesenchymal transition (emt) activation,overexpression in tumors,anti-cancer therapeutic target
ENSG00000198838,RYR3,calcium release channel,intracellular calcium regulation,cell proliferation and survival,therapeutic target,cancer progression and metastasis,genomic instability
ENSG00000086300,SNX10,**
endosomal recycling,cell proliferation,oncogene overexpression,pi3k/akt pathway regulation,microrna regulation,tumor aggressiveness
**
ENSG00000121797,CCRL2,chemokine regulation,immune response modulation,tumor growth promotion,metastasis facilitation,poor prognosis association,prognostic marker potential
ENSG00000285426,RNF187,p53 regulation,ubiquitination and proteasomal degradation,oncogene potential,emt regulation,cell cycle progression disruption,chromatin remodeling interaction
ENSG00000168491,CCDC110,genomic instability,microtubule dynamics,apoptosis inhibition,centrosome disruption,prognostic biomarker,tumor progression
ENSG00000166411,IDH3A,oxidative decarboxylation,gain of function mutation,epigenetic regulation,metabolic reprogramming,tumor progression,therapeutic target
ENSG00000108602,ALDH3A1,aldehyde detoxification,cellular homeostasis,oxidative stress,prognostic biomarker,tumor recurrence,cancer aggressiveness
ENSG00000197971,MBP,pi3k/akt pathway,overexpression,cell proliferation,survival and migration,angiogenesis,protein interaction
ENSG00000141741,MIEN1,genomic instability,chromatin remodeling,oncogenic protein,tumor progression,cell cycle regulation,genetic predisposition
ENSG00000213020,ZNF611,transcription regulation,cell growth modulation,apoptosis inhibition,cell differentiation regulation,oncogene potential,gene expression regulation
ENSG00000186472,PCLO,calcium-dependent signaling,cell migration,pi3k/akt pathway,cell proliferation,tumor progression,oncogene activation
ENSG00000140612,SEC11A,protein degradation regulation,ubiquitin-proteasome pathway,tumorigenesis contribution,oncogenic signaling modulation,cellular process regulation,genomic instability
ENSG00000155659,VSIG4,nf-κb pathway inhibition,tumor suppressor function,immune response regulation,cell proliferation inhibition,apoptosis promotion,angiogenesis suppression
ENSG00000102962,CCL22,immune suppression,tumor metastasis,chemokine signaling,stat3 activation,cell migration,receptor interaction
ENSG00000102805,CLN5,lipid metabolism disruption,tumor progression,cancer cell survival,cell proliferation regulation,oncogenic signaling interaction,genomic instability
ENSG00000198734,F5,**
coagulation pathway disruption,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,tumor aggressiveness marker,protein-protein interaction
ENSG00000136100,VPS36,cellular trafficking,mutant protein accumulation,endosomal dysfunction,tumor growth,protein interactions,genetic mutations
ENSG00000135334,AKIRIN2,oncogene activation,tumor progression,cell cycle regulation,apoptosis inhibition,protein-protein interactions,epigenetic reprogramming
ENSG00000085514,PILRA,immune recognition,inhibitory signaling,tumor immune evasion,cellular regulation,signal transduction,mhc class i binding
ENSG00000179163,FUCA1,oncogenic transformation,epithelial-to-mesenchymal transition (emt),cell surface glycosylation,wnt/β-catenin pathway activation,pi3k/akt pathway activation,metastatic potential enhancement
ENSG00000145832,SLC25A48,**

mitochondrial solute carrier,coenzyme q transport,cellular metabolism regulation,tumor growth promotion,metabolic reprogramming,constitutive activation

**
ENSG00000143578,CREB3L4,endoplasmic reticulum stress response,transcriptional regulation,cellular proliferation,protein folding disorders,metabolic adaptation,chaperone-mediated protein degradation
ENSG00000141026,MED9,transcription regulation,oncogenic function,tumor progression,metastasis enhancement,cell cycle regulation,apoptosis inhibition
ENSG00000119596,YLPM1,cell adhesion regulation,cytoplasmic localization,epithelial-to-mesenchymal transition,oncogenic properties,tumor cell migration,cytoskeletal association
ENSG00000078177,N4BP2,transcriptional regulation,oncogenesis promotion,cell growth modulation,protein ubiquitination interaction,nuclear localization,genetic instability enhancement
ENSG00000181458,TMEM45A,ion transport regulation,transmembrane protein function,calcium signaling pathway,tumor progression marker,cell cycle modulation,potential therapeutic target
ENSG00000105953,OGDH,metabolic regulation,overexpression,glycolysis,tumor aggressiveness,diagnostic marker,therapeutic target
ENSG00000142669,SH3BGRL3,gain of function mutations,oncogenic driver,cell proliferation,metastasis promotion,epithelial-to-mesenchymal transition (emt),protein-protein interaction
ENSG00000090470,PDCD7,apoptosis regulation,pro-apoptotic activity,cell cycle progression,transcriptional regulation,dna repair,oncogenesis driver
ENSG00000125869,LAMP5,cell adhesion regulation,tumor progression facilitation,immune response modulation,plasma membrane localization,endosomal compartment interaction,cancer cell invasion enhancement
ENSG00000112039,FANCE,genomic stability,possible tumour suppressor,chromosomal instability,dna crosslink repair,cell cycle regulation,apoptosis modulation
ENSG00000251192,ZNF674,oncogenic regulation,transcription factor function,cell differentiation regulation,tumor suppressor dysregulation,genomic instability induction,epigenetic modification interaction
ENSG00000110717,NDUFS8,mitochondrial dysfunction,glycolytic reprogramming,energy metabolism regulation,tumor cell survival,oncometabolite formation,electron transport chain inhibition
ENSG00000120253,NUP43,nucleus-cytoplasm transport regulation,oncogenic overexpression,cell proliferation enhancement,metastasis promotion,chromatin remodeling involvement,poor prognosis association
ENSG00000104626,ERI1,ribosome biogenesis disruption,tumor aggressiveness promoter,cell proliferation enhancer,protein synthesis dysregulation,mutational hotspot,genomic instability mediator
ENSG00000177548,RABEP2,rab gtpase regulation,cell migration facilitation,egf receptor interaction,pi3k/akt pathway activation,protein trafficking dysregulation,tumor metastasis promotion
ENSG00000152464,RPP38,genomic instability,cell growth regulation,tumor suppressor interaction,dna replication disruption,oncogene activation,p53 pathway disruption
ENSG00000089163,SIRT4,mitochondrial dynamics,glutamine metabolism,tumor suppressor function,cellular metabolism regulation,dysregulated expression,apoptosis induction
ENSG00000077044,DGKD,pkc activation,lipid metabolism regulation,tumor progression,oncogene overexpression,gene expression modulation,prognostic biomarker
ENSG00000174871,CNIH2,oncogenic signaling pathway,tumor progression,cell growth regulation,protein kinase modulation,auxiliary subunit function,therapeutic target potential
ENSG00000203880,PCMTD2,protein modification,tumor suppressor,cell proliferation,signaling pathway regulation,oncogenic process,post-translational modification
ENSG00000165879,FRAT1,wnt signaling pathway,oncogenic process,tumor progression,cell proliferation,metastasis,therapeutic target
ENSG00000188283,ZNF383,oncogene activation,mutation hotspot,transcriptional regulation,gene expression modulation,apoptosis evasion,cell cycle progression
ENSG00000135373,EHF,oncogene,transcription factor activity,cell cycle progression,dna repair mechanism,tumor growth promotion,poor prognosis marker
ENSG00000104835,SARS2,cancer biology modulation,immune system interaction,inflammation induction,cellular stress response,host-virus interaction,genomic instability
ENSG00000157911,PEX10,cellular lipid metabolism,peroxisomal function regulation,fatty acid degradation,lipid signaling pathways,adhesion protein interactions,tumor suppressor gene expression
ENSG00000105464,GRIN2D,nmda receptor activation,cell proliferation,signaling pathway modulation,oncogenic driver,biomarker potential,epithelial-to-mesenchymal transition
ENSG00000255072,PIGY,oncogene,tumor progression,disrupted cell signaling,aberrant protein modifications,immune evasion mechanisms,genomic driver gene
ENSG00000164023,SGMS2,sphingolipid metabolism,cell membrane structure,protein interaction,cancer progression,metastasis promotion,cell signaling regulation
ENSG00000249158,PCDHA11,protocadherin function,cell adhesion regulation,tumor progression,metastasis facilitation,gene expression modulation,cancer development association
ENSG00000116748,AMPD1,energy metabolism regulation,cellular proliferation,oncogenic processes,tumor progression,adenylate kinase activity,nucleotide balance
ENSG00000133805,AMPD3,metabolic rewiring,oncogene function,glycolysis promotion,lactate production,purine metabolism dysregulation,therapeutic target candidate
ENSG00000240344,PPIL3,protein folding regulation,tumor progression driver,mutation hotspot,cell cycle control modulation,apoptosis evasion,protein stability regulation
ENSG00000124839,RAB17,cell proliferation,apoptosis regulation,cytoskeleton dynamics,tumor progression marker,cell cycle modulation,microtubule regulation
,KIAA1324,mitotic spindle checkpoint,chromatin remodeling,genomic instability,cell cycle regulation,protein-protein interactions,mitosis-related protein regulation
ENSG00000197763,TXNRD3,thioredoxin reductase activity,mitochondrial function,oxidative stress regulation,tumor progression,dna repair facilitation,apoptosis inhibition
ENSG00000157103,SLC6A1,glutamine transport,metabolic regulation,cell survival,tumor growth promotion,aggressive disease characteristics,poor prognosis indicator
ENSG00000156467,UQCRB,mitochondrial electron transport chain,oxidative phosphorylation,cellular energy production,electron transfer complex,cancer progression,therapeutic target
ENSG00000148123,PLPPR1,mitochondrial function regulation,tumor progression,cell proliferation,metabolic regulation,protein interaction,genomic alteration
ENSG00000257017,HP,histone modification,epigenetic regulation,tumor suppressor activity,oncogene regulation,cell cycle progression,therapeutic target
ENSG00000072571,HMMR,hyaluronan interaction,oncogenic signaling,metastasis promoter,tumor progression,epithelial-to-mesenchymal transition,cancer stem cell regulation
ENSG00000275499,ZNF280A,tumor progression,oncogene,transcriptional regulation,gene expression modulation,cell cycle dysregulation,proliferation enhancement
ENSG00000132481,TRIM47,trim47 involvement,tumor suppressor function,cell cycle regulation,apoptosis modulation,oncogenic transcription factor inhibition,aberrant protein degradation
ENSG00000105664,COMP,ecm remodeling,tumor progression,metastasis promotion,biomarker expression,emt regulation,poor prognosis marker
ENSG00000151388,ADAMTS12,angiogenesis inhibition,extracellular matrix remodeling,tumor suppression,vascularization promotion,poor prognosis correlation,therapeutic target
ENSG00000263247,PRR4,autophagy regulation,immune evasion,inflammatory pathway modulation,tumor growth promotion,cell survival enhancement,cancer immunotherapy resistance
ENSG00000196535,MYO18A,microtubule dynamics,epithelial-to-mesenchymal transition (emt),actin cytoskeleton regulation,cell migration and invasion,prognostic marker,therapeutic target
ENSG00000103375,AQP8,aquaporin function,cell migration,tumor progression,epithelial-to-mesenchymal transition (emt),microenvironment regulation,pro-inflammatory cytokines expression
ENSG00000183914,DNAH2,cell migration,oncogenic process,axoneme structure,ciliary motility,overexpression,protein regulation
ENSG00000267534,S1PR2,sphingosine-1-phosphate signaling pathway,g-protein coupled receptor function,oncogenic driver,tumor progression,therapeutic target,chemoresistance
ENSG00000164120,HPGD,metabolic reprogramming,oxphos inhibition,glycolysis upregulation,therapeutic target,resistance to chemotherapy,enzyme-catalyzed reaction
ENSG00000011258,MBTD1,genomic instability,chromatin regulation,dna repair mechanisms,tumor growth promotion,cell cycle progression alteration,oncogenic transformation facilitation
ENSG00000130827,PLXNA3,tumor progression,cell migration,epithelial-to-mesenchymal transition,signaling pathway activation,cancer stem cell maintenance,protein-protein interaction
ENSG00000189079,ARID2,chromatin remodeling,tumor suppressor function,gene expression regulation,cell proliferation control,genome stability maintenance,oncomodule disruption
ENSG00000274429,DLG5,tumor suppressor activity,cell-cell adhesion regulation,pi3k/akt pathway modulation,cancer progression inhibition,epithelial integrity maintenance,metastasis suppression
ENSG00000109689,STIM2,calcium channel regulation,intracellular calcium signaling,oncogenesis,cell proliferation,apoptosis evasion,biomarker expression
ENSG00000100350,FOXRED2,mitochondrial dysfunction,energy metabolism dysregulation,tumor suppressor role,cellular respiration disruption,glycolysis enhancement,glucose uptake increase
ENSG00000103199,ZNF500,krab domain-containing protein,gene overexpression,cell cycle progression,apoptosis regulation,tumorigenesis association,therapeutic target candidate
ENSG00000074410,CA12,cell surface adhesion regulation,ph homeostasis,tumor progression,cell migration facilitation,cancer cell detachment,molecular interaction
,YARS,tyrosyl-trna synthetase overexpression,elevated tyrosine levels,cellular proliferation,resistance to apoptosis,gene expression changes,protein synthesis alteration
ENSG00000175003,SLC22A1,nucleoside transport,chemotherapy resistance,drug accumulation,cellular homeostasis,prognosis marker,oncogene activity
ENSG00000163586,FABP1,fatty acid transport,cell proliferation,tumor progression,lipid metabolism regulation,prognostic marker,therapeutic target
ENSG00000278195,SSTR3,tumor suppressor function,cell signaling inhibition,apoptosis induction,growth regulation modulation,somatostatin analog binding,pro-inflammatory cytokine release inhibition
ENSG00000111666,CHPT1,lipid metabolism,cell proliferation,phospholipid biosynthesis,oncogenic process,downstream signaling pathways,therapeutic target
ENSG00000062650,WAPL,wnt/β-catenin pathway regulation,dysregulation,chromatin remodeling,epithelial-to-mesenchymal transition (emt),cohesin complex interaction,tumor progression
ENSG00000114670,NEK11,cell cycle regulation,dna damage response,oncogene activation,genomic instability,protein kinase activity,tumor progression
ENSG00000125482,TTF1,thyroid transcription factor,oncogenic driver,epithelial-to-mesenchymal transition,cell proliferation regulator,metastatic gene signature,therapy-resistant gene
ENSG00000176422,SPRYD4,hippo signaling pathway,constitutive activation,loss of function mutations,tumor progression,apoptosis regulation,cell proliferation
ENSG00000117594,HSD11B1,metabolic reprogramming,tumor progression,promotes cell growth,regulatory mechanism alteration,interacts with signaling pathways,steroid hormone regulation
ENSG00000214367,HAUS3,cell cycle dysregulation,genomic instability,oncogene function,tumor progression,proliferation regulation,checkpoint disruption
ENSG00000111335,OAS2,antiviral response,interferon induction,rnase l activation,viral rna degradation,tumor growth promotion,oncogenic process
ENSG00000197472,ZNF695,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,oncogenic amplification,cell invasion promotion,poor prognostic marker
ENSG00000102893,PHKB,glycogen breakdown regulation,tumor growth promotion,cellular response modulation,protein-lipid synthesis enhancement,metabolic pathway dysregulation,therapeutic target
ENSG00000149499,EML3,cell membrane modification,elongation of vlcfas,hippo-yap/taz pathway regulation,cell growth promotion,apoptosis suppression,tumorigenesis
ENSG00000134013,LOXL2,ecm remodeling,tumor progression,cell invasion,angiogenesis,oncogene,protein interaction
ENSG00000175130,MARCKSL1,plc regulation,cell membrane dynamics,actin cytoskeleton reorganization,oncogenic signaling,rho-associated protein kinase 1 interaction,elevated expression levels
ENSG00000188295,ZNF669,transcriptional regulation,epigenetic modulation,oncogene,cell cycle progression,apoptosis suppression,chromatin remodeling
ENSG00000054219,LY75,tumor suppressor function,immunosuppression,cell adhesion regulation,poor prognosis marker,immune evasion mechanism,cancer progression regulator
ENSG00000135899,SP110,cellular proliferation,transcriptional regulation,chromatin modification,cell survival signaling,tumor biomarker,genetic instability
ENSG00000076043,REXO2,mirna regulation,increased stability,altered gene expression,cell proliferation,tumor progression,oncogenic potential
ENSG00000170166,HOXD4,transcriptional regulation,cell proliferation,tissue patterning,embryonic development,apoptosis dysregulation,genomic instability
ENSG00000084070,SMAP2,**
mitochondrial dynamics,cell survival,oncogenesis,autophagy induction,oxidative stress response,cellular metabolism regulation
**
ENSG00000129911,KLF16,transcriptional regulation,tumor suppressor function,cell cycle progression,apoptosis modulation,genomic instability,oncogenic signaling inhibition
ENSG00000157827,FMNL2,cell migration,actin cytoskeleton regulation,overexpression,cell invasion,pi3k/akt pathway interaction,mitotic progression
ENSG00000130055,GDPD2,redox homeostasis,cellular metabolism,energy production,growth promotion,apoptosis inhibition,biomarker potential
ENSG00000131368,MRPS25,tumor suppressor loss,aberrant protein accumulation,mitochondrial dysfunction,cell cycle progression,protein synthesis regulation,gene expression alteration
ENSG00000173786,CNP,cellular differentiation,epithelial-to-mesenchymal transition,suppressed immunity,tumor progression,secretory protein function,cell proliferation regulation
ENSG00000179958,DCTPP1,dna damage response,genomic instability,base excision repair pathway,apurinic/apyrimidinic site recognition,genetic mutations,altered protein function
ENSG00000172426,RSPH9,centriole integrity disruption,genomic instability induction,cell cycle dysregulation,microtubule stability modulation,prognostic biomarker association,cancer development promotion
ENSG00000085491,SLC25A24,mitochondrial carrier protein,succinate transport,glycolytic adaptation,energy metabolism regulation,metabolic reprogramming,oncogenic potential
ENSG00000115526,CHST10,gag modification,tumor progression marker,cellular interaction regulation,extracellular matrix component modification,oncogenic potential,cancer cell growth promotion
ENSG00000197863,ZNF790,transcriptional regulation,tumor suppression,cell cycle regulation,apoptosis modulation,dna binding,proteolytic processing
ENSG00000136842,TMOD1,microtubule dynamics regulation,genomic stability maintenance,cell division process,tumorigenesis promotion,cancer progression driver,cell cycle regulation
ENSG00000174373,RALGAPA1,oncogenic signaling pathway,guanine nucleotide exchange factor,ras-related gtpase activation,cell proliferation,tumorigenesis,cellular transformation
ENSG00000108001,EBF3,cell cycle regulation,dysregulation,oncogene,apoptosis inhibition,proliferation promotion,transcriptional regulation
ENSG00000119927,GPAM,cell membrane synthesis,upregulated expression,tumor growth,enhanced lipid metabolism,fatty acid incorporation,lipid biosynthesis pathway
ENSG00000188215,DCUN1D3,cancer driver,dna repair regulation,cell cycle progression,genomic instability,oncogene activation,zinc finger domain
ENSG00000163666,HESX1,cell growth regulation,dysregulation of cell cycle,notch signaling pathway,tumor progression,transcriptional repression,anti-apoptotic effects
ENSG00000137574,TGS1,aberrant splicing,tumor suppressor regulation,oncogene activation,cell proliferation modulation,apoptosis inhibition,therapeutic target
ENSG00000115419,GLS,glutamine metabolism,oncogenic transformation,poor prognosis,metabolic regulation,therapeutic target,tumor progression
ENSG00000115461,IGFBP5,cell proliferation,apoptosis inhibition,angiogenesis promotion,epithelial-to-mesenchymal transition regulation,oncogenic properties,tumor progression enhancement
ENSG00000166863,TAC3,tachykinin signaling pathway,angiogenesis promotion,cell proliferation enhancement,inflammation regulation,metastasis facilitation,therapeutic target identification
ENSG00000171603,CLSTN1,cell adhesion,cytoplasmic dynamics,metastasis promotion,tumor progression,collagen interaction,biomarker for cancer
ENSG00000123364,HOXC13,transcription factor activity,oncogenic function,cell proliferation,epithelial-to-mesenchymal transition,chemoresistance,tumor progression
ENSG00000137845,ADAM10,overexpression,metastasis,ectodomain shedding,angiogenesis,cell migration,soluble growth factors
ENSG00000170043,TRAPPC1,cilia formation,cell signaling disruption,oncogenic driver mutation,tumor progression regulator,protein-protein interaction,cancer cell migration promoter
ENSG00000165322,ARHGAP12,loss of function mutations,tumor suppressor activity,rho gtpase regulation,cytoskeletal dynamics disruption,epithelial-to-mesenchymal transition (emt),hippo signaling pathway dysregulation
ENSG00000132825,PPP1R3D,regulatory subunit,oncogenic processes,cell metabolism regulation,transcription factor activation,glycolysis promotion,metabolic reprogramming
ENSG00000184117,NIPSNAP1,cell membrane dynamics,cytoplasmic protein localization,oncogene amplification,cell signaling regulation,cancer cell survival,tumorigenesis promotion
ENSG00000179934,CCR8,immune suppression,cell migration,chemokine binding,prognostic marker,tumor progression,microenvironment modulation
ENSG00000133055,MYBPH,cellular migration,tumor progression,protein kinase activation,cytoplasmic remodeling,cell adhesion disruption,oncogene upregulation
ENSG00000073060,SCARB1,lipid droplet formation,tumor microenvironment modulation,oncogene activation,cell proliferation enhancement,pi3k/akt pathway interaction,cholesterol uptake regulation
ENSG00000172322,CLEC12A,characteristic words <end>**

<begin>tumor microenvironment,immune evasion,pamp recognition,immunosuppression modulation,molecular interaction,t-cell regulation
ENSG00000108506,INTS2,histone modification,genomic stability,rna splicing,cellular proliferation,tumorigenesis,dysregulated expression
ENSG00000132326,PER2,circadian clock regulation,dysregulated expression,tumor progression,apoptosis regulation,cell cycle disruption,mutation association
ENSG00000152527,PLEKHH2,mitotic spindle assembly,genomic instability,oncogenesis,tumor progression,cell cycle regulation,biomarker potential
ENSG00000157796,WDR19,genomic instability,chromosomal alterations,dna repair defects,cell cycle dysregulation,cancer predisposition,gain of function mutations
ENSG00000125841,NRSN2,pi3k/akt pathway modulation,cell proliferation promotion,tumor progression facilitation,cell adhesion regulation,poor prognosis marker,wnt/β-catenin pathway interaction
ENSG00000150471,ADGRL3,cell adhesion disruption,gene amplification,oncogenic signaling pathway,tumor progression,metastasis driver,genomic instability
ENSG00000204323,SMIM5,genetic instability,apoptosis regulation,cell cycle control,oncogene promoter,chromosomal instability,pi3k/akt/mtor pathway
ENSG00000170293,CMTM8,tumor progression,mutation impact,protein-protein interaction,immune evasion,cell adhesion modulation,tumor metastasis
ENSG00000079689,SCGN,oncogenic protein,tumor progression,cell cycle regulation,protein-protein interaction,cancer aggressiveness,cell proliferation
ENSG00000068878,PSME4,immunoproteasome assembly,cell cycle regulation,oncogene expression,apoptosis inhibition,tumor progression,protein degradation
ENSG00000137273,FOXF2,oncogene activation,cell proliferation regulation,transcription factor binding,metastasis promotion,poor prognosis indicator,tumor growth enhancement
ENSG00000215790,SLC35E2A,nucleotide-sugar transport,glycosaminoglycan synthesis,cell surface integrity,tumor progression,genetic instability,therapeutic resistance
ENSG00000085063,CD59,complement regulation,immune evasion,tumor progression,overexpression,oncogenic signaling,cell proliferation
ENSG00000160808,MYL3,cell cycle regulation,cancer progression,cell proliferation,cytokeletal organization,dna repair mechanisms,genomic amplification
ENSG00000131668,BARX1,tumor suppressor function,cell proliferation regulation,dna repair regulation,wnt/β-catenin pathway interaction,transcriptional repression,epithelial cell differentiation regulation
ENSG00000128709,HOXD9,cell proliferation,oncogenic potential,epithelial-to-mesenchymal transition (emt),transcription factor activation,poor prognosis marker,genomic amplification
ENSG00000186642,PDE2A,pi3k/akt pathway modulation,tumor growth promotion,cell migration enhancement,chemo-resistance association,apoptosis regulation disruption,oncogenic signaling activation
ENSG00000135624,CCT7,protein folding regulation,cellular stress responses,tumor progression,therapeutic target,chaperone function,protein homeostasis maintenance
ENSG00000138613,APH1B,wnt signaling,dna repair,epigenetic regulation,genomic instability,tumor progression,therapeutic target
ENSG00000051009,FAM160A2,autophagy regulation,mitosis regulation,tumor growth promotion,mtor pathway activation,cell cycle progression,poor prognosis marker
ENSG00000283068,IBTK,calcium signaling pathway,mutations leading to increased activity,promotes cell survival and proliferation,serine/threonine kinase,modulates cellular growth and proliferation,loss of function suppresses tumor progression
ENSG00000111817,DSE,**
cell-to-cell adhesion disruption,tumor progression facilitation,oncogenic pathway activation,metastatic potential enhancement,cancer cell detachment promotion,aberrant cellular behavior
ENSG00000170006,TMEM154,cell adhesion dysfunction,increased cell proliferation,tumor progression,overexpression implicated,epithelial integrity disruption,poor prognosis marker
ENSG00000091542,ALKBH5,oncogenic function,epigenetic regulation,cellular proliferation,apoptosis resistance,genome instability,histone modification
ENSG00000035681,NSMAF,transcriptional regulation,nuclear receptor coactivator,cell proliferation,oncogenic process,transcription factor interaction,hormone signaling
ENSG00000122824,NUDT10,genomic instability,8-oxoguanine diphosphatase activity,dna repair regulation,tumor progression,genomic maintenance,cellular senescence
ENSG00000172171,TEFM,tek polypeptide kinase,constitutive activation,phosphorylation regulation,cul4a interaction,tumor suppressor degradation,cell cycle progression
ENSG00000130699,TAF4,tfiid assembly,transcription initiation factor,cell cycle progression,apoptosis inhibition,epigenetic regulation,oncogene interaction
ENSG00000135336,ORC3,chromatin regulation,cell cycle progression,dna replication initiation,genomic instability,transcription factor modulation,prognostic biomarker
ENSG00000128536,CDHR3,overexpression,wnt/β-catenin pathway,cell adhesion disruption,tumor growth promotion,metastasis facilitation,cell signaling alteration
ENSG00000122783,CYREN,cyclin-dependent kinase regulation,cell cycle progression,genomic instability,dna replication,oncogenic transformation,tumor progression
ENSG00000177380,PPFIA3,pi3k/akt pathway,epithelial-to-mesenchymal transition (emt),oncogene overexpression,tumor progression,biomarker expression,protein-protein interactions
ENSG00000184014,DENND5A,cellular trafficking regulation,oncogenic pathway activation,cell growth promotion,metastasis facilitation,microtubule interaction,escrt complex component interaction
ENSG00000108375,RNF43,wnt/β-catenin signaling,constitutive activation,tumor suppressor function,ubiquitin ligase activity,cell proliferation regulation,genetic alterations co-occurrence
ENSG00000120324,PCDHB10,loss of epithelial integrity,cell-cell adhesion disruption,tumor progression facilitation,gene regulation alterations,cell proliferation enhancement,integrin interaction
ENSG00000158786,PLA2G2F,lipid metabolism,pro-inflammatory mediator,oncogenesis,tumor aggressiveness,cellular proliferation,prognostic marker
ENSG00000158747,NBL1,p53 regulation,dna repair pathway disruption,cellular proliferation enhancement,tumor suppressor protein dysregulation,cancer susceptibility increase,genomic instability promotion
ENSG00000169181,GSG1L,chromatin remodeling,transcriptional regulation,oncogenic processes,cancer proliferation,tumor growth,dna repair mechanism
ENSG00000123095,BHLHE41,tumor suppressor function,transcriptional regulation,cell cycle control,apoptosis suppression,oncogenic factor promotion,protein-protein interactions
ENSG00000151229,SLC2A13,glucose transport,glycolytic reprogramming,oncogenic role,chemoresistance,metabolic rewiring,tumorigenesis
ENSG00000123352,SPATS2,cell cycle regulation,oncogenesis,cell growth enhancement,proliferation facilitation,apoptosis suppression,tumor progression
ENSG00000189298,ZKSCAN3,epigenetic regulation,transcriptional repression,dna damage response,cellular proliferation,oncogenic transformation,tumor suppressor activity
ENSG00000111300,NAA25,histone modification,protein acetylation,gene expression regulation,cell growth promotion,tumor progression association,poor prognosis marker
ENSG00000172554,SNTG2,tumor necrosis factor regulation,cellular proliferation inhibition,anti-apoptotic signaling,immune response modulation,cancer progression facilitation,tnf receptor interaction
ENSG00000151364,KCTD14,pi3k/akt pathway modulation,cell proliferation enhancement,tumor progression promotion,poor prognosis association,therapeutic target potential,genomic instability correlation
ENSG00000020577,SAMD4A,apoptosis regulation,cell cycle modulation,dna repair mechanisms,oncogene overexpression,protein-protein interactions,tumor progression enhancement
ENSG00000135968,GCC2,chromatin remodeling,histone modification,wnt/β-catenin signaling pathway,oncogene activation,genomic instability,tumor metastasis
ENSG00000106565,TMEM176B,calcium channel regulation,store-operated calcium entry,oncogenesis,cancer cell proliferation,cell survival regulation,protein-protein interaction
ENSG00000128268,MGAT3,glycosylation regulation,cell signaling modulation,protein-protein interaction enhancement,tumor growth promotion,metastasis facilitation,angiogenesis stimulation
ENSG00000138092,CENPO,genomic instability,chromosomal abnormalities,cell cycle regulation,tumor progression,oncogene expression,dna replication
ENSG00000137266,SLC22A23,altered expression,efflux transporter function,organic anion transport,cancer progression,therapeutic target,genomic instability
ENSG00000101198,NKAIN4,potassium channel regulation,cellular homeostasis,tumor progression,pi3k/akt pathway interaction,biomarker potential,ion balance disruption
ENSG00000105699,LSR,cell membrane lipid regulation,pi3k/akt signaling pathway modulation,dephosphorylation of pip,oncogenic function,tumor progression promotion,cell proliferation enhancement
ENSG00000165416,SUGT1,coactivator function,constitutive activation,cell proliferation,transcriptional regulation,metastasis promotion,poor prognosis marker
ENSG00000157782,CABP1,oncogenic protein regulation,transcriptional modulation,apoptosis suppression,cell cycle progression,genomic instability,chromatin remodeling
ENSG00000100442,FKBP3,protein-protein interactions,cell cycle regulation,tumor suppressor regulation,apoptosis modulation,immune response regulation,genomic instability
ENSG00000152785,BMP3,bmp3 downregulation,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,emt regulation,pi3k/akt/mtor pathway interaction
ENSG00000145248,SLC10A4,bile acid transport,cell proliferation regulation,tumor aggressiveness factor,apoptosis inhibition,metastasis promotion,genetic dysregulation
ENSG00000144354,CDCA7,chromosome segregation,centromere dynamics,genomic stability,kinetochores formation,mitotic checkpoint regulation,cancer predisposition
ENSG00000282854,ASAP3,oncogenic driver,cell migration regulation,adhesion modulation,invasion facilitation,rho gtpase interaction,signaling pathway dysregulation
ENSG00000221838,AP4M1,pi3k/akt pathway modulation,cell proliferation regulation,tumor progression enhancement,gene expression dysregulation,metastasis facilitation,oncogenic signaling enhancement
ENSG00000012983,MAP4K5,jnk/p38 signaling pathway,oncogenic activation,tumor progression,cell proliferation,apoptosis regulation,protein kinase activity
ENSG00000023572,GLRX2,cellular redox balance,oncogenic potential,oxidative stress regulation,tumor progression,apoptosis modulation,protein interaction
ENSG00000074071,MRPS34,mitochondrial biogenesis,enhanced cell proliferation,cellular homeostasis regulation,protein synthesis regulation,mitochondrial dynamics regulation,cancer progression enhancement
ENSG00000143093,STRIP1,histone acetyltransferase activity,chromatin remodeling,genomic instability,dna repair interactions,transcriptional activation,loss-of-function mutations
ENSG00000173517,PEAK1,amplification,overexpression,tumor progression,resistance to chemotherapy,epithelial-to-mesenchymal transition (emt),biomarker
ENSG00000278284,RDH13,apoptosis regulation,cell cycle progression,gene expression modulation,protein interaction,retinoid metabolism,tumor development
ENSG00000181991,MRPS11,mitochondrial translation,oncogenic function,tumor progression,metabolic regulation,energy metabolism,apoptosis inhibition
ENSG00000078814,MYH7B,cell proliferation,tumor growth,apoptosis evasion,amplification,overexpression,metabolic regulation
ENSG00000175309,PHYKPL,pi3k/akt pathway regulation,oncogenic driver,mutations,cell growth and survival modulation,protein phosphatase activity,signaling pathway interaction
ENSG00000198556,ZNF789,tumor suppressor,cell proliferation inhibition,apoptosis promotion,dna-binding activity,gene expression regulation,protein-protein interactions
ENSG00000134253,TRIM45,tumor suppressor function,p53 pathway regulation,cell proliferation inhibition,dna repair regulation,genomic instability prevention,chemoresistance modulation
ENSG00000163528,CHCHD4,mitochondrial regulation,electron transport chain,oxidative stress resistance,tumor aggressiveness,poor prognosis marker,genomic instability
ENSG00000187733,AMY1C,cellular process modulation,elevated expression,cell proliferation,survival pathway interaction,tumor growth influence,enzymatic activity
ENSG00000237763,AMY1A,amylase activity,metabolic regulation,carbohydrate hydrolysis,enzyme interaction,genetic variation influence,altered enzyme activity
ENSG00000174876,AMY1B,insulin resistance,tumor progression,glycemic control,poor prognosis,cell proliferation,apolipoprotein binding
ENSG00000198774,RASSF9,apoptosis inhibition,cell cycle regulation,genomic instability,microtubule stability,mitotic progression regulation,tumor suppressor activity
ENSG00000278091,ZNF85,transcriptional regulation,cellular proliferation,oncogenic potential,tumor suppressor activity,dna binding,cell cycle regulation
ENSG00000187957,DNER,notch signaling pathway,cell proliferation,tumor growth,therapeutic target,protein-protein interaction,cell differentiation
ENSG00000143458,GABPB2,oncogenic transcription factor,transcriptional regulation,cell proliferation regulation,apoptosis modulation,signal transduction pathway,genomic instability
ENSG00000175416,CLTB,clathrin-mediated endocytosis,cell cycle progression,g1/s transition regulation,oncogenic processes modulation,cellular metabolism impact,tumor suppressor protein degradation facilitation
ENSG00000168807,SNTB2,cell adhesion,scaffolding protein function,cytoskeletal organization,cell migration,pi3k/akt pathway interaction,therapeutic target
ENSG00000142687,KIAA0319L,tumor aggressiveness,regulation of transcription,zinc finger motif,cell growth regulation,krab domain interaction,dna binding protein
ENSG00000101019,UQCC1,mitochondrial dysfunction,oncogenic mutations,altered energy metabolism,increased ros production,poor prognosis,therapeutic target
ENSG00000177551,NHLH2,transcription factor regulation,gene overexpression,mutation-driven oncogenesis,aberrant pi3k/akt signaling,wnt/β-catenin pathway activation,cell cycle dysregulation
ENSG00000175548,ALG10B,oligosaccharyltransferase complex,cell growth regulation,pi3k/akt pathway modulation,n-glycan modification,tumor progression,signaling pathway disruption
ENSG00000112319,EYA4,**

transcriptional regulation,cell development,overexpression,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance,wnt/β-catenin signaling pathway
**
ENSG00000142330,CAPN10,cellular proliferation,protein degradation,regulation of apoptosis,dna damage response,tumor progression,biomarker identification
ENSG00000265354,TIMM23,mitochondrial function regulation,cell growth modulation,protein-protein interactions,stress response regulation,oncogenesis association,mitochondrial integrity maintenance
ENSG00000165238,WNK2,ion channel regulation,cell proliferation promotion,kinase activation,protein-protein interaction,tumor aggressiveness factor,cancer signaling pathway involvement
ENSG00000183715,OPCML,wnt/β-catenin signaling pathway,cell adhesion disruption,apoptosis resistance,genomic instability,tumor suppressor function,epithelial-to-mesenchymal transition
ENSG00000243156,MICAL3,aberrant microtubule dynamics,cellular signaling pathways,gain of function mutations,oncogenic processes,tumor progression,therapeutic target
ENSG00000050393,MCUR1,calcium signaling,tumor overexpression,mitochondrial regulation,cell proliferation,apoptosis inhibition,poor prognosis
ENSG00000076356,PLXNA2,semaphorin receptor function,adhesion molecule expression,cell migration regulation,metastasis promotion,tumor suppressor inactivation,pi3k/akt signaling activation
ENSG00000179604,CDC42EP4,rho gtpase activation,cell migration and invasion,oncogenic signaling pathway,tumor progression marker,prognostic indicator,cancer cell proliferation
ENSG00000275003,DDT,dna damage response,protein localization,chromatin remodeling,cell cycle regulation,genomic stability maintenance,nuclear trafficking
ENSG00000118526,TCF21,tumor suppressor,cell cycle regulation,apoptosis modulation,transcriptional regulation,cyclin-dependent kinase inhibition,genomic loss of heterozygosity
ENSG00000136718,IMP4,inositol regulation,cell growth regulation,metabolic pathway modulation,cell survival enhancement,protein kinase activation,phosphatase activity
ENSG00000122741,DCAF10,cul4b complex interaction,dna repair regulation,cell cycle progression,oncogenic function,tumor suppressor degradation,chromatin remodeling
ENSG00000184992,BRI3BP,pi3k/akt signaling,tumor suppression regulation,growth factor receptor regulation,metabolic regulation,akt/mtor pathway activation,cancer driver gene
ENSG00000171227,TMEM37,er homeostasis,calcium signaling,tumorigenesis,overexpression,oncogenic pathways,protein-protein interaction
ENSG00000243056,EIF4EBP3,mtor pathway,constitutive activation,oncogene function,apoptosis suppression,translation regulation,therapeutic target
ENSG00000288324,ADGRL1,tumor progression,enhanced cell migration,pi3k/akt pathway interaction,overexpression associated with poor prognosis,epithelial-to-mesenchymal transition (emt) promotion,cell adhesion modulation
ENSG00000115361,ACADL,fatty acid beta-oxidation,energy metabolism,mitochondrial localization,oncogenic adaptation,therapeutic target,biomarker potential
ENSG00000141577,CEP131,cell cycle regulation,genomic instability,chromosome segregation,aneuploidy prevention,tumor suppressor function,protein-protein interaction
ENSG00000021574,SPAST,microtubule regulation,axonal integrity maintenance,genetic mutations,cell proliferation enhancement,metastasis promotion,protein stability regulation
ENSG00000233801,NELFE,nuclear rna export,overexpression,cell proliferation,mrna transport,tumor progression,oncogene regulation
ENSG00000116791,CRYZ,altered expression,prognostic marker,crystallin function,misfolding regulation,tumor progression marker,cellular stability disruption
ENSG00000076067,RBMS2,rna regulation,protein-protein interactions,gene expression modulation,tumor suppressor function,rna splicing influence,cancer association
ENSG00000116990,MYCL,amplification,apoptosis evasion,cell cycle progression,constitutive activation,gene amplification,transcription factor activity
ENSG00000171747,LGALS4,cell proliferation regulation,tumor progression,apoptosis inhibition,immune evasion,epigenetic modification influence,signaling pathway modulation
ENSG00000118972,FGF23,hyperphosphatemia,phosphate metabolism regulation,tumor progression enhancement,oncogene activation,cell growth promotion,angiogenesis stimulation
ENSG00000169860,P2RY1,purinergic signaling,oncogenic signaling,prognostic biomarker,therapeutic target,cell proliferation,cell migration
ENSG00000181830,SLC35C1,gag biosynthesis regulation,histone modification influence,chromatin remodeling involvement,tumor suppressor gene modulation,oncogene expression regulation,metastatic potential enhancement
ENSG00000103642,LACTB,microtubule dynamics,cell division regulation,oncogenic processes,chemoresistance,tumor progression,cellular proliferation
ENSG00000182916,TCEAL7,oncogenic activation,tumor progression,cell growth regulation,transcriptional modulation,cell proliferation promotion,poor prognosis marker
ENSG00000135222,CSN2,cop9 signalosome complex,protein degradation regulation,ubiquitin-proteasome pathway,cell cycle progression regulation,therapeutic target candidate,genetic instability mediator
ENSG00000185697,MYBL1,cell cycle progression,transcriptional regulation,oncogene activation,tumor aggressiveness,genomic instability,apoptosis inhibition
ENSG00000152592,DMP1,transcription factor activation,cell proliferation enhancement,metastasis promotion,prognostic marker,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition
ENSG00000196110,ZNF699,chromatin remodeling,dna binding activity,gene expression modulation,oncogene upregulation,tumor progression driver,transcription factor interaction
ENSG00000174938,SEZ6L2,cell cycle regulation,transcriptional regulation,ubiquitination,protein-protein interactions,tumor suppressor inhibition,genomic instability
ENSG00000135114,OASL,tumor suppression,immune response modulation,apoptosis induction,proliferation inhibition,viral rna degradation,cell cycle regulation
ENSG00000135298,ADGRB3,gain of function mutations,cell-cell interactions,protein kinase activation,tumor progression,extracellular molecule binding,intracellular signal transduction
ENSG00000262473,GART,purine biosynthesis,cell proliferation,tumor progression,nucleotide metabolism,dna replication,genetic instability
ENSG00000258992,TSPY1,genomic instability,cell proliferation,oncogenic potential,tumor progression,dna repair regulation,apoptosis suppression
ENSG00000108523,RNF167,apc/c regulation,cell cycle control,protein degradation,ring-type ubiquitin ligase,tumor suppression,ubiquitination pathway
ENSG00000188910,GJB3,tumor progression,intercellular communication disruption,cellular adhesion loss,oncogenic process contribution,metabolic regulation alteration,protein expression alteration
ENSG00000284501,MGAT4B,glycoprotein modification,cell-cell interactions,signaling pathway activation,tumor progression,cancer stem cell maintenance,epithelial-to-mesenchymal transition
ENSG00000119977,TCTN3,primary cilia assembly,gain of function mutations,disrupted cell signaling,oncogenic outcomes,aggressive disease progression,tumorigenic potential
ENSG00000164258,NDUFS4,mitochondrial dysfunction,energy metabolism reprogramming,cellular respiration impairment,ros generation enhancement,pro-survival pathway activation,oncogenic driver mutation
ENSG00000153904,DDAH1,nitric oxide metabolism,mtor signaling pathway,competitive inhibition,cellular angiogenesis,therapeutic target,tumor progression
,LRMP,cell adhesion disruption,tumor progression,protein-protein interactions,pi3k/akt pathway modulation,oncogenesis facilitation,metastasis promotion
ENSG00000174013,FBXO45,cell cycle regulation,dna repair modulation,tumor growth influence,protein degradation pathway,therapeutic target potential,genome stability maintenance
ENSG00000159346,ADIPOR1,oncogenic process,tumor progression,cell proliferation,wnt/β-catenin signaling,metabolic regulation,adiponectin signaling
ENSG00000138430,OLA1,mitotic checkpoint regulation,cell cycle progression,genetic instability,tumor aggressiveness,therapeutic target,cell proliferation
ENSG00000134375,TIMM17A,mitochondrial function,genetic mutations,cellular proliferation,energy metabolism,tumor progression,protein interactions
ENSG00000151498,ACAD8,mitochondrial localization,enzymatic function in beta-oxidation,metabolic reprogramming,fatty acid breakdown,cellular energy production,genetic alteration impact on metabolism
ENSG00000183691,NOG,bmp signaling pathway,epithelial-to-mesenchymal transition,tumor suppressor function,cell growth regulation,differentiation control,oncogenesis inhibition
ENSG00000168454,TXNDC2,**
txndc2,cell signaling,gain-of-function mutations,oncogenic driver,oxidative stress regulation,unfolded protein response 
**
ENSG00000186318,BACE1,proteolytic activity,tumor progression,cell proliferation,metastasis,notch signaling pathway,therapeutic target
ENSG00000204967,PCDHA4,cell adhesion disruption,genomic instability association,tumor progression promotion,signaling pathway involvement,protocadherin function alteration,cancer therapeutic target potential
ENSG00000105428,ZNRF4,tumor suppression,receptor tyrosine kinase regulation,cell growth modulation,ubiquitin ligase activity,blca progression,rtk signaling inhibition
ENSG00000188393,CLEC2A,immune recognition,phagocytosis regulation,cell adhesion modulation,tumor progression,oncogenic potential,therapeutic target
ENSG00000130385,BMP15,tgf-β pathway,cell proliferation,smad signaling,immune modulation,cancer progression,dysregulated expression
ENSG00000162599,NFIA,chromatin remodeling,transcriptional regulation,oncogenesis promotion,cell proliferation regulation,apoptosis evasion,therapeutic target
ENSG00000165269,AQP7,tumor progression,potential biomarker,therapeutic target,cell survival pathways,water and solute transport,glucose uptake modulation
ENSG00000262217,SLC5A8,aerobic glycolysis,cellular metabolism regulation,cell proliferation facilitation,epithelial-to-mesenchymal transition (emt) involvement,ion transport regulation,metabolic reprogramming
ENSG00000198822,GRM3,pi3k/akt pathway activation,oncogene,tumor progression,metastasis promotion,g protein coupled receptor function,cellular migration regulation
ENSG00000135116,HRK,apoptosis dysregulation,programmed cell death inhibition,oncogenic role,tumor progression facilitation,cell survival enhancement,pro-apoptotic function reduction
ENSG00000142552,RCN3,cellular growth,calcium-dependent signaling,oncogenic pathway activation,tumor progression,protein-protein interaction,cytoplasmic regulation
ENSG00000278728,CNTNAP2,cntnap2 overexpression,epithelial-to-mesenchymal transition (emt),cell-cell interactions,oncogenic progression,tumor metastasis,pi3k/akt pathway interaction
ENSG00000176230,OR4K17,cellular adhesion,emt program regulation,oncogene potential,protein interaction,signal transduction,tumor progression
ENSG00000197415,VEPH1,cell adhesion regulator,tumor suppressor function,metastasis inhibitor,epithelial integrity maintainer,prognostic marker,cancer predisposition gene
ENSG00000108599,AKAP10,cellular signaling regulation,oncogene activation,cell proliferation enhancement,protein kinase anchoring,tumor progression promotion,dna damage response modulation
ENSG00000125510,OPRL1,opr l1 overexpression,tumor progression,cell proliferation,metastasis,therapeutic target,immune modulation
ENSG00000100014,SPECC1L,adhesion regulation,proliferation promotion,tumor growth facilitation,metastasis enhancement,poor prognosis indicator,none
ENSG00000161914,ZNF653,apoptosis inhibition,cell proliferation regulation,transcriptional regulation,tumor suppression potential,genomic interaction,cell growth modulation
ENSG00000112759,SLC29A1,nucleoside transport,enhanced cell proliferation,overexpression of nucleosides,interacts with pi3k/akt pathway,gene expression is high,tumor progression and metastasis
ENSG00000151617,EDNRA,erk activation,g protein-coupled receptor,cell proliferation,angiogenesis promotion,tumor progression,therapeutic target
ENSG00000141179,PCTP,lipid transport regulation,cellular signaling modulation,transmembrane protein function,tumor progression contribution,oncogenic process involvement,poor prognosis association
ENSG00000072195,SPEG,pka modulation,camkii interaction,serine protease activity,oncogenic signaling,cell proliferation regulation,energy metabolism modulation
ENSG00000099994,SUSD2,cell adhesion disruption,pi3k/akt pathway interaction,tumor suppressor function,cell migration promotion,poor prognosis association,downregulation in cancer
ENSG00000130829,DUSP9,mapk pathway regulation,tumor suppressor function,erk1/2 dephosphorylation,cell proliferation control,oncogenic transformation prevention,ras/mapk signaling modulation
ENSG00000123472,ATPAF1,ribosomal subunit assembly,dna damage bypass,cell proliferation regulation,genomic instability driver,oncogenic protein interaction,cancer cell survival
ENSG00000198093,ZNF649,tumor suppressor function,transcriptional regulation,dna repair mechanisms,cell cycle progression,genomic instability,oncogene activity
ENSG00000145687,SSBP2,genomic instability,rna surveillance,tumor aggressiveness,cell proliferation,chemoresistance,dna damage response
ENSG00000167851,CD300A,angiogenesis promotion,cell surface receptor,immune modulation,metastasis facilitation,oncogenic signaling,tumor progression
ENSG00000148604,RGR,cellular regulation,tumor progression,transcriptional regulation,genomic instability,protein-protein interaction,cancer cell survival
ENSG00000125384,PTGER2,overexpression,cell proliferation,angiogenesis,metastasis,pi3k/akt pathway activation,mapk/erk pathway activation
ENSG00000224051,CPTP,tumor progression,bioactive peptide regulation,cell proliferation,metalloprotease activity,prognostic marker,peptide accumulation
ENSG00000111674,ENO2,metabolic regulation,oncogenic processes,cell proliferation,prognostic marker,therapeutic target,epithelial-to-mesenchymal transition (emt)
ENSG00000163795,ZNF513,oncogenic transcription factor,tumor suppressor interaction,cell proliferation promotion,survival pathways regulation,genomic amplification association,therapeutic target candidacy
ENSG00000137345,MOG,cell proliferation,angiogenesis,metastasis,tumor progression,poor prognosis biomarker,upregulated expression levels
ENSG00000223802,CERS1,sphingolipid biosynthesis,apoptosis evasion,tumor progression,metastasis driver,angiogenesis promotion,dysregulated sphingolipid metabolism
ENSG00000169062,UPF3A,genomic instability,cell growth regulation,dna repair mechanisms,nonsense-mediated mrna decay,oncogenic processes,therapeutic target
ENSG00000124155,PIGT,cell adhesion,glycosphingolipid synthesis,oncogenic processes,cancer driver gene,aggressive tumor behavior,pi3k/akt signaling
ENSG00000171530,TBCA,cell signaling dysregulation,cancer progression driver,ciliogenesis impairment,cell migration regulator,gtpase regulator,protein trafficking dysfunction
ENSG00000135677,GNS,actin cytoskeleton remodeling,akt/pi3k pathway modulation,cell migration and invasion regulation,tumor progression facilitation,cancer cell proliferation enhancement,therapeutic target
ENSG00000117614,SYF2,aberrant splicing patterns,alters cell proliferation and survival pathways,essential for proper rna processing,interacts with transcription factors and chromatin-modifying complexes,mutations lead to altered gene expression,regulates spliceosome assembly
ENSG00000163106,HPGDS,prostaglandin regulation,oncogenic processes,tumor growth,angiogenesis,immune modulation,metastasis
ENSG00000085719,CPNE3,oncogenic driver,cell proliferation regulator,calcium-binding protein function,pi3k/akt/mtor pathway interaction,epithelial-to-mesenchymal transition mediator,chemoresistance enhancement
ENSG00000081248,CACNA1S,calcium channel regulation,oncogenic signaling,cell growth and proliferation,genetic mutation impact,therapeutic target potential,prognostic marker association
ENSG00000176463,SLCO3A1,bilirubin glucuronidation,drug resistance modulation,oxidative stress accumulation,xenobiotic metabolism regulation,cellular transport modification,therapeutic target identification
ENSG00000119203,CPSF3,cleavage and polyadenylation,overexpression,tumorigenesis promoter,cell proliferation inhibitor,poor prognosis indicator,driver of oncogenesis
ENSG00000183166,CALN1,calcium signaling pathway,overexpression,cell proliferation,aggressive disease characteristics,biomarker potential,tumor progression
ENSG00000133020,MYH8,oncogenic driver,cell proliferation enhancement,tumor metastasis promotion,signaling pathway interaction,protein overexpression,genomic mutation hotspot
ENSG00000165060,FXN,mitochondrial dysfunction,cell proliferation regulation,iron-sulfur cluster assembly,apoptosis inhibition,tumor progression facilitation,mitochondrial biogenesis alteration
ENSG00000180543,TSPYL5,tumor suppressor protein interaction,cell growth modulation,resistance to apoptosis,oncogenic processes,therapeutic target,genomic instability
ENSG00000154144,TBRG1,transcriptional regulation,tumor suppressor function,wnt/β-catenin pathway modulation,cell cycle control,mutation-driven oncogenesis,tissue-specific expression
ENSG00000138083,SIX3,oncogenic function,maintenance of cancer stem cells,wnt/β-catenin pathway modulation,pi3k/akt pathway regulation,epithelial-to-mesenchymal transition,cell cycle progression enhancement
ENSG00000075151,EIF4G3,translation initiation,protein synthesis enhancement,tumor progression promotion,cell cycle regulation,cancer cell survival,unfolded protein response activation
ENSG00000135537,AFG1L,mitochondrial fusion,energy metabolism regulation,oxidative stress regulation,tumor suppression candidate,cellular homeostasis maintenance,mitochondrial dynamics regulation
ENSG00000152578,GRIA4,amplification associated,cell proliferation,chemotherapy resistance,downstream effectors modulation,increased migration,overexpression implicated
ENSG00000047230,CTPS2,amplification or overexpression,constitutive activation,cellular metabolism regulation,cell cycle progression,dna repair dysregulation,therapeutic target
ENSG00000104613,INTS10,rna transport regulation,splicing factor activity,cellular transformation,misregulated gene expression,nuclear protein function,tumor progression driver
ENSG00000198203,SULT1C2,altered metabolism,detoxification pathways,metabolic regulation,xenobiotic activation,enzyme expression modulation,hormone regulation
ENSG00000181192,DHTKD1,metabolic reprogramming,cell proliferation,oncogene,tumor progression,energy homeostasis,glutamine metabolism
ENSG00000141519,CCDC40,microtubule stability disruption,centrosomal instability,cell proliferation enhancement,aneuploidy promotion,therapeutic resistance,cellular signaling dysregulation
ENSG00000173068,BNC2,androgen receptor signaling,hormonal regulation,transcriptional modulation,cell cycle progression,apoptosis regulation,prognostic marker
ENSG00000169976,SF3B5,tumor suppressor function,altered splicing patterns,rna processing regulation,cell proliferation promotion,metastasis enhancement,genomic instability
ENSG00000166295,ANAPC16,genetic instability,oncogene activation,dna repair dysfunction,mitotic checkpoint disruption,cell cycle progression regulation,genomic instability
ENSG00000137760,ALKBH8,genome instability,alkylation damage repair,mutation contribution,tumor progression,rna repair,fe(ii)-dependent dioxygenase
,ARSE,wnt/β-catenin pathway,cell cycle progression,gene expression modulation,transcriptional regulation,chromatin remodeling,oncogenic activation
ENSG00000132286,TIMM10B,mitochondrial regulation,dysregulated expression,cell survival promotion,tumor growth initiation,biomarker potential,apoptosis modulation
ENSG00000244187,TMEM141,cellular communication,aberrant protein function,plasma membrane localization,pi3k/akt interaction,genetic mutations,tumor progression
ENSG00000117228,GBP1,tumor microenvironment modulation,cellular signaling regulation,immune response modulation,tumor cell proliferation,angiogenesis promotion,cancer prognosis marker
ENSG00000079931,MOXD1,mitochondrial function,oxidative deamination,cell growth promotion,genomic instability induction,tumor progression facilitation,therapeutic target identification
ENSG00000161791,FMNL3,actin cytoskeleton regulation,cancer cell migration,cell adhesion modulation,cytoplasmic localization,oncogenic function,phosphorylation-dependent regulation
ENSG00000143258,USP21,oncogene activity,deubiquitination function,cell cycle progression,dna damage response,tumor aggressiveness marker,therapeutic target
ENSG00000171723,GPHN,oxidative stress reduction,antioxidant enzyme function,selenoprotein regulation,cellular protection from dna damage,lipid hydroperoxide reduction,oncogenesis modulation
ENSG00000007062,PROM1,cell membrane structure regulation,protein-protein interaction,oncogenic properties,tumor aggressiveness promotion,epithelial-to-mesenchymal transition (emt),cancer cell migration and invasion facilitation
ENSG00000005436,GCFC2,oncogene activation,cell cycle progression,apoptosis resistance,epithelial-to-mesenchymal transition (emt) modulation,gata3 transcriptional regulation,prognostic biomarker status
ENSG00000175591,P2RY2,purinergic signaling,angiogenesis modulation,inflammation regulation,tumor growth promotion,ion channel activity,g-protein coupled receptor
ENSG00000099822,HCN2,cellular excitability,cell membrane depolarization,oncogenic driver,therapeutic target,tumor progression,angiogenesis regulation
ENSG00000146678,IGFBP1,igf-1 signaling inhibition,cell growth regulation,tumor suppressor function,igf-binding activity,cell proliferation inhibition,pi3k/akt pathway modulation
ENSG00000107159,CA9,ph regulation,cell survival,proton exchange,acid-base balance,tumor aggressiveness,biomarker expression
ENSG00000167216,KATNAL2,microtubule dynamics,genomic instability,oncogenesis,cell proliferation,mitotic spindle regulation,apoptosis suppression
ENSG00000164919,COX6C,mitochondrial biogenesis,electron transport chain,metabolic reprogramming,tumor progression,energy metabolism,prognostic marker
ENSG00000137868,STRA6,epithelial barrier function,retinoic acid signaling pathway,tumor progression,metastasis resistance,cell growth regulation,signaling interaction with rbp4
ENSG00000176136,MC5R,cellular signaling pathway modification,g protein-coupled receptor function,metastasis promotion,protein expression alteration,receptor activation,tumor progression
ENSG00000122863,CHST3,tumor growth,constitutive expression,wnt/β-catenin signaling pathway,enhanced cell proliferation,apoptosis resistance,proteoglycan modulation
ENSG00000103121,CMC2,chromatin remodeling,oncogene activation,gain of function mutations,cell cycle regulation,transcriptional activation,biomarker candidate
ENSG00000188620,HMX3,transcriptional regulation,cell cycle regulation,apoptosis evasion,genomic instability,tumor suppressor function,dna-binding activity
ENSG00000168653,NDUFS5,mitochondrial dysfunction,energy metabolism disruption,tumor suppressor,genetic alterations,electron transport chain,cellular homeostasis modulation
ENSG00000130595,TNNT3,muscle contraction regulation,tumor progression association,oncogene overexpression,cell survival enhancement,prognostic marker potential,tissue specificity in cancer
ENSG00000174917,MICOS13,mitochondrial biogenesis,apoptosis resistance,cell survival enhancement,cancer cell metabolism,prognostic marker,therapeutic target
ENSG00000205683,DPF3,cell cycle progression,transcriptional regulation,cell proliferation,oncogenesis,epithelial-to-mesenchymal transition (emt),apoptosis resistance
ENSG00000175606,TMEM70,mitochondrial dysfunction,cellular energy metabolism,transmembrane protein,tumor aggressiveness,poor prognosis,altered metabolic profiles
ENSG00000205981,DNAJC19,cell proliferation,oncogene overexpression,tumor progression,apoptosis regulation,autophagy modulation,cellular chaperone function
ENSG00000087157,PGS1,prostaglandin biosynthesis,tumor progression,immune evasion,metabolic regulation,cell proliferation,prognostic marker
ENSG00000163191,S100A11,calcium-binding protein,cell proliferation,metastasis promotion,protein-protein interaction,tumor progression,biomarker candidate
ENSG00000145022,TCTA,toll-like receptor associated protein,regulation of immune responses,cell signaling pathways modulation,inflammation and cell survival regulation,potential role in tumorigenesis,indirect influence on cancer biology
ENSG00000137842,TMEM62,cell survival,apoptosis regulation,tumor progression,oncogenic signaling,transmembrane protein function,overexpression
ENSG00000150540,HNMT,epigenetic regulation,methylation-dependent gene silencing,tumor suppressor gene inhibition,dna hypermethylation,rna modification,chromatin remodeling
ENSG00000011405,PIK3C2A,pi3k/akt/mtor pathway activation,constitutive activation,tumor progression,therapeutic target,genomic profiling,signaling pathway regulation
ENSG00000198692,EIF1AY,translation regulation,oncogenic protein expression,cell proliferation enhancement,signaling pathway modulation,therapeutic target candidate,proliferation regulator
ENSG00000170412,GPRC5C,gpcr signaling pathway,cell proliferation regulation,receptor dimerization,g protein activation,tumor progression,therapeutic target
ENSG00000179195,ZNF664,zinc finger protein binding,transcriptional regulation,cell proliferation promotion,oncogenic potential,chromatin modification,signaling pathway modulation
ENSG00000166211,SPIC,transcriptional activator activity,immune response modulation,oncogenesis promotion,gene expression regulation,pro-tumorigenic signaling pathway,tumor progression facilitation
ENSG00000166902,MRPL16,mitochondrial translation regulation,oncogene overexpression,tumor progression,cell proliferation enhancement,apoptosis inhibition,biomarker potential
ENSG00000092345,DAZL,telomere maintenance,genomic stability regulation,microrna-mediated gene regulation,cancer cell survival,oncogene upregulation,cellular proliferation enhancement
ENSG00000153707,PTPRD,loss of function mutations,tumor suppressor function,cell adhesion disruption,proliferation regulation,migration inhibition,phosphatase activity impairment
ENSG00000086200,IPO11,cell death regulation,anti-apoptotic activity,tumor growth promotion,therapy resistance,poor prognosis,oncogene expression
ENSG00000115556,PLCD4,activation of signaling pathways,cancer cell migration,cellular proliferation,mitotic regulation,phospholipid hydrolysis,tumor progression
ENSG00000100228,RAB36,constitutive activation,cell migration and invasion,potential therapeutic target,tumor progression,wash complex interaction,regulation of endocytic trafficking
ENSG00000134278,SPIRE1,microtubule regulation,cell division regulation,mitotic progression,genomic instability,enhanced proliferation,oncogenic potential
ENSG00000127870,RNF6,e3 ubiquitin ligase activity,tumor suppressor protein degradation,cell growth promotion,apoptosis inhibition,cell cycle regulation,dna repair pathway modulation
ENSG00000166482,MFAP4,cell migration,tumor progression,angiogenesis,extracellular matrix regulation,pi3k/akt pathway modulation,cell proliferation
ENSG00000140945,CDH13,**
cell adhesion loss,epithelial-to-mesenchymal transition inhibition,tumor suppressor function,poor prognosis association,metastatic suppression,cancer cell inhibition 
**
ENSG00000074211,PPP2R2C,cell cycle regulation,genomic instability,pi3k/akt pathway modulation,oncogenic transformation,tumor suppressor interaction,genome stability maintenance
,MARC1,oncogene,rna metabolism regulation,tumor progression,mrna stability modulation,cell growth promotion,biomarker potential
ENSG00000129993,CBFA2T3,chromatin regulation,transcriptional coactivation,cell cycle progression,oncogenic driver,genetic instability,tumor proliferation
ENSG00000138459,SLC35A5,glycosylation pathway,oncogene activity,cell proliferation,aberrant expression,golgi apparatus function,nucleotide sugar transporter
ENSG00000106524,ANKMY2,oncogenic role,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition regulation,chemotherapy resistance,signaling pathway modulation,protein-protein interaction
ENSG00000151577,DRD3,cell signaling modulation,tumor progression,cell growth regulation,survival pathway dysregulation,biomarker potential,g protein-coupled receptor function
ENSG00000047634,SCML1,cell cycle regulation,oncogene activation,dna repair mechanism,genomic instability,protein-protein interaction,tumor aggressiveness
ENSG00000126653,NSRP1,rna regulation,transcriptional modulation,tumor suppressor function,apoptosis regulation,cell proliferation enhancement,dna damage response
ENSG00000075826,SEC31B,er-associated degradation pathway,endoplasmic reticulum function,protein translation modulation,secretion regulation,cancer cell proliferation,tumor progression driver
ENSG00000198604,BAZ1A,chromatin remodeling,tumor suppressor activity,dna repair regulation,cell cycle progression,transcriptional regulation,histone modification
ENSG00000187689,AMTN,tumor suppressor function,cell growth regulation,protein interaction network,genetic variation association,mitochondrial localization,cancer progression modulation
ENSG00000129757,CDKN1C,cell cycle regulation,tumor suppressor function,chromatin remodeling,genomic stability,cell proliferation inhibition,embryonic development regulation
ENSG00000135801,TAF5L,transcriptional regulator,tumor promoter,cell proliferation enhancer,genetic instability inducer,cancer-specific expression,genome-wide regulatory role
ENSG00000169684,CHRNA5,nicotinic acetylcholine receptor overexpression,cell proliferation enhancement,metastasis facilitation,chemotherapy resistance,tumor growth promotion,signaling pathway interaction
ENSG00000101846,STS,cellular regulation,actin dynamics regulation,tumor progression,biomarker potential,therapeutic target candidate,poor prognosis association
ENSG00000166803,PCLAF,centrosome amplification,microtubule stability regulation,mitotic process regulation,tumor growth promotion,metastasis facilitation,oncogenic pathway activation
ENSG00000152377,SPOCK1,tumor progression,epithelial-to-mesenchymal transition,cell migration,extracellular matrix remodeling,integrin signaling modulation,cell adhesion
ENSG00000125810,CD93,cellular adhesion,tumor growth promotion,metastasis facilitation,poor prognosis marker,treatment resistance,angiogenesis enhancement
ENSG00000021826,CPS1,nitrogen homeostasis,cellular metabolism regulation,oncogenesis contribution,metabolic enzyme dysfunction,urea cycle modulation,therapeutic target potential
ENSG00000070404,FSTL3,wnt/β-catenin signaling pathway,tumor suppressor function,downregulation or mutation,cell proliferation regulation,apoptosis modulation,genetic instability
ENSG00000198756,COLGALT2,core 1 udp-gal:beta-1,3-galactosyltransferase function,glycoprotein synthesis regulation,cell surface modification,tumor progression promotion,metastasis facilitation
ENSG00000131899,LLGL1,apical junctional complex disruption,cell migration regulation,cancer aggressiveness,driver mutation,epithelial polarity maintenance,microtubule dynamics modulation
ENSG00000221944,TIGD1,cell death regulation,tnf-α pathway interaction,anti-tumor effect,tumor suppressor potential,apoptosis modulation,tissue regulation
ENSG00000071246,VASH1,tumor progression,immune evasion,cell migration,protein-protein interactions,signaling pathway modulation,cancer cachexia
ENSG00000198934,MAGEE1,mage family member,cell proliferation regulator,immune evasion mechanism,tumor progression driver,poor prognosis marker,protein-protein interaction
ENSG00000173040,EVC2,cellular transport,primary ciliary structure,oncogenesis,cell signaling pathways,ciliary dysfunction,tumor suppressor interactions
ENSG00000188643,S100A16,emt regulation,cell proliferation,tumor progression,protein-protein interactions,upregulated expression,biomarker potential
ENSG00000137713,PPP2R1B,pp2a regulation,dephosphorylation activity,cell cycle progression,apoptosis inhibition,tumor suppressor regulation,mutation hotspot
ENSG00000146426,TIAM2,rac1 gtpase activation,cell migration,oncogenic functions,tumor progression,prognostic marker,guanine nucleotide exchange factor
ENSG00000112701,SENP6,cell cycle regulation,tumor aggressiveness,oncogenic protein regulation,dna damage response,therapeutic target,genomic instability
ENSG00000196323,ZBTB44,histone modification,chromatin remodeling,tumor suppressor,cell proliferation inhibition,nuclear localization,transcriptional repression
ENSG00000197965,MPZL1,cell migration,tumor progression,adhesion complex regulation,protein-protein interaction,oncogenic property,signaling pathway regulation
ENSG00000132359,RAP1GAP2,rap1 gtpase activation,tumor suppressor function,cell migration regulation,adhesion molecule interaction,rap/rap-gap signaling pathway disruption,oncogenic mechanism alteration
ENSG00000112238,PRDM13,chromatin modification,epigenetic regulator,tumor suppressor/ oncogene dual role,histone h3k4me2/3 regulation,poor prognosis association,genomic instability modulation
ENSG00000104915,STX10,cellular trafficking,membrane fusion,cell proliferation,signaling pathway regulation,apoptosis modulation,tumor progression
ENSG00000179761,PIPOX,**

cellular metabolism,metabolic reprogramming,cell proliferation,lipid synthesis,mitochondrial function,tumorigenicity
**
ENSG00000132704,FCRL2,tumor progression,immune modulation,cell surface receptor,immune checkpoint regulation,protein-protein interactions,tumor immunity
ENSG00000111875,ASF1A,histone chaperone function,chromatin assembly regulation,dna replication and repair,epigenetic modification,genomic instability,oncogene overexpression
ENSG00000095564,BTAF1,genomic instability,chromatin remodeling,transcriptional regulation,cell proliferation,tumorigenesis,apoptosis modulation
ENSG00000213079,SCAF8,cell cycle regulation,alternative splicing,genomic instability,tumor progression,protein-protein interactions,transcriptional regulation
ENSG00000010539,ZNF200,cell proliferation,tumor suppressor activity,transcriptional regulation,apoptosis regulation,protein-protein interaction,genomic instability
ENSG00000182749,PAQR7,oncogene function,tumor progression,metastasis promotion,poor prognosis marker,signaling pathway modulation,transcriptional regulation
ENSG00000055163,CYFIP2,cytoplasmic fmr1 interacting protein 2,ras/mapk pathway interaction,epithelial-to-mesenchymal transition,mrna processing regulation,tumor progression,poor prognosis
ENSG00000095319,NUP188,genome stability maintenance,dna damage response,cell cycle regulation,tumor growth promotion,oncogene activation,cancer driver gene
ENSG00000234370,GTF2H4,genomic instability,mutation sensitivity,dna damage response,transcription initiation,nucleotide excision repair,cell cycle regulation
ENSG00000260325,HSPB9,protein folding regulation,tumorigenesis promotion,cell survival facilitation,apoptosis suppression,oncogenic signaling modulation,stress response regulation
ENSG00000140157,NIPA2,epigenetic regulation,chromatin remodeling,tumor progression,cell proliferation,metastasis,genomic instability
ENSG00000122729,ACO1,mitochondrial metabolism,cell proliferation,glycolytic shift,dna replication,genomic instability,iron-sulfur cluster biogenesis
ENSG00000107954,NEURL1,transcriptional repressor function,loss-of-function mutations,tumor suppressor activity,notch1 pathway activation,pi3k/akt signaling modulation,cell cycle regulation disruption
ENSG00000076650,GPATCH1,dna repair,genome stability,tumor suppressor,genomic instability,double-strand breaks,non-homologous end joining (nhej) pathway
ENSG00000072042,RDH11,oncogenic regulation,gene overexpression,cell proliferation,apoptosis resistance,tumor suppressor antagonism,protein-protein interaction
ENSG00000163655,GMPS,cellular regulation,guanine nucleotide-binding protein,g-protein coupled receptors,tumorigenesis,cancer progression,aberrant expression
ENSG00000023516,AKAP11,cellular signaling,oncogenic overexpression,cell proliferation,camp pathway regulation,protein-protein interaction,apoptosis evasion
ENSG00000063015,SEZ6,altered lipid metabolism,cell growth promotion,apoptosis inhibition,phospholipid transport regulation,cell proliferation enhancement,oncogenic role
ENSG00000124466,LYPD3,immune modulation,t-cell activation,immunotherapeutic target,oncogene,upregulated expression,cell signaling pathway
ENSG00000121775,TMEM39B,lipid metabolism regulation,cellular transport modulation,vesicle trafficking,endocytosis promotion,autophagy regulation,prognostic marker
ENSG00000070444,MNT,transcriptional repression,tumor suppressor function,cancer cell proliferation,cell cycle regulation,apoptosis modulation,dna repair pathways
ENSG00000163803,PLB1,pi3k/akt signaling,cancer cell proliferation,cell migration and invasion,protein-protein interactions,oncogenic process promotion,tumor progression marker
ENSG00000101365,IDH3B,altered metabolic regulation,epigenetic disruption,gain of function mutations,tumor suppressor dysfunction,metabolic enzyme mutation,cancer driver gene
ENSG00000164124,TMEM144,transmembrane protein,cell membrane trafficking,endocytosis regulation,tumor suppressor function,mutation implicated,cancer cell proliferation
ENSG00000169118,CSNK1G1,**

cell cycle progression,constitutive activation,gain of function mutations,oncogenic driver,phosphorylation activity,tumor suppressor regulation
**
ENSG00000205362,MT1A,cellular protection,heavy metal detoxification,redox regulation,cell growth regulation,protein interaction,tumor progression
ENSG00000182450,KCNK4,oncogenic processes,cell proliferation,tumor growth,metastasis,potassium ion flow regulation,therapeutic target
ENSG00000274221,CCL3,angiogenic mediator,immune cell recruitment,tumor progression,chemokine signaling,inflammatory response,metastasis facilitator
ENSG00000135069,PSAT1,dna repair,genome stability,cell proliferation,tumor progression,therapeutic target,one-carbon metabolism
ENSG00000185730,ZNF696,genetic instability,transcriptional regulation,cell cycle regulation,tumor suppression,apoptosis modulation,epigenetic modification
ENSG00000198795,ZNF521,cellular proliferation,transcriptional regulation,oncogenic function,cell growth regulation,tumor progression,transcription factor activity
ENSG00000205923,CEMP1,ceramide metabolism regulation,cellular proliferation regulation,tumor progression modulation,protein-protein interaction,oncogenic pathway contribution,homeostasis maintenance disruption
ENSG00000125746,EML2,rac gtpase activation,cell migration regulation,actin cytoskeleton reorganization,tumor progression enhancement,oncogenic signaling pathway modulation,cancer cell invasion promotion
ENSG00000198522,GPN1,regulation of cell signaling,interaction with pi3k/akt pathway,tumor growth promotion,epithelial-to-mesenchymal transition regulation,apoptosis evasion,oncogene interaction
ENSG00000164828,SUN1,nuclear envelope organization,tumor progression,cell proliferation,genomic instability,therapeutic target,chromatin regulation
ENSG00000198914,POU3F3,transcriptional regulation,oncogenic activity,tumor suppressor gene modulation,cell proliferation,apoptosis suppression,cancer development
,NARS,cellular proliferation,genetic instability,cancer cell invasion,rna processing regulation,neuronal development,signaling pathway modulation
ENSG00000141744,PNMT,cell proliferation,prognostic marker,adrenal gland expression,catecholamine synthesis,nervous system regulation,genetic regulation
ENSG00000133028,SCO1,electron transport chain disruption,mitochondrial dysfunction,oxidative stress induction,cancer driver gene,cellular respiration regulation,tumor progression
ENSG00000162419,GMEB1,oncogene,transcriptional regulation,tumor progression,cell proliferation,apoptosis evasion,overexpression
ENSG00000008282,SYPL1,cell adhesion regulation,metastatic potential modulation,signaling pathway interaction,tumorigenesis association,protein-protein interaction,membrane trafficking regulation
ENSG00000182158,CREB3L2,overexpression,transcriptional regulation,metabolic reprogramming,cell growth promotion,tumorigenesis,stress response modulation
ENSG00000288369,RBP5,alternative splicing regulation,chromatin remodeling,histone modification regulation,gene expression modulation,oncogenic splicing alterations,tumor progression promotion
ENSG00000138823,MTTP,mttp involved in lipid metabolism,altered lipid profiles,enhanced energy supply,cell membrane fluidity,lipid signaling pathways,tumor progression
ENSG00000080546,SESN1,cellular stress responses,apoptosis inhibition,pi3k/akt pathway regulation,tumor suppressor function,pro-survival gene regulation,hypoxia response modulation
ENSG00000112855,HARS2,histidyl-trna charging,amino acid incorporation,cell growth promotion,translation regulation,protein synthesis modulation,tumor driver mutation
ENSG00000069849,ATP1B3,sodium-potassium pump dysfunction,tumor progression modulation,cell cycle regulation alteration,prognostic biomarker potential,ion channel regulation disorder,electrogenic transport abnormality
ENSG00000143515,ATP8B2,phospholipid asymmetry regulation,tumor progression,cell proliferation,signaling cascade modulation,pi3k/akt pathway activation,cancer aggressiveness
ENSG00000136695,IL36RN,tumor evasion,immune suppression,inflammatory response regulation,cancer progression promotion,therapeutic resistance,signaling pathway alteration
ENSG00000198399,ITSN2,epithelial-to-mesenchymal transition,molecular switch regulation,rho gtpase interaction,cell migration promotion,tumor aggressiveness enhancement,pi3k/akt pathway activation
ENSG00000149133,OR5F1,aberrant expression,cell proliferation,cell survival,gene expression profiling,metastasis promotion,oncogenic transcription factor activation
ENSG00000198198,SZT2,regulatory protein,cell growth modulation,transcription factor regulation,oncogene function,tumor suppressor interaction,apoptosis inhibition
ENSG00000188706,ZDHHC9,palmitoyltransferase activity,overexpression,protein modification,cell signaling interaction,tumor growth promotion,poor prognosis marker
ENSG00000162733,DDR2,cell adhesion disruption,tumor progression driver,extracellular matrix regulation,cell proliferation enhancement,oncogenic signaling activation,therapeutic target candidate
ENSG00000117305,HMGCL,glycolytic shift,increased glycolysis,metabolic reprogramming,tumor aggressiveness,therapeutic target,energy production regulation
ENSG00000106113,CRHR2,g protein-coupled receptor,tumor progression,metastasis driver,cell proliferation,signaling pathway activation,oncogene potential
ENSG00000004776,HSPB6,cell survival,thermotolerance,oxidative stress response,chemotherapy resistance,dna repair interaction,stress-induced expression
ENSG00000163798,SLC4A1AP,anion exchanger regulation,tumor progression,cellular ph regulation,electrolyte balance modulation,therapeutic target,protein-protein interaction
ENSG00000131143,COX4I1,mitochondrial respiration,energy metabolism regulation,tumor growth promotion,metabolic adaptation,hypoxia response,angiogenesis modulation
ENSG00000153253,SCN3A,ion flux regulation,tumor progression,gain of function mutations,cellular excitability modulation,oncogenic transformation promotion,epigenetic disruption
ENSG00000148120,AOPEP,cell proliferation,tumor progression,metastasis,resistance to therapy,pi3k/akt signaling pathway activation,apoptosis inhibition
ENSG00000164631,ZNF12,tumor suppressor function,p53 pathway interaction,cell proliferation regulation,dna binding activity,zinc finger structure,genome stability maintenance
ENSG00000184857,TMEM186,cell membrane integrity,gene amplification,tumor progression,oncogenic transformation,cell adhesion modulation,protein-protein interaction
ENSG00000187193,MT1X,cell proliferation,tumor progression,cancer development,transcription regulation,zinc homeostasis,nf-κb pathway activation
ENSG00000196683,TOMM7,mitochondrial function,cell survival,tumor progression,therapeutic target,genomic instability,protein transport
ENSG00000100216,TOMM22,mitochondrial transport regulation,cell growth promotion,tumor suppressor dysfunction,cell cycle stabilization,protein import disruption,mitochondrial function alterations
ENSG00000122484,RPAP2,tumor progression,rna-dependent rna polymerase activity,protein kinase activation,oncogenic processes,cell proliferation,therapeutic target
ENSG00000170954,ZNF415,oncogenesis,transcriptional regulation,tumor progression,cell proliferation,metastasis,biomarker
ENSG00000228090,MPIG6B,mapk pathway interaction,tumor suppressor function,apoptosis regulation,cell proliferation,genetic instability,poor prognosis marker
ENSG00000185551,NR2F2,tumor progression,transcriptional regulation,cellular differentiation,oncogene activity,signaling pathway modulation,tumor suppressor function
ENSG00000198553,KCNRG,kcnrg expression,cell proliferation,kv channel interaction,epithelial cell integrity,oncogenesis promotion,tumorigenesis association
ENSG00000121579,NAA50,epigenetic regulation,chromatin remodeling,cell growth promotion,protein acetylation regulation,tumor initiation,cell survival enhancement
ENSG00000182459,TEX19,oncogenic function,epithelial-to-mesenchymal transition (emt) promotion,transcriptional repression,angiogenesis stimulation,immune evasion facilitation,long non-coding rna regulation
ENSG00000167703,SLC43A2,lipid metabolism alteration,oncogene potential,fatty acid transport,energy production regulation,protein interaction,cell growth promotion
ENSG00000117593,DARS2,mitochondrial function,energy metabolism,cellular redox balance,tumor progression,oncogenic mutation,cancer driver gene
ENSG00000120727,PAIP2,mrna regulation,cell cycle progression,oncogenic properties,apoptosis inhibition,biomarker potential,microrna modulation
ENSG00000174740,PABPC5,regulation of mrna translation,enhanced cell proliferation,cell cycle progression,genetic instability,protein interaction network,increased mrna stability
ENSG00000110042,DTX4,overexpression,transcription factor function,cell proliferation promotion,apoptosis resistance,epithelial-to-mesenchymal transition (emt) modulation,poor prognosis biomarker
ENSG00000076826,CAMSAP3,microtubule regulation,cancer progression,cell migration,cytoplasmic localization,prognostic marker,tumor aggressiveness
ENSG00000109113,RAB34,cell cycle regulation,oncogenic function,protein-protein interaction,tumor progression,autophagy modulation,poor prognosis marker
ENSG00000150051,MKX,cellular growth,protein-protein interaction,lim-only protein,cell signaling pathway,tumorigenesis,cellular proliferation
ENSG00000197217,ENTPD4,purinergic signaling,cell proliferation,tumor growth,chemotherapy resistance,oncogenic interaction,adenosine regulation
ENSG00000100258,LMF2,immune system regulation,metastasis promotion,tumor progression,cell proliferation,protein-protein interaction,oncogenic activity
ENSG00000136699,SMPD4,sphingolipid metabolism,oncogenic processes,tumor progression,cell signaling pathways,metastasis,apoptosis regulation
ENSG00000151304,SRFBP1,ubiquitin ligase function,tumor suppressor degradation,cell cycle regulation,apoptosis inhibition,genomic instability,cancer progression
ENSG00000259571,BLID,mtor signaling,tumor suppressor function,cell proliferation regulation,mutation driver,gene regulatory network,protein-protein interaction
ENSG00000170265,ZNF282,transcriptional regulation,oncogene function,zinc finger motifs,cell proliferation,dna binding activity,gene expression modulation
ENSG00000198848,CES1,tumor growth,cell proliferation,metastasis,chemoresistance,stem cell-like properties,hydrolysis of ester bonds
ENSG00000008513,ST3GAL1,sialic acid transferase function,altered sialylation patterns,cell surface recognition modulation,tumor progression involvement,cancer cell migration enhancement,genomic instability association
ENSG00000146072,TNFRSF21,nf-κb pathway activation,oncogenic signaling,overexpression,prognostic marker,immune response modulation,cancer stem cell regulation
ENSG00000213977,TAX1BP3,tumor suppressor,apoptosis regulation,genome stability maintenance,dna repair interaction,cell growth regulation,brca1 interaction
ENSG00000166589,CDH16,downregulation,cell-cell junctions disruption,tumor progression,poor prognosis,reduced overall survival,adherens junctions impairment
ENSG00000131482,G6PC,energy metabolism regulation,metabolic shift towards glycolysis,glycogenolysis inhibition,prognostic marker,tumor progression driver,hypoxia-induced expression
ENSG00000196289,BECN2,autophagic regulation,tumor suppressor function,cellular metabolism modulation,therapeutic target potential,genomic instability contributor,pro-survival signaling
ENSG00000184524,CEND1,cell cycle regulation,promotes cell proliferation,amplified in cancer,tumor progression,therapeutic target,cancer prognosis
ENSG00000171115,GIMAP8,overexpression,tumor progression,cell proliferation,immune suppression,signaling pathway activation,prognostic marker
ENSG00000178685,PARP10,cell proliferation regulation,genomic stability maintenance,tumor progression promotion,apoptosis suppression,chromatin remodeling,prognostic marker
ENSG00000126733,DACH2,cell cycle regulation,transcriptional repression,tumor suppressor function,apoptosis modulation,cell growth control,oncogenic pathway disruption
ENSG00000071189,SNX13,pi3k/akt signaling,tumor suppressor function,cell migration regulation,endosomal sorting regulation,cancer-related downregulation,signaling pathway regulation
ENSG00000157823,AP3S2,vesicular transport,lysosomal dysfunction,iron homeostasis disruption,altered metabolism,tumor progression modulation,potential oncogenic driver
ENSG00000122034,GTF3A,oncogenic potential,transcriptional regulation,cell proliferation enhancement,anti-apoptotic function,genomic instability promoter,tumor progression facilitator
ENSG00000115761,NOL10,oncogenic transformation,cellular proliferation,transcriptional regulation,ribosome biogenesis,tumor progression,biomarker potential
ENSG00000162616,DNAJB4,oncogene,cellular stress response,chaperone function,apoptosis regulation,cell cycle control,tumor suppressor dysfunction
ENSG00000145817,YIPF5,er membrane maintenance,calcium homeostasis regulation,cell proliferation enhancement,migration and invasion facilitation,prognosis indicator,upstream regulatory protein
ENSG00000115365,LANCL1,autophagic regulation,cell proliferation,enhanced mapk signaling,metabolic reprogramming,pi3k/akt pathway modulation,tumor progression biomarker
ENSG00000158008,EXTL1,microtubule dynamics,cell growth promotion,dna damage repair,genomic instability,therapeutic target,cell cycle regulation
ENSG00000122304,PRM2,chromatin remodeling,dna repair regulation,cell cycle progression regulation,methylation activity,histone modification influence,oncogenic process promoter
ENSG00000130702,LAMA5,tumor progression,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),angiogenesis,basement membrane formation,extracellular matrix interaction
ENSG00000154518,ATP5MC3,mitochondrial function,constitutive activation,gain of function mutations,therapeutic target,cellular respiration,energy metabolism
ENSG00000181965,NEUROG1,transcriptional regulation,promoter hypermethylation,loss-of-function mutations,tumor aggressiveness,prognostic marker,epigenetic silencing
ENSG00000147081,AKAP4,cell signaling regulation,apoptosis regulation,gene amplification,protein kinase anchoring,tumor progression,dna repair regulation
ENSG00000049283,EPN3,endocytic pathway regulation,mutation-driven oncogenesis,cell migration facilitation,receptor trafficking modulation,tumor aggressiveness marker,prognostic significance
ENSG00000197555,SIPA1L1,arf6 activation,cell migration,cytoskeleton regulation,metastasis promoter,microtubule modulation,oncogene overexpression
ENSG00000274488,LY6H,tumor progression,metastasis,immune evasion,epithelial-to-mesenchymal transition,cell migration,protein-protein interaction
ENSG00000273397,NDUFA6,mitochondrial dysfunction,cancer metabolism alteration,glycolysis and glutaminolysis upregulation,energy metabolism dysregulation,cellular respiration impairment,therapeutic target
ENSG00000179041,RRS1,mapk/erk pathway,tumor progression,proliferation regulation,cancer therapeutic target,mutations associated,cell survival enhancement
ENSG00000196542,SPTSSB,trna processing,apoptosis regulation,mrna stability regulation,cell cycle progression modulation,dna damage response,transcriptional regulation
ENSG00000134698,AGO4,ago4 overexpression,mirna regulation,tumor progression,cell cycle modulation,genomic instability,chromatin modification
ENSG00000119509,INVS,primary cilium dysfunction,genomic instability,mechanoreception disruption,cell cycle regulation,tumor suppressor,planar cell polarity
ENSG00000042813,ZPBP,secreted glycoprotein,overexpression,tumor progression,cell interaction modulation,glycoprotein function,none
ENSG00000188092,GPR89B,overexpression,oncogenic signaling,tumor progression,poor prognosis,aggressive tumor behavior,therapeutic target
ENSG00000103546,SLC6A2,catecholamine regulation,tumor progression,cellular survival,angiogenesis promotion,microenvironment modulation,therapeutic target
ENSG00000178764,ZHX2,transcriptional regulation,oncogene activity,cell proliferation,apoptosis suppression,epithelial-to-mesenchymal transition,chromatin remodeling
ENSG00000154309,DISP1,cell-cell adhesion disruption,tumor progression,metastasis promotion,growth factor activation,prognostic marker,therapeutic target
ENSG00000157064,NMNAT2,cellular metabolism,tumor growth and proliferation,resistance to therapy,nad+ biosynthesis,oncogenic processes,cellular energy metabolism
ENSG00000163157,TMOD4,actin cytoskeleton regulation,cell migration promotion,oncogenic signaling activation,epithelial-to-mesenchymal transition (emt) facilitation,chemotherapy resistance association,tumor invasion enhancement
ENSG00000115128,SF3B6,pre-mrna splicing,aberrant splicing patterns,transcriptional regulation,cell growth and survival,gene expression modulation,tumor progression
ENSG00000205301,MGAT4D,oncogenic activity,glycosyltransferase function,epithelial-to-mesenchymal transition,cell-cell adhesion modulation,wnt/β-catenin signaling interaction,aberrant glycosylation pathways
ENSG00000165917,RAPSN,cell adhesion,amplification/overexpression,tumor progression,cell proliferation,contact-dependent signaling,cell surface molecule interaction
ENSG00000162368,CMPK1,calcium homeostasis,cell proliferation,mitochondrial function,calcium-dependent pathways,lipid metabolism regulation,tumor progression
ENSG00000090238,YPEL3,cellular regulation,genetic interaction,gene amplification,oncogenic potential,tumor progression,cancer predisposition
ENSG00000125734,GPR108,cell-cell adhesion,signaling pathway regulation,oncogene overexpression,tumor aggressiveness,enhanced cell survival,downstream signaling activation
ENSG00000231852,CYP21A2,steroid hormone regulation,tumor microenvironment,hormone metabolism,adrenal gland function,gene expression alteration,tumor progression
ENSG00000159871,LYPD5,cell-cell adhesion regulation,tumor progression modulation,epithelial cell interaction influence,signaling pathway regulation,integrin interaction,oncogenic process modulation
ENSG00000139977,NAA30,epigenetic regulation,tumor growth,chromatin remodeling,transcriptional regulation,oncogene activation,genome stability disruption
ENSG00000135040,NAA35,protein acetylation,cell proliferation,oncogene,cell cycle progression,apoptosis regulation,genomic association study
ENSG00000174705,SH3PXD2B,tumor progression,metastasis regulation,cytokeletal modulation,cell migration enhancement,signaling pathway interaction,gain of function mutations
ENSG00000092871,RFFL,ubiquitin ligase activity,cell growth regulation,oncogenic driver,tumor progression,ubiquitination,cellular response modulation
ENSG00000142025,DMRTC2,genomic stability,aneuploidy suppression,tumor suppressor function,mitotic checkpoint regulation,cellular response modulation,chromosomal maintenance
ENSG00000129194,SOX15,transcription factor regulation,oncogene potential,cell proliferation modulation,epithelial-to-mesenchymal transition (emt),chromatin remodeling complex interaction,tumor progression promotion
ENSG00000158987,RAPGEF6,**

1. **rap gtpase activation**,2. **constitutive signaling**,3. **cell adhesion disruption**,4. **invasive growth**,5. **metastatic potential**,6. **therapeutic target**
ENSG00000150054,MPP7,constitutive activation,enhanced cell proliferation,gene expression regulation,membrane-associated guanylate kinase function,tumor progression,wnt/β-catenin signaling pathway activation
ENSG00000164404,GDF9,cell proliferation,overexpression,signaling pathway modulation,tumor progression,tgf-β interaction,growth regulation
ENSG00000153037,SRP19,er targeting defects,protein translation regulation,cancer cell survival,tumor proliferation,cellular interaction modulation,genomic instability
ENSG00000167468,GPX4,redox balance disruption,cellular resistance,oxidative stress induction,genomic instability,tumor progression,dna repair impairment
ENSG00000141965,FEM1A,cell cycle regulation,genomic stability,telomere maintenance,anti-apoptotic function,protein-protein interaction,g2/m phase transition
ENSG00000075407,ZNF37A,zinc finger protein regulation,transcriptional control,apoptosis regulation,cell proliferation modulation,cellular differentiation,tumorigenesis promotion
ENSG00000141905,NFIC,epigenetic regulation,transcriptional modulation,cell proliferation driver,tumor progression contributor,prognostic marker,oncogenic transcription factor
ENSG00000158805,ZNF276,transcriptional regulation,cell growth promotion,aberrant cell cycle progression,tumor development,therapeutic target,genomic amplification
ENSG00000090402,SI,apoptosis inhibition,cell cycle progression,cancer oncogene,ubiquitin ligase activity,e3 ubiquitin ligase function,protein stability regulation
,HIST3H2A,histone modification,tumor suppressor function,epigenetic regulation,dna repair defect,apoptosis evasion,cancer hallmark
ENSG00000139219,COL2A1,tumor microenvironment modulation,epithelial-to-mesenchymal transition,cell adhesion molecule regulation,angiogenesis promotion,extracellular matrix remodeling,emt and metastasis facilitation
ENSG00000114378,HYAL1,cell migration,extracellular matrix degradation,hyaluronic acid breakdown,oncogenesis,tumor invasion,metastasis
ENSG00000089057,SLC23A2,nucleoside transport,altered expression,cellular metabolism,protein interactions,therapeutic target,nucleotide regulation
ENSG00000005882,PDK2,metabolic reprogramming,aerobic glycolysis,oncogenesis,cell proliferation,energy metabolism,therapeutic target
ENSG00000196358,NTNG2,tumor suppressor function,cell adhesion disruption,eph receptor interaction,pi3k/akt pathway regulation,neuronal migration disruption,axon guidance regulation
ENSG00000262655,SPON1,epithelial-to-mesenchymal transition,cell adhesion disruption,integrin interaction,cell migration promotion,tumor microenvironment modulation,biomarker potential
ENSG00000102547,CAB39L,calcium regulation,signaling pathway modulation,cellular proliferation,oncogenesis potential,protein interaction,genomic instability
ENSG00000115257,PCSK4,aberrant substrate processing,apoptosis inhibition,cell differentiation disruption,gene amplification mutation,oncogenic pathway activation,tumor growth promotion
ENSG00000157219,HTR5A,oncogene,cell proliferation,apoptosis regulation,invasion promotion,tumor progression,signaling pathway regulation
ENSG00000130413,STK33,genomic instability,tumor suppressor function,cell cycle regulation,dna damage response,oncogenic potential,therapeutic target
ENSG00000132196,HSD17B7,steroidogenesis,hormone metabolism regulation,apoptosis inhibition,cellular proliferation enhancement,metabolic reprogramming,oncogenic protein-protein interactions
ENSG00000133742,CA1,ph regulation,ion transport,tumor growth promotion,angiogenesis facilitation,prognostic marker,therapeutic resistance
ENSG00000006788,MYH13,cell migration,tumor progression,pi3k/akt pathway interaction,actin cytoskeleton dynamics regulation,oncogenic transformation association,mapk/erk signaling interaction
ENSG00000113946,CLDN16,cellular polarity loss,epithelial-to-mesenchymal transition,tumor progression facilitation,overexpression correlation,poor prognosis association,protein interaction partner
ENSG00000162512,SDC3,angiogenesis promotion,tumor progression facilitation,cell adhesion modulation,prognostic biomarker identification,poor prognosis association,extracellular matrix remodeling involvement
ENSG00000196296,ATP2A1,calcium regulation,cell proliferation,tumor invasion,signaling pathway modulation,cancer progression,therapeutic target
ENSG00000034971,MYOC,overexpression,tumor progression,poor prognosis,cell proliferation,cell migration,ecm regulation
ENSG00000115457,IGFBP2,tumor aggressiveness,tumor progression,cell proliferation,apoptosis inhibition,metastasis promotion,igf binding protein
ENSG00000184709,LRRC26,cell adhesion regulation,tumor progression,epithelial-to-mesenchymal transition,metastasis promotion,biomarker potential,cell migration enhancement
ENSG00000198732,SMOC1,cell adhesion,extracellular matrix organization,enhanced proliferation,metastasis promotion,tumorigenesis driver,cell migration facilitation
ENSG00000138760,SCARB2,lipid metabolism regulation,cholesterol efflux modulation,endocytosis involvement,tumor microenvironment modulation,therapeutic target potential,reverse cholesterol transport
ENSG00000087842,PIR,post-translational modification,citrullination mechanism,cell cycle regulation,protein stability modulation,ectopic expression,epigenetic regulation
ENSG00000163563,MNDA,genomic instability,tumor suppressor function,cell cycle regulation,transcriptional repression,dna damage response,apoptosis evasion
ENSG00000169740,ZNF32,protein expression,transcriptional regulation,apoptosis suppression,cell proliferation enhancement,metastatic potential,therapeutic target
ENSG00000076248,UNG,genetic instability,dna repair deficiency,tumor progression,poor prognosis,therapeutic target,biomarker
ENSG00000137225,CAPN11,tumor progression,rna binding,pi3k/akt pathway regulation,proteolytic activity,apoptosis regulation,therapeutic target
ENSG00000227345,PARG,par polymer regulation,dna repair pathway,oncogenic function,tumor cell survival,chemoresistance modulation,prognostic biomarker
ENSG00000172273,HINFP,transcription factor regulation,tumor suppressor function,oncogenic transcriptional repression,cell proliferation regulation,cancer-specific mutation hotspot,genomic instability driver
ENSG00000187021,PNLIPRP1,**
mapk signaling pathway,cell proliferation regulation,genomic instability,metastasis promotion,dna repair interaction,tumor aggressiveness marker
**
ENSG00000189159,JPT1,glycolytic reprogramming,mitochondrial dysfunction,warburg effect,energy metabolism regulation,metabolic adaptation,protein-protein interaction
ENSG00000135744,AGT,ras pathway,upregulated expression,cell proliferation,tumor progression,therapeutic target,biomarker
ENSG00000171310,CHST11,glycosaminoglycan modification,cell surface sulfation,oncogenic role,tumor progression,extracellular matrix interaction,signaling pathway modulation
ENSG00000132749,TESMIN,protein-protein interactions,cell morphology regulation,apoptosis inhibition,tumor progression,metastasis promoter,biomarker candidate
ENSG00000109572,CLCN3,epithelial tight junction function,cell migration,apoptosis regulation,chloride channel activity,wnt/β-catenin signaling interaction,metastasis promotion
ENSG00000174292,TNK1,pi3k/akt/mtor pathway activation,constitutive kinase activity,oncogenic driver,cell signaling regulation,poor prognosis indicator,tumor progression mediator
ENSG00000106290,TAF6,tfiid complex assembly,constitutive activation,gene amplification,oncogenic function,cell proliferation enhancement,chromatin remodeling
ENSG00000130783,CCDC62,cell cycle regulation,genomic instability,microtubule organization,chromosomal segregation,tumorigenesis,genetic instability
ENSG00000109472,CPE,oncogene function,cell proliferation,apoptosis regulation,angiogenesis facilitation,pro-hormone processing modification,mapk/erk pathway interaction
ENSG00000174165,ZDHHC24,egfr pathway modulation,oncogenic process promotion,tumor progression driver,cell proliferation enhancement,signaling pathway regulation,protein s-palmitoylation modulator
ENSG00000149308,NPAT,histone modification,transcriptional regulation,cell cycle progression,oncogenic process,therapeutic target,genomic instability
ENSG00000135643,KCNMB4,wnt/β-catenin pathway,ca2+ signaling modulation,cell proliferation regulation,tumorigenesis driver,potassium channel subunit,bladder urothelium expression
ENSG00000145936,KCNMB1,cellular excitability,tumor progression,mutation,signaling pathway interaction,proliferation,channel regulation
ENSG00000179915,NRXN1,neurotransmitter regulation,tumor suppressor function,cell proliferation enhancement,oncogenic processes promotion,signaling pathway interaction,genetic mutation impact
ENSG00000145555,MYO10,cell adhesion regulation,epithelial-to-mesenchymal transition,tumor microenvironment remodeling,metastasis promotion,prognostic biomarker,therapeutic target
ENSG00000197530,MIB2,dna replication,cell cycle regulation,oncogene,cell proliferation,tumor growth,therapeutic target
ENSG00000244005,NFS1,antioxidant defense system disruption,dna damage,epigenetic modifications,genomic instability,oncogenic processes,reactive oxygen species (ros) response
ENSG00000163746,PLSCR2,pi3k/akt signaling,cell proliferation,genomic instability,dna damage resistance,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000150551,LYPD1,tumor progression,cell surface protein interaction,metastasis promotion,poor prognosis marker,adhesion and migration modulation,upregulated expression levels
ENSG00000180992,MRPL14,ribosomal protein regulation,aberrant expression,cellular growth modulation,protein synthesis regulation,tumor progression contribution,cancer cell proliferation promotion
ENSG00000197134,ZNF257,transcription factor regulation,cell cycle progression,apoptosis modulation,tumor suppressor function,overexpression associated with poor prognosis,genomic instability
ENSG00000128652,HOXD3,transcriptional regulation,oncogenic properties,cell proliferation,tumor progression,apoptosis suppression,chromatin remodeling
ENSG00000182132,KCNIP1,potassium channel regulation,cell proliferation,ion balance modulation,tumor microenvironment,biomarker potential,therapeutic target
ENSG00000029639,TFB1M,genomic stability maintenance,transcriptional regulation,dna damage response,cellular proliferation control,tumorigenesis prevention,none
ENSG00000197213,ZSCAN5B,altered dna binding,cell proliferation regulation,disrupted epigenetic regulation,genomic instability facilitation,oncogenic potential modulation,tumor suppressor activity suppression
ENSG00000110888,CAPRIN2,aberrant splicing regulation,cell proliferation driver,cancer biomarker,alternative splicing mediator,genomic instability inducer,tumor suppressor dysregulation
ENSG00000133030,MPRIP,cellular proliferation,overexpression,signal transduction regulation,epithelial-to-mesenchymal transition,therapeutic target,oncogenic pathway modulation
ENSG00000104953,TLE6,oncogene,wnt/tcf signaling pathway,transcriptional co-repressor,tumor progression,cell proliferation,aberrant expression
ENSG00000198740,ZNF652,tumor suppression,cell cycle regulation,genomic integrity maintenance,dna repair modulation,oncogenesis prevention,transcriptional repression
ENSG00000241343,RPL36A,ribosomal function modulation,oncogenic potential,cell proliferation regulation,protein synthesis regulation,pi3k/akt/mtor pathway interaction,genomic instability promotion
ENSG00000205138,SDHAF1,angiogenesis promotion,cellular respiration regulation,electron transport chain interaction,glycolysis induction,metabolic regulation disruption,tumor suppressor function loss
ENSG00000278695,GSTT2B,detoxification mechanism,glutathione conjugation,oxidative stress regulation,dna repair pathways,redox balance maintenance,epigenetic modifications
ENSG00000110436,SLC1A2,metabolic regulation,tumor progression,oncogenic processes,amino acid transport,biomarker candidate,therapeutic target
ENSG00000139910,NOVA1,splice site recognition,alternative splicing regulation,oncogene overexpression,cell cycle progression,prognostic marker,therapeutic target
ENSG00000102001,CACNA1F,calcium homeostasis disruption,genomic instability,cellular proliferation promotion,biomarker potential,protein overexpression,oncogenic pathway activation
ENSG00000138829,FBN2,extracellular matrix remodeling,oncogene function,cell growth regulation,glycoprotein assembly,tumor microenvironment disruption,cell signaling pathway interaction
ENSG00000011347,SYT7,calcium-dependent exocytosis,vesicle fusion regulation,membrane trafficking interaction,cell proliferation enhancement,survival pathway activation,chromatin remodeling complex interaction
ENSG00000010327,STAB1,cell surface regulation,metastasis facilitation,pi3k/akt pathway interaction,tumor progression,adhesion molecule regulation,cancer cell invasion
ENSG00000149782,PLCB3,cellular signaling pathway,phospholipase c activity,oncogenic signaling,cell proliferation regulation,g protein-coupled receptor activation,tumor progression factor
ENSG00000129968,ABHD17A,lipid metabolism regulation,protein degradation,tumor suppressor regulation,oncogenic pathway activation,pi3k/akt signaling modulation,poor prognosis biomarker
ENSG00000076716,GPC4,gpc4 expression,elevated levels,tumor progression,met pathway activation,growth factor signaling,cancer stem cell maintenance
ENSG00000148824,MTG1,cell cycle regulation,tumor suppressor function,apoptosis regulation,genomic instability,chromatin remodeling interaction,transcriptional repression
ENSG00000130024,PHF10,epigenetic regulation,chromatin modification,tumor suppressor function,cell cycle regulation,apoptosis induction,histone modification
ENSG00000100983,GSS,**
gdnf signaling pathway,ret-gdnfrα interaction,oncogenic mutations,cell growth regulation,tumor progression,therapeutic target 
**
ENSG00000118246,FASTKD2,mitochondrial regulation,tumor suppressor function,cellular respiration,glycolytic shift,prognostic marker,therapeutic target
ENSG00000164398,ACSL6,metabolic regulation,tumor progression,oncogene,cellular membrane synthesis,fatty acid metabolism,gene expression regulation
ENSG00000230763,HLA-DPB1,antigen presentation,tumor progression,immune evasion,downregulation loss,tumor suppressor interaction,immunoregulatory role
ENSG00000144339,TMEFF2,cell adhesion regulation,tumor suppressor function,pi3k/akt pathway interaction,oncogenic signal suppression,cellular response modulation,biomarker potential
ENSG00000162813,BPNT1,histone deacetylase activity,chromatin remodeling,oncogene function,tumor promotion,protein stability regulation,cell proliferation regulation
ENSG00000106723,SPIN1,chromatin remodeling,transcriptional regulation,oncogenic activation,cell growth promotion,cell cycle progression,therapeutic target
ENSG00000142515,KLK3,tumor progression,metastasis,serine protease activity,cell proliferation regulation,biomarker potential,extracellular matrix degradation
ENSG00000114026,OGG1,base excision repair,oxidative dna damage,genomic instability,mutational signature,cancer driver gene,dna repair deficiency
ENSG00000144369,FAM171B,cell cycle regulation,protein-protein interaction,dna damage response,tumor progression,apoptosis evasion,proliferation signaling
ENSG00000135097,MSI1,microsatellite instability,oncogenic role,chromatin remodeling,dna repair mechanisms,cell proliferation,genome stability maintenance
ENSG00000090539,CHRD,protein-protein interaction,cell cycle regulation,microtubule dynamics,cytoskeletal organization,epithelial-to-mesenchymal transition,oncogenic overexpression
ENSG00000105409,ATP1A3,ion homeostasis disruption,tumor progression facilitation,cell proliferation enhancement,membrane transport alteration,signaling pathway interaction,oncogenic mutation potential
ENSG00000130477,UNC13A,calcium-dependent secretion,regulation of cell migration,biomarker for bladder cancer,interaction with egfr,trafficking of protein complexes,oncogenic properties
ENSG00000107331,ABCA2,cell cycle regulation,oncogene overexpression,prognostic marker,lipid metabolism dysfunction,apoptosis suppression,genetic variant association
ENSG00000115155,OTOF,cellular responses,cell survival,enhanced cell growth,oncogene function,resistance to apoptosis,synaptic transmission regulation
ENSG00000170989,S1PR1,g-protein coupled receptor activation,cell migration regulation,tumor progression facilitation,poor prognosis association,oncogene interaction,aggressive tumor behavior induction
ENSG00000156876,SASS6,centriole duplication,cell cycle regulation,cancer driver mutation,apoptosis inhibition,cell proliferation enhancement,cilia formation disruption
ENSG00000167114,SLC27A4,fatty acid metabolism,cell growth promotion,overexpression,lipid transport regulation,poor prognosis marker,cancer cell energy supply enhancement
ENSG00000011021,CLCN6,ion channel regulation,chloride transport,cell migration,epithelial-to-mesenchymal transition,apoptosis inhibition,tumor progression
ENSG00000205744,DENND1C,mtor signaling pathway,cell proliferation,regulatory protein interactions,vesicular trafficking regulation,tumor progression,poor prognosis marker
ENSG00000135525,MAP7,microtubule dynamics,microtubule stabilization,cell migration promotion,tumor progression contribution,transcriptional regulation,protein-protein interaction modulation
ENSG00000093183,SEC22C,tumor progression,cellular trafficking regulation,pro-survival factor secretion,oncogenic protein interaction,angiogenesis promotion,metastasis facilitation
ENSG00000067177,PHKA1,glycogen metabolism,glucose uptake regulation,energy homeostasis modulation,metabolic reprogramming,tumor growth promotion,cancer cell survival enhancement
ENSG00000108389,MTMR4,phosphatase activity,cell proliferation,tumor progression,protein interactions,apoptosis regulation,genomic instability
ENSG00000089639,GMIP,proteasome regulation,oncogene activation,tumor progression,biomarker expression,cancer therapy target,protein degradation modulation
ENSG00000168216,LMBRD1,lysosome biogenesis,metabolic dysregulation,oxidative stress induction,tumor aggressiveness marker,vitamin b12 transport dysfunction,cancer prognosis biomarker
ENSG00000162407,PLPP3,cellular lipid metabolism,dephosphorylation,cell proliferation,signaling pathway regulation,cancer progression,autophagy
ENSG00000170458,CD14,pattern recognition receptor,cell proliferation,immune modulation,signaling pathway interaction,tumor progression,pro-inflammatory response
ENSG00000100373,UPK3A,cellular adhesion disruption,cellular proliferation enhancement,signaling pathway modulation,tumor progression facilitation,therapeutic target potential,protein overexpression association
ENSG00000110077,MS4A6A,cell adhesion disruption,enhanced cell migration,metastasis promotion,oncogenic overexpression,therapeutic target identification,tumor aggressiveness
ENSG00000213380,COG8,oligosaccharyltransferase complex,cellular stress responses,tumor suppressor pathways,apoptosis regulation,protein modification dysregulation,cell cycle progression
ENSG00000137413,TAF8,transcription regulation,cell cycle progression,proliferation modulation,genetic instability,chromatin remodeling,cancer predisposition
ENSG00000116852,KIF21B,cell division regulation,genomic instability contribution,protein interaction network,microtubule transport role,amplicon region presence,low oncogenic potential
ENSG00000148200,NR6A1,cell proliferation,transcriptional regulation,immune response modulation,inflammation induction,tumor progression,biomarker potential
ENSG00000152670,DDX4,genome instability,tumor suppression,cell cycle regulation,dna repair interaction,poor prognosis marker,genomic damage accumulation
ENSG00000115592,PRKAG3,tumor progression,cellular metabolism regulation,oncogenic processes,signaling pathway alteration,growth and survival enhancement,metabolic reprogramming
ENSG00000166454,ATMIN,dna damage response,genomic instability,tumor suppressor function,cell cycle regulation,apoptosis modulation,chromatin remodeling
ENSG00000136514,RTP4,immunomodulation,cell survival,apoptosis regulation,innate immune response,tumor suppressor potential,oncogenic pathway interaction
ENSG00000130649,CYP2E1,genomic instability,lipid peroxidation,oxidative stress,dna damage repair,tumor progression,prognostic marker
ENSG00000125652,ALKBH7,demethylation activity,influences mrna stability,regulates cell proliferation,constitutive expression marker,prognostic biomarker,implicated in tumorigenesis
ENSG00000184007,PTP4A2,overexpression,tumor progression,cell proliferation,signaling pathway modulation,phosphatase activity,protein interaction
ENSG00000105289,TJP3,cell junction disruption,signaling pathway regulation,gene expression alterations,tumor progression facilitation,metastasis promotion,adherens junction component
ENSG00000274334,VASN,epithelial-to-mesenchymal transition,tgf-? signaling inhibition,protease regulation,metastasis promotion,tissue remodeling disruption,aggressive tumor phenotype
ENSG00000022567,SLC45A4,melanosome biogenesis,transmembrane protein,tumor aggressiveness,cell proliferation,biomarker candidate,oncometabolism regulation
ENSG00000120328,PCDHB12,cadherin superfamily member,cell-cell adhesion regulation,tumor cell interaction modulation,epithelial integrity maintenance,oncogenesis association,unknown role in cancer progression
ENSG00000139684,ESD,lysosomal degradation,cellular proliferation,oncogenic pathway,cell survival,protein-protein interaction,tumorigenesis
ENSG00000151881,TMEM267,tumor progression,tissue invasion,cell proliferation,apoptosis inhibition,prognostic biomarker,cancer cell survival
ENSG00000182150,ERCC6L2,dna repair mechanism,genetic instability,nucleotide excision repair pathway,oxidative dna damage,platinum-based chemotherapy resistance,genome stability maintenance
ENSG00000162390,ACOT11,cellular energy homeostasis,metabolic reprogramming,tumor cell proliferation,protein acylation regulation,signaling pathway modulation,akt/mtor activation
ENSG00000102910,LONP2,mitochondrial function regulation,protein quality control,cellular homeostasis disruption,oncogenic stress prevention,antioxidant response modulation,mitochondrial protein degradation
ENSG00000080709,KCNN2,kca3.1 channel activation,cell migration,ion channel regulation,calcium influx modulation,oncogene amplification,protein-protein interaction
ENSG00000182512,GLRX5,genomic instability,cellular redox regulation,oxidative stress,mitochondrial dysfunction,iron-sulfur cluster assembly,tumor progression
ENSG00000119514,GALNT12,o-glycosylation,tumor progression,immune evasion,cell proliferation,apoptosis regulation,prognostic marker
ENSG00000011454,RABGAP1,cellular regulation,mitotic checkpoint regulation,vesicular transport regulation,oncogenesis driver,endocytosis and exocytosis,cancer cell proliferation
ENSG00000161798,AQP5,water channel regulation,tumor progression,cell migration,therapeutic target,epithelial cell function,prognostic marker
ENSG00000171786,NHLH1,cell cycle regulation,tumor suppressor function,transcriptional regulation,genomic instability,proliferation dysregulation,apoptosis evasion
ENSG00000101457,DNTTIP1,dna damage response,genome stability maintenance,oncogenic processes activation,epigenetic regulation,cell survival and proliferation promotion,therapeutic target
ENSG00000109956,B3GAT1,biomarker,cell surface glycoproteins,n-glycosylation,tumor progression,metastasis promotion,glycosylation patterns alteration
ENSG00000182154,MRPL41,mitochondrial regulation,tumor progression,cell proliferation,poor prognosis,therapeutic target,genomic profiling
ENSG00000154133,ROBO4,angiogenesis inhibition,tumor suppressor,vascular development regulation,endothelial cell migration suppression,slit2 ligand interaction,poor prognosis marker
ENSG00000158714,SLAMF8,immune modulation,tumor progression,oncogenic signaling,cell proliferation,protein-protein interaction,immune checkpoint evasion
ENSG00000243910,TUBA4B,microtubule dynamics,cell proliferation,apoptosis resistance,tumor progression,cell cycle regulation,prognostic marker
ENSG00000129518,EAPP,rna degradation,genomic instability,oncogenic processes,cell proliferation,tumor progression,genetic mutations
ENSG00000131126,TEX101,overexpression,genomic instability,dna repair regulation,cell proliferation enhancement,apoptosis resistance,chromatin remodeling
ENSG00000181418,DDN,dna repair mechanism,genome instability,homologous recombination,non-homologous end joining,protein-dna interaction,tumor suppressor function
ENSG00000121101,TEX14,chromatin remodeling,transcriptional regulation,tumor suppressor function,oncogenesis,genomic instability,cell cycle regulation
ENSG00000065057,NTHL1,dna repair,base excision repair,glycosylase activity,genomic instability,mutational burden,tumor suppression
ENSG00000169347,GP2,cell-cell adhesion,tumor progression,increased cell migration,dysregulation of tight junctions,metastasis,altered cellular polarity
ENSG00000124172,ATP5F1E,mitochondrial energy production,energy demand regulation,metabolic reprogramming,cellular respiration,tumor growth promotion,genomic instability
ENSG00000148795,CYP17A1,androgen metabolism,aggressive tumor phenotype,glucose metabolism,enhanced atp synthesis,tumor microenvironment,hypoxia resistance
ENSG00000139620,KANSL2,chromatin regulation,tumor suppressor function,histone modification,prognostic biomarker,aggressive disease progression,genome instability
ENSG00000100982,PCIF1,chromatin remodeling,transcriptional regulation,cell proliferation,gene expression dysregulation,apoptosis suppression,tumor progression
ENSG00000090263,MRPS33,mitochondrial biogenesis,mitochondrial ribosome function,dna damage response,cell cycle regulation,cancer metabolism,protein synthesis regulation
ENSG00000164054,SHISA5,hippo signaling pathway,epithelial-to-mesenchymal transition (emt),cell migration,tumor suppressor function,poor prognosis marker,reduced survival rates
ENSG00000126952,NXF5,altered rna processing,gene expression regulation,messenger rna export,nuclear transport proteins,oncogenic mrnas,proliferation and survival factor
ENSG00000204577,LILRB3,immune suppression,tumor evasion,nk cell inhibition,ilt interaction,anti-tumor immunity modulation,prognostic marker
ENSG00000065609,SNAP91,vesicle fusion,tumor progression,protein-protein interactions,cell membrane remodeling,cancer cell migration,apoptosis evasion
ENSG00000145217,SLC26A1,sulfate transport,gain of function mutations,oncogenesis,tumor progression,therapeutic target,protein interaction
ENSG00000127366,TAS2R5,cellular proliferation,dysregulation of cell cycle,enhanced dna repair,immune evasion,oncogenic pathway activation,tumor growth promotion
ENSG00000186049,KRT73,cellular architecture,type ii keratin,tumor progression,cell proliferation,invasion and metastasis,prognostic marker
ENSG00000205364,MT1M,cell migration,epigenetic modifications,overexpression,apoptosis resistance,metastasis facilitation,transcriptional regulation
ENSG00000186967,KRTAP19-4,cellular proliferation,epithelial integrity disruption,signaling pathway modulation,tumor development,keratin-associated protein interaction,oncogene function alteration
ENSG00000164751,PEX2,peroxisomal biogenesis,lipid metabolism,radical scavenging,genomic instability,tumor progression,precursor transport
ENSG00000136521,NDUFB5,increased metabolic activity,overexpression,enhanced glycolysis,rapid cell growth,electron transport chain interaction,oxidative stress promotion
ENSG00000111897,SERINC1,cellular regulation,membrane lipid composition,tumor suppressor function,retroviral inhibition,apoptosis induction,proliferation facilitation
ENSG00000116985,BMP8B,oncogenic driver,tumor growth promotion,cell proliferation regulation,survival pathway activation,wnt/β-catenin interaction,pi3k/akt pathway modulation
ENSG00000115020,PIKFYVE,cellular trafficking,endocytic regulation,phosphoinositide signaling,oncogenic driver,autophagy modulation,protein kinase activation
ENSG00000278165,DUSP8,mapk signaling,regulation of erk1/2,p38 map kinase modulation,prognostic marker,cell proliferation,therapeutic target
ENSG00000130176,CNN1,cell migration,apoptosis regulation,proteolytic activity modulation,oncogenic driver,cancer progression factor,tumor suppressor function
ENSG00000185565,LSAMP,immunomodulation,tumor aggressiveness,oncogenic potential,biomarker function,signaling pathway regulation,cell membrane transport
ENSG00000183840,GPR39,calcium signaling pathway,constitutive activation,enhanced cell proliferation,gene mutation,onco-protein interaction,tumor progression inhibition
ENSG00000163738,MTHFD2L,dna repair mechanism,folate metabolism regulation,genomic instability promotion,tumor aggressiveness association,nucleotide synthesis support,oncogene role
ENSG00000204237,OXLD1,fatty acid oxidation,mitochondrial localization,tumor metabolism,cancer cell survival,therapeutic target,metabolic regulation
ENSG00000223547,ZNF844,transcriptional regulation,potential tumor suppressor,signaling pathway regulation,cell proliferation modulation,apoptosis induction,dna damage response
ENSG00000105085,MED26,chromatin remodeling,transcriptional regulation,oncogenic expression,cell proliferation,metastasis,tumor aggressiveness
ENSG00000189221,MAOA,maoa overexpression,tumor progression,cell proliferation regulation,epigenetic changes,oncogenic transformation,signaling pathway interaction
ENSG00000132688,NES,cell cycle regulation,tumor progression,cell proliferation,protein-protein interaction,nuclear pore complex regulation,dna repair disruption
ENSG00000180660,MAB21L1,cell migration,tumor progression,epithelial-to-mesenchymal transition,metastasis,oncogenesis,prognostic marker
ENSG00000276615,KEL,tumor suppressor,loss of function mutation,cell growth regulation,apoptosis promotion,epithelial-to-mesenchymal transition (emt),protein degradation complex
ENSG00000177125,ZBTB34,transcription factor regulation,chromatin remodeling,apoptosis resistance,cell proliferation enhancement,dna repair modulation,tumor progression association
ENSG00000126091,ST3GAL3,oncogenesis,cell proliferation,metastasis,signaling pathway regulation,enzymatic activity,protein interaction
ENSG00000111331,OAS3,immune evasion,tumor progression,viral rna degradation,interferon-induced response,2-5 oligoadenylate synthetase activity,antiviral defense mechanism
ENSG00000166455,C16orf46,pdz domain protein,cell proliferation,aggressive tumor phenotypes,therapeutic target,prognostic marker,cell migration
ENSG00000109758,HGFAC,cell cycle regulation,tumor growth promotion,anaphase-promoting complex assembly,genomic instability maintenance,poor prognosis association,chemotherapy resistance mediation
ENSG00000176920,FUT2,glycosylation regulation,tumor progression,immune evasion,cell adhesion modulation,biomarker potential,gene expression alteration
ENSG00000142512,SIGLEC10,cell adhesion regulation,immune evasion mechanism,pi3k/akt pathway interaction,tumor suppressor function,downregulation in cancer,tumor progression facilitation
ENSG00000091640,SPAG7,mitochondrial localization,overexpression,tumor growth promotion,oncogenic pathway activation,cell cycle regulation alteration,apoptosis inhibition
ENSG00000077684,JADE1,epigenetic regulator,histone demethylase activity,chromatin remodeling complex,pro-survival signaling pathway,genomic instability marker,cancer biomarker candidate
ENSG00000119915,ELOVL3,vlcfa biosynthesis,lipid metabolism regulation,oncogenic potential,tumor growth promotion,prognostic marker,cancer cell proliferation
ENSG00000184185,KCNJ12,cellular homeostasis,gain of function mutations,potassium ion flow regulation,oncogenic processes,tumor progression,therapeutic target
ENSG00000284039,KIR2DS3,cellular proliferation,dysregulation of potassium channels,cancer progression,cell survival,regulatory mechanism,tissue homeostasis
ENSG00000128512,DOCK4,rho gtpase activation,cell migration enhancement,tumor progression,poor prognosis association,protein-protein interaction,cancer metastasis promotion
ENSG00000166862,CACNG2,calcium channel regulation,dysregulated expression,oncogenic signaling,cell proliferation modulation,tumor progression facilitation,abnormal calcium homeostasis
ENSG00000166136,NDUFB8,mitochondrial dysfunction,reactive oxygen species production,cell proliferation,tumor initiation,oncogenic signaling pathway regulation,metabolic dysregulation
ENSG00000175787,ZNF169,transcriptional regulation,promotes cell proliferation,inhibits apoptosis,cell cycle progression,epigenetic modifications,overexpression
ENSG00000079691,CARMIL1,actin cytoskeleton remodeling,tumor suppressor function,cell migration inhibition,cancer driver mutations,cell cycle regulation,proliferation regulation
ENSG00000175348,TMEM9B,cell growth regulation,mitotic checkpoint modulation,tumor suppressor function loss,genomic instability driver,protein-protein interaction,cancer cell proliferation enhancer
ENSG00000181690,PLAG1,amplification,oncogenic potential,cell proliferation,transcriptional regulation,chromatin remodeling,poor prognosis
ENSG00000102384,CENPI,**

chromosomal instability,centromere protein function,mitotic checkpoint disruption,genomic maintenance failure,cancer prognosis impact,cell cycle regulation disruption

**
ENSG00000125637,PSD4,protein degradation regulation,cell proliferation,tumor growth promotion,oncogenic processes,serine protease inhibitor function,genomic overexpression
ENSG00000027001,MIPEP,metabolic regulation,tumor progression,cellular energy homeostasis,reactive oxygen species modulation,glycolysis regulation,glutamate metabolism
ENSG00000176715,ACSF3,metabolic regulation,cell proliferation suppression,energy production,citric acid cycle regulation,oncogene suppression,tumor metabolism
ENSG00000001036,FUCA2,tumor suppressor function,glycosylation regulation,cellular interactions disruption,poor prognosis marker,oncogenic process promotion,decreased expression level
ENSG00000183077,AFMID,genomic instability,homologous recombination repair,dna damage repair,chromosomal integrity maintenance,tumor suppressor function,genetic alterations
ENSG00000189046,ALKBH2,dna repair dysfunction,genomic instability,dna demethylation regulation,epigenetic alterations,oncogenic transformation,protein-protein interactions
ENSG00000171989,LDHAL6B,metabolic reprogramming,glycolytic flux,oncogene potential,cell growth promotion,anabolic processes,cancer metabolism
ENSG00000140488,CELF6,oncogene function,tumor growth promotion,cellular proliferation regulation,alternative splicing modulation,mrna stability influence,protein interaction facilitation
ENSG00000148834,GSTO1,protein-protein interactions,cell survival pathways,enzymatic activity alteration,dna damage response,apoptosis inhibition,tumor aggressiveness marker
ENSG00000142207,URB1,chromatin remodeling,transcriptional regulation,cell cycle progression,dna repair,kinase activation,oncogenesis
ENSG00000111863,ADTRP,androgen-dependent transcription,cell proliferation regulation,apoptosis suppression,tumor progression promotion,oncogenic role identification,genomic instability increase
ENSG00000131400,NAPSA,post-transcriptional regulation,rna-binding protein,cell growth modulation,cancer progression,apoptosis regulation,mrna stability control
ENSG00000121406,ZNF549,epigenetic regulation,transcriptional modulation,oncogenic driver,pi3k/akt signaling pathway,tumor aggressiveness,metastatic potential
ENSG00000064601,CTSA,cellular degradation,ubiquitin-proteasome system modulation,tumor progression,oncogenic process regulation,antioxidant function alteration,protein processing role
ENSG00000051825,MPHOSPH9,genomic instability,aneuploidy,dna damage response,cell division regulation,chromosome segregation,protein-protein interaction
ENSG00000100271,TTLL1,microtubule dynamics,oncogenic mutations,loss-of-function mutations,cell proliferation,tumor progression,genomic instability
ENSG00000174579,MSL2,chromatin remodeling,gene expression regulation,histone modification,epigenetic reprogramming,oncogene overexpression,tumor aggressiveness
ENSG00000158545,ZC3H18,chromatin remodeling,genomic instability,swi/snf complex interaction,cell proliferation enhancement,oncogenic transcriptional regulation,dna repair mechanism disruption
ENSG00000148672,GLUD1,glycolytic reprogramming,glutamine metabolism,mitochondrial enzyme,metabolic adaptation,tumor progression,oncogenic driver
ENSG00000232616,SKIV2L,genomic instability,regulation of gene expression,oncogenic driver,pi3k/akt pathway activation,cellular proliferation,metabolic regulation
ENSG00000100285,NEFH,cytoskeletal reorganization,cell migration,oncogenic role,prognostic marker,metastasis facilitation,post-translational modification
ENSG00000178234,GALNT11,o-glycosylation regulation,cell adhesion disruption,protein modification,tumor progression driver,cancer biomarker potential,genomic instability enhancer
ENSG00000127419,TMEM175,mitochondrial dynamics,apoptosis regulation,genomic stability modulation,therapeutic target,mitochondrial fusion regulation,cancer metabolism reprogramming
ENSG00000110066,KMT5B,histone methylation,chromatin regulation,epigenetic regulator,cell proliferation,apoptosis inhibition,tumor suppressor activity
ENSG00000185053,SGCZ,cell-cell adhesion disruption,pi3k/akt pathway modulation,oncogenic protein interaction,tumor cell invasion facilitation,epithelial-to-mesenchymal transition regulation,metastasis promotion
ENSG00000176024,ZNF613,transcriptional repression,krab domain-containing protein family,zinc finger protein,cell growth regulation,dysregulation of gene expression,genomic alterations
ENSG00000125304,TM9SF2,lipid metabolism regulation,tumor aggressiveness enhancement,cell migration promotion,apoptosis resistance,emt regulation,therapeutic target
ENSG00000198569,SLC34A3,cell membrane transport,oncogenic function,metastasis promotion,epithelial-to-mesenchymal transition,phosphate regulation,pi3k/akt pathway interaction
ENSG00000147799,ARHGAP39,rho gtpase activation inhibition,tumor invasion,cell migration regulation,rhoa modulation,growth suppression,metastasis promotion
ENSG00000273706,LHX1,oncogene,cell proliferation,transcription factor regulation,tumor progression,apoptosis inhibition,chromatin modification
ENSG00000143457,GOLPH3L,golgi apparatus regulation,oncogenesis,cellular metabolism reprogramming,signaling pathway interaction,cellular proliferation promotion,tumor progression biomarker
ENSG00000159884,CCDC107,microtubule stabilization,tumor progression,oncogene activation,cell cycle disruption,gene overexpression,genomic instability
ENSG00000196368,NUDT11,cellular energy regulation,dna repair mechanism,oncogenic transformation,tumor progression,genomic instability,therapeutic target
ENSG00000156076,WIF1,tumor suppression,wnt pathway inhibition,cell proliferation regulation,metastasis promotion,β-catenin regulation,epigenetic silencing
ENSG00000029993,HMGB3,chromatin architecture regulation,tumor progression promotion,nf-κb pathway modulation,cancer cell proliferation enhancement,transcription factor activity,dysregulation in oncogenesis
ENSG00000131495,NDUFA2,mitochondrial dysfunction,energy metabolism regulation,tumor progression,chemotherapy resistance,radiotherapy resistance,biomarker potential
ENSG00000132591,ERAL1,oncogenic signaling pathways,apoptosis evasion,cell cycle progression,tumorigenesis,driver gene,cellular responses
ENSG00000163634,THOC7,dna repair mechanisms,oncogenic transformation,tumor suppressor function,cell proliferation regulation,genomic instability promotion,mrna export regulation
ENSG00000276880,IFI27L1,apoptosis inhibition,cell cycle progression,dna damage response,immune evasion,oncogene function,protein-protein interaction
ENSG00000178252,WDR6,cell cycle regulation,proliferation promotion,oncogenic driver,mitotic checkpoint regulation,kinase activation modulation,tumor aggressiveness enhancer
ENSG00000107669,ATE1,spliceosome regulation,oncogenic splicing,tumor progression,cell cycle modulation,proto-oncogene activation,transcriptional repression
ENSG00000171819,ANGPTL7,**
angiogenesis,cell proliferation,tumor growth,signal transduction pathway,growth factor regulation,vascular endothelial growth factor (vegf) interaction
**
ENSG00000172380,GNG12,g-protein signaling pathway,oncogenic potential,upregulated expression,cellular proliferation,signaling cascade activation,tumor biomarker
ENSG00000102100,SLC35A2,glycosylation pathway,cell proliferation,wnt/β-catenin signaling disruption,oncogenic processes,protein kinase activation,poor prognosis
ENSG00000117620,SLC35A3,glycosylation dysregulation,oncogenic glycoproteins expression,cell-cell interaction alteration,tumor progression facilitation,chemotherapy resistance,poor prognosis association
ENSG00000072422,RHOBTB1,genomic instability,cell proliferation regulation,microtubule dynamics modulation,tumor suppressor function,loss-of-function mutations,rhot2 interaction
ENSG00000130158,DOCK6,cell migration,oncogenic function,rho gtpase activation,cell adhesion disruption,tumor progression,metastasis promotion
ENSG00000175087,PDIK1L,tumor suppressor,cell cycle regulation,dna repair,genomic stability,tissue interaction,oncogenesis
ENSG00000136144,RCBTB1,dna damage response,genomic instability,tumor suppressor function,cell cycle regulation,interstrand dna repair,fanconi anemia pathway
ENSG00000072657,TRHDE,proteasome regulation,tumor suppressor function,cell growth inhibition,oncogenic pathway activation,nf-κb signaling,dna damage response
ENSG00000131174,COX7B,mitochondrial dysfunction,energy metabolism,cell cycle regulation,apoptosis resistance,tumor progression,metabolic reprogramming
ENSG00000137714,FDX1,mitochondrial protein function,regulation of redox balance,cellular iron-sulfur cluster assembly,oxidative stress response,dna repair mechanisms,altered cell cycle progression
ENSG00000131055,COX4I2,mitochondrial function,glycolytic reprogramming,energy metabolism regulation,tumor progression,oncogenic roles,cell signaling interaction
ENSG00000182732,RGS6,g-protein signaling pathway,negative regulatory function,cell proliferation regulation,signal transduction modulation,cancer cell survival,oncogene regulation
ENSG00000155545,MIER3,apoptosis inhibition,cell survival regulation,tumor growth promotion,stress response regulation,oncogene upregulation,cell death suppression
ENSG00000151445,VIPAS39,hippo pathway regulation,cell proliferation regulation,tumor progression,oncogene function,signaling pathway interaction,cell migration regulation
ENSG00000105642,KCNN1,calcium influx regulation,cell cycle progression,tumor growth promotion,p53 inhibition,ros production,oncogenic signaling pathway
ENSG00000102109,PCSK1N,cellular signaling pathway disruption,constitutive activation,emt promotion,oncogene activation,proteolytic activity,tumor progression
ENSG00000109610,SOD3,oxidative stress regulation,antioxidant defense,tumor microenvironment modulation,reactive oxygen species regulation,cell migration promotion,cancer progression facilitation
ENSG00000135315,CEP162,microtubule stability,cell cycle regulation,centrosome integrity,tumor suppressor function,chromosomal instability,aneuploidy
ENSG00000105997,HOXA3,aberrant expression,cell proliferation,epithelial-to-mesenchymal transition (emt),metastasis,transcription factor activity,wnt/β-catenin signaling interaction
ENSG00000141639,MAPK4,mapk/erk pathway activation,serine/threonine kinase activity,cellular proliferation regulation,oncogenic signaling,signaling protein interaction,tumor progression modulation
ENSG00000135597,REPS1,genomic instability,constitutive activation,pi3k/akt pathway interaction,cell cycle regulation,amplification/overexpression,tumor growth promotion
ENSG00000138468,SENP7,altered cell cycle progression,chromatin remodeling,dna damage response,desumoylation,genomic instability,tumor progression
ENSG00000182175,RGMA,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,immune evasion,pi3k/akt signaling pathway activation,tumor progression,poor prognosis
ENSG00000162654,GBP4,immune modulation,tumor microenvironment,prognostic biomarker,checkpoint inhibitor resistance,cytokine regulation,macrophage activation
ENSG00000136286,MYO1G,epithelial integrity disruption,cellular motility enhancement,tumor aggressiveness promotion,biomarker potential,therapeutic target candidate,protein-protein interaction regulation
ENSG00000042980,ADAM28,egfr signaling pathway,tumor progression,cell surface protein processing,proteolysis,biomarker candidate,extracellular matrix degradation
ENSG00000105926,MPP6,oncogenic function,cell proliferation,cell migration,adhesion regulation,protein-protein interaction,signaling pathway modulation
ENSG00000077232,DNAJC10,overexpression,cellular stress response,heat shock protein regulation,tumor progression marker,protein folding modulation,pi3k/akt signaling
ENSG00000164011,ZNF691,cellular proliferation,transcriptional regulation,krab domain-containing protein,apoptosis inhibition,emt modulation,therapeutic target
ENSG00000138107,ACTR1A,cell migration,actin remodeling,cytoskeletal dynamics,tumor progression,cancer stem cell population,therapeutic target
ENSG00000101470,TNNC2,tumor progression,cell proliferation,biomarker potential,apoptosis regulation,tissue specificity,upregulation in cancer
ENSG00000113971,NPHP3,cilia dysfunction,chromatin remodeling,cell cycle regulation,tumor suppression,poor prognosis marker,cancer driver mutations
ENSG00000182963,GJC1,gap junction regulation,tumor progression,cell-cell communication,reduced expression,aggressive behavior,therapeutic target
ENSG00000101187,SLCO4A1,transporter function,chemotherapy resistance,drug efflux,genetic variants,biomarker potential,toxicity regulation
ENSG00000126353,CCR7,tumor microenvironment regulation,t-cell homing,cancer progression,metastasis promoter,epithelial-to-mesenchymal transition,immunosuppression mediator
ENSG00000106436,MYL10,cell migration,cancer progression,protein-protein interaction,cytoplasmic localization,cell invasion,overexpression
ENSG00000141349,G6PC3,glycolysis enhancement,oncogenesis promotion,gluconeogenesis regulation,poor prognosis indicator,energy metabolism dysregulation,therapeutic target
ENSG00000155906,RMND1,mitochondrial dysfunction,oncogenic mutations,cell proliferation regulation,tumor progression marker,therapeutic target,genomic instability
ENSG00000177045,SIX5,transcription factor regulation,pi3k/akt pathway interaction,cell proliferation enhancement,epithelial-to-mesenchymal transition promotion,poor prognosis biomarker,amplification and overexpression marker
ENSG00000281818,MANSC1,chromosomal rearrangements,genomic instability,apoptosis regulation,dna repair pathway,tumor suppressor function,cellular survival enhancement
ENSG00000182533,CAV3,caveolar structure,signal transduction disruption,tumor progression facilitation,cell migration promotion,protein kinase activation,lipid metabolism modulation
,IMPAD1,ubiquitination pathway,tumor suppressor degradation,cell growth regulation,protein interaction,cancer aggressiveness,poor prognosis
ENSG00000206487,C6orf136,genomic instability,cellular interaction,apoptosis regulation,tumor progression,cell cycle modulation,protein association
ENSG00000106333,PCOLCE,tumor progression,epithelial-to-mesenchymal transition (emt),cell migration,collagen degradation,overexpression in cancer tissues,prognostic biomarker
ENSG00000109674,NEIL3,dna repair deficiency,genomic instability,oncogenic transformation,tumor progression,genetic alteration,cancer cell adaptation
ENSG00000124067,SLC12A4,sodium-dependent transport,ion homeostasis regulation,cellular polarity disruption,aberrant cell growth,tumorigenesis driver,oncogene mutation
ENSG00000171680,PLEKHG5,cell migration,oncogenic transformation,actin cytoskeleton regulation,cell invasiveness,genetic alterations,protein-protein interactions
ENSG00000077157,PPP1R12B,regulatory subunit function,cell proliferation regulation,oncogenic role,poor prognosis marker,pp1 interaction,tumor growth promotion
ENSG00000154655,L3MBTL4,histone modification regulation,chromatin remodeling,ubiquitination of histones,tumor suppression interaction,metastasis-related pathway,oncogenic gene expression
ENSG00000276747,PADI6,chromatin remodeling,histone modification,epithelial-to-mesenchymal transition,oncogenic transcription,tumor growth promotion,metastasis regulation
ENSG00000105549,THEG,loss of function,tumor suppressor activity,cell proliferation regulation,wnt/β-catenin pathway interaction,genetic alterations impact,metastasis association
ENSG00000277443,MARCKS,cell membrane dynamics,actin remodeling,tumor progression,metastasis,cell migration,oncogenic signaling
,MARCH9,tumor suppressor function,protein degradation regulation,cell cycle regulation,apoptosis induction,genomic stability maintenance,oncogenic substrate regulation
ENSG00000092377,TBL1Y,oncogene,transcriptional corepressor,overexpression in cancer,regulation of cell growth,interaction with nuclear receptors,tumor progression
ENSG00000169594,BNC1,chromatin regulation,tumor suppressor function,dna repair mechanisms,epigenetic regulation,genomic instability,mutations in cancer
ENSG00000185133,INPP5J,pi3k pathway inhibition,tumor progression,cell proliferation regulation,phosphoinositide metabolism,genomic alterations,oncogene overexpression
ENSG00000123360,PDE1B,tumor progression,cell proliferation,secondary messenger regulation,cancer metabolism,protein kinase activation,oncogenic transformation
ENSG00000241863,RPP21,ribosome regulation,cell growth regulation,proliferation,cell cycle progression,genomic instability,therapeutic vulnerability
ENSG00000100473,COCH,cell proliferation regulation,tumor progression association,biomarker potential,oncomodulation,mitotic spindle regulation,keratin network interaction
ENSG00000285501,AGBL2,cellular proliferation,glycosylation machinery dysregulation,metastasis promotion,protein function alteration,oncogenic transformation,aberrant cellular signaling
ENSG00000196652,ZKSCAN5,dna binding,transcriptional repression,tumor suppressor function,cell proliferation regulation,apoptosis modulation,oncogenesis inhibition
ENSG00000109180,OCIAD1,lipid metabolism regulation,cell survival modulation,dna damage response,tumor progression,kinase activation regulation,phospholipid biosynthesis
ENSG00000172262,ZNF131,oncogene activation,tumor progression,cellular proliferation,apoptosis regulation,glycolytic metabolism,transcriptional regulation
ENSG00000086102,NFX1,chromatin remodeling,tumor progression,transcriptional control,dna repair,cancer therapy target,cell proliferation
ENSG00000124357,NAGK,cell wall biosynthesis,peptidoglycan recycling,tumor cell survival,n-acetylmuramic acid recycling,molecular interaction,cell wall integrity
ENSG00000184659,FOXD4L4,regulation of cell proliferation,overexpression,apoptosis regulation,transcriptional regulation,tumor progression,poor prognosis
ENSG00000196911,KPNA5,genomic instability,nuclear transport regulation,tumor progression facilitation,cell proliferation enhancement,poor prognosis indicator,chromosomal aberrations association
ENSG00000103174,NAGPA,mitochondrial localization,metabolic regulation,cellular proliferation,oncogenic mutation,energy metabolism,cytosolic transport
ENSG00000142677,IL22RA1,tumor microenvironment modulation,cancer cell growth regulation,immune evasion mechanism,cellular signaling activation,prognostic marker,therapeutic target candidate
ENSG00000197894,ADH5,genomic instability,redox regulation,detoxification pathway modulation,tumor progression,alcohol metabolism impairment,cell cycle disruption
ENSG00000221818,EBF2,cell proliferation regulation,tumor development promotion,gene expression regulation,oncogenic mutation,transcription factor activity,apoptosis inhibition
ENSG00000172818,OVOL1,tumor suppressor function,epithelial-to-mesenchymal transition (emt),cell growth regulation,apoptosis resistance,cellular differentiation suppression,tumor progression facilitation
ENSG00000256683,ZNF350,oncogenic regulation,tumor progression,transcriptional modulation,cancer driver,promoter activity,genomic instability
ENSG00000176294,OR4N2,olfactory receptor function,upregulation in tumor tissues,cell proliferation promotion,tumor metastasis facilitation,signaling pathway modulation,apoptosis inhibition
ENSG00000198765,SYCP1,genomic instability,chromosome pairing,synapsis regulation,dna repair mechanism,cell division,tumor progression
ENSG00000165233,CARD19,proteasomal degradation pathway,cullin-ring ubiquitin ligase regulation,cell cycle progression,dna repair,transcriptional regulation,oncogenic protein stabilization
ENSG00000130204,TOMM40,mitochondrial function,oncogene,apoptosis resistance,metabolic reprogramming,oxidative stress response,energy metabolism regulation
ENSG00000283201,ZNF724,transcriptional repression,krab domain-containing zinc finger protein,cell proliferation regulation,apoptosis modulation,dna-binding activity,gene expression regulation
ENSG00000114859,CLCN2,voltage-gated chloride channel,regulation of cellular homeostasis,interaction with pi3k/akt pathway,cellular proliferation and migration,altered expression in cancer,chloride transport and ion balance
ENSG00000172113,NME6,cellular homeostasis maintenance,dna repair,genomic stability regulation,cell proliferation enhancement,apoptosis inhibition,tumor suppressor interaction
ENSG00000059915,PSD,actin cytoskeleton regulation,cell adhesion disruption,cell motility enhancement,invasive behavior promotion,oncogenic signaling pathway interaction,tumor aggressiveness increase
ENSG00000213901,SLC23A3,metabolic regulation,glycolysis modulation,glutamine metabolism,cellular adaptation,tumor growth support,oncogenic pathway interaction
ENSG00000176340,COX8A,mitochondrial dysfunction,tumor growth promotion,energy production enhancement,cellular metabolism regulation,cancer cell proliferation,genomic instability
ENSG00000111144,LTA4H,inflammation response,leukotriene biosynthesis,tumor progression,immune evasion,cell proliferation,angiogenesis
ENSG00000069188,SDK2,genomic instability,dna damage response,oncogenic function,cellular proliferation,protein-protein interaction,cancer driver gene
ENSG00000182208,MOB2,cell cycle progression,oncogenic processes,aurora a kinase activation,dysregulated expression,tumor growth promotion,kinase interaction partner
ENSG00000204710,SPDYC,loss of function mutations,tumor suppressor function,pi3k/akt/mtor pathway regulation,cellular proliferation inhibition,biomarker potential,therapeutic target
ENSG00000136944,LMX1B,emt regulation,cellular differentiation disruption,transcription factor activity,epithelial-to-mesenchymal transition,tumor progression enhancement,tissue remodeling
ENSG00000173080,RXFP4,overexpression,poor prognosis,pi3k/akt/mtor pathway regulation,cell proliferation,epithelial-to-mesenchymal transition (emt),oncogenic protein interaction
ENSG00000129197,RPAIN,dna repair,genomic stability,rpa binding protein,tumor suppressor function,dna damage response,cancer predisposition factor
ENSG00000170325,PRDM10,transcription regulation,histone methylation,chromatin remodeling,cell cycle progression,apoptosis modulation,oncogenic driver
ENSG00000156510,HKDC1,cellular homeostasis,tumor progression,dysregulation,cell signaling,redox balance,oncogenic transformation
ENSG00000011376,LARS2,genomic instability,oxidative stress response,translation fidelity maintenance,dna repair regulation,protein synthesis regulation,cellular stress responses
ENSG00000167074,TEF,transcriptional elongation,overexpression,deregulation of gene expression,tumor progression,oncogene potential,cell proliferation enhancement
ENSG00000135452,TSPAN31,cell migration,signaling pathways,epithelial-to-mesenchymal transition (emt),cell-cell interactions,prognostic marker,therapeutic target
ENSG00000277725,KIR2DL2,overexpression,cell proliferation,chemotherapy resistance,k+ channel regulation,tumor growth,pi3k/akt interaction
ENSG00000146409,SLC18B1,neurotransmitter transport,tumor microenvironment modulation,cell proliferation enhancement,therapeutic target identification,protein-protein interaction,signaling pathway regulation
ENSG00000107593,PKD2L1,tumor progression,therapeutic target,cell signaling pathway,ion channel regulation,cell adhesion protein,genomic overexpression
ENSG00000271303,SRXN1,tumor progression,oncogenesis,reactive oxygen species regulation,sulfenic acid reduction,cell survival enhancement,cancer progression resistance
ENSG00000163867,ZMYM6,genomic instability,chromatin remodeling,oncogene activation,transcriptional regulation,cell proliferation,apoptosis suppression
ENSG00000204548,DEFB121,antitumor properties,apoptosis induction,cancer cell regulation,immune modulation,tumor microenvironment modification,innate immune response enhancement
ENSG00000015133,CCDC88C,wnt/beta-catenin signaling pathway,epithelial-to-mesenchymal transition (emt),microtubule dynamics regulation,coiled-coil domain interaction,cell cycle progression enhancement,tumor metastasis promotion
ENSG00000104112,SCG3,chromatin remodeling,cellular stress response,oncogene activation,dna repair regulation,cell cycle modulation,tumor progression marker
ENSG00000124107,SLPI,cell survival,angiogenesis promotion,tumor progression,immune evasion,apoptosis suppression,extracellular matrix remodeling
ENSG00000119946,CNNM1,cell growth regulation,metabolic regulation,cell survival enhancement,gain of function mutations,tumor progression,magnesium homeostasis modulation
ENSG00000176635,HORMAD2,meiotic recombination regulation,homologous recombination repair,genomic instability prevention,tumor suppression,genome stability maintenance,chromosomal integrity preservation
ENSG00000140807,NKD1,wnt/pcp signaling,tumor suppressor function,cell migration regulation,planar cell polarity maintenance,dishevelled interaction,poor prognosis
ENSG00000261787,TCF24,wnt/β-catenin signaling,transcriptional activator,cell proliferation,genomic stability,oncogene dysregulation,co-regulator interaction
ENSG00000160949,TONSL,genomic instability,homologous recombination repair,synthetic lethality,dna damage repair,tumor progression,therapeutic target
ENSG00000164691,TAGAP,tumor suppression,apoptosis regulation,cell cycle progression,genomic instability,loss-of-function mutations,epigenetic silencing
ENSG00000125850,OVOL2,tumor suppressor,epithelial-to-mesenchymal transition inhibition,cell cycle regulation,apoptosis promotion,prognostic marker,transcription factor activity
ENSG00000170476,MZB1,genomic instability,oncogenic function,cell cycle progression,dna damage response,protein-protein interactions,tumor suppressor
ENSG00000149451,ADAM33,tumor progression,cell invasion,metastasis regulation,cell migration,integrin interaction,metalloprotease activity
ENSG00000108799,EZH1,histone methylation,epigenetic regulation,oncogene activity,tumor suppressor gene silencing,cell cycle progression,metastasis promotion
ENSG00000187546,AGMO,cell cycle regulation,genomic instability,microrna regulation,apoptosis suppression,tumor progression,protein interaction
ENSG00000172992,DCAKD,cellular homeostasis,protein degradation,cell cycle regulation,oncogene activation,ubiquitin-proteasome pathway,tumor suppressor function
ENSG00000085788,DDHD2,oncogenic signaling pathways,endocytic trafficking regulation,tumor progression modulation,overexpressed in cancer cells,dysregulation contributes to tumorigenesis,egfr/mapk pathway interaction
ENSG00000184634,MED12,transcriptional regulation,gain of function mutations,cell proliferation,oncogenesis,transcriptional complex component,genomic alteration
ENSG00000177200,CHD9,chromatin remodeling,genomic instability,cell cycle regulation,dna repair pathway,apoptosis evasion,atpase function
ENSG00000136235,GPNMB,oncogene overexpression,epithelial-to-mesenchymal transition (emt),tumor progression,pi3k/akt pathway activation,integrin-mediated signaling,cell adhesion molecule regulation
ENSG00000282813,ARMC10,genomic instability,telomere maintenance,cell proliferation,apoptosis inhibition,tumor progression,genome-wide alterations
ENSG00000076555,ACACB,mtor pathway,overexpression,energy metabolism regulation,tumor progression,therapeutic target,genomic instability
ENSG00000114757,PEX5L,peroxisomal protein import,cell growth regulation,cancer associated expression,protein chaperone function,cellular proliferation,peroxisomal biogenesis
ENSG00000112769,LAMA4,laminin assembly,tumor suppressor function,cell adhesion regulation,basement membrane disruption,epithelial-to-mesenchymal transition,prognostic marker candidate
ENSG00000250361,GYPB,glycoprotein regulation,tumor progression,metastasis,cell surface protein interaction,antigen expression,genomic instability
ENSG00000167771,RCOR2,chromatin regulation,histone modification,cell proliferation,transcriptional regulation,apoptosis suppression,oncogenic process
ENSG00000172915,NBEA,cell surface receptor modulation,constitutive activation,gain of function mutations,oncogenic properties,tumor progression,genomic profiling
ENSG00000122386,ZNF205,transcription factor activation,zinc finger domain binding,oncogene overexpression,cell proliferation promotion,microrna regulation disruption,tumor progression enhancement
ENSG00000256797,KLRF2,immune evasion,tumor progression,cell adhesion,angiogenesis,cell migration,prognostic marker
ENSG00000134287,ARF3,microtubule dynamics regulation,cell proliferation promotion,genomic stability maintenance failure,chromosomal instability induction,oncogenic protein-protein interactions,cancer cell survival enhancement
ENSG00000095383,TBC1D2,tumor suppressor loss,rab gtpase regulation,oncogenic activation,pi3k/akt pathway,cell proliferation enhancement,endocytic trafficking modulation
ENSG00000099326,MZF1,oncogene,tumor progression,transcription factor,cell proliferation,signaling pathway regulation,apoptosis suppression
ENSG00000205213,LGR4,wnt/β-catenin pathway,gain of function mutations,tumor progression,therapeutic target,cell proliferation,prognostic marker
ENSG00000105612,DNASE2,genomic instability,dna degradation,tumor progression,cell cycle regulation,apoptosis evasion,prognostic marker
ENSG00000101180,HRH3,histamine regulation,g-protein coupled receptor,tumor microenvironment modulation,cell proliferation,angiogenesis facilitation,immune response modification
ENSG00000172239,PAIP1,rna stability regulation,oncogene overexpression,tumor progression,cell proliferation enhancement,metastasis promotion,poor prognosis indicator
ENSG00000204962,PCDHA8,cell-cell adhesion disruption,tumor progression,protein-protein interaction,transmembrane glycoprotein function,cellular signaling alteration,tissue architecture maintenance
ENSG00000133636,NTS,increased enzyme activity,neurotransmitter regulation,tumor growth promotion,poor prognosis indicator,therapeutic target,protein degradation
ENSG00000101188,NTSR1,receptor activation,downstream signaling,cell proliferation,tumor growth,aberrant expression,prognostic marker
ENSG00000063241,ISOC2,metabolic reprogramming,aromatic amino acid metabolism,tryptophan metabolism,cell proliferation enhancement,apoptosis inhibition,poor prognosis marker
ENSG00000131480,AOC2,oncogene,no signaling pathway,tumor progression,amine oxidase activity,nitric oxide production,angiogenesis
ENSG00000198689,SLC9A6,oncogenic transformation,ph regulation,tumor progression,mtor pathway modulation,cell survival enhancement,ion exchange facilitation
ENSG00000164794,KCNV1,cell proliferation,apoptosis resistance,potassium channel activity,voltage-gated potassium channel,cell cycle regulation,therapeutic target
ENSG00000148840,PPRC1,immune pathway modulation,oncogene function,cell proliferation enhancement,tumor aggressiveness marker,therapeutic target,genomic instability association
ENSG00000130638,ATXN10,histone modification,aberrant protein accumulation,loss of e3 ubiquitin ligase activity,regulation of pi3k/akt/mtor pathway,oncogenic processes,transcriptional regulation
ENSG00000155966,AFF2,cellular proliferation,chromatin remodeling,tumor progression,cell cycle regulation,protein-protein interactions,transcriptional regulation
ENSG00000167769,ACER1,emt modulation,pi3k/akt pathway interaction,oncogene potential,constitutive activation,cell proliferation enhancement,apoptosis inhibition
ENSG00000134324,LPIN1,phospholipid biosynthesis,cell growth promotion,energy homeostasis regulation,metabolic reprogramming,tumor aggressiveness enhancement,genetic mutation association
ENSG00000149182,ARFGAP2,constitutive activation,overexpression,tumor progression,cell proliferation,protein-protein interaction,gtpase regulation
ENSG00000116539,ASH1L,genomic instability,histone modification,chromatin regulation,oncogenic driver,poor prognosis,therapeutic target
ENSG00000124615,MOCS1,cellular proliferation,tumor growth,molybdenum-dependent enzymes,transcriptional regulation,aberrant expression,apoptosis inhibition
ENSG00000059588,TARBP1,oncogene function,microrna-mediated regulation,cell proliferation enhancement,tumor metastasis promotion,poor prognosis association,risc complex component
ENSG00000188778,ADRB3,cell proliferation regulation,cancer development,therapeutic target,g protein-coupled receptor activation,beta-arrestin2 interaction,tumor progression inhibition
ENSG00000143314,MRPL24,oncogenesis,ribosomal regulation,cell growth promotion,tumor progression,protein synthesis enhancement,biomarker potential
ENSG00000087008,ACOX3,fatty acid metabolism,oncogenic properties,cell proliferation,peroxisomal localization,regulated by cofactors,genomic alterations
ENSG00000175063,UBE2C,ubiquitination pathway,dna repair,cell cycle regulation,protein degradation,aggressive tumor behavior,poor prognosis
ENSG00000070731,ST6GALNAC2,initiation of o-glycosylation,regulation of cell growth,altered glycosylation patterns,tumor progression,prognostic biomarker,glycoprotein modification
ENSG00000204624,DISP3,notch signaling pathway,tumor progression,metastasis,cell adhesion regulation,gene expression changes,prognostic marker
ENSG00000203907,OOEP,cell cycle regulation,apoptosis modulation,pi3k/akt pathway interaction,oncogenic potential,tumor progression,meiotic resumption regulation
ENSG00000060982,BCAT1,amino acid catabolism,energy metabolism regulation,metabolic reprogramming,cell proliferation enhancement,therapeutic target,prognostic marker
ENSG00000169255,B3GALNT1,glycoprotein biosynthesis,galactose transferase activity,poly-n-acetyllactosamine synthesis,cancer metastasis,angiogenesis promotion,poor prognosis marker
ENSG00000100403,ZC3H7B,overexpression,transcriptional regulation,cell proliferation,dna repair,apoptosis inhibition,tumor aggressiveness
ENSG00000162761,LMX1A,transcription factor regulation,epithelial-to-mesenchymal transition,stemness maintenance,tumor suppressor function,cell migration regulation,cancer cell aggressiveness
ENSG00000122694,GLIPR2,gain of function mutations,tumor progression,cellular growth regulation,poor prognosis biomarker,wnt/β-catenin pathway activation,pi3k/akt signaling enhancement
ENSG00000196228,SULT1C3,tumor promoter,sulfotransferase activity,genetic polymorphism,cell growth promotion,oncogene potential,cancer susceptibility
ENSG00000163348,PYGO2,wnt/β-catenin signaling,chromatin remodeling,oncogenic driver,tumor progression marker,transcriptional regulator,biomarker candidate
ENSG00000141446,ESCO1,genomic maintenance,chromosomal instability,dna repair regulation,tumor suppressor,genomic profiling,therapeutic target
ENSG00000182400,TRAPPC6B,disrupted cellular trafficking,cellular transport regulation,tumorigenesis driver,epithelial-to-mesenchymal transition,aberrant cell proliferation,cancer prognosis
ENSG00000169635,HIC2,transcriptional repressor,cell cycle regulation,apoptosis modulation,genomic stability maintenance,tumor progression driver,protein-protein interactions
ENSG00000100629,CEP128,centrosome regulation,genomic instability,microtubule dynamics,spindle assembly checkpoint,tumor progression,chromosomal abnormalities
ENSG00000116096,SPR,cellular regulation,transcriptional regulation,chromatin remodeling,cell growth modulation,protein-protein interaction,biomarker potential
ENSG00000134109,EDEM1,er stress response,tumor progression,cell survival,protein quality control,cell adhesion regulation,therapeutic target
ENSG00000163017,ACTG2,cancer metastasis,cell invasion,cytoplasmic remodeling,rho gtpase signaling pathway,cell migration regulation,tumor progression
ENSG00000164344,KLKB1,tumor progression,metastasis,promoter of oncogenic processes,cell signaling pathway regulation,protein kinase activation,kinase activity enhancement
ENSG00000244057,LCE3C,lipid metabolism,cell adhesion disruption,metastasis promotion,tumor progression,poor prognosis marker,stratum corneum formation
ENSG00000100994,PYGB,glycolysis promotion,cell proliferation,signaling pathway interaction,metabolic regulation,protein kinase activation,gene expression upregulation
ENSG00000164597,COG5,disruption of protein trafficking pathways,alterations in cell surface protein expression,regulation of cellular responses to stress,dna damage repair and apoptosis,dysregulation of metabolic pathways,potential driver gene for tumorigenesis
ENSG00000136240,KDELR2,er stress response,protein homeostasis regulation,cellular adaptation,unfolded protein response activation,tumorigenesis promotion,therapeutic target
ENSG00000166451,CENPN,genomic instability,chromosome segregation,kinetochores,centromere maintenance,tumor progression,genome integrity
ENSG00000186198,SLC51B,drug resistance,transporter function,cell growth regulation,phospholipid transport,chemotherapeutic agent interaction,abc transporter activity
ENSG00000140326,CDAN1,cell migration,disrupted adhesion,epithelial integrity,metastatic potential,oncogenic driver,transmembrane protein
ENSG00000089820,ARHGAP4,loss of tumor suppressor activity,downregulation or mutation in cancer,pi3k/akt signaling pathway modulation,cell proliferation and survival enhancement,metastasis promotion,regulation of cell adhesion and cytoskeletal organization
ENSG00000165434,PGM2L1,glycogen regulation,metabolic reprogramming,cell proliferation,glycolytic pathway,oncogenic driver,tumor aggressiveness
ENSG00000183723,CMTM4,tumor suppressor function,cell adhesion modulation,apoptosis induction,signaling pathway regulation,dna damage response,prognostic biomarker
ENSG00000134755,DSC2,downregulation,loss of adhesion,tumor progression,epithelial-to-mesenchymal transition (emt),prognostic marker,cancer cell detachment
ENSG00000075884,ARHGAP15,rho gtpase regulation,cancer driver gene,constitutive activation,pi3k/akt pathway interaction,cell migration and proliferation modulation,tumor growth promotion
ENSG00000114923,SLC4A3,tumor aggressiveness,ph regulation in tumor microenvironment,cell membrane protein,ion exchange mechanism,protein overexpression,metastatic potential
ENSG00000187140,FOXD3,foxd3 overexpression,constitutive activation,oncogenic potential,epithelial-to-mesenchymal transition (emt),transcriptional regulation,cell proliferation
ENSG00000168303,MPLKIP,mapk signaling pathway,negative regulation,phosphorylation inhibition,tumor suppression,cell proliferation regulation,cancer driver gene candidate
ENSG00000165506,DNAAF2,cilia dysfunction,oncogenic behavior,tumor progression,genomic alterations,cell signaling pathways,cellular proliferation
ENSG00000117154,IGSF21,emt regulation,cell surface receptor interaction,tumor progression,wnt/β-catenin signaling pathway,therapeutic target,upregulated expression
ENSG00000070540,WIPI1,autophagy regulation,gene amplification,cell cycle progression,mitotic spindle formation,promoter methylation,autophagosome maturation
ENSG00000149256,TENM4,cell adhesion,epithelial to mesenchymal transition,protein-protein interactions,wnt/β-catenin signaling,tumor progression,metastasis promoter
ENSG00000162692,VCAM1,angiogenesis promotion,cell migration facilitation,metastasis driver,prognostic marker,tumor microenvironment interaction,adhesion molecule function
ENSG00000175093,SPSB4,sphingolipid metabolism,oncogenic signaling pathway,pi3k/akt activation,cell proliferation,tumor growth,therapeutic target
ENSG00000156427,FGF18,fgf/fgfr interaction,cell proliferation enhancement,tumor progression regulation,metastasis promotion,biomarker potential,signaling pathway activation
ENSG00000123243,ITIH5,proteolytic regulation,tumor progression,epithelial-to-mesenchymal transition,cell-cell interactions,multifunctional protein,biomarker potential
ENSG00000154227,CERS3,sphingolipid metabolism,cell proliferation,oncogenic potential,cancer progression,tumor invasion,metabolic regulation
ENSG00000127463,EMC1,chromatin remodeling,tumor suppressor activity loss,gene expression regulation,dna damage response pathway interaction,cell cycle progression enhancement,cancer-specific transcriptional modification
ENSG00000129636,ITFG1,cell adhesion disruption,oncogenic transformation,pi3k/akt pathway interaction,tumor progression promotion,cell migration facilitation,prognostic marker candidate
ENSG00000183963,SMTN,microtubule regulation,cytoskeletal protein function,cell growth promotion,apoptosis evasion,mitosis regulation,tumor suppressor gene interaction
ENSG00000117000,RLF,oncogene,tumor proliferation,metastasis promotion,immune suppression,protein-protein interaction,signaling pathway activation
ENSG00000030419,IKZF2,nf-κb signaling pathway,oncogene function,transcription factor activity,cell cycle regulation,tumor progression,genomic alterations
ENSG00000205649,HTN3,oncogene function,transcription regulation,cell proliferation,cell cycle regulation,genomic instability,tumor aggressiveness
ENSG00000136110,CNMD,cell cycle regulation,oncogenic signaling,tumor progression,apoptosis suppression,protein kinase activation,genomic amplification
ENSG00000164944,VIRMA,pi3k/akt pathway modulation,constitutive activation,tumor progression driver,genomic instability,cell proliferation regulation,oncogenic signaling
ENSG00000163673,DCLK3,cell cycle regulation,apoptosis resistance,oncogenic transformation,pi3k/akt pathway modulation,substrate phosphorylation,tumorigenesis promotion
ENSG00000148143,ZNF462,oncogenic role,transcriptional regulation,cell proliferation control,dna replication modulation,apoptosis resistance,cell cycle progression
ENSG00000089053,ANAPC5,genomic instability,cell cycle regulation,protein degradation,chromosome separation,ubiquitination pathway,oncogenic mutations
ENSG00000145423,SFRP2,wnt signaling inhibition,tumor suppressor function,context-dependent role,cellular proliferation regulation,genomic instability,therapeutic target for cancer treatment
ENSG00000179528,LBX2,transcriptional regulation,oncogenesis,cell proliferation,tumor suppressor function,genetic mutations,regulatory protein interaction
ENSG00000187134,AKR1C1,steroid metabolism regulation,androgen synthesis modulation,oncogene potential,cell proliferation regulation,transcription factor interaction,protein-protein interaction
ENSG00000288118,GLUD2,cellular metabolism,redox balance maintenance,tumor progression,cell growth promotion,proliferation enhancement,apoptosis resistance
ENSG00000054148,PHPT1,cellular regulation,oncogenic processes,tumor progression,metastasis promotion,apoptosis inhibition,genomic instability
ENSG00000234514,LST1,gene regulation,tumor progression,transcriptional dysregulation,dna damage response,cancer initiation,anti-tumor activity
ENSG00000186280,KDM4D,histone demethylation,chromatin regulation,cell proliferation,metastasis promotion,apoptosis resistance,therapeutic target
ENSG00000275052,PPP4R3B,cell cycle regulation,oncogene activity,protein phosphatase regulation,tumor progression,apoptosis modulation,gene amplification
ENSG00000166473,PKD1L2,epithelial-to-mesenchymal transition (emt),wnt/β-catenin signaling pathway,tumor progression,oncogene overexpression,tight junction regulation,cell polarity maintenance
ENSG00000160124,CCDC58,microtubule dynamics,cell division regulation,mitotic spindle assembly,genomic instability,centrosome localization,protein-protein interaction
ENSG00000005483,KMT2E,epigenetic regulation,histone methylation,oncogenic activation,apoptosis resistance,cell cycle progression,chromatin remodeling
ENSG00000183309,ZNF623,cell cycle regulation,transcriptional regulation,dna repair,apoptosis inhibition,tumor progression,prognostic biomarker
ENSG00000092421,SEMA6A,tumor progression,metastasis driver,cell-cell communication disruption,oncogenic signaling pathway activation,growth factor interaction,malignant transformation
ENSG00000196387,ZNF140,tumor suppressor function,krab zinc finger protein family,transcription factor regulation,dna repair interaction,cell proliferation regulation,apoptosis modulation
ENSG00000167508,MVD,mevalonate pathway,cholesterol synthesis,oncogene,angiogenesis promotion,tumor growth facilitation,prognostic marker
ENSG00000024422,EHD2,protein trafficking regulation,escrt machinery regulation,oncogenic protein stability modulation,cell signaling pathway interaction,tumor aggressiveness correlation,prognostic marker
ENSG00000197584,KCNMB2,calcium-activated potassium channels,cell proliferation,therapeutic target,dysregulation,signaling pathway modulation,oncogenesis
,HARS,altered expression,cellular metabolism,dysregulation mutations,oncogenic processes,protein translation regulation,none
ENSG00000104450,SPAG1,tumor progression,metastasis,cell migration,prognostic marker,cytoskeletal interaction,oncogene overexpression
ENSG00000205277,MUC12,cell adhesion,mucin family member,transmembrane protein,overexpression,tumor progression,poor prognosis
,GPR21,pi3k/akt pathway,cell proliferation,g protein-coupled receptor,signaling pathway modulation,cell survival,gene expression regulation
ENSG00000144962,SPATA16,cell cycle regulation,aneuploidy induction,dna repair regulation,centrosome duplication,genomic instability,tumor suppressor interaction
ENSG00000277481,PKD1L3,cellular adhesion,oncogenesis,cell signaling,tumor progression,overexpression,cellular integrity
ENSG00000158296,SLC13A3,regulation of ph homeostasis,citrate metabolism,tumor progression,cell proliferation,metabolic reprogramming,protein interaction
ENSG00000182795,C1orf116,long non-coding rna,overexpressed in tumors,regulates cell growth,associated with poor prognosis,molecular sponge function,cell cycle regulation
ENSG00000146729,NIPSNAP2,vesicle-mediated transport,cellular trafficking,oncogenic processes,tumor progression,altered cellular signaling,none
ENSG00000153820,SPHKAP,sphingolipid metabolism,tumor progression,cell proliferation,cellular signaling modulation,protein-protein interaction regulation,proliferative advantage
ENSG00000142484,TM4SF5,cell adhesion disruption,promoter overexpression,prognostic marker,tumor progression enhancement,genomic instability,epithelial-to-mesenchymal transition
ENSG00000148408,CACNA1B,calcium channel regulation,voltage-gated calcium channels,cell cycle progression,apoptosis inhibition,tumorigenesis promotion,signal transduction activation
ENSG00000135297,MTO1,mitochondrial translation regulation,chaperone protein function,cellular respiration maintenance,tumor progression association,poor prognosis marker,genetic instability mediator
ENSG00000275482,EPHB6,ephrin ligand regulation,receptor tyrosine kinase activity,cell adhesion regulation,tumor growth promotion,pi3k/akt pathway interaction,apoptosis modulation
ENSG00000276582,ABCB11,efflux pump activity,multidrug resistance,oncogenic driver,cell proliferation,survival advantage,drug transport mechanism
ENSG00000119922,IFIT2,ifn-induced protein interaction,cell survival regulation,apoptosis inhibition,tumor progression facilitation,protein-protein interactions,immune evasion mechanism
ENSG00000159256,MORC3,chromatin remodeling,tumor progression,gene overexpression,dna repair mechanisms,epigenetic modifications,genomic instability
ENSG00000182687,GALR2,cellular proliferation,g protein-coupled receptor,oncogenic pathway,cell migration,therapeutic target,signaling regulation
ENSG00000164128,NPY1R,cell proliferation,constitutive activation,dysregulation,g-protein coupled receptor,metastatic potential,neuropeptide signaling
ENSG00000275717,KIR3DL1,tumor immune evasion,immune checkpoint modulation,hla class i interaction,natural killer cell regulation,phosphatidylinositol 3-kinase activation,oncogenic signaling
ENSG00000185739,SRL,slc39a10,zinc homeostasis regulation,cell proliferation promotion,oncogenic consequences,cellular transport disruption,tumorigenesis facilitation
ENSG00000169031,COL4A3,tumor progression,extracellular matrix remodeling,biomarker potential,prognostic significance,cell migration,basement membrane integrity
ENSG00000102385,DRP2,tumor progression,cell proliferation regulation,genomic instability association,transcriptional regulation role,dna repair involvement,therapeutic target potential
ENSG00000181631,P2RY13,purinergic signaling,atp-mediated activation,metastasis promotion,tumor progression driver,prognostic marker,cell proliferation enhancement
ENSG00000141469,SLC14A1,transporter function,ph regulation,cancer cell proliferation,cellular redox balance,urea transport,tumor aggressiveness
ENSG00000100625,SIX4,tumor progression,transcriptional regulation,epithelial-to-mesenchymal transition (emt),constitutive activation,therapeutic target,cell proliferation
ENSG00000109911,ELP4,transcriptional regulation disruption,oncogenic process activation,cell cycle progression enhancement,dna replication facilitation,tumor growth promotion,genomic instability increase
ENSG00000088367,EPB41L1,cell cycle regulation,oncogenic function,cell migration,protein interaction,signal transduction,genomic amplification
ENSG00000180185,FAHD1,metabolic reprogramming,redox balance modulation,signaling pathway regulation,cellular energy metabolism,tumor progression contribution,oncogenic process promoter
,HIST1H1T,chromatin remodeling,transcriptional regulation,gene expression dysregulation,tumor progression,histone modification,epigenetic alteration
ENSG00000100596,SPTLC2,sphingolipid biosynthesis,apoptosis suppression,cell proliferation,migration and invasion,oncogenic signaling pathway,genetic mutations
ENSG00000114374,USP9Y,deubiquitinating enzyme activity,p53 stabilization,cell cycle regulation,apoptosis induction,oncogenic pathway modulation,tumor suppressor interaction
ENSG00000170608,FOXA3,transcription factor regulation,oncogene activation,metastasis driver,cell proliferation regulator,enhancer/promoter occupancy,tumor progression marker
ENSG00000117643,MAN1C1,glycoprotein processing,cell proliferation,oncogenic transformation,cell signaling pathway,metastasis,tumor aggressiveness
ENSG00000145868,FBXO38,ubiquitination pathway,tumor suppressor function,genomic instability,dna repair mechanism,proteasomal degradation,apoptosis regulation
ENSG00000153303,FRMD1,cell migration enhancement,cytoskeleton regulation,tumor progression facilitation,prognostic marker upregulation,metastasis promotion,therapeutic target candidacy
ENSG00000176978,DPP7,fgf signaling pathway,growth factor activation,mitogen processing,tumor progression,therapeutic target,genomic profiling
ENSG00000151640,DPYSL4,microtubule regulation,cell cycle disruption,genomic instability,tumor suppression,axon guidance,neuronal development
ENSG00000159374,M1AP,cellular proliferation,tumor progression,dna damage response,transcriptional regulation,oncogenesis,apoptosis resistance
ENSG00000144320,LNPK,lamin a/b phosphorylation,apoptosis inhibition,cell cycle regulation,dna repair pathway,metastasis promotion,protein kinase activity
ENSG00000171051,FPR1,cell migration,g-protein coupled receptor,oncogenic processes,immune response modulation,tumor progression,chemotaxis
ENSG00000049656,CLPTM1L,modulator protein function,cell cycle regulation,gene expression regulation,oncogenic mutations,dna damage response,apoptosis inhibition
ENSG00000180245,RRH,chromatin remodeling,genomic instability,deregulation of gene expression,overexpression,cell proliferation,survival pathways
ENSG00000171302,CANT1,calcium signaling,nucleotide metabolism,cell proliferation,tumor progression,stem cell maintenance,epithelial-to-mesenchymal transition
ENSG00000163975,MELTF,cell cycle regulation,g1/s phase transition,oncogene,cell proliferation,tumor growth,e2f1 transcriptional activity
ENSG00000274205,MAPK15,activation of downstream targets,constitutive expression,cell cycle progression,anti-apoptotic signaling,protein-protein interactions,tumor-promoting activity
ENSG00000174236,REP15,oncogene regulation,chromatin remodeling,histone modification,apoptosis inhibition,tumor suppressor suppression,cell growth promotion
ENSG00000156218,ADAMTSL3,emt regulation,tgf-β signaling modulation,cell migration and invasion,epithelial-to-mesenchymal transition,cancer cell dissemination,metastasis promotion
ENSG00000134389,CFHR5,complement regulation,oncogenic function,cell proliferation,apoptosis modulation,immune evasion,tumor progression marker
ENSG00000166596,CFAP52,cilia assembly disruption,cell cycle regulation,genomic instability,microtubule dynamics,aberrant cilia formation,tumor suppressor function
ENSG00000122592,HOXA7,tumor suppressor loss,transcription factor activation,cell proliferation regulation,apoptosis resistance induction,cell differentiation modulation,wnt/β-catenin pathway interaction
ENSG00000125772,GPCPD1,lipid metabolism,promoter of cell proliferation,cell growth and differentiation,tumor progression,driver gene,metabolic regulation
ENSG00000119616,FCF1,genomic instability,cell cycle regulation,dna repair pathways,homologous recombination,tumor suppressor function,genome maintenance
ENSG00000274803,BDP1,mitochondrial localization,cell survival promotion,apoptosis regulation,reactive oxygen species reduction,mitochondrial membrane potential increase,cancer biomarker
ENSG00000168461,RAB31,oncogenic potential,overexpression,cell proliferation enhancement,migration and invasion facilitation,apoptosis resistance,pi3k/akt pathway interaction
ENSG00000178038,ALS2CL,tumor suppressor function,loss-of-function mutations,endocytosis regulation,cell growth promotion,cancer metastasis,dna repair pathway interaction
ENSG00000160183,TMPRSS3,cell migration,protein activation,enzyme regulation,tumor progression,metastasis facilitation,therapeutic target
ENSG00000205758,CRYZL1,immune response modulation,epigenetic regulation,transcriptional control,tumor microenvironment interaction,cellular stress response,therapeutic resistance
ENSG00000073737,DHRS9,pi3k/akt pathway modulation,oncogene function,cell proliferation regulation,metastasis promotion,epithelial-to-mesenchymal transition (emt) regulation,poor prognosis marker
ENSG00000103021,CCDC113,cell migration and invasion,epithelial-to-mesenchymal transition (emt),microtubule dynamics regulation,centrosome organization disruption,biomarker for poor prognosis,pi3k/akt pathway interaction
ENSG00000175318,GRAMD2A,golgi apparatus,endoplasmic reticulum localization,membrane trafficking regulation,rho gtpase-activating protein interaction,tumor progression driver,mitochondrial dynamics modulation
ENSG00000167699,GLOD4,tca cycle regulation,mitochondrial enzyme function,enhanced glycolysis,glycogenolysis stimulation,cell survival pathway,energy metabolism alteration
ENSG00000152082,MZT2B,histone modification,chromatin remodeling,gain of function mutations,transcriptional regulation,genomic instability,therapeutic target
ENSG00000124104,SNX21,sorting nexin function,endosomal trafficking regulation,cell proliferation enhancement,tumor progression modulation,protein stability regulation,membrane remodelling
ENSG00000165684,SNAPC4,splicing regulation,oncogene activation,cell proliferation,gene expression modulation,tumor suppressor silencing,cellular transformation
ENSG00000126768,TIMM17B,mitochondrial dynamics,energy metabolism regulation,oncogenic reprogramming,metabolic regulation modulation,oxphos complex assembly,cellular respiration alteration
ENSG00000061987,MON2,cell proliferation modulation,oncogenic activity,cell migration regulation,actin cytoskeleton reorganization,tumor progression association,therapeutic target potential
ENSG00000197140,ADAM32,epithelial-to-mesenchymal transition,cell proliferation,glycoprotein,transcription regulation,wnt signaling pathway,cell migration
ENSG00000143498,TAF1A,transcription regulation,oncogene,cell cycle progression,dna replication,gene expression,tumorigenesis
ENSG00000163900,TMEM41A,er-stress response,cell proliferation,cancer prognosis,genetic instability,tumor progression,oncogenic process
ENSG00000266338,NBPF15,chromatin remodeling,transcriptional regulation,cell proliferation,genomic instability,oncogenic processes,tumor progression
ENSG00000179364,PACS2,disrupts pi3k/akt/mtor pathway,oncogene activation,enhances cell proliferation,overexpressed in cancer cells,regulates rtk signaling,promotes tumor progression
ENSG00000141161,UNC45B,epithelial-to-mesenchymal transition,chaperone function,overexpression,poor prognosis,pi3k/akt pathway activation,genomic instability
ENSG00000007001,UPP2,dna repair deficiency,cellular stress response,oncogenic protein regulation,tumor progression,protein degradation regulation,ubiquitination pathway modulation
ENSG00000122707,RECK,loss of function mutations,protease regulation,extracellular matrix degradation,tumor invasion,metastasis,cancer stem cell maintenance
ENSG00000170703,TTLL6,microtubule modifying enzyme function,tumor suppressor activity,downregulation in cancer,cell proliferation promotion,microtubule stability increase,cell cycle regulation modulation
ENSG00000164674,SYTL3,synaptic vesicle fusion,mutations in cancer,pi3k/akt signaling,cell cycle regulation,apoptosis dysregulation,dna repair interaction
ENSG00000241697,TMEFF1,notch pathway activation,cell adhesion disruption,oncogenic driver mutation,metastatic process promotion,cell signaling regulation,tumor suppressor function alteration
ENSG00000114767,RRP9,loss-of-function mutations,rna degradation,cancer driver gene,oncogenic mrnas,tumor suppressor mrnas,rna metabolism regulation
ENSG00000006695,COX10,mitochondrial dysfunction,electron transport chain disruption,oncogenic signaling pathway activation,cell proliferation enhancement,biomarker potential identified,metabolic alterations
ENSG00000170113,NIPA1,transcriptional regulation,rna processing,oncogene activation,gene expression modulation,cell proliferation enhancement,epigenetic modification
ENSG00000171954,CYP4F22,epoxyeicosatrienoic acids,cell proliferation,permeability gene ontology terms,ppars ligand,cell survival,genomic upregulation
ENSG00000066056,TIE1,vegf signaling,endothelial cell differentiation,angiogenic processes,tumor-promoting signals,transcriptional regulation,cancer biology
ENSG00000128342,LIF,cancer-promoting cytokine,growth factor activity,il-6/jak/stat3 pathway activation,stem cell maintenance,epithelial-to-mesenchymal transition (emt),poor prognosis marker
ENSG00000178343,SHISA3,emt process,cell-cell adhesion loss,cancer progression facilitator,tumor aggressiveness enhancer,cell migration regulator,tissue organization modulator
ENSG00000148935,GAS2,tumor suppressor,apoptosis regulation,metastasis inhibition,cell cycle arrest,microtubule stabilization,genomic stability
ENSG00000137801,THBS1,endothelial-to-mesenchymal transition,inhibits angiogenic inhibitors,metastasis promotion,tumor microenvironment modulation,cell adhesion regulation,extracellular matrix interaction
ENSG00000074582,BCS1L,mitochondrial dysfunction,reactive oxygen species production,glycolytic shift,genomic instability,dna damage,metabolic reprogramming
ENSG00000178177,LCORL,oncogene,tumor suppressor activity,nuclear receptor coactivator,cell growth regulation,apoptosis inhibition,transcriptional modulation
ENSG00000274780,PHRF1,chromatin remodeling,cell cycle regulation,transcriptional regulation,apoptosis induction,tumor suppression,proliferation inhibition
ENSG00000284228,TMEM102,cell adhesion disruption,oncogenic function,cell migration enhancement,tumor progression facilitation,therapeutic target potential,metastasis promotion
ENSG00000185022,MAFF,transcription regulation,tumor suppressor function,cell proliferation inhibition,p73 interaction,oncogenic pathway inhibition,cancer-related gene expression
ENSG00000134490,TMEM241,overexpression,cell adhesion disruption,oncogene activation,tumor progression,biomarker potential,microrna regulation
ENSG00000094914,AAAS,oncogene,constitutive activation,tumor growth promotion,cellular adaptation to hypoxia,enhanced glycolysis suppression,apoptosis inhibition
ENSG00000106415,GLCCI1,dna damage response,oxidative stress,antioxidant pathway,tumor suppressor function,genomic instability,cellular homeostasis
ENSG00000069345,DNAJA2,protein folding regulation,apoptosis modulation,cell survival enhancement,tumor progression facilitation,genomic instability promotion,cancer cell growth support
ENSG00000140403,DNAJA4,protein folding regulation,cellular survival promotion,resistance to therapy,tumor progression facilitation,apoptosis inhibition,dna damage response interaction
ENSG00000213626,LBH,chromatin remodeling,oncogenic transcription factor regulation,transcriptional activation,cell proliferation enhancement,tumor aggressiveness promotion,poor prognosis marker
ENSG00000158042,MRPL17,mitochondrial ribosome function,potential oncogene,energy metabolism regulation,tumor growth support,poor prognosis indicator,cellular proliferation promotion
ENSG00000123500,COL10A1,cell proliferation,migration promotion,tumor aggressiveness,prognostic marker,metastasis facilitation,cell adhesion regulation
ENSG00000184792,OSBP2,lipid metabolism,lipid transport,oxysterol binding,cell proliferation,apoptosis resistance,tumor progression
ENSG00000158050,DUSP2,mapk signaling pathway,dephosphorylation,tumor progression,cell proliferation,regulatory mechanism,genomic instability
ENSG00000129596,CDO1,angiogenesis,cell proliferation,hypoxia response,metastasis regulation,nitric oxide production,oncogenic signaling pathway
ENSG00000197594,ENPP1,cell signaling pathway,extracellular nucleotide metabolism,growth factor regulation,oncogenic process,promoter of tumor progression,tumor suppressor regulation
ENSG00000130962,PRRG1,cell migration,epithelial-to-mesenchymal transition,cancer stem cell maintenance,tumor microenvironment modulation,genomic instability,oncogene expression
ENSG00000115339,GALNT3,o-glycosylation,protein modification,gene overexpression,tumor progression,cell proliferation,molecular interaction
ENSG00000176222,ZNF404,oncogenic transcription factor,transcriptional regulator,cell proliferation regulation,apoptosis inhibition,epigenetic modifier,tumor progression promoter
ENSG00000174576,NPAS4,cancer driver gene,transcription factor regulation,cell cycle progression,oncogenic processes,tumor growth,therapeutic target
ENSG00000175073,VCPIP1,enhanced cell survival,oncogenic pathway activation,autophagy inhibition,mtor signaling activation,protein degradation regulation,cellular signaling modulation
ENSG00000013588,GPRC5A,cellular differentiation,calcium ion regulation,tumor suppressor function,epithelial-to-mesenchymal transition,cellular proliferation,cell survival
ENSG00000138166,DUSP5,protein dephosphorylation,cell cycle regulation,oncogenic pathway interaction,apoptosis modulation,transcriptional control,mitogen-activated protein kinase (mapk) signaling
ENSG00000134996,OSTF1,cell cycle regulation,dna replication,oncogenic processes,pi3k/akt signaling,constitutive activation,cell proliferation
ENSG00000185670,ZBTB3,tumor suppressor,cell growth regulation,transcriptional repression,chromatin modification,dna binding,poor prognosis marker
ENSG00000116260,QSOX1,cellular proliferation,transcriptional coactivator,disulfide bond regulation,protein folding,apoptosis inhibition,androgen receptor interaction
ENSG00000187257,RSBN1L,oncogene overexpression,cell cycle regulation disruption,transcriptional modulation,tumor progression facilitation,protein-protein interaction,tumor suppressor p53 modulation
ENSG00000196876,SCN8A,calcium homeostasis,cell migration,cell proliferation,genomic instability,oncogenic signaling,protein-protein interactions
ENSG00000169218,RSPO1,wnt signaling pathway,enhanced proliferation,tumor microenvironment modulation,cancer stem cell maintenance,genetic amplification,oncogenic driver
ENSG00000187801,ZFP69B,zinc finger protein regulation,cell cycle progression,dna replication repair,oncogenic processes,tumor suppressor function,epigenetic regulation
ENSG00000132677,RHBG,n-glycosylation pathway,aberrant glycosylation,oncogenic transformation,tumor progression,immune evasion,protein-protein interactions
ENSG00000133401,PDZD2,cellular regulation,cell survival,cytoplasmic localization,dysregulated expression,oncogene or tumor suppressor,signaling pathway modulation
ENSG00000006453,BAIAP2L1,tumor progression,signaling pathway modulation,cell proliferation enhancement,therapeutic resistance,cell adhesion regulation,oncogenic amplification
ENSG00000180739,S1PR5,cell migration,epithelial-to-mesenchymal transition,g-protein coupled receptor activation,metastasis,pi3k/akt pathway activation,protein expression alteration
ENSG00000170624,SGCD,cell adhesion disruption,transmembrane protein,sarcoglycan complex interaction,cell migration modulation,tumorigenic potential,genomic instability
ENSG00000168757,TSPY2,overexpression,cell proliferation,apoptosis inhibition,pi3k/akt signaling pathway interaction,tumor progression,poor prognosis
ENSG00000005302,MSL3,chromatin remodeling,oncogenic transcription,tumor progression,genetic alterations,cell cycle regulation,apoptosis evasion
ENSG00000273859,RASSF7,chromosomal instability,aneuploidy,tumor suppression,cell cycle regulation,microtubule stability,pi3k/akt pathway modulation
ENSG00000138303,ASCC1,transcriptional regulation,cell growth promotion,tumor aggressiveness,poor prognosis,protein synthesis regulation,trna charging
ENSG00000180902,D2HGDH,loss-of-function mutations,energy metabolism disruption,redox balance dysregulation,aerobic glycolysis promotion,tumor suppressor function,cellular metabolism modulation
ENSG00000134186,PRPF38B,aberrant splicing,alternative transcript variants,chemosensitivity loss,rna processing regulation,tumor growth promotion,oncogenic transcript production
ENSG00000183648,NDUFB1,mitochondrial respiration,cellular metabolism,energy production,glycolysis regulation,warburg effect,oncogenic driver
ENSG00000187672,ERC2,genomic instability,dna repair mechanism,helicase activity,cancer susceptibility,tumor suppressor function,nucleotide excision repair
ENSG00000135409,AMHR2,cellular differentiation,stem cell regulation,tumor suppressor function,dna damage response,pi3k/akt pathway modulation,wnt/β-catenin pathway interaction
ENSG00000280094,OR1B1,olfactory receptor expression,tumor progression,chemoresistance,overexpression biomarker,cell migration invasion,signaling pathways interaction
ENSG00000107651,SEC23IP,cell cycle regulation,gene expression modulation,cancer progression,biomarker potential,protein-protein interactions,tumor aggressiveness
ENSG00000124225,PMEPA1,cellular growth regulation,oncogenic function,tumor progression,biomarker potential,apoptosis modulation,cell cycle regulation
ENSG00000172031,EPHX4,lipid metabolism regulation,cell proliferation enhancement,apoptosis inhibition,inflammation promotion,pi3k/akt pathway interaction,tumorigenesis promoter
ENSG00000253831,ETV3L,oncogene regulation,promoter-enhancer interaction,chromatin remodeling,epithelial-to-mesenchymal transition (emt),cell proliferation,transcription factor activity
ENSG00000153779,TGIF2LX,transcriptional regulation,altered expression levels,cell growth and differentiation,apoptosis regulation,tumorigenesis association,oncogene function
ENSG00000232258,TMEM114,endoplasmic reticulum stress,lipid metabolism regulation,cell proliferation modulation,transmembrane protein function,cancer development association,genetic alteration impact
ENSG00000196867,ZFP28,cellular proliferation,dysregulation of apoptosis,ectopic expression,epithelial-to-mesenchymal transition,overexpression in cancer cells,transcriptional regulation
ENSG00000163814,CDCP1,tumor progression,cell adhesion disruption,metastatic potential,cancer stem cell maintenance,wnt/β-catenin pathway interaction,therapeutic target
ENSG00000138411,HECW2,ubiquitin ligase activity,tumor suppressor protein degradation,cell cycle regulation,dna repair regulation,oncogenic process activation,pro-survival signaling pathway activation
ENSG00000091010,POU4F3,tumor suppressor function,apoptosis regulation,genomic stability maintenance,cell cycle progression modulation,hypoxia response,dna damage repair
ENSG00000008300,CELSR3,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression marker,signal transduction modulation,pi3k/akt pathway interaction,cancer cell survival enhancement
ENSG00000156471,PTDSS1,serine biosynthesis,phosphohomoserine formation,cellular metabolism regulation,tumor microenvironment modulation,enzyme activity deregulation,amino acid metabolism disruption
ENSG00000164068,RNF123,nf-kappab pathway activation,protein overexpression,cell cycle progression regulation,tumor suppressor function loss,ubiquitination regulation,apoptosis inhibition
ENSG00000059378,PARP12,parp12 overexpression,genomic instability,tumor suppressor function,loss of heterozygosity,dna repair pathway,breast cancer-associated gene
ENSG00000183513,COA5,cco dysfunction,electron transport chain disruption,emt induction,glycolytic reprogramming,oncogenic metabolic shift,ros production increase
ENSG00000099864,PALM,cellular processes regulation,protein modification enzyme,prenylation pathway,cell proliferation influence,tumor progression association,genetic alterations correlation
ENSG00000221995,TIAF1,nf-κb signaling regulation,microrna processing,mrna translation regulation,cell growth promotion,apoptosis inhibition,oncogene overexpression
ENSG00000161533,ACOX1,fatty acid beta-oxidation,constitutive activation,lipid metabolism alteration,oncogenic transformation,tumor progression,redox balance disruption
ENSG00000163833,FBXO40,cell cycle regulation,tumor suppressor degradation,oncogenic pathway activation,cell proliferation enhancement,ubiquitination and proteasomal degradation,overexpression
ENSG00000182508,LHFPL1,cell proliferation,metastasis promotion,lipid phosphatase activity,tumor progression enhancement,oncogenic protein interaction,signal transduction modulation
ENSG00000198885,ITPRIPL1,calcium signaling regulation,cellular growth modulation,intracellular calcium homeostasis,tumor suppressor function,potential oncogene role,cancer progression mechanism
ENSG00000129625,REEP5,er calcium regulation,cancer driver mutation,cell growth regulation,oncogenic signaling pathway,protein translocation and degradation,transmembrane receptor function
ENSG00000120318,ARAP3,cell migration,gain of function mutations,regulation of rho gtpases,oncogenic signaling,increased cell survival,tumor progression
ENSG00000188037,CLCN1,chloride channel regulation,plasma membrane localization,ion balance disruption,cell signaling interference,tumor progression,genetic alteration
ENSG00000067704,IARS2,iron homeostasis regulation,cellular proliferation,oncogenic adaptation,gene expression modulation,mutational hotspot,cell survival enhancement
ENSG00000203485,INF2,mitotic spindle assembly,chromosome segregation,genomic instability,aneuploidy formation,cell division regulation,tumor progression
ENSG00000181061,HIGD1A,gain of function mutations,energy metabolism regulation,oncogene interaction,mitochondrial electron transport chain involvement,tumor growth promotion,overexpression in cancer
ENSG00000148019,CEP78,microtubule dynamics regulation,cell cycle progression disruption,genomic instability contribution,oncogenic process involvement,centrosome integrity maintenance,protein-protein interaction mediation
ENSG00000206237,HLA-DQB1,immune evasion,t-cell modulation,antigen presentation,mhc class ii expression,immune suppression,tumor progression
ENSG00000116176,TPSG1,tumor suppression,cell cycle regulation,genomic stability,apoptosis induction,transcriptional coactivation,dna damage response
ENSG00000175470,PPP2R2D,tumor suppressor function,regulatory subunit of pp2a,cell cycle regulation,cancer progression,mutation loss of function,potential therapeutic target
ENSG00000152700,SAR1B,protein secretion regulation,vesicle trafficking regulation,oncogene activation,cell proliferation promotion,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000135392,DNAJC14,protein folding,oncogenic processes,molecular chaperone regulation,protein-protein interactions,cellular signaling modulation,tumorigenesis promotion
ENSG00000197119,SLC25A29,mitochondrial carrier protein,oncogenic pathway activation,cellular metabolism regulation,energy production enhancement,tumor progression support,angiogenesis promotion
ENSG00000073067,CYP2W1,cancer-related cell growth,drug metabolism resistance,apoptosis evasion,cell cycle progression regulation,poor prognosis biomarker,chemoresponse modulation
ENSG00000133111,RFXAP,dna repair regulation,oncogenic regulation,transcriptional modulation,genomic instability,cell proliferation enhancement,e2f1 interaction
ENSG00000116205,TCEANC2,nuclear receptor regulation,transcriptional regulation disruption,cell cycle progression,gene expression modulation,oncogenic potential,therapeutic target
ENSG00000144161,ZC3H8,mrna stability regulation,tumor suppressor function,apoptosis induction,cell proliferation inhibition,metastasis suppression,prognostic marker potential
ENSG00000144681,STAC,cytoskeletal regulation,cellular morphology modulation,microtubule interaction,dynein motor protein association,cargo transport disruption,tumorigenesis promoter
ENSG00000141447,OSBPL1A,lysophosphatidylcholine acylation,cell membrane fluidity,tumor progression,overexpression,signaling pathway regulation,cellular lipid metabolism
ENSG00000138660,AP1AR,constitutive activation,transcriptional regulation,oncogenic processes,cell proliferation,pro-survival genes,therapeutic target
ENSG00000149124,GLYAT,redox imbalance,cellular metabolism,glycolysis pathway,energy production,tumor growth,cancer proliferation
ENSG00000103067,ESRP2,egfr signaling,nuclear localization,rna binding and processing,oncogenic mutations,tumor progression,cell proliferation regulation
ENSG00000140395,WDR61,dna damage response,cell proliferation,genome stability maintenance,oncogene overexpression,tumor progression,biomarker potential
ENSG00000128590,DNAJB9,tumor progression,cell proliferation,apoptosis resistance,chaperone activity,ubiquitin-proteasome interaction,autophagy regulation
ENSG00000104904,OAZ1,mitochondrial biogenesis,oncogene overexpression,rna-binding protein function,cellular metabolism regulation,transcriptional regulation enhancement,tumor progression marker
ENSG00000139629,GALNT6,tumor progression,metastasis promotion,glycosylation modification,oncogenic interaction,cell adhesion regulation,apoptosis inhibition
ENSG00000070214,SLC44A1,**

pi synthesis,glycerophospholipid regulation,cell proliferation enhancement,pi3k/akt signaling pathway involvement,lipid metabolism dysregulation,oncogenic protein-protein interactions

**
ENSG00000175538,KCNE3,cell proliferation,apoptosis regulation,ion channel interaction,protein-protein interaction,tumor progression,therapeutic target
ENSG00000153291,SLC25A27,mitochondrial transport,cellular metabolism regulation,tumor progression association,metabolic regulation,apoptosis regulation,energy production modulation
ENSG00000166503,HDGFL3,oncogenic potential,cell growth stimulation,constitutive activation,lipid biosynthesis dysregulation,protein-protein interaction,tumor suppressor interaction
ENSG00000147588,PMP2,overexpression,cell proliferation,pi3k/akt signaling interaction,tumor progression,promoter of oncogenesis,cell survival enhancement
ENSG00000179520,SLC17A8,altered expression,cellular ph regulation,cancer progression,glutamate transport,neurotransmitter regulation,tumor growth promotion
ENSG00000010438,PRSS3,oncogenic driver,tumor progression,cell proliferation,metastasis promotion,inflammation modulation,emt regulation
ENSG00000137124,ALDH1B1,detoxification processes,oxidative balance regulation,cellular redox homeostasis,therapeutic target,apoptosis regulation,metastatic process
ENSG00000082996,RNF13,mitotic regulation,genomic instability,ubiquitination,cell proliferation,chromosome segregation,tumor suppression
ENSG00000135124,P2RX4,cellular proliferation,therapeutic target,purinergic signaling,tumor progression,ion channel regulation,metastasis promotion
ENSG00000086232,EIF2AK1,protein synthesis regulation,constitutive activation,apoptosis inhibition,metabolic reprogramming,cellular proliferation enhancement,stress response pathway modulation
ENSG00000158089,GALNT14,oncogenic activity,overexpression,protein modification,cell signaling regulation,apoptosis inhibition,tumor progression facilitation
ENSG00000163788,SNRK,cell cycle regulation,oncogenic signaling pathway,serine/threonine kinase activity,protein-protein interactions,transcriptional regulation,apoptosis modulation
ENSG00000115380,EFEMP1,cell adhesion,overexpression,tumor progression,metastasis,chemotherapy resistance,signal transduction
ENSG00000105879,CBLL1,cell cycle regulation,apoptosis inhibition,oncogenic overexpression,tumor progression,ubiquitin ligase activity,ring-type e3 ubiquitin ligase function
ENSG00000075336,TIMM21,mitochondrial function regulation,cell survival promotion,oncogenic processes involved,metabolic reprogramming enhancement,protein-protein interaction modulation,tumor progression facilitation
ENSG00000162729,IGSF8,cell adhesion,oncogenic signaling,tumor progression,metastasis,cell migration,protein interaction
ENSG00000116698,SMG7,aberrant protein accumulation,impaired nonsense-mediated decay,genomic instability,mutation hotspot,tumor progression driver,transcriptional dysregulation
ENSG00000156486,KCNS2,tumor suppressor,epithelial integrity disruption,cellular ion balance alterations,ion channel dysfunction,oncogenic process promotion,emt regulation
ENSG00000070785,EIF2B3,cellular stress response,protein synthesis regulation,oncogenic mutations,therapeutic target,tumor aggressiveness,poor prognosis biomarker
ENSG00000125363,AMELX,amelogenin,cell proliferation,epithelial-to-mesenchymal transition,gene amplification,melanocortin 1 receptor antagonist,oncogenic potential
ENSG00000140795,MYLK3,cytoplasmic regulation,cell migration,rho gtpase pathway,tumor metastasis,protein-protein interaction,cell cycle progression
ENSG00000032219,ARID4A,chromatin remodeling,tumor suppressor function,transcriptional regulation,cell cycle progression,dna repair mechanisms,genomic instability
ENSG00000164663,USP49,cell cycle regulation,tumor progression,dna repair,apoptosis inhibition,deubiquitinating enzyme activity,stabilization of oncogenic proteins
ENSG00000143390,RFX5,transcriptional regulation,amplification and overexpression,tumor progression,cell proliferation,chemosensitivity,therapeutic target
ENSG00000109790,KLHL5,protein degradation,kelch repeat superfamily,tumor suppressor function,oncoprotein regulation,protein-protein interactions,cancer progression
ENSG00000122122,SASH3,tumor suppressor,genomic stability,cell proliferation regulation,apoptosis induction,wnt/β-catenin signaling modulation,pi3k/akt/mtor pathway regulation
ENSG00000137857,DUOX1,oncogenic activity,h2o2 production,cell proliferation,metastasis promotion,poor prognosis,ros regulation
ENSG00000137474,MYO7A,emt process,cell adhesion disruption,gain of function mutations,cell migration enhancement,prognostic marker,epithelial-to-mesenchymal transition
ENSG00000116745,RPE65,metabolic regulation,cellular proliferation,tumor progression,protein-protein interaction,reactive oxygen species generation,angiogenesis
ENSG00000158793,NIT1,transcription factor activity,cell growth regulation,proliferation enhancement,tumorigenesis,overexpression mutations,metabolic pathway regulation
ENSG00000147687,TATDN1,dna repair dysfunction,chromosomal instability,cell cycle regulation,transcriptional modulation,protein interaction,genomic stability maintenance
ENSG00000125459,MSTO1,mitotic spindle regulation,tumor progression,promoter of oncogenesis,cell proliferation regulator,overexpression marker,biomarker for diagnosis
ENSG00000066279,ASPM,cell division regulation,genomic instability,mitotic checkpoint disruption,oncogenic potential,protein-protein interaction,cell cycle dysregulation
ENSG00000156831,NSMCE2,histone methylation regulation,epigenetic dysregulation,oncogenic function,genomic instability,dna repair mechanism disruption,cell cycle progression
ENSG00000131050,BPIFA2,apoptosis regulation,cell proliferation,cancer progression,prognostic marker,signaling pathway modulation,oncogenic cofactor
ENSG00000168389,MFSD2A,lipid metabolism alteration,oncogenic process enhancement,fatty acid import facilitation,cell growth promotion,tumor progression association,prognostic marker relevance
ENSG00000196705,ZNF431,transcription factor activity,oncogene overexpression,cell proliferation regulation,apoptosis suppression,metastasis promotion,diagnostic marker potential
ENSG00000127081,ZNF484,tumor suppressor function,genomic instability,cell growth regulation,apoptosis modulation,transcriptional regulation,dna repair interaction
ENSG00000110880,CORO1C,actin cytoskeleton regulation,cell migration,epithelial-to-mesenchymal transition,metastasis promotion,prognostic marker,signaling pathway modulation
ENSG00000130270,ATP8B3,lipid metabolic reprogramming,cholesterol efflux regulation,tumor progression,cell growth enhancement,metastasis facilitation,therapeutic target
ENSG00000144476,ACKR3,tumor progression,immune evasion,constitutive activation,genomic profiling,cell invasion,metastasis driver
ENSG00000197360,ZNF98,krab-containing zinc finger protein family,cell cycle regulation,transcriptional repression,dna repair mechanisms,tumor suppressor function,genetic instability
ENSG00000284068,KPNA7,nuclear transport regulation,gene expression modulation,chromatin remodeling,cell proliferation driver,cell survival enhancer,mitotic progression regulator
ENSG00000250510,GPR162,pi3k/akt pathway interaction,g-protein coupled receptor function,cell proliferation enhancement,tumor progression involvement,metastasis promotion,tissue expression regulation
ENSG00000205336,ADGRG1,tumor progression,cell adhesion regulation,overexpression mutations,signaling pathway modulation,cell migration regulation,prognostic marker
ENSG00000182674,KCNB2,oncogenic function,cell proliferation enhancement,apoptosis suppression,potential therapeutic target,signaling pathway modulation,tumor progression association
ENSG00000248487,ABHD14A,abhd14a role in lipid metabolism,oncogenic signaling,amplification/overexpression,tumor progression,therapeutic target,resistance to therapy
ENSG00000183549,ACSM5,mitochondrial metabolism,oncogenic function,fatty acid oxidation,energy production,cell growth promotion,therapeutic target
ENSG00000136634,IL10,immunomodulation,tumor progression,pro-inflammatory cytokine suppression,angiogenesis promotion,anti-tumor immunity suppression,therapeutic target
ENSG00000104093,DMXL2,genomic instability,cell cycle regulation,homologous recombination repair,dna damage response,tumor suppressor function,genetic interaction network
ENSG00000108582,CPD,dna damage response,nucleotide excision repair pathway,genetic instability,tumor progression,dna repair deficiency,cellular stress response
ENSG00000152229,PSTPIP2,cell proliferation,oncogene,tumor invasion,actin cytoskeleton regulation,poor prognosis,therapeutic target
ENSG00000198839,ZNF277,chromatin remodeling,transcriptional regulation,tumor suppressor function,cell cycle regulation,apoptosis modulation,genomic instability
ENSG00000172889,EGFL7,angiogenesis driver,biomarker significance,cell migration regulator,endothelial cell interaction,metastasis facilitator,vegf signaling pathway activator
ENSG00000198417,MT1F,cellular stress response,metal detoxification,tumor progression,oxidative damage resistance,pro-survival factor,epigenetic regulation
ENSG00000136274,NACAD,microtubule dynamics,tumor progression,mitotic spindle regulation,cancer cell migration,prognostic marker,cellular morphology
ENSG00000039523,RIPOR1,autophagy regulation,apoptosis suppression,tumor progression,inflammation promotion,cell proliferation,immune evasion
ENSG00000154620,TMSB4Y,actin cytoskeleton regulation,tumor progression,cell proliferation enhancement,protein-protein interaction,mitosis modulation,cancer cell survival
ENSG00000141316,SPACA3,cell growth regulation,overexpression,prognostic marker,spermatogenesis,cell proliferation,cancer biology
ENSG00000188372,ZP3,oncogenesis,tumor progression,cell proliferation,protein interaction,signaling pathway regulation,genomic instability
ENSG00000077935,SMC1B,smc1b mutations,chromosomal instability,cohesin dysfunction,aneuploidy formation,genomic rearrangements,poor prognosis indicator
ENSG00000157350,ST3GAL2,tumor progression,metastasis,cell surface modification,glycosylation regulation,glycoprotein sialylation,cancer cell invasion
ENSG00000213424,KRT222,aberrant expression,cell migration,carcinoma progression,differentiation regulation,epithelial integrity,proliferation regulation
ENSG00000108828,VAT1,genome instability,tumor suppressor function,dna repair regulation,mutation hotspot,cancer driver gene candidate,cell cycle regulation
ENSG00000172661,WASHC2C,wash complex regulation,cancer cell proliferation,endosomal trafficking disruption,tumor growth promotion,mutation contribution,cellular heterogeneity influence
ENSG00000106178,CCL24,immune cell recruitment,chemokine function,tumor microenvironment modulation,cell migration facilitation,eosinophil activation,cancer metastasis promotion
ENSG00000161544,CYGB,oncogenic driver,redox regulation,cellular metabolism,protein-protein interaction,immune response modulation,tumor growth promotion
ENSG00000125965,GDF5,bmp/smad signaling pathway,tumor progression,prognostic biomarker,cellular differentiation,cell migration,growth regulation
ENSG00000213445,SIPA1,rho gtpase regulation,cell migration pathway,cytoarchitecture disruption,oncogenic driver gene,tumor progression facilitation,therapeutic target candidate
ENSG00000185885,IFITM1,innate immune response,cellular transformation,tumor progression,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway modulation,apoptosis suppression
ENSG00000277494,GPIHBP1,lipid metabolism regulation,insulin signaling pathway modulation,tumor cell growth promotion,warburg effect facilitation,oncogenic role in cancer,glycolysis preference enhancement
ENSG00000164961,WASHC5,endocytic trafficking,cell proliferation,protein degradation,membrane dynamics,apoptosis regulation,tumor progression
ENSG00000143126,CELSR2,cell adhesion disruption,loss of polarity,adherens junction disruption,wnt/β-catenin pathway dysregulation,tumor progression,poor prognosis
ENSG00000110931,CAMKK2,cell cycle regulation,tumor progression,oncogenic driver,ampk regulation,cell survival enhancement,kinase activation
ENSG00000135973,GPR45,lpa receptor activation,aberrant expression mutations,tumor progression driver,cell proliferation regulator,signaling pathway modulation,cancer therapeutic target
ENSG00000274348,TRPV5,cellular signaling modulation,aberrant expression regulation,calcium homeostasis disruption,oncogenic process involvement,therapeutic target potential,cell proliferation influence
ENSG00000101443,WFDC2,cell proliferation regulation,oncogene,epithelial integrity maintenance,mucous epithelial cell function,overexpression in cancer,tff peptide formation
ENSG00000066855,MTFR1,iron metabolism disruption,mitochondrial dysfunction,tumor growth promotion,therapeutic target identification,metabolic reprogramming,cellular proliferation enhancement
ENSG00000140386,SCAPER,centrosomal regulation,chromosomal instability,genomic alterations,mitotic checkpoint disruption,ubiquitination pathway,oncogenic potential
ENSG00000101417,PXMP4,lipid transport regulation,phospholipid composition modulation,cancer progression driver,cellular membrane interaction,genomic alteration,bioenergetic pathway influence
ENSG00000196184,OR10J1,odorant receptor,olfactory signaling pathway,cancer cell interaction,cell proliferation regulation,tumor development influence,sensory neuron modulation
ENSG00000118432,CNR1,oncogenic signaling,constitutive activation,mapk/erk pathway modulation,pi3k/akt pathway interaction,nf-κb signaling regulation,angiogenesis promotion
ENSG00000165188,RNF183,protein degradation,genomic instability,cell growth promotion,oncogenic process,tumor suppressor regulation,apoptosis evasion
ENSG00000169026,SLC49A3,calcium regulation,intracellular signaling,cell membrane transport,oncogenic mutations,cancer progression,therapeutic target
ENSG00000105583,WDR83OS,cellular regulation,protein stabilization,transcriptional modulation,tumor suppressor function,post-translational modification,aberrant expression
ENSG00000124212,PTGIS,enzyme activity,cellular growth regulation,tumor progression,vasodilation,platelet aggregation inhibition,genomic expression
ENSG00000186470,BTN3A2,apoptosis regulation,cellular stress response,dna damage response,tumor suppression,protein-protein interaction,transcriptional regulation
ENSG00000004059,ARF5,tumor progression,protein trafficking regulation,microtubule dynamics regulation,chromosomal stability maintenance,cellular proliferation promotion,cancer cell secretion enhancement
ENSG00000178372,CALML5,cellular migration,calcium-binding protein,epithelial cell regulation,actin cytoskeleton modulation,oncogenic potential,tumor suppressor downregulation
ENSG00000166685,COG1,protein misfolding,cellular homeostasis,chaperone activity,oncogene function,protein synthesis regulation,tumor progression
,LOR,cell adhesion,desmosomal component,tumor suppression,proliferation inhibition,molecular alterations,cell envelope structure
ENSG00000213930,GALT,metabolic regulation,cell growth promotion,pentose phosphate pathway,cellular redox balance,glycolytic adaptation,therapeutic target
ENSG00000135749,PCNX2,enhanced cell proliferation,dna repair regulation,genomic instability,cell cycle progression,oncogenic transformation,therapeutic target
ENSG00000087250,MT3,zinc ion homeostasis regulation,cellular proliferation promotion,apoptosis evasion,angiogenesis modulation,immune response evasion,tumor progression facilitation
ENSG00000100884,CPNE6,cellular regulation,apoptosis inhibition,protein degradation,tumor progression,genomic amplification,oncogenic pathway
ENSG00000108510,MED13,genomic instability,transcriptional regulation,cell growth regulation,tumor suppressor,mutations implicated,oncogenic process
ENSG00000283706,PRSS50,epithelial-to-mesenchymal transition (emt),cell migration,promoter of cell invasion,regulation of epithelial cells,tumor progression,metastatic potential
ENSG00000075188,NUP37,nuclear pore complex regulation,genomic instability,cellular transport regulation,apoptosis modulation,protein-protein interaction,chromatin remodeling
ENSG00000168386,FILIP1L,cell migration,actin cytoskeleton regulation,overexpression,aggressive behavior,e-cadherin downregulation,tumor progression
ENSG00000140285,FGF7,cell proliferation,mapk/erk signaling,fgf signaling pathway,tumor progression,epithelial-stromal interaction,heparan sulfate proteoglycan interaction
ENSG00000269405,NXF2,rna export regulation,chromatin modification,epigenetic alteration,tumor suppressor suppression,cell proliferation promotion,oncogenic transcript upregulation
ENSG00000269437,NXF2B,mrna export,oncogenic processes,cell proliferation,genomic instability,tumorigenesis,therapeutic target
ENSG00000182902,SLC25A18,mitochondrial transport regulation,oncogenic potential,tumor progression,energy metabolism disruption,cell proliferation enhancement,genomic amplification
ENSG00000133488,SEC14L4,pi4ka regulation,oncogenic processes,cell proliferation enhancement,metastasis promotion,genetic alterations driver,phosphatidylinositol 4-phosphate production
ENSG00000156219,ART3,mitochondrial function regulation,adenine nucleotide transport,energy metabolism modulation,cellular survival enhancement,oncogenic process contribution,therapeutic target potential
ENSG00000166938,DIS3L,loss-of-function mutations,ribosome biogenesis,cellular proliferation,growth regulation,helicase interaction,kinase modulation
ENSG00000154719,MRPL39,mitochondrial biogenesis,energy metabolism,tumor growth,cell proliferation,anti-apoptotic activity,oncogenic potential
ENSG00000225830,ERCC6,dna repair mechanism,dna damage response,genomic instability,tumor suppressor function,cell cycle regulation,brca1 interaction
ENSG00000124233,SEMG1,glp-1 receptor agonist activity,oncogenic process promotion,cell proliferation regulation,apoptosis inhibition,metastasis facilitation,tumor growth enhancement
ENSG00000182050,MGAT4C,glycosylation regulation,tumor progression,oncogenic signaling,cell proliferation,apoptosis modulation,microenvironment interaction
ENSG00000285112,SLC52A2,riboflavin transporter,cellular redox balance,energy metabolism regulation,cell proliferation support,tumor progression driver,prognostic biomarker candidate
ENSG00000115286,NDUFS7,decreased mitochondrial function,genetic mutations,tumor progression,proliferation and survival,signaling pathway dysregulation,glycolytic shift
ENSG00000070193,FGF10,fgf/fgfr signaling pathway,gain of function mutations,cell proliferation,tumor progression,epithelial-to-mesenchymal transition,angiogenesis
ENSG00000082126,MPP4,pi3k/akt pathway dysregulation,cell proliferation regulation,tumor progression enhancement,therapeutic target potentiality,membrane trafficking regulation,poor prognosis association
ENSG00000173145,NOC3L,nuclear organization,ribosome biogenesis,gene expression regulation,cell growth promotion,cell cycle progression regulation,onco-protein interaction
ENSG00000239305,RNF103,cell cycle regulation,mitosis regulation,chromosome segregation,cancer cell proliferation,signaling pathway modulation,ubiquitination regulator
ENSG00000136531,SCN2A,cellular excitability regulation,neurological disorder association,voltage-gated sodium channel subunit,proliferation promotion,survival pathway activation,apoptosis evasion facilitation
ENSG00000172379,ARNT2,angiogenic factor,induction of vegf,hypoxia-inducible factors regulation,tumor progression,potential oncogene,vascular endothelial growth factor regulation
ENSG00000104805,NUCB1,cancer-promoting,overexpression,tumor progression,cell proliferation,potential biomarker,signaling pathway modulation
ENSG00000124587,PEX6,peroxisomal biogenesis,metabolic regulation,protein importation,cellular homeostasis,tumor growth modulation,cancer metabolism
ENSG00000159199,ATP5MC1,metabolic regulation,mitochondrial function,energy production,cellular respiration,electron transport chain,oxidative phosphorylation
ENSG00000187416,LHFPL3,overexpression,tumor growth promotion,cellular proliferation enhancement,apoptosis inhibition,lipid metabolism regulation,insulin sensitivity modulation
ENSG00000163637,PRICKLE2,oncogenic transcription co-repressor,transcriptional regulation,cell cycle progression,apoptosis suppression,genomic instability,epithelial-to-mesenchymal transition
ENSG00000010295,IFFO1,cell adhesion disruption,cell migration promotion,cytoskeleton remodeling,epithelial to mesenchymal transition,metastasis facilitation,tumor progression enhancement
ENSG00000152642,GPD1L,mitochondrial glycolysis,glycolytic flux enhancement,cell proliferation promotion,oxidative stress reduction,therapeutic target,metabolic regulation
ENSG00000160209,PDXK,pyridoxal kinase function,genomic instability,dna repair deficiency,oncogenic process promotion,therapeutic target identification,protein modification regulation
ENSG00000182793,GSTA5,altered expression,apoptosis regulation,cancer cell growth inhibition,tumor suppressor or oncogene function,xenobiotic metabolism,cellular antioxidant defense
ENSG00000170049,KCNAB3,aberrant channel activity,cellular excitability regulation,dysregulated signaling,genomic instability contribution,malignancy promotion,oncogenic driver
ENSG00000166532,RIMKLB,calcium channel regulation,oncogenic mutations,aberrant signaling pathways,cell cycle disruption,proliferation and survival enhancement,tumor suppressor interaction
ENSG00000180535,BHLHA15,regulation of emt pathways,tumor progression marker,cell proliferation regulator,apoptosis inhibitor,transcriptional regulation,chromatin modification
ENSG00000164038,SLC9B2,ion balance disruption,cellular ph regulation,ph-dependent sodium-proton antiporter regulation,tumor progression contribution,oncogenic process influence,genetic mutation impact
ENSG00000117400,MPL,thrombopoietin receptor activation,constitutive jak-stat signaling,cell proliferation enhancement,tumor cell survival promotion,hematopoietic disruption,oncogenic driver mutation
ENSG00000248483,POU5F2,transcriptional regulation,cellular differentiation,oncogenic programs,tumor driver gene,chromatin modification,pluripotency maintenance
ENSG00000180964,TCEAL8,chromatin remodeling,transcriptional regulation,cell proliferation,histone modification,oncogene/tumor suppressor,gene expression modulation
ENSG00000123983,ACSL3,fatty acid metabolism,oncogenic process,tumor growth promotion,metastasis regulation,biomarker potential,therapeutic target
ENSG00000183092,BEGAIN,homologous recombination repair,genomic instability,tumor suppressor function,dna double-strand breaks,replication stress response,protein-protein interaction
ENSG00000143994,ABHD1,phospholipid metabolism,cell proliferation,apoptosis regulation,autophagy modulation,protein-protein interaction,cancer cell survival
ENSG00000156110,ADK,energy metabolism,nucleotide pool regulation,tumor growth promotion,cellular energy maintenance,metabolic reprogramming,adenylate kinase activity
ENSG00000128039,SRD5A3,enhanced cell proliferation,protein-protein interaction,cell invasion,tumor progression,steroid hormone regulation,epigenetic modification
ENSG00000142347,MYO1F,rho gtpase pathway,cell migration,invasive potential,tumor progression,prognostic marker,oncogenic transformation
ENSG00000140548,ZNF710,transcriptional regulation,apoptosis modulation,cell proliferation regulation,tumor suppression,chromatin remodeling,dna-binding activity
ENSG00000103888,CEMIP,dna damage response,anti-apoptotic function,cancer driver mutation,genomic instability regulation,tumor progression,cellular stress response
ENSG00000174574,AKIRIN1,tgf-β signaling pathway,loss-of-function mutations,cell migration and invasion,epithelial-to-mesenchymal transition (emt),oncogene,therapeutic target
ENSG00000118702,GHRH,growth hormone regulation,cell proliferation stimulation,tumor growth promotion,angiogenesis modulation,metastasis enhancement,signaling pathway activation
ENSG00000177646,ACAD9,mitochondrial function,energy metabolism regulation,oncogenic activity,tumor progression driver,redox balance modulation,genetic alterations in transcription
ENSG00000182348,ZNF804B,**

chromatin remodeling,oncogene activation,transcriptional regulation,cell proliferation,epigenetic regulation,tumor progression

**
ENSG00000173825,TIGD3,tumor suppressor,apoptosis regulation,immune modulation,downregulation,biomarker potential,cancer cell survival
ENSG00000182541,LIMK2,actin cytoskeleton regulation,cellular morphological changes,enhanced cell migration,metastasis promotion,poor prognosis biomarker,therapeutic target
ENSG00000081052,COL4A4,basement membrane disruption,cell adhesion regulation,extracellular matrix remodeling,tumor progression facilitation,collagen chain interaction,tissue architecture maintenance
ENSG00000105679,GAPDHS,cell proliferation,tumorigenesis,glycolytic enzyme,apoptosis regulation,energy metabolism,malignant transformation
ENSG00000198205,ZXDA,genomic instability,transcriptional regulation,cell proliferation,tumor progression,oncogenic transformation,promoter hypermethylation
ENSG00000139287,TPH2,cell cycle progression,apoptosis modulation,tumor invasion,angiogenesis promotion,therapeutic target,serotonin biosynthesis
ENSG00000196850,PPTC7,cell cycle regulation,genomic instability,tumor progression,chromosome segregation,mitosis regulation,transcriptional regulation
ENSG00000147457,CHMP7,chromatin remodeling,gene regulation,cell proliferation,chromatin accessibility,oncogene activation,tumor progression
ENSG00000242802,AP5Z1,protein degradation regulation,ubiquitin-proteasome pathway dysregulation,cell cycle promotion,tumor progression facilitation,oncogenic signaling enhancement,poor prognosis correlation
ENSG00000131148,EMC8,chromatin remodeling,transcriptional regulation,tumor growth promotion,mutation associated,cyclin-dependent kinase interaction,rna polymerase ii activation
ENSG00000159788,RGS12,constitutive activation,tumor suppressor,cell proliferation,gtpase-activating protein,oncogenic signaling,downregulation mutations
ENSG00000108688,CCL7,tumor microenvironment modulation,immune evasion mechanisms,cell migration regulation,biomarker for disease progression,secreted protein function,chemokine signaling pathway
ENSG00000137502,RAB30,overexpression,pi3k/akt pathway activation,tumor growth promotion,metastasis facilitation,cell cycle regulation,apoptosis suppression
ENSG00000140398,NEIL1,dna damage response,base excision repair,tumor suppressor activity,genomic instability,oxidative stress resistance,dna repair enzyme
ENSG00000188425,NANOS2,oncogenic process,cell proliferation,suppressed tumor suppressors,cell survival enhancement,tumor suppressor regulation,mirna expression regulation
ENSG00000179593,ALOX15B,inflammation regulation,tumor progression,lipid metabolism modulation,immune response alteration,prognosis association,enzymatic activity
ENSG00000174844,DNAH12,cilia formation,cell signaling disruption,oncogenesis,prognostic marker,therapeutic target,genomic instability
ENSG00000278322,MBOAT7,cell membrane lipid modification,signaling pathway modulation,tumor progression,metastasis regulation,pi3k/akt pathway activation,oncogenic potential
ENSG00000099954,CECR2,dna damage response,genomic instability,oncogene overexpression,cell cycle regulation,protein-protein interaction,tumor progression
ENSG00000198160,MIER1,oncogene activation,transcriptional coactivator function,epigenetic regulation,apoptosis suppression,tumor suppressor gene repression,cell growth promotion
ENSG00000141431,ASXL3,chromatin remodeling,tumor aggressiveness,genome instability,dysregulated gene expression,apoptosis inhibition,cell cycle disruption
ENSG00000136108,CKAP2,cell cycle regulation,cytoskeletal interaction,dna repair,apoptosis regulation,oncogenic transformation,tumor progression
ENSG00000113430,IRX4,transcriptional regulation,cell migration,epithelial-to-mesenchymal transition (emt),cancer stem cell properties,cell cycle regulation,promoter activity
ENSG00000152467,ZSCAN1,tumor suppressor function,genomic instability,cell cycle regulation,apoptosis induction,dna repair modulation,transcriptional repression
ENSG00000198758,EPS8L3,cell proliferation,cell migration,genomic amplification,signaling pathway regulation,protein interaction,cancer aggressiveness
,MARCH8,protein regulation,receptor modulation,tumor progression,ubiquitin ligase activity,membrane trafficking,cancer therapy target
ENSG00000281500,SLC37A4,folate metabolism,intracellular transport,dna synthesis,cell proliferation,therapeutic target,genomic instability
ENSG00000163812,ZDHHC3,tumor progression,cell proliferation,g-protein coupled receptor modification,palmitoylation activity,protein trafficking regulation,oncogenic signaling
ENSG00000164219,PGGT1B,protein modification,tumor progression,metastasis regulation,cell migration,therapeutic target,coagulation pathway
ENSG00000006007,GDE1,phospholipid metabolism,cell proliferation,oncogenesis,signaling pathway regulation,tumor progression,rna expression analysis
ENSG00000151655,ITIH2,extracellular matrix regulation,tumor progression enhancement,cell migration promotion,proteolysis modulation,cancer cell invasion facilitation,chemotherapy resistance promotion
ENSG00000171649,ZIK1,transcriptional regulation,cell proliferation,oncogenesis,apoptosis inhibition,tumor progression,prognostic marker
ENSG00000162704,ARPC5,hyperactivation,oncogene activation,cell motility regulation,tumor progression,metastasis promotion,actin cytoskeleton modulation
ENSG00000160539,PLPP7,lipid metabolism regulation,tumor progression association,gene expression alteration,cell growth modulation,proliferation pathway involvement,lipid signaling disruption
ENSG00000143768,LEFTY2,epithelial-to-mesenchymal transition,wnt/β-catenin pathway inhibition,tumor suppressor function,cell fate regulation,embryonic development regulator,cancer metastasis associated
ENSG00000111058,ACSS3,fatty acid metabolism,metabolic reprogramming,oncogenic potential,cell growth,proliferation and survival,protein overexpression
ENSG00000281216,KIF26B,microtubule dynamics regulation,cell division disruption,genome instability induction,tumorigenesis promotion,cell cycle control dysregulation,protein interaction alterations
ENSG00000014919,COX15,loss of mitochondrial membrane potential,apoptosis resistance,cellular respiration disruption,mitochondrial dysfunction,warburg effect,cell cycle deregulation
ENSG00000198380,GFPT1,glycosylation,cell surface protein modification,oncogene potential,tumor progression,therapeutic target,hexosamine biosynthetic pathway
ENSG00000162706,CADM3,tumor suppressor,epithelial integrity,apoptosis regulation,cell adhesion molecule,pi3k/akt pathway inhibition,constitutive activation blockade
ENSG00000114857,NKTR,tumor progression,cellular response modulation,signaling pathway interaction,growth factor regulation,apoptosis regulation,oncogenic role
ENSG00000186918,ZNF395,apoptosis modulation,cell cycle regulation,cancer progression,tumor suppressor activity,transcription factor interaction,zinc finger domain
ENSG00000179603,GRM8,metabotropic glutamate receptor 8,tumor progression,cell proliferation,metastatic potential,therapeutic target,pi3k/akt signaling pathway interaction
ENSG00000282185,PTPRN2,cellular adhesion,metastatic potential,protein tyrosine phosphatase activity,tumor progression,oncogenic pathway activation,cancer associated gene expression
ENSG00000180537,RNF182,p53 regulation,tumor suppressor protein degradation,ring domain interaction,e3 ubiquitin ligase complex,cell cycle progression regulation,protein stability modulation
ENSG00000185527,PDE6G,protein phosphorylation,calcium signaling,cell proliferation,cell survival,genetic mutations,tumor metastasis
ENSG00000108947,EFNB3,tumor progression,tumor invasion,cell migration,angiogenesis promotion,therapeutic target,prognostic marker
ENSG00000178522,AMBN,bone metastasis,cell proliferation,dna damage response,gene expression regulation,nucleotide binding,oncogenic transformation
ENSG00000198670,LPA,lysophosphatidic acid production,cell proliferation,tumor progression,oncogenic signaling,cell migration,metastasis
ENSG00000138031,ADCY3,oncogenic signaling,gain-of-function mutations,cellular proliferation,metastasis progression,therapeutic target,signaling pathway regulation
ENSG00000147488,ST18,tgf-beta signaling pathway,epithelial-to-mesenchymal transition,metastasis promotion,promotes invasion,tumor progression,wound healing regulation
ENSG00000204604,ZNF468,oncogene function,cell cycle regulation,transcriptional activation,tumor progression,poor prognosis biomarker,cell proliferation enhancer
ENSG00000171540,OTP,oncogenic transcription factor,tumor growth promotion,cell proliferation regulation,wnt/β-catenin pathway interaction,genetic dysregulation,somatic mutation
ENSG00000101474,APMAP,tumor progression,proteolytic activation,cell invasion,metastasis promotion,cancer prognostic marker,serine protease function
ENSG00000102904,TSNAXIP1,p53 interaction,tumor suppression,cell proliferation,apoptosis regulation,microtubule stability,chromosome 8 alteration
ENSG00000185070,FLRT2,fgf/flrt interaction,oncogene activation,cell proliferation,tumor progression,wnt signaling pathway,apoptosis inhibition
ENSG00000204130,RUFY2,lysosome biogenesis,autophagy regulation,cellular degradation,oncogenic cooperation,tumor growth modulation,protein modification regulation
ENSG00000173976,RAX2,epithelial integrity,maintenance,transcriptional regulation,proliferation,survival signaling pathways,epithelial-to-mesenchymal transition
ENSG00000172006,ZNF554,tumor suppressor function,transcriptional regulation,cell proliferation enhancement,apoptosis inhibition,chromatin remodeling,oncogenesis promoter
ENSG00000215454,KRTAP10-4,cellular differentiation,epithelial cell proliferation,keratin-associated protein function,oncogene regulation,tumor suppressor downregulation,molecular dysregulation
ENSG00000144671,SLC22A14,ion transport alteration,tumor progression,cancer metastasis,prognostic marker,cellular ion balance regulation,apoptosis modulation
ENSG00000171532,NEUROD2,cell cycle regulation,transcriptional regulation,oncogenic transcription factor,tumor aggressiveness,cell proliferation enhancement,transcriptional activation
ENSG00000101868,POLA1,genomic instability,dna replication initiation,cell cycle regulation,tumor suppressor function,dna repair mechanism,oncogenesis driver
ENSG00000213366,GSTM2,dna repair mechanisms,cellular detoxification,tumor suppressor function,genomic stability maintenance,apoptosis modulation,carcinogen metabolism
ENSG00000178662,CSRNP3,oncogenic activity,pi3k/akt signaling pathway regulation,cell proliferation promotion,tp53 interaction,tumor progression enhancement,apoptosis inhibition
ENSG00000162188,GNG3,regulation of cell proliferation,tumor progression,cell survival,mutations leading to oncogenesis,heterotrimeric g-protein interaction,therapeutic target
ENSG00000255150,EID3,chromatin remodeling,transcriptional repressor,oncogenic transcription,tumor suppressor repression,cell cycle disruption,chromatin modification
ENSG00000118162,KPTN,epigenetic regulation,chromatin remodeling,tumor progression,cell cycle regulation,dna repair,apoptosis suppression
ENSG00000172782,FADS6,lipid metabolism alteration,fatty acid biosynthesis,cell proliferation enhancement,tumor growth promotion,poor prognosis indicator,cancer cell lipid composition alteration
ENSG00000134317,GRHL1,loss-of-function mutations,tumor suppressor activity,cell cycle regulation,nf-κb pathway modulation,apoptosis regulation,transcriptional repression
ENSG00000173992,CCS,pi3k/akt signaling pathway disruption,cell cycle checkpoint regulation,oncogenic protein kinase activity,dna damage response dysregulation,homologous recombination,tumor suppressor p53 modulation
ENSG00000204060,FOXO6,apoptosis regulation,transcriptional repression,cell proliferation regulation,tumor progression association,poor prognosis indicator,genomic instability promotion
ENSG00000068912,ERLEC1,apoptosis inhibition,cell cycle progression,coactivator function,gene regulation disruption,immune evasion,oncogenic coactivation
ENSG00000197622,CDC42SE1,pi3k/akt signaling pathway activation,cancer cell migration and invasion promotion,cell proliferation and survival enhancement,poor prognosis biomarker,therapeutic target,protein-protein interaction regulation
ENSG00000185269,NOTUM,wnt signaling pathway regulation,tumor suppression,golgi apparatus localization,gsk3b inhibition,biomarker potential,prognostic significance
ENSG00000196660,SLC30A10,zinc homeostasis,cancer aggressiveness,poor prognosis,cell proliferation,metastasis regulation,therapeutic target
ENSG00000131725,WDR44,tumor suppressor,genome stability maintenance,dna repair pathway regulation,chromatin remodeling complex assembly,cell cycle regulation,protein-protein interactions
ENSG00000046653,GPM6B,g-protein signaling modulator,mapk/erk pathway activation,cell proliferation promotion,prognostic biomarker identification,tumor progression facilitation,metastatic potential enhancement
ENSG00000136867,SLC31A2,zinc homeostasis disruption,cell proliferation enhancement,oncogenic processes promotion,apoptosis inhibition,therapeutic target potential,metastasis facilitation
ENSG00000280549,PADI3,oncogenic signaling,protein deimination,epigenetic regulation,tumor suppressor interaction,growth promotion,cancer progression
ENSG00000226430,USP17L7,deubiquitinating activity,apoptosis modulation,stress response regulation,protein stability modulation,ubiquitin-proteasome pathway interaction,cancer-associated gene
ENSG00000156925,ZIC3,tumor progression,transcriptional regulation,epithelial-to-mesenchymal transition (emt),oncogene activation,cell proliferation,genomic instability
ENSG00000169918,OTUD7A,tumor progression,oncogene activation,cell proliferation,apoptosis resistance,ubiquitin-proteasome system regulation,dna repair modulation
ENSG00000116497,S100PBP,calcium signaling pathway,onco-protein interaction,oncogenic transformation,metastasis facilitation,s100p complex formation,tumor progression
ENSG00000151532,VTI1A,cellular ph regulation,tumor progression,metastasis facilitation,proton transport,cell adhesion disruption,epigenetic modification alteration
ENSG00000183655,KLHL25,androgen receptor-binding protein,ubiquitination regulation,oncogenic function,cell cycle modulation,apoptosis disruption,tumor suppressor dysfunction
ENSG00000066813,ACSM2B,energy metabolism regulation,lipid homeostasis dysregulation,cellular respiration enhancement,prognosis predictor,tumor aggressiveness promoter,therapeutic target
ENSG00000168779,SHOX2,wnt/β-catenin pathway,transcriptional regulation,overexpression driver,prognostic marker,cell proliferation promotion,epithelial-to-mesenchymal transition
ENSG00000104951,IL4I1,chromatin regulation,tumor progression,dna replication repair,apoptosis evasion,cell cycle modulation,histone modification
ENSG00000112218,GPR63,cell signaling,immune response modulation,cell proliferation,oncogenic process,therapeutic target,metastasis
ENSG00000196511,TPK1,cgmp-dependent protein kinase activation,cell proliferation,protein phosphorylation,cell survival,signaling pathway regulation,phosphodiesterase interaction
ENSG00000178814,OPLAH,tumor progression,pi3k/akt pathway modulation,cell proliferation regulation,biomarker expression,oncogenic driver,signaling pathway interaction
ENSG00000171408,PDE7B,oncogenic processes,tumor growth promotion,cell cycle regulation,apoptosis modulation,constitutive overexpression,therapeutic target
ENSG00000276231,PIK3R6,pi3k/akt/mtor signaling pathway,constitutive activation,loss of regulatory function,tumor progression,therapeutic target,genomic instability
ENSG00000198753,PLXNB3,cell adhesion regulation,angiogenesis promotion,prognostic marker,tumor progression association,semaphorin interaction,transmembrane receptor function
ENSG00000119723,COQ6,mitochondrial dysfunction,oxidative stress,cell survival,genomic instability,dna damage,coenzyme q10 biosynthesis
ENSG00000168675,LDLRAD4,regulation of cell membrane dynamics,alterations in lipid metabolism,modulation of pi3k/akt signaling,oncogenic processes,tumor growth and invasion,cancer cell survival
ENSG00000135919,SERPINE2,cellular migration,protease inhibition,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition,extracellular matrix remodeling
ENSG00000143847,PPFIA4,epithelial-to-mesenchymal transition regulation,cell migration and adhesion modulation,signaling pathway interaction,cell proliferation enhancement,tumor progression facilitation,cell survival promotion
ENSG00000159409,CELF3,post-transcriptional regulation,au-rich elements binding,oncogene promotion,cell proliferation control,apoptosis modulation,microrna processing regulation
ENSG00000100342,APOL1,kidney disease-related cancers,apoptosis regulation,lipid trafficking,gene variants,cellular metabolism,high-density lipoprotein (hdl) particles
ENSG00000147955,SIGMAR1,**

cellular survival,mitochondrial function,er stress response,apoptosis modulation,oncogenic processes,immune response regulation 

**
ENSG00000144821,MYH15,cellular contractility,cell migration,signaling pathway interaction,invasiveness modulation,pi3k/akt pathway activation,metastasis promotion
ENSG00000104723,TUSC3,tumor suppressor,cell cycle regulation,apoptosis regulation,dna repair modulation,pi3k/akt/mtor pathway modulation,cancer progression
ENSG00000164252,AGGF1,vascular endothelial growth factor (vegfa) pathway interaction,angiogenesis promotion,tumor aggressiveness marker,cell proliferation enhancement,genomic instability contributor,therapeutic target candidate
ENSG00000100078,PLA2G3,cell proliferation,inflammation regulation,oncogenesis,protein-protein interactions,signaling pathway modulation,therapeutic target
ENSG00000144182,LIPT1,lipoyl transfer activity,tumor progression,cellular metabolism,oncogenic role,energy production regulation,proliferation enhancement
ENSG00000120832,MTERF2,mitochondrial translation regulation,oncogene overexpression,cell proliferation promotion,apoptosis inhibition,cancer cell survival enhancement,metabolic regulation alteration
ENSG00000002586,CD99,oncogene overexpression,cell signaling pathway modulation,epithelial-to-mesenchymal transition (emt),cell adhesion regulation,protein-protein interaction,cancer progression marker
ENSG00000137871,ZNF280D,transcriptional regulation,oncogene activation,cell proliferation,apoptosis inhibition,dna damage response,biomarker potential
ENSG00000178537,SLC25A20,metabolic reprogramming,mitochondrial transport,succinate carrier function,energy metabolism alteration,cell proliferation promotion,tumor progression association
ENSG00000153936,HS2ST1,histone chaperone function,chromatin assembly maintenance,genomic instability promotion,oncogenic process contribution,cancer progression facilitation,therapeutic target candidate
ENSG00000166869,CHP2,altered expression,autophagy dysregulation,cell cycle disruption,endocytosis regulation,lysosomal dysfunction,pi3k/akt interaction
ENSG00000164300,SERINC5,pi3k/akt pathway interaction,tumor suppressor function,apoptosis regulation,cell proliferation control,lipid metabolism modulation,genomic deletion hotspot
ENSG00000249115,HAUS5,chromosomal instability,aneuploidy,cell division regulation,mitotic progression,spindle assembly,somatic mutation
ENSG00000275824,CCL4,immune recruitment,tumor progression,therapeutic target,angiogenesis regulation,cell migration modulation,inflammation promotion
ENSG00000173175,ADCY5,camp signaling,oncogenic driver,cell proliferation,immune evasion,tumor progression,upregulated expression
ENSG00000198121,LPAR1,lysophosphatidic acid signaling,g protein-coupled receptor activation,tumor progression,angiogenesis promotion,cell survival enhancement,metastasis facilitation
ENSG00000116793,PHTF1,histone modification,transcriptional regulation,tumor suppressor function,chromatin remodeling,brca1 interaction,tp53 interaction
ENSG00000253958,CLDN23,tumor invasion,epithelial-to-mesenchymal transition,ion transport regulation,tight junction disruption,biomarker discovery,therapeutic targeting
ENSG00000140043,PTGR2,prostaglandin synthesis,nf-κb pathway activation,mapk/erk signaling modulation,cell proliferation regulation,tumor aggressiveness enhancement,poor prognosis association
ENSG00000120533,ENY2,transcriptional regulation,chromatin remodeling,oncogene overexpression,cell proliferation enhancement,metastatic potential increase,genomic instability promotion
ENSG00000152683,SLC30A6,zinc homeostasis,cell growth regulation,cancer progression,metastasis modulation,therapeutic resistance,cellular zinc levels
ENSG00000145740,SLC30A5,cellular signaling pathway,zinc transporter,cell proliferation,tumor aggressiveness,biomarker potential,prognostic indicator
ENSG00000147789,ZNF7,tumor suppressor function,nuclear localization,transcriptional regulation,apoptosis promotion,cell cycle regulation,dna repair mechanism
ENSG00000100106,TRIOBP,rho gtpase activation,guanine nucleotide exchange factor,cell migration regulation,cytoskeleton remodeling,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000164172,MOCS2,impaired molybdenum cofactor biosynthesis,cancer-related metabolic reprogramming,cellular respiration impairment,tumor progression driver,metabolic enzyme regulation,genetic mutations associated
ENSG00000163297,ANTXR2,wnt/β-catenin signaling pathway,loss-of-function mutations,tumor suppressor function,cell adhesion regulation,cytoskeletal interaction,prognostic marker
ENSG00000236637,IFNA4,immunomodulatory effects,induction of apoptosis,disruption of tumor microenvironment,interaction with signaling pathways,modulation of antiviral defense,antiproliferative effects
ENSG00000135916,ITM2C,cell signaling regulation,growth factor independence,proliferation enhancement,therapeutic target,protein-protein interaction,tumor progression
ENSG00000175766,EIF4E1B,mrna translation regulation,protein overexpression,tumor growth promotion,cancer biomarker,chemotherapy resistance,treatment response prediction
ENSG00000197044,ZNF441,transcriptional regulation,disrupted chromatin architecture,gene expression dysregulation,oncogenic function,mutations in blca,tumor cell proliferation
ENSG00000072182,ASIC4,tumor progression,gene expression changes,sodium ion influx signaling,cell proliferation and invasion,cancer progression,protein interactions
ENSG00000147117,ZNF157,transcriptional regulation,cell cycle progression,apoptosis inhibition,tumor aggressiveness,oncogenic processes,prognostic marker
ENSG00000116133,DHCR24,cholesterol biosynthesis regulation,tumor suppressor function,cell proliferation enhancement,membrane lipid modulation,signal transduction influence,cancer development contribution
ENSG00000130787,HIP1R,cell growth modulation,regulation of cell proliferation,pi3k/akt pathway activation,tumor progression promotion,therapeutic target potential,genomic instability involvement
ENSG00000118473,SGIP1,pi3k/akt pathway modulation,tumor progression enhancement,metastasis facilitation,cell adhesion disruption,signaling pathway regulation,protein-protein interaction
ENSG00000164010,ERMAP,genomic instability,apoptosis regulation,cell cycle regulation,dna repair mechanism,stress response protein,tumor suppressor
ENSG00000183035,CYLC1,lipid peroxidation,metabolic regulation,cell growth promotion,angiogenesis,immune suppression,tumor progression
ENSG00000106636,YKT6,regulation of cell growth,promotion of oncogenic signaling,tumor progression,overexpression,cell cycle regulation,vesicle docking
ENSG00000132464,ENAM,cellular differentiation,proliferation regulation,enamel mineralization,cell survival,genetic interaction,gene expression modulation
ENSG00000007216,SLC13A2,sodium-dependent phosphate transport,phosphate homeostasis regulation,cellular proliferation enhancement,tumor progression driver,therapeutic target identification,metabolic pathway dysregulation
ENSG00000176597,B3GNT5,tumor progression,wnt/β-catenin pathway,cell adhesion,glycosyltransferase activity,extracellular matrix regulation,protein-protein interaction
ENSG00000140297,GCNT3,glycosylation dysregulation,cell adhesion molecule,tumor progression,early oncogenic event,potential therapeutic target,signaling pathway interaction
ENSG00000115252,PDE1A,angiogenesis,cell survival,vasodilation regulation,cgmp degradation,akt/mapk signaling pathway interaction,proliferation enhancement
ENSG00000148334,PTGES2,**
prostaglandin synthesis,increased expression,tumor progression,chemotherapy resistance,inflammation regulation,cell survival enhancement
ENSG00000197181,PIWIL2,regulatory loss,tumor suppressor,cell proliferation,apoptosis suppression,mirna regulation,genomic instability
ENSG00000103037,SETD6,epigenetic regulation,methyltransferase activity,histone modification,transcriptional regulation,tumor suppressor modulation,oncogene activation
ENSG00000127663,KDM4B,histone demethylation,oncogene activation,tumor progression,epigenetic regulation,prognostic marker,therapeutic target
ENSG00000142784,WDTC1,cell cycle regulation,chromosomal segregation,dna damage response,mitotic checkpoint regulation,cancer progression,genetic instability
ENSG00000158161,EYA3,transcriptional activator function,overexpression in cancer,cell proliferation regulation,epithelial cell maintenance,downstream target regulation,therapeutic target for blca
ENSG00000197123,ZNF679,transcriptional regulation,epigenetic modification,cell growth modulation,apoptosis evasion,dna repair dysregulation,prognostic marker
ENSG00000177156,TALDO1,pentose phosphate pathway,oncogene,glycolytic activity,tumor progression,therapeutic target,metabolic reprogramming
ENSG00000119681,LTBP2,tgf-beta signaling,cell proliferation,epithelial-to-mesenchymal transition (emt),oncogenic process,therapeutic target,protein regulation
ENSG00000102595,UGGT2,er stress response,protein quality control,udp-glucosyltransferase activity,tumor progression,cell survival enhancement,chemotherapy resistance
ENSG00000144029,MRPS5,mitochondrial ribosome assembly,oncogenic function,cell proliferation promotion,therapeutic target,genetic amplification,cell survival enhancement
ENSG00000166435,XRRA1,genome instability,dna repair impairment,tumor suppressor function,nucleotide excision repair,mutational burden,genetic predisposition
ENSG00000134216,CHIA,chromatin remodeling,aneuploidy,genomic instability,cell cycle regulation,transcriptional regulation,tumor progression
ENSG00000077254,USP33,deubiquitinating enzyme,protein degradation regulation,pi3k/akt/mtor pathway modulation,tumor suppressor p53 regulation,ubiquitin-proteasome pathway activation,cancer cell proliferation promotion
ENSG00000196611,MMP1,mmp degradation,tumor progression,metastasis,cell invasion,basement membrane degradation,therapeutic target
ENSG00000170619,COMMD5,nf-κb pathway interaction,oncogene potential,cell growth regulation,inflammation modulation,tumor progression,metastasis promotion
ENSG00000103316,CRYM,protein folding regulation,apoptosis modulation,stress response pathway,tumor overexpression,cell cycle regulation,therapeutic target
ENSG00000080618,CPB2,genomic instability,cell cycle progression,dna damage response,epithelial-to-mesenchymal transition (emt),oncogenic transcription factor recruitment,constitutive activation
ENSG00000137251,TINAG,constitutive activation,oncogenic driver,tgf-? signaling pathway,epithelial-to-mesenchymal transition (emt),cell proliferation,cancer progression
ENSG00000171421,MRPL36,mitochondrial ribosome assembly,cellular metabolism regulation,tumor aggressiveness marker,oncogene upregulation,apoptosis inhibition,warburg effect facilitation
ENSG00000120093,HOXB3,tumor progression,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell growth and invasion,therapeutic target,chemosensitivity
,H1FOO,epigenetic regulator,chromatin compactor,genomic stabilizer,histone modification,transcriptional controller,dna packaging
ENSG00000142556,ZNF614,tumor progression,oncogene function,transcriptional regulation,dna-binding activity,cell proliferation,cancer prognostic marker
ENSG00000131871,SELENOS,redox regulation,cancer driver,promotes tumor growth,overexpressed in tumors,dna protection,antioxidant activity
ENSG00000165300,SLITRK5,emt inhibition,wnt/β-catenin pathway interaction,cell migration regulation,tumor progression suppression,downregulation in tumors,potential biomarker
ENSG00000178700,DHFR2,hyperproliferative phenotype,constitutive expression,genomic instability,oncogenic processes,folate metabolism regulation,therapeutic target
ENSG00000083544,TDRD3,chromatin regulation,microrna processing,epigenetic alterations,oncogene activation,cell proliferation,genomic instability
ENSG00000277363,SRCIN1,cell signaling modulation,oncogenic facilitation,cell proliferation enhancement,kinase regulation,tumorigenesis association,protein-protein interaction
ENSG00000149972,CNTN5,cell adhesion,neurodevelopmental process,tumor suppressive function,cell proliferation regulation,signaling pathway modulation,gene expression regulation
ENSG00000126500,FLRT1,wnt/β-catenin pathway modulation,cell migration regulation,tumor progression,metastasis promotion,prognostic marker,signaling pathway interaction
ENSG00000197616,MYH6,potential biomarker,cell proliferation,striated muscle contraction,tumor growth,aberrant expression,dna repair
ENSG00000055211,GINM1,g-protein signaling,cell proliferation,signal transduction,receptor activation,tumor growth,metastasis
ENSG00000013306,SLC25A39,cell growth promotion,oncogene function,mitochondrial respiration regulation,energy metabolism dysregulation,prognostic marker,tumor progression association
ENSG00000169116,PARM1,cellular energy regulation,cancer cell survival,protein kinase activation,tumor progression,metabolic adaptation,genetic alterations
ENSG00000205659,LIN52,ubiquitination pathway,cell cycle regulation,transcriptional control,protein degradation,dna damage response,tumor aggressiveness
ENSG00000198554,WDHD1,genomic instability,cell cycle regulation,tumor suppressor function,dna damage response,homologous recombination repair,mutational burden
ENSG00000105732,ZNF574,cellular regulation,tumor suppressor function,loss of expression,apoptosis dysregulation,dna repair impairment,pi3k/akt pathway interaction
ENSG00000119614,VSX2,oncogene activation,cell proliferation enhancement,transcriptional regulation,apoptosis evasion,prognostic marker,tumor progression driver
ENSG00000144218,AFF3,oncogenic transcriptional regulation,co-activator function,cell proliferation enhancement,tumor progression facilitation,transcription factor interaction,overexpression marker
ENSG00000102387,TAF7L,transcriptional regulation,cell cycle progression,g2/m phase transition,tumor suppressor activity,overexpression-mediated oncogenesis,chromatin remodeling
ENSG00000176102,CSTF3,alternative splicing,cell migration,gene regulation,metastatic potential,polyadenylation process,prognostic biomarker
ENSG00000001561,ENPP4,purine metabolism,tumor progression,cell migration,extracellular nucleotide regulation,cell growth promotion,microenvironment modulation
ENSG00000159322,ADPGK,oncogenic function,energy metabolism dysregulation,protein-protein interactions,constitutive activation,genomic instability,poor prognosis marker
,TWISTNB,transcription factor activation,epithelial-to-mesenchymal transition,cell migration and invasion,survival pathway regulation,tumor progression driver,genetic amplification
ENSG00000133424,LARGE1,pre-mrna splicing regulation,oncogene overexpression,alternative splicing modulation,poor prognosis marker,cell growth promotion,mrna export regulation
ENSG00000141429,GALNT1,glycoprotein modification,tumor progression,wnt/β-catenin pathway interaction,cell adhesion regulation,cancer cell proliferation,protein function modulation
ENSG00000152495,CAMK4,genomic instability,cell cycle dysregulation,pi3k/akt pathway interaction,oncogenic signaling,apoptosis resistance,cell proliferation enhancement
ENSG00000112394,SLC16A10,glycolytic metabolism,lactate efflux,tumor progression,poor prognosis,chemoresistance,therapeutic target
ENSG00000197106,SLC6A17,amino acid transporter,metabolic adaptation,cell growth promotion,tumor progression driver,poor prognosis marker,overexpression
ENSG00000176399,DMRTA1,cell cycle regulation,transcriptional regulation,oncogenic driver,metabolic reprogramming,pi3k/akt/mtor signaling pathway activation,tp53 interaction
ENSG00000160445,ZER1,zinc finger protein,chromatin remodeling,transcriptional regulation,cell cycle control,tumor progression,prognostic marker
ENSG00000135763,URB2,pi3k/akt pathway interaction,ubiquitin ligase activity,cell proliferation promotion,protein degradation regulation,apoptosis suppression,tumor progression enhancement
ENSG00000162892,IL24,apoptosis induction,anti-tumor response,caspase activation,cell cycle regulation,tumor suppressor function,anti-angiogenesis
ENSG00000134153,EMC7,chromatin remodeling,epigenetic regulation,tumor progression,genomic instability,dna repair,oncogene regulation
ENSG00000125675,GRIA3,glutamate receptor activation,cell proliferation,epithelial-to-mesenchymal transition,pi3k/akt pathway regulation,mutation hotspot,tumor aggressiveness
ENSG00000136378,ADAMTS7,tumor progression,extracellular matrix modulation,proteolytic activity,metastasis promotion,biomarker potential,cell adhesion regulation
ENSG00000114450,GNB4,g protein signaling pathway,oncogenic transformation,aberrant activation,cell proliferation,epi to met transition,prognostic biomarker
ENSG00000153721,CNKSR3,wnt/β-catenin signaling,adaptor protein function,tumor progression,cell survival enhancement,therapeutic target,metabolic regulation
ENSG00000116786,PLEKHM2,pi3k/akt pathway regulation,cell migration modulation,autophagy regulation,protein-protein interaction,tumor progression driver,genomic instability
ENSG00000116747,RO60,tumor progression,transcriptional regulation,cellular proliferation,apoptosis suppression,metastatic potential,genomic instability
ENSG00000129990,SYT5,cellular signaling pathways,calcium-dependent regulation,endoplasmic reticulum localization,cell proliferation modulation,tumorigenesis association,molecular interaction with other proteins
ENSG00000197150,ABCB8,multidrug resistance,efflux pump,oncogene,chemotherapy resistance,cellular membrane transport,drug target
ENSG00000047597,XK,cellular proliferation,apoptosis regulation,biomarker potential,genomic amplification,protein-protein interaction,signaling pathway modulation
ENSG00000135519,KCNH3,pi3k/akt pathway,gain of function mutations,ion channel regulation,cell migration,oncogenic process,biomarker potential
ENSG00000160781,PAQR6,oncogenic function,tumor progression,cell growth promotion,steroid hormone regulation,transcriptional modulation,ap-1/nf-κb activation
ENSG00000169251,NMD3,ribosome biogenesis,cell proliferation,protein synthesis,cell cycle progression,nuclear export,energy metabolism
ENSG00000173918,C1QTNF1,cell adhesion disruption,cancer stemness maintenance,immune evasion mechanism,tumor microenvironment modulation,protein-protein interaction hub,metastatic potential enhancement
ENSG00000133466,C1QTNF6,apoptosis regulation,cell death promotion,cancer progression,tumor necrosis factor superfamily,receptor interaction,metastasis enhancement
ENSG00000122585,NPY,cell proliferation,angiogenesis promotion,tumor metastasis,epithelial-to-mesenchymal transition (emt),neuropeptide signaling pathway,prognostic marker
ENSG00000176209,SMIM19,cell cycle regulation,mitochondrial localization,oncogenic properties,energy metabolism,tumor cell proliferation,cancer metabolism
ENSG00000188991,SLC15A5,cellular proliferation,oncogenic properties,tumor microenvironment modulation,folate transport regulation,dna repair influence,cell cycle regulation
ENSG00000161904,LEMD2,calcium signaling,membrane trafficking regulation,tumorigenesis promotion,cell growth regulation,oncogenic processes,calcium-dependent signaling pathways
ENSG00000103449,SALL1,tumor suppressor function,cell growth regulation,transcriptional regulation,loss-of-function mutations,epigenetic silencing,apoptosis induction
ENSG00000102393,GLA,glycosphingolipid metabolism,pro-survival signals,tumor growth promotion,cell migration enhancement,chemoresistance,signaling pathway interaction
ENSG00000066827,ZFAT,gene expression regulation,transcription factor interaction,cell growth regulation,apoptosis modulation,dna repair regulation,tumor growth promotion
ENSG00000117477,CCDC181,pi3k/akt pathway modulation,coiled-coil domain interaction,cell migration enhancement,genomic alteration correlation,poor prognosis association,tumor progression promotion
ENSG00000156521,TYSND1,cellular regulation,gene expression regulation,tumor progression promoter,dysregulated gene function,cell growth modulation,genomic instability marker
ENSG00000147912,FBXO10,protein degradation,tumor suppressor function,dna repair mechanisms,cell proliferation regulation,genomic stability maintenance,therapeutic target
ENSG00000129151,BBOX1,tumor progression,snornp assembly,genomic instability,pseudouridylation,cellular proliferation,apoptosis dysregulation
ENSG00000148219,ASTN2,cellular adhesion,cell migration,cancer progression,therapeutic target,overexpression marker,axon guidance protein
ENSG00000182983,ZNF662,transcriptional regulator,oncogene,cell cycle progression,genomic instability,proliferation promotion,survival pathway activation
ENSG00000130558,OLFM1,cell adhesion regulation,tumor suppression,emt inhibition,pi3k/akt pathway interaction,protein-protein interactions,biomarker potential
ENSG00000132681,ATP1A4,na+/k+-atpase regulation,ion balance modulation,tumor progression marker,altered cellular metabolism,enhanced cell growth and migration,potential therapeutic target
ENSG00000126545,CSN1S1,cancer cell proliferation,genomic instability,oncogene overexpression,cell cycle regulation,tumor progression,ubiquitination modification
ENSG00000018625,ATP1A2,oncogenesis,membrane potential regulation,cell proliferation regulation,therapeutic target,ion balance disruption,cell signaling pathway modulation
ENSG00000163923,RPL39L,ribosome assembly,translation regulation,cellular growth,proliferation control,protein expression,regulatory mechanism
ENSG00000126217,MCF2L,erk/mapk pathway activation,tumor progression,oncogenic signaling,therapeutic target,genetic alterations,cellular regulation
ENSG00000160991,ORAI2,calcium channel regulation,genomic instability,cell proliferation enhancement,oncogenic signaling pathway disruption,tumor progression facilitation,therapeutic target
ENSG00000141873,SLC39A3,zinc transporter regulation,aberrant expression,cellular proliferation,tumor progression,chemotherapy resistance,biomarker potential
ENSG00000168944,CEP120,centriolar regulation,cilia formation disruption,gene expression alteration,tumor progression promotion,cell migration enhancement,cancer driver gene
ENSG00000105136,ZNF419,tumor suppressor function,dna binding and transcriptional regulation,krab domain-containing zinc finger protein family member,loss of function contributes to tumorigenesis,regulation of cell cycle control and apoptosis,interaction with pi3k/akt signaling pathway
ENSG00000067533,RRP15,mrna regulation,oncogenic activity,cell growth promotion,apoptosis suppression,dna damage response,therapeutic target
ENSG00000129128,SPCS3,tumor progression,proteasome regulation,upp dysregulation,cancer driver gene,therapeutic target,apoptosis inhibition
ENSG00000145075,CCDC39,cilia dysfunction,tumor progression,cell growth regulation,genomic instability,chromosomal rearrangements,cell cycle dysregulation
ENSG00000172766,NAA16,protein modification,cell proliferation,genomic instability,tumor metastasis,pi3k/akt signaling,oncogenic process
ENSG00000182759,MAFA,transcriptional regulation,cellular transformation,oncogenic pathway activation,pi3k/akt signaling modulation,tumor progression facilitation,genomic instability promotion
ENSG00000128394,APOBEC3F,mutagenesis,cytidine deamination,genomic instability,oncogenesis,tumor suppression,dna repair
ENSG00000066926,FECH,**
heme biosynthesis regulation,gene silencing,tumor suppression,apoptosis evasion,oxidative stress induction,genomic instability promotion
**
ENSG00000156531,PHF6,loss of function mutations,oncogenic driver,cellular proliferation,apoptosis regulation,transcriptional regulation,chromatin remodeling
ENSG00000164742,ADCY1,camp signaling pathway,g protein coupled receptor interaction,cell proliferation regulation,tumor progression association,therapeutic target modulation,molecular mechanism alteration
ENSG00000198092,TMPRSS11F,transmembrane serine protease activity,oncogene potential,cell proliferation regulation,tumor progression role,pi3k/akt signaling interaction,epithelial-to-mesenchymal transition (emt) promoter
ENSG00000183576,SETD3,chromatin remodeling,genetic repression,histone methylation,oncogenic role,pi3k/akt pathway interaction,tumor suppression inhibition
ENSG00000130881,LRP3,endothelial-to-mesenchymal transition,glycosaminoglycan binding,lipid receptor activity,receptor tyrosine kinase binding,cell migration promotion,protein-ligand interaction
ENSG00000186684,CYP27C1,altered expression,cellular metabolism modulation,dna damage response,genomic instability,metabolic reprogramming,tumor aggressiveness
ENSG00000205358,MT1H,dna protection,cell survival,nf-κb signaling,oxidative stress response,metal ion homeostasis,oncogenic process
ENSG00000134825,TMEM258,cellular morphology disruption,altered cell adhesion,tumor progression,epithelial integrity maintenance,cell membrane dynamics regulation,morphological changes
ENSG00000112294,ALDH5A1,oncogenic function,aldehyde detoxification,cellular metabolism,redox balance regulation,tumor progression,therapeutic target
ENSG00000056291,NPFFR2,npffr2 signaling pathway,ligand binding,g-protein coupled receptor function,cell proliferation modulation,tumor development enhancement,genomic upregulation
ENSG00000130700,GATA5,cell proliferation,tumor invasion,transcriptional regulation,dna replication,apoptosis evasion,mutation hotspot
ENSG00000148498,PARD3,cell polarity disruption,loss of function mutations,oncogenic potential,cell migration enhancement,tumor progression promoter,epithelial-mesenchymal transition regulator
ENSG00000166557,TMED3,retrograde transport,protein trafficking,oncogenesis,tumor progression,cell survival,apoptosis regulation
ENSG00000198924,DCLRE1A,genomic instability,dna repair deficiency,nucleotide excision repair pathway,cell cycle regulation,tumor development,genetic alterations
ENSG00000253710,ALG11,protein glycosylation,oncogenic process,genomic amplification,oligosaccharyltransferase complex,cell proliferation,survival signaling
ENSG00000129038,LOXL1,oncogenic reprogramming,tumor microenvironment modulation,extracellular matrix remodeling,cell migration and invasion facilitation,therapeutic target identification,genomic instability promotion
ENSG00000143536,CRNN,oncogenic properties,tumor progression,cell proliferation,signaling pathway regulation,therapeutic target,biomarker candidate
ENSG00000261456,TUBB8,microtubule dynamics regulation,cell division promotion,tumor progression marker,therapeutic target identification,prognostic biomarker,genomic instability modulation
ENSG00000168802,CHTF8,transcriptional regulation,genomic instability,cell cycle progression,apoptosis resistance,chaperone activity,dna repair
ENSG00000110841,PPFIBP1,cell migration,oncogenic protein,metastasis promotion,protein-protein interaction,cytoskeleton regulation,tumor progression
ENSG00000112053,SLC26A8,ion transport regulation,epithelial integrity maintenance,cellular homeostasis modulation,tumor progression facilitation,oncogenic process activation,therapeutic target potential
ENSG00000175832,ETV4,etv4 transcription factor,oncogene function,cell proliferation regulation,apoptosis evasion,pi3k/akt pathway interaction,tumor progression promotion
ENSG00000101638,ST8SIA5,glycosylation regulation,dysregulated expression,tumor progression,poor prognosis indicator,therapeutic target candidate,cancer cell migration and invasion
ENSG00000111199,TRPV4,oncogenic signaling,channel activity regulation,metastatic progression,cell proliferation regulation,tumor microenvironment modulation,mechanosensing pathway interaction
ENSG00000198829,SUCNR1,pi3k/akt pathway activation,oncogenic signaling,tumor progression,metastasis promotion,poor prognosis marker,energy metabolism regulation
ENSG00000214872,SMTNL1,genomic stability loss,mitotic spindle assembly disruption,aneuploidy promotion,cell cycle progression alterations,chromosomal segregation regulation,protein kinase activation
ENSG00000168734,PKIG,cellular proliferation,phosphorylation regulation,oncogenic driver,tumor progression,metastatic potential,signaling pathway activation
ENSG00000188290,HES4,oncogenic transcription factor,repressor activity,tumor suppressor regulation,cell cycle modulation,wnt/β-catenin pathway interaction,emt induction
ENSG00000141200,KIF2B,microtubule dynamics,cell proliferation,chromosome segregation,cell cycle regulation,tumor progression,oncogenic transformation
ENSG00000181019,NQO1,antioxidant activity loss,genomic instability,dna damage response,epigenetic regulation,tumor suppression,cellular metabolism alteration
ENSG00000161671,EMC10,genomic stability,chromatin remodeling,tumor suppression,tumor progression,transcriptional regulation,dna repair pathways
ENSG00000255529,POLR2M,transcriptional dysregulation,rna polymerase ii activity,aberrant mrna expression,tumor progression,therapeutic target,genomic instability
ENSG00000183773,AIFM3,mitochondrial localization,apoptosis regulation,ros production,programmed cell death pathway,p53-dependent mechanism,tumor suppressor function
ENSG00000002726,AOC1,amine oxidation,apoptosis suppression,angiogenesis promotion,mitochondrial localization,metabolic regulation,tumor progression
ENSG00000197721,CR1L,immune regulation,cell signaling,complement system activation,potential tumor suppressor,inflammation modulation,cytokine interaction
ENSG00000114805,PLCH1,pi3k/akt activation,signaling pathway deregulation,cell proliferation promotion,tumor aggressiveness enhancement,genomic instability induction,protein-protein interaction
ENSG00000196214,ZNF766,oncogene,transcription factor,cell cycle progression,apoptosis evasion,pi3k/akt pathway regulation,tumor progression
ENSG00000196967,ZNF585A,histone methylation,chromatin remodeling,transcriptional regulation,oncogenesis,cancer biomarker,therapeutic target
ENSG00000123594,ATXN3L,tumor suppressor activity,ubiquitin-proteasome regulation,genomic instability,dna damage response,mitochondrial dysfunction,protein homeostasis disruption
ENSG00000198551,ZNF627,zinc finger protein interaction,transcriptional regulation,chromatin remodeling,oncogene function,cell proliferation,metastasis promotion
ENSG00000151151,IPMK,tumor suppressor function,cell cycle regulation,genomic stability maintenance,dna repair mechanisms,protein kinase activation,metabolic regulation
ENSG00000107815,TWNK,mitochondrial dysfunction,dna damage repair,oxidative stress regulation,cell proliferation enhancement,genomic instability promotion,tumor progression facilitation
ENSG00000142279,WTIP,zinc homeostasis regulation,tumor suppressor function,oncogenic processes modulation,cellular behavior disruption,genomic instability contribution,zinc signaling pathway interaction
ENSG00000230797,YY2,regulation of gene expression,promotion of oncogenic processes,interaction with pi3k/akt pathway,role in cell cycle progression,apoptosis evasion mechanisms,prognostic marker and therapeutic target
ENSG00000255974,CYP2A6,metabolic regulation,detoxification,carcinogen activation,dna damage,cytochrome p450 activity,xenobiotic metabolism
ENSG00000158435,CNOT11,cccr4-not complex,rna degradation regulation,cell proliferation enhancement,dna damage response mechanism,gene expression modulation,mrna stability increase
ENSG00000163394,CCKAR,mapk/erk pathway activation,cholecystokinin binding,gastric acid secretion regulation,tumor progression promotion,cell proliferation enhancement,poor prognosis association
ENSG00000160602,NEK8,genomic instability,loss-of-function mutations,cell cycle regulation,mitotic entry,spindle checkpoint modulation,dna damage response
ENSG00000135974,C2orf49,chromatin remodeling,transcriptional regulation,cell cycle progression,cancer driver gene,dna repair mechanism,protein-protein interaction
ENSG00000183044,ABAT,glutamate synthesis,cellular metabolism,tumor progression,prognostic marker,oncogenic function,metabolic regulation
ENSG00000176153,GPX2,cellular protection,oxidative stress regulation,nf-κb signaling pathway,apoptosis resistance,cell proliferation,tumor progression
ENSG00000032444,PNPLA6,loss of function mutations,lipid metabolism regulation,tumor progression,therapeutic target,cellular homeostasis disruption,autophagy modulation
ENSG00000140835,CHST4,aberrant expression,altered glycosylation,glycosaminoglycan biosynthesis,tumor progression,metastasis,cell migration
ENSG00000196090,PTPRT,loss-of-function mutations,tumor progression,cell-cell adhesion regulation,epithelial-to-mesenchymal transition inhibition,notch signaling pathway interaction,pi3k/akt pathway regulation
ENSG00000166743,ACSM1,mitochondrial transport,cell growth promotion,metabolic reprogramming,genomic instability,apoptosis suppression,proliferation enhancement
ENSG00000100852,ARHGAP5,rho gtpase regulation,tumor suppressor function,constitutive activation,cell migration and invasion,met and cytoskeleton modulation,pi3k/akt pathway dysregulation
ENSG00000116014,KISS1R,tumor progression,overexpression,gonadotropin-releasing hormone secretion modulation,cell proliferation regulation,angiogenesis modulation,prognostic biomarker
ENSG00000123505,AMD1,chromatin remodeling,epigenetic regulation,transcriptional activation,cell cycle progression,apoptosis regulation,dna repair
ENSG00000104313,EYA1,transcriptional coactivator,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,metastasis promoter,genomic overexpression
ENSG00000228628,ATF6B,er stress response,transcriptional regulation,pro-survival signaling,metabolic reprogramming,oncogenic activation,cell survival pathway
ENSG00000186517,ARHGAP30,loss of function mutation,cell proliferation regulation,rho gtpase signaling pathway modulation,tumor suppressor role,genomic instability maintenance,apoptosis regulation
ENSG00000110921,MVK,pi3k/akt pathway,oncogenic potential,tumor progression,biomarker identification,regulatory mechanism,therapeutic target
ENSG00000048740,CELF2,alternative splicing regulation,cancer-related gene expression,cell proliferation promotion,tumor progression enhancement,microrna-mediated repression,tumor suppressor gene silencing
ENSG00000146192,FGD2,gdp-fucose transporter dysfunction,fucosylated glycoprotein synthesis,signaling pathway activation,cell proliferation enhancement,tumor invasion facilitation,therapeutic target identification
ENSG00000053747,LAMA3,basement membrane integrity,cell migration and invasion,epithelial-to-mesenchymal transition,integrin interaction,metastasis promotion,tumor progression
ENSG00000163207,IVL,altered splicing,cellular proliferation,disrupted terminal differentiation,genomic structural variants,intronic mutations,promoter-enhancer dysregulation
ENSG00000275718,CCL15,pro-tumorigenic,chemokine signaling,tumor progression,metastasis promotion,immune suppression,angiogenesis promotion
ENSG00000167862,MRPL58,ribosomal protein overexpression,translation initiation complex,protein synthesis enhancement,oncogenic driver,tumor growth promotion,genomic amplification
ENSG00000158623,COPG2,pi3k/akt pathway interaction,tumor progression driver,oncogenic amplification,cell cycle regulation,dna repair enhancement,therapeutic target
ENSG00000011426,ANLN,mitotic spindle assembly,cytokinesis regulation,cell proliferation promotion,overexpression in cancer,tumor progression driver,therapeutic target potential
ENSG00000143341,HMCN1,loss of cellular adhesion,cell migration and invasion,epithelial-to-mesenchymal transition (emt),tight junction formation,cancer progression,metastasis
ENSG00000181619,GPR135,pi3k/akt signaling pathway regulation,g protein-coupled receptor function,tumor progression association,cellular proliferation regulation,dysregulation implicated,therapeutic target potential
ENSG00000185085,INTS5,pol ii regulation,dysregulation of transcription,mutation hotspot,oncogenic function,rna modification,transcriptional dysregulation
ENSG00000077147,TM9SF3,mitotic spindle assembly,mitotic catastrophe,dna repair,genomic instability,chromosome segregation,microtubule dynamics
ENSG00000143494,VASH2,overexpression,tumor progression,immune modulation,angiogenesis,g-protein coupled receptor,pi3k/akt pathway
ENSG00000162998,FRZB,tumor suppressor,wnt pathway inhibition,cell proliferation regulation,canonical wnt/β-catenin signaling,frizzled receptor modulation,secreted protein function
ENSG00000111046,MYF6,myf6 overexpression,cell cycle regulation,tumor growth promotion,apoptosis resistance,transcription factor activity,pi3k/akt pathway modulation
ENSG00000058063,ATP11B,p4-atpase activity,phospholipid asymmetry regulation,tumor progression,metastasis,therapeutic target,pi3k/akt pathway interaction
ENSG00000113196,HAND1,transcriptional regulation,oncogenesis,cell proliferation,epithelial-to-mesenchymal transition (emt),transcription factor activity,therapeutic target
ENSG00000143252,SDHC,mitochondrial electron transport,energy metabolism,cell proliferation,angiogenesis,apoptosis regulation,tumor metastasis
ENSG00000130529,TRPM4,calcium influx regulation,cell proliferation enhancement,epithelial-to-mesenchymal transition modulation,tumor progression correlation,oncogenic signaling pathway activation,cancer metastasis facilitation
ENSG00000102230,PCYT1B,pcyt1b overexpression,phosphatidylcholine biosynthesis,cell membrane integrity,apoptosis regulation,lipid metabolism,tumor progression
ENSG00000005206,SPPL2B,notch signaling pathway regulation,tumor suppressor function,endoplasmic reticulum localization,substrate regulation,cellular homeostasis maintenance,apoptosis modulation
ENSG00000177666,PNPLA2,lipid metabolism regulation,oncogenic signaling pathway activation,cell cycle progression modulation,apoptosis evasion mechanism,protein interaction partner,cancer cell growth promotion
ENSG00000071859,FAM50A,genomic instability,cell cycle regulation,dna replication,oncogenesis,tumor suppression,cancer progression
ENSG00000128242,GAL3ST1,glycan modification,cancer progression,potential therapeutic target,tumor progression,survival pathway modulation,growth regulation
ENSG00000262860,LSM14A,alternative splicing regulation,oncogenic mutations,cell cycle progression,transcriptional regulation,dna damage response,tumor progression
ENSG00000074603,DPP8,protein stability regulation,immune modulation,cell proliferation,tumor growth,cancer metastasis,proteolytic activity
ENSG00000181072,CHRM2,muscarinic receptor activation,cell proliferation,signaling pathway modulation,biomarker potential,epithelial-to-mesenchymal transition,pi3k/akt/mtor regulation
ENSG00000149021,SCGB1A1,reduced expression,tumor suppressor,promoter methylation,anti-apoptotic activity,cellular stress protection,epithelial tissue regulation
ENSG00000160326,SLC2A6,metabolic reprogramming,oncogenic potential,glucose metabolism,poor prognosis,rapid cell proliferation,pi3k/akt pathway interaction
ENSG00000171865,RNASEH1,tumor progression,oncogene,genomic instability,pi3k/akt pathway interaction,cell survival regulation,dna damage response modulation
ENSG00000143157,POGK,genomic instability,cell cycle regulation,tumor suppressor function,serine/threonine kinase activity,mitotic checkpoint regulation,dna replication errors
ENSG00000170615,SLC26A5,ion homeostasis disruption,cell proliferation regulation,oncogenic processes,therapeutic target,cell survival promotion,growth advantage
ENSG00000166847,DCTN5,microtubule regulation,cell proliferation promotion,akt signaling pathway interaction,oncogenic function,tumor cell survival enhancement,therapeutic target candidate
ENSG00000043355,ZIC2,transcription factor activity,oncogene activation,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,tumor progression driver,genomic instability maintenance
ENSG00000181652,ATG9B,autophagic regulation,lipid trafficking,oncogenic processes,tumor progression,therapeutic target,cellular homeostasis
ENSG00000163914,RHO,rho gtpase activation,enhanced cell proliferation,tumor progression,regulation of cytoskeleton organization,metastatic potential increase,therapeutic target for rock inhibitors
ENSG00000168538,TRAPPC11,activation of downstream pathways,cell growth regulation,membrane trafficking regulation,oncogenic process activation,pi3k/akt pathway activation,tumor progression promotion
ENSG00000111319,SCNN1A,epithelial sodium channel activation,sodium transport regulation,tumor aggressiveness,epithelial-to-mesenchymal transition,angiogenesis promotion,prognostic biomarker
ENSG00000163995,ABLIM2,actin cytoskeleton regulation,tumor progression,cancer driver gene candidate,cell adhesion disruption,overexpression in cancer,homo-oligomerization
ENSG00000136051,WASHC4,enhanced cell proliferation,protein sorting regulation,endosomal trafficking dysfunction,oncogenic process,tumor progression,genomic instability
ENSG00000140263,SORD,oxidative stress,dna damage response,redox regulation,detoxification pathway,cellular damage,genetic instability
ENSG00000152439,ZNF773,transcriptional regulation,chromatin remodeling,gene expression modulation,cell proliferation,survival pathway,protein interaction
ENSG00000129951,PLPPR3,cellular phospholipid hydrolysis,lysophospholipid generation,tumor progression marker,cellular growth promotion,phospholipid metabolism regulation,protein-lipid interaction modulation
ENSG00000179751,SYCN,cytoskeletal regulation,tumor progression,migration and invasion,epithelial barrier disruption,cancer cell motility,actin cytoskeleton interaction
ENSG00000187714,SLC18A3,slc18a3 is associated with pi3k/akt pathway,vmat2-mediated monoamine transport,oncogenic signaling,cell proliferation,prognostic biomarker,tumor progression
ENSG00000165383,LRRC18,cell migration,cytoskeleton organization,gene amplification,metastasis promotion,prognostic marker,tumor progression
ENSG00000049246,PER3,circadian rhythm regulation,dna damage response,genomic instability,cell cycle modulation,apoptosis resistance,tumor progression predictor
ENSG00000129657,SEC14L1,phosphoinositide-binding,vesicle transport regulation,cell proliferation enhancement,lipid metabolism dysregulation,therapeutic target potential,signaling pathway modulation
ENSG00000275013,PRAME,oncogenic driver,tumor antigen,cell proliferation,immune evasion,pi3k/akt pathway interaction,therapeutic target
ENSG00000130643,CALY,cell adhesion disruption,epithelial integrity loss,oncogenic potential,tumor progression facilitation,cell migration enhancement,epithelial-to-mesenchymal transition (emt)
ENSG00000031003,FAM13B,cell cycle regulation,rhogap domain activation,tumor progression,aberrant cell proliferation,genomic instability,pi3k/akt pathway interaction
ENSG00000110675,ELMOD1,gef activity,pi3k/akt pathway activation,rac-gtpase interaction,cell migration promotion,apoptosis resistance,oncogenic protein complex formation
ENSG00000148600,CDHR1,cell-cell adhesion disruption,oncogene activation,tumor progression facilitation,metastasis promotion,chemoresistance association,epithelial-to-mesenchymal transition interaction
ENSG00000082515,MRPL22,mitochondrial dysfunction,tumor suppressor gene,cellular homeostasis,biomarker for disease,signaling pathway activation,oncogenic process induction
ENSG00000282891,STATH,cell proliferation enhancement,stat family member,oncogene activity promotion,protein-protein interaction regulation,cell growth modulation,poor prognosis marker
ENSG00000076258,FMO4,xenobiotic metabolism,detoxification pathway,chemoresistance,cell proliferation regulation,tumor microenvironment modulation,epigenetic regulation influence
ENSG00000197565,COL4A6,basement membrane formation,tumor progression,metastasis,cell migration,oncogene,pi3k/akt pathway
ENSG00000133247,KMT5C,chromatin regulation,histone methylation,transcriptional activation,epigenetic regulator,cell cycle progression,tumor suppressor dysfunction
ENSG00000177106,EPS8L2,epidermal growth factor receptor interaction,pi3k/akt signaling regulation,cell migration promotion,oncogenic processes facilitation,prognostic marker overexpression,tumor progression enhancement
ENSG00000157734,SNX22,pten regulation,endosomal sorting defects,cell proliferation enhancement,metastasis promotion,protein trafficking dysregulation,akt/pi3k pathway interaction
ENSG00000162630,B3GALT2,tumor progression,cell-cell interactions,protein glycosylation,cancer biomarker,epigenetic regulation,metastasis suppression
ENSG00000128710,HOXD10,tumor suppressor function,repression of cell proliferation,downregulation in cancer,interaction with p53,cell cycle regulation,apoptosis induction
ENSG00000105808,RASA4,cell migration inhibition,cancer progression,rap1 signaling pathway activation,tumor suppressor function,cytoplasmic protein interaction,apoptosis regulation
ENSG00000173436,MICOS10,metabolic regulation,mitochondrial dynamics,cellular energy production,oncogenic potential,tumor suppressor function,protein-protein interaction
ENSG00000168564,CDKN2AIP,cell cycle regulation,pseudogene origin,tumor suppressor function,genomic instability,oncogenic processes,uncontrolled cell growth
ENSG00000151474,FRMD4A,cell proliferation,pi3k/akt signaling,oncogene activation,tumor progression,metastasis driver,cytoplasmic localization
ENSG00000134313,KIDINS220,nf-κb activation,wnt/β-catenin signaling pathway,microtubule dynamics,cell polarity regulation,oncogenic process modulation,tumor progression marker
ENSG00000136715,SAP130,regulation of gene expression,transcriptional repression,tumor suppressor function,gene silencing,cellular proliferation,epigenetic modification
ENSG00000130821,SLC6A8,cell proliferation regulation,energy metabolism alteration,prognosis indicator,survival pathway involvement,creatine transport dysfunction,tumor aggressiveness marker
ENSG00000167588,GPD1,metabolic reprogramming,fatty acid synthesis regulation,mitochondrial localization,glycolytic flux modulation,lipid metabolism regulation,oncogenic signaling pathway interaction
ENSG00000166676,TVP23A,microtubule regulation,cell cycle progression,oncogenic mutations,chromosomal instability,apoptosis inhibition,centrosome duplication
ENSG00000134644,PUM1,cellular regulation,rna binding protein,tumor suppressor function,cell cycle progression,apoptosis inhibition,oncogene regulation
ENSG00000139151,PLCZ1,phosphoinositide signaling,cell proliferation,oncogenic processes,therapeutic target,downstream effector activation,metabolic regulation
ENSG00000111254,AKAP3,camp-dependent signaling pathway,enhanced pka activity,cell proliferation,oncogenic processes,tumor progression,therapeutic target
ENSG00000005471,ABCB4,lipid transporter dysfunction,cancer cell proliferation,cellular survival enhancement,metabolic regulation modulation,therapeutic target identification,genomic instability contribution
ENSG00000048405,ZNF800,oncogene function,transcriptional regulation,dna binding properties,cell proliferation,apoptosis modulation,tumorigenesis driver
ENSG00000165566,AMER2,tumor suppressor,cell cycle regulation,dna repair,genomic instability,oncogenic transformation,apoptosis inhibition
ENSG00000138801,PAPSS1,tumor progression,tumor suppressor activation,oncogenic signaling,cell proliferation,sulfate metabolism regulation,genomic instability
ENSG00000236177,HLA-DPA1,antigen presentation,immune evasion,tumor antigens,biomarker,prognostic marker,mhc class i complex
ENSG00000242114,MTFP1,mitochondrial dynamics,cellular metabolism,protein interaction,tumorigenesis promotion,poor prognosis biomarker,aggressive tumor behavior
ENSG00000103150,MLYCD,cell migration and invasion,actin cytoskeleton dynamics,oncogenesis,prognostic marker,tumor progression,cancer metastasis
ENSG00000180613,GSX2,homeobox transcription factor,regulates cell proliferation,epithelial-to-mesenchymal transition (emt),promotes tumorigenesis,upregulated in cancer cells,resistance to chemotherapy
ENSG00000172586,CHCHD1,mitochondrial function regulation,cellular metabolism regulation,oncogenic pathway activation,genomic instability induction,cancer progression facilitation,tumor cell proliferation enhancement
ENSG00000203926,SPANXA2,oncogenesis,cell cycle regulation,tumor progression,overexpression,immune evasion,apoptosis suppression
ENSG00000198021,SPANXA1,**

cell growth regulation,oncogenesis,tumor progression,cell proliferation,protein-protein interaction,biomarker candidate

**
ENSG00000284938,FAM180B,genomic instability,chromosomal alterations,tumor progression,cell proliferation,gene expression regulation,dna repair interaction
ENSG00000165733,BMS1,genomic instability,cell cycle regulation,dna repair mechanism,ribonuclease activity,rna processing enzyme,oncogenic mutation
ENSG00000176165,FOXG1,oncogene activation,epithelial-to-mesenchymal transition (emt),transcription factor regulation,cell proliferation enhancement,poor prognosis association,genomic dysregulation
ENSG00000171201,SMR3B,genomic instability,chromatin remodeling,tumor suppressor function,cell cycle regulation,apoptosis evasion,therapeutic target
ENSG00000179774,ATOH7,atoh7 overexpression,mutations driving oncogenesis,cellular self-renewal,proliferation regulation,survival pathway modulation,dna damage response disruption
ENSG00000196604,POTEF,regulatory function,signaling pathway interaction,cellular response regulation,tumor progression,therapeutic target,mutational impact
ENSG00000205927,OLIG2,tumor progression,transcriptional regulation,cell cycle regulation,apoptosis inhibition,angiogenesis promotion,oncogenic interaction
ENSG00000026751,SLAMF7,slam/cd47 interaction,tumor progression,cancer stem cell maintenance,diagnostic/prognostic biomarker,immune regulation disruption,epigenetic modification
ENSG00000175768,TOMM5,mitochondrial import pathway,oncogenic transformation,cellular energy metabolism,apoptosis regulation,warburg effect,metabolic reprogramming
ENSG00000112041,TULP1,cell cycle regulation,apoptosis disruption,genomic instability,tumor suppressor downregulation,dna repair impairment,chromosomal alterations
ENSG00000197562,RAB40C,tumor progression,cell proliferation,oncogenic driver,protein-protein interaction,cell membrane trafficking,signaling pathway regulation
ENSG00000161036,LRWD1,tumor suppressor,genomic instability,dna repair deficiency,cell cycle dysregulation,oncogenic pathway suppression,wnt/β-catenin signaling
ENSG00000116254,CHD5,genomic instability,tumor suppressor function,cell cycle regulation,apoptosis modulation,chromatin remodeling complex,pi3k/akt pathway regulation
ENSG00000147251,DOCK11,oncogenic behavior,mutation,rho gtpase activation,cell migration,pi3k/akt pathway regulation,tumorigenesis driver
ENSG00000176076,KCNE5,**
kcne5 expression,tumor progression,potassium channel modulation,cell migration regulation,oncogene function,genetic alterations 
**
ENSG00000084090,STARD7,tumor progression,overexpression,lipid metabolism regulation,cell signaling modulation,oncogenic pathway activation,angiogenesis promotion
,HIST1H2BO,histone modification,chromatin structure regulation,epigenetic reprogramming,cell cycle progression,apoptosis regulation,genomic instability
ENSG00000130313,PGLS,glycosylation regulation,tumor progression,metastasis promotion,cell growth enhancement,altered protein function,dysregulation of homeostasis
ENSG00000063601,MTMR1,dephosphorylation,tumor suppression,autophagy regulation,pi3k/akt pathway modulation,oncogenic phosphatase counteraction,cellular homeostasis maintenance
ENSG00000035928,RFC1,dna replication,genomic instability,maintenance of genome integrity,cell cycle regulation,double-strand break repair,homologous recombination
ENSG00000149970,CNKSR2,regulatory scaffolding protein,oncogenic transformation,pi3k/akt pathway modulation,cell proliferation enhancement,apoptosis inhibition,protein kinase activation
ENSG00000171606,ZNF274,chromatin regulation,dna binding,tumor suppressor function,zinc finger domain interaction,cell proliferation regulation,histone modification
ENSG00000112679,DUSP22,mapk activation,dual specificity phosphatase,tumor progression,tumor metastasis,cell migration,cell survival
ENSG00000138346,DNA2,genomic instability,replication fork restart,double-strand break repair,dna repair mechanisms,mutational accumulation,therapeutic target
ENSG00000143486,EIF2D,protein synthesis regulation,tumor progression,unfolded protein response activation,cell growth modulation,anti-apoptotic signaling,therapeutic target
ENSG00000180263,FGD6,constitutive activation,overexpression,cell proliferation,tumor metastasis,epithelial-to-mesenchymal transition (emt),guanine nucleotide exchange factor (gef) activity
ENSG00000124784,RIOK1,cell proliferation,mutation and overexpression,translation regulation,metastasis promotion,kinase activity modulation,protein synthesis enhancement
ENSG00000073536,NLE1,cell cycle regulation,tumor suppressor activity,dna repair regulation,genomic instability,chromatin remodeling,oncogene activation
ENSG00000183426,NPIPA1,cell proliferation,transcriptional regulation,apoptosis inhibition,tumorigenesis promotion,gene expression modulation,protein interaction
ENSG00000182903,ZNF721,transcriptional regulation,oncogene function,cell proliferation,dna binding activity,apoptosis evasion,tumor suppressor suppression
ENSG00000175426,PCSK1,tumor progression,signaling pathway activation,enzymatic dysregulation,protein processing alterations,cancer cell growth promotion,oncogenic processes modulation
ENSG00000274671,MARVELD2,cell proliferation,overexpression,cell migration,ion channel regulation,tumor progression,cell polarity disruption
ENSG00000016391,CHDH,chromatin accessibility,histone modifications,tumor suppressor function,dna repair mechanisms,epigenetic regulation,cell cycle progression
ENSG00000177076,ACER2,lipid metabolism regulation,cell proliferation promotion,cancer cell survival enhancement,tumorigenesis promotion,metabolic reprogramming,acylation regulation
ENSG00000156642,NPTN,cell adhesion disruption,enhanced metastasis,overexpressed protein,signaling pathway activation,tumor progression facilitation,vegf interaction
ENSG00000138161,CUZD1,**
cell migration,cell proliferation,cell adhesion,oncogenesis,tumor progression,protein-protein interaction
**
ENSG00000132702,HAPLN2,tumor progression,metastasis facilitation,cell migration regulation,heparan sulfate proteoglycan modulation,promising therapeutic target,genetic alterations association
ENSG00000064933,PMS1,dna mismatch repair,tumor suppressor function,microsatellite instability,genomic stability maintenance,oncogenesis prevention,therapeutic target
ENSG00000130517,PGPEP1,tumor progression,immune evasion,cell migration,signaling pathway interaction,gene expression regulation,protein-protein interactions
ENSG00000054796,SPO11,dna repair,genomic instability,meiotic recombination,maintenance of genome stability,tumor suppressor,genome integrity
ENSG00000185024,BRF1,chromatin remodeling,epigenetic regulation,oncogenic transcriptional programs,brd4-brd3 complex,genomic instability,potential oncogene
ENSG00000159450,TCHH,genome instability,dna replication regulation,oncogene activation,tumor suppressor inactivation,homologous recombination,cancer cell proliferation
ENSG00000196188,CTSE,lysosomal cysteine protease,protein degradation regulation,tumor progression promotion,cell growth enhancement,metastasis facilitation,extracellular matrix regulation
ENSG00000275313,CCL4L2,chemokine receptor interaction,immunosuppressive cell recruitment,tumor progression,angiogenesis regulation,cellular response modulation,tumor microenvironment
ENSG00000278259,MYO19,cell membrane trafficking,unconventional myosin function,rab gtpase interaction,epithelial-to-mesenchymal transition (emt),oncogenic driver mutation,loss-of-function mutations
ENSG00000136213,CHST12,glycosaminoglycan biosynthesis,sulfotransferase activity,cell adhesion regulation,tumor progression,pi3k/akt pathway activation,oncogenic function
ENSG00000103047,TANGO6,er stress response,cellular homeostasis regulation,tumor progression,genetic instability,protein-protein interaction,mitochondrial dysfunction
ENSG00000174233,ADCY6,camp production,cell proliferation,constitutive activation,intracellular signaling,oncogene overexpression,tumor progression
ENSG00000114547,ROPN1B,rap protein activation,cell proliferation enhancement,metastatic potential increase,tumor progression promotion,oncogenic mutations,therapeutic target exploration
ENSG00000204899,MZT1,genomic instability,chromatin remodeling,transcriptional regulation,dna repair mechanisms,cell growth regulation,nucleotide excision repair
ENSG00000151726,ACSL1,tumor progression,metabolic reprogramming,fatty acid metabolism,cell proliferation,signaling pathway modulation,prognostic biomarker
ENSG00000135778,NTPCR,rna-binding protein function,nuclear localization signal,transcriptional regulation enhancement,dna damage response activation,cell cycle progression,tumor growth promotion
ENSG00000110844,PRPF40B,aberrant splicing,tumor progression,oncogenesis,cancer driver,cellular growth regulation,apoptosis suppression
ENSG00000168827,GFM1,mitochondrial function regulation,cellular metabolism enhancement,tumor progression facilitation,dna damage induction,protein-protein interaction,genomic instability promotion
ENSG00000205835,GMNC,metabolic reprogramming,glutamate metabolism,cellular energy homeostasis,oncogene potential,apoptosis regulation,prognostic marker
ENSG00000090266,NDUFB2,mitochondrial dysfunction,metabolic alterations,cellular proliferation,oncogenic signaling,reactive oxygen species,therapeutic target
ENSG00000126550,HTN1,cellular regulation,constitutive activation,oncogene activity,overexpression,cell proliferation,tumor suppressor interaction
ENSG00000123454,DBH,angiogenesis,tumor progression,metastasis,cell signaling pathway,growth factor regulation,poor prognosis
ENSG00000122299,ZC3H7A,oncogene activation,tumor progression,angiogenesis promotion,epithelial-to-mesenchymal transition regulation,chromatin remodeling involvement,cell cycle dysregulation
ENSG00000145757,SPATA9,genomic instability,centriole regulation,cell cycle progression,dna damage response,microtubule organization,protein-protein interaction
ENSG00000117226,GBP3,immune modulation,tumor microenvironment modulation,cell survival enhancement,protein-protein interaction,autophagy regulation,inflammation promotion
ENSG00000114480,GBE1,glycoprotein biosynthesis,pi3k/akt signaling,cell proliferation,oncogenesis,glycogen metabolism,metastasis
ENSG00000173253,DMRT2,oncogene,transcriptional regulator,tumor progression,cell proliferation,epithelial-to-mesenchymal transition (emt),chromatin remodeling
ENSG00000154646,TMPRSS15,metastasis promotion,extracellular matrix degradation,epithelial-to-mesenchymal transition,cancer stem cell maintenance,tumor invasion facilitation,therapeutic target
ENSG00000236221,TNXB,tumor progression,cell adhesion,metastasis promotion,extracellular matrix regulation,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000161381,PLXDC1,tumor progression,oncogene activation,pi3k/akt pathway interaction,cell migration and invasion,prognostic marker,potential therapeutic target
ENSG00000102996,MMP15,mmp15 overexpression,tumor progression,cell invasion,metastasis promotion,poor prognosis,proteolytic activity
ENSG00000149196,HIKESHI,genomic stability regulation,dna repair modulation,brca1/2 deficiency association,genetic instability facilitation,cell survival enhancement,homologous recombination influence
ENSG00000071909,MYO3B,myo3b function,overexpressed in cancer,cell adhesion regulation,tumor progression,constitutive activation,therapeutic target
ENSG00000138688,KIAA1109,chromatin remodeling,genomic instability,oncogenic transformation,cellular proliferation,apoptosis regulation,dna repair mechanisms
ENSG00000274276,CBSL,transsulfuration pathway,cell proliferation,methylation regulation,oncogenic process,homocysteine accumulation,epigenetic alterations
ENSG00000115318,LOXL3,ecm remodeling,tumor progression,metastasis promotion,biomarker for prognosis,cell invasion facilitation,signal pathway modulation
ENSG00000138772,ANXA3,cell adhesion disruption,apoptosis inhibition,cell cycle dysregulation,angiogenesis promotion,tumor invasion facilitation,protein-protein interaction enhancement
ENSG00000143473,KCNH1,ion channel regulation,voltage-gated potassium channels,cell proliferation enhancement,apoptosis resistance,cancer cell invasion,signaling pathway modulation
ENSG00000134240,HMGCS2,metabolic regulation,warburg effect,glycolytic shift,lipid metabolism,ancillary role,oncogenic processes
ENSG00000065320,NTN1,cell migration,oncogenic driver,tumor invasion,metastasis facilitation,wnt/β-catenin pathway interaction,immune evasion
ENSG00000162490,DRAXIN,cell migration,oncogenic behavior,tumor progression,aberrant expression,apoptosis inhibition,metastasis promotion
ENSG00000156502,SUPV3L1,oncogenic adaptation,cell cycle regulation,genomic stability,tumor progression,therapeutic target,protein-protein interaction
ENSG00000135838,NPL,cellular transformation,gene amplification,aberrant localization,nucleolar function disruption,cell cycle regulation,protein-protein interaction
ENSG00000176842,IRX5,cell proliferation,transcriptional regulation,apoptosis resistance,tumor growth promotion,oncogenic transcription factor,cell survival enhancement
ENSG00000103485,QPRT,cell proliferation,dna replication,nucleotide salvage pathway,parp1 interaction,genetic instability,poor prognosis marker
ENSG00000078618,NRDC,regulation of key signaling pathways,constitutive activation,aberrant expression associated with poor prognosis,tumor growth and metastasis,cell cycle regulation,transcriptional regulation
ENSG00000188820,CALHM6,calcium-dependent signaling,transmembrane receptor function,cellular homeostasis regulation,tumor suppressor activity,proliferation inhibition,metastasis suppression
ENSG00000122420,PTGFR,g protein-coupled receptor function,tumor progression,metastasis promotion,cell proliferation enhancement,survival pathway activation,prostaglandin binding
ENSG00000139651,ZNF740,zinc finger protein,transcription regulation,cell cycle progression,tumor aggressiveness,prognostic marker,genomic instability
ENSG00000242252,BGLAP,tumor microenvironment modulation,osteoblastic differentiation regulation,bone mineralization influence,tumor metastasis facilitation,cancer stem cell maintenance,epithelial-to-mesenchymal transition regulation
ENSG00000163453,IGFBP7,igf binding,tumor suppression,cell growth regulation,apoptosis modulation,epigenetic regulation,metastasis promotion
ENSG00000187048,CYP4A11,oncogene activation,cell proliferation regulation,oxidative stress modulation,cell signaling pathway interaction,tumor progression driver,therapeutic target potential
ENSG00000116731,PRDM2,genomic instability,tumor suppressor,dna repair regulation,transcriptional repression,cell cycle regulation,apoptosis modulation
ENSG00000138777,PPA2,oncogene,cell proliferation,apoptosis regulation,tumor progression,biomarker candidate,nucleotide binding
ENSG00000122042,UBL3,ring-type e3 ubiquitin ligase,cell cycle regulation,genomic instability,oncogenic driver,protein degradation regulation,therapeutic target
ENSG00000171611,PTCRA,immune response regulation,cell cycle modulation,tumor suppressor function,dna repair mechanism regulation,genome stability maintenance,oncogenic process involvement
ENSG00000188997,KCTD21,ion channel regulation,tumor suppressor activity,genomic instability,cellular excitability modulation,protein interaction networks,transcriptional regulation
ENSG00000148835,TAF5,transcriptional regulation,oncogene upregulation,cell proliferation,poor prognosis,transcription factor complex,dna damage response
ENSG00000188921,HACD4,fatty acid biosynthesis,tumor growth promotion,cell signaling regulation,protein-protein interactions,oncogenic function,therapeutic target
ENSG00000176953,NFATC2IP,nfatc2 regulation,tumor suppressor function,cell proliferation inhibition,anti-apoptotic effects,leucine zipper motif interaction,dna-binding domain inhibition
ENSG00000134255,CEPT1,cell division regulation,centrosome maturation,genomic instability,aneuploidy,aberrant expression,tumor progression
ENSG00000177283,FZD8,wnt/β-catenin pathway,oncogenic potential,tumor growth,cell survival,apoptosis regulation,wnt signaling dysregulation
ENSG00000112031,MTRF1L,apoptosis resistance,cellular metabolism regulation,dysregulated expression,mitochondrial biogenesis dysfunction,mitochondrial rna processing impairment,translational regulation disruption
ENSG00000140367,UBE2Q2,ubiquitin-conjugating enzyme family,chromatin structure modulation,histone-modifying complex interaction,oncogenic processes,epigenetic landscape modification,overexpression in cancer cells
ENSG00000125492,BARHL1,transcription factor regulation,embryonic development,overexpression mutations,aggressive tumor behavior,metastasis driver,poor prognosis indicator
ENSG00000198355,PIM3,cell cycle regulation,oncogenic driver,apoptosis inhibition,cell proliferation,kinase activation,tumor progression
ENSG00000197841,ZNF181,transcriptional regulation,cell proliferation,oncogene,tumor suppressor interaction,pi3k/akt pathway modulation,cell cycle regulation
ENSG00000133789,SWAP70,nf-κb activation,cell signaling regulation,tumor progression,immune evasion,mapk/erk pathway modulation,pro-inflammatory response facilitation
ENSG00000136720,HS6ST1,heparan sulfate biosynthesis,cell proliferation enhancement,epigenetic regulation,enhanced cell migration,angiogenesis promotion,tumor progression facilitation
ENSG00000187775,DNAH17,cytoplasmic transport disruptions,cytoskeletal disruption,cellular transport mechanism,mitotic spindle regulation,cell adhesion alterations,genetic heterogeneity
ENSG00000146233,CYP39A1,increased expression,enhanced cell proliferation,apoptosis resistance,angiogenesis promotion,cell growth regulation,steroid metabolism alteration
ENSG00000131238,PPT1,phosphatase activity,cell cycle regulation,apoptosis modulation,oncogenic pathway regulation,protein dephosphorylation,signal transduction
ENSG00000242389,RBMY1E,microrna regulation,micrornas processing,tumor aggressiveness,amplicon formation,cell migration,rna-binding protein function
ENSG00000120254,MTHFD1L,enhanced cell proliferation,altered folate metabolism,genetic instability,dysregulated dna synthesis,promotes oncogenesis,interaction with pi3k/akt pathway
ENSG00000116221,MRPL37,mitochondrial biogenesis,apoptosis regulation,cell proliferation enhancement,metabolic reprogramming,tumor progression association,therapeutic target potential
ENSG00000132958,TPTE2,pi3k/akt pathway modulation,genomic instability promotion,cell proliferation enhancement,oncogene overexpression,therapeutic target identification,tumour progression correlation
ENSG00000170802,FOXN2,tumor growth,oncogene role,tgf-β pathway regulation,cellular proliferation,epithelial integrity disruption,metastasis promotion
ENSG00000144136,SLC20A1,nucleotide transport,cell proliferation,constitutive expression,tumor progression,aggressive phenotype,metastatic potential
ENSG00000145494,NDUFS6,mitochondrial dysfunction,oxidative phosphorylation regulation,energy metabolism alteration,tumor progression facilitation,glycolysis shift promotion,cell survival enhancement
ENSG00000168874,ATOH8,epithelial cell development,oncogenic function,transcriptional regulation,cell cycle control,apoptosis evasion,wnt signaling pathway interaction
ENSG00000242612,DECR2,mitochondrial function,metabolic reprogramming,fatty acid biosynthesis,tumor growth promotion,cancer cell metabolism,lipid metabolism regulation
ENSG00000114812,VIPR1,tumor progression,proliferation,cell survival,signal transduction,oncogenic processes,biomarker
ENSG00000225614,ZNF469,tumor growth promotion,epithelial-to-mesenchymal transition,cell proliferation enhancement,poor prognosis biomarker,chromatin regulation,zinc finger protein function
ENSG00000171189,GRIK1,oncogene activation,cell proliferation,signaling pathway modulation,tumor growth promotion,metastasis regulation,prognostic marker status
ENSG00000146399,TAAR1,taar1 activation,pi3k/akt signaling,oncogenic function,tumor growth promotion,wnt/β-catenin interaction,neurotransmitter receptor function
ENSG00000105447,GRWD1,chromatin remodeling,genomic instability,tumor progression,cellular response to dna damage,epigenetic regulation,histone modification
ENSG00000173653,RCE1,er-resident chaperone,endoplasmic reticulum stress response,protein folding regulation,molecular sensor interaction,tumor progression driver,therapeutic resistance marker
ENSG00000163104,SMARCAD1,chromatin remodeling,transcriptional regulation,dna repair mechanism,genomic stability maintenance,cell cycle progression control,oncogenesis driver
ENSG00000073614,KDM5A,epigenetic regulation,tumor suppressor function,histone demethylation,cell cycle regulation,transcriptional repression,dna repair
ENSG00000198300,PEG3,tumor suppressor,p53 pathway regulation,cell cycle regulation,apoptosis regulation,epigenetic silencing,genomic stability maintenance
ENSG00000220201,ZGLP1,regulation of cell cycle,transcriptional regulation,dna damage response,oncogene activation,tumor suppressor interaction,therapeutic target
ENSG00000258315,C17orf49,cellular proliferation,protein-protein interactions,poor prognosis marker,upregulated expression,genomic gc content,sequence similarity to known proteins
ENSG00000102401,ARMCX3,chromatin remodeling,transcriptional regulation,oncogenic driver,cell cycle progression,genomic instability,tumor progression
ENSG00000136908,DPM2,dol-p-man synthesis,dysregulated glycosylation,oncogenic activity,tumor progression,cell surface modification,cancer driver gene
ENSG00000069122,ADGRF5,oncogene,tumor progression,pi3k/akt pathway regulation,epithelial-to-mesenchymal transition (emt) modulation,cellular adhesion regulation,therapeutic target
ENSG00000087269,NOP14,ribosome biogenesis,cell cycle progression,dna replication,genomic instability,tumor suppressor,oncogene
ENSG00000166920,C15orf48,microtubule regulation,mitotic progression,oncogene,tpx2-binding protein,cell division regulator,tumor aggressiveness marker
ENSG00000196632,WNK3,ion transport regulation,dysregulation of cell signaling pathways,overexpression in cancer,kinase activity modulation,cell proliferation enhancement,protein-protein interactions
ENSG00000185842,DNAH14,genomic instability,chromosomal rearrangements,aneuploidy,cytokinesis regulation,cell division dysregulation,motor protein interaction
ENSG00000188153,COL4A5,basement membrane formation,cellular adhesion,extracellular matrix regulation,genomic instability,signaling pathway interaction,transcriptional control
ENSG00000148339,SLC25A25,mitochondrial transport,energy metabolism regulation,cell growth and proliferation,metabolic reprogramming,therapeutic target,tumor progression
ENSG00000060558,GNA15,g protein-coupled receptor signaling,tumor progression,cell growth regulation,apoptosis modulation,oncogenic transformation,therapeutic target
ENSG00000140474,ULK3,oncogenic driver,autophagy regulation,cell survival enhancement,nutrient stress adaptation,kinase activation,tumor progression facilitation
ENSG00000150403,TMCO3,aberrant signaling pathways,cancer cell growth,cellular proliferation,dna repair mechanisms,genomic instability,ion channel regulation
ENSG00000198858,R3HDM4,transcriptional regulation,apoptosis inhibition,cell cycle arrest inhibition,tumor suppressor inhibition,protein-protein interaction modulation,oncogene activation
ENSG00000115902,SLC1A4,metabolic regulation,cell proliferation,transport activity,oncogenic process,tumor progression,prognostic marker
ENSG00000081803,CADPS2,calcium signaling pathway,oncogenic process,cell proliferation,tumor progression,calcium homeostasis regulation,cellular differentiation
ENSG00000138078,PREPL,pi3k/akt pathway,cell proliferation,protein processing,cell migration,oncogenic signaling,cell adhesion
ENSG00000104888,SLC17A7,glutamate signaling pathway,cell proliferation,overexpression,chemotherapy resistance,oncogenesis,metastasis
ENSG00000118997,DNAH7,microtubule regulation,dynein heavy chain function,cilia assembly,motor protein dysfunction,cell migration disorder,tumorigenic processes
ENSG00000186897,C1QL4,angiogenesis promotion,cell-cell interaction disruption,integrin binding protein,poor prognosis marker,tumor growth facilitation,overexpression in cancer
ENSG00000131620,ANO1,calcium-activated chloride channel function,cell proliferation regulation,oncogenic signaling,tumor progression,prognostic marker,therapeutic target
ENSG00000185610,DBX2,cell cycle regulation,cyclin-dependent kinase interaction,transcriptional repression,oncogenic transcription factor,tumor suppressor gene modulation,cancer cell proliferation
ENSG00000174695,TMEM167A,cell-cell interactions,pro-inflammatory cytokine expression,tumor progression facilitation,cancer cell aggressiveness,immune suppression,genetic mutations
ENSG00000121446,RGSL1,p53 regulation,genomic instability,tumor suppression,cell cycle regulation,mdm2 interaction,gene stability
ENSG00000021461,CYP3A43,altered drug metabolism,fatty acid metabolism,steroid hormone regulation,cytochrome p450 activity,enzyme induction,metabolic adaptation
ENSG00000235194,PPP1R3E,pp1 regulation,dysregulation in cancer,cell proliferation pathway,substrate specificity,oncogene overexpression,tumor aggressiveness
ENSG00000151014,NOCT,transcriptional repression,tumor suppression,cellular growth inhibition,oncogene regulation,apoptosis regulation,dna repair mechanism
ENSG00000115652,UXS1,cellular metabolism,tumor progression,metabolic regulation,gene expression modulation,therapeutic target,cell signaling pathway
ENSG00000177303,CASKIN2,camkii regulation,scaffolding protein function,neurological disorder association,tumor tissue overexpression,cellular proliferation modulation,signaling pathway interaction
ENSG00000159733,ZFYVE28,endosomal trafficking,oncogenic processes,tumor-promoting vesicles,cell migration and invasion,overexpression in tumors,protein-protein interactions
ENSG00000116147,TNR,genomic instability,dna repair mechanisms,chromatin remodeling,transcriptional regulation,cell cycle control,oncogene activity
ENSG00000139155,SLCO1C1,transporter function,chemotherapy resistance,cellular uptake regulation,disease progression,prediction biomarker,protein-protein interaction
ENSG00000066032,CTNNA2,wnt/β-catenin pathway disruption,tumor suppressor function loss,cell adhesion disruption,oncogenic consequence,metastasis promotion,prognostic significance
ENSG00000260314,MRC1,cell migration,cell adhesion,microtubule interaction,tumor progression,oncogenic protein interactions,poor prognosis
ENSG00000188487,INSC,chemokine regulation,metastasis promotion,cell migration,internalization process,tumor aggressiveness,poor prognosis
ENSG00000130921,C12orf65,apoptosis regulation,cancer progression marker,cell cycle control,overexpression associated,prognostic significance,tumor aggressiveness factor
ENSG00000097096,SYDE2,oncogenic driver,cell proliferation,signaling pathway modulation,cell migration and invasion,cytoskeletal regulation,tumor progression
ENSG00000196268,ZNF493,transcription factor activity,dna-binding activity,cell proliferation,oncogenic potential,tumor progression,overexpression
ENSG00000114349,GNAT1,overexpression,cell cycle regulation,apoptosis inhibition,tumor progression,sensory transduction,olfactory signaling
ENSG00000175970,UNC119B,cellular trafficking regulation,oncogenic driver,signaling pathway modulation,protein-lipid interaction,tumorigenesis association,cancer progression factor
ENSG00000095574,IKZF5,tumor progression,constitutive activation,transcriptional regulation,cell cycle progression,apoptosis suppression,oncogene overexpression
ENSG00000154845,PPP4R1,pp2a regulatory subunit,cell cycle regulation,dna repair mechanisms,tumor suppressor function,oncogene activation,protein phosphatase modulation
,SARS,viral interaction,genetic variation,host cell interaction,cellular replication,protein structure,none
ENSG00000151023,ENKUR,transcriptional regulation,androgen receptor coactivator,cell growth promotion,apoptosis inhibition,metastasis modulation,prognostic marker
ENSG00000186971,KRTAP13-4,cellular adhesion disruption,apoptosis regulation,cellular migration,tumor progression,epithelial integrity loss,cancer metastasis
ENSG00000163870,TPRA1,dna damage repair,transcriptional regulation,genome stability maintenance,p53 interaction,oncogene/tumor suppressor function,cellular response modulation
ENSG00000154079,SDHAF4,mitochondrial assembly,complex ii dysfunction,genomic instability,oxidative stress,energy metabolism reprogramming,tumor driver gene
ENSG00000188994,ZNF292,transcriptional regulation,oncogenic pathway activation,tumor progression,cell growth promotion,tumor suppressor gene repression,metastasis promotion
ENSG00000196620,UGT2B15,glucuronidation,phase ii metabolism,altered expression levels,tumorigenesis,chemotherapy sensitivity,enzyme regulation
ENSG00000074964,ARHGEF10L,rho gef activity,amplification in cancer,cell migration regulation,cell invasion promotion,tumor progression contribution,oncogenic pathway activation
ENSG00000172724,CCL19,tumor microenvironment,immune evasion,metastasis promotion,angiogenesis facilitation,lymphocyte recruitment,cell migration enhancement
ENSG00000172830,SSH3,actin cytoskeleton regulation,tumor metastasis,microtubule stability,cancer cell migration,cellular invasion,therapeutic target
ENSG00000162104,ADCY9,cellular signaling pathway,oncogenic signaling,cell proliferation enhancement,immune response modulation,adenylate cyclase activity,camp production
ENSG00000167130,DOLPP1,protein folding regulation,cell growth regulation,tumor suppressor activity,apoptosis modulation,ubiquitin-proteasome system interaction,oxidative stress response
ENSG00000171794,UTF1,cell cycle progression,transcriptional regulation,dna replication,oncogene activation,tumor growth promotion,prognostic marker
ENSG00000103160,HSDL1,esterification activity,fatty acid modification,lipid metabolism disorder,oncogenesis driver,cell proliferation enhancement,lipid synthesis regulation
ENSG00000175646,PRM1,proteasome subunit alpha type-1,enhanced proteolytic activity,tumor growth promotion,cell cycle regulation disruption,genomic instability contributor,therapeutic target
,ADSSL1,fatty acid regulation,lipid metabolism,oncogenic potential,tumor aggressiveness,poor prognosis marker,therapeutic target
ENSG00000092758,COL9A3,collagen regulation,cell adhesion modulation,fibronectin interaction,tumor invasion promotion,metastasis facilitation,protein-protein interaction
ENSG00000132819,RBM38,ribonucleic acid regulation,arginine methylation,transcriptional modulation,splicing process regulation,cancer cell survival,genomic instability
ENSG00000166592,RRAD,genomic stability,tumor suppressor function,microtubule dynamics regulation,cell cycle regulation,dna damage repair,chromosomal instability
ENSG00000119685,TTLL5,microtubule regulation,cell division,genomic instability,cancer progression,mitotic checkpoint,cell proliferation
ENSG00000037042,TUBG2,microtubule stabilization,cell cycle progression,oncogenic mutations,protein-protein interactions,tubulin dynamics regulation,cytoskeleton maintenance
ENSG00000138073,PREB,nascent polypeptide-associated complex assembly,aberrant expression,protein synthesis regulation,tumor progression,genomic instability,immunophilin-like function
ENSG00000081307,UBA5,ubiquitin activation,post-translational modification,dna repair regulation,cell cycle progression,oncogenesis driver,proteostasis regulation
ENSG00000105737,GRIK5,glutamate signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,neurotransmitter regulation
ENSG00000092096,SLC22A17,slc22 transport,cellular proliferation,oncogenic protein,substrate uptake regulation,signaling pathway interaction,upregulated expression
ENSG00000102218,RP2,primary cilia dysfunction,cellular stability maintenance,microtubule dynamics regulation,oncogenic potential,ciliopathy association,cell proliferation promotion
ENSG00000197177,ADGRA1,wnt/β-catenin signaling,promotes cell proliferation,g protein-coupled receptor,oncogenic processes,cell survival,protein-protein interaction
ENSG00000161091,MFSD12,lipid transport regulation,constitutive activation,lipid synthesis promotion,cellular energy dysregulation,tumor growth facilitation,oncogenic driver mutation
ENSG00000127954,STEAP4,oncogene activity,constitutive expression,iron regulation,cell proliferation,genomic instability,protein-protein interaction
ENSG00000081014,AP4E1,apoptosis regulation,lysosomal trafficking,pi3k/akt pathway interaction,protein sorting and trafficking,tumor growth promotion,cancer driver gene potential
ENSG00000167772,ANGPTL4,lipid metabolism regulation,tumor growth promotion,prognostic marker,cell survival enhancement,cell proliferation modulation,pi3k/akt pathway interaction
ENSG00000163507,CIP2A,**
hyperphosphorylation regulation,pp2a inhibition,oncogenic protein stabilization,cell cycle progression,apoptosis suppression,metastatic potential 
**
ENSG00000176890,TYMS,dna replication,nucleotide metabolism,cell proliferation,epigenetic regulation,thymidylate synthase activity,genomic instability
ENSG00000177508,IRX3,oncogene,transcriptional regulation,cell proliferation,genetic interaction,tumor aggressiveness,microarray profiling
ENSG00000170340,B3GNT2,cell adhesion disruption,glycosylation modification,oncogenic function,poor prognosis marker,tumor aggressiveness,tumorigenesis facilitation
ENSG00000177191,B3GNT8,n-glycans synthesis,glycosylation regulation,tumor progression,cell adhesion modulation,immunosuppressive environment creation,cancer metastasis potential enhancement
ENSG00000263309,KRT23,keratin overexpression,oncogenic potential,epithelial-to-mesenchymal transition (emt),cell proliferation promotion,prognostic biomarker,chemoresistance
ENSG00000140479,PCSK6,proteolytic processing,serine protease activity,cancer cell proliferation,tumor progression,prognostic biomarker,cell migration and invasion
ENSG00000173200,PARP15,genomic instability,tumor suppressor function,dna repair mechanisms,transcriptional regulation,homologous recombination repair,oncogenesis
ENSG00000108474,PIGL,phosphatidic acid regulation,oncogenic signaling modulation,tumor progression contribution,pi3k/akt interaction,cellular metabolism regulation,therapeutic target potential
ENSG00000138615,CILP,tgf-beta pathway inhibition,epithelial-to-mesenchymal transition regulation,cell proliferation suppression,metastasis inhibition,smad signaling regulation,cartilage intermediate layer protein function
ENSG00000078124,ACER3,cellular regulation,proteolytic enzyme processing,cancer progression,cell growth promotion,tumor metastasis,biomarker significance
ENSG00000175161,CADM2,cell adhesion modulation,tumor suppressor function,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway regulation,cell migration and invasion,tumor progression mediator
ENSG00000103274,NUBP1,overexpression,chromatin remodeling,cell cycle regulation,dna repair modulation,epithelial-to-mesenchymal transition,genomic instability
ENSG00000162572,SCNN1D,enac activation,sodium reabsorption,oncogenic function,emt pathway,cell proliferation,tumor progression
ENSG00000156875,MFSD14A,metabolic reprogramming,fatty acid uptake,cellular growth regulation,therapeutic target,signaling pathway interaction,cell survival enhancement
ENSG00000064687,ABCA7,cholesterol efflux regulation,lipid transport disruption,oncogenic potential,cellular homeostasis alteration,post-translational modification,protein-protein interaction
ENSG00000241360,PDXP,metabolic regulation,altered cellular metabolism,enzyme dysfunction,bh4 biosynthesis disruption,oncogenesis,tumor progression
ENSG00000173762,CD7,immune evasion,t cell modulation,surface antigen,overexpression,oncosuppressor function,epitope presentation
ENSG00000147481,SNTG1,mitotic checkpoint regulation,genomic instability,oncogene overexpression,cell cycle progression,tumor suppressor interaction,pi3k/akt pathway modulation
ENSG00000188937,NYX,tumor suppressor,cell proliferation,regulatory mechanism,genomic instability,potassium channel regulation,cancer prognosis
ENSG00000119411,BSPRY,genomic instability,chromosomal aberrations,dna repair pathway,genome maintenance,tumor suppressor function,protein-protein interactions
ENSG00000168010,ATG16L2,autophagosome formation,cellular homeostasis regulation,tumor growth promotion,dysregulated autophagy,autophagic degradation,therapeutic targeting
ENSG00000103310,ZP2,cellular interaction modulation,oncogene activation,tumor progression association,poor prognosis marker,cell migration promotion,signal transduction pathway interaction
ENSG00000280641,CDH4,cadherin dysfunction,epithelial-to-mesenchymal transition,e-cadherin loss,tumor progression,cancer stem cell maintenance,poor prognosis marker
ENSG00000254415,SIGLEC14,immune response modulation,cell-cell interaction,tumor microenvironment dynamics,adhesion and migration regulation,potential cancer driver gene,none
ENSG00000263014,ATP6V1G3,acidification regulation,tumor progression,mitochondrial function,cancer-associated mutations,cellular ph control,v-atpase assembly
ENSG00000105516,DBP,transcriptional regulation,cell growth and differentiation,oncogene function,tumorigenesis,gene expression modulation,cell proliferation promotion
ENSG00000145384,FABP2,lipid metabolism regulation,cell proliferation enhancement,metabolic reprogramming,oncogene overexpression,prognostic marker,tumor microenvironment adaptation
ENSG00000256060,TRAPPC2B,trapp complex dysregulation,cell cycle disruption,genome instability,oncogenic signaling,tumor aggressiveness,membrane trafficking alterations
ENSG00000128694,OSGEPL1,cellular regulation,kinase activation,signaling pathway modulation,tumor progression,prognostic marker,cell survival
ENSG00000137877,SPTBN5,cellular migration,cytoskeletal stability,oncogenic process,prognostic marker,protein interaction,tumor aggressiveness
ENSG00000127920,GNG11,cellular proliferation,signal transduction,g protein regulation,tumor progression,therapeutic target,genomic instability
ENSG00000164715,LMTK2,lrrtm domain,pi3k/akt pathway regulation,cell adhesion disruption,tumor suppressor function loss,apoptosis inhibition,genomic instability
ENSG00000102897,LYRM1,mitochondrial regulation,constitutive activation,gain of function mutations,cell proliferation,tumor progression,therapeutic target
ENSG00000083814,ZNF671,cell proliferation regulation,dna binding ability,genetic upregulation,oncogene potential,prognostic marker,transcriptional regulation
ENSG00000188690,UROS,heme biosynthesis,uroporphyrinogen iii conversion,iron metabolism regulation,porphyria cutanea tarda association,metabolic alteration influence,cellular heme homeostasis
ENSG00000160868,CYP3A4,oncogenic activity,metabolic regulation,environmental stress response,carcinogen metabolism,cell survival,protein-protein interactions
ENSG00000138131,LOXL4,cross-linking of collagen/elastin,ecm remodeling,tumor progression,cellular invasion/metastasis,signaling pathway activation,emt process
ENSG00000118707,TGIF2,oncogenic activity,aberrant expression,wnt/β-catenin pathway modulation,tumor progression,metastatic potential enhancement,transcriptional regulation
ENSG00000112333,NR2E1,tumor progression,oncogene activation,cell proliferation regulation,apoptosis inhibition,angiogenesis modulation,transcriptional regulation
ENSG00000205707,ETFRF1,pro-oncogenic role,cell proliferation promotion,immune evasion mechanism,genetic instability driver,dna repair regulation disruption,epigenetic silencing enhancement
ENSG00000282003,TUBGCP3,microtubule dynamics,tumor progression,genomic instability,cell migration,therapeutic target,protein-protein interaction
ENSG00000146216,TTBK1,microtubule stabilization,constitutive activation mutations,cellular proliferation,oncogenic driver gene,kinase activity regulation,cell cycle progression
ENSG00000171763,SPATA5L1,genomic instability,oncogene function,cell cycle progression,apoptosis inhibition,pi3k/akt pathway modulation,tumor metastasis
ENSG00000129103,SUMF2,sulfatase activation,cellular regulation,tumor progression,proliferation,metastasis,none
ENSG00000110245,APOC3,lipid metabolism dysregulation,tumor progression promotion,cell proliferation enhancement,therapeutic target potential,prognostic marker correlation,oncogenic pathway involvement
ENSG00000186912,P2RY4,g-protein coupled receptor,overexpression,cell proliferation,prognostic marker,tumor progression,angiogenesis and metastasis
ENSG00000185340,GAS2L1,tumor suppressor function,loss of heterozygosity,dna repair regulation,cell cycle arrest,apoptosis induction,genomic instability
ENSG00000183153,GJD3,pi3k/akt/mtor pathway activation,tumor progression,oncogenic signaling,cell survival evasion,chemotherapy resistance,epithelial tissue maintenance
ENSG00000138821,SLC39A8,zinc homeostasis regulation,pi3k/akt pathway modulation,matrix metalloproteinase expression,vascular endothelial growth factor upregulation,apoptosis evasion,oxidative stress survival
ENSG00000140497,SCAMP2,wnt/β-catenin signaling,tumor progression,biomarker,cell migration,cancer prognosis,protein secretion
ENSG00000137731,FXYD2,ion transport regulation,epithelial-to-mesenchymal transition (emt),cell proliferation,apoptosis regulation,signaling pathway modulation,protein-protein interactions
ENSG00000075790,BCAP29,apoptosis modulation,tumor progression,cell proliferation,signal transduction,protein-protein interaction,oncogenesis
ENSG00000138271,GPR87,cell surface receptor,overexpressed in cancer,gpcr signaling pathway,cell growth regulation,therapeutic target,signaling molecule activation
ENSG00000163607,GTPBP8,mrna processing,oncogene,tumor progression,cell growth regulation,signaling pathway modulation,protein-protein interaction
ENSG00000132330,SCLY,cell adhesion impairment,cytoskeletal organization,epithelial barrier dysfunction,tumor progression,metastasis facilitation,cell shape regulation
ENSG00000153487,ING1,genomic instability,tumor suppressor,cell cycle regulation,dna repair,chromatin remodeling,apoptosis resistance
ENSG00000063761,ADCK1,cell cycle regulation,apoptosis evasion,mitochondrial dysfunction,therapeutic target,tumor progression marker,prognostic indicator
ENSG00000142892,PIGK,cellular response modification,glycosylation regulation,protein localization,tumor aggressiveness promotion,prognostic marker,signaling pathway involvement
ENSG00000006576,PHTF2,epigenetic regulation,histone modification,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis inhibition
ENSG00000155463,OXA1L,mitochondrial function,overexpression,tumor progression,resistance to chemotherapy,cell growth,energy metabolism
ENSG00000006534,ALDH3B1,aldehyde detoxification,tumor suppressor activity,dna damage repair,cell cycle regulation,apoptosis modulation,genetic instability
ENSG00000120094,HOXB1,transcriptional regulation,promotes tumorigenesis,upregulated in cancer,enhances chemoresistance,elevated metastatic potential,cell cycle progression
ENSG00000130052,STARD8,lipid regulation,srebp processing,cellular homeostasis disruption,tumor progression driver,cholesterol biosynthesis regulation,cell survival enhancement
ENSG00000178732,GP5,cell adhesion regulation,metastasis facilitation,cell migration regulation,tumor progression promotion,cancer antigen status,microenvironment interaction
ENSG00000159713,TPPP3,genomic instability,cell proliferation,protein-protein interactions,microtubule dynamics,mitotic checkpoint regulation,tumor aggressiveness
ENSG00000139323,POC1B,centrosome amplification,genomic instability,microtubule dysregulation,oncogene overexpression,protein-protein interaction,cell proliferation regulation
ENSG00000117697,NSL1,chromatin modification,transcriptional regulation,histone acetylation,oncogenic process,tumor progression,upregulated expression
ENSG00000172590,MRPL52,ribosomal assembly,gene expression regulation,cell cycle progression,protein synthesis enhancement,cell proliferation increase,tumor progression promotion
ENSG00000067842,ATP2B3,cellular calcium regulation,dysregulated expression,invasive and metastatic potential,oncogenic transformation,regulation of cell growth and proliferation,signaling pathway modulation
ENSG00000179772,FOXS1,cell cycle regulation,tumor suppressor function,transcriptional regulation,apoptosis modulation,cancer pathogenesis,tissue differentiation
ENSG00000086712,TXLNG,redox regulation,cellular proliferation,apoptosis resistance,tumor growth promotion,antioxidant defense,protein interaction
ENSG00000104447,TRPS1,trps1 overexpression,tumor aggressiveness,zinc finger domain interaction,mutation biomarker,dysregulated cell cycle,apoptosis inhibition
ENSG00000127980,PEX1,peroxisomal biogenesis,transmembrane protein function,redox balance regulation,metabolic homeostasis modulation,tumor progression association,genomic instability link
ENSG00000138722,MMRN1,mitochondrial transcriptional regulation,cellular metabolism modulation,tumor growth promotion,gene expression regulation,energy production support,glycolytic reprogramming
ENSG00000182180,MRPS16,mitochondrial translation regulation,genetic instability,tumor progression,therapeutic target,energy metabolism modulation,cellular stress response modification
ENSG00000176383,B3GNT4,oncogenic gene,epithelial-to-mesenchymal transition (emt),glycosylation activity,metastasis driver,cell adhesion modulation,cancer stem cell population enhancement
ENSG00000181722,ZBTB20,cell cycle regulation,transcriptional repression,tumor suppression,apoptosis induction,protein-protein interaction,genetic regulation
ENSG00000139508,SLC46A3,cellular transport regulation,nucleoside uptake,oncogenic signaling,pi3k/akt pathway modulation,tumor progression enhancement,metabolic regulation disruption
ENSG00000176428,VPS37D,autophagy regulation,endosomal sorting,cancer cell proliferation,metastasis promotion,escrt-iii complex,tumor progression marker
ENSG00000102125,TAZ,taz/tead transcription complex,epithelial-to-mesenchymal transition,cell growth regulation,transcriptional coactivation,oncogenic properties,poor prognosis indicator
ENSG00000127990,SGCE,oncogene,proteolytic activity regulation,calcium-dependent signaling,cell growth regulation,survival pathway dysregulation,aggressive tumor behavior
ENSG00000102302,FGD1,gef activation,rho gtpase regulation,oncogenic driver,cell proliferation,tumor invasion,metastasis promotion
ENSG00000187118,CMC1,microtubule regulation,tumor growth promotion,genomic instability,cell cycle modulation,ciliogenesis dysfunction,proliferation enhancement
ENSG00000009335,UBE3C,cell proliferation,protein degradation,oncogene activation,polyubiquitination pathway,autophagy regulation,tumor progression
ENSG00000234906,APOC2,lipid regulation,cell proliferation,biomarker potential,oncogenic signaling,protein-protein interaction,metabolic regulation
ENSG00000180447,GAS1,tumor suppressor function,loss of function mutation,pi3k/akt pathway regulation,cell proliferation inhibition,immune response modulation,cell adhesion regulation
ENSG00000178403,NEUROG2,transcription factor function,loss of function mutations,tumor suppressor role,cellular differentiation disruption,gene expression modulation,cell cycle regulation interaction
ENSG00000117054,ACADM,fatty acid oxidation,mitochondrial function,metabolic regulation,cellular energy homeostasis,energy production,enzyme activity
ENSG00000137414,FAM8A1,tumor progression,protein-protein interactions,cell signaling regulation,epithelial-to-mesenchymal transition (emt),oncogenic protein expression,genomic mutations
ENSG00000140391,TSPAN3,tumor progression,cell migration,pi3k/akt pathway modulation,epithelial-to-mesenchymal transition (emt),chemoresistance,cell-cell adhesion
ENSG00000163359,COL6A3,tumor progression,cell adhesion,collagen deposition,metastasis facilitation,extracellular matrix regulation,pi3k/akt pathway interaction
ENSG00000005381,MPO,tumor microenvironment,oncogene,pro-inflammatory mediator,reactive oxygen species,cell adhesion molecule,peroxidase activity
ENSG00000109065,NAT9,cell cycle regulation,apoptosis evasion,tumor growth promotion,acetyltransferase activity,gene expression regulation,oncogenic process facilitation
ENSG00000152580,IGSF10,tumor progression,cell adhesion disruption,epithelial barrier dysfunction,metastasis promotion,stromal interaction enhancement,migratory behavior modulation
ENSG00000006071,ABCC8,cellular homeostasis,chemoresistance,ion transport regulation,tumor suppression dysfunction,therapeutic target discovery,biological interaction with sur1
ENSG00000275111,ZNF2,oncogenic activation,transcriptional regulation,cell proliferation,tumor progression,genomic instability,epigenetic modification
ENSG00000016602,CLCA4,calcium signaling,epithelial-to-mesenchymal transition,protein-protein interaction,cell migration,tumor progression,cancer prognosis
ENSG00000151834,GABRA2,altered expression,cell cycle regulation,dna damage response,apoptosis modulation,inhibitory neurotransmission,tumor suppressor function
ENSG00000254004,ZNF260,cellular proliferation,chromosomal instability,genomic stability,tumor suppressor,apoptosis,dna binding
ENSG00000275385,CCL18,tumor microenvironment modulation,immune suppression induction,tumor progression facilitation,metastasis enhancement,poor prognosis association,therapeutic target potential
ENSG00000171130,ATP6V0E2,atpase regulation,cellular metabolism,glycolytic shift,metabolic reprogramming,proton pump function,tumor suppressor activity
ENSG00000145214,DGKQ,oncogenic potential,pi3k/akt pathway interaction,cell growth regulation,apoptosis inhibition,mutational activation,tumor progression facilitation
ENSG00000140937,CDH11,cell adhesion disruption,tumor progression,epithelial-to-mesenchymal transition,metastasis promotion,cellular invasion facilitation,glycoprotein interaction
ENSG00000140284,SLC27A2,lipid metabolism regulation,long-chain fatty acid transport,cell proliferation promotion,energy production enhancement,tumorigenesis association,therapeutic target potential
ENSG00000102195,GPR50,cell proliferation,g protein-coupled receptor,gonadotropin-releasing hormone secretion,mt1a expression,oncogene potential,pi3k/akt pathway interaction
ENSG00000183856,IQGAP3,epithelial-to-mesenchymal transition,cell adhesion,actin cytoskeleton dynamics,oncogene,rho gtpase regulation,tumor progression
,TMEM246,tumor suppressor,cell growth regulation,vesicle trafficking,oncogenic process,cell membrane organization,snare complex formation
ENSG00000203747,FCGR3A,immune evasion,tumor progression,antibody-dependent cellular cytotoxicity,fc receptor expression,genetic dysregulation,prognostic marker
ENSG00000188266,HYKK,cellular adhesion,metastasis promotion,matrix remodeling,prognostic marker,tumor progression,cancer progression
ENSG00000165609,NUDT5,nad+ hydrolysis,cellular energy homeostasis,dna repair pathways,genomic instability,cell proliferation enhancement,oncogenic transformation
ENSG00000059377,TBXAS1,angiogenesis promoter,inflammatory response regulator,tumor progression driver,metastasis enhancer,vascular remodeling mediator,cell proliferation regulator
ENSG00000119013,NDUFB3,mitochondrial function,aerobic glycolysis,genomic instability,cell cycle regulation,tumor progression,apoptosis resistance
ENSG00000086205,FOLH1,folate metabolism,cell proliferation,tumor progression,therapeutic target,angiogenesis,glycolysis
,TSTA3,immune system regulation,tumor antigen overexpression,nf-κb pathway interaction,cell-mediated immunity modulation,tumor progression promotion,therapeutic target potential
ENSG00000145736,GTF2H2,genomic instability,dna repair mechanism,tumor progression,gene expression regulation,oncogenic function,prognostic marker
ENSG00000100678,SLC8A3,cell surface expression,emt process facilitation,increased cell migration,interactions with n-cadherin,role in metastasis promotion,sodium-calcium exchange regulation
ENSG00000240303,ACAD11,lipid metabolism regulation,fatty acid synthesis,cell membrane composition modification,tumor growth promotion,therapeutic target,enzyme interaction
ENSG00000054983,GALC,altered expression,tumor progression,cellular metabolism,oncogenesis,tumor suppressor,cellular homeostasis
ENSG00000288399,KCTD11,ion channel regulation,tumor suppressor function,proliferation regulation,apoptosis modulation,dysregulation in cancer,cellular excitability modification
ENSG00000126391,FRMD8,pi3k/akt pathway interaction,oncogenic driver,cell migration enhancement,tumor progression association,poor prognosis marker,genomic instability promotion
ENSG00000284752,GMPR2,cell adhesion regulation,tumor progression,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,cancer cell dissemination,therapeutic target
ENSG00000144895,EIF2A,protein synthesis regulation,cellular response modulation,stress response regulation,oncogene activation,autophagy regulation,tumor progression association
ENSG00000148634,HERC4,cell cycle regulation,protein degradation,oncogenesis,tumor suppressor regulation,apoptosis inhibition,ubiquitination
ENSG00000182362,YBEY,genomic instability,rna degradation,microrna regulation,tumor progression,aggressive behavior,cancer cell proliferation
ENSG00000197724,PHF2,tumor suppressor function,genomic instability prevention,dna damage response regulation,gene silencing,cell cycle progression regulation,chromatin remodeling interaction
ENSG00000103066,PLA2G15,pi3k/akt pathway activation,tumor progression,cellular migration,therapeutic target,tumor microenvironment modulation,cancer cell survival
ENSG00000244274,DBNDD2,microtubule dynamics,oncogenic processes,axonal transport,signaling pathway regulation,tumor progression,chemotherapy resistance
ENSG00000088881,EBF4,oncogenic transcription factor,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),metastasis facilitation,biomarker for treatment response,apoptosis inhibition
ENSG00000185480,PARPBP,parp1 interaction,dna repair facilitation,genomic stability modulation,cell survival promotion,therapeutic resistance,chromatin remodeling
ENSG00000240021,TEX35,alternative splicing regulation,oncogenic splicing modulation,tumor suppressor dysregulation,cell proliferation promotion,therapeutic target potential,genomic transcriptome alteration
ENSG00000157388,CACNA1D,calcium influx regulation,dysregulation of calcium signaling,tumor progression,cell proliferation and migration,therapeutic target,cancer biology interaction
ENSG00000256223,ZNF10,epigenetic regulator,tumor suppressor function,transcription factor activity,epithelial-to-mesenchymal transition (emt),gene expression regulation,zinc finger protein interaction
ENSG00000134575,ACP2,lysosomal metabolism,cell cycle regulation,apoptosis modulation,dna repair,tumor growth promotion,metabolic regulation
ENSG00000013563,DNASE1L1,genomic instability,chromosomal alterations,dna degradation,immune evasion,cancer cell survival,prognostic marker
ENSG00000101958,GLRA2,altered calcium regulation,cellular excitability modulation,ion channel function,cancer cell metabolism,cellular signaling dysregulation,oncogenic process impact
ENSG00000167522,ANKRD11,genomic instability,cell cycle regulation,tumor suppression,apoptosis regulation,dna damage response,ankyrin repeat domain
ENSG00000157869,RAB28,ras superfamily gtpase,cell growth promotion,tumor progression,cell survival enhancement,gene expression alteration,epigenetic modification influence
ENSG00000134716,CYP2J2,tumor suppressor function,redox balance regulation,anti-cancer metabolism,eet production,apoptosis induction,metastasis inhibition
ENSG00000137563,GGH,cell cycle regulation,genomic stability,mitotic spindle checkpoint control,chromosome segregation,aberrant expression,oncogene/tumor suppressor
ENSG00000172172,MRPL13,mitochondrial ribosome biogenesis,small subunit assembly,energy metabolism regulation,cell growth signaling,protein translation enhancement,tumorigenesis contribution
ENSG00000152782,PANK1,metabolic regulation,oncogenesis,constitutive activation,cell growth regulation,coenzyme-a synthesis,protein interaction
ENSG00000198918,RPL39,protein synthesis regulation,ribosome assembly,oncogenic mutations,cell proliferation,metabolic dysregulation,stress response activation
ENSG00000184005,ST6GALNAC3,cellular modulation,enzymatic function,tumor progression,prognostic marker,glycosylation regulation,cellular adhesion
ENSG00000131096,PYY,neuropeptide regulation,cell proliferation inhibition,signaling pathway modulation,gastrointestinal hormone regulation,tumor growth suppression,cancer cell differentiation modulation
,HIST1H2BJ,histone modification,chromatin remodeling,gene regulation,cell cycle progression,transcriptional regulation,genomic stability
ENSG00000170275,CRTAP,collagen stabilization,post-translational modifications,cellular structure regulation,tumor microenvironment modulation,extracellular matrix stability maintenance,osteogenesis imperfecta associated mutation
ENSG00000174840,PDE12,cellular proliferation,angiogenesis regulation,signaling pathway modulation,genomic instability,therapeutic target,cyclic nucleotide degradation
ENSG00000163508,EOMES,immune evasion,t-cell differentiation,transcriptional regulation,cell proliferation,therapeutic target,genomic instability
ENSG00000169490,TM2D2,tumor suppressor,regulates t-cell receptor signaling,impaired immune function,genomic instability,dna repair mechanism disruption,oncogene suppression
ENSG00000109158,GABRA4,gabaergic signaling,cell proliferation,stress response modulation,tumor progression,synaptic transmission regulation,oncogenesis facilitation
ENSG00000107020,PLGRKT,cell cycle regulation,tumor suppressor function,apoptosis promotion,cell proliferation inhibition,genetic alterations,oncogenesis prevention
ENSG00000176720,BOK,apoptosis regulation,pro-apoptotic function,bcl-2 family interaction,mitochondrial outer membrane permeabilization,cell survival modulation,therapeutic target
ENSG00000006377,DLX6,transcriptional regulation,oncogenic driver,cellular proliferation,apoptosis inhibition,signaling pathway activation,tumor progression
ENSG00000215045,GRID2IP,pi3k/akt pathway activation,calcium signaling regulation,cell proliferation promotion,tumor progression driver,therapeutic target,genomic instability
ENSG00000143443,C1orf56,cellular proliferation,pi3k/akt pathway interaction,oncogene potential,upregulated expression,cell survival regulation,protein-protein interactions
ENSG00000135870,RC3H1,apoptosis modulation,cell survival regulation,necroptosis involvement,tumor progression association,protein-protein interaction,oncogenic function
ENSG00000160746,ANO10,tumor progression,cell migration,epithelial integrity,cell polarity maintenance,calcium-activated chloride channel function,anoctamin family member
ENSG00000250722,SELENOP,seleno p alterations,selenoprotein regulation,antioxidant defenses,redox signaling,cell transformation,ros production
ENSG00000237693,IRGM,tumor suppressor,immune evasion,autophagy regulation,innate immunity modulation,biomarker potential,genetic variants associated with increased risk
ENSG00000179431,FJX1,tumor suppression,wnt/β-catenin pathway regulation,chromatin remodeling modulation,cell proliferation inhibition,gene expression regulation,oncogenic suppression
ENSG00000104901,DKKL1,wnt/β-catenin signaling inhibition,tumor suppressor activity,epithelial-to-mesenchymal transition regulation,poor prognosis association,aggressive tumor behavior,therapeutic target potential
ENSG00000125414,MYH2,cell migration,overexpression,signaling pathway modulation,cytoskeleton regulation,muscle tone disruption,prognostic biomarker
ENSG00000112486,CCR6,immune evasion,cell migration,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance,immunosuppression,pi3k/akt pathway interaction
ENSG00000183778,B3GALT5,altered expression,cell adhesion,cell growth,glycosylation regulation,proteoglycan biosynthesis,tumor progression
ENSG00000198342,ZNF442,transcriptional regulation,cell growth inhibition,tumor suppressor function loss,apoptosis evasion,genetic instability promotion,poor prognosis association
ENSG00000165496,RPL10L,ribosomal protein synthesis,cellular proliferation,aggressive tumor behavior,protein synthesis regulation,tumor progression,translational control
ENSG00000095596,CYP26A1,retinoic acid degradation,overexpression,cell growth inhibition,apoptosis suppression,protein-protein interaction,tumor progression promotion
ENSG00000173848,NET1,actin dynamics regulation,cytoskeletal reorganization,cell migration facilitation,tumor progression promotion,prognostic biomarker,cell motility modulation
ENSG00000158604,TMED4,hippo signaling pathway,tumor progression,hippo pathway activation,prognostic marker,cellular growth regulation,cancer cell survival
ENSG00000108306,FBXL20,cell cycle regulation,apoptosis inhibition,dna repair modulation,oncogenic pathway regulation,tumor suppressor degradation,genomic instability promotion
ENSG00000140534,TICRR,cell cycle regulation,tumor suppressor function,apoptosis regulation,cancer prognosis marker,overexpression in tumors,tpr domain-containing protein
ENSG00000105672,ETV2,epithelial-to-mesenchymal transition (emt),oncogene activation,transcriptional regulation,cell cycle progression,dna replication,chromatin remodeling
ENSG00000147408,CSGALNACT1,cell surface glycosylation regulation,extracellular matrix interactions modulation,tumor progression facilitation,metastasis promotion,apoptosis suppression,glycoprotein expression alteration
ENSG00000277354,CRIM1,**

cellular proliferation,oncogenic signaling,transcriptional regulation,apoptosis resistance,tumor progression,pi3k/akt pathway modulation 

**
ENSG00000265203,RBP3,regulation of retinoid transport,cell proliferation,pi3k/akt/mtor signaling pathway,lipid metabolism regulation,tumor progression,chromatin remodeling
ENSG00000166111,SVOP,apoptosis inhibition,cell survival promotion,tumor progression facilitation,mutation-associated overexpression,signaling pathway interaction,protease inhibitor function
ENSG00000124767,GLO1,glyoxalase i activity,constitutive overexpression,oncogenic potential,cell survival adaptation,tumor progression marker,genomic instability
ENSG00000103460,TOX3,transcription factor regulation,apoptosis suppression,cell cycle progression,genomic instability,protein-protein interaction,tumor aggressiveness
ENSG00000075673,ATP12A,mitochondrial regulation,oxidative stress management,iron homeostasis disruption,tumor suppressor function,loss of heterozygosity,genomic instability
ENSG00000176533,GNG7,heterotrimeric g-protein signaling,mapk/erk pathway activation,cell proliferation regulation,tumorigenesis association,protein-protein interaction dysregulation,oncogenic role
ENSG00000104368,PLAT,epithelial-to-mesenchymal transition,actin cytoskeleton dynamics,tumor progression,cancer cell invasion,metastasis promoter,overexpression
ENSG00000136856,SLC2A8,glucose metabolism regulation,oncogenic driver,tumor energy supply,cancer cell proliferation,poor prognosis indicator,metabolic dependency
ENSG00000273494,PANK4,mitochondrial localization,energy metabolism regulation,coenzyme a synthesis,fatty acid oxidation,oxidative phosphorylation,cell growth promotion
ENSG00000166272,WBP1L,ubiquitination regulation,ww domain-binding protein interaction,cell cycle control,tumor progression,oncogene overexpression,pi3k/akt pathway activation
ENSG00000162520,SYNC,nuclear envelope integrity,cell cycle regulation,tumor progression,chromatin remodeling,protein-protein interactions,oncogenic overexpression
ENSG00000141540,TTYH2,altered microtubule stability,chromosome alignment defect,cell cycle dysregulation,genomic instability driver,tumor progression marker,spindle assembly checkpoint dysfunction
ENSG00000180090,OR3A1,cell growth regulation,overexpression,tumor progression,survival pathway modulation,poor prognosis,none
ENSG00000100997,ABHD12,cellular lipid homeostasis disruption,lysophosphatidylcholine accumulation,tumor progression,poor prognosis,oncogenic processes,therapeutic target
ENSG00000184903,IMMP2L,tumor metastasis,epithelial-to-mesenchymal transition,cell adhesion regulation,prognostic marker,signaling pathway interaction,oncogenic function
ENSG00000070669,ASNS,tumor growth promotion,cellular metabolism regulation,protein synthesis enhancement,therapeutic resistance induction,cancer cell survival support,tumor microenvironment modification
ENSG00000122482,ZNF644,krab domain-containing zinc finger protein family,tumor suppressor or oncogene,cell growth regulation,dna repair mechanisms modulation,transcription factor activity,cell proliferation and survival pathways regulation
ENSG00000131373,HACL1,histone modification,cell cycle regulation,epigenetic reprogramming,tumor suppressor function,dna damage response,lysine demethylation
ENSG00000113805,CNTN3,cellular proliferation,tumor progression,biomarker potential,neural development regulation,axonal growth guidance,cell adhesion modulation
ENSG00000089050,RBBP9,genomic instability,cell cycle regulation,scaffold protein,ubiquitination pathway,protein degradation,apoptosis inhibition
ENSG00000203797,DDO,mtor signaling pathway,cell proliferation,tumor progression,phenylalanine metabolism,biosynthesis regulation,cancer associated protein
ENSG00000072840,EVC,cellular proliferation,tumor development,p53 pathway interaction,genomic instability,chromosomal alterations,akt signaling
ENSG00000170468,RIOX1,dna repair mechanism,constitutive overexpression,stabilization of oncogenic mrnas,cell cycle progression,genotoxic stress protection,tumor suppressor gene suppression
ENSG00000130294,KIF1A,microtubule dynamics,oncogenesis driver,chromosomal instability,mitotic spindle assembly,axonal transport impairment,pro-oncogenic signaling pathway
ENSG00000123213,NLN,brca1 complex interaction,genomic stability regulation,cell cycle progression regulation,oncogenic potential,tumorigenesis,dna repair
ENSG00000205863,C1QTNF9B,cell adhesion regulation,metastasis promotion,immune response modulation,tumor progression facilitation,signaling pathway activation,cell migration influence
,ELMSAN1,chromatin remodeling,transcriptional regulation,dna damage response,cell cycle progression,apoptosis resistance,cell proliferation enhancement
ENSG00000135164,DMTF1,transcriptional regulation,tumor suppressor function,epithelial-to-mesenchymal transition,cellular differentiation,apoptosis regulation,pi3k/akt pathway interaction
ENSG00000065613,SLK,slk overexpression,cell proliferation promotion,oncogenic signaling pathway,protein kinase activation,cell invasion facilitation,stress response regulation
,HIST1H2AA,histone modification,cancer progression,cell proliferation,chromatin regulation,transcriptional regulation,apoptosis suppression
ENSG00000119844,AFTPH,emt regulation,epithelial-to-mesenchymal transition,cell migration,oncogenic function,ankyrin repeat domain-containing protein,cell adhesion regulation
ENSG00000126773,PCNX4,epigenetic regulation,dna damage response,cell growth modulation,oncogenic driver,genomic stability maintenance,apoptosis regulation
ENSG00000160182,TFF1,tumor progression,microenvironment modulation,cell migration promotion,angiogenesis enhancement,cancer cell adaptation,oncogenic protein interaction
ENSG00000121904,CSMD2,tumor progression,oncogenic driver,overexpression,biomarker candidate,cell signaling modulation,metastasis promotion
ENSG00000187240,DYNC2H1,microtubule-based transport,genomic instability,oncogene overexpression,cell proliferation enhancement,prognostic marker,tumor suppressor interaction
ENSG00000214021,TTLL3,microtubule regulation,tumor progression,oncogene activation,cell proliferation,microtubule dynamics,dysregulated expression
ENSG00000108576,SLC6A4,serotonin regulation,genetic polymorphism,tumor suppressor function,biomarker potential,apoptosis regulation,cell proliferation influence
ENSG00000167549,CORO6,coatomer complex,vesicle transport,cell signaling pathway,tumor aggressiveness,apoptosis evasion,metastasis promotion
ENSG00000186310,NAP1L3,chromatin remodeling,cell cycle progression,epigenetic regulation,transcriptional modulation,histone modification,dna repair
ENSG00000100626,GALNT16,glycosylation,cell proliferation,apoptosis inhibition,tumor progression,signaling pathway activation,protein modification
ENSG00000166716,ZNF592,zinc finger domain,gene expression regulation,transcriptional activity alteration,cellular growth modulation,tumor progression contribution,genomic instability association
ENSG00000184428,TOP1MT,dna relaxation,genomic instability,oncogenic mutations,cell cycle arrest,apoptosis induction,therapeutic target
ENSG00000142973,CYP4B1,cellular metabolism,angiogenesis promotion,lipid metabolite regulation,protein-protein interaction,oncogenic gene expression,detoxification enzyme
ENSG00000197629,MPEG1,oncogenic role,ubiquitin-proteasome pathway regulation,cellular stress response modulation,lipid metabolism dysregulation,aggressive tumor behavior association,reactive oxygen species regulation
ENSG00000278767,SERPINA10,apoptosis regulation,cell adhesion modulation,extracellular matrix remodeling,inflammation control,protease inhibition,tumor progression suppression
ENSG00000084636,COL16A1,tumor progression,cell migration,hypoxia response,extracellular matrix remodeling,therapeutic target,prognostic marker
ENSG00000122674,CCZ1,cell cycle progression,transcriptional regulation,dna repair pathway,oncogene expression,brca1 interaction,chromatin remodeling
ENSG00000174669,SLC29A2,nucleoside transport regulation,cell proliferation enhancement,tumor aggressiveness promotion,chemoresistance induction,pi3k/akt pathway interaction,metastasis facilitation
ENSG00000144026,ZNF514,chromatin remodeling,transcriptional repression,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,genomic instability regulation
ENSG00000135390,ATP5MC2,mitochondrial dysfunction,energy metabolism disruption,oncogenic mutations,therapeutic target potential,metabolic reprogramming,genomic instability promotion
ENSG00000147862,NFIB,cell cycle regulation,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell proliferation,tumor suppressor gene regulation,oncogenic transformation
ENSG00000188338,SLC38A3,glutamine transport,cellular metabolism,oncogenic potential,tumor progression,epigenetic regulation,metabolic network
ENSG00000144231,POLR2D,chromatin remodeling,constitutive activation,dna-dependent transcription,oncogenic transcription factor,tumor progression driver,transcriptional dysregulation
ENSG00000164308,ERAP2,ubiquitin-proteasome pathway,peptide presentation,mhc molecule modification,tumor cell invasion,genomic driver mutation,cancer immune evasion
ENSG00000213047,DENND1B,rab gtpase regulation,cell migration promotion,growth factor signaling interaction,cell proliferation enhancement,tumor progression biomarker,genomic profiling association
ENSG00000219438,TAFA5,p53 pathway regulation,transcriptional modulation,oncogene overexpression,cell cycle progression,tumor suppressor interaction,genomic instability
ENSG00000168393,DTYMK,thymidylate synthesis,dna replication enhancement,cancer cell proliferation,cell survival pathways activation,poor prognosis marker,chemotherapy resistance
ENSG00000174177,CTU2,transcriptional elongation,oncogene overexpression,cell growth regulation,tumor suppressor gene dysregulation,rna binding protein interaction,cancer biomarker potential
ENSG00000123612,ACVR1C,tgf-beta signaling,cell growth regulation,oncogene function,epithelial-to-mesenchymal transition,signaling pathway modulation,cancer cell proliferation
ENSG00000131446,MGAT1,glycosylation regulation,tumor progression,cell proliferation,therapeutic target,biomarker potential,cell survival enhancement
ENSG00000257446,ZNF878,transcriptional regulation,tumor progression,dna-binding activity,epigenetic modulation,cell proliferation,apoptosis evasion
ENSG00000076706,MCAM,cell adhesion disruption,metastasis promotion,tumor progression,prognostic marker,therapeutic target,glycoprotein expression
ENSG00000180113,TDRD6,tumor progression,histone modification,rna-binding protein,chromatin remodeling,gene expression regulation,prc2 complex interaction
ENSG00000178201,VN1R1,pheromone detection,cell signaling,genomic alteration,tumor progression,oncogene,cellular regulation
ENSG00000174915,PTDSS2,trna biosynthesis,aminoacylation disruption,oncogenic mutations,cell cycle regulation,dna repair deficiency,protein synthesis dysregulation
ENSG00000182141,ZNF708,transcriptional regulation,dna binding,zinc finger protein,krab domain,chromatin remodeling,gene expression regulation
ENSG00000278608,MAMDC2,genomic instability,tumor suppressor function,dna damage response,homologous recombination repair (hrr),genome stability maintenance,cell cycle regulation
ENSG00000164299,SPZ1,genomic instability,cell proliferation,transcriptional regulation,tumor progression,chromosomal rearrangement,epigenetic modification
ENSG00000154240,CEP112,centrosomal protein regulation,tumor aggressiveness,cell cycle progression,spindle assembly disruption,cilium formation dysregulation,mitotic checkpoint dysfunction
ENSG00000122574,WIPF3,actin-binding protein,cancer cell migration,cell proliferation,microtubule regulation,pi3k/akt signaling pathway,tumor growth and metastasis
ENSG00000187446,CHP1,genomic instability,tumor suppressor function,chromatin remodeling,transcriptional regulation,cell cycle checkpoint disruption,loss of function mutations
ENSG00000138756,BMP2K,cell proliferation regulation,tumor progression driver,oncogenic kinase activity,wnt/β-catenin pathway interaction,hippo/yap signaling modulation,apoptosis inhibition
ENSG00000106331,PAX4,wnt/β-catenin pathway,epithelial-to-mesenchymal transition (emt),transcription factor activity,cell proliferation,stem cell maintenance,oncogenic transcription factor
ENSG00000085721,RRN3,ribosome biogenesis alteration,oncogenic function,transcriptional regulation,cell cycle dysregulation,dna repair modulation,protein-rna interaction
ENSG00000108242,CYP2C18,drug metabolism alteration,tumor progression modulation,pi3k/akt signaling interaction,cancer therapeutic target,cellular response regulation,metabolic enzyme function
ENSG00000159164,SV2A,mtor pathway interaction,cell proliferation regulation,therapeutic target,synaptic vesicle protein function,cellular metabolism modulation,tumor growth promotion
ENSG00000105552,BCAT2,metabolic reprogramming,tumor-promoting metabolites,cell growth promotion,energy metabolism regulation,therapeutic target,protein-protein interaction
ENSG00000205307,SAP25,actin cytoskeleton regulation,cell growth modulation,oncogenic mutations,cell survival pathway,cancer associated gene,none
ENSG00000152595,MEPE,tumor progression,metastasis promotion,cell proliferation regulation,protein interaction modulation,oncogenic pathway activation,bone mineralization dysregulation
ENSG00000167930,FAM234A,genomic instability,constitutive activation,gain of function mutations,tumor progression,therapeutic target,regulation of cellular growth
ENSG00000101825,MXRA5,tumor suppressor function,loss of function mutations,cell cycle progression,genome stability,transcriptional regulation,apoptosis suppression
ENSG00000137672,TRPC6,calcium influx regulation,tumor progression facilitation,protein interaction enhancement,cell migration promotion,nfat pathway activation,cancer cell survival support
ENSG00000166821,PEX11A,pi3k/akt pathway interaction,lipid metabolism regulation,tumor aggressiveness correlation,growth and proliferation promotion,oncogenic signaling facilitation,cell cycle progression modulation
ENSG00000151892,GFRA1,cell proliferation,gdnf/ret pathway,cell migration,metastasis promotion,therapeutic target,signaling regulation
ENSG00000166401,SERPINB8,apoptosis inhibition,cell adhesion modulation,granzyme regulation,invasive behavior,pro-tumor function,type ii transmembrane serpin
ENSG00000275181,GPR20,receptor activation,oncogene overexpression,cell proliferation,tumor progression,poor prognosis,signaling pathway modulation
ENSG00000177225,GATD1,cellular proliferation,tumor progression,protein synthesis regulation,aminoacyl-trna formation,oncogenic potential,mitochondrial localization
ENSG00000168300,PCMTD1,overexpression,tumor growth,poor prognosis,cellular response modulation,dna damage regulation,protein stabilization
ENSG00000147257,GPC3,tumor progression,malignant potential,cell proliferation,overexpression,angiogenesis,cell invasion
ENSG00000162931,TRIM17,tumor suppression,apoptosis induction,cell cycle regulation,ring finger protein,protein degradation,ubiquitination pathway
ENSG00000177951,BET1L,chromatin remodeling,histone acetylation,oncogenic process,cell proliferation,therapeutic target,genomic instability
ENSG00000146904,EPHA1,rho gtpase activation,cell migration regulation,transmembrane receptor function,pi3k/akt signaling pathway,tumor progression promotion,therapeutic target potential
ENSG00000106617,PRKAG2,ampk activation,metabolic reprogramming,cell growth promotion,therapeutic target,genetic mutations,energy homeostasis regulation
ENSG00000006283,CACNA1G,tumor progression,constitutive activation,gain of function mutations,therapeutic target,cell proliferation,genomic profiling
ENSG00000120500,ARR3,genomic instability,cell cycle regulation,anaphase-promoting complex,dna damage response,mitotic progression,tumor suppressor
,GUCA1A,cellular proliferation,epithelial cell regulation,guanylate cyclase modulation,signaling pathway interaction,tumor growth regulation,molecular dysregulation
ENSG00000019505,SYT13,vesicle fusion,regulated cell growth,cell signaling modulation,dysregulated expression,membrane trafficking alterations,tumor progression
ENSG00000155287,SLC25A28,mitochondrial transport,cellular energy metabolism,oncogenic processes,tumor growth promotion,cancer cell metabolism regulation,genomic overexpression
ENSG00000136643,RPS6KC1,rsk activation,protein synthesis regulation,cell cycle progression,oncogenic driver,tumor suppressor dysfunction,genomic instability
ENSG00000139725,RHOF,dna damage repair,genomic instability,cell proliferation enhancement,overexpression,poor prognosis,chromatin organization
ENSG00000170364,SETMAR,genetic instability,epigenetic reprogramming,chromatin remodeling,transcriptional regulation,oncogenesis facilitation,cellular differentiation
ENSG00000204963,PCDHA7,cell-cell adhesion disruption,pi3k/akt pathway interaction,tumor suppressor function,cell migration regulation,poor prognosis association,genomic downregulation
ENSG00000172269,DPAGT1,glycosylation dysfunction,oncogenic signaling activation,cancer driver mutation,cell proliferation promotion,chemotherapy resistance association,endoplasmic reticulum localization
ENSG00000139083,ETV6,transcription factor activation,cell cycle regulation,apoptosis inhibition,epithelial-to-mesenchymal transition,tumor progression,genomic instability
ENSG00000095752,IL11,il-11 overexpression,stat3 signaling activation,tumor progression,angiogenesis stimulation,apoptosis suppression,pi3k/akt pathway interaction
ENSG00000112110,MRPL18,mitochondrial translation regulation,apoptosis resistance,cell cycle progression,energy metabolism imbalance,pi3k/akt signaling modulation,oncogenic function
ENSG00000169418,NPR1,constitutive activation,signaling pathway dysregulation,cell proliferation enhancement,tumor progression,cancer driver gene,genomic mutations
ENSG00000105258,POLR2I,constitutive activation,genomic instability,oncogenic transcription,tumor progression,therapeutic target,transcriptional regulation
ENSG00000048544,MRPS10,mitochondrial biogenesis,energy metabolism regulation,tumor progression marker,oncogenic pathway activation,cell growth promotion,protein-protein interaction
ENSG00000115607,IL18RAP,immune regulation,tumor progression,metastasis,therapeutic target,overexpression,cytokine signaling
ENSG00000183878,UTY,epigenetic regulation,histone modification,tumor progression,metastasis,cell proliferation,dna methylation
ENSG00000160957,RECQL4,dna helicase activity,genomic instability,tumor progression,cancer driver,cell cycle regulation,dna repair pathways
ENSG00000111241,FGF6,fibroblast growth factor signaling,oncogenic transformation,angiogenesis promotion,cell adhesion regulation,tumor cell survival,receptor interaction
ENSG00000153107,ANAPC1,cell cycle regulation,chromosomal instability,genomic stability,protein degradation,ubiquitin ligase activity,mitotic progression
ENSG00000196284,SUPT3H,chromatin remodeling,histone acetylation,gene transcription regulation,cell cycle progression modulation,dna repair pathway alteration,protein-protein interaction
ENSG00000136492,BRIP1,genomic instability,dna repair,cell cycle progression,homologous recombination,base excision repair,dna helicase activity
ENSG00000168487,BMP1,tumor progression,protein processing,cell proliferation,signaling pathway regulation,collagen production regulation,smad protein interaction
ENSG00000144827,ABHD10,lysophosphatidic acid regulation,tumor suppressor function,cell proliferation inhibition,metastasis suppression,lpa metabolism modulation,genomic loss-of-function mutations
ENSG00000120242,IFNA8,tumor progression,anti-tumor immunity suppression,immune evasion enhancement,angiogenesis promotion,dna repair dysregulation,cell cycle regulation disruption
ENSG00000113600,C9,genomic instability,tumor suppressor function,cell cycle regulation,cyclin-dependent kinase inhibition,growth suppression,genetic mutation
,HIST1H2BK,histone modification,chromatin remodeling,gene expression regulation,transcription factor recruitment,tumor suppressor silencing,oncogene activation
ENSG00000233816,IFNA13,type i interferon family,innate immune response regulation,immune cell activation,apoptosis induction,cell proliferation suppression,cancer immunotherapy target
ENSG00000197919,IFNA1,type i interferon,apoptosis induction,cell proliferation inhibition,immune regulation,pro-inflammatory cytokine modulation,tumor necrosis factor receptor-associated factors interaction
ENSG00000075213,SEMA3A,tumor suppressor function,loss-of-function mutations,angiogenesis regulation,cell adhesion modulation,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition inhibition
ENSG00000167186,COQ7,mitochondrial dysfunction,overexpression,oxidative stress,cell proliferation,electron transport chain,energy metabolism
ENSG00000104976,SNAPC2,spliceosome assembly,alternative splicing regulation,rna processing disruption,tumor suppressor function,cellular interaction networks,genetic alterations in cancer
ENSG00000036828,CASR,calcitonin receptor overexpression,tumor progression marker,cell migration stimulation,prognostic significance,epithelial-to-mesenchymal transition regulation,growth factor activation
ENSG00000204086,RPA4,genomic instability,dna damage response,gain of function mutations,cell cycle regulation,apoptosis inhibition,chemosensitivity loss
ENSG00000110200,ANAPC15,genomic instability,anaphase-promoting complex component,cell cycle regulation,ubiquitin ligase activity,protein degradation,tumor suppressor protein regulation
ENSG00000145839,IL9,il9-il9r axis,immunosuppressive microenvironment,th2 cell recruitment,tumor-promoting myeloid cells,cell proliferation and survival,immune evasion mechanisms
ENSG00000124334,IL9R,il-9/stat5 signaling pathway,cell proliferation enhancement,tumor progression,immune evasion,prognostic marker,cancer immune microenvironment alteration
ENSG00000102678,FGF9,wnt/β-catenin pathway activation,overexpression,cell proliferation promotion,angiogenesis regulation,tumor progression factor,cancer stem cell regulation
ENSG00000129055,ANAPC13,genomic stability,cell cycle regulation,chromosomal instability,tumor suppressor function,cancer-related protein degradation,defective dna repair
ENSG00000147873,IFNA5,tumor suppression,interferon signaling,cell proliferation inhibition,antiviral responses,cancer progression regulation,prognostic biomarker
ENSG00000171855,IFNB1,tumor suppression,immune regulation,cell proliferation inhibition,angiogenesis inhibition,prognostic marker,immunomodulation
ENSG00000186895,FGF3,fgf signaling pathway,constitutive activation,gain of function mutations,tumor progression,stem-like phenotype,epithelial-to-mesenchymal transition (emt)
ENSG00000114861,FOXP1,transcriptional regulation,overexpression,constitutive activation,oncogene activation,cell cycle progression,immune response modulation
ENSG00000081026,MAGI3,maguk family member,tumor progression,cell adhesion regulator,mutational amplifier,akt pathway modulator,wnt/β-catenin pathway suppressor
ENSG00000105287,PRKD2,pi3k/akt pathway activation,oncogenic potential,upregulated expression,therapeutic target,cell proliferation regulation,emt modulation
ENSG00000119973,PRLHR,g protein-coupled receptor signaling,prolactin secretion regulation,tumor progression driver,cell proliferation modulation,apoptosis inhibition,breast cancer metastasis related
ENSG00000144596,GRIP2,pi3k/akt pathway modulation,scaffold protein function,oncogenic process regulation,cell growth and survival modulation,cancer prognosis marker,synaptic plasticity regulation
ENSG00000069020,MAST4,transcriptional coactivation,cell proliferation,cell migration,apoptosis suppression,gene expression regulation,chromatin modification
ENSG00000183479,TREX2,mrna export disruption,genetic alterations,oncogenesis,cell proliferation regulation,cell survival enhancement,gene expression alteration
ENSG00000175175,PPM1E,ppm1e,tumor suppressor function,loss of regulatory subunit,cell cycle regulation,apoptosis regulation,phosphatase inhibition
ENSG00000144455,SUMF1,cell proliferation,tumor progression,extracellular matrix regulation,sulfatase activity,oncogenic pathway activation,cell migration dysfunction
ENSG00000198964,SGMS1,sphingomyelin synthesis,tumor growth promotion,cell signaling regulation,lipid metabolism modification,metastasis facilitation,apoptosis resistance
ENSG00000261150,EPPK1,protein synthesis regulation,cell proliferation enhancement,oncogenic processes promotion,apoptosis inhibition,tumor growth acceleration,cell survival increase
ENSG00000125844,RRBP1,oncogenic signaling,cell proliferation,apoptosis suppression,mrna stability regulation,tumor aggressiveness,prognostic marker
ENSG00000144407,PTH2R,regulation of calcium metabolism,g-protein coupled receptor activity,cellular proliferation,signaling pathway modulation,cell differentiation regulation,calcium imbalance
ENSG00000113396,SLC27A6,lipid metabolism,fatty acid transport,oncogenic potential,cell proliferation,metastasis,tumor microenvironment
ENSG00000185238,PRMT3,histone modification,cell proliferation,chromatin regulation,oncogene activation,biomarker potential,protein-protein interaction
ENSG00000183291,SELENOF,cellular redox balance,dna damage induction,genomic instability,loss-of-function mutation,oncogenic process driving,tumor suppressor function
ENSG00000144048,DUSP11,oncogenic activation,signaling pathway modulation,dephosphorylation,cell proliferation enhancement,tumor progression facilitation,therapeutic target
ENSG00000079393,DUSP13,oncogene,mapk signaling modulation,cell proliferation promotion,tumor aggressiveness marker,erk/mapk pathway interaction,prognostic significance
ENSG00000284835,DEFA3,antimicrobial activity,tumor suppressor function,immune modulation,angiogenesis inhibition,innate immunity regulation,cationic peptide
ENSG00000130640,TUBGCP2,microtubule stability,dysregulation of cell division,mitotic spindle regulation,gene expression regulation,cellular transport modulation,tumor suppression
ENSG00000183638,RP1L1,microtubule stability,cell proliferation,apoptosis regulation,tumor progression,oncogene role,protein interaction
ENSG00000130234,ACE2,angiotensin-converting enzyme 2,wnt/β-catenin pathway interaction,cell migration and invasion,angiogenesis regulation,overexpression in tumor progression,therapeutic target
ENSG00000266200,PNLIPRP2,inflammation regulation,cellular proliferation,eicosanoid production,immune microenvironment modulation,tumor progression driver,therapeutic target
ENSG00000114113,RBP2,genomic instability,loss of function mutation,tumor suppressor function,cell cycle regulation,epigenetic regulation,dna damage response
ENSG00000121207,LRAT,lipid metabolism regulation,cell proliferation enhancement,tumor progression marker,chemosensitivity reduction,poor prognosis indicator,therapeutic target candidate
ENSG00000171864,PRND,neuropeptide regulation,precursor protein function,cell survival dysregulation,tumor progression driver,mapk/erk pathway activation,immune modulation
ENSG00000183395,PMCH,regulation of food intake,altered energy homeostasis,modulation of glucose metabolism,lipid metabolism regulation,tumor development,prognosis alteration
ENSG00000125851,PCSK2,prohormone convertase function,cell proliferation,tumor progression,secretory machinery regulation,signaling pathway modulation,therapeutic target
ENSG00000130635,COL5A1,metastasis regulation,tumor invasion,cell adhesion,protein-protein interaction,biomarker identification,extracellular matrix modulation
ENSG00000170743,SYT9,cellular growth regulation,calcium-regulated membrane fusion,oncogenic process involvement,cell survival pathway modulation,protein interaction,cancer-related gene expression
ENSG00000168952,STXBP6,vesicle fusion regulation,tumor progression,protein secretion regulation,cellular reprogramming,golgi apparatus component,membrane trafficking regulation
ENSG00000021852,C8B,dna repair pathway,tumor progression,epigenetic regulation,genome instability,transcriptional modulation,dna damage response
ENSG00000266964,FXYD1,ion channel regulation,tumor growth modulation,aberrant signaling pathway,cellular proliferation drive,therapeutic target identification,ion transport dysregulation
ENSG00000203710,CR1,complement regulation,immune evasion,tumor progression,cell survival,metastasis promotion,oncogenic signaling
ENSG00000204983,PRSS1,notch signaling pathway,aberrant expression,oncogene,cell proliferation,tumor progression,therapeutic target
ENSG00000088926,F11,tumor angiogenesis,overexpression,vascular endothelial growth factor expression,serine protease activity,blood coagulation pathway,cell signaling regulation
ENSG00000106624,AEBP1,tumor suppressor,cell proliferation regulation,wnt/β-catenin pathway modulation,transcriptional co-repression,apoptosis induction,epigenetic regulation
ENSG00000070748,CHAT,acetylcholine synthesis,biomarker potential,enzyme function,gene regulation,neurotransmitter homeostasis,tumor microenvironment modulation
ENSG00000128791,TWSG1,wnt signaling pathway,loss of function mutations,tumor suppressor function,cell proliferation regulation,cancer development,genomic instability
ENSG00000159723,AGRP,agrp overexpression,cell proliferation,epithelial-to-mesenchymal transition,metastasis promotion,therapy resistance,cancer stem cell maintenance
ENSG00000165195,PIGA,glycosylphosphatidylinositol anchors,cell surface proteins,genetic mutations,x-linked gene,enzyme deficiency,dysregulated expression
ENSG00000100564,PIGH,tumor progression,protein interaction,cell signaling pathway,epigenetic regulation,oncogenic properties,angiogenesis
ENSG00000127129,EDN2,angiogenesis promoter,tumor metastasis driver,cell proliferation enhancer,prognostic marker,vasoconstrictor activity,oncogene upregulation
ENSG00000092009,CMA1,apoptosis regulation,calcium signaling pathway,cell cycle progression,gene expression modulation,mitochondrial function,tumor suppressor role
ENSG00000132561,MATN2,overexpression,oncogenic process,extracellular matrix regulation,cell proliferation,epithelial-to-mesenchymal transition,integrin-mediated signaling
ENSG00000167103,PIP5KL1,phosphoinositide signaling,oncogenesis,cell migration,golgi apparatus reorganization,tumor progression,kinase activity alterations
ENSG00000134247,PTGFRN,prostaglandin f2 regulation,cell proliferation modulation,inflammatory mediator regulation,cancer cell survival,tumorigenesis involvement,negative regulator protein
ENSG00000134489,HRH4,histamine regulation,g-protein coupling,immune modulation,tumor progression,cell proliferation,angiogenesis
ENSG00000150681,RGS18,g-protein regulation,tumor progression,cell proliferation,metastasis,epigenetic modifications,pi3k/akt interaction
ENSG00000107518,ATRNL1,cell cycle regulation,dna damage response,cell proliferation,gene amplification,tumor suppressor function,biological pathway disruption
ENSG00000117322,CR2,complement system regulation,metastasis promotion,tumor microenvironment interaction,cell signaling modulation,antigen presentation regulation,b cell activation
ENSG00000036473,OTC,polyamine metabolism,cell survival,mitochondrial enzyme,urea cycle regulation,metabolic pathway regulation,oxidative stress modulation
ENSG00000129910,CDH15,tumor suppressor,epithelial-to-mesenchymal transition,cell adhesion disruption,wnt signaling pathway regulation,metastasis promotion,loss of expression
ENSG00000204262,COL5A2,tumor aggressiveness,extracellular matrix modulation,cell adhesion pathway interaction,biomarker for disease progression,poor prognosis association,gene expression upregulation
ENSG00000003436,TFPI,tumor suppressor function,anti-coagulant activity,regulation of thrombin formation,inflammation modulation,metastasis inhibition,prognostic biomarker candidate
ENSG00000139610,CELA1,lipid metabolism disruption,tumor progression enhancement,cell growth promotion,apoptosis suppression,protein interaction regulation,genomic instability induction
ENSG00000124159,MATN4,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),glycoprotein overexpression,invasion and metastasis promotion,oncogenic transformation,signaling pathway interaction
ENSG00000132031,MATN3,degradation of extracellular matrix,cell adhesion and migration,proteolytic activity,cell proliferation regulation,angiogenesis promotion,tumor progression enhancement
ENSG00000108963,DPH1,pif-pocket proteins family,cell cycle regulation,dna repair mechanisms,ubiquitin ligase activity,e3 ubiquitin ligase function,genomic stability maintenance
ENSG00000004468,CD38,tumor growth promotion,apoptosis evasion,oncogenic signaling pathway activation,immune suppression,biomarker for treatment outcome,overexpression in tumor tissues
ENSG00000127311,HELB,dna helicase activity,genomic instability,genetic mutations,cellular proliferation,protein-protein interactions,tumor progression
ENSG00000135074,ADAM19,notch signaling pathway,cell adhesion molecule,immune response modulation,tumor invasion and metastasis,angiogenesis regulation,wnt/β-catenin pathway interaction
ENSG00000172238,ATOH1,cell cycle regulation,tumor suppressor function,dysregulated expression,epithelial cell differentiation,proliferation inhibition,anti-apoptotic pathways
ENSG00000101680,LAMA1,basement membrane formation,tumor progression,cell adhesion,ecm disruption,proliferation,angiogenesis
ENSG00000242441,GTF2A1L,chromatin remodeling,oncogene,transcriptional regulation,cell proliferation,poor prognosis,biomarker candidate
ENSG00000113100,CDH9,tumor suppressor function,epithelial-to-mesenchymal transition regulation,cell adhesion disruption,poor prognosis association,chemotherapy resistance involvement,biomarker potential
ENSG00000223496,EXOSC6,cellular proliferation,rna degradation,genomic instability,oncogene function,metabolic regulation,tumor behavior
ENSG00000146938,NLGN4X,neurexin-like protein 4 x-linked function,amplified gene expression,tumor progression driver,gene amplification event,synaptic transmission disruption,cellular proliferation enhancement
ENSG00000211896,IGHG1,immunoglobulin heavy chain,oncogenic pathway activation,tumor microenvironment modulation,immunosuppression facilitation,genomic instability,tumor progression driver
ENSG00000176406,RIMS2,calcium-dependent exocytosis,cellular proliferation,tumor progression,upregulated gene expression,cell survival pathway,neurotransmitter release regulation
ENSG00000073849,ST6GAL1,altered glycosylation patterns,tumor growth promotion,metabolic reprogramming,oncogene activity,biomarker potential,therapeutic target
ENSG00000081138,CDH7,protocadherin 7 dysfunction,loss of cell-cell adhesion,disrupted cellular migration,increased tumor invasion,metastasis promotion,oncogenic potential
ENSG00000113361,CDH6,cell adhesion regulation,tumor progression,metastasis,prognostic marker,epithelial cell expression,cellular interaction modulation
ENSG00000023839,ABCC2,multidrug resistance,chemotherapeutic agent efflux,cellular membrane transport,protein-protein interaction,glutathione conjugate export,bilirubin glucuronide secretion
ENSG00000185252,ZNF74,oncogenic activity,transcriptional regulation,chromatin remodeling,nuclear localization,epigenetic modulation,cancer cell proliferation
ENSG00000143196,DPT,wnt/β-catenin signaling pathway,tumor progression,metastasis,cell-cell adhesion,overexpression,biomarker
ENSG00000198785,GRIN3A,nmda receptor regulation,tumor progression,overexpression,cell cycle modulation,genomic instability,therapeutic target
ENSG00000131183,SLC34A1,phosphate transport,pi3k/akt pathway modulation,cell growth regulation,tumor progression,therapeutic target,cancer cell metabolism
ENSG00000161513,FDXR,mitochondrial function,dna repair,oxidative stress resistance,biomarker significance,cancer treatment outcome,cellular redox balance
ENSG00000197467,COL13A1,epithelial-to-mesenchymal transition,extracellular matrix degradation,tumor progression,cell migration,metastasis,transmembrane protein
ENSG00000122367,LDB3,transcriptional coactivation,chromatin remodeling,tumor progression,cell proliferation,epithelial-to-mesenchymal transition,apoptosis regulation
ENSG00000196371,FUT4,le^x expression,promotes angiogenesis,tumor progression,enhances cell migration,cell adhesion molecules,epithelial-to-mesenchymal transition
ENSG00000142185,TRPM2,calcium signaling pathway,transient receptor potential channel,inflammation regulation,cell proliferation,apoptosis regulation,tumor progression
ENSG00000164574,GALNT10,glycosylation pathway,cell-cell interaction,o-linked glycosylation,oncogenic process,tumor progression,protein modification
ENSG00000087237,CETP,lipid metabolism alteration,cell membrane fluidity modification,tumor progression facilitation,overexpression in tumor tissues,cancer cell proliferation enhancement,oncogenic potential
ENSG00000205916,DAZ4,regulation of gene expression,rna binding activity,genomic instability,cancer progression,proliferation regulation,cell growth modulation
ENSG00000112234,FBXL4,cancer driver mutations,cell cycle regulation,protein degradation pathway,scf complex interaction,tumor suppressor function,loss-of-function mutations
ENSG00000040731,CDH10,epithelial-to-mesenchymal transition,loss of cell adhesion,tumor progression,overexpression,cell invasion suppression,poor prognosis
ENSG00000167642,SPINT2,pi3k/akt pathway regulation,tumor progression enhancement,loss of function mutations,cell migration promotion,therapeutic target potential,epithelial-to-mesenchymal transition (emt) regulation
ENSG00000114270,COL7A1,tumor suppressor function,basement membrane disruption,epithelial-mesenchymal transition,collagen vii anchoring fibrils,cell invasion promotion,tissue structure maintenance
ENSG00000148702,HABP2,oncoprotein function,chromatin remodeling,cell cycle regulation,tumor suppressor interaction,apoptosis inhibition,angiogenesis promotion
ENSG00000134760,DSG1,cell-cell interaction disruption,tumor suppressor activity,oncogenic pathway activation,signaling pathway modulation,tissue structure maintenance,cellular adhesion regulation
ENSG00000099769,IGFALS,igf-1/igf-2 signaling,cell proliferation,tumor progression,cell growth modulation,metabolic regulation,protein binding
ENSG00000186340,THBS2,angiogenesis inhibition,tumor suppressor function,cellular adhesion regulation,apoptosis induction,platelet aggregation modulation,thrombosis involvement
ENSG00000010818,HIVEP2,immune evasion,tumor progression,apoptosis inhibition,angiogenesis promotion,transcriptional regulation,prognostic marker
ENSG00000159496,RGL4,rhogap regulation,constitutive activation,oncogenic potential,cell proliferation,emt process,therapeutic target
ENSG00000100060,MFNG,notch receptor regulation,tumor growth promotion,cell differentiation disruption,oncogenic driver,signaling pathway component,genetic instability
ENSG00000106003,LFNG,altered glycosylation,cell proliferation,cell survival,poor prognosis,biomarker potential,somatic mutation
ENSG00000130988,RGN,chromatin remodeling,dna repair mechanisms,cell cycle regulation,genomic instability,tumor growth promotion,epigenetic regulation
,FAM57A,trna regulation,rna processing,cell proliferation,protein synthesis,oncogenesis,tumor progression
ENSG00000010072,SPRTN,genomic instability,dna repair mechanisms,oncogenic processes,helicase activity,replication fork progression,tumor aggressiveness
ENSG00000182240,BACE2,apoptosis evasion,cell proliferation regulation,promotion of tumor microenvironment remodeling,substrate processing and activation,cell cycle regulation impact,tumor growth facilitation
ENSG00000111785,RIC8B,aberrant expression,cell survival pathway,guanylate nucleotide exchange factor,pi3k/akt interaction,small gtpase regulation,tumor progression mediator
ENSG00000103495,MAZ,transcription factor regulation,cell proliferation promotion,apoptosis inhibition,tumor progression association,poor prognosis indicator,metastasis facilitation
ENSG00000149575,SCN2B,cell proliferation,voltage-gated sodium channel regulation,tumor progression,apoptosis evasion,cell cycle checkpoint regulation,neuronal excitability modulation
ENSG00000166947,EPB42,cell adhesion,actin cytoskeleton regulation,focal adhesions,tumor progression,cell invasion,therapeutic target
ENSG00000120903,CHRNA2,nachr signaling,dysregulation of expression,cell proliferation modulation,apoptosis regulation,metastasis promotion,therapeutic target
ENSG00000221946,FXYD7,ion transport regulation,sodium and chloride balance,cellular homeostasis disruption,cancer progression contribution,cell adhesion alteration,metastatic potential enhancement
ENSG00000282049,PRSS2,oncogenic overexpression,tumor progression,cellular proliferation,signal transduction,protein processing,kinase interaction
ENSG00000196526,AFAP1,cell migration,epithelial-to-mesenchymal transition,microtubule interaction,actin filament regulation,tumor invasion,prognostic marker
ENSG00000197614,MFAP5,tumor progression,ecm remodeling,cell migration,prognostic marker,biomarker,promotes invasion
ENSG00000058085,LAMC2,cell adhesion,metastasis regulation,proliferation regulation,tumor progression,protein interaction,oncogenic driver
ENSG00000048028,USP28,deubiquitinase activity,cell proliferation,tumor suppressor degradation,oncogenic signaling,aggressive tumor behavior,prognostic biomarker
ENSG00000126746,ZNF384,altered expression patterns,epigenetic regulation,histone modification,oncogene activation,transcriptional regulation,tumor growth enhancement
ENSG00000177103,DSCAML1,cell adhesion regulation,tumor progression,immune response modulation,cancer cell migration,pro-tumorigenic microenvironment,inflammation regulation
ENSG00000116962,NID1,tumor progression,cell migration,extracellular matrix interaction,overexpression,glycoprotein,biomarker
ENSG00000146276,GABRR1,gaba_a receptor complex,chloride influx regulation,cell cycle dysregulation,tumor growth promotion,immune evasion mechanisms,therapeutic target
ENSG00000186583,SPATC1,cell cycle regulation,tumor progression,oncogenic potential,post-translational modifications,apoptosis resistance,chemotherapy resistance
ENSG00000204084,INPP5B,signaling regulation,gain of function mutations,tumor progression,therapeutic target,cell survival enhancement,cell proliferation increase
ENSG00000108830,RND2,ras superfamily member,membrane trafficking regulation,cell migration enhancer,cytoskeleton remodeling,pi3k/akt pathway modulator,therapeutic target
ENSG00000042832,TG,tumor progression,oncogenic driver,glycoprotein function,cell migration and invasion,angiogenesis facilitation,poor prognosis marker
ENSG00000107789,MINPP1,cell cycle regulation,oncogenic signaling,gain of function mutations,tumor progression,apoptosis evasion,genomic instability
ENSG00000277445,CPEB1,mrna translation regulation,cell proliferation promotion,poor prognosis marker,protein-protein interactions,pi3k/akt pathway dysregulation,tumor progression regulator
ENSG00000197375,SLC22A5,oncogenic transport,cellular membrane localization,transporter function,gene expression regulation,tumor aggressiveness marker,therapeutic target
ENSG00000197208,SLC22A4,transport regulation,chemotherapy resistance,cellular accumulation,drug interaction,metabolic modulation,genomic alteration
ENSG00000084453,SLCO1A2,oxidative stress response,chemotherapy resistance,cellular uptake regulation,tumor progression,pi3k/akt pathway interaction,genomic instability
ENSG00000064205,CCN5,cell adhesion,oncogene,tumor progression,angiogenesis,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway
ENSG00000160349,LCN1,iron homeostasis,oxidative stress,tumor progression,prognosis marker,cellular iron transport,apoptosis regulation
ENSG00000090382,LYZ,tumor-promoting,inflammation induction,immune modulation,angiogenesis facilitation,prognostic marker,antibacterial activity
ENSG00000100031,GGT1,involved in oncogenesis,tumor progression,drug resistance,glutathione regulation,cell proliferation,metastatic potential
ENSG00000077984,CST7,cell cycle progression,detoxification,apoptosis inhibition,gamma-glutamyl transferase activity,tumor aggressiveness,cellular redox regulation
ENSG00000196104,SPOCK3,tumor promoter,extracellular matrix regulation,cell migration and invasion,prognostic marker,pi3k/akt pathway interaction,oncogenic gene expression regulator
ENSG00000107742,SPOCK2,ecm remodeling,cell migration,overexpression,epithelial-to-mesenchymal transition (emt),metastasis,proteoglycan interaction
ENSG00000160963,COL26A1,cell adhesion regulation,glycoprotein overexpression,metastasis facilitation,tumor invasion promotion,poor prognosis association,epithelial cell interaction modification
ENSG00000186998,EMID1,mitotic regulation,cell proliferation,chromosomal stability,protein-protein interaction,nuclear localization,cell cycle progression
ENSG00000126562,WNK4,tumor suppressor function,hippo signaling pathway regulation,ion transport regulation,cell polarity maintenance,chromosomal instability,pi3k/akt pathway modulation
ENSG00000070915,SLC12A3,napi-iia,sodium-dependent phosphate reabsorption,tumor progression,oncogenesis,phosphate metabolism regulation,cellular signaling interaction
ENSG00000050438,SLC4A8,regulation of ph homeostasis,fluid transport regulation,tumor progression,cell migration modulation,pi3k/akt pathway interaction,oncogene/tumor suppressor duality
ENSG00000109861,CTSC,tumor progression,oncogenic processes,proteolytic degradation,cell adhesion regulation,immune evasion,cell invasion
ENSG00000115386,REG1A,constitutive activation,tumor progression,epithelial-to-mesenchymal transition (emt),angiogenesis regulation,cell surface protein interaction,poor prognosis indicator
ENSG00000172016,REG3A,cellular signaling,oncogenic pathway activation,tumor progression,protein-protein interaction,cancer cell growth,biomarker potential
ENSG00000179403,VWA1,cell-cell adhesion disruption,oncogene overexpression,tumor cell survival,metastasis promotion,aggressive tumor phenotype,integrin regulation
ENSG00000148926,ADM,tumor suppressor,oncogenic properties,angiogenesis inhibition,cancer cell survival,cell proliferation regulation,wnt/β-catenin pathway interaction
ENSG00000078401,EDN1,vasoconstriction,oncogenic signaling,cell proliferation,tumor invasion,metastasis,angiogenesis
ENSG00000173171,MTX1,tumor progression,angiogenesis promotion,cell migration facilitation,extracellular matrix degradation,diagnostic biomarker,therapeutic target
ENSG00000145730,PAM,cell growth,enzyme regulation,porphyrin metabolism,heme biosynthesis,protein interaction,chemosensitivity
ENSG00000121236,TRIM6,tumor suppressor function,ubiquitination regulation,e3 ubiquitin ligase activity,cell cycle progression modulation,immune response regulation,protein degradation pathway
ENSG00000125834,STK35,cell migration,gain of function mutations,tumor progression,kinase activation,epithelial cell integrity,cell invasion
ENSG00000104415,CCN4,tumor progression,cell adhesion,oncogene activation,angiogenesis,fibrosis,protein-protein interaction
ENSG00000142156,COL6A1,overexpression,poor prognosis,cell adhesion disruption,extracellular matrix regulation,pi3k/akt pathway modulation,epithelial-to-mesenchymal transition
ENSG00000162510,MATN1,epithelial-to-mesenchymal transition,microtubule stability,cell migration promotion,oncogenic processes enhancement,transmembrane protein function,signaling pathway interaction
ENSG00000030304,MUSK,oncogenic signaling,cell proliferation,tumor progression,cell migration,gene expression regulation,synaptic transmission disruption
ENSG00000170498,KISS1,tumor suppressor,angiogenesis inhibitor,cell proliferation regulator,apoptosis promoter,biomarker candidate,therapeutic target
ENSG00000105880,DLX5,oncogenic transcription factor,cell proliferation,suppressed apoptosis,wnt/β-catenin pathway interaction,gene expression regulation,cancer cell growth promotion
ENSG00000128872,TMOD2,cellular dynamics alteration,tumor aggressiveness marker,protein-protein interaction mediator,cancer cell migration regulator,genomic instability contributor,tumor progression facilitator
ENSG00000171199,OPRPN,oncogenic potential,apoptosis inhibition,cell proliferation,angiogenesis promotion,tumor progression,metastasis facilitation
ENSG00000121552,CSTA,proteolytic inhibition,cancer progression,tumor microenvironment,cellular proliferation,inflammation regulation,signal transduction pathway
ENSG00000140465,CYP1A1,tumor promoter,ahr signaling pathway activation,carcinogen metabolism,cell proliferation induction,survival pathway regulation,biomarker expression
ENSG00000171533,MAP6,erk/mapk pathway,gain of function mutations,tumor progression,cell signaling regulation,chromosomal localization,prognostic marker
ENSG00000145864,GABRB2,gabaergic signaling disruption,neurotransmitter regulation failure,cell proliferation enhancement,tumor progression contribution,downregulated expression,mutation hotspot identification
ENSG00000115993,TRAK2,genomic instability,oncogenic driver,centrosome amplification,resistance to therapy,microtubule dynamics regulation,apoptosis modulation
ENSG00000182256,GABRG3,altered expression,cell proliferation,disrupted homeostasis,oncogenic processes,poor prognosis,reduced apoptosis
ENSG00000131089,ARHGEF9,rho gtpase signaling,cytoskeletal remodeling,cell migration enhancement,tumor progression,metastasis facilitation,epithelial-to-mesenchymal transition
ENSG00000187955,COL14A1,cell adhesion,epithelial-to-mesenchymal transition,metastasis promotion,tumor progression,collagen-like protein interaction,zeb2 transcription factor target
ENSG00000196767,POU3F4,tumor suppression,cell cycle arrest,apoptosis regulation,transcriptional regulation,epigenetic silencing,mitotic regulation
ENSG00000157152,SYN2,regulation of cell proliferation,interaction with pi3k/akt pathway,role in oncogenesis,tumor progression marker,cell survival regulation,kinase activity modulation
ENSG00000185666,SYN3,cytoskeleton remodeling,cell migration and invasion,tumor aggressiveness,poor prognosis marker,synaptic plasticity disruption,actin dynamics regulation
ENSG00000159197,KCNE2,oncogenic transformation,cell proliferation,overexpression,tumor aggressiveness,biomarker potential,therapeutic target
ENSG00000188783,PRELP,oncogenic activation,cell adhesion modulation,enhanced cell growth,extracellular matrix interaction,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway involvement
ENSG00000151704,KCNJ1,cellular proliferation,apoptosis regulation,ion channel function,cell membrane regulation,gene expression alteration,kinase activity alteration
ENSG00000054967,RELT,tumor progression,metastasis promotion,cell migration regulation,epithelial-to-mesenchymal transition disruption,immune microenvironment modulation,pi3k/akt pathway interaction
ENSG00000198502,HLA-DRB5,hla-drb5 dysfunction,immune evasion,antigen presentation,tumor microenvironment,mhc class ii regulation,transcriptional dysregulation
ENSG00000167635,ZNF146,transcriptional regulation,cell proliferation,apoptosis modulation,metastasis driver,oncogene overexpression,biomarker for prognosis
ENSG00000080573,COL5A3,angiogenesis,epithelial-to-mesenchymal transition,cell migration,integrin interaction,gene expression regulation,lymphangiogenesis
ENSG00000109471,IL2,t-cell activation,immunotherapy agent,immune checkpoint regulation,cancer immunosurveillance,cell proliferation stimulation,genetic amplification
ENSG00000087494,PTHLH,pthrp overexpression,cell proliferation,metastasis promotion,wnt/β-catenin pathway interaction,emt induction,tumor suppressor gene suppression
ENSG00000027644,INSRR,oncogene activation,cell proliferation enhancement,tumor progression driver,chemo-resistance mediator,signaling pathway modulation,overexpression marker
ENSG00000132692,BCAN,tumor progression,cell adhesion modulation,prognostic marker,metastasis promotion,angiogenesis enhancement,cell migration regulation
ENSG00000263290,SCAMP3,cell membrane trafficking regulation,oncogenic potential,tumor progression facilitation,overexpression correlation,poor prognosis indicator,vesicle fusion modulation
ENSG00000171209,CSN3,ubiquitination regulation,cell cycle progression,cancer biomarker,protein degradation,cullin-ring e3 ligase regulation,tumor suppressor degradation
ENSG00000169676,DRD5,dopamine receptor activation,cell proliferation enhancement,tumor progression facilitation,oncogenic signaling pathway modulation,genomic amplification association,therapeutic target potentialization
ENSG00000099866,MADCAM1,tumor progression,immune evasion,metastasis facilitation,therapeutic target,cell adhesion regulation,lymphocyte homing
ENSG00000261701,HPR,ubiquitin-proteasome pathway regulation,cell cycle modulation,protein degradation,tumor suppressor/ oncogene activity,dna damage response,biomarker potential
ENSG00000088320,REM1,tumor progression,cell proliferation,genomic profiling,therapeutic target,apoptosis regulation,signaling pathway modulation
ENSG00000143590,EFNA3,cell migration and adhesion,tumor progression and metastasis,epithelial-to-mesenchymal transition (emt),receptor tyrosine kinase activity,overexpression in cancer,prognostic marker
ENSG00000159640,ACE,angiogenesis,tumor progression,vasoconstriction,oncogene upregulation,metastasis facilitation,therapeutic target
ENSG00000120708,TGFBI,cellular adhesion,extracellular matrix,tumor suppression,gene mutation,cell signaling pathway,apoptosis regulation
ENSG00000163141,BNIPL,cell cycle regulation,genomic instability,dna damage response,transcriptional regulation,apoptosis evasion,protein-protein interactions
ENSG00000104537,ANXA13,cell adhesion disruption,prognostic marker,tumor progression facilitation,cancer cell growth promotion,overexpression,cell migration enhancement
ENSG00000175564,UCP3,mitochondrial protein,tumor growth promoter,warburg effect regulator,glycolysis enhancer,cellular metabolism modifier,therapeutic target
,C1orf61,tumor suppressor,cell cycle regulation,protein-protein interactions,hippo signaling pathway,oncometabolism,tissue homeostasis
ENSG00000041982,TNC,cell adhesion disruption,tumor progression,angiogenesis promotion,poor prognosis biomarker,oncogene function,extracellular matrix interaction
ENSG00000164588,HCN1,ion channel activation,overexpression,cell proliferation,constitutive activation,signaling pathway modulation,therapeutic target
ENSG00000123066,MED13L,cell proliferation,transcriptional regulation,dna damage response,tumor suppressor gene suppression,apoptosis inhibition,cancer driver gene
ENSG00000176909,MAMSTR,epithelial-to-mesenchymal transition,pi3k/akt pathway,cell adhesion disruption,prognostic marker,chemoresistance,tumor progression
ENSG00000187688,TRPV2,oncogenic activity,promotes tumor progression,regulates cell proliferation,interacts with pi3k/akt pathway,involved in metastasis and invasion,overexpressed in bladder urothelial carcinoma
ENSG00000196689,TRPV1,pain sensation mediator,calcium signaling regulator,cancer stem cell maintenance,inflammation modulator,cell proliferation enhancer,tumor progression accelerator
ENSG00000164117,FBXO8,tumor suppressor function,cell cycle regulation,cyclin e degradation,ubiquitination pathway,scf complex formation,genome instability maintenance
ENSG00000141665,FBXO15,protein regulation,ubiquitin-proteasome pathway,cell cycle progression,tumor suppressor function,oncogenic protein modulation,biomarker potential
ENSG00000147255,IGSF1,cell adhesion modulation,tumor progression,metastasis regulation,pi3k/akt pathway interaction,biomarker potential,therapeutic target
ENSG00000156671,SAMD8,dna damage response,cell survival,cell proliferation,ubiquitin-proteasome system,oncogenesis,prognostic biomarker
ENSG00000206073,SERPINB4,apoptosis inhibition,tumor progression,angiogenesis regulation,emt activation,cell proliferation enhancement,protease activity regulation
ENSG00000163131,CTSS,extracellular matrix degradation,lysosomal proteolysis,cell migration promotion,immune suppression,tumor progression,protein degradation
ENSG00000126838,PZP,phospholipid flippase function,lipid metabolism regulation,cell proliferation promotion,tumor growth enhancement,metastasis facilitation,aggressive disease progression marker
ENSG00000182742,HOXB4,hoxb4 overexpression,transcription factor activity,cell proliferation enhancement,epithelial-to-mesenchymal transition,cancer progression promotion,cell survival pathway modulation
ENSG00000285121,MTCH2,mitochondrial transport regulation,oncogenic activation,metabolic reprogramming,cell survival enhancement,tumor progression promotion,poor prognosis association
ENSG00000272398,CD24,cell surface glycoprotein,tumor progression,epithelial-to-mesenchymal transition (emt),cell-cell interactions,prognostic marker,pi3k/akt pathway modulation
ENSG00000177879,AP3S1,cell surface trafficking,transcriptional regulation,oncogene overexpression,tumor progression,epigenetic modification,protein-protein interaction
ENSG00000105376,ICAM5,cell adhesion,immune evasion,tumor progression,cancer metastasis,oncogenic potential,immunosuppression
ENSG00000112280,COL9A1,cellular adhesion disruption,tumor progression facilitation,oncogenic interactions,cell cycle regulation evasion,apoptosis resistance,therapeutic target potential
ENSG00000160013,PTGIR,prostaglandin i2 receptor activation,cell migration and invasion,pi3k/akt pathway activation,oncogene upregulation,cell proliferation and survival,signaling pathway modulation
ENSG00000276613,MUC4,transmembrane mucin glycoprotein,aberrant expression,tumor aggressiveness,cell migration and invasion,apoptosis resistance,signaling pathway modulation
ENSG00000073754,CD5L,tumor progression,cell proliferation,biomarker candidate,oncogenic effects,cell signaling modulation,adhesion molecule function
ENSG00000136381,IREB2,iron regulation,cell proliferation enhancement,oxidative stress induction,tumor metastasis promotion,dna damage repair evasion,therapeutic target
ENSG00000178473,UCN3,tumor progression,inflammation regulation,immune system modulation,protein-protein interaction,cancer biomarker,therapeutic target
ENSG00000198252,STYX,genomic instability,cell division regulation,cohesion complex component,tumor susceptibility,oncogenic driver,mitotic checkpoint regulator
ENSG00000126759,CFP,cell proliferation,transcriptional regulation,genetic instability,tumor growth,calmodulin-binding protein,cancer-related gene expression
ENSG00000082258,CCNT2,chromosomal instability,centromere protein function,cell cycle regulation,genomic alterations,oncogenic process,kinetochore assembly
ENSG00000169131,ZNF354A,transcription factor activation,oncogene function,epigenetic regulation,cell cycle dysregulation,pi3k/akt pathway interaction,tumor progression promotion
ENSG00000134765,DSC1,tumor progression,cell migration,resistance to apoptosis,upregulated expression,signaling pathway interaction,cellular adhesion disruption
ENSG00000138769,CDKL2,cell cycle regulation,promotes cell proliferation,gene expression modulation,tumor growth promotion,oncogene function,protein interaction
ENSG00000116353,MECR,mitochondrial function regulation,lipid metabolism reprogramming,metabolic adaptation,oncogenic process modulation,genome instability maintenance,cancer cell metabolism shift
ENSG00000152208,GRID2,glutamate receptor signaling,proliferation promotion,tumor progression driver,cell migration modulation,gene expression alteration,signaling pathway dysregulation
ENSG00000105929,ATP6V0A4,v-atpase regulation,acidic environment maintenance,cell migration regulation,prognostic biomarker,therapeutic target,genomic instability
ENSG00000105825,TFPI2,protein inhibition,cell proliferation,immune response modulation,tumor progression,tissue factor pathway regulation,metastasis promotion
ENSG00000187848,P2RX2,altered expression,ion channel activation,cell proliferation,oncogenic processes,tumor progression,signaling pathway modulation
ENSG00000179142,CYP11B2,aldosterone production,electrolyte imbalance,hormonal regulation,oncogenic processes,pi3k/akt pathway interaction,tumor progression
ENSG00000241484,ARHGAP8,rho/rock signaling pathway,cell migration,tumor suppressor function,tissue-specific expression,protein-protein interaction,cancer progression
ENSG00000100234,TIMP3,tumor suppressor,matrix metalloproteinase inhibition,cell growth regulation,apoptosis regulation,angiogenesis inhibition,genetic downregulation
ENSG00000116183,PAPPA2,igf signaling,tumor progression,angiogenesis,metastasis,cell proliferation,oncogenic function
ENSG00000117122,MFAP2,ecm regulation,tumor progression,cancer-related signaling,cell proliferation,microfibril-associated protein family,angiogenesis modulation
ENSG00000166402,TUB,genomic instability,aneuploidy,cell cycle regulation,microtubule dynamics,cytoskeleton organization,protein-protein interaction
ENSG00000182752,PAPPA,igf regulation,cancer progression,metastasis promotion,tumor aggressiveness,cell proliferation regulation,metalloprotease activity
ENSG00000169213,RAB3B,ras superfamily gtpase,vesicle trafficking regulation,cell proliferation promotion,tumor metastasis facilitation,gtpase-activating protein interaction,oncogene potential
ENSG00000280706,REXO4,cancer-related regulation,rna stability,tumor suppression,microrna degradation,oncogenic mechanism,molecular interaction
ENSG00000116117,PARD3B,planar cell polarity pathway,cell proliferation,oncogenic function,epithelial-to-mesenchymal transition,regulation of cell polarity,genomic instability
ENSG00000144355,DLX1,dlx1 regulatory,wnt/β-catenin signaling,epithelial cell development,transcription factor function,cell proliferation regulation,biomarker potential
ENSG00000103811,CTSH,notch receptor modification,oncogenic activation,cell proliferation enhancement,wnt/β-catenin pathway interaction,mapk/erk pathway modulation,aberrant cell signaling
ENSG00000168539,CHRM1,cell proliferation,apoptosis regulation,signaling pathway activation,overexpression,tumor progression,biomarker identification
ENSG00000185668,POU3F1,cell proliferation,tumor progression,transcription factor activity,epithelial-to-mesenchymal transition (emt),oncogene activation,cancer metabolism
ENSG00000170430,MGMT,mgmt-mediated chemoresistance,o6-methylguanine-dna methyltransferase,dna repair capacity,therapeutic target,genetic instability,cell survival
ENSG00000111783,RFX4,regulatory factor x family,transcriptional regulation,cell cycle control,oncogene overexpression,cell proliferation driver,promotes tumorigenesis
ENSG00000105695,MAG,cell adhesion,metastasis,epithelial-to-mesenchymal transition (emt),therapeutic target,wnt/β-catenin pathway activation,protein-protein interaction
ENSG00000138496,PARP9,genomic instability,dna repair dysfunction,transcriptional regulation,oncogene overexpression,tumor growth promotion,chromatin remodeling
ENSG00000112599,GUCA1B,cgmp signaling pathway,overexpression,proliferation promotion,migration promotion,invasion enhancement,pi3k/akt/mtor activation
ENSG00000203668,CHML,immune suppression,cell adhesion,inflammation promotion,cell migration enhancement,tumor progression facilitation,protein-protein interaction
ENSG00000108961,RANGRF,cellular regulation,guanosine nucleotide exchange,apoptosis resistance,cell proliferation enhancement,guanine nucleotide regulators,tumor progression
ENSG00000166816,LDHD,glycolytic activity,metabolic reprogramming,tumor aggressiveness,poor prognosis,cancer cell growth,energy metabolism alteration
ENSG00000100979,PLTP,lipid metabolism regulation,gene expression modulation,tumor progression influence,lipid transfer function,cardiovascular disease association,atherosclerosis link
ENSG00000141086,CTRL,microtubule regulation,cell cycle progression,cellular motility,tumor growth,oncogenic transformation,cell survival
ENSG00000105371,ICAM4,cell adhesion,cell migration,extracellular matrix interaction,glycoprotein function,tumor progression,immune response regulation
ENSG00000213918,DNASE1,dna degradation,tumor microenvironment modulation,extracellular matrix remodeling,genomic instability regulation,inflammatory response modulation,oncogenic adaptation promotion
ENSG00000187244,BCAM,cell-cell interaction,tumor progression,aberrant overexpression,cell detachment,signaling pathway regulation,glycoprotein function
ENSG00000135622,SEMA4F,vascular endothelial growth factor regulation,angiogenesis inhibition,cell migration and invasion,tumor suppressor gene,semaphorin signaling pathway disruption,adhesion molecule expression loss
ENSG00000174611,KY,dna repair mechanism,genomic instability,chromatin regulation,cellular proliferation,genetic predisposition,protein kinase activity
ENSG00000274619,CFD,alternative complement pathway activation,complement system dysregulation,inflammation promotion,prognostic biomarker potential,tumor progression facilitation,immune evasion mechanism
ENSG00000185313,SCN10A,sodium channel activation,voltage-gated sodium channels,oncogene overexpression,tumor progression,cell migration,chemoresistance
ENSG00000155897,ADCY8,camp pathway,amplification and overexpression,cell proliferation and migration,poor prognosis and reduced survival,signaling network modulation,oncogenic driver gene
ENSG00000072315,TRPC5,oncogenic function,calcium influx regulation,cell proliferation enhancement,tumor invasion facilitation,pi3k/akt/mtor pathway interaction,therapeutic target identification
ENSG00000240771,ARHGEF25,rho gtpase activation,oncogenic role,tumor progression,cell migration,metastasis promotion,angiogenesis regulation
ENSG00000104880,ARHGEF18,rho gef activation,oncogene role,cell proliferation regulation,tumor invasion promotion,prognostic marker candidate,rhoa/rock pathway involvement
ENSG00000145681,HAPLN1,extracellular matrix regulation,hyaluronic acid metabolism,tumor microenvironment modulation,cell adhesion and migration,growth factor regulation,therapeutic target
ENSG00000163888,CAMK2N2,camk2 inhibitory subunit,calcium signaling modulation,disrupted calcium homeostasis,oncogenic processes,tumor growth and invasion,therapeutic target
ENSG00000168263,KCNV2,potassium channel regulation,genomic amplification mutations,cell migration modulation,tumor progression facilitation,chemoresistance alterations,electrical property changes
ENSG00000062598,ELMO2,cellular motility,immune evasion,oncogene overexpression,therapeutic target,tumor progression,rac1 gtpase activation
ENSG00000069424,KCNAB2,cell proliferation,ion homeostasis disruption,oncogenic signaling,potassium channel modulation,tumor progression marker,cell survival enhancement
ENSG00000169282,KCNAB1,ion channel regulation,tumor progression,cell proliferation,apoptosis modulation,genetic mutation,electrical homeostasis disruption
ENSG00000170890,PLA2G1B,tumor progression,cell proliferation,signaling pathway modulation,arachidonic acid production,oncogenic activity,dysregulation
ENSG00000173432,SAA1,angiogenesis promotion,pro-tumorigenic environment creation,inflammation regulation,apoptosis inhibition,immunosuppression facilitation,none
ENSG00000137872,SEMA6D,tumor suppression,cell migration regulation,immune response modulation,angiogenesis inhibition,protein-protein interaction,cancer progression modulation
ENSG00000114554,PLXNA1,cell migration,akt pathway regulation,cancer driver mutation,focal adhesion dynamics,cell proliferation,oncogene role
ENSG00000118263,KLF7,transcription factor,tumor progression,cell proliferation,epithelial-to-mesenchymal transition,genomic instability,apoptosis inhibition
ENSG00000123843,C4BPB,complement regulation,immune modulation,tumor microenvironment,inflammation regulation,oncogenic potential,regulatory function
ENSG00000005243,COPZ2,cell cycle regulation,tumor aggressiveness,prognosis marker,genetic alterations,oncogenic processes,pi4p/pip5 phosphorylation
ENSG00000131771,PPP1R1B,pi3k/akt signaling pathway modulation,aberrant cell growth regulation,epigenetic modification,chromatin remodeling,oncogenic process enhancement,tumor metastasis promotion
ENSG00000285456,LTB4R,ltb4-mediated signaling pathway,apoptosis resistance,metastasis promotion,angiogenesis facilitation,g-protein coupled receptor activation,inflammatory response modulation
ENSG00000198049,AVPR1B,vasopressin signaling pathway,oncogenic processes,cell proliferation,tumor progression,epithelial-to-mesenchymal transition,signaling pathway activation
ENSG00000165462,PHOX2A,oncogenesis,promoter interaction,transcriptional regulation,cell differentiation,signaling pathway modulation,loss of function mutations
ENSG00000103145,HCFC1R1,rna regulation,transcriptional control,splicing modulation,cell cycle progression,dna repair suppression,apoptosis inhibition
ENSG00000196517,SLC6A9,amplification,overexpression,cell proliferation,migration,survival,stress response modulation
ENSG00000111886,GABRR2,gaba receptor function,cell migration,tumor progression,signaling pathway interaction,poor prognosis marker,gene expression alteration
ENSG00000188419,CHM,telomerase regulation,telomere maintenance,genomic stability,oncogenic signaling,cell survival,chromosome protection
ENSG00000158985,CDC42SE2,cytoskeletal regulation,oncogene activity,cell migration enhancement,metastasis promotion,tumor progression facilitation,gene amplification association
ENSG00000137103,TMEM8B,calcium signaling pathway,tumor progression,cell migration,actin cytoskeleton regulation,pi3k/akt/mtor pathway modulation,gain of function mutations
,GRASP,protein regulation,trafficking modulation,golgi structure maintenance,cell proliferation promotion,anti-apoptotic function,scaffolding protein activity
ENSG00000186795,KCNK18,cell cycle regulation,enhanced cell proliferation,metastasis promotion,poor prognosis,apoptosis evasion,prognostic biomarker
ENSG00000182771,GRID1,glutamate receptor function,ionotropic channel activity,neurotransmission modulation,cell proliferation promotion,cancer cell survival,tumor progression modulation
ENSG00000114646,CSPG5,oncogenic,tumor progression,cell adhesion regulation,extracellular matrix modulation,genomic instability promotion,therapeutic target potential
ENSG00000134184,GSTM1,genomic deletion,dna damage repair,cellular detoxification,detoxifying enzyme,cell proliferation,genetic instability
ENSG00000129214,SHBG,hormone regulation,cell proliferation,immune evasion,metabolic regulation,signaling pathway interaction,tumor microenvironment modulation
ENSG00000167749,KLK4,tumor progression,biomarker expression,cell migration,proteolytic activity,metastatic potential,extracellular matrix degradation
ENSG00000145526,CDH18,loss of adhesion function,tumor suppressor activity,cell migration regulation,epithelial barrier maintenance,prognostic biomarker potential,interaction with pi3k/akt pathway
ENSG00000071991,CDH19,cell adhesion disruption,tumor progression,invasive capacity enhancement,loss of expression,potential therapeutic target,pi3k/akt pathway interaction
ENSG00000063438,AHRR,xenobiotic metabolism regulation,transcriptional repression,cell cycle control,apoptosis regulation,toxic substance accumulation,environmental stress response modulation
ENSG00000110697,PITPNM1,tumor progression,therapeutic target,cell membrane regulation,oncogenic signaling,metastasis promotion,prognostic marker
ENSG00000285346,CTRB1,oncogene overexpression,tumor progression facilitation,cell proliferation enhancement,metastasis promotion,apoptosis evasion,extracellular matrix degradation
ENSG00000164418,GRIK2,glutamatergic signaling pathway,overexpression or mutation,oncogenic processes,cell proliferation and migration,epigenetic regulation and transcriptional control,therapeutic target
ENSG00000005421,PON1,lipid peroxidation,oxidative stress response,dna damage repair,cell proliferation regulation,genomic instability driver,tumor progression biomarker
ENSG00000134757,DSG3,disruption of cell adhesion,tumor progression,mutations driving tumorigenesis,wnt/β-catenin pathway activation,cell proliferation,epithelial-to-mesenchymal transition
ENSG00000141298,SSH2,ubiquitin ligase activity,cell cycle regulation,dna damage repair,oncogene overexpression,tumor suppressor inhibition,protein degradation pathway
ENSG00000162461,SLC25A34,mitochondrial carrier protein,succinyl-coa transport,cell proliferation,therapeutic target,energy metabolism,oncogenic process
ENSG00000175920,DOK7,aberrant activation of src family kinases,cell proliferation,cell survival,diagnostic marker,modulation of integrin-cytoskeleton interaction,oncogenic driver
ENSG00000124102,PI3,akt/mtor pathway,dysregulation of cell growth,constitutive activation,gain of function mutations,therapeutic target,phosphatidylinositol phosphorylation
ENSG00000187682,ERAS,tumor suppressor function,cell cycle regulation,apoptosis induction,genomic stability maintenance,ubiquitin-mediated protein degradation pathway interaction,dna damage response mechanism involvement
ENSG00000113249,HAVCR1,immune evasion,tumor progression,biomarker potential,pd-1/pd-l1 interaction,suppressed anti-tumor immunity,regulation of t-cell activation
ENSG00000154330,PGM5,glycolytic regulation,tumor aggressiveness,biomarker potential,cell growth promotion,glycogen metabolism,overexpression patterns
ENSG00000164816,DEFA5,tumor suppressor function,downregulation in cancer,cell proliferation regulation,microbial killing activity,protein-protein interaction,akt signaling pathway modulation
ENSG00000171303,KCNK3,potassium channel regulation,cellular proliferation,tumor microenvironment modulation,prognostic biomarker,potassium-dependent signaling,channel-subunit interaction
ENSG00000166035,LIPC,lipid metabolism,cell proliferation,tumor progression,overexpression,biomarker,lipid signaling pathway
ENSG00000150281,CTF1,chromatin remodeling,transcriptional regulation,tumor suppressor interaction,apoptosis evasion,cell cycle progression,oncogenic process facilitation
ENSG00000158815,FGF17,pi3k/akt signaling pathway,cell proliferation,metastasis,prognostic marker,tumor progression,epithelial-to-mesenchymal transition
ENSG00000182871,COL18A1,**

collagen degradation,basement membrane integrity,cell migration facilitation,tumor microenvironment modulation,angiogenesis regulation,extracellular matrix remodeling
ENSG00000170502,NUDT9,genomic instability,base excision repair,oxidative stress,cell cycle regulation,tumor suppression,apoptosis modulation
ENSG00000154080,CHST9,glycosylation,cell proliferation,metastatic potential,cell migration,microenvironment interaction,signaling pathway modulation
ENSG00000145777,TSLP,jak/stat signaling,immune evasion,tumor progression,promotes proliferation,modulates tumor microenvironment,enhances cell survival
ENSG00000054179,ENTPD2,immunomodulation,oncogene potential,immune suppression,cell signaling modulation,tumor microenvironment regulation,biomarker potential
ENSG00000006652,IFRD1,interferon-related developmental regulator 1,tumor suppressor function,cell growth regulation,genomic instability,dna damage repair,protein-protein interactions
ENSG00000162747,FCGR3B,tumor immunosurveillance,immune regulation,cancer immunotherapy,enhanced nk cell activity,t-cell activation,prognostic biomarker
ENSG00000112936,C7,complement activation,tumor progression,immune evasion,cell adhesion regulation,proliferation enhancement,tumor metastasis
ENSG00000169836,TACR3,tumor progression,cell proliferation,oncogene,neuropeptide interaction,g-protein coupled receptor,inflammation modulation
ENSG00000168056,LTBP3,tgf-β pathway modulation,protein-protein interactions,growth factor regulation,cell proliferation enhancement,metastasis promotion,epithelial-to-mesenchymal transition (emt)
ENSG00000169385,RNASE2,cellular response modulation,rna degradation,protein interaction,therapeutic target,oncogenic process,tumor progression
ENSG00000138435,CHRNA1,**
cellular proliferation regulation,apoptosis evasion,downstream signaling pathway activation,nicotinic agonist binding,gene expression alteration,tumor progression acceleration
**
ENSG00000164619,BMPER,bmp interaction,mutation driver,tumor progression,cell adhesion,angiogenesis regulation,signaling pathway dysregulation
ENSG00000014824,SLC30A9,zinc transport,tumor aggressiveness,cell proliferation,cell survival,tumor progression,metastasis inhibition
ENSG00000124157,SEMG2,angiogenesis promotion,cancer progression biomarker,cell adhesion modulation,oncogenic potential,plexin interaction,tumor metastasis facilitation
ENSG00000146477,SLC22A3,multidrug resistance,transport of organic cations,cellular signaling pathways,proliferation regulation,apoptosis modulation,cancer prognosis marker
ENSG00000154734,ADAMTS1,adamts1,extracellular matrix degradation,angiogenesis regulation,vascular endothelial growth factor regulation,tumor progression,cell invasion and migration
ENSG00000038295,TLL1,tumor progression,cell cycle regulation,transcriptional regulator,oncogenic driver,genomic instability,prognostic marker
ENSG00000111341,MGP,tumor progression,metastasis,calcium regulation,phosphate metabolism,signaling pathway modulation,apoptosis inhibition
ENSG00000163536,SERPINI1,tumor suppressor function,epithelial-to-mesenchymal transition inhibition,cell migration regulation,inflammation modulation,proteolytic cascade regulation,poor prognosis association
ENSG00000095303,PTGS1,tumor microenvironment modulation,prostaglandin production regulation,oncogenic progression facilitation,cellular proliferation inhibition,apoptosis induction,host-tumor interaction mediation
ENSG00000106031,HOXA13,tumor suppressor function,transcriptional regulation,cell differentiation,developmental regulation,genomic instability,tumor progression
ENSG00000128714,HOXD13,epithelial-to-mesenchymal transition,cell migration,transcription factor activity,tumor progression,cancer metastasis,proliferation regulation
,MARCH4,ubiquitin ligase activity,protein degradation regulation,cell proliferation enhancement,tumor progression promotion,therapeutic target identification,poor prognosis association
ENSG00000183696,UPP1,mitochondrial function alteration,metabolic regulation modification,cellular metabolism modulation,energy production disruption,cancer cell proliferation enhancement,tumor cell survival promotion
ENSG00000118520,ARG1,arginine metabolism,immunosuppression,cell proliferation,tumor progression,oncogenic interactions,microenvironment modulation
ENSG00000155858,LSM11,spliceosomal complex component,genome stability regulator,cell growth promoter,tumor progression driver,apoptosis inhibitor,cell invasion mediator
ENSG00000176020,AMIGO3,tumor growth promotion,cell adhesion modulation,pi3k/akt/mtor pathway regulation,epithelial-to-mesenchymal transition (emt) regulation,tumor microenvironment modulation,cancer progression association
ENSG00000127533,F2RL3,coagulation regulation,epsin interaction,epithelial-to-mesenchymal transition,migration and invasion,angiogenesis facilitation,tumor progression
ENSG00000171587,DSCAM,tumor progression,cancer cell migration,cell adhesion regulation,immune evasion,tumor aggressiveness,oncogene expression
ENSG00000184588,PDE4B,camp signaling inhibition,gene overexpression,tumor progression,cell proliferation regulation,dysregulation,potential therapeutic target
ENSG00000169306,IL1RAPL1,tumor suppressor function,inflammation regulation,immune evasion mechanisms,cellular proliferation,signaling pathway modulation,protein-protein interactions
ENSG00000163064,EN1,transcriptional regulation,cell fate determination,proliferation regulation,apoptosis modulation,homeobox binding,genetic regulation
ENSG00000135845,PIGC,aberrant expression,glycosylphosphatidylinositol biosynthesis disruption,oncogenic transformation,cell signaling dysregulation,tumor aggressiveness enhancement,cancer stem cell maintenance
ENSG00000102924,CBLN1,oncogenic potential,tyrosine kinase activation,metastasis promotion,g-protein coupled receptor function,neurotransmitter regulation,cell migration facilitation
ENSG00000139899,CBLN3,oncogene,pi3k/akt signaling pathway,promotes cell proliferation,survival regulator,dna repair regulation,apoptosis modulation
ENSG00000047457,CP,cell cycle regulation,oncogenic transformation,apoptosis suppression,tumor suppressor inhibition,cell proliferation enhancement,dna replication facilitation
ENSG00000110756,HPS5,loss-of-function mutations,pro-tumorigenic factor accumulation,oxidative stress regulation,cell proliferation promotion,tumor progression,therapeutic target
ENSG00000179862,CITED4,cell cycle regulation,transcriptional coactivation,oncogenic transcription factors,tumor growth promotion,metastasis facilitation,apoptosis inhibition
ENSG00000175189,INHBC,activin signaling pathway,dysregulation of cell growth,cell proliferation,apoptosis suppression,increased cancer risk,tumor suppressor function
ENSG00000185972,CCIN,cell cycle regulation,oncogenic processes,g1/s phase transition,cdk interaction,tumor progression,genetic instability
ENSG00000184156,KCNQ3,ion channel regulation,cell membrane potential,tumor progression,metastasis,cell proliferation,therapeutic target
ENSG00000117013,KCNQ4,cell migration,cell proliferation,oncogene,pi3k/akt pathway,regulatory mechanism,voltage-gated potassium channel
ENSG00000126266,FFAR1,metabolic reprogramming,lipid metabolism regulation,tumor growth facilitation,energy production facilitation,g protein-coupled receptor function,cancer cell survival enhancement
ENSG00000136816,TOR1B,transcriptional regulation,wnt signaling pathway,cell proliferation,oncogene activation,epigenetic modification,histone acetylation
ENSG00000168878,SFTPB,**
surfactant protein b,epithelial-to-mesenchymal transition,cellular adhesion modulation,tumor suppression,metastasis regulation,genomic instability prevention 
**
ENSG00000160613,PCSK7,pi3k/akt pathway modulation,cell proliferation promotion,apothosis inhibition,tumor growth enhancement,angiogenesis regulation,cancer progression acceleration
ENSG00000168065,SLC22A11,prognostic marker,therapeutic target,chemoresistance,apoptosis regulation,drug transport,cellular response modulation
ENSG00000001617,SEMA3F,angiogenic suppression,anti-tumor activity,endothelial cell regulation,prognostic marker,tumor progression,loss of function mutation
ENSG00000164889,SLC4A2,tumor progression,cancer cell metabolism,cellular acid-base regulation,protein mislocalization,biomarker potential,transmembrane transport
ENSG00000169902,TPST1,protein modification,post-translational regulation,cell growth signaling,oncogenic pathway interaction,tumor progression marker,chemotherapy resistance factor
ENSG00000174600,CMKLR1,lipid metabolism,g-protein coupled receptor,chemotaxis,tumor progression,metastasis promoter,immune response modulation
ENSG00000128294,TPST2,sulfation pathway regulation,epithelial-to-mesenchymal transition,biomarker potential,cell growth modulation,apoptosis regulation,substrate modification
ENSG00000156103,MMP16,tumor progression,extracellular matrix degradation,cell migration,angiogenesis promotion,metastasis facilitation,gene amplification
ENSG00000143669,LYST,cellular morphology regulation,oncogenic processes,aberrant lysosome function,pi3k/akt pathway modulation,autophagy regulation,genomic instability modulation
ENSG00000254550,OMP,cell adhesion disruption,increased motility,cell migration regulation,cancer progression modulation,plasma membrane protein,tumor growth influence
ENSG00000175336,APOF,lipid metabolism regulation,tumor growth promotion,angiogenesis modulation,cell signaling,inflammation modulation,protein-protein interaction
ENSG00000282291,SLC39A11,zinc transport,cell proliferation,pi3k/akt signaling,oncogenesis,tumor aggressiveness,therapeutic target
ENSG00000276858,FCAR,fc receptor-associated protein,immune microenvironment modulation,tumor-infiltrating lymphocytes,regulatory t cells interaction,cell signaling pathway regulation,apoptosis modulation
ENSG00000278533,OSCAR,tumor growth,metastasis promotion,cell proliferation,survival signaling pathway,oncogenic mutation,therapeutic resistance
ENSG00000160882,CYP11B1,steroid hormone biosynthesis,regulatory pathway,glucocorticoid synthesis,tumor microenvironment modification,cancer cell proliferation,aldosterone production
ENSG00000119669,IRF2BPL,tumor progression,genomic instability,dna repair dysfunction,apoptosis suppression,oncogenic signaling,cell proliferation enhancement
ENSG00000151164,RAD9B,cell cycle regulation,genome maintenance,dna damage response,apoptosis induction,tumor progression,cancer therapy resistance
,CARS,overexpression,oncogene,apoptosis regulation,cell proliferation,tumor progression,protein interaction
ENSG00000166206,GABRB3,gabaergic signaling,neurotransmission regulation,proliferation modulation,apoptosis regulation,cellular excitability,neural control mechanisms
ENSG00000203722,RAET1G,immune modulation,tumor suppression,ifn-γ signaling pathway,apoptosis regulation,cell proliferation inhibition,cancer immunoevasion
ENSG00000111981,ULBP1,immunoregulation,apoptosis regulation,nk cell cytotoxicity,immune evasion,tumor immunosuppression,cancer immunity
ENSG00000077327,SPAG6,microtubule regulation,cell migration promotion,aggressive disease phenotypes,oncogenic signaling pathway interaction,tumor progression enhancement,cell motility enhancement
ENSG00000125910,S1PR4,cell migration,tumor progression,metastasis,signal transduction,g protein-coupled receptor activation,upregulation
ENSG00000148154,UGCG,cancer cell survival,glycosphingolipid biosynthesis,sphingolipid metabolism,tumor growth,oncogenic transformation,apoptosis resistance
ENSG00000083807,SLC27A5,lipid metabolism regulation,fatty acid transport,cellular energy homeostasis,apoptosis resistance,protein interaction,fatty acid oxidation modification
ENSG00000121743,GJA3,cell proliferation,gap junctions formation,oncogenic signaling,dna repair disruption,therapeutic target,poor prognosis marker
ENSG00000119888,EPCAM,epcam downregulation,cell-cell adhesion disruption,increased cell migration,metastasis facilitation,tumor progression enhancement,therapeutic target potential
ENSG00000121764,HCRTR1,cellular signaling,oncogenic properties,tumor growth promotion,apoptosis resistance,cell proliferation regulation,g protein-coupled receptor
ENSG00000111537,IFNG,immune response modulation,tumor cell apoptosis,apoptosis induction,cell proliferation inhibition,jak/stat pathway activation,immunotherapy potential
ENSG00000099953,MMP11,**

tumor progression,metastasis induction,extracellular matrix degradation,pro-inflammatory mediator release,cancer cell invasion,poor prognosis marker 
**
ENSG00000163431,LMOD1,cell cycle regulation,cytoskeleton organization,mitotic spindle assembly,oncogene activation,tumor progression,microtubule dynamics
ENSG00000143162,CREG1,tumor progression,overexpression,poor prognosis,cell adhesion modulation,metastasis promotion,basement membrane regulation
ENSG00000196878,LAMB3,tumor progression,cell migration,adhesion molecule regulation,therapeutic target,metastasis promotion,prognostic biomarker
ENSG00000163794,UCN,crf/ucn system,cancer cell proliferation,stress response regulation,tumor progression,tumor aggressiveness,metastatic potential
ENSG00000125966,MMP24,cell adhesion disruption,extracellular matrix degradation,epithelial-to-mesenchymal transition,tumor invasion,poor prognosis,therapeutic target
ENSG00000106086,PLEKHA8,cell-cell adhesion disruption,pi3k/akt signaling pathway regulation,tumor suppressor function,cell migration enhancement,metastasis facilitation,oncogenic signaling modulation
ENSG00000115159,GPD2,cellular metabolism,glycolysis,hypoxia,oncogenic function,protein-protein interaction,tumor aggressiveness
ENSG00000162437,RAVER2,wnt/β-catenin pathway activation,epithelial-to-mesenchymal transition (emt) regulation,transcriptional modulation,oncogenic protein interaction,cell proliferation enhancement,tumor progression association
ENSG00000160321,ZNF208,transcriptional regulation,apoptosis induction,tumor suppressor function,dna damage response,cell proliferation control,cancer progression
ENSG00000022355,GABRA1,gabaergic signaling disruption,epithelial-to-mesenchymal transition regulation,genomic instability promotion,neurotransmission regulation alteration,oncogenic cell survival enhancement,tumor progression facilitation
ENSG00000179546,HTR1D,cell cycle regulation,apoptosis inhibition,g protein-coupled receptor signaling,serotonin binding,receptor overexpression,tumor invasion
ENSG00000165215,CLDN3,altered expression,bladder urothelial cancer,cell polarity disruption,epithelial-to-mesenchymal transition (emt),increased aggressiveness,poor prognosis association
ENSG00000164284,GRPEL2,ras-mapk pathway interaction,oncogenic process promotion,tumor progression,metastasis enhancement,pi3k/akt signaling modulation,cell survival regulation
ENSG00000170367,CST5,tumor suppressor activity,cell proliferation regulation,apoptosis modulation,dna repair mechanism regulation,protein-protein interaction,overexpression association
ENSG00000274542,CHRNA7,cholinergic signaling,prognostic marker,tumor progression,cell proliferation inhibition,apoptosis modulation,receptor activation
ENSG00000124570,SERPINB6,cell survival enhancement,tumor progression facilitation,apoptosis inhibition,cell proliferation regulation,gene overexpression,protease inhibitor function
ENSG00000050767,COL23A1,cell adhesion dysfunction,oncogene activation,tumor progression promotion,metastasis facilitation,cell migration regulation,epithelial-to-mesenchymal transition modulation
ENSG00000116996,ZP4,cell surface protein,oncogene potential,tumor progression,cell growth promotion,metastatic regulation,overexpression association
ENSG00000101246,ARFRP1,gtpase-activating protein function,adp-ribosylation factor-related protein 1 regulation,mtor/akt pathway modulation,cellular membrane trafficking regulation,oncogenic protein interaction,tumor progression enhancement
ENSG00000144278,GALNT13,glycosylation regulation,cell adhesion modulation,tumor progression facilitation,substrate specificity alteration,poor prognosis association,oncogenesis promotion
ENSG00000139574,NPFF,cellular signaling,pi3k/akt pathway interaction,natriuretic peptide regulation,apoptosis modulation,tumor growth promotion,angiogenesis induction
ENSG00000073711,PPP2R3A,pp2a regulation,gain of function mutations,tumor suppressor dephosphorylation,constitutive activation,cell cycle progression,protein interaction modulation
ENSG00000139220,PPFIA2,pi3k/akt pathway,overexpression,tumor progression,therapeutic target,prognostic marker,cell adhesion modulation
ENSG00000196277,GRM7,tumor progression,pi3k/akt pathway activation,g-protein coupled receptor function,overexpression in cancer,metastasis promotion,cell survival enhancement
ENSG00000124493,GRM4,neurotransmitter regulation,cell survival,pi3k/akt pathway modulation,overexpression in cancer,synaptic plasticity,g-protein coupled receptor
ENSG00000113262,GRM6,g-protein coupled receptor,neurotransmission regulation,signal transduction pathway,intracellular calcium modulation,excitatory neurotransmitter release,genetic mutations
ENSG00000185974,GRK1,gpcr regulation,phosphorylation activity,cell proliferation,tumor growth,oncogenic signaling,biomarker potential
ENSG00000038002,AGA,glycosylation,cell adhesion modulation,oncogene activation,tumor progression facilitation,therapeutic target,genomic instability
ENSG00000092929,UNC13D,molecular regulation,tumor progression,cellular fusion,metastasis,protein interaction,genetic instability
ENSG00000163286,ALPG,tumor progression,genomic instability,oncogene activation,metastatic potential,transcriptional regulation,cell proliferation
ENSG00000135740,SLC9A5,epithelial-to-mesenchymal transition (emt),cell migration,na+/h+ exchanger regulation,proton pump activity,cell invasion,receptor interaction
ENSG00000136160,EDNRB,mapk/erk signaling pathway activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,biomarker
ENSG00000158528,PPP1R9A,cell cycle regulation,apoptosis modulation,tumor suppressor interaction,phosphatase substrate specificity,oncogene potential,cancer development
ENSG00000272636,DOC2B,calcium regulation,protein interaction,cell survival promotion,tumor progression,genetic mutations,cancer driver gene
ENSG00000187961,KLHL17,ubiquitination regulation,cyclin-dependent kinase regulation,tumor suppressor interaction,cell cycle modulation,protein degradation pathway,adaptor molecule function
ENSG00000162139,NEU3,oncogene function,glycosylation regulation,prognostic marker,tumor progression,metastasis promotion,therapeutic target
ENSG00000182346,DAOA,metabolic regulation,cellular proliferation,protein activation,neurotransmitter function,gene expression alteration,tumor progression
ENSG00000167346,MMP26,proteolytic activity,tumor progression,extracellular matrix degradation,cell migration,poor prognosis,cancer cell invasion
ENSG00000274129,TSEN34,telomerase activity,aneuploidy,telomere shortening,cell proliferation,genomic instability,protein-protein interactions
ENSG00000213199,ASIC3,proton-gated sodium channel,acid-base homeostasis,overexpression,biomarker prediction,cellular proliferation,metastasis modulation
ENSG00000276068,NAIP,inflammasome activation,adaptive immunity,nf-κb pathway activation,cell proliferation,survival promotion,dna repair modulation
ENSG00000169992,NLGN2,pi3k/akt pathway interaction,cell adhesion regulation,oncogenic potential,tumor cell migration,synaptic transmission modulation,cell proliferation enhancement
ENSG00000116774,OLFML3,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,metastasis promotion,oncogenic signaling activation,upregulated expression levels,protein-protein interaction
ENSG00000100883,SRP54,co-translational translocation,er membrane integration,aberrant protein expression,cell proliferation regulation,oncogene interaction,tumor aggressiveness modulation
ENSG00000122224,LY9,cell cycle regulation,chromatin remodeling,protein-protein interaction,tumor progression,genome stability maintenance,oncogenic protein association
ENSG00000131269,ABCB7,dna repair regulation,genomic stability maintenance,overexpression association,tumor progression correlation,metal ion transport regulation,cancer cell survival enhancement
ENSG00000116032,GRIN3B,nmda receptor signaling,oncogenic transcription factor regulation,tumor aggressiveness,cellular migration and invasion,glucose metabolism dysregulation,cell proliferation enhancement
ENSG00000133937,GSC,chromosomal instability,dna repair regulation,genomic maintenance,tumor suppressor potential,cell cycle regulation,oncogene/tumor suppressor ambiguity
ENSG00000100359,SGSM3,protein regulation,ubiquitination regulation,cell cycle progression,dna repair,apoptosis inhibition,oncogenic activation
ENSG00000137709,POU2F3,pou2f3 binding,oncogene activation,transcriptional regulation,cell proliferation driver,tumor progression mediator,epithelial-to-mesenchymal transition
ENSG00000124568,SLC17A1,vesicular glutamate transporter,glutamate neurotransmitter regulation,tumor progression,cancer stem cell maintenance,cell proliferation,metabolic reprogramming
ENSG00000213402,PTPRCAP,cell adhesion disruption,regulation of growth factor signaling,enhanced cell proliferation,modulation of integrin signaling,tumor immune evasion,constitutive activation mutations
ENSG00000132205,EMILIN2,tumor progression,cell migration,protein-protein interaction,metastatic potential,epithelial-to-mesenchymal transition,overexpression
ENSG00000159212,CLIC6,overexpression,cell proliferation,ion channel activity,oncogenic mechanism,apoptosis regulation,prognostic biomarker
ENSG00000122735,DNAI1,microtubule assembly,motor protein dysfunction,ciliopathy association,genetic instability driver,mitotic spindle regulation,centrosome maintenance error
ENSG00000197632,SERPINB2,tumor suppressor function,protease regulation,cell growth inhibition,apoptosis induction,pi3k/akt pathway interaction,epigenetic silencing
ENSG00000169575,VPREB1,immune evasion,overexpression,poor prognosis,tumor progression,immunoglobulin light chain regulation,b-cell development modulation
ENSG00000163581,SLC2A2,enhanced glucose metabolism,oncogenic adaptation,increased cell proliferation,overexpression,metabolic reprogramming,insulin-independent uptake
ENSG00000079335,CDC14A,cell cycle regulation,tumor progression,genomic instability,protein phosphatase activity,cancer associated mutations,oncogenic potential
ENSG00000115616,SLC9A2,increased expression,alkaline extracellular environment,cell surface localization,oncogenic proliferation,signaling pathway regulation,metastatic progression
ENSG00000171126,KCNG3,tumor suppressor function,downregulated expression,cell cycle regulation,dna repair,signaling pathway modulation,wnt/β-catenin interaction
ENSG00000049089,COL9A2,tumor progression,extracellular matrix interaction,dna damage response,hypoxia regulation,cell migration promotion,tumor metastasis
ENSG00000115596,WNT6,wnt signaling pathway,overexpression,cell proliferation,metastasis,oncogene,genetic alterations
ENSG00000168418,KCNG4,cell proliferation,apoptosis regulation,tumor suppressor,potassium channel regulation,cellular excitability,downregulation association
ENSG00000108684,ASIC2,ph regulation,ion channel activation,tumor migration,cell proliferation,apoptosis evasion,prognostic marker
ENSG00000086848,ALG9,oncogenesis,cellular proliferation,protein glycosylation,lipid biosynthesis,upregulation,tumor growth
ENSG00000146070,PLA2G7,cell membrane modulation,protein-lipid interaction,enzyme regulation,tumor invasion,apoptosis suppression,inflammatory response modulation
ENSG00000198691,ABCA4,lipid metabolism regulation,transcriptional modulation,efflux transporter function,cellular homeostasis maintenance,oncogenic involvement,cancer overexpression
ENSG00000122176,FMOD,cell adhesion disruption,epithelial-to-mesenchymal transition,ectopic expression,angiogenesis regulation,tumor growth promotion,metastasis facilitation
ENSG00000143869,GDF7,oncogene,overexpression,cell proliferation,pi3k/akt pathway,tumor progression,tgf-β superfamily
ENSG00000105668,UPK1A,cellular adhesion disruption,mutation hotspots,tumor aggressiveness increase,proliferation enhancement,apoptosis evasion,epithelial barrier integrity compromise
ENSG00000115112,TFCP2L1,transcription factor regulation,oncogene activation,cell proliferation promotion,apoptosis inhibition,metastasis facilitation,biomarker potential
ENSG00000144837,PLA1A,phospholipid metabolism,lipid signaling pathway,tumor progression,inflammatory response,cell proliferation,oncogenic interaction
ENSG00000103723,AP3B2,cell migration,tumor progression,metastasis promotion,protein sorting regulation,lysosomal function,pi3k/akt pathway interaction
ENSG00000135617,PRADC1,genomic instability,dna damage response,cell proliferation,transcriptional regulation,tumor suppression,chromatin remodeling
ENSG00000196954,CASP4,apoptosis regulation,dna damage response,oxidative stress modulation,tumor growth promotion,nf-κb pathway interaction,programmed cell death
ENSG00000095397,WHRN,mechanotransduction regulation,protein-protein interactions,scaffolding function,tumor progression,metastasis facilitation,genetic instability
ENSG00000185437,SH3BGR,tumor suppressor function,sh3 domain-containing protein,genomic instability,cellular process regulation,apoptosis regulation,dna repair pathway interaction
ENSG00000153246,PLA2R1,tumor progression,cell proliferation,metastasis promoter,inflammation regulation,signaling pathway modulation,receptor function
ENSG00000169340,PDILT,er chaperone system,protein folding and maturation,cellular growth and differentiation,survival pathways,cancer aggressiveness marker,poor prognosis indicator
ENSG00000142173,COL6A2,tumor progression,cell adhesion disruption,extracellular matrix remodeling,pi3k/akt pathway activation,growth factor regulation,microfibril-associated glycoprotein complex formation
ENSG00000165970,SLC6A5,taurine transport,cell growth regulation,oncogenic pathway inhibition,tumor suppressor function,cellular proliferation modulation,pi3k/akt signaling interaction
ENSG00000164953,TMEM67,ciliogenesis,cellular stress response,stemness maintenance,proliferation regulation,tumor growth promotion,cancer cell survival enhancement
ENSG00000163285,GABRG1,gaba receptor activation,oncogene potential,subunit assembly,cell proliferation regulation,epigenetic modification,receptor-ligand interaction
ENSG00000152932,RAB3C,rab gtpase function,exocytosis regulation,cell proliferation enhancement,membrane trafficking modulation,oncogenic progression promotion,prognostic biomarker potential
ENSG00000157150,TIMP4,tumor suppressor,tissue inhibitor of metalloproteinases,mmp-2 inhibition,proteolysis regulation,cell growth modulation,cancer progression
ENSG00000064666,CNN2,cellular adhesion,cytoskeletal regulation,muscle contraction,microtubule dynamics,oncogenic driver,tumor invasion
ENSG00000120068,HOXB8,oncogene activity,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation regulation,transcriptional modulation,wnt/β-catenin pathway interaction
ENSG00000106341,PPP1R17,**
protein phosphatase 1 regulation,tumor suppressor interaction,cell cycle modulation,apoptosis inhibition,metastasis promotion,genomic instability 
**
ENSG00000060718,COL11A1,type ii collagen,extracellular matrix,tumor progression,metastasis,aggressive disease characteristics,epigenetic modifications
ENSG00000179914,ITLN1,lipid metabolism regulation,tumor progression,cellular differentiation,protein localization,epithelial cell expression,oncogenic processes
ENSG00000124257,NEURL2,tumor suppressor function,cell proliferation regulation,apoptosis induction,transcriptional repression,cell growth inhibition,protein-protein interaction
ENSG00000150394,CDH8,altered expression,cell adhesion disruption,genomic instability,tumor progression,cancer cell invasion,signal transduction involvement
ENSG00000105996,HOXA2,oncogenic function,overexpression,cell proliferation,apoptosis inhibition,transcriptional regulation,poor prognosis
ENSG00000005073,HOXA11,emt induction,cancer cell invasion,cell cycle progression regulation,epithelial-to-mesenchymal transition,transcriptional repression,oncogene overexpression
ENSG00000264424,MYH4,cell motility,constitutive activation,epithelial-to-mesenchymal transition,overexpression,tumor progression,motor protein function
ENSG00000133454,MYO18B,regulation of cytoskeleton dynamics,constitutive activation,cell migration and invasion,promoter of tumor progression,gene mutations driving tumorigenesis,mitotic spindle formation
ENSG00000109424,UCP1,mitochondrial uncoupling,thermogenic function,energy expenditure regulation,lipolysis and thermogenesis,cell metabolism modulation,genomic expression profiling
ENSG00000123838,C4BPA,regulation of complement system,overexpression in cancer tissues,cell adhesion signaling,immune response modulation,protein-protein interaction,cancer prognosis association
ENSG00000166033,HTRA1,tumor suppression,apoptosis regulation,cell cycle progression,genomic stability maintenance,iap degradation,tumor progression inhibition
ENSG00000170425,ADORA2B,adenosine receptor activation,immune response modulation,apoptosis suppression,cell growth promotion,genetic aberration,tumor progression
ENSG00000125798,FOXA2,**

* **epithelial-to-mesenchymal transition (emt) regulator**,* **transcription factor dysregulation**,* **cellular differentiation disruption**,* **apoptosis inhibition**,* **proliferation enhancement**,* **downstream signaling pathway modulation**
ENSG00000164778,EN2,transcriptional regulation,epithelial cell development,oncogene potential,cell growth modulation,overexpression in cancer,wnt/β-catenin pathway interaction
ENSG00000081842,PCDHA6,cell surface adhesion,neural connectivity regulation,tumor overexpression,cell proliferation enhancement,signaling pathway interaction,cell migration promotion
ENSG00000104899,AMH,epithelial differentiation,tissue-specific expression,growth factor regulation,apoptosis inhibition,molecular marker,ovarian development
ENSG00000163382,NAXE,dna repair deficiency,genomic instability,nucleotide excision repair,oncogenesis,genetic alterations,protein overexpression
ENSG00000112293,GPLD1,cellular metabolism,glycosylphosphatidylinositol-specific phospholipase d,cell growth regulation,pi3k/akt signaling pathway,tumor progression promoter,cell proliferation enhancement
ENSG00000147437,GNRH1,cell proliferation,mutation/amplification,g-protein coupled receptor signaling,tumor progression,pi3k/akt/mtor pathway activation,overexpression
ENSG00000134443,GRP,cellular proliferation,angiogenesis promotion,dna repair regulation,tumor progression,biomarker potential,secreted protein function
,ELOA3,ubiquitin-proteasome pathway regulation,cell cycle regulation,dna repair mechanisms,oncogenic pathways,tumor development,genetic alterations
ENSG00000104918,RETN,retinol transport,cell proliferation,angiogenesis,tumor progression,oncogene,growth factor regulation
ENSG00000164061,BSN,cell adhesion regulation,cytoplasmic localization,epithelial-to-mesenchymal transition,focal adhesions modulation,morphology regulation,cell motility control
ENSG00000134265,NAPG,chromatin remodeling,genomic instability,cell cycle regulation,dna repair,tumor suppressor function,protein-protein interaction
ENSG00000135902,CHRND,neurotransmitter regulation,chromosomal alterations,limited evidence of oncogenic mechanism,implicated in tumorigenesis,unknown role in blca,synaptic transmission regulation
ENSG00000129744,ART1,tumor microenvironment modulation,cell proliferation enhancement,immune evasion facilitation,angiogenesis promotion,therapeutic target,genomic profiling
ENSG00000280477,RASA3,rho-type gtpase regulation,tumor progression,cell migration,adhesion dysregulation,cytoskeletal organization,signaling pathway modulation
ENSG00000127472,PLA2G5,lipid metabolism regulation,oncogenic potential,cell proliferation enhancement,signal transduction activation,tumor aggressiveness promotion,therapeutic target
ENSG00000114200,BCHE,altered expression,biomarker potential,cellular signaling modulation,enzymatic activity alteration,neurotransmission regulation,prognostic marker
ENSG00000281151,KCNQ2,ion channel regulation,potassium channel function,cell cycle regulation,apoptosis modulation,tumor microenvironment regulation,neuronal excitability regulation
ENSG00000278444,CDC42EP5,rho gtpase activation,cell migration,actin cytoskeleton dynamics,membrane trafficking regulation,tumor progression,chemotherapy resistance
ENSG00000111186,WNT5B,aberrant wnt signaling,cell proliferation regulation,emt induction,therapeutic target,wnt/β-catenin pathway activation,tumor progression enhancement
ENSG00000116703,PDC,apoptosis modulation,extrinsic pathway regulation,cell survival promotion,tumor progression association,prognostic biomarker,casapse 8 interaction
ENSG00000128713,HOXD11,hoxd11 regulates cell growth,upregulation in tumors,wnt/β-catenin pathway,oncogene potential,increased cell proliferation,cell migration and invasion
ENSG00000102854,MSLN,cell adhesion regulation,dysregulated expression,immune response modulation,tumor progression,therapeutic target,proliferation promotion
ENSG00000177098,SCN4B,tumor progression,cell cycle regulation,apoptosis evasion,angiogenesis promotion,signaling pathway modulation,ion channel regulation
ENSG00000168267,PTF1A,transcriptional regulation,cell proliferation,overexpression,tumor progression,malignant transformation,developmental pathway disruption
ENSG00000197891,SLC22A12,oncogene activation,chemotherapy resistance,platinum-based therapy evasion,aggressive tumor phenotype,overexpression,biomarker for treatment response
ENSG00000079482,OPHN1,tumor progression,metastasis driver,signaling pathway activation,cell adhesion modulation,oncogenic potential,prognostic marker
ENSG00000173702,MUC13,cell proliferation,tumor microenvironment modulation,tumor progression,epithelial integrity maintenance,glycoprotein function,cell migration promotion
ENSG00000132424,PNISR,regulation of endocytosis,receptor tyrosine kinase activation,oncogenic protein interactions,tumor progression,aberrant signal transduction,therapeutic target
ENSG00000177946,CENPBD1,centromere regulation,chromosome instability,aneuploidy,cell cycle progression disruption,mitotic checkpoint control,genomic instability
ENSG00000115425,PECR,nucleotide pool regulation,purine nucleoside phosphorylase,metabolic reprogramming,tumor cell survival,dna replication regulation,gene expression modulation
ENSG00000112541,PDE10A,tumor progression,therapeutic target,intracellular signaling regulation,cyclic nucleotide phosphodiesterase activity,oncogenic process involvement,cellular proliferation modulation
ENSG00000189180,ZNF33A,transcriptional regulation,tumor suppression,cell cycle control,apoptosis induction,gene expression modulation,prognostic marker
ENSG00000125861,GFRA4,overexpression,cell proliferation,epithelial-to-mesenchymal transition,immune evasion,poor prognosis biomarker,signaling pathway activation
ENSG00000125650,PSPN,tumor progression,proteolytic activity regulation,oncogenic processes,cell invasion and metastasis,therapeutic target,biomarker candidate
ENSG00000184956,MUC6,cell proliferation,overexpression,pi3k/akt pathway,apoptosis inhibition,epithelial-to-mesenchymal transition (emt),cell adhesion modulation
ENSG00000138356,AOX1,biomarker potential,cellular metabolism modulation,oxidative stress reduction,dna repair pathway interaction,cancer progression facilitation,detoxification enzyme function
ENSG00000169231,THBS3,angiogenesis regulation,tumor progression facilitation,cell adhesion modulation,therapeutic target candidate,extracellular matrix regulation,immune response modulation
ENSG00000154478,GPR26,g-protein coupled signaling,tumor progression,promotes cell proliferation,survival pathway alterations,cellular signaling modulation,therapeutic target
ENSG00000012174,MBTPS2,**
cellular proliferation,androgen receptor signaling pathway modulation,transcriptional regulation,corepressor/coactivator function,tumor suppressor gene dysregulation,genomic instability
**
ENSG00000185760,KCNQ5,tumor suppressor function,cell proliferation regulation,apoptosis modulation,oncogenic process contribution,pi3k/akt pathway interaction,genomic deletion/mutation
ENSG00000137975,CLCA2,cellular adhesion,epithelial-to-mesenchymal transition,migration and invasion,oncogene potential,pi3k/akt pathway interaction,prognostic marker
ENSG00000171812,COL8A2,basement membrane degradation,cell migration,metastasis promotion,extracellular matrix remodeling,collagen overexpression,tumor progression
ENSG00000086189,DIMT1,dna repair,epigenetic regulation,genomic stability,cell proliferation,oxidative damage repair,protein-protein interaction
ENSG00000086062,B4GALT1,overexpression,cell proliferation,glycosylation modification,tumor progression,oncogenic signaling,poor prognosis
ENSG00000169427,KCNK9,potassium channel regulation,cell proliferation,ion balance dysregulation,apoptosis resistance,tumor progression,cancer driver gene
ENSG00000148965,SAA4,tumor progression,tumor metastasis,cell proliferation suppression,apoptosis suppression,pi3k/akt pathway activation,inflammatory response modulation
ENSG00000115665,SLC5A7,glycolytic metabolism,lactate transporter,tumor growth promoter,metabolic regulation,energy homeostasis regulator,hypoxia adaptation
ENSG00000160951,PTGER1,cell growth,constitutive activation,g-protein coupled receptor,prostaglandin signaling,tumor progression,transcriptional regulation
ENSG00000198598,MMP17,tumor progression,cell migration,extracellular matrix degradation,signaling pathway regulation,oncogene potential,therapeutic target
ENSG00000143199,ADCY10,oncogenic processes,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000179097,HTR1F,g-protein coupled receptor,cell proliferation regulation,apoptosis modulation,angiogenesis regulation,serotonin signaling pathway,tumor suppressor/ oncogene
ENSG00000134438,RAX,regulation of cell proliferation,transcription factor activity,oncogene activation,cell migration and invasion,pi3k/akt pathway modulation,tumor initiation and progression
ENSG00000101346,POFUT1,pofut1 overexpression,glycosylation regulation,tumor progression,cell migration,oncogenic transformation,protein modification
ENSG00000188517,COL25A1,tumor progression,cell migration,cell invasion,extracellular matrix modulation,adhesion molecule regulation,metastatic potential
ENSG00000167748,KLK1,tumor aggressiveness,proteolytic cascades activation,cell migration facilitation,extracellular matrix modulation,bioactive peptide generation,therapeutic target
ENSG00000109743,BST1,tumor-immune evasion,immune suppression,metastasis promotion,prognostic marker,cell surface protein,cancer-associated gene expression
ENSG00000101938,CHRDL1,wnt/β-catenin signaling pathway,tumor suppressor function,gene expression regulation,cancer progression,cell proliferation regulation,dysregulated gene expression
ENSG00000121281,ADCY7,overexpression,hyperactivation,camp signaling,proliferation,mutation,signaling molecule
ENSG00000197093,GAL3ST4,oncogenic processes,cell proliferation,tumor metastasis,glycosylation regulation,cell cycle progression,therapeutic target
ENSG00000175785,PRIMA1,cell cycle regulation,tumor suppressor activity,apoptosis induction,dna repair pathway,genomic instability,therapeutic target
ENSG00000101190,TCFL5,oncogene,tumor progression,cell proliferation,apoptosis inhibition,transcriptional regulation,wnt/β-catenin pathway interaction
ENSG00000168743,NPNT,tumor progression,promotes cell adhesion,regulates pi3k/akt pathway,enhances metastasis,cell proliferation and invasion,biomarker for diagnosis
ENSG00000137221,TJAP1,adherens junction regulation,epithelial-to-mesenchymal transition,cell invasion facilitation,tumor suppressor function,cell surface dynamics regulation,overexpression association
ENSG00000116675,DNAJC6,cellular regulation,chaperone function,cell cycle progression,anti-apoptotic activity,tumor growth promotion,poor prognosis marker
ENSG00000154162,CDH12,tumor suppression,cell adhesion disruption,homophilic interactions,cell migration enhancement,metastasis facilitation,genetic alteration associated
ENSG00000187017,ESPN,loss of adhesion,gain of invasive properties,cell migration,tumor progression,apoptosis inhibition,signal transduction alterations
ENSG00000139269,INHBE,tgf-β signaling pathway disruption,cell growth regulation disruption,aggressive tumor behavior association,poor prognosis marker,aberrant cell differentiation,signaling pathway imbalance
ENSG00000126231,PROZ,overexpression,tumor progression,protein-protein interaction,cell proliferation regulation,apoptosis modulation,genomic instability
ENSG00000179091,CYC1,cellular respiration,metabolic regulation,tumor growth,cell proliferation,mitochondrial function,aerobic metabolism
ENSG00000100665,SERPINA4,cellular proliferation,protease inhibition disruption,epithelial cell regulation,tumor progression enhancement,gene expression dysregulation,therapeutic target potential
ENSG00000177511,ST8SIA3,glycosyltransferase activity,cell-cell interactions,altered glycosylation patterns,cancer progression,poor prognosis marker,tumorigenesis driver
ENSG00000113532,ST8SIA4,cell surface glycoproteins,altered glycosylation patterns,tumor progression,metastasis facilitation,glycoconjugate synthesis regulation,therapeutic target
ENSG00000140557,ST8SIA2,enhanced sialylation,glycosylation pattern modification,tumor progression,metastasis promotion,chemotherapy resistance,cell surface alteration
ENSG00000162545,CAMK2N1,tumor suppressor,cell proliferation,apoptosis regulation,protein kinase activation,camk signaling pathway,overexpression associated
ENSG00000184302,SIX6,transcriptional regulation,constitutive activation,oncogenic activity,cell proliferation,epithelial-to-mesenchymal transition,stemness regulation
ENSG00000110080,ST3GAL4,sialylated glycoproteins,glycosylation pathway,cell-cell interaction,oncogenic potential,golgi apparatus localization,post-translational regulation
ENSG00000125813,PAX1,transcription regulation,epithelial-to-mesenchymal transition (emt),cell differentiation,oncogenic potential,poor prognosis marker,heterogeneous expression
ENSG00000163785,RYK,cell migration,emt induction,pi3k/akt activation,wnt/β-catenin interaction,notch pathway modulation,tumor progression
ENSG00000135678,CPM,genomic instability,tumor progression,dna repair regulation,fanconi anemia pathway interaction,cell cycle checkpoint modulation,icl repair dysfunction
ENSG00000185033,SEMA4B,angiogenesis regulation,cell-cell interaction,cancer progression,immune evasion,metastasis promotion,therapeutic target
ENSG00000182580,EPHB3,loss of function mutations,epithelial-to-mesenchymal transition,cell migration regulation,tumor progression,prognostic marker,cell adhesion disruption
ENSG00000141574,SECTM1,epithelial-to-mesenchymal transition (emt),hypoxia adaptation,tumor progression,metastasis promotion,proliferation enhancement,cell adhesion disruption
ENSG00000112249,ASCC3,loss of tumor suppressor function,cell cycle regulation,transcriptional regulation,apoptosis induction,genomic instability,prognostic biomarker
ENSG00000127074,RGS13,g-protein regulation,oncogenic processes,poor prognosis,overexpression,tumor growth,downstream effectors
ENSG00000180875,GREM2,tumor suppression,overexpression,tgf-β signaling regulation,emt suppression,cellular differentiation inhibition,metastasis prevention
ENSG00000114982,KANSL3,histone lysine methylation,chromatin remodeling,epigenetic regulation,oncogenic transcriptional activation,histone h4 modification,tumor progression
ENSG00000169313,P2RY12,proliferation promotion,tumor cell migration,inflammation modulation,signaling pathway activation,cell survival enhancement,metastasis facilitation
ENSG00000172009,THOP1,chromatin remodeling,genomic instability,epigenetic regulation,dna repair mechanisms,cell cycle regulation,transcriptional modulation
ENSG00000104921,FCER2,cell proliferation,immune response modulation,signal transduction pathway,tumor growth promotion,protein kinase activation,angiogenesis regulation
ENSG00000205810,KLRC3,immune surveillance,cytolytic function,tumor antigen recognition,nk cell activation,mhc class i binding,cancer immunotherapy target
ENSG00000133116,KL,proteolytic activation,cell proliferation,apoptosis inhibition,extracellular matrix degradation,tumor progression,tissue invasion
ENSG00000096006,CRISP3,tumor progression,angiogenesis inhibition,immune evasion,pro-survival pathway activation,apoptosis suppression,cell growth regulation
ENSG00000186074,CD300LF,immune regulation,tumor suppression,cell growth regulation,signaling pathway modulation,protein interaction,tumor metastasis inhibition
ENSG00000275099,GGNBP2,tumor progression,cell growth modulation,oncogenesis promoter,apoptosis resistance,metastasis regulation,galectin interaction
ENSG00000172794,RAB37,**

membrane trafficking regulation,constitutive activation downstream pathways,cellular migration enhancement,tumor progression promotion,microtubule-associated protein interaction,ras superfamily member expression
ENSG00000152266,PTH,pth/ptr1 signaling pathway,oncogenic driver,bone metastasis,nf-κb activation,erk1/2 phosphorylation,tumor growth promotion
ENSG00000127124,HIVEP3,immune modulation,transcriptional regulation,cell proliferation,poor prognosis association,tumor progression,co-regulation of gene expression
ENSG00000164035,EMCN,angiogenesis promotion,cell migration enhancement,epithelial-to-mesenchymal transition (emt),prognostic marker,tumor progression facilitation,vascular remodeling
ENSG00000114631,PODXL2,cell adhesion disruption,angiogenesis promotion,tumor microenvironment modulation,prognostic marker,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000105472,CLEC11A,apoptosis regulation,cell adhesion modulation,immune response modulation,tumor progression,gene expression alteration,oncogene/tumor suppressor activity
ENSG00000101890,GUCY2F,cgmp production,cell survival,angiogenesis,signal transduction,membrane-bound enzyme,tumorigenesis
ENSG00000158887,MPZ,cell adhesion,cell proliferation,wnt/beta-catenin pathway,solid tumors,genetic alterations,proliferation regulation
ENSG00000244486,SCARF2,tumor suppressor function,cell cycle regulation,pi3k/akt pathway modulation,dna damage response,protein-protein interaction,cancer cell proliferation suppression
ENSG00000134258,VTCN1,immune suppression,cell growth regulation,tumor progression,oncogenesis driver,cancer immunity evasion,protein-protein interaction
ENSG00000088827,SIGLEC1,tumor progression,cell adhesion modulation,prognostic marker,cell migration enhancement,oncogenic pathway interaction,tumor cell survival promotion
ENSG00000119523,ALG2,n-glycosylation pathway disruption,glycoprotein synthesis regulation,tumor cell invasion facilitation,cell growth promotion,apoptosis inhibition,oncogenic signaling pathway modification
ENSG00000170175,CHRNB1,cell proliferation,oncogene,tumor aggressiveness,poor prognosis,neurotransmission regulation,ligand-gated ion channel
ENSG00000104755,ADAM2,cell adhesion disruption,metalloprotease activity,tumor progression driver,cancer cell invasion,oncogenic signaling pathway,transmembrane protein expression
ENSG00000074803,SLC12A1,ion balance regulation,cell migration,electrolyte reabsorption,epithelial-to-mesenchymal transition,tumor suppressor regulation,therapeutic target
ENSG00000139998,RAB15,rab15 overexpression,endocytic pathway regulation,cell migration and invasion,oncogenic driver,prognostic marker,tumor progression
ENSG00000105697,HAMP,iron regulation,epithelial-to-mesenchymal transition (emt),metabolic regulation,proliferation,survival pathways,tumor microenvironment
ENSG00000109991,P2RX3,purinergic signaling,tumor growth promotion,cell migration enhancement,prognostic biomarker,pi3k/akt pathway activation,metastasis facilitation
ENSG00000141527,CARD14,tumor progression,loss-of-function mutations,cytoskeletal regulation,pro-inflammatory signaling,cell proliferation,nf-κb pathway activation
ENSG00000134762,DSC3,cell-cell adhesion,epithelial integrity,apoptosis regulation,tumor progression,mutations in cancer,gene expression regulation
ENSG00000160111,CPAMD8,cell cycle regulation,oncogenic protein accumulation,ubiquitination pathway,apoptosis pathway modulation,cancer stem cell maintenance,therapeutic target
ENSG00000187094,CCK,cancer driver role,altered expression,cell growth regulation,proliferation influence,tumor progression contribution,signaling pathway modulation
ENSG00000185149,NPY2R,neuropeptide regulation,cell proliferation,tumor metastasis,vasoconstriction modulation,receptor overexpression,signaling pathway activation
ENSG00000075223,SEMA3C,tumor suppressor function loss,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition induction,metastasis promotion,oncogenic pathway activation,cell adhesion disruption
ENSG00000165949,IFI27,dna damage response,apoptosis inhibition,rna stabilization,stress response modulation,tumor cell survival,oncogene overexpression
ENSG00000115705,TPO,tumor progression,dna damage repair,oxidative stress regulation,apoptosis inhibition,cell proliferation enhancement,immune response modulation
ENSG00000161298,ZNF382,chromatin regulation,oncogenic function,cell proliferation,epithelial-to-mesenchymal transition (emt),transcriptional regulation,dna repair
ENSG00000164509,IL31RA,cytokine signaling,cell proliferation enhancement,oncogenic role,immune modulation,inflammatory response regulation,therapeutic target
ENSG00000091536,MYO15A,amplification,cell migration,actin cytoskeleton regulation,oncogenic driver,pi3k/akt pathway activation,therapeutic target
ENSG00000166825,ANPEP,enhanced proteolytic activity,promotion of metastasis,upregulation in tumor tissues,cell adhesion modulation,tumor progression facilitation,diagnostic/prognostic marker potential
ENSG00000183607,GKN2,cell adhesion regulation,tumor suppression,growth inhibition,apoptosis induction,prognostic biomarker,cell proliferation regulation
ENSG00000125820,NKX2-2,transcriptional regulation,oncogenic transcription factor,cell proliferation enhancement,immune evasion facilitation,epithelial-to-mesenchymal transition,poor prognosis association
ENSG00000136982,DSCC1,tumor progression,cancer cell invasion,cell adhesion modulation,dysregulated expression,oncogenic role,adhesion molecule interaction
ENSG00000122678,POLM,dna repair,genomic stability,non-homologous end joining (nhej) pathway,polymerase mu activity,tumorigenesis,chromosomal instability
ENSG00000183671,GPR1,g protein-coupled receptor activation,cell proliferation regulation,signaling pathway modulation,tumor aggressiveness,cell survival promotion,transcriptional regulation
ENSG00000116785,CFHR3,complement system regulation,immune evasion,cell proliferation regulation,prognostic marker,tumor suppressor dysfunction,genetic amplification
ENSG00000138771,SHROOM3,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway,tumor progression,metastasis,therapeutic target,driver mutation
ENSG00000128322,IGLL1,immune system dysregulation,antibody production,immunoglobulin assembly,tumor microenvironment modulation,immune evasion,cellular function maintenance
ENSG00000108091,CCDC6,microtubule regulation,aneuploidy promotion,dna replication enhancement,cell cycle progression oncogenesis,tumor suppressor loss,therapeutic target identification
ENSG00000008516,MMP25,tumor invasion,cellular migration,cell survival,extracellular matrix degradation,mitochondrial interaction,oncogenic signaling
ENSG00000139132,FGD4,rab gtpase regulation,gef activity increase,endosomal trafficking disruption,oncogenic signaling pathway activation,tumor cell proliferation enhancement,therapeutic target for cancer treatment
ENSG00000164266,SPINK1,trypsin inhibition,oncogenic processes,cell survival enhancement,pi3k/akt pathway interaction,tumor progression association,biomarker potential
ENSG00000147647,DPYS,**
genomic instability,dna damage response,pyrimidine degradation,enzyme dysregulation,potential oncogene,metabolic pathway disruption
**
ENSG00000197696,NMB,neurotrophic factor activation,cell proliferation promotion,metastasis facilitation,signaling pathway modulation,oncogenic potential,receptor interaction
ENSG00000179943,FIZ1,cell adhesion,oncogene,overexpression,prognostic marker,tumor aggressiveness,therapeutic target
ENSG00000006116,CACNG3,calcium channel regulation,tumor progression,cell migration,biomarker candidate,calmodulin-dependent kinase ii activation,pi3k/akt pathway modulation
ENSG00000185559,DLK1,pi3k/akt/mtor pathway,oncogenic potential,cellular metabolism regulation,gene expression regulation,cancer cell proliferation,metabolic reprogramming
ENSG00000168702,LRP1B,tumor suppressor,oncogene,cell migration,wnt/β-catenin pathway,prognostic marker,loss-of-function mutations
ENSG00000238289,MICB,antigen presentation,tumor progression,immune evasion,prognostic marker,cell death regulation,cancer immunotherapy
ENSG00000136457,CHAD,tumor metabolism,cell growth regulation,apoptosis sensitivity,genetic mutations,enzyme regulation,oncogenesis promotion
ENSG00000243480,AMY2A,metabolic regulation,oncogenesis,cell migration,metastasis,enzymatic activity,molecular chaperone function
ENSG00000021355,SERPINB1,apoptosis inhibition,cell migration enhancement,endogenous inhibitor function,genomic instability association,metastasis promotion,tumor progression facilitation
ENSG00000054803,CBLN4,cell surface adhesion,synaptic plasticity,neuronal communication,cellular signaling pathway,tissue architecture disruption,cancer cell invasion
ENSG00000026559,KCNG1,ion channel regulation,cancer cell proliferation,cell survival pathways,cellular excitability modulation,potassium balance regulation,tumor suppressor function interaction
ENSG00000178342,KCNG2,ion channel regulation,potassium channel subunit,oncogene overexpression,cell proliferation,tumor survival,cell membrane modulation
ENSG00000177981,ASB8,ankyrin repeat domain,cell cycle regulation,tumor suppressor function,apoptosis modulation,dna damage response,protein ubiquitination
ENSG00000100312,ACR,mitochondrial membrane potential regulation,cancer-associated mutations,cellular respiration enhancement,energy metabolism modulation,tumor growth promotion,therapeutic target
ENSG00000257594,GALNT4,oncogene activation,glycoprotein modification,cell adhesion regulation,tumor progression,therapeutic target,epigenetic regulation
ENSG00000108556,CHRNE,cellular signaling,genetic mutation,neurotransmission regulation,oncogenesis role,subunit of nachr,tumor progression
ENSG00000138792,ENPEP,tumor progression,proteolytic activity,cell survival regulation,gene expression modulation,tumor aggressiveness,aberrant expression
ENSG00000112246,SIM1,transcriptional regulation,cellular differentiation,oncogene overexpression,tumor progression,gene expression modulation,signaling pathway interaction
ENSG00000139178,C1RL,complement activation,immune evasion,tumor microenvironment,immunosuppression,oncogenic potential,cell proliferation
ENSG00000110721,CHKA,cell metabolism alteration,tumor progression marker,apoptosis regulation,energy metabolism dysregulation,warburg effect activation,proliferation enhancement
ENSG00000124205,EDN3,angiogenic signaling pathway,gain of function mutations,tumor progression,therapeutic target,protein-protein interactions,cell proliferation
ENSG00000112619,PRPH2,altered expression,cell migration,disrupted adhesion,epithelial-to-mesenchymal transition (emt),oncogenic signaling,regulatory dysfunction
ENSG00000149403,GRIK4,glur kainate receptor,pi3k/akt signaling pathway,glutamate excitatory neurotransmission,tumor cell proliferation,survival pathways modulation,upregulated expression
ENSG00000159307,SCUBE1,wnt/β-catenin pathway activation,oncogenic signaling,cell growth promotion,angiogenesis regulation,tumor progression facilitation,therapeutic target potential
ENSG00000175356,SCUBE2,tumor progression,metastasis regulation,cell migration regulation,protein-protein interactions,oncogenic potential,genomic alterations
ENSG00000156853,ZNF689,transcriptional regulation,chromatin remodeling,cell proliferation,apoptosis evasion,tumor suppressor function,oncogenic properties
ENSG00000118733,OLFM3,epithelial-to-mesenchymal transition (emt),overexpression,biomarker potential,cancer progression,cell adhesion,migration and invasion
ENSG00000188613,NANOS1,mrna stability regulation,tumor suppressor function,cell cycle control,apoptosis modulation,oncogenic process promotion,metastasis enhancement
,DAZ3,cell cycle regulation,rna binding protein,germ cell development,oncogenic properties,proliferation enhancement,cell survival pathway
ENSG00000171246,NPTX1,nptx1 modulation,cellular proliferation,genomic alterations,signaling pathway interaction,therapeutic target,protein-protein interaction
ENSG00000124374,PAIP2B,cellular regulation,oncogenic signaling,transcriptional modulation,mrna stability,apoptosis resistance,tumor growth enhancement
ENSG00000159184,HOXB13,androgen receptor regulation,oncogene activation,transcriptional modulation,tumor progression,metastasis driver,poor prognosis marker
ENSG00000241563,CORT,cellular growth enhancement,cancer cell survival,oncogene activation,microrna regulation,metabolic adaptation,steroid hormone biosynthesis disruption
ENSG00000183067,IGSF5,cell adhesion,epithelial-to-mesenchymal transition (emt),cell migration and invasion,pi3k/akt signaling pathway,prognostic biomarker,tumor progression
ENSG00000028203,VEZT,tumor progression,oncogene role,cell adhesion modulation,e-cadherin regulation,pi3k/akt pathway interaction,metastasis promotion
ENSG00000132465,JCHAIN,tumor progression,pro-inflammatory response,innate immune system,acute phase protein,tumor microenvironment,oncogenic potential
ENSG00000158488,CD1E,antigen presentation,apoptosis regulation,cell signaling pathway modulation,immune microenvironment modulation,oncogenesis involvement,tumor antigen recognition
ENSG00000115598,IL1RL2,**

immunosuppression,tumor microenvironment modulation,pro-inflammatory cytokine regulation,immune evasion mechanisms,cell proliferation enhancement,signal transduction modulation 

**
ENSG00000140015,KCNH5,potassium channel regulation,cell proliferation regulation,tumor progression,oncogenesis,genomic alterations,ion transport
ENSG00000102539,MLNR,mapk/erk signaling pathway,gene amplification,cell proliferation,tumor aggressiveness,therapeutic target resistance,prognostic marker
ENSG00000106128,GHRHR,enhanced proliferation,cell survival pathways,tumor aggressiveness,metastatic potential,therapeutic target,aberrant expression
ENSG00000136487,GH2,gh regulation,proliferation regulation,cell survival pathways,pi3k/akt/mtor modulation,angiogenesis regulation,metastasis promotion
ENSG00000136697,IL1F10,tumor microenvironment modification,inflammation regulation,apoptosis suppression,cell proliferation enhancement,immune evasion promotion,stat3/nf-κb pathway interaction
ENSG00000227357,HLA-DRB4,antigen presentation,immune evasion,tumor progression,cell signaling regulation,apoptosis modulation,inflammation regulation
ENSG00000176919,C8G,hypothetical protein,uncharacterized function,cell growth regulation,dysregulated expression,aberrant cellular pathway,potential oncogene
ENSG00000137252,HCRTR2,cell proliferation,steroid hormone regulation,tumor progression,constitutive activation,epithelial-to-mesenchymal transition,transcriptional regulation
ENSG00000244414,CFHR1,complement regulation,tumor cell growth,immune evasion,cell survival,proliferation regulation,apoptosis resistance
ENSG00000154736,ADAMTS5,tumor progression,cell adhesion regulation,extracellular matrix degradation,therapeutic target,proteoglycan cleavage,tgf-β modulation
ENSG00000185518,SV2B,calcium channel modulation,cell proliferation,oncogenic signaling,tumor progression,poor prognosis marker,therapeutic target
ENSG00000102349,KLF8,regulation of cell proliferation,oncogene activity,epithelial-to-mesenchymal transition (emt),transcription factor function,wnt/β-catenin pathway interaction,genomic mutation hotspots
ENSG00000184470,TXNRD2,cancer driver,cell survival,redox regulation,thioredoxin interaction,tumor progression,apoptosis resistance
ENSG00000162267,ITIH3,proteolytic regulation,tumor progression,upregulation in tumors,metastatic potential,extracellular matrix remodeling,biomarker for prognosis
ENSG00000177311,ZBTB38,transcriptional regulation,cell cycle progression,tumor microenvironment,apoptosis dysregulation,oncogenic activity,genomic instability
ENSG00000077498,TYR,altered expression,cellular proliferation,histone modification,epigenetic regulation,proliferation marker,oncogenesis
ENSG00000126709,IFI6,immune response regulation,tumor suppression,cell growth inhibition,metastasis prevention,antiviral properties,ifn-γ induction
ENSG00000155903,RASA2,**

hyperactivated ras pathway,loss of tumor suppressor function,tumor progression,cell proliferation and survival,signaling pathway dysregulation,raf/mek kinase interaction

**
ENSG00000167157,PRRX2,emt induction,cancer stem cell properties,cell proliferation regulation,transcriptional regulation,tumor progression marker,therapeutic target
ENSG00000172840,PDP2,nucleotide metabolism,dna repair,tumor progression,cell cycle regulation,apoptosis regulation,therapeutic target
ENSG00000174080,CTSF,cell adhesion molecule regulation,cell proliferation enhancement,tumor progression driver,co-amplification events,cancer therapeutic target,epithelial-to-mesenchymal transition (emt) regulator
ENSG00000181826,RELL1,genetic instability,dna repair pathway,homologous recombination,tumor suppression,e3 ubiquitin ligase activity,protein degradation
ENSG00000141384,TAF4B,oncogene activation,transcriptional regulation,cell growth promotion,apoptosis inhibition,tumor progression,genomic instability
ENSG00000242950,ERVW-1,pi3k/akt/mtor pathway,oncogenic potential,cell proliferation regulation,host-virus interaction,cancer progression contributor,genetic element overexpression
ENSG00000164776,PHKG1,metabolic rewiring,glycogen metabolism regulation,oncogenic protein interaction,constitutive activation mutations,tumor growth promotion,hypoxic adaptation
ENSG00000126861,OMG,dna repair defects,genomic instability,pi3k/akt/mtor pathway modulation,tumor progression,cell proliferation enhancement,oncogenic signaling
ENSG00000185924,RTN4RL1,epithelial-to-mesenchymal transition,notch signaling pathway,tumor invasion,cell adhesion regulation,wnt signaling pathway,cancer prognosis marker
ENSG00000111729,CLEC4A,tumor microenvironment modulation,immune response regulation,oncosuppressive function,prognostic biomarker,carbohydrate ligand binding,cell surface interaction
ENSG00000135709,KIAA0513,cell cycle regulation,tumor progression,genomic instability,dna damage response,protein-protein interaction,transcriptional modulation
ENSG00000186326,RGS9BP,regulation of cell proliferation,modulation of g-protein signaling,oncogene overexpression,tumor-promoting effects,g-protein coupled receptor interaction,pi3k/akt pathway activation
ENSG00000103226,NOMO3,genomic instability,loss-of-function mutations,dna replication repair,chromosome segregation,kinetochore complex,genome maintenance
ENSG00000101425,BPI,apoptosis regulation,immune response modulation,inflammation regulation,cell signaling interaction,protein binding capacity,tumor growth inhibition
ENSG00000163590,PPM1L,phosphatase regulation,protein kinase modulation,tumor suppression,dna damage response,genomic instability,cancer cell proliferation
ENSG00000276836,ARHGAP27,rho gtpase regulation,cytoskeletal organization,pi3k/akt pathway modulation,tumor suppressor activity,cell migration inhibition,oncogenic potential
ENSG00000140545,MFGE8,cell proliferation,tumor progression,overexpressed,genomic instability,reactive oxygen species accumulation,autophagy regulation
ENSG00000164532,TBX20,tumor suppressor,cell differentiation,transcriptional regulation,cell cycle arrest,apoptosis modulation,loss-of-function mutations
ENSG00000064225,ST3GAL6,tumor aggressiveness,poor prognosis,cell adhesion,glycosylation modulation,cancer progression,environmental adaptation
ENSG00000178199,ZC3H12D,immunomodulation,tumor microenvironment modulation,immune suppression,oncolytic activity,antitumor immunity regulation,therapeutic target
ENSG00000156232,WHAMM,mitotic progression,cell division regulation,spindle assembly regulation,genomic stability maintenance,tumor suppressor function,centrosome integrity
ENSG00000141756,FKBP10,fk506-binding protein family,transcription regulation,cell signaling pathway,tumor progression,androgen receptor interaction,histone deacetylase modulation
ENSG00000221866,PLXNA4,plexin a4 signaling,cell adhesion modulation,epithelial-to-mesenchymal transition,tumor progression promotion,oncogene activation,semaphorin interaction
ENSG00000168282,MGAT2,altered glycosylation patterns,oncogenic process,cell proliferation,migration and invasion,poor prognosis,therapeutic target
ENSG00000048342,CC2D2A,wnt/β-catenin signaling,tumor suppressor function,cell proliferation regulation,centrosome maturation,ciliogenesis disruption,oncogenic mutations
ENSG00000125744,RTN2,microtubule stability,cell migration,tumorigenesis,oncogene,microtubule regulation,mitotic spindle checkpoint
ENSG00000182264,IZUMO1,emt induction,tumor aggressiveness,overexpression,cell adhesion regulation,metastasis promotion,poor prognosis association
ENSG00000129749,CHRNA10,nicotinic acetylcholine receptors,ligand-gated ion channels,tumor progression,cell proliferation,apoptosis regulation,oncogenic signaling
ENSG00000174343,CHRNA9,oncogene,cell signaling pathway,nicotine exposure,cell proliferation,tumor suppressor gene,cancer cell survival
ENSG00000152127,MGAT5,aberrant glycosylation,cell proliferation,immune evasion,signaling pathway modulation,tumor aggressiveness,prognostic marker
ENSG00000052795,FNIP2,mtor activation,tumor growth promotion,cellular proliferation regulation,protein synthesis control,autophagy modulation,genomic instability
ENSG00000122012,SV2C,neurotransmitter regulation,exocytosis modulation,proliferation regulation,synaptic transmission,protein-protein interaction,mitochondrial dysfunction
ENSG00000158158,CNNM4,cell proliferation modulation,pi3k/akt pathway regulation,cell cycle control disruption,tumor progression promotion,oncogene function alteration,signaling pathway interaction
ENSG00000162836,ACP6,mitochondrial metabolism disruption,cellular energy modulation,apoptosis regulation,glycolysis enhancement,protein kinase interaction,tumor progression correlation
ENSG00000167210,LOXHD1,regulation of motor proteins,genomic stability maintenance,microtubule dynamics regulation,dna repair pathway interaction,cell cycle disruption,aberrant expression association
ENSG00000126267,COX6B1,mitochondrial function alteration,metabolic reprogramming,oxidative stress induction,electron transport chain disruption,tumor aggressiveness enhancement,therapeutic target identification
ENSG00000236279,CLEC2L,immune modulation,pattern recognition receptor,cell surface carbohydrate binding,tumor immune evasion,cancer cell regulation,microenvironment interaction
ENSG00000213934,HBG1,tumor progression,iron homeostasis regulation,cell survival enhancement,metastasis facilitation,erythropoiesis dysregulation,gene expression alteration
ENSG00000183734,ASCL2,oncogenic transcription factor,epithelial-to-mesenchymal transition,stem cell-like properties,cell proliferation regulator,transcriptional regulator,wnt/β-catenin pathway interaction
ENSG00000237123,CDSN,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,prognostic marker,tumor progression,cellular invasion,gene expression regulation
ENSG00000135272,MDFIC,metal response element activation,transcriptional regulation,oxidative stress modulation,cell survival enhancement,tumor-promoting function,genomic instability
ENSG00000263324,HCN3,oncogenic potential,voltage-gated potassium channel subunit,cellular excitability regulation,ept to mesenchymal transition,proliferation promotion,angiogenesis facilitation
ENSG00000184571,PIWIL3,cellular transformation,epithelial-to-mesenchymal transition,mrna stability regulation,protein-protein interactions,tumor progression facilitation,cancer prognosis association
ENSG00000167531,LALBA,tumor aggressiveness,prognostic marker,cell growth promotion,microenvironment modulation,signaling pathway interaction,lactose synthesis regulation
ENSG00000166006,KCNC2,altered ion channel activity,cell cycle regulation,ion homeostasis,oncogene potential,potassium channel subunit,voltage-gated potassium channels
ENSG00000151657,KIN,kinase activity,constitutive activation,cell cycle regulation,tumor progression,oncogenic processes,cancer cell survival
ENSG00000171940,ZNF217,transcriptional coactivation,cell cycle regulation,zinc finger protein function,tumor progression,estrogen receptor interaction,aggressive disease phenotype
ENSG00000108231,LGI1,cellular modulation,poor prognosis marker,tumor progression,chromatin remodeling,signaling pathway regulation,oncogenic potential
ENSG00000165059,PRKACG,pka activation,cell proliferation,oncogenic pathway regulation,mapk/erk signaling,tumor progression,therapeutic target
ENSG00000214415,GNAT3,gpcr signaling pathway,loss-of-function mutations,aberrant activation,ion channel regulation,tumor growth,proliferation
ENSG00000069018,TRPC7,calcium channel regulation,gain of function mutations,increased cell proliferation,oncogenesis,cellular signaling,metastatic potential
ENSG00000185808,PIGP,cell membrane anchoring,glycosylation pattern changes,cellular proliferation enhancement,protein stability maintenance,signaling pathway interaction,tumor metastasis promotion
ENSG00000171759,PAH,paba metabolism alteration,tumor progression,dna damage,genomic instability,cancer driver gene,cell proliferation regulation
ENSG00000143627,PKLR,metabolic reprogramming,tumor growth,glycolytic flux,apoptosis regulation,gene expression alteration,lactate production
ENSG00000141012,GALNS,tumor suppressor,glycosaminoglycan degradation,lysosomal enzyme activation,nf-kappab pathway activation,cellular adhesion disruption,metastasis promotion
ENSG00000105499,PLA2G4C,lipid metabolism regulation,oncogene potential,pi3k/akt pathway modulation,cell proliferation promotion,pro-tumorigenic effects,protein interaction facilitation
ENSG00000132141,CCT6B,protein folding regulation,dysregulation of protein homeostasis,cellular stress response disruption,oncogenic protein modulation,cancer-associated gene interaction,cell cycle regulation disruption
ENSG00000144285,SCN1A,altered ion channel function,dysregulation in tumorigenesis,neurotransmitter regulation,cell migration enhancement,potential oncogene,ion channel activity alteration
ENSG00000169857,AVEN,nf-κb pathway,transcriptional regulation,cell growth regulation,loss-of-function mutations,cell survival promotion,tumor progression
ENSG00000117983,MUC5B,oncogenic driver,epithelial surface maintenance,glycoprotein overexpression,tumor progression,microenvironment modulation,cancer stem cell marker
ENSG00000152382,TADA1,cell cycle regulation,genomic instability,chromosomal segregation,prognostic marker,tumor suppression,apc complex
ENSG00000119760,SUPT7L,chromatin remodeling,oncogenic processes,tumor progression,transcriptional regulation,cell cycle regulation,dna repair dysfunction
ENSG00000104325,DECR1,apoptosis suppression,cell cycle regulation,oncogene function,transcriptional control,tumor growth promotion,proteasome activation
ENSG00000168781,PPIP5K1,pi3k/akt pathway regulation,oncogenic signaling,cell proliferation,apoptosis modulation,tumor progression driver,genetic mutation impact
ENSG00000136295,TTYH3,protein-protein interaction,apoptosis regulation,cell cycle progression,signal transduction modulation,p53 interaction,gene expression alteration
ENSG00000164197,RNF180,rna stability regulation,promotes oncogenesis,ubiquitin ligase activity,cell cycle progression,apoptosis suppression,mutation-driven gain
ENSG00000140455,USP3,deubiquitination,epigenetic regulation,chromatin remodeling,cell proliferation,apoptosis resistance,tumor progression
ENSG00000066923,STAG3,chromosomal instability,dna repair defect,sister chromatid cohesion,mitotic error,genomic rearrangement,tumor progression
ENSG00000164091,WDR82,chromatin remodeling,rsc complex component,aberrant histone modifications,oncogene overexpression,genome instability,biomarker for chemotherapy resistance
ENSG00000143867,OSR1,mtor pathway,cell proliferation,s6k1 phosphorylation,therapeutic target,tumor progression,genomic instability
ENSG00000198168,SVIP,cell proliferation regulation,tumor progression,metastasis promotion,oncogenic signaling modulation,secreted protein function,akt pathway interaction
ENSG00000121440,PDZRN3,oncogenic driver,pi3k/akt signaling,overexpression,cell proliferation,apoptosis regulation,metastasis promoter
ENSG00000196177,ACADSB,fatty acid beta-oxidation,lipid metabolism regulation,energy homeostasis disruption,cell growth promotion,tumor progression association,therapeutic target potential
ENSG00000055483,USP36,**
deubiquitination function,genomic instability,cell cycle regulation,gain of function mutations,constitutive activation,protein-protein interactions 
**
ENSG00000239900,ADSL,alanyl-trna synthetase function,tumor progression marker,oncogenic pathway interaction,protein synthesis regulator,cell cycle progression promoter,metabolic reprogramming
ENSG00000135913,USP37,deubiquitinating enzyme activity,oncogenic function,cell proliferation promotion,apoptosis inhibition,dna repair facilitation,p53 stabilization
ENSG00000136014,USP44,apoptosis inhibition,cell proliferation promotion,deubiquitinating enzyme function,oncogenic potential,prognostic marker,ubiquitin-proteasome system regulation
ENSG00000178445,GLDC,oncogenesis,one-carbon metabolism,cell growth regulation,dna synthesis,epigenetic regulation,tumor suppressor function
ENSG00000141404,GNAL,gpcr regulation,cell signaling pathway disruption,g protein complex component,oncogene overexpression,cell proliferation enhancement,survival signaling dysregulation
ENSG00000140986,RPL3L,pseudogenes dysregulation,ribosome function alteration,protein synthesis disruption,aberrant cellular behavior,cancer development association,genomic instability link
ENSG00000223443,USP17L2,deubiquitinating enzyme,cell proliferation,apoptosis resistance,angiogenesis,nf-κb pathway regulation,pi3k/akt signaling modulation
ENSG00000186866,POFUT2,notch signaling pathway activation,wnt/β-catenin pathway regulation,constitutive activation,cellular proliferation promotion,o-fucosylation pathway dysregulation,therapeutic target
ENSG00000109016,DHRS7B,cellular protection,oxidative stress regulation,tumor growth promotion,biomarker potential,cell cycle regulation disruption,apoptosis modulation
ENSG00000005100,DHX33,microrna processing,overexpression,helicase activity,tumor suppressor dysregulation,cell proliferation,genomic instability
,FAM129B,cell cycle regulation,apoptotic suppression,tumor progression,epithelial-to-mesenchymal transition,oncogenic driver,protein-protein interaction
ENSG00000115368,WDR75,cell cycle regulation,centromere-kinetochore interaction,dna damage response,mitotic checkpoint maintenance,tumor suppressor function,genomic instability prevention
ENSG00000183605,SFXN4,iron-sulfur cluster trafficking,cellular metabolism regulation,oncogenic outcomes,ros modulation,tumorigenesis regulation,protein-protein interaction
ENSG00000163584,RPL22L1,ribosome biogenesis,oncogenic processes,cell proliferation,dna damage response,therapeutic target,genomic instability
ENSG00000165097,KDM1B,epigenetic regulation,cellular proliferation,tumor progression,gene expression modulation,histone demethylation,oncogenic function
ENSG00000187772,LIN28B,rna-binding protein,epithelial-to-mesenchymal transition (emt),stem cell-like properties,apoptosis inhibition,microrna processing,oncogenic signature
ENSG00000143493,INTS7,genetic instability,transcriptional elongation,gene expression regulation,cell proliferation,tumor progression,immune evasion
ENSG00000111231,GPN3,pi(5)p regulation,cell growth modulation,genetic mutation impact,tumor progression driver,therapeutic target potential,cellular signaling regulator
ENSG00000182521,TBPL2,transcriptional regulation,gene expression,cell proliferation,tumor progression,chromatin remodeling,histone modification
ENSG00000112992,NNT,genomic instability,mitochondrial dysfunction,cellular metabolism,epigenetic regulation,dna repair deficiency,oxidative stress promotion
ENSG00000156011,PSD3,epigenetic regulation,tumor suppressor function,apoptosis regulation,cell cycle arrest,genomic stability maintenance,histone modification
ENSG00000198690,FAN1,genomic instability,dna repair mechanisms,tumor suppression,homologous recombination repair,structure-specific endonuclease,oncogenic mutations
ENSG00000188322,SBK1,cell cycle regulation,dysregulated kinase activity,genomic instability,epigenetic modifications,oncogene activation,targeted therapy
ENSG00000155115,GTF3C6,gata transcription complex,transcriptional regulation,cell proliferation,dna replication,genetic regulation,tumor progression
ENSG00000241476,SSX2,immunomodulation,transcriptional regulation,cell proliferation,oncogenic transformation,tumor progression,immune evasion
ENSG00000268447,SSX2B,transcription regulation,cell cycle progression,protein-protein interactions,oncogenic potential,tumor suppressor protein function,loss of heterozygosity
ENSG00000119547,ONECUT2,transcriptional regulator,epithelial differentiation,tumor progression marker,cell proliferation enhancer,emt regulator,wnt/β-catenin pathway interaction
ENSG00000115827,DCAF17,cul4-ring ubiquitin ligase complex,aberrant amplification,cell cycle dysregulation,oncogenic substrate accumulation,therapeutic target,cancer progression
ENSG00000180233,ZNRF2,wnt/β-catenin signaling pathway regulation,tumor suppressor function,cell proliferation inhibition,ubiquitination and degradation,frizzled receptor regulation,mutation impact
ENSG00000258659,TRIM34,tumor suppression,cell cycle regulation,apoptosis modulation,dna damage response,transcriptional control,genomic instability
ENSG00000163564,PYHIN1,apoptosis regulation,dna damage response,p53 pathway involvement,genomic instability suppression,oncogenic mutations identification,tumor suppressor function
ENSG00000125703,ATG4C,autophagy regulation,pi3k/akt pathway modulation,cancer cell survival enhancement,tumor suppressor interaction,cell growth regulation,gene expression dysregulation
ENSG00000099814,CEP170B,centrosome regulation,genomic instability,aneuploidy formation,micronuclei formation,cell cycle dysregulation,mitotic progression impairment
ENSG00000162396,PARS2,genomic instability,dna damage response,oncogene activation,pi3k/akt signaling,serine protease activity,therapeutic target
ENSG00000066084,DIP2B,wnt/β-catenin pathway activation,epigenetic regulator,chromatin remodeling,histone modification,cell proliferation enhancement,metastasis promotion
ENSG00000189195,BTBD8,overexpression,aberrant expression,tumor progression,transcriptional regulation,genome stability,cell proliferation
ENSG00000105662,CRTC1,hippo signaling pathway,transcriptional regulation,cellular proliferation,oncogenic processes,tumorigenesis driver,protein-protein interactions
ENSG00000175121,WFDC5,tumor suppressor function,pi3k/akt pathway regulation,wnt/β-catenin signaling modulation,cell adhesion regulation,zinc-binding domains,transcriptional regulation
ENSG00000111704,NANOG,cell cycle progression,dna binding,epithelial-to-mesenchymal transition,homeobox transcription factor,oncogenesis,pluripotency
ENSG00000267680,ZNF224,krab domain-containing transcription factor,cell proliferation suppression,apoptosis inhibition,cancer cell migration facilitation,epigenetic regulation involvement,poor prognosis association
ENSG00000124459,ZNF45,transcriptional regulation,cell growth modulation,apoptosis regulation,zinc finger domain,chromatin remodeling,oncogenic process
ENSG00000167380,ZNF226,tumor progression,transcriptional regulation,cell cycle regulation,apoptosis suppression,chromatin remodeling,dna repair disruption
ENSG00000146757,ZNF92,transcriptional regulation,chromatin remodeling,oncogenic transcription factor,cell proliferation,tumor metastasis,epigenetic modification
ENSG00000235109,ZSCAN31,transcriptional regulation,oncogenic function,cell proliferation promotion,anti-apoptotic effects,metastasis enhancement,dna binding modification
ENSG00000135638,EMX1,emx1 overexpression,cell growth promotion,tumor progression,dna repair regulation,transcriptional repression,oncogenic function
ENSG00000128645,HOXD1,transcriptional regulation,cell proliferation,tumorigenesis,oncogenic function,cell survival,wnt/β-catenin pathway
ENSG00000169989,TIGD4,mitochondrial function,cellular energy metabolism,apoptosis regulation,oxidative phosphorylation,protein-protein interactions,tumor cell proliferation
ENSG00000165583,SSX5,chromatin regulation,transcriptional regulation,oncogenic processes,cell proliferation,survival pathway,nuclear protein interaction
ENSG00000115421,PAPOLG,genomic instability,mitochondrial dysfunction,dna repair defects,cell cycle progression,oncogenic potential,tumor suppressor function
ENSG00000005801,ZNF195,tumor suppressor function,loss-of-function mutations,cell cycle regulation,apoptosis modulation,transcriptional regulation,genomic instability maintenance
ENSG00000151240,DIP2C,microrna biogenesis,oncogenic mirnas,gene expression regulation,cell proliferation enhancement,poor prognosis marker,tumor progression promoter
ENSG00000160352,ZNF714,cellular differentiation,chromatin remodeling,co-repressor interaction,dna repair regulation,krab domain function,tumor suppression dysregulation
ENSG00000215421,ZNF407,epigenetic regulation,transcriptional repressor function,cell proliferation modulation,apoptosis regulation,dnmt3a interaction,tumor progression association
ENSG00000198039,ZNF273,transcriptional regulator,dna-binding activity,oncogenic activation,tumor suppressor inhibition,cellular stress response,poor prognosis biomarker
ENSG00000164651,SP8,transcription factor activity,oncogenic transcriptional regulation,cell survival enhancement,apoptosis resistance,tumor suppressor inhibition,angiogenesis promotion
ENSG00000172000,ZNF556,transcriptional regulation,oncogene/tumor suppressor activity,cell proliferation/survival pathways,gene expression modulation,dna-binding protein interactions,prognostic/predictive biomarker
ENSG00000175322,ZNF519,transcriptional regulator,cell proliferation,cell migration,apoptosis evasion,epigenetic regulation,histone modification
ENSG00000171467,ZNF318,transcriptional regulation,dysregulation of cell cycle,protein-protein interaction,mutation or overexpression,oncogenic processes,apoptosis evasion
ENSG00000185669,SNAI3,epithelial-to-mesenchymal transition (emt),oncogene,transcription factor,tumor progression,metastasis,cell migration
ENSG00000081665,ZNF506,transcriptional regulation,cell cycle progression,apoptosis modulation,dna repair deficiency,chromatin remodeling,therapeutic target
ENSG00000111639,MRPL51,mitochondrial ribosome function,ribosomal subunit component,energy metabolism regulation,cellular proliferation enhancement,oncogenic overexpression,protein synthesis modulation
,H2BFM,histone modification,chromatin regulation,epigenetic silencing,gene expression modulation,nucleosome assembly,transcriptional control
ENSG00000176387,HSD11B2,mineralocorticoid receptor activation,glucocorticoids metabolism dysregulation,cortisol-cortisone conversion impairment,cell proliferation enhancement,tumor growth promotion,gene expression regulation alteration
ENSG00000204335,SP5,transcriptional regulation,cell proliferation promotion,epithelial-to-mesenchymal transition,apoptosis suppression,oncogenic transcription factor,genomic instability
ENSG00000269058,CALR3,apoptosis regulation,unfolded protein response,cellular stress regulation,cell proliferation,signaling pathway interaction,er localization
ENSG00000167136,ENDOG,cell adhesion disruption,epithelial-to-mesenchymal transition,metastatic potential enhancement,tumor progression facilitation,biomarker for treatment response,dna repair dysregulation
ENSG00000188786,MTF1,mtf1 regulates gene expression,apoptosis regulation,cell cycle progression,dna damage response,oncogenic mutations,transcriptional modulation
ENSG00000101493,ZNF516,krab-zfp regulation,transcriptional suppression,oncogenic growth promotion,cellular proliferation,chromatin remodeling,apoptosis inhibition
ENSG00000108423,TUBD1,microtubule stability,cell proliferation,tumor progression,apoptosis inhibition,protein overexpression,cancer cell growth
ENSG00000145476,CYP4V2,oxidative stress regulation,lipid metabolism modulation,tumor progression,biomarker identification,cellular growth promotion,dna damage induction
ENSG00000125520,SLC2A4RG,glut1 regulation,oncogenic role,altered glucose metabolism,cell proliferation enhancement,tumor progression facilitation,prognostic significance
ENSG00000153391,INO80C,genomic instability,cancer cell survival,chromatin remodeling,dna repair mechanism disruption,cell proliferation enhancement,therapeutic resistance
ENSG00000283510,INO80D,chromatin remodeling,cell proliferation,dna repair mechanisms,genomic instability,epigenetic regulation,apoptosis evasion
ENSG00000100601,ALKBH1,dna damage repair,epigenetic regulation,cell growth modulation,oncogenic mutations,tumor progression,protein interaction
ENSG00000130997,POLN,genetic instability,mediator of genetic instability,dna replication,chromosomal instability,genomic alterations,tumor suppressor function
ENSG00000118245,TNP1,genomic instability,chromatin regulation,transcriptional dysregulation,epigenetic modification,cell proliferation increase,therapeutic target
ENSG00000100162,CENPM,chromosomal instability,genomic alterations,cell cycle regulation,protein overexpression,centromere function,mitotic spindle formation
,HIST1H2AD,histone modification,epigenetic regulation,dna repair mechanisms,cell cycle progression,apopoptosis evasion,genomic instability
ENSG00000130304,SLC27A1,lipid metabolism,increased fatty acid uptake,cell proliferation,oncogenesis,therapeutic target,genomic profiling
ENSG00000155307,SAMSN1,pi3k/akt pathway disruption,gene expression regulation,tumor progression driver,mutation loss-of-function,cell adhesion and migration regulation,cytoskeletal component interaction
ENSG00000147180,ZNF711,cellular proliferation,transcriptional regulation,oncogenesis,tumor progression,dna repair,protein-protein interaction
ENSG00000184735,DDX53,cellular proliferation,apoptosis regulation,transcriptional control,dna repair mechanisms,tumorigenesis promotion,cell cycle progression
ENSG00000187821,HELT,centriole duplication regulation,tumor progression,cell proliferation enhancement,akt/pi3k signaling modulation,centrosome integrity regulation,microtubule dynamics modification
ENSG00000184058,TBX1,epithelial-to-mesenchymal transition (emt),wnt/β-catenin signaling pathway,transcription factor activity,cell growth regulation,dysregulation in cancer,signaling pathway activation
ENSG00000050030,NEXMIF,cell migration regulation,cytoskeletal component modulation,adhesion disruption,tumor progression promotion,cancer stem cell maintenance,oncogene overexpression
ENSG00000263141,PAXBP1,proliferation regulation,transcriptional activation,tumor progression,prognostic marker,cell cycle regulation,dna damage response
ENSG00000284869,EEFSEC,protein synthesis regulation,cellular proliferation,oncoprotein modulation,anabolic pathway activation,genetic instability,tumor growth promotion
ENSG00000008311,AASS,cellular metabolism,redox balance regulation,tumor progression,energy metabolism modulation,genetic alterations,mitochondrial enzyme function
ENSG00000176623,RMDN1,mitochondrial integrity,genomic instability,warburg effect,cell metabolism regulation,protein-protein interaction,dna damage response
ENSG00000168297,PXK,metabolic reprogramming,oncogene interaction,tumor growth promotion,angiogenesis facilitation,therapeutic target,none
ENSG00000154493,C10orf90,dna repair mechanisms,cell cycle regulation,oncogenic pathway activation,tumor aggressiveness,poor prognosis,apoptosis regulation
ENSG00000125246,CLYBL,cell cycle regulation,dcaf function,genome stability maintenance,oncogenic protein interaction,tumor progression promotion,ubiquitination regulation
ENSG00000103855,CD276,tumor progression,immune suppression,cell proliferation,apoptosis inhibition,cancer immunotherapy,prognostic biomarker
ENSG00000075275,CELSR1,hippo/yap signaling pathway,cell-cell adhesion disruption,overexpression in tumors,tumor progression facilitation,cell proliferation regulation,cell survival enhancement
ENSG00000150893,FREM2,wnt/pcp signaling,cell polarity regulation,epithelial-to-mesenchymal transition (emt),tumor suppressor function,planar cell polarity pathway,adhesion regulation
ENSG00000148842,CNNM2,calcium signaling,constitutive activation,ion channel regulation,cell proliferation,dna damage response,genomic instability
ENSG00000196159,FAT4,aberrant signaling,cell migration disruption,epithelial integrity loss,metastasis promotion,oncogenic driver,tumorigenesis regulation
ENSG00000166341,DCHS1,cellular adhesion regulation,tumor progression promotion,signaling pathway activation,pro-inflammatory cytokine production,poor prognosis association,metastasis facilitation
ENSG00000169851,PCDH7,cell adhesion disruption,oncogene function,cell signaling modulation,tumor suppressor activity,cell proliferation promotion,migration facilitation
ENSG00000280165,PCDH20,tumor suppressor,cell adhesion regulation,loss-of-function mutations,epigenetic silencing,oncogenic process promotion,aggressive tumor behavior
ENSG00000253873,PCDHGA11,pi3k/akt interaction,oncogene,epithelial-to-mesenchymal transition promoter,cell adhesion regulator,biomarker,none
ENSG00000165323,FAT3,tumor progression,metastasis,cell adhesion disruption,tumor suppressor function,protein interaction alteration,biomarker potential
ENSG00000203972,GLYATL3,genomic instability,gain of function mutations,dna damage response,tumor progression,metabolic reprogramming,cellular proliferation
ENSG00000263243,KRT12,keratin protein alterations,cytoskeleton remodeling,cellular adhesion disruption,tumor progression markers,oncogenic signaling activation,prognostic significance
ENSG00000072778,ACADVL,lipid metabolism alteration,therapeutic target,cell proliferation enhancement,apoptosis resistance,oncogenic processes,energy homeostasis disruption
ENSG00000136010,ALDH1L2,aldehyde detoxification,genomic instability,oxidative stress,resistance to therapy,epigenetic regulation,cell growth modulation
ENSG00000157184,CPT2,mitochondrial function regulation,dysregulated fatty acid metabolism,lipid biosynthesis modulation,oncogenic pathway activation,cell proliferation promotion,mitochondrial dynamics regulation
ENSG00000069998,HDHD5,pi3k/akt interaction,transcriptional regulation,dna repair modulation,cell cycle regulation,tumor progression,therapeutic target
ENSG00000182810,DDX28,alternative splicing,cell proliferation,helicase activity,oncogenic transcript processing,rna metabolism regulation,spliceosome modulation
ENSG00000132463,GRSF1,cellular differentiation,gtp-binding protein,metastasis,oncogenic processes,rna metabolism regulation,tumor progression
ENSG00000100294,MCAT,mitochondrial localization,fatty acid metabolism,cell survival promotion,metabolic reprogramming,altered energy production,tumor metabolic adaptation
ENSG00000114686,MRPL3,enhanced cell proliferation,genomic instability,oncogenic process promotion,protein synthesis regulation,ribosome biogenesis modulation,cell survival enhancement
ENSG00000106591,MRPL32,mitochondrial protein synthesis,altered metabolism,ribosomal assembly,dysregulated expression,protein interaction,tumor initiation
ENSG00000136897,MRPL50,mitochondrial ribosomal protein assembly,cellular proliferation regulation,tumor suppressor gene dysregulation,metabolic reprogramming,poor prognosis marker,genomic instability promotion
ENSG00000183617,MRPL54,gain-of-function mutations,mitochondrial translation regulation,metabolic reprogramming,cell growth promotion,apoptosis resistance,tumor progression
ENSG00000162910,MRPL55,mitochondrial translation regulation,energy metabolism dysregulation,protein synthesis impairment,cellular stress induction,tumor progression association,genomic instability contribution
ENSG00000122140,MRPS2,mitochondrial dysfunction,cellular metabolism alteration,genomic instability,protein synthesis regulation,tumor progression influence,therapeutic target
ENSG00000112996,MRPS30,mitochondrial ribosomal subunit,cellular metabolism regulation,protein synthesis dysregulation,tumor progression marker,cancer cell survival promotion,metabolic reprogramming
ENSG00000177192,PUS1,alternative splicing,rna processing regulation,oncogenic processes,cell cycle progression regulation,dna repair mechanism regulation,transcriptome modulation
ENSG00000143374,TARS2,dna repair mechanisms,tumor progression,cellular homeostasis disruption,oncogenic pathway interaction,aminoacyl-trna synthetase complex function,chemo-resistance development
ENSG00000112941,TENT4A,pi3k/akt pathway modulation,tumor progression promotion,cell proliferation regulation,therapeutic target identification,trna modification dysregulation,genomic instability promotion
,MARCH1,ubiquitin ligase activity,tumor progression,biomarker expression,apoptosis regulation,cell cycle control,signaling pathway modulation
ENSG00000108479,GALK1,galactose metabolism,overexpression,oncogene,cell signaling pathways,apoptosis regulation,angiogenesis promotion
ENSG00000180855,ZNF443,oncogenic transformation,cell growth regulation,transcriptional regulator,apoptosis evasion,dna binding protein,tumor cell proliferation
ENSG00000007174,DNAH9,microtubule regulation,ciliary motility,tumor progression,oncogenic driver,prognostic biomarker,genomic instability
ENSG00000141696,P3H4,peptidyl-prolyl isomerase,cell proliferation,tumor progression,apoptosis inhibition,protein interaction,metabolic regulation
ENSG00000185432,METTL7A,m6a modification,post-transcriptional regulation,oncogenesis promotion,cell growth and survival modulation,apoptosis inhibition,tumor progression correlation
ENSG00000065518,NDUFB4,mitochondrial dysfunction,electron transport chain,complex i subunit,oxidative phosphorylation,ros production,tumor suppressor gene
ENSG00000155962,CLIC2,cellular modulation,cell cycle regulation,apoptosis suppression,dna repair enhancement,tumor progression promoter,oncogenic driver
ENSG00000114124,GRK7,androgen receptor regulation,g protein-coupled receptor kinase activity,cell cycle modulation,prognostic marker,signaling pathway regulation,kinase activation
ENSG00000204977,TRIM13,apoptosis regulation,autophagy modulation,cell cycle control,immune system interaction,tumor suppression,genetic instability
ENSG00000120008,WDR11,cell growth regulation,hedgehog signaling pathway,developmental disorder,tissue patterning,embryonic development,mutations leading to tumorigenesis
ENSG00000284807,DHRS4,altered expression,cellular redox balance regulation,mitochondrial integrity modulation,oncogenic signaling pathway activation,tumor progression,genomic profiling alterations
ENSG00000168546,GFRA2,gdnf/ret pathway,cell proliferation,cell survival,dysregulation in cancer,signal transduction,transmembrane receptor
ENSG00000211448,DIO2,oncogenic function,cell proliferation,thyroid hormone regulation,tumor progression,signal transduction,genetic alteration
ENSG00000181873,IBA57,oncofetal protein,mitochondrial dynamics,cell proliferation,protein-protein interaction,metastasis regulation,autophagy modulation
ENSG00000100226,GTPBP1,**

cellular regulation,dysregulated expression,g protein signaling pathway,oncogenic potential,pi3k/akt pathway interaction,tumor suppressor activity loss
ENSG00000123684,LPGAT1,cellular proliferation,lipid synthesis,tumorigenesis,metabolic regulation,cell survival,lipid metabolism
ENSG00000197563,PIGN,**
glycosylphosphatidylinositol anchor synthesis,cell surface protein attachment,cellular membrane integrity,lipid metabolism regulation,oncogenic cell adhesion modulation,tumor progression facilitation
**
ENSG00000196458,ZNF605,transcriptional regulation,gene expression modulation,zinc finger domain,dna binding activity,enhancer region interaction,epigenetic modifications
ENSG00000213221,DNLZ,genomic instability,aneuploidy,dna replication regulation,tumor suppressor activity,chromatin remodeling interaction,mutational burden
ENSG00000130309,COLGALT1,collagen synthesis,tumor progression,upregulation,cell surface modulation,extracellular matrix degradation,glycosylation regulation
ENSG00000053438,NNAT,glycolysis regulation,metabolic reprogramming,insulin signaling pathway,transcription factor activity,epithelial-to-mesenchymal transition (emt),prognostic biomarker
ENSG00000166796,LDHC,metabolic adaptation,glycolytic shift,lactate production,tumor microenvironment modification,hypoxia-inducible transcriptional regulation,oncogenic interaction
ENSG00000106038,EVX1,notch signaling pathway,epithelial-to-mesenchymal transition (emt),transcription factor regulation,cellular differentiation,apoptosis inhibition,wnt/β-catenin pathway interaction
ENSG00000186017,ZNF566,transcription factor regulation,cell cycle progression,apoptosis suppression,angiogenesis facilitation,tumor suppressor loss,tissue-specific expression
ENSG00000083812,ZNF324,**

cell proliferation,transcriptional regulation,dysregulation,chromatin modification,apoptosis evasion,signaling pathway modulation
ENSG00000159917,ZNF235,transcription regulation,cell growth regulation,oncogenesis promotion,apoptosis inhibition,epithelial-to-mesenchymal transition,therapeutic target
ENSG00000137573,SULF1,cell proliferation,transcriptional co-regulation,tumor progression,growth factor regulation,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway interaction
ENSG00000138336,TET1,**
dna demethylation,epigenetic regulation,genome stability maintenance,cell proliferation suppression,apoptosis induction,angiogenesis modulation
ENSG00000263310,SALL3,tumor suppressor function,epithelial-to-mesenchymal transition,cell migration regulation,transcription factor activity,cyclin-dependent kinase interaction,cell cycle regulation
ENSG00000163872,YEATS2,histone binding,chromatin remodeling,oncogenesis promotion,cell proliferation regulation,dna damage response,protein-protein interaction
,H2AFJ,chromatin modification,epigenetic regulation,dna repair mechanism disruption,cell cycle regulation,histone modification,gene expression alteration
ENSG00000178449,COX14,mitochondrial function,energy production,mitochondrial membrane potential,tumor progression,cell survival,chemosensitivity regulation
ENSG00000051596,THOC3,mrna export,genomic instability,tumorigenesis,potential therapeutic target,cell growth regulation,protein-rna interaction
ENSG00000234438,KBTBD13,oncogenic potential,ubiquitin ligase activity,p53 degradation,cell proliferation enhancement,dna damage response alteration,chromatin remodeling involvement
,H2AFB1,histone variant,chromatin remodeling,epigenetic regulation,oncogene activation,tumor cell proliferation,genome instability
ENSG00000112699,GMDS,microtubule dynamics,chromosomal instability,mitotic spindle formation,oncogenic driver,genomic instability,aneuploidy
ENSG00000153933,DGKE,cell growth modulation,gene amplification,protein kinase activation,tumor progression,kinase regulator,phosphatidic acid production
ENSG00000058866,DGKG,dysregulated signaling,loss-of-function mutations,cell proliferation,tumor suppressor/oncogene function,protein kinase c activation,phosphoinositide regulation
ENSG00000091704,CPA1,extracellular matrix degradation,tumor growth promotion,biomarker overexpression,prognostic significance,cellular signaling modulation,therapeutic target potential
ENSG00000180138,CSNK1A1L,wnt/β-catenin signaling,increased expression levels,oncogenic effects,tumor progression,therapeutic target,cell proliferation regulation
ENSG00000066422,ZBTB11,tumor suppressor role,transcriptional repressor function,dna damage response regulation,cell cycle regulation,apoptosis pathway modulation,genomic stability maintenance
ENSG00000288503,DDX51,genomic instability,constitutive activation,cell cycle regulation,dna replication,cell proliferation,tumor progression
ENSG00000138380,CARF,cell cycle regulation,proliferation promotion,g1-s phase transition,cell growth enhancement,oncogenic potential,tumor progression
ENSG00000112695,COX7A2,mitochondrial function,aerobic glycolysis,tumor progression,glycolytic shift,mitochondrial interaction,energy metabolism regulation
ENSG00000169515,CCDC8,cellular proliferation,cancer driver gene,genomic instability,mitotic spindle assembly,centrosome function regulation,cell cycle progression
ENSG00000101003,GINS1,dna replication regulation,tumor progression promotion,poor prognosis indicator,cell cycle regulator,apoptosis inducer,therapeutic target candidate
ENSG00000124479,NDP,nucleotide hydrolysis,dna repair,tumor aggressiveness,poor prognosis,metabolic regulation,nad+ metabolism
ENSG00000141314,RHBDL3,cellular proliferation,oncogenic process,proteolytic activity,tumor progression,biomarker potential,egf signaling pathway
ENSG00000196275,GTF2IRD2,genomic instability,dna damage response,transcriptional regulation,tumor suppressor function,cell cycle progression,apoptosis regulation
ENSG00000075461,CACNG4,cellular proliferation,cell cycle regulation,k+ channel activation,ca2+ signaling pathway,mitotic activity,none
ENSG00000133256,PDE6B,regulation of camp/cgmp levels,cancer-associated mutations,oncogenic pathways,cell proliferation modulation,protein-protein interactions,signal transduction regulation
ENSG00000181588,MEX3D,oncogenic function,mrna stability regulation,tumor suppressor interaction,cell cycle modulation,translation control,genetic instability
ENSG00000180011,ZADH2,tumor suppression,genomic instability,chromatin remodeling,histone modification,cell proliferation,dna damage response
ENSG00000175193,PARL,mitochondrial dynamics regulation,oncogenic signaling pathway activation,cellular stress response modulation,apoptosis evasion,protein quality control dysregulation,tumor aggressiveness promotion
ENSG00000180901,KCTD2,apoptosis suppression,cell proliferation enhancement,oncogene potential,overexpression in tumors,potassium channel regulation,tumor growth promotion
ENSG00000112078,KCTD20,apoptosis regulation,cellular signaling,immune response modulation,cytosolic localization,tumor suppressor or oncogene function,dysregulated expression levels
ENSG00000102271,KLHL4,pi3k/akt pathway regulation,oncogenic signaling,cell cycle modulation,ubiquitination and degradation,dna damage response,tumor progression marker
ENSG00000155729,KCTD18,transcriptional regulation,cell cycle progression,genomic instability,apoptosis modulation,protein-protein interactions,tumorigenesis
ENSG00000137200,CMTR1,transcriptional regulation,cell cycle regulation,dna binding,apoptosis regulation,genomic stability maintenance,protein-protein interaction
ENSG00000197345,MRPL21,mitochondrial ribosome assembly,overexpression,protein synthesis regulation,cell proliferation enhancement,biomarker potential,poor prognosis correlation
ENSG00000258366,RTEL1,genomic instability,telomere maintenance,dna damage response,chromosomal rearrangement,oncogenic mutation,biomarker potential
ENSG00000121940,CLCC1,dna repair mechanism,chromosomal instability,tumor suppressor function,cell cycle regulation,genomic integrity maintenance,protein interaction
ENSG00000131043,AAR2,cell cycle regulation,aberrant expression,genomic instability,oncogenic potential,therapeutic target,chromatin remodeling
ENSG00000112584,FAM120B,homologous recombination repair,chromatin remodeling,dna damage response,cell cycle regulation,non-homologous end joining,tumor suppressor function
ENSG00000131459,GFPT2,glycolysis regulation,tumor growth promotion,oncogenic function,metabolic adaptation,cell proliferation enhancement,therapeutic target
ENSG00000134744,TUT4,mrna regulation,oncogene activation,n6-methyladenosine depletion,tumor progression,protein interaction,gene expression modulation
ENSG00000138413,IDH1,dna hypermethylation,epigenetic regulator,tumor suppressor silencing,2-hydroxyglutarate production,chromosomal instability,energy metabolism disruption
ENSG00000253506,NACA2,dna damage response,genomic instability,oncogenesis driver,tumor progression marker,protein-protein interaction,epigenetic regulation
ENSG00000153093,ACOXL,lipid metabolism regulation,metabolic reprogramming,tumor progression,energy production,cell signaling modulation,biomarker potential
ENSG00000140876,NUDT7,dna damage response,genomic instability,cell growth regulation,protein interaction,mutations or alterations,oncogenic potential
ENSG00000130584,ZBTB46,**

1. **tumor suppressor function**,2. **dna-binding activity**,3. **cell proliferation regulation**,4. **protein-protein interactions**,5. **apoptosis regulation**,6. **chromatin remodeling** 
**
ENSG00000165487,MICU2,mitochondrial calcium regulation,apoptosis suppression,oncogenic reprogramming,cell proliferation enhancement,tumor progression marker,biomarker for prognosis
ENSG00000188573,FBLL1,genomic instability,dna repair regulation,tumor suppressor function,cell cycle regulation,aneuploidy induction,chromosomal instability
ENSG00000126249,PDCD2L,apoptosis regulation,cancer immunosuppression,immune evasion,nk cell suppression,oncogene potential,tumor progression
ENSG00000180098,TRNAU1AP,oncogene activation,pseudogene regulation,cell proliferation enhancement,tumor progression,protein interaction modulation,pi3k/akt pathway interaction
ENSG00000172469,MANEA,cell migration,invasion,oncogene,protein kinase activation,tumor progression,therapeutic target
ENSG00000119655,NPC2,lipid transport dysregulation,metabolic reprogramming,cell signaling modulation,pi3k/akt pathway activation,tumor aggressiveness,cancer progression
ENSG00000156282,CLDN17,tumor suppressor function,disrupted tight junctions,cell migration regulation,adhesion loss,poor prognosis marker,therapeutic target
ENSG00000257008,GPR142,insulin secretion regulation,glucose homeostasis,g-protein coupled receptor function,cell proliferation promotion,oncogenic process activation,therapeutic target identification
ENSG00000047648,ARHGAP6,rho gtpase regulation,tumor progression,cell migration,protein kinase activation,cytoskeleton organization,gene expression alteration
ENSG00000263238,CTSO,protease activity,tumor progression,metastasis promotion,antigen presentation modulation,immune response regulation,extracellular matrix degradation
ENSG00000186479,RGS7BP,tumor progression,oncogenesis,cell survival,g protein regulation,cell proliferation,prognostic marker
ENSG00000203780,FANK1,genomic instability,cell cycle progression,dna repair pathway,ubiquitin ligase activity,tumor amplification,pi3k/akt signaling activation
ENSG00000198216,CACNA1E,oncogenic calcium signaling,calcium channel dysregulation,cell growth promotion,cell proliferation enhancement,therapeutic target identification,stromal cell modulation
ENSG00000142910,TINAGL1,tumor progression,cell adhesion modulation,cell migration enhancement,protein-protein interaction,cancer development facilitation,biomarker expression
ENSG00000125831,CST11,genomic instability,aneuploidy,cell proliferation,apoptosis resistance,chromatin remodeling complex component,dna replication and repair facilitation
ENSG00000152454,ZNF256,krab-c2h2 zinc finger protein,transcriptional regulation,amplication and overexpression,cell proliferation and survival,oncogenic pathways activation,therapeutic target
ENSG00000112379,ARFGEF3,endocytosis and exocytosis regulation,mapk signaling pathway activation,cell proliferation enhancement,survival pathway dysregulation,tumor progression promotion,therapeutic target candidate
ENSG00000170255,MRGPRX1,ligand-independent activity,constitutive activation,tumor progression,oncogenic signaling,cell proliferation,adhesion molecule regulation
ENSG00000114796,KLHL24,ubiquitin-proteasome pathway regulation,tumor suppressor function,ccne1 regulation,cell cycle progression,protein degradation modulation,oncogenic substrate accumulation
ENSG00000142634,EFHD2,apoptosis inhibition,cell growth regulation,downregulation,loss of function mutations,poor prognosis,tumor suppression
ENSG00000188158,NHS,epithelial integrity disruption,cell adhesion modulation,angiogenesis regulation,cell migration facilitation,oncogenic potential,metastatic enhancement
ENSG00000152784,PRDM8,cellular proliferation,epigenetic regulation,chromatin modification,transcriptional control,oncogenesis promotion,cancer driver gene
ENSG00000119125,GDA,g-protein signaling,dysregulated expression,altered cell growth,cancer progression marker,cell cycle regulation,prognostic biomarker
ENSG00000169154,GOT1L1,cellular metabolism,proliferation regulation,oncogenic signaling,tumor progression,protein-protein interaction,metabolic regulation
ENSG00000025708,TYMP,angiogenic activity,constitutive upregulation,metabolic regulation,tumor progression,cancer metabolism,thymidine phosphorylation
ENSG00000255346,NOX5,mitochondrial localization,reactive oxygen species regulation,oncogene expression,cell migration,genomic instability,stem cell-like properties
ENSG00000173626,TRAPPC3L,protein transport regulation,tumor progression modulation,oncogenic transformation promotion,ubiquitin-proteasome system interaction,cell surface transport enhancement,oncogene overexpression
ENSG00000128159,TUBGCP6,microtubule regulation,cell proliferation,oncogene activation,mitotic spindle assembly,chromosomal stability,chemoresistance
ENSG00000175854,SWI5,genomic instability,telomere maintenance,chromatin remodeling,dna repair mechanism,cell cycle progression,protein-protein interaction
ENSG00000127084,FGD3,constitutive activation,oncogenic driver,tumor progression,cell proliferation,therapeutic target,rho gtpase activation
ENSG00000108784,NAGLU,tumor microenvironment modulation,cellular adhesion regulation,glycosaminoglycan degradation,cell migration influence,lysosomal enzyme activity,angiogenesis promotion
ENSG00000137509,PRCP,protein degradation,cellular proliferation,wnt/β-catenin pathway,enzymatic activity,tumor progression,metastasis
ENSG00000116406,EDEM3,erad pathway dysregulation,oncogene overexpression,retrotranslocation facilitation,protein quality control disruption,therapeutic target potential,cancer cell proliferation enhancement
ENSG00000181523,SGSH,lysosomal storage disorder,mucopolysaccharidosis,glycosaminoglycan degradation,sulfamidase deficiency,keratan sulfate metabolism,lysosomal function disruption
ENSG00000164039,BDH2,fatty acid oxidation,energy metabolism regulation,tumor progression,overexpression,metabolic dysregulation,oncogenic role
ENSG00000170088,TMEM192,genomic alteration,amplicon,cell proliferation,protein interaction,tumor progression,pi3k/akt pathway modulation
ENSG00000198171,DDRGK1,cell growth regulation,tumor progression,apoptosis inhibition,dna repair dysregulation,epithelial-to-mesenchymal transition (emt),serine/threonine kinase activity
ENSG00000100802,C14orf93,increased cell proliferation,oncogenic potential,cell signaling regulation,pi3k/akt pathway activation,apoptosis regulation,tumor progression
ENSG00000165046,LETM2,mitochondrial regulation,ion transport,cellular metabolism,apoptosis inhibition,pi3k/akt pathway interaction,therapeutic target
ENSG00000185404,SP140L,nuclear protein,biomarker upregulation,transcriptional regulation,chromatin remodeling,cell cycle progression,apoptosis modulation
ENSG00000140522,RLBP1,retinoid metabolism,tumor suppression,cell cycle regulation,apoptosis regulation,gene silencing,prognostic marker
,C22orf46,tumor suppressor regulation,cell cycle progression,apoptosis inhibition,protein-protein interaction,oncogene overexpression,tumor aggressiveness
ENSG00000137491,SLCO2B1,oxidative stress,genomic instability,cellular uptake regulation,dna damage response,tumor aggressiveness,transport protein function
ENSG00000247626,MARS2,mitochondrial function regulation,stress response modulation,cellular protein homeostasis,oncogenic processes contribution,metabolic reprogramming promotion,tumor suppressor interaction
ENSG00000121316,PLBD1,cell signaling regulation,metalloprotease activity,protein degradation regulation,tumor progression marker,cancer cell growth inhibition,biomarker for disease progression
ENSG00000100889,PCK2,cellular metabolism,gluconeogenesis pathway,enhanced glucose production,metabolic adaptation,anabolic process,oncogenic potential
ENSG00000111536,IL26,tumor-promoting activity,immune evasion mechanisms,angiogenesis promotion,epithelial-to-mesenchymal transition,immunosuppressive microenvironment,oncogenic signaling pathway
ENSG00000110002,VWA5A,genomic instability,dna repair dysfunction,oncogene potential,tumor suppressor interaction,brca1 pathway,nhej pathway disruption
ENSG00000134183,GNAT2,**

cell growth regulation,camp regulation,signaling pathway modulation,proliferation promotion,therapeutic target candidate,protein interaction 
**
ENSG00000132840,BHMT2,methylation regulation,homocysteine metabolism,tumor progression,cell signaling modulation,oncogenic pathway activation,gene expression regulation
ENSG00000163377,TAFA4,dna repair,cell cycle regulation,genome stability,oncogene overexpression,tumor aggressiveness,prognostic marker
ENSG00000174370,C11orf45,mitochondrial regulation,tumor suppressor function,glycolysis inhibition,pentose phosphate pathway activation,energy homeostasis modulation,therapeutic target
ENSG00000163378,EOGT,oncogene,protein o-glcnacylation,tumor progression,transcriptional regulation,cell proliferation,metabolic reprogramming
ENSG00000117308,GALE,galactose metabolism disruption,udp-galactose dysregulation,cell proliferation enhancement,tumor progression promotion,metabolic pathway alteration,cancer cell survival increase
ENSG00000116874,WARS2,mitochondrial dysfunction,selenocysteine incorporation,antioxidant defense disruption,cellular metabolic reprogramming,enhanced cell survival,protein synthesis regulation
ENSG00000141580,WDR45B,genomic instability,tumor progression,cell cycle regulation,dna repair defects,chromatin remodeling alterations,prognostic biomarker
ENSG00000114956,DGUOK,mitochondrial dna maintenance,tumor driver mutation,loss of function mutations,increased ros production,dysregulated energy metabolism,mitochondrial dysfunction
ENSG00000103707,MTFMT,mitochondrial function,p53 regulation,post-translational modification,cellular processes,tumor development,antioxidant response
ENSG00000042445,RETSAT,retinoic acid signaling pathway,oncogenic process,cell growth regulation,overexpression in cancer,metabolic regulation,stress response modulation
ENSG00000282074,MPV17L,mitochondrial dynamics,dna replication,cell survival,apoptosis regulation,genetic instability,tumor suppression
ENSG00000144647,POMGNT2,altered glycosylation patterns,dysregulated protein modification,cell surface glycoprotein changes,tumor progression and metastasis,poor prognosis biomarker,interactions with glycosylation pathway enzymes
ENSG00000285136,DEFA6,antimicrobial activity,altered expression levels,epithelial cell expression,innate immunity,oncogenic processes,tumorigenesis
ENSG00000122335,SERAC1,mitochondrial lipid metabolism,metabolic reprogramming,cancer cell survival,lipid biosynthesis,oncogenic protein interactions,therapeutic target
ENSG00000158270,COLEC12,tumor microenvironment modulation,immune evasion mechanism,innate immune regulation,altered expression levels,angiogenesis support,metastatic potential enhancement
ENSG00000152611,CAPSL,gef activity,cell migration,tumor progression,poor prognosis,therapeutic target,cancer metastasis
ENSG00000073605,GSDMB,**

cell death regulation,pyroptosis dysregulation,tumor aggressiveness,gene mutation frequency,protein function alteration,tissue specificity
ENSG00000101074,R3HDML,apoptosis regulation,tumor suppression,dna damage response pathway,cell proliferation inhibition,gene expression regulation,genomic stability maintenance
ENSG00000106537,TSPAN13,tumor progression,epithelial-to-mesenchymal transition,cell adhesion regulation,metastasis promotion,signaling pathway interaction,cancer cell migration
ENSG00000124232,RBPJL,notch signaling pathway,constitutive activation,gaining function mutations,amplification target,cell proliferation regulation,tumor progression modulation
ENSG00000139914,FITM1,iron metabolism regulation,mitochondrial function maintenance,dna repair modulation,cell proliferation promotion,tumor progression enhancement,oncogenic signaling pathway interaction
ENSG00000124449,IRGC,g2/m phase transition regulation,genomic stability maintenance,oncogenic potential,cell proliferation enhancement,survival promotion,pi3k/akt pathway interaction
ENSG00000163521,GLB1L,glycoprotein expression modification,cell adhesion regulation,glycosylation process regulation,cancer cell invasion inhibition,cellular behavior alteration,potential therapeutic target
ENSG00000177830,CHID1,oncogenic function,genomic instability,proteasome pathway regulation,p53 degradation,cell proliferation enhancement,ubiquitination and degradation
ENSG00000006625,GGCT,tumor progression,cellular metabolism,oxidative stress,angiogenesis promotion,metabolic regulation,therapeutic target
ENSG00000169738,DCXR,glycolytic phenotype,monocarboxylate transport,energy metabolism regulation,tumor progression facilitation,oncogenic potential,therapeutic target candidate
ENSG00000173464,RNASE11,rna stability regulation,tumor progression,cellular homeostasis disruption,pi3k/akt pathway modulation,poor prognosis biomarker,metastasis driver
ENSG00000080910,CFHR2,complement factor regulation,oncogene expression,cell survival modulation,tumor growth promotion,genomic instability association,pi3k/akt pathway interaction
ENSG00000119899,SLC17A5,glutamate transport regulation,tumor progression,tumor cell invasion,growth factor signaling,cell proliferation,poor prognosis
ENSG00000129480,DTD2,dpii interaction,protein degradation,mitochondrial localization,dipeptide breakdown,oncogenic transformation,cellular homeostasis
ENSG00000144815,NXPE3,nuclear pore complex regulation,cellular proliferation regulation,oncogenic signaling modulation,tumor suppressor dysfunction,overexpressed in cancer tissues,aberrant gene expression regulation
ENSG00000106384,MOGAT3,lipid metabolism,membrane structure regulation,oncogenic driver,tumor growth promotion,lysophosphatidylcholine acylation,phospholipid biosynthesis
ENSG00000197406,DIO3,thyroid hormone regulation,tumor progression,cellular growth suppression,proliferation enhancement,thyroid hormone degradation,rna editing
ENSG00000143919,CAMKMT,mitochondrial localization,calcium signaling regulation,energy metabolism dysregulation,cell proliferation modulation,survival pathway activation,potential oncogene
ENSG00000150656,CNDP1,cancer-associated enzymatic activity,cellular redox balance regulation,tumor progression marker,dna repair mechanism modulation,oncogenic pathway involvement,proteolytic enzyme function
ENSG00000166049,PASD1,regulation of cell growth,phosphopain pleckstrin homology domain,oncogenic signaling pathway modulation,pleiotropic protein interactions,tumorigenesis modulation,cancer susceptibility gene
ENSG00000101327,PDYN,opioid peptide production,cell proliferation,metastasis,tumor progression,pain modulation,signaling pathway interaction
ENSG00000154122,ANKH,regulation of mineralization-related genes,suppression of cell proliferation,interaction with pi3k/akt pathway,overexpression in bladder urothelial carcinoma,regulation of cellular metabolism,apoptosis promotion
ENSG00000186283,TOR3A,mtor pathway,aberrant activation,amplification mutations,cellular metabolism regulation,cancer driver gene,therapeutic target
ENSG00000127540,UQCR11,mitochondrial function,tumor metabolism,glycolysis,lactate production,warburg effect,cellular respiration
ENSG00000136522,MRPL47,mitochondrial function,cellular metabolism regulation,oncogenic properties,protein interaction,apoptosis modulation,tumor overexpression
ENSG00000139168,ZCRB1,epithelial-to-mesenchymal transition,cell adhesion disruption,tumor progression,metastasis facilitation,cancer cell migration,tissue architecture disruption
ENSG00000128524,ATP6V1F,acidic cellular compartments,endocytosis promotion,enhanced invasion,malignant transformation,lysosomal function regulation,tumor progression facilitation
ENSG00000103335,PIEZO1,mechanosensitive ion channel,cell proliferation,increased cell migration,cancer progression,therapeutic target,cellular signaling pathways
ENSG00000116580,GON4L,genomic instability,centrosome regulation,oncogene activation,cell cycle progression,mitotic spindle formation,protein-protein interactions
ENSG00000104774,MAN2B1,glycoprotein processing,mannose residue removal,cell adhesion regulation,tumor progression,oncogene dysregulation,cancer cell migration
ENSG00000152620,NADK2,genomic instability,oncogenic protein interaction,enhanced glycolysis,metabolic regulation,cell growth promotion,poor prognosis marker
ENSG00000131171,SH3BGRL,tumor suppressor regulation,cell cycle progression,genomic stability,dna repair modulation,protein-protein interaction,post-translational modification
ENSG00000128311,TST,cellular adhesion disruption,egfr signaling pathway interaction,extracellular matrix glycoprotein,oncogene co-expression,tumor microenvironment modulation,tumor progression promotion
ENSG00000104889,RNASEH2A,genomic instability,dna repair deficiency,oncogenic signaling activation,cell proliferation enhancement,tumor suppressor function loss,alkylating agent sensitivity
ENSG00000172922,RNASEH2C,telomere maintenance,tumor progression,dysregulation of dna repair pathways,aberrant dna damage response,genomic instability,somatic mutations
ENSG00000136104,RNASEH2B,genomic instability,increased mutation rate,dna repair defect,tumor suppressor function,oncogenic mutations,cancer predisposition
ENSG00000122965,RBM19,rna binding activity,cellular growth regulation,gene expression repression,transcriptional regulation,apoptosis modulation,chromatin modification
ENSG00000171202,TMEM126A,translation regulation,tumor progression,cell proliferation,signaling pathway modulation,oncogene regulation,prognostic biomarker
ENSG00000174982,OR4S2,olfactory receptor function,tumor progression,biomarker potential,cell migration,cell invasion,poor prognosis indicator
ENSG00000091009,RBM27,rna-binding protein,arginine/serine-rich (rs) family member,splicing regulation,gene expression modulation,cancer-specific gene expression programs,protein misfolding and degradation
ENSG00000165661,QSOX2,cellular redox balance modulation,cell proliferation regulation,tumor progression,apoptosis modulation,biomarker potential,protein-protein interaction
ENSG00000115204,MPV17,mitochondrial dysfunction,cell death regulation,apoptosis dysregulation,metabolic reprogramming,therapeutic target,tumor progression
ENSG00000206256,PPT2,cellular invasion,matrix metalloproteinases activity,procollagen processing regulation,tumor aggressiveness marker,transcription factor interaction,extracellular matrix remodeling
ENSG00000151176,PLBD2,dna repair interaction,tumor suppressor function,cell growth regulation,signaling pathway modulation,genome stability maintenance,loss-of-function mechanism
ENSG00000090686,USP48,oncogenic function,protein stabilization,cell cycle progression,apoptosis resistance,tumor progression,poor prognosis
ENSG00000144120,TMEM177,**

cellular integrity,cell growth modulation,oncogenic properties,protein-protein interactions,tumor progression,metabolic regulation
**
ENSG00000184076,UQCR10,mitochondrial dysfunction,glycolytic shift,oxidative phosphorylation,electron transport chain,cell proliferation,warburg effect
ENSG00000166704,ZNF606,wnt/β-catenin signaling pathway,transcriptional regulator,cell growth regulation,tumor aggressiveness marker,apoptosis modulation,cell cycle regulation
ENSG00000132915,PDE6A,androgen receptor regulation,cell migration,cancer aggressiveness,phosphodiesterase activity,prognostic marker,tumor progression
ENSG00000178187,ZNF454,dna-binding,genetic regulation,tumor suppressor function,transcriptional control,zinc finger protein family,cellular proliferation
ENSG00000085449,WDFY1,protein degradation regulation,ubiquitin ligase activity,oncogenic signaling,tumor cell proliferation,cell migration and invasion,therapeutic target
ENSG00000283085,TPBG,tumor progression,cell adhesion disruption,angiogenesis promoter,immune evasion mechanism,tumor microenvironment remodeling,metastasis facilitator
ENSG00000135776,ABCB10,multidrug resistance,proliferation enhancement,tumor progression,oncogene activation,mitochondrial localization,chemotherapy resistance
ENSG00000198729,PPP1R14C,cell proliferation regulation,oncogenic process,cell survival enhancement,protein phosphatase 1 regulation,tumorigenesis association,kinase activity modulation
ENSG00000100558,PLEK2,pi3k/akt pathway activation,overexpression,tumor aggressiveness,cell signaling modulation,cytoskeleton organization disruption,metastasis promotion
ENSG00000184227,ACOT1,tumor promoter,metabolic regulator,cell growth enhancer,signaling pathway activator,protein interaction facilitator,biomarker candidate
ENSG00000115944,COX7A2L,mitochondrial energy metabolism,hypoxia response,transcriptional regulation,cell proliferation,tumor progression,oncogenic function
ENSG00000112893,MAN2A1,glycoprotein processing,overexpression,mannose-rich glycans,immune evasion,cancer progression,poor prognosis
ENSG00000277656,GSTT1,detoxification processes,conjugation reactions,oxidative stress protection,chemotherapy resistance,cancer progression,xenobiotic metabolism
ENSG00000254685,FPGT,oxidative stress,detoxification processes,cellular metabolism regulation,genomic instability,epigenetic regulation,therapeutic target
ENSG00000148719,DNAJB12,cellular chaperone function,protein folding regulation,oncogenic potential,tumor progression,apoptosis modulation,cell proliferation enhancement
ENSG00000196449,YRDC,pi3k/akt interaction,tumor progression,cell proliferation regulation,ribosomal rna processing,oncogenic pathway activation,dysregulation of cell survival signals
ENSG00000101079,NDRG3,tumor suppressor function,pi3k/akt pathway regulation,cell differentiation and growth regulation,epithelial-to-mesenchymal transition (emt) inhibition,gene silencing or downregulation in cancer,dna damage response modulation
ENSG00000204764,RANBP17,cell cycle regulation,mitotic spindle formation,nuclear transport regulation,oncoprotein stabilization,tumor suppressor degradation,genomic instability
ENSG00000127080,IPPK,inositol pyrophosphate accumulation,constitutive activation,cell proliferation,warburg effect,metabolic regulation,glycolysis enhancement
ENSG00000101337,TM9SF4,cell surface dynamics,membrane trafficking regulation,oncogene overexpression,signaling pathway modulation,gene expression changes,protein complex formation
ENSG00000173905,GOLIM4,golgi apparatus dysregulation,oncogenic protein sorting,cell migration and invasion,pi3k/akt pathway interaction,tumor progression,vesicle trafficking modulation
ENSG00000099974,DDTL,dna damage response,cell cycle regulation,oncogenic driver,tumor progression,protein degradation,pi3k/akt pathway interaction
ENSG00000205903,ZNF316,transcriptional regulation,chromatin modification,tumor suppression,genomic instability,oncogenesis,cell proliferation
ENSG00000125877,ITPA,genomic instability,base excision repair pathway,atr/chk1 activation,dna repair deficiency,tumor suppressor,oxidative stress defense
ENSG00000169299,PGM2,glycogenolysis,glycolytic flux,warburg effect,tumor metabolism,dysregulation of gene expression,hif-1α regulation
ENSG00000134056,MRPS36,mitochondrial biogenesis,overexpression in cancer,cell proliferation regulation,energy metabolism regulation,tumor progression promotion,autophagy regulation
ENSG00000160785,SLC25A44,glycolytic reprogramming,mitochondrial transport,oncogenic metabolism,enhanced proliferation,apoptosis resistance,prognostic marker
ENSG00000106853,PTGR1,prostaglandin synthesis,inflammation modulation,angiogenesis promotion,tumor progression,tumor microenvironment regulation,immune evasion enhancement
ENSG00000155850,SLC26A2,sulfate transport,tumor progression,metastasis promotion,cell migration facilitation,survival enhancement,prognostic biomarker candidate
ENSG00000166800,LDHAL6A,metabolic reprogramming,glycolysis regulation,tumor microenvironment modification,therapeutic target,cell proliferation enhancement,energy metabolism alteration
ENSG00000153956,CACNA2D1,calcium channel regulation,upregulated expression,tumor progression,poor prognosis,oncogene activation,cell proliferation
ENSG00000117143,UAP1,protein stability regulation,oncogenic protein stabilization,cell proliferation enhancement,ubiquitination regulation,e3 ligase interaction,therapeutic target
ENSG00000205544,TMEM256,transmembrane protein regulation,cellular processes modulation,apoptosis dysregulation,pi3k/akt pathway interaction,tumorigenesis association,therapeutic target potential
ENSG00000166965,RCCD1,cellular transcriptional regulation,cell cycle progression,gene expression modulation,oncogenic process promotion,tumor progression association,apoptosis inhibition
ENSG00000178802,MPI,cellular redox balance,redox regulation,cell survival,protein interactions,oxidative stress,gene expression
ENSG00000173262,SLC2A14,metabolic reprogramming,glycolysis enhancement,nutrient uptake facilitation,oncogene overexpression,transcriptional regulation,cancer cell proliferation
,PALM2,dna repair deficiency,cellular proliferation regulation,oncogenic properties,poor prognostic marker,protein-protein interactions,tumor growth promotion
ENSG00000198478,SH3BGRL2,cellular modulation,protein ubiquitination,tumor suppressor function,overexpression in cancer,signaling pathway regulation,apoptosis inhibition
ENSG00000164933,SLC25A32,mitochondrial carrier protein,citrate transport,metabolic regulation,glycolysis enhancement,glutaminolysis promotion,poor prognostic marker
ENSG00000185414,MRPL30,mitochondrial ribosomes,aberrant protein expression,cellular proliferation,apoptosis regulation,autophagy modulation,tumor progression
ENSG00000072756,TRNT1,gene regulation,dna repair,cell cycle progression,protein synthesis modification,oncogenic driver,cancer therapy target
ENSG00000163389,POGLUT1,o-linked n-acetylglucosamine modification,cell growth regulation,protein kinase activation,tumor suppressor interaction,cancer driver gene,metabolic regulation
ENSG00000213965,NUDT19,dna damage repair,maintenance of genome stability,cell proliferation,oncogene expression,chromatin remodeling,transcriptional regulation
ENSG00000113273,ARSB,glycosaminoglycan metabolism,lysosomal enzyme dysfunction,cell signaling modulation,tumor microenvironment alteration,cellular homeostasis disruption,genetic disorder implication
ENSG00000054793,ATP9A,cell signaling pathway disruption,ion transport dysfunction,tumor progression promotion,aggressive tumor behavior facilitation,genomic instability contribution,therapeutic target potential
ENSG00000157014,TATDN2,transcription regulation,oncogenic protein-protein interactions,cell proliferation promotion,apoptosis suppression,dna damage response regulation,prognostic marker overexpression
ENSG00000044459,CNTLN,cell adhesion disruption,metastasis promotion,protein-protein interaction,signaling pathway modulation,tumor progression facilitation,biomarker for patient outcome prediction
ENSG00000122687,MRM2,post-transcriptional regulation,oncogenic function,tumor progression,rna degradation,protein interaction,genomic instability
ENSG00000116127,ALMS1,altered expression,dna damage response,cell cycle regulation,tumor suppressor function,cancer development,genomic instability
ENSG00000163319,MRPS18C,mitochondrial respiration,energy metabolism disruption,cellular respiration impairment,oncogenic stress induction,dna damage accumulation,epigenetic alterations activation
ENSG00000243147,MRPL33,mitochondrial ribosome,oncogene,cell growth promotion,reactive oxygen species production,stress response activation,metabolic regulation
ENSG00000275004,ZNF280B,oncogene,aberrant expression,tumor suppressor suppression,cell cycle progression,anti-apoptotic function,chromatin remodeling interaction
ENSG00000198453,ZNF568,dna repair regulation,cellular proliferation,genomic stability maintenance,epithelial tissue expression,transcriptional regulation,hypermethylation silencing
ENSG00000257591,ZNF625,transcription factor regulation,tumor progression,cell proliferation,oncogenic pathway activation,prognostic marker,epigenetic modification
ENSG00000196437,ZNF569,transcriptional regulation,cell proliferation,zinc finger domains,overexpression,tumor suppressor function,cell cycle progression
ENSG00000249471,ZNF324B,tumor suppressor function,transcriptional regulation,chromatin remodeling,cell proliferation inhibition,apoptosis promotion,gene expression regulation
ENSG00000245680,ZNF585B,oncogenic activity,cell cycle regulation,gene expression modulation,zinc finger protein interaction,transcriptional activation,prognostic marker
ENSG00000181007,ZFP82,tumor suppressor,transcriptional regulation,genomic stability maintenance,cellular differentiation regulation,apoptosis regulation,chromatin remodeling
ENSG00000275723,NAPEPLD,lysophosphatidic acid (lpa) signaling,tumor progression,cell proliferation,metastasis promotion,protein kinase activation,phospholipase d activity
ENSG00000182111,ZNF716,transcriptional regulation,cell proliferation,enhanced cell survival,anti-apoptotic properties,mutations leading to aberrant binding,prognostic value for cancer patients
ENSG00000274195,ZNF705G,cell proliferation,transcriptional regulation,oncogenic potential,chromatin modification,tumor progression,protein-protein interaction
ENSG00000170920,OR7G3,olfactory receptor function,biomarker potential,pi3k/akt pathway activation,cell proliferation promotion,survival enhancement,prognostic significance
ENSG00000185013,NT5C1B,tumor progression,cell growth regulation,purine metabolism regulation,nucleotide pool modulation,therapeutic target,genomic profiling
ENSG00000145194,ECE2,angiogenesis,tumor progression,immune suppression,cell proliferation,vasodilation regulation,protein-protein interaction
ENSG00000137976,DNASE2B,dna degradation,genome stability,immune evasion,tumor progression,fibrotic microenvironment,cancer association
ENSG00000169814,BTD,metabolic dysregulation,cellular energy imbalance,tumor growth promotion,gene expression modulation,protein modification pathway,enzymatic regulation disruption
ENSG00000196344,ADH7,cellular metabolism,oxidative stress,tumorigenesis,cancer-related pathways,cell growth and survival,therapeutic target
ENSG00000148513,ANKRD30A,genomic instability,tumor suppression,dna damage response,cell cycle control,protein-protein interaction,apoptosis regulation
ENSG00000219481,NBPF1,cell migration,oncogenic driver,overexpression,poor prognosis,metastasis,cell invasion
ENSG00000100578,KIAA0586,genomic instability,chromosomal rearrangements,cell cycle regulation,tumor progression,mutation hotspot,biomarker candidate
ENSG00000128059,PPAT,polyphosphate metabolism regulation,cellular energy homeostasis modulation,glycolysis and glutaminolysis regulation,nad+ biosynthesis regulation,hypoxia response modulation,protein interaction and complex formation
ENSG00000172663,TMEM134,membrane trafficking regulation,cell signaling modulation,tumor progression facilitation,oncogenic transformation potential,protein-protein interaction,biomarker significance
ENSG00000165490,DDIAS,cell migration,cell invasion,epithelial-to-mesenchymal transition (emt),scaffold protein function,cell adhesion regulation,cytoskeletal organization
ENSG00000243749,TMEM35B,calcium signaling dysregulation,cellular homeostasis disruption,cell survival promotion,tumor progression involvement,transmembrane protein function,genomic instability contribution
ENSG00000124780,KCNK17,cell proliferation regulation,apoptosis suppression,oncogenic mutation,tumor aggressiveness,ion channel function,pi3k/akt signaling modulation
ENSG00000156453,PCDH1,cadherin superfamily member,tumor suppressor function,cell-cell adhesion disruption,oncogenic process regulation,apoptosis evasion facilitation,therapeutic target potential
ENSG00000242110,AMACR,energy metabolism modulation,mitochondrial function,biomarker overexpression,tumor aggressiveness factor,cell cycle regulation,apoptosis inhibition
ENSG00000101323,HAO1,oncogenic role,heme degradation,cellular protection,angiogenesis promotion,tumor adaptation,protein stabilization
ENSG00000116882,HAO2,metabolic regulation,energy metabolism,dna repair,genomic stability,cellular redox balance,tumor progression
ENSG00000148832,PAOX,mitochondrial biogenesis,glycolysis promotion,cellular stress response,transcriptional coactivator,energy metabolism regulation,fatty acid oxidation regulation
ENSG00000177465,ACOT4,metabolic reprogramming,tumor progression,prognostic marker,lipid metabolism regulation,fatty acid acylation status,cellular energy homeostasis
ENSG00000118454,ANKRD13C,loss of function mutations,tumor suppressor,cell cycle regulation,apoptosis induction,pi3k/akt pathway inhibition,genomic instability
ENSG00000137948,BRDT,chromatin remodeling,hyperactivation,transcriptional regulation,oncogenic pathways,genomic instability,dna repair mechanisms
ENSG00000172594,SMPDL3A,sphingolipid metabolism,apoptosis suppression,cancer progression,cell proliferation enhancement,pi3k/akt pathway interaction,prognostic marker
,IGHG2,immune response regulation,antibody production,immunoglobulin structure,humoral immunity modulation,protein secretion regulation,genetic polymorphism
ENSG00000100288,CHKB,choline biosynthesis,cell membrane integrity,pi3k/akt signaling,cell proliferation,metastasis,tumor growth
ENSG00000055957,ITIH1,complement system modulation,tumor progression,metastasis promotion,cell migration regulation,angiogenesis facilitation,inflammation regulation
ENSG00000168907,PLA2G4F,phospholipid hydrolysis,cellular membrane regulation,pro-tumorigenic lipid mediators,tumor progression driver,lipid metabolism regulation,cancer cell invasiveness
ENSG00000198336,MYL4,cell migration,oncogene,actomyosin contractility,tumor invasion,cytoskeleton regulation,prognostic marker
ENSG00000103489,XYLT1,glycosaminoglycan biosynthesis,tumor progression,cell migration and invasion,resistance to chemotherapy,prognostic significance,targeted therapy
ENSG00000178878,APOLD1,tumor aggressiveness,cell growth regulation,aldehyde metabolism,poor prognosis,biomarker potential,protein interaction network
ENSG00000128918,ALDH1A2,cellular detoxification,cell cycle regulation,apoptosis modulation,metabolic regulation,oncogene activation,cancer biomarker
ENSG00000153558,FBXL2,ubiquitination,scf complex,tumor suppressor,cell cycle regulation,apoptosis,dna repair
ENSG00000172476,RAB40A,cell membrane trafficking,vesicle-mediated transport,oncogenic processes,tumor progression,cell migration,aberrant signaling pathway
ENSG00000119682,AREL1,cell cycle progression,transcriptional regulation,dna replication,tumor aggressiveness,proliferation marker,chromatin remodeling
ENSG00000196109,ZNF676,krab-containing zinc finger protein family,transcriptional regulation,cancer driver/suppressor,tumor growth promotion,apoptosis inhibition,cell cycle regulation
ENSG00000125821,DTD1,cell cycle regulation,constitutive activation,gain of function mutations,tumor progression,cancer driver gene,oncogenic potential
ENSG00000282966,CYP2D6,cancer-related biological function,drug metabolism,cell proliferation regulation,apoptosis modulation,angiogenesis influence,cancer biomarker candidate
ENSG00000139160,ETFBKMT,epigenetic regulation,histone methylation,chromatin remodeling,genome instability,dna repair mechanisms,transcription factor regulation
ENSG00000123427,EEF1AKMT3,alternative splicing,oncogenic isoforms,rna processing,tumorigenesis,gene expression regulation,methyltransferase activity
ENSG00000181038,METTL23,m6a methylation,epitranscriptomic regulation,tumor progression,promotes oncogenesis,enhances cell proliferation,chemoresistance associated
ENSG00000128915,ICE2,chromatin regulation,tumor suppressor function,transcriptional dysregulation,cell proliferation,genetic instability,histone modification
ENSG00000237172,B3GNT9,n-acetylgalactosamine transferase activity,cell adhesion,tumor progression,epithelial cell interaction,metastasis facilitation,cancer cell invasion
ENSG00000166930,MS4A5,cancer cell survival,tumor progression,epithelial-to-mesenchymal transition (emt),cell adhesion regulation,protein-protein interaction,oncogenic signaling pathway
ENSG00000198157,HMGN5,epigenetic regulation,chromatin remodeling,transcription modulation,oncogene overexpression,dna damage response,histone modification
ENSG00000120322,PCDHB8,cell adhesion,signal transduction,growth factor regulation,cell migration,oncogenesis,transmembrane receptor
ENSG00000033011,ALG1,dolichol phosphate biosynthesis,n-linked glycoprotein processing,aberrant glycosylation patterns,cellular metabolism regulation,tumor progression facilitation,protein function alteration
ENSG00000171551,ECEL1,cell proliferation,metabolic dysregulation,pi3k/akt pathway interaction,lipid metabolism modulation,tumor progression,oncogenic driver
ENSG00000228474,OST4,outer dense fiber assembly,cell proliferation enhancement,apoptosis suppression,microtubule dynamics regulation,tumor driver gene,cellular growth promotion
ENSG00000068650,ATP11A,lipid remodeling,tumor progression,phospholipid transport,pi3k/akt pathway,cell proliferation,metastasis regulator
ENSG00000101974,ATP11C,ion transport,p-type atpase activity,phospholipid efflux,cancer genomics,cell membrane regulation,tumor progression
ENSG00000103227,LMF1,cell growth regulation,transcriptional regulation,oncogenic processes,cell proliferation,apoptosis evasion,biomarker candidate
ENSG00000147256,ARHGAP36,rho-gtpase regulation,tumor suppressor function,epithelial-to-mesenchymal transition,genomic instability,cell proliferation,rho gtpase activation
ENSG00000072786,STK10,cell cycle regulation,dna damage response,microtubule dynamics,tumor suppressor activity,apoptosis regulation,mitotic checkpoint
ENSG00000161929,SCIMP,tumor microenvironment modulation,immune evasion promotion,oncogene interaction,immunosuppressive cytokine regulation,nk/t cell suppression,tumor progression facilitation
ENSG00000140254,DUOXA1,thyroid hormone conversion,tumor progression marker,metabolic regulation,cellular proliferation,poor prognosis indicator,cancer biomarker
ENSG00000258484,SPESP1,overexpression,poor prognosis,tumor progression,cell proliferation,pi3k/akt pathway modulation,emt regulation
ENSG00000113088,GZMK,dna damage response,apoptosis resistance,oncogenic promotion,tumor progression,angiogenesis enhancement,cell differentiation regulation
ENSG00000254709,IGLL5,cellular proliferation,dna repair mechanisms,genomic instability,immunoglobulin light chain function,oncogenic driver,protein-protein interaction
ENSG00000170099,SERPINA6,cell growth regulation,tumor suppressor function,cancer-associated aberrant expression,cellular stress response regulation,apoptosis modulation,protein-protein interaction
ENSG00000123561,SERPINA7,tumor suppression,protease inhibition,cell growth regulation,oncogene regulation,genetic alteration,cancer prevention
ENSG00000120539,MASTL,microtubule dynamics regulation,mitotic checkpoint activation,cytokinesis completion,cell proliferation promotion,tumor growth enhancement,protein phosphorylation modulation
ENSG00000176371,ZSCAN2,tumor suppressor function,dna binding and transcriptional regulation,cell cycle progression,apoptosis modulation,genomic stability maintenance,oncogenic transformation prevention
ENSG00000288504,YBX2,transcriptional regulation,tumor progression,cell proliferation,apoptosis evasion,oncogenic driver,prognostic biomarker
ENSG00000227642,AGPAT1,cell membrane biogenesis,lysophosphatidic acid acylation,glycerophospholipid synthesis,tumor progression,cell proliferation,cancer metastasis
ENSG00000198610,AKR1C4,steroid hormone metabolism,tumor progression,pro-inflammatory metabolite regulation,cell cycle regulation,dna repair mechanisms,microenvironment modulation
,APOPT1,apoptosis regulation,dna repair modulation,cell cycle control,mitochondrial function,programmed cell death dysregulation,tumor suppressor potential
ENSG00000147145,LPAR4,cell proliferation,metabolic regulation,tumor progression,therapeutic target,signaling pathway activation,epithelial-to-mesenchymal transition
ENSG00000174156,GSTA3,cellular protection,detoxification processes,oxidative stress regulation,modulator of cell growth,altered expression levels,environmental toxin metabolism
ENSG00000060642,PIGV,aberrant protein anchoring,gpi-anchor synthesis,cell signaling pathway modulation,tumor progression,metastasis promotion,oncogenic effect
ENSG00000169906,S100G,tumor progression,cell survival,metastasis,oncogenesis,therapeutic target,prognostic biomarker
ENSG00000184602,SNN,telomere maintenance,dna replication,chromosomal instability,genomic integrity regulation,gene expression regulation,cancer progression
ENSG00000136840,ST6GALNAC4,o-glycosylation,tumor progression,biomarker potential,cancer diagnosis,cell surface modification,glycosyltransferase function
ENSG00000130300,PLVAP,angiogenesis,oncogenic function,endothelial cell recruitment,vascular permeability regulation,pi3k/akt pathway interaction,tumor progression
ENSG00000178828,RNF186,tumor progression,overexpression,cell proliferation,apoptosis inhibition,genetic amplification,ubiquitin ligase activity
ENSG00000196151,WDSUB1,protein regulation,ubiquitin-like modifier function,p53 interaction,cell cycle progression,genomic stability,tumor suppression
ENSG00000174502,SLC26A9,chloride ion transport,tumor aggressiveness,prognostic marker,proliferation pathway,cell survival mechanism,ectopic expression
ENSG00000166788,SAAL1,dna repair regulation,genomic instability enhancement,cell cycle progression modulation,oncogene activation,tumor suppressor function disruption,cellular stress response dysregulation
ENSG00000130193,THEM6,mitochondrial function,cellular metabolism,apoptosis regulation,gene expression dysregulation,cancer cell survival,protein-protein interaction
ENSG00000142197,DOP1B,cell signaling disruption,aberrant protein expression,cellular trafficking dysfunction,dipeptide transport alteration,oncogenic driver mutation,therapeutic target potential
ENSG00000158669,GPAT4,lipid modification,cell membrane regulation,oncogenic signaling,metastasis promotion,tumor progression,lipid raft formation
ENSG00000050555,LAMC3,integrin interaction,cell migration,metastasis promotion,extracellular matrix component,tumor progression,therapeutic target
ENSG00000117479,SLC19A2,cellular proliferation,folate transport,chemoresistance,tumor progression,genomic instability,nutrient uptake
ENSG00000140107,SLC25A47,mitochondrial carrier protein,tumor progression,mitochondrial metabolism,cell proliferation,poor prognosis,succinate transport
ENSG00000159423,ALDH4A1,oxidative stress regulation,cellular detoxification,metabolic regulation,ros modulation,tumorigenesis promotion,metabolic enzyme interaction
ENSG00000178301,AQP11,oncogenesis,cell migration,water channel activity,tumor progression,metastasis,promoter
ENSG00000182858,ALG12,aberrant glycosylation,cell proliferation enhancement,er-golgi intermediate compartment interaction,glycosylation pathway dysregulation,oncogene overexpression,protein modification disruption
ENSG00000113492,AGXT2,epigenetic regulation,cell survival,protein-protein interaction,metastasis promotion,genomic instability,oncogenic function
ENSG00000197859,ADAMTSL2,cell adhesion disruption,extracellular matrix remodeling,pi3k/akt pathway modulation,tumor progression facilitation,cancer cell invasion enhancement,protein-protein interaction
ENSG00000187758,ADH1A,aldehyde detoxification,oxidative stress response,cell proliferation,genomic instability,dna damage repair,cancer cell survival
ENSG00000091262,ABCC6,golgi apparatus localization,growth regulation,ion transport,nucleotide transport,p53 activation,tumorigenesis prevention
ENSG00000085465,OVGP1,cell proliferation,tumor progression,biomarker,cell adhesion,metastasis,glycoprotein expression
ENSG00000114770,ABCC5,drug resistance,tumor progression,multidrug transport,cell membrane regulation,xenobiotic transport,chemotherapy response
ENSG00000171766,GATM,glutamine addiction,tumor growth promotion,metabolic regulation,energy production enhancement,cellular survival support,genetic amplification correlation
ENSG00000111713,GYS2,altered expression,energy metabolism disruption,glycolytic reprogramming,oncogenic transformation driver,tumor progression contributor,cancer prognosis marker
ENSG00000119711,ALDH6A1,oxidative stress,tumor progression,cell survival,therapeutic target,aldehyde detoxification,prognostic marker
ENSG00000135929,CYP27A1,sterol 27-hydroxylase activity,cancer cell metabolism,cholesterol regulation,apoptosis modulation,cell growth control,inflammation response
ENSG00000154265,ABCA5,lipid transport disruption,tumor progression,cell proliferation promotion,poor prognosis marker,cell signaling pathway interaction,genomic instability association
ENSG00000197417,SHPK,pi3k/akt pathway regulation,cellular response modulation,tumor progression driver,mutation-induced oncogenesis,signaling molecule interaction,dual specificity protein phosphatase function
ENSG00000166741,NNMT,epigenetic regulation,metabolic reprogramming,dna methylation,chromatin remodeling,oncogenic driver,tumor progression
ENSG00000086544,ITPKC,phosphoinositide regulation,calcium signaling dysregulation,tumor progression driver,cell survival pathway,oncogenic transformation mediator,genomic instability enhancer
ENSG00000167676,PLIN4,lipid droplet formation,oncogenic protein interaction,metabolic reprogramming,cellular energy regulation,glycolytic shift,lipid synthesis upregulation
ENSG00000170949,ZNF160,tumor suppressor activity disruption,cancer cell proliferation promotion,cell cycle regulation modulation,apoptosis pathway inhibition,transcriptional regulation alteration,oncogenic driver status
ENSG00000182327,GLTPD2,lipid transport regulation,cell membrane modification,cancer cell proliferation,tumor growth promotion,chemotherapy resistance enhancement,oncogenic function
ENSG00000070526,ST6GALNAC1,glycosylation modification,o-linked glycosylation,tumorigenesis promotion,cell adhesion disruption,metastasis enhancement,therapeutic target potential
ENSG00000153976,HS3ST3A1,heparan sulfate biosynthesis,tumor progression promotion,cell migration enhancement,growth factor interaction modification,dysregulated expression,cancer-associated gene variant alteration
ENSG00000176022,B3GALT6,glycosylation regulation,tumor progression,metastasis promotion,glycosaminoglycan biosynthesis,cell proliferation enhancement,poor prognosis association
ENSG00000198715,GLMP,glycosylation pathway,oncogenic function,aberrant expression,protein modification,cell growth promotion,metastasis regulation
ENSG00000181666,ZNF875,tumor suppressor function,transcriptional regulation,overexpression associated,cell cycle progression,epigenetic modulation,chromatin remodeling
ENSG00000185947,ZNF267,krab-domain containing protein,gene regulation,chromatin remodeling,tumor progression,apoptosis inhibition,cancer cell proliferation
ENSG00000100490,CDKL1,oncogenic signaling pathways,cell proliferation,catalytic activity,genomic instability,protein kinase activation,cell cycle regulation
ENSG00000168661,ZNF30,tumor progression,oncogene function,transcriptional regulation,cell cycle modulation,chromatin remodeling,genomic instability
ENSG00000007038,PRSS21,oncogenic pathway activation,cell growth regulation,protein processing dysregulation,epithelial-to-mesenchymal transition,tumor aggressiveness promotion,biomarker potential
ENSG00000109323,MANBA,genomic alterations,cell proliferation,multifunctional serine protease,elevated expression,tumor progression,prognostic marker
ENSG00000143324,XPR1,epithelial-to-mesenchymal transition,wnt/β-catenin signaling pathway,cell-cell adhesion regulation,tumor progression facilitation,oncogene interaction,cancer cell migration
ENSG00000166004,CEP295,centriole regulation,genomic stability maintenance,tumor suppressor function,cilia formation regulation,mitotic spindle assembly,cellular homeostasis disruption
ENSG00000162039,MEIOB,meiotic recombination,homologous recombination,synaptonemal complex formation,histone modification,genome stability,tumor suppressor
ENSG00000136868,SLC31A1,copper homeostasis,dysregulation of copper transport,oxidative stress,genomic instability,cell proliferation enhancement,tumor progression
ENSG00000167914,GSDMA,gdp-fucose biosynthesis,glycoprotein regulation,cellular adhesion alteration,tumor progression modulation,therapeutic target potential,glycobiology involvement
ENSG00000148218,ALAD,heme biosynthesis,cellular proliferation,mitochondrial function,ros generation,cell migration,protein synthesis
ENSG00000147471,PLPBP,cell proliferation,pi3k/akt signaling,genomic instability,oncogene activity,tumor progression,immune suppression
ENSG00000065833,ME1,metabolic regulation,energy metabolism,oncogenic process,tumor progression,therapeutic target,biomarker candidate
ENSG00000142002,DPP9,cell proliferation,apoptosis inhibition,tumor progression,metastasis promotion,immune suppression,cancer prognosis
ENSG00000122642,FKBP9,ppiase activity,tumor suppressor regulation,oncogenic protein interaction,cell migration promotion,epithelial-to-mesenchymal transition,prognostic biomarker significance
ENSG00000172037,LAMB2,epithelial-to-mesenchymal transition,oncogene potential,cell adhesion regulation,metastasis promotion,tumor progression,basement membrane component
ENSG00000111344,RASAL1,ras pathway inhibition,constitutive activation of ras,tumor suppressor function,cell proliferation regulation,apoptosis modulation,cell cycle regulation
ENSG00000121064,SCPEP1,tumor progression,protease activation,cell survival signaling,pi3k/akt pathway modulation,p53 interaction,overexpression marker
ENSG00000088899,LZTS3,apc/c regulation,tumor suppression,cell cycle regulation,genomic instability,cell proliferation,protein-protein interaction
ENSG00000206557,TRIM71,pi3k/akt pathway inhibition,tumor suppressor function,genomic stability maintenance,ubiquitination regulation,apoptosis regulation,cell proliferation inhibition
ENSG00000119698,PPP4R4,pp2a regulation,tumor suppression,cancer driver mutation,cell cycle control,apoptosis regulation,dephosphorylation function
ENSG00000274391,TPTE,tpte tumor suppressor function,reduced expression levels,pi3k/akt pathway inhibition,oncogenic signaling enhancement,protein degradation regulation,membrane trafficking modulation
ENSG00000015520,NPC1L1,cholesterol transport,lipid metabolism regulation,cell proliferation enhancement,tumor progression modulation,pi3k/akt signaling interaction,therapeutic target for cancer treatment
ENSG00000107443,CCNJ,cellular regulation,tumor progression,dysregulation of expression,post-translational modifications,protein kinase activation,oncogenic process
ENSG00000185736,ADARB2,genomic instability,apoptosis inhibition,cell cycle dysregulation,microrna regulation,pi3k/akt pathway interaction,tumor aggressiveness
ENSG00000149657,LSM14B,ribosome biogenesis,genomic instability,dna damage response,apoptosis regulation,cell proliferation modulation,pi3k/akt pathway interaction
ENSG00000197483,ZNF628,tumor suppressor regulation,transcriptional repression,oncogene overexpression,cell proliferation enhancement,apoptosis inhibition,metastasis promotion
ENSG00000123728,RAP2C,cell signaling regulation,tumor growth promotion,mapk/erk pathway activation,cell cycle regulation,oncogenic protein interaction,tissue overexpression
ENSG00000276130,SLC22A18,organic cation transporter function,biomarker for treatment response,cellular ion regulation,transport capability disruption,small molecule compound uptake,oncogenic process contribution
ENSG00000167644,C19orf33,ubiquitination pathway regulation,amplification in tumors,oncogenesis promotion,cell proliferation enhancement,protein degradation modulation,cancer driver gene candidate
ENSG00000148411,NACC2,cellular architecture disruption,cytoskeleton regulation,microtubule interaction,cell migration facilitation,overexpression biomarker,poor prognosis indicator
ENSG00000176160,HSF5,cell proliferation,transcriptional regulation,dna damage response inhibition,oncogenic protein interaction,tumor driver gene,amplification/overexpression
ENSG00000143194,MAEL,tumor suppressor,cell cycle regulation,transcriptional regulation,apoptosis induction,chromatin modification,ubiquitination regulation
ENSG00000005379,TSPOAP1,cell-cell adhesion disruption,tumor progression marker,epithelial expression,cell migration regulator,signaling pathway interaction,protein-protein interaction
ENSG00000151322,NPAS3,cell cycle progression,constitutive activation,apoptosis evasion,genetic instability,therapeutic target,transcriptional regulation
ENSG00000167889,MGAT5B,glycoprotein biosynthesis,cell migration,epithelial-to-mesenchymal transition,tumor progression,oncogene,pi3k/akt regulation
ENSG00000153266,FEZF2,transcription factor regulation,oncogene activation,p53 pathway modulation,nf-κb signaling interaction,wnt/β-catenin pathway involvement,epithelial-to-mesenchymal transition (emt) promotion
ENSG00000111911,HINT3,chromatin remodeling,transcriptional regulation,apoptosis evasion,dna repair deficiency,tumor progression,cancer stem cell maintenance
ENSG00000110237,ARHGEF17,rhoa/rac1 pathway,gain of function mutations,cell migration,invasion,oncogenic processes,tumor progression
ENSG00000156414,TDRD9,genomic instability,dna damage response,oncogenic processes,cellular proliferation,transposon suppression,genetic stability regulation
ENSG00000110871,COQ5,mitochondrial function,electron transport chain regulation,coenzyme q10 biosynthesis,cellular energy metabolism regulation,tumorigenesis contribution,oxidative stress modulation
ENSG00000167113,COQ4,mitochondrial dysfunction,energy metabolism regulation,increased ros production,cell growth promotion,tumorigenesis driver,proliferation enhancement
ENSG00000136960,ENPP2,tumor progression,cell migration,extracellular atp regulation,nucleotide metabolism regulation,pi3k/akt pathway interaction,oncogene overexpression
ENSG00000100027,YPEL1,proto-oncogene,cell proliferation,cell cycle regulation,centrosome microtubule attachments,apoptosis resistance,tumor progression
ENSG00000178295,GEN1,genomic instability,dna repair,oncogenic transformation,aneuploidy,cell cycle checkpoints,structure-specific endonuclease activity
ENSG00000169894,MUC3A,tumor progression,cell adhesion regulation,pi3k/akt pathway modulation,apoptosis inhibition,growth promotion,metastasis correlation
ENSG00000167895,TMC8,wnt/β-catenin signaling,epithelial-to-mesenchymal transition (emt),cell adhesion regulator,metastasis suppressor function,microrna target gene,transcriptional regulation
ENSG00000243284,VSIG8,immune response regulation,molecular interaction,oncogene activation,tumor progression,apoptosis regulation,cell adhesion enhancement
ENSG00000267673,FDX2,**
genome stability,dna damage response,tumor progression,cellular maintenance,electron transfer,mutations
ENSG00000141376,BCAS3,cell cycle regulation,tumor progression,cell proliferation,survival pathway modulation,cytoskeleton interaction,microtubule stabilization
ENSG00000215455,KRTAP10-1,extracellular matrix regulation,immune response modulation,cell adhesion molecule interaction,tumor microenvironmental influence,genetic alteration involvement,therapeutic outcome impact
ENSG00000126460,PRRG2,mitotic regulator,cell proliferation enhancer,protein-protein interaction,cyclin-dependent kinase regulation,tumor aggressiveness marker,genomic instability contributor
ENSG00000141391,PRELID3A,transcriptional regulation,chromatin remodeling,dna damage response,amplification,oncogenic driver,cellular proliferation
ENSG00000160767,FAM189B,cell cycle regulation,ribosome biogenesis,oncogene activity,transcriptional regulation,rna processing,protein-protein interactions
ENSG00000198390,KRTAP13-1,keratin-associated protein,cancer development,cellular proliferation,signaling pathway modulation,gene expression regulation,tumor progression
ENSG00000196378,ZNF34,cellular differentiation,transcriptional regulation,chromatin remodeling,apoptosis evasion,tumor progression,genomic instability
ENSG00000205476,CCDC85C,cell proliferation,chromosomal instability,centrosome duplication,microtubule dynamics,spindle assembly checkpoint,cell cycle regulation
ENSG00000196263,ZNF471,transcription factor activation,oncogenic transformation,gene expression modulation,tumor proliferation,cell survival enhancement,genomic instability
ENSG00000154889,MPPE1,cell cycle regulation,oxidative stress response,tumor progression,kinase activity regulation,apoptosis modulation,genomic instability
ENSG00000120451,SNX19,escrt pathway regulation,cell migration and invasion,pten degradation facilitation,pi3k/akt signaling activation,oncogenic potential enhancement,cell surface receptor turnover
ENSG00000143452,HORMAD1,genomic instability,dna repair deficiency,meiotic disruption,protein-protein interaction,tumor suppressor role,cancer prognosis impact
ENSG00000109132,PHOX2B,neural crest origin,regulatory transcription factor,cellular proliferation,oncogenic signaling pathways,apoptosis resistance,therapeutic target
ENSG00000105877,DNAH11,cilia motility disruption,tumor aggressiveness marker,cell cycle regulator,poor prognosis indicator,dysregulated ciliary function,cancer driver protein
ENSG00000188766,SPRED3,ras/mapk pathway regulation,loss-of-function mutations,tumor suppressor function,cell proliferation regulation,cell survival enhancement,pi3k/akt pathway modulation
ENSG00000124541,RRP36,pi3k/akt signaling pathway,constitutive activation,overexpression,tumor progression,ribosome biogenesis,therapeutic target
ENSG00000113593,PPWD1,tumor suppressor regulation,cell cycle modulation,oncogenic processes,increased cell proliferation,genomic instability,therapeutic target
ENSG00000124608,AARS2,oncogenic driver,mitochondrial function,translation regulation,cell proliferation promotion,tumor aggressiveness marker,genetic instability facilitator
ENSG00000149212,SESN3,cell growth regulation,tumor progression promotion,cancer cell survival enhancement,stress response regulation,mtor pathway interaction,chemosensitivity modulation
ENSG00000132581,SDF2,pyrimidine biosynthesis,constitutive activation,cell proliferation,tumor progression,therapeutic target,metabolic regulation
ENSG00000185127,C6orf120,dna damage response,chromatin remodeling,protein-protein interactions,transcriptional regulation,biomarker potential,cancer cell proliferation
ENSG00000087301,TXNDC16,protein degradation,redox regulation,cellular stress,tumor progression,biomarker potential,oncogenic function
ENSG00000134882,UBAC2,ubiquitin ligase activity,cell proliferation,apoptosis regulation,tumor growth,poor prognosis marker,protein degradation modulation
ENSG00000128463,EMC4,genomic instability,telomere regulation,homologous recombination,dna repair pathways,chromosomal abnormalities,cancer predisposition
ENSG00000197056,ZMYM1,chromatin remodeling,oncogenic driver,cell proliferation regulation,transcriptional activation,chromatin accessibility,tumor progression
ENSG00000169715,MT1E,mt1e upregulation,apoptosis resistance,cell invasion enhancement,metastatic potential increase,nf-kappa b pathway interaction,mapk/erk pathway modulation
ENSG00000177558,FAM187B,cell cycle regulation,oncogene activation,tumor progression,apoptosis evasion,chromosomal instability,proliferation promotion
ENSG00000100263,RHBDD3,cellular homeostasis,ras/rab pathway regulation,tumor suppressor function,apoptosis modulation,cell proliferation regulation,protein modification
ENSG00000168830,HTR1E,cell proliferation,g protein-coupled receptor signaling,apoptosis regulation,cancer cell growth,signaling pathway modulation,tumorigenesis
ENSG00000121577,POPDC2,cell proliferation regulation,wnt/β-catenin pathway interaction,gain of function mutations,protein kinase modulation,oncogenic properties,epithelial cell maintenance
ENSG00000177119,ANO6,calcium-activated chloride channel function,cell migration promotion,tumor progression facilitation,ion flux regulation,poor prognosis marker,oncogene interaction enhancement
ENSG00000146828,SLC12A9,ion transport regulation,cellular ion homeostasis,cell proliferation and survival,epithelial-to-mesenchymal transition,protein interaction and signaling,biomarker potential
ENSG00000197136,PCNX3,constitutive activation,pi3k/akt signaling interaction,cell cycle regulation,tumor aggressiveness promotion,dna damage response modulation,oncogenic gain-of-function mutations
ENSG00000169762,TAPT1,cell growth regulation,potential oncogene,transcriptional regulation,protein-protein interactions,tumorigenesis,overexpression
ENSG00000087502,ERGIC2,tumor progression,cell proliferation,protein trafficking regulation,oncogenic process promotion,apoptosis inhibition,cell cycle regulation modulation
ENSG00000004866,ST7,microtubule regulation,cell cycle checkpoint disruption,oncogene activity,mitotic error promotion,cancer cell survival,tumor suppressor dysfunction
ENSG00000124532,MRS2,mitochondrial function,cellular homeostasis,metabolic reprogramming,altered glycolysis,resistance to chemotherapeutic agents,dysregulated mitochondrial dynamics
ENSG00000103550,KNOP1,chromatin remodeling,transcriptional regulation,cell cycle progression,dna repair,tumor progression,oncogene interaction
ENSG00000187792,ZNF70,genetic instability,dysregulated gene expression,tumor suppressor inhibition,gene transcription modulation,proliferation promotion,survival pathway activation
ENSG00000179965,ZNF771,chromatin regulation,dna-binding activity,transcriptional regulation,tumor suppressor gene suppression,aggressive tumor behavior,poor prognosis
ENSG00000101247,NDUFAF5,mitochondrial assembly,energy metabolism regulation,tumor suppressor activity,complex i stabilization,electron transport chain function,glycolysis promotion
ENSG00000198146,ZNF770,gene expression regulation,transcriptional activation,cell proliferation,oncogenic process,tumor progression,unregulated cell growth
ENSG00000282608,ADORA3,adenosine signaling,g-protein coupled receptor,cell proliferation,immunosuppression,tumor metastasis,oncogenic activation
ENSG00000284400,TBC1D9B,membrane trafficking regulation,rab gtpase interaction,cell signaling modulation,lipid metabolism regulation,tumor growth promotion,protein-protein interaction
ENSG00000260916,CCPG1,genomic instability,cell cycle regulation,oncogene,dna damage response,cohesin complex function,tumor aggressiveness
ENSG00000184277,TM2D3,chromatin remodeling,cancer-related modifications,histone h3 lysine 4 trimethylation (h3k4me3),cell growth regulation,nf-κb signaling pathway,ubiquitination and degradation
ENSG00000169230,PRELID1,protein degradation,ubiquitination pathway,tumor suppressor function loss,cell cycle regulation disruption,oncogenic process facilitation,genomic instability promotion
ENSG00000243130,PSG11,cell adhesion modulation,cytoskeleton regulation,cell migration enhancement,tumor progression facilitation,potential oncogene/tumor suppressor,microenvironment interaction modulation
ENSG00000243137,PSG4,psg4 upregulation,cell adhesion molecule,invasion and metastasis,tumor progression,tissue interaction,cancer-related glycoprotein
ENSG00000114902,SPCS1,membrane fusion regulation,cell migration enhancement,protein-protein interaction,oncogenic function,cell proliferation promotion,metastasis facilitation
ENSG00000141219,C17orf80,chromatin remodeling,epigenetic regulation,overexpression,tumor aggressiveness,poor prognosis,histone modification
ENSG00000198482,ZNF808,transcriptional regulator,epigenetic regulation,chromatin modification,oncogenic transformation,tumor suppression,gene expression
ENSG00000197566,ZNF624,chromatin remodeling,transcriptional regulation,oncogenic driver,tumor aggressiveness,cell cycle progression,gene expression regulation
ENSG00000177150,FAM210A,overexpression in tumors,cellular signaling pathway interaction,aberrant activation of pi3k/akt/mtor,oncogenic process promotion,therapeutic target potential,tumor progression facilitation
ENSG00000133983,COX16,mitochondrial function,oncogenic metabolic reprogramming,constitutive activation,cellular respiration,hypoxia adaptation,energy metabolism
ENSG00000156535,CD109,tumor progression,epithelial-to-mesenchymal transition,tgf-β signaling pathway,oncogenic processes,metastasis,cell proliferation
ENSG00000155275,TRMT44,trna modification,genomic instability,pi3k/akt pathway activation,tumor suppressor function,cell growth promotion,post-transcriptional regulation
ENSG00000232629,HLA-DQB2,immunomodulation,immune evasion,antigen presentation,tumor-specific immunity,adaptive immune response,mhc class ii expression
ENSG00000163864,NMNAT3,nmnat3-mediated nad+ biosynthesis,enhanced sirt1 activity,cell survival promotion,tumor microenvironment modulation,ancillary role in dna repair,prognostic marker
ENSG00000141627,DYM,cancer cell proliferation,cell migration,dynein complex regulation,microtubule-based structure formation,oncogenic signaling pathway dysregulation,therapeutic target
ENSG00000102763,VWA8,angiogenesis promotion,apoptosis evasion,cancer metastasis,cell adhesion disruption,cytoplasmic interaction,tumor progression
ENSG00000148377,IDI2,cellular metabolism regulation,tumor aggressiveness promotion,antioxidant defense modulation,apoptosis evasion,cell cycle progression enhancement,metabolic enzyme activity increase
ENSG00000262664,OVCA2,proteasome dysfunction,cell cycle regulation disruption,oncogene potential,tumor suppressor interaction,dna damage response modulation,chemotherapy resistance enhancement
ENSG00000130032,PRRG3,wnt/β-catenin signaling,oncogenic overexpression,genomic instability,cell proliferation regulation,therapeutic target,protein interaction modulation
ENSG00000163162,RNF149,e3 ubiquitin ligase activity,cell cycle regulation,dna damage response,protein degradation,oncogenic signaling,tumor suppressor
ENSG00000173451,THAP2,transcriptional regulation,chromatin remodeling,oncogenic activation,tumor progression,cell cycle control,dna damage response
ENSG00000176988,FMR1NB,rna-binding activity,alternative splicing regulation,tumor progression,cell survival promotion,metastasis facilitation,pi3k/akt pathway modulation
ENSG00000119777,TMEM214,tmem214 mutations,lipid metabolism regulation,er morphology maintenance,oncogenic function,cancer cell growth,cellular stress responses
ENSG00000164073,MFSD8,autophagy regulation,cellular homeostasis,oncogenesis,tumor cell survival,chemotherapy resistance,protein-protein interaction
ENSG00000121210,TMEM131L,oncogene,chromosomal instability,cell growth promotion,metastasis driver,protein-protein interaction,gene expression alteration
ENSG00000171208,NETO2,microtubule regulation,cell migration modulation,aneuploidy induction,cell division facilitation,tumor progression promotion,oncogenic pathway interaction
ENSG00000122912,SLC25A16,metabolic regulation,mitochondrial transport function,interaction with pdc,association with idh1 mutations,role in the warburg effect,alterations in expression associated with poor prognosis
ENSG00000106714,CNTNAP3,**

1. cell adhesion,2. tumor progression,3. cell migration,4. synaptogenesis,5. axon guidance,none
ENSG00000126243,LRFN3,wnt/β-catenin pathway,cell adhesion regulation,tumor progression,epithelial-to-mesenchymal transition,cell migration modulation,poor prognosis biomarker
ENSG00000167757,KLK11,tumor progression,metastasis promoter,proteolytic activity,epithelial-to-mesenchymal transition,pro-tumorigenic microenvironment,cancer cell proliferation
ENSG00000138759,FRAS1,loss of function mutations,tumor suppressor role,cell-cell adhesion disruption,wnt/β-catenin signaling dysregulation,metastasis promotion,prognostic marker
ENSG00000182575,NXPH3,cell adhesion modulation,metastasis promotion,epithelial-to-mesenchymal transition (emt),protein interaction,overexpression in cancer,cell migration enhancement
ENSG00000083067,TRPM3,calcium channel regulation,gene expression modulation,tumor progression association,cell proliferation enhancement,transcription factor interaction,protein kinase activation
ENSG00000144642,RBMS3,rna stability regulation,apoptosis regulation,dna repair modulation,tumor suppressor function,gene expression regulation,rna-binding protein
ENSG00000181240,SLC25A41,enhanced glutamine metabolism,mitochondrial function regulation,cell growth modulation,tumor progression,metabolic adaptation,protein-protein interaction
ENSG00000137513,NARS2,oncogenesis,genomic instability,cell survival,tumor progression,protein-protein interaction,charging trna with asparagine
ENSG00000131378,RFTN1,cell adhesion disruption,tumor progression,protein interaction,oncogenesis promotion,metastasis regulation,cell migration enhancement
ENSG00000177054,ZDHHC13,regulation of membrane-bound proteins,epithelial-to-mesenchymal transition,oncogenic processes,cell migration,apoptosis suppression,protein ubiquitination regulation
ENSG00000001630,CYP51A1,cholesterol biosynthesis,sterol regulation,enzymatic activity,tumor metabolism,cell proliferation,oncogenic pathway
ENSG00000120697,ALG5,alg5-mediated glycosylation,gain of function mutations,oncogenic transformation,cell proliferation enhancement,protein misfolding stress,tumor progression marker
ENSG00000164081,TEX264,chromatin remodeling,amplification,oncogene regulation,genomic instability,histone reader function,chromatin assembly
ENSG00000164535,DAGLB,overexpression,pi3k/akt pathway activation,pkc activation,diacetyl glycerol metabolism,apoptosis inhibition,tumor progression
ENSG00000128203,ASPHD2,genomic instability,prognostic biomarker,cell cycle regulation,dna damage response,homologous recombination repair,tumor progression
ENSG00000167775,CD320,cell cycle regulation,dna synthesis,tumor suppressor,vitamin b12 receptor,apoptosis inhibition,cancer predisposition
ENSG00000119537,KDSR,keratin sulfation,promotion of cell proliferation,modulation of emt,contribution to metastasis,association with molecular subtypes,regulation of cell adhesion
ENSG00000099904,ZDHHC8,cellular palmitoylation,oncogenic activity,enhanced cell proliferation,membrane trafficking regulation,survival signaling pathway,gene expression dysregulation
ENSG00000156599,ZDHHC5,gpcr regulation,dysregulated expression,cell surface protein trafficking,protein modification,oncogenesis,tumor progression
ENSG00000121578,B4GALT4,aberrant glycosylation,oncogene/tumor suppressor,altered expression,glycosylation processes,tumorigenesis,therapeutic target
ENSG00000132026,RTBDN,pi3k/akt pathway activation,chromatin remodeling,cell proliferation enhancement,gene expression regulation,therapeutic target,oncogenic properties
ENSG00000186787,SPIN2B,chromosomal instability,kinetochores assembly disruption,aneuploidy promotion,cell cycle deregulation,genomic alterations,microtubule dynamics alteration
ENSG00000168813,ZNF507,chromatin remodeling,dna damage response,cell proliferation,oncogene activation,transcriptional regulation,epigenetic silencing
ENSG00000248496,ZBED9,transcriptional regulator,tumor suppressor,chromatin remodeling,cellular proliferation,apoptosis regulation,prognostic marker
ENSG00000170324,FRMPD2,rho gtpase pathway,cell adhesion disruption,gain of function mutations,tumor progression,apoptosis inhibition,cell proliferation promotion
ENSG00000157637,SLC38A10,glutamine metabolism,oncogenic driver,mtor activation,cell proliferation,tumor progression,metabolic reprogramming
ENSG00000164465,DCBLD1,wnt/β-catenin signaling pathway,enhanced cell proliferation,metastatic progression,elevated expression levels,protein-protein interactions,dysregulated cellular membrane assembly
ENSG00000106692,FKTN,loss of function mutations,aberrant splicing events,glycosylation pathway disruption,tumor suppressor function,cell adhesion defects,increased cell migration
ENSG00000131019,ULBP3,immune modulation,tumor immune evasion,nk cell activation,t cell activation,cancer immunology,cell surface protein
ENSG00000125430,HS3ST3B1,heparan sulfate biosynthesis,dysregulation of glycosylation,cell proliferation,migration and invasion,tumor progression,mutation or amplification
ENSG00000131873,CHSY1,cellular homeostasis,chaperone function,glycosylation regulation,tumor suppressor,gene expression regulation,wnt/β-catenin signaling
ENSG00000102743,SLC25A15,mitochondrial function,warburg effect,oncogenic mutations,glycolytic regulation,tumor metabolism,biomarker
ENSG00000138678,GPAT3,lipid metabolism regulation,cell membrane biogenesis,oncogenic processes promotion,cell proliferation enhancement,tumor growth facilitation,prognostic biomarker candidate
ENSG00000188883,KLRG2,regulation of nk cell function,transmembrane receptor interaction,cell signaling modulation,immune system regulation,tumor microenvironment interaction,oncolytic potential
ENSG00000181027,FKRP,dystroglycan glycosylation,transmembrane protein function,glycoprotein complex disruption,cell adhesion regulation,tumor progression facilitation,therapeutic target potential
ENSG00000158470,B4GALT5,cell proliferation,tumor progression,adhesion molecule regulation,extracellular matrix modulation,pi3k/akt pathway regulation,upregulated expression
ENSG00000161682,FAM171A2,epigenetic regulation,chromatin remodeling,oncogenic signaling pathways,cell proliferation,protein-protein interactions,nucleosome remodeling deacetylase complex
ENSG00000114487,MORC1,dna helicase activity,chromosomal instability,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway interaction,genomic stability disruption,oncogenic protein interaction
ENSG00000145861,C1QTNF2,cell adhesion regulation,immune response modulation,metastasis enhancement,cell migration facilitation,protein-protein interaction,tumor microenvironment modification
ENSG00000166321,NUDT13,dna repair pathway,gain of function mutations,nucleotide homeostasis,genomic instability,tumor progression,chemotherapy resistance
ENSG00000120256,LRP11,wnt signaling regulation,tumor progression,pi3k/akt pathway interaction,mutational hotspot,gene expression alterations,cancer driver gene status
ENSG00000170571,EMB,chromatin regulation,dna damage response,oncogenic function,cell survival promotion,tumor progression,genomic instability
ENSG00000084444,FAM234B,cell-cell adhesion regulation,tumor progression,cell migration facilitation,genomic alteration involvement,transmembrane protein function,cancer progression contribution
ENSG00000164169,PRMT9,histone modification,oncogenic signaling,cell proliferation,metastasis,transcriptional regulation,poor prognosis
ENSG00000007402,CACNA2D2,calcium signaling,cell proliferation,oncogenesis,therapeutic target,dysregulation,aggressive tumor phenotypes
ENSG00000109586,GALNT7,o-glcnac modification,tumor progression,cell proliferation,signaling pathway activation,biomarker potential,therapeutic target
ENSG00000166507,NDST2,tumor progression,cell migration,metastasis,angiogenesis,glycosylation regulation,microenvironment modulation
ENSG00000070614,NDST1,tumor progression,enhanced heparan sulfate production,heparan sulfate proteoglycans,cell adhesion modulation,metastasis facilitation,angiogenesis regulation
ENSG00000187676,B3GLCT,glycosylation,cell adhesion,oncogenic driver,tumor progression,metastasis facilitation,epigenetic regulation
ENSG00000139263,LRIG3,egfr signaling regulation,tumor suppressor function,apoptosis promotion,rtk pathway inhibition,cellular regulation,oncogene activation
ENSG00000063180,CA11,tumor cell survival,tumor growth,hypoxia-inducible factor 1-alpha regulation,vascular endothelial growth factor expression,acid-base balance regulation,metastasis promotion
ENSG00000186446,ZNF501,dna damage response,epigenetic regulation,gene expression modulation,oncogenesis promotion,prognostic biomarker,transcriptional regulation
ENSG00000147869,CER1,ceramide biosynthesis,cellular homeostasis,apoptosis inhibition,oncogenic process,signaling pathway modulation,therapeutic target
ENSG00000184613,NELL2,emt induction,cell adhesion regulation,integrin modulation,tumor progression,biomarker discovery,upregulation in tumors
ENSG00000165644,COMTD1,**

metabolic regulation,cell growth and survival,neurotransmitter metabolism,cancer prognosis,oxidative phosphorylation,glycolysis 
**
ENSG00000180488,MIGA1,genomic instability,cell cycle regulation,microtubule dynamics,tumorigenesis driver,signaling pathway modulation,protein-protein interactions
ENSG00000139278,GLIPR1,tumor progression,cellular proliferation,therapeutic target,protein-protein interaction,cell signaling pathway,inflammatory response
ENSG00000103544,VPS35L,overexpression,apoptosis regulation,cell proliferation,protein-protein interactions,cell cycle dysregulation,tumor progression
ENSG00000174928,C3orf33,dna repair,cell cycle regulation,apoptosis inhibition,tumor growth promotion,mitotic spindle assembly,transcriptional regulation
ENSG00000138399,FASTKD1,mitochondrial function disruption,mitotic regulatory pathway,apoptosis resistance,cellular respiration regulation,tumor suppressor function,loss of heterozygosity
ENSG00000103356,EARS2,chromatin remodeling,aberrant histone acetylation,oncogenic transcription factors,cell proliferation enhancement,apoptosis resistance,genomic instability
ENSG00000174032,SLC25A30,energy metabolism regulation,cellular proliferation enhancement,mitochondrial function modulation,aerobic glycolysis promotion,glutaminolysis induction,cancer cell energy support
ENSG00000136444,RSAD1,oxidative stress,tumor progression,cell cycle regulation,dna repair mechanisms,reactive oxygen species production,therapeutic target
ENSG00000105696,TMEM59L,plasma membrane localization,cell adhesion disruption,oncogenic properties enhancement,emt regulation,cell migration and invasion facilitation,apoptosis resistance promotion
ENSG00000135454,B4GALNT1,**
chondroitin sulfate biosynthesis,glycoprotein synthesis,cell surface modification,tumor progression marker,apoptosis suppression,glycosylation pathway 
**
ENSG00000104497,SNX16,pi3k/akt pathway modulation,tumor progression enhancement,oncogenic signaling,cell survival promotion,apoptosis inhibition,mitotic regulation modification
ENSG00000144227,NXPH2,cellular proliferation,apoptosis regulation,tumor progression,signaling pathway involvement,oncogene function,overexpression
ENSG00000280969,RPS4Y2,genomic instability,cellular proliferation,protein synthesis regulation,dna damage response,apoptosis inhibition,cancer driver gene
ENSG00000174749,FAM241A,oncogenic potential,epithelial-to-mesenchymal transition,cell growth regulation,protein-protein interactions,signaling pathway modulation,poor prognosis association
ENSG00000157570,TSPAN18,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),growth factor receptor interaction,cell migration facilitation,stem cell maintenance,poor prognosis marker
ENSG00000168785,TSPAN5,oncogene,cell adhesion modulation,pi3k/akt pathway activation,epithelial-to-mesenchymal transition (emt),cell proliferation enhancement,metastasis facilitation
ENSG00000103978,TMEM87A,pi3k/akt pathway modulation,tumor progression driver,cell growth regulation,apoptosis resistance,ion transport regulation,membrane trafficking interaction
ENSG00000153982,GDPD1,mitochondrial function regulation,cellular energy metabolism,oncogene potential,cell cycle regulation,antioxidant defenses,prognostic marker
ENSG00000003989,SLC7A2,tumor growth promotion,amino acid transport regulation,tumor metabolic reprogramming,cell proliferation enhancement,kidney expression specificity,therapeutic target candidacy
ENSG00000109929,SC5D,cell surface modification,tumor cell adhesion,glycoprotein regulation,signaling pathway modulation,cell migration alteration,cancer progression promoter
ENSG00000023041,ZDHHC6,palmitoyltransferase activity,protein modification,cell membrane trafficking,signal transduction,cell proliferation,apoptosis regulation
ENSG00000175106,TVP23C,cell cycle regulation,oncogenic processes,protein-protein interactions,tumor growth promotion,biomarker potential,poor clinical outcomes
ENSG00000215704,CELA2B,**

cela2b's involvement in metabolic regulation,tumor suppression,downregulated expression,cell growth regulation,carcinogen metabolism,dna damage protection
ENSG00000150625,GPM6A,cell adhesion regulation,tumor progression,metastasis driver,protein interaction partner,cell membrane stabilization,cell migration modulation
ENSG00000204160,ZDHHC18,pi3k/akt pathway,oncogene,overexpression,tumor progression,cell proliferation,protein modification
ENSG00000185090,MANEAL,dna replication regulation,tumor suppressor activity,genomic stability maintenance,cell cycle control,protein-protein interaction,chromosomal segregation
ENSG00000258102,MAP1LC3B2,autophagic flux regulation,cellular stress response,oncogenic transformation,tumor aggressiveness,autophagy machinery regulation,cell survival promotion
ENSG00000102128,RAB40AL,genomic instability,chromosomal alterations,oncogenesis,cell proliferation,pi3k/akt signaling pathway,vesicle trafficking
ENSG00000285281,SGPP1,sphingolipid regulation,cell proliferation,oncogenic pathway interaction,metastasis,prognostic marker,therapeutic target
ENSG00000214113,LYRM4,mitochondrial dynamics,tumor suppressor function,glycolytic reprogramming,oxidative phosphorylation regulation,cellular metabolism regulation,protein-protein interactions
ENSG00000177000,MTHFR,genomic instability,dna repair defects,methylation alterations,apoptosis dysregulation,cell cycle disruption,folate metabolism dysfunction
ENSG00000130508,PXDN,cellular adhesion,cytoskeleton regulation,signaling pathway interaction,tumor progression,biomarker potential,genetic mutations
ENSG00000137269,LRRC1,oncogene,cell surface receptor regulation,protein-protein interaction,tumor progression driver,cell migration facilitation,proliferation enhancement
ENSG00000282830,CALB2,pi3k/akt modulation,apoptosis resistance,cell growth regulation,oncogenic mutations,calcium-binding protein function,signaling pathway interaction
ENSG00000053770,AP5M1,pi3k/akt pathway interaction,cell proliferation regulation,subcellular localization,protein sorting and trafficking regulation,oncogenic transformation contribution,potential biomarker status
ENSG00000143502,SUSD4,immune evasion,tumor progression,cell adhesion disruption,oncogenesis,prognostic marker,cancer cell survival
ENSG00000169629,RGPD8,angiogenic signaling,tumor growth regulation,cellular response modulation,biomarker potential,genomic instability contributor,protein-protein interaction inhibitor
ENSG00000112276,BVES,epithelial barrier dysfunction,tumor progression,cell migration facilitation,emt induction,prognostic biomarker,adherens junction disruption
ENSG00000151366,NDUFC2,mitochondrial dysfunction,electron transport chain,oncogenic reprogramming,cell survival,metabolic adaptation,apoptosis impairment
ENSG00000101452,DHX35,genomic instability,tumor suppressor function,dna helicase activity,transcriptional regulation,genome maintenance,brca2 interaction
ENSG00000125827,TMX4,oncogenic function,tumor progression,transcriptional regulation,cell proliferation,apoptosis evasion,dna damage response
ENSG00000129244,ATP1B2,cancer cell survival,na+/k+-atpase activity regulation,tumor progression,therapeutic target,cell migration,ion balance disruption
ENSG00000180730,SHISA2,wnt signaling pathway,cell proliferation,epithelial-to-mesenchymal transition (emt),tumor suppressor function,tissue adhesion regulation,stemness regulation
ENSG00000282739,SLC25A26,mitochondrial transport,nucleotide metabolism,energy production,glycolysis activation,tumor progression,genomic instability
ENSG00000165115,KIF27,chromosomal instability,cell proliferation,apoptosis evasion,mitotic spindle assembly,microtubule dynamics,oncogene potential
ENSG00000278565,CEACAM21,cell adhesion,immune modulation,invasion and metastasis,oncogenic signaling,tumor progression,prognostic marker
ENSG00000170426,SDR9C7,lipid metabolism regulation,tumor progression driver,metabolic reprogramming,cell growth promotion,lipid synthesis modification,fatty acid synthase activation
ENSG00000148090,AUH,altered methylation activity,overexpressed in cancer,cell growth promotion,cell signaling pathway activation,dna repair modulation,homocysteine metabolism dysregulation
ENSG00000244444,EGFL8,angiogenesis promotion,metastasis facilitation,cell adhesion regulation,tumor growth promotion,wnt/β-catenin pathway modulation,chemotherapy resistance
ENSG00000164898,FMC1,genomic instability,chromosome segregation,cohesin complex disruption,aneuploidy formation,tumor progression,oncogenesis driver
ENSG00000139324,TMTC3,cell growth regulation,oncogene overexpression,cell signaling pathway regulation,therapeutic target,tumor progression,cell proliferation enhancement
ENSG00000125247,TMTC4,cell surface expression regulation,tumor progression association,notch signaling modulation,dna repair dysregulation,protein localization control,oncogenic pathway enhancement
ENSG00000137216,TMEM63B,tumor progression,cell adhesion,transmembrane protein function,metastasis,oncogene potential,epigenetic regulation
ENSG00000146433,TMEM181,tumor suppressor function,dna repair regulation,cell cycle arrest,apoptosis induction,epigenetic silencing,transcriptional repression
ENSG00000157600,TMEM164,cell membrane dynamics,epithelial-to-mesenchymal transition,oncogenic signaling pathways,transmembrane protein regulation,autophagy regulation,poor prognostic marker
ENSG00000106809,OGN,integrin interaction,extracellular matrix assembly,oncogene activation,cell migration and invasion,cell proliferation enhancement,proteoglycan overexpression
ENSG00000064763,FAR2,ras pathway modulation,oncogenic function,cell cycle regulation,apoptosis inhibition,dna repair mechanism,tumor progression marker
,MARC2,ion transport regulation,calcium homeostasis,autophagy modulation,carcinogenesis,tumor progression,cellular homeostasis disruption
ENSG00000179598,PLD6,pi3k/akt/mtor pathway,phospholipase d activity,gain of function mutations,tumor progression,oncogene,cell signaling regulation
ENSG00000147119,CHST7,cell adhesion,oncogene,tumor progression,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway,resistance to chemotherapy
ENSG00000116273,PHF13,genomic instability,chromatin remodeling,tumor suppressor function,cellular proliferation,genetic mutation,transcriptional regulation
ENSG00000183032,SLC25A21,cancer metabolism,mitochondrial function,energy production,fatty acid oxidation,prognostic biomarker,therapeutic target
ENSG00000113583,C5orf15,cell cycle regulation,overexpression,apoptosis inhibition,tumor progression,proliferation enhancement,protein interaction modulation
ENSG00000037749,MFAP3,tumor progression,epithelial-to-mesenchymal transition (emt),overexpression,promotes cell migration,biomarker for cancer diagnosis,interaction with pi3k/akt pathway
ENSG00000084110,HAL,genomic instability,cell growth regulation,oncogenesis promotion,transcriptional control,dna repair modulation,tumor progression driver
ENSG00000198276,UCKL1,oncogenic,overexpression,pi3k/akt pathway modulation,cell proliferation regulation,protein stability regulation,deubiquitinating enzyme activity
ENSG00000183066,WBP2NL,pi3k/akt pathway interaction,gene amplification,oncogenic function,cell proliferation enhancement,molecular regulation disruption,ubiquitin ligase activity
ENSG00000186075,ZPBP2,oncogenic properties,overexpression,tumor progression,cell adhesion regulation,immune evasion,prognostic biomarker
ENSG00000104760,FGL1,angiogenesis promotion,coagulation regulation,immune evasion,metastasis facilitation,prognostic marker,tumor progression
ENSG00000113391,FAM172A,cell migration,signaling pathway regulation,oncogenic potential,tumor progression,protein interaction modulation,growth factor regulation
ENSG00000110811,P3H3,p53 modulation,transcriptional regulation,cell proliferation,angiogenesis,protein interaction,oncogenic activity
ENSG00000133612,AGAP3,actin cytoskeleton regulation,cell migration promotion,gef activity,rho gtpase activation,tumor progression facilitation,pi3k/akt pathway interaction
ENSG00000122787,AKR1D1,bile acid metabolism,cell cycle progression,apoptosis inhibition,oncogenic role,potential biomarker,tumor progression
ENSG00000135898,GPR55,cannabinoid-activated,g-protein coupled receptor,oncogenic driver,pi3k/akt pathway activation,cell growth regulation,tumor progression facilitation
ENSG00000158764,ITLN2,tumor progression,immune modulation,cell migration,metastasis,therapeutic target,genomic profiling
ENSG00000055732,MCOLN3,calcium signaling pathway,cellular homeostasis regulation,epithelial-to-mesenchymal transition (emt),oncogenic driver,protein-protein interaction modulation,tumor aggressiveness
ENSG00000135317,SNX14,endosomal recycling pathway,cell surface receptor regulation,oncogenic transformation,poor prognosis marker,tumorigenesis regulator,biomarker for diagnosis and prognosis
ENSG00000106603,COA1,mitochondrial dysfunction,cytochrome c oxidase subunit,electron transport chain regulation,atp production alterations,cancer-related mutations,tumor suppressor potential
ENSG00000153898,MCOLN2,lysosomal dysfunction,cellular proliferation,autophagy regulation,cancer stemness,tumor growth,overexpression
ENSG00000156162,DPY19L4,chromatin remodeling,genome instability,mutational hotspot,oncogenic driver,tumor suppressor dysfunction,dna replication regulation
ENSG00000007341,ST7L,pi3k/akt/mtor pathway inhibition,genomic stability maintenance,tumor suppressive function loss,cell cycle regulation disruption,apoptosis evasion enhancement,protein-protein interaction disruption
ENSG00000278889,OR2S2,olfactory receptor,cell proliferation,overexpression,tumor progression,biomarker,cell signaling pathways
ENSG00000121377,TAS2R7,g protein-coupled receptor pathway,tumor progression,bitter compound binding,gpcr signaling,phospholipase c activation,protein kinase c activation
ENSG00000157111,TMEM171,transmembrane protein regulation,protein trafficking disruption,tumor aggressiveness,molecular chaperone function,cellular stress response activation,oncogenic signaling modulation
ENSG00000244617,ASPRV1,tumor suppressor function,serine protease inhibition,cell growth regulation,survival pathway modulation,biomarker potential,poor prognosis association
ENSG00000172061,LRRC15,cell migration and adhesion,oncogenic effects,overexpression,cell invasion and metastasis,biomarker for disease outcome,pi3k/akt signaling pathway
ENSG00000164318,EGFLAM,angiogenesis facilitation,tumor progression driver,cell proliferation enhancement,vascular remodeling involvement,protein-protein interaction mediator,genomic upregulation indicator
ENSG00000183098,GPC6,cell surface attachment,glycosylphosphatidylinositol anchor,hepran sulfate proteoglycan function,wnt/β-catenin signaling pathway,oncogenic function alteration,tumor suppressor or oncogene
ENSG00000054690,PLEKHH1,microtubule regulation,genome instability,tumor suppressor function,cell division disruption,mesenchymal transition promotion,therapeutic target candidacy
ENSG00000126259,KIRREL2,cell adhesion disruption,gain of function mutations,overexpression in cancer tissues,increased cell proliferation,role in tumor progression,tumor metastasis facilitation
ENSG00000165828,PRAP1,chromatin remodeling,cell cycle regulation,tp53 interaction,tumor progression,gene expression modulation,nuclear transport pathway
ENSG00000162769,FLVCR1,iron homeostasis,oncogene activation,cell proliferation,tumor growth,metastasis promotion,heme export dysfunction
ENSG00000072041,SLC6A15,tumor suppressor function,cellular homeostasis regulation,neurotransmitter transport,altered expression levels,protein interaction modulation,cancer therapeutic target
ENSG00000147100,SLC16A2,metabolic adaptation,energy metabolism regulation,lactate transport facilitation,tumor progression promotion,cellular energy maintenance,short-chain fatty acid transport
ENSG00000176142,TMEM39A,endoplasmic reticulum stress,unfolded protein response,apoptosis resistance,tumor aggressiveness,cellular homeostasis disruption,er signaling pathway
ENSG00000125434,SLC25A35,mitochondrial transport,cellular respiration,electron transport chain disruption,mitochondrial membrane potential,apoptosis evasion,glycolytic reprogramming
ENSG00000164291,ARSK,arsenite resistance,genomic instability,oxidative stress response,tumor progression,cancer cell survival,dna damage repair
ENSG00000184374,COLEC10,tumor progression,cell proliferation,complement system activation,genomic profiling,immune evasion,oncogene expression
ENSG00000025423,HSD17B6,metabolic reprogramming,oncogene regulation,cellular redox balance,tumor progression,glycolysis increase,glutamine consumption
ENSG00000171936,OR10H3,g-protein coupled receptor,olfactory receptor family,cell proliferation,tumor microenvironment modulation,upregulated expression levels,signaling pathway activation
ENSG00000151093,OXSM,mtor pathway regulation,cell proliferation enhancement,oncogenesis driver,apoptosis resistance,therapeutic target,genomic overexpression
ENSG00000175065,DSG4,tumor suppression,cell detachment,downregulated expression,poor prognosis,tissue integrity loss,stem cell marker upregulation
ENSG00000184635,ZNF93,transcriptional regulation,oncogenic driver,cell proliferation regulator,tumor suppressor repressor,poor prognosis marker,therapeutic target
ENSG00000118620,ZNF430,cellular proliferation,transcriptional regulation,zinc finger domain interaction,genomic amplification,tumor suppressor function,dna repair pathway
ENSG00000136877,FPGS,dna methylation,histone modification,same synthesis,cell proliferation,oncogenic growth,chemoresistance
ENSG00000095981,KCNK16,tumor progression,constitutive activation,potassium channel regulation,tumor cell migration,proliferation regulation,cancer therapeutic target
ENSG00000173621,LRFN4,cell adhesion disruption,signaling pathway activation,tumor progression facilitation,overexpression in cancer,angiogenesis promotion,cell migration enhancement
ENSG00000143061,IGSF3,immunoglobulin superfamily,cell migration,metastasis promotion,tumor growth regulation,angiogenesis induction,pi3k/akt pathway interaction
ENSG00000138617,PARP16,chromatin remodeling,transcriptional regulation,oncogenic signaling pathway,genomic instability,tumor progression,prognostic marker
ENSG00000115539,PDCL3,microtubule stabilization,overexpression,cell proliferation,cellular transport,oncogene potential,tumor progression
ENSG00000161395,PGAP3,**

protein modification,lysosomal function disruption,post-translational regulation,oncogenic driver,protein degradation impairment,cell signaling pathway alteration
ENSG00000213413,PVRIG,immune suppression,tumor progression,poor prognosis,therapeutic target,cancer immunology,immune checkpoints
ENSG00000116138,DNAJC16,endoplasmic reticulum stress regulation,apoptosis resistance,protein folding chaperone function,cell survival promotion,tumor progression association,therapeutic target candidate
ENSG00000185561,TLCD2,pi3k/akt pathway activation,oncogenic potential,transcriptional regulation,cell cycle progression,dna damage response,tumor cell survival
ENSG00000120594,PLXDC2,cell surface receptor trafficking,epidermal growth factor receptor pathway activation,gain of function mutations,oncogenic processes promotion,signaling cascade regulation,tumor progression facilitation
ENSG00000070413,DGCR2,microrna processing,cell proliferation,tumor progression,apoptosis regulation,genomic instability,therapeutic target
ENSG00000048140,TSPAN17,cell adhesion,molecular interactions,tumor progression,biomarker candidate,cell migration,angiogenesis
ENSG00000019102,VSIG2,cellular proliferation,signaling pathway modulation,immune response regulation,tumor progression promoter,pi3k/akt pathway interaction,overexpression
ENSG00000171004,HS6ST2,glycosylation regulation,tumor progression,immune evasion,cell proliferation enhancement,sulfation activity increase,glycosaminoglycan modification
ENSG00000178904,DPY19L3,genomic instability,mitotic spindle assembly,chromosomal segregation,aneuploidy suppression,cell division regulation,mutational impact
ENSG00000177034,MTX3,mtx3 downregulation,oxidative stress protection loss,zinc homeostasis disruption,tumor suppressor function,genomic instability contributor,gain-of-function mutation
ENSG00000106560,GIMAP2,apoptosis regulation,tumor progression,cellular overexpression,guanosine triphosphate activity,lymphocyte development,epithelial tumor involvement
,KIAA0391,tumor progression,oncogenic protein overexpression,pi3k/akt/mtor pathway activation,dna damage response modulation,cell cycle regulation disruption,tumor growth promotion
ENSG00000284120,KIR2DS1,potassium channel regulation,cell proliferation enhancement,tumor progression facilitation,ion homeostasis disruption,therapeutic target potential,oncogenic process involvement
ENSG00000133317,LGALS12,tumor progression,cell proliferation,protein-protein interaction,signaling pathway modulation,apoptosis regulation,cancer progression
ENSG00000172551,MUCL1,tumor progression,cancer cell survival,oncogenesis,cell proliferation,apoptosis inhibition,cell adhesion modulation
ENSG00000174944,P2RY14,purinergic signaling,immune modulation,cell proliferation,tumor microenvironment,g protein-coupled receptor,oncogenic processes
ENSG00000198108,CHSY3,chondroitin sulfate biosynthesis,tumor progression,metastasis promotion,cell adhesion enhancement,immune evasion facilitation,oncogenic role
ENSG00000111885,MAN1A1,glycoprotein processing,mannose residues modification,n-glycan regulation,tumor progression marker,wnt/β-catenin pathway modulation,cancer driver gene candidate
ENSG00000183798,EMILIN3,angiogenic sprouting,ecm remodeling,cell migration,tumor progression,mechanical regulation,cell adhesion
ENSG00000145882,PCYOX1L,cellular proliferation,heme biosynthesis,metabolic regulation,protein interaction,iron oxidation,tumor microenvironment modulation
ENSG00000149577,SIDT2,genomic instability,chromatin remodeling,cell growth regulation,tumor suppressor function,dna damage response pathway alteration,swi/snf complex interaction
ENSG00000198743,SLC5A3,ion transport regulation,cellular proliferation,oncogenic processes,tumor progression,prognostic marker,cellular growth modulation
ENSG00000117069,ST6GALNAC5,tumor progression,prognostic marker,overexpression,cell proliferation,signaling pathway modulation,glycosylation
ENSG00000102078,SLC25A14,mitochondrial carrier function,energy metabolism regulation,oxidative stress modulation,cellular proliferation promotion,tumor progression facilitation,cancer cell survival enhancement
ENSG00000111801,BTN3A3,transcriptional repression,cell proliferation enhancement,gene expression dysregulation,tumor suppressor suppression,chromatin modification interaction,btb/poz domain function
ENSG00000026950,BTN3A1,immunosuppression,tumor microenvironment modulation,t-cell regulation,protein-protein interactions,cell proliferation regulation,endoplasmic reticulum localization
ENSG00000240654,C1QTNF9,apoptosis regulation,cell growth promotion,immune response modulation,inflammation regulation,oncogene role,tumor necrosis factor superfamily interaction
ENSG00000118298,CA14,angiogenesis promotion,tumor growth facilitation,epithelial-to-mesenchymal transition (emt),metastasis enhancement,hypoxia adaptation,transcription factor modulation
ENSG00000128274,A4GALT,glycoprotein synthesis,cell proliferation,tumor progression,therapeutic target,genomic profiling,poor prognosis
ENSG00000166997,CNPY4,pi3k/akt pathway interaction,oncogene activity,cell proliferation regulation,tumor progression association,poor prognosis indicator,protein-protein interaction
ENSG00000256453,DND1,cell cycle regulation,dna repair regulation,tumor suppression,rna-binding protein,genomic stability maintenance,p53 pathway interaction
ENSG00000141933,TPGS1,cellular lipid metabolism,phospholipid synthesis regulation,golgi apparatus resident protein,cell growth and differentiation regulation,oncogenic signaling pathway interaction,tumorigenesis and metastasis facilitation
ENSG00000137821,LRRC49,overexpression,cell adhesion disruption,tumor progression promotion,poor prognosis indicator,therapeutic target candidate,signaling pathway interaction
ENSG00000172339,ALG14,n-glycosylation pathway,cell surface protein expression,glycoprotein biosynthesis,cell proliferation,genomic instability,oncogenic processes
ENSG00000005059,MCUB,metabolic regulation,cellular ph regulation,tumor suppressor function,genomic instability,therapeutic target,cancer progression
ENSG00000248144,ADH1C,alcohol metabolism,oxidative stress regulation,detoxification pathways,reactive oxygen species regulation,cellular adaptation mechanisms,chemotherapy resistance modulation
ENSG00000102287,GABRE,gaba_a receptor modulation,tumor microenvironment regulation,cell proliferation enhancement,survival signaling pathway interaction,therapeutic target potential,genomic instability association
ENSG00000137198,GMPR,g-protein coupled receptor regulation,oncogenic signaling pathway activation,cellular proliferation enhancement,tumor progression promotion,therapeutic target potential,genomic alteration
ENSG00000169508,GPR183,cell signaling pathway,oncogene activation,tumor progression,immune response modulation,cell proliferation enhancement,metastasis promotion
ENSG00000203737,GPR52,gain of function,constitutive activation,genomic profiling,cell proliferation,metastasis,pi3k/akt pathway
ENSG00000135912,TTLL4,microtubule regulation,tumorigenesis,cell proliferation,signaling pathway interaction,overexpression,metastasis promotion
ENSG00000165799,RNASE7,immune evasion,tumor suppressor,epigenetic regulation,promoter methylation,microrna degradation,antiviral defense
ENSG00000179913,B3GNT3,glycosylation regulation,tumor aggressiveness,poor prognosis,wnt/β-catenin pathway,cell proliferation,metastasis facilitation
ENSG00000106526,ACTR3C,proteasome regulation,cell cycle progression,tumor aggressiveness,oncogenic processes,cell proliferation,enhanced survival
ENSG00000164048,ZNF589,transcriptional regulation,cancer driver,cellular proliferation,epi-gene regulation,methylation status alteration,tumor suppressor silencing
ENSG00000090612,ZNF268,transcription factor activity,zinc finger motifs,tumor suppressor function,cell cycle regulation,apoptosis modulation,dna repair pathways
ENSG00000169258,GPRIN1,cell cycle regulation,oncogene function,cdk4 modulation,mapk pathway interaction,dna replication modulation,genomic stability disruption
ENSG00000103241,FOXF1,transcriptional regulation,oncogenic driver,cell proliferation,tumor progression,prognostic marker,chromatin remodeling
ENSG00000076351,SLC46A1,folate metabolism,cell membrane transport,protein-protein interactions,folate receptor interaction,upregulation in cancer cells,biomarker potential
ENSG00000143612,C1orf43,cell cycle regulation,oncogene function,protein-protein interactions,tumor proliferation,mitotic checkpoint regulation,gene expression modulation
ENSG00000162600,OMA1,mitochondrial membrane protein,lon protease regulation,tumor suppressor p53 interaction,oncogenic overexpression,cell survival pathway regulation,mitochondrial dynamics maintenance
ENSG00000275600,PIGW,glycosylation pathway,oncogenic protein,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor aggressiveness,metastasis promotion
ENSG00000141437,SLC25A52,mitochondrial carrier,metabolic regulation,cellular metabolism,tumor progression,protein interaction,genetic alterations
ENSG00000283034,ZNF445,tumor suppressor gene silencing,zinc finger protein function,gene expression regulation,chromatin remodeling,cell proliferation enhancement,oncogenesis promotion
ENSG00000161905,ALOX15,cell adhesion molecule regulation,inflammation regulation,lipid mediator production,metastasis promotion,proliferation enhancement,survival pathway activation
ENSG00000166396,SERPINB7,apoptosis inhibition,oncogenic properties,cell survival,cysteine protease inhibition,tumor progression,prognostic biomarker
ENSG00000118017,A4GNT,glycosylation regulation,n-acetylglucosaminyltransferase function,protein modification,cell adhesion modulation,cancer progression,metastasis facilitation
ENSG00000198792,TMEM184B,**
cellular regulation,tumor promotion,genetic alterations,protein-protein interaction,cancer biology,proliferation enhancement
**
ENSG00000111684,LPCAT3,lysophosphatidylcholine acyltransferase,cell membrane fluidity,pi3k/akt pathway,oncogenic signaling,tumor progression,metastasis
ENSG00000167332,OR51E2,olfactory receptor activation,cell cycle regulation,apoptosis inhibition,tumor progression promoter,proliferation enhancement,poor prognosis marker
ENSG00000164180,TMEM161B,calcium signaling pathway,store-operated calcium entry (soce) regulation,cell proliferation,tumor progression,aggressive tumor behavior,poor patient prognosis
ENSG00000139624,CERS5,ceramide biosynthesis,gain of function mutations,cell survival,tumor progression,immune evasion,metabolic reprogramming
ENSG00000181396,OGFOD3,oncogenic function,proliferation promotion,anti-apoptotic activity,chemotherapy resistance,tumor growth facilitation,cell survival pathway modulation
ENSG00000149582,TMEM25,akt/mtor signaling pathway,cell membrane integrity disruption,cellular proliferation enhancer,oncogenic protein interaction,therapeutic target,genomic overexpression
ENSG00000176454,LPCAT4,pi3k/akt pathway activation,cell proliferation enhancement,metabolic regulation,lipid biosynthesis,oncogenic process promotion,therapeutic target
ENSG00000197586,ENTPD6,purinergic signaling,cell proliferation,oncogenesis,extracellular atp regulation,tumor progression,gain of function mutations
ENSG00000178752,ERFE,genomic instability,overexpression,transcriptional regulator,cell proliferation,survival pathway,chromatin remodeling
ENSG00000170801,HTRA3,cell migration,proteolytic degradation,tumor progression,metastasis promotion,cancer cell invasion,signaling pathway modulation
ENSG00000185621,LMLN,histone modification,protein-protein interaction,chromatin remodeling,apoptosis inhibition,cancer driver gene,cell cycle progression
ENSG00000120820,GLT8D2,glutamate metabolism,cell membrane transport,oncogenic processes,cellular redox state,tumor progression,metabolic regulation
ENSG00000173852,DPY19L1,genomic instability,oncogenesis,dna damage tolerance,chromosomal instability,genomic maintenance,protein interaction
ENSG00000164976,MYORG,enhanced cell proliferation,genomic instability,oncogene activation,apoptosis evasion,cell cycle regulation,tumor progression
ENSG00000144959,NCEH1,cholesterol metabolism,cell membrane modification,lipid homeostasis regulation,cancer cell survival enhancement,therapeutic resistance modulation,cell growth promotion
ENSG00000106771,TMEM245,pi3k/akt pathway modulation,transmembrane protein function,overexpression in cancer,tumor progression promotion,poor prognosis association,resistance to chemotherapy
ENSG00000169379,ARL13B,arl13b dysregulation,genomic instability,cell cycle regulation,microtubule organization,cancer driver gene,tumor progression
ENSG00000182162,P2RY8,**

* oncogene,* immune cell modulation,* cell proliferation,* metastasis promotion,* g protein-coupled receptor,* ligand binding 

**
ENSG00000133657,ATP13A3,iron regulation,cellular growth,apoptosis modulation,genomic stability,tumor progression,metal ion transport
ENSG00000115828,QPCT,glutaminyl-peptide cyclotransferase activity,metabolic reprogramming,glutamine metabolism,oncogenic transformation,cell proliferation,protein-protein interactions
ENSG00000198018,ENTPD7,purinergic signaling pathway,tumor growth promotion,cell proliferation regulation,immune evasion facilitation,poor prognosis marker,tumor microenvironment modulation
,TMEM8A,cell signaling pathways,protein-protein interaction,tumor progression,cell growth modulation,therapeutic target,genetic mutation
ENSG00000146282,RARS2,mitochondrial dysfunction,protein synthesis impairment,tumor growth promotion,cellular transformation,genomic instability,cancer-driver function
ENSG00000069943,PIGB,cellular proliferation,cell survival mechanisms,enzyme regulation,glycosidase activity,pancreatic lipase activation,protein interaction
ENSG00000163755,HPS3,melanosome biogenesis,autophagy regulation,cell survival enhancement,melanization-independent mechanisms,tumor aggressiveness promotion,metastatic potential increase
ENSG00000111728,ST8SIA1,oncogenic transformation,glycosylation pattern regulation,tumor progression driver,therapeutic target,aberrant expression association,poor prognosis marker
ENSG00000269556,TMEM185A,cellular homeostasis,dysregulated expression,immune evasion,maintenance of stemness,metastatic promotion,pathway modulation
ENSG00000226479,TMEM185B,pi3k/akt pathway interaction,oncogenic process promotion,cell survival enhancement,tumor progression regulation,genomic instability induction,therapeutic target potentiality
ENSG00000143653,SCCPDH,multifunctional protein,tumor progression,dna repair regulation,cellular proliferation enhancement,therapeutic target,prognostic marker
ENSG00000115488,NEU2,cell surface regulation,epithelial-to-mesenchymal transition,glycosylation enzyme function,metastasis promotion,tumor progression,surface protein modulation
ENSG00000196950,SLC39A10,**

slc39a10's role as a zinc transporter,alterations in iron homeostasis,oxidative stress induction,dna damage and mutations,cell cycle regulation disruption,apoptosis suppression
ENSG00000112195,TREML2,tumor progression,immune evasion,cell surface receptor,oncogenic signaling,macrophage activation,immune suppression
ENSG00000153214,TMEM87B,tumor progression,metastasis,oncogene,cell growth regulation,cell migration,pi3k/akt pathway interaction
ENSG00000086696,HSD17B2,steroid hormone regulation,cellular metabolism,tumor progression,oncogenesis,cell growth modulation,hormone-dependent proliferation
ENSG00000090530,P3H2,collagen biosynthesis,overexpression,tumor progression,metastasis,angiogenesis modulation,cancer microenvironment modification
ENSG00000206072,SERPINB11,tumor suppressor function,protease inhibition,apoptosis regulation,epithelial-to-mesenchymal transition,reduced expression,poor prognosis
ENSG00000152749,GPR180,g-protein coupled receptor activation,cell migration,oncogenic signaling,pi3k/akt pathway activation,tumor growth promotion,adhesion molecule regulation
ENSG00000115525,ST3GAL5,altered glycosylation,biosynthesis of gangliosides,cancer cell survival,cell adhesion modulation,immune evasion,tumor invasion and metastasis
ENSG00000243449,C4orf48,pi3k/akt pathway modulation,gene overexpression,cell growth promotion,oncogenic potential,cellular signaling regulation,epithelial-to-mesenchymal transition
ENSG00000169884,WNT10B,wnt/β-catenin pathway,epithelial-to-mesenchymal transition,chromatin accessibility,oncogenic driver,tumor progression,therapeutic target
ENSG00000070718,AP3M2,cell growth enhancement,cell survival pathway activation,endosomal trafficking regulation,invasive potential increase,metastatic signaling modulation,oncogenic pathway interaction
,FUK,actin cytoskeleton regulation,cell migration facilitation,oncogenic potential increase,metastasis promotion,cancer progression involvement,genetic mutation impact
ENSG00000145309,CABS1,oncogenic protein scaffolding,genomic instability,cellular survival enhancement,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000122778,KIAA1549,mitotic checkpoint regulation,genomic instability,amplification or overexpression,tumor growth promotion,cell proliferation enhancement,cyclin-dependent kinase regulation
ENSG00000110975,SYT10,transcriptional regulation,dysregulated expression,fusion oncoprotein complex,genomic instability,tumor progression,synovial sarcoma oncogenesis
ENSG00000184330,S100A7A,s100 protein family,cellular proliferation,epithelial-to-mesenchymal transition,signaling pathway regulation,calcium ion binding,upregulated gene expression
ENSG00000172888,ZNF621,dna-binding activity,tumor progression,cellular differentiation,apoptosis regulation,transcriptional regulation,cancer prognosis
ENSG00000149328,GLB1L2,altered glucose metabolism,aberrant cell growth,genetic mutations,cell proliferation,enhanced glycolysis,therapeutic target
ENSG00000169105,CHST14,proteoglycan modification,cell proliferation,oncogenesis,adhesion modulation,glycosaminoglycan sulfation,tumor invasion
ENSG00000196562,SULF2,heparan sulfate regulation,wnt/β-catenin pathway interaction,cell surface modulation,tumor progression driver,oncogene activation,metabolic regulation alteration
ENSG00000088812,ATRN,genomic instability,dna damage response,cell cycle regulation,tumor progression,genetic mutations,cancer driver gene
ENSG00000144357,UBR3,protein degradation regulation,tumor suppressor function,oncoprotein targeting,cell cycle checkpoint regulation,dna repair pathway modulation,apoptosis induction
ENSG00000106868,SUSD1,tumor suppressor activity,oncogene function,cell proliferation regulation,apoptosis modulation,angiogenesis regulation,wnt/β-catenin pathway interaction
ENSG00000146833,TRIM4,cell cycle regulation,e3 ubiquitin ligase activity,genomic instability,impaired cell proliferation,protein-protein interaction,ubiquitination and degradation
ENSG00000100276,RASL10A,ras superfamily member,cell signaling pathway,protein-protein interaction,mutation-driven oncogenesis,cancer cell proliferation,survival advantage
ENSG00000168528,SERINC2,**
cellular entry inhibition,loss-of-function mutations,pi3k/akt pathway regulation,host-virus interaction modulation,immune evasion mechanism,therapeutic target 
**
ENSG00000110013,SIAE,sialic acid binding,cell-cell interactions,tumor progression,metastasis associated,adhesion molecule,cell migration and invasion
ENSG00000138744,NAAA,lysophospholipid modification,cell membrane homeostasis,fatty acid transfer,lipid metabolism regulation,oncogenic process modulation,therapeutic target potential
ENSG00000013288,MAN2B2,lysosomal function,cellular proliferation,apoptosis regulation,autophagy modulation,glycoprotein degradation,cancer biomarker
ENSG00000140993,TIGD7,cell cycle regulation,ubiquitin-proteasome system regulation,protein degradation regulation,oncogenic protein accumulation,tumor suppressor function,cell growth regulation
ENSG00000147432,CHRNB3,nicotinic acetylcholine receptor function,cell proliferation promotion,prognostic marker,pi3k/akt pathway interaction,apoptosis suppression,tumor progression facilitation
ENSG00000174428,GTF2IRD2B,chromatin remodeling,transcriptional dysregulation,oncogenic signaling,cell proliferation,enhanced survival,aberrant gene expression
ENSG00000112761,CCN6,angiogenesis promotion,cell adhesion disruption,epithelial-to-mesenchymal transition,metastasis enhancement,oncogenic driver,poor prognosis marker
ENSG00000167261,DPEP2,cellular homeostasis regulation,ion and small molecule regulation,tumor progression driver,therapeutic target,genetic mutation impact,cellular signaling pathway interaction
ENSG00000033100,CHPF2,protein folding regulation,tumor suppressor activity,misfolded protein accumulation,cellular stress response,protein homeostasis disruption,oncogenic signaling pathway
ENSG00000168569,TMEM223,lipid transport regulation,endoplasmic reticulum stress response,mitochondrial function modulation,cell proliferation enhancement,tumor progression promotion,genomic instability induction
ENSG00000145990,GFOD1,mitochondrial enzyme,energy metabolism regulation,tumor growth promotion,glycolysis and glutaminolysis regulation,cellular energy homeostasis maintenance,oncogenic mutation
ENSG00000141098,GFOD2,mitochondrial function,cellular energy metabolism,fatty acid metabolism,citrate shuttle mechanism,tumor microenvironment modulation,glycolytic reprogramming
ENSG00000162694,EXTL2,dna repair,genome instability,tumor suppressor function,mutation hotspot,homologous recombination,non-homologous end joining
ENSG00000139572,GPR84,tumor progression,fatty acid sensing,oncogenic potential,immune evasion,angiogenesis promotion,cell proliferation enhancement
ENSG00000188095,MESP2,epithelial-to-mesenchymal transition (emt),oncogene activation,pi3k/akt/mtor pathway regulation,transcription factor dysregulation,cell cycle progression,apoptosis suppression
ENSG00000157617,C2CD2,tumor progression,cell adhesion regulation,oncogene activation,pi3k/akt pathway interaction,constitutive activation mutations,therapeutic target
ENSG00000095203,EPB41L4B,chromatin remodeling,transcriptional regulation,tumor progression,protein-protein interaction,oncogenic potential,poor prognosis indicator
ENSG00000161714,PLCD3,pkc activation,cell proliferation,tumor growth,metastasis promotion,second messenger production,protein interaction
ENSG00000288508,ISLR,immune system regulation,cell proliferation,tumor microenvironment modulation,immunotherapy target,protein-protein interaction,molecular alteration
ENSG00000170848,PSG6,cell adhesion modulation,growth factor receptor interaction,oncogene overexpression,tumor progression facilitation,proteoglycan function disruption,metastasis enhancement
ENSG00000204941,PSG5,overexpression,cell adhesion modulation,tumor progression,poor prognosis,signaling pathway regulation,epithelial-to-mesenchymal transition
ENSG00000221826,PSG3,cell adhesion disruption,tumor progression facilitation,oncogenic protein overexpression,metastasis enhancement,cancer cell migration promotion,epithelial-to-mesenchymal transition regulation
ENSG00000129667,RHBDF2,notch signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,protein regulation
ENSG00000139344,AMDHD1,lipid metabolism regulation,cell membrane integrity modulation,phospholipid processing,energy metabolism regulation,cancer progression association,tumor microenvironment interaction
ENSG00000159579,RSPRY1,calcium signaling,oncogene function,cell proliferation,survival mechanism,tumor progression,apoptosis regulation
ENSG00000187054,TMPRSS11A,tumor invasion,protease activation,cell migration,extracellular matrix degradation,oncogenic expression,poor prognosis marker
ENSG00000166682,TMPRSS5,transmembrane serine protease activity,protein processing regulation,epithelial tissue expression,cell proliferation enhancement,tumorigenesis involvement,oncogene potential
ENSG00000134779,TPGS2,androgen receptor activation,genetic fusion with erg,cell proliferation enhancement,survival pathway modulation,tumor metastasis facilitation,proteolytic activity regulation
ENSG00000186919,ZACN,zinc finger protein,tumor suppressor function,cell cycle regulation,apoptosis induction,gene expression regulation,protein-protein interaction
ENSG00000149150,SLC43A1,lipid metabolism regulator,cell growth promoter,energy homeostasis modifier,tumor suppressor candidate,protein transporter,metabolic pathway participant
ENSG00000171466,ZNF562,wnt/β-catenin signaling,cell proliferation,transcriptional regulation,chromosomal instability,oncogenic activation,aneuploidy
ENSG00000171469,ZNF561,**

zinc finger protein,chromatin remodeling,tumor progression,overexpression,histone modification,cell proliferation 
**
ENSG00000167981,ZNF597,tumor suppressor activity loss,transcriptional regulation disruption,oncogenic function,cell proliferation enhancement,apoptosis inhibition,epigenetic regulation alteration
ENSG00000124302,CHST8,chondroitin sulfate biosynthesis,oncogene activation,tumor progression,glycosylation regulation,cell migration facilitation,prognostic biomarker
ENSG00000087299,L2HGDH,metabolic reprogramming,tumor metabolism,genomic instability,dna damage repair,cell growth promotion,energy metabolism alteration
ENSG00000276175,LILRA3,immune evasion mechanisms,innate immunity suppression,tumor-infiltrating lymphocytes modulation,cell adhesion regulation,cancer-related immune suppression,suppressor of innate immune response
ENSG00000277398,LILRA1,immunosuppression,tumor microenvironment modulation,immune checkpoint regulation,effector t-cell inhibition,regulatory t-cell promotion,poor prognosis association
ENSG00000149054,ZNF215,oncogene overexpression,transcriptional regulation,cell proliferation,dna damage repair,aggressive tumor behavior,poor prognosis
ENSG00000166979,EVA1C,cell cycle regulation,tumor suppression,genomic instability,uncontrolled proliferation,cancer development,p53 interaction
ENSG00000125355,TMEM255A,transmembrane protein function,cell growth regulation,pi3k/akt pathway activation,gene expression modulation,dna damage response,protein-protein interaction
ENSG00000115226,FNDC4,oncogene activation,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),prognostic marker,overexpression
ENSG00000122986,HVCN1,**

cellular proliferation,ion channel regulation,oncogenic signaling,tumor progression,prognostic biomarker,epigenetic modification

**
ENSG00000118242,MREG,microtubule stabilization,mitotic spindle formation,cell proliferation,chromosomal instability,protein regulation,tumor progression
ENSG00000177181,RIMKLA,ribosome maturation,cell proliferation,oncogenic transformation,tumor growth,apoptosis resistance,metastasis promotion
ENSG00000188352,FOCAD,epithelial-to-mesenchymal transition,cell adhesion regulation,metastasis promotion,prognostic marker,tumor progression,promoter interaction
ENSG00000072954,TMEM38A,cellular calcium regulation,cancer-related alterations,tumor progression facilitation,calcium channel modulation,oncogene potential,cell proliferation influence
ENSG00000151806,GUF1,cell migration,epithelial-to-mesenchymal transition (emt),guanine nucleotide exchange factor (gef) activity,rho gtpase regulation,tumor progression,therapeutic target
ENSG00000188175,HEPACAM2,epithelial-to-mesenchymal transition (emt),cell migration,tumor progression,cell adhesion,metastasis facilitation,signaling pathway interaction
ENSG00000068137,PLEKHH3,microtubule regulation,cellular structure maintenance,oncogenic processes promotion,tumor progression influence,protein-protein interactions,cell survival enhancement
ENSG00000168671,UGT3A2,genomic expression,metabolic regulation,chemotherapy efficacy,tumor progression,protein interaction,detoxification mechanism
ENSG00000163898,LIPH,wnt/β-catenin signaling,lactosylceramide accumulation,loss-of-function mutations,cell surface lipid composition,oncogenic process,glycosphingolipid regulation
ENSG00000087116,ADAMTS2,tumor progression,cell migration,angiogenesis promotion,pi3k/akt pathway activation,metastasis prediction,extracellular matrix degradation
ENSG00000214456,PLIN5,lipid droplet regulation,apoptosis resistance,cell proliferation promotion,tumor progression facilitation,lipolysis modulation,therapeutic target
ENSG00000100344,PNPLA3,lipid metabolism,cellular energy homeostasis,tumor progression,metabolic reprogramming,protein kinase c activation,pi3k/akt pathway interaction
ENSG00000139974,SLC38A6,glutamine metabolism,metabolic reprogramming,cell proliferation,oncogenic process,tumor progression,therapeutic target
ENSG00000281919,SLC45A2,cellular trafficking,dna repair mechanism,immune suppression,oncogenic transformation,signaling pathway modulation,tumor aggressiveness
ENSG00000140675,SLC5A2,metabolic reprogramming,glycolysis enhancement,oncogene overexpression,tumor progression,cellular proliferation,epigenetic modulation
ENSG00000113296,THBS4,tumor progression,cell adhesion regulation,angiogenesis promotion,integrin interaction,protease activation,biomarker potential
ENSG00000205268,PDE7A,cellular proliferation enhancement,camp regulation,oncogenic potential,cell survival promotion,apoptosis resistance,signaling pathway modulation
ENSG00000188782,CATSPER4,calcium influx regulation,cell proliferation,migration and invasion promotion,tumor progression correlation,poor prognosis association,fertilization mechanism alteration
ENSG00000170464,DNAJC18,protein stabilization,oncoprotein regulation,ubiquitin-proteasome pathway,cell survival promotion,protein folding regulation,chaperone interaction
ENSG00000103196,CRISPLD2,tumor suppressor regulation,immune modulation,cell proliferation,apoptosis resistance,aggressive tumor behavior,signaling pathway interaction
ENSG00000164176,EDIL3,emt induction,cell migration,extracellular matrix regulation,signaling pathway interaction,oncogenic potential,therapeutic target
ENSG00000136883,KIF12,chromosomal instability,increased cell proliferation,mitotic spindle formation,genome stability maintenance,oncogenic processes promotion,tumor progression
ENSG00000146006,LRRTM2,notch signaling pathway activation,cell adhesion regulation,oncogene overexpression,genomic amplification,cell proliferation enhancement,tumor progression driver
ENSG00000198754,OXCT2,fatty acid metabolism,mitochondrial function,oncogene potential,metabolic reprogramming,cell survival pathways,therapeutic target
ENSG00000094975,SUCO,mitochondrial function,energy metabolism regulation,metabolic reprogramming,cancer cell proliferation,cellular survival enhancement,oncogenic potential
ENSG00000163053,SLC16A14,metabolic reprogramming,glycolytic shift,monocarboxylate transport,lactate-pyruvate shuttle,cellular metabolism regulation,tumor microenvironment
ENSG00000138111,MFSD13A,lipid biosynthesis,tumor suppressor function,cellular metabolism regulation,stress response modulation,apoptosis regulation,metastasis promotion
ENSG00000186377,CYP4X1,lipid metabolism regulation,tissue specificity expression,cellular signaling influence,prognostic biomarker candidate,therapeutic target potential,gene expression correlation
ENSG00000196636,SDHAF3,mitochondrial dysfunction,cellular respiration disruption,gene mutations associated with cancer,hypoxia-inducible factor pathway activation,angiogenesis promotion,energy metabolism dysregulation
ENSG00000276114,CCL23,immune suppression,immunomodulatory function,cell migration promotion,epithelial-to-mesenchymal transition,tumor progression facilitation,cancer cell evasion
ENSG00000173638,SLC19A1,nucleobase transporter,cell proliferation,thymidine uptake,dna synthesis,genomic stability,oncogenic driver
ENSG00000148950,IMMP1L,mitochondrial function disruption,cellular metabolism dysregulation,tumor progression association,poor prognosis marker,genomic amplification,cell proliferation regulation
ENSG00000248099,INSL3,tumor progression,cell proliferation,cancer development,reproductive tissue maintenance,insulin-like peptide activity,growth regulation
ENSG00000150045,KLRF1,cellular adhesion disruption,tumor suppressor function,loss of expression,pi3k/akt pathway regulation,cell migration enhancement,epithelial-to-mesenchymal transition (emt)
ENSG00000206150,RNASE13,cellular regulation,rna processing,cell cycle control,tumor progression,genomic instability,rna metabolism
ENSG00000177202,SPACA4,spermatogenesis regulation,overexpression in cancer,cell proliferation enhancement,prognostic marker,poor prognosis association,tumor progression promotion
ENSG00000134905,CARS2,glutathione synthesis,redox balance regulation,oxidative damage prevention,cellular antioxidant defense,tumorigenesis association,protein interaction with nfe2l2 and mafg
ENSG00000164494,PDSS2,coq10 biosynthesis,mitochondrial function,oncogene overexpression,tumor resistance,p53 regulation,pi3k/akt signaling
ENSG00000204140,CLPSL1,protein degradation,cellular homeostasis,regulatory mechanisms,tumorigenesis,genomic instability,subcellular localization
ENSG00000188811,NHLRC3,cellular regulation,tumor suppression,apoptosis regulation,protein degradation regulation,ubiquitination modulation,cancer-related instability
ENSG00000228083,IFNA14,antiviral defense,apoptosis induction,immune regulation,interferon-alpha receptor activation,transcriptional regulation,tumor suppression
ENSG00000234829,IFNA17,tumor evasion,immune modulation,dual-function cytokine,oncogenic potential,therapeutic target,cytokine regulation
ENSG00000138308,PLA2G12B,pla2g12b modulation,cellular membrane regulation,inflammation regulation,immune response modulation,tumor growth promotion,oncogenic signaling pathway
ENSG00000263961,RHEX,transcription factor activity,gene overexpression,tumor progression,proliferation regulation,apoptosis inhibition,cell cycle dysregulation
ENSG00000173947,PIFO,oncogene,driver mutation,tumor suppressor function loss,cell proliferation regulation,apoptosis regulation,pi3k/akt pathway activation
ENSG00000109762,SNX25,regulation of protein trafficking,oncogenic signaling pathways,cell surface receptor regulation,tumor progression facilitation,autophagy modulation,escrt machinery interaction
ENSG00000090975,PITPNM2,pi turnover regulation,oncogenic driver mutations,cell surface receptor modulation,genomic instability contributor,signaling pathway dysregulation,prognostic biomarker candidate
ENSG00000148343,MIGA2,cell cycle regulation,tumor progression,oncogene,protein degradation,signaling pathway modulation,ubiquitination
ENSG00000205111,CDKL4,cell cycle progression,cyclin-dependent kinase activation,constitutive expression,cell proliferation,apoptosis resistance,tumor stage advancement
ENSG00000185838,GNB1L,pi3k/akt/mtor pathway regulation,g-protein coupled receptor signaling modulation,tumor progression facilitation,oncogenic protein interaction enhancement,constitutive activation contribution,cellular proliferation promotion
ENSG00000176204,LRRTM4,cell adhesion disruption,emt process involvement,metastasis promotion,protein overexpression,immune evasion mechanism,cancer cell proliferation
ENSG00000139044,B4GALNT3,aberrant glycosylation,glycan synthesis,oncogenic function,therapeutic target,tumor progression,cell migration
ENSG00000182272,B4GALNT4,tumor progression,epithelial-to-mesenchymal transition,cell surface receptor regulation,resistance to chemotherapy,oncogenic signaling pathways,cell adhesion and migration
ENSG00000198799,LRIG2,rtk inhibition,tumor suppressor function,downstream signaling inhibition,akt/pi3k pathway modulation,cell proliferation inhibition,growth factor regulation
ENSG00000146530,VWDE,transcription factor activity,cell proliferation regulation,apoptosis regulation,dna-binding activity,oncogene potential,tumor progression
ENSG00000119900,OGFRL1,g-protein coupled receptor signaling pathway,cell proliferation,tumor progression,apoptosis regulation,cell migration,oncogenic processes
ENSG00000113119,TMCO6,mitochondrial regulation,cellular metabolism,oncogenic processes,metabolic reprogramming,transmembrane transport,energy homeostasis
ENSG00000171595,DNAI2,dynein dysfunction,cilia assembly disruption,mitotic spindle dysregulation,cell proliferation enhancement,tumor aggressiveness promotion,genetic instability increase
ENSG00000101448,EPPIN,extracellular matrix regulation,tissue inhibitors of metalloproteinases inhibition,cell invasion promotion,urokinase-type plasminogen activator interaction,cancer cell migration facilitation,poor prognosis marker
ENSG00000249139,EPPIN-WFDC6,wfdc domain protein,tumor progression,cell migration regulation,protein-protein interactions,cell adhesion modulation,biomarker potential
ENSG00000187800,PEAR1,pi3k signaling pathway,cell proliferation regulation,tumor progression marker,oncogene overexpression,metabolic regulation involvement,cancer aggressiveness enhancer
ENSG00000180626,ZNF594,chromatin remodeling,transcriptional dysregulation,cell proliferation,apoptosis evasion,tumor progression,oncogenic property
ENSG00000154415,PPP1R3A,regulation of glycogen metabolism,cell proliferation and invasion,tumor progression,protein phosphatase regulation,enhanced cell survival,upregulation in cancer tissues
ENSG00000139292,LGR5,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition,stem cell maintenance,cell proliferation enhancement,metastasis promotion,chemoresistance induction
ENSG00000173114,LRRN3,cell cycle regulation,cell migration,apoptosis modulation,oncogenic process,tumor growth,metastasis promotion
ENSG00000182168,UNC5C,tumor suppressor function,pi3k/akt pathway inhibition,cell migration regulation,apoptosis induction,netrin-1 interaction,gene expression downregulation
ENSG00000148468,FAM171A1,chromatin regulation,tumor progression,epigenetic alteration,cellular proliferation,therapeutic target,biomarker potential
ENSG00000152767,FARP1,cell motility regulation,rho-gtpase activation,metalloprotease activity,tumor progression,metastasis promotion,cytoplasmic localization
ENSG00000224940,PRRT4,cell membrane transport,tumor progression,peptide uptake,proton-dependent mechanism,signaling pathway modulation,constitutive activation
ENSG00000113205,PCDHB3,cellular adhesion disruption,gene expression alterations,tumor growth promotion,signaling pathway dysregulation,molecular mechanisms unknown,adhesion complex maintenance
ENSG00000117114,ADGRL2,regulatory role,cell surface receptor,tumor progression,cell migration,invasion and metastasis,adgr family receptor
ENSG00000081760,AACS,enhanced cellular damage,detoxification failure,xenobiotic metabolism,environmental carcinogen susceptibility,reduced metabolic capacity,tumor progression
ENSG00000108846,ABCC3,drug efflux,multidrug resistance,poor prognosis,chemotherapy resistance,prognostic marker,tumor progression
ENSG00000112812,PRSS16,tumor progression,pi3k/akt pathway,cell proliferation,apoptosis regulation,serine protease activity,immune response modulation
ENSG00000151005,TKTL2,ppp regulation,glycolytic shift,oncogenic function,metabolic reprogramming,nadph synthesis,warburg effect
ENSG00000170950,PGK2,glycolytic regulation,metabolic adaptation,tumor growth promotion,energy metabolism enhancement,warburg effect activation,therapeutic target
ENSG00000164434,FABP7,cellular proliferation,epithelial-to-mesenchymal transition,gene expression regulation,lipid metabolism regulation,oncogene overexpression,tumor progression
ENSG00000047365,ARAP2,arf gtpase-activating protein activity,cell migration and invasion regulation,epithelial integrity maintenance,gtpase activation,tumor suppressor function,loss of expression in cancer tissues
ENSG00000143891,GALM,altered metabolism,glycolytic enhancement,hypoxia response,oncogenic transformation,cell proliferation modulation,enzymatic activity alteration
ENSG00000101311,FERMT1,cell migration,integrin signaling,oncogenesis,cell adhesion,protein-protein interactions,cytoskeletal regulation
ENSG00000100033,PRODH,tumor suppressor function,loss-of-function mutations,cellular metabolism regulation,proline accumulation,genetic instability,dna damage response
ENSG00000253626,EIF5AL1,oncogene activation,cell proliferation enhancement,mrna translation regulation,emt regulatory element,stemness maintenance factor,tumorigenesis promotion
ENSG00000134398,ERN2,regulation of mrna export,interaction with naf1 and ejc components,altered gene expression patterns,role in dna repair mechanisms,influence on tumorigenesis,cellular localization
ENSG00000156958,GALK2,hexosamine biosynthesis pathway,enhanced cell survival,cell proliferation,tumor progression,glycosylation regulation,protein-protein interaction
ENSG00000183208,GDPGP1,glycosylation pathway,metabolic regulation,cell surface modification,signaling molecule interaction,cell adhesion and migration,indirect oncogenic contribution
ENSG00000196475,GK2,metabolic reprogramming,altered glucose metabolism,aerobic glycolysis,warburg effect,cancer metabolism,cellular energy production
ENSG00000099984,GSTT2,biomarker,detoxification,dna damage response,oxidative stress regulation,resistance to therapy,therapeutic target
ENSG00000107902,LHPP,metabolic adaptation,mitochondrial dysfunction,glutamine metabolism,oncogenic pathway activation,therapeutic target,genomic profiling
ENSG00000198951,NAGA,metabolic reprogramming,arginine biosynthesis,cell growth promotion,therapeutic target,cancer cell metabolism,glycolysis enhancement
ENSG00000185792,NLRP9,inflammatory response,apoptosis induction,innate immune regulation,cell death pathway,tumor progression,genetic mutation
ENSG00000215440,NPEPL1,protein degradation,signaling pathway activation,oncogenic processes,tumor progression,biomarker potential,cellular signaling regulation
ENSG00000157045,NTAN1,proteolytic regulation,protein degradation,oncogenic protein accumulation,cell cycle progression,tumor suppressor dysfunction,pi3k/akt signaling activation
ENSG00000218823,PAPOLB,glycosylation regulation,tumor progression,biomarker overexpression,cell surface protein modification,prognostic significance,therapeutic target interaction
ENSG00000127125,PPCS,g2/m phase transition,genomic instability,cell cycle regulation,tumor progression,apoptosis regulation,cancer aggressiveness
ENSG00000185164,NOMO2,chromosomal instability,genomic maintenance,cell division regulation,tumor progression,aggressiveness marker,cytogenetic abnormality
ENSG00000013583,HEBP1,oncogenic driver,apoptosis inhibitor,cell cycle regulator,pi3k/akt pathway activator,genomic instability mediator,tumor progression promoter
ENSG00000145284,SCD5,lipid metabolism regulation,cell proliferation,signaling pathway activation,tumorigenesis association,chemoresistance mechanism,genomic amplification
ENSG00000100092,SH3BP1,rtk regulation,pi3k pathway modulation,cell proliferation promotion,apoptosis suppression,metastasis facilitation,drug resistance mediation
ENSG00000171612,SLC25A33,mitochondrial function,cancer metabolism,lipid transport regulation,cell growth promotion,fatty acid oxidation enhancement,tumor aggressiveness
ENSG00000114779,ABHD14B,lipid metabolism regulation,tumor progression promotion,cell signaling modulation,cancer cell aggressiveness,overexpression correlation,potential therapeutic target
ENSG00000109667,SLC2A9,glucose metabolism,oncogene,glycolysis,warburg effect,tumor growth,prognostic biomarker
ENSG00000142871,CCN1,tumor metastasis,cell adhesion regulation,focal adhesion formation,oncogenic potential,prognostic marker,therapeutic target
ENSG00000167962,ZNF598,genomic instability,tumor suppressor activity,dna damage response,homologous recombination repair (hrr),cell cycle regulation,cell proliferation control
ENSG00000214338,SOGA3,apurinic/apyrimidinic site recognition,base excision repair pathway,genomic instability,dna damage response,genome stability maintenance,oncogenic driver mutation
ENSG00000176393,RNPEP,arginine metabolism regulation,tumor progression enhancement,oncogenic process modulation,cell migration promotion,protein interaction with pi3k/akt pathway,immune evasion support
ENSG00000105778,AVL9,apc/c complex regulation,cell cycle dysregulation,oncogene activation,tumor aggressiveness,prognostic marker,genetic instability
ENSG00000254656,RTL1,oncogene activation,cell trafficking regulation,autophagy dysregulation,mitotic progression,apoptosis evasion,prognostic marker
ENSG00000172318,B3GALT1,tumor progression,cell adhesion,glycosylation modulation,metastasis facilitation,proteoglycan synthesis,poor prognosis marker
ENSG00000172733,PURG,genomic instability,cell cycle regulation,dna repair deficiency,oncogenic mutations,tumor suppressor loss,cancer progression
ENSG00000106034,CPED1,cell cycle regulation,oncogene,tumor progression,cell proliferation,centromere binding,apoptosis resistance
ENSG00000154165,GPR15,tumor cell migration,chemokine signaling,immunotherapy target,metastatic potential,tumor microenvironment modulation,cellular adhesion regulation
ENSG00000181827,RFX7,genomic instability,dna repair regulation,oncogenic role,transcriptional modulation,cell cycle progression,apoptosis suppression
ENSG00000121075,TBX4,transcription factor activity,cell proliferation regulation,urothelium development,oncogenic potential,emt regulation,tumor aggressiveness
ENSG00000248905,FMN1,mitochondrial energy metabolism,electron transport chain regulation,cellular respiration modulation,tumor cell proliferation,cancer progression influence,metabolic regulation alterations
ENSG00000160094,ZNF362,transcriptional repression,tumor progression,cell proliferation,krab-c2h2 zinc finger protein,overexpression in blca,ptm regulation
ENSG00000156787,TBC1D31,pi3k/akt pathway enhancement,gain of function mutations,oncogenic activity increase,poor prognosis marker,cell survival and proliferation promotion,membrane trafficking regulation
ENSG00000104983,CCDC61,mitotic regulation,microtubule dynamics,oncogene activity,cell proliferation,genomic instability,protein-protein interaction
ENSG00000277848,MEGF11,wnt/β-catenin pathway activation,constitutive signaling,tumor suppressor loss,cell proliferation enhancement,therapeutic target identification,protein-protein interaction
ENSG00000143971,ETAA1,cell cycle regulation,oncogene function,cell proliferation promotion,p21cip1/waf1 interaction,dna replication modulation,chemotherapy resistance contribution
ENSG00000196074,SYCP2,genomic instability,chromosomal abnormalities,dna damage response,homologous recombination repair,meiotic recombination,tumor progression
ENSG00000263002,ZNF234,transcriptional regulation,tumor progression,epithelial-to-mesenchymal transition (emt),chromatin modification,oncogenic processes,cell proliferation
ENSG00000186020,ZNF529,transcriptional regulation,oncogene,tumor suppression disruption,apoptosis inhibition,cell cycle progression,poor prognosis marker
ENSG00000204611,ZNF616,cell cycle regulation,tumor progression,oncogenic regulator,gene expression modulation,apoptosis inhibition,proliferation pathway activation
ENSG00000244588,RAD21L1,chromatin remodeling,genomic instability,dna repair mechanism,cell cycle regulation,co-activator function,tumor progression marker
,FOPNL,tumor suppressor loss,cell proliferation enhancement,oncogenic driver,transcriptional regulation disruption,wnt/β-catenin pathway activation,metastasis promotion
ENSG00000169607,CKAP2L,microtubule dynamics,cell cycle regulation,chromosomal instability,tumor suppression degradation,dna repair mechanisms,genomic stability maintenance
ENSG00000133739,LRRCC1,cellular response modulation,dna damage repair,cancer development driver,cell cycle regulation,protein-protein interaction,none
ENSG00000169359,SLC33A1,gck domain-containing protein 1,overexpressed in tumors,regulation of pi3k/akt pathway,cell proliferation enhancement,tumor progression promoter,potential therapeutic target
ENSG00000006831,ADIPOR2,inflammation regulation,oncogenic properties,tumor cell proliferation,cell survival promotion,metabolic dysregulation,protein kinase activation
ENSG00000138018,SELENOI,mitochondrial localization,overexpression in cancer,cellular antioxidant defense,hydrogen peroxide reduction,oxidative stress modulation,genomic instability promotion
ENSG00000164168,TMEM184C,cellular regulation,tumor suppressor function,proliferation inhibition,migration and invasion regulation,ecm interaction,prognostic value
ENSG00000146842,TMEM209,transmembrane protein,cell-cell interactions,signaling pathway regulation,oncogenic driver,cell proliferation enhancement,genomic amplification
ENSG00000166471,TMEM41B,autophagy regulation,er stress response,cell growth regulation,overexpression in tumors,tumor microenvironment interaction,mitochondrial function modulation
ENSG00000175274,TP53I11,p53-mediated pathway,tumor suppressor function,genomic stability regulation,dna damage response,cell cycle progression regulation,onco-suppressor activity
ENSG00000139636,LMBR1L,tumor suppressor activity,cell proliferation regulation,wnt/β-catenin signaling modulation,embryonic development involvement,proliferation factor role,cancer driver potential
ENSG00000143797,MBOAT2,**

sphingolipid metabolism,oncogene activation,tumor progression,cell proliferation,membrane trafficking,lipid modification 

**
ENSG00000111860,CEP85L,centrosomal regulation,microtubule organization,mitotic checkpoint control,genomic instability,chromosomal abnormalities,aberrant cell division
ENSG00000170390,DCLK2,wnt/β-catenin activation,cell cycle regulation,oncogenic driver,apoptosis inhibition,stem cell maintenance,tumor progression
ENSG00000100147,CCDC134,aberrant protein-protein interactions,ciliogenesis regulation,coiled-coil domain involvement,cellular proliferation regulation,genomic instability contribution,tumor progression association
ENSG00000158966,CACHD1,genomic instability,dna repair deficiency,homologous recombination repair,non-homologous end joining,tumor suppressor function,genome maintenance
ENSG00000148358,GPR107,cell signaling regulation,gpcr function,cancer progression,dysregulation,pi3k/akt pathway interaction,cell growth modulation
ENSG00000176018,LYSMD3,immune response modulation,cellular signaling pathway disruption,tumor suppressor dysregulation,oncogenic pathway activation,apoptosis inhibition,cell proliferation enhancement
ENSG00000124786,SLC35B3,glycosylation enhancement,nucleotide sugar transporter function,oncogene activation,cell proliferation promotion,protein-lipid modification,increased cellular migration
ENSG00000131389,SLC6A6,overexpression,chemotherapy resistance,cellular uptake,protein-protein interaction,tumor progression,cancer cell proliferation
ENSG00000149483,TMEM138,tumor progression,cellular transport regulation,mutations as driver,therapeutic target,oncogenic pathway modulation,overexpression in tumor tissues
ENSG00000180776,ZDHHC20,oncogenic protein regulation,cellular growth modulation,endoplasmic reticulum-associated palmitoylation,signaling pathway dysregulation,tumor suppressor modulation,potential cancer driver mutation
ENSG00000163704,PRRT3,protein-protein interaction,cell surface protein,tumor progression,cell migration,oncogenic signaling,signaling pathway modulation
ENSG00000173930,SLCO4C1,cellular transport,endogenous compound regulation,metabolic regulation,tumor microenvironment,drug target,cell signaling modulation
ENSG00000187049,TMEM216,genomic instability,mitotic spindle regulation,cell cycle progression,oncogene overexpression,apoptosis regulation,cancer cell proliferation
ENSG00000116396,KCNC4,constitutive activation,cellular proliferation,action potential regulation,neuronal expression,potassium channel dysregulation,apoptosis inhibition
ENSG00000103061,SLC7A6OS,amino acid transport,cell proliferation,metabolic regulation,cell survival,oncogenic processes,genomic instability
ENSG00000164403,SHROOM1,cell cycle regulation,oncogene potential,microtubule interaction,emt induction,tumor progression,metastasis promotion
ENSG00000100124,ANKRD54,transcriptional regulation,cell cycle regulation,tumor progression,prognostic marker,dna damage response,scaffold protein function
ENSG00000114541,FRMD4B,loss of tumor suppressor activity,hippo signaling pathway regulation,tumor progression,oncogenic pathway activation,cell proliferation,metastatic potential
,KIAA0556,chromatin remodeling,genome instability,homologous recombination repair,oncogenic mutations,pi3k/akt pathway dysregulation,transcriptional regulation
ENSG00000148459,PDSS1,prenylation,protein function stability,cell proliferation,oncogenic driver,tumor aggressiveness,genomic amplification
ENSG00000019186,CYP24A1,apoptosis resistance,calcium homeostasis regulation,cancer progression driver,poor prognosis marker,signaling pathway activation,tumor growth facilitator
ENSG00000174886,NDUFA11,mitochondrial energy metabolism,tumor suppressor activity,cellular respiration regulation,oncogenic process suppression,electron transport chain component,genomic instability contributor
ENSG00000110074,FOXRED1,cellular metabolism alteration,redox imbalance,tumor aggressiveness increase,oncogenic signaling activation,metabolic reprogramming,poor prognosis association
ENSG00000144406,UNC80,calcium signaling pathway alterations,oncogenesis,cell proliferation,cancer cell survival,protein-protein interaction,gene expression regulation
ENSG00000164296,TIGD6,genomic instability,cell growth regulation,genetic mutation,protein interaction,tumor suppressor function,dna damage response
ENSG00000004848,ARX,chromatin remodeling,transcriptional regulation,cell cycle progression,apoptosis regulation,tumor suppressor function,oncogene role
ENSG00000172197,MBOAT1,lipid metabolism,cell membrane remodeling,oncogenic process,altered lipid profiles,tumor progression,therapeutic target
ENSG00000171487,NLRP5,dna damage response,innate immune sensor,pattern recognition receptor,cell death regulation,inflammatory responses,mutations and dysregulation
ENSG00000183340,JRKL,cell proliferation,oncogenic function,phosphorylation activation,mapk/erk pathway interaction,autophagy regulation,poor prognosis
ENSG00000167701,GPT,metabolic regulation,tumor progression,cell signaling,energy metabolism,redox balance,apoptosis inhibition
ENSG00000131848,ZSCAN5A,oncogenic potential,transcriptional regulation,chromatin remodeling,epithelial-to-mesenchymal transition,stem cell maintenance,pi3k/akt pathway modulation
ENSG00000113248,PCDHB15,cell adhesion disruption,epithelial-to-mesenchymal transition,overexpression,prognostic marker,tumor progression,promoter hypermethylation
ENSG00000166548,TK2,mitochondrial localization,dna replication,oncogene,genomic instability,cell proliferation,chemoresistance
ENSG00000274538,PHLDA2,cell cycle regulation,genomic instability,tumor suppressor function,cdk4/6 inhibition,pi3k/akt pathway dysregulation,loss of heterozygosity
ENSG00000005889,ZFX,transcriptional regulation,chromatin remodeling,tumor suppressor gene expression,oncogenic processes,apoptosis regulation,cell cycle progression
ENSG00000164099,PRSS12,cell migration,proteolytic activity,cell invasion,transcriptional regulation,tumor progression,cell signaling
ENSG00000275568,ARHGAP11A,rho gtpase-activating protein function,enhanced cell migration,metastasis,pi3k/akt/mtor signaling activation,epithelial-to-mesenchymal transition regulation,poor prognosis association
ENSG00000138640,FAM13A,microtubule stabilization,cell proliferation enhancer,mitotic spindle formation regulator,protein kinase activity,ran gtpase interaction,genomic instability maintenance
ENSG00000173083,HPSE,extracellular matrix degradation,tumor progression,immune modulation,metastasis facilitation,cell migration enhancement,angiogenesis promotion
ENSG00000134802,SLC43A3,slc43a3 is associated with increased expression,alters nutrient uptake,interacts with pi3k/akt pathway,contributes to cell proliferation,oncogenic mutations identified,role in tumor metabolism
ENSG00000111696,NT5DC3,nucleotide metabolism,cell proliferation,oncogenic processes,tumor progression,metastasis,pi3k/akt pathway
ENSG00000056586,RC3H2,protein-protein interaction regulation,cell growth modulation,tumor tissue expression alteration,signaling pathway interaction,biomarker for diagnosis/prognosis,cell cycle progression regulation
ENSG00000074657,ZNF532,krab domain-containing zinc finger protein,transcriptional repressor activity,nuclear localization,dna binding specificity,cancer-related downregulation,tumor progression facilitation
ENSG00000024526,DEPDC1,gtpase-activating protein function,mutated in cancer,oncogene activation,rho gtpase regulation,tumor progression driver,cell signaling dysregulation
ENSG00000125454,SLC25A19,mitochondrial metabolism,energy production,cellular redox balance,tumor growth promotion,therapeutic target,poor prognosis correlation
ENSG00000134343,ANO3,cellular stress response,cell migration,regulation of proliferation,regulation of differentiation,tumorigenesis,bladder epithelium expression
ENSG00000123600,METTL8,mrna regulation,tumor progression,cell proliferation,metastasis,apoptosis resistance,pi3k/akt pathway
ENSG00000091622,PITPNM3,cell signaling regulation,overexpression in cancer,pi3k/akt pathway activation,endocytosis regulation,vesicle transport modulation,cell growth promotion
ENSG00000204991,SPIRE2,cell migration,oncogenic processes,cell adhesion,actin polymerization,tumor progression,prognostic marker
ENSG00000186001,LRCH3,cellular process regulation,dna damage response,tumorigenesis,transcriptional regulation,protein-protein interaction,leucine-rich repeat domains
ENSG00000213799,ZNF845,transcriptional regulation,chromatin remodeling,oncogenic pathway activation,cell proliferation promotion,tumor suppressor gene suppression,therapeutic target
ENSG00000017483,SLC38A5,glutamine metabolism,neutral amino acid transporter,tumor growth,cell proliferation,drug resistance,amino acid transport
ENSG00000203705,TATDN3,genomic instability,dna damage response,tumor suppressor,genome stability maintenance,cancer driver mutations,cell cycle regulation
ENSG00000123165,ACTRT1,wnt/β-catenin pathway,cell migration,epithelial-to-mesenchymal transition,prognostic marker,amplification,overexpression
ENSG00000180346,TIGD2,regulatory function,transmembrane receptor,tumor necrosis factor receptor-like domain,cell death regulation,immune response modulation,oncogene alteration
ENSG00000173681,BCLAF3,genomic instability,hyperactive cell growth,apoptosis resistance,tumor progression driver,transcriptional regulation,dna repair modulation
ENSG00000277972,CISD3,iron-sulfur cluster assembly,redox signaling pathway,tumor progression,oxidative stress,dna damage response,cell proliferation regulation
ENSG00000185189,NRBP2,tumor suppressor regulation,apoptosis regulation,cell cycle progression,oncogenic potential,pi3k/akt pathway interaction,genomic instability
ENSG00000257315,ZBED6,dna binding,transcriptional regulation,oncogene function,cell proliferation,chromatin modification,zinc-finger domain
ENSG00000070601,FRMPD1,frm domain-containing protein,tumor suppressor function,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway regulation,wnt/β-catenin signaling disruption,cancer cell migration modulation
ENSG00000163623,NKX6-1,transcriptional regulation,tumor suppressor,cell cycle regulation,apoptosis induction,dna repair regulation,developmental biology
ENSG00000104967,NOVA2,alternative splicing regulation,multiple protein interactions,tumor progression modulation,rna-binding activity,polyadenylation regulation,oncogenic process promotion
ENSG00000184677,ZBTB40,overexpression,transcriptional regulation,cell proliferation,apoptosis suppression,therapeutic target,genomic profiling
ENSG00000251493,FOXD1,transcriptional regulation,constitutive activation,growth factor regulation,cellular proliferation,tumor progression,poor prognosis
ENSG00000178919,FOXE1,cellular proliferation,oncogene activation,transcriptional regulation,tumor progression,biomarker potential,genomic instability
ENSG00000186766,FOXI2,transcriptional regulation,oncogenic transcription factor,cell cycle progression,tumor growth promotion,apoptosis evasion,aggressive clinicopathological features
ENSG00000179981,TSHZ1,transcription factor regulation,cell proliferation enhancement,wnt/β-catenin pathway activation,epithelial-to-mesenchymal transition,oncogenic function,chromatin remodeling interaction
ENSG00000176678,FOXL1,foxl1,transcription factor activity,oncogene activation,cell proliferation regulation,tumor suppressor inhibition,epithelial-to-mesenchymal transition
ENSG00000164379,FOXQ1,cell proliferation,transcriptional regulation,oncogenic properties,tumor progression,therapeutic target,genomic profiling
ENSG00000267728,KRTAP9-9,keratin filament assembly,epithelial-to-mesenchymal transition,tumor progression,aggressive behavior,cell migration,adhesion molecule interaction
ENSG00000180386,KRTAP9-7,cellular signaling pathways,overexpression,tumor progression,cell adhesion modulation,apoptosis evasion,transcriptional regulation
ENSG00000240542,KRTAP9-1,cell adhesion alterations,oncogenic protein interactions,tumor progression biomarker,epithelial cell migration,keratin-associated protein function,cell proliferation promotion
ENSG00000162782,TDRD5,gene regulation,transcriptional repression,rna-binding protein,p-body component,tumor progression,oncogenic pathway
ENSG00000227140,USP17L5,deubiquitinating activity,cell cycle regulation,transcriptional modulation,oncogene overexpression,tumor suppressor downregulation,cancer driver gene
ENSG00000230549,USP17L1,deubiquitinating enzyme function,oncogenic pathway regulation,cell cycle progression modulation,tumor progression driver,protein degradation regulation,gene expression control
ENSG00000144659,SLC25A38,mitochondrial transport,aspartate transport,tumor progression,dysregulated expression,poor prognosis,drug resistance
ENSG00000188452,CERKL,ceramide regulation,sphingosine-1-phosphate pathway,cellular signaling,protein-protein interactions,oncogenic processes,tumor progression
ENSG00000176567,OR4X1,altered gene expression,cell proliferation enhancement,cell survival regulation,ligand binding,oncogenic signaling pathway activation,tumor progression promotion
ENSG00000214435,AS3MT,genomic instability,gene expression regulation,dna damage response,cell signaling pathway alteration,therapeutic target,oxidative stress modulation
ENSG00000196917,HCAR1,tumor aggressiveness,cell adhesion modulation,tumor microenvironment modification,cell proliferation enhancement,angiogenesis promotion,apoptosis inhibition
ENSG00000184347,SLIT3,cell migration regulation,angiogenesis inhibition,tumor suppressor function,biomarker potential,pi3k/akt pathway modulation,adhesion molecule regulation
ENSG00000165973,NELL1,cell adhesion disruption,emt induction,epithelial-to-mesenchymal transition,oncogenic transcription factor interaction,transcriptional regulation modulation,tumor progression promotion
ENSG00000171714,ANO5,er stress response,autophagy induction,cellular stress response,er-mitochondria interaction,cancer driver mutation,apoptosis evasion
ENSG00000170613,FAM71B,dna damage response,oncogenic function,cell cycle progression,apoptosis regulation,genomic instability,tumor cell proliferation
ENSG00000261221,ZNF865,krab domain-containing transcription factor,genetic regulation,oncogene suppression,tumor development,cell growth regulation,transcriptional repression
ENSG00000139800,ZIC5,transcription regulation,oncogene activity,epithelial-to-mesenchymal transition,cell proliferation,wnt/β-catenin pathway,transcription factor function
ENSG00000224877,NDUFAF8,mitochondrial function,antitumor potential,dysregulated metabolism,oncogenic mutations,mitochondrial biogenesis,tumor suppressor activity
ENSG00000240857,RDH14,altered enzyme activity,cellular processes,disrupted visual pigment regeneration,implicated in tumorigenesis,potential oncogene,regulatory mechanism
ENSG00000101166,PRELID3B,p53 regulation,apoptosis suppression,oncogenic function,cell cycle progression,dna repair inhibition,tumor suppressor interaction
ENSG00000127184,COX7C,mitochondrial biogenesis,oxidative phosphorylation,aerobic glycolysis,cellular stress response,glycolytic enzyme regulation,tumor microenvironment adaptation
ENSG00000240230,COX19,mitochondrial function,energy production,cancer mutations,cellular respiration regulation,mitochondrial biogenesis regulation,anticancer therapy target
ENSG00000123815,COQ8B,mitochondrial dysfunction,electron transport chain regulation,cancer cell metabolism,tumor growth modulation,energy homeostasis disruption,genetic alterations
ENSG00000135469,COQ10A,mitochondrial dysfunction,oncogenesis,genomic instability,electron transport chain disruption,ros production,energy metabolism regulation
ENSG00000173085,COQ2,mitochondrial function,oxidative stress regulation,tumor progression,electron transport chain,cellular energy production,redox balance maintenance
ENSG00000167799,NUDT8,genomic instability,dna repair deficiency,oncogenic potential,homologous recombination repair,tumor progression,pi3k/akt signaling
ENSG00000165443,PHYHIPL,genomic instability,cell cycle regulation,chromatin remodeling,g2/m checkpoint modulation,dna damage response,mitotic progression
ENSG00000115520,COQ10B,mitochondrial function regulation,coenzyme q10 biosynthesis,energetic stress modulation,cellular energy production regulation,oxidative stress induction,dna damage response activation
ENSG00000185973,TMLHE,steroid hormone signaling,altered expression,modulation of transcription factors,regulation of cell growth,androgen receptor interaction,metabolic regulation
ENSG00000006282,SPATA20,genomic instability,homologous recombination repair,dna repair pathway,genome stability maintenance,cell proliferation regulation,pi3k/akt signaling interaction
ENSG00000146250,PRSS35,oncogenic potential,tumor progression,cell proliferation,proteolytic activity,signal transduction,dysregulation
ENSG00000184831,APOO,oncogene,cell proliferation,angiogenesis,metastasis promoter,protein-protein interaction,poor prognosis biomarker
ENSG00000144481,TRPM8,regulation of cell proliferation,ion channel activity,cell migration modulation,upregulated expression,poor prognosis association,mapk/erk pathway interaction
ENSG00000198771,RCSD1,tumor progression,promoter of oncogenic pathways,dysregulated dna repair,cell cycle regulation,therapeutic target,constitutive activation
ENSG00000276776,TC2N,loss of cell-cell adhesion,gain of migratory properties,cell proliferation,cancer driver genes,epithelial-to-mesenchymal transition,mechanical stability disruption
ENSG00000163608,NEPRO,centriole regulation,cell cycle progression,oncogenic potential,tumor progression,cell division dysregulation,chromosome instability
ENSG00000174990,CA5A,ph regulation,tumor microenvironment modulation,extracellular matrix degradation,cell migration facilitation,metabolic reprogramming,acidic environment maintenance
ENSG00000167800,TBX10,tbx10 binding sites,tumor suppressor,epithelial maintenance,cell proliferation regulation,emt modulation,gene expression regulation
ENSG00000235608,NKX1-1,transcription factor regulation,oncogene activation,cell proliferation suppression,apoptosis evasion,metabolic reprogramming,gene expression modulation
ENSG00000131845,ZNF304,transcriptional regulation,oncogenic potential,cell cycle regulation,dna binding activity,protein-protein interactions,tumor suppressor dysregulation
ENSG00000105467,SYNGR4,oncogenic processes,cell proliferation regulation,eph receptor interaction,tumorigenesis promotion,dna repair dysregulation,pik3ca interaction
ENSG00000213853,EMP2,epithelial-to-mesenchymal transition,tumor progression,cell migration,overexpression,poor prognosis,therapeutic target
ENSG00000132294,EFR3A,cell adhesion,cell migration,epithelial-to-mesenchymal transition (emt),metastasis,signaling regulation,tumor progression
ENSG00000165757,JCAD,promotes tumor progression,cell-cell adhesion disruption,regulates emt,enhances cell migration,associated with poor prognosis,interacts with wnt/β-catenin pathway
ENSG00000165959,CLMN,cell proliferation,gene expression regulation,cytoskeleton regulation,mitotic progression,protein kinase activation,cell migration
ENSG00000115459,ELMOD3,cytoskeleton regulation,cell migration and invasion,pi3k/akt signaling activation,oncogenesis,biomarker expression,chromosomal amplification
ENSG00000166897,ELFN2,cell growth regulation,egf-like domain-containing family,protein-protein interaction,signal transduction pathway,cell cycle regulation,tumorigenesis
ENSG00000288318,PALM3,cell signaling,protein modification,tumor progression,therapeutic target,oncogenesis,subcellular localization
ENSG00000215252,GOLGA8B,golgi apparatus regulation,protein trafficking disruption,cell growth regulation,oncogenic processes,therapeutic target,aberrant expression
ENSG00000116157,GPX7,cell cycle regulation,dna repair mechanism,tumor progression,oncogenic pathway activation,therapeutic target,epigenetic modification
ENSG00000212657,KRTAP16-1,keratin filament structure,cell proliferation,microtubule interaction,cancer cell migration,protein-protein interaction,biomarker potential
ENSG00000170667,RASA4B,rap1 gtpase regulation,tumor suppressor function,epithelial-to-mesenchymal transition,cell adhesion disruption,constitutive activation,poor prognosis marker
ENSG00000284965,OR2F2,tumor invasion,mutant protein activation,immune response modulation,enhanced cell proliferation,cell survival regulation,overexpression
ENSG00000130368,MAS1,tumor suppressor function,matrix metalloproteinase regulation,cell growth inhibition,apoptosis induction,extracellular matrix degradation,genomic downregulation
ENSG00000154678,PDE1C,cell proliferation regulation,mtor pathway interaction,energy metabolism regulation,oncogenic potential,hypoxia adaptation,cell survival modulation
ENSG00000188107,EYS,dysregulated expression,transcriptional regulation,dna repair mechanisms,tumor progression,cell cycle disruption,cancer development
ENSG00000172824,CES4A,ester hydrolysis,detoxification pathways,transporter regulation,apoptosis modulation,cell migration promotion,prognostic marker
ENSG00000214595,EML6,rho gtpase regulation,actin cytoskeleton reorganization,motility and invasiveness,tumor progression,cancer cell migration,cellular adhesion disruption
ENSG00000238243,OR2W3,inflammatory response,cell migration,oncogenesis,proliferation,epithelial-to-mesenchymal transition,signal transduction
,PRSS42,protease activity,cell migration,epithelial-to-mesenchymal transition (emt),cancer progression,serine protease function,tumor aggressiveness
126231,ZNF573,transcriptional regulation,zinc finger domains,dna binding,chromatin remodeling,cellular growth,gene expression
ENSG00000102043,MTMR8,phosphatase regulation,tumor progression,membrane trafficking,protein dephosphorylation,cellular proliferation,survival pathway
ENSG00000189108,IL1RAPL2,inflammation regulation,immune modulation,nf-κb pathway activation,tumor progression promotion,epithelial-to-mesenchymal transition regulation,cell proliferation enhancement
ENSG00000254245,PCDHGA3,epithelial-to-mesenchymal transition,oncogenic role,overexpression in cancer,cell-cell adhesion disruption,immune evasion mechanisms,tumor progression and metastasis
ENSG00000174948,GPR149,g protein-coupled receptor function,cell proliferation regulation,tumor progression marker,signaling pathway modulation,gene expression upregulation,poor prognosis indicator
ENSG00000167065,DUSP18,cell cycle regulation,dephosphorylation,mapk signaling inhibition,mitogen-activated protein kinase,apoptosis induction,tumor suppression
ENSG00000156194,PPEF2,pp2a regulation,serine protease activity,oncogenic properties,cell proliferation enhancement,gsk3β inhibition,wnt/β-catenin signaling activation
ENSG00000203867,RBM20,alternative splicing,genetic instability,chromatin remodeling,therapeutic target,tumor aggressiveness,rna processing
ENSG00000167861,HID1,protein export regulation,cellular homeostasis disruption,oncogenic process contribution,tumor suppressor or oncogene identity,therapeutic target potential,genomic instability promotion
ENSG00000198585,NUDT16,genome instability,nucleotide regulation,dna damage response,tumor suppressor function,chemoresistance modulation,cellular nucleotide metabolism
ENSG00000213973,ZNF99,transcriptional regulation,dna binding activity,cell cycle modulation,apoptosis evasion,oncogenic potential,genomic instability
ENSG00000263464,PPIAL4C,oncogenic transformation,cell proliferation,protein processing,tumor progression,signaling pathway regulation,overexpression
ENSG00000137080,IFNA21,tumor-suppressor,immune modulation,antiviral activity,cell proliferation inhibition,apoptosis induction,nf-κb transcription regulation
ENSG00000174482,LINGO2,pi3k/akt pathway activation,oncogene function,cell proliferation promotion,tumor progression,immune response regulation,epithelial-to-mesenchymal transition (emt) modulation
ENSG00000197479,PCDHB11,cell-cell adhesion disruption,cell migration enhancement,genomic instability driver,metastasis promoter,oncogene expression,signaling pathway modulation
ENSG00000250120,PCDHA10,overexpression,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,metastasis,poor prognosis
ENSG00000211679,IGLC3,immune modulation,tumor progression,immune evasion,cancer immunotherapy,immunoglobulin function,adaptive immunity
ENSG00000253910,PCDHGB2,cell-cell adhesion disruption,glycosylated cadherin function,increased cell migration,reduced expression levels,signaling pathway modulation,tumor progression facilitation
ENSG00000254221,PCDHGB1,cadherin signaling,cell adhesion disruption,gene expression regulation,cellular invasion enhancement,tumor metastasis facilitation,cell surface receptor function
ENSG00000248383,PCDHAC1,cell adhesion disruption,tumor suppressor function,epithelial-to-mesenchymal transition (emt),homophilic binding,cell migration,loss of expression
ENSG00000198077,CYP2A7,carcinogen metabolism,treatment resistance,cell proliferation regulation,dna repair mechanisms modulation,oncogene expression,tumor progression facilitation
ENSG00000186190,BPIFB3,chromatin regulation,genomic instability,cell migration,tumor progression,oncogene overexpression,epigenetic modification
ENSG00000165246,NLGN4Y,neuronal interaction,cell adhesion molecule,protein-protein interaction,oncogene overexpression,cancer prognosis,signaling pathway modulation
ENSG00000236334,PPIAL4G,proteolytic processing,cell proliferation,signaling pathway regulation,overexpression,tumor aggressiveness,prolipid modification
ENSG00000131398,KCNC3,pi3k/akt interaction,voltage-gated potassium channel subunit,cellular signaling modulation,tumor suppressor function,potential therapeutic target,overexpression in tumors
ENSG00000272674,PCDHB16,cell-cell adhesion disruption,oncogene overexpression,angiogenesis promotion,apoptosis suppression,signaling pathway interaction,transmembrane protein function
ENSG00000251664,PCDHA12,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),immune microenvironment modulation,prognostic biomarker,tumor progression facilitation,cell migration regulation
,IGLC2,immune evasion,co-expression,tumor microenvironment modulation,proliferation regulation,survival pathway enhancement,genomic instability
ENSG00000187372,PCDHB13,tumor suppressor function,cell-cell adhesion disruption,oncogenic process promotion,pi3k/akt pathway interaction,urothelial integrity maintenance,therapeutic target potential
ENSG00000255408,PCDHA3,cell adhesion disruption,epithelial-to-mesenchymal transition (emt) induction,pi3k/akt pathway activation,mapk/erk signaling enhancement,tumor progression facilitation,prognostic biomarker and potential therapeutic target
ENSG00000162365,CYP4A22,lipid metabolism,inflammation regulation,cell growth promotion,tumor microenvironment modulation,protein-ligand interaction,genetic variation impact
ENSG00000239389,PCDHA13,cell adhesion disruption,tumor progression,metastasis promotion,prognostic biomarker,cell migration regulation,signal transduction modulation
ENSG00000204961,PCDHA9,cell adhesion disruption,cancer progression,cytoplasmic signaling,epigenetic regulation,oncogenic transformation,signaling pathway interaction
ENSG00000160870,CYP3A7,cancer cell proliferation,steroid metabolism,dna repair regulation,cell cycle modulation,biomarker re-expression,enzyme activation
ENSG00000186526,CYP4F8,arachidonic acid metabolism,cell growth regulation,cancer metastasis,prostaglandin production,lipid peroxidation regulation,apoptosis modulation
ENSG00000276547,PCDHGB5,cell adhesion disruption,tumor suppressor function,loss of expression,proliferation and migration increase,signaling pathway interaction,genomic instability
ENSG00000253953,PCDHGB4,cadherin signaling,cell adhesion disruption,epithelial-to-mesenchymal transition,tumor suppressor function,metastatic suppression,synaptic plasticity regulation
ENSG00000166173,LARP6,oncogenic mirna regulation,tumor suppressor interaction,cell proliferation modulation,alternative splicing regulation,mrna stability control,prognostic biomarker
ENSG00000284810,CTRB2,metastasis promotion,cell proliferation regulation,protease activation,extracellular matrix degradation,signaling pathway modulation,tumor aggressiveness enhancement
ENSG00000100012,SEC14L3,phosphatidylinositol transfer protein function,cell growth regulation,pkb/akt pathway modulation,lipid metabolism regulation,cell survival enhancement,tumor progression driver
ENSG00000253485,PCDHGA5,cell adhesion disruption,glycosylphosphatidylinositol-anchored molecule,oncogenic signaling,tumor progression biomarker,poor prognosis marker,adhesion complex modulation
ENSG00000197838,CYP2A13,cytochrome p450,metabolic regulation,xenobiotic metabolism,phase i metabolism,gene expression regulation,enzyme catalysis
ENSG00000105889,STEAP1B,iron homeostasis,cellular growth promotion,tumor progression,metastasis regulation,plasma membrane localization,protein-protein interactions
ENSG00000051128,HOMER3,coactivator function,transcriptional regulation,oncogenic processes,cell proliferation enhancement,tumor progression facilitation,pi3k/akt pathway interaction
ENSG00000262209,PCDHGB3,cell adhesion modulation,tumor suppressor function,cell migration regulation,genomic mutations,signaling pathway interaction,epithelial cell differentiation
ENSG00000214042,IFNA7,cytokine activation,apoptosis regulation,immune response modulation,tumor immune evasion,cell cycle arrest,viral replication inhibition
ENSG00000243709,LEFTY1,tgf-β signaling pathway,oncogene function,proliferation regulation,cell differentiation,cancer progression,gene expression dysregulation
ENSG00000124467,PSG8,oncogenic function,tumor progression,cell proliferation,epithelial cell expression,immune response modulation,prognostic significance
ENSG00000071073,MGAT4A,cell adhesion,glycosylation modification,tumor progression,cell proliferation,signal transduction,oncogenic processes
ENSG00000130751,NPAS1,cancer-related transcription factor,regulatory interaction,chromatin remodeling,cell cycle regulation,oncogenic process,potential biomarker
ENSG00000095587,TLL2,wnt signaling pathway,cell proliferation,growth factor regulation,oncogenic driver,tumor progression,cell differentiation
ENSG00000163295,ALPI,tumor invasion,oncogene,extracellular matrix degradation,tumor progression,cancer prognosis,poor survival outcomes
ENSG00000059691,GATB,protein synthesis,cellular interaction,apoptosis regulation,cell cycle progression,genomic stability,oncogene expression
ENSG00000004809,SLC22A16,drug metabolism,chemotherapy resistance,folate transport,nutrient uptake,cell membrane transport,transporter interaction
ENSG00000113212,PCDHB7,cell-cell adhesion disruption,tumor progression,wnt/?-catenin pathway modulation,oncogenesis,epithelial-to-mesenchymal transition (emt),immune suppression
ENSG00000204970,PCDHA1,cadherin superfamily,tumor progression,wnt/β-catenin pathway,cancer cell migration,cell-cell adhesion alterations,signal transduction regulation
ENSG00000131409,LRRC4B,epithelial-to-mesenchymal transition,tumor suppressor function loss,cell proliferation regulation,cell growth modulation,multiprotein interactions,tumor progression associated
ENSG00000198131,ZNF544,transcriptional regulation,overexpression in tumors,epithelial-to-mesenchymal transition,cell proliferation enhancement,histone modification regulation,tumor metastasis promotion
ENSG00000186297,GABRA5,gaba receptor activation,cell proliferation,genetic amplification,signaling pathway modulation,tumor progression,prognostic marker
ENSG00000174348,PODN,cell adhesion disruption,metastasis promotion,angiogenesis regulation,tumor progression marker,therapeutic target,glycoprotein function
ENSG00000189184,PCDH18,cell-cell adhesion disruption,tumor suppression,poor prognosis association,pi3k/akt pathway interaction,biomarker potential,downregulated expression
ENSG00000242419,PCDHGC4,cell surface protein,tumor suppression,disrupted adhesion,oncogenesis,protein-protein interaction,apoptosis regulation
ENSG00000100003,SEC14L2,lipid synthesis regulation,tumor promoter,phospholipid trafficking modulation,cancer driver gene,cell growth enhancement,constitutive activation signaling
ENSG00000112852,PCDHB2,homophilic adhesion disruption,cell-cell interaction modulation,tumor progression facilitation,metastasis promotion,cell migration enhancement,signal transduction pathway regulation
ENSG00000111799,COL12A1,basement membrane disruption,cell adhesion modulation,collagen network alteration,extracellular matrix remodeling,growth factor pathway modulation,tumor invasion facilitation
ENSG00000213512,GBP7,autophagy regulation,tumor progression,immune response modulation,cell death pathway alteration,prognostic biomarker,therapeutic target
ENSG00000228278,ORM2,energy metabolism regulation,cellular stress response modulation,tumor suppressor potential,oncogene possibility,mitochondrial function interaction,genomic instability association
ENSG00000185674,LYG2,immune response modulation,oncogene activation,tumor progression facilitation,cell signaling regulation,metastasis promotion,pi3k/akt pathway interaction
ENSG00000134249,ADAM30,cell proliferation,protein-protein interaction,egfr activation,oncogenic processes,cell migration,therapeutic target
ENSG00000015413,DPEP1,dipeptide regulation,overexpression,cell proliferation,biomarker potential,aggressive tumor behavior,poor prognosis
ENSG00000139200,PIANP,tumor progression,prognostic marker,endocytic regulation,oncogenic signaling,cell surface receptor internalization,molecular interaction
ENSG00000141096,DPEP3,bradykinin degradation,cell proliferation,angiogenesis modulation,metastasis promotion,peptide hormone regulation,adhesion molecule regulation
ENSG00000113211,PCDHB6,cell adhesion disruption,tumor progression,epithelial-to-mesenchymal transition (emt) modulation,signaling pathway modulation,mutation-driven tumorigenesis,tissue structure disruption
ENSG00000138650,PCDH10,tumor suppressor,cell-cell adhesion,loss of function mutations,invadopodia formation,apoptosis regulation,epithelial-to-mesenchymal transition
ENSG00000118946,PCDH17,tumor suppression,wnt/β-catenin pathway inhibition,emt regulation,cell-cell adhesion disruption,cancer metastasis promotion,gene expression loss
ENSG00000167740,CYB5D2,metabolic reprogramming,glycolysis regulation,cytochrome c reduction,oxidative stress response modulation,tumor progression factor,cell proliferation promotion
ENSG00000158467,AHCYL2,adp-ribose metabolism,loss-of-function mutations,gain-of-function effects,nad+ dependent regulation,sirt1 activation,oxidative stress response
ENSG00000074935,TUBE1,mitotic spindle assembly,chromosomal instability,aneuploidy,cell cycle regulation,tumor suppressor function,genomic integrity
ENSG00000165105,RASEF,tumor progression,immune evasion,protein-protein interaction,cellular signaling pathway,dysregulated expression,microenvironment modulation
ENSG00000221968,FADS3,lipid biosynthesis,cell proliferation,fatty acid desaturation,oncogenesis,cell membrane composition,inflammation regulation
ENSG00000136478,TEX2,telomere regulation,tumor progression,promoter maintenance,cell proliferation,genome stability,chromosome protection
ENSG00000170373,CST1,oncogenic process,tumor suppressor function,cysteine cathepsin inhibition,cell proliferation regulation,genetic mutation impact,proteinase activity modulation
ENSG00000101441,CST4,cysteine protease inhibition,overexpression in tumor tissues,tumor progression and invasion,prognostic marker,interaction with cathepsins,therapeutic target
ENSG00000057704,TMCC3,tmcc3/tumor suppressor function,cell cycle regulation,dna damage response,apoptosis modulation,cyclin-dependent kinase inhibition,tumorigenic potential enhancement
ENSG00000179104,TMTC2,altered signaling pathways,cell proliferation,dna damage response,genomic instability,mutational activation,protein-protein interactions
ENSG00000166450,PRTG,erk/mapk signaling pathway,overexpression,tumor progression,angiogenesis,cell growth,protein-protein interaction
ENSG00000113555,PCDH12,tumor suppressor,cell-cell adhesion disruption,pi3k/akt pathway interaction,poor prognosis indicator,metastasis promoter,apoptosis inhibitor
ENSG00000198538,ZNF28,transcriptional regulation,tumor suppressor gene suppression,angiogenesis,cell growth regulation,dna binding,cancer prognosis marker
ENSG00000253537,PCDHGA7,disrupted cell-cell interactions,cell adhesion loss,epithelial-to-mesenchymal transition (emt),tumor progression marker,therapeutic target candidate,cell migration enhancement
ENSG00000168515,SCGB1D1,oncogenic potential,tumor progression,promotes cell proliferation,overexpression,pi3k/akt pathway interaction,modulates tumor microenvironment
ENSG00000162877,PM20D1,mitochondrial regulation,tumor suppressor,cellular homeostasis,energy metabolism,oxidative stress regulation,tumorigenesis promotion
ENSG00000167904,TMEM68,apoptosis regulation,cell cycle arrest,tumor suppressor function,cell growth regulation,genetic loss-of-function mutations,signaling pathway interaction
ENSG00000103742,IGDCC4,apoptosis regulation,cell proliferation enhancement,genomic amplification,oncogenic process contributor,protein interaction modulation,tumor progression facilitator
ENSG00000165023,DIRAS2,pi3k/akt pathway interaction,gtpase regulation,apoptosis evasion,cell proliferation,metastasis promotion,tumor growth support
ENSG00000185909,KLHDC8B,oncogenic driver,transcriptional regulation,chromatin remodeling,pi3k/akt pathway interaction,cell proliferation promoter,epigenetic reprogramming mediator
ENSG00000177047,IFNW1,**
tumor immunomodulation,interferon signaling pathway,cell surface receptor interaction,immune cell activation,pro-inflammatory cytokine induction,cancer immune surveillance
**
ENSG00000134533,RERG,tumor suppressor,pi3k/akt pathway activation,cell proliferation promotion,apoptosis regulation,cell cycle regulation disruption,loss-of-function mutations
ENSG00000127418,FGFRL1,cell proliferation inhibition,tumor suppressor function,wnt/β-catenin pathway regulation,fgf signaling modulation,cell survival inhibition,oncogenic transformation
ENSG00000156150,ALX3,ahr signaling pathway,genetic amplification,cell growth regulation,dysregulated expression,apoptosis inhibition,tumor progression
ENSG00000139330,KERA,keratin regulation,altered cell morphology,cellular structural support,tumor progression,signaling pathway modulation,cancer metastasis
ENSG00000274349,ZNF658,oncogenic function,cell proliferation,apoptosis evasion,transcriptional regulation,protein overexpression,krab domain-containing family
ENSG00000178163,ZNF518B,gene regulation,tumor development,dna binding,cell proliferation,zinc finger structure,genetic dysregulation
ENSG00000175697,GPR156,g protein-coupled receptor activation,cell proliferation regulation,oncogenic signaling pathway,cell survival enhancement,tumor progression facilitation,predictive biomarker
ENSG00000221890,NPTXR,cellular growth regulation,transcriptional modulation,signaling pathway dysregulation,wnt/β-catenin pathway activation,tumor progression facilitation,cell survival enhancement
ENSG00000159618,ADGRG5,oncogene overexpression,cell adhesion disruption,signaling pathway activation,tumor progression facilitation,poor prognosis indicator,therapeutic target potential
ENSG00000172878,METAP1D,mitochondrial protein processing,tumor suppressor activity,oxidative stress regulation,cell proliferation,protein kinase activation,amino acid metabolism
ENSG00000136169,SETDB2,tumor suppressor function,epigenetic regulation,histone methylation,chromatin modification,dysregulation in cancer,biomarker for cancer diagnosis
ENSG00000174326,SLC16A11,glucose transporter function,aerobic glycolysis,warburg effect,energy metabolism,metabolic regulation,nutrient acquisition
ENSG00000062370,ZNF112,transcriptional regulation,tumor suppressor function,cell cycle regulation,nuclear localization,apoptosis modulation,genomic instability
ENSG00000197363,ZNF517,transcriptional repression,epigenetic regulation,cell proliferation regulation,tumor suppressor function,chromatin remodeling,krab domain interaction
ENSG00000198759,EGFL6,angiogenesis promotion,cell migration regulation,overexpression in tumors,vascular development involved,tumor growth facilitation,adhesion molecule interaction
ENSG00000278216,UGT2A3,detoxification mechanism,conjugation process,hormone regulation,xenobiotic metabolism,cellular defense,liver expression
ENSG00000173227,SYT12,transcriptional regulation,chromatin remodeling,oncogene amplification,cell proliferation,genomic instability,metastatic potential
ENSG00000173391,OLR1,oncogene,overexpression,tumor progression,cell proliferation,ligand-binding,apoptosis evasion
ENSG00000160161,CILP2,wnt/β-catenin signaling,growth factor regulation,cell surface interactions,secreted protein function,oncogene activation,prognostic biomarker
ENSG00000166535,A2ML1,proteolytic regulation,tumor progression,cell migration,metastasis promotion,signaling pathway interaction,oncogenic role
ENSG00000122254,HS3ST2,heparan sulfate modification,tumor progression,cell adhesion,angiogenesis promotion,glycosaminoglycan biosynthesis,inflammation-induced expression
ENSG00000149742,SLC22A9,transport protein,resistance to chemotherapy,cellular signaling pathways,protein overexpression,tumor progression,genetic susceptibility
ENSG00000164451,CALHM4,calcium signaling,cell proliferation,pro-inflammatory cytokine regulation,nf-κb pathway activation,tumor progression,metastasis promotion
ENSG00000170044,ZPLD1,epigenetic regulation,dysregulation of transcription,transcriptional coactivation,tumor aggressiveness,promoter recruitment,rna polymerase ii interaction
ENSG00000140511,HAPLN3,extracellular matrix regulation,tumor progression,cell migration and invasion,hyaluronic acid synthesis,poor prognosis biomarker,pro-tumorigenic microenvironment
ENSG00000168903,BTNL3,cellular adhesion,apoptosis inhibition,genomic instability,immunomodulation,oncogene,proliferation promotion
ENSG00000149218,ENDOD1,genomic instability,oncogenesis,dna damage response,cell survival,apoptosis regulation,protein-dna interaction
ENSG00000100416,TRMU,trna modification,cell growth promotion,apoptosis inhibition,pi3k/akt pathway regulation,genomic instability contribution,tumor progression facilitation
ENSG00000167992,VWCE,genomic instability,tumor suppressor function,chromosomal instability,dna repair regulation,dysregulation in cancer,ploidy control
ENSG00000075429,CACNG5,calcium channel modulation,dysregulated ion flux,potential oncogenic role,cellular proliferation,apoptosis regulation,voltage-gated calcium channels
ENSG00000110900,TSPAN11,tumor suppressor loss,cell adhesion modulation,pi3k/akt pathway interaction,immune evasion,oncogenic protein expression,therapeutic target candidate
ENSG00000120519,SLC10A7,slc10 family transport,oncogenic properties,overexpression correlation,cell signaling regulation,tumor aggressiveness marker,pi3k/akt pathway interaction
ENSG00000205359,SLCO6A1,transporter activity,chemotherapy resistance,tumorigenesis regulation,cellular uptake modulation,oxidative stress response,inflammation regulation
ENSG00000145863,GABRA6,chemotherapy resistance,tumor progression,oncogenic signaling pathway,neurotransmission regulation,cell proliferation enhancement,cancer stem cell maintenance
ENSG00000185664,PMEL,melanosome formation,cellular pigmentation,oncogenesis association,genetic instability,unrelated to cancer,melanocyte development
ENSG00000122711,SPINK4,proteolytic regulation,tumor growth modulation,egfr pathway interaction,signal transduction modulation,oncogenic process contribution,cellular response regulation
ENSG00000164411,GJB7,loss-of-function mutations,gap junction disruption,cellular communication impairment,tumor progression,genomic instability,apoptosis resistance
ENSG00000119004,CYP20A1,aberrant activation,apoptosis regulation,biotransformation,cell proliferation,genomic instability,metabolic regulation
ENSG00000180432,CYP8B1,cholesterol catabolism,lipid metabolism regulation,tumor progression,metabolic reprogramming,protein-protein interaction,steroid synthesis
ENSG00000163626,COX18,mitochondrial function,nuclear-encoded gene,presequence translocase component,oncogenic process contribution,cellular growth and division regulation,overexpression in cancer tissues
ENSG00000197020,ZNF100,transcriptional regulation,tumor suppressor function,loss of heterozygosity,cancer driver mutation,genomic instability,gene amplification
ENSG00000065308,TRAM2,**

mitochondrial dynamics,cellular metabolism regulation,glycolysis promotion,lipid biosynthesis activation,oncogenic function support,biomarker identification

**
ENSG00000112337,SLC17A2,cell growth regulation,glutamate transport,oncogenic process contribution,tumor progression modulation,cellular redox balance influence,transport protein interaction
ENSG00000157693,TMEM268,epithelial-to-mesenchymal transition,oncogene function,cell migration promotion,signaling pathway interaction,cell survival enhancement,tumor progression association
ENSG00000117151,CTBS,cellular proliferation,signaling pathway regulation,apoptosis modulation,dna repair interaction,tumor progression marker,oncogene overexpression
ENSG00000139540,SLC39A5,iron regulation,zinc transport,tumor aggressiveness,poor prognosis,cell survival,therapeutic target
ENSG00000167280,ENGASE,endocytic regulation,cell surface receptor recycling,cytoskeleton organization,vesicle transport,oncogenic signaling,tumor progression
ENSG00000172828,CES3,oncogenic function,overexpression,cell proliferation,metabolic regulation,enzymatic activity,tumor progression
ENSG00000095713,CRTAC1,cell cycle regulation,chromatin remodeling,chromatin interaction,genomic instability,metastasis promotion,apoptosis suppression
ENSG00000148482,SLC39A12,iron homeostasis disruption,tumor progression enhancement,cell proliferation promotion,metastasis facilitation,hypoxia-inducible factor regulation,zip14 overexpression
ENSG00000134193,REG4,regulatory protein,oncogenic driver,cell proliferation,tumor progression,immune evasion,prognostic marker
ENSG00000124785,NRN1,nrn1 overexpression,transcriptional regulation,rna processing,cell growth modulation,tumor progression correlation,oncogene interaction
ENSG00000164520,RAET1E,immune evasion,oncogenic function,tumor progression,cell proliferation,apoptosis suppression,signal transduction pathway regulation
ENSG00000103260,METRN,angiogenesis promotion,microtubule regulation,tumor progression facilitation,oncogenic signaling pathway interaction,therapeutic target potential,metabolic adaptation enhancement
ENSG00000198797,BRINP2,genomic instability,homologous recombination repair (hrr),tumor suppressor activity,dna replication regulation,genome maintenance,protein-protein interactions
ENSG00000162670,BRINP3,oncogene activation,tumor growth promotion,transcriptional coactivation,cell cycle progression,apoptosis evasion,chromatin remodeling
ENSG00000182986,ZNF320,transcriptional regulation,cell cycle control,tumor suppressor function,dna binding activity,epithelial cell regulation,genomic stability maintenance
ENSG00000232143,GNL1,cell cycle regulation,microtubule dynamics regulation,apoptosis inhibition,tumor progression promotion,cell proliferation enhancement,poor prognosis association
ENSG00000186777,ZNF732,transcriptional regulation,tumor suppressor activity,gene expression modulation,cellular differentiation,dna binding interaction,apoptosis inhibition
ENSG00000165953,SERPINA12,tumor progression,metastasis regulation,cell migration,high expression levels,prognostic marker,pi3k/akt pathway interaction
ENSG00000162687,KCNT2,altered channel function,aberrant signaling pathway,cellular growth promotion,sodium-potassium balance disruption,voltage-gated potassium channel regulation,membrane potential modulation
ENSG00000162086,ZNF75A,krab domain interaction,transcriptional regulation,cell cycle progression,tumor aggressiveness,cell proliferation,gene expression disruption
ENSG00000162944,RFTN2,cellular interaction,cell cycle regulation,apoptosis modulation,tumor progression,oncogenic potential,overexpression hallmark
ENSG00000186803,IFNA10,tumor suppression,immune modulation,apoptosis induction,cancer progression,cellular differentiation,gene expression regulation
ENSG00000185873,TMPRSS11B,cell surface regulation,proteolytic activity,growth factor activation,oncogenic signaling,tumor progression,metastasis promoter
ENSG00000183196,CHST6,cell adhesion,chondroitin sulfate biosynthesis,dermatan sulfate synthesis,glycosaminoglycan regulation,tumor progression,metastasis facilitation
ENSG00000243232,PCDHAC2,cell-cell adhesion disruption,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition,tumor metastasis promotion,chromatin remodeling,protein-protein interactions
ENSG00000162496,DHRS3,tumor suppressor function,cellular differentiation,immune response regulation,eicosanoid metabolism,prostaglandin e2 regulation,kinase modulation
ENSG00000178502,KLHL11,ubiquitination regulation,cell cycle progression,tumor suppressor function,protein degradation pathway,adaptor protein interaction,cancer cell proliferation
ENSG00000145103,ILDR1,cell surface expression,immune system modulation,apoptosis regulation,tumor progression,cell proliferation enhancement,overexpression in tumors
ENSG00000253767,PCDHGA8,cell adhesion regulation,gpi-anchored protein,epithelial-to-mesenchymal transition,cell migration modulation,adhesion molecule function,molecular interaction modification
ENSG00000180423,HARBI1,chromatin remodeling,transcriptional regulation,oncogenic pathway,pi3k/akt signaling,cell proliferation,tumor suppressor function
ENSG00000133069,TMCC2,tgf-β signaling,cell proliferation,protein-protein interaction,tumor progression,poor prognosis marker,genomic instability
ENSG00000183979,NPB,cell adhesion disruption,metastatic progression,wound healing dysregulation,tumor growth promotion,epithelial-to-mesenchymal transition regulation,extracellular matrix interaction alteration
ENSG00000160233,LRRC3,tumor progression,metastasis driver,cell adhesion regulation,cancer diagnostic marker,pi3k/akt pathway interaction,prognostic biomarker
ENSG00000146453,PNLDC1,er stress response,oncogene activation,cellular homeostasis regulation,tumor progression promotion,protein folding regulation,chaperone interaction
ENSG00000186452,TMPRSS12,extracellular matrix degradation,cell adhesion modulation,proteolytic activity,tumor progression,metastasis facilitation,signaling molecule activation
,IGHA2,nf-kb pathway activation,oncogene activation,genetic alterations,epigenetic modifications,immunoglobulin production,tumor suppressor dysfunction
ENSG00000197745,SCGB1D4,tumor microenvironment modulation,biomarker potential,angiogenesis promotion,apoptosis inhibition,tumor growth inhibition,cell proliferation regulation
ENSG00000141337,ARSG,androgen biosynthesis,oncogenic process,tumor progression,genomic amplification,protein-protein interaction,steroid hormone regulation
ENSG00000182612,TSPAN10,biomarker potential,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor progression marker,signal transduction modulation,cancer cell invasion facilitation
ENSG00000170382,LRRN2,cell adhesion disruption,tumor progression,oncogenic driver,cell migration facilitation,prognostic marker,signal transduction pathway modulation
ENSG00000101203,COL20A1,collagen assembly,connective tissue integrity,extracellular matrix modulation,tissue elasticity regulation,cartilage formation,genetic variation impact
ENSG00000283934,IGSF6,tumor progression,cell migration,angiogenesis promotion,immune response modulation,cell proliferation,genomic upregulation
ENSG00000162951,LRRTM1,cell adhesion regulation,epithelial-to-mesenchymal transition promotion,chemosensitivity modulation,tumor growth facilitation,protein-protein interaction,transmembrane protein function
ENSG00000133597,ADCK2,genomic instability,cell cycle regulation,dna repair mechanisms,mitochondrial dynamics,pi3k/akt signaling pathway,oncogenic mutations
ENSG00000171462,DLK2,tumor suppressor pathway interaction,p53 regulation,genomic stability maintenance,cancer initiation,cell differentiation regulation,apoptosis modulation
ENSG00000203697,CAPN8,cancer progression,cell cycle regulation,cytoskeletal degradation,apoptosis inhibition,calcium-dependent protease,oncogenic signaling
ENSG00000150967,ABCB9,multidrug resistance,abc transporter function,prognostic marker,drug efflux mechanism,epigenetic regulation,therapeutic target
ENSG00000166118,SPATA19,genomic instability,cell cycle regulation,dna damage response,genetic predisposition,tumor suppression,proliferation control
ENSG00000126010,GRPR,er stress regulation,cell survival promotion,tumor progression facilitation,mtor/mapk signaling modulation,autophagy regulation,poor prognosis association
ENSG00000137507,LRRC32,hippo signaling pathway,oncogene activation,cell migration regulation,tumor progression promotion,immune evasion mechanism,adhesion molecule function
ENSG00000169955,ZNF747,genetic regulation,transcription factor activity,epithelial-to-mesenchymal transition,cell proliferation,tumor metastasis,poor prognosis
ENSG00000151033,LYZL2,cellular growth regulation,oncogenic transformation,zinc-dependent metalloprotease activity,tumor progression,epithelial cell expression,catalytic zinc-binding site
ENSG00000115084,SLC35F5,glycosylation pathway disruption,aberrant glycan structures accumulation,cell proliferation enhancement,survival signaling activation,tumor progression promotion,gene expression alteration
ENSG00000146411,SLC2A12,glycolytic activation,constitutive overexpression,cell proliferation promotion,glycemic regulation disruption,oncogenic protein interaction,metabolic adaptation enhancement
ENSG00000135407,AVIL,cell adhesion,signaling pathway activation,tumor progression,metastasis promotion,protein-protein interaction,oncogene activity
ENSG00000253159,PCDHGA12,wnt/β-catenin signaling,cell-cell adhesion,glycosylphosphatidylinositol-anchored protein,nf-κb regulation,transcriptional dysregulation,metastatic progression
ENSG00000137968,SLC44A5,pi3k/akt signaling pathway,overexpression,cancer cell growth promotion,tumor suppressor dysfunction,therapeutic target,gene expression regulation
ENSG00000135697,BCO1,mitochondrial function regulation,oncogene activation,antioxidant defense modulation,cellular energy metabolism,cancer progression promotion,therapeutic target identification
,C12orf49,cell cycle regulation,apoptosis modulation,upregulated expression,tumorigenesis association,cell proliferation promotion,genomic amplification
ENSG00000157214,STEAP2,iron homeostasis regulation,cell proliferation promotion,cancer cell support,iron-dependent pathways modulation,metalloreductase activity,transferrin-bound iron export
,KIAA1324L,lncrna regulation,oncogene activation,epigenetic modulation,tumor metastasis,poor prognosis marker,cellular proliferation
ENSG00000077713,SLC25A43,mitochondrial citrate transporter function,cellular metabolism regulation,tumor cell energy supply enhancement,amplicon formation,cancer cell proliferation promotion,disease aggressiveness association
ENSG00000050165,DKK3,wnt signaling pathway,tumor suppressor activity,epithelial-to-mesenchymal transition,cell proliferation regulation,β-catenin/tcf complex interaction,poor prognosis marker
ENSG00000137869,CYP19A1,estrogen signaling pathway,oncogene potential,hormone-dependent growth,therapeutic target,enzymatic activity,cancer progression
ENSG00000204524,ZNF805,transcriptional regulation,overexpression,epithelial-to-mesenchymal transition (emt),cell cycle progression,apoptosis suppression,genomic instability
ENSG00000197408,CYP2B6,cancer susceptibility,genetic variations,environmental carcinogens,xenobiotic metabolism,procarcinogen activation,dna damage
ENSG00000164484,TMEM200A,tumor suppressor,epithelial-to-mesenchymal transition (emt) regulation,cell migration and invasion enhancement,apoptosis regulation,autophagy modulation,metastatic progression
ENSG00000164855,TMEM184A,calcium signaling dysregulation,cellular proliferation enhancement,therapeutic target potential,gene expression upregulation,protein-protein interaction,membrane trafficking regulation
ENSG00000016402,IL20RA,il-20/il-20r axis,epithelial-to-mesenchymal transition (emt),prognostic biomarker,cross-talk with pi3k/akt/mtor pathway,constitutive activation,tumor progression
ENSG00000184254,ALDH1A3,detoxification of oxidative stress,aldehyde oxidation,tumor progression,cell survival,oxidative dna damage,redox balance regulation
ENSG00000177932,ZNF354C,transcriptional regulation,cellular proliferation,zinc finger protein function,dna binding affinity,chromatin remodeling interaction,genomic regulatory network
ENSG00000121417,ZNF211,oncogene overexpression,cell proliferation promotion,transcriptional regulation disruption,chromatin remodeling,g2/m phase transition modulation,poor prognosis association
ENSG00000160097,FNDC5,adhesion molecule regulation,cell migration promotion,emt process modulation,metastasis facilitation,oncogene activation,poor prognosis biomarker
ENSG00000155970,MICU3,apoptosis inhibition,mitochondrial function regulation,cancer cell survival,cellular metabolism regulation,tumor progression,therapeutic target
ENSG00000174951,FUT1,angiogenesis promotion,carbohydrate antigen synthesis,epithelial-to-mesenchymal transition (emt),tumor cell invasion facilitation,metastasis enhancement,poor prognosis association
ENSG00000186026,ZNF284,oncogene,transcriptional regulation,cell proliferation,apoptosis suppression,epigenetic modification,tumor suppressor gene suppression
ENSG00000091490,SEL1L3,erad regulation,protein quality control,cell proliferation,tumor progression,metastasis driver,biomarker expression
ENSG00000184599,TAFA3,chromatin remodeling,dna repair mechanisms,genomic instability,tumor progression,oncogene regulation,protein-protein interactions
ENSG00000157315,TMED6,golgi apparatus disruption,aberrant protein processing,cellular metabolism modulation,gene expression regulation,oncogenic process contribution,tumor progression promotion
ENSG00000180257,ZNF816,epigenetic regulation,tumor progression,multifunctional protein,transcriptional modulation,gene expression regulation,histone modification
ENSG00000174514,MFSD4A,cancer cell invasion,cell migration regulation,tumor progression marker,glycolytic metabolism,epithelial cell disruption,cell adhesion modulation
ENSG00000106328,FSCN3,cell migration,cytoskeletal reorganization,metastasis promotion,oncogene overexpression,rho gtpase interaction,tumor progression
ENSG00000149050,ZNF214,transcriptional regulation,cell proliferation,apoptosis inhibition,poor prognosis,genomic instability,tumor progression
ENSG00000139985,ADAM21,adam21 mediated cell adhesion,tumor progression mediator,pro-tumor factor shedding,egfr interaction,pi3k pathway enhancement,integrin-mediated signaling
ENSG00000166509,CLEC3A,immunomodulatory function,cell proliferation,pi3k/akt signaling pathway regulation,immune response modulation,tumor progression promotion,mutational hotspot
ENSG00000189050,RNFT1,chromatin remodeling,transcriptional regulation,tumor suppressor function,cell cycle regulation,genomic instability,protein-protein interactions
ENSG00000187037,GPR141,g-protein coupled receptor,class a rhodopsin-like gpcr family,oncogene activation,pi3k/akt pathway modulation,epithelial-to-mesenchymal transition (emt),immune response regulation
ENSG00000105852,PON3,oxidative stress modulation,altered expression,cell signaling regulation,detoxification activity,antioxidant effects,inflammatory response modulation
ENSG00000165194,PCDH19,cell-cell adhesion disruption,oncogenic signaling,increased cell proliferation,tumor invasion,metastasis facilitation,disrupted cellular function
ENSG00000124574,ABCC10,multidrug resistance,chemosensitization,transporter function,xenobiotic efflux,overexpression,poor prognosis
ENSG00000174842,GLMN,tumor progression,epithelial-to-mesenchymal transition,transcriptional regulation,oncoprotein overexpression,cell proliferation,apoptosis evasion
ENSG00000218336,TENM3,tumor progression,epithelial-to-mesenchymal transition (emt),immune evasion,angiogenesis,cell migration,prognostic marker
ENSG00000198346,ZNF813,oncogene,transcriptional repressor,cell proliferation,survival and metastasis,epigenetic regulator,dysregulated gene expression
ENSG00000213096,ZNF254,epigenetic regulation,oncogenic transcription factor,cell cycle progression,apoptosis inhibition,chemotherapy resistance,tumor suppressor gene silencing
ENSG00000165475,CRYL1,cellular metabolism regulation,pi3k/akt signaling pathway interaction,protein-protein interaction,tumor progression association,oncogenesis modulation,cell cycle regulation influence
ENSG00000162078,ZG16B,tumor suppressor function,cell cycle regulation,apoptosis modulation,poor prognosis association,downregulated expression,reduced cellular differentiation
ENSG00000183569,SERHL2,nf-κb signaling pathway,protein interaction,oncogene role,cell survival regulation,tumor progression marker,genomic amplification
ENSG00000135953,MFSD9,autophagy regulation,gain-of-function mutations,lipid metabolism regulation,oncogene activity,pi3k/akt pathway interaction,tumor progression promotion
ENSG00000175928,LRRN1,cell adhesion disruption,cytoskeleton dysregulation,integrin interaction,focal adhesion kinase complex,protein-protein interaction,tumor progression
ENSG00000172687,ZNF738,cell cycle dysregulation,apoptosis evasion,transcription factor regulation,chromatin remodeling,protein-dna interaction,tumor suppressor down-regulation
ENSG00000144045,DQX1,genomic stability,dna repair mechanisms,therapeutic target,cell survival enhancement,protein interaction,oncogenic process
ENSG00000120563,LYZL1,oncogene,cellular proliferation,epithelial-to-mesenchymal transition,dna repair regulation,biomarker candidate,genetic instability
ENSG00000125900,SIRPD,tumor progression,metastasis promotion,cell growth regulation,apoptosis modulation,protein-protein interaction,genomic instability
ENSG00000182489,XKRX,proteasome regulation,dna repair mechanism,tumor aggressiveness,cell cycle regulation,apoptosis inhibition,genomic instability
ENSG00000005189,REXO5,microrna regulation,cell proliferation,exoribonuclease activity,tumor progression,oncogene activation,rna processing
ENSG00000146066,HIGD2A,mitochondrial function,electron transport chain regulation,energy metabolism alteration,tumorigenesis promotion,cancer progression driver,cellular respiration regulation
ENSG00000174109,C16orf91,tumor progression,cell proliferation,oncogene function,signaling pathway modulation,dna damage response,cell cycle regulation
ENSG00000273111,LYPD4,cell adhesion facilitation,epithelial-to-mesenchymal transition,tumor progression marker,cell migration enhancement,biomarker potential,therapeutic target exploration
ENSG00000172940,SLC22A13,organic cation transport,chemotherapy resistance,oncogenesis,tumor growth,cellular survival,plasma membrane localization
ENSG00000169758,TMEM266,cell proliferation,tumor progression,apoptosis regulation,cell cycle arrest,metastasis promotion,signaling pathway interaction
ENSG00000113108,APBB3,wnt/β-catenin pathway activation,cell survival promotion,oncogenic signaling modulation,kinase activity regulation,tumor progression facilitation,therapeutic target potential
ENSG00000107362,ABHD17B,lipid metabolism,oncogenesis,cell proliferation,tumor progression,metabolic regulation,protein interaction
ENSG00000237814,SFTA2,emt regulation,cell migration enhancement,apoptosis resistance,genetic mutations,tumor aggressiveness,therapeutic target
ENSG00000157837,SPPL3,notch receptor processing,dysregulated cellular trafficking,aberrant cell signaling,tumor initiation,oncogenic processes,cellular homeostasis disruption
ENSG00000275031,METRNL,**

1. **protein degradation regulation**,2. **cell cycle control**,3. **tumor suppressor function**,4. **ubiquitin-proteasome pathway modulation**,5. **oncogenic process prevention**,6. **genomic instability mitigation**.

**
ENSG00000136237,RAPGEF5,rhoa activation,cell proliferation,epithelial-to-mesenchymal transition (emt),guanine nucleotide exchange factor (gef),cancer metastasis,therapeutic target
ENSG00000105088,OLFM2,oncogene,epithelial-to-mesenchymal transition (emt),stem cell-related gene expression,cell adhesion regulation,prognostic marker,cancer initiation and progression
ENSG00000166575,TMEM135,er homeostasis disruption,genomic instability induction,cellular signaling alteration,oncoprotein function activation,tumor progression facilitation,overexpression association
ENSG00000182534,MXRA7,oncogenic function,cell proliferation,apoptosis regulation,transcriptional modulation,dna repair pathway,stem cell-like properties
ENSG00000119686,FLVCR2,angiogenesis facilitation,iron homeostasis regulation,heme metabolism regulator,oncogene overexpression,tumor progression,cancer cell survival
ENSG00000188467,SLC24A5,epithelial-to-mesenchymal transition,constitutive expression,overexpression,cell migration,protein interaction,signaling pathway regulation
ENSG00000158516,CPA2,cell proliferation,protease regulation,extracellular matrix degradation,tumor growth,metastasis,prognosis
ENSG00000163959,SLC51A,cell membrane integrity,lipid raft association,protein-protein interaction,vesicular trafficking,tumor progression,clinical biomarker
ENSG00000128040,SPINK2,tumor progression,oncogene activation,protease inhibition,cell survival promotion,pi3k/akt pathway modulation,extracellular matrix degradation
ENSG00000083454,P2RX5,atp signaling pathway,oncogenic processes,tumor progression,metastasis facilitation,cell migration regulation,protein interaction modulation
ENSG00000205669,ACOT6,oncogenic driver,tumor proliferation,epigenetic regulation,cell migration,protein-protein interaction,signaling pathway modulation
ENSG00000180479,ZNF571,cell proliferation,oncogene,transcription regulation,epithelial-to-mesenchymal transition,apoptosis evasion,tumor aggressiveness
ENSG00000173875,ZNF791,transcriptional regulator,oncogenic function,tumor progression,cell proliferation,apoptosis inhibition,dna repair dysregulation
ENSG00000159905,ZNF221,transcriptional regulation,dna damage response,chromatin remodeling,apoptosis regulation,genome stability maintenance,tumorigenesis association
ENSG00000256294,ZNF225,tumor suppressor function,transcriptional regulation,krab domain-containing family,poor prognosis,gene overexpression,oncogenic processes
ENSG00000163328,GPR155,shh pathway activation,constitutive activation,cell proliferation,therapeutic target,genomic alterations,signaling complex component
ENSG00000173950,XXYLT1,glycosaminoglycan synthesis,tumor progression,cell adhesion regulation,cell proliferation enhancement,apoptosis evasion,metastasis facilitation
ENSG00000124935,SCGB1D2,epithelial-to-mesenchymal transition,inflammation regulation,cell proliferation enhancement,pi3k/akt pathway interaction,metastasis promotion,poor prognosis biomarker
ENSG00000235589,ZNF311,dna repair mechanisms,chromatin remodeling complex interactions,tumor suppressor function,cell cycle regulation,gene expression modulation,genomic instability prevention
ENSG00000145451,GLRA3,tumor suppressor,downregulation in cancer,glycine receptor modulation,cell signaling pathway interaction,pi3k/akt pathway dysregulation,potential biomarker and therapeutic target
ENSG00000141449,GREB1L,transcriptional repressor,cell growth regulation,downregulation in cancer,cell cycle progression,genetic regulatory network,tumorigenesis pathway
ENSG00000144043,TEX261,transcriptional regulation,histone modification,chromatin remodeling,gene expression regulation,cell proliferation,dna repair
ENSG00000172817,CYP7B1,bile acid metabolism,cell survival,gain of function mutations,oncogenic processes,tumor microenvironment,dna repair
ENSG00000151948,GLT1D1,transcriptional regulation,cell proliferation,survival pathways,overexpression,metastasis promoter,dna binding protein
ENSG00000104499,GML,growth factor regulation,grb2 interaction,cell migration enhancement,tumor progression driver,signaling pathway modulation,oncogenic transformation promoter
ENSG00000269743,SLC25A53,mitochondrial carrier protein,tumor progression marker,cell metabolic regulation,energy production enhancement,protein-protein interaction,poor prognosis indicator
ENSG00000139433,GLTP,lipid metabolism regulation,cancer cell survival,tumor progression,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,therapeutic target
ENSG00000172986,GXYLT2,glycosaminoglycan biosynthesis,extracellular matrix modulation,oncogenic processes promotion,cellular proliferation enhancement,therapeutic target identification,tumor progression association
ENSG00000151233,GXYLT1,glycoprotein synthesis,tumor progression,cell proliferation,survival pathways,transcriptional regulation,oncogenic process
ENSG00000099998,GGT5,overexpression,glycosylation regulation,tumor progression,cell proliferation,poor prognosis,pi3k/akt interaction
ENSG00000124490,CRISP2,apoptosis regulation,cell death modulation,tumor progression,protein-protein interactions,genomic instability,cell survival pathways
ENSG00000099999,RNF215,pi3k/akt signaling pathway,tumor suppressor regulation,ubiquitination and protein stability regulation,dna repair and damage response,cell proliferation and survival enhancement,overexpression in tumors and poor clinical outcomes
ENSG00000158156,XKR8,genomic instability,cell cycle regulation,ubiquitination and degradation,dna damage response,tumor aggressiveness,oncogenic driver
ENSG00000115649,CNPPD1,cellular signaling,oncogenesis,protein-protein interactions,cell proliferation,tumor progression,cancer driver gene
ENSG00000163710,PCOLCE2,extracellular matrix remodeling,tumor progression,cell migration,proteoglycan function,cancer cell invasion,therapeutic target
ENSG00000103355,PRSS33,tumor progression,proteolytic activity,apoptosis regulation,tumor growth promotion,metastasis facilitation,cancer biomarker
ENSG00000131781,FMO5,cancer metabolism,detoxification process,oncogene overexpression,metabolic regulation,tumor progression,clinical outcomes
ENSG00000131044,TTLL9,microtubule dynamics,tyrosination regulation,cancer driver mutation,cell division disruption,oncogenic process,protein interaction
ENSG00000124251,TP53TG5,dna damage response,genomic stability maintenance,tumor suppressor activity,cell cycle regulation,transcriptional modulation,post-translational modification
ENSG00000167562,ZNF701,transcriptional regulation,cell proliferation,zinc finger protein interaction,histone modification,chromatin remodeling,tumor suppressor
ENSG00000169397,RNASE3,cellular degradation pathway,apoptosis regulation,tumor progression,biomarker for prognosis,immunotherapeutic target,genomic upregulation
ENSG00000080166,DCT,oncogene,cell proliferation,cell migration,tumor progression,poor prognosis,autophagy regulation
ENSG00000213085,CFAP45,altered cilia formation,gene mutations,hippo/yap pathway dysregulation,cancer cell morphology changes,cell growth enhancement,tissue homeostasis disruption
ENSG00000184995,IFNE,anti-tumor activity,immune regulation,immunomodulatory effects,inhibition of angiogenesis,tumor suppressor function,tumor progression inhibition
ENSG00000078795,PKD2L2,calcium signaling pathway,cell growth regulation,mechanotransduction,polycystin-like receptor function,tumor progression driver,emt and stem cell maintenance regulator
ENSG00000176782,DEFB104A,antimicrobial activity,innate immunity modulation,apoptosis induction,cancer immunomodulation,tumor suppression hypothesis,altered expression pattern
ENSG00000277006,DEFB104B,antimicrobial activity,immune response modulation,inflammation regulation,tumor progression,prognostic biomarker,therapeutic target
ENSG00000101670,LIPG,lipid metabolism regulation,cholesterol accumulation,triglyceride hydrolysis,cell proliferation enhancement,fatty acid production increase,energy homeostasis disruption
ENSG00000125458,NT5C,adenosine regulation,cell surface enzyme,immune modulation,nucleotide conversion,oncogenic property,tumor progression marker
ENSG00000143297,FCRL5,immune modulation,cancer immunoediting,tumor progression,prognostic marker,immune checkpoint regulation,b-cell receptor signaling
ENSG00000007350,TKTL1,warburg effect,metabolic reprogramming,anaerobic glycolysis,energy metabolism regulation,tumor cell proliferation,pyruvate production enhancement
ENSG00000165076,PRSS37,cancer cell proliferation,cell invasion and metastasis,protein-protein interaction,growth factor activation,tumor aggressiveness,biomarker potential
ENSG00000118276,B4GALT6,**
cell adhesion,dysregulation,glycoprotein synthesis,immune evasion,metastasis promotion,tumor progression 
**
ENSG00000183709,IFNL2,immune modulation,tumor microenvironment,inflammation regulation,cancer immunity evasion,cellular response,viral defense mechanisms
ENSG00000104804,TULP2,genomic instability,cell cycle regulation,tumor suppressor function,protein-protein interaction,mitotic checkpoint regulation,dna repair mechanism
ENSG00000134538,SLCO1B1,transport of chemotherapeutic agents,altered expression and function,poorer prognosis associated,oncogene potential confirmed,modulation of p-gp and mrp2 interactions,pharmacogenomics significance identified
ENSG00000117009,KMO,aerobic glycolysis,immunosuppression,nadph production,oncogenic metabolism,tumor progression,therapeutic target
ENSG00000167543,TP53I13,p53 pathway disruption,cell cycle regulation disruption,tumor suppressor function alteration,oncogenic driver mutation,genomic instability,therapeutic target
ENSG00000198812,LRRC10,cell migration regulation,dysregulation associated,tumor growth promotion,mutation identification,signaling pathway modulation,cancer progression marker
ENSG00000142694,EVA1B,pi3k/akt signaling pathway,dysregulation of gene function,increased cell proliferation,enhanced tumor growth,protein-protein interactions,therapeutic target
ENSG00000186334,SLC36A3,tumor metabolism,amino acid transporter,metabolic reprogramming,nutrient uptake regulation,cell proliferation enhancement,therapeutic target identification
ENSG00000109576,AADAT,tumor aggressiveness,amplification,metabolic reprogramming,cellular metabolism,prognostic biomarker,transcriptional regulation
ENSG00000145879,SPINK7,overexpression,apoptosis inhibition,cell survival enhancement,serine protease inhibition,tumor progression facilitation,epithelial-to-mesenchymal transition promotion
ENSG00000138463,SLC49A4,pi3k/akt pathway modulation,oxidative stress regulation,phosphate homeostasis disruption,metabolic reprogramming,cell survival promotion,therapeutic target potential
ENSG00000166250,CLMP,epithelial-to-mesenchymal transition,overexpression,cell growth regulation,mitotic signaling pathway interaction,apoptosis inhibition,tumor progression
ENSG00000144908,ALDH1L1,metabolic reprogramming,genomic instability,cell growth regulation,detoxification process,oncogenic properties,resistance to chemotherapy
ENSG00000158865,SLC5A11,na+/monocarboxylate transporter,metabolic reprogramming,glycolytic phenotype,lactate export,ph regulation,cellular metabolism
ENSG00000172728,FUT10,aberrant glycosylation,biomarker potential,cell adhesion disruption,gene expression regulation,glycoprotein modification,signaling pathway alteration
ENSG00000002745,WNT16,wnt signaling pathway activation,epithelial-to-mesenchymal transition promoter,cell proliferation enhancer,poor prognosis marker,cancer stem cell regulator,transcriptional activator
ENSG00000004846,ABCB5,chemoresistance,tumor-initiating cell maintenance,epithelial-to-mesenchymal transition (emt),drug efflux mechanism,stem-like properties maintenance,prognostic marker
ENSG00000167536,DHRS13,apoptosis regulation,cell cycle progression,tumor promoter,metastasis,steroid hormone biosynthesis,protein interaction
ENSG00000155893,PXYLP1,genomic instability,cellular response regulation,oxidative stress modulation,dna repair pathway interaction,signaling pathway modulation,tumor suppressor function
ENSG00000174562,KLK15,protease activity,promotes cell proliferation,angiogenesis regulation,cleavage of pro-angiogenic factors,enhances tumor invasion,cell signaling modulation
ENSG00000254402,LRRC24,cell cycle regulation,centromere formation,oncogenesis,cell growth regulation,protein interaction,mitotic regulation
ENSG00000168890,TMEM150A,cellular proliferation,oncogene function,tumor suppressor dysregulation,nuclear envelope integrity,cell cycle progression,aberrant gene expression
ENSG00000179954,SSC5D,cell membrane trafficking,autophagy,actin cytoskeleton regulation,cytoskeletal disruption,protein-protein interactions,cell migration
ENSG00000205221,VIT,pi3k/akt pathway modulation,oncogenic function,cell proliferation regulation,immune microenvironment modulation,tumor aggressiveness enhancement,prognostic marker
ENSG00000134285,FKBP11,cell cycle regulation,apoptosis modulation,protein-protein interaction,tumor progression,oncogene activation,microtubule dynamics
ENSG00000157800,SLC37A3,metabolic reprogramming,glycolysis regulation,sulfur-containing amino acid homeostasis,cellular proliferation enhancement,protein synthesis regulation,tumor suppressor dysfunction
ENSG00000149564,ESAM,tumor angiogenesis,platelet activation,thrombin generation,vascular stability,endothelial cell interaction,cancer metastasis
ENSG00000156574,NODAL,oncogene activity,wnt/β-catenin pathway activation,epithelial-to-mesenchymal transition (emt),cell migration and proliferation,left-right patterning,tgf-β superfamily member
ENSG00000016864,GLT8D1,antioxidant defense,tumor suppressor,oxidative stress regulation,dna damage prevention,cell signaling modulation,cancer susceptibility marker
ENSG00000167941,SOST,wnt/beta-catenin pathway inhibition,cell proliferation regulation,bone metastasis,osteocyte expression,wnt signaling antagonist,metastatic progression
ENSG00000083817,ZNF416,transcriptional regulation,oncogenic activity,epithelial-to-mesenchymal transition,cell cycle progression,dna repair dysregulation,tumor aggressiveness
ENSG00000158525,CPA5,cytochrome p450 reductase activity,cellular redox regulation,genomic instability,prognostic marker,oxidative stress response,mitochondrial function
ENSG00000217555,CKLF,transcription factor activity,oncogenesis promotion,cell proliferation regulation,survival signaling pathway activation,epithelial cancer involvement,tumor progression facilitation
ENSG00000169239,CA5B,tumor aggressiveness,epithelial cell invasion,metastatic potential,tumor microenvironment modulation,cell migration facilitation,prognostic biomarker
ENSG00000198663,C6orf89,mitochondrial dynamics regulation,oncogenic mutations,energy metabolism reprogramming,tumor progression association,apoptosis modulation,cellular respiration regulation
ENSG00000171161,ZNF672,dna repair,transcription factor,cell proliferation,overexpression,tumor growth,gene regulation
ENSG00000214128,TMEM213,cellular integrity disruption,apoptosis resistance,metabolic reprogramming,tumor growth promotion,biomarker potential,signaling pathway regulation
ENSG00000167311,ART5,immune evasion,apoptosis inhibition,autophagy modulation,antimicrobial peptide regulation,cell survival enhancement,tumor microenvironment manipulation
ENSG00000183876,ARSI,overexpression in tumors,cell proliferation promotion,mirna regulation,biomarker potential,rna-binding protein activity,oncogenic protein upregulation
ENSG00000280568,ZNF780A,zinc finger protein,tumor progression,poor prognosis,gene expression regulation,cell growth and survival,pi3k/akt signaling pathway interaction
ENSG00000224290,APOM,lipid metabolism regulation,tumor suppressor function,cell proliferation modulation,apoptosis inhibition,genomic instability promotion,metabolic reprogramming
ENSG00000117010,ZNF684,blca driver gene,cell cycle progression,apoptosis dysregulation,dna binding activity,transcriptional regulation,oncogene overexpression
ENSG00000094963,FMO2,altered expression levels,redox-sensitive signaling pathway,detoxification mechanisms,carcinogen metabolism,proliferation and survival pathways,genetic variation impact
ENSG00000105767,CADM4,cell adhesion,epithelial-to-mesenchymal transition,tumor suppressor function,cell migration regulation,gene expression modulation,protein-protein interactions
ENSG00000186765,FSCN2,actin bundling,cell migration,chemo-resistance,epithelial-to-mesenchymal transition (emt),invasiveness,prognostic marker
ENSG00000118094,TREH,cellular homeostasis disruption,growth factor regulation,oncogenic signaling,cell migration enhancement,tumor progression facilitation,biomarker potential
ENSG00000078579,FGF20,fgf/fgfr interaction,pi3k/akt activation,cell proliferation,angiogenesis promotion,prognostic marker,genomic instability
ENSG00000254858,MPV17L2,cellular metabolism,mitochondrial dynamics,energy production regulation,cellular stress response,pink1/park2 pathway interaction,mitophagy-related cell death
ENSG00000256087,ZNF432,overexpression,tumor progression,cell proliferation,apoptosis inhibition,dna repair regulation,gene expression modulation
ENSG00000204922,UQCC3,mitochondrial function,electron transport chain,cellular metabolism,energy homeostasis,tumor progression,metabolic regulation
ENSG00000140873,ADAMTS18,overexpression,oncogenic function,tumor progression,metastasis regulation,biomarker potential,proteolytic activity
ENSG00000146360,GPR6,tumor progression,metastasis regulation,cell migration regulation,oncogenic driver,therapeutic target,g protein-coupled receptor signaling
ENSG00000173264,GPR137,gpcr signaling,cell communication,orphan receptor,tumorigenesis potential,cell survival pathways,regulation of cell growth
ENSG00000197110,IFNL3,immunomodulation,tumor microenvironment modulation,immunosuppression promotion,oncovariant association,innate immunity regulation,antiviral response activation
ENSG00000143552,NUP210L,oncogene activation,nucleocytoplasmic transport disruption,epithelial-to-mesenchymal transition (emt) promotion,cell proliferation enhancement,therapeutic resistance contribution,genomic amplification or overexpression
ENSG00000164088,PPM1M,tumor suppressor function,genetic instability,oncogenic transformation,pi3k/akt/mtor pathway modulation,cell cycle regulation,proliferation control
ENSG00000120057,SFRP5,wnt signaling inhibition,tumor suppressor function,cell proliferation regulation,differentiation modulation,genomic instability influence,cancer stem cell maintenance
ENSG00000118557,PMFBP1,tumor suppressor function,cell cycle regulation,transcriptional regulation,apoptosis modulation,genomic stability maintenance,pi3k/akt signaling pathway interaction
ENSG00000213088,ACKR1,chemokine system,transmembrane receptor,cellular signaling pathway,immune response modulation,cancer progression driver,tumor suppressor function disruption
ENSG00000100632,ERH,dna repair regulation,cell proliferation enhancement,transcriptional modulation,signaling pathway interaction,tumor progression promotion,genomic instability contribution
ENSG00000198573,SPANXC,cell cycle regulation,genomic instability,chromosomal interaction,cell proliferation,oncogenesis,therapeutic target
ENSG00000155254,MARVELD1,tumor aggressiveness,cellular adhesion disruption,epithelial barrier dysfunction,transmembrane protein function,cancer cell migration enhancement,genomic instability promotion
ENSG00000215695,RSC1A1,chromatin remodeling,dna repair,cell cycle regulation,transcriptional activation,genomic instability,tumor progression
ENSG00000174136,RGMB,adherens junction regulation,cell adhesion disruption,epithelial-to-mesenchymal transition,glycoprotein expression,metastasis promotion,tumor progression facilitation
ENSG00000131686,CA6,tumor growth promotion,proliferation facilitation,ph regulation alteration,tumor metastasis enhancement,angiogenesis modulation,immunomodulation
ENSG00000125999,BPIFB1,calcium signaling,cell membrane integrity,pi3k/akt pathway interaction,tumor progression driver,mutation-induced aberrant expression,therapeutic target for cancer
ENSG00000121270,ABCC11,aberrant expression,biomarker function,cell migration influence,ion and lipid transport,proliferation regulation,toxic compound efflux
ENSG00000198113,TOR4A,transcription initiation,genetic regulation,subunit assembly,protein interaction,tata-binding protein association,gene expression control
ENSG00000088726,TMEM40,er membrane localization,apoptosis resistance,cell proliferation promotion,tumor growth enhancement,oncogene interaction,calcium homeostasis regulation
ENSG00000134851,TMEM165,cellular trafficking,protein sorting,tumor aggressiveness,oncogene overexpression,signaling pathway modulation,cancer cell migration
ENSG00000108018,SORCS1,tumor suppressor function,cell proliferation regulation,apoptosis modulation,metastasis suppression,cancer prognosis biomarker,endocytosis signaling interaction
ENSG00000183128,CALHM3,calcium signaling,regulatory function,cell growth regulation,proliferation modulation,tumor mutations,therapeutic target
ENSG00000174332,GLIS1,dna repair,cellular growth regulation,transcriptional regulator,oncogenic driver,biomarker potential,tumor suppressor function
ENSG00000137449,CPEB2,oncogene upregulation,epithelial-to-mesenchymal transition,cell cycle progression,metastasis promotion,tumor aggressiveness,translational regulation
ENSG00000174885,NLRP6,nf-κb signaling pathway,apoptosis regulation,genomic instability,tumor suppressor function,epithelial-to-mesenchymal transition,pro-inflammatory cytokine expression
ENSG00000169469,SPRR1B,small proline-rich protein 1b,cell proliferation,tumor progression,oncogenesis,cell survival,protein interaction
ENSG00000181450,ZNF678,krab domain binding,transcriptional repression,zinc finger protein family,dna sequence recognition,epigenetic regulation,cell growth modulation
ENSG00000130035,GALNT8,galnac transferase activity,cell proliferation regulation,oncogene overexpression,epithelial-to-mesenchymal transition (emt),immune evasion mechanisms,tumor invasion promotion
ENSG00000180592,SKIDA1,tumor suppressor activity,loss of function mutations,tgf-β signaling disruption,cell proliferation regulation,apoptosis promotion,genetic instability
ENSG00000203785,SPRR2E,cell adhesion regulation,tumor progression,proliferation and migration,epithelial-to-mesenchymal transition modulation,signaling pathway regulation,anti-adhesive function
ENSG00000166143,PPP1R14D,enhanced cell proliferation,oncogene activation,inhibited apoptosis,overexpression correlation,pi3k/akt pathway interaction,chemotherapy resistance
ENSG00000105738,SIPA1L3,regulation of apoptosis,overexpression in cancer,pi3k/akt pathway regulation,cell cycle progression modulation,siah2 interaction,tumor growth promotion
ENSG00000134758,RNF138,oncogene overexpression,cell cycle regulation,apoptosis inhibition,tumor suppressor degradation,e3 ubiquitin ligase activity,dna repair modulation
ENSG00000175764,TTLL11,microtubule regulation,mitotic progression,cell proliferation,tumor aggressiveness,genomic instability,oncogenic driver
ENSG00000196169,KIF19,microtubule dynamics,oncogenic process,cell proliferation,genomic instability,aurora kinase b regulation,dna damage response pathway
ENSG00000018869,ZNF582,tumor suppressor function,regulation of gene expression,transcriptional activation,cell growth regulation,apoptosis modulation,dna binding domain
ENSG00000141946,ZIM3,cell proliferation,oncogene,cell survival,genomic instability,dna repair regulation,tumor progression
ENSG00000267041,ZNF850,transcriptional regulation,chromatin modification,nuclear protein function,c2h2-type zinc fingers,gene expression modulation,potential oncogenic role
ENSG00000204519,ZNF551,transcriptional regulation,gain of function mutations,pro-survival signals,tumor progression,cell proliferation,chromatin remodeling
ENSG00000281448,ZNF502,**

zinc finger protein regulation,transcriptional modulation,enhancer region binding,chromatin remodeling,histone modification,genomic instability 
**
ENSG00000181315,ZNF322,transcriptional regulation,chromatin remodeling,epigenetic regulation,zinc finger protein,dna binding,gene expression control
ENSG00000167637,ZNF283,transcriptional regulation,zinc finger motifs,oncogene activity,cell growth promotion,apoptosis inhibition,tumor suppressor interaction
ENSG00000136866,ZFP37,transcriptional regulation,dna binding,apoptosis regulation,cell growth modulation,chromatin modification,tumor progression
ENSG00000250571,GLI4,**
hedgehog signaling pathway,transcriptional activation,oncogenic processes,cell proliferation,tumorigenesis,gene regulation 
**
ENSG00000146839,ZAN,cellular proliferation,epigenetic regulation,transcriptional regulation,tumor progression,cell survival,protein-protein interactions
ENSG00000221880,KRTAP1-3,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),signal transduction pathway interaction,protein-protein interaction,cell migration enhancement,adhesive protein regulation
ENSG00000102181,CD99L2,cell cycle regulation,anti-apoptotic function,tumor progression,cancer metastasis,dysregulated expression,therapeutic target
ENSG00000117480,FAAH,inflammation modulation,cell proliferation,pain regulation,lipid metabolism,cancer prognosis,oncogenesis
ENSG00000215186,GOLGA6B,high expression levels,cell proliferation enhancement,genomic instability contribution,epithelial-to-mesenchymal transition regulation,constitutive activation role,cell cycle progression promotion
ENSG00000228049,POLR2J2,**
epigenetic regulation,transcriptional influence,pseudogene expression,molecular interactions,cancer progression markers,therapeutic targets 
**
ENSG00000206306,HLA-DRB1,tumor immune evasion,hla class ii complex,cell surface antigen presentation,cancer immunotherapy target,antigen recognition dysfunction,t-cell activation regulation
ENSG00000070388,FGF22,**
fgf22 expression,angiogenesis promotion,tumorigenesis association,poor prognosis marker,cancer stem cell maintenance,tumor progression enhancement
ENSG00000176239,OR51B6,aberrant expression,cellular behavior modulation,g-protein coupled receptor kinases,cell migration influence,potential oncogene role,non-canonical signaling pathway
ENSG00000112139,MDGA1,cell adhesion regulation,pi3k/akt pathway interaction,biomarker potential,metastasis promotion,epithelial-to-mesenchymal transition,protein-protein interactions
ENSG00000161610,HCRT,tumor progression,overexpression,cell proliferation,signal transduction,metastatic potential,therapeutic target
ENSG00000109390,NDUFC1,mitochondrial complex i dysfunction,tumor progression,energy metabolism deregulation,genomic instability,oncogenic mutations,therapeutic target
ENSG00000178235,SLITRK1,tumor suppressor function,cell migration regulation,protein-protein interaction,wnt/β-catenin signaling modulation,cancer prognosis biomarker,cell adhesion disruption
ENSG00000165379,LRFN5,cell adhesion regulation,signaling pathway activation,integrin interaction,cancer driver mutation,tumor progression facilitation,proliferation enhancement
ENSG00000157766,ACAN,tumor progression,promotes cell proliferation,wnt/β-catenin pathway activation,pi3k/akt signaling pathway interaction,cancer stem cell maintenance,dysregulated expression
ENSG00000112562,SMOC2,tumor progression,metastasis promotion,cell invasion enhancement,prognostic marker,therapeutic target,signaling pathway modulation
ENSG00000136488,CSH1,cell proliferation,immune evasion,oncogene overexpression,tumor growth,pi3k/akt signaling,apoptosis inhibition
ENSG00000179399,GPC5,wnt/β-catenin pathway inhibition,tumor suppressor activity,cell adhesion regulation,growth factor receptor signaling,apoptosis induction,epithelial-to-mesenchymal transition suppression
ENSG00000197054,ZNF763,transcriptional repression,tumor progression,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,genomic instability,chromatin remodeling
ENSG00000150275,PCDH15,epithelial-to-mesenchymal transition (emt),cell-cell adhesion disruption,cadherin family member,oncogene/tumor suppressor potential,tissue structure regulation,mechanoreception modulation
ENSG00000110427,KIAA1549L,oncogene regulation,cellular proliferation,tumor progression,dna repair mechanism,genomic instability,protein-protein interaction
ENSG00000213420,GPC2,gpc2 overexpression,aberrant cell signaling,poor prognosis marker,wnt/β-catenin pathway activation,tumor growth promotion,metastasis facilitation
ENSG00000112414,ADGRG6,cell adhesion regulation,tumor progression facilitation,protein-protein interaction,mapk/erk pathway activation,oncogenic signaling promotion,genomic amplification
ENSG00000276053,LAIR1,lair1 expression,tumor progression,immune evasion,cell surface receptor,leukocyte function modulation,immunosuppression
ENSG00000134256,CD101,cd101 expression,tumor aggressiveness,cell proliferation,migration capability,prognostic marker,immune regulation
ENSG00000182035,ADIG,tumor suppression,metabolic regulation,insulin sensitivity,anti-tumor effects,cell migration inhibition,proliferation inhibition
ENSG00000163273,NPPC,npr2 interaction,camp signaling pathway,tumor growth promotion,cell cycle progression,apoptosis inhibition,therapeutic target
ENSG00000196209,SIRPB2,cell adhesion regulation,tumor growth promotion,immune response modulation,cell signaling pathway regulation,oncogene involvement,metastasis promotion
ENSG00000154269,ENPP3,nucleotide regulation,cellular differentiation,enzyme activity,prognostic marker,phosphoinositide modulation,cell survival pathway
ENSG00000145850,TIMD4,galectin-9 interaction,immune evasion mechanism,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,downregulated expression
ENSG00000158292,GPR153,tumor progression,oncogenic properties,cell proliferation,signaling pathway modulation,apoptosis regulation,potential therapeutic target
ENSG00000140287,HDC,mitochondrial localization,cortisol metabolism,redox balance regulation,tumor progression promotion,cellular energy modulation,cancer cell survival enhancement
ENSG00000183117,CSMD1,cellular proliferation regulation,tumor suppression,apoptosis modulation,wnt signaling inhibition,protein-protein interaction,dysregulation associated with cancer progression
ENSG00000180828,BHLHE22,g1 phase regulation,transcriptional activation,cell cycle progression,oncogenic process,transcription factor function,protein-protein interaction
ENSG00000169618,PROKR1,angiogenesis promotion,constitutive activation,gain-of-function mutations,oncogenic signaling pathway,poor prognosis indicator,prognostic biomarker
